SJNB	SJN	BATCHNUMBER	moabox_id	inchi_key	smiles	cas_number	moa	gene_symbols[1]	gene_symbols[2]	gene_symbols[3]	gene_symbols[4]	gene_symbols[5]	gene_symbols[6]	gene_symbols[7]	gene_symbols[8]	gene_symbols[9]	gene_symbols[10]	gene_symbols[11]	gene_symbols[12]	gene_symbols[13]	gene_symbols[14]	gene_symbols[15]	gene_symbols[16]	gene_symbols[17]	gene_symbols[18]	gene_symbols[19]	gene_symbols[20]	gene_symbols[21]	gene_symbols[22]	gene_symbols[23]	gene_symbols[24]	gene_symbols[25]	gene_symbols[26]	gene_symbols[27]	gene_symbols[28]	gene_symbols[29]	gene_symbols[30]	gene_symbols[31]	gene_symbols[32]	gene_ids[2]	gene_ids[3]	gene_ids[4]	gene_ids[5]	gene_ids[6]	gene_ids[7]	gene_ids[8]	gene_ids[9]	gene_ids[10]	gene_ids[11]	gene_ids[12]	gene_ids[13]	gene_ids[14]	gene_ids[15]	gene_ids[16]	gene_ids[17]	gene_ids[18]	gene_ids[19]	gene_ids[20]	gene_ids[21]	gene_ids[22]	gene_ids[23]	gene_ids[24]	gene_ids[25]	gene_ids[26]	gene_ids[27]	gene_ids[28]	gene_ids[29]	gene_ids[30]	gene_ids[31]	gene_ids[32]	chembl_ids[1]	chembl_ids[2]	chembl_ids[3]	chembl_ids[4]	chembl_ids[5]	chembl_ids[6]	chembl_ids[7]	chembl_ids[8]	chembl_ids[9]	chembl_ids[10]	chembl_ids[11]	pubchem_ids[1]	pubchem_ids[2]	pubchem_ids[3]	pubchem_ids[4]	pubchem_ids[5]	member_status	dois[1]	dois[2]	dois[3]	dois[4]	dois[5]	dois[6]	dois[7]	dois[8]	dois[9]	dois[10]	dois[11]	dois[12]	dois[13]	dois[14]	dois[15]	dois[16]	dois[17]	dois[18]	dois[19]	dois[20]	dois[21]	dois[22]	dois[23]	dois[24]	dois[25]	dois[26]	dois[27]	dois[28]	dois[29]	dois[30]	dois[31]	dois[32]	dois[33]	dois[34]	dois[35]	dois[36]	dois[37]	dois[38]	dois[39]	dois[40]	dois[41]	dois[42]	dois[43]	dois[44]	dois[45]	dois[46]	dois[47]	dois[48]	dois[49]	dois[50]	dois[51]	dois[52]	dois[53]	dois[54]	dois[55]	dois[56]	dois[57]	dois[58]	dois[59]	dois[60]	dois[61]	dois[62]	dois[63]	dois[64]	dois[65]	dois[66]	dois[67]	dois[68]	dois[69]	dois[70]	dois[71]	dois[72]	dois[73]	dois[74]	dois[75]	dois[76]	dois[77]	dois[78]	dois[79]	dois[80]	dois[81]	dois[82]	dois[83]	dois[84]	dois[85]	dois[86]	dois[87]	dois[88]	dois[89]	dois[90]	dois[91]	dois[92]	dois[93]	dois[94]	dois[95]	dois[96]	dois[97]	dois[98]	dois[99]	dois[100]	dois[101]	dois[102]	dois[103]	dois[104]	dois[105]	dois[106]	dois[107]	dois[108]	dois[109]	dois[110]	dois[111]	dois[112]	dois[113]	dois[114]	dois[115]	dois[116]	dois[117]	dois[118]	dois[119]	dois[120]	dois[121]	dois[122]	dois[123]	dois[124]	dois[125]	dois[126]	dois[127]	dois[128]	dois[129]	dois[130]	dois[131]	dois[132]	dois[133]	dois[134]	dois[135]	dois[136]	dois[137]	dois[138]	dois[139]	dois[140]	dois[141]	dois[142]	dois[143]	dois[144]	dois[145]	dois[146]	dois[147]	dois[148]	dois[149]	dois[150]	dois[151]	dois[152]	dois[153]	dois[154]	dois[155]	dois[156]	dois[157]	dois[158]	dois[159]	pubmed_ids[1]	pubmed_ids[2]	pubmed_ids[3]	pubmed_ids[4]	pubmed_ids[5]	pubmed_ids[6]	pubmed_ids[7]	pubmed_ids[8]	pubmed_ids[9]	pubmed_ids[10]	pubmed_ids[11]	pubmed_ids[12]	pubmed_ids[13]	pubmed_ids[14]	pubmed_ids[15]	pubmed_ids[16]	pubmed_ids[17]	pubmed_ids[18]	pubmed_ids[19]	pubmed_ids[20]	pubmed_ids[21]	pubmed_ids[22]	pubmed_ids[23]	pubmed_ids[24]	pubmed_ids[25]	pubmed_ids[26]	pubmed_ids[27]	pubmed_ids[28]	pubmed_ids[29]	pubmed_ids[30]	pubmed_ids[31]	pubmed_ids[32]	pubmed_ids[33]	pubmed_ids[34]	pubmed_ids[35]	pubmed_ids[36]	pubmed_ids[37]	pubmed_ids[38]	pubmed_ids[39]	pubmed_ids[40]	pubmed_ids[41]	pubmed_ids[42]	pubmed_ids[43]	pubmed_ids[44]	pubmed_ids[45]	pubmed_ids[46]	pubmed_ids[47]	pubmed_ids[48]	pubmed_ids[49]	pubmed_ids[50]	pubmed_ids[51]	pubmed_ids[52]	pubmed_ids[53]	pubmed_ids[54]	pubmed_ids[55]	pubmed_ids[56]	pubmed_ids[57]	pubmed_ids[58]	pubmed_ids[59]	pubmed_ids[60]	pubmed_ids[61]	pubmed_ids[62]	pubmed_ids[63]	pubmed_ids[64]	pubmed_ids[65]	pubmed_ids[66]	pubmed_ids[67]	pubmed_ids[68]	pubmed_ids[69]	pubmed_ids[70]	pubmed_ids[71]	pubmed_ids[72]	pubmed_ids[73]	pubmed_ids[74]	pubmed_ids[75]	pubmed_ids[76]	pubmed_ids[77]	pubmed_ids[78]	pubmed_ids[79]	pubmed_ids[80]	pubmed_ids[81]	pubmed_ids[82]	pubmed_ids[83]	pubmed_ids[84]	pubmed_ids[85]	pubmed_ids[86]	pubmed_ids[87]	pubmed_ids[88]	pubmed_ids[89]	pubmed_ids[90]	pubmed_ids[91]	pubmed_ids[92]	pubmed_ids[93]	pubmed_ids[94]	pubmed_ids[95]	pubmed_ids[96]	pubmed_ids[97]	pubmed_ids[98]	pubmed_ids[99]	pubmed_ids[100]	pubmed_ids[101]	pubmed_ids[102]	pubmed_ids[103]	pubmed_ids[104]	pubmed_ids[105]	pubmed_ids[106]	pubmed_ids[107]	pubmed_ids[108]	pubmed_ids[109]	pubmed_ids[110]	pubmed_ids[111]	pubmed_ids[112]	pubmed_ids[113]	pubmed_ids[114]	pubmed_ids[115]	pubmed_ids[116]	pubmed_ids[117]	pubmed_ids[118]	pubmed_ids[119]	pubmed_ids[120]	pubmed_ids[121]	pubmed_ids[122]	pubmed_ids[123]	pubmed_ids[124]	pubmed_ids[125]	pubmed_ids[126]	pubmed_ids[127]	pubmed_ids[128]	pubmed_ids[129]	pubmed_ids[130]	pubmed_ids[131]	pubmed_ids[132]	pubmed_ids[133]	pubmed_ids[134]	pubmed_ids[135]	pubmed_ids[136]	pubmed_ids[137]	pubmed_ids[138]	pubmed_ids[139]	pubmed_ids[140]	pubmed_ids[141]	pubmed_ids[142]	pubmed_ids[143]	pubmed_ids[144]	pubmed_ids[145]	pubmed_ids[146]	pubmed_ids[147]	pubmed_ids[148]	pubmed_ids[149]	pubmed_ids[150]	pubmed_ids[151]	pubmed_ids[152]	pubmed_ids[153]	pubmed_ids[154]	pubmed_ids[155]	pubmed_ids[156]	pubmed_ids[157]	pubmed_ids[158]	pubmed_ids[159]	pubmed_ids[160]	pubmed_ids[161]	pubmed_ids[162]	pubmed_ids[163]	pubmed_ids[164]	pubmed_ids[165]	pubmed_ids[166]	pubmed_ids[167]	pubmed_ids[168]	pubmed_ids[169]	pubmed_ids[170]	pubmed_ids[171]	pubmed_ids[172]	pubmed_ids[173]	pubmed_ids[174]	pubmed_ids[175]	pubmed_ids[176]	pubmed_ids[177]	pubmed_ids[178]	pubmed_ids[179]	pubmed_ids[180]	pubmed_ids[181]	pubmed_ids[182]	pubmed_ids[183]	pubmed_ids[184]	pubmed_ids[185]	pubmed_ids[186]	pubmed_ids[187]	pubmed_ids[188]	pubmed_ids[189]	pubmed_ids[190]	pubmed_ids[191]	pubmed_ids[192]	pubmed_ids[193]	pubmed_ids[194]	pubmed_ids[195]	pubmed_ids[196]	pubmed_ids[197]	pubmed_ids[198]	pubmed_ids[199]	pubmed_ids[200]	pubmed_ids[201]	pubmed_ids[202]	pubmed_ids[203]	pubmed_ids[204]	pubmed_ids[205]	pubmed_ids[206]	pubmed_ids[207]	pubmed_ids[208]	pubmed_ids[209]	pubmed_ids[210]	pubmed_ids[211]	pubmed_ids[212]	pubmed_ids[213]	pubmed_ids[214]	pubmed_ids[215]	pubmed_ids[216]	pubmed_ids[217]	pubmed_ids[218]	pubmed_ids[219]	pubmed_ids[220]	pubmed_ids[221]	pubmed_ids[222]	pubmed_ids[223]	pubmed_ids[224]	pubmed_ids[225]	pubmed_ids[226]	pubmed_ids[227]	pubmed_ids[228]	pubmed_ids[229]	pubmed_ids[230]	pubmed_ids[231]	pubmed_ids[232]	pubmed_ids[233]	pubmed_ids[234]	pubmed_ids[235]	pubmed_ids[236]	pubmed_ids[237]	pubmed_ids[238]	pubmed_ids[239]	pubmed_ids[240]	pubmed_ids[241]	pubmed_ids[242]	pubmed_ids[243]	pubmed_ids[244]	pubmed_ids[245]	pubmed_ids[246]	pubmed_ids[247]	pubmed_ids[248]	pubmed_ids[249]	pubmed_ids[250]	pubmed_ids[251]	pubmed_ids[252]	pubmed_ids[253]	pubmed_ids[254]	pubmed_ids[255]	pubmed_ids[256]	pubmed_ids[257]	pubmed_ids[258]	pubmed_ids[259]	pubmed_ids[260]	pubmed_ids[261]	pubmed_ids[262]	pubmed_ids[263]	pubmed_ids[264]	pubmed_ids[265]	pubmed_ids[266]	pubmed_ids[267]	pubmed_ids[268]	pubmed_ids[269]	pubmed_ids[270]	pubmed_ids[271]	pubmed_ids[272]	pubmed_ids[273]	pubmed_ids[274]	pubmed_ids[275]	pubmed_ids[276]	pubmed_ids[277]	pubmed_ids[278]	pubmed_ids[279]	pubmed_ids[280]	pubmed_ids[281]	pubmed_ids[282]	pubmed_ids[283]	pubmed_ids[284]	pubmed_ids[285]	pubmed_ids[286]	pubmed_ids[287]	pubmed_ids[288]	pubmed_ids[289]	pubmed_ids[290]	pubmed_ids[291]	pubmed_ids[292]	pubmed_ids[293]	pubmed_ids[294]	pubmed_ids[295]	pubmed_ids[296]	pubmed_ids[297]	pubmed_ids[298]	pubmed_ids[299]	pubmed_ids[300]	pubmed_ids[301]	pubmed_ids[302]	pubmed_ids[303]	pubmed_ids[304]	pubmed_ids[305]	pubmed_ids[306]	pubmed_ids[307]	pubmed_ids[308]	pubmed_ids[309]	pubmed_ids[310]	pubmed_ids[311]	pubmed_ids[312]	pubmed_ids[313]	pubmed_ids[314]	pubmed_ids[315]	pubmed_ids[316]	pubmed_ids[317]	pubmed_ids[318]	pubmed_ids[319]	pubmed_ids[320]	pubmed_ids[321]	pubmed_ids[322]	pubmed_ids[323]	pubmed_ids[324]	pubmed_ids[325]	pubmed_ids[326]	pubmed_ids[327]	pubmed_ids[328]	pubmed_ids[329]	pubmed_ids[330]	pubmed_ids[331]	pubmed_ids[332]	pubmed_ids[333]	pubmed_ids[334]	pubmed_ids[335]	pubmed_ids[336]	pubmed_ids[337]	pubmed_ids[338]	pubmed_ids[339]	pubmed_ids[340]	pubmed_ids[341]	pubmed_ids[342]	pubmed_ids[343]	pubmed_ids[344]	pubmed_ids[345]	pubmed_ids[346]	pubmed_ids[347]	pubmed_ids[348]	pubmed_ids[349]	pubmed_ids[350]	pubmed_ids[351]	pubmed_ids[352]	pubmed_ids[353]	pubmed_ids[354]	pubmed_ids[355]	pubmed_ids[356]	pubmed_ids[357]	pubmed_ids[358]	pubmed_ids[359]	pubmed_ids[360]	pubmed_ids[361]	pubmed_ids[362]	pubmed_ids[363]	pubmed_ids[364]	pubmed_ids[365]	pubmed_ids[366]	pubmed_ids[367]	pubmed_ids[368]	pubmed_ids[369]	pubmed_ids[370]	pubmed_ids[371]	pubmed_ids[372]	pubmed_ids[373]	pubmed_ids[374]	pubmed_ids[375]	pubmed_ids[376]	pubmed_ids[377]	pubmed_ids[378]	pubmed_ids[379]	pubmed_ids[380]	pubmed_ids[381]	pubmed_ids[382]	pubmed_ids[383]	pubmed_ids[384]	pubmed_ids[385]	pubmed_ids[386]	pubmed_ids[387]	pubmed_ids[388]	pubmed_ids[389]	pubmed_ids[390]	pubmed_ids[391]	pubmed_ids[392]	pubmed_ids[393]	pubmed_ids[394]	pubmed_ids[395]	pubmed_ids[396]	pubmed_ids[397]	pubmed_ids[398]	pubmed_ids[399]	pubmed_ids[400]	pubmed_ids[401]	pubmed_ids[402]	pubmed_ids[403]	pubmed_ids[404]	pubmed_ids[405]	pubmed_ids[406]	pubmed_ids[407]	pubmed_ids[408]	pubmed_ids[409]	pubmed_ids[410]	pubmed_ids[411]	pubmed_ids[412]	pubmed_ids[413]	pubmed_ids[414]	pubmed_ids[415]	pubmed_ids[416]	pubmed_ids[417]	pubmed_ids[418]	pubmed_ids[419]	pubmed_ids[420]	pubmed_ids[421]	pubmed_ids[422]	pubmed_ids[423]	pubmed_ids[424]	pubmed_ids[425]	pubmed_ids[426]	pubmed_ids[427]	pubmed_ids[428]	pubmed_ids[429]	pubmed_ids[430]	pubmed_ids[431]	pubmed_ids[432]	pubmed_ids[433]	pubmed_ids[434]	pubmed_ids[435]	pubmed_ids[436]	pubmed_ids[437]	pubmed_ids[438]	pubmed_ids[439]	pubmed_ids[440]	pubmed_ids[441]	pubmed_ids[442]	pubmed_ids[443]	pubmed_ids[444]	pubmed_ids[445]	pubmed_ids[446]	pubmed_ids[447]	pubmed_ids[448]	pubmed_ids[449]	pubmed_ids[450]	pubmed_ids[451]	pubmed_ids[452]	pubmed_ids[453]	pubmed_ids[454]	pubmed_ids[455]	pubmed_ids[456]	pubmed_ids[457]	pubmed_ids[458]	pubmed_ids[459]	pubmed_ids[460]	pubmed_ids[461]	pubmed_ids[462]	pubmed_ids[463]	pubmed_ids[464]	pubmed_ids[465]	pubmed_ids[466]	pubmed_ids[467]	pubmed_ids[468]	pubmed_ids[469]	pubmed_ids[470]	pubmed_ids[471]	pubmed_ids[472]	pubmed_ids[473]	pubmed_ids[474]	pubmed_ids[475]	pubmed_ids[476]	pubmed_ids[477]	pubmed_ids[478]	pubmed_ids[479]	pubmed_ids[480]	pubmed_ids[481]	pubmed_ids[482]	pubmed_ids[483]	pubmed_ids[484]	pubmed_ids[485]	pubmed_ids[486]	pubmed_ids[487]	pubmed_ids[488]	pubmed_ids[489]	pubmed_ids[490]	pubmed_ids[491]	pubmed_ids[492]	pubmed_ids[493]	pubmed_ids[494]	pubmed_ids[495]	pubmed_ids[496]	pubmed_ids[497]	pubmed_ids[498]	pubmed_ids[499]	pubmed_ids[500]	pubmed_ids[501]	pubmed_ids[502]	pubmed_ids[503]	pubmed_ids[504]	pubmed_ids[505]	pubmed_ids[506]	pubmed_ids[507]	pubmed_ids[508]	pubmed_ids[509]	pubmed_ids[510]	pubmed_ids[511]	pubmed_ids[512]	pubmed_ids[513]	pubmed_ids[514]	pubmed_ids[515]	pubmed_ids[516]	pubmed_ids[517]	pubmed_ids[518]	pubmed_ids[519]	pubmed_ids[520]	pubmed_ids[521]	pubmed_ids[522]	pubmed_ids[523]	pubmed_ids[524]	pubmed_ids[525]	pubmed_ids[526]	pubmed_ids[527]	pubmed_ids[528]	pubmed_ids[529]	pubmed_ids[530]	pubmed_ids[531]	pubmed_ids[532]	pubmed_ids[533]	pubmed_ids[534]	pubmed_ids[535]	pubmed_ids[536]	pubmed_ids[537]	pubmed_ids[538]	pubmed_ids[539]	pubmed_ids[540]	pubmed_ids[541]	pubmed_ids[542]	pubmed_ids[543]	pubmed_ids[544]	pubmed_ids[545]	pubmed_ids[546]	pubmed_ids[547]	pubmed_ids[548]	pubmed_ids[549]	target_scores[1]	target_scores[2]	target_scores[3]	target_scores[4]	target_scores[5]	target_scores[6]	target_scores[7]	target_scores[8]	target_scores[9]	target_scores[10]	target_scores[11]	target_scores[12]	target_scores[13]	target_scores[14]	target_scores[15]	target_scores[16]	target_scores[17]	target_scores[18]	target_scores[19]	target_scores[20]	target_scores[21]	target_scores[22]	target_scores[23]	target_scores[24]	target_scores[25]	target_scores[26]	target_scores[27]	target_scores[28]	target_scores[29]	target_scores[30]	target_scores[31]	target_scores[32]	selectivities[1]	selectivities[2]	selectivities[3]	selectivities[4]	selectivities[5]	selectivities[6]	selectivities[7]	selectivities[8]	selectivities[9]	selectivities[10]	selectivities[11]	selectivities[12]	selectivities[13]	selectivities[14]	selectivities[15]	selectivities[16]	selectivities[17]	selectivities[18]	selectivities[19]	selectivities[20]	selectivities[21]	selectivities[22]	selectivities[23]	selectivities[24]	selectivities[25]	selectivities[26]	selectivities[27]	selectivities[28]	selectivities[29]	selectivities[30]	selectivities[31]	selectivities[32]	active_strengths[1]	active_strengths[2]	active_strengths[3]	active_strengths[4]	active_strengths[5]	active_strengths[6]	active_strengths[7]	active_strengths[8]	active_strengths[9]	active_strengths[10]	active_strengths[11]	active_strengths[12]	active_strengths[13]	active_strengths[14]	active_strengths[15]	active_strengths[16]	active_strengths[17]	active_strengths[18]	active_strengths[19]	active_strengths[20]	active_strengths[21]	active_strengths[22]	active_strengths[23]	active_strengths[24]	active_strengths[25]	active_strengths[26]	active_strengths[27]	active_strengths[28]	active_strengths[29]	active_strengths[30]	active_strengths[31]	active_strengths[32]	UNIQUEID	VENDORNAME	BATCHCOMMENT	MOLSMILES	CAS	LOT	BATCHPROJECT	SALT_NAME	SALT_EQUIVALENTS	SOLVATE_NAME	SOLVATE_EQUIVALENTS	BATCH_INTERNAL_ID	MolecularWeight	SynonymPrimary	Synonym	MCE_Pathway	MCE_Research_Area	MOABOX_ID	Primary_Target	MOA
SJ000285373-25	SJ000285373	25	MOABOX:4	RKUNBYITZUJHSG-UHFFFAOYSA-N	CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2	101-31-5	Muscarinic receptor antagonist	CHRM1	CHRM2	CHRM3	CHRM4	CHRM5																												1129	1131	1132	1133																												CHEMBL1396281	CHEMBL1607275	CHEMBL9751									3661	5927	17184	20733	36634	member	10.1002/(SICI)1098-2299(199701)40:1<1::AID-DDR1>3.0.CO;2-Q	10.1002/ddr.430240105																																																																																																																																																														2016720	3494849	8057277	8496700	11831911	12467616	12678783	16970392	17256466	20345348	21075638	21139051	22329602	23181587	23523385	25650309	28388054																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.70512	0.3038	0.18832	0.44786	0.35448																												0.08814	0.0434	0.02354	0.06398	0.05064																												8	7	8	7	7																												HY-N0471	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:4|CHRM1|Muscarinic receptor antagonist	CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)[C@H](CO)c3ccccc3	101-31-5	13318	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468913	289.36942	ATROPINE	ATROPINE | (L)-HYOSCYAMINE | ATROPINE SULFATE MONOHYDRATE | ATROPINE SULFATE | ATROPINE | (L)-HYOSCYAMINE | ATROPINE SULFATE MONOHYDRATE | ATROPINE SULFATE	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:4	CHRM1	Muscarinic receptor antagonist
SJ000285902-10	SJ000285902	10	MOABOX:8	PJDFLNIOAUIZSL-UHFFFAOYSA-N	C=CC(N)CCC(=O)O	1391054-02-6	GABA Aminotransferase Inhibitors	ABAT																																																															CHEMBL89598											5665	24802583	25202592	46178261	71666447	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-9.6e-003																																-0.0012																																8																																HY-B0033	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:8|ABAT|GABA Aminotransferase Inhibitors	NC(CCC(=O)O)C=C	1391054-02-6	50212	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469252	129.15704	VIGABATRIN	"VIGABATRIN | (±)-GAMMA-VINYL GABA | ""VIGABATRIN | CPP-109 | GVG | M071754 | MDL-71754 | RMI-71754 |"" | VIGABATRIN | (±)-GAMMA-VINYL GABA | ""VIGABATRIN | CPP-109 | GVG | M071754 | MDL-71754 | RMI-71754 |"""	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:8	ABAT	GABA Aminotransferase Inhibitors
SJ000870449-3	SJ000870449	3	MOABOX:12	IBLNKMRFIPWSOY-FNORWQNLSA-N	CC(C)(C)C(O)/C=C/c1ccc2c(c1)OCO2	1185239-64-8	GABA Reuptake Inhibitors;GABA Aminotransferase Inhibitors	ABAT																																																															CHEMBL1983350											5311454	144865856				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																BS-16863	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)(C)C(O)\C=C\c1ccc2OCOc2c1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466839	234.29092	BCX-2600 | ME-2080 | STIRIPENTOL	"""BCX-2600 | ME-2080 | STIRIPENTOL"" | ""BCX-2600 | ME-2080 | STIRIPENTOL"""			MOABOX:12	ABAT	GABA Reuptake Inhibitors;GABA Aminotransferase Inhibitors
SJ001035009-1	SJ001035009	1	MOABOX:14	DTQNEFOKTXXQKV-HKUYNNGSSA-N	COc1ccccc1CN[C@H]1CCCN[C@H]1c1ccccc1	136870-97-8	Tachykinin NK1 Antagonists	CYP2D6																																																															CHEMBL441225											5311057	9894745	68466923	70162973	88453223	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.71968																																-0.08996																																8																																27669	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-800|MOABOX:14|CYP2D6|Tachykinin NK1 Antagonists	COc1ccccc1CN[C@H]2CCCN[C@H]2c3ccccc3	145148-39-6	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468463	296.40666	"CP 99,994 HCL"	"CP 99,994 HCL | CP 99,994 HCL"			MOABOX:14	CYP2D6	Tachykinin NK1 Antagonists
SJ000287188-11	SJ000287188	11	MOABOX:16	ZJJXGWJIGJFDTL-UHFFFAOYSA-N	Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1	172964-66-8	K(ATP) Channel Blockers	KCNJ11	ABCC8	ABCC9																														6833	10060																														CHEMBL1073											3478	9810676	9832272	9872935	9939064	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0.32662																														0.0	0.0	0.04666																														7	7	7																														KS-1068	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Cc1cnc(cn1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466704	445.53518	GLIPIZIDE	GLIPIZIDE | GLIPIZIDE			MOABOX:16	KCNJ11	K(ATP) Channel Blockers
SJ000785937-2	SJ000785937	2	MOABOX:20	FRPJGTNLZNXQEX-UHFFFAOYSA-N	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1	587870-77-7	Dopamine D4 Agonists	DRD4																																																															CHEMBL1600943	CHEMBL440687										5025739	10456082	16759165	22221499	69199029	member	10.1021/jm0305669																																																																																																																																																															15084133	15087502	15239663	16613551	17073641	17149874																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																2.27128																																0.28391																																8																																HY-103409	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:20|DRD4|Dopamine D4 Agonists	C(N1CCN(CC1)c2ccccn2)c3nc4ccccc4[nH]3	587870-77-7	79024	GENERAL	CHLORIDE	3	NO_SOLVATE	0	1469454	293.36626	ABT 724 TRIHYDROCHLORIDE |	ABT 724 TRIHYDROCHLORIDE | | ABT 724 TRIHYDROCHLORIDE |	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:20	DRD4	Dopamine D4 Agonists
SJ001034948-1	SJ001034948	1	MOABOX:28	HKPHVFFQXHMOHX-UHFFFAOYSA-N	N=C(N)Nc1ccccc1Cl	24067-11-6	5-HT3 receptor agonist	HTR3B	HTR3C	HTR3D	HTR3E																													170572	200909	285242																													CHEMBL41853											12253678	44135793	53408663	91417286		virtual																																																																																																																																																																8831767	11412989																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.6128	0.6128	0.6128	0.6128																													0.0766	0.0766	0.0766	0.0766																													8	8	8	8																													BD00799395	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-140-994|MOABOX:28|HTR3B|5-HT3 receptor agonist	NC(=N)Nc1ccccc1Cl	24067-11-6	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468341	169.61152	BD00799395	BD00799395 | BD00799395			MOABOX:28	HTR3B	5-HT3 receptor agonist
SJ001010980-2	SJ001010980	2	MOABOX:30	NQQBNZBOOHHVQP-UHFFFAOYSA-N	Nc1nnc(Sc2ncc([N+](=O)[O-])s2)s1	40045-50-9	SAPK1c (JNK1) Inhibitors	MAPK8																																																															CHEMBL510038											11837140					member																																																																																																																																																																19271755	23208773																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.53088																																0.06636																																8																																HY-107597	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: MAPK/ERK Pathway | Research Area: Metabolic Disease; Inflammation/Immunology|MOABOX:30|MAPK8|SAPK1c (JNK1) Inhibitors	Nc1nnc(Sc2ncc(s2)[N+](=O)[O-])s1	40045-50-9	63212	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469508	261.30462	SU3327	SU3327 | SU3327	Pathway: MAPK/ERK Pathway	Research Area: Metabolic Disease; Inflammation/Immunology	MOABOX:30	MAPK8	SAPK1c (JNK1) Inhibitors
SJ001034673-1	SJ001034673	1	MOABOX:32	YPRWYZSUBZXORL-UHFFFAOYSA-N	O=[N+]([O-])c1ccc2c(c1)CNCC2	1198285-38-9	phenylethanolamine N-methyltransferase inhibitor	PNMT																																																															CHEMBL281289											6424833	13521670	69459646	141965540	142921755	member																																																																																																																																																																15670935	16686536	17126018	17845018																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.6736																																0.2092																																8																																DS-14339	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	[O-][N+](=O)c1ccc2CCNCc2c1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466843	178.1879	DS-14339	DS-14339 | DS-14339			MOABOX:32	PNMT	phenylethanolamine N-methyltransferase inhibitor
SJ001035057-1	SJ001035057	1	MOABOX:40	IUNFWMWQNWQIFS-UHFFFAOYSA-N	N=C(N)Nc1ccc(C(F)(F)F)cc1	130066-24-9	5-HT3 receptor agonist	HTR3B	HTR3C	HTR3D	HTR3E																													170572	200909	285242																													CHEMBL43961											19841587	68418800	68452688	70547249		virtual																																																																																																																																																																11412989	13129581																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.6404	0.6404	0.6404	0.6404																													0.08005	0.08005	0.08005	0.08005																													8	8	8	8																													EN300-6487359	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-509-826|MOABOX:40|HTR3B|5-HT3 receptor agonist	NC(=N)Nc1ccc(cc1)C(F)(F)F	1225613-82-0	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468562	203.16443	EN300-6487359	EN300-6487359 | EN300-6487359			MOABOX:40	HTR3B	5-HT3 receptor agonist
SJ000870588-3	SJ000870588	3	MOABOX:46	KYWWJENKIMRJBI-UHFFFAOYSA-N	Fc1ccc(-c2c3cccc(C(F)(F)F)c3nn2Cc2ccc(F)cc2Cl)cc1	875787-07-8	Liver X Receptor (LXR) Agonists;ABCA1 Expression Enhancers	ABCA1	NR1H2																															7376																															CHEMBL456237											16734800					member	10.1016/j.bmcl.2009.11.062	10.1021/jm800799q																																																																																																																																																														18973288	19318684	19962892	26990539	28169169	31202993																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																-0.37814	2.24216																															-0.05402	0.28027																															7	8																															HY-10629	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease; Cancer|MOABOX:46|ABCA1|Liver X Receptor (LXR) Agonists;ABCA1 Expression Enhancers	Fc1ccc(cc1)c2c3cccc(c3nn2Cc4ccc(F)cc4Cl)C(F)(F)F	875787-07-8	12871	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469411	422.7784	WAY-252623	WAY-252623 | LXR-623 | WAY-252623 | LXR-623	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease; Cancer	MOABOX:46	ABCA1	Liver X Receptor (LXR) Agonists;ABCA1 Expression Enhancers
SJ000546512-4	SJ000546512	4	MOABOX:48	NAXSRXHZFIBFMI-UHFFFAOYSA-N	O=C(O)Cc1cccc(OCCCN(Cc2cccc(C(F)(F)F)c2Cl)CC(c2ccccc2)c2ccccc2)c1	405911-09-3	Liver X Receptor (LXR) Agonists;ABCA1 Expression Enhancers	NR1H2	NR1H3																															10062																															CHEMBL4060455	CHEMBL59030										447905	9854655	11297713	16078973	71297144	member	10.1016/j.bmcl.2007.03.076	10.1016/j.bmcl.2007.06.017	10.1016/j.bmcl.2009.01.004	10.1016/j.bmcl.2009.02.039	10.1016/j.bmcl.2009.08.036	10.1016/j.bmcl.2015.07.047	10.1021/jm0255116	10.1021/jm050532w	10.1021/jm0609566	10.1021/jm070453f	10.1021/jm800612u	10.1021/jm800799q	10.2174/156802608784535075																																																																																																																																																			11985463	16101409	16107141	17034119	17416521	17587573	17665897	18220775	18537688	18800767	18855890	18973288	19167885	19264481	19717304	20345102	24832115	25677664	25998501	26238323	26990539	31202993																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																2.98912	0.57432																															0.37364	0.07179																															8	8																															HY-10627A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease; Cancer|MOABOX:48|NR1H2|Liver X Receptor (LXR) Agonists;ABCA1 Expression Enhancers	OC(=O)Cc1cccc(OCCCN(CC(c2ccccc2)c3ccccc3)Cc4cccc(c4Cl)C(F)(F)F)c1	405911-17-3	31561	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468798	582.05235	GW 3965 HYDROCHLORIDE	GW 3965 HYDROCHLORIDE | GW3965 HCL | GW 3965 HYDROCHLORIDE | GW3965 HCL	Pathway: Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease; Cancer	MOABOX:48	NR1H2	Liver X Receptor (LXR) Agonists;ABCA1 Expression Enhancers
SJ000285337-42	SJ000285337	42	MOABOX:54	SHGAZHPCJJPHSC-ZVCIMWCZSA-N	CC1=C(/C=C/C(C)=C\C=C\C(C)=C\C(=O)O)C(C)(C)CCC1	124510-04-9	ABCA1 Expression Enhancers;Retinoid RAR Agonists;Retinoid RXR Agonists	ABCA1	RARA	RXRA																														5914	6256																														CHEMBL705											449171	87672395	87816674	131699163	136375917	virtual	10.1002/cmdc.200800447	10.1016/0304-4165(95)00179-4	10.1016/0960-894X(95)00455-3	10.1016/S0960-894X(00)00243-2	10.1016/S0960-894X(02)00924-1	10.1016/j.bmcl.2005.12.003	10.1021/acs.jmedchem.5b00829	10.1021/jm00029a013	10.1021/jm5004792	10.1021/jm960386h	10.1021/jm980058c	10.1074/jbc.270.51.30765	10.1124/mol.104.008409																																																																																																																																																			7636843	7650690	8308867	8410972	8709094	8765503	8784454	8809153	9435893	10098670	10585206	10637371	10890152	11428923	12182871	12482435	15134501	15317450	16190748	16364638	18690216	19216008	22242853	24359708	24801499	25305688	26331194	28735214																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										0	5.168e-002	0.98344																														0.0	0.00646	0.12293																														7	8	8																														AG00I5O2	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-883-857|MOABOX:54|ABCA1|ABCA1 Expression Enhancers;Retinoid RAR Agonists;Retinoid RXR Agonists	C\C(=C/C=C/C(=C/C(=O)O)/C)\C=C\C1=C(C)CCCC1(C)C	302-79-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468564	300.43512	TRETINON	"TRETINON | ISOTRETINON | RETINOIC ACID | ISOTRETINOIN | 13-CIS-RETINOIC ACID | ACCUTANE | TRETINOIN | 9-CIS RETINOIC ACID | RETINOIC ACID, ALL-TRANS | RETINOIC ACID, 9-CIS | RETINOIC ACID, ALL TRANS | ""13-CIS-RETINOIC ACID | ISOTRETINOIN |"" | ""9-CIS-RETINOIC ACID | ALITRETINOIN |"" | 13-CIS RETINOIC ACID | TRETINON | ISOTRETINON | RETINOIC ACID | ISOTRETINOIN | 13-CIS-RETINOIC ACID | ACCUTANE | TRETINOIN | 9-CIS RETINOIC ACID | RETINOIC ACID, ALL-TRANS | RETINOIC ACID, 9-CIS | RETINOIC ACID, ALL TRANS | ""13-CIS-RETINOIC ACID | ISOTRETINOIN |"" | ""9-CIS-RETINOIC ACID | ALITRETINOIN |"" | 13-CIS RETINOIC ACID"			MOABOX:54	ABCA1	ABCA1 Expression Enhancers;Retinoid RAR Agonists;Retinoid RXR Agonists
SJ000285337-41	SJ000285337	41	MOABOX:54	SHGAZHPCJJPHSC-ZVCIMWCZSA-N	CC1=C(/C=C/C(C)=C\C=C\C(C)=C\C(=O)O)C(C)(C)CCC1	124510-04-9	ABCA1 Expression Enhancers;Retinoid RAR Agonists;Retinoid RXR Agonists	ABCA1	RARA	RXRA																														5914	6256																														CHEMBL705											449171	87672395	87816674	131699163	136375917	virtual	10.1002/cmdc.200800447	10.1016/0304-4165(95)00179-4	10.1016/0960-894X(95)00455-3	10.1016/S0960-894X(00)00243-2	10.1016/S0960-894X(02)00924-1	10.1016/j.bmcl.2005.12.003	10.1021/acs.jmedchem.5b00829	10.1021/jm00029a013	10.1021/jm5004792	10.1021/jm960386h	10.1021/jm980058c	10.1074/jbc.270.51.30765	10.1124/mol.104.008409																																																																																																																																																			7636843	7650690	8308867	8410972	8709094	8765503	8784454	8809153	9435893	10098670	10585206	10637371	10890152	11428923	12182871	12482435	15134501	15317450	16190748	16364638	18690216	19216008	22242853	24359708	24801499	25305688	26331194	28735214																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										0	5.168e-002	0.98344																														0.0	0.00646	0.12293																														7	8	8																														DS-3367	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	C\C(=C\C(=O)O)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466841	300.43512	TRETINON	"TRETINON | ISOTRETINON | RETINOIC ACID | ISOTRETINOIN | 13-CIS-RETINOIC ACID | ACCUTANE | TRETINOIN | 9-CIS RETINOIC ACID | RETINOIC ACID, ALL-TRANS | RETINOIC ACID, 9-CIS | RETINOIC ACID, ALL TRANS | ""13-CIS-RETINOIC ACID | ISOTRETINOIN |"" | ""9-CIS-RETINOIC ACID | ALITRETINOIN |"" | 13-CIS RETINOIC ACID | TRETINON | ISOTRETINON | RETINOIC ACID | ISOTRETINOIN | 13-CIS-RETINOIC ACID | ACCUTANE | TRETINOIN | 9-CIS RETINOIC ACID | RETINOIC ACID, ALL-TRANS | RETINOIC ACID, 9-CIS | RETINOIC ACID, ALL TRANS | ""13-CIS-RETINOIC ACID | ISOTRETINOIN |"" | ""9-CIS-RETINOIC ACID | ALITRETINOIN |"" | 13-CIS RETINOIC ACID"			MOABOX:54	ABCA1	ABCA1 Expression Enhancers;Retinoid RAR Agonists;Retinoid RXR Agonists
SJ000855396-5	SJ000855396	5	MOABOX:56	JQSAYKKFZOSZGJ-UHFFFAOYSA-N	COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC	101477-54-7	P-Glycoprotein (MDR-1) Inhibitors;Calcium Channel Blockers	CACNA1A	ABCB1																															5243																															CHEMBL1404407	CHEMBL2356978	CHEMBL29188									3949	122125	11542436	13579832	20204604	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.3437	0																															0.0491	0.0																															7	7																															HY-B0768A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:56|CACNA1A|P-Glycoprotein (MDR-1) Inhibitors;Calcium Channel Blockers	COc1ccc(CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4)c(OC)c1OC	101477-54-7	29691	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469646	468.53551	LOMERIZINE HCL	LOMERIZINE HCL | LOMERIZINE HCL	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:56	CACNA1A	P-Glycoprotein (MDR-1) Inhibitors;Calcium Channel Blockers
SJ000285546-9	SJ000285546	9	MOABOX:62	DBABZHXKTCFAPX-UHFFFAOYSA-N	CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1	57-66-9	MRP-1 Inhibitors;TRPV2 (Vanilloid VR2 Receptor) Agonists	ABCC1	SLC22A6	TRPV2																														9356	51393																														CHEMBL897											4911	451584	17841439	17937797	23619924	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.31738	0.92764	0																														-0.04534	0.13252	0.0																														7	7	7																														HY-B0545	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Metabolic Disease|MOABOX:62|ABCC1|MRP-1 Inhibitors;TRPV2 (Vanilloid VR2 Receptor) Agonists	CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)O	57-66-9	14181	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469779	285.35926	PROBENECID	PROBENECID | PROBENECID	Pathway: Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Metabolic Disease	MOABOX:62	ABCC1	MRP-1 Inhibitors;TRPV2 (Vanilloid VR2 Receptor) Agonists
SJ000286901-14	SJ000286901	14	MOABOX:64	MLKXDPUZXIRXEP-MFOYZWKCSA-N	CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1	32004-68-5	ABCC1 Expression Enhancers;ABCC3 Expression Enhancers;Non-Steroidal Antiinflammatory Drugs;NF-kappaB (NFKB) Activation Inhibitors	PTGS2	TTR	ABCC3																														7276	8714																														CHEMBL15770											1548887	9807260	9828090	9875262	11512976	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.13566	0	-0.27517																														0.01938	0.0	-0.03931																														7	7	7																														KS-5153	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC1=C(CC(=O)O)c2cc(F)ccc2/C/1=C\c3ccc(cc3)S(=O)C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466698	356.41058	SULINDAC	"SULINDAC | SULINDAC| CLINORIL | ""SULINDAC | MK-231 |"" | SULINDAC | SULINDAC| CLINORIL | ""SULINDAC | MK-231 |"""			MOABOX:64	PTGS2	ABCC1 Expression Enhancers;ABCC3 Expression Enhancers;Non-Steroidal Antiinflammatory Drugs;NF-kappaB (NFKB) Activation Inhibitors
SJ000287194-5	SJ000287194	5	MOABOX:66	SUBDBMMJDZJVOS-UHFFFAOYSA-N	COc1ccc2nc([S+]([O-])Cc3ncc(C)c(OC)c3C)[nH]c2c1	119141-89-8	ABCC3 Expression Enhancers;H+/K+-ATPase Inhibitors	ATP4A	ATP4B	ABCC3																														496	8714																														CHEMBL1503											4594	3027339	3047802	9849424	9894406	virtual																																																																																																																																																																1313110	2842503	9022797																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.7748	0.67319	-0.29981																														0.09685	0.09617	-0.04283																														8	7	7																														HS-0055	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1ccc2[nH]c(nc2c1)S(=O)Cc3ncc(C)c(OC)c3C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466673	345.41606	OMEPRAZOLE	OMEPRAZOLE | ESOMEPRAZOLE SODIUM | ESOMEPRAZOLE | OMEPRAZOLE | ESOMEPRAZOLE SODIUM | ESOMEPRAZOLE			MOABOX:66	ATP4A	ABCC3 Expression Enhancers;H+/K+-ATPase Inhibitors
SJ001035297-1	SJ001035297	1	MOABOX:68	AXUZQJFHDNNPFG-UXBLZVDNSA-N	CN(C)C(=O)CCSC(SCCC(=O)O)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1	115103-85-0	Leukotriene CysLT1 (LTD4) Antagonists;Leukotriene Synthesis Inhibitors	ABCC4	CYSLTR1																															10800																															CHEMBL15177											5281888	11239921	132274686			member	10.1016/j.bcp.2005.05.022	10.1038/21658	10.1124/jpet.103.059824																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		7.028e-002	0.95802																															0.01004	0.13686																															7	7																															HY-19989A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Inflammation/Immunology|MOABOX:68|ABCC4|Leukotriene CysLT1 (LTD4) Antagonists;Leukotriene Synthesis Inhibitors	CN(C)C(=O)CCSC(SCCC(=O)O)c1cccc(\C=C\c2ccc3ccc(Cl)cc3n2)c1	115103-85-0	64102	GENERAL	SODIUM(I)	1	NO_SOLVATE	0	1469525	515.08718	MK-571 SODIUM SALT | L-660711 SODIUM SALT	"""MK-571 SODIUM SALT | L-660711 SODIUM SALT"" | ""MK-571 SODIUM SALT | L-660711 SODIUM SALT"""	Pathway: GPCR/G Protein	Research Area: Inflammation/Immunology	MOABOX:68	ABCC4	Leukotriene CysLT1 (LTD4) Antagonists;Leukotriene Synthesis Inhibitors
SJ000288216-5	SJ000288216	5	MOABOX:70	MCMSJVMUSBZUCN-UHFFFAOYSA-N	COc1cc2c(cc1OC)-c1cc(=Nc3c(C)cc(C)cc3C)n(C)c(=O)n1CC2	78416-81-6		ABCC5	ENPP4																															22875																															CHEMBL527956	CHEMBL588593															member																																																																																																																																																																15345330																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.61369	7.665e-002																															0.08767	0.01095																															7	7																															17217	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-400|MOABOX:70|ABCC5|	COc1cc2CCN3C(=O)N(C)\C(=N\c4c(C)cc(C)cc4C)\C=C3c2cc1OC	78416-81-6	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468700	405.48948	TREQUINSIN HYDROCHLORIDE	"TREQUINSIN HYDROCHLORIDE | ""TREQUINSIN HYDROCHLORIDE | HL 725 |"" | TREQUINSIN HYDROCHLORIDE | ""TREQUINSIN HYDROCHLORIDE | HL 725 |"""			MOABOX:70	ABCC5	
SJ000286039-8	SJ000286039	8	MOABOX:74	BOVGTQGAOIONJV-UHFFFAOYSA-N	Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1	21187-98-4	K(ATP) Channel Blockers	KCNJ11	ABCC8	ABCC9																														6833	10060																														CHEMBL427216											3475	9803924	11542151	22138402	66747157	member																																																																																																																																																																15294453																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.25909	0	0																														0.17987	0.0	0.0																														7	7	7																														HY-B0753	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Cardiovascular Disease|MOABOX:74|KCNJ11|K(ATP) Channel Blockers	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2	21187-98-4	16579	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468878	323.41054	GLICLAZIDE	GLICLAZIDE | GLICLAZIDE	Pathway: Membrane Transporter/Ion Channel	Research Area: Cardiovascular Disease	MOABOX:74	KCNJ11	K(ATP) Channel Blockers
SJ001034929-1	SJ001034929	1	MOABOX:76	BUXACHZAYWAZJL-UHFFFAOYSA-N	N=C(N)NC(=N)Nc1cc(Cl)cc(Cl)c1	1672-93-1	5-HT3 receptor agonist	HTR3B	HTR3C	HTR3D	HTR3E																													170572	200909	285242																													CHEMBL40929											558969	2729977	45108645	50938725	50938726	virtual																																																																																																																																																																11412989	13129581																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.66232	0.66232	0.66232	0.66232																													0.08279	0.08279	0.08279	0.08279																													8	8	8	8																													AA0020KR	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-759-182|MOABOX:76|HTR3B|5-HT3 receptor agonist	NC(=N)NC(=N)Nc1cc(Cl)cc(Cl)c1	175205-04-6	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468264	246.09656	AA0020KR	AA0020KR | AA0020KR			MOABOX:76	HTR3B	5-HT3 receptor agonist
SJ000285391-13	SJ000285391	13	MOABOX:78	ZNNLBTZKUZBEKO-UHFFFAOYSA-N	COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1	10238-21-8	K(ATP) Channel Blockers	KCNJ8	KCNJ11	ABCC8	ABCC9																													3767	6833	10060																													CHEMBL472											3488	200105	6452619	9831606	9854150	member	10.1021/jm000484+																																																																																																																																																															9464357	11356099	15294453	15678092	25203779																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.61096	0.61688	0.70416	0.50112																													0.07637	0.07711	0.08802	0.06264																													8	8	8	8																													HY-15206	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Membrane Transporter/Ion Channel | Research Area: Metabolic Disease|MOABOX:78|KCNJ8|K(ATP) Channel Blockers	COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3	10238-21-8	11855	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469437	494.00352	GLYBURIDE	GLYBURIDE | GLIBENCLAMIDE | GLYBURIDE | GLIBENCLAMIDE	Pathway: Autophagy; Membrane Transporter/Ion Channel	Research Area: Metabolic Disease	MOABOX:78	KCNJ8	K(ATP) Channel Blockers
SJ001034991-1	SJ001034991	1	MOABOX:82	RJLZHYQYYJPEOG-RIYZIHGNSA-N	COc1ccc(/C(C#N)=C/c2cccc(O)c2)cc1OC		"Potassium Channel Activators;""Breast Cancer-Resistant Protein (BCRP; ABCG2) Inhibitors"""	ABCG2																																																																										870301					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																5572089	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-157-428|MOABOX:82|ABCG2|Potassium Channel Activators;\Breast Cancer-Resistant Protein (BCRP; ABCG2) Inhibitors\	COc1ccc(cc1OC)\C(=C\c2cccc(O)c2)\C#N	741737-84-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468435	281.3059	5572089	5572089 | 5572089			MOABOX:82	ABCG2	Potassium Channel Activators;\Breast Cancer-Resistant Protein (BCRP; ABCG2) Inhibitors\
SJ000286914-6	SJ000286914	6	MOABOX:84	RTIXKCRFFJGDFG-UHFFFAOYSA-N	O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12	480-40-0	"Apoptosis Inducers;Breast Cancer-Resistant Protein (BCRP;ABCG2) Inhibitors;Antiinflammatory Drugs;Antioxidants;""Apoptosis Inducers;Breast Cancer-Resistant Protein (BCRP;ABCG2) Inhibitors;Antiinflammatory Drugs;Antioxidants"""	ABCG2	HSD17B10	HSD17B7	HSD17B2	HSD17B8	HSD17B6	HSD17B12	HSD17B11	HSD17B14	HSD17B13																							3028	51478	3294	7923	8630	51144	51170	51171	345275																							CHEMBL117											5281607	11562090	20431397	66762077	68648461	member	10.1023/B:PHAM.0000033015.84146.4c																																																																																																																																																															19075617	22583399																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.19887	0	0	0	0.28528	0	0	0	0	0																							-0.02841	0.0	0.0	0.0	0.03566	0.0	0.0	0.0	0.0	0.0																							7	7	7	7	8	7	7	7	7	7																							HY-14589	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:84|ABCG2|Apoptosis Inducers;Breast Cancer-Resistant Protein (BCRP;ABCG2) Inhibitors;Antiinflammatory Drugs;Antioxidants;\Apoptosis Inducers;Breast Cancer-Resistant Protein (BCRP;ABCG2) Inhibitors;Antiinflammatory Drugs;Antioxidants\	Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3	480-40-0	25819	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469682	254.2375	CHRYSIN	"CHRYSIN | 5,7-DIHYDROXYFLAVONE | CHRYSIN | 5,7-DIHYDROXYFLAVONE"	Pathway: Others	Research Area: Cancer	MOABOX:84	ABCG2	Apoptosis Inducers;Breast Cancer-Resistant Protein (BCRP;ABCG2) Inhibitors;Antiinflammatory Drugs;Antioxidants;\Apoptosis Inducers;Breast Cancer-Resistant Protein (BCRP;ABCG2) Inhibitors;Antiinflammatory Drugs;Antioxidants\
SJ000518951-17	SJ000518951	17	MOABOX:88	KTUFNOKKBVMGRW-UHFFFAOYSA-N	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1	1080014-82-9	Abl Kinase Inhibitors;Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways	ABL1	DDR1	KIT	PDGFRA	PDGFRB	PPARG																											780	3815	5156	5159	5468																											CHEMBL1642	CHEMBL941										5291	123596	9810756	9832741	9853547	virtual	10.1002/cmdc.200900394	10.1002/cmdc.201700829	10.1002/ijc.23131	10.1016/j.abb.2012.05.025	10.1016/j.bmc.2010.08.026	10.1016/j.bmcl.2004.09.042	10.1016/j.chembiol.2004.02.029	10.1021/jm020143r	10.1021/jm050231m	10.1021/jm0506423	10.1021/jm4004076	10.1021/jm5012319	10.1021/jm800188g	10.1021/jm800988r	10.1021/jm900424a	10.1038/leu.2009.228	10.1073/pnas.0812413106	10.1158/0008-5472.CAN-05-2050	10.1158/0008-5472.CAN-06-0165	10.1158/0008-5472.CAN-06-1199	10.1158/0008-5472.CAN-07-0345	10.1200/JCO.2007.15.7461	10.1248/cpb.55.255	10.2337/db15-1382																																																																																																																																								10021925	10608920	11607931	11749388	12166950	12171522	12951113	15032674	15157880	15711537	15975507	16190746	16220969	16397263	16415863	16570914	16678414	16783341	16873019	16873026	17268099	17300160	17305593	17376680	17541990	17572088	17718712	17983688	18045055	18077425	18078752	18183025	18342402	18447379	18554909	18673174	18710211	18723346	19075651	19149613	19167366	19199984	19301902	19374919	19689368	19714578	19754394	19950162	20147452	20166671	20188579	20235539	20449474	20500152	20817538	21118377	21322567	21376587	21429632	21443205	21651486	21700206	21990039	22033461	22037378	22087818	22221201	22434539	22683649	22789429	23088644	23301703	23410162	23410165	23410168	23441572	23473682	23600806	23611771	23773153	23937569	24280068	24681986	25464886	25569119	25757603	25881828	26195136	26231079	26298495	26451772	26526740	26562217	26789553	27010810	27077705	27189674	27502700	27545040	27966954	28280261	28541695	28991465	29191878	29280989	29544149	29945794	30204441	30317026	30620194	30754629	30968693	31046271	31185413																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.52472	0.87	3.25032	1.76168	1.60064	-0.45682																											0.44059	0.10875	0.40629	0.22021	0.20008	-0.06526																											8	8	8	8	8	7																											ES-0058	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466683	493.60274	IMATINIB	IMATINIB | CGP-57148B | NSC-716051 | STI571 | IMATINIB MESYLATE | IMATINIB | CGP-57148B | NSC-716051 | STI571 | IMATINIB MESYLATE			MOABOX:88	ABL1	Abl Kinase Inhibitors;Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways
SJ000791566-13	SJ000791566	13	MOABOX:92	PHXJVRSECIGDHY-UHFFFAOYSA-N	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12	1114544-31-8	Inhibitors of Signal Transduction Pathways;Bcr-Abl Kinase Inhibitors	ABL1	ABL2	BCR																														27	613																														CHEMBL1171837	CHEMBL2105708										24826799	46908927	91810332	91810335	124126783	virtual	10.1002/cmdc.201700829	10.1080/14756366.2016.1250757																																																																																																																																																														20513156	21118377	21561767	23301703	23441572	23600806	23773153	26195136	27010810	27750146	27914362	29191878	29648816																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									2.16552	0.13864	0.93896																														0.27069	0.01733	0.11737																														8	8	8																														AS-19133	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-009-679-483|MOABOX:92|ABL1|Inhibitors of Signal Transduction Pathways;Bcr-Abl Kinase Inhibitors	CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc4cnc5cccnn45)cc2C(F)(F)F)CC1	943319-70-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468361	532.55949	PONATINIB	PONATINIB | AP-24534 | PONATINIB (AP24534) | PONATINIB | AP-24534 | PONATINIB (AP24534)			MOABOX:92	ABL1	Inhibitors of Signal Transduction Pathways;Bcr-Abl Kinase Inhibitors
SJ000855236-4	SJ000855236	4	MOABOX:94	IIQUYGWWHIHOCF-UHFFFAOYSA-N	O=C(NCCO)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1	778277-15-9	"Inhibitors of Signal Transduction Pathways;Bcr-Abl Kinase Inhibitors;""Inhibitors of Signal Transduction Pathways;Bcr-Abl Kinase Inhibitors"""	ABL1	BCR	ABL2																														613	27																														CHEMBL1257423											44129660					member																																																																																																																																																																20828158																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.4508	0	0.33728																														0.30635	0.0	0.04216																														8	7	8																														HY-15738	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:94|ABL1|Inhibitors of Signal Transduction Pathways;Bcr-Abl Kinase Inhibitors;\Inhibitors of Signal Transduction Pathways;Bcr-Abl Kinase Inhibitors\	OCCNC(=O)c1cccc(c1)c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2	778277-15-9	11010	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469141	418.36919	GNF-5	GNF-5 | GNF-5	Pathway: Anti-infection; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:94	ABL1	Inhibitors of Signal Transduction Pathways;Bcr-Abl Kinase Inhibitors;\Inhibitors of Signal Transduction Pathways;Bcr-Abl Kinase Inhibitors\
SJ000518964-14	SJ000518964	14	MOABOX:96	HHZIURLSWUIHRB-UHFFFAOYSA-N	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1	1353151-22-0	Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;Bcr-Abl Kinase Inhibitors	ABL1	ABL2	BCR	PDGFRB																													27	613	5159																													CHEMBL1201740	CHEMBL255863										644241	11665134	15950379	16006179	16006180	member	10.1016/j.bmcl.2012.11.111	10.1080/14756366.2016.1250757																																																																																																																																																														16842147	18045055	19075651	19149608	19149613	19714578	19895503	20166671	20817538	21118377	21376587	21651486	22037378	22087818	22607148	23088644	23273517	23301703	23410165	23521020	23538233	26195136	26789553	28280261	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3.24168	0.1757	1.86208	0.7608																													0.40521	0.0251	0.23276	0.0951																													8	7	8	8																													AS-16214	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Cc1cn(cn1)c2cc(NC(=O)c3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)cc(c2)C(F)(F)F	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466823	529.51579	NILOTINIB	"NILOTINIB | ""NILOTINIB HYDROCHLORIDE MONOHYDRATE | AMN-107 | TASIGNA"" | NILOTINIB (AMN-107) | NILOTINIB | ""NILOTINIB HYDROCHLORIDE MONOHYDRATE | AMN-107 | TASIGNA"" | NILOTINIB (AMN-107)"			MOABOX:96	ABL1	Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;Bcr-Abl Kinase Inhibitors
SJ000518976-21	SJ000518976	21	MOABOX:98	ZBNZXTGUTAYRHI-UHFFFAOYSA-N	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1	302962-49-8	Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Bruton's Tyrosine Kinase (BTK) Inhibitors;Bcr-Abl Kinase Inhibitors	ABL1	ABL2	BTK	FYN	LCK	MAPK12	SRC	YES1																									27	695	2534	3932	6300	6714	7525																									CHEMBL1421											3062316	11466607	11540687	11849173	16034848	virtual	10.1002/cmdc.201500428	10.1016/j.bmcl.2013.05.072	10.1021/jm060727j	10.1038/leu.2008.334	10.1038/nchembio.481	10.1038/s41389-017-0015-5	10.1111/j.1747-0285.2009.00905.x	10.1158/0008-5472.CAN-06-3469	10.1182/blood-2009-11-251751	10.2174/092986708784310404																																																																																																																																																						1794960	15615512	15930265	16787379	17154512	17363602	17684099	17718712	17956080	18045060	18045061	18183025	18473810	18673174	18710211	18829496	18849971	19075651	19282395	19321350	19396179	19714578	19895503	20166671	20235539	21113169	21118377	21459579	21499265	21651486	21651487	21794960	21855335	22037378	22087818	22394077	22594639	23088644	23143416	23301703	23787099	25835317	26191369	26195136	26451772	26789553	27010810	27115835	27154914	27155464	27474918	27739679	29191878	29648816	30227617	30562697	30754629																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2.46448	0.52696	0.50048	0.79328	1.14576	-0.41601	1.54928	1.124																									0.30806	0.06587	0.06256	0.09916	0.14322	-0.05943	0.19366	0.1405																									8	8	8	8	8	7	8	8																									HY-10181	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:98|ABL1|Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Bruton's Tyrosine Kinase (BTK) Inhibitors;Bcr-Abl Kinase Inhibitors	Cc1nc(Nc2ncc(s2)C(=O)Nc3c(C)cccc3Cl)cc(n1)N4CCN(CCO)CC4	302962-49-8	13044	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468897	488.00554	DASATINIB	DASATINIB | NSC-732517 | DASATINIB HCL | DASATINIB | NSC-732517 | DASATINIB HCL	Pathway: Apoptosis; Autophagy; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:98	ABL1	Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Bruton's Tyrosine Kinase (BTK) Inhibitors;Bcr-Abl Kinase Inhibitors
SJ000841758-8	SJ000841758	8	MOABOX:114	OUKYUETWWIPKQR-UHFFFAOYSA-N	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1	379231-04-6	Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Abl Kinase Inhibitors	ABL1	ABL2	CSK	SRC	YES1																												27	1445	6714	7525																												CHEMBL2105677	CHEMBL217092										10302451	11571609	24849184	44195703	68976452	virtual	10.1016/j.bmcl.2013.05.072	10.1021/jm060434q	10.1124/mol.108.052464																																																																																																																																																													17064066	17360676	18045060	18077425	19291104	19321350	20218623	21459579	22414081	23143416	23410165	23787099	26191369	29191878	30832206																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							0.24488	-0.11008	-0.3688	1.95152	1.27768																												0.03061	-0.01376	-0.0461	0.24394	0.15971																												8	8	8	8	8																												HY-10234	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:114|ABL1|Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Abl Kinase Inhibitors	CN1CCN(CCOc2cc(OC3CCOCC3)c4c(Nc5c(Cl)ccc6OCOc56)ncnc4c2)CC1	379231-04-6	4963	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468871	542.02648	SARACATINIB	SARACATINIB | AZD0530 | SARACATINIB | AZD0530	Pathway: Autophagy; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:114	ABL1	Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Abl Kinase Inhibitors
SJ000840396-5	SJ000840396	5	MOABOX:116	ZVPDNRVYHLRXLX-UHFFFAOYSA-N	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1	172889-26-8	"Apoptosis Inducers;Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Abl Kinase Inhibitors;""Apoptosis Inducers;Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Abl Kinase Inhibitors"""	ABL1	FYN	HCK	SRC	ABL2																												2534	3055	6714	27																												CHEMBL306380											1400					virtual	10.1016/S0014-5793(03)00069-3	10.1161/01.RES.85.1.12																																																																																																																																																														10608920	11012021	12171518	12512083	15008512	17305593	17627544	18045061	18473810	18537718	18782057	18849971	19601892	19714578	21651487	23352142	27115835																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.13168	0	2.13776	0.86168	0.64656																												-0.01646	0.0	0.26722	0.10771	0.08082																												8	7	8	8	8																												HY-13804	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:116|ABL1|Apoptosis Inducers;Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Abl Kinase Inhibitors;\Apoptosis Inducers;Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Abl Kinase Inhibitors\	Cc1ccc(cc1)c2nn(c3ncnc(N)c23)C(C)(C)C	172889-26-8	9735	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469146	281.35556	PP 1	PP 1 | PP1 | PP 1 | PP1	Pathway: Apoptosis; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:116	ABL1	Apoptosis Inducers;Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Abl Kinase Inhibitors;\Apoptosis Inducers;Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Abl Kinase Inhibitors\
SJ000560626-4	SJ000560626	4	MOABOX:118	WEVYNIUIFUYDGI-UHFFFAOYSA-N	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1	778270-11-4	"Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;""Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways"""	ABL1	ABL2																															27																															CHEMBL483847											5311510	143835388	143835389			virtual																																																																																																																																																																16415863	19538165	20072125	20828158	21517764	21864276																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.92056	0																															0.24007	0.0																															8	7																															HY-11007	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:118|ABL1|Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;\Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways\	NC(=O)c1cccc(c1)c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2	778270-11-4	10886	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469575	374.31663	GNF-2	GNF-2 | GNF-2	Pathway: Anti-infection; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:118	ABL1	Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;\Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways\
SJ000803719-4	SJ000803719	4	MOABOX:142	CZRCFAOMWRAFIC-UHFFFAOYSA-N	CCCCCCCCCCCCCCOc1ccc(C(=O)O)o1	54857-86-2	Acetyl-CoA Carboxylase 1 (ACC1) Inhibitors;Acetyl-CoA Carboxylase 2 (ACC2) Inhibitors	ACACA	ACACB																															32																															CHEMBL1562779											115175	69095097	131747424			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.17668	-0.17668																															-0.02524	-0.02524																															7	7																															HY-101068	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:142|ACACA|Acetyl-CoA Carboxylase 1 (ACC1) Inhibitors;Acetyl-CoA Carboxylase 2 (ACC2) Inhibitors	CCCCCCCCCCCCCCOc1oc(cc1)C(=O)O	54857-86-2	33509	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469633	324.45498	TOFA	"TOFA | ""5-(TETRADECYLOXY)-2-FUROIC ACID | TOFA"" | AC-8632 | RMI-14514 | TOFA | ""5-(TETRADECYLOXY)-2-FUROIC ACID | TOFA"" | AC-8632 | RMI-14514"	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:142	ACACA	Acetyl-CoA Carboxylase 1 (ACC1) Inhibitors;Acetyl-CoA Carboxylase 2 (ACC2) Inhibitors
SJ001035053-1	SJ001035053	1	MOABOX:152	HGKIBQCJDDCQAV-UHFFFAOYSA-N	COc1ccc(C(=O)CN2CCN(c3cc(C)nc4ccccc34)CC2)cc1		Acid-Sensing Ion Channels 1 (ASIC1) Blockers	ASIC1																																																															CHEMBL1376808											2728466					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																RH02163	MAYBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-842-681|MOABOX:152|ASIC1|Acid-Sensing Ion Channels 1 (ASIC1) Blockers	COc1ccc(cc1)C(=O)CN2CCN(CC2)c3cc(C)nc4ccccc34	308088-10-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468556	375.4635	RH02163	RH02163 | RH02163			MOABOX:152	ASIC1	Acid-Sensing Ion Channels 1 (ASIC1) Blockers
SJ001034652-1	SJ001034652	1	MOABOX:154	FHHHOYXPRDYHEZ-COXVUDFISA-N	CC(=O)SC[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O	219554-02-6	Angiotensin-I Converting Enzyme (ACE) Inhibitors	ACE																																																															CHEMBL2103775											71992	9875706	87771199	88413209		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																KS-1321	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	C[C@H](CSC(=O)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc2ccccc2)C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466728	406.49584	KS-1321	KS-1321 | KS-1321			MOABOX:154	ACE	Angiotensin-I Converting Enzyme (ACE) Inhibitors
SJ000287048-8	SJ000287048	8	MOABOX:158	HDACQVRGBOVJII-JBDAPHQKSA-N	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21	1028843-43-7	Angiotensin-I Converting Enzyme (ACE) Inhibitors	ACE																																																															CHEMBL1168											5362129	6992028	9803939	9832256	9896426	member																																																																																																																																																																10669559	22229560																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.22904																																0.40363																																8																																KS-1103	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466707	416.51058	RAMIPRIL	RAMIPRIL | RAMIPRIL			MOABOX:158	ACE	Angiotensin-I Converting Enzyme (ACE) Inhibitors
SJ000286076-10	SJ000286076	10	MOABOX:160	XPCFTKFZXHTYIP-PMACEKPBSA-N	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O	109010-10-8	Angiotensin-I Converting Enzyme (ACE) Inhibitors	ACE																																																															CHEMBL1694	CHEMBL838										5362123	5362124	5746247	9876522	9898390	member																																																																																																																																																																2999394	10669559	22711801																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.3468																																0.29335																																8																																AG003O08	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-601|MOABOX:160|ACE|Angiotensin-I Converting Enzyme (ACE) Inhibitors	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]2CCc3ccccc3N(CC(=O)O)C2=O	86541-74-4	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468238	424.48952	BENAZEPRIL HYDROCHLORIDE	BENAZEPRIL HYDROCHLORIDE | BENAZEPRIL HCL | BENAZEPRIL HYDROCHLORIDE | BENAZEPRIL HCL			MOABOX:160	ACE	Angiotensin-I Converting Enzyme (ACE) Inhibitors
SJ001034971-1	SJ001034971	1	MOABOX:166	LVRLSYPNFFBYCZ-VGWMRTNUSA-N	O=C(N[C@H]1CCS[C@H]2CCC[C@@H](C(=O)O)N2C1=O)[C@@H](S)Cc1ccccc1	159317-63-2	"Angiotensin-I Converting Enzyme (ACE) Inhibitors;Neprilysin (Enkephalinase, Neutral Endopeptidase, NEP) Inhibitors"	ACE	MME																															4311																															CHEMBL289556											656629	9940172	16678089			virtual	10.1124/jpet.115.231167																																																																																																																																																															12968984	16787202	19899765	22229560	22680630	23410171	30655952																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															1.19368	0.31744																															0.14921	0.03968																															8	8																															CS-6369	CHEMSCENE	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-417-205|MOABOX:166|ACE|Angiotensin-I Converting Enzyme (ACE) Inhibitors;Neprilysin (Enkephalinase, Neutral Endopeptidase, NEP) Inhibitors"	OC(=O)[C@@H]1CCC[C@@H]2SCC[C@H](NC(=O)[C@@H](S)Cc3ccccc3)C(=O)N12	167305-00-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468405	408.53486	OMAPATRILAT	OMAPATRILAT | OMAPATRILAT			MOABOX:166	ACE	"Angiotensin-I Converting Enzyme (ACE) Inhibitors;Neprilysin (Enkephalinase, Neutral Endopeptidase, NEP) Inhibitors"
SJ000287712-5	SJ000287712	5	MOABOX:168	RSRUDTPYRBLHEO-UHFFFAOYSA-N	CN1CCc2cccc(Cl)c2CC1	73943-10-9	alpha2-Adrenoceptor Antagonists	ADRA1B																																																															CHEMBL123349	CHEMBL536803										123981	10220250	44272692			virtual																																																																																																																																																																7562902	8770394																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.38728																																-0.04841																																8																																11953	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-959-503|MOABOX:168|ADRA1B|alpha2-Adrenoceptor Antagonists	CN1CCc2cccc(Cl)c2CC1	86129-54-6	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468305	195.68856	SKF 86466	SKF 86466 | SKF 86466 HYDROCHLORIDE | SKF 86466 | SKF 86466 HYDROCHLORIDE			MOABOX:168	ADRA1B	alpha2-Adrenoceptor Antagonists
SJ001035109-2	SJ001035109	2	MOABOX:172	NTCCRGGIJNDEAB-IRXDYDNUSA-N	CC(C)C[C@H](N[C@@H](Cc1cncn1Cc1cc(Cl)cc(Cl)c1)C(=O)O)C(=O)O	1315337-39-3	Angiotensin-I Converting Enzyme-Related Carboxypeptidase (ACE2) Inhibitors	ACE2																																																															CHEMBL429844											448281	44224173	53339147	53339148	53339149	member	10.1016/j.ejphar.2016.01.007	10.1021/ja0277226																																																																																																																																																														12358520	18243695	18324760																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.86032																																0.48254																																8																																HY-19414	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease|MOABOX:172|ACE2|Angiotensin-I Converting Enzyme-Related Carboxypeptidase (ACE2) Inhibitors	CC(C)C[C@H](N[C@@H](Cc1cncn1Cc2cc(Cl)cc(Cl)c2)C(=O)O)C(=O)O	305335-31-3	84495	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469816	428.30962	MLN-4760	MLN-4760 | MLN-4760	Pathway: Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease	MOABOX:172	ACE2	Angiotensin-I Converting Enzyme-Related Carboxypeptidase (ACE2) Inhibitors
SJ001035109-1	SJ001035109	1	MOABOX:172	NTCCRGGIJNDEAB-IRXDYDNUSA-N	CC(C)C[C@H](N[C@@H](Cc1cncn1Cc1cc(Cl)cc(Cl)c1)C(=O)O)C(=O)O	1315337-39-3	Angiotensin-I Converting Enzyme-Related Carboxypeptidase (ACE2) Inhibitors	ACE2																																																															CHEMBL429844											448281	44224173	53339147	53339148	53339149	member	10.1016/j.ejphar.2016.01.007	10.1021/ja0277226																																																																																																																																																														12358520	18243695	18324760																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.86032																																0.48254																																8																																CS-0015513	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-028-617-523|MOABOX:172|ACE2|Angiotensin-I Converting Enzyme-Related Carboxypeptidase (ACE2) Inhibitors	CC(C)C[C@H](N[C@@H](Cc1cncn1Cc2cc(Cl)cc(Cl)c2)C(=O)O)C(=O)O	305335-31-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468706	428.30962	MLN-4760	MLN-4760 | MLN-4760			MOABOX:172	ACE2	Angiotensin-I Converting Enzyme-Related Carboxypeptidase (ACE2) Inhibitors
SJ000555704-5	SJ000555704	5	MOABOX:174	ADEBPBSSDYVVLD-UHFFFAOYSA-N	COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2	110119-84-1	Acetylcholinesterase Inhibitors	ACHE																																																															CHEMBL1678	CHEMBL2337271	CHEMBL502									3152	5741	9809646	9810733	9830939	member	10.1002/anie.200700256	10.1002/ardp.201300228	10.1002/ardp.201300242	10.1002/ardp.201500117	10.1002/ardp.201800310	10.1002/cmdc.201000210	10.1002/cmdc.201000322	10.1002/cmdc.201500104	10.1002/cmdc.201500124	10.1002/cmdc.201500334	10.1002/cmdc.201500392	10.1016/S0960-894X(01)00703-X	10.1016/S0960-894X(02)00482-1	10.1016/S0960-894X(98)00076-6	10.1016/S0968-0896(00)00020-1	10.1016/j.bbapap.2014.03.006	10.1016/j.bioorg.2018.06.031	10.1016/j.bioorg.2018.09.010	10.1016/j.bioorg.2019.01.044	10.1016/j.bioorg.2019.103025	10.1016/j.bioorg.2019.103080	10.1016/j.biopha.2018.11.115	10.1016/j.bmc.2008.12.067	10.1016/j.bmc.2010.01.071	10.1016/j.bmc.2011.02.030	10.1016/j.bmc.2013.12.066	10.1016/j.bmc.2016.02.023	10.1016/j.bmc.2016.07.025	10.1016/j.bmcl.2010.09.108	10.1016/j.bmcl.2011.07.091	10.1016/j.bmcl.2012.05.077	10.1016/j.bmcl.2012.11.064	10.1016/j.bmcl.2013.05.092	10.1016/j.bmcl.2017.09.055	10.1016/j.ejmech.2008.02.035	10.1016/j.ejmech.2011.02.019	10.1016/j.ejmech.2011.02.071	10.1016/j.ejmech.2012.09.030	10.1016/j.ejmech.2013.06.021	10.1016/j.ejmech.2013.11.026	10.1016/j.ejmech.2014.02.045	10.1016/j.ejmech.2014.05.066	10.1016/j.ejmech.2015.02.063	10.1016/j.ejmech.2015.10.001	10.1016/j.ejmech.2016.05.055	10.1016/j.ejmech.2016.12.009	10.1016/j.ejmech.2017.02.034	10.1016/j.ejmech.2017.02.039	10.1016/j.ejmech.2017.02.042	10.1016/j.ejmech.2017.02.045	10.1016/j.ejmech.2017.04.054	10.1016/j.ejmech.2017.07.055	10.1016/j.ejmech.2017.07.077	10.1016/j.ejmech.2017.08.051	10.1016/j.ejmech.2017.09.022	10.1016/j.ejmech.2018.01.007	10.1016/j.ejmech.2018.01.055	10.1016/j.ejmech.2018.07.026	10.1016/j.ejmech.2018.08.005	10.1016/j.ejmech.2018.10.064	10.1016/j.ejmech.2019.02.030	10.1016/j.ejmech.2019.05.062	10.1016/j.ejmech.2019.111707	10.1021/acs.jmedchem.5b00115	10.1021/acs.jmedchem.5b00624	10.1021/acs.jmedchem.6b00426	10.1021/acs.jmedchem.7b00702	10.1021/acschemneuro.7b00257	10.1021/acschemneuro.8b00699	10.1021/acschemneuro.9b00226	10.1021/acsmedchemlett.5b00483	10.1021/jm00007a005	10.1021/jm00043a012	10.1021/jm001088u	10.1021/jm010491d	10.1021/jm0340602	10.1021/jm049309+	10.1021/jm070559a	10.1021/jm100573q	10.1021/jm101299d	10.1021/jm401047q	10.1021/jm8001313	10.1021/jm8009684	10.1021/jm901902w	10.1021/jm981101z	10.1039/c3md00041a	10.1039/c6md00053c	10.1039/c7md00199a	10.1080/14756366.2016.1256883	10.1080/14756366.2018.1545766	10.1080/14756366.2019.1581184	10.2174/092986706775527974	10.2174/092986708785909067	10.2174/092986710791111198	10.2174/092986711797200435	10.2174/138161209787315648	10.2174/138161210793176536	10.2174/15680266113139990139	10.2174/1570180814666161228143846																																																													1738151	7707311	8064800	8558505	8893840	8894101	9871563	10052979	10819162	11495583	11689088	12166941	12182861	12773032	15139762	15544502	15544505	15582466	15588084	15715468	16137794	16475930	16570913	17105433	17397121	17624631	17681794	17850125	18082383	18181565	18220785	18249544	18396354	18517184	18570368	18701305	18855672	18954037	19162488	19199987	19252271	19643609	20053484	20171894	20235539	20345342	20420456	20575555	20673725	20677317	20684567	20698824	20859987	20951037	21067438	21074294	21106907	21216144	21397996	21417225	21429752	21459491	21621414	21669479	21873056	21989769	22023459	22050745	22142546	22288410	22467516	22472693	22503231	22549828	22633691	22704921	22726458	23078965	23140986	23199476	23273219	23273608	23276831	23376249	23434223	23438968	23562059	23582449	23603045	23644208	23721952	23791077	23810675	23838422	23852709	23881696	23886696	23931437	23931440	23988409	24160297	24211638	24378710	24461494	24530494	24589487	24657052	24675179	24681070	24681981	24813882	24929293	24941128	24980117	25036795	25189690	25282266	25418133	25455147	25594344	25621991	25624107	25642838	25678013	25681712	25707322	25764491	25778991	25793650	25868744	25969170	26025073	26107513	26159481	26181606	26244990	26337018	26363866	26363872	26454504	26471320	26509353	26514744	26588065	26827140	26861273	26917219	26947607	26999091	27017111	27023510	27083471	27096037	27157006	27190595	27214510	27227482	27253679	27267007	27347731	27353888	27405689	27445168	27460699	27484514	27560283	27668683	27687968	27721153	27721157	27744252	27769620	27780618	27783974	27789142	27823887	27923535	27951485	27951490	28126439	28237559	28242549	28242552	28279845	28282613	28388521	28406297	28454848	28458136	28478343	28487125	28552337	28587871	28613859	28672874	28751142	28797883	28800459	28841514	28863358	29033232	29033233	29089261	29283428	29320423	29324339	29335209	29407958	29414887	29421570	29429576	29438888	29500132	29524731	29763808	29857276	29886083	29960728	30017317	30025348	30031971	30096650	30110946	30177651	30190181	30223122	30245401	30366255	30447434	30470598	30503937	30544832	30685536	30765302	30772129	30784883	30795991	30823470	30939771	31029943	31055149	31128990	31136894	31151057	31158754	31176571	31288978	31444085																																																																																																																																																																																																																																																																																																														4.29392																																0.53674																																8																																BD40670	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-847-014|MOABOX:174|ACHE|Acetylcholinesterase Inhibitors	COc1cc2CC(CC3CCN(Cc4ccccc4)CC3)C(=O)c2cc1OC	120014-06-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468344	379.49196	DONEPEZIL HYDROCHLORIDE	DONEPEZIL HYDROCHLORIDE | DONEPEZIL HYDROCHLORIDE			MOABOX:174	ACHE	Acetylcholinesterase Inhibitors
SJ000287288-9	SJ000287288	9	MOABOX:176	ALWKGYPQUAPLQC-UHFFFAOYSA-N	CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1	114-80-7	Acetylcholinesterase Inhibitors	ACHE																																																															CHEMBL211471	CHEMBL278020	CHEMBL54126									4456	5824	8246	14596	417610	member	10.1016/S0960-894X(01)00703-X	10.1016/j.bmc.2007.07.014	10.1016/j.bmc.2010.05.022	10.1016/j.bmc.2010.07.034	10.1016/j.bmcl.2006.05.030	10.1016/j.cbi.2007.09.006	10.1016/j.ejmech.2009.04.042	10.1124/jpet.108.146241	10.1248/cpb.c17-00416	10.2174/092986710791111198																																																																																																																																																						3193422	5659052	8496937	8978837	9435905	11755352	11858995	16735118	17888667	17980356	18588282	19493592	20138518	20345342	20627738	20875743	21123674	21406034	21688779	23376249	24360998	26509353																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.36288																																0.17036																																8																																HY-B0423	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Metabolic Disease|MOABOX:176|ACHE|Acetylcholinesterase Inhibitors	CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C	114-80-7	17024	GENERAL	BROMIDE	1	NO_SOLVATE	0	1469836	223.29146	NEOSTIGMINE BROMIDE	NEOSTIGMINE BROMIDE | NEOSTIGMINE BROMIDE	Pathway: Others	Research Area: Metabolic Disease	MOABOX:176	ACHE	Acetylcholinesterase Inhibitors
SJ000287011-8	SJ000287011	8	MOABOX:180	ASUTZQLVASHGKV-JDFRZJQESA-N	COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2	1008759-59-8	Acetylcholinesterase Inhibitors;Butyrylcholinesterase Inhibitors	ACHE	BCHE																															590																															CHEMBL1555	CHEMBL659										9651	121587	9804594	9808644	11154086	member	10.1002/ardp.201800310	10.1016/0960-894X(96)00102-3	10.1016/j.bmcl.2012.02.057	10.1016/j.bmcl.2015.06.047	10.1016/j.cbi.2008.04.037	10.1016/j.ejmech.2011.02.071	10.1016/j.ejmech.2014.05.022	10.1016/j.phytol.2014.12.009	10.1021/acs.jmedchem.5b00624	10.1021/jm010491d	10.1021/jm049309+	10.1021/jm050578p	10.1021/jm901902w	10.1021/np2009626	10.1021/np400978x	10.1097/00008571-199912000-00001	10.2174/1381612043386509	10.2174/15680266113139990139																																																																																																																																														9839013	10762042	10869205	12166941	12729674	15080903	15715468	16250834	16483771	16570913	16945529	17317172	17451950	17902635	18082383	18479118	18650096	18681480	20053484	20575555	20655219	20954721	21049906	21216144	21459491	22425563	22775474	22931533	23041347	23199476	24606395	25088549	25189690	25921269	26159481	26841168	28279561	29227101	30300845																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															3.25024	-0.15824																															0.40628	-0.01978																															8	8																															AG0034YM	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-665-621|MOABOX:180|ACHE|Acetylcholinesterase Inhibitors;Butyrylcholinesterase Inhibitors	COc1ccc2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3Oc1c24	1953-04-04	NA	GENERAL	BROMIDE	1	NO_SOLVATE	0	1468210	287.35354	GALANTHAMINE HYDROBROMIDE	GALANTHAMINE HYDROBROMIDE | GALANTHAMINE HYDROGEN BROMIDE | GALANTHAMINE HBR | GALANTHAMINE HYDROBROMIDE | GALANTHAMINE HYDROGEN BROMIDE | GALANTHAMINE HBR			MOABOX:180	ACHE	Acetylcholinesterase Inhibitors;Butyrylcholinesterase Inhibitors
SJ000285525-14	SJ000285525	14	MOABOX:182	YLJREFDVOIBQDA-UHFFFAOYSA-N	Nc1c2c(nc3ccccc13)CCCC2	1684-40-8	Acetylcholinesterase Inhibitors;Butyrylcholinesterase Inhibitors	ACHE	BCHE	CHRNE																														590	1145																														CHEMBL1337960	CHEMBL1677	CHEMBL95									1935	370558	2723754	6420002	6610725	member	10.1002/ardp.201500117	10.1002/ardp.201800029	10.1002/ardp.201800310	10.1002/cmdc.200800414	10.1002/cmdc.201100239	10.1002/cmdc.201500383	10.1007/s00044-015-1316-x	10.1016/0960-894X(96)00102-3	10.1016/S0960-894X(03)00397-4	10.1016/S0968-0896(00)00020-1	10.1016/S0968-0896(01)00171-7	10.1016/S0968-0896(99)00306-5	10.1016/j.bioorg.2018.09.018	10.1016/j.bioorg.2018.11.051	10.1016/j.bioorg.2018.12.023	10.1016/j.bioorg.2019.01.044	10.1016/j.bioorg.2019.103312	10.1016/j.bmc.2005.09.029	10.1016/j.bmc.2006.07.059	10.1016/j.bmc.2007.07.003	10.1016/j.bmc.2008.07.005	10.1016/j.bmc.2009.08.017	10.1016/j.bmc.2011.02.030	10.1016/j.bmc.2013.05.001	10.1016/j.bmc.2013.06.065	10.1016/j.bmc.2013.09.050	10.1016/j.bmc.2013.12.066	10.1016/j.bmc.2014.06.045	10.1016/j.bmc.2014.08.035	10.1016/j.bmc.2015.06.010	10.1016/j.bmc.2015.07.029	10.1016/j.bmc.2016.07.025	10.1016/j.bmc.2016.11.032	10.1016/j.bmc.2017.05.045	10.1016/j.bmc.2017.09.028	10.1016/j.bmc.2018.08.010	10.1016/j.bmcl.2010.08.044	10.1016/j.bmcl.2011.07.091	10.1016/j.bmcl.2011.08.042	10.1016/j.bmcl.2013.05.092	10.1016/j.bmcl.2013.09.091	10.1016/j.bmcl.2013.10.034	10.1016/j.bmcl.2014.12.071	10.1016/j.bmcl.2015.06.047	10.1016/j.cbi.2006.06.002	10.1016/j.cbi.2008.04.037	10.1016/j.ejmech.2011.02.073	10.1016/j.ejmech.2011.07.004	10.1016/j.ejmech.2012.03.022	10.1016/j.ejmech.2012.06.038	10.1016/j.ejmech.2012.10.045	10.1016/j.ejmech.2013.12.008	10.1016/j.ejmech.2014.01.020	10.1016/j.ejmech.2014.03.044	10.1016/j.ejmech.2014.05.066	10.1016/j.ejmech.2014.10.084	10.1016/j.ejmech.2015.01.058	10.1016/j.ejmech.2015.03.040	10.1016/j.ejmech.2016.06.025	10.1016/j.ejmech.2016.11.050	10.1016/j.ejmech.2017.01.042	10.1016/j.ejmech.2017.02.042	10.1016/j.ejmech.2017.08.051	10.1016/j.ejmech.2017.09.008	10.1016/j.ejmech.2017.09.022	10.1016/j.ejmech.2018.01.028	10.1016/j.ejmech.2018.01.055	10.1016/j.ejmech.2018.02.083	10.1016/j.ejmech.2018.06.044	10.1016/j.ejmech.2018.07.033	10.1016/j.ejmech.2018.07.056	10.1016/j.ejmech.2018.12.063	10.1016/j.ejmech.2019.02.008	10.1016/j.ejmech.2019.02.012	10.1016/j.ejmech.2019.02.021	10.1016/j.ijbiomac.2017.06.006	10.1021/acs.jmedchem.5b00624	10.1021/acs.jmedchem.5b01119	10.1021/acs.jmedchem.5b01325	10.1021/acs.jmedchem.6b00426	10.1021/acs.jmedchem.7b00702	10.1021/acs.jmedchem.7b01086	10.1021/acs.jmedchem.7b01760	10.1021/acs.joc.7b01230	10.1021/acs.molpharmaceut.8b01058	10.1021/acschemneuro.8b00699	10.1021/acschemneuro.9b00226	10.1021/acsmedchemlett.7b00463	10.1021/cn500016p	10.1021/jm00007a005	10.1021/jm00015a002	10.1021/jm00043a012	10.1021/jm00084a015	10.1021/jm00095a008	10.1021/jm000980y	10.1021/jm010308g	10.1021/jm010491d	10.1021/jm010949b	10.1021/jm049309+	10.1021/jm0493461	10.1021/jm0496741	10.1021/jm0503289	10.1021/jm050578p	10.1021/jm050746d	10.1021/jm060945c	10.1021/jm061047j	10.1021/jm070536w	10.1021/jm070559a	10.1021/jm070859s	10.1021/jm100329q	10.1021/jm100573q	10.1021/jm101299d	10.1021/jm200840c	10.1021/jm200853t	10.1021/jm201460y	10.1021/jm401047q	10.1021/jm5000613	10.1021/jm5008648	10.1021/jm5010804	10.1021/jm701225u	10.1021/jm8001313	10.1021/jm800577j	10.1021/jm801292b	10.1021/jm900628z	10.1021/jm901902w	10.1021/jm9602266	10.1021/jm970150t	10.1021/jm970210v	10.1021/jm980620z	10.1021/jm981101z	10.1021/jm990971t	10.1021/ol500808p	10.1021/tx400138s	10.1039/c1md00221j	10.1039/c3nj01384g	10.1039/c3ob41762j	10.1039/c7md00143f	10.1039/c9nj01982k	10.1080/14756360600988781	10.1080/14756366.2016.1189422	10.1080/14756366.2018.1545766	10.1080/14786419.2012.708660	10.2174/092986706775527974	10.2174/092986707782023217	10.2174/092986708785909067	10.2174/092986710791111206	10.2174/092986711794480186	10.2174/092986711795328355	10.2174/092986711797200435	10.2174/092986711797535245	10.2174/138161210793176536	10.2174/1389557013406828	10.2174/1389557023406494	10.2174/156802610791111560	10.2174/156802611798184427	10.2174/15680266113139990139	10.2174/1570180814666161228143846	10.2174/187152007780058669	10.25135/rnp.71.17.04.074	1507203	1552502	1738151	7636841	7707311	8064800	8558505	8604434	8709135	8978837	9288171	9357518	9435905	9784091	9839013	10052979	10464010	10637368	10732965	10762042	10819162	10821713	11101357	11310608	11495583	11563919	11597473	11689088	11741490	11776439	12014965	12166941	12369955	12369972	12500289	12617774	12620072	12729674	12824041	12871155	15080903	15080920	15317459	15544502	15544505	15582466	15588084	15603953	15633997	15634018	15658850	15670925	15715468	15771413	15878275	15887964	15935907	16129518	16182411	16230018	16250834	16279781	16279811	16366609	16420031	16475930	16570913	16722663	16860785	16908175	16989531	17005406	17030484	17077538	17084612	17105433	17154513	17181144	17252943	17348825	17373546	17624631	17681794	17822295	17850125	17902635	17944454	17979717	18047264	18082383	18181565	18232655	18406135	18479118	18517184	18524585	18554580	18605718	18640842	18782050	18786825	18855672	18958411	18987590	19043195	19053746	19199985	19252271	19308922	19374444	19422203	19726199	19856923	20047331	20053484	20061157	20079560	20158205	20166948	20233015	20345341	20347302	20361801	20472431	20545360	20575555	20684567	20698824	20817518	20828184	20880702	20926161	20943395	21067438	21111515	21143111	21152577	21163662	21211982	21216144	21222577	21232964	21367493	21411323	21417225	21417964	21428895	21429752	21435752	21459491	21497959	21570751	21621811	21641207	21669479	21715067	21798635	21861820	21871694	21873056	21920739	21939219	21990269	22000936	22019228	22023459	22039876	22050745	22185619	22243648	22341944	22380775	22420827	22444876	22467516	22472046	22503231	22512543	22549828	22624880	22633691	22680630	22795665	22818849	22944335	22949848	22981331	23000296	23041347	23134335	23164658	23199476	23330848	23376249	23410166	23437770	23454517	23501115	23511019	23535563	23541836	23639542	23685572	23719283	23768661	23791077	23891231	23931440	23988412	24095756	24128814	24140444	24148835	24160297	24220172	24290065	24360998	24389509	24461494	24502897	24508831	24521095	24657052	24681980	24704618	24738476	24794747	24835788	24836068	24929293	24934993	25017625	25047936	25088549	25089370	25226236	25259726	25282266	25282654	25418133	25461317	25462245	25462251	25597004	25597007	25621991	25656088	25707322	25812965	25868744	25969170	26003339	26116179	26158767	26159481	26181606	26212777	26242241	26278660	26503905	26510670	26583263	26588065	26632651	26805806	26827140	26861273	26869193	26917219	27023499	27023510	27061983	27068142	27083471	27128182	27157006	27187348	27227482	27253679	27328658	27343850	27376495	27392529	27405689	27445168	27455222	27460699	27484514	27484515	27560283	27668683	27720328	27721153	27727187	27736061	27744252	27783974	27863370	27908752	27918993	27951490	27998671	28064079	28189905	28242549	28406297	28445039	28454848	28478343	28578994	28613859	28629119	28672874	28788095	28803044	28810188	28841514	28863358	28923380	28986116	28991198	29031067	29227101	29268129	29283428	29324339	29353726	29400965	29407958	29414887	29466774	29533874	29534488	29541355	29887354	30031971	30061534	30104121	30110946	30134630	30245401	30301153	30579802	30621100	30686752	30736275	30736397	30771601	30771604	30798053	30851693	30939771	30999586	31281020	31311169																																																																																																																																																																																																			0.25992	3.79648	3.465e-002																														0.03249	0.47456	0.00495																														8	8	7																														HY-B1488	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:182|ACHE|Acetylcholinesterase Inhibitors;Butyrylcholinesterase Inhibitors	Nc1c2CCCCc2nc3ccccc13	1684-40-8	78798	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469460	198.26366	TACRINE HYDROCHLORIDE HYDRATE	"TACRINE HYDROCHLORIDE HYDRATE | ""TACRINE HYDROCHLORIDE | COGNEX"" | TACRINE HCL | TACRINE HYDROCHLORIDE HYDRATE | ""TACRINE HYDROCHLORIDE | COGNEX"" | TACRINE HCL"	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:182	ACHE	Acetylcholinesterase Inhibitors;Butyrylcholinesterase Inhibitors
SJ000312354-10	SJ000312354	10	MOABOX:184	XSVMFMHYUFZWBK-NSHDSACASA-N	CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1	123441-03-2	Acetylcholinesterase Inhibitors;Butyrylcholinesterase Inhibitors	ACHE	BCHE																															590																															CHEMBL215645	CHEMBL3187096	CHEMBL636									77990	77991	6918078	9936019	9952812	virtual	10.1016/j.bmc.2009.05.057	10.1016/j.bmc.2016.11.002	10.1016/j.bmcl.2015.06.047	10.1016/j.ejmech.2011.02.071	10.1016/j.ejmech.2012.10.045	10.1016/j.ejmech.2013.11.026	10.1016/j.ejmech.2019.01.030	10.1016/j.farmac.2005.03.010	10.1021/acs.jmedchem.6b00356	10.1021/jm010491d	10.1021/jm049309+	10.1021/jm049782n	10.1021/jm070559a	10.1021/jm8002747	10.1021/jm9014845	10.1021/ml200313p	10.2174/138161209787315648																																																																																																																																															12166941	12431053	15537349	15544502	15715468	15878569	16570913	17850125	18181565	18419109	19199987	19423342	19520578	20067290	21216144	21459491	21924801	22303968	22680630	23164658	23199476	24378710	24900454	25226236	25260958	26159481	26244990	27309570	27405689	27668683	27856236	27951489	28089589	29031070	29227101	30031971	30685536																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	5.296e-002	3.39296																															0.00662	0.42412																															8	8																															HY-17368	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Neuronal Signaling | Research Area: Neurological Disease|MOABOX:184|ACHE|Acetylcholinesterase Inhibitors;Butyrylcholinesterase Inhibitors	CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C	123441-03-2	7195	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469711	250.33668	RIVASTIGMINE TARTRATE	"RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTATE SALT | RIVASTIGMINE TARTATE | ""RIVASTIGMINE TARTRATE| EXELON | 3-(1-(DIMETHYLAMINO)ETHYL)PHENYL ETHYL(METHYL)CARBAMATE | RIVASTIGMINE TARTATE SALT | RIVASTIGMINE TARTATE"" | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTATE SALT | RIVASTIGMINE TARTATE | ""RIVASTIGMINE TARTRATE| EXELON | 3-(1-(DIMETHYLAMINO)ETHYL)PHENYL ETHYL(METHYL)CARBAMATE | RIVASTIGMINE TARTATE SALT | RIVASTIGMINE TARTATE"""	Pathway: Neuronal Signaling	Research Area: Neurological Disease	MOABOX:184	ACHE	Acetylcholinesterase Inhibitors;Butyrylcholinesterase Inhibitors
SJ001035368-1	SJ001035368	1	MOABOX:186	RKFAZBXYICVSKP-AATRIKPKSA-N	C/C=C/c1cc(OC)c(OC)cc1OC	2883-98-9	Acetylcholinesterase Inhibitors;HMG-CoA Reductase Inhibitors	ACHE	HMGCR																															3156																															CHEMBL333306											636822	6439566				virtual																																																																																																																																																																25311563																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.56448	1.82184																															0.08064	0.22773																															7	8																															HY-N0700	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:186|ACHE|Acetylcholinesterase Inhibitors;HMG-CoA Reductase Inhibitors	COc1cc(OC)c(\C=C\C)cc1OC	2883-98-9	20205	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469803	208.25364	ALPHA-ASARONE | TRANS-ASARONE	"""ALPHA-ASARONE | TRANS-ASARONE"" | ""ALPHA-ASARONE | TRANS-ASARONE"""	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:186	ACHE	Acetylcholinesterase Inhibitors;HMG-CoA Reductase Inhibitors
SJ000285342-6	SJ000285342	6	MOABOX:188	RODXRVNMMDRFIK-UHFFFAOYSA-N	COc1cc2ccc(=O)oc2cc1O	92-61-5	Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Nicotinic Receptor Agonists;Acetylcholinesterase Inhibitors;LDL Antioxidants	ACHE	NOS2																															4843																															CHEMBL71851											5280460	87771399	88539590	138734493		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.23702	0																															-0.03386	0.0																															7	7																															TS112386	CHEMNORM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-707-493|MOABOX:188|ACHE|Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Nicotinic Receptor Agonists;Acetylcholinesterase Inhibitors;LDL Antioxidants	COc1cc2C=CC(=O)Oc2cc1O	92-61-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468558	192.16812	SCOPOLETIN	SCOPOLETIN | SCOPOLETIN			MOABOX:188	ACHE	Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Nicotinic Receptor Agonists;Acetylcholinesterase Inhibitors;LDL Antioxidants
SJ001035177-1	SJ001035177	1	MOABOX:192	GPTFURBXHJWNHR-UHFFFAOYSA-N	CN1CCc2cc3c(cc2C(=O)Cc2ccc4c(c2C1)OCO4)OCO3	130-86-9	Acetylcholinesterase Inhibitors;Norepinephrine Transporter (NET) Inhibitors;Serotonin Transporter (SERT) Inhibitors;Inhibits LPS induced cytokine secretion	ACHE	SLC6A2	SLC6A4	HDAC6																													6530	6532	10013																													CHEMBL2165579	CHEMBL453019										4970	22543	12300136	70356421	74765185	member	10.1016/j.jep.2016.09.013																																																																																																																																																															19601791																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.27825	0	0.496	0																													-0.03975	0.0	0.062	0.0																													7	7	8	7																													HY-N0793	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?B | Research Area: Cancer|MOABOX:192|ACHE|Acetylcholinesterase Inhibitors;Norepinephrine Transporter (NET) Inhibitors;Serotonin Transporter (SERT) Inhibitors;Inhibits LPS induced cytokine secretion	CN1CCc2cc3OCOc3cc2C(=O)Cc4ccc5OCOc5c4C1	130-86-9	23154	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469002	353.36856	PROTOPINE | CORYDININE	"""PROTOPINE | CORYDININE"" | ""PROTOPINE | CORYDININE"""	Pathway: Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?B	Research Area: Cancer	MOABOX:192	ACHE	Acetylcholinesterase Inhibitors;Norepinephrine Transporter (NET) Inhibitors;Serotonin Transporter (SERT) Inhibitors;Inhibits LPS induced cytokine secretion
SJ000803697-6	SJ000803697	6	MOABOX:196	WYZWZEOGROVVHK-GTMNPGAYSA-N	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1	12772-57-5	HSP90 gene modulator	HSP90AA1																																																															CHEMBL414883																member	10.1002/anie.200800233	10.1021/ja043101w																																																																																																																																																														9925731	14698151	15974572	16202589	16913725	17114002	18316043	19017562	19200020	19519743	19860733	19860734	20536417	21106457	22253097	23362862	24495105																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.21296																																0.27662																																8																																HY-N6769	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease | Research Area: Infection|MOABOX:196|HSP90AA1|HSP90 gene modulator	C[C@@H]1C[C@H]2O[C@@H]2\C=C/C=C/C(=O)Cc3c(Cl)c(O)cc(O)c3C(=O)O1	12772-57-5	78871	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469492	364.77698	RADICICOL	"RADICICOL | ""NSC-294404 | MONORDEN"" | RADICICOL | ""NSC-294404 | MONORDEN"""	Pathway: Anti-infection; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Research Area: Infection	MOABOX:196	HSP90AA1	HSP90 gene modulator
SJ000834146-3	SJ000834146	3	MOABOX:200	CDOVNWNANFFLFJ-UHFFFAOYSA-N	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1	1062368-24-4	Activin Receptor Like Kinase 3 (ALK3 BMPR-IA) Inhibitors;Activin Receptor Like Kinase 2 (ALK2 ActR-IA) Inhibitors	ACVR1	BMPR1A	BMPR1B																														657	658																														CHEMBL513147											25195294	54613581	66576997	91654949	91900717	member	10.1016/j.bmcl.2013.03.113	10.1021/acs.jmedchem.6b01679	10.1021/cb9002865																																																																																																																																																													23639540	28103025	28696690	30227946	30258545	30384048	30828000	30973727																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														1.54952	1.0584	0.65176																														0.19369	0.1323	0.08147																														8	8	8																														HY-12071A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: TGF-beta/Smad | Research Area: Cancer|MOABOX:200|ACVR1|Activin Receptor Like Kinase 3 (ALK3 BMPR-IA) Inhibitors;Activin Receptor Like Kinase 2 (ALK2 ActR-IA) Inhibitors	C1CN(CCN1)c2ccc(cc2)c3cnc4c(cnn4c3)c5ccnc6ccccc56	2310134-98-4	6241	GENERAL	CHLORIDE	4	NO_SOLVATE	0	1469058	406.48238	LDN-193189	LDN-193189 | LDN-193189	Pathway: TGF-beta/Smad	Research Area: Cancer	MOABOX:200	ACVR1	Activin Receptor Like Kinase 3 (ALK3 BMPR-IA) Inhibitors;Activin Receptor Like Kinase 2 (ALK2 ActR-IA) Inhibitors
SJ000534767-10	SJ000534767	10	MOABOX:204	FPVKHBSQESCIEP-JQCXWYLXSA-N	OC[C@H]1O[C@@H](n2cnc3c2N=CNC[C@H]3O)C[C@@H]1O	53910-25-1	"Antimetabolites;Adenosine Deaminase Inhibitors;""Antimetabolites;Adenosine Deaminase Inhibitors"""	ADA	ADAR																															103																															CHEMBL1580	CHEMBL3144002	CHEMBL3144005	CHEMBL3144045								439693	472203	484237	66780312	67036615	member																																																																																																																																																																6604819	7310814	12643924	23084905																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.60352	0																															0.32544	0.0																															8	7																															HY-A0006	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:204|ADA|Antimetabolites;Adenosine Deaminase Inhibitors;\Antimetabolites;Adenosine Deaminase Inhibitors\	OC[C@H]1O[C@H](C[C@@H]1O)n2cnc3[C@H](O)CN=CNc23	53910-25-1	83523	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469168	268.26914	PENTOSTATIN	"PENTOSTATIN | ""NSC-218321 | PD-81565"" | ""PENTOSTATIN | CI-825 | CL-67310465 | NSC-218321 | PD-81565 | YK-176 | COVIDARABINE | DEOXYCOFORMYCIN |"" | ""PENTOSTATIN  | DEOXYCOFORMYCIN | COVIDARABINE | CI-825 | CL-67310465 | NSC-218321 | PD-81565 | YK-176 |"" | PENTOSTATIN | ""NSC-218321 | PD-81565"" | ""PENTOSTATIN | CI-825 | CL-67310465 | NSC-218321 | PD-81565 | YK-176 | COVIDARABINE | DEOXYCOFORMYCIN |"" | ""PENTOSTATIN  | DEOXYCOFORMYCIN | COVIDARABINE | CI-825 | CL-67310465 | NSC-218321 | PD-81565 | YK-176 |"""	Pathway: Anti-infection; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:204	ADA	Antimetabolites;Adenosine Deaminase Inhibitors;\Antimetabolites;Adenosine Deaminase Inhibitors\
SJ000312321-20	SJ000312321	20	MOABOX:206	PTOAARAWEBMLNO-KVQBGUIXSA-N	Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1	24757-90-2	"Antimetabolites;Apoptosis Inducers;Adenosine Deaminase Inhibitors;""Antimetabolites;Apoptosis Inducers;Adenosine Deaminase Inhibitors"""	ADA	ADAR																															103																															CHEMBL1619											20279	21120181	87063438	87182360	87278957	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															12085	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-054-532|MOABOX:206|ADA|Antimetabolites;Apoptosis Inducers;Adenosine Deaminase Inhibitors;\Antimetabolites;Apoptosis Inducers;Adenosine Deaminase Inhibitors\	Nc1nc(Cl)nc2c1ncn2[C@H]3C[C@H](O)[C@@H](CO)O3	4291-63-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468306	285.68698	CLADRIBINE	CLADRIBINE | 2-CHLORO-2'-DEOXYADENOSINE | 2-CDA | NSC-105014 | RWJ-26251 | RWJ-26251-000 | CLADRIBINE | 2-CHLORO-2'-DEOXYADENOSINE | 2-CDA | NSC-105014 | RWJ-26251 | RWJ-26251-000			MOABOX:206	ADA	Antimetabolites;Apoptosis Inducers;Adenosine Deaminase Inhibitors;\Antimetabolites;Apoptosis Inducers;Adenosine Deaminase Inhibitors\
SJ000286229-13	SJ000286229	13	MOABOX:222	OHCQJHSOBUTRHG-KGGHGJDLSA-N	C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C	64657-11-0	Adenylate Cyclase Activators	ADCY1	ADCY2	ADCY3	ADCY6	ADCY8	ADCYAP1	ADCY4																										108	109	112	114	116	196883																										CHEMBL52606											47936	46848038	67061590	67321979	67738101	member																																																																																																																																																																8709105																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.59752	0.3632	0.3178	0.3178	0.3178	0.3178	0.3178																										0.07469	0.0454	0.0454	0.0454	0.0454	0.0454	0.0454																										8	8	7	7	7	7	7																										T2939	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-493-717|MOABOX:222|ADCY1|Adenylate Cyclase Activators	CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]3(O)C(=O)C[C@@](C)(O[C@]13C)C=C	66575-29-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468581	410.50116	COLFORSIN	"COLFORSIN | FORSKOLIN | ""FORSKOLIN | COLFORSIN | BOFORSIN | COLEONOL | HL-362 | L-751362B | M-410 |"" | COLFORSIN | FORSKOLIN | ""FORSKOLIN | COLFORSIN | BOFORSIN | COLEONOL | HL-362 | L-751362B | M-410 |"""			MOABOX:222	ADCY1	Adenylate Cyclase Activators
SJ000013265-2	SJ000013265	2	MOABOX:224	SOJUSNIBPPMLCC-UHFFFAOYSA-N	Nc1ncc2c(n1)CC(c1ccco1)CC2=O	299442-43-6	Adenylate Cyclase Type V Inhibitors	ADCY5																																																															CHEMBL1456284											2772368					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.17486																																-0.02498																																7																																HY-103195	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Metabolic Disease|MOABOX:224|ADCY5|Adenylate Cyclase Type V Inhibitors	Nc1ncc2C(=O)CC(Cc2n1)c3occc3	299442-43-6	80257	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468754	229.23464			Pathway: GPCR/G Protein	Research Area: Metabolic Disease	MOABOX:224	ADCY5	Adenylate Cyclase Type V Inhibitors
SJ001010949-2	SJ001010949	2	MOABOX:228	XOKJUSAYZUAMGJ-WOUKDFQISA-N	N#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12	606-58-6		ADK																																																															CHEMBL99668											11824	129660609	131740595	131740596	131740597	virtual																																																																																																																																																																10956196	11958989																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-7.931e-002																																-0.01133																																7																																HY-103248	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Apoptosis; Cell Cycle/DNA Damage | Research Area: Cancer; Infection|MOABOX:228|ADK|	Nc1ncnc2c1c(cn2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C#N	606-58-6	83963	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469218	291.26272	TOYOCAMYCIN	TOYOCAMYCIN | TOYOCAMYCIN	Pathway: Anti-infection; Apoptosis; Cell Cycle/DNA Damage	Research Area: Cancer; Infection	MOABOX:228	ADK	
SJ001035091-1	SJ001035091	1	MOABOX:234	JAKAFSGZUXCHLF-LSCFUAHRSA-N	CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(NC3CCCCC3)ncnc21	130714-47-5	Adenosine A1 Agonists;ADORA1 agonist	ADORA1																																																															CHEMBL117904											164305	71351377				member	10.1517/13543780802497284																																																																																																																																																															7996449	10479279																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.44888																																0.05611																																8																																1265	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-443|MOABOX:234|ADORA1|Adenosine A1 Agonists;ADORA1 agonist	CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n2cnc3c(NC4CCCCC4)ncnc23	130714-47-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468667	363.4115	SDZ-WAG 994 | WAG 994	"""SDZ-WAG 994 | WAG 994"" | ""SDZ-WAG 994 | WAG 994"""			MOABOX:234	ADORA1	Adenosine A1 Agonists;ADORA1 agonist
SJ000855411-4	SJ000855411	4	MOABOX:236	HWXIGFIVGWUZAO-UHFFFAOYSA-N	Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O	69975-86-6	Adenosine A1 Antagonists	ADORA1																																																															CHEMBL1527608											50942	69622005	71548177	73505677	91886054	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-B0004	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:236|ADORA1|Adenosine A1 Antagonists	CN1C(=O)N(C)c2ncn(CC3OCCO3)c2C1=O	69975-86-6	27081	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468788	266.25326	DOXOFYLLINE	DOXOFYLLINE | DOXOFYLLINE	Pathway: GPCR/G Protein; Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:236	ADORA1	Adenosine A1 Antagonists
SJ001034903-1	SJ001034903	1	MOABOX:238	BEPGKLOHQTXUHX-UHFFFAOYSA-N	Nc1nc(-c2ccc(Cl)c(Cl)c2)c(-c2ccncc2)s1	252198-68-8	Adenosine A1 Antagonists;Adenosine A2B Antagonists;Adenosine A3 Antagonists;Phosphodiesterase IV Inhibitors;p38 MAPK Inhibitors	ADORA1	ADORA2B	ADORA3	PDE2A	MAPK13																												136	140	5138	5603																												CHEMBL1551336	CHEMBL1624302										5282339	16759176	71297117	140668833		member	10.1038/sj.bjp.0706132																																																																																																																																																															15685201	16918456																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.31816	0.37808	0.39824	0	0																												0.16477	0.04726	0.04978	0.0	0.0																												8	8	8	7	7																												2344	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-402|MOABOX:238|ADORA1|Adenosine A1 Antagonists;Adenosine A2B Antagonists;Adenosine A3 Antagonists;Phosphodiesterase IV Inhibitors;p38 MAPK Inhibitors	Nc1nc(c2ccc(Cl)c(Cl)c2)c(s1)c3ccncc3	1177618-54-0	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468209	322.21236	CGH 2466 DIHCL	CGH 2466 DIHCL | CGH 2466 DIHCL			MOABOX:238	ADORA1	Adenosine A1 Antagonists;Adenosine A2B Antagonists;Adenosine A3 Antagonists;Phosphodiesterase IV Inhibitors;p38 MAPK Inhibitors
SJ000287772-6	SJ000287772	6	MOABOX:240	PAOANWZGLPPROA-RQXXJAGISA-N	CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(CCC(=O)O)cc4)nc32)[C@H](O)[C@@H]1O	120225-54-9	Adenosine A2A Agonists	ADORA2A																																																															CHEMBL331372	CHEMBL537419										3086598	3086599	10256643	44404043	44471686	member	10.1007/s00210-002-0617-z	10.1007/s00210-007-0135-0	10.1016/0014-2999(96)00495-5	10.1016/S0006-2952(98)00298-6	10.1016/j.bmcl.2009.11.131	10.1016/j.bmcl.2013.01.025	10.1021/jm501203v	10.1038/sj.bjp.0701119	10.1039/c7md00247e	10.1074/jbc.270.23.13987																																																																																																																																																						2016707	9258366	10212124	15267242	17350268	18262425	19481943	20031406	22104008	23245803	24164628	24900277	25221664	25780876	26356532	26513641																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						2.40824																																0.30103																																8																																HY-13201A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Neurological Disease|MOABOX:240|ADORA2A|Adenosine A2A Agonists	CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(N)nc(NCCc4ccc(CCC(=O)O)cc4)nc23	124431-80-7	22627	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468952	499.51966	CGS-21680 HYDROCHLORIDE	"CGS-21680 HYDROCHLORIDE | ""CGS 21680 HYDROCHLORIDE | CRX-501 |"" | CGS 21680 HCL | CGS-21680 HYDROCHLORIDE | ""CGS 21680 HYDROCHLORIDE | CRX-501 |"" | CGS 21680 HCL"	Pathway: GPCR/G Protein	Research Area: Neurological Disease	MOABOX:240	ADORA2A	Adenosine A2A Agonists
SJ000855321-4	SJ000855321	4	MOABOX:244	IQVRBWUUXZMOPW-PKNBQFBNSA-N	CCn1c(=O)c2c(nc(/C=C/c3ccc(OC)c(OC)c3)n2C)n(CC)c1=O	155270-99-8	Adenosine A2A Antagonists	ADORA2A																																																															CHEMBL431770											5311037	11239347	11342797			member	10.1007/s00210-007-0135-0	10.1017/S1461145705006188	10.1021/cn5001606																																																																																																																																																													16250647	16844379	16971117	17177231	17684118	18189346	18255063	19362836	20370660	20659802	21185259	21210664	21628909	21661720	21664729	22335511	23281824	23602401	23631427	24139167	24164628	25701253	28629145	29268131	30808606																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1.46168																																0.18271																																8																																HY-10888	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Neurological Disease|MOABOX:244|ADORA2A|Adenosine A2A Antagonists	CCN1C(=O)N(CC)c2nc(\C=C\c3ccc(OC)c(OC)c3)n(C)c2C1=O	155270-99-8	6185	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469194	384.42896	ISTRADEFYLLINE	ISTRADEFYLLINE | ISTRADEFYLLINE	Pathway: GPCR/G Protein	Research Area: Neurological Disease	MOABOX:244	ADORA2A	Adenosine A2A Antagonists
SJ000288120-5	SJ000288120	5	MOABOX:246	SCNILGOVBBRMBK-SDBHATRESA-N	Nc1nc(Nc2ccccc2)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	53296-10-9	ADORA2A agonist;ADORA2B agonist;Adenosine A2A Agonists;Adenosine A2B Agonists	ADORA2A	ADORA2B																															136																															CHEMBL1256672											6917803					virtual	10.1016/S0006-2952(98)00298-6	10.1038/sj.bjp.0701119																																																																																																																																																														2016707	2795469																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.85976	0.47112																															0.10747	0.05889																															8	8																															28734	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-194|MOABOX:246|ADORA2A|ADORA2A agonist;ADORA2B agonist;Adenosine A2A Agonists;Adenosine A2B Agonists	Nc1nc(Nc2ccccc2)nc3c1ncn3[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O	53296-10-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468468	358.35192	2-PHENYLAMINOADENOSINE	"2-PHENYLAMINOADENOSINE | ""CV 1808 | 2-PHENYLAMINOADENOSINE |"" | 2-PHENYLAMINOADENOSINE | ""CV 1808 | 2-PHENYLAMINOADENOSINE |"""			MOABOX:246	ADORA2A	ADORA2A agonist;ADORA2B agonist;Adenosine A2A Agonists;Adenosine A2B Agonists
SJ000832246-3	SJ000832246	3	MOABOX:248	PWTBZOIUWZOPFT-UHFFFAOYSA-N	Nc1nc(NCCc2ccc(O)cc2)nc2nc(-c3ccco3)nn12	139180-30-6	Adenosine A2A Antagonists;Adenosine A2B Antagonists	ADORA2A	ADORA2B																															136																															CHEMBL113142											176407					member	10.1007/s00210-002-0617-z	10.1016/j.ejmech.2017.12.007	10.1021/acs.jmedchem.6b01068																																																																																																																																																													11347973	11734617	11809867	11976268	12570759	12570760	15149696	15194002	15294001	16153830	16250647	16375751	16380972	16847822	17168717	17168726	17177231	18255063	18537675	18637670	18687311	19036477	19743865	20018509	20095623	20202853	20537438	21185259	21214204	21661720	22335511	23200243	23602401	24164628	24972108	25105925	25490054	26356532	26717203	26824742	27312113	27933962	28368607	28626529	29268131	29681156	29909340	30080404	30322034																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					4.84536	-0.33104																															0.60567	-0.04138																															8	8																															HY-19532	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Neurological Disease; Cancer|MOABOX:248|ADORA2A|Adenosine A2A Antagonists;Adenosine A2B Antagonists	Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4	139180-30-6	22530	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469114	337.336	ZM 241385	ZM 241385 | ZM 241385	Pathway: GPCR/G Protein	Research Area: Neurological Disease; Cancer	MOABOX:248	ADORA2A	Adenosine A2A Antagonists;Adenosine A2B Antagonists
SJ000287815-5	SJ000287815	5	MOABOX:252	WBWFIUAVMCNYPG-BQYQJAHWSA-N	Cn1c(=O)c2c(nc(/C=C/c3cccc(Cl)c3)n2C)n(C)c1=O	147700-11-6	Adenosine A2A Antagonists;MAO-B Inhibitors	ADORA2A	MAOB																															4129																															CHEMBL26138											5353365	53249314	69967925			member	10.1016/j.bmc.2013.09.044	10.1021/jm400336x																																																																																																																																																														11087559	12570759	12628657	18181565	19342233	21134756	21185259	21864289	23281824	23631427	23892098	24139167	25600407	25915162	30808606																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							0.4332	0.662																															0.05415	0.08275																															8	8																															29704	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-940-662|MOABOX:252|ADORA2A|Adenosine A2A Antagonists;MAO-B Inhibitors	CN1C(=O)N(C)c2nc(\C=C\c3cccc(Cl)c3)n(C)c2C1=O	147700-11-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468650	330.7689	8-(3-CHLOROSTYRYL)CAFFEINE	8-(3-CHLOROSTYRYL)CAFFEINE | 8-(3-CHLOROSTYRYL)CAFFEINE			MOABOX:252	ADORA2A	Adenosine A2A Antagonists;MAO-B Inhibitors
SJ001035136-1	SJ001035136	1	MOABOX:254	ZTYHZMAZUWOXNC-UHFFFAOYSA-N	N#Cc1c(N)nc(SCC(N)=O)c(C#N)c1-c1ccc(OCC2CC2)cc1	910487-58-0	Adenosine A2B Agonists	ADORA2B																																																																										11717831					member																																																																																																																																																																20370659	21185259	21649583	29525433																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		3.11824																																0.38978																																8																																HY-103171	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Inflammation/Immunology; Cardiovascular Disease|MOABOX:254|ADORA2B|Adenosine A2B Agonists	NC(=O)CSc1nc(N)c(C#N)c(c2ccc(OCC3CC3)cc2)c1C#N	910487-58-0	64820	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468834	379.43558	BAY 60-6583	BAY 60-6583 | BAY 60-6583	Pathway: GPCR/G Protein	Research Area: Inflammation/Immunology; Cardiovascular Disease	MOABOX:254	ADORA2B	Adenosine A2B Agonists
SJ000287997-4	SJ000287997	4	MOABOX:258	AJBBEYXFRYFVNM-UHFFFAOYSA-N	CCCn1c(=O)c2[nH]c(-c3ccc(OCC(=O)Nc4ccc(C#N)cc4)cc3)nc2n(CCC)c1=O	264622-58-4	Adenosine A2B Antagonists	ADORA2B																																																															CHEMBL273807											6603931	71311720				member																																																																																																																																																																10737749	11226132	11264476	11266650	11834616	11906291	12369947	12570714	15664822	15748700	16155103	16375751	16380972	16392813	16545350	16759111	16821798	16847822	16918456	17168717	18687311	19346133	19569717	20370659	20537438	21185259	21628909	22148859	22703703	26824742	27842891	28368607																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						4.9184																																0.6148																																8																																HY-14121	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Metabolic Disease; Inflammation/Immunology|MOABOX:258|ADORA2B|Adenosine A2B Antagonists	CCCN1C(=O)N(CCC)c2nc([nH]c2C1=O)c3ccc(OCC(=O)Nc4ccc(cc4)C#N)cc3	264622-58-4	41953	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469698	486.52244	MRS 1754	MRS 1754 | MRS 1754	Pathway: GPCR/G Protein	Research Area: Metabolic Disease; Inflammation/Immunology	MOABOX:258	ADORA2B	Adenosine A2B Antagonists
SJ000832268-3	SJ000832268	3	MOABOX:262	IPSYPUKKXMNCNQ-PFHKOEEOSA-N	CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)nc(Cl)nc32)[C@H](O)[C@@H]1O	163042-96-4	Adenosine A3 Agonists	ADORA3																																																															CHEMBL431733											3035850					member	10.1016/S0028-3908(97)00104-4	10.1016/j.bcp.2003.10.006	10.1016/j.bcp.2008.05.032	10.1016/j.bmc.2014.05.036	10.1016/j.bmcl.2005.10.054	10.1021/jm0408161	10.1021/jm058008c	10.1021/jm900754g	10.1074/jbc.M110960200																																																																																																																																																							9703464	9873431	11708915	12238926	12540233	12930138	15341491	15341938	15481989	15743197	15771421	16487705	17555308	17927167	18255292	18269230	18424135	18752961	18811138	18973967	19375920	19879151	22257095	22468757	23200243	24077183	24175626	24931275	26390077	28380296	28799755																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							1.71816																																0.21477																																8																																HY-12365	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cancer|MOABOX:262|ADORA3|Adenosine A3 Agonists	CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NCc4cccc(I)c4)nc(Cl)nc23	163042-96-4	84965	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469632	544.73079	1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-BETA-D-RIBOFURANURONAMIDE	1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-BETA-D-RIBOFURANURONAMIDE | 2-Cl-IB-MECA | CI-IB-MECA | 1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-BETA-D-RIBOFURANURONAMIDE | 2-Cl-IB-MECA | CI-IB-MECA	Pathway: GPCR/G Protein	Research Area: Cancer	MOABOX:262	ADORA3	Adenosine A3 Agonists
SJ000560625-3	SJ000560625	3	MOABOX:266	ZFLJHSQHILSNCM-UHFFFAOYSA-N	c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1	656820-32-5	Aurora-B (ARK2) Kinase Inhibitors;Antimitotic Drugs;Aurora-A (ARK1) Kinase Inhibitors;Adenosine A3 Antagonists;Differentiation Inhibitors	ADORA3	AURKA	AURKB																														6790	9212																														CHEMBL188343											210332	137524582				virtual	10.1158/1535-7163.MCT-07-2051	10.2174/092986709788682227																																																																																																																																																														16033270	18483302	19519375	22632936																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.12424	0.46656	-0.1776																														0.01553	0.05832	-0.0222																														8	8	8																														HY-14711	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:266|ADORA3|Aurora-B (ARK2) Kinase Inhibitors;Antimitotic Drugs;Aurora-A (ARK1) Kinase Inhibitors;Adenosine A3 Antagonists;Differentiation Inhibitors	C1CCC(CC1)Nc2nc(Nc3ccc(cc3)N4CCOCC4)nc5[nH]cnc25	656820-32-5	9473	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469070	393.48538	REVERSINE	REVERSINE | REVERSINE	Pathway: Autophagy; Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:266	ADORA3	Aurora-B (ARK2) Kinase Inhibitors;Antimitotic Drugs;Aurora-A (ARK1) Kinase Inhibitors;Adenosine A3 Antagonists;Differentiation Inhibitors
SJ000285535-12	SJ000285535	12	MOABOX:270	SONNWYBIRXJNDC-VIFPVBQESA-N	CNC[C@H](O)c1cccc(O)c1	1228015-39-1	alpha1A-Adrenoceptor Ligands;alpha1-Adrenoceptor Agonists	ADRA1A																																																															CHEMBL1200339	CHEMBL1215	CHEMBL2062264									6041	657210	3084270	5284443	9816652	member																																																																																																																																																																25813897	27658792																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.54368																																0.06796																																8																																J10876	AK_SCIENTIFIC	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-004-285-491|MOABOX:270|ADRA1A|alpha1A-Adrenoceptor Ligands;alpha1-Adrenoceptor Agonists	CNC[C@H](O)c1cccc(O)c1	61-76-7	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468257	167.20502	PHENYLEPHRINE	"PHENYLEPHRINE | ""PSD-503 | SLV-325 | VEN-308"" | (L)-PHENYLEPHRINE | PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE | ""PSD-503 | SLV-325 | VEN-308"" | (L)-PHENYLEPHRINE | PHENYLEPHRINE HYDROCHLORIDE"			MOABOX:270	ADRA1A	alpha1A-Adrenoceptor Ligands;alpha1-Adrenoceptor Agonists
SJ000285535-13	SJ000285535	13	MOABOX:270	SONNWYBIRXJNDC-VIFPVBQESA-N	CNC[C@H](O)c1cccc(O)c1	1228015-39-1	alpha1A-Adrenoceptor Ligands;alpha1-Adrenoceptor Agonists	ADRA1A																																																															CHEMBL1200339	CHEMBL1215	CHEMBL2062264									6041	657210	3084270	5284443	9816652	member																																																																																																																																																																25813897	27658792																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.54368																																0.06796																																8																																AA00IAPH	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-260|MOABOX:270|ADRA1A|alpha1A-Adrenoceptor Ligands;alpha1-Adrenoceptor Agonists	CNC[C@H](O)c1cccc(O)c1	61-76-7	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468276	167.20502	PHENYLEPHRINE	"PHENYLEPHRINE | ""PSD-503 | SLV-325 | VEN-308"" | (L)-PHENYLEPHRINE | PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE | ""PSD-503 | SLV-325 | VEN-308"" | (L)-PHENYLEPHRINE | PHENYLEPHRINE HYDROCHLORIDE"			MOABOX:270	ADRA1A	alpha1A-Adrenoceptor Ligands;alpha1-Adrenoceptor Agonists
SJ000312299-5	SJ000312299	5	MOABOX:274	DRHKJLXJIQTDTD-OAHLLOKOSA-N	CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1	106133-20-4	alpha1-Adrenoceptor Antagonists	ADRA1B	ADRA1A																															148																															CHEMBL1200914	CHEMBL836										129211	5362376	9984663	9987642	10005750	member																																																																																																																																																																9135028	9276013	9359081	9379432	10780916	10841797	10968279	11026539	11384242	15664832	17052252	17168713	17452102	17517507	17904840	17917257	18055202	18379048	20934789	27448917	27658792	27709945																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.34808	1.30136																															0.04351	0.16267																															8	8																															HY-B0661	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Cancer; Endocrinology; Neurological Disease|MOABOX:274|ADRA1B|alpha1-Adrenoceptor Antagonists	CCOc1ccccc1OCCN[C@H](C)Cc2ccc(OC)c(c2)S(=O)(=O)N	106133-20-4	13388	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469870	408.51172	(R) -TAMSULOSIN HYDROCHLORIDE| FLOMAX| HARNAL| OMNIC| PRADIF	"(R) -TAMSULOSIN HYDROCHLORIDE| FLOMAX| HARNAL| OMNIC| PRADIF | TAMSULOSIN HYDROCHLORIDE| FLOMAX | ""(R) -TAMSULOSIN HYDROCHLORIDE | HARNAL | OMNIC | PRADIF | TAMSULOSIN HYDROCHLORIDE | FLOMAX | ALNA | ALNAOCAS | JOSIR | OMIC | OMIX | SECOTEX | UROLOSIN | AMSULOSIN HYDROCHLORIDE | EU-617 | LY-253351 | Y-617 | YM-12617-1 | YM-617 |"" | (R) -TAMSULOSIN HYDROCHLORIDE| FLOMAX| HARNAL| OMNIC| PRADIF | TAMSULOSIN HYDROCHLORIDE| FLOMAX | ""(R) -TAMSULOSIN HYDROCHLORIDE | HARNAL | OMNIC | PRADIF | TAMSULOSIN HYDROCHLORIDE | FLOMAX | ALNA | ALNAOCAS | JOSIR | OMIC | OMIX | SECOTEX | UROLOSIN | AMSULOSIN HYDROCHLORIDE | EU-617 | LY-253351 | Y-617 | YM-12617-1 | YM-617 |"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Cancer; Endocrinology; Neurological Disease	MOABOX:274	ADRA1B	alpha1-Adrenoceptor Antagonists
SJ000285681-15	SJ000285681	15	MOABOX:276	WYWIFABBXFUGLM-UHFFFAOYSA-N	Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1	1491-59-4	alpha1A-Adrenoceptor Agonists;alpha2A(2D)-Adrenoceptor Agonists	ADRA1B	ADRA1A	ADRA2A	HTR1E																													148	150	3354																													CHEMBL1200791	CHEMBL762										4636	66259	9848897	9850061	21114704	member	10.1074/jbc.M004550200																																																																																																																																																															7658428	8831777	9632357	11281844	11597419	11844675	12014961	15655522	17266604	18621536	20978120	21558436	22020552	22711801	24365159	25703306	28319392	29767967																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.40453	-0.2168	-7.336e-002	0.6992																													-0.05779	-0.0271	-0.00917	0.0874																													7	8	8	8																													NB-48-0716-100MG	BIOTREND	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-709-375|MOABOX:276|ADRA1B|alpha1A-Adrenoceptor Agonists;alpha2A(2D)-Adrenoceptor Agonists	Cc1cc(c(O)c(C)c1CC2=NCCN2)C(C)(C)C	2315-02-08	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468353	260.37456	OXYMETAZOLINE HYDROCHLORIDE	"OXYMETAZOLINE HYDROCHLORIDE | ""AFRIN | MUCINEX"" | OXYMETAZOLINE HCL | OXYMETAZOLINE HYDROCHLORIDE | ""AFRIN | MUCINEX"" | OXYMETAZOLINE HCL"			MOABOX:276	ADRA1B	alpha1A-Adrenoceptor Agonists;alpha2A(2D)-Adrenoceptor Agonists
SJ000796099-2	SJ000796099	2	MOABOX:278	TZJUVVIWVWFLCD-UHFFFAOYSA-N	O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ncccn2)CC1	92589-98-5	HTR1A agonist;5-HT1A Receptor Agonists;ADRA1B gene modulator	ADRA1B	HTR1A																															3350																															CHEMBL2107276	CHEMBL8412										56971	71187				virtual	10.1016/S0014-2999(98)00483-X																																																																																																																																																															1359584	3543362	7831380	9873561	9873568	11945120	15341483	16029144	16722631	17897004	19754201																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											-0.26448	1.61728																															-0.03306	0.20216																															8	8																															AU-059/43515096	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-477|MOABOX:278|ADRA1B|HTR1A agonist;5-HT1A Receptor Agonists;ADRA1B gene modulator	O=C1N(CCCCN2CCN(CC2)c3ncccn3)S(=O)(=O)c4ccccc14	92589-98-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468530	401.48262	IPSAPIRONE | TVX Q 7821 | BAY-Q-7821 |	"""IPSAPIRONE | TVX Q 7821 | BAY-Q-7821 |"" | ""IPSAPIRONE | TVX Q 7821 | BAY-Q-7821 |"""			MOABOX:278	ADRA1B	HTR1A agonist;5-HT1A Receptor Agonists;ADRA1B gene modulator
SJ001034956-1	SJ001034956	1	MOABOX:282	UMTDAKAAYOXIKU-UHFFFAOYSA-N	COc1ccccc1N1CCN(CC(C(=O)NC(C)(C)C)c2ccccc2)CC1	133025-23-7	5-HT1A Receptor Antagonists;ADRA1B gene modulator	ADRA1B	HTR1A																															3350																															CHEMBL22564											115111	14801905	71297027	129848556		virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.35532	0.99544																															-0.05076	0.12443																															7	8																															1360	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-665-680|MOABOX:282|ADRA1B|5-HT1A Receptor Antagonists;ADRA1B gene modulator	COc1ccccc1N2CCN(CC(C(=O)NC(C)(C)C)c3ccccc3)CC2	149055-79-8	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468368	395.53772	WAY 100135 DIHCL	WAY 100135 DIHCL | WAY 100135 DIHCL			MOABOX:282	ADRA1B	5-HT1A Receptor Antagonists;ADRA1B gene modulator
SJ000287725-7	SJ000287725	7	MOABOX:286	AYYCFGDXLUPJAQ-UHFFFAOYSA-N	COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1	1348935-37-4	5-HT1A Receptor Antagonists;alpha1D-Adrenoceptor Antagonists	ADRA1D	HTR1A																															3350																															CHEMBL1256934	CHEMBL13647	CHEMBL543741									2419	210172	23640914	44275113	53313209	member																																																																																																																																																																9135028	9548811	9822553	9871765	10514291	11354357	11931617	12672251	12825930	15055991	15686938	15828846	18817363	20185311	20605276	21514979	22145629	23252794	23902232	27662034	27689727																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.96176	2.35456																															0.24522	0.29432																															8	8																															MG-0114	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-940-399|MOABOX:286|ADRA1D|5-HT1A Receptor Antagonists;alpha1D-Adrenoceptor Antagonists	COc1ccccc1N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2	21102-94-3	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468360	385.49984	BMY 7378 DIHYDROCHLORIDE	BMY 7378 DIHYDROCHLORIDE | BMY 7378 HCL | BMY 7378 | BMY 7378 DIHYDROCHLORIDE | BMY 7378 HCL | BMY 7378			MOABOX:286	ADRA1D	5-HT1A Receptor Antagonists;alpha1D-Adrenoceptor Antagonists
SJ001034922-1	SJ001034922	1	MOABOX:288	YVWGGGGMRDLOGA-GOSISDBHSA-N	Cc1cccc(S(=O)(=O)N2CCC[C@@H]2CCN2CCC(C)CC2)c1	201038-58-6	ADRA1B gene modulator;5-HT7 Antagonists	HTR7	ADRA1B																															147																															CHEMBL12624											9863250	90470912				virtual																																																																																																																																																																10669560	10843226	12825922	14667218	15032609	15816047																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																-0.69202	2.37904																															-0.09886	0.29738																															7	8																															1100	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-665-634|MOABOX:288|HTR7|ADRA1B gene modulator;5-HT7 Antagonists	CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c3cccc(C)c3)CC1	201038-58-6	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468248	350.5187	SB 258741 HCL	SB 258741 HCL | SB 258741 HCL			MOABOX:288	HTR7	ADRA1B gene modulator;5-HT7 Antagonists
SJ000288285-5	SJ000288285	5	MOABOX:290	HIHZDNKKIUQQSC-UHFFFAOYSA-N	COc1ccccc1N1CCN(CCCNc2c(C)c(=O)n(C)c(=O)n2C)CC1	34661-85-3	alpha1A-Adrenoceptor Antagonists	ADRA1B																																																															CHEMBL420060											5640	11181197	16220063	129718192		virtual																																																																																																																																																																7658428	8831777	9135028	9276013	10968279	16420037																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																-4.784e-002																																-0.00598																																8																																ST110920	TIMTEC	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-959-839|MOABOX:290|ADRA1B|alpha1A-Adrenoceptor Antagonists	COc1ccccc1N2CCN(CCCNC3=C(C)C(=O)N(C)C(=O)N3C)CC2	34661-85-3	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468719	401.50254	"URAPIDIL, 5-METHYL-"	"URAPIDIL, 5-METHYL- | 5-METHYLURAPIDIL | URAPIDIL, 5-METHYL- | 5-METHYLURAPIDIL"			MOABOX:290	ADRA1B	alpha1A-Adrenoceptor Antagonists
SJ000286094-11	SJ000286094	11	MOABOX:292	WNMJYKCGWZFFKR-UHFFFAOYSA-N	COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC	1100050-87-0	alpha1-Adrenoceptor Antagonists	ADRA1B																																																															CHEMBL1723	CHEMBL709										2092	71764	9809802	19430893	19430895	virtual																																																																																																																																																																7658428	9135028	9190863	9190864	9223558	10968279	16420037	17168713																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														1.11032																																0.13879																																8																																AA0052MG	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-391-851|MOABOX:292|ADRA1B|alpha1-Adrenoceptor Antagonists	COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C3CCCO3	81403-68-1	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468272	389.44878	ALFLUZOCIN	"ALFLUZOCIN | ALFUZOSIN HYDROCHLORIDE | ""ALFUZOSIN HYDROCHLORIDE | UROXATRAL"" | ALFUZOSIN HCL | ALFLUZOCIN | ALFUZOSIN HYDROCHLORIDE | ""ALFUZOSIN HYDROCHLORIDE | UROXATRAL"" | ALFUZOSIN HCL"			MOABOX:292	ADRA1B	alpha1-Adrenoceptor Antagonists
SJ000285944-12	SJ000285944	12	MOABOX:294	ICMGLRUYEQNHPF-UHFFFAOYSA-N	COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1	102411-11-0	alpha1-Adrenoceptor Antagonists	ADRA1B																																																															CHEMBL1256716	CHEMBL279229										5639	167980	9870716	45114226	69402080	member																																																																																																																																																																9135028	10490890	17168713	26386822																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.48272																																0.06896																																7																																KS-5208	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1ccccc1N2CCN(CCCNC3=CC(=O)N(C)C(=O)N3C)CC2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466689	387.47596	URAPIDIL	URAPIDIL | URAPIDIL HYDROCHLORIDE | URAPIDIL HCL | URAPIDIL | URAPIDIL HYDROCHLORIDE | URAPIDIL HCL			MOABOX:294	ADRA1B	alpha1-Adrenoceptor Antagonists
SJ000285473-7	SJ000285473	7	MOABOX:296	GYSZUJHYXCZAKI-UHFFFAOYSA-N	COc1cccc(OC)c1OCCNCC1COc2ccccc2O1	2170-58-3	alpha1-Adrenoceptor Antagonists	ADRA1B																																																															CHEMBL25554	CHEMBL556001										5685	11957505	44277011			virtual																																																																																																																																																																40029	7658428	8667368	9135028	10425105	10514291	10893315	11931617	12672251	14584940	16420037	17125266	17168713	17266603	18817363	20801662	21571945	23252794																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-8.2e-002																																-0.01025																																8																																29528	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-495|MOABOX:296|ADRA1B|alpha1-Adrenoceptor Antagonists	COc1cccc(OC)c1OCCNCC2COc3ccccc3O2	2170-58-3	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468300	345.38962	WB-4101 HYDROCHLORIDE	WB-4101 HYDROCHLORIDE | WB 4101 HCL | WB-4101 HYDROCHLORIDE | WB 4101 HCL			MOABOX:296	ADRA1B	alpha1-Adrenoceptor Antagonists
SJ000113084-11	SJ000113084	11	MOABOX:302	RUZYUOTYCVRMRZ-UHFFFAOYSA-N	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC	137888-77-8	alpha1-Adrenoceptor Antagonists;Apoptosis Inducers	ADRA1D	ADRA1B	ADRA1A																														147	148																														CHEMBL1200561	CHEMBL707										3157	62978	9810149	9830597	9962390	virtual																																																																																																																																																																2879919	7658428	9135028	9223558	10900216	10968279	11384242	15120318	16302814	16420037	17052252	17168713	19719240	27774138	28499171																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							0.65136	1.16632	0.42584																														0.08142	0.14579	0.05323																														8	8	8																														AG00ICWG	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-427|MOABOX:302|ADRA1D|alpha1-Adrenoceptor Antagonists;Apoptosis Inducers	COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4COc5ccccc5O4	77883-43-3	NA	GENERAL	METHANESULFONATE	1	NO_SOLVATE	0	1468237	451.4751	DOXAZOSIN MESYLATE	DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE			MOABOX:302	ADRA1D	alpha1-Adrenoceptor Antagonists;Apoptosis Inducers
SJ000287588-5	SJ000287588	5	MOABOX:304	IEJXVRYNEISIKR-UHFFFAOYSA-N	Nc1cc(Cl)c(NC2=NCCN2)c(Cl)c1	66711-21-5	alpha2-Adrenoceptor Agonists	ADRA1A	ADRA2A																															150																															CHEMBL1200379	CHEMBL647										2216	51763	21479682	51371111	57515911	member	10.1038/sj.bjp.0705439	10.1124/mol.59.5.1343																																																																																																																																																														3037080	8784451	17266604																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			-0.51784	1.09752																															-0.06473	0.13719																															8	8																															HY-12720A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Neurological Disease|MOABOX:304|ADRA1A|alpha2-Adrenoceptor Agonists	Nc1cc(Cl)c(NC2=NCCN2)c(Cl)c1	73218-79-8	64012	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468985	245.1085	P-AMINOCLONIDINE HYDROCHLORIDE	"P-AMINOCLONIDINE HYDROCHLORIDE | ""APRACLONIDINE HYDROCHLORIDE | IOPIDINE"" | P-AMINOCLONIDINE HYDROCHLORIDE | ""APRACLONIDINE HYDROCHLORIDE | IOPIDINE"""	Pathway: Others	Research Area: Neurological Disease	MOABOX:304	ADRA1A	alpha2-Adrenoceptor Agonists
SJ000286481-14	SJ000286481	14	MOABOX:304	IEJXVRYNEISIKR-UHFFFAOYSA-N	Nc1cc(Cl)c(NC2=NCCN2)c(Cl)c1	66711-21-5	alpha2-Adrenoceptor Agonists	ADRA1A	ADRA2A																															150																															CHEMBL1200379	CHEMBL647										2216	51763	21479682	51371111	57515911	member	10.1038/sj.bjp.0705439	10.1124/mol.59.5.1343																																																																																																																																																														3037080	8784451	17266604																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			-0.51784	1.09752																															-0.06473	0.13719																															8	8																															HY-12721	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:304|ADRA1A|alpha2-Adrenoceptor Agonists	Clc1cccc(Cl)c1NC2=NCCN2	4205-90-7	90287	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468934	230.09386	CLONIDINE	CLONIDINE | DURACLON | CLONIDINE HYDROCHLORIDE | CLONIDINE | DURACLON | CLONIDINE HYDROCHLORIDE	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:304	ADRA1A	alpha2-Adrenoceptor Agonists
SJ000286135-14	SJ000286135	14	MOABOX:306	MRBDMNSDAVCSSF-UHFFFAOYSA-N	Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1	249607-96-3	alpha-Adrenoceptor Antagonists	ADRA1B																																																															CHEMBL1200873	CHEMBL1204146	CHEMBL597									5775	91430	657359	4920903	5702144	member																																																																																																																																																																2886664	6115059	6124636	8496700	10968279	12519065	16153828	21558436	23181587	23787101	24161678	24691057	26005522	26821136	27774138																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							0.1884																																0.02355																																8																																AG00IBFO	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-959-154|MOABOX:306|ADRA1B|alpha-Adrenoceptor Antagonists	Cc1ccc(cc1)N(CC2=NCCN2)c3cccc(O)c3	65-28-1	NA	GENERAL	METHANESULFONATE	1	NO_SOLVATE	0	1468388	281.35226	PHENTOLAMINE HYDROCHLORIDE	PHENTOLAMINE HYDROCHLORIDE | PHENTOLAMINE MESYLATE | PHENTOLAMINE HCL | PHENTOLAMINE HYDROCHLORIDE | PHENTOLAMINE MESYLATE | PHENTOLAMINE HCL			MOABOX:306	ADRA1B	alpha-Adrenoceptor Antagonists
SJ000833115-2	SJ000833115	2	MOABOX:308	PZZOEXPDTYIBPI-UHFFFAOYSA-N	O=C1c2ccccc2CCC1CNCCc1ccc(O)cc1	30007-39-7	ADRA1A antagonist;ADRA1B antagonist;ADRA1D antagonist;alpha-Adrenoceptor Antagonists	ADRA1D	ADRA1B	ADRA1A																														147	148																														CHEMBL1515808											34772	6917680	71296963			virtual																																																																																																																																																																16882319	21571945																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.39013	1.39013	1.39013																														0.19859	0.19859	0.19859																														7	7	7																														535	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-585|MOABOX:308|ADRA1D|ADRA1A antagonist;ADRA1B antagonist;ADRA1D antagonist;alpha-Adrenoceptor Antagonists	Oc1ccc(CCNCC2CCc3ccccc3C2=O)cc1	30007-39-7	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468235	295.37554	HEAT HCL	HEAT HCL | HEAT HCL			MOABOX:308	ADRA1D	ADRA1A antagonist;ADRA1B antagonist;ADRA1D antagonist;alpha-Adrenoceptor Antagonists
SJ000288071-2	SJ000288071	2	MOABOX:310	DHMLNZRDVQLQBB-UHFFFAOYSA-N	COc1ccccc1N1CCN(CCN(C(=O)c2ccc(I)cc2)c2ccccn2)CC1	155204-23-2	alpha-Adrenoceptor Antagonists	ADRA1B																																																															CHEMBL1256777	CHEMBL29027										4658	11957651	126456147			virtual																																																																																																																																																																11945120	16029144																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.23828																																-0.03404																																7																																CS-0078959	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-958-663|MOABOX:310|ADRA1B|alpha-Adrenoceptor Antagonists	COc1ccccc1N2CCN(CCN(C(=O)c3ccc(I)cc3)c4ccccn4)CC2	220643-77-6	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468609	542.41195	P-MPPI HYDROCHLORIDE	P-MPPI HYDROCHLORIDE | P-MPPI HYDROCHLORIDE			MOABOX:310	ADRA1B	alpha-Adrenoceptor Antagonists
SJ000285625-20	SJ000285625	20	MOABOX:318	BLGXFZZNTVWLAY-DIRVCLHFSA-N	COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21	112350-93-3	alpha-Adrenoceptor Antagonists	ADRA1B																																																															CHEMBL10347	CHEMBL1257131										197067	206870	643606	44149861	44154284	member																																																																																																																																																																7658428																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-5.6e-004																																-7e-05																																8																																AA00H772	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-069-047|MOABOX:318|ADRA1B|alpha-Adrenoceptor Antagonists	COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12	65-19-0	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468275	354.44274	YOHIMBINE	YOHIMBINE | RAUWOLSCINE HYDROCHLORIDE | CORYNANTHINE HYDROCHLORIDE | CORYNANTHINE | YOHIMBINE HYDROCHLORIDE | RAUWOLSCINE HCL | YOHIMBINE | RAUWOLSCINE HYDROCHLORIDE | CORYNANTHINE HYDROCHLORIDE | CORYNANTHINE | YOHIMBINE HYDROCHLORIDE | RAUWOLSCINE HCL			MOABOX:318	ADRA1B	alpha-Adrenoceptor Antagonists
SJ000285625-21	SJ000285625	21	MOABOX:318	BLGXFZZNTVWLAY-DIRVCLHFSA-N	COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21	112350-93-3	alpha-Adrenoceptor Antagonists	ADRA1B																																																															CHEMBL10347	CHEMBL1257131										197067	206870	643606	44149861	44154284	member																																																																																																																																																																7658428																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-5.6e-004																																-7e-05																																8																																15596	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-665-637|MOABOX:318|ADRA1B|alpha-Adrenoceptor Antagonists	COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12	6211-32-1	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468469	354.44274	YOHIMBINE	YOHIMBINE | RAUWOLSCINE HYDROCHLORIDE | CORYNANTHINE HYDROCHLORIDE | CORYNANTHINE | YOHIMBINE HYDROCHLORIDE | RAUWOLSCINE HCL | YOHIMBINE | RAUWOLSCINE HYDROCHLORIDE | CORYNANTHINE HYDROCHLORIDE | CORYNANTHINE | YOHIMBINE HYDROCHLORIDE | RAUWOLSCINE HCL			MOABOX:318	ADRA1B	alpha-Adrenoceptor Antagonists
SJ000285669-18	SJ000285669	18	MOABOX:320	SFLSHLFXELFNJZ-UHFFFAOYSA-N	NCC(O)c1ccc(O)c(O)c1	104655-07-4	alpha-Adrenoceptor Antagonists	ADRA1B																																																															CHEMBL1734806	CHEMBL2062273	CHEMBL432									951	5813	5923	165118	297812	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.561e-002																																0.00223																																7																																HY-13715	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Endocrinology; Cardiovascular Disease|MOABOX:320|ADRA1B|alpha-Adrenoceptor Antagonists	NC[C@H](O)c1ccc(O)c(O)c1	51-41-2	45282	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469860	169.17784	NOREPINEPHRINE	"NOREPINEPHRINE | (±)-NOREPINEPHRINE (+)-BITARTRATE | (L)-(-)-NOREPINEPHRINE BITARTRATE | ""DL-NOREPINEPHRINE HYDROCHLORIDE | LEVOPHED"" | L-(-)-NOREPINEPHRINE BITARTRATE MONOHYDRATE | NORADRENALINE BITARTRATE MONOHYDRATE | NOREPINEPHRINE | (±)-NOREPINEPHRINE (+)-BITARTRATE | (L)-(-)-NOREPINEPHRINE BITARTRATE | ""DL-NOREPINEPHRINE HYDROCHLORIDE | LEVOPHED"" | L-(-)-NOREPINEPHRINE BITARTRATE MONOHYDRATE | NORADRENALINE BITARTRATE MONOHYDRATE"	Pathway: Autophagy; GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Endocrinology; Cardiovascular Disease	MOABOX:320	ADRA1B	alpha-Adrenoceptor Antagonists
SJ000285669-17	SJ000285669	17	MOABOX:320	SFLSHLFXELFNJZ-UHFFFAOYSA-N	NCC(O)c1ccc(O)c(O)c1	104655-07-4	alpha-Adrenoceptor Antagonists	ADRA1B																																																															CHEMBL1734806	CHEMBL2062273	CHEMBL432									951	5813	5923	165118	297812	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.561e-002																																0.00223																																7																																AG003AXE	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-193-549|MOABOX:320|ADRA1B|alpha-Adrenoceptor Antagonists	NC[C@H](O)c1ccc(O)c(O)c1	69815-49-2	NA	GENERAL	TARTRATE	1	H2O	1	1468674	169.17784	NOREPINEPHRINE	"NOREPINEPHRINE | (±)-NOREPINEPHRINE (+)-BITARTRATE | (L)-(-)-NOREPINEPHRINE BITARTRATE | ""DL-NOREPINEPHRINE HYDROCHLORIDE | LEVOPHED"" | L-(-)-NOREPINEPHRINE BITARTRATE MONOHYDRATE | NORADRENALINE BITARTRATE MONOHYDRATE | NOREPINEPHRINE | (±)-NOREPINEPHRINE (+)-BITARTRATE | (L)-(-)-NOREPINEPHRINE BITARTRATE | ""DL-NOREPINEPHRINE HYDROCHLORIDE | LEVOPHED"" | L-(-)-NOREPINEPHRINE BITARTRATE MONOHYDRATE | NORADRENALINE BITARTRATE MONOHYDRATE"			MOABOX:320	ADRA1B	alpha-Adrenoceptor Antagonists
SJ000285664-15	SJ000285664	15	MOABOX:324	CNIIGCLFLJGOGP-UHFFFAOYSA-N	c1ccc2c(CC3=NCCN3)cccc2c1	10061-11-7	alpha-Adrenoceptor Antagonists	ADRA1B																																																															CHEMBL1706	CHEMBL761										4436	11079	82332	657295	19981026	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.68607																																-0.09801																																7																																AG00DDW1	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-904-680|MOABOX:324|ADRA1B|alpha-Adrenoceptor Antagonists	C(C1=NCCN1)c2cccc3ccccc23	550-99-2	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468198	210.27436	NAPHAZOLINE	NAPHAZOLINE | ALBALON | NAPHAZOLINE HYDROCHLORIDE | SJ000288053 | NAPHAZOLINE HCL | NAPHAZOLINE | ALBALON | NAPHAZOLINE HYDROCHLORIDE | SJ000288053 | NAPHAZOLINE HCL			MOABOX:324	ADRA1B	alpha-Adrenoceptor Antagonists
SJ000285755-24	SJ000285755	24	MOABOX:326	UCTWMZQNUQWSLP-UHFFFAOYSA-N	CNCC(O)c1ccc(O)c(O)c1	104655-05-2	alpha-Adrenoceptor Antagonists	ADRA1B																																																															CHEMBL1255663	CHEMBL1514721	CHEMBL1740									838	5924	89249	307959	4866774	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.9142																																0.1306																																7																																EN300-120880	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-051-368|MOABOX:326|ADRA1B|alpha-Adrenoceptor Antagonists	CNC[C@@H](O)c1ccc(O)c(O)c1	51-43-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468075	183.20442	ADRENALINE BITARTRATE	"ADRENALINE BITARTRATE | (-)-EPINEPHRINE BITARTRATE | (±)-EPINEPHRINE HYDROCHLORIDE | L-ADRENALINE | ""EPINEPHRINE, RACEMIC | ADRENALINE |"" | EPINEPHRINE BITARTRATE | EPINEPHRINE HCL | ADRENALINE BITARTRATE | (-)-EPINEPHRINE BITARTRATE | (±)-EPINEPHRINE HYDROCHLORIDE | L-ADRENALINE | ""EPINEPHRINE, RACEMIC | ADRENALINE |"" | EPINEPHRINE BITARTRATE | EPINEPHRINE HCL"			MOABOX:326	ADRA1B	alpha-Adrenoceptor Antagonists
SJ000285755-25	SJ000285755	25	MOABOX:326	UCTWMZQNUQWSLP-UHFFFAOYSA-N	CNCC(O)c1ccc(O)c(O)c1	104655-05-2	alpha-Adrenoceptor Antagonists	ADRA1B																																																															CHEMBL1255663	CHEMBL1514721	CHEMBL1740									838	5924	89249	307959	4866774	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.9142																																0.1306																																7																																AG00ILOI	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-941-285|MOABOX:326|ADRA1B|alpha-Adrenoceptor Antagonists	CNCC(O)c1ccc(O)c(O)c1	329-63-5	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468399	183.20442	ADRENALINE BITARTRATE	"ADRENALINE BITARTRATE | (-)-EPINEPHRINE BITARTRATE | (±)-EPINEPHRINE HYDROCHLORIDE | L-ADRENALINE | ""EPINEPHRINE, RACEMIC | ADRENALINE |"" | EPINEPHRINE BITARTRATE | EPINEPHRINE HCL | ADRENALINE BITARTRATE | (-)-EPINEPHRINE BITARTRATE | (±)-EPINEPHRINE HYDROCHLORIDE | L-ADRENALINE | ""EPINEPHRINE, RACEMIC | ADRENALINE |"" | EPINEPHRINE BITARTRATE | EPINEPHRINE HCL"			MOABOX:326	ADRA1B	alpha-Adrenoceptor Antagonists
SJ000287913-8	SJ000287913	8	MOABOX:334	ASXGJMSKWNBENU-UHFFFAOYSA-N	CCCN(CCC)C1CCc2cccc(O)c2C1	105558-30-3	alpha-Adrenoceptor Antagonists	ADRA1B																																																															CHEMBL505765	CHEMBL56										1220	6917794	9825063	9844518	11714608	virtual																																																																																																																																																																10425105	10514291	18817363	19101959	20185311	22145629	23252794	27662034	30844609	31112892																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												-0.74552																																-0.09319																																8																																CS-0043224	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-830-676|MOABOX:334|ADRA1B|alpha-Adrenoceptor Antagonists	CCCN(CCC)C1CCc2cccc(O)c2C1	105558-30-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468495	247.3758	(±)-8-HYDROXY-DPAT HYDROBROMIDE	(±)-8-HYDROXY-DPAT HYDROBROMIDE | R-(+)-8-HYDROXY-DPAT HYDROBROMIDE | 8-HYDROXY-DPAT HBR | (±)-8-HYDROXY-DPAT HYDROBROMIDE | R-(+)-8-HYDROXY-DPAT HYDROBROMIDE | 8-HYDROXY-DPAT HBR			MOABOX:334	ADRA1B	alpha-Adrenoceptor Antagonists
SJ000988611-2	SJ000988611	2	MOABOX:338	HDOZVRUNCMBHFH-UHFFFAOYSA-N	CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21	1200591-33-8	Adrenergic receptor modulator;Dopamine D2 Antagonists;Serotonin Antagonists	ADRA1B	HTR1E	HTR1F																														3354	3355																														CHEMBL285802											5736	44546572	44548220	44548400	66989032	member																																																																																																																																																																11170639	11945123	12021408	14998318																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		-0.38703	-0.38703	0.48712																														-0.05529	-0.05529	0.06089																														7	7	8																														AG002TV2	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-986-686|MOABOX:338|ADRA1B|Adrenergic receptor modulator;Dopamine D2 Antagonists;Serotonin Antagonists	CN(C)CCOC1=Cc2ccccc2Sc3ccc(Cl)cc13	26615-21-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468664	331.85962	ZOTEPINE	ZOTEPINE | ZOTEPINE			MOABOX:338	ADRA1B	Adrenergic receptor modulator;Dopamine D2 Antagonists;Serotonin Antagonists
SJ000988618-4	SJ000988618	4	MOABOX:340	GZKLJWGUPQBVJQ-UHFFFAOYSA-N	O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1	106516-24-9	5-HT2A Antagonists;Dopamine D2 Antagonists	ADRA1B	HTR1E	HTR1F																														3354	3355																														CHEMBL12713											60149	68756379	89525701	124160043	124160152	member																																																																																																																																																																11945123	12519065	12614894	14998318	16918396	18378462	20857909	21366526	23218776																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0.46976	0	0																														0.05872	0.0	0.0																														8	7	7																														HY-14543	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease; Cancer|MOABOX:340|ADRA1B|5-HT2A Antagonists;Dopamine D2 Antagonists	Fc1ccc(cc1)n2cc(C3CCN(CCN4CCNC4=O)CC3)c5cc(Cl)ccc25	106516-24-9	16635	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469776	440.94084	SERTINDOLE | LU 23-174	"""SERTINDOLE | LU 23-174"" | ""SERTINDOLE | LU 23-174"""	Pathway: Autophagy; GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease; Cancer	MOABOX:340	ADRA1B	5-HT2A Antagonists;Dopamine D2 Antagonists
SJ001034648-1	SJ001034648	1	MOABOX:342	JXZZEXZZKAWDSP-UHFFFAOYSA-N	O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1	26844-12-2	alpha1-Adrenoceptor Antagonists	ADRA1B	HTR1E	HTR1F																														3354	3355																														CHEMBL2104941	CHEMBL279516										33625	38102	158814	6440767	20839506	virtual																																																																																																																																																																7658428	9135028	10968279	17168713																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.14912	-0.55986	-0.55986																														0.14364	-0.07998	-0.07998																														8	7	7																														AF-0013	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c4ccccc4	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466674	347.4534	AF-0013	AF-0013 | AF-0013			MOABOX:342	ADRA1B	alpha1-Adrenoceptor Antagonists
SJ000312300-8	SJ000312300	8	MOABOX:346	URKOMYMAXPYINW-UHFFFAOYSA-N	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1	111974-69-7	alpha1-Adrenoceptor Antagonists	ADRA1B	HTR1E	HTR1F																														3354	3355																														CHEMBL1200911	CHEMBL3188993	CHEMBL716									5002	73286	441261	5281025	6436253	virtual																																																																																																																																																																11170639	14998318																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.73648	0	0																														0.09206	0.0	0.0																														8	7	7																														HY-14544	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:346|ADRA1B|alpha1-Adrenoceptor Antagonists	OCCOCCN1CCN(CC1)C2=Nc3ccccc3Sc4ccccc24	111974-69-7	8076	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469251	383.5071	QUETIAPINE HEMIFUMARATE	"QUETIAPINE HEMIFUMARATE | QUETIAPINE FUMARATE| SEROQUEL XR | ""QUETIAPINE HEMIFUMARATE | SEROQUEL | (E)-2-(2-(4-(DIBENZO[B,F][1,4]THIAZEPIN-11-YL)PIPERAZIN-1-YL)ETHOXY)ETHANOL | QUETIAPINE FUMARATE | SEROQUEL XR | FK-949 | FK-949E | ICI-204636 | ZD-5077 | ZM-204636 |"" | QUETIAPINE FUMARATE | QUETIAPINE HEMIFUMARATE | QUETIAPINE FUMARATE| SEROQUEL XR | ""QUETIAPINE HEMIFUMARATE | SEROQUEL | (E)-2-(2-(4-(DIBENZO[B,F][1,4]THIAZEPIN-11-YL)PIPERAZIN-1-YL)ETHOXY)ETHANOL | QUETIAPINE FUMARATE | SEROQUEL XR | FK-949 | FK-949E | ICI-204636 | ZD-5077 | ZM-204636 |"" | QUETIAPINE FUMARATE"	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:346	ADRA1B	alpha1-Adrenoceptor Antagonists
SJ000287388-11	SJ000287388	11	MOABOX:352	VCKUSRYTPJJLNI-UHFFFAOYSA-N	COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC	141269-45-6	PGK1 activator;alpha1-Adrenoceptor Antagonists	ADRA1D	ADRA1B	ADRA1A	PGK1																													147	148	5230																													CHEMBL1201091	CHEMBL1256665	CHEMBL3989562	CHEMBL611								5401	44383	63016	663211	9803362	member	10.1038/nchembio.1657																																																																																																																																																															7658428	7752182	9135028	9190863	9190864	9223558	9276013	9359081	9379432	9548811	9651170	9873563	10490890	10579840	10579841	10579842	10780916	10968279	11384242	11805207	25813897	27658792																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.25592	1.77592	0.52144	0																													0.15699	0.22199	0.06518	0.0																													8	8	8	7																													HY-B0371D	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Endocrinology|MOABOX:352|ADRA1D|PGK1 activator;alpha1-Adrenoceptor Antagonists	COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)[C@@H]4CCCO4	109351-33-9	61526	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468896	387.4329	TERAZOSIN HYDROCHLORIDE	TERAZOSIN HYDROCHLORIDE | TERAZOSIN HCL | TERAZOSIN HYDROCHLORIDE | TERAZOSIN HCL	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Endocrinology	MOABOX:352	ADRA1D	PGK1 activator;alpha1-Adrenoceptor Antagonists
SJ001034941-1	SJ001034941	1	MOABOX:354	VBWVJJZYUPVDPN-UHFFFAOYSA-N	O=C(CCCN1CCc2[nH]c3ccc(F)cc3c2C1)c1ccc(F)cc1	31540-62-2	HTR1 modulator;ADRA1B antagonist	ADRA1B	HTR1E	HTR1F																														3354	3355																														CHEMBL1301183	CHEMBL350462										35836	24213095				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.33894	-0.4284	-0.66374																														0.04842	-0.0612	-0.09482																														7	7	7																														PHAR057983	PHARMEKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-743-055|MOABOX:354|ADRA1B|HTR1 modulator;ADRA1B antagonist	Fc1ccc(cc1)C(=O)CCCN2CCc3[nH]c4ccc(F)cc4c3C2	31540-62-2	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468322	354.39311	PHAR057983	PHAR057983 | PHAR057983			MOABOX:354	ADRA1B	HTR1 modulator;ADRA1B antagonist
SJ000288072-5	SJ000288072	5	MOABOX:356	SJDOMIRMMUGQQK-UHFFFAOYSA-N	COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1	102392-05-2	"5-HT1A Receptor Antagonists;ADRA2A antagonist;""5-HT1A Receptor Antagonists;ADRA2A antagonist"""	HTR1A	ADRA2A																															150																															CHEMBL1256701	CHEMBL126632	CHEMBL8618									4431	107966	44350679	51371246	71312138	member	10.1016/j.bbr.2017.06.032	10.1016/j.ejmech.2017.05.047																																																																																																																																																														1359584	11472239	11945120	16029144	19705871	24295064	25128671	28575721	29730027																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0	0.37392																															0.0	0.04674																															7	8																															HY-19818A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:356|HTR1A|5-HT1A Receptor Antagonists;ADRA2A antagonist;\5-HT1A Receptor Antagonists;ADRA2A antagonist\	COc1ccccc1N2CCN(CCCCN3C(=O)c4ccccc4C3=O)CC2	115338-32-4	19915	GENERAL	BROMIDE	1	NO_SOLVATE	0	1469785	393.47878	NAN-190 HYDROBROMIDE	NAN-190 HYDROBROMIDE | NAN-190 HBR | NAN-190 HYDROBROMIDE | NAN-190 HBR	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:356	HTR1A	5-HT1A Receptor Antagonists;ADRA2A antagonist;\5-HT1A Receptor Antagonists;ADRA2A antagonist\
SJ000287472-11	SJ000287472	11	MOABOX:360	HRRBJVNMSRJFHQ-UHFFFAOYSA-N	COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1	1164469-60-6	alpha1D-Adrenoceptor Antagonists	ADRA1D																																																															CHEMBL1257069	CHEMBL142635	CHEMBL1532139	CHEMBL1593765								4418	6603044	11957660	25102347	51371242	member																																																																																																																																																																12052168	25874333	26643219	29615343																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.16168																																0.14521																																8																																HY-B0391	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Cardiovascular Disease; Endocrinology|MOABOX:360|ADRA1D|alpha1D-Adrenoceptor Antagonists	COc1ccccc1N2CCN(CC(O)COc3cccc4ccccc34)CC2	57149-07-2	16555	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469694	392.49072	NAFTOPIDIL DIHYDROCHLORIDE	NAFTOPIDIL DIHYDROCHLORIDE | NAFTOPIDIL HCL | NAFTOPIDIL DIHCL | NAFTOPIDIL | NAFTOPIDIL DIHYDROCHLORIDE | NAFTOPIDIL HCL | NAFTOPIDIL DIHCL | NAFTOPIDIL	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Cardiovascular Disease; Endocrinology	MOABOX:360	ADRA1D	alpha1D-Adrenoceptor Antagonists
SJ000287244-8	SJ000287244	8	MOABOX:362	INJOMKTZOLKMBF-UHFFFAOYSA-N	N=C(N)NC(=O)Cc1c(Cl)cccc1Cl	29110-47-2	alpha2-Adrenoceptor Agonists	ADRA2A																																																															CHEMBL1200494	CHEMBL862										3519	71401	9826299	45114257	53474704	member	10.2174/1386207311316070003																																																																																																																																																															17266604	18621536																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.28008																																0.16001																																8																																HY-17416	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Cardiovascular Disease; Endocrinology|MOABOX:362|ADRA2A|alpha2-Adrenoceptor Agonists	NC(=N)NC(=O)Cc1c(Cl)cccc1Cl	29110-48-3	20251	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468872	246.09326	GUANFACINE HYDROCHLORIDE	GUANFACINE HYDROCHLORIDE | GUANFACINE HCL | GUANFACINE HYDROCHLORIDE | GUANFACINE HCL	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Cardiovascular Disease; Endocrinology	MOABOX:362	ADRA2A	alpha2-Adrenoceptor Agonists
SJ000285617-11	SJ000285617	11	MOABOX:370	HUCJFAOMUPXHDK-UHFFFAOYSA-N	Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1	1218-35-5	alpha2A(2D)-Adrenoceptor Agonists;alpha2B-Adrenoceptor Agonists;alpha2C-Adrenoceptor Agonists	ADRA1B	ADRA2A	ADRA2B	ADRA2C																													150	151	152																													CHEMBL1256400	CHEMBL312448										5709	174122	657235	5282386	9814971	virtual																																																																																																																																																																9632357	15324890																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.28392	0.2192	-0.21056	-0.20336																													-0.03549	0.0274	-0.02632	-0.02542																													8	8	8	8																													HY-B0475	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Cardiovascular Disease; Endocrinology|MOABOX:370|ADRA1B|alpha2A(2D)-Adrenoceptor Agonists;alpha2B-Adrenoceptor Agonists;alpha2C-Adrenoceptor Agonists	Cc1cc(cc(C)c1CC2=NCCN2)C(C)(C)C	1218-35-5	16644	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469789	244.37516	XYLOMETAZOLINE HYDROCHLORIDE	XYLOMETAZOLINE HYDROCHLORIDE | XYLOMETAZOLINE HCL | XYLOMETAZOLINE HYDROCHLORIDE | XYLOMETAZOLINE HCL	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Cardiovascular Disease; Endocrinology	MOABOX:370	ADRA1B	alpha2A(2D)-Adrenoceptor Agonists;alpha2B-Adrenoceptor Agonists;alpha2C-Adrenoceptor Agonists
SJ000795313-2	SJ000795313	2	MOABOX:374	QZKGUNQLVFEEBA-UHFFFAOYSA-N	CN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1	1259314-65-2	ADRA2C antagonist;alpha2C-Adrenoceptor Antagonists	ADRA2C																																																															CHEMBL106525	CHEMBL3277408										540335	49855035	71311599	90679813	91885446	member	10.1038/sj.bjp.0707005																																																																																																																																																															17034141	17220913	21277656																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.80096																																0.22512																																8																																HY-103213	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease; Endocrinology|MOABOX:374|ADRA2C|ADRA2C antagonist;alpha2C-Adrenoceptor Antagonists	CN1CCN(CC1)c2ccc(Nc3c4ccccc4nc5ccccc35)cc2	1259314-65-2	79752	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469084	368.47416	GNF-PF-3427|0075-0068	GNF-PF-3427|0075-0068 | GNF-PF-3427|0075-0068	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease; Endocrinology	MOABOX:374	ADRA2C	ADRA2C antagonist;alpha2C-Adrenoceptor Antagonists
SJ000286065-13	SJ000286065	13	MOABOX:378	OGHNVEJMJSYVRP-UHFFFAOYSA-N	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12	107741-96-8	beta1-Adrenoceptor Antagonists	ADRB1																																																															CHEMBL1201167	CHEMBL1437006	CHEMBL723									2585	9827459	9870806	9874939	9895248	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.34584																																0.16823																																8																																KS-1037	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1ccccc1OCCNCC(O)COc2cccc3[nH]c4ccccc4c23	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466711	406.47424	CARVEDILOL	"CARVEDILOL | ""CARVEDILOL | BM-14190 | DQ-2466 | EG-P042 | SKF-105517 |"" | CARVEDILOL | ""CARVEDILOL | BM-14190 | DQ-2466 | EG-P042 | SKF-105517 |"""			MOABOX:378	ADRB1	beta1-Adrenoceptor Antagonists
SJ000285468-19	SJ000285468	19	MOABOX:380	METKIMKYRPQLGS-UHFFFAOYSA-N	CC(C)NCC(O)COc1ccc(CC(N)=O)cc1	106020-65-9	beta1-Adrenoceptor Antagonists	ADRB1																																																															CHEMBL24											2249	119274	173202	3083063	9818853	member	10.1016/S0028-3908(03)00305-8	10.1016/j.bmcl.2018.03.093	10.1016/j.ejphar.2007.10.017	10.1016/j.ejphar.2009.03.006	10.1021/acs.jmedchem.8b01759	10.1021/cn5001606	10.1021/jm200536d	10.1124/jpet.110.173245																																																																																																																																																								11858844	17266607	18670082	18983139	21084390	21688779	21726069	21777010	23023262	23466604	26988801	27876250	28106992	28471663	28947942	29631962	30810314																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.38816																																0.17352																																8																																KS-5341	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)NCC(O)COc1ccc(CC(=O)N)cc1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466720	266.33608	ATENOLOL	ATENOLOL | (S)-(-)-ATENOLOL | (R)-(+)-ATENOLOL | (±)-ATENOLOL | TENORMIN | R-(+)-ATENOLOL | S-(-)-ATENOLOL | ATENOLOL | (S)-(-)-ATENOLOL | (R)-(+)-ATENOLOL | (±)-ATENOLOL | TENORMIN | R-(+)-ATENOLOL | S-(-)-ATENOLOL			MOABOX:380	ADRB1	beta1-Adrenoceptor Antagonists
SJ000852768-7	SJ000852768	7	MOABOX:388	QZZUEBNBZAPZLX-QFIPXVFZSA-N	CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2	1000160-87-1	beta2-Adrenoceptor Agonists	ADRB2																																																															CHEMBL1095777	CHEMBL1789842										6918554	9827599	10053080	10255695	10414119	member	10.1016/j.bmcl.2011.01.043	10.1016/j.bmcl.2012.07.096	10.1016/j.bmcl.2014.06.014	10.1016/j.ejphar.2017.11.043	10.1021/jm100068m	10.1124/jpet.107.129296	10.1124/jpet.112.193284																																																																																																																																																									16434564	20402514	20655218	21310610	22079756	22932315	25065493																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															1.38544																																0.17318																																8																																T1239	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-035-395-723|MOABOX:388|ADRB2|beta2-Adrenoceptor Agonists	CCc1cc2CC(Cc2cc1CC)NC[C@H](O)c3ccc(O)c4NC(=O)C=Cc34	753498-25-8	NA	GENERAL	MALEATE	1	NO_SOLVATE	0	1468585	392.49072	INDACATEROL MALEATE	INDACATEROL MALEATE | INDACATEROL MALEATE			MOABOX:388	ADRB2	beta2-Adrenoceptor Agonists
SJ000285605-10	SJ000285605	10	MOABOX:390	XWTYSIMOBUGWOL-UHFFFAOYSA-N	CC(C)(C)NCC(O)c1cc(O)cc(O)c1	1164563-86-3	beta2-Adrenoceptor Agonists	ADRB2																																																															CHEMBL1160544	CHEMBL1315867	CHEMBL1760									5403	441334	657301	6365506	9881485	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.384e-002																																0.00298																																8																																29337	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-850-418|MOABOX:390|ADRB2|beta2-Adrenoceptor Agonists	CC(C)(C)NCC(O)c1cc(O)cc(O)c1	23031-25-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468301	225.28416	TERBUTALINE HEMISULFATE	TERBUTALINE HEMISULFATE | TERBUTALINE SULFATE | TERBUTALINE HEMISULFATE | TERBUTALINE SULFATE			MOABOX:390	ADRB2	beta2-Adrenoceptor Agonists
SJ000287219-14	SJ000287219	14	MOABOX:392	NDAUXUAQIAJITI-UHFFFAOYSA-N	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1	148563-15-9	beta2-Adrenoceptor Agonists	ADRB2																																																															CHEMBL1201026	CHEMBL1437301	CHEMBL1441059	CHEMBL714								2083	39859	161912	177325	177872	member	10.1021/jm100068m	10.1021/jm801211c	10.1074/jbc.272.38.23871	10.1074/jbc.M102734200	10.1124/jpet.107.129296	10.1124/jpet.114.216861																																																																																																																																																										19245211	20402514	21652207	22178551																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.18728																																0.14841																																8																																KS-5209	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466738	239.31074	SALBUTAMOL	"SALBUTAMOL | ALBUTEROL HEMISULFATE | ""LEVALBUTEROL HYDROCHLORIDE | XOPENEX"" | ""SALBUTAMOL FREE BASE | ALBUTEROL | AH-3365 | TBS-7 | TQ-1016 |"" | SALBUTAMOL HEMISULFATE | SALBUTAMOL | ALBUTEROL HEMISULFATE | ""LEVALBUTEROL HYDROCHLORIDE | XOPENEX"" | ""SALBUTAMOL FREE BASE | ALBUTEROL | AH-3365 | TBS-7 | TQ-1016 |"" | SALBUTAMOL HEMISULFATE"			MOABOX:392	ADRB2	beta2-Adrenoceptor Agonists
SJ000287760-4	SJ000287760	4	MOABOX:402	JEDJMKTVUPSHFW-ABAIWWIYSA-N	C[C@H](Cc1ccc2c(c1)OC(C(=O)O)(C(=O)O)O2)NC[C@H](O)c1cccc(Cl)c1	138908-40-4	beta3-Adrenoceptor Agonists;ADRB3 agonist	ADRB3																																																															CHEMBL1204876											5486546	10004798	90469192			member	10.1248/cpb.58.533																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.48237																																-0.06891																																7																																HY-116771A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Metabolic Disease | DISSOLVED IN H2O|MOABOX:402|ADRB3|beta3-Adrenoceptor Agonists;ADRB3 agonist	C[C@H](Cc1ccc2OC(Oc2c1)(C(=O)O)C(=O)O)NC[C@H](O)c3cccc(Cl)c3	138908-40-4	78772	GENERAL	SODIUM(I)	2	NO_SOLVATE	0	1469247	421.8283	"CL 316,243"	"CL 316,243 | CL 316,243"	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Metabolic Disease	MOABOX:402	ADRB3	
SJ000286674-7	SJ000286674	7	MOABOX:408	YOSHYTLCDANDAN-UHFFFAOYSA-N	CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1	138402-11-6	Angiotensin AT1 Antagonists	AGTR1																																																															CHEMBL1513											3749	9810243	9831761	9897443	9918698	member	10.1002/cmdc.201800638	10.1021/jm010457z	10.1021/jm9904147	10.1124/jpet.110.176636	10.2174/1568016043477378																																																																																																																																																											10893306	12190306	12361407	14718594	15634011	15974591	16220969	17628868	18220718	19199984	21071232	21123673	21568894	21713967	22931505	23410171	29195045																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.23352																																0.15419																																8																																HY-B0202	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; GPCR/G Protein | Research Area: Cardiovascular Disease; Endocrinology|MOABOX:408|AGTR1|Angiotensin AT1 Antagonists	CCCCC1=NC2(CCCC2)C(=O)N1Cc3ccc(cc3)c4ccccc4c5nnn[nH]5	138402-11-6	14030	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469371	428.52942	IRBESARTAN	IRBESARTAN | IRBESARTAN	Pathway: Apoptosis; GPCR/G Protein	Research Area: Cardiovascular Disease; Endocrinology	MOABOX:408	AGTR1	Angiotensin AT1 Antagonists
SJ000785904-7	SJ000785904	7	MOABOX:416	OMKHWTRUYNAGFG-IEBDPFPHSA-N	Nc1nccc2c1ncn2[C@@H]1C=C(CO)[C@@H](O)[C@H]1O	102052-95-9	S-Adenosyl-L-homocysteine Hydrolase Inhibitors	AHCY																																																															CHEMBL154745											73087	14563109				member	10.1016/j.ejphar.2017.07.023																																																																																																																																																															17168721	26010585	26260336	30385162																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.9804																																0.37255																																8																																HY-12186	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:416|AHCY|S-Adenosyl-L-homocysteine Hydrolase Inhibitors	Nc1nccc2c1ncn2[C@@H]3C=C(CO)[C@@H](O)[C@H]3O	120964-45-6	13696	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469548	262.26456	3-DEAZANEPLANOCIN	"3-DEAZANEPLANOCIN | ""3-DNPA | DZNEP | C3NEP | 3-DEAZANEPLANOCIN HCL SALT"" | 3-DEAZANEPLANOCIN A (DZNEP) | 3-DEAZANEPLANOCIN | ""3-DNPA | DZNEP | C3NEP | 3-DEAZANEPLANOCIN HCL SALT"" | 3-DEAZANEPLANOCIN A (DZNEP)"	Pathway: Epigenetics	Research Area: Cancer	MOABOX:416	AHCY	S-Adenosyl-L-homocysteine Hydrolase Inhibitors
SJ000286219-6	SJ000286219	6	MOABOX:418	GZSOSUNBTXMUFQ-YFAPSIMESA-N	COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O	520-27-4	Aryl Hydrocarbon Receptor (AhR) Agonists	AHR																																																															CHEMBL231884											5281613	11651089	70581252	88048771	88075887	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-N0178	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Cancer; Cardiovascular Disease|MOABOX:418|AHR|Aryl Hydrocarbon Receptor (AhR) Agonists	COc1ccc(cc1O)C2=CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2	520-27-4	27582	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469626	608.54468	DIOSMIN	DIOSMIN | DIOSMIN	Pathway: Immunology/Inflammation	Research Area: Cancer; Cardiovascular Disease	MOABOX:418	AHR	Aryl Hydrocarbon Receptor (AhR) Agonists
SJ001034942-1	SJ001034942	1	MOABOX:420	IDBCUMFOZBUJCL-UHFFFAOYSA-N	Cc1cc(-c2nc3ccccc3s2)ccc1N	178804-04-1	Aryl Hydrocarbon Receptor (AhR) Agonists	AHR																																																															CHEMBL11825											384525	20760355	20760357	90484286	142942988	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																PHAR146887	PHARMEKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-810-817|MOABOX:420|AHR|Aryl Hydrocarbon Receptor (AhR) Agonists	Cc1cc(ccc1N)c2nc3ccccc3s2	178804-04-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468325	240.32348	PHAR146887	PHAR146887 | PHAR146887			MOABOX:420	AHR	Aryl Hydrocarbon Receptor (AhR) Agonists
SJ000821687-6	SJ000821687	6	MOABOX:424	CHNUOJQWGUIOLD-SMTGYRLFSA-N	CC(=C\c1ccccc1)/C=C1/SC(=S)N(CC(=O)O)C1=O	82159-09-9	Aldose Reductase Inhibitors	AKR1A1																																																															CHEMBL7537											1584822	21158571	87229081	88398554	118484209	member																																																																																																																																																																12540241																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.30121																																0.04303																																7																																HY-66009	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:424|AKR1A1|Aldose Reductase Inhibitors	C\C(=C/c1ccccc1)\C=C\2/SC(=S)N(CC(=O)O)C2=O	82159-09-9	15664	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469494	319.39862	EPALRESTAT	EPALRESTAT | EPALRESTAT	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:424	AKR1A1	Aldose Reductase Inhibitors
SJ000287096-4	SJ000287096	4	MOABOX:428	GCUCIFQCGJIRNT-UHFFFAOYSA-N	O=C(O)CN1C(=O)c2cccc3cccc(c23)C1=O	51411-04-2	Aldose Reductase Inhibitors	AKR1B1																																																															CHEMBL63055											2120	18177367	139022842			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.27965																																-0.03995																																7																																HY-B1202	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Endocrinology|MOABOX:428|AKR1B1|Aldose Reductase Inhibitors	OC(=O)CN1C(=O)c2cccc3cccc(C1=O)c23	51411-04-2	27314	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468838	255.22556	ALRESTATIN	ALRESTATIN | ALRESTATIN	Pathway: Metabolic Enzyme/Protease	Research Area: Endocrinology	MOABOX:428	AKR1B1	Aldose Reductase Inhibitors
SJ000285500-3	SJ000285500	3	MOABOX:430	LKBFFDOJUKLQNY-UHFFFAOYSA-N	O=C(O)Cc1nn(Cc2ccc(Br)cc2F)c(=O)c2ccccc12	72702-95-5	Aldose Reductase Inhibitors	AKR1B1	AKR1A1																															10327																															CHEMBL7679											5278					member	10.1016/j.biochi.2010.02.001	10.1016/j.bmc.2004.05.014	10.1016/j.bmc.2007.08.019																																																																																																																																																													1899452	9839011	10418995	10737739	15210146	17870536																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.38096	-5.929e-002																															0.04762	-0.00847																															8	7																															HY-106697	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:430|AKR1B1|Aldose Reductase Inhibitors	OC(=O)CC1=NN(Cc2ccc(Br)cc2F)C(=O)c3ccccc13	72702-95-5	66818	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469197	391.19118	STATIL	STATIL | STATIL	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:430	AKR1B1	Aldose Reductase Inhibitors
SJ000829176-4	SJ000829176	4	MOABOX:432	KJPRLNWUNMBNBZ-QPJJXVBHSA-N	O=C/C=C/c1ccccc1	104-55-2	TRPA1 Agonists;Aldose Reductase Inhibitors	AKR1B1	TRPA1																															8989																															CHEMBL293492											637511	11022011	17975541	18417962	19704683	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.33994	0																															0.19142	0.0																															7	7																															AS-12078	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	O=C\C=C\c1ccccc1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466821	132.15922					MOABOX:432	AKR1B1	TRPA1 Agonists;Aldose Reductase Inhibitors
SJ001034976-1	SJ001034976	1	MOABOX:434	SBOKKVUBLNZTCT-OUKQBFOZSA-N	O=C(/C=C/c1nc2ccccc2[nH]1)c1c(O)nc2ccc(Cl)cc2c1-c1ccccc1	1233322-09-2	Apoptosis Inhibitors;PKB alpha/Akt1 Inhibitors	AKT1																																																															CHEMBL190313											5343381					member	10.1038/bjc.2014.227																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				6.37e-003																																0.00091																																7																																1000-1319	CHEMDIV	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-009-685-187|MOABOX:434|AKT1|Apoptosis Inhibitors;PKB alpha/Akt1 Inhibitors	Oc1nc2ccc(Cl)cc2c(c3ccccc3)c1C(=O)\C=C\c4nc5ccccc5[nH]4	1233322-09-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468417	425.86644	1000-1319	1000-1319 | 1000-1319			MOABOX:434	AKT1	Apoptosis Inhibitors;PKB alpha/Akt1 Inhibitors
SJ000821874-9	SJ000821874	9	MOABOX:436	STUWGJZDJHPWGZ-LBPRGKRZSA-N	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1	1217486-47-9	PI3Kalpha inhibitor;PIK3CA inhibitor	AKT1	PIK3CA																															5290																															CHEMBL2396661											56649450	71525306	73425579	139035009		virtual																																																																																																																																																																21649578	23726034	26164189	26206504	27644332	28341403																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																2.70344	0.10112																															0.33793	0.01264																															8	8																															CS-0663	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-028-720-400|MOABOX:436|AKT1|PI3Kalpha inhibitor;PIK3CA inhibitor	Cc1nc(NC(=O)N2CCC[C@H]2C(=O)N)sc1c3ccnc(c3)C(C)(C)C(F)(F)F	1217486-61-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468676	441.47049	Alpelisib	"Alpelisib | ""BYL-719 | BYL719"" | Alpelisib | ""BYL-719 | BYL719"""			MOABOX:436	AKT1	PI3Kalpha inhibitor;PIK3CA inhibitor
SJ000571299-15	SJ000571299	15	MOABOX:444	JOGKUKXHTYWRGZ-UHFFFAOYSA-N	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21	1028385-31-0	PI3K inhibitor;MTOR inhibitor;PKB alpha/Akt1 Inhibitors	AKT1	MTOR	PIK3CA																														2475	5290																														CHEMBL1879463	CHEMBL1911126	CHEMBL3039506									11977753	44622824	49792853	49803145	57402553	virtual	10.1016/j.bioorg.2019.103232	10.1016/j.bmcl.2019.04.007	10.1016/j.ccr.2008.06.014	10.1021/acsmedchemlett.6b00119	10.1021/bi100673c	10.2147/OTT.S142492	10.2174/09298673113209990124	10.2174/138161212800626210																																																																																																																																																								19275602	19689267	20939811	21649577	21649578	21649581	21651476	22475451	22544264	23063403	23651303	24530495	24805946	25893045	26046312	26210161	26321603	26596710	26652969	27479483	27544401	27563400	27644332	28109945	28835805	29407971	29475582	29937355	29945756	29954109	30071408	30077608	30245395	30605829	30655957	30975623	31228810																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	4.88e-002	0.81656	1.56504																														0.0061	0.10207	0.19563																														8	8	8																														ES-0038	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CN1C(=O)N(c2ccc(cc2)C(C)(C)C#N)c3c1cnc4ccc(cc34)c5cnc6ccccc6c5	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466680	469.53652	DACTOLISIB	"DACTOLISIB | ""NVP-BEZ235 | BEZ-235"" | BEZ235 (NVP-BEZ235, DACTOLISIB) | DACTOLISIB | ""NVP-BEZ235 | BEZ-235"" | BEZ235 (NVP-BEZ235, DACTOLISIB)"			MOABOX:444	AKT1	PI3K inhibitor;MTOR inhibitor;PKB alpha/Akt1 Inhibitors
SJ000852518-6	SJ000852518	6	MOABOX:446	KGPGFQWBCSZGEL-ZDUSSCGKSA-N	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21	937174-76-0	Inhibitors of Signal Transduction Pathways;PKB alpha/Akt1 Inhibitors;PKB beta/Akt2 Inhibitors;PKB gamma/Akt3 Inhibitors	AKT1	AKT2	DAPK3	PRKG1	PRKX	AKT3	PAK6																										208	1613	5592	5613	10000	56924																										CHEMBL494089											16725726	92044511	131668405			member	10.1016/j.bmcl.2009.01.002	10.1021/ml500088x	10.1158/0008-5472.CAN-07-5783	10.2174/187152009787047734																																																																																																																																																												18381444	18800763	19149480	19179070	19519296	20166671	20180757	22037378	22353219	22512570	24900862	28704757	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									2.55344	0.308	-0.25104	-0.1404	0.42544	0.948	0.2148																										0.31918	0.0385	-0.03138	-0.01755	0.05318	0.1185	0.02685																										8	8	8	8	8	8	8																										HY-10249	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Epigenetics; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:446|AKT1|Inhibitors of Signal Transduction Pathways;PKB alpha/Akt1 Inhibitors;PKB beta/Akt2 Inhibitors;PKB gamma/Akt3 Inhibitors	CCn1c(nc2c(ncc(OC[C@H]3CCCNC3)c12)C#CC(C)(C)O)c4nonc4N	937174-76-0	3864	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469258	425.48418	GSK690693	GSK690693 | GSK690693	Pathway: Autophagy; Epigenetics; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:446	AKT1	Inhibitors of Signal Transduction Pathways;PKB alpha/Akt1 Inhibitors;PKB beta/Akt2 Inhibitors;PKB gamma/Akt3 Inhibitors
SJ000803729-5	SJ000803729	5	MOABOX:450	DMMILYKXNCVKOJ-UHFFFAOYSA-N	O=C(Nc1cccc(Nc2ncc(Br)c(NCCc3c[nH]cn3)n2)c1)N1CCCC1	702674-56-4	PKB beta/Akt2 Inhibitors	AKT2																																																															CHEMBL3916849											11754511					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.7756																																0.09695																																8																																HY-11005	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:450|AKT2|PKB beta/Akt2 Inhibitors	Brc1cnc(Nc2cccc(NC(=O)N3CCCC3)c2)nc1NCCc4c[nH]cn4	702674-56-4	9171	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469355	471.35362	BX-912	BX-912 | BX-912	Pathway: Apoptosis; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:450	AKT2	PKB beta/Akt2 Inhibitors
SJ001034671-1	SJ001034671	1	MOABOX:452	WJXSWCUQABXPFS-UHFFFAOYSA-N	Nc1c(O)cccc1C(=O)O	4920-81-4	Aldehyde Dehydrogenase Inhibitor	ALDH2	ALDH7A1	ALDH5A1	ALDH1A2																													501	7915	8854																													CHEMBL445304											86	5743254	21121929	66880740	67779997	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0																													0.0	0.0	0.0	0.0																													7	7	7	7																													GS-4375	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Nc1c(O)cccc1C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466837	153.13538	GS-4375	GS-4375 | GS-4375			MOABOX:452	ALDH2	Aldehyde Dehydrogenase Inhibitor
SJ000851890-10	SJ000851890	10	MOABOX:462	VERWOWGGCGHDQE-UHFFFAOYSA-N	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1	1032900-25-6	ALK Inhibitors	ALK																																																															CHEMBL2403108											57379345	67973512	78243744	86345965	90718206	virtual	10.1007/s11523-017-0528-z	10.1016/j.ejmech.2018.09.012	10.1016/j.ejmech.2019.03.038	10.1016/j.taap.2019.114781	10.1021/jm400402q																																																																																																																																																											23742252	23837797	24785465	25200979	26020125	26235945	26568289	26712094	26750252	26923695	27474925	27915169	28385505	28528303	29174809	29288940	30789735	30927566																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				4.72608																																0.59076																																8																																HY-15656	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer; Endocrinology|MOABOX:462|ALK|ALK Inhibitors	CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3	1032900-25-6	19216	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469686	558.13514	CERITINIB	CERITINIB | LDK378 | CERITINIB | LDK378	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer; Endocrinology	MOABOX:462	ALK	ALK Inhibitors
SJ000565231-8	SJ000565231	8	MOABOX:464	QQWUGDVOUVUTOY-UHFFFAOYSA-N	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1	761439-42-3	Inhibitors of Signal Transduction Pathways;ALK Inhibitors	ALK																																																															CHEMBL509032											16038120	57343737				virtual	10.1002/med.20109	10.1021/bi1005514	10.1021/ml400373j																																																																																																																																																													17185414	17694547	18077425	21502504	21572589	21721129	22034911	22037378	23107363	23742252	24468632	24900831	25461320	27144831	28850922	29660984																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						3.67944																																0.45993																																8																																HY-10192	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:464|ALK|Inhibitors of Signal Transduction Pathways;ALK Inhibitors	COc1cc(ccc1Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)N4CCC(CC4)N5CCN(C)CC5	761439-42-3	3481	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468820	614.2017	NVP-TAE684	"NVP-TAE684 | ""TAE-684 | TAE684"" | ""TAE684 | NVP-TAE684 |"" | TAE684 (NVP-TAE684) | NVP-TAE684 | ""TAE-684 | TAE684"" | ""TAE684 | NVP-TAE684 |"" | TAE684 (NVP-TAE684)"	Pathway: Apoptosis; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:464	ALK	Inhibitors of Signal Transduction Pathways;ALK Inhibitors
SJ001035111-1	SJ001035111	1	MOABOX:470	KCGLTUBCAGZLHP-XYOKQWHBSA-N	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)OCCc1cccs1	132465-10-2	12-Lipoxygenase Inhibitors	ALOX12																																																															CHEMBL37081											6069552					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.15715																																-0.02245																																7																																645	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-275-908|MOABOX:470|ALOX12|12-Lipoxygenase Inhibitors	Oc1ccc(C=C(C#N)C(=O)OCCc2cccs2)cc1O	132465-10-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468711	315.34372	2-TEDC	2-TEDC | 2-TEDC			MOABOX:470	ALOX12	12-Lipoxygenase Inhibitors
SJ000288073-10	SJ000288073	10	MOABOX:472	HCZKYJDFEPMADG-UHFFFAOYSA-N	CC(Cc1ccc(O)c(O)c1)C(C)Cc1ccc(O)c(O)c1	103185-28-0	Antioxidant agent	ALOX12	ALOX5	ALOX15	COMT	CYP19A1																												240	246	1312	1588																												CHEMBL52											4534	44237816				virtual	10.1016/j.bioorg.2018.05.014	10.1016/j.bmc.2007.07.036	10.1016/j.bmc.2011.09.001	10.1016/j.bmc.2012.07.025	10.1016/j.bmcl.2010.03.113	10.1021/jm0201262	10.1021/jm049872s	10.1021/jm1008852	10.1021/jm101165z	10.1080/14756366.2019.1581184	10.1111/j.1471-4159.1984.tb02755.x																																																																																																																																																					2157009	2542553	9544564	12036375	12608855	17378609	17869117	18976930	19848434	20413308	21739938	21958737	21958738	24684213																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								0.28056	1.2664	0.93808	0	0.60736																												0.04008	0.1583	0.11726	0.0	0.07592																												7	8	8	7	8																												BD145457	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-793-905|MOABOX:472|ALOX12|Antioxidant agent	CC(Cc1ccc(O)c(O)c1)C(C)Cc2ccc(O)c(O)c2	500-38-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468659	302.36488	MASOPROCOL | NDGA | NORDIHYDROGUAIARETIC ACID | CHX-100 | MESO-NDGA	"""MASOPROCOL | NDGA | NORDIHYDROGUAIARETIC ACID | CHX-100 | MESO-NDGA"" | NORDIHYDROGUAIARETIC ACID FROM LARREA DIVARICATA (CREOSOTE BUSH) | ""MASOPROCOL | CHX-100 | MESO-NDGA |,MASOPROCOL"" | NDGA | ""MASOPROCOL | NDGA | NORDIHYDROGUAIARETIC ACID | CHX-100 | MESO-NDGA"" | NORDIHYDROGUAIARETIC ACID FROM LARREA DIVARICATA (CREOSOTE BUSH) | ""MASOPROCOL | CHX-100 | MESO-NDGA |,MASOPROCOL"" | NDGA"			MOABOX:472	ALOX12	Antioxidant agent
SJ001034837-1	SJ001034837	1	MOABOX:474	CTDQKZGWJQNLIZ-UHFFFAOYSA-N	O=S(=O)(NCCc1c[nH]c2ccccc12)c1ccccc1	32585-54-9	15-Lipoxygenase Inhibitors	ALOX15	ALOX15B																															247																															CHEMBL1371590											2475352	66783092				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															Z45538837	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-768-966|MOABOX:474|ALOX15|15-Lipoxygenase Inhibitors	O=S(=O)(NCCc1c[nH]c2ccccc12)c3ccccc3	32585-54-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468079	300.37544	Z45538837	Z45538837 | Z45538837			MOABOX:474	ALOX15	15-Lipoxygenase Inhibitors
SJ000312303-10	SJ000312303	10	MOABOX:476	MWLSOWXNZPKENC-UHFFFAOYSA-N	CC(c1cc2ccccc2s1)N(O)C(N)=O	111406-87-2	5-Lipoxygenase inhibitor;5-Lipoxygenase Inhibitors;Leukotriene Synthesis Inhibitors	ALOX5																																																															CHEMBL93											60490	19846307	88015828	91403349	140557786	member	10.1002/ardp.201700311	10.1002/cmdc.201600536	10.1016/S0968-0896(96)00255-6	10.1016/S0968-0896(99)00047-4	10.1016/j.bmc.2010.04.034	10.1016/j.bmcl.2004.02.005	10.1016/j.bmcl.2004.08.060	10.1016/j.bmcl.2004.12.023	10.1016/j.ejmech.2014.05.033	10.1016/j.ejmech.2015.07.011	10.1021/acs.jnatprod.6b01011	10.1021/acs.jnatprod.6b01126	10.1021/jm00024a004	10.1021/jm301617j	10.1021/jm401557w	10.1021/jm401740w	10.1021/jm801085s	10.1021/jm900212y	10.1021/jm9606150	10.1021/np401010x	10.1038/s41467-018-06158-5	10.1080/14756366.2019.1581184																																																																																																																																										1324317	7490726	8246226	9057869	9207936	10691695	15081022	15482930	15686917	19053751	19492852	20451397	21868137	22326163	22380511	22551629	22789707	23871907	24074025	24171493	24508141	24568174	24697244	24871899	25765759	26197161	26922224	27597418	28165233	28240894																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								1.0884																																0.13605																																8																																HY-14164	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology; Cancer|MOABOX:476|ALOX5|5-Lipoxygenase inhibitor;5-Lipoxygenase Inhibitors;Leukotriene Synthesis Inhibitors	CC(N(O)C(=O)N)c1cc2ccccc2s1	111406-87-2	15663	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469422	236.29018	ZILEUTON	ZILEUTON | LEUTROL | ZILEUTON | LEUTROL	Pathway: Apoptosis; Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology; Cancer	MOABOX:476	ALOX5	5-Lipoxygenase inhibitor;5-Lipoxygenase Inhibitors;Leukotriene Synthesis Inhibitors
SJ000287435-10	SJ000287435	10	MOABOX:478	QAIPRVGONGVQAS-DUXPYHPUSA-N	O=C(O)/C=C/c1ccc(O)c(O)c1	331-39-5	5-Lipoxygenase Inhibitors;HIV Integrase Inhibitors;Antioxidants	ALOX5																																																															CHEMBL145											689043	6442872	6476954	11300090	19810319	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.52388																																0.07484																																7																																HY-N0172	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Inflammation/Immunology; Cancer|MOABOX:478|ALOX5|5-Lipoxygenase Inhibitors;HIV Integrase Inhibitors;Antioxidants	OC(=O)\C=C\c1ccc(O)c(O)c1	331-39-5	27665	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469887	180.15742	CAFFEIC ACID	CAFFEIC ACID | CAFFEIC ACID	Pathway: Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Inflammation/Immunology; Cancer	MOABOX:478	ALOX5	5-Lipoxygenase Inhibitors;HIV Integrase Inhibitors;Antioxidants
SJ001035274-1	SJ001035274	1	MOABOX:480	VQQVWGVXDIPORV-UHFFFAOYSA-N	O=C1c2ccccc2-n2c1nc1ccccc1c2=O	13220-57-0	5-Lipoxygenase Inhibitors;Hepatocyte Growth Factor (HGF) Antagonists;Cyclooxygenase-2 Inhibitors	ALOX5	HGF	PTGS2																														3082	5743																														CHEMBL306946											73549	54528398	91027663	139083024	139178792	member																																																																																																																																																																16038536	16529558	22819942	23146282																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.63416	0	0.60256																														0.07927	0.0	0.07532																														8	7	8																														HY-N6607	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Inflammation/Immunology|MOABOX:480|ALOX5|5-Lipoxygenase Inhibitors;Hepatocyte Growth Factor (HGF) Antagonists;Cyclooxygenase-2 Inhibitors	O=C1N2C(=Nc3ccccc13)C(=O)c4ccccc24	13220-57-0	46030	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469464	248.23622	TRYPTANTHRIN	TRYPTANTHRIN | TRYPTANTHRIN	Pathway: Others	Research Area: Inflammation/Immunology	MOABOX:480	ALOX5	5-Lipoxygenase Inhibitors;Hepatocyte Growth Factor (HGF) Antagonists;Cyclooxygenase-2 Inhibitors
SJ001035273-1	SJ001035273	1	MOABOX:484	FBSFWRHWHYMIOG-UHFFFAOYSA-N	COC(=O)c1cc(O)c(O)c(O)c1	99-24-1	5-Lipoxygenase Inhibitors;Cyclooxygenase-2 Inhibitors;Antioxidants	ALOX5	PTGS2																															5743																															CHEMBL65675											7428	22764786	87228016	87408103	88233953	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-N2010	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?B | Research Area: Cancer; Infection; Cardiovascular Disease|MOABOX:484|ALOX5|5-Lipoxygenase Inhibitors;Cyclooxygenase-2 Inhibitors;Antioxidants	COC(=O)c1cc(O)c(O)c(O)c1	99-24-1	30022	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469450	184.14612	METHYL GALLATE | GALLINCIN | NSC 363001	"""METHYL GALLATE | GALLINCIN | NSC 363001"" | ""METHYL GALLATE | GALLINCIN | NSC 363001"""	Pathway: Anti-infection; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?B	Research Area: Cancer; Infection; Cardiovascular Disease	MOABOX:484	ALOX5	5-Lipoxygenase Inhibitors;Cyclooxygenase-2 Inhibitors;Antioxidants
SJ000288023-5	SJ000288023	5	MOABOX:488	QAOAOVKBIIKRNL-UHFFFAOYSA-N	CC(C)c1ccc2c(c1)c(SC(C)(C)C)c(CC(C)(C)C(=O)O)n2Cc1ccc(Cl)cc1	118414-82-7	PPAR Modulators;5-Lipoxygenase-Activating Protein (FLAP) Inhibitors;Leukotriene Synthesis Inhibitors	ALOX5AP																																																															CHEMBL29097											3651377	24795095	126456788			member	10.1016/j.bmcl.2005.05.027	10.1021/jm00022a020	10.1021/jm960088k																																																																																																																																																													7473582	8709092	18459759	19719242	20144869	22059882	22607880	23266122																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														2.30936																																0.28867																																8																																HY-14166	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage; GPCR/G Protein; Immunology/Inflammation | Research Area: Cancer|MOABOX:488|ALOX5AP|PPAR Modulators;5-Lipoxygenase-Activating Protein (FLAP) Inhibitors;Leukotriene Synthesis Inhibitors	CC(C)c1ccc2c(c1)c(SC(C)(C)C)c(CC(C)(C)C(=O)O)n2Cc3ccc(Cl)cc3	118414-82-7	21379	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469865	472.08236	MK-886	"MK-886 | ""MK-886 | L-663536 |"" | MK-886 | ""MK-886 | L-663536 |"""	Pathway: Apoptosis; Cell Cycle/DNA Damage; GPCR/G Protein; Immunology/Inflammation	Research Area: Cancer	MOABOX:488	ALOX5AP	PPAR Modulators;5-Lipoxygenase-Activating Protein (FLAP) Inhibitors;Leukotriene Synthesis Inhibitors
SJ000285551-15	SJ000285551	15	MOABOX:490	RJKFOVLPORLFTN-LEKSSAKUSA-N	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	137940-28-4	Progesterone Receptor Agonists	ALPI	ALPL	ALPP	PGR																													249	250	5241																													CHEMBL103											5994	492401	9830432	9960082	9962773	member	10.1016/0014-2999(96)00036-2	10.1016/S0014-2999(01)01382-6	10.1016/S0039-128X(00)00120-3	10.1016/S0960-0760(00)00134-5	10.1016/S0960-0760(02)00192-9	10.1016/S0960-894X(00)00011-1	10.1016/S0960-894X(02)00025-2	10.1016/S0960-894X(03)00128-8	10.1016/S0960-894X(03)00255-5	10.1016/S0960-894X(98)00608-8	10.1016/j.bcp.2008.10.016	10.1016/j.bmc.2006.03.018	10.1016/j.bmc.2006.03.022	10.1016/j.bmc.2007.07.011	10.1016/j.bmc.2010.04.092	10.1016/j.bmcl.2004.02.054	10.1016/j.jsbmb.2003.12.004	10.1016/j.jsbmb.2004.02.003	10.1016/j.jsbmb.2007.10.008	10.1016/j.jsbmb.2008.08.007	10.1016/j.jsbmb.2009.11.008	10.1016/j.steroids.2003.12.007	10.1016/j.steroids.2005.07.003	10.1016/j.steroids.2006.02.002	10.1016/j.steroids.2010.01.010	10.1016/j.steroids.2011.02.043	10.1021/jm020477g	10.1021/jm9705768	10.1021/jm9705770	10.1021/jm980190c	10.1021/jm980366a	10.1021/jm980723h	10.1038/ja.2008.50	10.1124/jpet.104.074146	10.1210/endo.136.12.7588320	10.2174/1389557054553794																																																																																																																												8523399	8523400	8627601	9464360	9464361	9667968	9784110	9873735	10212133	10743938	11859003	12657271	12781197	12954062	15072922	16101406	16580209	16580213	16821785	17681796	18061638	18553958	18667783	18722119	19013437	19863083	19864132	20510622	24900290	25305688	27652492																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							0.88284	0.88284	0.88284	4.96792																													0.12612	0.12612	0.12612	0.62099																													7	7	7	8																													AG00IA68	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-794-643|MOABOX:490|ALPI|Progesterone Receptor Agonists	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	57-83-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468603	314.4617	PROGESTERONE	PROGESTERONE | PROGESTERONE| PROMETRIUM | PROGESTERONE | PROGESTERONE| PROMETRIUM			MOABOX:490	ALPI	Progesterone Receptor Agonists
SJ000836346-2	SJ000836346	2	MOABOX:494	MXWHMTNPTTVWDM-NXOFHUPFSA-N	CC(/C=N/NC(=N)N)=N\NC(=N)N	13922-04-8	Polyamine Biosynthesis Inhibitors;S-Adenosyl-L-methionine Decarboxylase Inhibitors	AMD1																																																															CHEMBL1995011	CHEMBL216913										5351153	5351154	5354894	9570252	9573249	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																CS-0026193	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-028-754-467|MOABOX:494|AMD1|Polyamine Biosynthesis Inhibitors;S-Adenosyl-L-methionine Decarboxylase Inhibitors	C\C(=N/N=C(N)N)\C=N\N=C(N)N	459-86-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468540	184.20238	MITOGUAZONE	MITOGUAZONE | MITOGUAZONE			MOABOX:494	AMD1	Polyamine Biosynthesis Inhibitors;S-Adenosyl-L-methionine Decarboxylase Inhibitors
SJ000285589-8	SJ000285589	8	MOABOX:502	XJLATMLVMSFZBN-VYDXJSESSA-N	CCCCC[C@H](CC(=O)NO)C(=O)N[C@H](C(=O)N1CCC[C@H]1CO)C(C)C	13434-13-4	Mitochondrial Translation Inhibitors;Peptide Deformylase (PDF) Inhibitors;Membrane Alanine Aminopeptidase (Aminopeptidase N) Inhibitors	ANPEP	PDF																															64146																															CHEMBL308333											443600	9897107				member	10.1002/med.20044	10.5012/bkcs.2013.34.12.3885																																																																																																																																																														11158755	11502510	11551755	12951107	16216010	17201406	17429823	18473835	18991640																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													-0.29936	1.76784																															-0.03742	0.22098																															8	8																															HY-113952	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Apoptosis; Metabolic Enzyme/Protease | Research Area: Cancer; Infection|MOABOX:502|ANPEP|Mitochondrial Translation Inhibitors;Peptide Deformylase (PDF) Inhibitors;Membrane Alanine Aminopeptidase (Aminopeptidase N) Inhibitors	CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1CO	13434-13-4	91044	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469221	385.4983	ACTINONIN	ACTINONIN | ACTINONIN	Pathway: Anti-infection; Apoptosis; Metabolic Enzyme/Protease	Research Area: Cancer; Infection	MOABOX:502	ANPEP	Mitochondrial Translation Inhibitors;Peptide Deformylase (PDF) Inhibitors;Membrane Alanine Aminopeptidase (Aminopeptidase N) Inhibitors
SJ001034667-1	SJ001034667	1	MOABOX:504	AGNFWIZBEATIAK-UHFFFAOYSA-N	NCCCCc1ccccc1	120375-45-3	Semicarbazide-Sensitive Amine Oxidase (SSAO| VAP-1)  Inhibitors	AOC3																																																															CHEMBL79512											83242	141580	11572046	18790221	23298601	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																STR06036	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NCCCCc1ccccc1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466786	149.2328	STR06036	STR06036 | STR06036			MOABOX:504	AOC3	Semicarbazide-Sensitive Amine Oxidase (SSAO| VAP-1)  Inhibitors
SJ000833876-7	SJ000833876	7	MOABOX:506	NETXMUIMUZJUTB-UHFFFAOYSA-N	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1	1044870-39-4	BRD2/3/4/T BET familiy inhibitor;APOA1 Expression Enhancers;BRD4 inhibitor	BRD4																																																															CHEMBL2393130											135564749	141762206				member	10.1016/j.bmcl.2017.07.054																																																																																																																																																															25678016	26367539	26572217	27266999	28195723	28765013	29649741	30253095	30529546	30613330	30926312	31257080																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										2.02864																																0.25358																																8																																HY-16652	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Epigenetics | Research Area: Cancer|MOABOX:506|BRD4|BRD2/3/4/T BET familiy inhibitor;APOA1 Expression Enhancers;BRD4 inhibitor	COc1cc(OC)c2C(=O)NC(=Nc2c1)c3cc(C)c(OCCO)c(C)c3	1044870-39-4	13314	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468778	370.39908	RVX-208	RVX-208 | RVX-208	Pathway: Anti-infection; Epigenetics	Research Area: Cancer	MOABOX:506	BRD4	BRD2/3/4/T BET familiy inhibitor;APOA1 Expression Enhancers;BRD4 inhibitor
SJ000285834-13	SJ000285834	13	MOABOX:510	YMTINGFKWWXKFG-UHFFFAOYSA-N	CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1	49562-28-9	APOA1 Expression Enhancers;PPARalpha Agonists	PPARA																																																															CHEMBL672											3339	9810651	9822130	9831692	9874937	member																																																																																																																																																																19530681																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					9.704e-002																																0.01213																																8																																HY-17356	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease; Cancer|MOABOX:510|PPARA|APOA1 Expression Enhancers;PPARalpha Agonists	CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c2ccc(Cl)cc2	49562-28-9	60044	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468939	360.83134	FENOFIBRATE	FENOFIBRATE | FENOFIBRATE	Pathway: Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease; Cancer	MOABOX:510	PPARA	APOA1 Expression Enhancers;PPARalpha Agonists
SJ001035043-1	SJ001035043	1	MOABOX:522	INRRBCBUMMJGOS-UHFFFAOYSA-N	CC(C)(c1cc(Br)c(OCC(O)CN2CCOCC2)c(Br)c1)c1cc(Br)c(OCC(O)CN2CCOCC2)c(Br)c1	299420-64-7	beta-Amyloid (Abeta) Aggregation Inhibitors	APP																																																															CHEMBL1271166											3090938					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.42238																																-0.06034																																7																																PHAR075854	PHARMEKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-467-513|MOABOX:522|APP|beta-Amyloid (Abeta) Aggregation Inhibitors	CC(C)(c1cc(Br)c(OCC(O)CN2CCOCC2)c(Br)c1)c3cc(Br)c(OCC(O)CN4CCOCC4)c(Br)c3	299420-64-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468543	830.23782	PHAR075854	PHAR075854 | PHAR075854			MOABOX:522	APP	beta-Amyloid (Abeta) Aggregation Inhibitors
SJ000285466-7	SJ000285466	7	MOABOX:524	SNKZJIOFVMKAOJ-UHFFFAOYSA-N	NCCCS(=O)(=O)O	14650-46-5	beta-Amyloid (Abeta) Aggregation Inhibitors;Antiamyloidogenic Agents	APP																																																															CHEMBL149082											1646	6991996	21693794	25163030	53429901	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.58702																																-0.08386																																7																																GS-3103	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NCCCS(=O)(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466829	139.17346	3-AMINOPROPANESULPHONIC ACID	3-AMINOPROPANESULPHONIC ACID | 3-AMINO-1-PROPANESULFONIC ACID SODIUM | 3-AMINOPROPANESULFONIC ACID | 3-AMINOPROPANESULPHONIC ACID | 3-AMINO-1-PROPANESULFONIC ACID SODIUM | 3-AMINOPROPANESULFONIC ACID			MOABOX:524	APP	beta-Amyloid (Abeta) Aggregation Inhibitors;Antiamyloidogenic Agents
SJ000286467-9	SJ000286467	9	MOABOX:528	LNTHITQWFMADLM-UHFFFAOYSA-N	O=C(O)c1cc(O)c(O)c(O)c1	137657-43-3	Apoptosis Inducers;beta-Amyloid (Abeta) Aggregation Inhibitors;Antioxidants;PPARgamma Agonists;beta-Amyloid (Abeta) Protein Neurotoxicity Inhibitors	APP	PPARG																															5468																															CHEMBL288114	CHEMBL3634562										370	220772	6328166	9878340	18454925	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															PS-8710	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC(=O)c1cc(O)c(O)c(O)c1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466748	170.11954	GALLIC ACID	GALLIC ACID | GALLIC ACID			MOABOX:528	APP	Apoptosis Inducers;beta-Amyloid (Abeta) Aggregation Inhibitors;Antioxidants;PPARgamma Agonists;beta-Amyloid (Abeta) Protein Neurotoxicity Inhibitors
SJ000312309-11	SJ000312309	11	MOABOX:534	LKJPYSCBVHEWIU-UHFFFAOYSA-N	CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	90357-06-5	Androgen Receptor Antagonists	AR	CYP27A1																															1593																															CHEMBL409											2375	9810295	9810435	9961918	11534028	member	10.1016/S0960-0760(97)00151-9	10.1016/S0960-894X(00)00010-X	10.1016/S0960-894X(98)00107-3	10.1016/S0960-894X(99)00118-3	10.1016/j.bmc.2006.09.072	10.1016/j.bmc.2010.03.036	10.1016/j.bmc.2010.10.023	10.1016/j.bmc.2011.10.067	10.1016/j.bmcl.2004.09.049	10.1016/j.bmcl.2004.10.051	10.1016/j.bmcl.2004.10.085	10.1016/j.bmcl.2007.01.001	10.1016/j.bmcl.2007.01.007	10.1016/j.bmcl.2007.07.090	10.1016/j.bmcl.2008.02.006	10.1016/j.bmcl.2008.03.062	10.1016/j.bmcl.2008.03.085	10.1021/acsmedchemlett.5b00173	10.1021/jm040202w	10.1021/jm050293c	10.1021/jm070231h	10.1021/jm501995n	10.1021/jm901488g	10.1021/jm970699s	10.1038/bjp.2008.107	10.1073/pnas.0807282106	10.1158/0008-5472.CAN-09-1111	10.1158/0008-5472.CAN-11-3948	10.1248/cpb.52.1330	10.1248/cpb.53.402	10.1248/cpb.59.1363																																																																																																																																	9484511	9871534	10230628	10743937	15516756	15546739	15603938	15603960	15828836	16054371	16420057	17064916	17257838	17804229	18291644	18400499	18442912	18571420	18582482	20381361	20584610	20826091	21050768	22041072	22094279	22174412	22391033	22396588	23199477	23713567	23727044	25591066	25646649	26046313	26288692	27836399																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		3.29312	0																															0.41164	0.0																															8	7																															HY-14249	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Others | Research Area: Cancer|MOABOX:534|AR|Androgen Receptor Antagonists	CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc2ccc(C#N)c(c2)C(F)(F)F	90357-06-5	15754	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468767	430.37337	BICALUTAMIDE	"BICALUTAMIDE | BICALUTAMIDE | ""BICALUTAMIDE| CASODEX | N-(4-CYANO-3-(TRIFLUOROMETHYL)PHENYL)-3-(4-FLUOROPHENYLSULFONYL)-2-HYDROXY-2-METHYLPROPANAMIDE | BICALUTAMIDE"" | ""BICALUTAMIDE | ICI-176334 |"" | BICALUTAMIDE | ""BICALUTAMIDE| CASODEX | N-(4-CYANO-3-(TRIFLUOROMETHYL)PHENYL)-3-(4-FLUOROPHENYLSULFONYL)-2-HYDROXY-2-METHYLPROPANAMIDE | BICALUTAMIDE"" | ""BICALUTAMIDE | ICI-176334 |"""	Pathway: Autophagy; Others	Research Area: Cancer	MOABOX:534	AR	Androgen Receptor Antagonists
SJ000286182-9	SJ000286182	9	MOABOX:538	VFTRKSBEFQDZKX-UHFFFAOYSA-N	c1ccc2c(Cc3c[nH]c4ccccc34)c[nH]c2c1	1968-05-4	"Androgen Receptor Antagonists;Indoleamine 2,3-dioxygenase Inhibitors;Aryl Hydrocarbon Receptor (AhR) Agonists"	AHR	AR	IDO1																														367	3620																														CHEMBL446452											3071	143959995				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.43239	-0.31374	0																														0.06177	-0.04482	0.0																														7	7	7																														KS-5266	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	C(c1c[nH]c2ccccc12)c3c[nH]c4ccccc34	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466827	246.30646	"3,3'-DIINDOLYLMETHANE"	"3,3'-DIINDOLYLMETHANE | DIINDOLYLMETHANE | 3,3'-DIINDOLYLMETHANE | DIINDOLYLMETHANE"			MOABOX:538	AHR	"Androgen Receptor Antagonists;Indoleamine 2,3-dioxygenase Inhibitors;Aryl Hydrocarbon Receptor (AhR) Agonists"
SJ000852840-4	SJ000852840	4	MOABOX:540	PAFKTGFSEFKSQG-PAASFTFBSA-N	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2n1cnc2ccccc21	851983-85-2	Androgen Receptor Antagonists;Cytochrome P450 CYP17 (17alpha-Hydroxylase/C17-20 Lyase) Inhibitors	AR	CYP17A1																															1586																															CHEMBL2105738											11188409	46848046	46853725	136218665		member	10.1021/jm020576u	10.1021/jm040202w	10.1021/jm400048v																																																																																																																																																													23713567	25591066	29792703																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.53328	1.77976																															0.06666	0.22247																															8	8																															HY-70006	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:540|AR|Androgen Receptor Antagonists;Cytochrome P450 CYP17 (17alpha-Hydroxylase/C17-20 Lyase) Inhibitors	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CC=C2n5cnc6ccccc56	851983-85-2	1546	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469459	388.54508	GALETERONE	GALETERONE | GALETERONE	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:540	AR	Androgen Receptor Antagonists;Cytochrome P450 CYP17 (17alpha-Hydroxylase/C17-20 Lyase) Inhibitors
SJ000286129-15	SJ000286129	15	MOABOX:542	MKXKFYHWDHIYRV-UHFFFAOYSA-N	CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1	13311-84-7	Androgen Receptor Antagonists	AR	CYP1B1																															1545																															CHEMBL806											3397	11582200	17898263	46864459	67731539	member	10.1016/j.bmc.2005.06.061	10.1016/j.bmc.2008.07.055	10.1016/j.bmcl.2009.06.073	10.1021/jm0303305	10.1021/jm0495226																																																																																																																																																											11160641	12939788	14613328	15509168	15892636	16054371	16099660	18707892	19592245	19754423	20226658	22396588																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										2.16072	0.46592																															0.27009	0.06656																															8	7																															HY-B0022	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:542|AR|Androgen Receptor Antagonists	CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+](=O)[O-]	13311-84-7	13790	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468786	276.21185	FLUTAMIDE	FLUTAMIDE | FLUTAMIDE| EULEXIN | FLUTAMIDE | FLUTAMIDE| EULEXIN	Pathway: Others	Research Area: Cancer	MOABOX:542	AR	Androgen Receptor Antagonists
SJ000287287-9	SJ000287287	9	MOABOX:544	IKMDFBPHZNJCSN-UHFFFAOYSA-N	O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12	529-44-2	Androgen Receptor Ligands;Cytochrome P450 CYP3A4 Inhibitors;Antioxidants	AR	CYP3A4																															1576																															CHEMBL164											5281672	56837170	57520431	57520432	87194553	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	-0.20741																															0.0	-0.02963																															7	7																															HY-15097	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:544|AR|Androgen Receptor Ligands;Cytochrome P450 CYP3A4 Inhibitors;Antioxidants	OC1=C(Oc2cc(O)cc(O)c2C1=O)c3cc(O)c(O)c(O)c3	529-44-2	23537	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468880	318.2351	MYRICETIN	"MYRICETIN | MYRICETIN; 3,5,7,3',4',5'-HEXAHYDROXYFLAVONE | MYRICETIN | MYRICETIN; 3,5,7,3',4',5'-HEXAHYDROXYFLAVONE"	Pathway: Apoptosis; Autophagy; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:544	AR	Androgen Receptor Ligands;Cytochrome P450 CYP3A4 Inhibitors;Antioxidants
SJ000572860-2	SJ000572860	2	MOABOX:548	PKQYVFHRKFDVCH-UHFFFAOYSA-N	Cc1ccc(NC(=N)N)cc1	1187927-45-2	5-HT3 receptor agonist	HTR3B	HTR3C	HTR3D	HTR3E																													170572	200909	285242																													CHEMBL1204200	CHEMBL43415										409364	3028500	12818157	12910055	21661084	virtual																																																																																																																																																																11412989	13129581																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.63008	0.63008	0.63008	0.63008																													0.07876	0.07876	0.07876	0.07876																													8	8	8	8																													WXCD01005093	WUXI_APPTECH	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-007-994-804|MOABOX:548|HTR3B|5-HT3 receptor agonist	Cc1ccc(NC(=N)N)cc1	1187927-45-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468109	149.19304					MOABOX:548	HTR3B	5-HT3 receptor agonist
SJ000287236-12	SJ000287236	12	MOABOX:550	VKHAHZOOUSRJNA-GCNJZUOMSA-N	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C	122742-25-0	Androgen Receptor Ligands;Glucocorticoid Receptor (GR) Antagonists;Internal Ribosomal Entry Site (IRES) Inhibitors;Progesterone Receptor Antagonists	ALPI	ALPL	ALPP	AR	NR3C1	PGR																											249	250	367	2908	5241																											CHEMBL1276308	CHEMBL319896	CHEMBL329913	CHEMBL540699								55245	9831122	9831779	9853602	9875273	member	10.1016/S0014-2999(01)01382-6	10.1016/S0960-0760(00)00134-5	10.1016/S0960-0760(02)00157-7	10.1016/S0960-894X(01)00554-6	10.1016/S0960-894X(02)00025-2	10.1016/S0960-894X(02)00746-1	10.1016/S0960-894X(03)00255-5	10.1016/S0960-894X(03)00256-7	10.1016/S0960-894X(03)00431-1	10.1016/S0960-894X(98)00482-X	10.1016/j.bcp.2008.10.016	10.1016/j.bmc.2006.03.018	10.1016/j.bmc.2006.05.066	10.1016/j.bmc.2008.05.018	10.1016/j.bmc.2010.01.048	10.1016/j.bmc.2010.04.092	10.1016/j.bmcl.2004.02.048	10.1016/j.bmcl.2004.02.054	10.1016/j.bmcl.2004.06.021	10.1016/j.bmcl.2004.06.022	10.1016/j.bmcl.2005.07.025	10.1016/j.bmcl.2006.08.133	10.1016/j.bmcl.2006.10.003	10.1016/j.bmcl.2006.11.062	10.1016/j.bmcl.2007.02.013	10.1016/j.bmcl.2007.08.064	10.1016/j.bmcl.2009.01.095	10.1016/j.bmcl.2010.06.109	10.1016/j.cclet.2014.03.017	10.1016/j.jsbmb.2003.12.004	10.1016/j.jsbmb.2004.10.014	10.1016/j.jsbmb.2009.12.011	10.1016/j.jsbmb.2012.10.015	10.1016/j.steroids.2006.02.002	10.1016/j.steroids.2006.07.003	10.1016/j.steroids.2008.03.005	10.1016/j.steroids.2011.02.043	10.1021/acs.jmedchem.7b01690	10.1021/acs.jmedchem.8b00743	10.1021/acs.jmedchem.9b00711	10.1021/acsmedchemlett.8b00058	10.1021/jm001000c	10.1021/jm025555e	10.1021/jm0342515	10.1021/jm050205o	10.1021/jm070370z	10.1021/jm701080t	10.1021/jm800985z	10.1021/jm950747d	10.1021/jm970699s	10.1021/jm9801915	10.1074/jbc.M504144200	10.1111/j.1476-5381.2009.00238.x	10.1124/jpet.108.140467	10.1124/mol.113.085860	10.1210/endo.136.12.7588320	10.1210/me.2006-0524	10.2174/1389557054553794																																																																																																						8627601	9484511	9719599	9873612	11150172	11591515	11859003	12036351	12238914	12419390	12781197	12781198	12824023	15080982	15081005	15261265	15261266	15293993	15456242	15544551	15925510	16078847	16101406	16112571	16580213	16678409	16821781	16934845	16987661	17070047	17169557	17258455	17317167	17616395	17705362	17822897	17855092	18038970	18226897	18318463	18472121	18504132	18722119	18855890	19013437	19216549	19217285	19863083	20149664	20334371	20469868	20510622	20638844	22104142	25978072	26218343	28368581	28506584	29424542	29670697	30034593	30091920	31274313																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							0.72905	0.72905	0.72905	-0.3728	0.24272	5.04328																											0.10415	0.10415	0.10415	-0.0466	0.03034	0.63041																											7	7	7	8	8	8																											AG00359Q	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-849-222|MOABOX:550|ALPI|Androgen Receptor Ligands;Glucocorticoid Receptor (GR) Antagonists;Internal Ribosomal Entry Site (IRES) Inhibitors;Progesterone Receptor Antagonists	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c5ccc(cc5)N(C)C	84371-65-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468365	429.5937	MIFEPRISTONE	MIFEPRISTONE | MIFEPRISTONE| MIFEPREX | MIFEPRISTONE | MIFEPRISTONE| MIFEPREX			MOABOX:550	ALPI	Androgen Receptor Ligands;Glucocorticoid Receptor (GR) Antagonists;Internal Ribosomal Entry Site (IRES) Inhibitors;Progesterone Receptor Antagonists
SJ000785933-2	SJ000785933	2	MOABOX:554	OTJHLDXXJHAZTN-BYPYZUCNSA-N	N[C@@H](CSCCB(O)O)C(=O)O	222638-67-7	"Arginase, Inhibitors"	ARG1	ARG2																															384																																										9877608	91826515	129626601			member																																																																																																																																																																12647314	20153713	23583962																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.46811	1.00639																															0.20973	0.14377																															7	7																															HY-19548A	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation; Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:554|ARG1|Arginase, Inhibitors"	N[C@@H](CSCCB(O)O)C(=O)O	222638-67-7	21663	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469807	193.02908	BEC HYDROCHLORIDE |	BEC HYDROCHLORIDE | | BEC HYDROCHLORIDE |	Pathway: Immunology/Inflammation; Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:554	ARG1	"Arginase, Inhibitors"
SJ000781113-8	SJ000781113	8	MOABOX:560	XRKYMMUGXMWDAO-UHFFFAOYSA-N	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1	587871-26-9	ATM Kinase Inhibitors;DNA Repair Inhibitors	ATM																																																															CHEMBL222102											5278396	5278397				member	10.1021/jm061121y	10.1158/0008-5472.CAN-04-2727																																																																																																																																																														15604286	15975507	16912188	17371003	20423312	21413798	22835870	25387153	26632965	27259031	29683659	30840447																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										4.38016																																0.54752																																8																																HY-12016	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Cell Cycle/DNA Damage; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:560|ATM|ATM Kinase Inhibitors;DNA Repair Inhibitors	O=C1C=C(OC(=C1)c2cccc3Sc4ccccc4Sc23)N5CCOCC5	587871-26-9	4906	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468852	395.49458	KU55933	"KU55933 | ""KU-55933 | KU-0064 |"" | KU-55933 (ATM KINASE INHIBITOR) | KU 55933 | KU55933 | ""KU-55933 | KU-0064 |"" | KU-55933 (ATM KINASE INHIBITOR) | KU 55933"	Pathway: Autophagy; Cell Cycle/DNA Damage; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:560	ATM	ATM Kinase Inhibitors;DNA Repair Inhibitors
SJ000287272-4	SJ000287272	4	MOABOX:562	XZTUSOXSLKTKJQ-CESUGQOBSA-N	C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12O	143-62-4	Cardiac glycoside	ATP1A1	ATP1A2	ATP1A3	ATP1A4	ATP1B1	ATP1B2	ATP1B3																										477	478	480	481	482	483																										CHEMBL1453											4369270	68142531	139063143			member																																																																																																																																																																1895297	3020248	8421289	11689068	11754591	12904068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.46837	0.46837	0.46837	0.46837	0.46837	0.46837	0.46837																										0.06691	0.06691	0.06691	0.06691	0.06691	0.06691	0.06691																										7	7	7	7	7	7	7																										18229	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-513-646|MOABOX:562|ATP1A1|Cardiac glycoside	C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4(C)[C@H](CC[C@]34O)C5=CC(=O)OC5	143-62-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468302	374.51366	DIGITOXIGENIN	DIGITOXIGENIN | DIGITOXIGENIN			MOABOX:562	ATP1A1	Cardiac glycoside
SJ000312306-6	SJ000312306	6	MOABOX:566	YREYEVIYCVEVJK-UHFFFAOYSA-N	COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C	117976-89-3	H+/K+-ATPase Inhibitors	ATP4A	ATP4B																															496																															CHEMBL1219											5029	9822268	9908058	11502922	11640843	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-B0656A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Membrane Transporter/Ion Channel | Research Area: Inflammation/Immunology; Cancer|MOABOX:566|ATP4A|H+/K+-ATPase Inhibitors	COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C	117976-90-6	81737	GENERAL	SODIUM(I)	1	NO_SOLVATE	0	1469246	359.44264	RABEPRAZOLE SODIUM	"RABEPRAZOLE SODIUM | RABEPRAZOLE SODIUM SALT | ""RABEPRAZOLE SODIUM | 2-((4-(3-METHOXYPROPOXY)-3-METHYLPYRIDIN-2-YL)METHYLSULFINYL)-1H-BENZO[D]IMIDAZOLE | RABEPRAZOLE SODIUM SALT"" | RABEPRAZOLE SODIUM | RABEPRAZOLE SODIUM SALT | ""RABEPRAZOLE SODIUM | 2-((4-(3-METHOXYPROPOXY)-3-METHYLPYRIDIN-2-YL)METHYLSULFINYL)-1H-BENZO[D]IMIDAZOLE | RABEPRAZOLE SODIUM SALT"""	Pathway: Apoptosis; Membrane Transporter/Ion Channel	Research Area: Inflammation/Immunology; Cancer	MOABOX:566	ATP4A	H+/K+-ATPase Inhibitors
SJ000286012-10	SJ000286012	10	MOABOX:568	MJIHNNLFOKEZEW-UHFFFAOYSA-N	Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1	103577-45-3	H+/K+-ATPase Inhibitors	ATP4A	ATP4B																															496																															CHEMBL480											3883	9807568	9871772	10207561	10271919	member																																																																																																																																																																1313110																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.282	0.24675																															0.03525	0.03525																															8	7																															HY-13662	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology; Cancer|MOABOX:568|ATP4A|H+/K+-ATPase Inhibitors	Cc1c(OCC(F)(F)F)ccnc1CS(=O)c2nc3ccccc3[nH]2	103577-45-3	11850	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469263	369.36147	LANSOPRAZOLE	"LANSOPRAZOLE | ""LANSOPRAZOLE | PREVACID"" | ""LANSOPRAZOLE | A-65006 | ABT-006 | AG-1749 | CG-4801 |"" | LANSOPRAZOLE | ""LANSOPRAZOLE | PREVACID"" | ""LANSOPRAZOLE | A-65006 | ABT-006 | AG-1749 | CG-4801 |"""	Pathway: Anti-infection; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology; Cancer	MOABOX:568	ATP4A	H+/K+-ATPase Inhibitors
SJ001034854-1	SJ001034854	1	MOABOX:582	UQHINZSKNAAVOZ-UHFFFAOYSA-N	OCCNc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12		Antimitotic Drugs;Aurora-A (ARK1) Kinase Inhibitors	AURKA																																																															CHEMBL189434											1587957					member																																																																																																																																																																20039358	20550212	23808327	29202231																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		3.01808																																0.37726																																8																																PHAR026504	PHARMEKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-717-552|MOABOX:582|AURKA|Antimitotic Drugs;Aurora-A (ARK1) Kinase Inhibitors	OCCNc1ncnc2oc(c3ccccc3)c(c4ccccc4)c12	380348-87-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468103	331.36788	PHAR026504	PHAR026504 | PHAR026504			MOABOX:582	AURKA	Antimitotic Drugs;Aurora-A (ARK1) Kinase Inhibitors
SJ000784320-12	SJ000784320	12	MOABOX:586	BLQYVHBZHAISJM-CMDGGOBGSA-N	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)[nH]n1	1291074-87-7	Antimitotic Drugs;Aurora-A (ARK1) Kinase Inhibitors;Angiogenesis Inhibitors;Protein Kinase Inhibitors	AURKA																																																															CHEMBL3237191	CHEMBL482968										16041424	24776050	66576993	89790691		virtual	10.1002/cmdc.201200479	10.1016/j.bmcl.2010.04.119	10.1016/j.bmcl.2011.02.110	10.1158/1535-7163.MCT-10-0574	10.2174/157489208786242322																																																																																																																																																											18991785	19320489	19568282	20573509	21421314	23281044	24681066	25369539	29191878	29202231	30241010	30502115																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										2.15552																																0.26944																																8																																HY-10987	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:586|AURKA|Antimitotic Drugs;Aurora-A (ARK1) Kinase Inhibitors;Angiogenesis Inhibitors;Protein Kinase Inhibitors	CN1CCN(CC1)c2cc(Nc3cc(C)[nH]n3)nc(\C=C\c4ccccc4)n2	1291074-87-7	4818	GENERAL	TARTRATE	1	NO_SOLVATE	0	1469337	375.4701	ENMD-2076	ENMD-2076 | ENMD-981693 | ENMD-2076 | ENMD-981693	Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:586	AURKA	Antimitotic Drugs;Aurora-A (ARK1) Kinase Inhibitors;Angiogenesis Inhibitors;Protein Kinase Inhibitors
SJ001011153-2	SJ001011153	2	MOABOX:588	AWDORCFLUJZUQS-ZDUSSCGKSA-N	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12	451462-58-1	ROCK gene inhibitor;PKC Kinase nhibitor	PRKACA	ROCK1	ROCK2																														6093	9475																														CHEMBL406821											448043	9841609	11560225	117073037	135503085	member	10.1007/s00044-015-1463-0	10.1016/j.bmcl.2009.12.012	10.1021/jm9014263	10.2174/138161212800672688																																																																																																																																																												15857612	16249185	17368019	19355891	19689376	20000469	22571664	24412071	25248678	26486225	27080184																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											-0.21832	2.17736	3.21096																														-0.02729	0.27217	0.40137																														8	8	8																														HY-15720A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad | Research Area: Neurological Disease|MOABOX:588|PRKACA|ROCK gene inhibitor;PKC Kinase nhibitor	C[C@H]1CNCCCN1S(=O)(=O)c2cccc3cncc(C)c23	871543-07-6	78847	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468784	319.42184	H-1152 (DIHYDROCHLORIDE)	H-1152 (DIHYDROCHLORIDE) | H-1152 (DIHYDROCHLORIDE)	Pathway: Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad	Research Area: Neurological Disease	MOABOX:588	PRKACA	ROCK gene inhibitor;PKC Kinase nhibitor
SJ000574291-11	SJ000574291	11	MOABOX:590	QYZOGCMHVIGURT-UHFFFAOYSA-N	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1	1218904-24-5	Aurora-B (ARK2) Kinase Inhibitors;Antimitotic Drugs;Inhibitors of Signal Transduction Pathways;Aurora-C (ARK3) Kinase Inhibitors	AURKC	AURKB																															9212																															CHEMBL215152											16007391	68816358	143578512	143578521		member	10.1002/cmdc.201200479	10.1016/j.abb.2010.08.004	10.1021/jm061335f	10.1097/CAD.0000000000000523	10.1111/j.1747-0285.2008.00751.x	10.2174/092986709788682227																																																																																																																																																										17373783	18183025	19075809	19152640	19320489	19519375	20699085	22037378	23281044	23664099	25089810	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										0.81312	3.38528																															0.10164	0.42316																															8	8																															CS-0163	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-016-631-863|MOABOX:590|AURKC|Aurora-B (ARK2) Kinase Inhibitors;Antimitotic Drugs;Inhibitors of Signal Transduction Pathways;Aurora-C (ARK3) Kinase Inhibitors	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)n[nH]3)ncnc2c1	722544-51-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468498	507.5599	AZD1152-HQPA	AZD1152-HQPA | BARASERTIB pro-drug | AZD1152-HQPA | BARASERTIB pro-drug			MOABOX:590	AURKC	Aurora-B (ARK2) Kinase Inhibitors;Antimitotic Drugs;Inhibitors of Signal Transduction Pathways;Aurora-C (ARK3) Kinase Inhibitors
SJ001032989-2	SJ001032989	2	MOABOX:596	KSNUCNRMDYJBKT-UHFFFAOYSA-N	CC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1	1262770-69-3	Vasopressin (AVP) V1a Antagonists	AVPR1A																																																															CHEMBL296908											114904	71312005				virtual																																																																																																																																																																7807119	8979247																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-4.648e-002																																-0.00581																																8																																HY-15009	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cardiovascular Disease; Endocrinology|MOABOX:596|AVPR1A|Vasopressin (AVP) V1a Antagonists	CC(=O)NCCCOc1ccc(cc1)C(=O)N2CCC(CC2)N3C(=O)CCc4ccccc34	131631-89-5	30977	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469367	449.54204	OPC 21268	OPC 21268 | OPC 21268	Pathway: GPCR/G Protein	Research Area: Cardiovascular Disease; Endocrinology	MOABOX:596	AVPR1A	Vasopressin (AVP) V1a Antagonists
SJ000855370-4	SJ000855370	4	MOABOX:604	WRNXUQJJCIZICJ-UHFFFAOYSA-N	Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1	137975-06-5	Vasopressin (AVP) V2 Antagonists	AVPR2																																																															CHEMBL420762											119369	636389	46941605			member	10.1016/S0960-894X(02)00649-2	10.1021/jm030287l																																																																																																																																																														7241506	11087564	17922627	22984902																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.18072																																0.14759																																8																																HY-18346	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cancer; Endocrinology; Metabolic Disease|MOABOX:604|AVPR2|Vasopressin (AVP) V2 Antagonists	CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c4ccccc14	137975-06-5	23864	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469810	427.53806	MOZAVAPTAN	MOZAVAPTAN | MOZAVAPTAN	Pathway: GPCR/G Protein	Research Area: Cancer; Endocrinology; Metabolic Disease	MOABOX:604	AVPR2	Vasopressin (AVP) V2 Antagonists
SJ000786000-4	SJ000786000	4	MOABOX:614	VPNIQGRFZCTBEZ-SPTGULJVSA-N	C[C@@H](NC(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CC2)cc(N(C)S(C)(=O)=O)c1)c1ccccc1	797035-11-1	beta-Secretase 1 (BACE1) Inhibitors	BACE1																																																															CHEMBL378225											5287532					member	10.1002/ddr.21544	10.1016/j.ab.2005.04.019	10.1016/j.ejmech.2009.11.013	10.1016/j.ejmech.2010.02.046	10.1016/j.tet.2009.09.106	10.1021/acschemneuro.7b00461	10.1021/jm049379g	10.1038/aps.2008.26	10.1111/jnc.14467	10.2174/092986609787049439	10.2174/092986709788186174																																																																																																																																																					15588077	16263281	16375745	16611149	16712492	16787223	16821787	17034118	17149856	17432843	17458843	17508931	18261904	18651582	19013792	19442147	20128595	20303626	20486153	20503979	20698824	21621412	22209418	22225636	22381116	23170891	23181502	25842365	26003339	27068363	27211244	27721153	29414887	29775538	30017317	30544832																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.89208																																0.36151																																8																																1125	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-665-642|MOABOX:614|BACE1|beta-Secretase 1 (BACE1) Inhibitors	C[C@@H](NC(=O)c1cc(cc(c1)C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC3CC3)N(C)S(=O)(=O)C)c4ccccc4	797035-11-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468366	578.72222	BETA-SECRETASE INHIBITOR IV	BETA-SECRETASE INHIBITOR IV | BETA-SECRETASE INHIBITOR IV			MOABOX:614	BACE1	beta-Secretase 1 (BACE1) Inhibitors
SJ000287169-2	SJ000287169	2	MOABOX:642	NFACJZMKEDPNKN-UHFFFAOYSA-N	COP(=O)(OC)C(O)C(Cl)(Cl)Cl	26373-97-7	Butyrylcholinesterase Inhibitors	BCHE																																																															CHEMBL167150											5853	21128958	22436278	87722836	88077203	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																C270-0076	CHEMDIV	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-797-006|MOABOX:642|BCHE|Butyrylcholinesterase Inhibitors	COP(=O)(OC)C(O)C(Cl)(Cl)Cl	26373-97-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468424	257.43668	TRICHLORFON	TRICHLORFON | TRICHLORFON			MOABOX:642	BCHE	Butyrylcholinesterase Inhibitors
SJ000285765-6	SJ000285765	6	MOABOX:644	CDOZDBSBBXSXLB-UHFFFAOYSA-N	CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21	1094-08-2	NMDA Antagonists;Butyrylcholinesterase Inhibitors	BCHE																																																															CHEMBL1200970	CHEMBL1206										3290	122824	248027	11954330	17903272	member	10.1016/j.ejmech.2011.02.071																																																																																																																																																															12502352	25226236																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.58728																																0.19841																																8																																28493	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-188|MOABOX:644|BCHE|NMDA Antagonists;Butyrylcholinesterase Inhibitors	CCN(CC)C(C)CN1c2ccccc2Sc3ccccc13	1094-08-2	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468307	312.47226	ETHOPROPAZINE HYDROCHLORIDE	ETHOPROPAZINE HYDROCHLORIDE | ETHOPROPAZINE HYDROCHLORIDE|  PARSIDOL | ETHOPROPAZINE HYDROCHLORIDE | ETHOPROPAZINE HYDROCHLORIDE|  PARSIDOL			MOABOX:644	BCHE	NMDA Antagonists;Butyrylcholinesterase Inhibitors
SJ000560620-22	SJ000560620	22	MOABOX:654	JLYAXFNOILIKPP-KXQOOQHDSA-N	CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1	1093851-28-5	BCL-2/xL inhibitor;Apoptosis Inducers;Bcl-2 Inhibitors;Bcl-xl Inhibitors;Bcl-w Inhibitors	BCL2	BCL2L1	BCL2L2																														598	599																														CHEMBL2105690	CHEMBL443684										24978538	46937443	52952796	73425583	73427223	member	10.1002/prp2.178	10.1016/j.bmcl.2014.05.036	10.1021/jm800669s																																																																																																																																																													18457385	18841882	19875081	20192224	20925433	21413808	22650253	22650257	23410165	24215352	24751445	24881567	25437618	25971770	26988306	29407973																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						0.896	2.412	0.63592																														0.112	0.3015	0.07949																														8	8	8																														CS-0013	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-391-499|MOABOX:654|BCL2|BCL-2/xL inhibitor;Apoptosis Inducers;Bcl-2 Inhibitors;Bcl-xl Inhibitors;Bcl-w Inhibitors	CC1(C)CCC(=C(CN2CCN(CC2)c3ccc(cc3)C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc6ccccc6)c(c4)S(=O)(=O)C(F)(F)F)C1)c7ccc(Cl)cc7	923564-51-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468600	974.61271	NAVITOCLAX	"NAVITOCLAX | ""ABT-263 | RG-7433"" | ABT-263 (NAVITOCLAX) | NAVITOCLAX | ""ABT-263 | RG-7433"" | ABT-263 (NAVITOCLAX)"			MOABOX:654	BCL2	BCL-2/xL inhibitor;Apoptosis Inducers;Bcl-2 Inhibitors;Bcl-xl Inhibitors;Bcl-w Inhibitors
SJ000534764-12	SJ000534764	12	MOABOX:658	HPLNQCPCUACXLM-PGUFJCEWSA-N	CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]	852808-04-9	Apoptosis Inducers;Bcl-2 Inhibitors;Bcl-xl Inhibitors;Bcl-w Inhibitors	BCL2	BCL2L1	BCL2L2																														598	599																														CHEMBL376408											11228183	73334085	73425924	91669232	91810306	member	10.1021/jm100189a	10.1021/jm300608w	10.1021/jm400556w	10.1021/jm800669s																																																																																																																																																												17125250	17256834	17629704	18040043	18841882	19743858	20192224	20236080	20728251	20800501	20925433	21320056	21366295	21807512	22172701	22227462	22414090	22425031	22448988	22650257	22739087	22747598	22999885	23030453	23047228	23167494	23206987	23603658	23767404	24215352	24751445	24811300	24900514	24900652	24901800	25797160	26988306	27008174	27712939	27749061	29160716																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1.14688	1.722	0.4728																														0.14336	0.21525	0.0591																														8	8	8																														HY-50907	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy | Research Area: Cancer|MOABOX:658|BCL2|Apoptosis Inducers;Bcl-2 Inhibitors;Bcl-xl Inhibitors;Bcl-w Inhibitors	CN(C)CC[C@H](CSc1ccccc1)Nc2ccc(cc2[N+](=O)[O-])S(=O)(=O)NC(=O)c3ccc(cc3)N4CCN(Cc5ccccc5c6ccc(Cl)cc6)CC4	852808-04-9	4753	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469919	813.4269	ABT-737	ABT-737 | ABT-737	Pathway: Apoptosis; Autophagy	Research Area: Cancer	MOABOX:658	BCL2	Apoptosis Inducers;Bcl-2 Inhibitors;Bcl-xl Inhibitors;Bcl-w Inhibitors
SJ000287741-10	SJ000287741	10	MOABOX:664	LLEJIEBFSOEYIV-UHFFFAOYSA-N	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC	34316-15-9	Bcl-xl Inhibitors;P2X7 Receptor Antagonists;Apoptosis Inducers;Rho GTPase Inhibitors;Protein Kinase C (PKC) Inhibitors	BCL2L1	P2RX7																															5027																															CHEMBL13045	CHEMBL1971693	CHEMBL258893									2703	72311	5351594	10260067	13394150	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.22666	0																															0.03238	0.0																															7	7																															HY-12048	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Epigenetics; TGF-beta/Smad | Research Area: Cancer; Metabolic Disease; Inflammation/Immunology|MOABOX:664|BCL2L1|Bcl-xl Inhibitors;P2X7 Receptor Antagonists;Apoptosis Inducers;Rho GTPase Inhibitors;Protein Kinase C (PKC) Inhibitors	COc1ccc2c(c[n+](C)c3c2ccc4cc5OCOc5cc34)c1OC	3895-92-9	26018	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468991	348.37192	CHELERYTHRINE CHLORIDE	"CHELERYTHRINE CHLORIDE | ""CHELERYTHRINE CHLORIDE | MP-0922 | NSC-646662 | TODDALIN |"" | CHELERYTHRINE | CHELERYTHRINE CHLORIDE | ""CHELERYTHRINE CHLORIDE | MP-0922 | NSC-646662 | TODDALIN |"" | CHELERYTHRINE"	Pathway: Apoptosis; Autophagy; Epigenetics; TGF-beta/Smad	Research Area: Cancer; Metabolic Disease; Inflammation/Immunology	MOABOX:664	BCL2L1	Bcl-xl Inhibitors;P2X7 Receptor Antagonists;Apoptosis Inducers;Rho GTPase Inhibitors;Protein Kinase C (PKC) Inhibitors
SJ000574298-3	SJ000574298	3	MOABOX:670	LWQQLNNNIPYSNX-UROSTWAQSA-N	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/[C@@H](O)C2CC2)C[C@@H](O)C[C@@H]1O	112828-00-9	Vitamin D analog	BGLAP	VDR																															7421																															CHEMBL1200666											5288783	9918645	11571161	11954479	16654968	member																																																																																																																																																																11462969	17300160																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.71568	1.8028																															0.10224	0.22535																															7	8																															CS-0812	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-008-155-972|MOABOX:670|BGLAP|Vitamin D analog	C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]2CC[C@H]3\C(=C\C=C/4\C[C@@H](O)C[C@H](O)C4=C)\CCC[C@]23C	147657-22-5	NA	GENERAL	NO_SALT	0	H2O	1	1468704	412.6047	CALCIPOTRIOL | DOVONEX | CALCIPOTRIENE	"""CALCIPOTRIOL | DOVONEX | CALCIPOTRIENE"" | ""CALCIPOTRIOL | DOVONEX | CALCIPOTRIENE"""			MOABOX:670	BGLAP	Vitamin D analog
SJ000832933-3	SJ000832933	3	MOABOX:672	UFPFGVNKHCLJJO-SSKFGXFMSA-N	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1	1005342-46-0	Inhibitor of Apoptosis Proteins (IAP) Inhibitors	BIRC2	XIAP																															331																															CHEMBL2431768											24737642	137528282				virtual	10.1021/acs.jmedchem.9b00561																																																																																																																																																															24083782	24093940	28492317	29940121	31095386																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.11112	1.26232																															0.13889	0.15779																															8	8																															HY-15518	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis | Research Area: Cancer|MOABOX:672|BIRC2|Inhibitor of Apoptosis Proteins (IAP) Inhibitors	CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2c3nc(cs3)C(=O)c4ccc(F)cc4	1005342-46-0	16169	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469420	500.62862	LCL-161	LCL-161 | LCL-161	Pathway: Apoptosis	Research Area: Cancer	MOABOX:672	BIRC2	Inhibitor of Apoptosis Proteins (IAP) Inhibitors
SJ000574274-13	SJ000574274	13	MOABOX:690	GPXBXXGIAQBQNI-UHFFFAOYSA-N	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F	1029872-54-5	Inhibitors of Signal Transduction Pathways;Raf kinase B Inhibitors	BRAF																																																															CHEMBL1229517											42611257	46940822	46940823	46940824	46940825	member	10.1002/cbdv.201700504	10.1016/j.ejmech.2017.02.041	10.1016/j.ejmech.2018.11.033	10.1016/j.ejmech.2019.06.042	10.1021/jm300613w	10.7150/thno.18238																																																																																																																																																										21426297	22808911	22858139	23410157	23623674	24424304	24588073	25267006	25462267	25965804	26005530	26298497	26724730	26852623	27085672	27155899	27634195	28242553	28280261	28485964	28557458	28586211	29407977	29940463	30529543	30613326	31312411																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											2.52544																																0.31568																																8																																ME-0096	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)c4ccc(Cl)cc4)c1F	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466773	489.92213	VEMURAFENIB	"VEMURAFENIB | ""PLX-4032 | R-7204 | RG-7204 | RO-5185426 | PLX4032 | RG7204"" | VEMURAFENIB (PLX4032, RG7204) | VEMURAFENIB | ""PLX-4032 | R-7204 | RG-7204 | RO-5185426 | PLX4032 | RG7204"" | VEMURAFENIB (PLX4032, RG7204)"			MOABOX:690	BRAF	Inhibitors of Signal Transduction Pathways;Raf kinase B Inhibitors
SJ000857693-10	SJ000857693	10	MOABOX:692	CMJCXYNUCSMDBY-ZDUSSCGKSA-N	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1	1269440-17-6	Mutant Raf kinase B Inhibitors	BRAF																																																															CHEMBL3301612											50922675	72734496	72944989	73890956	91809193	virtual																																																																																																																																																																29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.27576																																0.28447																																8																																HY-15605	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: MAPK/ERK Pathway | Research Area: Cancer|MOABOX:692|BRAF|Mutant Raf kinase B Inhibitors	COC(=O)N[C@@H](C)CNc1nccc(n1)c2cn(nc2c3cc(Cl)cc(NS(=O)(=O)C)c3F)C(C)C	1269440-17-6	78652	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469285	540.01068	LGX-818	LGX-818 | LGX-818	Pathway: MAPK/ERK Pathway	Research Area: Cancer	MOABOX:692	BRAF	Mutant Raf kinase B Inhibitors
SJ000855312-5	SJ000855312	5	MOABOX:694	ZGBGPEDJXCYQPH-UHFFFAOYSA-N	Cc1ccc(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1Nc1ccc2ncn(C)c(=O)c2c1	878739-06-1	Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;Raf kinase B Inhibitors;Raf kinase C Inhibitors	BRAF	RAF1																															5894																															CHEMBL2144069											11676786	24970299	144981770			member	10.1021/jm301658d																																																																																																																																																															18077425	18559533	23398453	23685672	24675381	30613326																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.32152	2.47992																															0.04019	0.30999																															8	8																															HY-11004	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; MAPK/ERK Pathway | Research Area: Cancer|MOABOX:694|BRAF|Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;Raf kinase B Inhibitors;Raf kinase C Inhibitors	CN1C=Nc2ccc(Nc3cc(NC(=O)c4cccc(c4)C(C)(C)C#N)ccc3C)cc2C1=O	878739-06-1	7223	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469839	451.5197	AZ 628	AZ 628 | AZ 628	Pathway: Apoptosis; MAPK/ERK Pathway	Research Area: Cancer	MOABOX:694	BRAF	Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;Raf kinase B Inhibitors;Raf kinase C Inhibitors
SJ000836349-5	SJ000836349	5	MOABOX:700	LMMJFBMMJUMSJS-UHFFFAOYSA-N	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F	946128-88-7	MEK1 Inhibitors	MAP2K1																																																															CHEMBL3264002											16719221	143749885	145264182			member	10.1158/0008-5472.																																																																																																																																																															24900832	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.03824																																0.12978																																8																																HY-18652	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: MAPK/ERK Pathway | Research Area: Cancer|MOABOX:700|MAP2K1|MEK1 Inhibitors	CNS(=O)(=O)Nc1nccc(CC2=C(C)c3ccc(Oc4ncccn4)cc3OC2=O)c1F	946128-88-7	18808	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469092	471.46152	RO-5126766	RO-5126766 | RO-5126766	Pathway: MAPK/ERK Pathway	Research Area: Cancer	MOABOX:700	MAP2K1	MEK1 Inhibitors
SJ000574790-26	SJ000574790	26	MOABOX:702	DNVXATUJJDPFDM-KRWDZBQOSA-N	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2	1268524-70-4	"Bromodomain-Containing Protein 4 (Brd4, HUNK1) Inhibitors;BRD2/3/4/T BET familiy inhibitor"	BRD4																																																															CHEMBL1957266											46907787	72199294				member	10.1016/j.bioorg.2019.103044	10.1016/j.bmc.2019.05.006	10.1016/j.bmcl.2016.04.034	10.1016/j.ejmech.2017.05.049	10.1016/j.ejmech.2018.04.034	10.1016/j.ejmech.2019.06.067	10.1021/acs.jmedchem.7b00193	10.1021/acs.jmedchem.7b00275	10.1021/acs.jmedchem.8b00506	10.1021/acsmedchemlett.8b00380	10.1021/jm300915b	10.1021/jm301588r	10.1038/nature09504	10.1080/14756366.2019.1587417	10.2174/1570180813666160715160857																																																																																																																																																	22136469	22137933	22316554	22509028	22510649	22924434	23517011	23530754	24090311	24497428	24900532	24900758	25559428	25678016	25851940	26080064	26263125	26572217	26731490	26815195	26985289	27142751	27266999	28024402	28195723	28209615	28300771	28314513	28339196	28463487	28535045	28549889	28586718	28595007	28636361	28765013	28835800	28949521	29259751	29541371	29566488	29649741	29656650	29758518	29776834	30019901	30125504	30165024	30253095	30529546	30613330	30926312	31079968																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	2.25984																																0.28248																																8																																HY-13030	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Epigenetics; PROTAC | Research Area: Cancer|MOABOX:702|BRD4|Bromodomain-Containing Protein 4 (Brd4, HUNK1) Inhibitors;BRD2/3/4/T BET familiy inhibitor"	Cc1sc2c(C(=N[C@@H](CC(=O)OC(C)(C)C)c3nnc(C)n23)c4ccc(Cl)cc4)c1C	1268524-70-4	57452	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469923	456.9882	JQ1	"JQ1 | ADMG-032 | JQ1,(+) | JQ1,(+)- | (+)-JQ1 | JQ1 | ADMG-032 | JQ1,(+) | JQ1,(+)- | (+)-JQ1"	Pathway: Autophagy; Epigenetics; PROTAC	Research Area: Cancer	MOABOX:702	BRD4	"Bromodomain-Containing Protein 4 (Brd4, HUNK1) Inhibitors;BRD2/3/4/T BET familiy inhibitor"
SJ001034836-1	SJ001034836	1	MOABOX:704	WEUJYFZQFFQFND-UHFFFAOYSA-N	Nc1n[nH]c2nc(N3CCCCC3)c3c(c12)CCN(Cc1ccccc1)C3	371227-84-8	ADAM17 (TNF-alpha-Converting Enzyme (TACE) Inhibitors);MMP-13 (Collagenase 3) Inhibitors;MMP-1 (Interstitial Collagenase) Inhibitors;MMP-2 (Gelatinase A) Inhibitors;MMP-3 (Stromelysin 1) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;BRS3 agonist	BRS3																																																															CHEMBL1095423											4254919					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.19341																																-0.02763																																7																																STL321719	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-538-808|MOABOX:704|BRS3|ADAM17 (TNF-alpha-Converting Enzyme (TACE) Inhibitors);MMP-13 (Collagenase 3) Inhibitors;MMP-1 (Interstitial Collagenase) Inhibitors;MMP-2 (Gelatinase A) Inhibitors;MMP-3 (Stromelysin 1) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;BRS3 agonist	Nc1n[nH]c2nc(N3CCCCC3)c4CN(Cc5ccccc5)CCc4c12	371227-84-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468078	362.47134	STL321719	STL321719 | STL321719			MOABOX:704	BRS3	ADAM17 (TNF-alpha-Converting Enzyme (TACE) Inhibitors);MMP-13 (Collagenase 3) Inhibitors;MMP-1 (Interstitial Collagenase) Inhibitors;MMP-2 (Gelatinase A) Inhibitors;MMP-3 (Stromelysin 1) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;BRS3 agonist
SJ000784309-11	SJ000784309	11	MOABOX:706	XYFPWWZEPKGCCK-UHFFFAOYSA-N	C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1	936563-87-0	Bruton's Tyrosine Kinase (BTK) Inhibitors	BTK																																																															CHEMBL3182647											16126651	67332048	144171486			member																																																																																																																																																																17154430	23438744																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.06528																																0.38316																																8																																HY-10997A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:706|BTK|Bruton's Tyrosine Kinase (BTK) Inhibitors	Nc1ncnc2c1c(nn2C3CCCN(C3)C(=O)C=C)c4ccc(Oc5ccccc5)cc4	936563-87-0	11158	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469593	440.49706	IBRUTINIB	"IBRUTINIB | ""PCI-32765 | BTK INHIBITOR III | BRUTONS TYROSINE KINASE INHIBITOR III"" | IBRUTINIB (PC-32765) | IBRUTINIB (PCI-32765) | IBRUTINIB | ""PCI-32765 | BTK INHIBITOR III | BRUTONS TYROSINE KINASE INHIBITOR III"" | IBRUTINIB (PC-32765) | IBRUTINIB (PCI-32765)"	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:706	BTK	Bruton's Tyrosine Kinase (BTK) Inhibitors
SJ001010568-4	SJ001010568	4	MOABOX:708	CDOOFZZILLRUQH-GDLZYMKVSA-N	Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc([C@@H]3C(=O)N(C)CCN3C)cc2)n1	1133432-46-8	Bruton's Tyrosine Kinase (BTK) Inhibitors	BTK																																																															CHEMBL2057915											25234918					member	10.1021/jm300035p	10.1124/jpet.111.181545																																																																																																																																																														21521773	22394077	25701252	26675441																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.37064																																0.29633																																8																																HY-15427A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Inflammation/Immunology|MOABOX:708|BTK|Bruton's Tyrosine Kinase (BTK) Inhibitors	CN1CCN(C)C(=O)C1c2ccc(NC3=NC(=CN(C)C3=O)c4cccc(NC(=O)c5cc6CCCCc6s5)c4C)cc2	1133432-46-8	12298	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469055	596.74234	GDC-0834 (RACEMATE)	GDC-0834 (RACEMATE) | GDC-0834 (RACEMATE)	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Inflammation/Immunology	MOABOX:708	BTK	Bruton's Tyrosine Kinase (BTK) Inhibitors
SJ000287950-5	SJ000287950	5	MOABOX:710	UVSVTDVJQAJIFG-VURMDHGXSA-N	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br	244240-24-2	Inhibitors of Signal Transduction Pathways;Bruton's Tyrosine Kinase (BTK) Inhibitors	BTK																																																															CHEMBL228043											54676905					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.94969																																0.13567																																7																																HY-18009	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt | Research Area: Cancer|MOABOX:710|BTK|Inhibitors of Signal Transduction Pathways;Bruton's Tyrosine Kinase (BTK) Inhibitors	CC(=O)C(C#N)C(=O)Nc1cc(Br)ccc1Br	244240-24-2	15376	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469321	360.00142	LFM-A13	LFM-A13 | LFM-A13	Pathway: Cell Cycle/DNA Damage; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Research Area: Cancer	MOABOX:710	BTK	Inhibitors of Signal Transduction Pathways;Bruton's Tyrosine Kinase (BTK) Inhibitors
SJ000755087-7	SJ000755087	7	MOABOX:716	MQQNFDZXWVTQEH-UHFFFAOYSA-N	N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1	80251-32-7	Tryptase Inhibitors	C1S	F11	F12	KLK1	PLG	PROC	TPSAB1	KLK8	KLK5	KLK14	TPSB2	KLK2	KLK3	KLK6	KLK10	KLK4	KLK11	KLK13	KLK12	KLK15	KLK9												2160	2161	3816	5340	5624	7177	11202	25818	43847	64499	3817	354	5653	5655	9622	11012	26085	43849	55554	284366												CHEMBL1091841	CHEMBL273264	CHEMBL3989553									4413	5271803	5311180	9868041	13050562	member																																																																																																																																																																12939527	17313363																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0	0.73752	0	0	0	0.2312	0.33012	-0.19688	0.47648	0.19728	0	-0.32432	0	0.17003	3.84e-002	0	-0.13376	0	1.20416	0												0.0	0.0	0.10536	0.0	0.0	0.0	0.0289	0.04716	-0.02461	0.05956	0.02466	0.0	-0.04054	0.0	0.02429	0.0048	0.0	-0.01672	0.0	0.15052	0.0												7	7	7	7	7	7	8	7	8	8	8	7	8	7	7	8	7	8	7	8	7												HY-B0190A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Apoptosis; Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease; Cancer|MOABOX:716|C1S|Tryptase Inhibitors	NC(=N)Nc1ccc(cc1)C(=O)Oc2ccc3cc(ccc3c2)C(=N)N	82956-11-4	39511	GENERAL	METHANESULFONATE	1	NO_SOLVATE	0	1469812	347.37058	NAFAMOSTAT MESYLATE	NAFAMOSTAT MESYLATE | 6-CARBAMIMIDOYLNAPHTHALEN-2-YL 4-CARBAMIMIDAMIDOBE | NAFAMOSTAT MESYLATE | 6-CARBAMIMIDOYLNAPHTHALEN-2-YL 4-CARBAMIMIDAMIDOBE	Pathway: Anti-infection; Apoptosis; Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease; Cancer	MOABOX:716	C1S	Tryptase Inhibitors
SJ001035014-1	SJ001035014	1	MOABOX:722	ITACCRHKSPSKKL-UHFFFAOYSA-N	CCCCn1c(-c2ccccc2)nc(-c2ccccc2)c1CN(Cc1ccc2c(c1)OCO2)Cc1ccc2c(c1)OCO2	439571-48-9	C5a Antagonists	C5AR1																																																																										10210160					member	10.1124/jpet.108.141572																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.64976																																0.45622																																8																																24448	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-759|MOABOX:722|C5AR1|C5a Antagonists	CCCCn1c(CN(Cc2ccc3OCOc3c2)Cc4ccc5OCOc5c4)c(nc1c6ccccc6)c7ccccc7	439571-48-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468470	573.6808	NDT 9513727	NDT 9513727 | NDT 9513727			MOABOX:722	C5AR1	C5a Antagonists
SJ001035211-1	SJ001035211	1	MOABOX:724	YOKBGCTZYPOSQM-HPSWDUTRSA-N	CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1CCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CC2CCCCC2)NC(=O)[C@@H]2CCCN2C1=O	219639-75-5	C5a Antagonists	C5AR1																																																															CHEMBL41547											6918468					member	10.1016/j.bmcl.2006.07.036	10.1021/jm1003705	10.1021/jm9806594																																																																																																																																																													11931608	16876401	20527893																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.02664																																0.37833																																8																																HY-106178	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Cancer; Inflammation/Immunology; Cardiovascular Disease|MOABOX:724|C5AR1|C5a Antagonists	CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]2CCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@@H](CC5CCCCC5)NC(=O)[C@@H]6CCCN6C2=O	219639-75-5	92823	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469130	896.0885	PMX-53 | 3D53	"""PMX-53 | 3D53"" | ""PMX-53 | 3D53"""	Pathway: Immunology/Inflammation	Research Area: Cancer; Inflammation/Immunology; Cardiovascular Disease	MOABOX:724	C5AR1	C5a Antagonists
SJ001034654-1	SJ001034654	1	MOABOX:728	FLKRMXAWABTWSH-UHFFFAOYSA-N	NS(=O)(=O)N1CCCCC1	4108-90-1	"Carbonic anhydrase inhibitor;Angiogenesis Inhibitors;Apoptosis Inducers;Nicotinamide Phosphoribosyltransferase (NMPRTase) Inhibitors;""Carbonic anhydrase inhibitor;Angiogenesis Inhibitors;Apoptosis Inducers;Nicotinamide Phosphoribosyltransferase (NMPRTase) Inhibitors"""	CA1	CA2	NAMPT																														760	10135																														CHEMBL169370											276741	68737459	69690089	123933761	141015180	virtual																																																																																																																																																																12617903	16710859	16918498	17504128																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		-5.36e-003	2.89712	0																														-0.00067	0.36214	0.0																														8	8	7																														BS-3897	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NS(=O)(=O)N1CCCCC1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466756	164.22598	BS-3897	BS-3897 | BS-3897			MOABOX:728	CA1	"Carbonic anhydrase inhibitor;Angiogenesis Inhibitors;Apoptosis Inducers;Nicotinamide Phosphoribosyltransferase (NMPRTase) Inhibitors;""Carbonic anhydrase inhibitor;Angiogenesis Inhibitors;Apoptosis Inducers;Nicotinamide Phosphoribosyltransferase (NMPRTase) Inhibitors"""
SJ001034843-1	SJ001034843	1	MOABOX:734	DEVUYWTZRXOMSI-UHFFFAOYSA-N	NS(=O)(=O)Nc1ccccc1	15959-53-2	carbonic anhydrase inhibitor	CA1																																																															CHEMBL168514											15569631	66894918	70087962	88813055		virtual																																																																																																																																																																12617903	16710859	16918498	16999776	17504128																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	2.256e-002																																0.00282																																8																																PB2234708675	UKRORGSYNTH	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-030-912-022|MOABOX:734|CA1|carbonic anhydrase inhibitor	NS(=O)(=O)Nc1ccccc1	15959-53-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468086	172.20492	PB2234708675	PB2234708675 | PB2234708675			MOABOX:734	CA1	carbonic anhydrase inhibitor
SJ001034880-1	SJ001034880	1	MOABOX:736	SYKLNLIUTCAYCR-UHFFFAOYSA-N	NS(=O)(=O)NCc1ccccc1	14101-58-7	Carbonic anhydrase inhibitor	CA1	CA2																															760																															CHEMBL168526											12354987	12354988	69176204	87331405		member																																																																																																																																																																12617903	16710859	16918498	17504128	23266178																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	-0.16728	0.18496																															-0.02091	0.02312																															8	8																															STK352980	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-884-418|MOABOX:736|CA1|Carbonic anhydrase inhibitor	NS(=O)(=O)NCc1ccccc1	14101-58-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468180	186.2315	STK352980	STK352980 | STK352980			MOABOX:736	CA1	Carbonic anhydrase inhibitor
SJ001034853-1	SJ001034853	1	MOABOX:738	AGZMQTIIZFXACL-UHFFFAOYSA-N	NS(=O)(=O)c1ccc(NS(=O)(=O)c2ccc([N+](=O)[O-])cc2)cc1	7478-00-4	Carbonic anhydrase inhibitor	CA1																																																															CHEMBL23684											345312					virtual																																																																																																																																																																14971907																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.13096																																-0.01637																																8																																PHAR363393	PHARMEKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-526-812|MOABOX:738|CA1|Carbonic anhydrase inhibitor	NS(=O)(=O)c1ccc(NS(=O)(=O)c2ccc(cc2)[N+](=O)[O-])cc1	7478-00-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468101	357.36224	PHAR363393	PHAR363393 | PHAR363393			MOABOX:738	CA1	Carbonic anhydrase inhibitor
SJ000292619-2	SJ000292619	2	MOABOX:740	USGGSIVMQBZIHX-UHFFFAOYSA-N	NS(=O)(=O)c1ccc(NS(=O)(=O)c2ccc(F)cc2)cc1		Carbonic anhydrase inhibitor	CA1	CA2																															760																															CHEMBL23922											743904					virtual																																																																																																																																																																14971907	16213737																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.1656	2.98992																															-0.0207	0.37374																															8	8																															STK041516	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-521-299|MOABOX:740|CA1|Carbonic anhydrase inhibitor	NS(=O)(=O)c1ccc(NS(=O)(=O)c2ccc(F)cc2)cc1	250210-24-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468601	330.35514					MOABOX:740	CA1	Carbonic anhydrase inhibitor
SJ001034851-1	SJ001034851	1	MOABOX:744	GOWDFSKVUJAHJJ-UHFFFAOYSA-N	NS(=O)(=O)N1CCCCCC1	4108-89-8	Carbonic anhydrase inhibitor	CA1	CA2																															760																															CHEMBL165939											192792	142513165				virtual																																																																																																																																																																12617903	16710859	16918498	17504128																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		-2.488e-002	2.9284																															-0.00311	0.36605																															8	8																															Z300096516	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-004-311-461|MOABOX:744|CA1|Carbonic anhydrase inhibitor	NS(=O)(=O)N1CCCCCC1	4108-89-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468096	178.25256	Z300096516	Z300096516 | Z300096516			MOABOX:744	CA1	Carbonic anhydrase inhibitor
SJ001034861-1	SJ001034861	1	MOABOX:750	QOWRADOKRZQCAQ-UHFFFAOYSA-N	NS(=O)(=O)c1ccc(CCNC(=S)Nc2ccccc2)cc1	10079-93-3	Carbonic anhydrase inhibitor	CA9																																																															CHEMBL254833											747569					member																																																																																																																																																																16006130	16168653	22178187																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.96656																																0.12082																																8																																STK079034	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-507-012|MOABOX:750|CA9|Carbonic anhydrase inhibitor	NS(=O)(=O)c1ccc(CCNC(=S)Nc2ccccc2)cc1	10079-93-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468114	335.44438	STK079034	STK079034 | STK079034			MOABOX:750	CA9	Carbonic anhydrase inhibitor
SJ001035054-1	SJ001035054	1	MOABOX:752	SYIVDRTWCRQIBC-UHFFFAOYSA-N	CCCCNS(N)(=O)=O	42731-63-5	Carbonic anhydrase inhibitor	CA1	CA2																															760																															CHEMBL170015											12355589	23174827	68447973			virtual																																																																																																																																																																12617903	16710859	16918498	17504128																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		-0.87552	-0.84816																															-0.10944	-0.10602																															8	8																															HTS004626	HTS_BIOCHEMIE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-029-941-779|MOABOX:752|CA1|Carbonic anhydrase inhibitor	CCCCNS(=O)(=O)N	42731-63-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468557	152.21528	HTS004626	HTS004626 | HTS004626			MOABOX:752	CA1	Carbonic anhydrase inhibitor
SJ001034848-1	SJ001034848	1	MOABOX:754	XOIYZMDJFLKIEI-UHFFFAOYSA-N	NS(=O)(=O)Oc1ccccc1	19792-91-7	Carbonic anhydrase inhibitor	CA2																																																															CHEMBL24259											11030308	68141362	69106826	91501726		member																																																																																																																																																																12747791	15478125	16203142	16759092	16918498	16999776	19632111	22424239																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														1.80528																																0.22566																																8																																Z1255360895	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-020-173-642|MOABOX:754|CA2|Carbonic anhydrase inhibitor	NS(=O)(=O)Oc1ccccc1	19792-91-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468093	173.18968	Z1255360895	Z1255360895 | Z1255360895			MOABOX:754	CA2	Carbonic anhydrase inhibitor
SJ001034669-1	SJ001034669	1	MOABOX:756	IHJCXVZDYSXXFT-UHFFFAOYSA-N	Nc1cc(Cl)c(S(N)(=O)=O)cc1S(N)(=O)=O	1184995-49-0	Carbonic Anhydrase Type II Inhibitors	CA1	CA3	CA4	CA5A	CA8	CA11	CA5B	CA10																									761	762	763	767	770	11238	56934																									CHEMBL266240											67136					virtual																																																																																																																																																																11229775	11906288	12110322	15686931	17540563	20158185	21251841	26068018	26691758	30832211																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												-0.46018	-0.12922	-7.664e-002	-0.4018	-0.10759	-0.10759	-0.12257	-0.10759																									-0.06574	-0.01846	-0.00958	-0.0574	-0.01537	-0.01537	-0.01751	-0.01537																									7	7	8	7	7	7	7	7																									AS-12956	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Nc1cc(Cl)c(cc1S(=O)(=O)N)S(=O)(=O)N	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466822	285.72842	AS-12956	AS-12956 | AS-12956			MOABOX:756	CA1	Carbonic Anhydrase Type II Inhibitors
SJ000286207-10	SJ000286207	10	MOABOX:758	FDDDEECHVMSUSB-UHFFFAOYSA-N	Nc1ccc(S(N)(=O)=O)cc1	10103-15-8	MEK1 Inhibitors	CA1	CA3	CA4	CA5A	CA8	CA11	CA5B	CA10																									761	762	763	767	770	11238	56934																									CHEMBL21											5333	80197	18348497	19702442	21219865	virtual																																																																																																																																																																11087579	12110322	12164387	20028100	24746465	26691758	30832211																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															-0.52528	-0.13904	-0.2093	-0.15449	-8.939e-002	-8.939e-002	-9.044e-002	-8.939e-002																									-0.06566	-0.01738	-0.0299	-0.02207	-0.01277	-0.01277	-0.01292	-0.01277																									8	8	7	7	7	7	7	7																									AS-13239	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Nc1ccc(cc1)S(=O)(=O)N	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466667	172.20492	SULFANILAMIDE	SULFANILAMIDE | SULPHANILAMIDE | SULFANILAMIDE | SULPHANILAMIDE			MOABOX:758	CA1	MEK1 Inhibitors
SJ000285326-8	SJ000285326	8	MOABOX:760	TYMRLRRVMHJFTF-UHFFFAOYSA-N	NCc1ccc(S(N)(=O)=O)cc1	12001-72-8	Carbonic anhydrase inhibitor	CA1	CA3	CA4	CA5A	CA7	CA8	CA11	CA5B	CA10																								761	762	763	766	767	770	11238	56934																								CHEMBL1201161	CHEMBL1593568	CHEMBL419									3998	25590	67313	20056793	21584567	member																																																																																																																																																																12110322	15686895	20158185	21251841	24746465	26691758	30832211																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															-0.55	-0.37961	-0.27139	-0.51569	0.26376	-0.12908	-0.12908	-0.1449	-0.12908																								-0.06875	-0.05423	-0.03877	-0.07367	0.03297	-0.01844	-0.01844	-0.0207	-0.01844																								8	7	7	7	8	7	7	7	7																								AA003K2Y	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-056-401|MOABOX:760|CA1|Carbonic anhydrase inhibitor	NCc1ccc(cc1)S(=O)(=O)N	138-37-4	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468270	186.2315	MAFENIDE HYDROCHLORIDE	MAFENIDE HYDROCHLORIDE | SULFAMYLON | MAFENIDE ACETATE | MAFENIDE HYDROCHLORIDE | SULFAMYLON | MAFENIDE ACETATE			MOABOX:760	CA1	Carbonic anhydrase inhibitor
SJ000312384-6	SJ000312384	6	MOABOX:764	OUZWUKMCLIBBOG-UHFFFAOYSA-N	CCOc1ccc2nc(S(N)(=O)=O)sc2c1	452-35-7	CA1 inhibitor;CA2 inhibitor;CA4 inhibitor;CA7 inhibitor	CA1	CA3	CA4	CA5A	CA7	CA8	CA11	CA5B	CA10																								761	762	763	766	767	770	11238	56934																								CHEMBL18											3295	67392105	69747405	69779288	70502541	member	10.1016/j.bmc.2010.03.014	10.1016/j.bmcl.2013.04.048																																																																																																																																																														11087579	11123998	11203012	11310605	11906288	12039560	12500287	12617903	12617904	12643899	12683750	12747790	12747791	14567548	14611846	14640555	14684333	14971907	15081039	15139757	15454239	15456265	15499999	15501039	15546717	15664816	15686894	15686895	15686931	15771455	15837316	15837325	15905091	15908201	15908204	16033263	16039853	16119190	16165351	16168653	16206834	16302824	16321542	16459077	16539401	16809036	16942027	17059166	17064072	17125255	17194028	17228881	17251018	17276072	17343373	17475500	17482815	17504127	17540563	17588751	17646100	17681760	17826101	18024029	18042384	18242985	18242998	18307288	18336305	18336307	18336309	18336316	18359629	18374572	18481843	18513964	18600270	18956406	19115843	19119014	19124253	19186056	19193158	19201197	19317447	19330012	19338333	19375309	19410461	19435663	19450983	19520577	19846301	20158185	20202722	20299219	20363633	20472429	20478708	20554082	20624682	20819061	20819062	20819063	20819064	21208801	21251841	21300547	21377369	21515057	21757360	21820216	22145674	22145694	22146078	22230050	22245047	22285172	22775345	22883029	22910138	23181552	23199478	23391336	23394791	23429054	23664215	23777827	23867389	23965175	23977960	24095761	24103428	24287559	24291567	24316122	24507918	24513184	24792813	24852120	24871996	25016228	25129169	25533402	25773015	25882523	25913118	25913199	26048024	26525863	26691758	26850377	26920803	27485387	28025002	28501430	28511911	29146134	30832211																																																																																																																																																																																																																																																																																																																																																																																																							-7.304e-002	-0.63511	-0.258	-5.064e-002	2.33056	0.30513	0.30513	0.12112	0.30513																								-0.00913	-0.09073	-0.03225	-0.00633	0.29132	0.04359	0.04359	0.01514	0.04359																								8	7	8	8	8	7	7	8	7																								HY-B1480	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Metabolic Enzyme/Protease | Research Area: Infection; Inflammation/Immunology|MOABOX:764|CA1|CA1 inhibitor;CA2 inhibitor;CA4 inhibitor;CA7 inhibitor	CCOc1ccc2nc(sc2c1)S(=O)(=O)N	452-35-7	26531	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469091	258.3173	ETHOXZOLAMIDE	"ETHOXZOLAMIDE | 6-ETHOXY-2-BENZOTHIAZOLESULFONAMIDE | ""ETHOXZOLAMIDE| CARDRASE| ETHAMIDE| GLAUCOTENSIL| REDUPRESIN | 6-ETHOXYBENZO[D]THIAZOLE-2-SULFONAMIDE | 6-ETHOXY-2-BENZOTHIAZOLESULFONAMIDE"" | ETHOXZOLAMIDE | ETHOXZOLAMIDE | 6-ETHOXY-2-BENZOTHIAZOLESULFONAMIDE | ""ETHOXZOLAMIDE| CARDRASE| ETHAMIDE| GLAUCOTENSIL| REDUPRESIN | 6-ETHOXYBENZO[D]THIAZOLE-2-SULFONAMIDE | 6-ETHOXY-2-BENZOTHIAZOLESULFONAMIDE"""	Pathway: Anti-infection; Metabolic Enzyme/Protease	Research Area: Infection; Inflammation/Immunology	MOABOX:764	CA1	CA1 inhibitor;CA2 inhibitor;CA4 inhibitor;CA7 inhibitor
SJ000287442-2	SJ000287442	2	MOABOX:768	YAZSBRQTAHVVGE-UHFFFAOYSA-N	Nc1ccccc1S(N)(=O)=O	1348915-35-4	Carbonic anhydrase inhibitor	CA1	CA3	CA4	CA5A	CA8	CA11	CA5B	CA10																									761	762	763	767	770	11238	56934																									CHEMBL6705											72894	57346908	69528651	69858350	70110826	virtual																																																																																																																																																																26691758																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.49077	-0.28763	3.801e-002	-0.37373	6.769e-002	6.769e-002	3.64e-002	6.769e-002																									-0.07011	-0.04109	0.00543	-0.05339	0.00967	0.00967	0.0052	0.00967																									7	7	7	7	7	7	7	7																									PS-4507	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Nc1ccccc1S(=O)(=O)N	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466806	172.20492	2-AMINOBENZENESULFONAMIDE	2-AMINOBENZENESULFONAMIDE | 2-AMINOBENZENESULFONAMIDE			MOABOX:768	CA1	Carbonic anhydrase inhibitor
SJ000285389-15	SJ000285389	15	MOABOX:772	JBMKAUGHUNFTOL-UHFFFAOYSA-N	NS(=O)(=O)c1cc2c(cc1Cl)N=CNS2(=O)=O	58-94-6	SLC12A3 inhibitor;CA1 inhibitor;CA2 inhibitor;CA4 inhibitor	CA1	CA2	CA3	CA4	CA5A	CA8	CA11	SLC12A3	CA5B	CA10																							760	761	762	763	767	770	6559	11238	56934																							CHEMBL842											2720	16051990	21740372	87294084	129846846	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.23408	0.23408	0.20482	0.23408	0.20482	0.20482	0.20482	0	0.20482	0.20482																							0.02926	0.02926	0.02926	0.02926	0.02926	0.02926	0.02926	0.0	0.02926	0.02926																							8	8	7	8	7	7	7	7	7	7																							HY-B0224	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cardiovascular Disease|MOABOX:772|CA1|SLC12A3 inhibitor;CA1 inhibitor;CA2 inhibitor;CA4 inhibitor	NS(=O)(=O)c1cc2c(cc1Cl)N=CNS2(=O)=O	58-94-6	15327	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469306	295.72324	CHLOROTHIAZIDE	CHLOROTHIAZIDE | CHLOROTHIAZIDE | | CHLOROTHIAZIDE | CHLOROTHIAZIDE |	Pathway: Others	Research Area: Cardiovascular Disease	MOABOX:772	CA1	SLC12A3 inhibitor;CA1 inhibitor;CA2 inhibitor;CA4 inhibitor
SJ001035173-1	SJ001035173	1	MOABOX:774	HMHVCUVYZFYAJI-UHFFFAOYSA-N	NS(=O)(=O)c1ccc(N2CCCCS2(=O)=O)cc1	61-56-3	Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type IX Inhibitors;Carbonic Anhydrase Type VII Inhibitors;Carbonic Anhydrase Type XII Inhibitors	CA1	CA4	CA5A	CA5B																													762	763	11238																													CHEMBL328560											5356	67512515	68937516	70301204	70976965	virtual																																																																																																																																																																17588751	18336312	19124253	19193158	19317447	19338333	19450983	19520577	19703035	20819061	21208801	21757360	22285172	22883029	23181552	23199478	23391336	23777827	23977960	24316122	24792813	24852120	25129169	25533402	25773015	25882523	25913199	26525863	26691758	26850377	26920803	27485387	28025002	28501430	28511911	30832211																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		-0.3956	-0.26112	-0.2068	-0.24144																													-0.04945	-0.03264	-0.02585	-0.03018																													8	8	8	8																													HY-108316	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Neurological Disease|MOABOX:774|CA1|Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type IX Inhibitors;Carbonic Anhydrase Type VII Inhibitors;Carbonic Anhydrase Type XII Inhibitors	NS(=O)(=O)c1ccc(cc1)N2CCCCS2(=O)=O	61-56-3	87866	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468984	290.35916	SULTIAME	SULTIAME | SULTIAME	Pathway: Metabolic Enzyme/Protease	Research Area: Neurological Disease	MOABOX:774	CA1	Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type IX Inhibitors;Carbonic Anhydrase Type VII Inhibitors;Carbonic Anhydrase Type XII Inhibitors
SJ000285772-12	SJ000285772	12	MOABOX:776	ZZUFCTLCJUWOSV-UHFFFAOYSA-N	NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl	106391-48-4	Antidiuretic	CA1	CA4	CA5A	TPMT	CA5B																												762	763	7172	11238																												CHEMBL1788133	CHEMBL35										3440	129315	146367	173490	9825066	virtual	10.1016/j.bmc.2008.12.023.																																																																																																																																																															18336309	18374572	18600270	19119014	19580287																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.862	4.264e-002	0.10208	0	0.47768																												0.10775	0.00533	0.01276	0.0	0.05971																												8	8	8	7	8																												KS-1226	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NS(=O)(=O)c1cc(C(=O)O)c(NCc2occc2)cc1Cl	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466714	330.74414	FUROSEMIDE	FUROSEMIDE | SJ000287892 | FUROSEMIDE | SJ000287892			MOABOX:776	CA1	Antidiuretic
SJ000285785-12	SJ000285785	12	MOABOX:778	JZUFKLXOESDKRF-UHFFFAOYSA-N	NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O	125727-50-6	SLC12A3 gene inhibitor	CA1	CA4	SLC12A3	CA5B																													762	6559	11238																													CHEMBL435											3639	107748	148451	171558	11513067	member																																																																																																																																																																18336309	18374572	18600270	21377369	21757360	22285172	22883029	23181552	23391336	23777827	23977960	24316122	24792813	24852120	25129169	25533402	25773015	25882523	25913199	26525863	26691758	26850377	26920803	27485387	28025002	28501430	28511911	30832211																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										0.21216	7.6e-003	0	-2.464e-002																													0.02652	0.00095	0.0	-0.00352																													8	8	7	7																													PS-3162	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1Cl	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466645	297.73912	HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE			MOABOX:778	CA1	SLC12A3 gene inhibitor
SJ000287402-7	SJ000287402	7	MOABOX:784	GJQPMPFPNINLKP-UHFFFAOYSA-N	NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1	120-97-8	Carbonic Anhydrase Inhibitors	CA1	CA3	CA4	CA5A	CA8	CA11	CA12	CA5B	CA10																								761	762	763	767	770	771	11238	56934																								CHEMBL17											3038	20466646	20466647	66646951	66885395	virtual																																																																																																																																																																12500287	15499999	15603956	15686894	15908204	16039848	16039853	16119190	16290146	16302824	16809036	17125255	17157501	17194028	17475500	17504127	17540563	17588751	18242998	18336305	18336309	18359629	18374572	18481843	18600270	19193158	19338333	19375921	19410461	19846301	20158185	20202722	20554082	20590092	20819062	20819064	21251841	21300547	21470859	21515057	21549597	21820216	21852133	22775345	22910138	24095761	24291567	24746465	24871996	25016228	25913118	26145821	26691758	28947941	29146134																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															-0.346	-0.51114	-0.12544	-0.31704	4.529e-002	4.529e-002	9.12e-002	1.07048	4.529e-002																								-0.04325	-0.07302	-0.01568	-0.03963	0.00647	0.00647	0.0114	0.13381	0.00647																								8	7	8	8	7	7	8	8	7																								HY-B0397	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Neurological Disease|MOABOX:784|CA1|Carbonic Anhydrase Inhibitors	NS(=O)(=O)c1cc(Cl)c(Cl)c(c1)S(=O)(=O)N	120-97-8	67670	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469065	305.15884	DICHLORPHENAMIDE	DICHLORPHENAMIDE | DICHLORPHENAMIDE| DARANIDE | DICHLORPHENAMIDE | DICHLORPHENAMIDE| DARANIDE	Pathway: Metabolic Enzyme/Protease	Research Area: Neurological Disease	MOABOX:784	CA1	Carbonic Anhydrase Inhibitors
SJ000285393-7	SJ000285393	7	MOABOX:786	JIVPVXMEBJLZRO-UHFFFAOYSA-N	NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl	74658-80-3	Carbonic Anhydrase Type VII Inhibitors	CA1	CA4	CA5A	CA7	CA12	CA5B																											762	763	766	771	11238																											CHEMBL1055											2732	146406	165703	23018991	23047688	virtual																																																																																																																																																																18374572	19115843	19119014																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			-5.67e-002	6.16e-003	-0.16667	0.93112	0.75159	0.67438																											-0.0081	0.00088	-0.02381	0.11639	0.10737	0.09634																											7	7	7	8	7	7																											KS-1342	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NS(=O)(=O)c1cc(ccc1Cl)C2(O)NC(=O)c3ccccc23	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466729	338.76614	CHLORTHALIDONE	"CHLORTHALIDONE | ""CHLORTHALIDONE | G-33182 | NSC-69200 | PHTHALAMUDINE |"" | ""CHLORTHALIDONE | G-33182 | NSC-69200 | CHLORTALIDONE |"" | CHLORTHALIDONE | ""CHLORTHALIDONE | G-33182 | NSC-69200 | PHTHALAMUDINE |"" | ""CHLORTHALIDONE | G-33182 | NSC-69200 | CHLORTALIDONE |"""			MOABOX:786	CA1	Carbonic Anhydrase Type VII Inhibitors
SJ000286110-14	SJ000286110	14	MOABOX:788	AQCHWTWZEMGIFD-UHFFFAOYSA-N	Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C	17560-51-9	Carbonic Anhydrase Type VII Inhibitors	CA4	CA5A	CA7	CA12	CA5B																												763	766	771	11238																												CHEMBL878											4170	60908	67079889	67605391	68666232	virtual																																																																																																																																																																18336309	18374572	18600270	24287559																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.65408	-9.144e-002	1.66024	1.15952	5.888e-002																												0.08176	-0.01143	0.20753	0.14494	0.00736																												8	8	8	8	8																												HY-B0209	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease|MOABOX:788|CA4|Carbonic Anhydrase Type VII Inhibitors	CC1Nc2cc(Cl)c(cc2C(=O)N1c3ccccc3C)S(=O)(=O)N	17560-51-9	16558	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468870	365.83454	METOLAZONE	"METOLAZONE | ""METOLAZONE | DIULO"" | SJ000287700 | METOLAZONE | ""METOLAZONE | DIULO"" | SJ000287700"	Pathway: Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease	MOABOX:788	CA4	Carbonic Anhydrase Type VII Inhibitors
SJ000285632-9	SJ000285632	9	MOABOX:790	NDDAHWYSQHTHNT-UHFFFAOYSA-N	CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1	26807-65-8	Carbonic Anhydrase Type VII Inhibitors	CA4	CA5A	CA7	CA12	CA5B																												763	766	771	11238																												CHEMBL406											3702	12598932	23018996	23725081	66960282	member																																																																																																																																																																18336309	18374572	18600270	19115843	19119014	20926301	24103428	24287559																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														2.352e-002	-0.22528	1.81168	0.95464	-4.144e-002																												0.00294	-0.02816	0.22646	0.11933	-0.00518																												8	8	8	8	8																												HY-B0259	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Cardiovascular Disease|MOABOX:790|CA4|Carbonic Anhydrase Type VII Inhibitors	CC1Cc2ccccc2N1NC(=O)c3ccc(Cl)c(c3)S(=O)(=O)N	26807-65-8	13761	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468807	365.83454	INDAPAMIDE	INDAPAMIDE | RAC-INDAPAMIDE | INDAPAMIDE | RAC-INDAPAMIDE	Pathway: Membrane Transporter/Ion Channel	Research Area: Cardiovascular Disease	MOABOX:790	CA4	Carbonic Anhydrase Type VII Inhibitors
SJ000287173-17	SJ000287173	17	MOABOX:792	BGRJTUBHPOOWDU-UHFFFAOYSA-N	CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC	15676-16-1	Dopamine D2 Antagonists;Carbonic Anhydrase Type VII Inhibitors	CA7	CA12	DRD2																														771	1813																														CHEMBL26											5355	150255	155718	155872	192082	virtual	10.1007/s00213-014-3726-8	10.1021/jm200288r																																																																																																																																																														15686894	15689154	21495689	23965175	24287559	24513184	28186762																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															0.33656	0.51702	0.43472																														0.04207	0.07386	0.05434																														8	7	8																														HY-B1019	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:792|CA7|Dopamine D2 Antagonists;Carbonic Anhydrase Type VII Inhibitors	CCN1CCCC1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N	15676-16-1	17274	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469129	341.42582	SULPIRIDE	SULPIRIDE | (±)-SULPIRIDE | (-)-SULPIRIDE | (RS)-(±)-SULPIRIDE | S(-)-SULPIRIDE | SJ000285857 | LEVOSULPIRIDE | SULPIRIDE | (±)-SULPIRIDE | (-)-SULPIRIDE | (RS)-(±)-SULPIRIDE | S(-)-SULPIRIDE | SJ000285857 | LEVOSULPIRIDE	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:792	CA7	Dopamine D2 Antagonists;Carbonic Anhydrase Type VII Inhibitors
SJ001034670-1	SJ001034670	1	MOABOX:794	ZSHHRBYVHTVRFK-UHFFFAOYSA-N	NS(=O)(=O)c1cc(C(=O)O)c(Cl)cc1Cl	2736-23-4	Carbonic Anhydrase Type I Inhibitors;Carbonic Anhydrase Type II Inhibitors	CA2																																																															CHEMBL120886	CHEMBL590825										17655	13529164	49797666	50942703	50942798	member	10.1016/j.bmc.2009.11.031	10.3109/14756361003733639																																																																																																																																																														20006931																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.1076																																0.26345																																8																																AS-10817	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NS(=O)(=O)c1cc(C(=O)O)c(Cl)cc1Cl	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466835	270.0899	AS-10817	AS-10817 | AS-10817			MOABOX:794	CA2	Carbonic Anhydrase Type I Inhibitors;Carbonic Anhydrase Type II Inhibitors
SJ001034830-1	SJ001034830	1	MOABOX:796	QOAXQANKSMHFKJ-UHFFFAOYSA-N	Nc1nccc(Nc2ccc(S(N)(=O)=O)cc2)n1	1350283-39-4	Carbonic Anhydrase Type I Inhibitors;Carbonic Anhydrase Type II Inhibitors	CA1	CA2	CA3	CA4	CA5A	CA8	CA11	CA12	CA5B	CA10																							760	761	762	763	767	770	771	11238	56934																							CHEMBL6633											31035	31036	49877622			virtual	10.1016/j.bmcl.2004.07.085																																																																																																																																																															10479300	10620731	10649985	10785557	11310605	12365464	12643899	15482952	15686894	15686895	16039848	16302824	16459077	16539401	17228881	17482815	17607683	17826101	18336307	19124253	19193158	19317447	19338333	19438226	19450983	19520577	19846301	20158185	20819061	20819063	20819064	21208801	21251841	21757360	22285172	22424239	22883029	23181552	23199478	23391336	23511020	23977960	24314394	24316122	24792813	24852120	25129169	25533402	25773015	25882523	25913199	26174556	26691758	26832216	26850377	26920803	26972117	27485387	28025002	28501430	28511911	30832211																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								-4.8e-002	3.61496	-8.603e-002	-8.19e-002	-0.63266	-6.111e-002	-6.111e-002	0.61056	-8.596e-002	-6.111e-002																							-0.006	0.45187	-0.01229	-0.0117	-0.09038	-0.00873	-0.00873	0.07632	-0.01228	-0.00873																							8	8	7	7	7	7	7	8	7	7																							EN300-21442	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-004-618-013|MOABOX:796|CA1|Carbonic Anhydrase Type I Inhibitors;Carbonic Anhydrase Type II Inhibitors	Nc1nccc(Nc2ccc(cc2)S(=O)(=O)N)n1	22199-93-5	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468071	265.29164	EN300-21442	EN300-21442 | EN300-21442			MOABOX:796	CA1	Carbonic Anhydrase Type I Inhibitors;Carbonic Anhydrase Type II Inhibitors
SJ000287570-6	SJ000287570	6	MOABOX:798	IAVUPMFITXYVAF-XPUUQOCRSA-N	CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21	120279-96-1	Carbonic Anhydrase Type II Inhibitors	CA1	CA2	CA4	CA5A	CA12	CA5B	CA3	CA8	CA11	CA10																							760	762	763	771	11238	761	767	770	56934																							CHEMBL1201162	CHEMBL218490										5284549	6918132	24864227	51371451	67374829	member	10.1016/j.bmc.2010.03.014	10.1021/acs.jmedchem.5b00043	10.1021/jm00034a001	10.1021/jm030912m	10.1111/cbdd.12695	10.3109/14756366.2015.1043298	10.3109/14756366.2016.1170014																																																																																																																																																									8164249	8295211	10411484	10479300	10762051	10843231	11087579	11123998	11229775	11425561	11906288	12039560	12166932	12617903	12643899	12747790	14611846	14684332	14736236	14971907	15081039	15139757	15203157	15454239	15456265	15603956	15664816	15686894	15686895	15686931	15771455	15905091	16039848	16039853	16290146	16302824	16459077	16539401	17125255	17157501	17228881	17475500	17482815	17540563	17681760	18307288	18359629	18481843	19124253	19193158	19286378	19317447	19338333	19520577	19632111	19651511	19731956	19773173	19846301	19854054	20363633	21208801	21251841	21377369	21549597	21757360	22285172	22424239	22883029	23317571	23391336	23867389	23965175	24090602	24314394	24513184	24792813	25129169	25533402	25728019	25773015	25882523	25913118	25921269	26174556	26319622	26525863	26691758	26832216	26850377	26920803	28025002	28511911																																																																																																																																																																																																																																																																																																																																																																																																																																																																									-0.99856	4.50984	-0.68803	-0.17952	-0.13055	0	0	1.11216	-0.10241	0																							-0.12482	0.56373	-0.09829	-0.02244	-0.01865	0.0	0.0	0.15888	-0.01463	0.0																							8	8	7	8	7	7	7	7	7	7																							HY-B0109A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: others|MOABOX:798|CA1|Carbonic Anhydrase Type II Inhibitors	CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(cc12)S(=O)(=O)N	130693-82-2	14418	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468921	324.44004	DORZOLAMIDE HYDROCHLORIDE	DORZOLAMIDE HYDROCHLORIDE | DORZOLAMIDE HYDROCHLORIDE	Pathway: Metabolic Enzyme/Protease	Research Area: others	MOABOX:798	CA1	Carbonic Anhydrase Type II Inhibitors
SJ000312361-8	SJ000312361	8	MOABOX:800	KJADKKWYZYXHBB-XBWDGYHZSA-N	CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1	122-09-8	"Carbonic Anhydrase Type II Inhibitors;Kainate Receptor Antagonists;AMPA Receptor Antagonists;""Carbonic Anhydrase Type II Inhibitors;Kainate Receptor Antagonists;AMPA Receptor Antagonists"""	CA1	CA2	CA3	CA4	CA5A	CA8	CA11	CA12	CA5B	CA10	GRIA1	GRIA2	GRIA3	GRIA4																			760	761	762	763	767	770	771	11238	56934	2890	2891	2892	2893																			CHEMBL220492											5284627	9848354	9939194	11204618	11317314	member	10.1016/j.bmcl.2003.11.014																																																																																																																																																															11784136	12166931	12617904	12747791	14684331	14698154	14971907	15110853	15500000	15546717	15638779	15686894	15686895	15686931	15771438	15837316	16134940	16302824	16459077	16539401	16759092	16918498	16999776	17125255	17228881	17376683	17420132	17475500	17482815	17504127	17504128	17504132	17540563	17588751	17607683	17646100	17658252	17826101	18336305	18336306	18336307	18336311	18336312	18363349	18640037	18644716	18990571	19058143	19124253	19193158	19317447	19338333	19388676	19398204	19435663	19450983	19520577	19539481	19703035	19827837	19846301	19860705	19962903	20028100	20158185	20170095	20201556	20349499	20472429	20624682	20819061	20819063	20819064	20819066	21208801	21251841	21300547	21314129	21332115	21395315	21506569	21723123	21757360	22041171	22285172	22386980	22424239	22443141	22883029	23199478	23391336	23511020	23777827	23867389	23965175	23977960	24205976	24314394	24316122	24513184	24792813	24852120	25129169	25533402	25773015	25882523	25913199	26174556	26525863	26691758	26832216	26850377	26920803	27485387	28025002	28253618	28501430	28511911	29795760	30832211																																																																																																																																																																																																																																																																																																																																																																																																																																														-0.3616	4.09064	-1.14149	-0.71736	-0.1968	-0.17262	-0.19728	1.25104	0	0	0	0	2.72e-003	-0.17262																			-0.0452	0.51133	-0.16307	-0.08967	-0.0246	-0.02466	-0.02466	0.15638	0.0	0.0	0.0	0.0	0.00034	-0.02466																			8	8	7	8	8	7	8	8	7	7	7	7	8	7																			KS-1122	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC1(C)O[C@@H]2CO[C@@]3(COS(=O)(=O)N)OC(C)(C)O[C@H]3[C@@H]2O1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466751	339.36204	TOPIRAMATE	"TOPIRAMATE | TOPIRAMATE| TOPAMAX SPRINKLE | ""TOPIRAMATE| TOPIRAMIC ACID | (2,2,7,7-TETRAMETHYLTETRAHYDRO-3AH-BIS[1,3]DIOXOLO[4,5-B:4',5'-D]PYRAN-3A-YL)METHYL SULFAMATE | TOPIRAMATE| TOPAMAX SPRINKLE"" | TOPIRAMATE | TOPIRAMATE | TOPIRAMATE| TOPAMAX SPRINKLE | ""TOPIRAMATE| TOPIRAMIC ACID | (2,2,7,7-TETRAMETHYLTETRAHYDRO-3AH-BIS[1,3]DIOXOLO[4,5-B:4',5'-D]PYRAN-3A-YL)METHYL SULFAMATE | TOPIRAMATE| TOPAMAX SPRINKLE"""			MOABOX:800	CA1	"Carbonic Anhydrase Type II Inhibitors;Kainate Receptor Antagonists;AMPA Receptor Antagonists;""Carbonic Anhydrase Type II Inhibitors;Kainate Receptor Antagonists;AMPA Receptor Antagonists"""
SJ000285803-9	SJ000285803	9	MOABOX:802	BZKPWHYZMXOIDC-UHFFFAOYSA-N	CC(=O)Nc1nnc(S(N)(=O)=O)s1	124442-28-0	Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type XIII Inhibitors;Carbonic Anhydrase Type VI Inhibitors;Carbonic Anhydrase Type XIV Inhibitors;Carbonic Anhydrase Type XV Inhibitors	AQP4	CA1	CA2	CA3	CA4	CA5A	CA6	CA8	CA11	CA12	CA5B	CA14	CA10	CA13																			759	760	761	762	763	765	767	770	771	11238	23632	56934	377677																			CHEMBL20	CHEMBL542496										1986	16051949	16223983	20558603	67364212	member	10.1002/ardp.201600183	10.1002/ardp.201700045	10.1002/ardp.201700198	10.1002/ardp.201700314	10.1002/ardp.201800029	10.1002/ardp.201800146	10.1002/ardp.201800150	10.1002/ardp.201800200	10.1002/ardp.201800292	10.1002/ardp.201800359	10.1002/cbdv.201900243	10.1007/s00044-015-1493-7	10.1016/S0960-894X(03)00009-X	10.1016/S0968-0896(00)00026-2	10.1016/S0968-0896(96)00272-6	10.1016/j.bioorg.2018.09.013	10.1016/j.bioorg.2018.11.001	10.1016/j.bioorg.2018.12.012	10.1016/j.bioorg.2018.12.028	10.1016/j.bioorg.2018.12.035	10.1016/j.bioorg.2019.02.008	10.1016/j.bioorg.2019.102980	10.1016/j.bioorg.2019.103004	10.1016/j.bioorg.2019.103017	10.1016/j.bioorg.2019.103095	10.1016/j.bioorg.2019.103096	10.1016/j.bioorg.2019.103134	10.1016/j.bioorg.2019.103153	10.1016/j.bioorg.2019.103213	10.1016/j.bmc.2005.10.054	10.1016/j.bmc.2010.03.014	10.1016/j.bmc.2016.04.002	10.1016/j.bmc.2017.05.005	10.1016/j.bmc.2017.08.027	10.1016/j.bmcl.2003.11.014	10.1016/j.bmcl.2006.12.010	10.1016/j.bmcl.2008.02.008	10.1016/j.bmcl.2008.03.012	10.1016/j.bmcl.2011.12.134	10.1016/j.bmcl.2013.04.048	10.1016/j.bmcl.2014.03.001	10.1016/j.bmcl.2014.04.077	10.1016/j.bmcl.2014.05.086	10.1016/j.ejmech.2009.11.052	10.1016/j.ejmech.2013.04.035	10.1016/j.ejmech.2016.09.035	10.1016/j.ejmech.2017.03.023	10.1016/j.ejmech.2018.05.034	10.1016/j.ijpddr.2017.01.003	10.1021/jm00037a015	10.1021/jm00067a012	10.1021/jm00131a011	10.1021/jm00132a003	10.1021/jm00132a009	10.1021/jm011112j	10.1021/jm030912m	10.1021/jm301506h	10.1039/c4ra03819c	10.1080/14756360701404100	10.1080/14756366.2016.1181627	10.1080/14756366.2016.1187605	10.1080/14756366.2016.1189422	10.1080/14756366.2016.1238367	10.1080/14756366.2016.1244533	10.1080/14756366.2016.1247058	10.1080/14756366.2016.1254207	10.1080/14756366.2017.1368019	10.1080/14756366.2017.1378192	10.1080/14756366.2018.1481404	10.1080/14756366.2018.1559840	10.1111/cbdd.12695	10.1111/cbdd.13149	10.2174/156802607780636771	10.2174/1570180814666161128120612	10.25135/rnp.71.17.04.074	10.3109/14756366.2010.503610	10.3109/14756366.2011.574130	10.3109/14756366.2015.1014476	10.3109/14756366.2015.1043298	10.3109/14756366.2015.1054820	10.3109/14756366.2015.1120723	10.3109/14756366.2015.1134524	10.3109/14756366.2016.1149477	10.3109/14756366.2016.1149479	10.3109/14756366.2016.1160077	10.3109/14756366.2016.1170014																																																																										1635066	2585439	2585443	2810337	3669014	3735316	8027991	8201598	8340917	9113330	10620731	10882008	11003159	11006487	11087579	11123998	11203012	11229775	11310605	11784136	11906288	12039560	12166932	12500287	12617903	12617904	12617909	12643899	12683750	12747790	12747791	14567548	14611844	14611846	14640555	14684331	14684332	14684333	14698154	14736236	14971907	15012984	15081039	15084132	15110853	15139757	15203157	15279596	15388166	15454239	15456265	15499999	15500000	15501039	15501040	15546717	15598570	15603956	15664816	15686894	15686895	15686931	15771438	15771455	15837316	15837323	15837325	15905091	15908201	15908204	16006130	16033263	16039848	16039853	16119190	16165351	16168653	16203142	16206834	16290146	16297631	16302824	16321542	16459077	16539401	16640335	16759092	16809036	16918498	16942027	16999776	17000110	17059166	17059184	17064072	17125255	17127063	17157501	17178220	17194028	17228881	17251018	17276072	17300160	17343373	17376683	17475500	17482815	17499996	17504127	17504128	17504130	17504132	17504133	17504134	17504136	17540563	17588751	17607683	17646100	17658252	17681760	17822907	17826101	18042384	18162396	18178093	18242985	18242998	18295485	18307288	18336305	18336306	18336307	18336308	18336309	18336312	18336313	18336316	18341250	18341261	18353640	18359629	18374572	18406497	18479784	18481843	18501600	18513964	18572406	18579385	18600270	18640037	18723348	18956406	18990571	19053764	19097911	19115843	19119014	19121582	19124253	19186056	19193158	19201197	19208476	19231207	19286378	19317447	19338333	19375309	19410461	19435663	19438226	19450983	19520577	19527930	19539481	19549076	19574046	19580287	19632111	19651511	19731956	19751975	19773173	19824891	19827837	19846301	19962903	20028100	20036446	20158185	20166809	20166929	20170095	20185318	20201556	20202722	20211561	20299219	20349499	20363633	20472429	20478708	20554082	20554206	20580561	20590092	20598552	20605094	20624682	20687792	20819061	20819062	20819063	20819064	20880712	20889345	21145236	21163660	21208801	21251841	21300547	21332115	21361354	21377369	21381885	21395315	21402476	21420862	21470859	21476925	21506569	21515057	21534860	21549597	21570835	21620713	21669522	21679053	21699374	21757360	21815772	21820216	21821413	21851094	21852133	21903393	21985426	21999604	22050606	22079760	22145674	22145694	22145736	22146078	22168126	22209456	22227210	22230050	22245047	22276570	22277279	22285172	22299576	22299577	22299585	22370338	22380772	22386980	22424239	22443141	22468747	22687439	22775345	22835873	22883029	22894736	22901388	22910138	22989910	23072866	23078755	23168081	23173744	23176597	23181552	23190033	23199478	23200251	23241068	23265898	23290254	23317571	23352754	23391336	23394791	23414801	23429054	23490152	23511020	23623256	23642478	23647428	23649517	23664215	23706268	23769167	23769640	23777827	23777898	23815159	23827177	23842519	23859774	23867389	23910989	23965175	23977960	23993330	24074025	24090602	24095761	24103428	24103430	24128000	24189056	24200125	24205976	24210500	24268544	24287559	24291567	24300919	24314394	24316122	24332658	24461298	24507918	24513184	24513186	24518190	24529310	24560737	24560739	24589484	24589511	24650641	24713308	24746465	24792813	24813742	24852120	24871996	24878197	24878360	24948563	25011913	25016228	25019479	25027802	25050167	25050173	25129169	25147616	25168745	25168748	25194929	25255434	25267005	25310626	25358036	25358084	25432060	25438758	25442309	25456084	25468040	25533402	25581127	25614109	25753329	25757603	25766630	25773015	25804721	25846066	25863492	25875209	25882523	25910585	25912674	25913118	25913199	25921266	25921269	26007302	26014482	26048024	26068018	26073005	26073006	26088336	26105196	26145820	26145821	26174556	26191373	26203869	26233435	26233796	26264840	26276436	26347950	26408817	26422787	26432607	26459213	26497049	26498393	26520662	26522624	26525863	26678172	26682703	26688270	26691758	26741028	26778292	26795114	26796953	26803577	26804228	26810710	26810836	26832216	26840366	26850377	26875933	26920803	26951893	26972117	27068142	27137360	27144971	27166574	27172398	27234893	27253845	27283786	27290692	27298005	27316543	27322137	27396930	27469982	27485387	27657811	27823879	27876475	27884694	27919611	27933963	27939347	28002963	28024887	28025002	28057408	28065499	28075587	28109946	28111158	28161252	28237553	28238511	28253618	28256371	28272885	28277280	28302505	28318894	28334643	28343756	28347633	28389112	28400084	28416101	28453941	28501430	28511907	28511911	28522267	28545816	28658574	28672822	28728897	28754318	28789908	28802125	28835790	28886996	28887000	28947941	28947945	29048889	29057059	29146134	29152053	29197732	29259736	29259754	29266943	29271882	29305297	29329232	29407972	29466001	29566486	29571155	29635168	29684705	29746127	29795760	29803994	29851481	29909339	29912561	29962205	30015076	30034608	30071407	30193219	30300845	30344913	30344915	30433782	30445264	30530195	30594030	30826507	30832211	30846402	30925064	30996772	30996814	31071549	31136893	31287314	-0.49432	-0.30824	4.10984	-0.71272	-0.19976	-0.1772	0.85816	9.695e-002	0.1364	3.39952	-0.16264	-9.888e-002	9.695e-002	0.17056																			-0.06179	-0.03853	0.51373	-0.08909	-0.02497	-0.02215	0.10727	0.01385	0.01705	0.42494	-0.02033	-0.01236	0.01385	0.02132																			8	8	8	8	8	8	8	7	8	8	8	8	7	8																			AS-13169	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(=O)Nc1nnc(s1)S(=O)(=O)N	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466795	222.24544	ACETAZOLAMIDE	ACETAZOLAMIDE | ACETAZOLAMIDE			MOABOX:802	AQP4	Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type XIII Inhibitors;Carbonic Anhydrase Type VI Inhibitors;Carbonic Anhydrase Type XIV Inhibitors;Carbonic Anhydrase Type XV Inhibitors
SJ001032992-2	SJ001032992	2	MOABOX:804	DSLPMJSGSBLWRE-UHFFFAOYSA-N	NS(=O)(=O)Oc1ccc2c3c(c(=O)oc2c1)CCCCC3	288628-05-7	Carbonic Anhydrase Type II Inhibitors;Steryl Sulfatase Inhibitors	STS	CA2	CA12																														760	771																														CHEMBL286738											5287541	46865597	46865598	139196294		member	10.1002/cmdc.201000203	10.1002/cmdc.201100145	10.1002/cmdc.201100288	10.1002/med.20008	10.1002/med.20021	10.1016/S0960-894X(03)00009-X	10.1016/j.bmc.2011.08.046	10.1016/j.bmc.2011.12.036	10.1016/j.bmc.2016.04.040	10.1016/j.bmcl.2008.06.105	10.1016/j.ejmech.2015.06.051	10.1021/acs.jmedchem.7b00062	10.1021/jm800168s	10.1021/jm901705h	10.1039/b707768h	10.1042/BJ20041037	10.2174/138955706777934946	10.2174/187152009788679985																																																																																																																																														11714597	12617909	12878177	14741252	15170594	15453828	15478125	16918498	17073630	17580845	17728860	18341250	18590272	18640037	18816537	19601744	20148564	20632362	21608133	21919848	21925885	21990014	22264754	24463645	26163883	26974384	27143133	28406629																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										3.82488	2.752e-002	1.376e-002																														0.47811	0.00344	0.00172																														8	8	8																														HY-14586	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:804|STS|Carbonic Anhydrase Type II Inhibitors;Steryl Sulfatase Inhibitors	NS(=O)(=O)Oc1ccc2C3=C(CCCCC3)C(=O)Oc2c1	288628-05-7	31124	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469791	309.3376	IROSUSTAT	IROSUSTAT | IROSUSTAT	Pathway: Others	Research Area: Cancer	MOABOX:804	STS	Carbonic Anhydrase Type II Inhibitors;Steryl Sulfatase Inhibitors
SJ000572675-5	SJ000572675	5	MOABOX:806	LMYRWZFENFIFIT-UHFFFAOYSA-N	Cc1ccc(S(N)(=O)=O)cc1	12552-95-3	Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type III Inhibitors	CA2	CA3																															761																															CHEMBL574											6269	159985	168268	169188	18184235	member	10.1016/j.bmcl.2004.07.085																																																																																																																																																															15482952	15686894	15686895	16302824	16459077	16539401	17228881	17482815	19124253	19193158	19317447	19338333	19520577	19846301	21208801	21251841	21757360	22285172	22424239	22974493	23391336	24314394	24792813	25129169	25533402	25773015	25882523	26174556	26691758	26832216	26850377	26920803	26972117	28025002	28511911	29466001																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		3.12128	-0.31136																															0.39016	-0.04448																															8	7																															FS-3585	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Cc1ccc(cc1)S(=O)(=O)N	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466782	171.21686					MOABOX:806	CA2	Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type III Inhibitors
SJ001035030-1	SJ001035030	1	MOABOX:808	ZKUIDNFBWWVULC-UHFFFAOYSA-N	NS(=O)(=O)c1ccc(NC(=O)CN2CCOCC2)cc1	91533-01-6	Carbonic Anhydrase Type I Inhibitors;Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type IX Inhibitors	CA2	CA9																															768																															CHEMBL180943											180598					member																																																																																																																																																																15603956																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.22392	-0.33704																															-0.02799	-0.04213																															8	8																															AE-848/36321029	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-225-319|MOABOX:808|CA2|Carbonic Anhydrase Type I Inhibitors;Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type IX Inhibitors	NS(=O)(=O)c1ccc(NC(=O)CN2CCOCC2)cc1	91533-01-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468517	299.34608	AE-848/36321029	AE-848/36321029 | AE-848/36321029			MOABOX:808	CA2	Carbonic Anhydrase Type I Inhibitors;Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type IX Inhibitors
SJ001035234-1	SJ001035234	1	MOABOX:810	XPEIJWZLPWNNOK-UHFFFAOYSA-N	OB(O)c1ccc(-c2ccccc2)cc1	5122-94-1	Carbonic Anhydrase Type I Inhibitors;Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type IX Inhibitors;Carbonic Anhydrase Type XII Inhibitors	CA2	CA9	CA12																														768	771																														CHEMBL485742											151253	89406100	91134403	134067417	143678663	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.36918	-0.47719	-0.42532																														-0.05274	-0.06817	-0.06076																														7	7	7																														HY-W002364	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: | Research Area: |MOABOX:810|CA2|Carbonic Anhydrase Type I Inhibitors;Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type IX Inhibitors;Carbonic Anhydrase Type XII Inhibitors	OB(O)c1ccc(cc1)c2ccccc2	5122-94-1	99292	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469237	198.02554	"[1,1'-BIPHENYL]-4-YLBORONIC ACID"	"[1,1'-BIPHENYL]-4-YLBORONIC ACID | [1,1'-BIPHENYL]-4-YLBORONIC ACID"	Pathway:	Research Area:	MOABOX:810	CA2	Carbonic Anhydrase Type I Inhibitors;Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type IX Inhibitors;Carbonic Anhydrase Type XII Inhibitors
SJ001034821-1	SJ001034821	1	MOABOX:812	RERPSPPBSSELBR-UHFFFAOYSA-N	NS(=O)(=O)N1CCc2ccccc2C1	15211-62-8	Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type IX Inhibitors;Carbonic Anhydrase Type XIV Inhibitors	CA2	CA9	CA14																														768	23632																														CHEMBL1077219											14787907					member																																																																																																																																																																20170095	20349499																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.25032	1.9496	-3.544e-002																														-0.03129	0.2437	-0.00443																														8	8	8																														Z286001556	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-009-532-084|MOABOX:812|CA2|Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type IX Inhibitors;Carbonic Anhydrase Type XIV Inhibitors	NS(=O)(=O)N1CCc2ccccc2C1	15211-62-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468062	212.26878	Z286001556	Z286001556 | Z286001556			MOABOX:812	CA2	Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type IX Inhibitors;Carbonic Anhydrase Type XIV Inhibitors
SJ001035235-1	SJ001035235	1	MOABOX:814	HXITXNWTGFUOAU-UHFFFAOYSA-N	OB(O)c1ccccc1	98-80-6	Carbonic anhydrase inhibitor	CA4																																																															CHEMBL21485											66827	17801156	22176598	22227069	23226632	virtual																																																																																																																																																																15501038	19128966	28277280																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.08168																																0.13521																																8																																HY-W001090	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: | Research Area: |MOABOX:814|CA4|Carbonic anhydrase inhibitor	OB(O)c1ccccc1	98-80-6	99295	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469238	121.92958	PHENYLBORONIC ACID	PHENYLBORONIC ACID | PHENYLBORONIC ACID	Pathway:	Research Area:	MOABOX:814	CA4	Carbonic anhydrase inhibitor
SJ000285893-13	SJ000285893	13	MOABOX:816	MAEIEVLCKWDQJH-UHFFFAOYSA-N	CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1	28395-03-1	Inhibits the sodium-potassium ATPase pump	CA4	CA5A	GPR35	SLC12A1	SLC12A2	SLC12A4	CA5B	SLC12A5																									763	2859	6557	6558	6560	11238	57468																									CHEMBL1072											2471	23018995	53377599	57454390	66628238	member	10.1159/000335127																																																																																																																																																															18336309	18374572	18600270																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.65112	0.54048	0.28609	0	0	0	0.59088	0																									0.08139	0.06756	0.04087	0.0	0.0	0.0	0.07386	0.0																									8	8	7	7	7	7	8	7																									HY-17468	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Metabolic Disease; Cardiovascular Disease|MOABOX:816|CA4|Inhibits the sodium-potassium ATPase pump	CCCCNc1cc(cc(c1Oc2ccccc2)S(=O)(=O)N)C(=O)O	28395-03-1	25266	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469288	364.4161	BUMETANIDE	BUMETANIDE | BUMETANIDE	Pathway: Membrane Transporter/Ion Channel	Research Area: Metabolic Disease; Cardiovascular Disease	MOABOX:816	CA4	Inhibits the sodium-potassium ATPase pump
SJ000285788-5	SJ000285788	5	MOABOX:818	DMDGGSIALPNSEE-UHFFFAOYSA-N	NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O	135-09-1	Carbonic anhydrase inhibitor	CA5B																																																															CHEMBL1763											3647	67874555	68453848	70571580	88488694	member																																																																																																																																																																18336309	18374572	18600270																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.64701																																0.09243																																7																																SB01887	MAYBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-771-232|MOABOX:818|CA5B|Carbonic anhydrase inhibitor	NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1C(F)(F)F	135-09-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468546	331.29203	HYDROFLUMETHIAZIDE	HYDROFLUMETHIAZIDE | DIUCARDIN | HYDROFLUMETHIAZIDE | DIUCARDIN			MOABOX:818	CA5B	Carbonic anhydrase inhibitor
SJ000286557-2	SJ000286557	2	MOABOX:820	ORHBXUUXSCNDEV-UHFFFAOYSA-N	O=c1ccc2ccc(O)cc2o1	142044-47-1	Carbonic Anhydrase Type IX Inhibitors;Carbonic Anhydrase Type XII Inhibitors;Cyclooxygenase-2 Inhibitors;Antioxidants	CA9	CA12	PTGS2																														771	5743																														CHEMBL51628											5281426	11313356	21322196	21972050	22015805	virtual																																																																																																																																																																20580555	21067924	22077347	22377674	26688270	29197732																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.4072	1.15128	-7.077e-002																														0.1759	0.14391	-0.01011																														8	8	7																														STR04824	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Oc1ccc2C=CC(=O)Oc2c1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466789	162.14214	UMBELLIFERONE	UMBELLIFERONE | UMBELLIFERONE			MOABOX:820	CA9	Carbonic Anhydrase Type IX Inhibitors;Carbonic Anhydrase Type XII Inhibitors;Cyclooxygenase-2 Inhibitors;Antioxidants
SJ000287293-14	SJ000287293	14	MOABOX:822	RZTAMFZIAATZDJ-UHFFFAOYSA-N	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl	72509-76-3	Calcium Channel Blockers	CACNA1C	CACNA1D	CACNA1S	CACNA1A	CACNA1E	CACNB1	CACNB4	CACNG1																									776	779	773	777	782	785	786																									CHEMBL1480											3333	19026228	20214968	25007952	56655543	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0	0	0	0	0																									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0																									7	7	7	7	7	7	7	7																									HY-B0309	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Cardiovascular Disease|MOABOX:822|CACNA1C|Calcium Channel Blockers	CCOC(=O)C1=C(C)NC(=C(C1c2cccc(Cl)c2Cl)C(=O)OC)C	72509-76-3	14820	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469261	384.25376	FELODIPINE	FELODIPINE | FELODIPINE	Pathway: Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Cardiovascular Disease	MOABOX:822	CACNA1C	Calcium Channel Blockers
SJ000285666-18	SJ000285666	18	MOABOX:824	HYIMSNHJOBLJNT-UHFFFAOYSA-N	COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]	101539-70-2	"Calcium Channel Blockers;Antioxidants;""Calcium Channel Blockers;Antioxidants"""	CACNA1C	CACNA1D	CACNA1S	CACNA1H	CACNA1E	CACNA1A	CACNB1	CACNB4	CACNG1																								776	779	8912	777	773	782	785	786																								CHEMBL193											4485	63011	489226	9852110	9959755	member																																																																																																																																																																2435904	2834556	7837222	8496700	16472138	19004630	21300721	21558436	22547813	22761000	23181587	23586669	23812503	30861492																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								0	1.8512	0.81672	0	1.36296	0	0	0	0.88616																								0.0	0.2314	0.10209	0.0	0.17037	0.0	0.0	0.0	0.11077																								7	8	8	7	8	7	7	7	8																								KS-1456	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COC(=O)C1=C(C)NC(=C(C1c2ccccc2[N+](=O)[O-])C(=O)OC)C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466813	346.33462	NIFEDIPINE	NIFEDIPINE | ADALAT | NIFEDIPINE | ADALAT			MOABOX:824	CACNA1C	"Calcium Channel Blockers;Antioxidants;""Calcium Channel Blockers;Antioxidants"""
SJ000796094-3	SJ000796094	3	MOABOX:826	QDMAKDIDFJTXEL-UHFFFAOYSA-N	Cc1c(C2CCN(CCc3ccccc3)CC2)noc1-c1ccc(Cl)cc1	156337-32-5	"Dopamine D4 Antagonists;DRD4 antagonist;""Dopamine D4 Antagonists;DRD4 antagonist"""	DRD4	CACNA1A	CACNA1C	CACNA1D	CACNA1E	CACNA1S	CACNB1	CACNB4	CACNG1																								773	775	776	777	779	782	785	786																								CHEMBL444309											133008	24744861	71297048			member																																																																																																																																																																8642551	9240352	9681140	10411491	11170639	16613551	28489950																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															0	0	0	0	0	0	0	3.54928	0																								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.44366	0.0																								7	7	7	7	7	7	7	8	7																								1004	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-275-974|MOABOX:826|DRD4|Dopamine D4 Antagonists;DRD4 antagonist;\Dopamine D4 Antagonists;DRD4 antagonist\	Cc1c(onc1C2CCN(CCc3ccccc3)CC2)c4ccc(Cl)cc4	874882-93-6	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468504	380.9104	"L-741,742"	"L-741,742 | L-741,742 HYDROCHLORIDE | L-741,742 | L-741,742 HYDROCHLORIDE"			MOABOX:826	DRD4	Dopamine D4 Antagonists;DRD4 antagonist;\Dopamine D4 Antagonists;DRD4 antagonist\
SJ000285435-19	SJ000285435	19	MOABOX:828	UIAGMCDKSXEBJQ-UHFFFAOYSA-N	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1	1246815-36-0	Calcium channel inhibitor L-type	CACNA1C	CACNA1D	CACNA1S	CACNB1	CACNB4	CACNA1A	CACNA1E	CACNG1																									776	779	782	785	773	777	786																									CHEMBL1428											4497	9832364	9853739	9896619	9897147	member																																																																																																																																																																22761000																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	1.14288	0	0	0	-0.26894	0	0																									0.0	0.14286	0.0	0.0	0.0	-0.03842	0.0	0.0																									7	8	7	7	7	7	7	7																									KS-1304	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COCCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC(C)C)C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466752	418.44034	NIMODIPINE	NIMODIPINE | NIMODIPINE			MOABOX:828	CACNA1C	Calcium channel inhibitor L-type
SJ001035027-1	SJ001035027	1	MOABOX:830	PSKQVPLMVPZZPQ-UHFFFAOYSA-N	Cc1ccc(-n2c(Cc3ccccc3)nnc2SCC(=O)Nc2ccccc2Cl)cc1		N-Type Calcium Channel (Ca(v) 2.2) Blockers	CACNA1B																																																															CHEMBL377896											1144328					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																ST072407	TIMTEC	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-971-924|MOABOX:830|CACNA1B|N-Type Calcium Channel (Ca(v) 2.2) Blockers	Cc1ccc(cc1)n2c(Cc3ccccc3)nnc2SCC(=O)Nc4ccccc4Cl	332947-35-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468514	448.96774	ST072407	ST072407 | ST072407			MOABOX:830	CACNA1B	N-Type Calcium Channel (Ca(v) 2.2) Blockers
SJ001034986-1	SJ001034986	1	MOABOX:832	URUHKHGBRNTPGA-UHFFFAOYSA-N	Nc1cc(-c2ccccc2)nc2ccccc12	111273-28-0	N-Type Calcium Channel (Ca(v) 2.2) Blockers	CACNA1B																																																															CHEMBL50608											453077	2855010	51057793	51058346	134690731	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.21833																																-0.03119																																7																																5607559	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-008-383-421|MOABOX:832|CACNA1B|N-Type Calcium Channel (Ca(v) 2.2) Blockers	Nc1cc(nc2ccccc12)c3ccccc3	111273-28-0	NA	GENERAL	OXALATE	1	NO_SOLVATE	0	1468429	220.26918	5607559	5607559 | 5607559			MOABOX:832	CACNA1B	N-Type Calcium Channel (Ca(v) 2.2) Blockers
SJ001035288-1	SJ001035288	1	MOABOX:834	VCPMZDWBEWTGNW-UHFFFAOYSA-N	O=C(CC(c1ccccc1)c1ccccc1)N1CCN(C(c2ccccc2)c2ccccc2)CC1	41332-24-5	N-Type Calcium Channel (Ca(v) 2.2) Blockers	CACNA1A	CACNA1B	CACNA1C	CACNA1S																													774	775	779																													CHEMBL604710											4988454	91588150	119057587	144438556		member	10.1111/bph.13910																																																																																																																																																															19442208	20117000																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.34097	0.64408	-7.609e-002	-7.609e-002																													0.04871	0.08051	-0.01087	-0.01087																													7	8	7	7																													HY-14462	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Cardiovascular Disease|MOABOX:834|CACNA1A|N-Type Calcium Channel (Ca(v) 2.2) Blockers	O=C(CC(c1ccccc1)c2ccccc2)N3CCN(CC3)C(c4ccccc4)c5ccccc5	41332-24-5	39020	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469504	460.60928	NP118809 | 39-1B4	"""NP118809 | 39-1B4"" | ""NP118809 | 39-1B4"""	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Cardiovascular Disease	MOABOX:834	CACNA1A	N-Type Calcium Channel (Ca(v) 2.2) Blockers
SJ001035203-1	SJ001035203	1	MOABOX:836	PDOCBJADCWMDGL-UHFFFAOYSA-N	CN1CCN(c2ncc(-c3cc(Cl)cc(Cl)c3Cl)c(N)n2)CC1	130800-90-7	N-Type Calcium Channel (Ca(v) 2.2) Blockers;Glutamate Release Inhibitors;Nav1.2 (Brain Type II) Sodium Channel Blockers	CACNA1B	SCN2A																															6326																															CHEMBL28854											60803	9956295	124125184			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0.51527																															0.0	0.07361																															7	7																															HY-108335	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:836|CACNA1B|N-Type Calcium Channel (Ca(v) 2.2) Blockers;Glutamate Release Inhibitors;Nav1.2 (Brain Type II) Sodium Channel Blockers	CN1CCN(CC1)c2ncc(c(N)n2)c3cc(Cl)cc(Cl)c3Cl	130800-90-7	66612	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469086	372.68004	SIPATRIGINE | 619C89 | BW 619C89	"""SIPATRIGINE | 619C89 | BW 619C89"" | ""SIPATRIGINE | 619C89 | BW 619C89"""	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:836	CACNA1B	N-Type Calcium Channel (Ca(v) 2.2) Blockers;Glutamate Release Inhibitors;Nav1.2 (Brain Type II) Sodium Channel Blockers
SJ001034890-1	SJ001034890	1	MOABOX:838	FLNYLINBEZROPL-NSOVKSMOSA-N	COc1ccccc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1	129912-34-1	Non-Steroidal Antiinflammatory Drugs;Tachykinin NK1 Antagonists	CACNA1C	CACNA1F	CACNA1S																														778	779																														CHEMBL16192											104943					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.62286	-0.62286	-0.62286																														-0.08898	-0.08898	-0.08898																														7	7	7																														2893	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-594|MOABOX:838|CACNA1C|Non-Steroidal Antiinflammatory Drugs;Tachykinin NK1 Antagonists	COc1ccccc1CN[C@H]2C3CCN(CC3)[C@H]2C(c4ccccc4)c5ccccc5	132746-60-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468191	412.56648	CP 96345	CP 96345 | CP 96345			MOABOX:838	CACNA1C	Non-Steroidal Antiinflammatory Drugs;Tachykinin NK1 Antagonists
SJ000285364-16	SJ000285364	16	MOABOX:844	HSUGRBWQSSZJOP-RTWAWAEBSA-N	COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1	103532-26-9	L-Type Calcium Channel Blockers	CACNA1C	CACNA1S																															779																															CHEMBL1200805	CHEMBL1697	CHEMBL23									39186	62920	168918	657259	3037122	member																																																																																																																																																																16722655	21300721	21688779	23812503																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.91952	1.01792																															0.11494	0.12724																															8	8																															BD125212	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-931-523|MOABOX:844|CACNA1C|L-Type Calcium Channel Blockers	COc1ccc(cc1)C2Sc3ccccc3N(CCN(C)C)C(=O)C2OC(=O)C	33286-22-5	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468345	414.51784	DILTIAZEM HYDROCHLORIDE	DILTIAZEM HYDROCHLORIDE | DILTIAZEM | DILTIAZEM HCL | L-(-)-CIS-DILTIAZEM HCL | DILTIAZEM HYDROCHLORIDE | DILTIAZEM | DILTIAZEM HCL | L-(-)-CIS-DILTIAZEM HCL			MOABOX:844	CACNA1C	L-Type Calcium Channel Blockers
SJ000285990-17	SJ000285990	17	MOABOX:846	PVHUJELLJLJGLN-UHFFFAOYSA-N	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1	39562-70-4	L-Type Calcium Channel Blockers	CACNA1C	CACNA1S																															779																															CHEMBL475534											4507	20041241	20212048	25007949	67236458	member	10.1021/np3000987																																																																																																																																																															2329573	2391701	2435904	2840498	16722655	21300721	21688779	22694270	23812503																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2.22992	1.56672																															0.27874	0.19584																															8	8																															HY-B0424	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Cardiovascular Disease|MOABOX:846|CACNA1C|L-Type Calcium Channel Blockers	CCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC)C	39562-70-4	16660	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468877	360.3612	NITRENDIPINE	NITRENDIPINE | BAYPRESS | NITRENDIPINE | BAYPRESS	Pathway: Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Cardiovascular Disease	MOABOX:846	CACNA1C	L-Type Calcium Channel Blockers
SJ000518960-2	SJ000518960	2	MOABOX:848	AYXYPKUFHZROOJ-ZETCQYMHSA-N	CC(C)C[C@H](CN)CC(=O)O	1414928-41-8	L-Type Calcium Channel Blockers;Calcium Channels (Voltage-Gated) alpha2/delta-1 Subunit Ligands	CACNA1D	CACNA2D1																															781																															CHEMBL1059	CHEMBL2348413										5486971	9863374	11842610	16756913	25271887	virtual																																																																																																																																																																16621528	17181137																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-2.856e-002	0.73048																															-0.00408	0.09131																															7	8																															KS-5378	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)C[C@H](CN)CC(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466641	159.22608	PREGABALIN| LYRICA	PREGABALIN| LYRICA | PREGABALIN| LYRICA			MOABOX:848	CACNA1D	L-Type Calcium Channel Blockers;Calcium Channels (Voltage-Gated) alpha2/delta-1 Subunit Ligands
SJ000287210-11	SJ000287210	11	MOABOX:850	UGJMXCAKCUNAIE-UHFFFAOYSA-N	NCC1(CC(=O)O)CCCCC1	1185039-20-6	Calcium Channels (Voltage-Gated) alpha2/delta-1 Subunit Ligands;Calcium Channels (Voltage-Gated) alpha2/delta-2 Subunit Ligands	CACNA1D	CACNA2D1	CACNA2D2	CACNA2D3																													781	9254	55799																													CHEMBL2348410	CHEMBL542620	CHEMBL940									3446	6453919	6919078	9797872	9845173	member																																																																																																																																																																9599234	10400324	15050626	23676307																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.36337	0.25816	6.896e-002	-9.975e-002																													0.05191	0.03227	0.00862	-0.01425																													7	8	8	7																													KS-1064	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NCC1(CC(=O)O)CCCCC1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466703	171.23678	GABAPENTIN	GABAPENTIN | GABAPENTIN			MOABOX:850	CACNA1D	Calcium Channels (Voltage-Gated) alpha2/delta-1 Subunit Ligands;Calcium Channels (Voltage-Gated) alpha2/delta-2 Subunit Ligands
SJ001035363-1	SJ001035363	1	MOABOX:852	ZZKNRXZVGOYGJT-VKHMYHEASA-N	O=C(O)C[C@H](NC(=O)CP(=O)(O)O)C(=O)O	51321-79-0	Antimetabolites;Aspartate Carbamoyltransferase Inhibitors	CAD																																																															CHEMBL504802											39981	11709221	21144793	23568310	88003134	virtual																																																																																																																																																																17336518	19097895	19828320	22198283																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.28304																																0.28538																																8																																HY-112732B	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer; Metabolic Disease|MOABOX:852|CAD|Antimetabolites;Aspartate Carbamoyltransferase Inhibitors	OC(=O)C[C@H](NC(=O)CP(=O)(O)O)C(=O)O	70962-66-2	64982	GENERAL	SODIUM(I)	3	NO_SOLVATE	0	1469767	255.11926	SPARFOSIC ACID TRISODIUM	SPARFOSIC ACID TRISODIUM | SPARFOSIC ACID TRISODIUM	Pathway: Others	Research Area: Cancer; Metabolic Disease	MOABOX:852	CAD	Antimetabolites;Aspartate Carbamoyltransferase Inhibitors
SJ001034650-1	SJ001034650	1	MOABOX:854	YXHLPJQQPOMPGE-UHFFFAOYSA-N	Cc1ccccc1N(C)C(=O)c1ccc([S+]([O-])c2nccs2)c([N+](=O)[O-])c1	217438-17-0	Calcitonin Gene-Related Peptides (CGRP) Antagonists	CALCRL																																																																										6918567					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.0628																																0.13285																																8																																SS-4391	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CN(C(=O)c1ccc(c(c1)[N+](=O)[O-])S(=O)c2nccs2)c3ccccc3C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466691	401.4594	SS-4391	SS-4391 | SS-4391			MOABOX:854	CALCRL	Calcitonin Gene-Related Peptides (CGRP) Antagonists
SJ001034958-1	SJ001034958	1	MOABOX:856	HTGCJAAPDHZCHL-UHFFFAOYSA-N	CC1(CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)OCc2ccccc2-n2cccc21	109826-26-8	Calmodulin Antagonists	CALM1																																																															CHEMBL1474352											65909	3086537	6450522	14171586		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																1252	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-367|MOABOX:856|CALM1|Calmodulin Antagonists	CC1(CN2CCC(CC2)N3C(=O)Nc4ccccc34)OCc5ccccc5n6cccc16	109826-27-9	NA	GENERAL	MALEATE	1	NO_SOLVATE	0	1468373	428.52612	CGS 9343B | ZALDARIDE MALEATE	"""CGS 9343B | ZALDARIDE MALEATE"" | ""CGS 9343B | ZALDARIDE MALEATE"""			MOABOX:856	CALM1	Calmodulin Antagonists
SJ000285470-6	SJ000285470	6	MOABOX:860	IDEHCMNLNCJQST-UHFFFAOYSA-N	NCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12	61714-27-0	K(V)11.1 (erg1) Channel Blockers;K(V)1.5 Channel Blockers;Calmodulin Antagonists	CALM1	KCNA5	KCNH2																														3741	3757																														CHEMBL41631	CHEMBL513116										5681	124887	21946294	44350582	74764506	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	-3.542e-002	3.416e-002																														0.0	-0.00506	0.00488																														8	7	7																														HY-100912	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cytoskeleton; Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Cancer|MOABOX:860|CALM1|K(V)11.1 (erg1) Channel Blockers;K(V)1.5 Channel Blockers;Calmodulin Antagonists	NCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12	61714-27-0	96966	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469699	340.86814	W-7 HYDROCHLORIDE	W-7 HYDROCHLORIDE | W-7 HYDROCHLORIDE	Pathway: Apoptosis; Cytoskeleton; Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Cancer	MOABOX:860	CALM1	K(V)11.1 (erg1) Channel Blockers;K(V)1.5 Channel Blockers;Calmodulin Antagonists
SJ001010867-2	SJ001010867	2	MOABOX:862	RJVLFQBBRSMWHX-DHUJRADRSA-N	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12	127191-97-3	"P2X7 Receptor Antagonists;Calmodulin-Dependent Protein Kinase II (CaMK-II) Inhibitors;Calmodulin Antagonists;""P2X7 Receptor Antagonists;Calmodulin-Dependent Protein Kinase II (CaMK-II) Inhibitors;Calmodulin Antagonists"""	CALM1	P2RX7	CAMK2A																														5027	815																														CHEMBL28324											5312126	87075136	87602822			member	10.1002/cmdc.200800453	10.1002/ddr.1207	10.1016/S0960-894X(00)00083-4	10.1016/j.bmc.2009.05.083	10.1016/j.bmcl.2007.11.077	10.1016/j.bmcl.2008.11.088	10.1016/j.bmcl.2009.09.053	10.1016/j.bmcl.2015.06.001	10.1016/j.bmcl.2017.01.039	10.1016/j.ejmech.2013.10.026	10.1016/j.ejmech.2015.10.036	10.1016/j.ejmech.2018.03.023	10.1016/j.farmac.2004.09.007	10.1016/j.taap.2011.02.009	10.1021/acs.jmedchem.5b01690	10.1021/jm020046y	10.1021/jm021049d	10.1021/jm070443e	10.1021/jm2012326	10.1021/jm700949w	10.1038/sj.bjp.0701081	10.2174/092986707780831023	10.2174/1568026043387223	10.2174/187152712803581137																																																																																																																																								10762053	11181928	12213051	12672232	14592505	15579103	15784237	18078749	19110420	19191585	19326385	19540765	19800793	22400713	22963440	24246730	24314880	25597334	26099538	26547056	27427902	28126517																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0	0	3.1788																														0.0	0.0	0.39735																														7	7	8																														HY-13290	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Metabolic Disease; Cancer|MOABOX:862|CALM1|P2X7 Receptor Antagonists;Calmodulin-Dependent Protein Kinase II (CaMK-II) Inhibitors;Calmodulin Antagonists;\P2X7 Receptor Antagonists;Calmodulin-Dependent Protein Kinase II (CaMK-II) Inhibitors;Calmodulin Antagonists\	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N4CCN(CC4)c5ccccc5)S(=O)(=O)c6cccc7cnccc67	127191-97-3	15584	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469229	721.8444	KN-62	KN-62 | KN-62	Pathway: Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Metabolic Disease; Cancer	MOABOX:862	CALM1	P2X7 Receptor Antagonists;Calmodulin-Dependent Protein Kinase II (CaMK-II) Inhibitors;Calmodulin Antagonists;\P2X7 Receptor Antagonists;Calmodulin-Dependent Protein Kinase II (CaMK-II) Inhibitors;Calmodulin Antagonists\
SJ001034662-1	SJ001034662	1	MOABOX:864	PDOCNPCPPLPXRV-UHFFFAOYSA-N	Nc1nc2ccc(Cl)cc2[nH]1	1018894-96-6	5-HT3 receptor ligand	HTR3B	HTR3C	HTR3D	HTR3E																													170572	200909	285242																													CHEMBL269158											21527	66623406				virtual																																																																																																																																																																12643925																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.60424	0.60424	0.60424	0.60424																													0.07553	0.07553	0.07553	0.07553																													8	8	8	8																													FS-1408	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Nc1nc2cc(Cl)ccc2[nH]1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466774	167.59564	FS-1408	FS-1408 | FS-1408			MOABOX:864	HTR3B	5-HT3 receptor ligand
SJ000785915-5	SJ000785915	5	MOABOX:866	GDQXJQSQYMMKRA-UHFFFAOYSA-N	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21	221244-14-0	"Extracellular-Regulated Kinase (ERK) Inhibitors;Calmodulin-Dependent Protein Kinase II (CaMK-II) Inhibitors;""Extracellular-Regulated Kinase (ERK) Inhibitors;Calmodulin-Dependent Protein Kinase II (CaMK-II) Inhibitors"""	CAMK2A	CAMK2B	FYN	MAPK13	CAMK2G																												816	2534	5603	818																												CHEMBL2069955	CHEMBL573578										5154691	70686735				member																																																																																																																																																																16408016																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.20016	0	1.05623	0.33488	0																												-0.02502	0.0	0.15089	0.04784	0.0																												8	7	7	7	7																												HY-13942	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:866|CAMK2A|Extracellular-Regulated Kinase (ERK) Inhibitors;Calmodulin-Dependent Protein Kinase II (CaMK-II) Inhibitors;\Extracellular-Regulated Kinase (ERK) Inhibitors;Calmodulin-Dependent Protein Kinase II (CaMK-II) Inhibitors\	CC(C)(C)n1nc(Cc2cccc3ccccc23)c4c(N)ncnc14	221244-14-0	11422	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469413	331.41424	1NM-PP1 | PP1 ANALOG II | MUTANT KINASE INHIBITORS II | NM |	"""1NM-PP1 | PP1 ANALOG II | MUTANT KINASE INHIBITORS II | NM |"" | 1NM-PP1 | ""1NM-PP1 | PP1 ANALOG II | MUTANT KINASE INHIBITORS II | NM |"" | 1NM-PP1"	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:866	CAMK2A	Extracellular-Regulated Kinase (ERK) Inhibitors;Calmodulin-Dependent Protein Kinase II (CaMK-II) Inhibitors;\Extracellular-Regulated Kinase (ERK) Inhibitors;Calmodulin-Dependent Protein Kinase II (CaMK-II) Inhibitors\
SJ000574289-18	SJ000574289	18	MOABOX:870	HKSZLNNOFSGOKW-FYTWVXJKSA-N	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4	109189-95-9	"Signal transduction modulator;Protein Kinase C (PKC) Inhibitors;""Signal transduction modulator;Protein Kinase C (PKC) Inhibitors"""	CAMK2B	CAMK2G	PRKACA	PRKACB	PRKACG	PRKCG	PRKCH	PRKCI	PRKCZ	MAPK7	MAPK12	CCNA1	MAPK15	MAPK6	MAPK4																		818	5566	5567	5568	5582	5583	5584	5590	5598	6300	8900	225689	5597	5596																		CHEMBL3436363	CHEMBL388978										44259	16686137	76962610	131741001		virtual	10.1016/S0960-894X(03)00286-5	10.1016/j.bmc.2006.05.033	10.1016/j.chembiol.2011.04.011	10.1021/acs.jmedchem.8b01606	10.1021/jm401073p	10.1021/jm950588y	10.1124/jpet.108.146241	10.1126/science.272.5262.728																																																																																																																																																								8421286	8709095	11462969	12166950	12749884	12941331	14552791	15711537	15771419	16403626	16413780	16765046	17875639	18183025	19397322	21435888	22037378	23252711	23600925	24321345	26318067	27288183	28259529																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															0.57464	0.49378	0.55448	0.21966	0.23695	0.28992	0.58992	0.25336	0.12808	0	-0.62958	-0.56588	-0.15365	-0.37712	0.36596																		0.07183	0.07054	0.06931	0.03138	0.03385	0.03624	0.07374	0.03167	0.01601	0.0	-0.08994	-0.08084	-0.02195	-0.04714	0.05228																		8	7	8	7	7	8	8	8	8	7	7	7	7	8	7																		CS-2716	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-004-963-434|MOABOX:870|CAMK2B|Signal transduction modulator;Protein Kinase C (PKC) Inhibitors;\Signal transduction modulator;Protein Kinase C (PKC) Inhibitors\	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35	62996-74-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468400	466.53104	STAUROSPORINE	STAUROSPORINE | AM-2282 | STAUROSPORINE | AM-2282			MOABOX:870	CAMK2B	Signal transduction modulator;Protein Kinase C (PKC) Inhibitors;\Signal transduction modulator;Protein Kinase C (PKC) Inhibitors\
SJ000773147-3	SJ000773147	3	MOABOX:874	DJCVSFWGKYHMKH-YVMONPNESA-N	O=C(O)/C(S)=C/c1ccc(I)cc1	179528-45-1	Calpain Inhibitors	CAPN1																																																															CHEMBL366254											9839500					member	10.1016/j.bmcl.2005.04.031																																																																																																																																																															11032966	15896956	17168715	20166953	25546626																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.2688																																0.1586																																8																																HY-100529	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:874|CAPN1|Calpain Inhibitors	OC(=O)\C(=C\c1ccc(I)cc1)\S	179528-45-1	26066	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469722	306.12015	PD150606	PD150606 | PD 150606 | PD150606 | PD 150606	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:874	CAPN1	Calpain Inhibitors
SJ001035265-1	SJ001035265	1	MOABOX:878	GJNDXQBALKCYSZ-RYUDHWBXSA-N	CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O	3918-92-1	Calpain Inhibitors	CAPN1																																																															CHEMBL8486											6993119	6993120	22815432	131718982	139056960	member	10.1016/S0960-894X(97)00063-2	10.1016/j.bmcl.2003.11.037																																																																																																																																																														15013018																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.21616																																0.40202																																8																																HY-107378	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:878|CAPN1|Calpain Inhibitors	CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O	3918-92-1	26714	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469406	264.3202	L-VALYL-L-PHENYLALANINE | VALYLPHENYLALANINE | H-VAL-PHE-OH	"""L-VALYL-L-PHENYLALANINE | VALYLPHENYLALANINE | H-VAL-PHE-OH"" | ""L-VALYL-L-PHENYLALANINE | VALYLPHENYLALANINE | H-VAL-PHE-OH"""	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:878	CAPN1	Calpain Inhibitors
SJ000287998-10	SJ000287998	10	MOABOX:880	NGBKFLTYGSREKK-PMACEKPBSA-N	CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](C=O)Cc1ccccc1	756485-04-8	Calpain Inhibitors	CAPN1																																																															CHEMBL286722											72430					member	10.1016/S0960-894X(96)00286-7	10.1016/S0960-894X(97)00003-6	10.1016/S0960-894X(97)00063-2	10.1016/j.bmcl.2005.03.095	10.1016/j.bmcl.2007.10.097	10.1016/j.bmcl.2008.11.030	10.1016/j.ejmech.2008.02.023	10.1016/j.ejps.2012.01.015	10.1021/jm010178b	10.1021/jm8014734	10.1021/jm980035y																																																																																																																																																					9667954	11032966	18396356	20166953	22333440																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.35032																																0.04379																																8																																T2470	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-483-560|MOABOX:880|CAPN1|Calpain Inhibitors	CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)NC(Cc2ccccc2)C=O	88191-84-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468584	382.45284	CALPAIN INHIBITOR III	"CALPAIN INHIBITOR III | MDL-28170 | ""CALPAIN INHIBITOR III | MDL 28170 |"" | CALPAIN INHIBITOR III | MDL-28170 | ""CALPAIN INHIBITOR III | MDL 28170 |"""			MOABOX:880	CAPN1	Calpain Inhibitors
SJ001035239-1	SJ001035239	1	MOABOX:888	FKJMFCOMZYPWCO-HNNXBMFYSA-N	O=C(O)C[C@H](NC(=O)OCc1ccccc1)C(=O)COC(=O)c1c(Cl)cccc1Cl	153088-73-4	Caspase 1 (IL-1beta Converting Enzyme) Inhibitors	CASP1																																																															CHEMBL108574											9911778					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.71408																																0.21426																																8																																HY-113953	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis | Research Area: Inflammation/Immunology|MOABOX:888|CASP1|Caspase 1 (IL-1beta Converting Enzyme) Inhibitors	OC(=O)C[C@H](NC(=O)OCc1ccccc1)C(=O)COC(=O)c2c(Cl)cccc2Cl	153088-73-4	57953	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469244	454.25748	Z-ASP-CH2-DCB	Z-ASP-CH2-DCB | Z-ASP-CH2-DCB	Pathway: Apoptosis	Research Area: Inflammation/Immunology	MOABOX:888	CASP1	Caspase 1 (IL-1beta Converting Enzyme) Inhibitors
SJ000287663-12	SJ000287663	12	MOABOX:896	KQNZDYYTLMIZCT-KQPMLPITSA-N	C[C@H]1CCC/C=C/[C@@H]2C[C@H](O)C[C@H]2[C@H](O)/C=C/C(=O)O1	11006-23-8	"Apoptosis Inducers;Caspase 3 Activators;Autophagy inducer;""Apoptosis Inducers;Caspase 3 Activators;Autophagy inducer"""	ARF1	GBF1	CYTH2	ARFGEF2	ARFGEF1	CYTH1																											8729	9266	10564	10565	9267																											CHEMBL19980											5287620					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0	0	0																											0.0	0.0	0.0	0.0	0.0	0.0																											7	7	7	7	7	7																											T6062	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-845-305|MOABOX:896|ARF1|Apoptosis Inducers;Caspase 3 Activators;Autophagy inducer;\Apoptosis Inducers;Caspase 3 Activators;Autophagy inducer\	C[C@H]1CCC\C=C\[C@@H]2C[C@H](O)C[C@H]2[C@H](O)\C=C\C(=O)O1	20350-15-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468587	280.35936	BREFELDIN A	"BREFELDIN A | NSC-89671 | ""BREFELDIN A | BFA | NSC-89671 | ASCOTOXIN | CYANEIN | DECUMBIN | SYNERGISIDIN |"" | BREFELDIN A | NSC-89671 | ""BREFELDIN A | BFA | NSC-89671 | ASCOTOXIN | CYANEIN | DECUMBIN | SYNERGISIDIN |"""			MOABOX:896	ARF1	Apoptosis Inducers;Caspase 3 Activators;Autophagy inducer;\Apoptosis Inducers;Caspase 3 Activators;Autophagy inducer\
SJ000111466-5	SJ000111466	5	MOABOX:898	YQNRVGJCPCNMKT-LFVJCYFKSA-N	C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O	315183-21-2	Apoptosis Inducers;Procaspase 3 Activators	CASP3																																																															CHEMBL591429											9675990	135421197	136219165	136219175	136226128	member																																																																																																																																																																16936720	25856364																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.584																																0.198																																8																																HY-13523	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy | Research Area: Cancer|MOABOX:898|CASP3|Apoptosis Inducers;Procaspase 3 Activators	Oc1c(CC=C)cccc1\C=N\NC(=O)CN2CCN(Cc3ccccc3)CC2	315183-21-2	14157	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469582	392.49402	PAC-1	PAC-1 | PAC-1	Pathway: Apoptosis; Autophagy	Research Area: Cancer	MOABOX:898	CASP3	Apoptosis Inducers;Procaspase 3 Activators
SJ000518968-25	SJ000518968	25	MOABOX:908	GXJABQQUPOEUTA-RDJZCZTQSA-N	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O	179324-69-7	Proteasome inhibitor;Proteasome Inhibitors;Apoptosis Inducers;Caspase 3 Activators;NF-kappaB (NFKB) Activation Inhibitors	CASP3	CTRB1	PSMA1	PSMA2	PSMA3	PSMA4	PSMA5	PSMA6	PSMA7	PSMB1	PSMB2	PSMB3	PSMB4	PSMB5	PSMB6	PSMB7	PSMB8	PSMB9	PSMB10	PSMC3	PSMC5	PSMD1	PSMD2	PSMD3	PSMD4	PSMD7	PSMD8	PSMD11	PSMD13	CTRC	PSMB11	PSMA8	1504	5682	5683	5684	5685	5686	5687	5688	5689	5690	5691	5692	5693	5694	5695	5696	5698	5699	5702	5705	5707	5708	5709	5710	5713	5714	5717	5719	11330	122706	143471	CHEMBL325041											387447	11621761	11621932	24755625	24768578	virtual	10.1016/j.bmc.2016.04.005	10.1016/j.bmc.2018.06.020	10.1016/j.ejmech.2018.01.045	10.1038/nchembio.779	10.1073/pnas.1806109115																																																																																																																																																											9871680	12647314	17849483	19348473	20875739	22711801	22978849	23151134	23181576	23531219	23547757	23639651	24524217	24561716	24767818	24946214	26965867	27112450	27117691	27769033	27994734	28182990	28441582	28634039	28642029	29407987	29934218	30373366	30611983	30639896	31283222																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							3.216e-002	3.216e-002	3.216e-002	3.216e-002	3.216e-002	3.216e-002	-9.192e-002	3.216e-002	-0.16328	-0.48	-0.3544	3.216e-002	4.472e-002	0.68472	3.216e-002	3.216e-002	0.16288	0.16776	6.48e-003	0.52392	0.52392	0.52392	0.52392	0.52392	0.52392	0.52392	0.52392	0.52392	0.52392	-0.48096	2.814e-002	2.814e-002	0.00402	0.00402	0.00402	0.00402	0.00402	0.00402	-0.01149	0.00402	-0.02041	-0.06	-0.0443	0.00402	0.00559	0.08559	0.00402	0.00402	0.02036	0.02097	0.00081	0.06549	0.06549	0.06549	0.06549	0.06549	0.06549	0.06549	0.06549	0.06549	0.06549	-0.06012	0.00402	0.00402	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	7	7	HY-10227	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Metabolic Enzyme/Protease; NF-?B | Research Area: Cancer|MOABOX:908|CASP3|Proteasome inhibitor;Proteasome Inhibitors;Apoptosis Inducers;Caspase 3 Activators;NF-kappaB (NFKB) Activation Inhibitors	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O	179324-69-7	26341	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469074	384.2372	BORTEZOMIB	"BORTEZOMIB | ""BORTEZOMIB | DPBA | JNJ-26866138 | LDP-341 | MLN-341 | NSC-681239 | PS-341 | VELCADE"" | BORTEZOMIB (PS-341) | BORTEZOMIB | ""BORTEZOMIB | DPBA | JNJ-26866138 | LDP-341 | MLN-341 | NSC-681239 | PS-341 | VELCADE"" | BORTEZOMIB (PS-341)"	Pathway: Apoptosis; Autophagy; Metabolic Enzyme/Protease; NF-?B	Research Area: Cancer	MOABOX:908	CASP3	Proteasome inhibitor;Proteasome Inhibitors;Apoptosis Inducers;Caspase 3 Activators;NF-kappaB (NFKB) Activation Inhibitors
SJ001035316-1	SJ001035316	1	MOABOX:910	HUWWIHVYVDAXCT-UHFFFAOYSA-N	N#Cc1nc2c(nc1C#N)-c1ccccc1C2=O	40114-84-9	Caspase 3 Inhibitors;Ubiquitin Carboxyl-terminal Hydrolase Inhibitors;Cathepsin B Inhibitors	CASP3	CTSB	USP8																														1508	9101																																									292929	143406781				virtual	10.1002/cmdc.200900409																																																																																																																																																															20186914																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0																														0.0	0.0	0.0																														7	7	7																														HY-32247	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: | Research Area: |MOABOX:910|CASP3|Caspase 3 Inhibitors;Ubiquitin Carboxyl-terminal Hydrolase Inhibitors;Cathepsin B Inhibitors	O=C1c2ccccc2c3nc(C#N)c(nc13)C#N	40114-84-9	62740	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469556	232.19706	"9-OXO-9H-INDENO[1,2-B]PYRAZINE-2,3-DICARBONITRILE"	"9-OXO-9H-INDENO[1,2-B]PYRAZINE-2,3-DICARBONITRILE | 9-OXO-9H-INDENO[1,2-B]PYRAZINE-2,3-DICARBONITRILE"	Pathway:	Research Area:	MOABOX:910	CASP3	Caspase 3 Inhibitors;Ubiquitin Carboxyl-terminal Hydrolase Inhibitors;Cathepsin B Inhibitors
SJ000285232-33	SJ000285232	33	MOABOX:912	YJGVMLPVUAXIQN-HAEOHBJNSA-N	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC	118627-04-6	CASP3 activator;apoptosis inhibitor;IGF1R inhibitor;IGF-1R Inhibitors;Caspase 3 Activators;Apoptosis Inducers	CASP3	IGF1R																															3480																															CHEMBL283120											72435	56967273	68740894			member	10.1158/0008-5472.CAN-03-2522	10.3390/cells7090131																																																																																																																																																														14729630	22571659																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	2.72048																															0.0	0.34006																															7	8																															T6943	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-665-514|MOABOX:912|CASP3|CASP3 activator;apoptosis inhibitor;IGF1R inhibitor;IGF-1R Inhibitors;Caspase 3 Activators;Apoptosis Inducers	COc1cc(cc(OC)c1OC)[C@H]2[C@H]3[C@H](COC3=O)[C@@H](O)c4cc5OCOc5cc24	477-47-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468583	414.40528	PODOFILOX	"PODOFILOX | PICROPODOPHYLLOTOXIN | PODOPHYLLOTOXIN | NSC-36407 | JMUS PD | ""PODOPHYLLOTOXIN | PODOFILOX |"" | PODOFILOX | PICROPODOPHYLLOTOXIN | PODOPHYLLOTOXIN | NSC-36407 | JMUS PD | ""PODOPHYLLOTOXIN | PODOFILOX |"""			MOABOX:912	CASP3	CASP3 activator;apoptosis inhibitor;IGF1R inhibitor;IGF-1R Inhibitors;Caspase 3 Activators;Apoptosis Inducers
SJ000285232-32	SJ000285232	32	MOABOX:912	YJGVMLPVUAXIQN-HAEOHBJNSA-N	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC	118627-04-6	CASP3 activator;apoptosis inhibitor;IGF1R inhibitor;IGF-1R Inhibitors;Caspase 3 Activators;Apoptosis Inducers	CASP3	IGF1R																															3480																															CHEMBL283120											72435	56967273	68740894			member	10.1158/0008-5472.CAN-03-2522	10.3390/cells7090131																																																																																																																																																														14729630	22571659																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	2.72048																															0.0	0.34006																															7	8																															KS-1281	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1cc(cc(OC)c1OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](O)c4cc5OCOc5cc24	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466727	414.40528	PODOFILOX	"PODOFILOX | PICROPODOPHYLLOTOXIN | PODOPHYLLOTOXIN | NSC-36407 | JMUS PD | ""PODOPHYLLOTOXIN | PODOFILOX |"" | PODOFILOX | PICROPODOPHYLLOTOXIN | PODOPHYLLOTOXIN | NSC-36407 | JMUS PD | ""PODOPHYLLOTOXIN | PODOFILOX |"""			MOABOX:912	CASP3	CASP3 activator;apoptosis inhibitor;IGF1R inhibitor;IGF-1R Inhibitors;Caspase 3 Activators;Apoptosis Inducers
SJ000755124-5	SJ000755124	5	MOABOX:914	ZGLXUQQMLLIKAN-SVIJTADQSA-N	COc1cc([C@@H]2c3cc4c(cc3C[C@H]3COC(=O)[C@@H]32)OCO4)cc(OC)c1OC	100348-38-7	Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs;Angiogenesis Inhibitors	CASP3	PTGS2																															5743																															CHEMBL63970											345501					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															CFN99888	CHEMFACES	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-220-685|MOABOX:914|CASP3|Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs;Angiogenesis Inhibitors	COc1cc(cc(OC)c1OC)[C@H]2[C@@H]3[C@H](COC3=O)Cc4cc5OCOc5cc24	19186-35-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468416	398.40588	(-)-DEOXYPODOPHYLLOTOXIN | QL-1-64B	"""(-)-DEOXYPODOPHYLLOTOXIN | QL-1-64B"" | ""DEOXYPODOPHYLLOTOXIN | QL-1-64B |"" | ""DEOXYPODOPHYLLOTOXIN | JP-D |"" | ""(-)-DEOXYPODOPHYLLOTOXIN | QL-1-64B"" | ""DEOXYPODOPHYLLOTOXIN | QL-1-64B |"" | ""DEOXYPODOPHYLLOTOXIN | JP-D |"""			MOABOX:914	CASP3	Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs;Angiogenesis Inhibitors
SJ000287137-11	SJ000287137	11	MOABOX:916	RZEKVGVHFLEQIL-UHFFFAOYSA-N	Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1	169590-42-5	"Cyclooxygenase-2 Inhibitors;Angiogenesis Inhibitors;""Cyclooxygenase-2 Inhibitors;Angiogenesis Inhibitors"""	PTGS2	SC5D	CASP3																														6309	836																														CHEMBL118											2662	9808243	9809217	9868827	9870677	virtual	10.1002/(SICI)1098-1128(199905)19:3<199::AID-MED1>3.0.CO;2-7	10.1002/ardp.200500178	10.1002/ardp.201400219	10.1002/ardp.201500274	10.1002/ardp.201600386	10.1002/ardp.201700093	10.1002/ardp.201700311	10.1002/ardp.201800008	10.1002/cmdc.201100393	10.1002/cmdc.201100460	10.1002/cmdc.201300355	10.1002/jhet.3118	10.1002/med.20182	10.1016/S0223-5234(02)01336-3	10.1016/S0960-894X(00)00329-2	10.1016/S0960-894X(01)00800-9	10.1016/S0960-894X(01)00825-3	10.1016/S0960-894X(03)00046-5	10.1016/S0960-894X(03)00282-8	10.1016/S0960-894X(98)00627-1	10.1016/S0960-894X(99)00157-2	10.1016/S0960-894X(99)00288-7	10.1016/S0960-894X(99)00365-0	10.1016/S0960-894X(99)00559-4	10.1016/S0960-894X(99)00560-0	10.1016/j.bcp.2008.06.025	10.1016/j.bioorg.2014.05.004	10.1016/j.bioorg.2018.06.036	10.1016/j.bioorg.2018.07.007	10.1016/j.bioorg.2019.02.031	10.1016/j.bioorg.2019.103132	10.1016/j.bmc.2004.01.033	10.1016/j.bmc.2004.01.037	10.1016/j.bmc.2004.08.008	10.1016/j.bmc.2006.03.023	10.1016/j.bmc.2006.08.024	10.1016/j.bmc.2007.06.030	10.1016/j.bmc.2007.11.033	10.1016/j.bmc.2008.07.058	10.1016/j.bmc.2009.05.046	10.1016/j.bmc.2010.04.034	10.1016/j.bmc.2011.04.050	10.1016/j.bmc.2012.02.021	10.1016/j.bmc.2013.01.058	10.1016/j.bmc.2013.04.074	10.1016/j.bmc.2013.12.008	10.1016/j.bmc.2014.02.032	10.1016/j.bmc.2016.11.037	10.1016/j.bmc.2017.06.027	10.1016/j.bmc.2017.08.039	10.1016/j.bmc.2018.01.007	10.1016/j.bmc.2018.06.038	10.1016/j.bmcl.2003.10.004	10.1016/j.bmcl.2003.10.027	10.1016/j.bmcl.2004.01.053	10.1016/j.bmcl.2004.07.089	10.1016/j.bmcl.2006.05.028	10.1016/j.bmcl.2006.06.036	10.1016/j.bmcl.2008.12.066	10.1016/j.bmcl.2009.02.085	10.1016/j.bmcl.2010.01.014	10.1016/j.bmcl.2010.06.022	10.1016/j.bmcl.2010.06.155	10.1016/j.bmcl.2010.12.023	10.1016/j.bmcl.2011.05.017	10.1016/j.bmcl.2012.01.093	10.1016/j.bmcl.2012.01.130	10.1016/j.bmcl.2012.06.012	10.1016/j.bmcl.2012.08.082	10.1016/j.bmcl.2012.10.131	10.1016/j.bmcl.2013.11.080	10.1016/j.bmcl.2014.02.074	10.1016/j.bmcl.2015.03.017	10.1016/j.bmcl.2015.04.085	10.1016/j.bmcl.2015.05.059	10.1016/j.bmcl.2015.10.047	10.1016/j.bmcl.2015.11.105	10.1016/j.bmcl.2016.06.037	10.1016/j.bmcl.2017.02.076	10.1016/j.ejmech.2005.03.016	10.1016/j.ejmech.2010.10.001	10.1016/j.ejmech.2011.10.029	10.1016/j.ejmech.2013.10.032	10.1016/j.ejmech.2013.12.033	10.1016/j.ejmech.2014.01.030	10.1016/j.ejmech.2014.02.033	10.1016/j.ejmech.2014.04.045	10.1016/j.ejmech.2015.04.044	10.1016/j.ejmech.2016.12.030	10.1016/j.ejmech.2017.08.046	10.1016/j.ejmech.2017.12.065	10.1016/j.ejmech.2019.02.034	10.1016/j.ejmech.2019.03.036	10.1016/j.ejmech.2019.111601	10.1016/j.fitote.2018.06.019	10.1016/j.fitote.2018.10.016	10.1016/j.jep.2019.111900	10.1021/acs.jmedchem.6b00134	10.1021/acs.jmedchem.6b01484	10.1021/jm0009383	10.1021/jm010458r	10.1021/jm010484p	10.1021/jm020563g	10.1021/jm030268b	10.1021/jm030765s	10.1021/jm0407761	10.1021/jm049480l	10.1021/jm0707525	10.1021/jm2001376	10.1021/jm200715n	10.1021/jm8015188	10.1021/jm900702b	10.1021/jm901269y	10.1021/jm960803q	10.1021/jm980642l	10.1021/jm990577v	10.1021/jm9906015	10.1021/jm990965x	10.1021/ml100232q	10.1021/ml400500e	10.1038/s41467-016-0009-6	10.1039/b402787f	10.1039/c3ob41935e	10.1039/c8cc08533a	10.1080/14756366.2016.1201815	10.1111/j.1745-7254.2005.00222.x	10.1124/jpet.104.070052	10.1124/jpet.104.076877	10.1248/bpb.32.1032	10.1248/cpb.55.64	10.1371/journal.pone.0139147	10.2174/0929867024606786	10.2174/092986710793205408	10.2174/092986711795328364	10.2174/1381612043453108	10.2174/1573406410666140815121613	10.2174/1573406414666180322091832																							9135032	9399978	9934449	10197970	10232649	10328307	10406640	10411562	10465547	10576684	10576685	10715145	10821716	10911017	10937738	11101350	11160644	11311743	11462976	11520200	11520213	11563921	11814774	11844666	11906281	11906292	11960669	11966448	12217369	12383007	12643942	12729631	12877584	12954051	14584938	14640557	14698190	14965322	15026050	15051057	15051061	15194006	15277581	15279593	15326524	15454242	15465334	15566290	15615524	15638729	15784239	15960895	15961192	16250658	16252917	16297351	16581252	16730986	16806914	16814546	16918460	16949828	17166726	17202703	17532544	17604631	17696334	17714833	17822894	17915854	17976864	17994684	18063374	18084318	18226898	18633528	18674517	18752957	18930406	19097798	19136259	19157881	19296694	19378317	19483310	19500994	19520573	19560931	19791801	19883244	19957931	19967720	20061161	20097072	20166930	20235539	20451397	20576432	20650641	20655211	20800934	20804197	20858219	20879982	20970223	21215625	21316237	21318094	21345672	21349729	21388719	21413808	21428878	21434686	21570308	21570309	21640445	21641217	21804236	21890358	21939759	21990143	21992176	22000948	22019186	22076641	22095955	22119153	22217871	22263894	22341941	22361134	22386983	22493984	22516282	22560838	22749420	22830349	23010270	23062711	23200247	23353741	23473947	23528298	23670888	23680444	23703900	23706267	23734609	23769654	24006310	24211633	24295787	24332492	24361187	24373735	24376205	24440378	24531199	24576797	24602792	24607877	24631365	24631898	24650702	24656662	24745964	24751552	24763362	24780593	24836072	24900871	24934992	24983538	25016229	25147154	25219899	25221653	25444084	25549551	25629725	25819096	25866240	25956953	25980909	26081289	26122769	26204057	26316467	26455657	26546221	26638042	26691756	26774035	26867188	26898334	26999325	27019010	27025563	27325447	27344214	27349331	27447606	27567369	27658794	27837994	27916468	28038322	28057407	28089698	28284805	28427813	28475316	28610982	28669741	28720504	28881288	28891941	28916158	29031075	29289887	29373271	29903990	29980364	30031652	30095904	30149323	30216848	30293795	30388842	30771604	30818268	30877972	30904755	30928706	30928709	31052167	31064095	31244108																																																																																																																																																																																																																																																																																																																							0	3.77664	1.26616																														0.0	0.47208	0.18088																														7	8	7																														HY-14398	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Inflammation/Immunology; Cancer|MOABOX:916|PTGS2|Cyclooxygenase-2 Inhibitors;Angiogenesis Inhibitors;\Cyclooxygenase-2 Inhibitors;Angiogenesis Inhibitors\	Cc1ccc(cc1)c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)(F)F	169590-42-5	19552	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468909	381.37217	CELECOXIB	CELECOXIB | CELEBREX | CELECOXIB | CELEBREX	Pathway: Immunology/Inflammation	Research Area: Inflammation/Immunology; Cancer	MOABOX:916	PTGS2	Cyclooxygenase-2 Inhibitors;Angiogenesis Inhibitors;\Cyclooxygenase-2 Inhibitors;Angiogenesis Inhibitors\
SJ000312311-9	SJ000312311	9	MOABOX:918	VDHAWDNDOKGFTD-MRXNPFEDSA-N	C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12	1025064-29-2	Calcium-Sensing Receptor (CaSR) Agonists	CASR																																																															CHEMBL1200776	CHEMBL1201284										156418	156419	11201833	25174135	25197204	member	10.1039/c2ob26402a	10.1124/jpet.103.057273																																																																																																																																																														18220738	19557759	20727747	22940747	23465611	29724589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.21152																																0.15144																																8																																AG00I787	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-028-751-552|MOABOX:918|CASR|Calcium-Sensing Receptor (CaSR) Agonists	C[C@@H](NCCCc1cccc(c1)C(F)(F)F)c2cccc3ccccc23	364782-34-3	NA	GENERAL	CHLORIDE	1	H2O	1	1468669	357.41199	CINACALCET	"CINACALCET | SENSIPAR | ""AMG-073 | KRN-1493 | NPS-1493 |"" | CINACALCET HCL | CINACALCET | SENSIPAR | ""AMG-073 | KRN-1493 | NPS-1493 |"" | CINACALCET HCL"			MOABOX:918	CASR	Calcium-Sensing Receptor (CaSR) Agonists
SJ001035179-1	SJ001035179	1	MOABOX:926	RXVZJHDMMKTKDR-UHFFFAOYSA-N	C#CCOc1ccc2c(c1)c(-c1ccc(C(C)C)cc1)nc(=O)n2C(C)C	478963-79-0	Calcium-Sensing Receptor (CaSR) Antagonists;Parathyroid Hormone Secretion Stimulants	CASR																																																															CHEMBL592176											10109178					member	10.1021/jm901811v																																																																																																																																																															20158186																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.64104																																0.45513																																8																																HY-50713	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Others|MOABOX:926|CASR|Calcium-Sensing Receptor (CaSR) Antagonists;Parathyroid Hormone Secretion Stimulants	CC(C)N1C(=O)N=C(c2ccc(cc2)C(C)C)c3cc(OCC#C)ccc13	478963-79-0	606	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469006	360.44886	CALCIUM-SENSING RECEPTOR ANTAGONISTS I	CALCIUM-SENSING RECEPTOR ANTAGONISTS I | CALCIUM-SENSING RECEPTOR ANTAGONISTS I	Pathway: GPCR/G Protein	Research Area: Others	MOABOX:926	CASR	Calcium-Sensing Receptor (CaSR) Antagonists;Parathyroid Hormone Secretion Stimulants
SJ000286104-6	SJ000286104	6	MOABOX:944	IEKOTSCYBBDIJC-UHFFFAOYSA-N	CCCCCN(CCCCC)C(=O)C(CCC(=O)O)NC(=O)c1ccc(Cl)c(Cl)c1	1021868-76-7	CCK1 (CCKA) Antagonists	CCKAR																																																															CHEMBL24938											3960	60148451	67896919	67896922	141489371	member	10.1177/1087057110369702	10.2174/092986709787549307	10.2174/156802607780960519																																																																																																																																																													17584143	19275595																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-3.112e-002																																-0.00389																																8																																HY-B1439B	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Metabolic Disease; Endocrinology|MOABOX:944|CCKAR|CCK1 (CCKA) Antagonists	CCCCCN(CCCCC)C(=O)C(CCC(=O)O)NC(=O)c1ccc(Cl)c(Cl)c1	1021868-76-7	87550	GENERAL	SODIUM(I)	1	NO_SOLVATE	0	1469710	459.40648	LORGLUMIDE SODIUM	LORGLUMIDE SODIUM | LORGLUMIDE SODIUM SALT | LORGLUMIDE SODIUM | LORGLUMIDE SODIUM SALT	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Metabolic Disease; Endocrinology	MOABOX:944	CCKAR	CCK1 (CCKA) Antagonists
SJ001034975-1	SJ001034975	1	MOABOX:946	NFHRQQKPEBFUJK-HSZRJFAPSA-N	CN1C(=O)[C@@H](NC(=O)c2cc3ccccc3[nH]2)N=C(c2ccccc2)c2ccccc21	103420-77-5	CCK1 (CCKA) Antagonists	CCKAR																																																															CHEMBL9506											443375	9853054	69722476	134210415		member	10.1002/1097-0282(2000)56:2<55::AID-BIP1052>3.0.CO;2-M	10.1006/bbrc.1993.1610	10.1006/bbrc.1993.1894	10.1006/bbrc.1995.2206	10.1074/jbc.270.10.5019	10.1124/jpet.108.141572	10.1124/mol.114.095430	10.2174/156802607780960519																																																																																																																																																								2848124	7837233	8340909	9722499	15765098	16570921	17584143	17933530	18588282	21728335																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												0.96736																																0.12092																																8																																CS-0025544	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-871|MOABOX:946|CCKAR|CCK1 (CCKA) Antagonists	CN1C(=O)[C@@H](NC(=O)c2cc3ccccc3[nH]2)N=C(c4ccccc4)c5ccccc15	103420-77-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468414	408.4519	DEVAZEPIDE	DEVAZEPIDE | DEVAZEPIDE			MOABOX:946	CCKAR	CCK1 (CCKA) Antagonists
SJ001034916-1	SJ001034916	1	MOABOX:948	KDFQABSFVYLGPM-QFIPXVFZSA-N	Cc1cccc(NC(=O)N[C@@H]2N=C(c3ccccc3)c3ccccc3N(C)C2=O)c1	118101-09-0	CCK2 (CCKB/Gastrin) Antagonists	CCKBR																																																															CHEMBL9387											5311201					member	10.1038/362348a0	10.1074/jbc.270.10.5019	10.1248/cpb.47.755	10.2174/138955710791112532	10.2174/156802607780960519																																																																																																																																																											2016728	2299627	2909725	7837233	7966138	8145219	8277510	8340909	8421283	8632408	9258356	9397166	9397175	9722499	11020274	12477342	16220969	16570921	17584143	19113864	20380639																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	2.17248																																0.27156																																8																																2767	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-729-072|MOABOX:948|CCKBR|CCK2 (CCKB/Gastrin) Antagonists	CN1C(=O)[C@H](NC(=O)Nc2cccc(C)c2)N=C(c3ccccc3)c4ccccc14	118101-09-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468227	398.45708	"L-365,260"	"L-365,260 | L-365,260"			MOABOX:948	CCKBR	CCK2 (CCKB/Gastrin) Antagonists
SJ000285463-8	SJ000285463	8	MOABOX:950	DGMKFQYCZXERLX-UHFFFAOYSA-N	CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1	24485-90-3	CCK2 (CCKB/Gastrin) Antagonists	CCKBR																																																															CHEMBL316561											4922	11410827	20244109	67832412	67893229	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.73556																																-0.10508																																7																																KS-1212	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466713	334.41004	PROGLUMIDE	PROGLUMIDE | PROGLUMIDE			MOABOX:950	CCKBR	CCK2 (CCKB/Gastrin) Antagonists
SJ000312388-9	SJ000312388	9	MOABOX:952	GXPHKUHSUJUWKP-UHFFFAOYSA-N	Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2	97322-87-7	Insulin Sensitizers;PPARgamma Agonists;CCL2 Expression Inhibitors;EGR1 Expression Enhancers	PPARG	CCL2																															6347																															CHEMBL408											5591	9808967	9832395	9854063	9872854	member	10.1006/bbrc.2000.3868	10.1016/j.ejphar.2004.05.020																																																																																																																																																														9836620	10612594	10691680	11831892	12570700	15003718	15379708	15715931	16454728	16650995	18951882	21493073	21800856	22242855	22342624	22381047	22424300	22512587	22579420	23031596	23207631	23910984	26048793	29398443	30352713	30429097																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												4.60472	0																															0.57559	0.0																															8	7																															HY-50935	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:952|PPARG|Insulin Sensitizers;PPARgamma Agonists;CCL2 Expression Inhibitors;EGR1 Expression Enhancers	Cc1c(C)c2OC(C)(COc3ccc(CC4SC(=O)NC4=O)cc3)CCc2c(C)c1O	97322-87-7	9730	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469516	441.53988	TROGLITAZONE	"TROGLITAZONE | ""TROGLITAZONE | 5-(4-((6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-YL)METHOXY)BENZYL)THIAZOLIDINE-2,4-DIONE"" | TROGLITAZONE | ""TROGLITAZONE | 5-(4-((6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-YL)METHOXY)BENZYL)THIAZOLIDINE-2,4-DIONE"""	Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:952	PPARG	Insulin Sensitizers;PPARgamma Agonists;CCL2 Expression Inhibitors;EGR1 Expression Enhancers
SJ000312176-10	SJ000312176	10	MOABOX:954	KDKUVYLMPJIGKA-UHFFFAOYSA-N	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F	443797-96-4	Antimitotic Drugs;Apoptosis Inducers;Aurora Kinase Inhibitors;CDK1/Cyclin B Inhibitors;CDK2/Cyclin A Inhibitors;Inhibitors of Signal Transduction Pathways	CDK1	CDK2	AURKA	CCNA1																													1017	6790	8900																													CHEMBL191003											5330790	11201266	11213662	11386334	11752195	member	10.1021/jm050267e	10.1158/0008-5472.CAN-05-0882	10.2174/092986709788682227																																																																																																																																																													15853645	15974571	16204078	16682186	18183025	19519375	21517772	23937569	27391133	30091915	30234987																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											0.74312	0.62136	1.34904	1.50952																													0.09289	0.07767	0.16863	0.18869																													8	8	8	8																													HY-10329	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:954|CDK1|Antimitotic Drugs;Apoptosis Inducers;Aurora Kinase Inhibitors;CDK1/Cyclin B Inhibitors;CDK2/Cyclin A Inhibitors;Inhibitors of Signal Transduction Pathways	Nc1nc(Nc2ccc(cc2)S(=O)(=O)N)nn1C(=O)c3c(F)cccc3F	443797-96-4	43173	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469783	394.35599	AURORA KINASE/CDK INHIBITOR	"AURORA KINASE/CDK INHIBITOR | JNJ-7706621 | ""AURORA KINASE/CDK INHIBITOR | 4-(5-AMINO-1-(2,6-DIFLUOROBENZOYL)-1H-1,2,4-TRIAZOL-3-YLAMINO)BENZENESULFONAMIDE |"" | ""JNJ-7706621 | RWJ-387252 |"" | AURORA KINASE/CDK INHIBITOR | JNJ-7706621 | ""AURORA KINASE/CDK INHIBITOR | 4-(5-AMINO-1-(2,6-DIFLUOROBENZOYL)-1H-1,2,4-TRIAZOL-3-YLAMINO)BENZENESULFONAMIDE |"" | ""JNJ-7706621 | RWJ-387252 |"""	Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:954	CDK1	Antimitotic Drugs;Apoptosis Inducers;Aurora Kinase Inhibitors;CDK1/Cyclin B Inhibitors;CDK2/Cyclin A Inhibitors;Inhibitors of Signal Transduction Pathways
SJ001034950-1	SJ001034950	1	MOABOX:966	HQHSJJZIICGOIX-UHFFFAOYSA-N	Nc1nccc(-c2c[nH]c3ncccc23)n1	341998-55-8	CDK inhibitors	CDK2	CDK9	DYRK1A	CCNA1	CCNB2	ROCK2	CCNB3																										1025	1859	8900	9133	9475	85417																										CHEMBL405665											11637090					member	10.1021/jm700940h	10.1158/0008-5472.CAN-07-1826																																																																																																																																																														17804748	18232649	21534931	23016545	27171036	29144137																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.68584	0.92296	0.40752	0.36704	-0.21168	0.42456	-0.21168																										0.08573	0.11537	0.05094	0.04588	-0.03024	0.05307	-0.03024																										8	8	8	8	7	8	7																										BD331336	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-035-777-204|MOABOX:966|CDK2|CDK inhibitors	Nc1nccc(n1)c2c[nH]c3ncccc23	341998-55-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468343	211.22266	BD331336	BD331336 | BD331336			MOABOX:966	CDK2	CDK inhibitors
SJ000287758-9	SJ000287758	9	MOABOX:968	UTBSBSOBZHXMHI-CABCVRRESA-N	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CCCC[C@H]3N)nc21		CDK inhibitor	CDK1	CDK2	CCNA1	CCNB2	CCNB3																												1017	8900	9133	85417																																							9908173	20846166				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.75584	1.38999	0	0	0																												0.09448	0.19857	0.0	0.0	0.0																												8	7	7	7	7																												5472	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-338-057|MOABOX:968|CDK1|CDK inhibitor	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]4CCCC[C@@H]4N)nc12	NA	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468219	385.89376	CGP-74514A HYDROCHLORIDE	"CGP-74514A HYDROCHLORIDE | CDK1 INHIBITOR, CGP74514A | CGP-74514A | CGP-74514A HYDROCHLORIDE | CDK1 INHIBITOR, CGP74514A | CGP-74514A"			MOABOX:968	CDK1	CDK inhibitor
SJ000288178-16	SJ000288178	16	MOABOX:970	BTIHMVBBUGXLCJ-OAHLLOKOSA-N	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1	186692-46-6	CDK inhibitors	CDK2	CDK5R1	CCNA1	CCNB2	CCNE2	CCNB3																											8851	8900	9133	9134	85417																											CHEMBL14762											160355	9917040	16750140	86636851	143981768	member	10.1016/S0223-5234(03)00065-5	10.1016/S0960-894X(00)00014-7	10.1016/j.bbrc.2008.11.077	10.1016/j.bioorg.2018.06.010	10.1016/j.bmc.2005.06.007	10.1016/j.bmc.2011.08.051	10.1016/j.bmcl.2004.12.073	10.1016/j.bmcl.2009.10.025	10.1016/j.bmcl.2012.10.141	10.1016/j.chembiol.2004.02.001	10.1016/j.ejmech.2009.12.026	10.1016/j.ejmech.2011.09.041	10.1016/j.ejmech.2012.06.036	10.1016/j.ejmech.2012.08.033	10.1016/j.ejmech.2013.07.003	10.1021/jm001043t	10.1021/jm200064p	10.1021/jm801340z	10.1021/ml3002083	10.1038/onc.2008.191	10.1042/BJ20021535	10.1042/BJ20070797	10.1124/mol.109.060327	10.1158/0008-5472.CAN-09-0301	10.1158/1535-7163.MCT-08-0080	10.1523/JNEUROSCI.4629-12.2013	10.2174/0929867003374048																																																																																																																																					10633033	10743948	10753466	11170642	11909733	12036347	12392733	15026054	15689152	15958589	16584130	17850214	17981370	18313174	18656911	18680271	19128055	19846305	19854650	21080703	21144757	21353545	21417417	21420204	21982796	22000924	22770608	22982525	23063566	23218601	23252711	23301767	23399722	23829517	23927974	23933045	24417566	24681986	24936234	24998602	25757603	26741853	26851505	27189674	28557430																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									2.0904	0.46949	0.32137	0.10262	8.96e-002	0.10262																											0.2613	0.06707	0.04591	0.01466	0.0128	0.01466																											8	7	7	7	7	7																											HY-30237	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:970|CDK2|CDK inhibitors	CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1	186692-46-6	17817	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468884	354.44934	ROSCOVITINE	"ROSCOVITINE | (R)-ROSCOVITINE | SELICICLIB | NSC-701554 | CYC-202 | ""ROSCOVITINE | SELICICLIB |"" | ROSCOVITINE (SELICICLIB,CYC202) | ROSCOVITINE | (R)-ROSCOVITINE | SELICICLIB | NSC-701554 | CYC-202 | ""ROSCOVITINE | SELICICLIB |"" | ROSCOVITINE (SELICICLIB,CYC202)"	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:970	CDK2	CDK inhibitors
SJ000288106-7	SJ000288106	7	MOABOX:972	PMXCMJLOPOFPBT-HNNXBMFYSA-N	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1	212844-53-6	CDK1/Cyclin B Inhibitors;CDK2/Cyclin A Inhibitors;CDK2/Cyclin E Inhibitors;CDK4/Cyclin D1 Inhibitors;CDK5 Inhibitors;Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase (DYRK) Inhibitors	CHUK	CCNA1	CCNB2	CCNE2	CCNB3																												8900	9133	9134	85417																												CHEMBL23327											456214					member																																																																																																																																																																10753466	11032968	11607930	12036347	12171570	12392733	12534346	12678910	14754453	16492148	17850214	19128055	21517772	21523912	23016545	23218601	27643641	30091915																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.23688	-4.064e-002	1.19064	0.6628	1.19064																												0.03384	-0.00508	0.14883	0.08285	0.14883																												7	8	8	8	8																												HY-18299A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:972|CHUK|CDK1/Cyclin B Inhibitors;CDK2/Cyclin A Inhibitors;CDK2/Cyclin E Inhibitors;CDK4/Cyclin D1 Inhibitors;CDK5 Inhibitors;Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase (DYRK) Inhibitors	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c3ncn(C(C)C)c3n1	212844-53-6	15672	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469642	388.8944	PURVALANOL A	"PURVALANOL A | ""PURVALANOL A | NG-60 |"" | PURVALANOL A | ""PURVALANOL A | NG-60 |"""	Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:972	CHUK	CDK1/Cyclin B Inhibitors;CDK2/Cyclin A Inhibitors;CDK2/Cyclin E Inhibitors;CDK4/Cyclin D1 Inhibitors;CDK5 Inhibitors;Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase (DYRK) Inhibitors
SJ000574279-12	SJ000574279	12	MOABOX:978	BIIVYFLTOXDAOV-YVEFUNNKSA-N	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1	131740-09-5	CDK9 inhibitor	CDK9	CCNB2																															9133																															CHEMBL2105698	CHEMBL428690										5287969	9910986	9935025	53341035	67107845	virtual	10.1158/1535-7163.MCT-08-0836																																																																																																																																																															10633033	11032968	12190313	12593668	12643928	15125971	15559249	15689157	15780638	16250643	16641271	18183025	18423896	18469809	19275730	19568282	19601848	20638755	21143121	21354673	21517772	22037378	23252711	24417566	24742150	25914804	27171036	29144137	29191878	29370702																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								2.04472	0.42416																															0.25559	0.05302																															8	8																															HY-10006	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Autophagy; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:978|CDK9|CDK9 inhibitor	CN1CC[C@@H]([C@H](O)C1)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccccc4Cl	131740-09-5	5427	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469148	401.8402	ALVOCIDIB	"ALVOCIDIB | ""FLAVOPIRIDOL | HMR-1275 | L868275 | HL-275 | MDL-107826A | NSC-649890"" | FLAVOPIRIDOL HCL | ALVOCIDIB | ""FLAVOPIRIDOL | HMR-1275 | L868275 | HL-275 | MDL-107826A | NSC-649890"" | FLAVOPIRIDOL HCL"	Pathway: Anti-infection; Autophagy; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:978	CDK9	CDK9 inhibitor
SJ001035121-1	SJ001035121	1	MOABOX:990	WYQIPCUPNMRAKP-UHFFFAOYSA-O	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21	114719-57-2	CDK6 Inhibitors;DNA-Intercalating Drugs;CDK4/Cyclin D1 Inhibitors;CDC25B Inhibitors	CCND1	CDK4	CDK6																														1019	1021																														CHEMBL258765	CHEMBL602937										73292	73293	11057252	71311597		member	10.1016/j.bmc.2008.07.002	10.1016/j.bmc.2009.06.070	10.1016/j.chembiol.2004.03.022	10.3390/md16100383																																																																																																																																																												15123247	16441060	16493461	16750360	16904725	17268643	18650093	19632122	19929781	21143121	22512549	25368960	26560048	26569265	26741853	30322180	30665142																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.856	1.33616	0.10664																														0.107	0.16702	0.01333																														8	8	8																														F2167-9960	LIFE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-016-580-773|MOABOX:990|CCND1|CDK6 Inhibitors;DNA-Intercalating Drugs;CDK4/Cyclin D1 Inhibitors;CDC25B Inhibitors	O=C1c2ccccc2[n+]3ccc4c5ccccc5[nH]c4c13	114719-57-2	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468730	271.29274	F2167-9960	F2167-9960 | F2167-9960			MOABOX:990	CCND1	CDK6 Inhibitors;DNA-Intercalating Drugs;CDK4/Cyclin D1 Inhibitors;CDC25B Inhibitors
SJ000786028-5	SJ000786028	5	MOABOX:992	QMGUOJYZJKLOLH-UHFFFAOYSA-N	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21	133052-90-1	CDK4/Cyclin D1 Inhibitors;Leucine-Rich Repeat Kinase 2 (LRRK2;Dardarin) Inhibitors;Protein Kinase C (PKC) Inhibitors	CCND1	CDK4	PRKCG	PRKCH	PRKCI	PRKCZ	RPS6KA1	RPS6KA2	RPS6KA3	RPS6KB2	LRRK2																						1019	5582	5583	5584	5590	6195	6196	6197	6199	120892																						CHEMBL7463											2396	6419775	129848328			member	10.1021/bi061128h																																																																																																																																																															7473193	14552792	15806113	15821757	16297374	16332251	17875639	18473812	18855572	19827831	23651307																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											-0.37448	-0.37448	0.432	0.51848	0.46256	0.24584	-0.26796	-7.168e-002	-8.176e-002	-0.19033	-0.4438																						-0.04681	-0.04681	0.054	0.06481	0.05782	0.03073	-0.03828	-0.01024	-0.01022	-0.02719	-0.0634																						8	8	8	8	8	8	7	7	8	7	7																						HY-13867	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics; TGF-beta/Smad | Research Area: Metabolic Disease; Cancer|MOABOX:992|CCND1|CDK4/Cyclin D1 Inhibitors;Leucine-Rich Repeat Kinase 2 (LRRK2;Dardarin) Inhibitors;Protein Kinase C (PKC) Inhibitors	CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15	133052-90-1	23241	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469332	412.48366	BISINDOLYMALEIMIDE I | GF 109203X | G-6850 | GOE-6850 |	"""BISINDOLYMALEIMIDE I | GF 109203X | G-6850 | GOE-6850 |"" | GO6850 | ""BISINDOLYMALEIMIDE I | GF 109203X | G-6850 | GOE-6850 |"" | GO6850"	Pathway: Epigenetics; TGF-beta/Smad	Research Area: Metabolic Disease; Cancer	MOABOX:992	CCND1	CDK4/Cyclin D1 Inhibitors;Leucine-Rich Repeat Kinase 2 (LRRK2;Dardarin) Inhibitors;Protein Kinase C (PKC) Inhibitors
SJ001034932-1	SJ001034932	1	MOABOX:994	QKRVSWPBAOCWHY-UHFFFAOYSA-N	CSc1ncc(C=O)c(NC2CCCC2)n1	211245-64-6	CDK inhibitors	CCND2	CCND3																															896																																										10799896					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.17621	1.17621																															0.16803	0.16803																															7	7																															AA002L66	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-005-942-805|MOABOX:994|CCND2|CDK inhibitors	CSc1ncc(C=O)c(NC2CCCC2)n1	211245-64-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468269	237.3213	AA002L66	AA002L66 | AA002L66			MOABOX:994	CCND2	CDK inhibitors
SJ001034949-1	SJ001034949	1	MOABOX:996	GHESWKCVPRIYLS-UHFFFAOYSA-N	O=[N+]([O-])c1ccc(N2CCCC(CO)C2)cc1	166438-83-1	CDK Inhibitors	CCND2	CCND3	CDK6																														896	1021																																									18375105	144806851				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.0514	1.0514	1.11153																														0.1502	0.1502	0.15879																														7	7	7																														BD212504	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-010-304-913|MOABOX:996|CCND2|CDK Inhibitors	OCC1CCCN(C1)c2ccc(cc2)[N+](=O)[O-]	166438-83-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468342	236.26704	BD212504	BD212504 | BD212504			MOABOX:996	CCND2	CDK Inhibitors
SJ001035088-1	SJ001035088	1	MOABOX:998	ZPGVLDQXMSGLHG-UHFFFAOYSA-N	Nc1ccc(N2CCCC(CO)C2)cc1	211247-50-6	CDK Inhibitors	CCND2	CCND3																															896																																										18375251					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.0787	1.0787																															0.1541	0.1541																															7	7																															BD00789245	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-012-119-736|MOABOX:998|CCND2|CDK Inhibitors	Nc1ccc(cc1)N2CCCC(CO)C2	211247-50-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468657	206.28412	BD00789245	BD00789245 | BD00789245			MOABOX:998	CCND2	CDK Inhibitors
SJ001034639-1	SJ001034639	1	MOABOX:1000	VDDZMXQAZJMGPK-UHFFFAOYSA-N	CCOC(=O)c1cnc(SC)nc1NC	76360-82-2	CDK Inhibitors	CCND2	CCND3																															896																																										295697					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.18083	1.18083																															0.16869	0.16869																															7	7																															7N-512S	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCOC(=O)c1cnc(SC)nc1NC	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466636	227.28342	7N-512S	7N-512S | 7N-512S			MOABOX:1000	CCND2	CDK Inhibitors
SJ001034638-1	SJ001034638	1	MOABOX:1002	RNPWPESLLCUROD-UHFFFAOYSA-N	O=[N+]([O-])c1ccc(N2CCC(O)CC2)cc1	79421-45-7	CDK Inhibitors	CCND2	CCND3																															896																																										613768					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.14639	1.14639																															0.16377	0.16377																															7	7																															5F-952	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC1CCN(CC1)c2ccc(cc2)[N+](=O)[O-]	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466635	222.24046	5F-952	5F-952 | 5F-952			MOABOX:1002	CCND2	CDK Inhibitors
SJ001034672-1	SJ001034672	1	MOABOX:1004	NXNGLEYSIAXGCL-UHFFFAOYSA-N	CNc1nc(SC)ncc1CO	17759-30-7	CDK Inhibitors	CCND2	CCND3																															896																																										10679092	142858869				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.18083	1.18083																															0.16869	0.16869																															7	7																															DS-2253	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CNc1nc(SC)ncc1CO	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466838	185.24674	DS-2253	DS-2253 | DS-2253			MOABOX:1004	CCND2	CDK Inhibitors
SJ001035357-1	SJ001035357	1	MOABOX:1006	QINRQIZOBCQKAZ-UHFFFAOYSA-N	CCOC(=O)c1cnc(SC)nc1N	776-53-4	CDK Inhibitors	CCND2	CCND3																															896																															CHEMBL1713273											222666	91895085	143180035	144339672		virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.13463	1.13463																															0.16209	0.16209																															7	7																															HY-W008025	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: | Research Area: |MOABOX:1006|CCND2|CDK Inhibitors	CCOC(=O)C1=CN=C(NC1=N)SC	776-53-4	99294	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469731	213.25684	ETHYL 4-AMINO-2-(METHYLTHIO)PYRIMIDIN-5-CARBOXYLATE	ETHYL 4-AMINO-2-(METHYLTHIO)PYRIMIDIN-5-CARBOXYLATE | ETHYL 4-AMINO-2-(METHYLTHIO)PYRIMIDIN-5-CARBOXYLATE	Pathway:	Research Area:	MOABOX:1006	CCND2	CDK Inhibitors
SJ001034892-1	SJ001034892	1	MOABOX:1010	MYJQMHHJSZBXNK-UHFFFAOYSA-N	CCOC(=O)c1cnc(SC)nc1NC1CCCC1	211245-62-4	CDK Inhibitors	CCND2	CCND3																															896																																										9151473					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.21898	1.21898																															0.17414	0.17414																															7	7																															WXCD00687914	WUXI_APPTECH	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-005-942-803|MOABOX:1010|CCND2|CDK Inhibitors	CCOC(=O)c1cnc(SC)nc1NC2CCCC2	211245-62-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468195	281.37386	WXCD00687914	WXCD00687914 | WXCD00687914			MOABOX:1010	CCND2	CDK Inhibitors
SJ001034832-1	SJ001034832	1	MOABOX:1012	PFDUBQQHEHJNQX-UHFFFAOYSA-N	CN(C)C1CCN(c2ccc(N)cc2)CC1	211247-62-0	CDK Inhibitors	CCND2	CCND3																															896																																										10889414	143125143	145414012			virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.12294	1.12294																															0.16042	0.16042																															7	7																															EN300-126026	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-012-114-703|MOABOX:1012|CCND2|CDK Inhibitors	CN(C)C1CCN(CC1)c2ccc(N)cc2	211247-62-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468073	219.32594	EN300-126026	EN300-126026 | EN300-126026			MOABOX:1012	CCND2	CDK Inhibitors
SJ001035359-1	SJ001035359	1	MOABOX:1014	XLVOWGDFXAVSFE-UHFFFAOYSA-N	CSc1ncc(CO)c(N)n1	588-36-3	CDK Inhibitors	CCND2	CCND3																															896																																										220531	144899628				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.18216	1.18216																															0.16888	0.16888																															7	7																															HY-W052931	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: | Research Area: |MOABOX:1014|CCND2|CDK Inhibitors	CSc1ncc(CO)c(N)n1	588-36-3	99303	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469733	171.22016	4-AMINO-5-HYDROXYMETHYL-2-(METHYLTHIO)PYRIMIDINE	4-AMINO-5-HYDROXYMETHYL-2-(METHYLTHIO)PYRIMIDINE | 4-AMINO-5-HYDROXYMETHYL-2-(METHYLTHIO)PYRIMIDINE	Pathway:	Research Area:	MOABOX:1014	CCND2	CDK Inhibitors
SJ001035237-1	SJ001035237	1	MOABOX:1016	WGUCZWYLSKPURM-UHFFFAOYSA-N	CNc1nc(SC)ncc1C=O	185040-32-8	CDK Inhibitors	CCND2	CCND3																															896																																										10607520	142923553	143260446			virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.18083	1.18083																															0.16869	0.16869																															7	7																															HY-W000299	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: | Research Area: |MOABOX:1016|CCND2|CDK Inhibitors	CNc1nc(SC)ncc1C=O	185040-32-8	99293	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469240	183.23086	4-(METHYLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBALDEHYDE	4-(METHYLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBALDEHYDE | 4-(METHYLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBALDEHYDE	Pathway:	Research Area:	MOABOX:1016	CCND2	CDK Inhibitors
SJ001035383-1	SJ001035383	1	MOABOX:1018	BJXPIIDUCADEKU-UHFFFAOYSA-N	Nc1ccc(N2CCC(O)CC2)cc1	142752-12-3	CDK Inhibitors	CCND2	CCND3																															896																																										16792107	73554182				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.9688	0.9688																															0.1384	0.1384																															7	7																															HY-W038299	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: | Research Area: |MOABOX:1018|CCND2|CDK Inhibitors	Nc1ccc(cc1)N2CCC(O)CC2	142752-12-3	42791	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469855	192.25754	1-(4-AMINOPHENYL)PIPERIDIN-4-OL	1-(4-AMINOPHENYL)PIPERIDIN-4-OL | 1-(4-AMINOPHENYL)PIPERIDIN-4-OL	Pathway:	Research Area:	MOABOX:1018	CCND2	CDK Inhibitors
SJ001034931-1	SJ001034931	1	MOABOX:1020	HKGVZNNJDXEJQC-UHFFFAOYSA-N	CSc1ncc(CO)c(NC2CCCC2)n1	211245-63-5	CDK Inhibitors	CCND2	CCND3																															896																																										10752510					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.18083	1.18083																															0.16869	0.16869																															7	7																															AA002L67	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-005-942-804|MOABOX:1020|CCND2|CDK Inhibitors	CSc1ncc(CO)c(NC2CCCC2)n1	211245-63-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468268	239.33718	AA002L67	AA002L67 | AA002L67			MOABOX:1020	CCND2	CDK Inhibitors
SJ001035200-1	SJ001035200	1	MOABOX:1022	RNYUFDKLBWLNCR-UHFFFAOYSA-N	CCn1c(=O)ccc2cnc(SC)nc21	211244-82-5	CDK Inhibitors	CCND2	CCND3																															896																																										10560946					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.11314	1.11314																															0.15902	0.15902																															7	7																															HY-79441	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: | Research Area: |MOABOX:1022|CCND2|CDK Inhibitors	CCN1C(=O)C=Cc2cnc(SC)nc12	211244-82-5	14272	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469056	221.27884	"8-ETHYL-2-METHANETHIO-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE"	"8-ETHYL-2-METHANETHIO-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE | 8-ETHYL-2-METHANETHIO-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE"	Pathway:	Research Area:	MOABOX:1022	CCND2	CDK Inhibitors
SJ001035202-1	SJ001035202	1	MOABOX:1034	XQYASZNUFDVMFH-CQSZACIVSA-N	C[C@@H]1CN(Cc2ccc(F)cc2)CCN1C(=O)COc1ccc(Cl)cc1NC(N)=O	217645-70-0	Chemokine CCR1 Antagonists	CCR1																																																															CHEMBL232656	CHEMBL535607										512282	5311124	69944960	69944961		member	10.1016/j.bmcl.2005.08.057	10.1016/j.bmcl.2007.03.104	10.1021/jm801416q	10.2174/1389557054867057	10.2174/156802610791561192																																																																																																																																																											12769747	16178722	16198561	16378503	16918451	17383873	17446072	19183043	20536422	20536425	22931505	30595446																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										4.68208																																0.58526																																8																																HY-12080	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation | Research Area: Inflammation/Immunology; Endocrinology|MOABOX:1034|CCR1|Chemokine CCR1 Antagonists	C[C@@H]1CN(Cc2ccc(F)cc2)CCN1C(=O)COc3ccc(Cl)cc3NC(=O)N	217645-70-0	13193	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469075	434.89166	BX471 | ZK-811752	"""BX471 | ZK-811752"" | ""BX471 | ZK-811752"""	Pathway: GPCR/G Protein; Immunology/Inflammation	Research Area: Inflammation/Immunology; Endocrinology	MOABOX:1034	CCR1	Chemokine CCR1 Antagonists
SJ001035092-1	SJ001035092	1	MOABOX:1036	DUFKTZBQJIHIAQ-VGZDNEPHSA-N	CC(=O)Nc1cc(Cl)ccc1/C=C/C(=O)N1CCN(Cc2ccc(F)cc2)C[C@H]1C	685534-25-2	Chemokine CCR1 Antagonists	CCR1																																																															CHEMBL198949											11743399	91826455				member	10.1016/B978-0-12-417150-3.00010-7	10.1016/j.bmcl.2005.08.057																																																																																																																																																														16198561																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.65																																0.45625																																8																																1179	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-665-663|MOABOX:1036|CCR1|Chemokine CCR1 Antagonists	C[C@@H]1CN(Cc2ccc(F)cc2)CCN1C(=O)\C=C\c3ccc(Cl)cc3NC(=O)C	685534-25-2	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468670	429.9149	A1B1 HCL	A1B1 HCL | A1B1 HCL			MOABOX:1036	CCR1	Chemokine CCR1 Antagonists
SJ001035050-1	SJ001035050	1	MOABOX:1064	QNKLFDFMOINNIW-UHFFFAOYSA-N	Cc1csc(Nc2cccc3ccccc23)n1	1957-01-3	Chemokine CCR4 Antagonists	CCR4																																																															CHEMBL1382364	CHEMBL383736										692856	16195899	49876588			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.62832																																0.32854																																8																																RDR01836	MAYBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-432-043|MOABOX:1064|CCR4|Chemokine CCR4 Antagonists	Cc1csc(Nc2cccc3ccccc23)n1	1957-01-03	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468553	240.32348	RDR01836	RDR01836 | RDR01836			MOABOX:1064	CCR4	Chemokine CCR4 Antagonists
SJ001035220-1	SJ001035220	1	MOABOX:1072	XNHZXMPLVSJQFK-UHFFFAOYSA-O	Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCC3)cc1	229005-80-5	Chemokine CXCR3 Antagonists;HIV Attachment Inhibitors;Chemokine CCR5 Antagonists	CCR5	CXCR3	CCR2																														2833	729230																														CHEMBL1178786	CHEMBL41275	CHEMBL64322									183789	183790	9873244	9873888	87456137	member	10.1002/(SICI)1098-1128(200003)20:2<155::AID-MED3>3.0.CO;2-G	10.1016/S0960-894X(00)00347-4	10.1016/j.bmc.2011.05.022	10.1016/j.bmcl.2006.07.011	10.1016/j.bmcl.2008.12.050	10.1016/j.bmcl.2011.07.058	10.1016/j.ejmech.2017.04.046	10.1021/jm0509703	10.1021/jm300682j	10.1021/jm9906264	10.1073/pnas.96.10.5698	10.1080/14756360290024227	10.1124/mol.107.042101	10.1128/JVI.79.4.2087-2096.2005	10.1248/cpb.52.254	10.1248/cpb.52.577	10.2174/156802610791561192																																																																																																																																															10723026	10821717	10969972	11206474	11931608	12420752	12788340	12871111	12954060	15133211	15193136	15579085	15892677	16539392	16611075	16719830	16870431	16918451	17627557	17715128	19237282	19640721	20156158	20536422	20536423	20536424	21128884	21227704	21820898	22931505	24217712	25766632	28463783	29805075																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.7892	-0.74921	4.72e-002																														0.47365	-0.10703	0.0059																														8	7	8																														HY-13406	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; GPCR/G Protein; Immunology/Inflammation | Research Area: Infection; Inflammation/Immunology; Endocrinology|MOABOX:1072|CCR5|Chemokine CXCR3 Antagonists;HIV Attachment Inhibitors;Chemokine CCR5 Antagonists	Cc1ccc(cc1)c2ccc3CCCC(=Cc3c2)C(=O)Nc4ccc(C[N+](C)(C)C5CCOCC5)cc4	229005-80-5	33400	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469170	495.67496	TAK-779 | TAKEDA 779	"""TAK-779 | TAKEDA 779"" | ""TAK-779 | TAKEDA 779"""	Pathway: Anti-infection; GPCR/G Protein; Immunology/Inflammation	Research Area: Infection; Inflammation/Immunology; Endocrinology	MOABOX:1072	CCR5	Chemokine CXCR3 Antagonists;HIV Attachment Inhibitors;Chemokine CCR5 Antagonists
SJ001034655-1	SJ001034655	1	MOABOX:1074	ZQGHKUXYQHDKBP-UHFFFAOYSA-N	CC(C)(C)c1ccc(S(=O)(=O)Nc2ccsc2C(=O)O)cc1	1111300-51-6	Chemokine CCR9 Receptor Antagonists	CCR9																																																																										44610603					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.61448																																0.32681																																8																																BS-3696	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc2ccsc2C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466758	339.42978	BS-3696	BS-3696 | BS-3696			MOABOX:1074	CCR9	Chemokine CCR9 Receptor Antagonists
SJ000855298-3	SJ000855298	3	MOABOX:1086	DKXHSOUZPMHNIZ-UHFFFAOYSA-N	O=C1NCCc2[nH]c(-c3ccncc3)cc21	845538-12-7	Inhibitors of Signal Transduction Pathways;Cell Division Cycle 7-Related Protein Kinase (CDC7) Inhibitors	CDC7																																																															CHEMBL225519											11715766	11715767	16719860	91594790		member																																																																																																																																																																18201066	18469809	19115845	20873740	28279847																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.83824																																0.22978																																8																																AA00GU6L	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-681|MOABOX:1086|CDC7|Inhibitors of Signal Transduction Pathways;Cell Division Cycle 7-Related Protein Kinase (CDC7) Inhibitors	O=C1NCCc2[nH]c(cc12)c3ccncc3	942425-68-5	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468271	213.23524	PHA-767491	PHA-767491 | PHA-767491			MOABOX:1086	CDC7	Inhibitors of Signal Transduction Pathways;Cell Division Cycle 7-Related Protein Kinase (CDC7) Inhibitors
SJ000285540-15	SJ000285540	15	MOABOX:1098	IENZQIKPVFGBNW-UHFFFAOYSA-N	COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC	19216-56-9	CDK1 Inhibitors;Apoptosis Inducers;ADRA1B antagonist	ADRA1B	CDK1																															983																															CHEMBL1347191	CHEMBL1558	CHEMBL2									4893	68546	134687	158073	657274	member																																																																																																																																																																2863377	2879919	2884316	2886664	7658428	7731013	7752182	8770394	8917649	9135028	9276013	9359081	9548811	9730228	9822553	9857099	9888842	10490890	10522703	10579841	10893315	10968279	11448222	12519065	12614894	14584940	15544485	15633998	16420037	17052252	17100639	17168713	17266603	17763374	17917257	21084390	21232965	21688779	21726069	21777010	23023262	23466604	23582449	24365159	26821136	27774138	28471663	28499171	28947942	29291438	29631962	29767967	30810314																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.304	0																															0.163	0.0																															8	7																															HY-B0193A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; GPCR/G Protein; Neuronal Signaling | Research Area: Cardiovascular Disease; Endocrinology; Cancer|MOABOX:1098|ADRA1B|CDK1 Inhibitors;Apoptosis Inducers;ADRA1B antagonist	COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4occc4	19237-84-4	15874	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469881	383.40114	PRAZOSIN	PRAZOSIN | PRAZOSIN HYDROCHLORIDE | SJ000288135 | PRAZOSIN HCL | PRAZOSIN | PRAZOSIN HYDROCHLORIDE | SJ000288135 | PRAZOSIN HCL	Pathway: Autophagy; GPCR/G Protein; Neuronal Signaling	Research Area: Cardiovascular Disease; Endocrinology; Cancer	MOABOX:1098	ADRA1B	CDK1 Inhibitors;Apoptosis Inducers;ADRA1B antagonist
SJ000782374-20	SJ000782374	20	MOABOX:1100	OVPNQJVDAFNBDN-UHFFFAOYSA-N	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl	844442-38-2	CDK1/Cyclin B Inhibitors;Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;CDK2/Cyclin A Inhibitors	CCNA2	CCNB1	CDK1	CDK2																													891	983	1017																													CHEMBL445813	CHEMBL497478										11338033	11527497	11542340	11556560	11697928	member	10.1016/j.bmcl.2018.10.020	10.1021/acs.jmedchem.7b01261	10.1021/jm100189a																																																																																																																																																													18656911	19568282	19754394	19757441	20925433	21707503	22037378	23651307	26115571	27171036	28174091	29191878	29357250	30091915																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								0.30528	-9.712e-002	-1.504e-002	0.7232																													0.03816	-0.01214	-0.00188	0.0904																													8	8	8	8																													HY-50940	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:1100|CCNA2|CDK1/Cyclin B Inhibitors;Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;CDK2/Cyclin A Inhibitors	Clc1cccc(Cl)c1C(=O)Nc2c[nH]nc2C(=O)NC3CCNCC3	844442-38-2	29787	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468864	382.24448	AT-7519	AT-7519 | AT-7519  | AT-7519M | | AT-7519 | AT7519 | AT-7519 | AT-7519  | AT-7519M | | AT7519	Pathway: Apoptosis; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:1100	CCNA2	CDK1/Cyclin B Inhibitors;Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;CDK2/Cyclin A Inhibitors
SJ001011030-2	SJ001011030	2	MOABOX:1104	IYNDTACKOAXKBJ-UHFFFAOYSA-N	OCCCNc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1	164658-13-3	Protein Kinase C (PKC) Inhibitors;CDK1 Inhibitors;CDK2 Inhibitors	CDK1	CDK2																															1017																															CHEMBL300389											644215	19689570	143189511			member	10.1021/jm040099a																																																																																																																																																															10633032	10633033	11562278	15771433	21517772	23021994	30234987																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															0.8464	0.49816																															0.1058	0.06227																															8	8																															HY-11009	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics; TGF-beta/Smad | Research Area: Cancer|MOABOX:1104|CDK1|Protein Kinase C (PKC) Inhibitors;CDK1 Inhibitors;CDK2 Inhibitors	OCCCNc1cc(ccn1)c2ccnc(Nc3cccc(Cl)c3)n2	164658-13-3	3173	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469094	355.82142	CGP60474	CGP60474 | CGP60474	Pathway: Cell Cycle/DNA Damage; Epigenetics; TGF-beta/Smad	Research Area: Cancer	MOABOX:1104	CDK1	Protein Kinase C (PKC) Inhibitors;CDK1 Inhibitors;CDK2 Inhibitors
SJ000288077-7	SJ000288077	7	MOABOX:1110	GTVPOLSIJWJJNY-UHFFFAOYSA-N	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21	101622-51-9	CDK5 Inhibitors;Inhibitors of Signal Transduction Pathways;CDK1 Inhibitors;CDK2 Inhibitors	CDK1	CDK2	CDK5																														1017	1020																														CHEMBL280074											4592					member	10.1016/j.ejmech.2010.06.034																																																																																																																																																															10743948	12767603	14754453	20638755																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.46512	0.91472	0.77328																														0.05814	0.11434	0.09666																														8	8	8																														10010240	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-849-700|MOABOX:1110|CDK1|CDK5 Inhibitors;Inhibitors of Signal Transduction Pathways;CDK1 Inhibitors;CDK2 Inhibitors	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12	101622-51-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468295	298.34302	OLOMOUCINE	OLOMOUCINE | CYCLIN-DEPENDENT PROTEIN KINASE INHIBITOR SET | | OLOMOUCINE | CYCLIN-DEPENDENT PROTEIN KINASE INHIBITOR SET |			MOABOX:1110	CDK1	CDK5 Inhibitors;Inhibitors of Signal Transduction Pathways;CDK1 Inhibitors;CDK2 Inhibitors
SJ000288211-5	SJ000288211	5	MOABOX:1116	GSQOBTOAOGXIFL-LFIBNONCSA-N	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCCc1ccccc1	133550-34-2	Tyrosine Kinase Inhibitors;CDK2 Inhibitors	CDK2																																																															CHEMBL53898											5328770					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-15336	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:1116|CDK2|Tyrosine Kinase Inhibitors;CDK2 Inhibitors	Oc1ccc(\C=C(/C#N)\C(=O)NCCCc2ccccc2)cc1O	133550-34-2	25884	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469891	322.35782	TYRPHOSTIN AG 555	TYRPHOSTIN AG 555 | TYRPHOSTIN AG 555	Pathway: Anti-infection; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:1116	CDK2	Tyrosine Kinase Inhibitors;CDK2 Inhibitors
SJ000574284-13	SJ000574284	13	MOABOX:1126	OUSFTKFNBAZUKL-UHFFFAOYSA-N	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1	345627-80-7	CDK7 Inhibitors;CDK2/Cyclin E Inhibitors;CDK9 Inhibitors	CCNE1	CDK2	CDK7	CDK9	CCNA1	CCNE2																											1017	1022	1025	8900	9134																											CHEMBL296468											3025986	6918586	9823239	11158726	11533843	member	10.1016/j.bmcl.2008.09.073	10.1016/j.bmcl.2018.08.035	10.1182/blood-2008-12-190256																																																																																																																																																													15027863	15853645	18183025	18423896	18842409	18926699	19234140	19568282	19757441	21143121	22037378	23252711	23410165	24417566	27171036	28174091	29191878	30091915	30197029	30234987																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.41384	1.63536	0.31296	1.56992	0.48433	0.35328																											0.05173	0.20442	0.03912	0.19624	0.06919	0.04416																											8	8	8	8	7	8																											HY-10008	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:1126|CCNE1|CDK7 Inhibitors;CDK2/Cyclin E Inhibitors;CDK9 Inhibitors	CC(C)(C)c1oc(CSc2cnc(NC(=O)C3CCNCC3)s2)nc1	345627-80-7	41555	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469059	380.52806	BMS-387032	BMS-387032 | SNS-032 | BMS-387032 | SNS-032	Pathway: Apoptosis; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:1126	CCNE1	CDK7 Inhibitors;CDK2/Cyclin E Inhibitors;CDK9 Inhibitors
SJ000826825-20	SJ000826825	20	MOABOX:1134	RHXHGRAEPCAFML-UHFFFAOYSA-N	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1	1211441-98-3	CDK inhibitor;CDK4 Inhibitors;CDK6 Inhibitors;Jak3 Inhibitors	CDK4	CDK6																															1021																															CHEMBL3545110	CHEMBL3707266										44631912	57334219	67242274	71475832	75593353	virtual																																																																																																																																																																26115571	28174091	28651979	29191878	29518312	30234987																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.5732	0.49464																															0.19665	0.06183																															8	8																															HY-15777	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:1134|CDK4|CDK inhibitor;CDK4 Inhibitors;CDK6 Inhibitors;Jak3 Inhibitors	CN(C)C(=O)c1cc2cnc(Nc3ccc(cn3)N4CCNCC4)nc2n1C5CCCC5	1211441-98-3	28237	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469579	434.5373	Ribociclib	"Ribociclib | ""NVP-LEE011-BB-30 | LEE011"" | Ribociclib | ""NVP-LEE011-BB-30 | LEE011"""	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:1134	CDK4	CDK inhibitor;CDK4 Inhibitors;CDK6 Inhibitors;Jak3 Inhibitors
SJ001035120-1	SJ001035120	1	MOABOX:1142	RPELAWNEKQODNO-UHFFFAOYSA-N	COc1ccccc1NS(=O)(=O)c1sc2ccc(Cl)cc2c1C		CDK5/p25 Inhibitors	CDK5																																																																										2824096					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																MWP00157	MAYBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-909-716|MOABOX:1142|CDK5|CDK5/p25 Inhibitors	COc1ccccc1NS(=O)(=O)c2sc3ccc(Cl)cc3c2C	883027-32-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468729	367.87026	MWP00157	MWP00157 | MWP00157			MOABOX:1142	CDK5	CDK5/p25 Inhibitors
SJ001035325-1	SJ001035325	1	MOABOX:1146	XWQVQSXLXAXOPJ-NJDAHSKKSA-N	COC[C@@H](C)N[C@H]1CC[C@H](Nc2cc(-c3cccc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CDK9/Cyclin T1 Inhibitors	CCNT1	CDK9																															1025																															CHEMBL3656841																member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.03136	1.48312																															0.12892	0.18539																															8	8																															HY-12214A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:1146|CCNT1|CDK9/Cyclin T1 Inhibitors	COC[C@@H](C)N[C@@H]1CC[C@H](CC1)Nc2cc(c(Cl)cn2)c3cccc(NCC4(CCOCC4)C#N)n3	1263373-43-8	19221	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469588	513.07468	NVP-2	NVP-2 | NVP-2	Pathway: Apoptosis; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:1146	CCNT1	CDK9/Cyclin T1 Inhibitors
SJ001033104-2	SJ001033104	2	MOABOX:1154	ZVNYJIZDIRKMBF-UHFFFAOYSA-N	COc1ccc(C(=O)N2CCN(c3ccc4c(c3)CCC(=O)N4)CC2)cc1OC	81840-15-5	"Apoptosis Inducers;CDKN1A Expression Enhancers;Transitional Endoplasmic Reticulum ATPase (VCP, p97) Inhibitors"	CDKN1A	VCP	PDE3A																														7415	5139																														CHEMBL17423											5663	69718360	70093884	87636715		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	-0.18361	0																														0.0	-0.02623	0.0																														7	7	7																														HY-15297	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Metabolic Enzyme/Protease | Research Area: Infection|MOABOX:1154|CDKN1A|Apoptosis Inducers;CDKN1A Expression Enhancers;Transitional Endoplasmic Reticulum ATPase (VCP, p97) Inhibitors"	COc1ccc(cc1OC)C(=O)N2CCN(CC2)c3ccc4NC(=O)CCc4c3	81840-15-5	19423	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469089	395.4516	VESNARINONE | OPC-8212	"""VESNARINONE | OPC-8212"" | ""VESNARINONE | OPC-8212"""	Pathway: Anti-infection; Metabolic Enzyme/Protease	Research Area: Infection	MOABOX:1154	CDKN1A	"Apoptosis Inducers;CDKN1A Expression Enhancers;Transitional Endoplasmic Reticulum ATPase (VCP, p97) Inhibitors"
SJ000311845-3	SJ000311845	3	MOABOX:1160	WURBFLDFSFBTLW-UHFFFAOYSA-N	O=C(C(=O)c1ccccc1)c1ccccc1	103852-36-4	Carboxylesterase Inhibitors	CES1	CES2	CES3	CES1P1	CES5A																												8824	23491	51716	221223																												CHEMBL189886											8651	17791526	18352251	18366401	18673429	member																																																																																																																																																																15828829	16107154	16611083	17399985	17941623	18023188	19062296	21733699	23286284	26827140																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												0.7268	0.86264	0.36624	0.36624	0.36624																												0.09085	0.10783	0.05232	0.05232	0.05232																												8	8	7	7	7																												BS-15243	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	O=C(C(=O)c1ccccc1)c2ccccc2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466780	210.228	BENZIL	BENZIL | BENZIL			MOABOX:1160	CES1	Carboxylesterase Inhibitors
SJ000311908-2	SJ000311908	2	MOABOX:1162	YNANGXWUZWWFKX-UHFFFAOYSA-N	COc1ccc(C(=O)C(=O)c2ccc(OC)cc2)cc1	1226-42-2	Carboxylesterase Inhibitors	CES1	CES2	CES3	CES1P1	CES5A																												8824	23491	51716	221223																												CHEMBL191513											71043					member																																																																																																																																																																15828829	17941623	19062296																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.14588	1.13808	0.3913	0.3913	0.3913																												0.02084	0.14226	0.0559	0.0559	0.0559																												7	8	7	7	7																												HY-103610	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:1162|CES1|Carboxylesterase Inhibitors	COc1ccc(cc1)C(=O)C(=O)c2ccc(OC)cc2	1226-42-2	26422	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469144	270.27996	"1,2-BIS(4-METHOXYPHENYL)ETHANE-1,2-DIONE"	"1,2-BIS(4-METHOXYPHENYL)ETHANE-1,2-DIONE | 1,2-BIS(4-METHOXYPHENYL)ETHANE-1,2-DIONE"	Pathway: Others	Research Area: Cancer	MOABOX:1162	CES1	Carboxylesterase Inhibitors
SJ000180926-3	SJ000180926	3	MOABOX:1164	GPDKREBNFFEDHW-UHFFFAOYSA-N	O=C(C(=O)c1ccc([N+](=O)[O-])cc1)c1ccccc1	22711-24-6	Carboxylesterase Inhibitors	CES1	CES2	CES3	CES1P1	CES5A																												8824	23491	51716	221223																												CHEMBL192589											283893	20280597	88850940	88850941		virtual																																																																																																																																																																15828829	19062296																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.5052	0.53384	0.48258	0.48258	0.48258																												0.06315	0.06673	0.06894	0.06894	0.06894																												8	8	7	7	7																												7214587	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-146-024|MOABOX:1164|CES1|Carboxylesterase Inhibitors	[O-][N+](=O)c1ccc(cc1)C(=O)C(=O)c2ccccc2	22711-24-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468442	255.22556					MOABOX:1164	CES1	Carboxylesterase Inhibitors
SJ000141041-3	SJ000141041	3	MOABOX:1166	DCKZGFRFXGBGOQ-UHFFFAOYSA-N	O=S(=O)(Nc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1)c1ccc(Cl)cc1	2654-68-4	Carboxylesterase Inhibitors	CES1	CES2	CES3	CES1P1	CES5A																												8824	23491	51716	221223																												CHEMBL254426											988563					member																																																																																																																																																																15892680	19534556																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.42665	0.62783	0.47418	0.47418	0.47418																												0.06095	0.08969	0.06774	0.06774	0.06774																												7	7	7	7	7																												5158536	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-516-540|MOABOX:1166|CES1|Carboxylesterase Inhibitors	Clc1ccc(cc1)S(=O)(=O)Nc2ccc(NS(=O)(=O)c3ccc(Cl)cc3)cc2	2654-68-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468439	457.35076	4-CHLORO-N-(4-{[(4-CHLOROPHENYL)SULFONYL]AMINO}PHENYL)BENZENESULFONAMIDE	4-CHLORO-N-(4-{[(4-CHLOROPHENYL)SULFONYL]AMINO}PHENYL)BENZENESULFONAMIDE | 4-CHLORO-N-(4-{[(4-CHLOROPHENYL)SULFONYL]AMINO}PHENYL)BENZENESULFONAMIDE			MOABOX:1166	CES1	Carboxylesterase Inhibitors
SJ000140745-3	SJ000140745	3	MOABOX:1170	NTINAJCDYRYMML-UHFFFAOYSA-N	COc1ccc(C(=O)C(=O)c2ccccc2)cc1	22711-21-3	Carboxylesterase Inhibitors	CES1	CES2	CES3	CES1P1	CES5A																												8824	23491	51716	221223																												CHEMBL192474											31494	66838101	66838237	66865872	86650127	member																																																																																																																																																																15828829	19062296																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.264	1.49928	0.10199	0.10199	0.10199																												0.033	0.18741	0.01457	0.01457	0.01457																												8	8	7	7	7																												5128365	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-788-309|MOABOX:1170|CES1|Carboxylesterase Inhibitors	COc1ccc(cc1)C(=O)C(=O)c2ccccc2	22711-21-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468441	240.25398					MOABOX:1170	CES1	Carboxylesterase Inhibitors
SJ000311906-2	SJ000311906	2	MOABOX:1172	BCWCEHMHCDCJAD-UHFFFAOYSA-N	Cc1ccc(C(=O)C(=O)c2ccc(C)cc2)cc1	3457-48-5	Carboxylesterase Inhibitors	CES1	CES2	CES3	CES1P1	CES5A																												8824	23491	51716	221223																												CHEMBL192625											76996	67928581	143079508			member																																																																																																																																																																15828829	19062296																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.47312	0.5004	0.45479	0.45479	0.45479																												0.05914	0.06255	0.06497	0.06497	0.06497																												8	8	7	7	7																												AG003KG0	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-663-506|MOABOX:1172|CES1|Carboxylesterase Inhibitors	Cc1ccc(cc1)C(=O)C(=O)c2ccc(C)cc2	3457-48-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468193	238.28116	"1,2-BIS(4-METHYLPHENYL)ETHANE-1,2-DIONE"	"1,2-BIS(4-METHYLPHENYL)ETHANE-1,2-DIONE | 1,2-BIS(4-METHYLPHENYL)ETHANE-1,2-DIONE"			MOABOX:1172	CES1	Carboxylesterase Inhibitors
SJ000311847-2	SJ000311847	2	MOABOX:1174	XMAWUPHYEABFDR-UHFFFAOYSA-N	O=C(C(=O)c1ccc(Cl)cc1)c1ccc(Cl)cc1	3457-46-3	Carboxylesterase Inhibitors	CES1	CES2	CES3	CES1P1	CES5A																												8824	23491	51716	221223																												CHEMBL192139											18946	67298566	67298568	67928569	70357490	virtual																																																																																																																																																																15828829	19062296																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.93352	0.31352	0.35287	0.35287	0.35287																												0.11669	0.03919	0.05041	0.05041	0.05041																												8	8	7	7	7																												EN300-04843	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-657-277|MOABOX:1174|CES1|Carboxylesterase Inhibitors	Clc1ccc(cc1)C(=O)C(=O)c2ccc(Cl)cc2	3457-46-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468351	279.11812	"1,2-BIS(4-CHLOROPHENYL)ETHANE-1,2-DIONE"	"1,2-BIS(4-CHLOROPHENYL)ETHANE-1,2-DIONE | 1,2-BIS(4-CHLOROPHENYL)ETHANE-1,2-DIONE"			MOABOX:1174	CES1	Carboxylesterase Inhibitors
SJ000357927-2	SJ000357927	2	MOABOX:1176	XNUCDMDHVWJDIP-UHFFFAOYSA-N	O=S(=O)(Nc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c2ccccc12)c1ccc(Cl)cc1	167321-71-3	Carboxylesterase Inhibitors	CES1	CES2	CES3	CES1P1	CES5A																												8824	23491	51716	221223																												CHEMBL484276											1103353					member																																																																																																																																																																15892680	19534556																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.44107	0.58982	0.44107	0.44107	0.44107																												0.06301	0.08426	0.06301	0.06301	0.06301																												7	7	7	7	7																												5158558	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-563-933|MOABOX:1176|CES1|Carboxylesterase Inhibitors	Clc1ccc(cc1)S(=O)(=O)Nc2ccc(NS(=O)(=O)c3ccc(Cl)cc3)c4ccccc24	167321-71-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468689	507.40944	4-CHLORO-N-(4-{[(4-CHLOROPHENYL)SULFONYL]AMINO}1-NAPHTHYL)BENZENESULFONAMIDE	4-CHLORO-N-(4-{[(4-CHLOROPHENYL)SULFONYL]AMINO}1-NAPHTHYL)BENZENESULFONAMIDE | 4-CHLORO-N-(4-{[(4-CHLOROPHENYL)SULFONYL]AMINO}1-NAPHTHYL)BENZENESULFONAMIDE			MOABOX:1176	CES1	Carboxylesterase Inhibitors
SJ000311848-2	SJ000311848	2	MOABOX:1178	VOSNNSVWVJFJCR-UHFFFAOYSA-N	O=C(C(=O)c1ccccc1Cl)c1ccccc1Cl	21854-95-5	Carboxylesterase Inhibitors	CES1	CES2	CES3	CES1P1	CES5A																												8824	23491	51716	221223																												CHEMBL365392											89076	69739828				member																																																																																																																																																																15828829	19062296																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.43876	0.5244	0.47628	0.47628	0.47628																												0.06268	0.06555	0.06804	0.06804	0.06804																												7	8	7	7	7																												AE-562/43458948	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-915-120|MOABOX:1178|CES1|Carboxylesterase Inhibitors	Clc1ccccc1C(=O)C(=O)c2ccccc2Cl	21854-95-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468527	279.11812	"1,2-BIS(2-CHLOROPHENYL)ETHANE-1,2-DIONE"	"1,2-BIS(2-CHLOROPHENYL)ETHANE-1,2-DIONE | 1,2-BIS(2-CHLOROPHENYL)ETHANE-1,2-DIONE"			MOABOX:1178	CES1	Carboxylesterase Inhibitors
SJ001034884-1	SJ001034884	1	MOABOX:1180	PPLNRTPNYCWODC-UHFFFAOYSA-N	O=C(Nc1ccc(Cl)cc1)c1cc2c(cc1O)[nH]c1ccccc12	132-61-6	Carboxylesterase Inhibitors	CES2																																																															CHEMBL1574280											67238	21118662				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.53725																																0.07675																																7																																STK833494	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-835-150|MOABOX:1180|CES2|Carboxylesterase Inhibitors	Oc1cc2[nH]c3ccccc3c2cc1C(=O)Nc4ccc(Cl)cc4	132-61-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468184	336.77172	STK833494	STK833494 | STK833494			MOABOX:1180	CES2	Carboxylesterase Inhibitors
SJ000852831-4	SJ000852831	4	MOABOX:1182	YZQLWPMZQVHJED-UHFFFAOYSA-N	CCC(CC)CC1(C(=O)Nc2ccccc2SC(=O)C(C)C)CCCCC1	211513-37-0	Cholesteryl Ester Transfer Protein (CETP) Inhibitors	CETP																																																															CHEMBL313006											6918540	143083989				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.47894																																0.06842																																7																																HY-14950	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease; Cancer|MOABOX:1182|CETP|Cholesteryl Ester Transfer Protein (CETP) Inhibitors	CCC(CC)CC1(CCCCC1)C(=O)Nc2ccccc2SC(=O)C(C)C	211513-37-0	6600	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468903	389.5945	JTT-705	"JTT-705 | DALCETRAPIB (JTT-705, RO4607381) | JTT-705 | DALCETRAPIB (JTT-705, RO4607381)"	Pathway: Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease; Cancer	MOABOX:1182	CETP	Cholesteryl Ester Transfer Protein (CETP) Inhibitors
SJ000784307-4	SJ000784307	4	MOABOX:1186	CMSGWTNRGKRWGS-NQIIRXRSSA-N	CCOC(=O)N1c2ccc(C(F)(F)F)cc2[C@@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(=O)OC)C[C@H]1CC	262352-17-0	Cholesteryl Ester Transfer Protein (CETP) Inhibitors	CETP																																																															CHEMBL479527											159325	9854664	15547299	87969516		member	10.1016/j.bmcl.2010.01.071	10.1016/j.bmcl.2010.10.110	10.1016/j.bmcl.2012.03.075	10.1016/j.bmcl.2012.04.042	10.1021/jm058224l	10.1021/ml100309n	10.1194/jlr.M007468	10.3109/00498254.2013.874611																																																																																																																																																								16392785	17963209	20137927	21084191	21824085	22497761	22543028	22650305	24900324	26985312	27010500	29035537	31223447																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									2.62456																																0.32807																																8																																HY-12089	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Endocrinology|MOABOX:1186|CETP|Cholesteryl Ester Transfer Protein (CETP) Inhibitors	CCOC(=O)N1[C@H](CC)C[C@H](N(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(=O)OC)c3cc(ccc13)C(F)(F)F	262352-17-0	14028	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469345	600.47333	TORCETRAPIB | CP-529414 |	"""TORCETRAPIB | CP-529414 |"" | TORCETRAPIB | ""TORCETRAPIB | CP-529414 |"" | TORCETRAPIB"	Pathway: Metabolic Enzyme/Protease	Research Area: Endocrinology	MOABOX:1186	CETP	Cholesteryl Ester Transfer Protein (CETP) Inhibitors
SJ000851911-7	SJ000851911	7	MOABOX:1200	PURKAOJPTOLRMP-UHFFFAOYSA-N	CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O	1134822-00-6	CFTR Channel Activators	CFTR																																																															CHEMBL2010601											16220172	71494926	77845104	77845176	78357768	member																																																																																																																																																																25384240	25441013	29148763																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.36208																																0.42026																																8																																LE-0002	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)(C)c1cc(c(NC(=O)C2=CNc3ccccc3C2=O)cc1O)C(C)(C)C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466684	392.49072	IVACAFTOR	IVACAFTOR | VX-770 | IVACAFTOR | VX-770			MOABOX:1200	CFTR	CFTR Channel Activators
SJ000855521-2	SJ000855521	2	MOABOX:1202	JIMHYXZZCWVCMI-RIYZIHGNSA-N	O=C(O)c1ccc(/C=C2/SC(=S)N(c3cccc(C(F)(F)F)c3)C2=O)cc1	307510-92-5	CFTR Channel Inhibitors	CFTR																																																															CHEMBL1554655											1554210					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-16671	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Membrane Transporter/Ion Channel | Research Area: Others|MOABOX:1202|CFTR|CFTR Channel Inhibitors	OC(=O)c1ccc(\C=C\2/SC(=S)N(C2=O)c3cccc(c3)C(F)(F)F)cc1	307510-92-5	17392	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469441	409.40211	CFTRINH-172	CFTRINH-172 | CFTRINH-172	Pathway: Autophagy; Membrane Transporter/Ion Channel	Research Area: Others	MOABOX:1202	CFTR	CFTR Channel Inhibitors
SJ000785951-11	SJ000785951	11	MOABOX:1208	IAYGCINLNONXHY-LBPRGKRZSA-N	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1	1019773-80-8	Checkpoint Kinase 1 (Chk1) Inhibitors;Checkpoint Kinase 2 (Chk2) Inhibitors;DNA Repair Inhibitor	CHEK1	CHEK2																															11200																															CHEMBL2041933											11152667	44472770	44472771	56972142	71600006	member	10.1021/jm300025r	10.1158/1535-7163.MCT-08-0492																																																																																																																																																														18593978	18790776	20423312	21861812	22551018	25042558	29191878	29301085																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														1.65736	0.59352																															0.20717	0.07419																															8	8																															CS-0025	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-016-633-230|MOABOX:1208|CHEK1|Checkpoint Kinase 1 (Chk1) Inhibitors;Checkpoint Kinase 2 (Chk2) Inhibitors;DNA Repair Inhibitor	NC(=O)Nc1cc(sc1C(=O)N[C@H]2CCCNC2)c3cccc(F)c3	860352-01-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468490	362.42176	AZD-7762	AZD-7762 | AZD-7762			MOABOX:1208	CHEK1	Checkpoint Kinase 1 (Chk1) Inhibitors;Checkpoint Kinase 2 (Chk2) Inhibitors;DNA Repair Inhibitor
SJ001034995-1	SJ001034995	1	MOABOX:1210	HCAQGQIHBFVVIX-LYXAAFRTSA-N	C/C(=N\NC(=N)N)c1ccc(NC(=O)Nc2ccc(/C(C)=N/NC(=N)N)cc2)cc1	1048364-29-9	Ribonuclease P Inhibitors;Checkpoint Kinase 2 (Chk2) Inhibitors	CHEK2																																																															CHEMBL142485											6328182	9570312	9573495	9577144	12449850	member	10.1124/mol.107.035832																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.00936																																0.12617																																8																																19811	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-561-642|MOABOX:1210|CHEK2|Ribonuclease P Inhibitors;Checkpoint Kinase 2 (Chk2) Inhibitors	C\C(=N/NC(=N)N)\c1ccc(NC(=O)Nc2ccc(cc2)\C(=N\NC(=N)N)\C)cc1	15427-93-7	NA	GENERAL	METHANESULFONATE	2	NO_SOLVATE	0	1468445	408.46026	NSC 109555 | DDUG | NCI C04808	"""NSC 109555 | DDUG | NCI C04808"" | ""NSC 109555 | DDUG | NCI C04808"""			MOABOX:1210	CHEK2	Ribonuclease P Inhibitors;Checkpoint Kinase 2 (Chk2) Inhibitors
SJ001035086-1	SJ001035086	1	MOABOX:1214	RYYVLZVUVIJVGH-UHFFFAOYSA-N	Cn1c(=O)c2c(ncn2C)n(C)c1=O	114303-55-8	Adenosine A2a receptor antagonist;Chitinase antagonist	ADORA2A	CHIA																															27159																															CHEMBL113	CHEMBL1200569										2519	6241	25434	64119	64120	virtual																																																																																																																																																																20370659	21628909																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.86312	-0.30996																															0.23289	-0.04428																															8	7																															AA00BEH7	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-702-677|MOABOX:1214|ADORA2A|Adenosine A2a receptor antagonist;Chitinase antagonist	[2H]C([2H])([2H])N1C(=O)N(C)c2ncn(C)c2C1=O	26351-03-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468640	197.20909	CAFFEINE-D3	CAFFEINE-D3 | CAFFEINE-D3			MOABOX:1214	ADORA2A	Adenosine A2a receptor antagonist;Chitinase antagonist
SJ000285992-10	SJ000285992	10	MOABOX:1216	BYPFEZZEUUWMEJ-UHFFFAOYSA-N	CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O	6493-05-6	Chitinase Inhibitors;Phosphodiesterase Inhibitors;TNF-alpha Production Inhibitors	PDE4A	PDE4B	TNF	PDE5A	CHIA																												5142	7124	8654	27159																												CHEMBL628											4740	9887646	17876751	21713320	24812746	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.14777	-0.12152	-0.13349	0	-0.38304																												-0.02111	-0.01736	-0.01907	0.0	-0.05472																												7	7	7	7	7																												HY-B0715	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Autophagy; Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease; Cancer|MOABOX:1216|PDE4A|Chitinase Inhibitors;Phosphodiesterase Inhibitors;TNF-alpha Production Inhibitors	CN1C(=O)N(CCCCC(=O)C)C(=O)c2c1ncn2C	6493-05-06	16821	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469433	278.30702	PENTOXIFYLLINE	PENTOXIFYLLINE | PENTOXIFYLLINE	Pathway: Anti-infection; Autophagy; Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease; Cancer	MOABOX:1216	PDE4A	Chitinase Inhibitors;Phosphodiesterase Inhibitors;TNF-alpha Production Inhibitors
SJ000285848-9	SJ000285848	9	MOABOX:1222	RMHMFHUVIITRHF-UHFFFAOYSA-N	CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1	28797-61-7	Muscarinic M1 Antagonists	CHRM1																																																															CHEMBL1257024	CHEMBL1531864	CHEMBL9967									4848	71405	185248	657247	11954384	member	10.1002/(SICI)1098-2299(199701)40:1<1::AID-DDR1>3.0.CO;2-Q	10.1006/phrs.1998.0340	10.1016/S0028-3908(03)00305-8	10.1016/S0960-894X(99)00477-1	10.1016/j.bmc.2010.07.034	10.1016/j.bmc.2013.03.016	10.1016/j.bmcl.2018.03.093	10.1016/j.ejphar.2007.10.017	10.1016/j.ejphar.2009.03.006	10.1016/j.neuropharm.2006.02.002	10.1021/acs.jmedchem.8b01759	10.1021/cn5001606	10.1021/jm200536d	10.1021/jm980067l	10.1124/jpet.110.173245																																																																																																																																																	1379640	7853341	9721598	9986705	10522693	15294002	15723094	16290166	16302823	16444291	16722655	16902941	16981004	17889543	18588282	18595721	18781940	18983139	20345348	20875743	21084390	21688779	21777010	23023262	23379472	23466604	23582449	24805037	25275964	25557493	25650309	26988801	27876250	27997171	28106992	28471663	28763213	28947942	29631962	30300845	30810314																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3.80864																																0.47608																																8																																HY-17037	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Inflammation/Immunology; Neurological Disease|MOABOX:1222|CHRM1|Muscarinic M1 Antagonists	CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc4cccnc24)CC1	29868-97-1	25525	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469032	351.40234	PIRENZEPINE HYDROCHLORIDE	PIRENZEPINE HYDROCHLORIDE | PIRENZEPINE DIHYDROCHLORIDE | PIRENZEPINE HCL | PIRENZEPINE HYDROCHLORIDE | PIRENZEPINE DIHYDROCHLORIDE | PIRENZEPINE HCL	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Inflammation/Immunology; Neurological Disease	MOABOX:1222	CHRM1	Muscarinic M1 Antagonists
SJ000285734-11	SJ000285734	11	MOABOX:1224	CURUTKGFNZGFSE-UHFFFAOYSA-N	CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1	104959-55-9	Muscarinic M1 Antagonists	CHRM1																																																															CHEMBL1123	CHEMBL1200479										3042	441344	657341	6437056	9806565	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.37008																																0.17126																																8																																T1460	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-161|MOABOX:1224|CHRM1|Muscarinic M1 Antagonists	CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2	67-92-5	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468146	309.4867	DICYCLOMINE HYDROCHLORIDE	DICYCLOMINE HYDROCHLORIDE | DICYCLOMINE HCL | DICYCLOMINE HYDROCHLORIDE | DICYCLOMINE HCL			MOABOX:1224	CHRM1	Muscarinic M1 Antagonists
SJ000287229-5	SJ000287229	5	MOABOX:1238	OGAKLTJNUQRZJU-UHFFFAOYSA-N	OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1	19-11-4	Muscarinic M1 Receptor Ligands;Muscarinic M3 Receptor Ligands;Muscarinic M4 Receptor Ligands	CHRM1	CHRM3	CHRM4																														1131	1132																														CHEMBL1529	CHEMBL2105784	CHEMBL936									3055	66266	3084455	11954372	51371355	member																																																																																																																																																																18395442																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.72768	0.73016	0.84224																														0.09096	0.09127	0.10528																														8	8	8																														93475	FLUOROCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-941-110|MOABOX:1238|CHRM1|Muscarinic M1 Receptor Ligands;Muscarinic M3 Receptor Ligands;Muscarinic M4 Receptor Ligands	OC(CCCN1CCCCC1)(c2ccccc2)c3ccccc3	3254-89-5	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468578	309.44518	DIPHENIDOL HYDROCHLORIDE	"DIPHENIDOL HYDROCHLORIDE | ""DIPHENIDOL HYDROCHLORIDE | SKF-478A |"" | DIFENIDOL HCL | DIPHENIDOL HYDROCHLORIDE | ""DIPHENIDOL HYDROCHLORIDE | SKF-478A |"" | DIFENIDOL HCL"			MOABOX:1238	CHRM1	Muscarinic M1 Receptor Ligands;Muscarinic M3 Receptor Ligands;Muscarinic M4 Receptor Ligands
SJ000796050-3	SJ000796050	3	MOABOX:1242	UBRKDAVQCKZSPO-UHFFFAOYSA-N	CCN(CC)CC1CCCCN1CC(=O)N1c2ccccc2C(=O)Nc2cccnc21	100158-38-1	CHRM2 antagonist;Muscarinic M2 Antagonists	CHRM2																																																															CHEMBL17045											107867					member	10.1159/000028382	10.1177/1087057105284340																																																																																																																																																														8981565	9399977	9454790	10215674	11961069	14563784	15723094	16981004	23379472	25650309																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												1.5904																																0.1988																																8																																30871	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-816|MOABOX:1242|CHRM2|CHRM2 antagonist;Muscarinic M2 Antagonists	CCN(CC)CC1CCCCN1CC(=O)N2c3ccccc3C(=O)Nc4cccnc24	102394-31-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468303	421.53524	OTENZEPAD | AF-DX 116 |	"""OTENZEPAD | AF-DX 116 |"" | AF-DX 116 | ""OTENZEPAD | AF-DX 116 |"" | AF-DX 116"			MOABOX:1242	CHRM2	CHRM2 antagonist;Muscarinic M2 Antagonists
SJ000556736-6	SJ000556736	6	MOABOX:1244	LERNTVKEWCAPOY-FPISHFTHSA-N	C[N+]1(C)[C@H]2CC(OC(=O)C(O)(c3cccs3)c3cccs3)C[C@@H]1[C@H]1O[C@@H]21	136310-93-5	Muscarinic M3 Antagonists	CHRM3																																																															CHEMBL3189058	CHEMBL3305968										5487426	5487427	11203068	11224106	11354940	member	10.1016/j.bmcl.2011.03.096																																																																																																																																																															19399831	21524581	21870878	25629394	26335976	31204225																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.8692																																0.10865																																8																																HY-17360	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:1244|CHRM3|Muscarinic M3 Antagonists	C[N+]1(C)[C@@H]2C[C@H](C[C@H]1[C@@H]3O[C@H]23)OC(=O)C(O)(c4cccs4)c5cccs5	136310-93-5	41730	GENERAL	BROMIDE	1	NO_SOLVATE	0	1469341	392.51228	TIOTROPIUM BROMIDE	TIOTROPIUM BROMIDE | TIOTROPIUM BROMIDE HYDRATE | TIOTROPIUM BROMIDE | TIOTROPIUM BROMIDE HYDRATE	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:1244	CHRM3	Muscarinic M3 Antagonists
SJ000286075-9	SJ000286075	9	MOABOX:1250	OOGJQPCLVADCPB-HXUWFJFHSA-N	Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1	124937-51-5	Muscarinic M3 Antagonists	CHRM3	CHRM4	CHRM5																														1132	1133																														CHEMBL1382	CHEMBL1722209										443878	443879	9847786	9895641	9918214	virtual																																																																																																																																																																9121357	16275087	18042383	19168050	21075627	21863888																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.96312	0.61608	0.57264																														0.12039	0.07701	0.07158																														8	8	8																														HY-A0024	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:1250|CHRM3|Muscarinic M3 Antagonists	CC(C)N(CC[C@H](c1ccccc1)c2cc(C)ccc2O)C(C)C	124937-51-5	61393	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469100	325.48764	TOLTERODINE HYDROCHLORIDE	"TOLTERODINE HYDROCHLORIDE | ""TOLTERODINE TARTRATE | DETROL LA"" | TOLTERODINE TARTRATE | TOLTERODINE HYDROCHLORIDE | ""TOLTERODINE TARTRATE | DETROL LA"" | TOLTERODINE TARTRATE"	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:1250	CHRM3	Muscarinic M3 Antagonists
SJ000285695-12	SJ000285695	12	MOABOX:1252	VPJXQGSRWJZDOB-UHFFFAOYSA-O	C[N+](C)(C)CCOC(N)=O	2260-51-7	Cholinergics	CHRM1	CHRM5																															1133																															CHEMBL14	CHEMBL965										2551	5831	200564	206532	521353	virtual	10.1016/0006-2952(95)02234-1	10.1016/0014-2999(95)00639-7	10.1016/0024-3205(95)00019-3	10.1021/acschemneuro.6b00334	10.1021/bi972132j	10.1021/jm00012a019	10.1021/jm201348t	10.1021/jm960683m	10.1073/pnas.1835612100	10.1074/jbc.271.6.2882																																																																																																																																																						2258904	3336015	7783150	10891110	16981004	17149881	22329602	24128660	25275964	29589445																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												-0.30352	4.672e-002																															-0.03794	0.00584																															8	8																															EN300-122286	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-136|MOABOX:1252|CHRM1|Cholinergics	C[N+](C)(C)CCOC(=O)N	51-83-2	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468567	147.1955	CARBACHOL	CARBACHOL | CARBAMYLCHOLINE CHLORIDE | CARBACHOL | CARBAMYLCHOLINE CHLORIDE			MOABOX:1252	CHRM1	Cholinergics
SJ000286907-11	SJ000286907	11	MOABOX:1254	HJJPJSXJAXAIPN-UHFFFAOYSA-N	COC(=O)C1=CCCN(C)C1	131448-18-5	Muscarinic Receptor Agonists;Potassium Channel Subfamily K Member 18 (TRESK KCNK18) Blockers	CHRM1	CHRM2	CHRM3	CHRM4	CHRM5	KCNK18																											1129	1131	1132	1133	338567																											CHEMBL449209	CHEMBL7303										2230	6107	9301	28362	5351517	virtual	10.1002/ardp.200300730	10.1016/0014-2999(95)00639-7	10.1016/S0960-894X(01)00559-5	10.1016/j.ejphar.2008.12.044	10.1111/j.1476-5381.1995.tb13339.x																																																																																																																																																											1433209	1995893	3712371	7783150	7990109	9152396	9399977	9622546	9732369	10891110	11597415	15655507	15777212	22680630																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								-0.34937	-4.88e-002	0.38656	-0.1304	1.536e-002	-0.19472																											-0.04991	-0.0061	0.04832	-0.0163	0.00192	-0.02434																											7	8	8	8	8	8																											AG0034H7	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-742-600|MOABOX:1254|CHRM1|Muscarinic Receptor Agonists;Potassium Channel Subfamily K Member 18 (TRESK KCNK18) Blockers	COC(=O)C1=CCCN(C)C1	300-08-3	NA	GENERAL	BROMIDE	1	NO_SOLVATE	0	1468357	155.19432	ARECOLINE HYDROBROMIDE	ARECOLINE HYDROBROMIDE | ARECOLINE HBR | ARECOLINE | ARECOLINE HYDROBROMIDE | ARECOLINE HBR | ARECOLINE			MOABOX:1254	CHRM1	Muscarinic Receptor Agonists;Potassium Channel Subfamily K Member 18 (TRESK KCNK18) Blockers
SJ000287753-5	SJ000287753	5	MOABOX:1262	DDKOMKXCUXCQBS-UHFFFAOYSA-O	C[N+](C)(C)CC#CCOC(=O)Nc1cccc(Cl)c1	50510-07-1	Muscarinic receptor agonist	CHRM1	CHRM4	CHRM5	CHRM2	CHRM3																												1132	1133	1129	1131																												CHEMBL3275112	CHEMBL40554	CHEMBL74300									4022	5926	16219154	90678886		member	10.1016/0014-2999(95)00639-7	10.1111/j.1476-5381.1995.tb13339.x	10.3109/10799899909036662																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		-9.68e-002	-0.22393	-5.915e-002	0.3648	-7.208e-002																												-0.0121	-0.03199	-0.00845	0.0456	-0.00901																												8	7	7	8	8																												30961	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-822-477|MOABOX:1262|CHRM1|Muscarinic receptor agonist	C[N+](C)(C)CC#CCOC(=O)Nc1cccc(Cl)c1	55-45-8	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468296	281.75792	MCN-A-343	MCN-A-343 | MCN A-343 | MCN-A-343 | MCN A-343			MOABOX:1262	CHRM1	Muscarinic receptor agonist
SJ001033374-2	SJ001033374	2	MOABOX:1268	JOLJIIDDOBNFHW-UHFFFAOYSA-N	CCCCCCOc1nsnc1C1=CCCN(C)C1	1018845-70-9	Muscarinic M1 receptor agonist;Muscarinic M4 receptor agonist;Muscarinic M5 receptor agonist;Cholinergic Muscarinic 1-4 agonist	CHRM1	CHRM4	CHRM5																														1132	1133																														CHEMBL21536	CHEMBL2336050	CHEMBL73149									60809	71456	18177385	18920248	21115033	member	10.1002/(SICI)1098-2299(199701)40:1<1::AID-DDR1>3.0.CO;2-Q	10.1002/(SICI)1098-2299(199702)40:2<185::AID-DDR8>3.0.CO;2-H	10.1002/ardp.200300730	10.1016/j.bmcl.2014.04.085	10.1016/j.bmcl.2015.09.032	10.1016/j.ejphar.2008.12.044	10.1021/acschemneuro.8b00625	10.1021/jm0102405	10.1021/jm100697g	10.1021/ml300372f	10.1111/bph.14510																																																																																																																																																					1433209	9464368	10354408	10450949	11741475	13678406	17149881	17977730	18182302	20684563	25275964	26299349																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										0.47688	0.22616	-0.19944																														0.05961	0.02827	-0.02493																														8	8	8																														DS-15663	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCCCCCOc1nsnc1C2=CCCN(C)C2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466769	281.41692	XANOMELINE (OXALATE); LY246708 (OXALATE)	XANOMELINE (OXALATE); LY246708 (OXALATE) | XANOMELINE (OXALATE); LY246708 (OXALATE)			MOABOX:1268	CHRM1	Muscarinic M1 receptor agonist;Muscarinic M4 receptor agonist;Muscarinic M5 receptor agonist;Cholinergic Muscarinic 1-4 agonist
SJ000286553-10	SJ000286553	10	MOABOX:1272	IMYZQPCYWPFTAG-UHFFFAOYSA-N	CNC1(C)C2CCC(C2)C1(C)C	107538-05-6	Nicotinic Receptor Antagonists	CHRNA2	CHRNA3	CHRNA5	CHRNB4	CHRNB3	CHRNA6	CHRNA1	CHRNB1	CHRND	CHRNE	CHRNG	CHRNA9	CHRNA10																				1136	1138	1143	1142	8973	1134	1140	1144	1145	1146	55584	57053																				CHEMBL1237082	CHEMBL267936										4032	13221	9949380	9949803	11186181	member	10.1016/j.bmc.2013.03.082																																																																																																																																																															12769608	15203153	16033252	17238157	17826746	18059317	23036283	23757208																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														0	0.59784	0.75632	0.19285	0	-0.3962	0.35928	0	0	0	-0.3962	0	0																				0.0	0.07473	0.09454	0.02755	0.0	-0.0566	0.04491	0.0	0.0	0.0	-0.0566	0.0	0.0																				7	8	8	7	7	7	8	7	7	7	7	7	7																				AC29999	A2BCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-220|MOABOX:1272|CHRNA2|Nicotinic Receptor Antagonists	CNC1(C)C2CCC(C2)C1(C)C	107538-05-6	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468643	167.29114	MECAMYLAMINE HYDROCHLORIDE	"MECAMYLAMINE HYDROCHLORIDE | ""MECAMYLAMINE | INVERSINE"" | MECAMYLAMINE HYDROCHLORIDE | ""MECAMYLAMINE | INVERSINE"""			MOABOX:1272	CHRNA2	Nicotinic Receptor Antagonists
SJ000285302-11	SJ000285302	11	MOABOX:1280	SNICXCGAKADSCV-JTQLQIEISA-N	CN1CCC[C@H]1c1cccnc1	104062-50-2	Nicotinic alpha7 Partial Agonists	CHRNA3	CHRNB4																															1143																															CHEMBL1448280	CHEMBL151515	CHEMBL225057	CHEMBL3	CHEMBL3137669	CHEMBL3182465	CHEMBL3989563					89593	89594	114837	121455	169012	member	10.1016/S0006-8993(03)02979-2	10.1038/sj.bjp.0702526																																																																																																																																																														11212100	11312774	14684341	15771418	15887955	15908213	16171993	20663668	22148173	22793665	23092294	23461628	23641311	23692872	23734673	26225816	27810599	27818109																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.43928	-0.47064																															-0.05491	-0.05883																															8	8																															EN300-304948	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-744-731|MOABOX:1280|CHRNA3|Nicotinic alpha7 Partial Agonists	CN1CCC[C@H]1c2cccnc2	54-11-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468559	162.23156	NICOTINE DITARTRATE	NICOTINE DITARTRATE | (-)-NICOTINE HYDROGEN TARTRATE SALT | (-)-NICOTINE | NICOTINE DITARTRATE | (-)-NICOTINE HYDROGEN TARTRATE SALT | (-)-NICOTINE			MOABOX:1280	CHRNA3	Nicotinic alpha7 Partial Agonists
SJ000796008-2	SJ000796008	2	MOABOX:1282	ALSKYCOJJPXPFS-BBRMVZONSA-N	CO[C@H]1CC=C2CCN3CCC4=C(CC(=O)OC4)[C@]23C1	1328-90-1	Nicotinic alpha4beta2 Antagonists	CHRNA4	CHRNB2																															1141																															CHEMBL1319741	CHEMBL293950										31762	11957537	23617475	51371187		virtual	10.1124/mol.110.065490	10.1124/mol.64.6.1283																																																																																																																																																														23561269	24187998																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.01304	1.0716																															0.12663	0.13395																															8	8																															2349	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-940-972|MOABOX:1282|CHRNA4|Nicotinic alpha4beta2 Antagonists	COC1CC23C(CCN2CCC4=C3CC(=O)OC4)C=C1	29734-68-7	NA	GENERAL	BROMIDE	1	NO_SOLVATE	0	1468125	275.34284	DIHYDRO-BETA-ERYTHODINE HYDROBROMIDE | DHBE |	"""DIHYDRO-BETA-ERYTHODINE HYDROBROMIDE | DHBE |"" | ""DIHYDRO-BETA-ERYTHODINE HYDROBROMIDE | DHBE |"""			MOABOX:1282	CHRNA4	Nicotinic alpha4beta2 Antagonists
SJ000833339-2	SJ000833339	2	MOABOX:1284	JUOSGGQXEBBCJB-GORDUTHDSA-N	CNCC/C=C/c1cccnc1	1129-68-6	Nicotinic Receptor Agonists;Nicotinic alpha4beta2 Agonists	CHRNA4	CHRNB2																															1141																															CHEMBL132966	CHEMBL1783879	CHEMBL2107367									5310967	9951347	23298272	45073451	46174135	member																																																																																																																																																																14698195	15003719	17073685	20822184	23025891																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.574	0.62776																															0.07175	0.07847																															8	8																															1053	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-052-173|MOABOX:1284|CHRNA4|Nicotinic Receptor Agonists;Nicotinic alpha4beta2 Agonists	CNCC\C=C\c1cccnc1	220662-95-3	NA	GENERAL	OXALATE	1	NO_SOLVATE	0	1468500	162.23156	RJR 2403	RJR 2403 | RJR 2403 OXALATE | RJR 2403 | RJR 2403 OXALATE			MOABOX:1284	CHRNA4	Nicotinic Receptor Agonists;Nicotinic alpha4beta2 Agonists
SJ000286234-7	SJ000286234	7	MOABOX:1286	ANJTVLIZGCUXLD-DTWKUNHWSA-N	O=c1cccc2n1C[C@@H]1CNC[C@H]2C1	115051-74-6	Nicotinic alpha4beta2 Partial Agonists	CHRNA1	CHRNA3	CHRNA4	CHRNB1	CHRNB2	CHRNB4	CHRND	CHRNG																									1136	1137	1140	1141	1143	1144	1146																									CHEMBL497939											10235	16637613	20056518	23620749	67055279	member	10.1016/S0028-3908(03)00025-X	10.1016/j.bmcl.2004.11.073	10.1073/pnas.0630641100	10.1111/j.1476-5381.2010.00682.x	10.1124/mol.64.6.1283																																																																																																																																																											12769608	15686946	15887955	15908213	16033252	16171993	16934977	18356044	19501054	21285282	22170047	22619328	23025891	23461628	24901260																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							-0.13456	-0.68848	0.5312	-0.13456	0.48008	-0.53096	-0.5316	-0.5316																									-0.01682	-0.08606	0.0664	-0.01682	0.06001	-0.06637	-0.06645	-0.06645																									8	8	8	8	8	8	8	8																									AS-19539	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	O=C1C=CC=C2[C@H]3CNC[C@H](C3)CN12	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466761	190.24166	CYTISINE	CYTISINE | CYTISINE (-) | (-)-CYTISINE | CYTISINE | CYTISINE (-) | (-)-CYTISINE			MOABOX:1286	CHRNA1	Nicotinic alpha4beta2 Partial Agonists
SJ001033580-2	SJ001033580	2	MOABOX:1296	RPYWXZCFYPVCNQ-RVDMUPIBSA-N	COc1ccc(/C=C2\CCCN=C2c2cccnc2)c(OC)c1	148372-04-7	Nicotinic alpha7 Partial Agonists	CHRNA7																																																															CHEMBL134713											5310985	6438361	9825995	25259372	53493005	member																																																																																																																																																																18826295																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-1.656e-002																																-0.00207																																8																																HY-14564A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Inflammation/Immunology|MOABOX:1296|CHRNA7|Nicotinic alpha7 Partial Agonists	COc1ccc(\C=C\2/CCCN=C2c3cccnc3)c(OC)c1	156223-05-1	20261	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469825	308.3743	GTS-21 (DIHYDROCHLORIDE); DMXB-A; DMBX-ANABASEINE	GTS-21 (DIHYDROCHLORIDE); DMXB-A; DMBX-ANABASEINE | GTS-21 (DIHYDROCHLORIDE); DMXB-A; DMBX-ANABASEINE	Pathway: GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Inflammation/Immunology	MOABOX:1296	CHRNA7	Nicotinic alpha7 Partial Agonists
SJ001034663-1	SJ001034663	1	MOABOX:1304	YOYDGKNKZANQBG-UHFFFAOYSA-N	Clc1ccc2[nH]c3cnccc3c2c1	30684-46-9		CHUK																																																															CHEMBL311201											11287153					virtual																																																																																																																																																																12824047																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.32192																																0.41524																																8																																SS-3002	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Clc1ccc2[nH]c3cnccc3c2c1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466775	202.63968	SS-3002	SS-3002 | SS-3002			MOABOX:1304	CHUK	
SJ000834145-3	SJ000834145	3	MOABOX:1310	JZRMBDHPALEPDM-UHFFFAOYSA-N	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1	1049743-58-9	Apoptosis Inducers;IKK-2 (IKK-beta) Inhibitors	CHUK	IKBKG																															8517																															CHEMBL79004											9949093	16219884				virtual																																																																																																																																																																11872748	12824047	15723624	19689370	19834513																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.34392	0.38962																															0.16799	0.05566																															8	7																															HY-18008	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; NF-?B | Research Area: Cancer|MOABOX:1310|CHUK|Apoptosis Inducers;IKK-2 (IKK-beta) Inhibitors	Clc1cc(NC(=O)c2cccnc2)c3[nH]c4cnccc4c3c1	431898-65-6	19625	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469802	322.74844	PS-1145	PS-1145 | PS-1145	Pathway: Apoptosis; NF-?B	Research Area: Cancer	MOABOX:1310	CHUK	Apoptosis Inducers;IKK-2 (IKK-beta) Inhibitors
SJ000574295-3	SJ000574295	3	MOABOX:1314	ANMLJLFWUCQGKZ-UHFFFAOYSA-N	O=C1OC(OC(=O)c2cccnc2Nc2cccc(C(F)(F)F)c2)c2ccccc21	66898-62-2	"Calcium-activated Chloride Channels 1 Blockers;Mucin Production, Inhibitors;""Calcium-activated Chloride Channels 1 Blockers;Mucin Production, Inhibitors"""	CLCA1	SLC26A3																															1811																															CHEMBL1081506											48229	20392372	66622369	66685436		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-103370	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Inflammation/Immunology|MOABOX:1314|CLCA1|Calcium-activated Chloride Channels 1 Blockers;Mucin Production, Inhibitors;\Calcium-activated Chloride Channels 1 Blockers;Mucin Production, Inhibitors\"	FC(F)(F)c1cccc(Nc2ncccc2C(=O)OC3OC(=O)c4ccccc34)c1	66898-62-2	64023	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469385	414.33413	TALNIFLUMATE | GENAERA	"""TALNIFLUMATE | GENAERA"" | ""TALNIFLUMATE | GENAERA"""	Pathway: Membrane Transporter/Ion Channel	Research Area: Inflammation/Immunology	MOABOX:1314	CLCA1	"Calcium-activated Chloride Channels 1 Blockers;Mucin Production, Inhibitors;\Calcium-activated Chloride Channels 1 Blockers;Mucin Production, Inhibitors\"
SJ001034659-1	SJ001034659	1	MOABOX:1316	YDZNRNHKJQTGCG-UHFFFAOYSA-N	O=C(O)c1ccc2ccccc2c1-c1c(C(=O)O)ccc2ccccc12	18531-96-9	CDC-Like Kinase 4 (CLK4) Inhibitors	CLK4																																																															CHEMBL1231559											2810167	139075352	139146758	139146759	139146760	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																SS-4976	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC(=O)c1ccc2ccccc2c1c3c(ccc4ccccc34)C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466766	342.34416	SS-4976	SS-4976 | SS-4976			MOABOX:1316	CLK4	CDC-Like Kinase 4 (CLK4) Inhibitors
SJ001034915-1	SJ001034915	1	MOABOX:1326	FJMQJSUOOGOWBD-UHFFFAOYSA-N	CC(F)(F)CN1CCOc2c(nn(-c3ccccc3Cl)c2-c2ccc(Cl)cc2)C1=O	851728-60-4	Cannabinoid CB1 Antagonists	CNR1																																																															CHEMBL484929											11316919					member																																																																																																																																																																19351113	24900484	29509713																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.44128																																0.43016																																8																																3676	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-895|MOABOX:1326|CNR1|Cannabinoid CB1 Antagonists	CC(F)(F)CN1CCOc2c(nn(c3ccccc3Cl)c2c4ccc(Cl)cc4)C1=O	851728-60-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468225	452.28139	PF 514273	PF 514273 | PF 514273			MOABOX:1326	CNR1	Cannabinoid CB1 Antagonists
SJ001033315-2	SJ001033315	2	MOABOX:1328	QLYKJCMUNUWAGO-GAJHUEQPSA-N	C[C@H](NC(=O)C(C)(C)Oc1ccc(C(F)(F)F)cn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1	1204240-86-7	Cannabinoid CB1 Inverse Agonists	CNR1																																																															CHEMBL220360											11226090	11949683				member	10.1002/ardp.200700255	10.1016/j.bmcl.2007.01.087	10.1016/j.bmcl.2009.03.005	10.1016/j.bmcl.2009.07.046	10.1016/j.bmcl.2010.06.127	10.1016/j.bmcl.2010.07.018	10.1021/jm060996+	10.1021/jm070131b	10.1021/jm100023j	10.1021/jm7014974	10.1124/jpet.106.118737																																																																																																																																																					17181138	17608398	18333607	18335976	18570365	18574849	19328684	19520572	19632830	19689362	20096577	20423086	20483606	20643546	20667724																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							3.46888																																0.43361																																8																																1550	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-020-014-681|MOABOX:1328|CNR1|Cannabinoid CB1 Inverse Agonists	C[C@H](NC(=O)C(C)(C)Oc1ccc(cn1)C(F)(F)F)[C@@H](Cc2ccc(Cl)cc2)c3cccc(c3)C#N	701977-09-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468382	515.95451	TARANABANT; MK-0364	TARANABANT; MK-0364 | TARANABANT; MK-0364			MOABOX:1328	CNR1	Cannabinoid CB1 Inverse Agonists
SJ000784310-6	SJ000784310	6	MOABOX:1336	JZCPYUJPEARBJL-UHFFFAOYSA-N	Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1	158681-13-1	CNR1 antagonist;Cannabinoid CB1 Inverse Agonists;IL-6 production inhibitor	CNR1																																																															CHEMBL111	CHEMBL558598										104849	104850	11193824	11622058	11956162	member	10.1002/ardp.200700255	10.1002/cmdc.201000246	10.1016/0014-5793(94)00773-X	10.1016/j.bcp.2017.10.014	10.1016/j.bmc.2008.01.023	10.1016/j.bmc.2009.12.040	10.1016/j.bmc.2016.01.033	10.1016/j.bmcl.2004.11.031	10.1016/j.bmcl.2004.12.078	10.1016/j.bmcl.2005.10.028	10.1016/j.bmcl.2007.01.087	10.1016/j.bmcl.2007.11.133	10.1016/j.bmcl.2008.11.029	10.1016/j.bmcl.2009.03.046	10.1016/j.bmcl.2009.05.114	10.1016/j.bmcl.2009.10.015	10.1016/j.bmcl.2009.11.047	10.1016/j.bmcl.2009.12.003	10.1016/j.bmcl.2010.07.018	10.1016/j.bmcl.2013.06.066	10.1016/j.bmcl.2014.07.038	10.1016/j.ejmech.2009.12.018	10.1016/j.ejmech.2013.12.018	10.1016/j.ejmech.2018.05.019	10.1016/j.phrs.2010.06.001	10.1021/acs.jmedchem.8b01467	10.1021/jm0503906	10.1021/jm050484f	10.1021/jm060996+	10.1021/jm4010708	10.1021/jm401158e	10.1021/jm800066v	10.1021/jm900471u	10.1034/j.1399-3011.2002.21066.x	10.1038/sj.bjp.0707347	10.1038/sj.bjp.0707568	10.1039/b716434c	10.1039/b807648k	10.1074/jbc.271.12.6941	10.1124/jpet.105.093500	10.1152/ajpendo.00264.2007	10.2174/0929867054020891	10.2174/092986712803341575	10.2174/1381612033454577																																																																																																																				10465552	10882356	11960486	14613317	14736243	14980654	15664830	15713403	15771428	15801840	16140010	16263283	16279809	16392793	16451053	17004712	17181138	17293109	17383180	17433696	17942307	17979261	18083560	18243711	18293908	18335976	18342403	18363352	18448340	18511157	18512901	18579386	18680276	18712856	18754613	18800770	19095444	19102698	19328683	19338356	19351113	19520572	19530697	19595596	19683918	19767206	19954978	20005704	20015647	20018510	20045337	20047331	20047779	20363132	20718492	20845959	20943290	21334892	21376588	21428406	21702498	21962575	22372835	22548457	22916707	22959249	23072339	23085772	23406429	23434135	24175572	24445310	24729834	24900484	24900561	24936232	24944734	25096297	25644673	26151231	26756097	26827137	29400965																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.78232																																0.47279																																8																																HY-14137	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; GPCR/G Protein; Neuronal Signaling | Research Area: Cancer; Infection; Metabolic Disease|MOABOX:1336|CNR1|CNR1 antagonist;Cannabinoid CB1 Inverse Agonists;IL-6 production inhibitor	Cc1c(nn(c2ccc(Cl)cc2Cl)c1c3ccc(Cl)cc3)C(=O)NN4CCCCC4	158681-13-1	8612	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469708	463.78734	RIMONABANT	RIMONABANT | AC-163720 | RIMONABANT | AC-163720	Pathway: Anti-infection; GPCR/G Protein; Neuronal Signaling	Research Area: Cancer; Infection; Metabolic Disease	MOABOX:1336	CNR1	CNR1 antagonist;Cannabinoid CB1 Inverse Agonists;IL-6 production inhibitor
SJ000831452-4	SJ000831452	4	MOABOX:1338	LGEQQWMQCRIYKG-DOFZRALJSA-N	CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO	94421-68-8	Cannabinoid CB1 Agonists;TRPV1 (Vanilloid VR1 Receptor) Agonists;K(V)4.3 Channel Blocker	CNR1	CNR2	TRPV1	GPR55																													1269	7442	9290																													CHEMBL15848											5281969	23757304	68990113	69142421	88098815	member	10.1002/cbic.200800827	10.1002/cmdc.200800271	10.1016/0167-4781(96)00047-4	10.1016/S0006-2952(03)00005-4	10.1016/S0014-5793(00)02082-2	10.1016/S0014-5793(02)03537-8	10.1016/S0968-0896(02)00567-9	10.1016/j.bcp.2004.08.033	10.1016/j.ejphar.2004.09.058	10.1021/jm051240y	10.1021/jm300484d	10.1021/jm4005626	10.1021/jm900130m	10.1038/sj.bjp.0704732	10.1038/sj.bjp.0707460	10.1038/sj.bjp.0707464	10.1038/sj.bjp.0707481	10.1073/pnas.122196999	10.1074/jbc.M806516200	10.1111/bph.13889	10.2174/092986710790980069	10.2174/092986710790980096																																																																																																																																										9435190	9864268	10688601	10882356	10903399	11425567	11945130	12023948	12166938	12614867	12871061	14613317	15638794	15892633	16026309	16078824	16213718	16279794	16408004	16570929	16682198	17430144	17521177	17561406	17641667	17827022	17876300	17876302	17906678	17982478	18026124	18537620	18537724	18777572	19003845	19161308	19331413	19361197	19456285	19456289	19533710	20166921	20166924	20166927	20166928	20370711	20817522	21233197	21867920	22044209	23143757	23384387	23865723	25065940	26890113	27624523	30196704																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2.0264	0.11288	-0.20536	1.47256																													0.2533	0.01411	-0.02567	0.18407																													8	8	8	8																													HY-10863	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Inflammation/Immunology|MOABOX:1338|CNR1|Cannabinoid CB1 Agonists;TRPV1 (Vanilloid VR1 Receptor) Agonists;K(V)4.3 Channel Blocker	CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO	94421-68-8	60742	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469714	347.53468	ANANDAMIDE	"ANANDAMIDE | ANANDAMIDE (20:4, N-6) | ARACHIDONOYL ETHANOLAMIDE | ANANDAMIDE | ANANDAMIDE (20:4, N-6) | ARACHIDONOYL ETHANOLAMIDE"	Pathway: GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Inflammation/Immunology	MOABOX:1338	CNR1	Cannabinoid CB1 Agonists;TRPV1 (Vanilloid VR1 Receptor) Agonists;K(V)4.3 Channel Blocker
SJ000855342-3	SJ000855342	3	MOABOX:1340	TWQYWUXBZHPIIV-UHFFFAOYSA-N	O=C(NCC1CCOCC1)c1cnc(Nc2ccc(Cl)cc2Cl)nc1C(F)(F)F	666260-75-9	Cannabinoid CB2 Agonists	CNR2																																																															CHEMBL225411											10253143	24947116				member	10.1002/mop.21636	10.1016/S0065-7743(09)04411-X	10.1016/j.bmc.2007.10.087	10.1016/j.bmc.2014.11.002	10.1016/j.bmcl.2008.01.042	10.1016/j.bmcl.2009.02.033	10.1016/j.bmcl.2014.12.033	10.1021/jm061195+	10.1021/jm9009857	10.1038/sj.bjp.0707568	10.1124/jpet.108.145011	10.2174/138161209789105027	10.2174/138955709787001785																																																																																																																																																			16918457	17477516	17643986	18006322	18255291	19143566	19149657	19243942	19689286	19743867	19860684	23865723	25487422	25556098	25644673	26151231	28626532	28651225	30583970																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.77904																																0.34738																																8																																HY-14167	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Inflammation/Immunology; Neurological Disease|MOABOX:1340|CNR2|Cannabinoid CB2 Agonists	FC(F)(F)c1nc(Nc2ccc(Cl)cc2Cl)ncc1C(=O)NCC3CCOCC3	666260-75-9	27756	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469326	449.25439	GW842166X	GW842166X | GW842166X	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Inflammation/Immunology; Neurological Disease	MOABOX:1340	CNR2	Cannabinoid CB2 Agonists
SJ001035229-1	SJ001035229	1	MOABOX:1342	SUGVYNSRNKFXQM-XRHWURSXSA-N	Cc1ccc(Cn2nc(C(=O)N[C@@H]3C(C)(C)[C@@H]4CC[C@@]3(C)C4)cc2-c2ccc(Cl)c(C)c2)cc1	192703-06-3	Cannabinoid CB2 Inverse Agonists;ACAT Inhibitors	CNR2																																																															CHEMBL381791											3081355					member	10.1016/j.bmc.2014.06.008	10.1016/j.ejmech.2017.11.076	10.1016/j.ejmech.2019.07.002	10.1021/acsmedchemlett.7b00396	10.1021/jm400070u	10.1038/sj.bjp.0706838																																																																																																																																																										9454810	9918562	12871061	15892633	15974990	15994087	16420048	16539390	16712486	16894349	16918457	17915849	17942307	17982478	18293908	18680276	19435366	19533710	19595596	20031412	20166921	20166927	20718492	20979417	21183257	21996466	22383251	22483967	22830341	23072339	23085772	23855811	24518874	24856183	24984935	25486424	25699149	26209834	26275680	26756097	27448919	27624523	28088085	29259753	29400965	29407590	30359820	30783505																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						1.882																																0.23525																																8																																HY-13439	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:1342|CNR2|Cannabinoid CB2 Inverse Agonists;ACAT Inhibitors	Cc1ccc(Cn2nc(cc2c3ccc(Cl)c(C)c3)C(=O)N[C@H]4[C@@]5(C)CC[C@H](C5)C4(C)C)cc1	192703-06-3	28675	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469205	476.05276	SR144528	SR144528 | SR144528	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:1342	CNR2	Cannabinoid CB2 Inverse Agonists;ACAT Inhibitors
SJ000288086-6	SJ000288086	6	MOABOX:1344	HXYVTAGFYLMHSO-UHFFFAOYSA-N	CCCCCCCCCCCCCCCC(=O)NCCO	544-31-0	Cannabinoid CB2 Agonists	CNR2	GPR55																															9290																															CHEMBL417675											4671	16752678	19606634	44610674	86582942	member	10.1038/sj.bjp.0707460	10.1038/sj.bjp.0707464	10.1038/sj.bjp.0707481	10.2174/092986710790980096																																																																																																																																																												11945130	16318877	17876300	17876302	17906678	20166928																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																-0.36688	2.3476																															-0.04586	0.29345																															8	8																															HY-20685	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Metabolic Enzyme/Protease | Research Area: Infection|MOABOX:1344|CNR2|Cannabinoid CB2 Agonists	CCCCCCCCCCCCCCCC(=O)NCCO	544-31-0	92377	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469529	299.49188	PALMITOYLETHANOLAMIDE	PALMITOYLETHANOLAMIDE | PALMITYLETHANOLAMIDE | PALMITOYL ETHANOLAMIDE | PALMITOYLETHANOLAMIDE | PALMITYLETHANOLAMIDE | PALMITOYL ETHANOLAMIDE	Pathway: Anti-infection; Metabolic Enzyme/Protease	Research Area: Infection	MOABOX:1344	CNR2	Cannabinoid CB2 Agonists
SJ001034987-1	SJ001034987	1	MOABOX:1346	BFXLAXBXCXOWNH-UHFFFAOYSA-N	O=C(Nc1ccc(Cl)cc1)c1cc(Cl)ccc1NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1	136402-17-0	Phosphopantetheine Adenylyltransferase (PPAT) Inhibitors	COASY																																																																										2832019					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.33376																																0.04768																																7																																5175347	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-703-374|MOABOX:1346|COASY|Phosphopantetheine Adenylyltransferase (PPAT) Inhibitors	[O-][N+](=O)c1cc(ccc1Cl)S(=O)(=O)Nc2ccc(Cl)cc2C(=O)Nc3ccc(Cl)cc3	136402-17-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468430	500.73968	5175347	5175347 | 5175347			MOABOX:1346	COASY	Phosphopantetheine Adenylyltransferase (PPAT) Inhibitors
SJ000312328-10	SJ000312328	10	MOABOX:1348	MIQPIUSUKVNLNT-UHFFFAOYSA-N	Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1	1246816-93-2	COMT Inhibitors	COMT																																																															CHEMBL1324											4659569	71519710	87662850	87844396	139561123	member	10.1021/acs.jmedchem.5b01970																																																																																																																																																															22483290	27074629																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.204																																0.1505																																8																																KS-1314	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Cc1ccc(cc1)C(=O)c2cc(O)c(O)c(c2)[N+](=O)[O-]	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466744	273.24084	TOLCAPONE	TOLCAPONE | RO-40-7592 | TASMAR | TOLCAPONE | RO-40-7592 | TASMAR			MOABOX:1348	COMT	COMT Inhibitors
SJ000518958-8	SJ000518958	8	MOABOX:1350	JRURYQJSLYLRLN-BJMVGYQFSA-N	CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1	1047659-02-8	COMT Inhibitors	COMT																																																															CHEMBL953											5281081	9831783	11605783	23642277	25002353	member	10.1021/acs.jmedchem.5b01970																																																																																																																																																															22483290	27074629																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.8836																																0.11045																																8																																HY-14280	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:1350|COMT|COMT Inhibitors	CCN(CC)C(=O)\C(=C\c1cc(O)c(O)c(c1)[N+](=O)[O-])\C#N	130929-57-6	10600	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469788	305.286	ENTACAPONE	"ENTACAPONE | COMTAN | ""ENTACAPONE | COM-998 | OR-611 | ENTACAPONUM |"" | ENTACAPONE | COMTAN | ""ENTACAPONE | COM-998 | OR-611 | ENTACAPONUM |"""	Pathway: Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:1350	COMT	COMT Inhibitors
SJ000782318-3	SJ000782318	3	MOABOX:1354	LCQLHJZYVOQKHU-VKHMYHEASA-N	NC(=O)N[C@@H](CCC(=O)O)C(=O)O	1188-38-1	Carbamoyl Phosphate Synthetase 1 (CPS1) Activators	CPS1																																																															CHEMBL1201780											121396	44155734	90647191	139199884	141207509	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																8																																HY-B0711	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:1354|CPS1|Carbamoyl Phosphate Synthetase 1 (CPS1) Activators	NC(=O)N[C@@H](CCC(=O)O)C(=O)O	1188-38-1	27668	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468801	190.154	N-CARBAMYL-L-GLUTAMIC ACID | GLUTAMICACID |	"""N-CARBAMYL-L-GLUTAMIC ACID | GLUTAMICACID |"" | ""N-CARBAMYL-L-GLUTAMIC ACID | GLUTAMICACID |"""	Pathway: Others	Research Area: Cancer	MOABOX:1354	CPS1	Carbamoyl Phosphate Synthetase 1 (CPS1) Activators
SJ000294116-3	SJ000294116	3	MOABOX:1362	OHAXNCGNVGGWSO-UHFFFAOYSA-N	O=C(Nc1ccc(Cl)cc1)c1cc2ccccc2cc1O	92-78-4	Cyclic AMP Response Element-Binding Protein (CREB) Inhibitors	CREB1																																																															CHEMBL65653											66720	21118641	70504709	70504931	70505389	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-104068	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:1362|CREB1|Cyclic AMP Response Element-Binding Protein (CREB) Inhibitors	Oc1cc2ccccc2cc1C(=O)Nc3ccc(Cl)cc3	92-78-4	90277	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469906	297.73568	KIX-KID INTERACTION INHIBITOR | CBP-CREB INTERACTION INHIBITOR | AMANIL NAPHTHOL AS-E | NAPHTANILIDE E | CIBANAPHTHOL RC |	"""KIX-KID INTERACTION INHIBITOR | CBP-CREB INTERACTION INHIBITOR | AMANIL NAPHTHOL AS-E | NAPHTANILIDE E | CIBANAPHTHOL RC |"" | ""KIX-KID INTERACTION INHIBITOR | CBP-CREB INTERACTION INHIBITOR | AMANIL NAPHTHOL AS-E | NAPHTANILIDE E | CIBANAPHTHOL RC |"""	Pathway: Epigenetics	Research Area: Cancer	MOABOX:1362	CREB1	Cyclic AMP Response Element-Binding Protein (CREB) Inhibitors
SJ001035174-1	SJ001035174	1	MOABOX:1366	LBWQSAZEYIZZCE-SNVBAGLBSA-N	CC[C@@H](C)Nc1nc(C)nc2c(-c3ccc(OC)nc3C)c(C)nn12	459856-18-9	CRF1 Antagonists	CRHR1																																																															CHEMBL482950											9884366					member	10.1021/jm900025h																																																																																																																																																															25105925	26335976	28174066																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.27936																																0.03492																																8																																HY-12127	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Neurological Disease; Endocrinology|MOABOX:1366|CRHR1|CRF1 Antagonists	CC[C@@H](C)Nc1nc(C)nc2c(c(C)nn12)c3ccc(OC)nc3C	459856-18-9	63999	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468986	340.42276	PEXACERFONT | BMS-562086	"""PEXACERFONT | BMS-562086"" | ""PEXACERFONT | BMS-562086"""	Pathway: GPCR/G Protein	Research Area: Neurological Disease; Endocrinology	MOABOX:1366	CRHR1	CRF1 Antagonists
SJ001035356-1	SJ001035356	1	MOABOX:1368	ANNRUWYFVIGKHA-UHFFFAOYSA-N	CCCN(CCC)c1cc(C)nc2c(-c3cnc(N(C)C)cc3C)c(C)nn12	195055-03-9	CRF1 Antagonists	CRHR1																																																															CHEMBL309138											9821250	22029352				member	10.1016/j.ejphar.2010.09.008	10.1021/jm050384+	10.1021/jm300864p	10.1124/mol.107.042978	10.2174/092986706776873014																																																																																																																																																											12127521	12769601	12774695	15341493	15974983	16078829	16378503	16712469	16750175	17073626	18397172	18672365	18989952	20185312	21074436	21618986	22587443	22971011	26335976	26456805	26901666	28174066																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																2.32232																																0.29029																																8																																HY-14127	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Neurological Disease; Endocrinology|MOABOX:1368|CRHR1|CRF1 Antagonists	CCCN(CCC)c1cc(C)nc2c(c(C)nn12)c3cnc(cc3C)N(C)C	195055-03-9	23577	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469716	380.52968	R121919 | NBI30775	"""R121919 | NBI30775"" | ""R121919 | NBI30775"""	Pathway: GPCR/G Protein	Research Area: Neurological Disease; Endocrinology	MOABOX:1368	CRHR1	CRF1 Antagonists
SJ000287677-5	SJ000287677	5	MOABOX:1382	DVKQVRZMKBDMDH-UUOKFMHZSA-N	Nc1ncnc2c1nc(Br)n2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1O	23583-48-4	activator of cGMP-dependent protein kinases;activators of cyclic nucleotide-regulated ion channels	CNGB1	CNGA2	CNGA4	PRKACA																													1260	1262	5566																													CHEMBL1626177											32014	126480007	131954754			member	10.1016/j.bmc.2019.03.024	10.1073/pnas.79.21.6470																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0	0	0	0																													0.0	0.0	0.0	0.0																													7	7	7	7																													HY-12306	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK; Stem Cell/Wnt | Research Area: Cancer|MOABOX:1382|CNGB1|activator of cGMP-dependent protein kinases;activators of cyclic nucleotide-regulated ion channels	Nc1ncnc2c1nc(Br)n2[C@@H]3O[C@@H]4COP(=O)(O)O[C@H]4[C@H]3O	76939-46-3	39604	GENERAL	SODIUM(I)	1	NO_SOLVATE	0	1468886	408.102	8-BROMO-CAMP SODIUM	8-BROMO-CAMP SODIUM | 8-BROMO-CAMP SODIUM	Pathway: Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Research Area: Cancer	MOABOX:1382	CNGB1	activator of cGMP-dependent protein kinases;activators of cyclic nucleotide-regulated ion channels
SJ001007922-8	SJ001007922	8	MOABOX:1386	ADZBMFGQQWPHMJ-RHSMWYFYSA-N	CNC(=O)c1cc(Oc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)ccn1	953769-46-5	Kinase inhibitors;CSF1R (c-FMS) Inhibitors;Angiogenesis Inhibitors	CSF1R																																																																										46184986	138455086	141759984			virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.3432																																0.2929																																8																																HY-12768	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:1386|CSF1R|Kinase inhibitors;CSF1R (c-FMS) Inhibitors;Angiogenesis Inhibitors	CNC(=O)c1cc(Oc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)ccn1	953769-46-5	24135	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469790	398.47868	BLZ945	BLZ945 | BLZ945	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:1386	CSF1R	Kinase inhibitors;CSF1R (c-FMS) Inhibitors;Angiogenesis Inhibitors
SJ001007922-7	SJ001007922	7	MOABOX:1386	ADZBMFGQQWPHMJ-RHSMWYFYSA-N	CNC(=O)c1cc(Oc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)ccn1	953769-46-5	Kinase inhibitors;CSF1R (c-FMS) Inhibitors;Angiogenesis Inhibitors	CSF1R																																																																										46184986	138455086	141759984			virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.3432																																0.2929																																8																																CS-3971	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-035-941-523|MOABOX:1386|CSF1R|Kinase inhibitors;CSF1R (c-FMS) Inhibitors;Angiogenesis Inhibitors	CNC(=O)c1cc(Oc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)ccn1	953769-46-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468703	398.47868	BLZ945	BLZ945 | BLZ945			MOABOX:1386	CSF1R	Kinase inhibitors;CSF1R (c-FMS) Inhibitors;Angiogenesis Inhibitors
SJ000831741-6	SJ000831741	6	MOABOX:1388	AUMDBEHGJRZSOO-UHFFFAOYSA-N	Nc1ncnc2c1c(COc1cccc(Cl)c1)nn2C1CCOCC1	1188296-52-7	Casein Kinase CK1epsilon Inhibitors	CSNK1E																																																															CHEMBL2069623											53472153	71751553				member	10.1021/jm301336n	10.1124/jpet.109.151415																																																																																																																																																														20577972	22944772	23106386	25899335																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.77752																																0.22219																																8																																HY-12470	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Stem Cell/Wnt | Research Area: Others|MOABOX:1388|CSNK1E|Casein Kinase CK1epsilon Inhibitors	Nc1ncnc2c1c(COc3cccc(Cl)c3)nn2C4CCOCC4	1188296-52-7	34830	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468776	359.81012	PF-4800567	PF-4800567 | PF-4800567	Pathway: Cell Cycle/DNA Damage; Stem Cell/Wnt	Research Area: Others	MOABOX:1388	CSNK1E	Casein Kinase CK1epsilon Inhibitors
SJ000285325-11	SJ000285325	11	MOABOX:1390	RHMXXJGYXNZAPX-UHFFFAOYSA-N	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O	518-82-1	Casein Kinase II (CK2) Inhibitors	CSNK2A1	CSNK2A2	CSNK2B																														1459	1460																														CHEMBL289277											3220	23615701	66941273	139071120	139388911	member	10.1002/med.20164	10.1016/j.bmc.2012.02.017	10.1016/j.ejmech.2017.12.058	10.1021/bi048999g	10.1042/BJ20030674																																																																																																																																																											12816539	17064064	19526464	21185805	22377675	23016545	23711832	25272055	29288942	30965682																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												2.83736	0.43078	0.66816																														0.35467	0.06154	0.08352																														8	7	8																														HY-14393	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Autophagy; Cell Cycle/DNA Damage; Stem Cell/Wnt | Research Area: Cancer|MOABOX:1390|CSNK2A1|Casein Kinase II (CK2) Inhibitors	Cc1cc(O)c2C(=O)c3c(O)cc(O)cc3C(=O)c2c1	518-82-1	10833	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468793	270.2369	EMODIN	EMODIN | EMODIN	Pathway: Anti-infection; Autophagy; Cell Cycle/DNA Damage; Stem Cell/Wnt	Research Area: Cancer	MOABOX:1390	CSNK2A1	Casein Kinase II (CK2) Inhibitors
SJ000805868-10	SJ000805868	10	MOABOX:1392	MUOKSQABCJCOPU-UHFFFAOYSA-N	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12	1009820-21-6	Casein Kinase II (CK2) Inhibitors	CSNK2A1	CSNK2A2	CSNK2B	MTOR	PIK3CD																												1459	1460	2475	5293																												CHEMBL1230165											24748573	53241014	53241015	53241018	53241114	member	10.1002/med.20164	10.1007/s11010-016-2892-x	10.1016/j.bmc.2012.02.017	10.1021/jm101251q	10.1039/c2ob26022k	10.1158/0008-5472.CAN-10-1893	10.2174/092986711796150423	10.2174/138955712800493915																																																																																																																																																								21174434	21982499	22169261	23711832	24681986	25272055	26850376	27017545	28274673	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												3.3576	1.40176	1.218	-0.3234	-0.32256																												0.4197	0.17522	0.15225	-0.0462	-0.04608																												8	8	8	7	7																												HY-50855	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Cell Cycle/DNA Damage; Stem Cell/Wnt | Research Area: Cancer|MOABOX:1392|CSNK2A1|Casein Kinase II (CK2) Inhibitors	OC(=O)c1ccc2c(c1)nc(Nc3cccc(Cl)c3)c4ccncc24	1009820-21-6	39119	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468957	349.77048	CX-9545	CX-9545 | SILMITASERTIB (CX-4945) | CX-4945 (SILMITASERTIB) | CX4945 | CX-9545 | SILMITASERTIB (CX-4945) | CX-4945 (SILMITASERTIB) | CX4945	Pathway: Autophagy; Cell Cycle/DNA Damage; Stem Cell/Wnt	Research Area: Cancer	MOABOX:1392	CSNK2A1	Casein Kinase II (CK2) Inhibitors
SJ000287542-8	SJ000287542	8	MOABOX:1398	KBOPZPXVLCULAV-UHFFFAOYSA-N	Nc1ccc(O)c(C(=O)O)c1	1261398-47-3	Non-Steroidal Antiinflammatory Drugs;PPAR Gamma Inhibitor	PPARG																																																															CHEMBL704											4075	201587	19909449	20038734	21127634	virtual	10.1016/j.bcp.2012.10.026.																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-7.238e-002																																-0.01034																																7																																HS-0100	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Nc1ccc(O)c(c1)C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466661	153.13538	MESALAMINE	"MESALAMINE | ""MESALAMINE | PENTASA"" | MESALAMINE | ""MESALAMINE | PENTASA"""			MOABOX:1398	PPARG	Non-Steroidal Antiinflammatory Drugs;PPAR Gamma Inhibitor
SJ000755090-3	SJ000755090	3	MOABOX:1402	ASXVEBPEZMSPHB-YJBOKZPZSA-N	C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1)C(=O)CF	105637-38-5	Cathepsin B Inhibitors	CTSB																																																															CHEMBL2402203											5311161					member																																																																																																																																																																16918467																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-2.096e-002																																-0.00262																																8																																CS-0059074	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-035-395-895|MOABOX:1402|CTSB|Cathepsin B Inhibitors	C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc2ccccc2)C(=O)CF	105637-38-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468497	386.41672	Z-FA-FMK|BENZYL N-[(1S)-1-{[(2S)-4-FLUORO-3-OXOBUTAN-2-YL]CARBAMOYL}-2-PHENYLETHYL]CARBAMATE	Z-FA-FMK|BENZYL N-[(1S)-1-{[(2S)-4-FLUORO-3-OXOBUTAN-2-YL]CARBAMOYL}-2-PHENYLETHYL]CARBAMATE | Z-FA-FMK | Z-FA-FMK|BENZYL N-[(1S)-1-{[(2S)-4-FLUORO-3-OXOBUTAN-2-YL]CARBAMOYL}-2-PHENYLETHYL]CARBAMATE | Z-FA-FMK			MOABOX:1402	CTSB	Cathepsin B Inhibitors
SJ000782371-7	SJ000782371	7	MOABOX:1412	YIQPUIGJQJDJOS-UHFFFAOYSA-N	c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1	110078-46-1	Chelating Agents;Chemokine CXCR4 (SDF-1 Receptor) Antagonists;HIV Attachment Inhibitors;CXCR4 antagonist	CXCR4																																																															CHEMBL1788331	CHEMBL18442	CHEMBL2088494	CHEMBL2311028	CHEMBL2311089	CHEMBL2373140						65014	65015	3000775	3000776	3001837	member	10.1002/cbic.201100441	10.1002/cmdc.201000548	10.1002/cmdc.201100525	10.1002/cmdc.201300289	10.1002/cmdc.201700229	10.1016/j.bcp.2005.05.035	10.1016/j.bmc.2009.01.014	10.1016/j.bmcl.2012.04.032	10.1016/j.chembiol.2019.01.012	10.1016/j.ejmech.2018.02.042	10.1016/j.nucmedbio.2018.01.004	10.1021/acs.jmedchem.7b01062	10.1021/acs.jmedchem.7b01322	10.1021/jm100786g	10.1021/jm300682j	10.1021/jm301337y	10.1021/jm301468k	10.1021/jm501769r	10.1021/jm501772w	10.1021/jm901530b	10.1021/jm990211i	10.1038/sj.leu.2402998	10.1039/c2md20117h	10.1073/pnas.0630420100	10.1074/jbc.M105670200	10.1074/jbc.M200889200	10.1074/jbc.M309546200	10.1080/14756360290024227	10.1097/00126334-200010010-00001	10.1124/mol.108.049775	10.1124/mol.55.1.67	10.1128/AAC.00513-13	10.1371/journal.pone.0176057	10.2174/138161210794455003																																																																																																																														10508445	11103038	11154697	12420752	12835717	15193136	15279544	15892677	16815309	17599916	17627557	17715128	18991641	19053768	19188071	19451305	20088780	21105715	21158728	21381769	21998043	22190478	22431600	22909088	22931505	24936240	25584630	25686267	27179215	27571038	27914361	29125295	29314840	30476826	30978562																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.74336																																0.34292																																8																																HY-10046	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; GPCR/G Protein; Immunology/Inflammation | Research Area: Cancer; Infection; Endocrinology; Inflammation/Immunology | DISSOLVED IN EtOH|MOABOX:1412|CXCR4|Chelating Agents;Chemokine CXCR4 (SDF-1 Receptor) Antagonists;HIV Attachment Inhibitors;CXCR4 antagonist	C(N1CCCNCCNCCCNCC1)c2ccc(CN3CCCNCCNCCCNCC3)cc2	110078-46-1	26711	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469749	502.78196	PLERIXAFOR	PLERIXAFOR | PLERIXAFOR HYDROCHLORIDE HYDRATE | PLERIXAFOR | PLERIXAFOR HYDROCHLORIDE HYDRATE	Pathway: Anti-infection; GPCR/G Protein; Immunology/Inflammation	Research Area: Cancer; Infection; Endocrinology; Inflammation/Immunology	MOABOX:1412	CXCR4	
SJ001033488-2	SJ001033488	2	MOABOX:1426	LLCRBOWRJOUJAE-UHFFFAOYSA-N	CCCN1CCN(c2ccc(C(=O)NC3(C(=O)NCC#N)CCCCC3)cc2)CC1	354813-19-7	Cathepsin K Inhibitors	CTSK																																																															CHEMBL371064											10201696	11398403	11679043	87855541		member	10.1016/j.bmcl.2007.12.047	10.1021/acs.jmedchem.5b00746	10.1021/jm301119s	10.1021/jm9018756	10.2174/156802610790725452																																																																																																																																																											16302795	17311556	18022984	18226527	20166952	20218623	20337585	22742641	22984809	26280490																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												3.4308																																0.42885																																8																																HY-15100	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:1426|CTSK|Cathepsin K Inhibitors	CCCN1CCN(CC1)c2ccc(cc2)C(=O)NC3(CCCCC3)C(=O)NCC#N	354813-19-7	11335	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469360	411.54042	BALICATIB; AAE581	BALICATIB; AAE581 | BALICATIB; AAE581	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:1426	CTSK	Cathepsin K Inhibitors
SJ000855340-2	SJ000855340	2	MOABOX:1440	MZRVIHRERYCHBL-HNNXBMFYSA-N	Cn1nc(C(C)(C)C)cc1C(=O)N[C@@H](Cc1cccc(Cl)c1)C(=O)NCC#N	225120-65-0	Cathepsin L Inhibitors	CTSL	CTSV	CTSL3P																														1515	392360																														CHEMBL564131											44224135					member																																																																																																																																																																19515558	19616430	29590751																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.89696	-0.27208	0																														0.36212	-0.03401	0.0																														8	8	7																														S2847	SELLECK	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-035-395-738|MOABOX:1440|CTSL|Cathepsin L Inhibitors	Cn1nc(cc1C(=O)N[C@@H](Cc2cccc(Cl)c2)C(=O)NCC#N)C(C)(C)C	225120-65-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468531	401.88986	CATHEPSIN INHIBITOR 1	CATHEPSIN INHIBITOR 1 | CATHEPSIN INHIBITOR 1			MOABOX:1440	CTSL	Cathepsin L Inhibitors
SJ001010892-3	SJ001010892	3	MOABOX:1466	MWKYMZXCGYXLPL-ZDUSSCGKSA-N	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1	1354690-24-6	PI3K Delta inhibitor	PIK3CD	CXCL13																															10563																															CHEMBL3643413	CHEMBL3989909										57495353	90214476	90214482	90214495	90214497	virtual																																																																																																																																																																28947947	30755348																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.6036	0																															0.20045	0.0																															8	7																															HY-17635	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: PI3K/Akt/mTOR | Research Area: Inflammation/Immunology|MOABOX:1466|PIK3CD|PI3K Delta inhibitor	CCC(=O)N1CC[C@@H](C1)Nc2ncnc3CCN(Cc23)c4cnc(OC)c(c4)C(F)(F)F	1354690-24-6	25785	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469138	450.45741	LENIOLISIB	LENIOLISIB | LENIOLISIB	Pathway: PI3K/Akt/mTOR	Research Area: Inflammation/Immunology	MOABOX:1466	PIK3CD	PI3K Delta inhibitor
SJ001033346-2	SJ001033346	2	MOABOX:1468	RXIUEIPPLAFSDF-CYBMUJFWSA-N	CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1	473727-83-2	Apoptosis Inducers;Chemokine CXCR1 (IL-8 alpha Receptor) Antagonists;Chemokine CXCR2  (IL-8 beta Receptor) Antagonists;Angiogenesis Inhibitors	CXCR1	CXCR2																															3579																															CHEMBL2103864	CHEMBL216981										9865554	11281445	139045178	139045179		member	10.1021/jm0609622	10.1021/jm300682j	10.1124/jpet.106.118927	10.2174/156802610791561246																																																																																																																																																												17181143	17459706	19196511	19525110	19557759	20536426	21413808	22931505	25455491																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0.55568	2.09424																															0.06946	0.26178																															8	8																															HY-10198	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation | Research Area: Inflammation/Immunology; Endocrinology|MOABOX:1468|CXCR1|Apoptosis Inducers;Chemokine CXCR1 (IL-8 alpha Receptor) Antagonists;Chemokine CXCR2 (IL-8 beta Receptor) Antagonists;Angiogenesis Inhibitors	CC[C@@H](NC1=C(Nc2cccc(C(=O)N(C)C)c2O)C(=O)C1=O)c3oc(C)cc3	473727-83-2	5280	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469502	397.42442	NAVARIXIN; SCH 527123; MK-7123	NAVARIXIN; SCH 527123; MK-7123 | NAVARIXIN; SCH 527123; MK-7123	Pathway: GPCR/G Protein; Immunology/Inflammation	Research Area: Inflammation/Immunology; Endocrinology	MOABOX:1468	CXCR1	Apoptosis Inducers;Chemokine CXCR1 (IL-8 alpha Receptor) Antagonists;Chemokine CXCR2 (IL-8 beta Receptor) Antagonists;Angiogenesis Inhibitors
SJ001034827-1	SJ001034827	1	MOABOX:1470	KNPLCJZGNRGZAN-UHFFFAOYSA-N	COc1ccccc1NC(=O)Nc1ccc([N+](=O)[O-])cc1O	182498-30-2	Chemokine CXCR1 (IL-8 alpha Receptor) Antagonists;Chemokine CXCR2  (IL-8 beta Receptor) Antagonists	CXCR1	CXCR2																															3579																																										9796445	88046120				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	-0.1834																															0.0	-0.0262																															7	7																															EN300-26958303	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-635-265|MOABOX:1470|CXCR1|Chemokine CXCR1 (IL-8 alpha Receptor) Antagonists;Chemokine CXCR2 (IL-8 beta Receptor) Antagonists	COc1ccccc1NC(=O)Nc2ccc(cc2O)[N+](=O)[O-]	182498-30-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468068	303.27012	EN300-26958303	EN300-26958303 | EN300-26958303			MOABOX:1470	CXCR1	Chemokine CXCR1 (IL-8 alpha Receptor) Antagonists;Chemokine CXCR2 (IL-8 beta Receptor) Antagonists
SJ001034965-1	SJ001034965	1	MOABOX:1474	WTLRWOHEKQGKDS-UHFFFAOYSA-N	NS(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2cccc(Cl)c2Cl)c1O	276700-41-5	Chemokine CXCR2  (IL-8 beta Receptor) Antagonists	CXCR2																																																															CHEMBL3819292											9887803					member	10.1016/j.bmc.2005.08.026	10.1124/jpet.106.118927	10.4049/jimmunol.169.11.6435																																																																																																																																																													16182534	16378503	27096048																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.49784																																0.31223																																8																																2593	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-624-550|MOABOX:1474|CXCR2|Chemokine CXCR2 (IL-8 beta Receptor) Antagonists	NS(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2cccc(Cl)c2Cl)c1O	276702-15-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468383	410.6602	SB 332235	SB 332235 | SB 332235			MOABOX:1474	CXCR2	Chemokine CXCR2 (IL-8 beta Receptor) Antagonists
SJ001035289-1	SJ001035289	1	MOABOX:1482	WQTKNBPCJKRYPA-OAQYLSRUSA-N	CCOc1ccc(-n2c([C@@H](C)N(Cc3cccnc3)C(=O)Cc3ccc(OC(F)(F)F)cc3)nc3ncccc3c2=O)cc1	473719-41-4	Chemokine CXCR3 Antagonists	CXCR3																																																															CHEMBL397983											24957182					member	10.1002/cmdc.200700365	10.1016/j.bmcl.2007.03.106	10.1016/j.bmcl.2008.07.115	10.1016/j.bmcl.2009.07.021	10.1016/j.bmcl.2009.07.032	10.1016/j.bmcl.2011.10.120																																																																																																																																																										17448658	18061451	18442035	18922694	19299127	19631529	19632842	21570852	22130135	22689503	22931505	27789141																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										4.52856																																0.56607																																8																																HY-15319	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation | Research Area: Cancer; Inflammation/Immunology; Endocrinology|MOABOX:1482|CXCR3|Chemokine CXCR3 Antagonists	CCOc1ccc(cc1)N2C(=O)c3cccnc3N=C2[C@@H](C)N(Cc4cccnc4)C(=O)Cc5ccc(OC(F)(F)F)cc5	473719-41-4	61713	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469506	603.59103	AMG 487	AMG 487 | AMG 487	Pathway: GPCR/G Protein; Immunology/Inflammation	Research Area: Cancer; Inflammation/Immunology; Endocrinology	MOABOX:1482	CXCR3	Chemokine CXCR3 Antagonists
SJ001033246-2	SJ001033246	2	MOABOX:1490	USUZGMWDZDXMDG-CYBMUJFWSA-N	N#Cc1ccc([C@H]2CCc3cncn32)c(F)c1	1304733-26-3	Raf kinase B Inhibitors;Cytochrome P450 11B2 (Aldosterone Synthase) Inhibitors;Cytochrome P450 CYP11B1 (Steroid 11-beta Hydroxylase) Inhibitors	CYP11B1	CYP11B2																															1585																															CHEMBL3099695	CHEMBL3707393										44139752	53327096	71009737	71666588	89704510	virtual	10.1016/j.ejmech.2014.12.022	10.1021/acs.jmedchem.5b00079	10.1021/acs.jmedchem.5b00851	10.1021/acs.jmedchem.5b01545	10.1021/acs.jmedchem.7b00437	10.1021/acs.jmedchem.8b00328	10.1021/acsmedchemlett.6b00455	10.1021/jm500140c	10.1021/ml400324c																																																																																																																																																							23688131	24422519	24899257	24900631	25528333	25711516	26403853	26540564	28105288	28570067	31312408																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											-6.376e-002	3.7084																															-0.00797	0.46355																															8	8																															T4277	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-560-410|MOABOX:1490|CYP11B1|Raf kinase B Inhibitors;Cytochrome P450 11B2 (Aldosterone Synthase) Inhibitors;Cytochrome P450 CYP11B1 (Steroid 11-beta Hydroxylase) Inhibitors	Fc1cc(ccc1[C@H]2CCc3cncn23)C#N	928134-65-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468145	227.237	OSILODROSTAT; LCI699	OSILODROSTAT; LCI699 | OSILODROSTAT; LCI699			MOABOX:1490	CYP11B1	Raf kinase B Inhibitors;Cytochrome P450 11B2 (Aldosterone Synthase) Inhibitors;Cytochrome P450 CYP11B1 (Steroid 11-beta Hydroxylase) Inhibitors
SJ000840383-3	SJ000840383	3	MOABOX:1504	CLPFFLWZZBQMAO-CQSZACIVSA-N	N#Cc1ccc([C@H]2CCCc3cncn32)cc1	102676-87-9	Cytochrome P450 11B2 (Aldosterone Synthase) Inhibitors	CYP11B2																																																															CHEMBL287677	CHEMBL480718										9815923	9838063	76966866			member	10.1016/j.bmcl.2010.06.086	10.1016/j.bmcl.2017.03.034	10.1016/j.ejphar.2016.11.049	10.1021/acs.jmedchem.5b00851	10.1021/jm901356d	10.1021/ml400324c	10.2174/1568026611313120003																																																																																																																																																									20121113	20615692	23688131	24422519	24900631	26403853	28359792																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															3.25192																																0.40649																																8																																CS-7759	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-005-940-728|MOABOX:1504|CYP11B2|Cytochrome P450 11B2 (Aldosterone Synthase) Inhibitors	N#Cc1ccc(cc1)C2CCCc3cncn23	102676-47-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468415	223.27312	FADROZOLE HYDROCHLORIDE	FADROZOLE HYDROCHLORIDE | FADROZOLE HYDROCHLORIDE			MOABOX:1504	CYP11B2	Cytochrome P450 11B2 (Aldosterone Synthase) Inhibitors
SJ000782322-7	SJ000782322	7	MOABOX:1506	UVIQSJCZCSLXRZ-UBUQANBQSA-N	CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC=C(c5cccnc5)[C@@]4(C)CC[C@@H]32)C1	154229-18-2	Androgen Biosynthesis Inhibitors;Cytochrome P450 CYP17 (17alpha-Hydroxylase/C17-20 Lyase) Inhibitors	CYP17A1																																																															CHEMBL271227											9821849	11670322	24744037	71696658	75201460	member	10.1007/s00044-015-1480-z	10.1016/j.bmcl.2014.04.024																																																																																																																																																														7608911																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.18																																0.3975																																8																																HY-75054	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:1506|CYP17A1|Androgen Biosynthesis Inhibitors;Cytochrome P450 CYP17 (17alpha-Hydroxylase/C17-20 Lyase) Inhibitors	CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC=C4c5cccnc5)[C@@H]3CC=C2C1	154229-18-2	6003	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469595	391.54572	ABIRATERONE ACETATE	"ABIRATERONE ACETATE | ""CB-7630 | JNJ-2012082 "" | ABIRATERONE ACETATE | ""CB-7630 | JNJ-2012082 """	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:1506	CYP17A1	Androgen Biosynthesis Inhibitors;Cytochrome P450 CYP17 (17alpha-Hydroxylase/C17-20 Lyase) Inhibitors
SJ000852772-4	SJ000852772	4	MOABOX:1508	OZPFIJIOIVJZMN-SFHVURJKSA-N	CNC(=O)c1ccc2cc([C@@]3(O)CCn4cncc43)ccc2c1	566939-85-3	Androgen Biosynthesis Inhibitors;Cytochrome P450 CYP17 (17alpha-Hydroxylase/C17-20 Lyase) Inhibitors	CYP17A1																																																															CHEMBL1921976											9796590	81689737	131673815			member	10.1016/j.bmc.2011.08.066																																																																																																																																																															21978946																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.59056																																0.32382																																8																																HY-10505	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:1508|CYP17A1|Androgen Biosynthesis Inhibitors;Cytochrome P450 CYP17 (17alpha-Hydroxylase/C17-20 Lyase) Inhibitors	CNC(=O)c1ccc2cc(ccc2c1)[C@@]3(O)CCn4cncc34	566939-85-3	5286	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469843	307.34648	TAK-700	TAK-700 | TAK-700 (ORTERONEL) | TAK-700 | TAK-700 (ORTERONEL)	Pathway: Others	Research Area: Cancer	MOABOX:1508	CYP17A1	Androgen Biosynthesis Inhibitors;Cytochrome P450 CYP17 (17alpha-Hydroxylase/C17-20 Lyase) Inhibitors
SJ000518963-7	SJ000518963	7	MOABOX:1514	BFYIZQONLCFLEV-DAELLWKTSA-N	C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12	107868-30-4	Aromatase Inhibitors	CYP19A1																																																															CHEMBL1200374											60198	9829943	66611980	66615143	66963456	virtual	10.1016/j.bmc.2016.04.056	10.1021/jm300930n	10.1158/0008-5472.CAN-06-2134	10.1158/0008-5472.CAN-06-2168																																																																																																																																																												16474421	16712450	17145897	22951074	25277066	26469743	27160054	27690428	28512028																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3.75448																																0.46931																																8																																HY-13632	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer; Endocrinology|MOABOX:1514|CYP19A1|Aromatase Inhibitors	C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O	107868-30-4	11302	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469457	296.40336	EXEMESTANE	EXEMESTANE | AROMASIN | EXEMESTANE | AROMASIN	Pathway: Others	Research Area: Cancer; Endocrinology	MOABOX:1514	CYP19A1	Aromatase Inhibitors
SJ000312330-10	SJ000312330	10	MOABOX:1518	YBBLVLTVTVSKRW-UHFFFAOYSA-N	CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1	120511-73-1	Aromatase Inhibitors	CYP19A1																																																															CHEMBL1399											2187	9937928	11496765	11531183	11533789	virtual	10.1002/cmdc.200700266	10.1016/j.bcp.2008.04.011	10.1016/j.bmc.2012.01.047	10.1016/j.bmc.2012.02.042	10.1016/j.bmcl.2008.06.094	10.1016/j.bmcl.2010.03.113	10.1016/j.dmpk.2017.09.003	10.1021/ja9037609	10.1021/jm0508282	10.1021/jm901705h	10.1039/b707768h	10.1080/14756360400015256	10.1080/14756360701652658	10.1158/0008-5472.CAN-06-2168	10.2174/187152006776930873																																																																																																																																																	9597182	15968818	16279787	16451067	16712450	17145897	17728860	18035835	18236493	18550029	18640836	18816537	20148564	20413308	22320301	22386564	22444875	22711801	25992880	26689671	27690428	28776988																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																5.98904																																0.74863																																8																																HY-14274	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:1518|CYP19A1|Aromatase Inhibitors	CC(C)(C#N)c1cc(Cn2cncn2)cc(c1)C(C)(C)C#N	120511-73-1	8916	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469644	293.36626	ANASTROZOLE	"ANASTROZOLE | ""ANASTROZOLE| ZD-1033| ICI-D-1033| ARIMIDEX | 2,2'-(5-((1H-1,2,4-TRIAZOL-1-YL)METHYL)-1,3-PHENYLENE)BIS(2-METHYLPROPANENITRILE) | ANASTROZOLE| ARIMIDEX"" | ANASTROZOLE | ""ANASTROZOLE| ZD-1033| ICI-D-1033| ARIMIDEX | 2,2'-(5-((1H-1,2,4-TRIAZOL-1-YL)METHYL)-1,3-PHENYLENE)BIS(2-METHYLPROPANENITRILE) | ANASTROZOLE| ARIMIDEX"""	Pathway: Others	Research Area: Cancer	MOABOX:1518	CYP19A1	Aromatase Inhibitors
SJ000287514-9	SJ000287514	9	MOABOX:1520	HPJKCIUCZWXJDR-UHFFFAOYSA-N	N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1	112809-51-5	Aromatase Inhibitors	CYP19A1																																																															CHEMBL1444											3902	9807804	9872558	25229624	44514426	virtual	10.1002/cmdc.201100145	10.1016/S0928-0987(00)00074-9	10.1016/j.bcp.2008.04.011	10.1016/j.bioorg.2004.06.008	10.1016/j.bioorg.2019.103327	10.1016/j.bmc.2012.01.047	10.1016/j.bmc.2013.11.045	10.1016/j.bmcl.2008.06.094	10.1016/j.bmcl.2010.03.113	10.1016/j.bmcl.2013.01.045	10.1016/j.bmcl.2016.04.078	10.1016/j.ejmech.2011.03.043	10.1016/j.ejmech.2017.11.057	10.1016/j.ejmech.2019.02.045	10.1016/j.tox.2005.10.020	10.1016/j.yrtph.2019.04.009	10.1021/jm2000689	10.1021/jm300930n	10.1021/jm301408t	10.1021/jm400377z	10.1021/jm501218e	10.1021/jm800168s	10.1021/jm800945c	10.1021/jm901705h	10.1038/aps.2014.53	10.1039/c2md20072d	10.1039/c3md00166k	10.1080/14756360701652658	10.1158/0008-5472.CAN-06-2168	10.2174/1570180813666161103144822	10.2174/187152006776930873																																																																																																																																	9597182	10915960	15530990	16279787	16712450	18035835	18550029	18590272	18640836	18816537	19072235	19217534	20148564	20388115	20413308	20738251	21497425	21604760	21608133	21703734	21919848	22335894	22386564	22711801	22951074	23281812	23403081	23495205	23651485	24025069	24345481	25751283	25934226	25992880	27161804	27567077	27647367	27690428	28776988	29137864	29153737	29202405	30822713																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											4.84408																																0.60551																																8																																HY-14248	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Others | Research Area: Cancer|MOABOX:1520|CYP19A1|Aromatase Inhibitors	N#Cc1ccc(cc1)C(c2ccc(cc2)C#N)n3cncn3	112809-51-5	12854	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469076	285.30274	LETROZOLE	LETROZOLE | LETROZOLE| FEMARA | LETROZOLE | LETROZOLE| FEMARA	Pathway: Autophagy; Others	Research Area: Cancer	MOABOX:1520	CYP19A1	Aromatase Inhibitors
SJ000869505-2	SJ000869505	2	MOABOX:1526	VHBFFQKBGNRLFZ-UHFFFAOYSA-N	O=c1cc(-c2ccccc2)oc2ccccc12	11091-19-3	Cytochrome P450 CYP1A1 Inhibitors	CYP1A1																																																															CHEMBL275638											10680	18392028	19936274	20058735	20480804	member	10.1016/j.bmc.2005.04.066	10.1021/tx100286d	10.2174/092986709789378198																																																																																																																																																													15914008	19754423																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.7164																																0.08955																																8																																AS-58464	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	O=C1C=C(Oc2ccccc12)c3ccccc3	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466800	222.2387	FLAVONE(RG)	FLAVONE(RG) | FLAVONE(RG)			MOABOX:1526	CYP1A1	Cytochrome P450 CYP1A1 Inhibitors
SJ000562450-2	SJ000562450	2	MOABOX:1528	MQGPSCMMNJKMHQ-UHFFFAOYSA-N	O=c1cc(-c2ccccc2)oc2cc(O)ccc12	6665-86-7	Cytochrome P450 CYP1A1 Inhibitors	CYP1A1																																																															CHEMBL276915											5281894	10461235	16760565	25210302	68936142	member	10.1016/j.bmc.2005.04.066	10.2174/092986709789378198	10.2174/138920009789895552																																																																																																																																																													15914008	19702529	19754423																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.19544																																0.14943																																8																																OR1155	APOLLO_SCI	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-742-467|MOABOX:1528|CYP1A1|Cytochrome P450 CYP1A1 Inhibitors	Oc1ccc2C(=O)C=C(Oc2c1)c3ccccc3	6665-86-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468390	238.2381	7-HYDROXYFLAVONE	7-HYDROXYFLAVONE | 7-HYDROXYFLAVONE			MOABOX:1528	CYP1A1	Cytochrome P450 CYP1A1 Inhibitors
SJ000891031-2	SJ000891031	2	MOABOX:1530	VFMMPHCGEFXGIP-UHFFFAOYSA-N	O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12	604-59-1	"Breast Cancer-Resistant Protein (BCRP;ABCG2) Inhibitors;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators"	CYP1A1	CYP1B1																															1545																															CHEMBL283196											11790	68735774	87309728	118540028	131666849	member	10.1002/med.10050	10.1007/s10989-016-9560-6	10.1016/j.bmc.2018.04.054	10.1016/j.bmc.2018.11.045	10.1016/j.bmcl.2017.11.009	10.1016/j.bmcl.2017.11.013	10.1016/j.ejmech.2017.02.016	10.1016/j.ejmech.2017.02.032	10.1016/j.ejps.2019.02.016	10.1021/acs.jmedchem.5b00265	10.1021/acs.jmedchem.8b00907	10.1021/tx100286d	10.1021/tx900127s	10.1021/tx980090+	10.1080/004982500237541	10.1111/j.1365-2125.1995.tb04472.x	10.1111/j.1600-0773.1998.tb01418.x	10.1111/jphp.12820	10.1124/dmd.106.011601	10.1124/dmd.109.026997	10.1124/dmd.119.086892																																																																																																																																											12939788	17291041	17544277	23373653	23600958	25799264	26222195	27002486	27687674	28222316	28259840	28458135	28489395	28711350	29138024	29150398	29152048	30216063	30422652	30448188	30553624	30613334																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.7636	1.60152																															0.09545	0.20019																															8	8																															HY-125833	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:1530|CYP1A1|Breast Cancer-Resistant Protein (BCRP;ABCG2) Inhibitors;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators"	O=C1C=C(Oc2c1ccc3ccccc23)c4ccccc4	604-59-1	51611	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469693	272.29738	ALPHA-NAPTHOFLAVONE	ALPHA-NAPTHOFLAVONE | ALPHA-NAPTHOFLAVONE	Pathway: Others	Research Area: Cancer	MOABOX:1530	CYP1A1	"Breast Cancer-Resistant Protein (BCRP;ABCG2) Inhibitors;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators"
SJ000286926-3	SJ000286926	3	MOABOX:1532	HVQAJTFOCKOKIN-UHFFFAOYSA-N	O=c1c(O)c(-c2ccccc2)oc2ccccc12	142416-04-4	"Drugs Acting on Beta-Amyloid;DNA binder;""Drugs Acting on Beta-Amyloid;DNA binder"""	CYP1A1	HSD17B7	HSD17B10	HSD17B2	HSD17B8	HSD17B6	HSD17B12	HSD17B11	HSD17B14	HSD17B13																							51478	3028	3294	7923	8630	51144	51170	51171	345275																							CHEMBL294009											11349	15447045	20580038	21155570	22338828	member	10.1016/j.bmc.2005.04.066	10.1021/jp508599h	10.2174/092986709789378198	10.2174/138920009789895552																																																																																																																																																												15914008	19702529	19754423																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.5448	0	0	0	0	0	0	0	0	0																							0.1931	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0																							8	7	7	7	7	7	7	7	7	7																							AS-19638	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC1=C(Oc2ccccc2C1=O)c3ccccc3	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466798	238.2381	3-HYDROXYFLAVONE	3-HYDROXYFLAVONE | 3-HYDROXYFLAVONE			MOABOX:1532	CYP1A1	"Drugs Acting on Beta-Amyloid;DNA binder;""Drugs Acting on Beta-Amyloid;DNA binder"""
SJ000562452-2	SJ000562452	2	MOABOX:1534	IYBLVRRCNVHZQJ-UHFFFAOYSA-N	O=c1cc(-c2ccccc2)oc2cccc(O)c12	491-78-1		CYP1A1	HSD17B7	HSD17B10	HSD17B2	HSD17B8	HSD17B6	HSD17B12	HSD17B11	HSD17B14	HSD17B13																							51478	3028	3294	7923	8630	51144	51170	51171	345275																							CHEMBL16807											68112	20580040	22338834	22338842	67389869	member	10.1016/j.bmc.2005.04.066	10.2174/092986709789378198	10.2174/138920009789895552																																																																																																																																																													15914008	19702529	19754423																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.29128	0	0	0	0	0	0	0	0	0																							0.16141	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0																							8	7	7	7	7	7	7	7	7	7																							HY-22024	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:1534|CYP1A1|	Oc1cccc2OC(=CC(=O)c12)c3ccccc3	491-78-1	26384	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469637	238.2381	PRIMULETIN;5-HYDROXYFLAVONE	PRIMULETIN;5-HYDROXYFLAVONE | PRIMULETIN;5-HYDROXYFLAVONE	Pathway: Others	Research Area: Cancer	MOABOX:1534	CYP1A1	
SJ000285330-11	SJ000285330	11	MOABOX:1536	QXKHYNVANLEOEG-UHFFFAOYSA-N	COc1c2occc2cc2ccc(=O)oc12	12692-94-3	DNA-Damaging Drugs;Cytochrome P450 CYP1A2 Inhibitors	CYP1A2																																																															CHEMBL416											4114	19759776	23313280	77843975	87131111	member	10.1080/00498254.2018.1434913	10.1124/dmd.31.8.1005																																																																																																																																																														11353760																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.0776																																0.1347																																8																																DS-5159	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1c2OC(=O)C=Cc2cc3ccoc13	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466783	216.18952	METHOXSALEN	METHOXSALEN | METHOXY-8-PSORALEN | 8-MOP | METHOXSALEN | METHOXY-8-PSORALEN | 8-MOP			MOABOX:1536	CYP1A2	DNA-Damaging Drugs;Cytochrome P450 CYP1A2 Inhibitors
SJ001034994-1	SJ001034994	1	MOABOX:1540	HQTBIZDUNOAXTD-UHFFFAOYSA-N	NCc1cc(-c2cccnc2)no1	543713-43-5	Cytochrome P450 CYP2A6 Inhibitors	CYP2A6																																																															CHEMBL217125											11993864	11993865				member																																																																																																																																																																17125252																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.09576																																0.38697																																8																																4010763	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-029-997-304|MOABOX:1540|CYP2A6|Cytochrome P450 CYP2A6 Inhibitors	NCc1onc(c1)c2cccnc2	543713-43-5	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468444	175.18726	4010763	4010763 | 4010763			MOABOX:1540	CYP2A6	Cytochrome P450 CYP2A6 Inhibitors
SJ000285763-9	SJ000285763	9	MOABOX:1542	BFPYWIDHMRZLRN-SLHNCBLASA-N	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C	1050678-65-3	Estrogen Receptor (ER) Agonists	CYP2B6	ESR1	ESR2																														2099	2100																														CHEMBL691											5991	23615828	25067580	87194723	87246695	member	10.1016/S0039-128X(01)00194-5	10.1016/S0039-128X(02)00021-1	10.1016/S0300-483X(01)00437-1	10.1016/S0960-0760(00)00126-6	10.1016/j.jsbmb.2004.03.118	10.1016/j.jsbmb.2004.09.004	10.1021/jm060353u	10.1039/b303985d																																																																																																																																																								536998	16248836	16554039	16611025	16722623	17073575	17512176	20408532	20836985	28049591																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												-5.472e-002	3.03064	2.01728																														-0.00684	0.37883	0.25216																														8	8	8																														KS-5257	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466753	296.40336	ETHINYL ESTRADIOL	ETHINYL ESTRADIOL | 17ALPHA-ETHYNYLESTRADIOL | ETHINYL ESTRADIOL | 17ALPHA-ETHYNYLESTRADIOL			MOABOX:1542	CYP2B6	Estrogen Receptor (ER) Agonists
SJ001034917-1	SJ001034917	1	MOABOX:1550	OQZOXHCRSXYSPM-UHFFFAOYSA-N	CSc1cc2c(cc1C(F)(F)F)N(C(=O)Nc1cccnc1)CC2	196965-14-7	5-HT2B Antagonists;5-HT2C Antagonists	CYP2D6																																																															CHEMBL276140											443389	18005146				member	10.1021/jm970424c	10.1021/jm990388c																																																																																																																																																														9357513	10737744																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.21656																																-0.02707																																8																																1379	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-959-520|MOABOX:1550|CYP2D6|5-HT2B Antagonists;5-HT2C Antagonists	CSc1cc2CCN(C(=O)Nc3cccnc3)c2cc1C(F)(F)F	196965-14-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468229	353.36207	SB 221284	SB 221284 | SB 221284			MOABOX:1550	CYP2D6	5-HT2B Antagonists;5-HT2C Antagonists
SJ001034910-1	SJ001034910	1	MOABOX:1552	ZIWFCOIGUNPHPM-HKUYNNGSSA-N	COc1ccc(OC(F)(F)F)cc1CN[C@H]1CCCN[C@H]1c1ccccc1	145742-28-5	Neurokinin 1 receptor antagonist;Tachykinin NK1 Antagonists	CYP2D6																																																															CHEMBL319118	CHEMBL3215877										9821217	9919067	11606655	57393951	90664465	member																																																																																																																																																																18640044	19689286																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.50704																																-0.06338																																8																																3649	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-628-948|MOABOX:1552|CYP2D6|Neurokinin 1 receptor antagonist;Tachykinin NK1 Antagonists	COc1ccc(OC(F)(F)F)cc1CN[C@H]2CCCN[C@H]2c3ccccc3	145877-52-7	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468220	380.40403	CP 122721 HCL	CP 122721 HCL | CP 122721 HCL			MOABOX:1552	CYP2D6	Neurokinin 1 receptor antagonist;Tachykinin NK1 Antagonists
SJ000832168-2	SJ000832168	2	MOABOX:1554	OVZWUDZIAAHNFG-HXUWFJFHSA-N	CN(C(=O)Cc1ccccc1)[C@H](CN1CCCC1)c1ccccc1	207452-97-9		CYP2D6																																																															CHEMBL94734											190901	56972158	91275660			member	10.1016/j.bmcl.2005.03.020	10.2174/092986709788803033																																																																																																																																																														15863335	19689286																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.3908																																-0.04885																																8																																783	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-275-932|MOABOX:1554|CYP2D6|	CN(C(CN1CCCC1)c2ccccc2)C(=O)Cc3ccccc3	207452-97-9	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468697	322.44394	N-MPPP HCL	N-MPPP HCL | N-MPPP HCL			MOABOX:1554	CYP2D6	
SJ000312343-7	SJ000312343	7	MOABOX:1566	UCHDWCPVSPXUMX-TZIWLTJVSA-N	CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1	1124196-02-6	Leukotriene CysLT1 (LTD4) Antagonists	GPR17	CYSLTR1																															10800																															CHEMBL787											5281040	9854596	9897843	9897846	11520399	member	10.1016/S0002-9440(10)63937-5	10.1016/S0960-894X(98)00051-1	10.1038/21658	10.1038/sj.emboj.7601341	10.1124/jpet.103.059824	10.1124/jpet.110.178715																																																																																																																																																										8709092	9871597	20621485	26200813																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		-0.12831	2.26888																															-0.01833	0.28361																															7	8																															AG003S60	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-885-842|MOABOX:1566|GPR17|Leukotriene CysLT1 (LTD4) Antagonists	CC(C)(O)c1ccccc1CCC(SCC2(CC(=O)O)CC2)c3cccc(\C=C\c4ccc5ccc(Cl)cc5n4)c3	151767-02-1	NA	GENERAL	SODIUM(I)	1	NO_SOLVATE	0	1468241	586.18324	MONTELUKAST SODIUM	"MONTELUKAST SODIUM | MONTELUKAST SODIUM| SINGULAIR | ""MONTELUKAST SODIUM | (E)-2-(1-((1-(3-(2-(7-CHLOROQUINOLIN-2-YL)VINYL)PHENYL)-3-(2-(2-HYDROXYPROPAN-2-YL)PHENYL)PROPYLTHIO)METHYL)CYCLOPROPYL)ACETIC ACID | MONTELUKAST SODIUM| SINGULAIR"" | MONTELUKAST SODIUM | MONTELUKAST SODIUM| SINGULAIR | ""MONTELUKAST SODIUM | (E)-2-(1-((1-(3-(2-(7-CHLOROQUINOLIN-2-YL)VINYL)PHENYL)-3-(2-(2-HYDROXYPROPAN-2-YL)PHENYL)PROPYLTHIO)METHYL)CYCLOPROPYL)ACETIC ACID | MONTELUKAST SODIUM| SINGULAIR"""			MOABOX:1566	GPR17	Leukotriene CysLT1 (LTD4) Antagonists
SJ000312293-9	SJ000312293	9	MOABOX:1568	YEEZWCHGZNKEEK-UHFFFAOYSA-N	COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12	107753-78-6	Leukotriene CysLT1 (LTD4) Antagonists	CYSLTR1	CYSLTR2																															57105																															CHEMBL603											5717	9852071	9919747	11181062	11228396	member	10.1016/S0960-894X(98)00273-X	10.1016/S0960-894X(98)00442-9	10.1016/S0960-894X(98)00654-4	10.1016/S0960-894X(99)00461-8	10.1021/acs.jmedchem.5b00741	10.1038/21658	10.1111/j.1476-5381.2010.00730.x	10.1124/jpet.103.059824																																																																																																																																																								8709092	9871521	9873435	21574253	26200813	26985325	28252961																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															2.25992	-0.50148																															0.28249	-0.07164																															8	7																															HY-17492	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Inflammation/Immunology; Cancer|MOABOX:1568|CYSLTR1|Leukotriene CysLT1 (LTD4) Antagonists	COc1cc(ccc1Cc2cn(C)c3ccc(NC(=O)OC4CCCC4)cc23)C(=O)NS(=O)(=O)c5ccccc5C	107753-78-6	25341	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469476	575.67522	ZAFIRLUKAST	"ZAFIRLUKAST | ""ZAFIRLUKAST | ACCOLATE | CYCLOPENTYL 3-(2-METHOXY-4-(O-TOLYLSULFONYLCARBAMOYL)BENZYL)-1-METHYL-1H-INDOL-5-YLCARBAMATE | ACCOLEIT | OLMORAN | RESPIX | ZAFIRST | ICI-204219 |"" | ZAFIRLUKAST | ZAFIRLUKAST | ""ZAFIRLUKAST | ACCOLATE | CYCLOPENTYL 3-(2-METHOXY-4-(O-TOLYLSULFONYLCARBAMOYL)BENZYL)-1-METHYL-1H-INDOL-5-YLCARBAMATE | ACCOLEIT | OLMORAN | RESPIX | ZAFIRST | ICI-204219 |"""	Pathway: GPCR/G Protein	Research Area: Inflammation/Immunology; Cancer	MOABOX:1568	CYSLTR1	Leukotriene CysLT1 (LTD4) Antagonists
SJ000287924-6	SJ000287924	6	MOABOX:1570	ZJVFLBOZORBYFE-UHFFFAOYSA-N	CC(C)C(=O)c1c(C(C)C)nn2ccccc12	050847-11-5	TLR4 (LPS) Receptor Antagonists;Leukotriene CysLT1 (LTD4) Antagonists;Phosphodiesterase Inhibitors;Mediator Release Inhibitors	PDE4A	PDE4B	PDE4C	PDE4D	TLR4	CYSLTR1																											5142	5143	5144	7099	10800																											CHEMBL19449											3671	16049385	24795102	66847492	66913033	virtual	10.1021/jm800582j																																																																																																																																																															18686943	21456625																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.37688	0.87512	0.64952	0.86808	0	0																											0.17211	0.10939	0.08119	0.10851	0.0	0.0																											8	8	8	8	7	7																											H-20256	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)C(=O)c1c(nn2ccccc12)C(C)C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466670	230.30552	IBUDILAST	IBUDILAST | IBUDILAST			MOABOX:1570	PDE4A	TLR4 (LPS) Receptor Antagonists;Leukotriene CysLT1 (LTD4) Antagonists;Phosphodiesterase Inhibitors;Mediator Release Inhibitors
SJ001035236-1	SJ001035236	1	MOABOX:1578	SJAPSPJRTQCDNO-UHFFFAOYSA-N	Oc1noc2cc(Cl)ccc12	61977-29-5	D-Amino Acid Oxidase (DAAO) Inhibitors	DAO																																																															CHEMBL445990											2781852					member	10.1016/j.bmc.2018.02.004	10.1016/j.bmcl.2008.04.020	10.1016/j.ejmech.2016.04.017	10.2174/1381612811319140002																																																																																																																																																												18455394	18507366	21880399	23116391	23683589	27089209	29472125																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															3.05736																																0.38217																																8																																HY-W046317	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: | Research Area: |MOABOX:1578|DAO|D-Amino Acid Oxidase (DAAO) Inhibitors	Clc1ccc2C(=O)NOc2c1	61977-29-5	99300	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469239	169.56516	6-CHLOROBENZO[D]ISOXAZOL-3(2H)-ONE	6-CHLOROBENZO[D]ISOXAZOL-3(2H)-ONE | 6-CHLOROBENZO[D]ISOXAZOL-3(2H)-ONE	Pathway:	Research Area:	MOABOX:1578	DAO	D-Amino Acid Oxidase (DAAO) Inhibitors
SJ001034859-1	SJ001034859	1	MOABOX:1580	PXHPPVLWNLIWNR-UHFFFAOYSA-N	S=c1[nH]nc(-c2cccnc2)n1Cc1ccccc1	129119-80-8	Dopamine beta-monooxygenase Inhibitors	DBH																																																															CHEMBL1370673											667615					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																PHAR214829	PHARMEKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-244-102|MOABOX:1580|DBH|Dopamine beta-monooxygenase Inhibitors	S=C1NN=C(N1Cc2ccccc2)c3cccnc3	129119-80-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468112	268.33688	PHAR214829	PHAR214829 | PHAR214829			MOABOX:1580	DBH	Dopamine beta-monooxygenase Inhibitors
SJ000851927-3	SJ000851927	3	MOABOX:1582	GEVVQZHMFVFGLN-HDJSIYSDSA-N	Nc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2	1109276-89-2	Diacylglycerol Acyltransferase type 1 (DGAT-1) Inhibitors	DGAT1																																																															CHEMBL1835919																member	10.1016/S0065-7743(10)45007-1	10.1016/j.bmc.2013.06.045	10.1016/j.bmcl.2011.08.028	10.1016/j.ejmech.2014.03.077	10.1021/ml200051p																																																																																																																																																											21908190	22073239	23810496	23871442	23919406	24735646	24900321																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															3.04712																																0.38089																																8																																HY-13009	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:1582|DGAT1|Diacylglycerol Acyltransferase type 1 (DGAT-1) Inhibitors	Nc1ncnc2OCCN(C(=O)c12)c3ccc(cc3)[C@@H]4CC[C@@H](CC(=O)O)CC4	1109276-89-2	7225	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469226	396.43966	PF-04620110	PF-04620110 | PF-04620110	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:1582	DGAT1	Diacylglycerol Acyltransferase type 1 (DGAT-1) Inhibitors
SJ001033305-2	SJ001033305	2	MOABOX:1594	GXALXAKNHIROPE-QAQDUYKDSA-N	O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(Nc4ccc(C(F)(F)F)nc4)cn3)cc2)CC1	956136-98-4	Diacylglycerol Acyltransferase type 1 (DGAT-1) Inhibitors	DGAT1																																																															CHEMBL2364624																virtual	10.1021/acsmedchemlett.9b00117																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.6616																																0.3327																																8																																HY-16278	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:1594|DGAT1|Diacylglycerol Acyltransferase type 1 (DGAT-1) Inhibitors	OC(=O)C[C@@H]1CC[C@H](CC1)c2ccc(cc2)c3ccc(Nc4ccc(nc4)C(F)(F)F)cn3	956136-95-1	8164	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468851	455.47217	PRADIGASTAT; LCQ-908	PRADIGASTAT; LCQ-908 | PRADIGASTAT; LCQ-908	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:1594	DGAT1	Diacylglycerol Acyltransferase type 1 (DGAT-1) Inhibitors
SJ000574313-10	SJ000574313	10	MOABOX:1600	NOYPYLRCIDNJJB-UHFFFAOYSA-N	COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC	251301-18-5	Antimetabolites;Dihydrofolate Reductase (DHFR) Inhibitors	DHFR																																																															CHEMBL119	CHEMBL2007423	CHEMBL2218878	CHEMBL2358886	CHEMBL3392303							5583	54949	332299	336805	461570	member	10.1016/j.bmc.2010.04.020	10.1021/acs.jmedchem.8b01754	10.1021/cr0301144	10.1021/jm00018a021	10.1021/jm00040a008	10.1021/jm00073a009	10.1021/jm0202369	10.1021/jm400086g	10.1128/AAC.44.10.2784-2793.2000	10.1128/AAC.44.11.3092-3096.2000	10.1128/AAC.44.4.1019-1028.2000	10.1128/AAC.46.9.3101-3103.2002	10.1128/AAC.49.8.3234-3238.2005																																																																																																																																																			7490723	7629801	7658448	7658454	7752201	7783147	7799402	7877140	8035423	8230096	8230134	8627607	8632413	8632434	8691474	9046337	9089339	9191966	9191971	9301665	9301666	9357537	9526565	9548816	9554874	9719595	9804692	10395486	10579848	10722506	10991861	11036028	11384244	11448221	11472209	11597474	12110323	12183283	12408727	12832132	14584957	15026078	15113582	15115391	15214795	15700958	16475929	17010625	17346178	18288923	18605720	18771252	19874136	20056546	20452776	21395543	22625412	23627352																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												0.54072																																0.06759																																8																																CS-4063	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-167-723|MOABOX:1600|DHFR|Antimetabolites;Dihydrofolate Reductase (DHFR) Inhibitors	COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC	52128-35-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468169	369.41762	TRIMETREXATE	"TRIMETREXATE | ""CI 898 TRIHYDROCHLORIDE | TMQ | TRIMETREXATE GLUCURONATE | NSC-249008 | JB-11 | NSC-352122 | NEUTREXIN"" | CI 898 TRIHYDROCHLORIDE | TRIMETREXATE | ""CI 898 TRIHYDROCHLORIDE | TMQ | TRIMETREXATE GLUCURONATE | NSC-249008 | JB-11 | NSC-352122 | NEUTREXIN"" | CI 898 TRIHYDROCHLORIDE"			MOABOX:1600	DHFR	Antimetabolites;Dihydrofolate Reductase (DHFR) Inhibitors
SJ000855129-8	SJ000855129	8	MOABOX:1604	FBOZXECLQNJBKD-ZDUSSCGKSA-N	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1	102613-64-9	Folate Antagonists;Dihydrofolate Reductase (DHFR) Inhibitors	DHFR	FOLR1																															2348																															CHEMBL1376974	CHEMBL34259										126941	163214	165528	486218	9810946	member	10.1016/j.bioorg.2018.04.022	10.1016/j.bmc.2005.04.087	10.1016/j.bmc.2006.08.029	10.1016/j.bmc.2009.11.029	10.1016/j.bmc.2012.05.068	10.1016/j.bmc.2018.04.035	10.1016/j.bmc.2019.02.053	10.1016/j.bmcl.2017.02.018	10.1016/j.ejmech.2012.09.027	10.1016/j.ejmech.2013.04.017	10.1016/j.ejmech.2013.05.039	10.1016/j.ejmech.2017.01.033	10.1016/j.ejmech.2019.06.013	10.1021/acs.jmedchem.6b01253	10.1021/acs.jmedchem.8b01754	10.1021/acsmedchemlett.6b00328	10.1021/cr0301144	10.1021/jm0009639	10.1021/jm0202369	10.1021/jm058213s	10.1021/jm061475p	10.1021/jm070165j	10.1021/jm400086g	10.1021/jm401139z	10.1021/jm8006933	10.1021/jm900490a	10.1021/jm9011142	10.1021/jm9015729	10.1111/febs.13244	10.2174/187152008783497064																																																																																																																																		110934	1578484	1992118	1992121	1992122	1995880	2296020	2704031	2738891	2918496	3091832	3339615	6403710	6772788	7365749	7562910	7877140	8035423	8164259	8568827	8568828	8691451	8691474	9857098	10360757	10956221	11052789	11052790	11384244	11960504	12408727	12570380	15615522	15615538	15700958	16039863	16078850	16279780	16451071	16990006	17127067	17532099	17552508	17569517	18072727	18205293	18288923	18555562	18605720	18800768	19174154	19719239	19748785	20056546	20085328	20092323	20350811	20580561	21466465	21550809	21879757	22142685	22225916	22739090	22946585	23124219	23627352	23665106	23792351	24111942	24256410	24428639	24469112	25234128	25602637	26317331	26617968	26670841	26994844	27437079	27458733	27886545	27994750	28152430	28177228	28258797	28477572	29111368	29274493	29691154	30827867																																																																																																																																																																																																																																																																																																																																																																																																																																																																											2.50344	-0.30424																															0.31293	-0.03803																															8	8																															KS-5093	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CN(Cc1cnc2nc(N)nc(N)c2n1)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466730	454.43928	METHOTREXATE	METHOTREXATE | METHOTREXATE			MOABOX:1604	DHFR	Folate Antagonists;Dihydrofolate Reductase (DHFR) Inhibitors
SJ000286159-17	SJ000286159	17	MOABOX:1606	WKSAUQYGYAYLPV-UHFFFAOYSA-N	CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1	19085-09-7	Pharmacological Chaperones;Dihydrofolate Reductase (DHFR) Inhibitors	DHFR	GSTP1																															2950																															CHEMBL3137689	CHEMBL36										4993	65405	161085	235684	248396	member	10.1016/j.ejmech.2017.04.070	10.1021/acsmedchemlett.6b00328	10.1021/jm400086g	10.1128/AAC.44.11.3092-3096.2000	10.2174/092986706776872934																																																																																																																																																											1495020	3290487	4585973	7490723	8632413	8632434	9191966	9357537	9449279	9526565	10090784	10428380	10543874	11036028	11451529	11472209	11597474	11881993	12183283	12825927	12929634	14736247	15293997	15700958	16475929	16719788	16750361	16954316	17300160	17346178	17530725	17875995	18605720	19895504	20350951	21401508	21619511	22192590	22242845	22739090	23587422	23627352	27994750	28477572	29111368	30613332																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								2.71432	-0.256																															0.33929	-0.032																															8	8																															KS-5223	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCc1nc(N)nc(N)c1c2ccc(Cl)cc2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466690	248.71142	PYRIMETHAMINE	"PYRIMETHAMINE | PYRIMETHAMINE| DARAPRIM | ""PYRIMETHAMINE | EXR-101 | DARAPRIM |"" | ""PYRIMETHAMINE | EXR-101 |"" | PYRIMETHAMINE | PYRIMETHAMINE| DARAPRIM | ""PYRIMETHAMINE | EXR-101 | DARAPRIM |"" | ""PYRIMETHAMINE | EXR-101 |"""			MOABOX:1606	DHFR	Pharmacological Chaperones;Dihydrofolate Reductase (DHFR) Inhibitors
SJ000520380-2	SJ000520380	2	MOABOX:1616	UBHJFPVTEATUFS-UHFFFAOYSA-N	COc1cc(OC)cc(C(=O)Nc2ccc(Cl)c(-c3nc4cc(N(C)C)ccc4[nH]3)c2)c1	496794-70-8	Hedgehog Signaling Inhibitors	SHH	SMO	IHH	DHH																													6608	3549	50846																													CHEMBL516246											9911630					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	1.29752	1.31784	0																													0.0	0.16219	0.16473	0.0																													7	8	8	7																													HY-15412	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Stem Cell/Wnt | Research Area: Cancer|MOABOX:1616|SHH|Hedgehog Signaling Inhibitors	COc1cc(OC)cc(c1)C(=O)Nc2ccc(Cl)c(c2)c3nc4ccc(cc4[nH]3)N(C)C	496794-70-8	8212	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469712	450.91742			Pathway: Stem Cell/Wnt	Research Area: Cancer	MOABOX:1616	SHH	Hedgehog Signaling Inhibitors
SJ001033373-2	SJ001033373	2	MOABOX:1618	XPRDUGXOWVXZLL-UHFFFAOYSA-N	COc1cccc(-c2ccc(NC(=O)C3=C(C(=O)O)CCC3)c(F)c2)c1	717824-30-1	Anti-IL-17;Dihydroorotate Dehydrogenase (DHODH) Inhibitors	DHODH																																																															CHEMBL197194											9820008	56596115	56596116	56596118	56596162	member	10.1016/j.bmcl.2005.07.053	10.1016/j.bmcl.2005.10.011	10.2174/138955711797247707																																																																																																																																																													16143532	16246558	21861807																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.44968																																0.43121																																8																																HY-14908	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:1618|DHODH|Anti-IL-17;Dihydroorotate Dehydrogenase (DHODH) Inhibitors	COc1cccc(c1)c2ccc(NC(=O)C3=C(CCC3)C(=O)O)c(F)c2	717824-30-1	13605	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469347	355.35962	VIDOFLUDIMUS; 4SC-101; SC12267	VIDOFLUDIMUS; 4SC-101; SC12267 | VIDOFLUDIMUS; 4SC-101; SC12267	Pathway: Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:1618	DHODH	Anti-IL-17;Dihydroorotate Dehydrogenase (DHODH) Inhibitors
SJ000831511-2	SJ000831511	2	MOABOX:1620	YQUVCSBJEUQKSH-UHFFFAOYSA-N	O=C(O)c1ccc(O)c(O)c1	1225528-47-1	Apoptosis Inhibitors;Dihydroorotate Dehydrogenase (DHODH) Inhibitors;Antioxidants;beta-Amyloid (Abeta) Protein Neurotoxicity Inhibitors	DHODH																																																															CHEMBL37537											72	434929	23558402	24200154	24211997	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.22988																																-0.03284																																7																																AS-10808	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC(=O)c1ccc(O)c(O)c1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466793	154.12014	PROTOCATECHUIC ACID	PROTOCATECHUIC ACID | PROTOCATECHUIC ACID			MOABOX:1620	DHODH	Apoptosis Inhibitors;Dihydroorotate Dehydrogenase (DHODH) Inhibitors;Antioxidants;beta-Amyloid (Abeta) Protein Neurotoxicity Inhibitors
SJ000556684-6	SJ000556684	6	MOABOX:1622	UTNUDOFZCWSZMS-YFHOEESVSA-N	C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1	108605-62-5	Dihydroorotate Dehydrogenase (DHODH) Inhibitors	DHODH																																																															CHEMBL973											54684141	54692947	54698001	54730194	122177192	member	10.1002/cmdc.200900454	10.1016/S0006-2952(98)00145-2	10.1016/j.ejmech.2017.02.017	10.1021/acs.jmedchem.5b00606	10.1021/acs.jmedchem.8b00373	10.1021/jm060687j	10.1021/jm300630p	10.1021/jm400938g	10.1021/jm500481t	10.1021/jm501127s	10.1021/jm800963t	10.2174/092986710790820660	10.2174/092986711794927748																																																																																																																																																			9873513	14684297	16143532	17228860	19351152	20156168	20183850	21182479	21861807	22984987	24073986	24801997	25580811	26079043	26915022	27220723	28235702	29939742	30776695	30938999																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.86496																																0.10812																																8																																LE-0275	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(=O)C(C#N)C(=O)Nc1ccc(cc1)C(F)(F)F	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466754	270.20727	TERIFLUNOMIDE	TERIFLUNOMIDE | TERIFLUNOMIDE			MOABOX:1622	DHODH	Dihydroorotate Dehydrogenase (DHODH) Inhibitors
SJ001034983-1	SJ001034983	1	MOABOX:1626	NJQHZBRWPXRTIW-UHFFFAOYSA-N	O=C(O)c1ccc(Nc2nc(Cl)nc(Cl)n2)cc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12		Deoxyribonuclease (DNase) gamma Inhibitors	DNASE1L3																																																															CHEMBL222509											2829313	139024036				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.57318																																0.22474																																7																																5135283	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-737-048|MOABOX:1626|DNASE1L3|Deoxyribonuclease (DNase) gamma Inhibitors	OC(=O)c1ccc(Nc2nc(Cl)nc(Cl)n2)cc1C3=C4C=CC(=O)C=C4Oc5cc(O)ccc35	NA	NA	GENERAL	CHLORIDE	1	H2O	3	1468426	495.27118	5135283	5135283 | 5135283			MOABOX:1626	DNASE1L3	Deoxyribonuclease (DNase) gamma Inhibitors
SJ001034860-1	SJ001034860	1	MOABOX:1628	UCIVYNVXNNEYDV-KRWDZBQOSA-N	O=C(O)[C@H](Cc1c[nH]c2ccccc12)N1Cc2ccccc2C1=O		DNA Methyltransferase 1 (DNMT1) Inhibitors	DNMT1																																																																										1473532					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																PHBB_NC-03263	PHARMEKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-019-825-691|MOABOX:1628|DNMT1|DNA Methyltransferase 1 (DNMT1) Inhibitors	OC(=O)[C@H](Cc1c[nH]c2ccccc12)N3Cc4ccccc4C3=O	919767-13-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468113	320.34194	PHBB_NC-03263	PHBB_NC-03263 | PHBB_NC-03263			MOABOX:1628	DNMT1	DNA Methyltransferase 1 (DNMT1) Inhibitors
SJ000755095-5	SJ000755095	5	MOABOX:1630	DHSUYTOATWAVLW-WFVMDLQDSA-N	CC1(C)C[C@@H]1C(=O)N/C(=C\CCCCSC[C@H](N)C(=O)O)C(=O)O	81129-83-1	Dehydropeptidase I Inhibitors	DPEP1																																																															CHEMBL1628401	CHEMBL296854	CHEMBL766									6435415	9929824	11552566	17756656	52950467	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-A0166	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Infection|MOABOX:1630|DPEP1|Dehydropeptidase I Inhibitors	CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(=O)O)\C(=O)O	82009-34-5	27577	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469563	358.45304	CILASTATIN	CILASTATIN | CILASTATIN SODIUM | CILASTATIN | CILASTATIN SODIUM	Pathway: Anti-infection	Research Area: Infection	MOABOX:1630	DPEP1	Dehydropeptidase I Inhibitors
SJ000806135-6	SJ000806135	6	MOABOX:1632	LTXREWYXXSTFRX-QGZVFWFLSA-N	CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C	1233245-11-8	Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors	DPP4																																																															CHEMBL237500											10096344	25227474	44230858	46178292	46235889	virtual	10.1016/j.bmc.2012.07.046	10.1016/j.bmcl.2008.04.075	10.1016/j.bmcl.2011.11.054	10.1016/j.ejmech.2014.06.044	10.1021/acsmedchemlett.6b00027	10.1021/jm500031w	10.1021/jm701280z	10.1111/cbdd.12560	10.2174/092986711797535290																																																																																																																																																							18052023	18485703	19075765	19217790	21919850	22177783	22709010	22938786	23358258	23623674	24617858	24900696	24996141	27190600	27438064	28826083	30642693																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					4.80712																																0.60089																																8																																AS-35080	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC#CCn1c(nc2N(C)C(=O)N(Cc3nc(C)c4ccccc4n3)C(=O)c12)N5CCC[C@@H](N)C5	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466799	472.54222	LINAGLIPTIN	"LINAGLIPTIN | ""LINAGLIPTIN | BI-1356 | BI-1356-BS |"" | LINAGLIPTIN | ""LINAGLIPTIN | BI-1356 | BI-1356-BS |"""			MOABOX:1632	DPP4	Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors
SJ000852790-4	SJ000852790	4	MOABOX:1634	ZSBOMTDTBDDKMP-OAHLLOKOSA-N	Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O	1246610-75-2	Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors	DPP4																																																															CHEMBL227529	CHEMBL376359	CHEMBL458537	CHEMBL459806								11450633	16088021	16214940	16658243	24764414	member	10.1007/s11418-015-0914-8	10.1016/j.bmc.2011.07.042	10.1016/j.bmc.2012.07.046	10.1016/j.bmc.2018.01.006	10.1016/j.bmc.2019.01.001	10.1016/j.bmcl.2006.09.024	10.1016/j.ejmech.2009.03.021	10.1016/j.ejmech.2012.03.015	10.1016/j.ejmech.2013.08.010	10.1016/j.ejmech.2014.06.044	10.1016/j.ejmech.2019.07.045	10.1016/j.ejphar.2008.04.047	10.1021/acsmedchemlett.6b00027	10.1021/jm101016w	10.1021/ml5001905	10.1111/cbdd.12058	10.1111/cbdd.12560	10.2174/092986711797535290	10.2174/138955709787316100	10.2174/156802607780091064	10.3109/14756366.2014.1002402																																																																																																																																											17010607	17352678	17352679	17352681	17441705	18223196	18538760	19075765	19200026	19217790	19375196	21106276	21186796	21334204	21865048	21919850	22475866	22709010	22938786	22994702	23170960	23623674	23994324	24099035	24996141	25147615	25532473	27190600	27438064	28421763	29373269																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							3.72632																																0.46579																																8																																AG00IDIW	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-005-933-065|MOABOX:1634|DPP4|Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors	CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(Cc3ccccc3C#N)C1=O	850649-61-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468624	339.39164	ALOGLIPTIN BENZOATE	ALOGLIPTIN BENZOATE | ALOGLIPTIN | ALOGLIPTIN BENZOATE | ALOGLIPTIN			MOABOX:1634	DPP4	Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors
SJ000855168-6	SJ000855168	6	MOABOX:1638	QGJUIPDUBHWZPV-SGTAVMJGSA-N	N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2	1073057-20-1	Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors	DPP4																																																															CHEMBL1201743	CHEMBL2103745	CHEMBL385517									11243969	23645676	49800073	53297473	91617812	member	10.1016/j.bcp.2008.03.021	10.1016/j.bmc.2012.07.046	10.1016/j.bmc.2013.12.061	10.1016/j.bmcl.2009.05.048	10.1021/jm200383j	10.2174/138955709787316100	10.2174/156802607780091064																																																																																																																																																									16033281	16375746	17034148	17073841	17352679	17352680	17352681	17352682	17937986	18223196	19200026	19217790	19375196	19482472	20483603	21510839	21711053	21919850	22938786	23170960	23623674	24099035	24457090	25532473	27438064	27820798																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												4.34568																																0.54321																																8																																BD00960287	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-634-270|MOABOX:1638|DPP4|Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors	N[C@H](C(=O)N1[C@@H](C[C@@H]2C[C@H]12)C#N)C34CC5CC(CC(O)(C5)C3)C4	1073057-20-1	NA	GENERAL	CHLORIDE	1	H2O	2	1468660	315.41	SAXAGLIPTIN	SAXAGLIPTIN | SAXAGLIPTIN			MOABOX:1638	DPP4	Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors
SJ000806146-5	SJ000806146	5	MOABOX:1640	MFFMDFFZMYYVKS-SECBINFHSA-N	N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F	1169707-31-6	Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors	DPP4																																																															CHEMBL1201174	CHEMBL1422	CHEMBL393336	CHEMBL539077								4369359	6451150	11386885	11476287	11505000	virtual	10.1016/j.bcp.2008.03.021	10.1016/j.bioorg.2018.09.021	10.1016/j.bmc.2009.02.020	10.1016/j.bmc.2011.07.042	10.1016/j.bmc.2012.07.046	10.1016/j.bmc.2013.07.034	10.1016/j.bmc.2014.09.051	10.1016/j.bmc.2019.01.001	10.1016/j.bmcl.2005.11.052	10.1016/j.bmcl.2006.03.037	10.1016/j.bmcl.2006.09.099	10.1016/j.bmcl.2007.03.095	10.1016/j.bmcl.2007.03.098	10.1016/j.bmcl.2010.04.124	10.1016/j.bmcl.2010.12.060	10.1016/j.bmcl.2011.01.041	10.1016/j.bmcl.2011.01.086	10.1016/j.bmcl.2012.07.033	10.1016/j.bmcl.2013.07.061	10.1016/j.bmcl.2013.12.118	10.1016/j.bmcl.2014.03.009	10.1016/j.bmcl.2017.04.036	10.1016/j.bmcl.2018.05.022	10.1016/j.bmcl.2018.10.019	10.1016/j.ejmech.2007.11.029	10.1016/j.ejmech.2009.03.021	10.1016/j.ejmech.2014.01.021	10.1016/j.ejmech.2014.08.059	10.1016/j.ejphar.2016.06.016	10.1021/acs.jmedchem.6b01801	10.1021/jm0493156	10.1021/jm0505866	10.1021/jm070330v	10.1021/jm1002556	10.1021/jm200383j	10.1021/ml5001905	10.1111/cbdd.12327	10.2174/092986709788803114	10.2174/092986712802002491	10.2174/138920011794520053	10.2174/156802607780091064	10.3109/14756366.2014.1002402																																																																																																																						15634008	16332437	16375746	16488579	17055272	17331715	17352677	17352679	17352681	17352682	17433672	17434732	17502141	17827003	17869513	18201067	18207285	18223196	18243422	18468582	18556199	18570365	18996694	19217790	19261480	19269819	19275548	19375196	19689275	20029928	20235539	20483603	20718420	20800322	21303332	21306895	21320777	21334204	21510839	21711053	21865048	21919850	22525314	22709010	22853995	22938786	23170960	23358258	23623674	23938053	23972441	24099035	24439847	24531224	24660890	24675378	24948564	25147615	25164763	25457126	25532473	25815154	25838146	26005541	26200936	26372650	27396490	27438064	27560285	27820798	28128944	28442252	28826083	29773502	30103438	30343953	30642693	30694668																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								5.99728																																0.74966																																8																																AA00IBF4	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-666-483|MOABOX:1640|DPP4|Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors	N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc3cc(F)c(F)cc3F	654671-77-9	NA	GENERAL	PHOSPHATE	1	H2O	1	1468278	407.31362	SITAGLIPTIN PHOSPHATE | MK-0431 | MK-431 | ONO-5435 |	"""SITAGLIPTIN PHOSPHATE | MK-0431 | MK-431 | ONO-5435 |"" | SITAGLIPTIN PHOSPHATE MONOHYDRATE | ""SITAGLIPTIN PHOSPHATE | MK-0431 | MK-431 | ONO-5435 |"" | SITAGLIPTIN PHOSPHATE MONOHYDRATE"			MOABOX:1640	DPP4	Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors
SJ000951758-3	SJ000951758	3	MOABOX:1670	FKCMADOPPWWGNZ-YUMQZZPRSA-N	CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O	149682-77-9	Dipeptidyl Peptidase II (DPPII;DPP2;DPP7) Inhibitors;Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors;Dipeptidyl Peptidase IX (DPP9;DPRP2) Inhibitors;Dipeptidyl Peptidase VIII (DPP8) Inhibitors;Fibroblast Activation Protein-alpha (FAPalpha) Inhibitors	DPP7	DPP8	DPP9																														54878	91039																														CHEMBL3545064	CHEMBL67279										6918572	11522448	91667091	124082054		member	10.1016/j.bmcl.2005.06.076	10.1016/j.bmcl.2006.10.012	10.1021/jm1002556	10.1021/jm400351a	10.1021/jm500031w	10.2337/diabetes.54.10.2988																																																																																																																																																										8642568	12270155	15293982	16084722	17055271	17352682	18537727	18556199	18783201	20718420	22525314	23594271	24617858	24900696	27820798	28826083																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						-0.28768	0.30288	0.98048																														-0.03596	0.03786	0.12256																														8	8	8																														HY-13233A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer; Inflammation/Immunology|MOABOX:1670|DPP7|Dipeptidyl Peptidase II (DPPII;DPP2;DPP7) Inhibitors;Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors;Dipeptidyl Peptidase IX (DPP9;DPRP2) Inhibitors;Dipeptidyl Peptidase VIII (DPP8) Inhibitors;Fibroblast Activation Protein-alpha (FAPalpha) Inhibitors	CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O	150080-09-4	28049	GENERAL	METHANESULFONATE	1	NO_SOLVATE	0	1468866	214.06976	TALABOSTAT MESYLATE | BXCL-701 | PT-100 | VALBOROPRO	"""TALABOSTAT MESYLATE | BXCL-701 | PT-100 | VALBOROPRO"" | ""TALABOSTAT MESYLATE | BXCL-701 | PT-100 | VALBOROPRO"""	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer; Inflammation/Immunology	MOABOX:1670	DPP7	Dipeptidyl Peptidase II (DPPII;DPP2;DPP7) Inhibitors;Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors;Dipeptidyl Peptidase IX (DPP9;DPRP2) Inhibitors;Dipeptidyl Peptidase VIII (DPP8) Inhibitors;Fibroblast Activation Protein-alpha (FAPalpha) Inhibitors
SJ001034819-1	SJ001034819	1	MOABOX:1672	RWNSISJNBAQNTF-NSHDSACASA-N	N[C@H](C(=O)N1CCCC1)C1CCCCC1		Dipeptidyl Peptidase VIII (DPP8) Inhibitors;Dipeptidyl Peptidase IX (DPP9| DPRP2) Inhibitors;Dipeptidyl Peptidase IV (CD26| DPP-IV| DP-IV) Inhibitors	DPP8																																																															CHEMBL278393											23646031					member	10.1016/j.bmcl.2004.11.023																																																																																																																																																															15664838	21510839																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.50168																																0.18771																																8																																EN300-4699185	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-104-793|MOABOX:1672|DPP8|Dipeptidyl Peptidase VIII (DPP8) Inhibitors;Dipeptidyl Peptidase IX (DPP9| DPRP2) Inhibitors;Dipeptidyl Peptidase IV (CD26| DPP-IV| DP-IV) Inhibitors	N[C@@H](C1CCCCC1)C(=O)N2CCCC2	171092-49-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468060	210.31588	EN300-4699185	EN300-4699185 | EN300-4699185			MOABOX:1672	DPP8	Dipeptidyl Peptidase VIII (DPP8) Inhibitors;Dipeptidyl Peptidase IX (DPP9|DPRP2) Inhibitors;Dipeptidyl Peptidase IV (CD26|DPP-IV|DP-IV) Inhibitors
SJ001035267-1	SJ001035267	1	MOABOX:1674	YDYSCRZHYWLSPQ-INIZCTEOSA-N	N[C@@H](CCCCNC(=O)OCc1ccc([N+](=O)[O-])cc1)C(=O)N1CCCC1	136259-18-2	Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors	DPP8	DPP9																															91039																															CHEMBL505629											9209502	131698216				member	10.1016/j.ejphar.2006.08.011	10.2337/diabetes.54.10.2988																																																																																																																																																														17352682	18602260																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.42304	0.77064																															0.30288	0.09633																															8	8																															HY-108319	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology; Neurological Disease|MOABOX:1674|DPP8|Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors	N[C@@H](CCCCNC(=O)OCc1ccc(cc1)[N+](=O)[O-])C(=O)N2CCCC2	136259-18-2	27643	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469410	378.42284	DPP-IV-IN-2	DPP-IV-IN-2 | DPP-IV-IN-2	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology; Neurological Disease	MOABOX:1674	DPP8	Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors
SJ000855205-5	SJ000855205	5	MOABOX:1684	ZPLQIPFOCGIIHV-UHFFFAOYSA-N	O=c1cc(O)c(Cl)c[nH]1	103766-25-2	Dihydropyrimidine Dehydrogenase Inhibitors	DPYD																																																															CHEMBL1730601											54679224	67907508				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-17469	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:1684|DPYD|Dihydropyrimidine Dehydrogenase Inhibitors	OC1=CC(=O)NC=C1Cl	103766-25-2	11965	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469372	145.54376	GIMERACIL	GIMERACIL | GIMERACIL	Pathway: Others	Research Area: Cancer	MOABOX:1684	DPYD	Dihydropyrimidine Dehydrogenase Inhibitors
SJ000287900-7	SJ000287900	7	MOABOX:1686	TVURRHSHRRELCG-UHFFFAOYSA-N	Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1	1092382-99-4	Dopamine D1 Agonists	DRD1																																																															CHEMBL1026	CHEMBL1256646	CHEMBL588									3341	49659	11957552	20498371	20572558	member	10.1074/jbc.M000157200																																																																																																																																																															8632409	9784114	10807903	18782049																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.60144																																0.20018																																8																																CS-4212	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-835|MOABOX:1686|DRD1|Dopamine D1 Agonists	Oc1ccc(cc1)C2CNCCc3c(Cl)c(O)c(O)cc23	67227-57-0	NA	GENERAL	METHANESULFONATE	1	NO_SOLVATE	0	1468403	305.75614	FENOLDOPAM BROMIDE	FENOLDOPAM BROMIDE | FENOLDOPAM MESYLATE | FENOLDOPAM HCL | FENOLDOPAM BROMIDE | FENOLDOPAM MESYLATE | FENOLDOPAM HCL			MOABOX:1686	DRD1	Dopamine D1 Agonists
SJ000833098-2	SJ000833098	2	MOABOX:1688	WRNKIDLXXXIELU-IEBWSBKVSA-N	CN1Cc2ccccc2[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21	100999-26-6	Dopamine D1 Agonists	DRD1																																																															CHEMBL313737											58144					virtual																																																																																																																																																																18782049																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.40672																																0.17584																																8																																1249	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-825|MOABOX:1688|DRD1|Dopamine D1 Agonists	CN1Cc2ccccc2[C@H]3[C@H]1Cc4c[nH]c5cccc3c45	100999-26-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468501	274.35962	CY 208-243	CY 208-243 | CY 208-243			MOABOX:1688	DRD1	Dopamine D1 Agonists
SJ000782319-6	SJ000782319	6	MOABOX:1696	VSWBSWWIRNCQIJ-HUUCEWRRSA-N	CN1C[C@@H]2c3ccccc3Oc3ccc(Cl)cc3[C@H]2C1	1412458-61-7	Dopamine D1 Antagonists;Dopamine D2 Antagonists;5-HT2 Antagonists	DRD1	DRD2																															1813																															CHEMBL504548											163091	6917875	9846279	49849508	57354691	member	10.1124/jpet.114.219717																																																																																																																																																															18308814	20166946	21366526																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			5.12e-003	3.936e-002																															0.00064	0.00492																															8	8																															HY-16567	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:1696|DRD1|Dopamine D1 Antagonists;Dopamine D2 Antagonists;5-HT2 Antagonists	CN1C[C@H]2[C@H](C1)c3cc(Cl)ccc3Oc4ccccc24	1412458-61-7	43790	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468955	285.76804	ASENAPINE MALEATE	"ASENAPINE MALEATE | ""ASENAPINE MALEATE | ORG-5222 | SCH-900274 |"" | ASENAPINE MALEATE | ""ASENAPINE MALEATE | ORG-5222 | SCH-900274 |"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:1696	DRD1	Dopamine D1 Antagonists;Dopamine D2 Antagonists;5-HT2 Antagonists
SJ000286106-13	SJ000286106	13	MOABOX:1702	XJGVXQDUIWGIRW-UHFFFAOYSA-N	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1	1977-10-2	Dopamine D4 Receptor Ligands;Dopamine D2 Antagonists;Dopamine D1 Receptor Ligands;Dopamine D3 Receptor Ligands;5-HT2 Antagonists	DRD1	DRD2	DRD3	DRD4	HTR2A																												1813	1814	1815	3356																												CHEMBL1201060	CHEMBL1201155	CHEMBL831									3964	71399	71400	16219553	18787834	virtual	10.1021/jm991005d	10.1124/jpet.114.219717																																																																																																																																																														7861418	8064797	10377229	22268448																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.2832	0.82904	0.62408	0.71936	0.98576																												0.0354	0.10363	0.07801	0.08992	0.12322																												8	8	8	8	8																												HY-17390	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:1702|DRD1|Dopamine D4 Receptor Ligands;Dopamine D2 Antagonists;Dopamine D1 Receptor Ligands;Dopamine D3 Receptor Ligands;5-HT2 Antagonists	CN1CCN(CC1)C2=Nc3ccccc3Oc4ccc(Cl)cc24	1977-10-02	7892	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468802	327.80802	LOXAPINE SUCCINATE	LOXAPINE SUCCINATE | LOXAPINE SUCCINATE	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:1702	DRD1	Dopamine D4 Receptor Ligands;Dopamine D2 Antagonists;Dopamine D1 Receptor Ligands;Dopamine D3 Receptor Ligands;5-HT2 Antagonists
SJ000287852-5	SJ000287852	5	MOABOX:1704	GOTMKOSCLKVOGG-OAHLLOKOSA-N	CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1	125941-87-9	Dopamine D1 Antagonists;Dopamine D5 Antagonists;DRD1 antagonist;DRD5 antagonist	DRD1	DRD5																															1816																															CHEMBL1256645	CHEMBL1814790	CHEMBL2158641	CHEMBL62								3036864	6440792	9873937	11957535	45114249	member	10.1016/S0028-3908(03)00305-8	10.1016/j.bmc.2010.07.034	10.1016/j.bmc.2012.05.057	10.1016/j.bmc.2012.12.016	10.1016/j.ejphar.2007.10.017	10.1016/j.ejphar.2009.03.006	10.1016/j.neuropharm.2006.02.002	10.1021/jm401158e	10.1021/jm501203v	10.1038/sj.bjp.0707005	10.1124/jpet.107.122010	10.1124/jpet.108.141572	10.1124/jpet.108.146241	10.1124/jpet.114.219717	10.3390/md17020108																																																																																																																																																	1355478	1531075	1531365	1973733	2405157	2527994	3263503	8093734	15659110	15689153	15801855	16613551	16722655	17220913	18562201	18588282	18642350	18782049	18983139	19643610	20061148	20875743	21084390	21558436	21688779	21726069	21777010	22748706	23018094	23023262	23332346	23403082	23466604	23582449	24805037	25308766	25557493	26227779	26478787	26988801	28106992	28471663	28947942	29631962	30383372	30744179	30810314	30981605	31021617	31238535																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.41128	0.70176																															0.30141	0.08772																															8	8																															HY-19545A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:1704|DRD1|Dopamine D1 Antagonists;Dopamine D5 Antagonists;DRD1 antagonist;DRD5 antagonist	CN1CCc2cc(Cl)c(O)cc2[C@H](C1)c3ccccc3	125941-87-9	42022	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469362	287.78392	R(+)-SCH-23390 HYDROCHLORIDE	R(+)-SCH-23390 HYDROCHLORIDE | SCH 23390 HCL | R(+)-SCH-23390 HYDROCHLORIDE | SCH 23390 HCL	Pathway: GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:1704	DRD1	Dopamine D1 Antagonists;Dopamine D5 Antagonists;DRD1 antagonist;DRD5 antagonist
SJ000285610-15	SJ000285610	15	MOABOX:1706	KLBQZWRITKRQQV-UHFFFAOYSA-N	CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2	107388-89-6	Dopamine D2 Antagonists	DRD2																																																															CHEMBL1200916	CHEMBL479										5452	66062	657213	18787836	21707757	virtual																																																																																																																																																																10465402	11171942	11561089	12747773	16613551	16613552	24088053																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															1.17336																																0.14667																																8																																AA0073R7	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-727-928|MOABOX:1706|DRD2|Dopamine D2 Antagonists	CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1	130-61-0	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468281	370.57454	THIORIDAZINE HYDROCHLORIDE	THIORIDAZINE HYDROCHLORIDE | THIORIDAZINE HYDROCHLORIDE| MELLARIL-S | THIORIDAZINE HCL | THIORIDAZINE HYDROCHLORIDE | THIORIDAZINE HYDROCHLORIDE| MELLARIL-S | THIORIDAZINE HCL			MOABOX:1706	DRD2	Dopamine D2 Antagonists
SJ000285780-13	SJ000285780	13	MOABOX:1714	LNEPOXFFQSENCJ-UHFFFAOYSA-N	O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1	1511-16-6	Dopamine D2 receptor inverse agonist;Dopamine D3 receptor inverse agonist;ADRA1B antagonist	ADRA1B																																																															CHEMBL1160253	CHEMBL2096643	CHEMBL54	CHEMBL545608								3559	9808700	9828220	9829539	9830472	member																																																																																																																																																																10464021	14998318																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.507e-002																																0.00501																																7																																HY-14538	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:1714|ADRA1B|Dopamine D2 receptor inverse agonist;Dopamine D3 receptor inverse agonist;ADRA1B antagonist	OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3	52-86-8	11046	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468849	375.86422	HALOPERIDOL	HALOPERIDOL | HALDOL | HALOPERIDOL HCL | HALOPERIDOL | HALDOL | HALOPERIDOL HCL	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:1714	ADRA1B	Dopamine D2 receptor inverse agonist;Dopamine D3 receptor inverse agonist;ADRA1B antagonist
SJ000286113-17	SJ000286113	17	MOABOX:1716	SGTNSNPWRIOYBX-UHFFFAOYSA-N	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC	152-11-4	Dopamine D2 Antagonists;L-Type Calcium Channel Blockers;Calcium Channel Blockers	CACNA1C	CACNA1S																															779																															CHEMBL1280	CHEMBL140591	CHEMBL143836	CHEMBL1707604	CHEMBL342314	CHEMBL6966						2520	62969	461538	492231	657390	member	10.1021/np3000987																																																																																																																																																															8474099	22694270	23812503																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.33992	0.58416																															0.04249	0.07302																															8	8																															HY-A0064	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Cardiovascular Disease|MOABOX:1716|CACNA1C|Dopamine D2 Antagonists;L-Type Calcium Channel Blockers;Calcium Channel Blockers	COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC	152-11-4	33538	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469351	454.60162	VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE | (±)-VERAPAMIL HYDROCHLORIDE | VERAPAMIL | VERAPAMIL HCL | (±)-VERAPAMIL HCL | VERAPAMIL HYDROCHLORIDE | (±)-VERAPAMIL HYDROCHLORIDE | VERAPAMIL | VERAPAMIL HCL | (±)-VERAPAMIL HCL	Pathway: Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Cardiovascular Disease	MOABOX:1716	CACNA1C	Dopamine D2 Antagonists;L-Type Calcium Channel Blockers;Calcium Channel Blockers
SJ000287475-8	SJ000287475	8	MOABOX:1720	OQDPVLVUJFGPGQ-UHFFFAOYSA-N	c1cnc(N2CCN(Cc3ccc4c(c3)OCO4)CC2)nc1	1451048-94-4	Dopamine D2 Agonists;Dopamine D3 Agonists;alpha2-Adrenoceptor Antagonists	DRD2	DRD3																															1814																															CHEMBL1256997	CHEMBL1371770	CHEMBL1468572	CHEMBL1865834								4850	198284	3038520	11957664	23581808	member																																																																																																																																																																16613551																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.70616	0.84208																															0.08827	0.10526																															8	8																															HY-12707	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease; Endocrinology|MOABOX:1720|DRD2|Dopamine D2 Agonists;Dopamine D3 Agonists;alpha2-Adrenoceptor Antagonists	C(N1CCN(CC1)c2ncccn2)c3ccc4OCOc4c3	3605-01-04	27071	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469618	298.33972	PIRIBEDIL HYDROCHLORIDE	PIRIBEDIL HYDROCHLORIDE | PIRIBEDIL MALEATE | PIRIBEDIL HCL | PIRIBEDIL HYDROCHLORIDE | PIRIBEDIL MALEATE | PIRIBEDIL HCL	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease; Endocrinology	MOABOX:1720	DRD2	Dopamine D2 Agonists;Dopamine D3 Agonists;alpha2-Adrenoceptor Antagonists
SJ000288167-5	SJ000288167	5	MOABOX:1724	WAOQONBSWFLFPE-VIFPVBQESA-N	CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC	104953-11-9	Dopamine D2 Antagonists;Dopamine D3 Antagonists	DRD2	DRD3																															1814																															CHEMBL1369632	CHEMBL8809										3033769	9805865	11663304	16219926	54752790	member	10.1124/jpet.105.092155																																																																																																																																																															2391685	7838916	9311022	9687580	10411608	10604931	10991990	11171942	12021408	12490615	14521403	16055122	16480275	16613551	16613552	16918396	17765546	18436192	24779610	24848155																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.24176	1.07624																															0.15522	0.13453																															8	8																															CS-0027846	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-671|MOABOX:1724|DRD2|Dopamine D2 Antagonists;Dopamine D3 Antagonists	CCN1CCC[C@H]1CNC(=O)c2c(O)c(Cl)cc(Cl)c2OC	84225-95-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468401	347.2369	S(+)-RACLOPRIDE L-TARTRATE	S(+)-RACLOPRIDE L-TARTRATE | S(-)-RACLOPRIDE TARTRATE | S(+)-RACLOPRIDE L-TARTRATE | S(-)-RACLOPRIDE TARTRATE			MOABOX:1724	DRD2	Dopamine D2 Antagonists;Dopamine D3 Antagonists
SJ000285814-14	SJ000285814	14	MOABOX:1726	OZVBMTJYIDMWIL-AYFBDAFISA-N	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12	22260-51-1	Dopamine D2 Agonists;Prolactin Secretion Inhibitors	DRD2	PRL																															5617																															CHEMBL1200503	CHEMBL1255752	CHEMBL493									31100	31101	9811539	9854170	9876111	virtual	10.1124/jpet.114.220293																																																																																																																																																															9057850	9311022	16613551	24878269																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0	1.47624																															0.0	0.18453																															7	8																															HY-12705A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease; Cancer|MOABOX:1726|DRD2|Dopamine D2 Agonists;Prolactin Secretion Inhibitors	CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C	22260-51-1	89385	GENERAL	METHANESULFONATE	1	NO_SOLVATE	0	1469448	654.5945	BROMOCRIPTINE MESYLATE	"BROMOCRIPTINE MESYLATE | BROMOCRYPTINE MESYLATE | (+)-BROMOCRIPTINE METHANESULFONATE | ""BROMOCRIPTINE MESYLATE | BROMOCRIPTINE MESILATE | BROMOCRIPTINE MESYLATE | BROMOCRYPTINE METHANESULFONATE | CB-154 |"" | BROMOCRIPTINE MESYLATE | BROMOCRYPTINE MESYLATE | (+)-BROMOCRIPTINE METHANESULFONATE | ""BROMOCRIPTINE MESYLATE | BROMOCRIPTINE MESILATE | BROMOCRIPTINE MESYLATE | BROMOCRYPTINE METHANESULFONATE | CB-154 |"""	Pathway: Autophagy; GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease; Cancer	MOABOX:1726	DRD2	Dopamine D2 Agonists;Prolactin Secretion Inhibitors
SJ000518985-4	SJ000518985	4	MOABOX:1728	KORNTPPJEAJQIU-KJXAQDMKSA-N	C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21	81409-90-7	Dopamine D2 Agonists;Prolactin Secretion Inhibitors	DRD2	HTR2B	PRL																														3357	5617																														CHEMBL1201087											54746	83879	9853560	9917528	11411853	member	10.1021/ml3003814																																																																																																																																																															10418123	16613551	18782049	22697513	23606928																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.96968	1.47936	0																														0.12121	0.18492	0.0																														8	8	7																														HY-15296	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; GPCR/G Protein; Neuronal Signaling | Research Area: Endocrinology|MOABOX:1728|DRD2|Dopamine D2 Agonists;Prolactin Secretion Inhibitors	CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1CC2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1	81409-90-7	16632	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469257	451.60428	CABERGOLINE	CABERGOLINE | SJ000833105 | CABERGOLINE | SJ000833105	Pathway: Autophagy; GPCR/G Protein; Neuronal Signaling	Research Area: Endocrinology	MOABOX:1728	DRD2	Dopamine D2 Agonists;Prolactin Secretion Inhibitors
SJ000286185-17	SJ000286185	17	MOABOX:1730	ZEWQUBUPAILYHI-UHFFFAOYSA-N	CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	117-89-5	Dopamine D2 Antagonists;Nav1.4 (SkM1) Sodium Channel Blockers;Nav1.7 ( PN1/hNE-Na) Sodium Channel Blockers	DRD2	S100A4	SCN4A	SCN9A																													6275	6329	6335																													CHEMBL1257040	CHEMBL1710	CHEMBL1726794	CHEMBL422								5566	66064	120294	240091	443974	virtual	10.1073/pnas.0913660107																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.948	0	0	0																													0.1185	0.0	0.0	0.0																													8	7	7	7																													AG0072LC	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-917-737|MOABOX:1730|DRD2|Dopamine D2 Antagonists;Nav1.4 (SkM1) Sodium Channel Blockers;Nav1.7 ( PN1/hNE-Na) Sodium Channel Blockers	CN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1	440-17-5	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468249	407.49557	TRIFLUOPERAZINE	TRIFLUOPERAZINE | TRIFLUOPERAZINE DIHYDROCHLORIDE | TRIFLUOPERAZINE HYDROCHLORIDE | SKF-5019 | TRIFLUOPERAZINE HCL | TRIFLUOPERAZINE 2HCL | TRIFLUOPERAZINE | TRIFLUOPERAZINE DIHYDROCHLORIDE | TRIFLUOPERAZINE HYDROCHLORIDE | SKF-5019 | TRIFLUOPERAZINE HCL | TRIFLUOPERAZINE 2HCL			MOABOX:1730	DRD2	Dopamine D2 Antagonists;Nav1.4 (SkM1) Sodium Channel Blockers;Nav1.7 ( PN1/hNE-Na) Sodium Channel Blockers
SJ000312286-11	SJ000312286	11	MOABOX:1732	FASDKYOPVNHBLU-ZETCQYMHSA-N	CCCN[C@H]1CCc2nc(N)sc2C1	104617-85-8	Dopamine D3 Agonists	DRD3																																																															CHEMBL301265	CHEMBL3143955	CHEMBL3182733	CHEMBL542257								119569	119570	166589	9922090	9922620	member	10.1016/S0960-894X(02)00390-6	10.1016/j.ejphar.2011.05.050	10.1021/acschemneuro.6b00221	10.1021/acschemneuro.8b00291	10.1021/jm049269+	10.1021/jm0503805	10.1021/jm401798r	10.1038/sj.bjp.0702905																																																																																																																																																								9311022	10509922	11000009	12161137	15801839	16134944	17976986	24012118	24848155																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3.12648																																0.39081																																8																																BD17396	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-849-957|MOABOX:1732|DRD3|Dopamine D3 Agonists	CCCN[C@H]1CCc2nc(N)sc2C1	104632-26-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468347	211.32708	PRAMIPEXOLE DIHYDROCHLORIDE	"PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | ""PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE | PNU-98528E | SND-919 | SND-919Y |"" | MIRAPEX | PRAMIPEXOLE DIHYDROCHLORIDE | ""PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE | PNU-98528E | SND-919 | SND-919Y |"" | MIRAPEX"			MOABOX:1732	DRD3	Dopamine D3 Agonists
SJ000287314-5	SJ000287314	5	MOABOX:1734	MNHDKMDLOJSCGN-UHFFFAOYSA-N	COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1	192384-87-5	Dopamine D3 Agonists	DRD3																																																															CHEMBL25236	CHEMBL540612										3038494	3038495	6420036	44400546	51371409	member	10.1002/cmdc.200700327	10.1016/j.bcp.2004.05.019	10.1021/jm025558r	10.1021/jm030836n	10.1021/jm040190e	10.1021/jm060138d	10.1021/jm401798r	10.1038/22560	10.1124/jpet.106.107920																																																																																																																																																							12361386	12362359	12930150	15276084	15727854	15916415	15916420	16335915	16613551	16613552	16750374	16759104	17266201	17405129	17477344	17826096	18306190	19081257	21495689	23618707	24848155	26723530	30360553																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															4.3184																																0.5398																																8																																25831	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-069-360|MOABOX:1734|DRD3|Dopamine D3 Agonists	COc1ccccc1N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2	314776-92-6	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468317	417.54324	DO 897/99	DO 897/99 | BP 897 | DO 897/99 | BP 897			MOABOX:1734	DRD3	Dopamine D3 Agonists
SJ000287076-13	SJ000287076	13	MOABOX:1738	QZUDBNBUXVUHMW-UHFFFAOYSA-N	CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1	5786-21-0	Dopamine D4 Antagonists;5-HT2 Antagonists;ADRA1B gene inhibitor	ADRA1B	CHRM5	DRD4	HTR1E	HTR1F																												1133	1815	3354	3355																												CHEMBL42	CHEMBL538973										135398737	135430968	135444782	135461113	135494390	member	10.1016/j.neuropharm.2006.02.002	10.1021/jm981041x	10.1038/sj.bjp.0707005	10.1073/pnas.1835612100	10.3390/md17020108	10.3390/md17060377																																																																																																																																																										2542551	7861418	8064797	8523409	8642550	8642551	8691438	8709107	8831770	9016321	9240352	9276014	9406594	9736928	9822559	9839003	9871530	9876110	9990464	10340615	10377229	10411491	10450964	10464021	10560741	10604931	10649982	10893315	10987445	10999484	11052797	11087581	11101359	11170639	11171942	11392544	11495580	11711296	11844688	11937325	11945123	12113813	12372512	12408724	12477356	12519065	12614894	12639562	14552778	14736232	14998318	15110844	15180482	15261283	15276084	15380206	16220969	16613551	16613552	16621538	16789750	16918396	17676831	17880057	18537627	18595716	18673166	18782049	18983139	19155177	19481941	20875743	21366526	22245230	22268448	23353740	23410162	23466604	23582449	23792350	24559051	24805037	25557493	26988801	28489950	30744179	31238535																																																																																																																																																																																																																																																																																																																																																																																																																																																																															0.62544	-1.56e-002	0.88288	-0.4388	-0.38003																												0.07818	-0.00195	0.11036	-0.05485	-0.05429																												8	8	8	8	7																												HY-14539	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:1738|ADRA1B|Dopamine D4 Antagonists;5-HT2 Antagonists;ADRA1B gene inhibitor	CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24	5786-21-0	15729	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469423	326.82326	CLOZAPINE	CLOZAPINE | CLOZAPINE| FAZACLO ODT | CLOZAPINE | CLOZAPINE| FAZACLO ODT	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:1738	ADRA1B	Dopamine D4 Antagonists;5-HT2 Antagonists;ADRA1B gene inhibitor
SJ000288172-6	SJ000288172	6	MOABOX:1742	ZPHBZEQOLSRPAK-XLCYBJAPSA-N	CC(C)C[C@H](NP(=O)(O)O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	119942-99-3	Endothelin-Converting Enzyme (ECE) Inhibitors	ECE1	ECE2																															9718																															CHEMBL479579											445114	78046661				member	10.1016/0960-894X(96)00227-2	10.1016/S0960-894X(02)00254-8	10.1016/j.bmcl.2009.06.064	10.1021/jm00012a011	10.1021/jm040857x																																																																																																																																																											7783143	15658862	19596577	23988485																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		-0.42488	0.3269																															-0.05311	0.0467																															8	7																															BIMI0549	APOLLO_SCI	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-939-220|MOABOX:1742|ECE1|Endothelin-Converting Enzyme (ECE) Inhibitors	CC(C)C[C@H](NP(=O)(O)O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O	119942-99-3	NA	GENERAL	SODIUM(I)	2	NO_SOLVATE	0	1468372	543.50392	PHOSPHORAMIDON DISODIUM	"PHOSPHORAMIDON DISODIUM | PHOSPHORAMIDON|DISODIUM (2S)-3-(1H-INDOL-3-YL)-2-[(2S)-4-METHYL-2-[({[(2S,3R,4R,5R,6S)-3,4,5-TRIHYDROXY-6-METHYLOXAN-2-YL]OXY}PHOSPHINATO)AMINO]PENTANAMIDO]PROPANOATE | PHOSPHORAMIDON | PHOSPHORAMIDON DISODIUM | PHOSPHORAMIDON|DISODIUM (2S)-3-(1H-INDOL-3-YL)-2-[(2S)-4-METHYL-2-[({[(2S,3R,4R,5R,6S)-3,4,5-TRIHYDROXY-6-METHYLOXAN-2-YL]OXY}PHOSPHINATO)AMINO]PENTANAMIDO]PROPANOATE | PHOSPHORAMIDON"			MOABOX:1742	ECE1	Endothelin-Converting Enzyme (ECE) Inhibitors
SJ001033465-2	SJ001033465	2	MOABOX:1754	YBWLTKFZAOSWSM-UHFFFAOYSA-N	COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(-c2ccncc2)nc1OC	290815-26-8	Endothelin ETA Receptor Antagonists	EDNRA																																																															CHEMBL3989834											9912992	143931439				member																																																																																																																																																																11860362																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.026																																0.25325																																8																																HY-15195	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cardiovascular Disease; Endocrinology|MOABOX:1754|EDNRA|Endothelin ETA Receptor Antagonists	COc1ccccc1Oc2c(NS(=O)(=O)c3ccc(C)cn3)nc(nc2OC)c4ccncc4	290815-26-8	5697	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469297	479.50834	AVOSENTAN; RO 67-0565; SPP-301	AVOSENTAN; RO 67-0565; SPP-301 | AVOSENTAN; RO 67-0565; SPP-301	Pathway: GPCR/G Protein	Research Area: Cardiovascular Disease; Endocrinology	MOABOX:1754	EDNRA	Endothelin ETA Receptor Antagonists
SJ001035077-1	SJ001035077	1	MOABOX:1756	MJRGSRRZKSJHOE-UHFFFAOYSA-N	Cc1noc(NS(=O)(=O)c2cccc3c(N(C)C)cccc23)c1C	1215703-04-0	EDNRA antagonist;Endothelin ETA Receptor Antagonists	EDNRA																																																															CHEMBL267458											122272	53804160	56972163	71297041		member	10.1016/0960-894X(96)00441-6	10.1021/bi951836v																																																																																																																																																														8308857	8676339	8979248	9083490	9703472	9857090	10956219	11860362	11945124	14998318	21728984																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											2.35104																																0.29388																																8																																1441	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-102|MOABOX:1756|EDNRA|EDNRA antagonist;Endothelin ETA Receptor Antagonists	CN(C)c1cccc2c(cccc12)S(=O)(=O)Nc3onc(C)c3C	1215703-04-0	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468610	345.41606	BMS 182874 HCL	BMS 182874 HCL | BMS 182874 HCL			MOABOX:1756	EDNRA	EDNRA antagonist;Endothelin ETA Receptor Antagonists
SJ001033608-2	SJ001033608	2	MOABOX:1758	VYCMAAOURFJIHD-PJNXIOHISA-N	CC(C)C[C@@H]1NC(=O)[C@@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC1=O	136553-81-6	Endothelin ETA Receptor Antagonists	EDNRA																																																															CHEMBL314691											443289	11193802				member	10.1006/bbrc.1994.1504	10.1021/bi951836v	10.1021/jm00021a021	10.1021/jm031041j	10.2174/1389557053544010																																																																																																																																																											7768260	8336519	15853628	20932745	25614116	27318985																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.79192																																0.22399																																8																																HY-12378	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cardiovascular Disease|MOABOX:1758|EDNRA|Endothelin ETA Receptor Antagonists	CC(C)C[C@@H]1NC(=O)[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](Cc3c[nH]c4ccccc34)NC1=O)C(C)C	136553-81-6	81325	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469242	610.70118	BQ-123	BQ-123 | BQ-123	Pathway: GPCR/G Protein	Research Area: Cardiovascular Disease	MOABOX:1758	EDNRA	Endothelin ETA Receptor Antagonists
SJ001035305-1	SJ001035305	1	MOABOX:1766	LPAHKJMGDSJDRG-RJTBUBHNSA-N	CCCC[C@@H](NC(=O)[C@@H](Cc1cn(C(=O)OC)c2ccccc12)NC(=O)[C@H](CC(C)(C)C)NC(=O)N1C(C)CCCC1C)C(=O)O	156161-89-6	Endothelin ETB Receptor Antagonists	EDNRB																																																																										9917435					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					4.557e-002																																0.00651																																7																																HY-15894	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cardiovascular Disease; Endocrinology; Cancer|MOABOX:1766|EDNRB|Endothelin ETB Receptor Antagonists	CCCC[C@@H](NC(=O)[C@@H](Cc1cn(C(=O)OC)c2ccccc12)NC(=O)[C@H](CC(C)(C)C)NC(=O)N3[C@H](C)CCC[C@@H]3C)C(=O)O	156161-89-6	21340	GENERAL	SODIUM(I)	1	NO_SOLVATE	0	1469535	641.79804	BQ-788 SODIUM SALT	BQ-788 SODIUM SALT | BQ-788 SODIUM SALT	Pathway: GPCR/G Protein	Research Area: Cardiovascular Disease; Endocrinology; Cancer	MOABOX:1766	EDNRB	Endothelin ETB Receptor Antagonists
SJ000796108-3	SJ000796108	3	MOABOX:1768	UZDORQWMYRRLQV-JHOUSYSJSA-N	Cc1cc(C)cc(C(=O)N(C)[C@H](Cc2ccc(-c3ccccc3)cc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)c1	169545-27-1	EDNRB antagonist;Endothelin ETB Receptor Antagonists	EDNRB																																																															CHEMBL72410											5311192					virtual	10.2174/138161211797416101																																																																																																																																																															9873521	21728984																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.27632																																0.28454																																8																																HY-103460	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cardiovascular Disease|MOABOX:1768|EDNRB|EDNRB antagonist;Endothelin ETB Receptor Antagonists	CN([C@H](Cc1ccc(cc1)c2ccccc2)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)C(=O)c5cc(C)cc(C)c5	169545-27-1	57862	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469208	573.6808	IRL-2500	IRL-2500 | IRL-2500	Pathway: GPCR/G Protein	Research Area: Cardiovascular Disease	MOABOX:1768	EDNRB	EDNRB antagonist;Endothelin ETB Receptor Antagonists
SJ000796108-2	SJ000796108	2	MOABOX:1768	UZDORQWMYRRLQV-JHOUSYSJSA-N	Cc1cc(C)cc(C(=O)N(C)[C@H](Cc2ccc(-c3ccccc3)cc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)c1	169545-27-1	EDNRB antagonist;Endothelin ETB Receptor Antagonists	EDNRB																																																															CHEMBL72410											5311192					virtual	10.2174/138161211797416101																																																																																																																																																															9873521	21728984																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.27632																																0.28454																																8																																1838	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-837|MOABOX:1768|EDNRB|EDNRB antagonist;Endothelin ETB Receptor Antagonists	CN([C@H](Cc1ccc(cc1)c2ccccc2)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)C(=O)c5cc(C)cc(C)c5	169545-27-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468512	573.6808	IRL-2500	IRL-2500 | IRL-2500			MOABOX:1768	EDNRB	EDNRB antagonist;Endothelin ETB Receptor Antagonists
SJ001034858-1	SJ001034858	1	MOABOX:1770	QBTUKQKTXYTWPD-UHFFFAOYSA-N	N#Cc1c2c(c3nncn3c1NCc1ccco1)CN(Cc1ccccc1)CC2		PRC2/EED;EED	EED																																																															CHEMBL4096234											29111296					virtual																																																																																																																																																																28092155																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.83384																																0.22923																																8																																PHAR320870	PHARMEKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-005-926-058|MOABOX:1770|EED|PRC2/EED;EED	N#Cc1c2CCN(Cc3ccccc3)Cc2c4nncn4c1NCc5occc5	1010897-73-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468111	384.4338	PHAR320870	PHAR320870 | PHAR320870			MOABOX:1770	EED	PRC2/EED;EED
SJ000015916-2	SJ000015916	2	MOABOX:1772	IHZDCGSHXDMDGU-UHFFFAOYSA-N	CCOC(=O)C1=C(C)NC(=S)NC1c1cccc(OC)c1		"Antimitotic Drugs;Kinesin-Like Spindle Protein  KIF11 (KSP, Eg5) Inhibitors"	KIF11																																																															CHEMBL2013077											2859799					member	10.1186/1472-6769-6-2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																PHAR129677	PHARMEKS	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-197-533|MOABOX:1772|KIF11|Antimitotic Drugs;Kinesin-Like Spindle Protein KIF11 (KSP, Eg5) Inhibitors"	CCOC(=O)C1=C(C)NC(=S)NC1c2cccc(OC)c2	292871-43-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468102	306.38002					MOABOX:1772	KIF11	"Antimitotic Drugs;Kinesin-Like Spindle Protein KIF11 (KSP, Eg5) Inhibitors"
SJ000852773-5	SJ000852773	5	MOABOX:1774	OONFNUWBHFSNBT-HXUWFJFHSA-N	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1	497839-62-0	Angiogenesis Inhibitors;EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-2 (FLK-1/KDR) Inhibitors	EGFR	ERBB2																															2064																															CHEMBL587723											10297043					member	10.1158/0008-5472.CAN-03-3681	10.2174/138161209787582219																																																																																																																																																														15256466	16788977	19275641	20698825	21034401	22018877	23098265	23410174	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2.77576	1.5276																															0.34697	0.19095																															8	8																															HY-10045	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:1774|EGFR|Angiogenesis Inhibitors;EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-2 (FLK-1/KDR) Inhibitors	CCN1CCN(Cc2ccc(cc2)c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)CC1	497839-62-0	17390	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469368	440.58318	AEE788	AEE788 | AEE788 (NVP-AEE788) | AEE788 | AEE788 (NVP-AEE788)	Pathway: Apoptosis; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:1774	EGFR	Angiogenesis Inhibitors;EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-2 (FLK-1/KDR) Inhibitors
SJ000312295-19	SJ000312295	19	MOABOX:1778	AAKJLRGGTJKAMG-UHFFFAOYSA-N	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1	1429636-49-6	Inhibitors of Signal Transduction Pathways;EGFR (HER1 or erbB1) Inhibitors	EGFR																																																															CHEMBL1079742	CHEMBL553										176870	176871	9913428	11354735	11498511	member	10.1002/ardp.200500126	10.1002/cmdc.200800073	10.1016/j.bmc.2009.10.051	10.1016/j.bmc.2009.10.054	10.1016/j.bmc.2009.11.035	10.1016/j.bmc.2009.11.037	10.1016/j.bmc.2010.06.003	10.1016/j.bmc.2011.08.038	10.1016/j.bmc.2012.01.004	10.1016/j.bmc.2012.01.051	10.1016/j.bmc.2012.04.042	10.1016/j.bmc.2013.01.013	10.1016/j.bmcl.2007.08.020	10.1016/j.bmcl.2007.10.084	10.1016/j.bmcl.2009.09.038	10.1016/j.bmcl.2010.03.015	10.1016/j.bmcl.2010.08.052	10.1016/j.bmcl.2011.07.010	10.1016/j.bmcl.2013.09.005	10.1016/j.bmcl.2013.12.079	10.1016/j.bmcl.2015.11.040	10.1016/j.chembiol.2011.04.011	10.1016/j.ejmech.2007.09.018	10.1016/j.ejmech.2018.12.011	10.1021/jm050936o	10.1021/jm400822z	10.1021/jm901146p	10.1021/jm901877j	10.1021/ml100031a	10.1042/BJ20080728	10.1073/pnas.0510284103	10.1124/mol.107.041236	10.1158/0008-5472.CAN-06-0453	10.1158/0008-5472.CAN-07-5428	10.1158/1078-0432.CCR-06-2590	10.1158/1535-7163.MCT-12-1210	10.1182/blood-2007-09-115030	10.2147/DDDT.S85357	10.2174/138161209787582219	10.2174/1389557043487349	10.3109/14756366.2012.719504	10.3390/molecules19067269	10.4161/cbt.6.5.4003																																																																																																																					3400505	10608920	12171522	12171567	14684309	15032674	15711537	16480284	16719802	16788977	16818618	17283159	17889528	17981366	18077425	18089823	18183025	18316192	18465761	18710211	19028424	19275641	19374919	19815412	19888761	19914835	19914837	19969465	20005116	20143778	20166671	20222733	20298154	20346655	20594859	20627597	20698825	20817523	20824148	21334203	21700206	21763148	21802290	21816517	21920766	22037378	22043991	22101132	22112541	22169601	22277588	22361272	22607878	22773810	22901387	23245570	23391364	23410174	23930994	23932070	23962660	24144854	24183742	24411123	24556149	24565969	24607998	24630412	24890652	24900830	25172421	25383627	25461317	25768701	25822739	25882519	26188620	26256032	26455919	26487917	26599532	26639762	26652482	26756222	26819674	26879314	27010345	27235841	27524310	27564586	27614407	27894589	28287730	28431353	28435529	28478927	29028534	29407956	29549841	30002297	30047410	30098869	30633509	30744932	30897725	30973735	31078412	31108261	31129055																																																																																																																																																																																																																																																																																																																																																																																																																																																									5.27528																																0.65941																																8																																AS-35132	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466840	393.43572	ERLOTINIB	ERLOTINIB | TARCEVA | CP-358774 | SJ000518937 | ERLOTINIB HYDROCHLORIDE | OSI-744 | ERLOTINIB | TARCEVA | CP-358774 | SJ000518937 | ERLOTINIB HYDROCHLORIDE | OSI-744			MOABOX:1778	EGFR	Inhibitors of Signal Transduction Pathways;EGFR (HER1 or erbB1) Inhibitors
SJ000574282-5	SJ000574282	5	MOABOX:1780	WVUNYSQLFKLYNI-AATRIKPKSA-N	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C	105628-07-7	EGFR (HER1;erbB1) Inhibitors;Inhibitors of Signal Transduction Pathways	EGFR																																																															CHEMBL607707											6445562	11848216	67076822	87849383	144209661	virtual	10.1002/ardp.200800009	10.1016/S0960-894X(02)00598-X	10.1016/j.bmc.2007.03.055	10.1016/j.bmc.2010.08.004	10.1016/j.bmcl.2004.01.034	10.1016/j.bmcl.2004.04.080	10.1021/cr000250y	10.1021/jm020241c	10.1021/jm040159c	10.1073/pnas.0502860102	10.1073/pnas.0504952102	10.2174/1389557043487349	10.2174/187152007784111313																																																																																																																																																			10973323	11749388	12171571	12270171	12502359	15006373	15032674	15177440	15711537	15715478	15897464	17416531	17689836	18045063	18183025	18493974	18680272	20698825	20797871	21651479	22204331	23410174	24517277	26256032	28754471	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												5.19848																																0.64981																																8																																CS-0037	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-395-626|MOABOX:1780|EGFR|EGFR (HER1;erbB1) Inhibitors;Inhibitors of Signal Transduction Pathways	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)\C=C\CN(C)C	257933-82-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468097	467.92312	PELITINIB	PELITINIB | WAY-EKB 569 | EKB-569 | PELITINIB | WAY-EKB 569 | EKB-569			MOABOX:1780	EGFR	EGFR (HER1;erbB1) Inhibitors;Inhibitors of Signal Transduction Pathways
SJ000518956-16	SJ000518956	16	MOABOX:1784	BCFGMOOMADDAQU-UHFFFAOYSA-N	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	1092929-10-6	EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;Inhibitors of Signal Transduction Pathways	EGFR	ERBB2																															2064																															CHEMBL1076241	CHEMBL1201179	CHEMBL554									208908	208909	9941095	10306585	11457225	member	10.1007/s10637-018-0649-y	10.1016/j.bmc.2011.11.056	10.1016/j.bmcl.2006.01.111	10.1016/j.bmcl.2006.05.090	10.1016/j.bmcl.2008.11.023	10.1016/j.bmcl.2009.09.038	10.1016/j.bmcl.2010.03.015	10.1016/j.bmcl.2010.08.052	10.1016/j.bmcl.2011.10.103	10.1016/j.bmcl.2013.11.064	10.1016/j.bmcl.2015.11.040	10.1016/j.ejmech.2016.04.072	10.1016/j.ejmech.2016.12.055	10.1016/j.ejmech.2018.06.011	10.1021/acs.jmedchem.8b01612	10.1021/jm100665z	10.1021/jm201758g	10.1021/jm7013875	10.1021/jm800829v	10.1021/jm901146p	10.1039/c1md00126d	10.1042/BJ20080728	10.1080/14756366.2019.1667341	10.1124/mol.107.041236	10.1158/0008-5472.CAN-07-2404	10.1158/1078-0432.CCR-09-2353	10.2174/138161209787582219	10.2174/1389557043487349	10.3390/md16050157																																																																																																																																			11749388	14684309	15032674	15528979	15711537	16483772	16719802	16777410	16788977	16842151	18183025	18199554	18500794	18710211	19028424	19111461	19149613	19170633	19199984	19275641	19815412	19888761	20143778	20166671	20235539	20346655	20817523	21080629	21334203	22037378	22043991	22101132	22169601	22182581	22227214	22368762	22372864	22595177	22697512	23410165	23410174	23932070	24121234	24355130	25305330	25768701	26256032	26475520	26652482	27187856	27288180	27769671	28218686	28238614	28711703	28754471	28838691	29191878	29275232	29421573	30096580	30508379	30973735																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							3.88016	2.4624																															0.48502	0.3078																															8	8																															AS-14065	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466846	581.05754	LAPATINIB	LAPATINIB | GSK572016 | GW-572016 | LAPATINIB DITOSYLATE | LAPATINIB | GSK572016 | GW-572016 | LAPATINIB DITOSYLATE			MOABOX:1784	EGFR	EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;Inhibitors of Signal Transduction Pathways
SJ001011048-2	SJ001011048	2	MOABOX:1786	XRYJULCDUUATMC-CYBMUJFWSA-N	C[C@@H](Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1ccccc1	1350639-79-0	EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;Inhibitors of Signal Transduction Pathways	EGFR	ERBB2																															2064																															CHEMBL1914653	CHEMBL1963502										6918403	9918746	57401512	91691117	134261070	member	10.2174/138161209787582219																																																																																																																																																															11607931	11749388	16788977	19275641	22018877																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	2.48216	1.26576																															0.31027	0.15822																															8	8																															21896	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-181-388|MOABOX:1786|EGFR|EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;Inhibitors of Signal Transduction Pathways	C[C@@H](Nc1ncnc2[nH]c(cc12)c3ccc(O)cc3)c4ccccc4	187724-61-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468323	330.38312	PKI-166	PKI-166 | PKI-166			MOABOX:1786	EGFR	EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;Inhibitors of Signal Transduction Pathways
SJ000855122-10	SJ000855122	10	MOABOX:1788	ULXXDDBFHOBEHA-CWDCEQMOSA-N	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1	1254955-21-9	Irreversible EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;Inhibitors of Signal Transduction Pathways	EGFR	ERBB2	ERBB4																														2064	2066																														CHEMBL1173655	CHEMBL2105712										10184653	11204194	15606394	49805823	49805824	member	10.1007/s10637-018-0649-y	10.1016/j.bmcl.2018.12.056	10.1021/jm400822z	10.2174/138161209787582219																																																																																																																																																												3400505	17208435	19028424	19275641	20550212	21651479	22037378	22418700	22621397	23410165	23410174	23930994	24183742	24565969	25409491	26310890	26906472	27564586	28428040	28603991	28987609	29133033	29191878	29523467	29775935	30554954	30600209	30803229	30973735																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									5.56536	0.17624	0.40904																														0.69567	0.02203	0.05113																														8	8	8																														AB45626	A2BCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-009-679-394|MOABOX:1788|EGFR|Irreversible EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;Inhibitors of Signal Transduction Pathways	CN(C)C\C=C\C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]4CCOC4	1254955-21-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468290	485.9384	AFATINIB	AFATINIB | BIBW-2992 | AFATINIB | BIBW-2992			MOABOX:1788	EGFR	Irreversible EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;Inhibitors of Signal Transduction Pathways
SJ000785985-6	SJ000785985	6	MOABOX:1790	LUJZZYWHBDHDQX-QFIPXVFZSA-N	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12	714971-09-2	EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;HER3 (erbB3) Inhibitors;HER4 (erbB4) Inhibitors	EGFR	ERBB2	ERBB3	ERBB4																													2064	2065	2066																													CHEMBL1645462											10437018	46930994	53376983	53385966	53385967	member	10.1021/jm9010065	10.1158/1078-0432.CCR-06-0642																																																																																																																																																														16788977	18991750	19821562	21177105	23410165	23410174	28218686	28754471	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2.36512	1.53848	0	-0.19184																													0.29564	0.19231	0.0	-0.02398																													8	8	7	8																													HY-12010	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: JAK/STAT Signaling; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:1790|EGFR|EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;HER3 (erbB3) Inhibitors;HER4 (erbB4) Inhibitors	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn3ncnc(Nc4ccc5c(cnn5Cc6cccc(F)c6)c4)c13	873837-23-1	4218	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469342	530.55348	BMS-599626	BMS-599626 | AC480 | BMS-599626 | AC480	Pathway: JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:1790	EGFR	EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;HER3 (erbB3) Inhibitors;HER4 (erbB4) Inhibitors
SJ001010957-3	SJ001010957	3	MOABOX:1792	HXHAJRMTJXHJJZ-UHFFFAOYSA-N	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1	252003-65-9	EGFR (HER1| erbB1) Inhibitors;PDGFR Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;Inhibitors of Signal Transduction Pathways;Angiogenesis Inhibitors	EGFR	FGFR1	FGFR3	FLT4	KDR	DDR2	RET	TEK																									2260	2261	2324	3791	4921	5979	7010																									CHEMBL253969											9811610	9811611	9873725	10031918	10121291	virtual	10.1016/j.bmcl.2008.02.001	10.1021/jm0301641	10.1158/0008-5472.CAN-04-4409	10.1158/1078-0432.CCR-05-2028																																																																																																																																																												14640546	16890434	17979703	18308565	18676144	21762098	23098265	24754677	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													-0.34174	0.77184	0.59272	0.35752	0.48768	2.00968	0.81848	0.45392																									-0.04882	0.09648	0.07409	0.04469	0.06096	0.25121	0.10231	0.05674																									7	8	8	8	8	8	8	8																									CS-0138566	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-594-898|MOABOX:1792|EGFR|EGFR (HER1| erbB1) Inhibitors;PDGFR Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;Inhibitors of Signal Transduction Pathways;Angiogenesis Inhibitors	NC(=O)c1c(NC(=O)NCCCCN2CCCC2)snc1OCc3c(F)cc(Br)cc3F	252003-65-9	NA	GENERAL	"2,2,2-TRIFLUOROACETATE"	1	NO_SOLVATE	0	1468480	532.40207	CP-547632	CP-547632 | CP-547632			MOABOX:1792	EGFR	EGFR (HER1|erbB1) Inhibitors;PDGFR Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;Inhibitors of Signal Transduction Pathways;Angiogenesis Inhibitors
SJ000572971-6	SJ000572971	6	MOABOX:1796	QOECJCJVIMVJGX-UHFFFAOYSA-N	COc1cc2c(NC3CCN(C(C)C)CC3)nc(C3CCCCC3)nc2cc1OCCCN1CCCC1	1255517-77-1	"EHMT1/2;Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 (EHMT2| G9a) Inhibitors"	EHMT2	EHMT1																															79813																															CHEMBL1231795											46224516	71312000				member	10.1021/acs.jmedchem.7b01926	10.1021/acs.jmedchem.8b02008	10.1021/jm401480r																																																																																																																																																													21743462	21780790	21966347	22510649	22975593	23210854	24102134	24300735	25750706	27720557	28739157	29890830	29953809	30753076	31350126																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							3.1776	0.61776																															0.3972	0.07722																															8	8																															T3257	TARGETMOL	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-277-154|MOABOX:1796|EHMT2|EHMT1/2;Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 (EHMT2| G9a) Inhibitors"	COc1cc2c(NC3CCN(CC3)C(C)C)nc(nc2cc1OCCCN4CCCC4)C5CCCCC5	1255580-76-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468134	509.72648	UNC0638	UNC0638 | UNC0638 HYDRATE | UNC0638 | UNC0638 HYDRATE			MOABOX:1796	EHMT2	"EHMT1/2;Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 (EHMT2|G9a) Inhibitors"
SJ000784241-7	SJ000784241	7	MOABOX:1800	OSXFATOLZGZLSK-UHFFFAOYSA-N	COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC	1392399-03-9	"EHMT1/2;DNA Methyltransferase (DNMT) Inhibitors;Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 (EHMT2| G9a) Inhibitors"	EHMT2	EHMT1																															79813																															CHEMBL569864											25150857	46945860	51371252	73357457	91885946	member	10.1021/jm901543m																																																																																																																																																															19891491	20614940	20659682	21743462	22039877	22194015	22975593	23210854	25406853	25750706	28739157	29953809																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										2.42872	1.43784																															0.30359	0.17973																															8	8																															AF-0051	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1cc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC)N5CCCN(C)CC5	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466675	490.64032	BIX 01294	"BIX 01294 | ""BIX 01294 | HISTONE LYSINE METHYLTRANSFERASE INHIBITOR |"" | BIX 01294 | ""BIX 01294 | HISTONE LYSINE METHYLTRANSFERASE INHIBITOR |"""			MOABOX:1800	EHMT2	"EHMT1/2;DNA Methyltransferase (DNMT) Inhibitors;Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 (EHMT2| G9a) Inhibitors"
SJ001035335-1	SJ001035335	1	MOABOX:1804	KFRKRECSIYXARE-HYARGMPZSA-N	O=C(O)/C(Cc1ccccc1[N+](=O)[O-])=N/Nc1nc(-c2ccc(Cl)c(Cl)c2)cs1	315706-13-9	EIF4E-EIF6G interaction inhibitor;eiF4F complex assembly inhibitor	EIF4E	EIF4G1																															1981																															CHEMBL3310197											5717952	9584973				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-7.917e-002	-7.056e-002																															-0.01131	-0.01008																															7	7																															HY-19831	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:1804|EIF4E|EIF4E-EIF6G interaction inhibitor;eiF4F complex assembly inhibitor	OC(=O)\C(=N\Nc1nc(cs1)c2ccc(Cl)c(Cl)c2)\Cc3ccccc3[N+](=O)[O-]	315706-13-9	63936	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469621	451.28328	4EGI-1	4EGI-1 | 4EGI-1	Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:1804	EIF4E	EIF4E-EIF6G interaction inhibitor;eiF4F complex assembly inhibitor
SJ000556638-5	SJ000556638	5	MOABOX:1808	BTGNGJJLZOIYID-UHFFFAOYSA-N	CC(C)(C)C(=O)Oc1ccc(S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)O)cc1	127373-66-4	Leukocyte Elastase Inhibitors;Elastase inhibitor	CELA1	ELANE																															1991																															CHEMBL76688											107706	9918786	21123688	22992413	69867575	member	10.1002/ddr.21539	10.1016/S0960-894X(02)00393-1	10.1016/S0968-0896(96)00216-7	10.1016/j.bmc.2014.12.056	10.1016/j.bmc.2018.09.034	10.1021/acs.joc.5b02386	10.1021/jm100118x	10.1021/jm301000k	10.1021/jm3017305	10.1021/jm4011725	10.1021/jm990412m	10.1039/c1ob05714f	10.1080/10286020.2019.1571489	10.1080/14756366.2017.1326915																																																																																																																																																		10669559	12161131	21741848	23350733	24224573	25650311																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.497	3.11448																															0.071	0.38931																															7	8																															HY-17443	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:1808|CELA1|Leukocyte Elastase Inhibitors;Elastase inhibitor	CC(C)(C)C(=O)Oc1ccc(cc1)S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)O	127373-66-4	26626	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469124	434.46288	SIVELESTAT SODIUM SALT	SIVELESTAT SODIUM SALT | SIVELESTAT SODIUM SALT	Pathway: Anti-infection; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:1808	CELA1	Leukocyte Elastase Inhibitors;Elastase inhibitor
SJ000033874-2	SJ000033874	2	MOABOX:1812	YOIDHZBOHMNTNP-UHFFFAOYSA-N	Cc1ccc(S(=O)(=O)NC(=O)Nc2ccc(Cl)cc2)cc1	3955-50-8	Tumor NADH Oxidase (tNOX) Inhibitors	ENOX2																																																															CHEMBL7829											160725	87982009				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																MS-8358	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Cc1ccc(cc1)S(=O)(=O)NC(=O)Nc2ccc(Cl)cc2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466770	324.78262					MOABOX:1812	ENOX2	Tumor NADH Oxidase (tNOX) Inhibitors
SJ000833855-5	SJ000833855	5	MOABOX:1814	ZZUBHVMHNVYXRR-UHFFFAOYSA-N	Oc1ccc(C2=Cc3ccc(O)cc3OC2)cc1	81267-65-4	"Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;BIRC4 Expression Inhibitors;Sphingosine Kinase Inhibitors;Tumor NADH Oxidase (tNOX) Inhibitors;""Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;BIRC4 Expression Inhibitors;Sphingosine Kinase Inhibitors;Tumor NADH Oxidase (tNOX) Inhibitors"""	ENOX2	SPHK2																															56848																															CHEMBL1957038											219100	9958931	58691109			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															8	7																															HY-13721	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:1814|ENOX2|Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;BIRC4 Expression Inhibitors;Sphingosine Kinase Inhibitors;Tumor NADH Oxidase (tNOX) Inhibitors;\Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;BIRC4 Expression Inhibitors;Sphingosine Kinase Inhibitors;Tumor NADH Oxidase (tNOX) Inhibitors\	Oc1ccc(cc1)C2=Cc3ccc(O)cc3OC2	81267-65-4	64736	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469742	240.25398	IDRONOXIL	"IDRONOXIL | ""PHENOXODIOL | DEHYDROEQUOL | HAGANIN E | IDRONOXIL | NV-06 |"" | IDRONOXIL | ""PHENOXODIOL | DEHYDROEQUOL | HAGANIN E | IDRONOXIL | NV-06 |"""	Pathway: Apoptosis; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:1814	ENOX2	Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;BIRC4 Expression Inhibitors;Sphingosine Kinase Inhibitors;Tumor NADH Oxidase (tNOX) Inhibitors;\Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;BIRC4 Expression Inhibitors;Sphingosine Kinase Inhibitors;Tumor NADH Oxidase (tNOX) Inhibitors\
SJ000833851-2	SJ000833851	2	MOABOX:1816	JMSUDQYHPSNBSN-UHFFFAOYSA-N	O=C(CCN1CCN(C(=O)OCc2cc(Cl)cc(Cl)c2)CC1)c1ccc2[nH]c(=O)oc2c1	1144035-53-9	Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 (ENPP2;Autotaxin) Inhibitors	ENPP2																																																															CHEMBL3186509											25265312	78357775				member	10.1021/acsmedchemlett.7b00312	10.1124/jpet.110.165845	10.1124/jpet.116.237156	10.1124/mol.115.100404																																																																																																																																																												20392816	23300119	26745766	27544588	27660691	27780639	27982588	28165241	28743508	29259743	29620892	29798825																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										3.49672																																0.43709																																8																																HY-13344	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer; Inflammation/Immunology|MOABOX:1816|ENPP2|Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 (ENPP2;Autotaxin) Inhibitors	Clc1cc(Cl)cc(COC(=O)N2CCN(CCC(=O)c3ccc4NC(=O)Oc4c3)CC2)c1	1144035-53-9	6113	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469813	478.32524	PF-8380	PF-8380 | PF-8380	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer; Inflammation/Immunology	MOABOX:1816	ENPP2	Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 (ENPP2;Autotaxin) Inhibitors
SJ000285273-8	SJ000285273	8	MOABOX:1818	ACGUYXCXAPNIKK-UHFFFAOYSA-N	Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl	139411-96-4	"Large Conductance K(Ca) 1.1 (BK, maxi K+) Channel Activators;Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 (ENPP2;Autotaxin) Inhibitors"	ENPP2	SDHD																															6392																															CHEMBL496											3598	192116	3080841	23093390	87428683	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.16709	0																															-0.02387	0.0																															7	7																															J10539	AK_SCIENTIFIC	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-785-865|MOABOX:1818|ENPP2|Large Conductance K(Ca) 1.1 (BK, maxi K+) Channel Activators;Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 (ENPP2;Autotaxin) Inhibitors"	Oc1c(Cl)cc(Cl)c(Cl)c1Cc2c(O)c(Cl)cc(Cl)c2Cl	70-30-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468258	406.90354	HEXACHLOROPHENE	HEXACHLOROPHENE | HEXACHLOROPHENE			MOABOX:1818	ENPP2	"Large Conductance K(Ca) 1.1 (BK, maxi K+) Channel Activators;Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 (ENPP2;Autotaxin) Inhibitors"
SJ000287757-5	SJ000287757	5	MOABOX:1822	UIAYVIIHMORPSJ-UHFFFAOYSA-N	CN(C(=O)CCCOc1ccc2nc(O)ccc2c1)C1CCCCC1	68550-75-4	Phosphodiesterase III Inhibitors	PDE3A	PDE3B	ENPP3																														5140	5169																														CHEMBL34431											2753	9809186	70149459	70561120		member	10.1016/j.bmcl.2003.08.056	10.1016/j.bmcl.2011.01.120																																																																																																																																																														2985781	3027338	14556790	14592490	15125967	15887951	16041400	16336197	17305583	21330134	21847495																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											1.96104	1.43864	0.59353																														0.24513	0.17983	0.08479																														8	8	7																														HY-101312	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease|MOABOX:1822|PDE3A|Phosphodiesterase III Inhibitors	CN(C1CCCCC1)C(=O)CCCOc2ccc3NC(=O)C=Cc3c2	68550-75-4	32053	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469570	342.43204	CILOSTAMIDE	"CILOSTAMIDE | ""CILOSTAMIDE | OPC-3689 |"" | CILOSTAMIDE | ""CILOSTAMIDE | OPC-3689 |"""	Pathway: Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease	MOABOX:1822	PDE3A	Phosphodiesterase III Inhibitors
SJ000287539-10	SJ000287539	10	MOABOX:1824	PZRHRDRVRGEVNW-UHFFFAOYSA-N	Cc1nc(O)c(C#N)cc1-c1ccncc1	100286-97-3	Phosphodiesterase III Inhibitors	PDE3A	PDE3B	ENPP3																														5140	5169																														CHEMBL1200977	CHEMBL189										4197	172293	22605028	24906308	25030212	member	10.1016/j.bmcl.2003.08.056	10.1016/j.bmcl.2005.10.092																																																																																																																																																														1336055	2846839	3027339	8295212	8388468	9154964	9767640	11125024	14529391	14592490	14987986	15125945	15887951	16041400	16290931	16336197	17305583	17500510	18282564	18473926	21688779	23425969	25369539	30300845																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														1.2672	1.16376	0.49357																														0.1584	0.14547	0.07051																														8	8	7																														HY-14252	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease|MOABOX:1824|PDE3A|Phosphodiesterase III Inhibitors	CC1=C(C=C(C#N)C(=O)N1)c2ccncc2	78415-72-2	12250	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469796	211.21936	MILRINONE	"MILRINONE | ""MILRINONE LACTATE | WIN-47203 | YM-018 | COROTROPE | PRIMACOR |"" | MILRINONE | ""MILRINONE LACTATE | WIN-47203 | YM-018 | COROTROPE | PRIMACOR |"""	Pathway: Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease	MOABOX:1824	PDE3A	Phosphodiesterase III Inhibitors
SJ000287447-16	SJ000287447	16	MOABOX:1830	HJORMJIFDVBMOB-UHFFFAOYSA-N	COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1	61413-54-5	Phosphodiesterase IV Inhibitors	PDE4C	ENPP4																															22875																															CHEMBL63											5092	9833414	23177709	67900513	69295221	member	10.1016/j.ejmech.2016.08.052	10.1021/acschemneuro.6b00271																																																																																																																																																														7490734	8201604	8544172	9154964	9191951	9400021	9767640	9808700	9871649	9873449	9873593	9873594	9873600	9873675	9873708	10090791	10889326	11012037	11052785	11123995	11128646	11140727	11259554	11472206	11738561	12036360	12036361	12052219	12192136	12824031	15498513	15715490	15780616	15887951	16250839	16336197	17336928	17704822	18686943	19303290	19442182	19827751	20854254	21688779	22607677	26526739	27597413	29040954																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						3.76e-003	0.24143																															0.00047	0.03449																															8	7																															HY-16900	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Metabolic Enzyme/Protease | Research Area: Neurological Disease; Cancer|MOABOX:1830|PDE4C|Phosphodiesterase IV Inhibitors	COc1ccc(cc1OC2CCCC2)C3CNC(=O)C3	61413-54-5	13060	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468768	275.34284	ROLIPRAM	ROLIPRAM | S- (+)-ROLIPRAM | ROLIPRAM | S- (+)-ROLIPRAM	Pathway: Anti-infection; Metabolic Enzyme/Protease	Research Area: Neurological Disease; Cancer	MOABOX:1830	PDE4C	Phosphodiesterase IV Inhibitors
SJ000285885-8	SJ000285885	8	MOABOX:1832	REZGGXNDEMKIQB-UHFFFAOYSA-N	CCCOc1ccccc1-c1nc(=O)c2nn[nH]c2[nH]1	1110670-37-5	Phosphodiesterase V (PDE5A) Inhibitors;GPR35 agonist	GPR35	PDE6A	PDE5A	ENPP6																													5145	8654	133121																													CHEMBL28079											135399235	135494258	135494284	135703030	136376021	member	10.1016/S0014-2999(00)00824-4	10.1016/j.bmcl.2012.04.057	10.1021/jm950812j	10.1021/ml300076u	10.1042/BJ20050425	10.1080/1475636021000008494	10.1124/mol.113.089482	10.1159/000157625																																																																																																																																																								7503759	8120866	8254606	8388468	8648603	10385692	11137852	12530475	12774696	14556647	15294449	15887951	16038615	16336197	17383621	18282564	18655195	18818509	20235539	21950657	22572579	22607677	23713606	23888932	24900447	24900508	27976894																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											1.1868	0.22624	1.458	0.55006																													0.14835	0.02828	0.18225	0.07858																													8	8	8	7																													10010421	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-387|MOABOX:1832|GPR35|Phosphodiesterase V (PDE5A) Inhibitors;GPR35 agonist	CCCOc1ccccc1C2=Nc3nn[nH]c3C(=O)N2	37762-06-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468320	271.27462	ZAPRINAST	ZAPRINAST | ZAPRINAST			MOABOX:1832	GPR35	Phosphodiesterase V (PDE5A) Inhibitors;GPR35 agonist
SJ000489300-2	SJ000489300	2	MOABOX:1834	JOEYVYNGBCYTGH-UHFFFAOYSA-N	Cn1c(=O)[nH]c(=O)c2c1nc1n(CCCCO)c(-c3ccccc3)cn21	633281-74-0	EphB4 Inhibitors	EPHB4																																																															CHEMBL271179											3818114					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.36087																																0.19441																																7																																PHAR149410	PHARMEKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-813-094|MOABOX:1834|EPHB4|EphB4 Inhibitors	CN1C(=O)N=C(O)c2c1nc3n(CCCCO)c(cn23)c4ccccc4	633281-74-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468336	353.37516					MOABOX:1834	EPHB4	EphB4 Inhibitors
SJ000821582-4	SJ000821582	4	MOABOX:1836	XSHQBIXMLULFEV-UHFFFAOYSA-N	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21	221243-82-9	"Extracellular-Regulated Kinase (ERK) Inhibitors;EphB4 Inhibitors;Angiogenesis Inhibitors;""Extracellular-Regulated Kinase (ERK) Inhibitors;EphB4 Inhibitors;Angiogenesis Inhibitors"""	CAMK2B	EPHB4	FYN	MAPK13	CAMK2G																												2050	2534	5603	818																												CHEMBL264406											4877	10066681				member																																																																																																																																																																16408016	18077363																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.30723	0	0.42864	0.91256	0																												0.04389	0.0	0.05358	0.11407	0.0																												7	7	8	8	7																												HY-13941	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:1836|CAMK2B|Extracellular-Regulated Kinase (ERK) Inhibitors;EphB4 Inhibitors;Angiogenesis Inhibitors;\Extracellular-Regulated Kinase (ERK) Inhibitors;EphB4 Inhibitors;Angiogenesis Inhibitors\	CC(C)(C)n1nc(c2cccc3ccccc23)c4c(N)ncnc14	221243-82-9	12452	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469348	317.38766	1-NA-PP1	1-NA-PP1 | 1-NA-PP1	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:1836	CAMK2B	Extracellular-Regulated Kinase (ERK) Inhibitors;EphB4 Inhibitors;Angiogenesis Inhibitors;\Extracellular-Regulated Kinase (ERK) Inhibitors;EphB4 Inhibitors;Angiogenesis Inhibitors\
SJ001035364-1	SJ001035364	1	MOABOX:1838	KNBWKJBQDAQARU-KSSCSKLYSA-N	O=C(NC12CC3CC(CC(C3)C1)C2)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1	885012-33-9	Soluble Epoxide Hydrolase Inhibitors	EPHX2																																																															CHEMBL242459																member	10.1016/j.bmc.2012.03.058	10.1016/j.bmc.2014.03.001	10.1016/j.ejps.2012.12.013	10.1021/jm070270t	10.1021/jm101087u	10.1021/jm2001376	10.1021/jm201468j	10.1039/c2md00288d																																																																																																																																																								17616115	20359531	21070033	21143109	21434686	22079754	22168898	22522007	23291046	23684894	23726028	24656800	26882208	29366648																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								3.078																																0.38475																																8																																HY-113974	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:1838|EPHX2|Soluble Epoxide Hydrolase Inhibitors	OC(=O)c1ccc(O[C@@H]2CC[C@H](CC2)NC(=O)NC34C[C@@H]5C[C@@H](C[C@@H](C5)C3)C4)cc1	885012-33-9	84323	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469772	412.52188	TRANS-AUCB | T-AUCB	"""TRANS-AUCB | T-AUCB"" | ""TRANS-AUCB | T-AUCB"""	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:1838	EPHX2	Soluble Epoxide Hydrolase Inhibitors
SJ001035219-1	SJ001035219	1	MOABOX:1842	XLGSEOAVLVTJDH-UHFFFAOYSA-N	O=C(O)CCCCCCCCCCCNC(=O)NC12CC3CC(CC(C3)C1)C2	479413-70-2	Soluble Epoxide Hydrolase Inhibitors	EPHX2																																																															CHEMBL215387											10069117					virtual	10.1016/S0006-2952(02)00952-8	10.1016/j.ab.2005.03.041	10.1016/j.ab.2006.04.045	10.1016/j.bmc.2006.09.057	10.1016/j.bmc.2013.12.027	10.1016/j.bmc.2015.10.016	10.1016/j.bmcl.2006.07.073	10.1016/j.bmcl.2010.12.042	10.1016/j.bmcl.2011.10.074	10.1016/j.bmcl.2013.02.048	10.1016/j.bmcl.2013.08.054	10.1016/j.bmcl.2013.12.020	10.1016/j.ejmech.2011.01.047	10.1021/jm070270t	10.1021/jm101087u	10.1021/jm201468j	10.1021/jm301617j	10.1021/jm500262m	10.1021/jm900634w	10.1021/jm900725r																																																																																																																																												16870439	16908134	17046265	17616115	19645482	19653681	20359531	21070033	21354674	22079754	22168898	23017883	23130964	23356879	23489630	23596124	24373724	24433964	24679441	25119815	26372074	26483136	26507430	26882208	27092411	27120257	27246857	28558206	28867792	30354105																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								2.8424																																0.3553																																8																																HY-108570	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:1842|EPHX2|Soluble Epoxide Hydrolase Inhibitors	OC(=O)CCCCCCCCCCCNC(=O)NC12CC3CC(CC(C3)C1)C2	479413-70-2	63474	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469169	392.5753	AUDA	AUDA | AUDA	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:1842	EPHX2	Soluble Epoxide Hydrolase Inhibitors
SJ000834166-8	SJ000834166	8	MOABOX:1844	DFBIRQPKNDILPW-KTGKZQHOSA-N	CC(C)[C@]12O[C@H]1[C@@H]1O[C@@]13[C@@]1(C)CCC4=C(COC4=O)C1C[C@@H]1O[C@@]13[C@@H]2O	38748-32-2	ERCC3 (TFIIH subunit)	ERCC3																																																																										16220015	143112055	145215005			member	10.1038/nchembio.522																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-32735	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; NF-?B | Research Area: Cancer|MOABOX:1844|ERCC3|ERCC3 (TFIIH subunit)	CC(C)[C@]12O[C@H]1[C@@H]3O[C@@]34[C@@]5(C)CCC6=C(COC6=O)[C@@H]5C[C@@H]7O[C@]47[C@@H]2O	38748-32-2	23064	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469859	360.40096	TRIPTOLIDE	TRIPTOLIDE | TRIPTOLIDE (PG490) | TRIPTOLIDE | TRIPTOLIDE (PG490)	Pathway: Apoptosis; NF-?B	Research Area: Cancer	MOABOX:1844	ERCC3	ERCC3 (TFIIH subunit)
SJ000834166-7	SJ000834166	7	MOABOX:1844	DFBIRQPKNDILPW-KTGKZQHOSA-N	CC(C)[C@]12O[C@H]1[C@@H]1O[C@@]13[C@@]1(C)CCC4=C(COC4=O)C1C[C@@H]1O[C@@]13[C@@H]2O	38748-32-2	ERCC3 (TFIIH subunit)	ERCC3																																																																										16220015	143112055	145215005			member	10.1038/nchembio.522																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																AA0035S7	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-016-638-463|MOABOX:1844|ERCC3|ERCC3 (TFIIH subunit)	CC(C)[C@]12O[C@H]1[C@@H]3O[C@@]34[C@@]5(C)CCC6=C(COC6=O)[C@@H]5C[C@@H]7O[C@]47[C@@H]2O	38748-32-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468279	360.40096	TRIPTOLIDE	TRIPTOLIDE | TRIPTOLIDE (PG490) | TRIPTOLIDE | TRIPTOLIDE (PG490)			MOABOX:1844	ERCC3	ERCC3 (TFIIH subunit)
SJ000285712-9	SJ000285712	9	MOABOX:1850	GKIRPKYJQBWNGO-OCEACIFDSA-N	CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1	14158-65-7	Estrogen Receptor (ER) Antagonists	ESR1																																																															CHEMBL1200667	CHEMBL954										1548953	6420009	9940081	11534475	15604709	virtual																																																																																																																																																																20615952																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.21616																																0.15202																																8																																HY-118861A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Inflammation/Immunology|MOABOX:1850|ESR1|Estrogen Receptor (ER) Antagonists	CCN(CC)CCOc1ccc(cc1)\C(=C(\Cl)/c2ccccc2)\c3ccccc3	7599-79-3	42747	GENERAL	CITRATE	1	NO_SOLVATE	0	1468890	405.95962	CLOMIPHENE	"CLOMIPHENE | (Z,E)-CLOMIPHENE CITRATE | CLOMIFENE CITRATE | CLOMIPHENE | (Z,E)-CLOMIPHENE CITRATE | CLOMIFENE CITRATE"	Pathway: Others	Research Area: Inflammation/Immunology	MOABOX:1850	ESR1	Estrogen Receptor (ER) Antagonists
SJ000829914-3	SJ000829914	3	MOABOX:1852	ZZIALNLLNHEQPJ-UHFFFAOYSA-N	O=c1oc2cc(O)ccc2c2oc3cc(O)ccc3c12	479-13-0	Estrogen Receptor (ER) alpha Ligands;Estrogen Receptor (ER) beta Ligands;AGE Inhibitors (Maillard's Reaction Inhibitors)	ESR1	ESR2																															2100																															CHEMBL30707											5281707	69009536				member	10.1016/S0039-128X(01)00194-5	10.1016/S0039-128X(96)00246-2	10.1016/S0960-0760(00)00126-6	10.1016/S0960-894X(96)00502-1	10.1016/j.bmcl.2004.01.031	10.1016/j.jsbmb.2004.03.118	10.1016/j.jsbmb.2004.09.004	10.1021/jm0490538	10.1039/b303985d	10.1210/en.2006-0113	10.1210/endo.139.10.6216	10.1271/bbb.66.1479																																																																																																																																																				12224631	15006374	15887952	16118406	16554039	18096694																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.87984	2.16992																															0.23498	0.27124																															8	8																															HY-N2335	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:1852|ESR1|Estrogen Receptor (ER) alpha Ligands;Estrogen Receptor (ER) beta Ligands;AGE Inhibitors (Maillard's Reaction Inhibitors)	Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	479-13-0	98072	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469768	268.22102			Pathway: Others	Research Area: Cancer	MOABOX:1852	ESR1	Estrogen Receptor (ER) alpha Ligands;Estrogen Receptor (ER) beta Ligands;AGE Inhibitors (Maillard's Reaction Inhibitors)
SJ001035116-1	SJ001035116	1	MOABOX:1854	ILEIGUXOYKZHRK-UHFFFAOYSA-N	Cc1ccc(NC(=N)NC(=N)N)cc1	15233-33-7	5-HT3 receptor agonist	HTR3B	HTR3C	HTR3D	HTR3E																													170572	200909	285242																													CHEMBL291064											2730262	2730263	21240406	21536450	70011948	virtual																																																																																																																																																																11412989	13129581																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.59264	0.59264	0.59264	0.59264																													0.07408	0.07408	0.07408	0.07408																													8	8	8	8																													AH-478/02713030	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-471-472|MOABOX:1854|HTR3B|5-HT3 receptor agonist	Cc1ccc(NC(=N)NC(=N)N)cc1	15233-33-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468723	191.23302	AH-478/02713030	AH-478/02713030 | AH-478/02713030			MOABOX:1854	HTR3B	5-HT3 receptor agonist
SJ001034925-1	SJ001034925	1	MOABOX:1858	SCVIEONTACSLJA-VZBZSUMNSA-N	CC/C(=C(/c1ccc(O)cc1)c1ccc(/C=C/C(=O)O)cc1)c1ccccc1	361203-06-7	Selective Estrogen Receptor Downregulators (SERDs)	ESR1	ESR2																															2100																															CHEMBL1091137											46885714					virtual	10.1021/jm100047k																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.66576	0																															0.33322	0.0																															8	7																															SYN5135	AK_SCIENTIFIC	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-138-750|MOABOX:1858|ESR1|Selective Estrogen Receptor Downregulators (SERDs)	CC\C(=C(/c1ccc(O)cc1)\c2ccc(\C=C\C(=O)O)cc2)\c3ccccc3	195611-82-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468255	370.44038	GW7604	GW7604 | GW7604			MOABOX:1858	ESR1	Selective Estrogen Receptor Downregulators (SERDs)
SJ000546506-4	SJ000546506	4	MOABOX:1862	NFIXBCVWIPOYCD-UHFFFAOYSA-N	CCN(CC)CCOc1ccc(Cc2ccccc2)cc1	1185241-83-1	Estrogen Receptor (ER) Antagonists;Histamine Receptor Antagonists	ESR1	LTA4H																															4048																															CHEMBL2107467	CHEMBL26424										108092	175534	45073473	57369471	57504193	member																																																																																																																																																																10691697	20615952																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.5495	2.29696																															0.0785	0.28712																															7	8																															743	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-762|MOABOX:1862|ESR1|Estrogen Receptor (ER) Antagonists;Histamine Receptor Antagonists	CCN(CC)CCOc1ccc(Cc2ccccc2)cc1	1185241-83-1	NA	GENERAL	FUMARATE	1	NO_SOLVATE	0	1468712	283.4079	DPPE FUMARATE	"DPPE FUMARATE | N,N-DIETHYL-2-[4-(PHENYLMETHYL)PHENOXY]ETHANAMINE FUMARATE | ""TESMILIFENE HCL | BMS-217380 | BMY-33419 | DPPE | N,N-DPPE |"" | DPPE FUMARATE | N,N-DIETHYL-2-[4-(PHENYLMETHYL)PHENOXY]ETHANAMINE FUMARATE | ""TESMILIFENE HCL | BMS-217380 | BMY-33419 | DPPE | N,N-DPPE |"""			MOABOX:1862	ESR1	Estrogen Receptor (ER) Antagonists;Histamine Receptor Antagonists
SJ001033292-2	SJ001033292	2	MOABOX:1864	MQIMZDXIAHJKQP-UHFFFAOYSA-N	C=Cc1cc(O)cc2nc(-c3ccc(O)c(F)c3)oc12	524684-52-4	Estrogen Receptor (ER) beta Agonists	ESR2																																																															CHEMBL450940											656954	135520445				member	10.1016/j.ejmech.2007.03.002	10.1021/ja047633o	10.1021/jm049719y	10.1210/en.2003-0550	10.2174/0929867053764662	10.2174/092986710792927813																																																																																																																																																										15456246	15892637	17459530	20738246																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.35824																																0.29478																																8																																HY-14933	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Others; Stem Cell/Wnt | Research Area: Cancer|MOABOX:1864|ESR2|Estrogen Receptor (ER) beta Agonists	Oc1cc(C=C)c2oc(nc2c1)c3ccc(O)c(F)c3	524684-52-4	15857	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469331	271.2432	PRINABEREL; ERB-041	PRINABEREL; ERB-041 | PRINABEREL; ERB-041	Pathway: Apoptosis; Others; Stem Cell/Wnt	Research Area: Cancer	MOABOX:1864	ESR2	Estrogen Receptor (ER) beta Agonists
SJ001035365-1	SJ001035365	1	MOABOX:1868	HQFNFOOGGLSBBT-AWNIVKPZSA-N	COc1cc(/C=C(\C#N)C(=O)Nc2nnc(C(F)(F)F)s2)ccc1OCc1ccc(C(F)(F)F)cc1C(F)(F)F	725247-18-7	"Estrogen-Related Receptor alpha (ERRalpha, ERR1) Inverse Agonists"	ESRRA																																																															CHEMBL189753											6918788					member	10.2174/1568026610606030203																																																																																																																																																															15509154	16515477	21218783	22632982	23656512	28525844	31097997																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															3.14584																																0.39323																																8																																HY-10426	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Others | Research Area: Cancer|MOABOX:1868|ESRRA|Estrogen-Related Receptor alpha (ERRalpha, ERR1) Inverse Agonists"	COc1cc(\C=C(/C#N)\C(=O)Nc2nnc(s2)C(F)(F)F)ccc1OCc3ccc(cc3C(F)(F)F)C(F)(F)F	725247-18-7	11963	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469780	596.42495	XCT790	XCT790 | XCT790	Pathway: Autophagy; Others	Research Area: Cancer	MOABOX:1868	ESRRA	"Estrogen-Related Receptor alpha (ERRalpha, ERR1) Inverse Agonists"
SJ000546501-2	SJ000546501	2	MOABOX:1870	WLKOCYWYAWBGKY-CPNJWEJPSA-N	CCN(CC)c1ccc(/C=N/NC(=O)c2ccc(O)cc2)cc1	95167-41-2	"Estrogen-Related Receptor beta (ERRbeta, ERR2) Agonists;Estrogen-Related Receptor gamma (ERRgamma) Agonists"	ESRRG																																																															CHEMBL192509											5497124					member	10.1021/jm050161j	10.2174/1568026610606030203																																																																																																																																																														15857113	16515477																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.59912																																0.44989																																8																																HY-15483	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Others; Stem Cell/Wnt | Research Area: Cancer; Endocrinology|MOABOX:1870|ESRRG|Estrogen-Related Receptor beta (ERRbeta, ERR2) Agonists;Estrogen-Related Receptor gamma (ERRgamma) Agonists"	CCN(CC)c1ccc(\C=N\NC(=O)c2ccc(O)cc2)cc1	95167-41-2	16606	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469676	311.37824	DY131	DY131 | DY131	Pathway: Others; Stem Cell/Wnt	Research Area: Cancer; Endocrinology	MOABOX:1870	ESRRG	"Estrogen-Related Receptor beta (ERRbeta, ERR2) Agonists;Estrogen-Related Receptor gamma (ERRgamma) Agonists"
SJ000852524-6	SJ000852524	6	MOABOX:1880	KGFYHTZWPPHNLQ-AWEZNQCLSA-N	O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1	1429742-50-6	Inhibitors of Blood Coagulation Pathways;Coagulation Factor Xa Inhibitors	F10																																																															CHEMBL198362											9875400	9875401	11848166	44537831	44543920	member	10.1016/j.ejmech.2012.10.005 Oct 16.	10.1016/j.ejmech.2015.04.025	10.1016/j.ejmech.2015.06.012	10.1021/jm050101d	10.1021/jm2006589	10.1111/j.1538-7836.2005.01166.x	10.2165/0003088-200948010-00001	10.2174/156802605775009702	10.2174/156802610790725506																																																																																																																																																							15748242	16161994	16305517	16375748	16638738	17313362	19071881	19297154	19967784	20166954	20235539	20503967	21515813	21732671	21955945	22680641	23124211	23644213	24175584	25179681	25911624	26114810	27089317	28937618																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														4.15112																																0.51889																																8																																HY-76948	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease|MOABOX:1880|F10|Inhibitors of Blood Coagulation Pathways;Coagulation Factor Xa Inhibitors	Clc1ccc(s1)C(=O)NC[C@@H]2CN(C(=O)O2)c3ccc(cc3)N4CCOCC4=O	865479-71-6	4895	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468840	435.88132	RIVAROXABAN	RIVAROXABAN | RIVAROXABAN	Pathway: Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease	MOABOX:1880	F10	Inhibitors of Blood Coagulation Pathways;Coagulation Factor Xa Inhibitors
SJ000852524-5	SJ000852524	5	MOABOX:1880	KGFYHTZWPPHNLQ-AWEZNQCLSA-N	O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1	1429742-50-6	Inhibitors of Blood Coagulation Pathways;Coagulation Factor Xa Inhibitors	F10																																																															CHEMBL198362											9875400	9875401	11848166	44537831	44543920	member	10.1016/j.ejmech.2012.10.005 Oct 16.	10.1016/j.ejmech.2015.04.025	10.1016/j.ejmech.2015.06.012	10.1021/jm050101d	10.1021/jm2006589	10.1111/j.1538-7836.2005.01166.x	10.2165/0003088-200948010-00001	10.2174/156802605775009702	10.2174/156802610790725506																																																																																																																																																							15748242	16161994	16305517	16375748	16638738	17313362	19071881	19297154	19967784	20166954	20235539	20503967	21515813	21732671	21955945	22680641	23124211	23644213	24175584	25179681	25911624	26114810	27089317	28937618																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														4.15112																																0.51889																																8																																CS-0730	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-035-784-297|MOABOX:1880|F10|Inhibitors of Blood Coagulation Pathways;Coagulation Factor Xa Inhibitors	Clc1ccc(s1)C(=O)NC[C@@H]2CN(C(=O)O2)c3ccc(cc3)N4CCOCC4=O	865479-71-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468477	435.88132	RIVAROXABAN	RIVAROXABAN | RIVAROXABAN			MOABOX:1880	F10	Inhibitors of Blood Coagulation Pathways;Coagulation Factor Xa Inhibitors
SJ000312314-10	SJ000312314	10	MOABOX:1888	KXNPVXPOPUZYGB-IOVMHBDKSA-N	CC1CNc2c(cccc2S(=O)(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CC[C@@H](C)C[C@@H]2C(=O)O)C1	121785-71-5	Inhibitors of Blood Coagulation Pathways;Thrombin Inhibitors	F2																																																															CHEMBL1166											92721	92722	9876225	54711934	86595909	member																																																																																																																																																																7582977	7582987	7966150	8713795	8759623	10340604	10669559	10794696	11738569	11738570	12238922	12811006	12904065	15771442	16294249	16302799	17010480	17883259	20235539	22680641	23899618	25874337	26537784	27884512	28850227																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3.36648																																0.42081																																8																																19639	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-069-116|MOABOX:1888|F2|Inhibitors of Blood Coagulation Pathways;Thrombin Inhibitors	CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)c2cccc3CC(C)CNc23	74863-84-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468652	508.63414	ARGATROBAN	"ARGATROBAN | ""ARGATROBAN | 1-(5-(DIAMINOMETHYLENEAMINO)-2-(3-METHYL-1,2,3,4-TETRAHYDROQUINOLINE-8-SULFONAMIDO)PENTANOYL)-4-METHYLPIPERIDINE-2-CARBOXYLIC ACID"" | ARGATROBAN|(2R,4R)-1-[(2S)-5-CARBAMIMIDAMIDO-2-(3-METHYL-1,2,3,4-TETRAHYDROQUINOLINE-8-SULFONAMIDO)PENTANOYL]-4-METHYLPIPERIDINE-2-CARBOXYLIC ACID | ARGATROBAN | ""ARGATROBAN | 1-(5-(DIAMINOMETHYLENEAMINO)-2-(3-METHYL-1,2,3,4-TETRAHYDROQUINOLINE-8-SULFONAMIDO)PENTANOYL)-4-METHYLPIPERIDINE-2-CARBOXYLIC ACID"" | ARGATROBAN|(2R,4R)-1-[(2S)-5-CARBAMIMIDAMIDO-2-(3-METHYL-1,2,3,4-TETRAHYDROQUINOLINE-8-SULFONAMIDO)PENTANOYL]-4-METHYLPIPERIDINE-2-CARBOXYLIC ACID"			MOABOX:1888	F2	Inhibitors of Blood Coagulation Pathways;Thrombin Inhibitors
SJ000775206-14	SJ000775206	14	MOABOX:1892	LPLVUJXQOOQHMX-QWBHMCJMSA-N	CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C	132215-36-2	Inhibitors of Blood Coagulation Pathways;Thrombin Inhibitors;Antioxidants;Cell Adhesion Inhibitors	F2																																																															CHEMBL441687											14982	62074	155042	163463	656656	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																AS-13001	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]3(C)[C@@H]2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]34C)C(=O)O)O[C@H]6O[C@@H]([C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)C(=O)O)C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466794	822.93208	GLYCYRRHIZIN PARENT	GLYCYRRHIZIN PARENT | GLYCYRRHIZIN | AMMONIUM GLYCYRRHIZINATE | GLYCYRRHIZIN PARENT | GLYCYRRHIZIN | AMMONIUM GLYCYRRHIZINATE			MOABOX:1892	F2	Inhibitors of Blood Coagulation Pathways;Thrombin Inhibitors;Antioxidants;Cell Adhesion Inhibitors
SJ000785953-2	SJ000785953	2	MOABOX:1896	RQKXQCSEZPQBNZ-QSBCOWLBSA-N	C/C(=N\NC(=O)[C@@H]1C(=O)NC[C@H]1c1ccccc1)c1cccc(Br)c1	1051487-82-1	PAR2 Agonists;F2RL1 agonist	F2RL1																																																															CHEMBL494502											25108278	76962802				member																																																																																																																																																																18720984	23895492																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.81864																																0.35233																																8																																3370	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-778|MOABOX:1896|F2RL1|PAR2 Agonists;F2RL1 agonist	C\C(=N/NC(=O)[C@H]1[C@@H](CNC1=O)c2ccccc2)\c3cccc(Br)c3	1051487-82-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468212	400.26912	AC 264613	AC 264613 | AC 264613			MOABOX:1896	F2RL1	PAR2 Agonists;F2RL1 agonist
SJ001035045-1	SJ001035045	1	MOABOX:1898	VHYTVSSUVKUYOG-UHFFFAOYSA-N	COc1ccc(Br)c(-c2nc3ccccc3c(=O)o2)c1		Inhibitors of Blood Coagulation Pathways;Coagulation Factor VIIa Inhibitors	F7																																																																										2731929					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-4.284e-002																																-0.00612																																7																																S06924	MAYBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-917-958|MOABOX:1898|F7|Inhibitors of Blood Coagulation Pathways;Coagulation Factor VIIa Inhibitors	COc1ccc(Br)c(c1)C2=Nc3ccccc3C(=O)O2	244206-28-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468545	332.1488	S06924	S06924 | S06924			MOABOX:1898	F7	Inhibitors of Blood Coagulation Pathways;Coagulation Factor VIIa Inhibitors
SJ001035061-1	SJ001035061	1	MOABOX:1902	ILOIOIGZFHGSMS-UHFFFAOYSA-N	O=C(CCCCCCc1ccccc1)c1ncc(-c2ccccn2)o1	681135-77-3	Fatty Acid Amide Hydrolase (FAAH) Inhibitors	CES1	FAAH																															2166																															CHEMBL177577											10427006					member	10.1016/j.bmc.2013.06.034	10.1016/j.bmcl.2008.01.091	10.1016/j.bmcl.2009.05.097	10.1021/jm061414r	10.1021/jm200723m	10.1021/jm300689c	10.1021/jm701210y	10.1073/pnas.1016167108																																																																																																																																																								15713400	15771430	16918457	17279090	17279740	17559203	18053726	18247553	18289091	18289847	18630870	18639454	18644727	18693015	18983142	19515560	21428410	21502526	21764305	21899370	22779702	23218778	23410152	23891163	27130358	30503633																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												-0.58624	0.87576																															-0.07328	0.10947																															8	8																															Z168828818	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-737-038|MOABOX:1902|CES1|Fatty Acid Amide Hydrolase (FAAH) Inhibitors	O=C(CCCCCCc1ccccc1)c2oc(cn2)c3ccccn3	681135-77-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468568	334.41158	Z168828818	Z168828818 | Z168828818			MOABOX:1902	CES1	Fatty Acid Amide Hydrolase (FAAH) Inhibitors
SJ000795990-6	SJ000795990	6	MOABOX:1910	SJRVJRYZAQYCEE-UHFFFAOYSA-N	CCc1c(-c2ccccc2)c(-c2ccccc2)nn1-c1ccccc1-c1cccc(OCC(=O)O)c1	300657-03-8	Adypocyte Fatty Acid Binding Protein (A-FABP;FABP4;FABPaP2) Inhibitors	FABP4	FABP1	FABP2	FABP3	FABP5	FABP6	FABP7	FABP9	FABP12																								2168	2169	2170	2171	2172	2173	646480	646486																								CHEMBL247920											16122583					member																																																																																																																																																																17502136	17554340	18855890	21481589	22170058	22223390	23395658	27096055	27460668																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0.21798	0.21798	1.75192	0.21798	0.21798	0.25224	0.2084	0.21798	0.21798																								0.03114	0.03114	0.21899	0.03114	0.03114	0.03153	0.02605	0.03114	0.03114																								7	7	8	7	7	8	8	7	7																								HY-101903	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease; Cardiovascular Disease|MOABOX:1910|FABP4|Adypocyte Fatty Acid Binding Protein (A-FABP;FABP4;FABPaP2) Inhibitors	CCc1c(c2ccccc2)c(nn1c3ccccc3c4cccc(OCC(=O)O)c4)c5ccccc5	300657-03-8	41681	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469620	474.54974	FABP4 INHIBITOR 	FABP4 INHIBITOR  | FABP4 ADIPOCYTE FATTY-ACID-BINDING PROTEIN INHIBIT | FABP4 INHIBITOR  | FABP4 ADIPOCYTE FATTY-ACID-BINDING PROTEIN INHIBIT	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease; Cardiovascular Disease	MOABOX:1910	FABP4	Adypocyte Fatty Acid Binding Protein (A-FABP;FABP4;FABPaP2) Inhibitors
SJ000862064-3	SJ000862064	3	MOABOX:1920	UPABQMWFWCMOFV-UHFFFAOYSA-N	c1ccc(CCNCc2ccccc2)cc1	3240-91-3		FARS2																																																															CHEMBL1379176	CHEMBL1618762										65055	201099	19733512	20291452	23298585	member																																																																																																																																																																390149	794470																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.0535																																0.1505																																7																																PS-13583	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	C(Cc1ccccc1)NCc2ccccc2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466805	211.30218	N-BENZYL-2-PHENYLETHAN-1-AMINE	N-BENZYL-2-PHENYLETHAN-1-AMINE | N-BENZYL-2-PHENYLETHAN-1-AMINE			MOABOX:1920	FARS2	
SJ000286071-13	SJ000286071	13	MOABOX:1922	AHLBNYSZXLDEJQ-FWEHEUNISA-N	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O	104872-04-0	Fatty Acid Synthase Inhibitors;Pancreatic Triacylglycerol Lipase Inhibitors;Gastric Triacylglycerol Lipase Inhibitors	DAGLA	FASN	LIPA	PNLIP	LIPF	DAGLB																											2194	3988	5406	8513	221955																											CHEMBL175247											3034010	9831053	9832565	9854377	9875528	virtual	10.1016/j.bmcl.2012.05.101	10.1021/jm800978m	10.1194/jlr.D058438																																																																																																																																																													7844031	16078824	18657971	18831576	19442134	21726077	22738638	24747066	26917221	28006918	28958622	30034597	30613337																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									1.03776	-0.10792	9.919e-002	3.776e-002	0	0.22272																											0.12972	-0.01349	0.01417	0.00472	0.0	0.02784																											8	8	7	8	8	8																											KS-1183	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466723	495.73482	ORLISTAT	"ORLISTAT | ""ORLISTAT | R-212 | RO-18-0647 | RO-18-0647/002 | ORLIPASTAT | TETRAHYDROLIPSTATIN |"" | ORLISTAT | ""ORLISTAT | R-212 | RO-18-0647 | RO-18-0647/002 | ORLIPASTAT | TETRAHYDROLIPSTATIN |"""			MOABOX:1922	DAGLA	Fatty Acid Synthase Inhibitors;Pancreatic Triacylglycerol Lipase Inhibitors;Gastric Triacylglycerol Lipase Inhibitors
SJ000286846-5	SJ000286846	5	MOABOX:1924	GNRIZKKCNOBBMO-UHFFFAOYSA-N	COc1c(O)cc2oc3cc(O)c(CC=C(C)C)c(O)c3c(=O)c2c1CC=C(C)C	6147-11-1	Fatty Acid Synthase Inhibitors;Acidic Sphingomyelinase (A-SMase) Inhibitors;Antioxidants	FASN	SMPD1																															6609																															CHEMBL323197											5281650	66766234	69611925			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-1.876e-002	-0.15148																															-0.00268	-0.02164																															7	7																															HY-N0328	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?B | Research Area: Cancer|MOABOX:1924|FASN|Fatty Acid Synthase Inhibitors;Acidic Sphingomyelinase (A-SMase) Inhibitors;Antioxidants	COc1c(O)cc2Oc3cc(O)c(CC=C(C)C)c(O)c3C(=O)c2c1CC=C(C)C	6147-11-01	24375	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469201	410.45964	ALPHA-MANGOSTIN	ALPHA-MANGOSTIN | ALPHA MANGOSTIN | ALPHA-MANGOSTIN | ALPHA MANGOSTIN	Pathway: Anti-infection; Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?B	Research Area: Cancer	MOABOX:1924	FASN	Fatty Acid Synthase Inhibitors;Acidic Sphingomyelinase (A-SMase) Inhibitors;Antioxidants
SJ000285626-6	SJ000285626	6	MOABOX:1928	UDMBCSSLTHHNCD-KQYNXXCUSA-N	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O	13270-66-1	"nucleotide;AMPK activator;""nucleotide;AMPK activator"""	PRKAG1	FBP2	PRKAG2	PRKAG3																													8789	51422	53632																													CHEMBL1315633	CHEMBL3350529	CHEMBL752									6083	24332	32741	65361	162816	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.1386	0	-1.855e-002	0																													0.0198	0.0	-0.00265	0.0																													7	7	7	7																													AS-11783	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466809	347.22122	ADENOSINE PHOSPHATE	ADENOSINE PHOSPHATE | ADENOSINE 5'-MONOPHOSPHATE MONOHYDRATE | ADENOSINE-5'-MONOPHOSPHATE (AMP) | ADENOSINE PHOSPHATE | ADENOSINE 5'-MONOPHOSPHATE MONOHYDRATE | ADENOSINE-5'-MONOPHOSPHATE (AMP)			MOABOX:1928	PRKAG1	"nucleotide;AMPK activator;""nucleotide;AMPK activator"""
SJ000772428-3	SJ000772428	3	MOABOX:1930	XFILPEOLDIKJHX-QYZOEREBSA-N	CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)[C@H](CSc1cccs1)C(=O)NO	130370-60-4	"Angiogenesis Inhibitors;Matrix Metalloproteinase Inhibitors;""Angiogenesis Inhibitors;Matrix Metalloproteinase Inhibitors"""	FCER2	MMP14	MMP16	MMP11	FCER1A	MS4A2	MMP15	MMP17	MMP19	MMP23A	MMP20	MS4A7	MMP27	MMP28	MMP21																		4323	4325	4320	2205	2206	4324	4326	4327	8511	9313	58475	64066	79148	118856																		CHEMBL279786											5362422	9809485	87433984	87553858		member	10.1016/j.bmcl.2004.10.010	10.1021/acschembio.8b00257	10.1021/jacs.7b06935	10.2174/187152009788451842																																																																																																																																																												9548812	9871622	9871623	11229773	12877590	15582436																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																9.8e-004	9.8e-004	-0.4515	0	-0.11032	0	0	0	0	0	0	9.8e-004	0	0	0																		0.00014	0.00014	-0.0645	0.0	-0.01379	0.0	0.0	0.0	0.0	0.0	0.0	0.00014	0.0	0.0	0.0																		7	7	7	7	8	7	7	7	7	7	7	7	7	7	7																		HY-13564	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:1930|FCER2|Angiogenesis Inhibitors;Matrix Metalloproteinase Inhibitors;\Angiogenesis Inhibitors;Matrix Metalloproteinase Inhibitors\	CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)[C@H](CSc2cccs2)C(=O)NO	130370-60-4	15708	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469910	477.63994	BATIMASTAT	BATIMASTAT | BATIMASTAT (BB-94) | BATIMASTAT | BATIMASTAT (BB-94)	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:1930	FCER2	Angiogenesis Inhibitors;Matrix Metalloproteinase Inhibitors;\Angiogenesis Inhibitors;Matrix Metalloproteinase Inhibitors\
SJ000796145-3	SJ000796145	3	MOABOX:1944	DGENZVKCTGIDRZ-UHFFFAOYSA-N	O=C(O)CCc1ccc(NCc2cccc(Oc3ccccc3)c2)cc1	885101-89-3	FFAR1 agonist;Free Fatty Acid Receptor 1 (FFAR1;GPR40) Agonists	FFAR1																																																															CHEMBL207881											11595431					member	10.1016/j.bmcl.2014.04.065	10.1016/j.ejmech.2017.09.019	10.1021/jm0614782	10.1111/cbdd.13321																																																																																																																																																												16439116	17240142	17552505	18947221	20064714	21854074	22519963	24835985	24900217	25441945	25638496	26482570	26945112	27074625	28285923	28938138	29259758	29980358	30082106																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.4848																																0.4356																																8																																HY-15589	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Membrane Transporter/Ion Channel | Research Area: Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease|MOABOX:1944|FFAR1|FFAR1 agonist;Free Fatty Acid Receptor 1 (FFAR1;GPR40) Agonists	OC(=O)CCc1ccc(NCc2cccc(Oc3ccccc3)c2)cc1	885101-89-3	8442	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469383	347.40704	GW 9508	GW 9508 | GW9508 | GW 9508 | GW9508	Pathway: GPCR/G Protein; Membrane Transporter/Ion Channel	Research Area: Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease	MOABOX:1944	FFAR1	FFAR1 agonist;Free Fatty Acid Receptor 1 (FFAR1;GPR40) Agonists
SJ000773199-3	SJ000773199	3	MOABOX:1952	NHJSWORVNIOXIT-UHFFFAOYSA-N	COc1cc(OC)cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1	192705-79-6	Tyrosine Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Basic Fibroblast Growth Factor (bFGF;FGF2) Inhibitors;Angiogenesis Inhibitors	FGF2	FGFR3P1																															100462812																															CHEMBL299763											5328127					member																																																																																																																																																																9599227																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.23536	6.608e-002																															0.02942	0.00944																															8	7																															HY-101296	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:1952|FGF2|Tyrosine Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Basic Fibroblast Growth Factor (bFGF;FGF2) Inhibitors;Angiogenesis Inhibitors	COc1cc(OC)cc(c1)c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C	192705-79-6	24286	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469883	396.44296	PD 166866 | FGF RECEPTOR TYROSINE KINASE INHIBITOR |	"""PD 166866 | FGF RECEPTOR TYROSINE KINASE INHIBITOR |"" | ""PD 166866 | FGF RECEPTOR TYROSINE KINASE INHIBITOR |"""	Pathway: Autophagy; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:1952	FGF2	Tyrosine Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Basic Fibroblast Growth Factor (bFGF;FGF2) Inhibitors;Angiogenesis Inhibitors
SJ000556676-13	SJ000556676	13	MOABOX:1958	WJEOLQLKVOPQFV-UHFFFAOYSA-N	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1	790299-79-5	Inhibitors of Signal Transduction Pathways;FGFR3 Inhibitors;KIT (C-KIT) Inhibitors;Angiogenesis Inhibitors	FGFR3	KIT																															3815																															CHEMBL1908391											10074640	24857218	25024769	60152982	87367736	member																																																																																																																																																																22037378																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.19684	1.73864																															-0.02812	0.21733																															7	8																															HY-10209	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:1958|FGFR3|Inhibitors of Signal Transduction Pathways;FGFR3 Inhibitors;KIT (C-KIT) Inhibitors;Angiogenesis Inhibitors	CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nc(cs4)c5cccnc5)c3)CC1	790299-79-5	9866	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469577	498.6424	MASITINIB	MASITINIB | AB-1010 | MASITINIB (AB1010) | MASITINIB | AB-1010 | MASITINIB (AB1010)	Pathway: Apoptosis; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:1958	FGFR3	Inhibitors of Signal Transduction Pathways;FGFR3 Inhibitors;KIT (C-KIT) Inhibitors;Angiogenesis Inhibitors
SJ000821578-9	SJ000821578	9	MOABOX:1962	QADPYRIHXKWUSV-UHFFFAOYSA-N	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1	1310746-10-1	pan FGF-R kinase inhibitor;Angiogenesis Inhibitors;FGFR1 Inhibitors;FGFR2 Inhibitors;FGFR3 Inhibitors;FGFR4 Inhibitors;pan-FGFR inhibitor	FGFR4																																																															CHEMBL1834657	CHEMBL1852688										53235509	53235510	53244951	53245018	56669626	virtual																																																																																																																																																																21936542	23016864	23272905	27326339	27782099	27914362	29522671	30754629																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														0.41832																																0.05229																																8																																HY-13311	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:1962|FGFR4|pan FGF-R kinase inhibitor;Angiogenesis Inhibitors;FGFR1 Inhibitors;FGFR2 Inhibitors;FGFR3 Inhibitors;FGFR4 Inhibitors;pan-FGFR inhibitor	CCN1CCN(CC1)c2ccc(Nc3cc(ncn3)N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)cc2	872511-34-7	11138	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469610	560.47544	NVP-BGJ398	"NVP-BGJ398 | ""BGJ-398 | BGJ398"" | BGJ398 (NVP-BGJ398) | NVP-BGJ398 | ""BGJ-398 | BGJ398"" | BGJ398 (NVP-BGJ398)"	Pathway: Apoptosis; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:1962	FGFR4	pan FGF-R kinase inhibitor;Angiogenesis Inhibitors;FGFR1 Inhibitors;FGFR2 Inhibitors;FGFR3 Inhibitors;FGFR4 Inhibitors;pan-FGFR inhibitor
SJ000312357-16	SJ000312357	16	MOABOX:1964	WINHZLLDWRZWRT-ATVHPVEESA-N	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C	1126641-10-8		PTK2B	RET	FGFR3P1																														5979	100462812																														CHEMBL1567	CHEMBL3109278	CHEMBL535									5329102	6456015	9853091	11520637	16085318	member	10.1021/acsmedchemlett.8b00035	10.1038/nchembio.117																																																																																																																																																														15032674	17367763	18045055	18183025	18849971	19654408	20105131	22037378	23410162	25625428	26629594	29191878	30034590	30742435	30754629																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							-0.30051	-2.168e-002	0.57968																														-0.04293	-0.00271	0.07246																														7	8	8																														KS-5022	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c1C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466685	398.47378	SUNITINIB	SUNITINIB | SUTENT | SUNITINIB MALATE | SUNITINIB MALEATE | SU-11248 | SUNITINIB | SUTENT | SUNITINIB MALATE | SUNITINIB MALEATE | SU-11248			MOABOX:1964	PTK2B	
SJ000574276-9	SJ000574276	9	MOABOX:1976	XXJWYDDUDKYVKI-UHFFFAOYSA-N	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1	288383-20-0	VEGFR-1 (Flt-1) Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-3 (FLT4) Inhibitors;Angiogenesis Inhibitors	FLT1	FLT4	KDR																														2324	3791																														CHEMBL2103798	CHEMBL491473										9933475	11158819	11226834	11320480	11411646	virtual	10.1016/j.ejmech.2010.09.002	10.1016/j.ejmech.2014.04.007	10.1158/0008-5472.CAN-04-4409	10.1158/1078-0432.CCR-05-2028	10.2174/187152009789735080																																																																																																																																																											17692027	17979703	19671039	19925393	20869793	21034401	21762098	22037378	22571655	23098265	24747748																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											1.62296	1.47936	3.77448																														0.20287	0.18492	0.47181																														8	8	8																														HY-10205	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:1976|FLT1|VEGFR-1 (Flt-1) Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-3 (FLT4) Inhibitors;Angiogenesis Inhibitors	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN5CCCC5	288383-20-0	15565	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468772	450.50528	CEDIRANIB | AZD2171 | RECENTIN	"""CEDIRANIB | AZD2171 | RECENTIN"" | ""CEDIRANIB | AZD2171 | NSC-732208 |"" | CEDIRANIB (AZD2171) | ""CEDIRANIB | AZD2171 | RECENTIN"" | ""CEDIRANIB | AZD2171 | NSC-732208 |"" | CEDIRANIB (AZD2171)"	Pathway: Autophagy; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:1976	FLT1	VEGFR-1 (Flt-1) Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-3 (FLT4) Inhibitors;Angiogenesis Inhibitors
SJ000574278-10	SJ000574278	10	MOABOX:1978	SPMVMDHWKHCIDT-UHFFFAOYSA-N	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC	475108-18-0	VEGFR-1 (Flt-1) Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;VEGFR-3 (FLT4) Inhibitors;Angiogenesis Inhibitors	ABL1	FLT1	FLT4	KDR	RET																												2321	2324	3791	5979																												CHEMBL1289494	CHEMBL2105756										9911830	11547978	21079505	21079507	21079510	member	10.1016/j.ejmech.2010.09.002	10.1039/c3ob41136b	10.1158/0008-5472.CAN-05-4290																																																																																																																																																													16982756	17979703	20869793	21762098	22571661	23098265	24583357	25908516	26799148	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												-0.18656	1.11664	0.9724	2.044	-9.28e-002																												-0.02332	0.13958	0.12155	0.2555	-0.0116																												8	8	8	8	8																												HY-10977	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:1978|ABL1|VEGFR-1 (Flt-1) Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;VEGFR-3 (FLT4) Inhibitors;Angiogenesis Inhibitors	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC	475108-18-0	7642	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469328	454.86306	TIVOZANIB	"TIVOZANIB | ""AV-951 | ASP-4130 | KRN-951 | KIL-8951"" | ""TIVOZANIB, FREE BASE | AV-951 | KRN-951 | ASP-4130 | KIL-8951 |"" | TIVOZANIB (AV-951) | TIVOZANIB | ""AV-951 | ASP-4130 | KRN-951 | KIL-8951"" | ""TIVOZANIB, FREE BASE | AV-951 | KRN-951 | ASP-4130 | KIL-8951 |"" | TIVOZANIB (AV-951)"	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:1978	ABL1	VEGFR-1 (Flt-1) Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;VEGFR-3 (FLT4) Inhibitors;Angiogenesis Inhibitors
SJ001035071-1	SJ001035071	1	MOABOX:1982	VQQRBBFRJRBWPF-UHFFFAOYSA-N	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4ccnc(N)n4)cc3)cc2C(F)(F)F)CC1	853299-52-2	Flt3 (FLK2/STK1) Inhibitors	FLT3																																																																										11477833					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.48152																																0.06019																																8																																T7673	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-133-899|MOABOX:1982|FLT3|Flt3 (FLK2/STK1) Inhibitors	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4ccnc(N)n4)cc3)cc2C(F)(F)F)CC1	853299-52-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468592	515.53073	ATH 686	ATH 686 | ATH 686			MOABOX:1982	FLT3	Flt3 (FLK2/STK1) Inhibitors
SJ001011088-2	SJ001011088	2	MOABOX:1984	ODPGGGTTYSGTGO-UHFFFAOYSA-N	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1	630124-46-8	Flt3 (FLK2/STK1) Inhibitors;Inhibitors of Signal Transduction Pathways	MAPK14	FLT3	KIT	PDGFRB	MAPK8	MAPK10																											2322	3815	5159	5599	5602																											CHEMBL574738											11409972					virtual																																																																																																																																																																17638907	18183025	18820131	21429632	22037378	23937569	26629594																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															0.18584	1.802	1.03544	0.66128	-0.12592	2.16e-002																											0.02323	0.22525	0.12943	0.08266	-0.01574	0.0027																											8	8	8	8	8	8																											HY-15002	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:1984|MAPK14|Flt3 (FLK2/STK1) Inhibitors;Inhibitors of Signal Transduction Pathways	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1	630124-46-8	7302	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469622	529.55731	AST 487	AST 487 | AST 487	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:1984	MAPK14	Flt3 (FLK2/STK1) Inhibitors;Inhibitors of Signal Transduction Pathways
SJ000784318-10	SJ000784318	10	MOABOX:1992	JOOXLOJCABQBSG-UHFFFAOYSA-N	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1	1374744-69-0	Jak2 Inhibitors;Flt3 (FLK2/STK1) Inhibitors	FLT3	JAK2	BRD4																														3717	23476																														CHEMBL1287853											16722836	67517580	67518325			virtual	10.1016/j.ccr.2008.02.009																																																																																																																																																															18394554	21034406	21106455	22037378	22286129	23317159	26288683	28280261	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0.13472	1.0308	1.68304																														0.01684	0.12885	0.21038																														8	8	8																														HY-10409A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Epigenetics; JAK/STAT Signaling; Stem Cell/Wnt | Research Area: Cancer|MOABOX:1992|FLT3|Jak2 Inhibitors;Flt3 (FLK2/STK1) Inhibitors	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc4cccc(c4)S(=O)(=O)NC(C)(C)C	1374744-69-0	66991	GENERAL	CHLORIDE	2	H2O	1	1469591	524.67814	FEDRATINIB	"FEDRATINIB | ""TG-101348 | SAR-302503"" | FEDRATINIB (TG101348) | TG101348 (SAR302503) | TG101348 | FEDRATINIB | ""TG-101348 | SAR-302503"" | FEDRATINIB (TG101348) | TG101348 (SAR302503) | TG101348"	Pathway: Apoptosis; Epigenetics; JAK/STAT Signaling; Stem Cell/Wnt	Research Area: Cancer	MOABOX:1992	FLT3	Jak2 Inhibitors;Flt3 (FLK2/STK1) Inhibitors
SJ000556683-10	SJ000556683	10	MOABOX:1994	UXXQOJXBIDBUAC-UHFFFAOYSA-N	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1	1227636-17-0	Flt3 (FLK2/STK1) Inhibitors;PDGFRbeta Inhibitors;KIT (C-KIT) Inhibitors;Angiogenesis Inhibitors	FLT3	KIT	PDGFRB																														3815	5159																														CHEMBL124660											3038522	12002085	46196593	67429192	71584894	member	10.1016/S1535-6108(02)00070-3	10.1016/j.bmcl.2014.04.058	10.1016/j.ejmech.2014.08.001	10.1021/jm020143r	10.1021/jm201198w	10.1182/blood-2004-06-2189	10.1182/blood-2009-05-222034	10.1371/journal.pone.0181178	10.2174/1381612043452604	10.2174/1389557043487394																																																																																																																																																						12166950	15032673	15078134	15180525	15711537	16250847	17652007	17692027	18183025	19075657	19654408	20570526	21429632	22037378	22221201	22452518	24813730	25108079	27266526	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.74336	1.94824	1.63936																														0.34292	0.24353	0.20492																														8	8	8																														ES-0051	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1cc2c(ncnc2cc1OCCCN3CCCCC3)N4CCN(CC4)C(=O)Nc5ccc(OC(C)C)cc5	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466682	562.70298	TANDUTINIB | MLN-518 | MLN-0518 | CT-53518	"""TANDUTINIB | MLN-518 | MLN-0518 | CT-53518"" | ""TANDUTINIB | MLN-518 | MLN-0518 | CT-53518 |"" | TANDUTINIB (MLN518) | ""TANDUTINIB | MLN-518 | MLN-0518 | CT-53518"" | ""TANDUTINIB | MLN-518 | MLN-0518 | CT-53518 |"" | TANDUTINIB (MLN518)"			MOABOX:1994	FLT3	Flt3 (FLK2/STK1) Inhibitors;PDGFRbeta Inhibitors;KIT (C-KIT) Inhibitors;Angiogenesis Inhibitors
SJ000556677-13	SJ000556677	13	MOABOX:1996	BMGQWWVMWDBQGC-IIFHNQTCSA-N	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4	120685-11-2	Inhibitors of Signal Transduction Pathways;Flt3 (FLK2/STK1) Inhibitors;Protein Kinase C (PKC) Inhibitors;Angiogenesis Inhibitors	FLT3	PRKCQ																															5588																															CHEMBL608533											9829523	11263132	11355216	11963974	12001200	member	10.1016/j.canlet.2019.01.001	10.1021/acs.biochem.8b00727																																																																																																																																																														10608920	18183025	19654408	22037378	24044867	26081023	27190596	27266526	29191878	30565931	30742435																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											3.12e-002	2.76648																															0.0039	0.34581																															8	8																															HY-10230	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics; TGF-beta/Smad | Research Area: Cancer|MOABOX:1996|FLT3|Inhibitors of Signal Transduction Pathways;Flt3 (FLK2/STK1) Inhibitors;Protein Kinase C (PKC) Inhibitors;Angiogenesis Inhibitors	CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35)N(C)C(=O)c9ccccc9	120685-11-2	38575	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469401	570.6371	MIDOSTAURIN	"MIDOSTAURIN | ""PKC-412 | CGP-41251 | MIDOSTAURIN |"" | SJ000565228 | MIDOSTAURIN | ""PKC-412 | CGP-41251 | MIDOSTAURIN |"" | SJ000565228"	Pathway: Epigenetics; TGF-beta/Smad	Research Area: Cancer	MOABOX:1996	FLT3	Inhibitors of Signal Transduction Pathways;Flt3 (FLK2/STK1) Inhibitors;Protein Kinase C (PKC) Inhibitors;Angiogenesis Inhibitors
SJ000803699-5	SJ000803699	5	MOABOX:2002	GKFPROVOIQKYTO-UZLBHIALSA-N	COC(=O)[C@H](CCSC)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1	1217447-06-7	Inhibitors of Signal Transduction Pathways;Farnesyltransferase (geranylgeranyl pyrophosphate synthase) Inhibitors	FNTA	FNTB																															2342																															CHEMBL135561											3005532	71311821	88309922	90719057	91885490	virtual																																																																																																																																																																9301658	14711313																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.47056	1.0633																															0.18382	0.1519																															8	7																															CS-3863	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-035-944-329|MOABOX:2002|FNTA|Inhibitors of Signal Transduction Pathways;Farnesyltransferase (geranylgeranyl pyrophosphate synthase) Inhibitors	COC(=O)[C@H](CCSC)NC(=O)c1ccc(NC[C@@H](N)CS)cc1c2ccccc2	180977-34-8	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468478	447.61396	FTI-277 TTRIFLUOROACETATE	FTI-277 TTRIFLUOROACETATE | FTI-277 | FTI-277 TTRIFLUOROACETATE | FTI-277			MOABOX:2002	FNTA	Inhibitors of Signal Transduction Pathways;Farnesyltransferase (geranylgeranyl pyrophosphate synthase) Inhibitors
SJ001035310-1	SJ001035310	1	MOABOX:2004	ZIXDDEATQSBHHL-BEFAXECRSA-N	CSCC[C@H](NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1)C(=O)O	1217471-51-6	Farnesyltransferase (geranylgeranyl pyrophosphate synthase) Inhibitors;Inhibitors of Signal Transduction Pathways	FNTB																																																															CHEMBL54044											395753	395754	16760436			virtual																																																																																																																																																																9301658	10201832	10328287	11277514	11562276	11677136	11754590	11944822	12194969	12733981	14711313	15055985	16446806	17305534	21256013	22233543	24821376	26266415	27240468	27282741	28666857																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.79492																																0.11356																																7																																HY-15873A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:2004|FNTB|Farnesyltransferase (geranylgeranyl pyrophosphate synthase) Inhibitors;Inhibitors of Signal Transduction Pathways	CSCC[C@H](NC(=O)c1ccc(NC[C@@H](N)CS)cc1c2ccccc2)C(=O)O	1217471-51-6	87377	GENERAL	"2,2,2-TRIFLUOROACETATE"	1	NO_SOLVATE	0	1469547	433.58738	FTI 276 TFA	FTI 276 TFA | FTI 276 TFA	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:2004	FNTB	Farnesyltransferase (geranylgeranyl pyrophosphate synthase) Inhibitors;Inhibitors of Signal Transduction Pathways
SJ000556672-20	SJ000556672	20	MOABOX:2016	UBPYILGKFZZVDX-UHFFFAOYSA-N	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl	380843-75-4	Abl Kinase Inhibitors;Apoptosis Inducers;Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Src Kinase Inhibitors;STAT-5 Inhibitors	FYN																																																															CHEMBL2131134	CHEMBL288441										5328940	11990828	44199377	46178285	46780884	virtual	10.1038/leu.2008.334																																																																																																																																																															11689083	12941315	19039322	21651487	22037378	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.43872																																0.05484																																8																																HY-10158	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:2016|FYN|Abl Kinase Inhibitors;Apoptosis Inducers;Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Src Kinase Inhibitors;STAT-5 Inhibitors	COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl	380843-75-4	4163	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469308	530.44616	BOSUTINIB	"BOSUTINIB | ""PF-5208763 | SKI-606"" | BOSUTINIB (SKI-606) | BOSUTINIB | ""PF-5208763 | SKI-606"" | BOSUTINIB (SKI-606)"	Pathway: Autophagy; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:2016	FYN	Abl Kinase Inhibitors;Apoptosis Inducers;Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Src Kinase Inhibitors;STAT-5 Inhibitors
SJ000513004-2	SJ000513004	2	MOABOX:2022	MVSJKTQQXQNEHK-PXLXIMEGSA-N	Oc1ccc(/C=N/N(Cc2ccccc2)Cc2ccccc2)cc1		Glucose-6-phosphatase Inhibitors	G6PC																																																															CHEMBL70032											135409477	136440150	136475549	136475564		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.19229																																-0.02747																																7																																AH-034/11365851	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-964-486|MOABOX:2022|G6PC|Glucose-6-phosphatase Inhibitors	Oc1ccc(\C=N\N(Cc2ccccc2)Cc3ccccc3)cc1	237403-58-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468529	316.3963					MOABOX:2022	G6PC	Glucose-6-phosphatase Inhibitors
SJ001034644-1	SJ001034644	1	MOABOX:2024	IHFRMUGEILMHNU-UHFFFAOYSA-N	O=Cc1cc([N+](=O)[O-])ccc1O	58983-36-1	Glucose-6-phosphatase Inhibitors	G6PC																																																															CHEMBL3660344											66808	23337688	54602952	88235909	91386369	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																PS-6254	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Oc1ccc(cc1C=O)[N+](=O)[O-]	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466644	167.1189	PS-6254	PS-6254 | PS-6254			MOABOX:2024	G6PC	Glucose-6-phosphatase Inhibitors
SJ000841736-5	SJ000841736	5	MOABOX:2026	FZNCGRZWXLXZSZ-CIQUZCHMSA-N	OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O	83480-29-9	alpha-Glucosidase Inhibitors;inhibits digestion and absorption of glucose from intestine	GAA	SI																															6476																															CHEMBL476960											444020	11771108	56646244	66671322	66790570	member																																																																																																																																																																18595718																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.38904	0																															0.04863	0.0																															8	7																															HY-B0025	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:2026|GAA|alpha-Glucosidase Inhibitors;inhibits digestion and absorption of glucose from intestine	OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O	83480-29-9	15823	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469890	267.27624	VOGLIBOSE	"VOGLIBOSE | ""VOGLIBOSE | A-71100 | AO-128 |"" | VOGLIBOSE | ""VOGLIBOSE | A-71100 | AO-128 |"""	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:2026	GAA	alpha-Glucosidase Inhibitors;inhibits digestion and absorption of glucose from intestine
SJ000286070-8	SJ000286070	8	MOABOX:2028	IBAQFPQHRJAVAV-ULAWRXDQSA-N	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	1204250-58-7	SGLT-3 Activators;alpha-Glucosidase Inhibitors	GAA	SLC5A4																															6527																															CHEMBL1561											441314	71598727	71660907	72203239	90118564	member	10.1016/j.bmc.2008.06.026																																																																																																																																																															11858756	18595718	21512716	21669536	26375725	27956035	28751199																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															0.65096	0																															0.08137	0.0																															8	7																															KS-1242	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466725	207.22428	MIGLITOL	"MIGLITOL | ""MIGLITOL | GLYSET"" | MIGLITOL | ""MIGLITOL | GLYSET"""			MOABOX:2028	GAA	SGLT-3 Activators;alpha-Glucosidase Inhibitors
SJ000285686-12	SJ000285686	12	MOABOX:2030	KPYSYYIEGFHWSV-UHFFFAOYSA-N	NCC(CC(=O)O)c1ccc(Cl)cc1	1134-47-0	GABA(B) Agonists	GABBR1	GABBR2																															9568																															CHEMBL1897150	CHEMBL701										2284	6602720	19876930	46178298	53314268	member	10.1124/jpet.108.141572	10.1124/jpet.109.153593																																																																																																																																																														7650684	8634834	18578471	23428109																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.26112	0.18216																															0.03264	0.02277																															8	8																															HY-17354	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2030|GABBR1|GABA(B) Agonists	NC[C@H](CC(=O)O)c1ccc(Cl)cc1	69308-37-8	16166	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469054	213.66078	BACLOFEN	"BACLOFEN | (R,S)-BACLOFEN | (±)-BACLOFEN | LIORESAL | BACLOFEN | (R,S)-BACLOFEN | (±)-BACLOFEN | LIORESAL"	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2030	GABBR1	GABA(B) Agonists
SJ000287622-5	SJ000287622	5	MOABOX:2034	NHVRIDDXGZPJTJ-UHFFFAOYSA-N	CP(=O)(O)CCCN	127729-35-5	GABA(B) Agonists;GABBR1 agonist	GABBR1	GABBR2																															9568																															CHEMBL112710	CHEMBL1256147										5230	659966	6603339	28559746	53346869	member																																																																																																																																																																7650684	18578471																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-9.36e-003	4.24e-003																															-0.00117	0.00053																															8	8																															PHAR038590	PHARMEKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-727-377|MOABOX:2034|GABBR1|GABA(B) Agonists;GABBR1 agonist	CP(=O)(O)CCCN	127729-35-5	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468099	137.11734	SKF 97541 HYDROCHLORIDE	SKF 97541 HYDROCHLORIDE | SKF 97541 | SKF 97541 HYDROCHLORIDE | SKF 97541			MOABOX:2034	GABBR1	GABA(B) Agonists;GABBR1 agonist
SJ000832223-2	SJ000832223	2	MOABOX:2036	GUOQUXNJZHGPQF-UHFFFAOYSA-N	Cc1nnc2ccc(-c3cccc(C(F)(F)F)c3)nn12	66548-69-4	Anxiolytics	GABRA1																																																															CHEMBL13662											107950					member	10.1016/S0014-2999(02)01279-7																																																																																																																																																															9651158	10633039	15027873	15743180	20888240	21050172																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.65632																																0.08204																																8																																1709	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-958-694|MOABOX:2036|GABRA1|Anxiolytics	Cc1nnc2ccc(nn12)c3cccc(c3)C(F)(F)F	66548-69-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468718	278.23257	CL 218872	CL 218872 | CL 218872			MOABOX:2036	GABRA1	Anxiolytics
SJ000285474-8	SJ000285474	8	MOABOX:2040	ZXRVKCBLGJOCEE-UHFFFAOYSA-N	O=c1[nH]oc2c1CCNC2	64603-91-4	GABA(A) Receptor Partial Agonists;Selective GABAA-delta agonist	GABRA1	GABRA2	GABRA3	GABRA4	GABRA5	GABRA6																											2555	2556	2557	2558	2559																											CHEMBL1255746	CHEMBL312443										3448	198486	5702253	11389533	11651776	member	10.1016/S0014-2999(00)00898-0	10.2174/1568026023393525																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			-0.46165	-0.20258	0	-0.38164	-0.54222	0																											-0.06595	-0.02894	0.0	-0.05452	-0.07746	0.0																											7	7	7	7	7	7																											HY-10232	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2040|GABRA1|GABA(A) Receptor Partial Agonists;Selective GABAA-delta agonist	O=C1NOC2=C1CCNC2	64603-91-4	90180	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469704	140.13992	GABOXADOL HYDROCHLORIDE	"GABOXADOL HYDROCHLORIDE | THIP HYDROCHLORIDE | 4,5,6,7-TETRAHYDROISOXAZOLO[5,4-C]PYRIDIN-3-OL HCL | GABOXADOL HYDROCHLORIDE | THIP HYDROCHLORIDE | 4,5,6,7-TETRAHYDROISOXAZOLO[5,4-C]PYRIDIN-3-OL HCL"	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2040	GABRA1	GABA(A) Receptor Partial Agonists;Selective GABAA-delta agonist
SJ000287922-5	SJ000287922	5	MOABOX:2042	ZJQHPWUVQPJPQT-UHFFFAOYSA-N	NCc1cc(O)no1	18174-72-6	GABA A receptor agonist	GABRA1	GABRA2	GABRA3	GABRA4	GABRA5	GABRA6																											2555	2556	2557	2558	2559																											CHEMBL1256363	CHEMBL273481										4266	205536	12313010	21694579	22020639	member	10.1016/S0014-2999(00)00898-0	10.1021/jm070447j	10.1021/jm301473k	10.2174/1568026023393525																																																																																																																																																												1331456	7392039	21688779	23006041	23294161	25038482	30300845																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															-2.256e-002	-1.632e-002	-3.296e-002	5.376e-002	5.352e-002	5.376e-002																											-0.00282	-0.00204	-0.00412	0.00768	0.00669	0.00768																											8	8	8	7	8	7																											13667	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-849-288|MOABOX:2042|GABRA1|GABA A receptor agonist	NCc1onc(O)c1	2763-96-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468263	114.10264	MUSCIMOL HYDROBROMIDE	MUSCIMOL HYDROBROMIDE | MUSCIMOL | MUSCIMOL HYDROBROMIDE | MUSCIMOL			MOABOX:2042	GABRA1	GABA A receptor agonist
SJ000287880-10	SJ000287880	10	MOABOX:2046	OFBIFZUFASYYRE-UHFFFAOYSA-N	CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2	78755-81-4	GABA(A) BZ Site Receptor Antagonists	GABRA1	GABRA2	GABRA3	GABRA4	GABRA5	GABRA6	GABRB1	GABRB2	GABRB3	GABRD	GABRE	GABRG1	GABRG2	GABRG3	GABRP	GABRQ																	2555	2556	2557	2558	2559	2560	2561	2562	2563	2564	2565	2566	2567	2568	55879																	CHEMBL357362	CHEMBL407	CHEMBL68606	CHEMBL70504								3373	44310846	44311222	44368801	60163640	member																																																																																																																																																																9767648	10633039	12477354	15828832	18045122	18537233	18637672	18973287	21751815	23121096	26982523																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											0.1096	0.13744	0.11816	6.464e-002	0.49368	-0.56984	7.856e-002	-0.11088	0.49536	7.856e-002	7.856e-002	7.856e-002	0.29792	7.856e-002	7.856e-002	7.856e-002																	0.0137	0.01718	0.01477	0.00808	0.06171	-0.07123	0.00982	-0.01386	0.06192	0.00982	0.00982	0.00982	0.03724	0.00982	0.00982	0.00982																	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8	8																	HY-B0009	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2046|GABRA1|GABA(A) BZ Site Receptor Antagonists	CCOC(=O)c1ncn2c1CN(C)C(=O)c3cc(F)ccc23	78755-81-4	29055	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469060	303.28836	FLUMAZENIL	FLUMAZENIL | FLUMAZENIL	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2046	GABRA1	GABA(A) BZ Site Receptor Antagonists
SJ001034649-1	SJ001034649	1	MOABOX:2048	LWUDDYHYYNNIQI-ZDUSSCGKSA-N	CC(C)(C)OC(=O)c1ncn2c1[C@@H]1CCCN1C(=O)c1c(Br)cccc1-2	84379-13-5	GABA(A) BZ Site Receptor Partial Agonists	GABRA1	GABRA2	GABRA3	GABRA4	GABRA5	GABRA6	GABRB3	GABRG2																									2555	2556	2557	2558	2559	2562	2566																									CHEMBL366947											107926	25015074	136393254			member	10.1016/S0028-3908(96)00066-4																																																																																																																																																															10633039	12871032	16184188																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.71536	0.21712	0.48408	-0.37464	-1.528e-002	-0.40936	0.83032	0.74592																									0.08942	0.02714	0.06051	-0.05352	-0.00191	-0.05117	0.10379	0.09324																									8	8	8	7	8	8	8	8																									ES-0044	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)(C)OC(=O)c1ncn2c1[C@@H]3CCCN3C(=O)c4c(Br)cccc24	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466681	418.2844	ES-0044	ES-0044 | ES-0044			MOABOX:2048	GABRA1	GABA(A) BZ Site Receptor Partial Agonists
SJ001035317-1	SJ001035317	1	MOABOX:2050	CFSOJZTUTOQNIA-UHFFFAOYSA-N	CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(N=[N+]=[N-])ccc1-2	91917-65-6	GABA(A) BZ Site Receptor Inverse Agonists	GABRA1	GABRA2	GABRA3	GABRA5	GABRA6	GABRB2	GABRB3	GABRG2																									2555	2556	2558	2559	2561	2562	2566																									CHEMBL6597											5081					member																																																																																																																																																																8145225	8568803	8627617	8917654	9767648	10633039	12871032	14667209	17626010	18537233	18973287	21050171																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										1.33368	-1.44e-002	0.3048	0.71864	0.95336	3.024e-002	0.24632	0.41936																									0.16671	-0.0018	0.0381	0.08983	0.11917	0.00378	0.03079	0.05242																									8	8	8	8	8	8	8	8																									HY-103476	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2050|GABRA1|GABA(A) BZ Site Receptor Inverse Agonists	CCOC(=O)c1ncn2c1CN(C)C(=O)c3cc(ccc23)N=[N+]=[N-]	91917-65-6	57589	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469557	326.31006	RO15-4513	RO15-4513 | RO15-4513	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2050	GABRA1	GABA(A) BZ Site Receptor Inverse Agonists
SJ001035195-1	SJ001035195	1	MOABOX:2052	GADIKQPUNWAMEB-UHFFFAOYSA-N	CCc1c(C(=O)OC)ncc2[nH]c3cc(OC)c(OC)cc3c12	1215833-62-7	Ligand of the GABAA receptor subtypes	GABRA1	GABRA2	GABRA3	GABRA5	GABRA6	GABRB2	GABRB3	GABRG2																									2555	2556	2558	2559	2561	2562	2566																																				104999	45261899				member	10.1016/j.bmc.2010.09.058																																																																																																																																																															9651158	10633039	11881985	11960500	12747794	15084116	15537339	20980155																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														-7.032e-002	-6.872e-002	0.12579	0.94344	-0.35532	0.37792	0.36216	0.64864																									-0.00879	-0.00859	0.01797	0.11793	-0.05076	0.04724	0.04527	0.08108																									8	8	7	8	7	8	8	8																									HY-100369A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2052|GABRA1|Ligand of the GABAA receptor subtypes	CCc1c(ncc2[nH]c3cc(OC)c(OC)cc3c12)C(=O)OC	1215833-62-7	21094	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469049	314.33582	DMCM HYDROCHLORIDE	DMCM HYDROCHLORIDE | DMCM HYDROCHLORIDE	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2052	GABRA1	Ligand of the GABAA receptor subtypes
SJ001035062-1	SJ001035062	1	MOABOX:2056	YMIKAQYPFQWUEM-UHFFFAOYSA-N	CSc1sc(-c2cc[nH]n2)c2c1C(=O)CC(C)(C)C2	207307-44-6	Ligand of the GABAA alpha5 receptor subtype	GABRA1	GABRA2	GABRA3	GABRA5	GABRB2	GABRB3	GABRG2																										2555	2556	2558	2561	2562	2566																										CHEMBL17354											2820108					member																																																																																																																																																																11881985	12747794	17979718	21050171																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		-0.29368	-0.26112	0.37632	0.84856	0.52787	0.41792	1.06752																										-0.03671	-0.03264	0.04704	0.10607	0.07541	0.05224	0.13344																										8	8	8	8	7	8	8																										KM03422	MAYBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-906-232|MOABOX:2056|GABRA1|Ligand of the GABAA alpha5 receptor subtype	CSc1sc(c2CC(C)(C)CC(=O)c12)c3cc[nH]n3	207307-44-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468569	292.41964	KM03422	KM03422 | KM03422			MOABOX:2056	GABRA1	Ligand of the GABAA alpha5 receptor subtype
SJ001035080-1	SJ001035080	1	MOABOX:2064	ALBKMJDFBZVHAK-UHFFFAOYSA-N	CCOC(=O)c1ncc2[nH]c3ccc(OCc4ccccc4)cc3c2c1COC	83910-44-5	Anxiolytics	GABRA1	GABRA2	GABRA3	GABRB3	GABRG2																												2555	2556	2562	2566																												CHEMBL1518572											121926	56972166	71297071			member																																																																																																																																																																9651158	10633039	18045122																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			-0.10424	-0.13984	-0.2072	-0.16024	-0.1632																												-0.01303	-0.01748	-0.0259	-0.02003	-0.0204																												8	8	8	8	8																												1994	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-299|MOABOX:2064|GABRA1|Anxiolytics	CCOC(=O)c1ncc2[nH]c3ccc(OCc4ccccc4)cc3c2c1COC	1216574-52-5	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468614	390.43178	ZK 93423 HCL	ZK 93423 HCL | ZK 93423 HCL			MOABOX:2064	GABRA1	Anxiolytics
SJ001035047-1	SJ001035047	1	MOABOX:2066	KOVRZNUMIKACTB-UHFFFAOYSA-N	CCOC(=O)c1cc2c(cn1)[nH]c1ccccc12	124475-91-8	receptor blocker	GABRA1	GABRA2	GABRA3	GABRB3	GABRG2																												2555	2556	2562	2566																												CHEMBL454606											105078	45261970	90102057			member																																																																																																																																																																9651158	10633039	20888240																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.53739	0.18137	-8.575e-002	0.17773	-0.13356																												0.07677	0.02591	-0.01225	0.02539	-0.01908																												7	7	7	7	7																												JFD03941	MAYBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-904-683|MOABOX:2066|GABRA1|receptor blocker	CCOC(=O)c1cc2c(cn1)[nH]c3ccccc23	124475-91-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468549	240.25728	JFD03941	JFD03941 | JFD03941			MOABOX:2066	GABRA1	receptor blocker
SJ000287274-3	SJ000287274	3	MOABOX:2068	ACVGNKYJVGNLIL-UHFFFAOYSA-N	COc1ccc(-c2ccc(=N)n(CCCC(=O)O)n2)cc1	104104-50-9	GABA(A) Receptor Antagonists	GABRA1	GABRB3	GABRG2																														2562	2566																														CHEMBL32503											107895	107896	46919528	71297033	74763967	member	10.1016/S0014-2999(00)00898-0	10.1016/S0223-5234(03)00056-4	10.1038/sj.bjp.0704796																																																																																																																																																													1331456	16480274	21664131	23855889																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.1404	0.79784	0.53832																														0.01755	0.09973	0.06729																														8	8	8																														HY-103533	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2068|GABRA1|GABA(A) Receptor Antagonists	COc1ccc(cc1)C2=NN(CCCC(=O)O)C(=N)C=C2	104104-50-9	32308	GENERAL	BROMIDE	1	NO_SOLVATE	0	1468837	287.31378	GABAZINE	GABAZINE | SJ000832222 | GABAZINE | SJ000832222	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2068	GABRA1	GABA(A) Receptor Antagonists
SJ001034889-1	SJ001034889	1	MOABOX:2070	BQDUNOMMYOKHEP-UHFFFAOYSA-N	Cn1ncnc1COc1nn2c(-c3cc(F)ccc3F)nnc2cc1C(C)(C)C	286456-42-6	GABA(A) BZ Site Receptor Agonists;GABA(A) BZ Site Receptor Antagonists	GABRA2	GABRA3																															2556																															CHEMBL373250											9908880					member																																																																																																																																																																12871032	16392789	21050171	21050172	23121096																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.89984	0.90392																															0.11248	0.11299																															8	8																															1196	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-848-438|MOABOX:2070|GABRA2|GABA(A) BZ Site Receptor Agonists;GABA(A) BZ Site Receptor Antagonists	Cn1ncnc1COc2nn3c(nnc3cc2C(C)(C)C)c4cc(F)ccc4F	286456-42-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468190	399.39727	L 838417	L 838417 | L 838417			MOABOX:2070	GABRA2	GABA(A) BZ Site Receptor Agonists;GABA(A) BZ Site Receptor Antagonists
SJ001034864-1	SJ001034864	1	MOABOX:2074	JQUJTHQSFVWZEH-UHFFFAOYSA-N	CSc1sc(-c2ccn(C(C)=O)n2)c2c1C(=O)CC(C)(C)C2			GABRA5																																																																										2820113					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.45579																																0.20797																																7																																KM03430	MAYBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-906-237|MOABOX:2074|GABRA5|	CSc1sc(c2CC(C)(C)CC(=O)c12)c3ccn(n3)C(=O)C	207307-48-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468118	334.45632	KM03430	KM03430 | KM03430			MOABOX:2074	GABRA5	
SJ000286906-6	SJ000286906	6	MOABOX:2076	BTCSSZJGUNDROE-UHFFFAOYSA-N	NCCCC(=O)O	123774-72-1		GABRR1																																																															CHEMBL96											119	210329	3050504	6992099	9859232	member	10.1016/S0014-2999(97)10121-2	10.1016/j.neuropharm.2006.09.014	10.1021/cn200121r	10.1021/ml300476v																																																																																																																																																												16231008	17655213	17722904	18528996	23294161	24900684	25038482																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															0.10536																																0.01317																																8																																KS-5273	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NCCCC(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466790	103.11976	GAMMA-AMINOBUTYRIC ACID	GAMMA-AMINOBUTYRIC ACID | GABA | GAMMA-AMINOBUTYRIC ACID | GABA			MOABOX:2076	GABRR1	
SJ001035013-1	SJ001035013	1	MOABOX:2100	QLMMOGWZCFQAPU-UHFFFAOYSA-N	C#CCN(C)CC1=Cc2ccccc2Oc2ccccc21	181296-84-4	Apoptosis Inhibitors;Glyceraldehyde 3-phosphate Dehydrogenase (GAPDH) Inhibitors	GAPDH																																																															CHEMBL1232111											6419718	9821821	11295161	85045593	87917606	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																23362	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-617|MOABOX:2100|GAPDH|Apoptosis Inhibitors;Glyceraldehyde 3-phosphate Dehydrogenase (GAPDH) Inhibitors	CN(CC#C)CC1=Cc2ccccc2Oc3ccccc13	200189-97-5	NA	GENERAL	MALEATE	1	NO_SOLVATE	0	1468467	275.34438	CGP 3466 MALEATE | CGP 3466B	"""CGP 3466 MALEATE | CGP 3466B"" | ""CGP 3466 MALEATE | CGP 3466B"""			MOABOX:2100	GAPDH	Apoptosis Inhibitors;Glyceraldehyde 3-phosphate Dehydrogenase (GAPDH) Inhibitors
SJ000796110-2	SJ000796110	2	MOABOX:2102	HHBOWXZOLYQFNY-UHFFFAOYSA-N	CCCOc1ccc(Br)cc1-c1cc(-c2ccc(Cl)cc2)[nH]c1-c1ccncc1	191034-25-0	GCGR antagonist;Glucagon Receptor (GCGR) Antagonists	GCGR																																																															CHEMBL351772											5311276					member	10.1016/S0960-894X(99)00081-5	10.1016/j.bmc.2005.10.008	10.1074/jbc.274.13.8694	10.2174/0929867033368556	10.2174/1381612013397393																																																																																																																																																											10085108	10201821	11529255	12570714	16256355	19557759																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																3.27376																																0.40922																																8																																2311	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-604|MOABOX:2102|GCGR|GCGR antagonist;Glucagon Receptor (GCGR) Antagonists	CCCOc1ccc(Br)cc1c2cc([nH]c2c3ccncc3)c4ccc(Cl)cc4	191034-25-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468503	467.7854	L-168049	L-168049 | L-168049			MOABOX:2102	GCGR	GCGR antagonist;Glucagon Receptor (GCGR) Antagonists
SJ001010827-2	SJ001010827	2	MOABOX:2106	NEQSWPCDHDQINX-MRXNPFEDSA-N	CS(=O)(=O)c1ccc([C@@H](CC2CCCC2)C(=O)Nc2nccs2)cc1	599164-57-5	Glucokinase Activators;Glucose Lowering Agents	GCK																																																															CHEMBL1096435											9886086					member	10.1016/j.bmcl.2009.04.107	10.1016/j.bmcl.2013.01.093	10.1039/c1md00116g	10.2174/092986709789177993	10.2174/092986712801323225																																																																																																																																																											19435665	19747136	20805029	22664250	22809456	23434031	24294411																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															1.63488																																0.20436																																8																																1356	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-139-790|MOABOX:2106|GCK|Glucokinase Activators;Glucose Lowering Agents	CS(=O)(=O)c1ccc(cc1)[C@@H](CC2CCCC2)C(=O)Nc3nccs3	300353-13-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468668	378.50888	RO 28-1675	RO 28-1675 | RO 28-1675			MOABOX:2106	GCK	Glucokinase Activators;Glucose Lowering Agents
SJ001034904-1	SJ001034904	1	MOABOX:2108	OCBMECSFDVUYQN-ROUUACIJSA-N	COC[C@H](C)Oc1cc(O[C@@H](C)Cc2ccccc2)cc(C(=O)Nc2ccc(C(=O)O)cn2)c1	851884-87-2	Glucokinase Activators;Glucose Lowering Agents	GCK																																																															CHEMBL205627											11340230					member	10.1016/j.bmc.2010.04.038	10.1016/j.bmc.2012.03.008	10.1016/j.bmcl.2009.04.107	10.2174/092986709789177993																																																																																																																																																												19435665	19747136	20472448	21515051	22459213																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.72016																																0.21502																																8																																5133	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-035-765-954|MOABOX:2108|GCK|Glucokinase Activators;Glucose Lowering Agents	COC[C@H](C)Oc1cc(O[C@@H](C)Cc2ccccc2)cc(c1)C(=O)Nc3ccc(cn3)C(=O)O	851884-87-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468211	464.51032	GKA 50	GKA 50 | GKA 50			MOABOX:2108	GCK	Glucokinase Activators;Glucose Lowering Agents
SJ001033377-2	SJ001033377	2	MOABOX:2120	UMUPQWIGCOZEOY-JOCHJYFZSA-N	CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12	159634-47-6	Growth Hormone Secretagogues	GH1																																																															CHEMBL13817	CHEMBL2105872	CHEMBL542653									178024	6450830	9832625	9919679	9963383	member	10.1002/cmdc.200700015																																																																																																																																																															17520591																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-6.072e-002																																-0.00759																																8																																HY-50844	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Endocrinology|MOABOX:2120|GH1|Growth Hormone Secretagogues	CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N2CCC3(CC2)CN(c4ccccc34)S(=O)(=O)C	159752-10-0	8683	GENERAL	METHANESULFONATE	1	NO_SOLVATE	0	1469245	528.66354	IBUTAMOREN (MESYLATE); MK-677; MK-0677	IBUTAMOREN (MESYLATE); MK-677; MK-0677 | IBUTAMOREN (MESYLATE); MK-677; MK-0677	Pathway: GPCR/G Protein	Research Area: Endocrinology	MOABOX:2120	GH1	Growth Hormone Secretagogues
SJ001035154-1	SJ001035154	1	MOABOX:2126	SBJLJOFPWOYATP-XMMPIXPASA-N	CC(C)(N)CC(=O)N[C@@H]1CCc2ccccc2N(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)C1=O	145455-23-8	GHS Receptor Antagonists;GHSR agonist	GHSR																																																															CHEMBL308716											121879	18651446	22854476			member																																																																																																																																																																8627599																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					9.064e-002																																0.01133																																8																																HY-10957	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Metabolic Disease|MOABOX:2126|GHSR|GHS Receptor Antagonists;GHSR agonist	CC(C)(N)CC(=O)N[C@@H]1CCc2ccccc2N(Cc3ccc(cc3)c4ccccc4c5nn[nH]n5)C1=O	145455-23-8	84335	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468938	509.60214	L-692429 | MK-0751	"""L-692429 | MK-0751"" | ""L-692429 | MK-0751"""	Pathway: GPCR/G Protein	Research Area: Metabolic Disease	MOABOX:2126	GHSR	GHS Receptor Antagonists;GHSR agonist
SJ001035132-1	SJ001035132	1	MOABOX:2130	KVLLHLWBPNCVNR-SKCUWOTOSA-N	CN1N=C2CCN(C(=O)[C@@H](COCc3ccccc3)NC(=O)C(C)(C)N)C[C@@]2(Cc2ccccc2)C1=O	193273-66-4	GHS Receptor Agonists;Growth Hormone Secretagogues;Growth hormone secretagogue receptor (ghrelin) agonist	GH1	GHSR																															2693																															CHEMBL113313											216208	9852609	9852610	9919321	9940764	member	10.1002/cmdc.200700015	10.1016/j.bmc.2007.01.057																																																																																																																																																														12392732	12538023	17329109	17520591	29909635																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.5996	1.07136																															0.07495	0.13392																															8	8																															HY-15243	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Neurological Disease; Endocrinology|MOABOX:2130|GH1|GHS Receptor Agonists;Growth Hormone Secretagogues;Growth hormone secretagogue receptor (ghrelin) agonist	CN1N=C2CCN(C[C@@]2(Cc3ccccc3)C1=O)C(=O)[C@@H](COCc4ccccc4)NC(=O)C(C)(C)N	193273-69-7	89938	GENERAL	TARTRATE	1	NO_SOLVATE	0	1468804	505.6086	CAPROMORELIN TARTRATE | CP 424391-18	"""CAPROMORELIN TARTRATE | CP 424391-18"" | ""CAPROMORELIN TARTRATE | CP 424391-18"""	Pathway: GPCR/G Protein	Research Area: Neurological Disease; Endocrinology	MOABOX:2130	GH1	GHS Receptor Agonists;Growth Hormone Secretagogues;Growth hormone secretagogue receptor (ghrelin) agonist
SJ001034878-1	SJ001034878	1	MOABOX:2134	GNZCSGYHILBXLL-UHFFFAOYSA-N	CC(C)(C)Nc1nc2cc(Cl)c(Cl)cc2nc1S(C)(=O)=O	281209-71-0	GLP-1 Receptor Agonists;positive allosteric modulator of GLP1R	GLP1R																																																															CHEMBL398714											16007289					virtual	10.1016/j.bmcl.2007.06.086	10.1038/nature22378	10.1073/pnas.0605701104	10.1074/jbc.M115.696039																																																																																																																																																												17213325	17827014	19557759																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.39744																																0.29968																																8																																1907	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-874|MOABOX:2134|GLP1R|GLP-1 Receptor Agonists;positive allosteric modulator of GLP1R	CC(C)(C)Nc1nc2cc(Cl)c(Cl)cc2nc1S(=O)(=O)C	281209-71-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468176	348.2481	GLP-1R AGONIST DMB	GLP-1R AGONIST DMB | GLP-1R AGONIST DMB			MOABOX:2134	GLP1R	GLP-1 Receptor Agonists;positive allosteric modulator of GLP1R
SJ000286056-7	SJ000286056	7	MOABOX:2142	RQQJJXVETXFINY-UHFFFAOYSA-N	N=C(N)NC(=O)c1nc(Cl)c(N2CCCCCC2)nc1N	1345839-29-3	GnRH (LHRH) Antagonists;Na+/H+ Exchanger (NHE) Inhibitors	GNRHR	SLC9A2	GNRH1																														6549	2796																														CHEMBL1909810	CHEMBL501701										1794	56935636	86296917	137321145	137630298	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	-0.25844	0.98672																														0.0	-0.03692	0.12334																														7	7	8																														CS-0095166	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-545|MOABOX:2142|GNRHR|GnRH (LHRH) Antagonists;Na+/H+ Exchanger (NHE) Inhibitors	NC(=N)NC(=O)c1nc(Cl)c(nc1N)N2CCCCCC2	1428-95-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468707	311.77062	"N,N-HEXAMETHYLENEAMILORIDE"	"N,N-HEXAMETHYLENEAMILORIDE | 5-(N,N-HEXAMETHYLENE)AMILORIDE | N,N-HEXAMETHYLENEAMILORIDE | 5-(N,N-HEXAMETHYLENE)AMILORIDE"			MOABOX:2142	GNRHR	GnRH (LHRH) Antagonists;Na+/H+ Exchanger (NHE) Inhibitors
SJ001035266-1	SJ001035266	1	MOABOX:2150	VHSVKVWHYFBIFJ-HKZYLEAXSA-N	CC(=O)c1ccc2c(c1)[C@@H]1C=CC[C@@H]1[C@H](c1cc3c(cc1Br)OCO3)N2	881639-98-1	GPER agonist;Estrogen (GPR30) Receptor Agonists	GPER1																																																															CHEMBL569766											5322399	139191315				member	10.1021/jm9011802	10.1038/nchembio775																																																																																																																																																														16520733	19430488	19807662	20041667	23116143	23672690																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																3.50584																																0.43823																																8																																HY-107216	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:2150|GPER1|GPER agonist;Estrogen (GPR30) Receptor Agonists	CC(=O)c1ccc2N[C@H]([C@H]3CC=C[C@H]3c2c1)c4cc5OCOc5cc4Br	881639-98-1	28964	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469409	412.27652	G-1	G-1 | G-1	Pathway: Others	Research Area: Cancer	MOABOX:2150	GPER1	GPER agonist;Estrogen (GPR30) Receptor Agonists
SJ000518940-8	SJ000518940	8	MOABOX:2154	RTGDFNSFWBGLEC-SYZQJQIISA-N	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2	1132748-21-0	Nicotinic Acid (Niacin;GPR109A;HM74A) Receptor Agonists;Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors	IMPDH1	IMPDH2																															3615																															CHEMBL1200955	CHEMBL1456										5281078	6441022	6474989	9918263	9918987	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															KS-1209	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)OCCN3CCOCC3	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466712	433.49474	MYCOPHENOLATE MOFETIL	"MYCOPHENOLATE MOFETIL | ""MYCOPHENOLATE MOFETIL HYDROCHLORIDE | ME-MPA | MMF | R-99 | RS-61443 | RS-61443-190 | RS-61443 | CELLCEPT"" | MYCOPHENOLATE MOFETIL | ""MYCOPHENOLATE MOFETIL HYDROCHLORIDE | ME-MPA | MMF | R-99 | RS-61443 | RS-61443-190 | RS-61443 | CELLCEPT"""			MOABOX:2154	IMPDH1	Nicotinic Acid (Niacin;GPR109A;HM74A) Receptor Agonists;Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors
SJ000796123-2	SJ000796123	2	MOABOX:2156	RUTVRAJKELSHCC-UHFFFAOYSA-N	CC(C)n1nnc2cc(C(=O)O)ccc21	306935-41-1	Nicotinic Acid (Niacin;GPR109B;HM74) Receptor Agonists;GPR109B agonist	HCAR3																																																															CHEMBL381638											2736690					member	10.1016/j.tips.2006.05.008																																																																																																																																																															16480258	16766048	18037924	18983141																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		3.10152																																0.38769																																8																																PS-3172	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)n1nnc2cc(ccc12)C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466647	205.21324	IBC 293	IBC 293 | IBC 293			MOABOX:2156	HCAR3	Nicotinic Acid (Niacin;GPR109B;HM74) Receptor Agonists;GPR109B agonist
SJ000288107-10	SJ000288107	10	MOABOX:2170	BOWVQLFMWHZBEF-KTKRTIGZSA-N	CCCCCCCC/C=C\CCCCCCCC(=O)NCCO	111-58-0	"Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists;K(V)4.3 Channel Blockers"	KCND3	GPR55	GPR119																														9290	139760																														CHEMBL280065											5283454	6437546	9808884	9918716	57411067	member	10.1038/sj.bjp.0707460	10.1038/sj.bjp.0707464	10.1038/sj.bjp.0707481																																																																																																																																																													17876300	17876302	17906678																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			5.25e-003	0.93216	6.68e-002																														0.00075	0.11652	0.00835																														7	8	8																														HY-107542	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Metabolic Enzyme/Protease | Research Area: Metabolic Disease; Cardiovascular Disease|MOABOX:2170|KCND3|Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119) Agonists;K(V)4.3 Channel Blockers"	CCCCCCCC\C=C/CCCCCCCC(=O)NCCO	111-58-0	65118	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469435	325.52916	N-OLEOYLETHANOLAMINE	N-OLEOYLETHANOLAMINE | N-OLEOYLETHANOLAMIDE | N-OLEYLETHANOLAMIDE | OLEOYL ETHANOLAMIDE | OLEYLETHANOLAMIDE | N-OLEOYLETHANOLAMINE | N-OLEOYLETHANOLAMIDE | N-OLEYLETHANOLAMIDE | OLEOYL ETHANOLAMIDE | OLEYLETHANOLAMIDE	Pathway: Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Research Area: Metabolic Disease; Cardiovascular Disease	MOABOX:2170	KCND3	"Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119) Agonists;K(V)4.3 Channel Blockers"
SJ000866917-3	SJ000866917	3	MOABOX:2174	WLJNZVDCPSBLRP-UHFFFAOYSA-N	O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O	108626-78-4	G Protein-Coupled Receptor GPR35 Agonists	GPR35																																																															CHEMBL1201741	CHEMBL1517986	CHEMBL1599768	CHEMBL177880	CHEMBL2105884	CHEMBL3187835	CHEMBL3392244	CHEMBL3989694	CHEMBL3989825	CHEMBL3989845	CHEMBL588912	8546	11870	24040	24296	24904	member																																																																																																																																																																23713606	23888932	27976894																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.56392																																0.32049																																8																																KS-5172	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC(=O)c1cc2ccccc2c(Cc3c(O)c(cc4ccccc34)C(=O)O)c1O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466688	388.36954	EMBONIC ACID(RG)	EMBONIC ACID(RG) | EMBONIC ACID(RG)			MOABOX:2174	GPR35	G Protein-Coupled Receptor GPR35 Agonists
SJ000855323-3	SJ000855323	3	MOABOX:2186	FATGTHLOZSXOBC-UHFFFAOYSA-N	Cc1c(Cc2ccc3ccccc3n2)c2cc(F)ccc2n1CC(=O)O	851723-84-7	CRTH2 Receptor Antagonists	PTGDR2																																																															CHEMBL560993											11462174	24743127	24743128	24743129	24743130	member	10.1016/j.bmcl.2009.06.085	10.1124/jpet.111.187203	10.1124/mol.115.101832																																																																																																																																																													19608418	22224640	23601708	24292338																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		3.11944																																0.38993																																8																																HY-15342	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Inflammation/Immunology; Endocrinology|MOABOX:2186|PTGDR2|CRTH2 Receptor Antagonists	Cc1c(Cc2ccc3ccccc3n2)c4cc(F)ccc4n1CC(=O)O	851723-84-7	43701	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469522	348.37028	OC000459	OC000459 | OC000459	Pathway: GPCR/G Protein	Research Area: Inflammation/Immunology; Endocrinology	MOABOX:2186	PTGDR2	CRTH2 Receptor Antagonists
SJ001033601-2	SJ001033601	2	MOABOX:2188	GFPPXZDRVCSVNR-UHFFFAOYSA-N	Cc1c(CC(=O)O)c2cccnc2n1Cc1ccc(S(C)(=O)=O)cc1C(F)(F)F	872365-14-5	CRTH2 Receptor Antagonists	PTGDR2																																																															CHEMBL3137332											23582412					virtual	10.1021/acsmedchemlett.7b00157	10.1124/mol.115.101832																																																																																																																																																														28523115																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.66808																																0.20851																																8																																HY-16768	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation | Research Area: Cancer; Endocrinology|MOABOX:2188|PTGDR2|CRTH2 Receptor Antagonists	Cc1c(CC(=O)O)c2cccnc2n1Cc3ccc(cc3C(F)(F)F)S(=O)(=O)C	872365-14-5	24097	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469118	426.40949	FEVIPIPRANT; QAW039; NVP-QAW039	FEVIPIPRANT; QAW039; NVP-QAW039 | FEVIPIPRANT; QAW039; NVP-QAW039	Pathway: GPCR/G Protein; Immunology/Inflammation	Research Area: Cancer; Endocrinology	MOABOX:2188	PTGDR2	CRTH2 Receptor Antagonists
SJ000821690-4	SJ000821690	4	MOABOX:2190	LDXDSHIEDAPSSA-OAHLLOKOSA-N	O=C(O)CCn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2	116649-85-5	GPR44 antagonist;PTGDR antagonist;CRTH2 Receptor Antagonists;CCL2 Expression Inhibitors;Prostanoid TP Antagonists	PTGDR	CCL2	TBXA2R	PTGDR2																													6347	6915	11251																													CHEMBL361812											123879	24825731	42636962	44232508	53250084	member	10.1016/S0960-894X(98)00220-0	10.1016/j.bmcl.2004.12.055	10.1016/j.bmcl.2009.06.085	10.1016/j.ejphar.2005.09.005	10.1021/jm049036i	10.1021/jm1014549	10.1021/jm701383e	10.1124/jpet.102.046748	10.1124/jpet.103.055442	10.1124/mol.115.101832																																																																																																																																																						12649388	12975488	15179446	15715457	15745833	16256979	16918458	18318469	18837743	19592244	19608418	20943773	21106375	21355602	22224640	23624353																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						-0.41408	0	2.04544	1.3868																													-0.05176	0.0	0.25568	0.17335																													8	7	8	8																													HY-B0745	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Inflammation/Immunology; Endocrinology; Cancer|MOABOX:2190|PTGDR|GPR44 antagonist;PTGDR antagonist;CRTH2 Receptor Antagonists;CCL2 Expression Inhibitors;Prostanoid TP Antagonists	OC(=O)CCn1c2CC[C@H](Cc2c3ccccc13)NS(=O)(=O)c4ccc(F)cc4	116649-85-5	14525	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469614	416.46584	RAMATROBAN	RAMATROBAN | RAMATROBAN	Pathway: GPCR/G Protein	Research Area: Inflammation/Immunology; Endocrinology; Cancer	MOABOX:2190	PTGDR	GPR44 antagonist;PTGDR antagonist;CRTH2 Receptor Antagonists;CCL2 Expression Inhibitors;Prostanoid TP Antagonists
SJ000821690-3	SJ000821690	3	MOABOX:2190	LDXDSHIEDAPSSA-OAHLLOKOSA-N	O=C(O)CCn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2	116649-85-5	GPR44 antagonist;PTGDR antagonist;CRTH2 Receptor Antagonists;CCL2 Expression Inhibitors;Prostanoid TP Antagonists	PTGDR	CCL2	TBXA2R	PTGDR2																													6347	6915	11251																													CHEMBL361812											123879	24825731	42636962	44232508	53250084	member	10.1016/S0960-894X(98)00220-0	10.1016/j.bmcl.2004.12.055	10.1016/j.bmcl.2009.06.085	10.1016/j.ejphar.2005.09.005	10.1021/jm049036i	10.1021/jm1014549	10.1021/jm701383e	10.1124/jpet.102.046748	10.1124/jpet.103.055442	10.1124/mol.115.101832																																																																																																																																																						12649388	12975488	15179446	15715457	15745833	16256979	16918458	18318469	18837743	19592244	19608418	20943773	21106375	21355602	22224640	23624353																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						-0.41408	0	2.04544	1.3868																													-0.05176	0.0	0.25568	0.17335																													8	7	8	8																													T2396	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-005-943-701|MOABOX:2190|PTGDR|GPR44 antagonist;PTGDR antagonist;CRTH2 Receptor Antagonists;CCL2 Expression Inhibitors;Prostanoid TP Antagonists	OC(=O)CCn1c2CC[C@H](Cc2c3ccccc13)NS(=O)(=O)c4ccc(F)cc4	116649-85-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468160	416.46584	RAMATROBAN	RAMATROBAN | RAMATROBAN			MOABOX:2190	PTGDR	GPR44 antagonist;PTGDR antagonist;CRTH2 Receptor Antagonists;CCL2 Expression Inhibitors;Prostanoid TP Antagonists
SJ000831732-4	SJ000831732	4	MOABOX:2194	BUZAJRPLUGXRAB-UHFFFAOYSA-N	Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(I)cc1	183232-66-8	ACAT Inhibitors;Cannabinoid CB1 Inverse Agonists	GPR55																																																															CHEMBL285932											2125	11564197	24871499	46837031		member	10.1038/sj.bjp.0707460	10.1038/sj.bjp.0707464	10.1038/sj.bjp.0707481	10.1074/jbc.M111.296020	10.2174/092986710790980050																																																																																																																																																											17876300	17876302	17906678	20166927	22027819																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	-0.49312																																-0.06164																																8																																HY-15443	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2194|GPR55|ACAT Inhibitors;Cannabinoid CB1 Inverse Agonists	Cc1c(nn(c2ccc(Cl)cc2Cl)c1c3ccc(I)cc3)C(=O)NN4CCCCC4	183232-66-8	15269	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469428	555.23881	AM251	AM251 | AM251	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2194	GPR55	ACAT Inhibitors;Cannabinoid CB1 Inverse Agonists
SJ001033538-2	SJ001033538	2	MOABOX:2212	JACAAXNEHGBPOQ-LLVKDONJSA-N	CC(=O)N1N=C(c2ccc(N)cc2)c2cc3c(cc2C[C@H]1C)OCO3	161832-65-1	AMPA Non-Competitive Antagonists;Kainate Antagonists	GRIA1	GRIA2	GRIA3	GRIA4																													2891	2892	2893																													CHEMBL61872											164509	44511397				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.26481	0.26369	0.25711	0.26537																													0.03783	0.03767	0.03673	0.03791																													7	7	7	7																													HY-15079	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2212|GRIA1|AMPA Non-Competitive Antagonists;Kainate Antagonists	C[C@@H]1Cc2cc3OCOc3cc2C(=NN1C(=O)C)c4ccc(N)cc4	161832-65-1	18773	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469390	337.37246	TALAMPANEL; GYKI-53773; LY-300164	TALAMPANEL; GYKI-53773; LY-300164 | TALAMPANEL; GYKI-53773; LY-300164	Pathway: Apoptosis; Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2212	GRIA1	AMPA Non-Competitive Antagonists;Kainate Antagonists
SJ000287916-6	SJ000287916	6	MOABOX:2218	UUDAMDVQRQNNHZ-UHFFFAOYSA-N	Cc1o[nH]c(=O)c1CC(N)C(=O)O	110592-37-5		GRIA4																																																															CHEMBL13378	CHEMBL608555										1221	11957558	44373828	51371156	53393722	member																																																																																																																																																																1825114	9288165	12747796	21558436	23181587																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.28376																																0.03547																																8																																14571	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-605-341|MOABOX:2218|GRIA4|	Cc1onc(O)c1CC(N)C(=O)O	77521-29-0	NA	GENERAL	NO_SALT	0	H2O	1	1468321	186.1653	(±)-AMPA HYDROBROMIDE	(±)-AMPA HYDROBROMIDE | ( R )-±-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID | (S)-±-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID | (±)-AMPA HYDROBROMIDE | ( R )-±-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID | (S)-±-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID			MOABOX:2218	GRIA4	
SJ000287786-6	SJ000287786	6	MOABOX:2222	RWVIMCIPOAXUDG-UHFFFAOYSA-N	O=[N+]([O-])c1cc2nc(O)c(O)nc2cc1[N+](=O)[O-]	1312992-24-7		GRIA4																																																															CHEMBL155265											3899541					member																																																																																																																																																																7532226	8523401	11945136	12519060	23322633																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.5236																																0.06545																																8																																STL431184	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-846-931|MOABOX:2222|GRIA4|	[O-][N+](=O)c1cc2NC(=O)C(=O)Nc2cc1[N+](=O)[O-]	1312992-24-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468602	252.14056	DNQX	"DNQX | 6,7-DINITROQUINOXALINE-2,3-DIONE | SJ000510884 | DNQX | 6,7-DINITROQUINOXALINE-2,3-DIONE | SJ000510884"			MOABOX:2222	GRIA4	
SJ000287860-5	SJ000287860	5	MOABOX:2234	GGUSQTSTQSHJAH-UHFFFAOYSA-N	OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1ccc(Cl)cc1	119431-25-3	NMDA Antagonists	GRIN1																																																															CHEMBL28564											60703	178359	9896709	117772173		member																																																																																																																																																																9223571	11080197	11123375	20965739	29289890																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	6.688e-002																																0.00836																																8																																HY-12881	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2234|GRIN1|NMDA Antagonists	OC(CN1CCC(Cc2ccc(F)cc2)CC1)c3ccc(Cl)cc3	119431-25-3	16508	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469403	347.85412	ELIPRODIL	ELIPRODIL | ELIPRODIL	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2234	GRIN1	NMDA Antagonists
SJ000287579-7	SJ000287579	7	MOABOX:2236	VOROEQBFPPIACJ-SCSAIBSYSA-N	N[C@H](CCCP(=O)(O)O)C(=O)O	76326-31-3	NMDA Antagonists	GRIN1																																																															CHEMBL84612											135342					virtual																																																																																																																																																																10893301	22172060																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.38776																																0.04847																																8																																HY-100714A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2236|GRIN1|NMDA Antagonists	N[C@H](CCCP(=O)(O)O)C(=O)O	79055-68-8	97462	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469545	197.12624	(±)-2-AMINO-5-PHOSPHONOPENTANOIC ACID	(±)-2-AMINO-5-PHOSPHONOPENTANOIC ACID | D(-)-2-AMINO-5-PHOSPONOVALERIC ACID | DL-2-AMINO-5-PHOSPONOVALERIC ACID | L(+)-2-AMINO-5-PHOSPONOVALERIC ACID | (±)-2-AMINO-5-PHOSPHONOPENTANOIC ACID | D(-)-2-AMINO-5-PHOSPONOVALERIC ACID | DL-2-AMINO-5-PHOSPONOVALERIC ACID | L(+)-2-AMINO-5-PHOSPONOVALERIC ACID	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2236	GRIN1	NMDA Antagonists
SJ001035096-1	SJ001035096	1	MOABOX:2244	XVMFFIALWXXWPW-UHFFFAOYSA-N	O=C(NCc1cccnc1)c1ccc(CNS(=O)(=O)c2ccc(F)cc2)cc1		NR2A Antagonists	GRIN2A																																																																										5165428					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																K788-2368	CHEMDIV	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-007-939-691|MOABOX:2244|GRIN2A|NR2A Antagonists	Fc1ccc(cc1)S(=O)(=O)NCc2ccc(cc2)C(=O)NCc3cccnc3	898203-28-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468682	399.43862	K788-2368	K788-2368 | K788-2368			MOABOX:2244	GRIN2A	NR2A Antagonists
SJ001035240-1	SJ001035240	1	MOABOX:2246	XXZGNAZRWCBSBK-WFVOFKTRSA-N	C[C@H](NC(c1cccc2[nH]c(=O)c(=O)[nH]c12)P(=O)(O)O)c1ccc(Br)cc1	459836-30-7	NR2A Antagonists	GRIN2A																																																															CHEMBL273636											9868551					virtual	10.1016/S0960-894X(02)00074-4																																																																																																																																																															11909726	20810618	22172060																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.38104																																0.04763																																8																																HY-12294A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease | DISSOLVED IN H2O|MOABOX:2246|GRIN2A|NR2A Antagonists	C[C@H](NC(c1cccc2nc(O)c(O)nc12)P(=O)(O)O)c3ccc(Br)cc3	NA	13739	GENERAL	SODIUM(I)	4	H2O	1	1469248	454.21174	PEAQX TETRASODIUM HYDRATE | NVP-AAM077 TETRASODIUM HYDRATE	"""PEAQX TETRASODIUM HYDRATE | NVP-AAM077 TETRASODIUM HYDRATE"" | ""PEAQX TETRASODIUM HYDRATE | NVP-AAM077 TETRASODIUM HYDRATE"""	Pathway: Apoptosis; Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2246	GRIN2A	
SJ001035112-1	SJ001035112	1	MOABOX:2248	JJEXWPHPFZLTCU-UHFFFAOYSA-N	Oc1nc2cc(C#CCN3CCC(Cc4ccccc4)CC3)ccc2[nH]1	302799-86-6	NR2B Antagonists	GRIN2B																																																															CHEMBL117260											9863010					member																																																																																																																																																																10978188	11945135	15158791	16719809	20692832																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.05704																																0.13213																																8																																2782	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-577|MOABOX:2248|GRIN2B|NR2B Antagonists	O=C1Nc2ccc(cc2N1)C#CCN3CCC(Cc4ccccc4)CC3	302799-86-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468714	345.43752	TCS 46B	TCS 46B | TCS 46B			MOABOX:2248	GRIN2B	NR2B Antagonists
SJ000288166-4	SJ000288166	4	MOABOX:2250	WVZSEUPGUDIELE-HTAPYJJXSA-N	C[C@@H](CN1CCC(Cc2ccccc2)CC1)[C@@H](O)c1ccc(O)cc1	1312991-76-6	ADRA1B gene modulator;NR2B Antagonists (molecular mechanism);Antioxidant (cellular mechanism)	ADRA1B	GRIN2A	GRIN2B	GRIN3A	GRIN3B																												2903	2904	116443	116444																												CHEMBL1256726	CHEMBL305195										6604887	11957690	51371276	53250677	71308760	virtual	10.1124/jpet.103.056291	10.1124/jpet.117.242784																																																																																																																																																														9400004	11514163	12617901	12639560	14534359	14552795	15225705	16719815	20692832	20810618	23140383																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											-0.39168	0.27648	0.2532	0.27648	0.27648																												-0.04896	0.03456	0.03165	0.03456	0.03456																												8	8	8	8	8																												HY-13993A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2250|ADRA1B|ADRA1B gene modulator;NR2B Antagonists (molecular mechanism);Antioxidant (cellular mechanism)	C[C@@H](CN1CCC(Cc2ccccc2)CC1)[C@@H](O)c3ccc(O)cc3	1312991-76-6	20933	GENERAL	MALEATE	1	NO_SOLVATE	0	1468999	339.47116	RO 25-6981 HYDROCHLORIDE	RO 25-6981 HYDROCHLORIDE | RO 25-6981 HYDROCHLORIDE	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2250	ADRA1B	ADRA1B gene modulator;NR2B Antagonists (molecular mechanism);Antioxidant (cellular mechanism)
SJ001035142-1	SJ001035142	1	MOABOX:2252	QEMSVZNTSXPFJA-HNAYVOBHSA-N	C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(O)(c2ccccc2)CC1	134234-12-1	NR2B Antagonists	GRIN2A	GRIN2B																															2904																															CHEMBL17350	CHEMBL3989673										219101	9802399	9826324	9852386	11465714	member	10.1124/jpet.117.242784																																																																																																																																																															12617901	12639560	15225705	16719815	20810618	21524576																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.2948	0.35808																															0.03685	0.04476																															8	8																															HY-W018061	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2252|GRIN2A|NR2B Antagonists	C[C@@H]([C@@H](O)c1ccc(O)cc1)N2CCC(O)(CC2)c3ccccc3	134234-12-1	60034	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468881	327.4174	TRAXOPRODIL	TRAXOPRODIL | TRAXOPRODIL	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2252	GRIN2A	NR2B Antagonists
SJ000234064-2	SJ000234064	2	MOABOX:2254	KLJQHLQVCFUHRQ-UHFFFAOYSA-N	COc1ccc(OCC2c3cc(OC)c(OC)cc3CCN2C(=O)c2ccc(Cl)cc2)cc1	486427-18-3	NMDA NR2C Receptor Ligands;NMDA NR2D Receptor Ligands	GRIN2C	GRIN2D																															2906																															CHEMBL2397099											4575073					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.25853	-2.212e-002																															0.17979	-0.00316																															7	7																															K407-0490	CHEMDIV	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-021-717|MOABOX:2254|GRIN2C|NMDA NR2C Receptor Ligands;NMDA NR2D Receptor Ligands	COc1ccc(OCC2N(CCc3cc(OC)c(OC)cc23)C(=O)c4ccc(Cl)cc4)cc1	486427-18-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468418	467.94134					MOABOX:2254	GRIN2C	NMDA NR2C Receptor Ligands;NMDA NR2D Receptor Ligands
SJ001035037-1	SJ001035037	1	MOABOX:2258	COQPVKMATNFNLG-UHFFFAOYSA-N	COc1ccc(-n2cnc3c(sc4nccc(N(C)C)c43)c2=O)cc1		mgluR1 Antagonists	GRM1																																																															CHEMBL428909											1208332	143487252				member	10.1016/j.bmcl.2009.04.104	10.1016/j.bmcl.2012.09.048																																																																																																																																																														17929793	19433355	20346665	21316965	22266036	23084894																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																2.77128																																0.34641																																8																																AH-262/36083018	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-756-937|MOABOX:2258|GRM1|mgluR1 Antagonists	COc1ccc(cc1)N2C=Nc3c(sc4nccc(N(C)C)c34)C2=O	159583-16-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468525	352.41024	AH-262/36083018	AH-262/36083018 | AH-262/36083018			MOABOX:2258	GRM1	mgluR1 Antagonists
SJ000796056-2	SJ000796056	2	MOABOX:2264	ZKFVOZCCAXQXBU-UHFFFAOYSA-N	O=C(NC12CC3CC(CC(C3)C1)C2)c1cnc2ccccc2n1	226878-01-9	mgluR1 Antagonists;mgluR5 Antagonists	GRM1	GRM5																															2915																															CHEMBL399160											7067728					virtual																																																																																																																																																																18173231																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.4884	-0.22272																															0.06105	-0.02784																															8	8																															T8457	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-351-281|MOABOX:2264|GRM1|mgluR1 Antagonists;mgluR5 Antagonists	O=C(NC12CC3CC(CC(C3)C1)C2)c4cnc5ccccc5n4	226878-01-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468157	307.38954	NPS 2390	NPS 2390 | NPS 2390			MOABOX:2264	GRM1	mgluR1 Antagonists;mgluR5 Antagonists
SJ001034896-1	SJ001034896	1	MOABOX:2266	ALMACYDZFBMGOR-UHFFFAOYSA-N	COc1ccccc1Oc1ccc(N(Cc2cccnc2)S(=O)(=O)CC(F)(F)F)cc1	353229-59-1	mgluR2 Agonists	GRM2																																																															CHEMBL108939											9825084	56972206				member	10.1021/jm034015u	10.1124/jpet.113.204990	10.2174/092986711793979706	10.2174/1568026054750281																																																																																																																																																												12852748	16178732	21110815																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.36648																																0.29581																																8																																3283	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-732|MOABOX:2266|GRM2|mgluR2 Agonists	COc1ccccc1Oc2ccc(cc2)N(Cc3cccnc3)S(=O)(=O)CC(F)(F)F	353229-59-1	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468202	452.44677	LY 487379 HCL	LY 487379 HCL | LY 487379 HCL			MOABOX:2266	GRM2	mgluR2 Agonists
SJ001035323-1	SJ001035323	1	MOABOX:2270	KMKBEESNZAPKMP-UHFFFAOYSA-N	Cc1c(OCc2cccc(-c3ccc(C(=O)O)cc3)c2)cc2c(c1C)C(=O)C(C1CCCC1)C2	866823-73-6	mgluR2 Positive Allosteric Modulator;GRM2 agonist	GRM2																																																															CHEMBL593013											9868580					member	10.1016/j.bmcl.2005.06.062	10.1124/jpet.106.102046	10.1124/jpet.113.204990	10.2174/092986711793979706																																																																																																																																																												16046122	19932615	21110815	24735492	28704052																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	2.5048																																0.3131																																8																																HY-15442	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2270|GRM2|mgluR2 Positive Allosteric Modulator;GRM2 agonist	Cc1c(C)c2C(=O)C(Cc2cc1OCc3cccc(c3)c4ccc(cc4)C(=O)O)C5CCCC5	866823-73-6	66195	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469572	454.5568	BIPHENYLINDANONE A | BINA	"""BIPHENYLINDANONE A | BINA"" | ""BIPHENYLINDANONE A | BINA"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2270	GRM2	mgluR2 Positive Allosteric Modulator;GRM2 agonist
SJ000795986-2	SJ000795986	2	MOABOX:2280	DWPQODZAOSWNHB-UHFFFAOYSA-N	CN1CC(=O)N=C1NC(=O)Nc1cccc(Cl)c1	57653-26-6	mgluR5 Antagonists;GRM5 antagonist	GRM5																																																															CHEMBL2103779	CHEMBL239800										135413554	135416855	135497698	135564682	135659063	member	10.1016/j.bmc.2015.05.008	10.1021/acs.jmedchem.8b01226	10.1021/jm100736h	10.1021/ml200162f	10.1111/j.1471-4159.2006.03886.x	10.1124/jpet.105.089839																																																																																																																																																										16040814	16380255	16439120	16805850	17189691	17196387	19557759	20483612	20615697	20809633	22523618	26014480	26774652	30624919																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								3.37784																																0.42223																																8																																1345	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-494-450|MOABOX:2280|GRM5|mgluR5 Antagonists;GRM5 antagonist	CN1CC(=O)N=C1NC(=O)Nc2cccc(Cl)c2	57653-26-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468369	266.68364	FENOBAM | MCN-3377 | NPL-2009 |	"""FENOBAM | MCN-3377 | NPL-2009 |"" | ""FENOBAM | MCN-3377 | NPL-2009 |"""			MOABOX:2280	GRM5	mgluR5 Antagonists;GRM5 antagonist
SJ000288222-6	SJ000288222	6	MOABOX:2286	SISOFUCTXZKSOQ-ZHACJKMWSA-N	Cc1cccc(/C=C/c2ccccc2)n1	6266-99-5	mgluR5 Antagonists	GRM5																																																															CHEMBL88612											5311432	24213368				member	10.1124/jpet.105.089839	10.2174/09298673113209990167	10.2174/1568026054750263	10.2174/1568026611109060680																																																																																																																																																												10639281	10893301	16178733	17504108	19557759	21261592	23862615																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															2.14992																																0.26874																																8																																1214	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-959-634|MOABOX:2286|GRM5|mgluR5 Antagonists	Cc1cccc(\C=C\c2ccccc2)n1	6266-99-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468506	195.25972	SIB 1893	SIB 1893 | SIB 1983 | SIB 1893 | SIB 1983			MOABOX:2286	GRM5	mgluR5 Antagonists
SJ001035082-1	SJ001035082	1	MOABOX:2290	CNNZLFXCUQLKOB-BMRADRMJSA-N	CO/N=C1/C=C(C#Cc2cccc(C)n2)CCC1		mgluR5 Antagonists	GRM5																																																															CHEMBL227853											11481862	138319992				member																																																																																																																																																																17110115																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.4488																																0.3061																																8																																5229	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-101-293|MOABOX:2290|GRM5|mgluR5 Antagonists	CO\N=C\1/CCCC(=C1)C#Cc2cccc(C)n2	924298-51-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468616	240.30034	ABP 688	ABP 688 | ABP 688			MOABOX:2290	GRM5	mgluR5 Antagonists
SJ001033430-2	SJ001033430	2	MOABOX:2308	ZFPZEYHRWGMJCV-ZHALLVOQSA-N	COC(=O)N1CC[C@@H]2[C@H]1CCC[C@@]2(O)C#Cc1cccc(C)c1	543906-09-8	mgluR5 Antagonists	GRM5																																																															CHEMBL3087515											9926832	44545850				virtual	10.1016/j.bmc.2014.09.033	10.1016/j.bmcl.2013.09.059																																																																																																																																																														24125886	25316499	26225459	26598462	26706173																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	2.2264																																0.2783																																8																																HY-15257	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2308|GRM5|mgluR5 Antagonists	COC(=O)N1CC[C@@H]2[C@H]1CCC[C@@]2(O)C#Cc3cccc(C)c3	543906-09-8	19405	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468900	313.39082	MAVOGLURANT; AFQ056	MAVOGLURANT; AFQ056 | MAVOGLURANT; AFQ056	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2308	GRM5	mgluR5 Antagonists
SJ000288317-4	SJ000288317	4	MOABOX:2312	DTZDSNQYNPNCPK-UHFFFAOYSA-N	c1ccc(C(NCCNC(c2ccccc2)c2ccccc2)c2ccccc2)cc1	83027-13-8	mgluR7 Agonists	GRM7																																																															CHEMBL1387826	CHEMBL1613220										1894361	11698390	51371244	140735808		member	10.1016/B978-0-12-386009-5.00026-6	10.1124/jpet.107.124701	10.1124/jpet.110.177378																																																																																																																																																													21508084																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.82904																																0.22863																																8																																STL321288	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-917-606|MOABOX:2312|GRM7|mgluR7 Agonists	C(CNC(c1ccccc1)c2ccccc2)NC(c3ccccc3)c4ccccc4	83027-13-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468228	392.53532	AMN082	AMN082 | AMN 082 DIHYDROCHLORIDE | AMN082 | AMN 082 DIHYDROCHLORIDE			MOABOX:2312	GRM7	mgluR7 Agonists
SJ000785943-3	SJ000785943	3	MOABOX:2320	IJVMOGKBEVRBPP-ZETCQYMHSA-N	N[C@H](C(=O)O)c1ccc(C(=O)O)c(C(=O)O)c1	201730-11-2	mgluR8 Agonists	GRM8																																																															CHEMBL143210											16062593					member	10.1016/S0028-3908(00)00169-6	10.1016/j.bmcl.2006.06.062	10.1021/jm030967o																																																																																																																																																													16828551	29397723	30365309																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.16256																																0.27032																																8																																22072	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-549|MOABOX:2320|GRM8|mgluR8 Agonists	N[C@H](C(=O)O)c1ccc(C(=O)O)c(c1)C(=O)O	201730-11-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468710	239.18156	"S-3,4-DCPG | UBP 1109 |"	"""S-3,4-DCPG | UBP 1109 |"" | (S)-3,4-DICARBOXYPHENYLGLYCINE | ""S-3,4-DCPG | UBP 1109 |"" | (S)-3,4-DICARBOXYPHENYLGLYCINE"			MOABOX:2320	GRM8	mgluR8 Agonists
SJ000288103-9	SJ000288103	9	MOABOX:2322	JCSGFHVFHSKIJH-UHFFFAOYSA-N	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21	280744-09-4	Glycogen Synthase Kinase 3 (GSK-3) Inhibitors	GSK3A																																																															CHEMBL102714											176158					member	10.1016/S1074-5521(00)00025-9	10.2174/1389557043403459																																																																																																																																																														12111750	15032729	15078145	15173837	15544551	15559249	17399989	19328817	21115250	26005531	27128528	28119025																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										1.32792																																0.16599																																8																																HY-12012	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; PI3K/Akt/mTOR; Stem Cell/Wnt | Research Area: Neurological Disease; Cancer|MOABOX:2322|GSK3A|Glycogen Synthase Kinase 3 (GSK-3) Inhibitors	Cn1cc(C2=C(C(=O)NC2=O)c3ccc(Cl)cc3Cl)c4ccccc14	280744-09-4	10415	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469741	371.21678	SB 216763	SB 216763 | SB-216763 | SB216763 | SB 216763 | SB-216763 | SB216763	Pathway: Autophagy; PI3K/Akt/mTOR; Stem Cell/Wnt	Research Area: Neurological Disease; Cancer	MOABOX:2322	GSK3A	Glycogen Synthase Kinase 3 (GSK-3) Inhibitors
SJ000855356-7	SJ000855356	7	MOABOX:2324	AQGNHMOJWBZFQQ-UHFFFAOYSA-N	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1	252917-06-9	Glycogen Synthase Kinase 3 (GSK-3) Inhibitors	GSK3A	GSK3B																															2932																															CHEMBL412142											9956119	71295844	78243722	91826519	91885584	member	10.1016/j.bmc.2011.12.046	10.1021/acs.jmedchem.7b00922	10.1021/acsmedchemlett.6b00405	10.2174/1381612043452668	10.2337/diabetes.52.3.588																																																																																																																																																											12171564	12606497	15078145	15173837	15559249	19366619	20858169	22261023	27128528	27643925	28337318	29016121	30902399																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									1.6152	3.53008																															0.2019	0.44126																															8	8																															HY-10182	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; PI3K/Akt/mTOR; Stem Cell/Wnt | Research Area: Cancer|MOABOX:2324|GSK3A|Glycogen Synthase Kinase 3 (GSK-3) Inhibitors	Cc1cnc([nH]1)c2cnc(NCCNc3ccc(cn3)C#N)nc2c4ccc(Cl)cc4Cl	252917-06-9	85398	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469921	465.33792	CHIR-99021	CHIR-99021 | CT99021 | CHIR-99021 HYDROCHLORIDE | CHIR-99021 | CT99021 | CHIR-99021 HYDROCHLORIDE	Pathway: Autophagy; PI3K/Akt/mTOR; Stem Cell/Wnt	Research Area: Cancer	MOABOX:2324	GSK3A	Glycogen Synthase Kinase 3 (GSK-3) Inhibitors
SJ000285228-22	SJ000285228	22	MOABOX:2328	YPHMISFOHDHNIV-FSZOTQKASA-N	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1	1154-57-0	"Translation Inhibitor;Glycogen Synthase Kinase 3 beta (GSK-3beta;tau Protein Kinase I) Inhibitors;""Translation Inhibitor;Glycogen Synthase Kinase 3 beta (GSK-3beta;tau Protein Kinase I) Inhibitors"""	GSK3B	RPL6																															6128																															CHEMBL123292											6197	21139557	23617515	67259777	67829488	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															14126	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-070-550|MOABOX:2328|GSK3B|Translation Inhibitor;Glycogen Synthase Kinase 3 beta (GSK-3beta;tau Protein Kinase I) Inhibitors;\Translation Inhibitor;Glycogen Synthase Kinase 3 beta (GSK-3beta;tau Protein Kinase I) Inhibitors\	C[C@H]1C[C@H](C)C(=O)[C@@H](C1)[C@H](O)CC2CC(=O)NC(=O)C2	66-81-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468314	281.34742	CYCLOHEXIMIDE | NARAMYCIN A | U-4527 | EXSB/NBC-6607	"""CYCLOHEXIMIDE | NARAMYCIN A | U-4527 | EXSB/NBC-6607"" | CYCLOHEXIMIDE | ""CYCLOHEXIMIDE | NARAMYCIN A | U-4527 | EXSB/NBC-6607"" | CYCLOHEXIMIDE"			MOABOX:2328	GSK3B	Translation Inhibitor;Glycogen Synthase Kinase 3 beta (GSK-3beta;tau Protein Kinase I) Inhibitors;\Translation Inhibitor;Glycogen Synthase Kinase 3 beta (GSK-3beta;tau Protein Kinase I) Inhibitors\
SJ000784270-2	SJ000784270	2	MOABOX:2340	YYTHPXHGWSAKIZ-UHFFFAOYSA-N	Clc1ccc(-c2csc(NN=C3CCCC3)n2)cc1	357649-93-5	Histone N-Acetyltransferase (HAT) Inhibitors	KAT2A	HAT1																															8520																															CHEMBL246811											25193530	129241190				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-W013274	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Epigenetics | Research Area: Cancer|MOABOX:2340|KAT2A|Histone N-Acetyltransferase (HAT) Inhibitors	Clc1ccc(cc1)c2csc(NN=C3CCCC3)n2	357649-93-5	62573	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469787	291.79906	CPTH2	CPTH2 | CPTH2	Pathway: Apoptosis; Epigenetics	Research Area: Cancer	MOABOX:2340	KAT2A	Histone N-Acetyltransferase (HAT) Inhibitors
SJ001034974-1	SJ001034974	1	MOABOX:2344	KEDQCFRVSHYKLR-UHFFFAOYSA-N	COc1ccc(CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1OC	125846-52-8	HCN [I(f)] Blockers	HCN2	HCN4	HCN3	HCN1																													10021	57657	348980																													CHEMBL543767	CHEMBL69679										65637	3045335	20433685	44284596	67592507	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	-1.078e-002	0	0																													0.0	-0.00154	0.0	0.0																													7	7	7	7																													CS-3620	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-568-078|MOABOX:2344|HCN2|HCN [I(f)] Blockers	COc1ccc(CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1OC	85175-67-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468412	456.57444	ZATEBRADINE	ZATEBRADINE | ZATEBRADINE			MOABOX:2344	HCN2	HCN [I(f)] Blockers
SJ001034872-1	SJ001034872	1	MOABOX:2346	JABSKGQQWUDVRU-UHFFFAOYSA-O	CCN(c1ccccc1)c1cc(NC)[n+](C)c(C)n1	133059-95-7	HCN [I(h)] Blockers	HCN2	HCN4	HCN3	HCN1																													10021	57657	348980																													CHEMBL1314022	CHEMBL2052019										3938007	9796088				member																																																																																																																																																																21824780																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0.98896	0	0.80608																													0.0	0.12362	0.0	0.10076																													7	8	7	8																													T7516	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-133-867|MOABOX:2346|HCN2|HCN [I(h)] Blockers	CCN(C1=CC(=NC)N(C)C(=N1)C)c2ccccc2	133059-99-1	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468155	256.3461	ZD7288 | ICI D7288	"""ZD7288 | ICI D7288"" | ""ZD7288 | ICI D7288"""			MOABOX:2346	HCN2	HCN [I(h)] Blockers
SJ000840367-2	SJ000840367	2	MOABOX:2350	AKMNUCBQGHFICM-UHFFFAOYSA-N	Cc1nc2ccc(NC(=O)Nc3ccnc4cccnc34)cc2o1	249889-64-3	HCRTR1 antagonist;Orexin OX-1 Antagonists	HCRTR1																																																															CHEMBL2111553	CHEMBL291536										6604926	9798764	141593005			member	10.1124/mol.109.055152																																																																																																																																																															14691055	21478014	22617492	23031594	23891187	23941044	24944734	27818110																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														3.11376																																0.38922																																8																																HY-10895A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease; Endocrinology|MOABOX:2350|HCRTR1|HCRTR1 antagonist;Orexin OX-1 Antagonists	Cc1oc2cc(NC(=O)Nc3ccnc4cccnc34)ccc2n1	792173-99-0	12280	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469343	319.31742	SB 334867	SB 334867 | SB 334867	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease; Endocrinology	MOABOX:2350	HCRTR1	HCRTR1 antagonist;Orexin OX-1 Antagonists
SJ001035133-1	SJ001035133	1	MOABOX:2352	YSBGRVXJEMSEQY-DEOSSOPVSA-N	Cn1c(SCC(=O)N2CCC[C@H]2C(=O)Nc2ccccc2-c2ccccc2)nc2ccccc21	916141-36-1	Orexin OX-1 Antagonists;Orexin OX-2 Antagonists	HCRTR1	HCRTR2																															3062																															CHEMBL429848											11960895					member																																																																																																																																																																18207395	18673167	21261591	22364813	22506484																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.85008	2.31664																															0.10626	0.28958																															8	8																															HY-10900	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease; Endocrinology|MOABOX:2352|HCRTR1|Orexin OX-1 Antagonists;Orexin OX-2 Antagonists	Cn1c(SCC(=O)N2CCC[C@H]2C(=O)Nc3ccccc3c4ccccc4)nc5ccccc15	916141-36-1	11011	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468805	470.58594	TCS 1102	TCS 1102 | TCS 1102	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease; Endocrinology	MOABOX:2352	HCRTR1	Orexin OX-1 Antagonists;Orexin OX-2 Antagonists
SJ001033350-2	SJ001033350	2	MOABOX:2356	DKMACHNQISHMDN-RPLLCQBOSA-N	CNC(=O)[C@@H](c1ccccc1)N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(C(F)(F)F)cc1	1266467-63-3	Orexin OX-1 Antagonists;Orexin OX-2 Antagonists	HCRTR1	HCRTR2																															3062																															CHEMBL455136											23727689	25227440	143828340			member	10.1016/j.bmcl.2013.04.071	10.1021/jm801296d	10.1124/jpet.117.241422	10.1124/mol.109.055152	10.2174/138161211796197089	10.2174/156802608784936746																																																																																																																																																										18673167	19199652	21476951	23719231	23891187	23941044	25267004	26317591																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														1.376e-002	3.12552																															0.00172	0.39069																															8	8																															CS-2484	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-021-804-912|MOABOX:2356|HCRTR1|Orexin OX-1 Antagonists;Orexin OX-2 Antagonists	CNC(=O)[C@H](N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc3ccc(cc3)C(F)(F)F)c4ccccc4	871224-64-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468487	512.56325	ALMOREXANT; ACT 078573	ALMOREXANT; ACT 078573 | ALMOREXANT; ACT 078573			MOABOX:2356	HCRTR1	Orexin OX-1 Antagonists;Orexin OX-2 Antagonists
SJ000840398-2	SJ000840398	2	MOABOX:2358	COFVZFLCAOUMJT-OAQYLSRUSA-N	COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1ccncc1)C(C)(C)C)CC2	1610882-30-8	HCRTR2 antagonist;Orexin OX-2 Antagonists	HCRTR2																																																															CHEMBL142009											10408514	53302033				member	10.1016/j.bmcl.2003.08.038	10.1021/jm801296d	10.1124/mol.109.055152																																																																																																																																																													14643355	18673167	19199652	21261591	23692283	23891187																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																3.42272																																0.42784																																8																																HY-100452	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Cancer; Endocrinology|MOABOX:2358|HCRTR2|HCRTR2 antagonist;Orexin OX-2 Antagonists	COc1cc2CCN(Cc2cc1OC)C(=O)[C@@H](NCc3ccncc3)C(C)(C)C	372523-75-6	21406	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469349	397.51054	TCS OX2 29	TCS OX2 29 | TCS OX2 29	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Cancer; Endocrinology	MOABOX:2358	HCRTR2	HCRTR2 antagonist;Orexin OX-2 Antagonists
SJ001035126-1	SJ001035126	1	MOABOX:2362	KJPHTXTWFHVJIG-UHFFFAOYSA-N	CCN(Cc1cccnc1)C(=O)CN(c1ccc(OC)nc1)S(=O)(=O)c1ccccc1C	680590-49-2	Orexin OX-2 Antagonists	HCRTR2																																																															CHEMBL2385132											9981404					member	10.1111/j.1476-5381.2009.00127.x	10.1124/mol.109.055152																																																																																																																																																														23601709	23891187																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				4.18992																																0.52374																																8																																HY-108682	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2362|HCRTR2|Orexin OX-2 Antagonists	CCN(Cc1cccnc1)C(=O)CN(c2ccc(OC)nc2)S(=O)(=O)c3ccccc3C	680590-49-2	79058	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468760	454.54194	EMPA	EMPA | EMPA	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2362	HCRTR2	Orexin OX-2 Antagonists
SJ000556678-14	SJ000556678	14	MOABOX:2374	HRNLUBSXIHFDHP-UHFFFAOYSA-N	Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1	726169-73-9	HDAC1/2;Apoptosis Inducers;Histone Deacetylase 1 (HDAC1) Inhibitors	HDAC1	HDAC2	HDAC3																														3066	8841																														CHEMBL272980	CHEMBL481122										9865515	24978504	123743209	129710068	143867515	member	10.1016/j.bmc.2013.09.023	10.1016/j.bmcl.2007.08.023	10.1016/j.bmcl.2008.12.048	10.1016/j.bmcl.2009.08.010	10.1016/j.ejmech.2010.02.030	10.1021/jm301098e	10.1042/BJ20070779	10.2174/138161208783885317	10.2174/138161208783885335	10.2174/138161208783885353	10.2174/187152012800228814																																																																																																																																																					17896917	18247554	18308563	18336297	18336298	18336299	18537607	18568166	18570366	19114304	19699639	19751207	20139990	20223566	20616024	21742496	22263804	22827519	23009203	23206867	23651307	23829483	24095018	24730063	25805446	26287310																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												3.14848	1.7344	1.512e-002																														0.39356	0.2168	0.00189																														8	8	8																														HY-12164	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:2374|HDAC1|HDAC1/2;Apoptosis Inducers;Histone Deacetylase 1 (HDAC1) Inhibitors	Nc1ccccc1NC(=O)c2ccc(CNc3nccc(n3)c4cccnc4)cc2	726169-73-9	5264	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469253	396.4445	MOCETINOSTAT	"MOCETINOSTAT | MOCETIONOSTAT DIHYDROBROMIDE | ""MGCD-0103 | MG-0103"" | MOCETINOSTAT (MGCD0103) | MOCETINOSTAT | MOCETIONOSTAT DIHYDROBROMIDE | ""MGCD-0103 | MG-0103"" | MOCETINOSTAT (MGCD0103)"	Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:2374	HDAC1	HDAC1/2;Apoptosis Inducers;Histone Deacetylase 1 (HDAC1) Inhibitors
SJ000287008-20	SJ000287008	20	MOABOX:2378	NIJJYAXOARWZEE-UHFFFAOYSA-N	CCCC(CCC)C(=O)O	1069-66-5	Histone Deacetylase 1 (HDAC1) Inhibitors;GABAergic Transmission Enhancers	ABAT	ACADSB	HDAC1	SCN1A	HDAC9																												36	3065	6323	9734																												CHEMBL109	CHEMBL2105613										3121	203121	499162	9818208	15940218	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0.30471	0	0.2562																												0.0	0.0	0.04353	0.0	0.0366																												7	7	7	7	7																												HY-10585A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Autophagy; Cell Cycle/DNA Damage; Epigenetics; Neuronal Signaling; Stem Cell/Wnt | Research Area: Cancer|MOABOX:2378|ABAT|Histone Deacetylase 1 (HDAC1) Inhibitors;GABAergic Transmission Enhancers	CCCC(CCC)C(=O)O	1069-66-5	14924	GENERAL	SODIUM(I)	1	NO_SOLVATE	0	1469408	144.21144	VALPROATE SODIUM	"VALPROATE SODIUM | VALPROIC ACID SODIUM | DIVALPROEX SODIUM | ""SODIUM VALPROATE | ABBOTT-44090 | NIK-313 | NIK-317 | VALPROATE SODIUM | VALPROIC ACID SODIUM SALT |"" | ""SODIUM VALPROATE | VALPROATE SODIUM | VALPROIC ACID SODIUM SALT | ABBOTT-44090 | NIK-313 | NIK-317 |"" | SODIUM VALPROATE | VALPROIC ACID SODIUM SALT (SODIUM VALPROATE) | VALPROATE SODIUM | VALPROIC ACID SODIUM | DIVALPROEX SODIUM | ""SODIUM VALPROATE | ABBOTT-44090 | NIK-313 | NIK-317 | VALPROATE SODIUM | VALPROIC ACID SODIUM SALT |"" | ""SODIUM VALPROATE | VALPROATE SODIUM | VALPROIC ACID SODIUM SALT | ABBOTT-44090 | NIK-313 | NIK-317 |"" | SODIUM VALPROATE | VALPROIC ACID SODIUM SALT (SODIUM VALPROATE)"	Pathway: Anti-infection; Autophagy; Cell Cycle/DNA Damage; Epigenetics; Neuronal Signaling; Stem Cell/Wnt	Research Area: Cancer	MOABOX:2378	ABAT	Histone Deacetylase 1 (HDAC1) Inhibitors;GABAergic Transmission Enhancers
SJ000574277-13	SJ000574277	13	MOABOX:2380	NCNRHFGMJRPRSK-MDZDMXLPSA-N	O=C(/C=C/c1cccc(S(=O)(=O)Nc2ccccc2)c1)NO	414864-00-9	HDACs;Apoptosis Inducers;Histone Deacetylase 1 (HDAC1) Inhibitors;Histone Deacetylase 2 (HDAC2) Inhibitors;Angiogenesis Inhibitors	HDAC1	HDAC2	HDAC9	HDAC5	HDAC7	HDAC8	HDAC11	HDAC10																									3066	9734	10014	51564	55869	79885	83933																									CHEMBL408513											6918638	46830078	91576694	143454942	145403553	member	10.1016/j.ejmech.2010.02.030	10.1021/jm2003552	10.1042/BJ20070779																																																																																																																																																													18247554	18308563	20139990	20223566	21634430	21742496	23639537	25113875	25637120	27344487	28395150	29533873	30879863																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									0.8952	0.58864	0.1488	0.16592	7.832e-002	0.30848	0.13704	0.10288																									0.1119	0.07358	0.0186	0.02074	0.00979	0.03856	0.01713	0.01286																									8	8	8	8	8	8	8	8																									BD627982	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-009-679-433|MOABOX:2380|HDAC1|HDACs;Apoptosis Inducers;Histone Deacetylase 1 (HDAC1) Inhibitors;Histone Deacetylase 2 (HDAC2) Inhibitors;Angiogenesis Inhibitors	ONC(=O)\C=C\c1cccc(c1)S(=O)(=O)Nc2ccccc2	866323-14-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468338	318.34766	BELINOSTAT	"BELINOSTAT | ""PDX-101 | PX-105684"" | BELINOSTAT  | BELINOSTAT (PXD101) | BELINOSTAT | ""PDX-101 | PX-105684"" | BELINOSTAT  | BELINOSTAT (PXD101)"			MOABOX:2380	HDAC1	HDACs;Apoptosis Inducers;Histone Deacetylase 1 (HDAC1) Inhibitors;Histone Deacetylase 2 (HDAC2) Inhibitors;Angiogenesis Inhibitors
SJ000518939-26	SJ000518939	26	MOABOX:2382	WAEXFXRVDQXREF-UHFFFAOYSA-N	O=C(CCCCCCC(=O)Nc1ccccc1)NO	1227736-21-1	"HDACs;Apoptosis Inducers;Histone Deacetylase 1 (HDAC1) Inhibitors;Histone Deacetylase 2 (HDAC2) Inhibitors;Histone Deacetylase 6 (HDAC6) Inhibitors;Histone Deacetylase 3 (HDAC3) Inhibitors;Inhibitor;""HDACs;Apoptosis Inducers;Histone Deacetylase 1 (HDAC1) Inhibitors;Histone Deacetylase 2 (HDAC2) Inhibitors;Histone Deacetylase 6 (HDAC6) Inhibitors;Histone Deacetylase 3 (HDAC3) Inhibitors;Inhibitor"""	HDAC1	HDAC2	HDAC3	HDAC9	HDAC6	HDAC5	HDAC7	HDAC8	HDAC11	HDAC10	STAT3																						3066	8841	9734	10013	10014	51564	55869	79885	83933	6774																						CHEMBL98											5311	11455306	16729200	24764488	24824248	member	10.1002/ardp.201700096	10.1002/cmdc.201000166	10.1002/cmdc.201200450	10.1002/cmdc.201300270	10.1002/cmdc.201300297	10.1002/cmdc.201300433	10.1002/cmdc.201700360	10.1002/cmdc.201700449	10.1002/cmdc.201800367	10.1002/cmdc.201800808	10.1016/S0960-894X(02)00754-0	10.1016/j.bbrc.2004.10.082	10.1016/j.bioorg.2018.12.011	10.1016/j.bmc.2005.12.047	10.1016/j.bmc.2008.07.066	10.1016/j.bmc.2010.03.080	10.1016/j.bmc.2013.03.049	10.1016/j.bmc.2013.09.023	10.1016/j.bmc.2014.01.045	10.1016/j.bmc.2014.05.001	10.1016/j.bmc.2015.04.028	10.1016/j.bmc.2015.06.071	10.1016/j.bmc.2016.05.019	10.1016/j.bmc.2017.08.029	10.1016/j.bmc.2018.07.026	10.1016/j.bmc.2019.07.055	10.1016/j.bmcl.2007.04.089	10.1016/j.bmcl.2007.08.023	10.1016/j.bmcl.2008.11.081	10.1016/j.bmcl.2009.08.010	10.1016/j.bmcl.2009.10.028	10.1016/j.bmcl.2010.03.091	10.1016/j.bmcl.2010.05.020	10.1016/j.bmcl.2010.09.100	10.1016/j.bmcl.2011.06.046	10.1016/j.bmcl.2011.08.027	10.1016/j.bmcl.2012.05.123	10.1016/j.bmcl.2012.06.017	10.1016/j.bmcl.2012.08.104	10.1016/j.bmcl.2013.03.102	10.1016/j.bmcl.2014.10.022	10.1016/j.bmcl.2015.12.007	10.1016/j.bmcl.2016.01.022	10.1016/j.bmcl.2017.06.027	10.1016/j.bmcl.2017.09.036	10.1016/j.cclet.2013.11.039	10.1016/j.ejmech.2008.06.020	10.1016/j.ejmech.2008.11.005	10.1016/j.ejmech.2010.02.030	10.1016/j.ejmech.2010.06.035	10.1016/j.ejmech.2011.08.045	10.1016/j.ejmech.2013.03.061	10.1016/j.ejmech.2013.05.017	10.1016/j.ejmech.2014.01.056	10.1016/j.ejmech.2014.09.024	10.1016/j.ejmech.2014.10.052	10.1016/j.ejmech.2016.01.013	10.1016/j.ejmech.2016.02.001	10.1016/j.ejmech.2016.02.003	10.1016/j.ejmech.2016.06.023	10.1016/j.ejmech.2016.12.032	10.1016/j.ejmech.2017.03.079	10.1016/j.ejmech.2018.01.021	10.1016/j.ejmech.2018.03.002	10.1016/j.ejmech.2018.03.005	10.1016/j.ejmech.2018.09.018	10.1016/j.ejmech.2019.111672	10.1016/j.ejphar.2018.02.004	10.1016/j.ijpddr.2018.01.002	10.1016/j.lfs.2008.03.004	10.1021/acs.jmedchem.5b01044	10.1021/acs.jmedchem.5b01052	10.1021/acs.jmedchem.5b01478	10.1021/acs.jmedchem.5b01493	10.1021/acs.jmedchem.6b01538	10.1021/acs.jmedchem.7b00197	10.1021/acs.jmedchem.8b01090	10.1021/acs.jnatprod.5b00741	10.1021/acs.jnatprod.8b00843	10.1021/acschemneuro.8b00116	10.1021/acsmedchemlett.6b00124	10.1021/acsmedchemlett.7b00414	10.1021/acsmedchemlett.9b00071	10.1021/acsmedchemlett.9b00084	10.1021/acsmedchemlett.9b00287	10.1021/jm0498497	10.1021/jm061082q	10.1021/jm0703136	10.1021/jm0703800	10.1021/jm100244y	10.1021/jm100665z	10.1021/jm101092u	10.1021/jm101177s	10.1021/jm101373a	10.1021/jm2001025	10.1021/jm2003552	10.1021/jm200799p	10.1021/jm2016182	10.1021/jm300197a	10.1021/jm300837y	10.1021/jm301355j	10.1021/jm400179b	10.1021/jm400385r	10.1021/jm400467w	10.1021/jm4011884	10.1021/jm401536b	10.1021/jm401899x	10.1021/jm500303u	10.1021/jm5008209	10.1021/jm500872p	10.1021/jm5012148	10.1021/jm7011408	10.1021/jm7015254	10.1021/jm8005355	10.1021/jm800988r	10.1021/jm801128g	10.1021/jm900125m	10.1021/jm9004303	10.1021/jm901561u	10.1021/ml100028g	10.1021/ml100295v	10.1021/ml200136e	10.1021/ml300371t	10.1021/ml5000959	10.1021/np400198r	10.1021/ol035056n	10.1039/c0md00119h	10.1039/c3md00285c	10.1039/c8md00454d	10.1042/BJ20070779	10.1073/pnas.95.6.3003	10.1111/cbdd.13041	10.1111/cbdd.13405	10.1515/hsz-2018-0363	10.2174/0929867033456576	10.2174/138161208783885317	10.2174/138161208783885353	10.2174/1570180814666170505123930	10.2174/187152009788679976	10.3390/ijms20020383	10.3390/molecules18066491																			11831887	11960489	12109913	12270175	12419380	12570373	12749893	14521422	14529480	14552787	14584932	14592473	14613312	14643318	14698179	14971890	14998325	15134505	15149697	15189037	15541343	15603949	15713393	15715470	15717297	15857140	16165353	16420064	16434199	16719774	16723227	16892355	16987657	17004718	17095213	17107790	17307359	17325656	17419603	17477518	17507219	17588744	17606370	17662606	17691763	17761416	17904843	17958342	18038969	18060775	18181121	18212103	18247554	18308563	18336297	18336299	18370373	18397827	18412327	18430569	18494463	18537607	18558669	18642892	18672316	18701301	18809328	18942826	18954984	19007204	19084294	19084395	19093884	19181524	19223622	19301902	19317450	19344175	19350613	19410459	19419205	19419863	19441846	19457659	19601748	19608304	19699639	19751207	19779641	19854643	19886628	19914074	19966789	20055418	20139990	20143778	20143840	20167479	20209563	20217840	20223566	20392638	20423312	20451378	20452225	20472442	20491440	20533500	20536416	20572281	20576572	20605448	20616024	20637529	20669972	20884208	20947351	21067930	21073160	21080629	21080647	21334896	21374822	21417297	21420302	21420859	21436030	21476600	21548582	21572592	21621883	21634430	21712146	21714538	21721525	21742496	21745740	21875796	21889343	21924799	21978679	21984958	22172064	22182579	22260166	22263799	22280363	22435669	22439863	22607140	22698782	22738629	22771007	22827519	22877635	22921063	22932316	23010266	23089527	23116147	23184734	23252603	23276137	23368884	23453219	23493449	23510562	23526814	23547652	23570542	23581848	23591111	23601706	23602523	23622981	23639537	23644210	23651307	23672185	23786452	23792316	23820574	23860593	23865683	23906422	23956109	23964961	24015327	24074025	24095018	24119555	24164245	24227760	24261862	24304348	24328302	24345446	24375963	24525003	24565573	24588105	24694055	24702857	24742384	24755524	24766560	24864038	24900500	24900575	24900743	24972008	25182565	25203558	25218912	25221651	25233084	25238284	25240614	25261927	25311567	25360834	25380299	25454270	25462248	25462271	25563890	25734520	25757142	25800646	25811792	25815139	25874326	25899338	25906087	25953722	25974739	25993269	26005563	26100440	26122774	26149591	26211462	26216016	26226379	26264503	26331334	26376355	26386821	26443078	26475519	26486498	26555243	26611919	26613635	26629857	26629860	26653328	26681404	26689485	26706171	26741358	26804233	26814680	26890114	26890116	26907204	26937828	27055940	27142751	27177826	27186676	27190592	27240467	27344487	27541357	27597246	27606546	27614919	27769671	27886544	28026946	28131715	28213282	28259626	28337317	28368585	28371677	28395150	28419930	28501514	28541690	28574690	28581289	28601509	28629630	28648461	28648462	28765013	28818449	28835797	28885834	28947154	28953386	28987602	29057046	29102179	29150330	29202397	29223096	29288941	29317150	29348808	29360358	29393896	29396364	29496367	29498707	29500130	29518312	29533873	29545103	29549837	29670692	29787262	29940115	29945795	29954683	30045621	30078609	30115492	30122227	30243158	30385227	30455152	30594434	30597327	30629434	30645113	30802729	30851694	30901208	30964290	30996781	30996816	31117517	31163697	31177073	31201063	31235266	31311163	31400938																																																																																																																																																																																																							3.45536	0.50912	0	2.26416	4.8e-003	3.55168	-3.52e-002	-1.304e-002	-0.13208	4.32e-003	3.752e-002																						0.43192	0.06364	0.0	0.28302	0.0006	0.44396	-0.0044	-0.00163	-0.01651	0.00054	0.00469																						8	8	7	8	8	8	8	8	8	8	8																						DG-0025	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	ONC(=O)CCCCCCC(=O)Nc1ccccc1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466651	264.3202	VORINOSTAT	"VORINOSTAT | ""SAHA | MK-0683 | NSC-701852 | SW-064652 | SUBERANILOHYDROXAMIC ACID | SUBEROYLANILIDE HYDROXAMIC ACID | ZOLINZA"" | VORINOSTAT  | ""VORINOSTAT | SAHA | MK-0683 | SUBERANILOHYDROXAMIC ACID | SUBEROYLANILIDE HYDROXAMIC ACID | NSC-701852 | SW-064652 |"" | VORINOSTAT (SAHA, MK0683) | VORINOSTAT | ""SAHA | MK-0683 | NSC-701852 | SW-064652 | SUBERANILOHYDROXAMIC ACID | SUBEROYLANILIDE HYDROXAMIC ACID | ZOLINZA"" | VORINOSTAT  | ""VORINOSTAT | SAHA | MK-0683 | SUBERANILOHYDROXAMIC ACID | SUBEROYLANILIDE HYDROXAMIC ACID | NSC-701852 | SW-064652 |"" | VORINOSTAT (SAHA, MK0683)"			MOABOX:2382	HDAC1	"HDACs;Apoptosis Inducers;Histone Deacetylase 1 (HDAC1) Inhibitors;Histone Deacetylase 2 (HDAC2) Inhibitors;Histone Deacetylase 6 (HDAC6) Inhibitors;Histone Deacetylase 3 (HDAC3) Inhibitors;Inhibitor;""HDACs;Apoptosis Inducers;Histone Deacetylase 1 (HDAC1) Inhibitors;Histone Deacetylase 2 (HDAC2) Inhibitors;Histone Deacetylase 6 (HDAC6) Inhibitors;Histone Deacetylase 3 (HDAC3) Inhibitors;Inhibitor"""
SJ000785895-4	SJ000785895	4	MOABOX:2386	PTJGLFIIZFVFJV-UHFFFAOYSA-N	O=C(CCCCCCC(=O)Nc1cccnc1)NO	382180-17-8	Histone Deacetylase (HDAC) Inhibitors	HDAC9	HDAC5	HDAC7	HDAC8	HDAC11	HDAC10																											10014	51564	55869	79885	83933																											CHEMBL353581											4996					member																																																																																																																																																																11831887	20139990																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.1715	-0.18823	-0.16429	-0.40024	-0.16429	-0.16429																											-0.0245	-0.02689	-0.02347	-0.05003	-0.02347	-0.02347																											7	7	7	8	7	7																											HY-13216	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:2386|HDAC9|Histone Deacetylase (HDAC) Inhibitors	ONC(=O)CCCCCCC(=O)Nc1cccnc1	382180-17-8	55406	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469786	265.30826	PYROXAMIDE	PYROXAMIDE | NSC-696085 | PYROXAMIDE | NSC-696085	Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:2386	HDAC9	Histone Deacetylase (HDAC) Inhibitors
SJ000784274-5	SJ000784274	5	MOABOX:2388	MXWDSZWTBOCWBK-UHFFFAOYSA-N	CN(C)c1ccc(C(=O)NCCCCCCC(=O)NO)cc1	251456-60-7	Histone Deacetylase (HDAC) Inhibitors	HDAC9	HDAC5	HDAC7	HDAC8	HDAC11	HDAC10																											10014	51564	55869	79885	83933																											CHEMBL140000											3994					member																																																																																																																																																																11831887																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.13566	0.30112	0.14798	0.16968	0.14798	0.14798																											0.01938	0.03764	0.02114	0.02121	0.02114	0.02114																											7	8	7	8	7	7																											HY-13506	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:2388|HDAC9|Histone Deacetylase (HDAC) Inhibitors	CN(C)c1ccc(cc1)C(=O)NCCCCCCC(=O)NO	251456-60-7	8541	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468917	307.388	M344	"M344 | ""MS-344 | D-237"" | M344 | ""MS-344 | D-237"""	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:2388	HDAC9	Histone Deacetylase (HDAC) Inhibitors
SJ001034939-1	SJ001034939	1	MOABOX:2392	RGWSSTALGUXZMU-UHFFFAOYSA-N	CN(C)c1ccc(C(=O)NCCCCCC(=O)NO)cc1	193551-00-7	Histone Deacetylase (HDAC) Inhibitors	HDAC9	HDAC5	HDAC7	HDAC8	HDAC11	HDAC10																											10014	51564	55869	79885	83933																											CHEMBL46942											3811	142131260				member																																																																																																																																																																11831887	14613312	18672316																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.1358	0.31376	0.18431	0.18431	0.18431	0.18431																											0.0194	0.03922	0.02633	0.02633	0.02633	0.02633																											7	8	7	7	7	7																											89740	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-009-018-828|MOABOX:2392|HDAC9|Histone Deacetylase (HDAC) Inhibitors	CN(C)c1ccc(cc1)C(=O)NCCCCCC(=O)NO	193551-00-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468316	293.36142	CAY10398 | MD 85 | PX 089274	"""CAY10398 | MD 85 | PX 089274"" | ""CAY10398 | MD 85 | PX 089274"""			MOABOX:2392	HDAC9	Histone Deacetylase (HDAC) Inhibitors
SJ001035253-1	SJ001035253	1	MOABOX:2418	QRDAPCMJAOQZSU-KQQUZDAGSA-N	Cn1cc(/C=C/C(=O)c2cccc(F)c2)cc1/C=C/C(=O)NO	852475-26-4	Histone Deacetylase 2 (HDAC2) Inhibitors	HDAC2																																																															CHEMBL191089											11381449					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.44471																																-0.06353																																7																																HY-16914	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:2418|HDAC2|Histone Deacetylase 2 (HDAC2) Inhibitors	Cn1c(\C=C\C(=O)NO)ccc1\C=C\C(=O)c2cccc(F)c2	852475-26-4	16783	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469323	314.311	MC1568	MC1568 | MC1568	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:2418	HDAC2	Histone Deacetylase 2 (HDAC2) Inhibitors
SJ000784264-15	SJ000784264	15	MOABOX:2424	FPOHNWQLNRZRFC-ZHACJKMWSA-N	Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1	404950-80-7	HDACs;Apoptosis Inducers;Histone Deacetylase (HDAC) Inhibitors	HDAC3	HDAC9	HDAC6	HDAC5	HDAC7	HDAC8	HDAC11	HDAC10																									9734	10013	10014	51564	55869	79885	83933																									CHEMBL3545368	CHEMBL483254										6918837	9955757	11751012	23725208	23725408	virtual	10.1016/j.ejmech.2010.02.030	10.1021/jm301355j	10.1042/BJ20070779																																																																																																																																																													18537607	20139990	20223566	20616024	21436030	21634430	22344701	23368884	23639537	23672185	25637120	26443078	27186676	27377864	27606546	28109947	29016123	30122227																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.18504	6.e-003	0.60904	-0.19584	-0.11024	-0.30664	-7.096e-002	9.12e-002																									0.14813	0.00075	0.07613	-0.02448	-0.01378	-0.03833	-0.00887	0.0114																									8	8	8	8	8	8	8	8																									HY-10224	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:2424|HDAC3|HDACs;Apoptosis Inducers;Histone Deacetylase (HDAC) Inhibitors	Cc1[nH]c2ccccc2c1CCNCc3ccc(\C=C\C(=O)NO)cc3	404950-80-7	15791	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469370	349.42622	PANOBINOSTAT	"PANOBINOSTAT | ""LBH-589 | LBH-589B | NVP-LBH-589"" | PANOBINOSTAT  | PANOBINOSTAT | ""LBH-589 | LBH-589B | NVP-LBH-589"" | PANOBINOSTAT "	Pathway: Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:2424	HDAC3	HDACs;Apoptosis Inducers;Histone Deacetylase (HDAC) Inhibitors
SJ000565185-10	SJ000565185	10	MOABOX:2432	BWDQBBCUWLSASG-MDZDMXLPSA-N	O=C(/C=C/c1ccc(CN(CCO)CCc2c[nH]c3ccccc23)cc1)NO	404951-53-7	HDAC 1/2/3/6/8/10/11;Antimitotic Drugs;Apoptosis Inducers;Histone Deacetylase (HDAC) Inhibitors	HDAC9	HDAC6	HDAC5	HDAC7	HDAC8	HDAC11	HDAC10																										10013	10014	51564	55869	79885	83933																										CHEMBL356066											6445533	11158415	90818978	90853890	129280864	member	10.1016/j.bmcl.2009.08.010	10.1016/j.ejmech.2010.02.030	10.1021/jm101092u	10.1021/jm701079h	10.1021/ml100028g	10.1042/BJ20070779	10.2174/138161208783885353																																																																																																																																																									14521422	14613312	17941625	18247554	18308563	18336297	19699639	20139990	20223566	20616024	21073160	25637120																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										7.952e-002	0.468	0.18816	4.464e-002	-3.464e-002	0.2932	2.032e-002																										0.00994	0.0585	0.02352	0.00558	-0.00433	0.03665	0.00254																										8	8	8	8	8	8	8																										HY-13606	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:2432|HDAC9|HDAC 1/2/3/6/8/10/11;Antimitotic Drugs;Apoptosis Inducers;Histone Deacetylase (HDAC) Inhibitors	OCCN(CCc1c[nH]c2ccccc12)Cc3ccc(\C=C\C(=O)NO)cc3	404951-53-7	12279	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469444	379.4522	DACINOSTAT	"DACINOSTAT | ""DACINOSTAT | LAQ-824 | NVP-LAQ-824 |"" | ""LAQ824 | NVP-LAQ824 | DACINOSTAT |"" | ""LAQ-824 | NVP-LAQ-824 | DACINOSTAT |"" | DACTINOSTAT | LAQ824 (DACINOSTAT) | DACINOSTAT | ""DACINOSTAT | LAQ-824 | NVP-LAQ-824 |"" | ""LAQ824 | NVP-LAQ824 | DACINOSTAT |"" | ""LAQ-824 | NVP-LAQ-824 | DACINOSTAT |"" | DACTINOSTAT | LAQ824 (DACINOSTAT)"	Pathway: Autophagy; Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:2432	HDAC9	HDAC 1/2/3/6/8/10/11;Antimitotic Drugs;Apoptosis Inducers;Histone Deacetylase (HDAC) Inhibitors
SJ000518948-12	SJ000518948	12	MOABOX:2442	XUKUURHRXDUEBC-KAYWLYCHSA-N	CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O	110862-48-1	HMG-CoA Reductase Inhibitors	HMGCR																																																															CHEMBL1487	CHEMBL1790017										60823	9808782	9811345	9811759	9812043	member	10.1021/jm300256z	10.2174/1568026053544524																																																																																																																																																														15686906	23570542																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.38976																																0.29872																																8																																HY-B0589	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Metabolic Enzyme/Protease | Research Area: Metabolic Disease; Inflammation/Immunology|MOABOX:2442|HMGCR|HMG-CoA Reductase Inhibitors	CC(C)c1c(C(=O)Nc2ccccc2)c(c3ccccc3)c(c4ccc(F)cc4)n1CC[C@@H](O)C[C@@H](O)CC(=O)O	134523-00-5	79961	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469030	558.6398	ATORVASTATIN	"ATORVASTATIN | ""SJ000285996 | CI-981 | YM-548 | LIPITOR"" | ATORVASTATIN CALCIUM | ATORVASTATIN | ""SJ000285996 | CI-981 | YM-548 | LIPITOR"" | ATORVASTATIN CALCIUM"	Pathway: Autophagy; Metabolic Enzyme/Protease	Research Area: Metabolic Disease; Inflammation/Immunology	MOABOX:2442	HMGCR	HMG-CoA Reductase Inhibitors
SJ000286063-17	SJ000286063	17	MOABOX:2444	RYMZZMVNJRMUDD-HGQWONQESA-N	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21	79902-63-9	HMG-CoA Reductase Inhibitors;HDL-Cholesterol Increasing Agents	CES1	HMGCR																															3156																															CHEMBL1064											54454	9808638	9810636	9811807	9832423	member	10.1016/j.bmcl.2004.12.046																																																																																																																																																															12871130	15686898	15686906	15974884	17574411	17574412	18537716	22512563	22711801	22907901	25311563	28850227																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										0	2.30344																															0.0	0.28793																															7	8																															HY-17502	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease; Cancer|MOABOX:2444|CES1|HMG-CoA Reductase Inhibitors;HDL-Cholesterol Increasing Agents	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12	79902-63-9	15375	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469023	418.56622	SIMVASTATIN	"SIMVASTATIN | ""MK-733 | SYNVINOLIN"" | SIMVASTATIN | ""MK-733 | SYNVINOLIN"""	Pathway: Apoptosis; Autophagy; Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease; Cancer	MOABOX:2444	CES1	HMG-CoA Reductase Inhibitors;HDL-Cholesterol Increasing Agents
SJ001035369-1	SJ001035369	1	MOABOX:2448	KIVUHCNVDWYUNP-UHFFFAOYSA-N	Nc1cc2c3ccccc3ccc2c2ccccc12	2642-98-0		HPRT1																																																															CHEMBL313154											17534	53405544				member																																																																																																																																																																12773058																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.95024																																0.11878																																8																																HY-108315	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer; Inflammation/Immunology|MOABOX:2448|HPRT1|	Nc1cc2c3ccccc3ccc2c4ccccc14	2642-98-0	26876	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469808	243.30252	6-AMINOCHRYSENE | 6-CHRYSENAMINE	"""6-AMINOCHRYSENE | 6-CHRYSENAMINE"" | ""6-AMINOCHRYSENE | 6-CHRYSENAMINE"""	Pathway: Others	Research Area: Cancer; Inflammation/Immunology	MOABOX:2448	HPRT1	
SJ000127027-14	SJ000127027	14	MOABOX:2450	ZZVUWRFHKOJYTH-UHFFFAOYSA-N	CN(C)CCOC(c1ccccc1)c1ccccc1	110491-04-8	Histamine H1 Receptor Antagonists	HRH1																																																															CHEMBL1200406	CHEMBL1201089	CHEMBL1536197	CHEMBL1620	CHEMBL3707215	CHEMBL3707341	CHEMBL657					3100	8980	10660	24098	35726	member																																																																																																																																																																16460947	21944853																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.20696																																0.15087																																8																																AG003S9A	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-837-708|MOABOX:2450|HRH1|Histamine H1 Receptor Antagonists	CN(C)CCOC(c1ccccc1)c2ccccc2	147-24-0	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468626	255.35474	DIPHENHYDRAMINE HYDROCHLORIDE	DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HCL | DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HCL			MOABOX:2450	HRH1	Histamine H1 Receptor Antagonists
SJ000287112-11	SJ000287112	11	MOABOX:2452	RWTNPBWLLIMQHL-UHFFFAOYSA-N	CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1	1319714-86-7	Histamine H1 Receptor Antagonists	HRH1																																																															CHEMBL1200618	CHEMBL914										3348	63002	9831873	9875263	9919379	member	10.1016/j.bcp.2004.10.006	10.1016/j.bmc.2011.03.003	10.1016/j.bmcl.2009.03.124																																																																																																																																																													19362477	19660947	21470866	25494650																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.29824																																0.28728																																8																																AA007I62	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-536|MOABOX:2452|HRH1|Histamine H1 Receptor Antagonists	CC(C)(C(=O)O)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4	153439-40-8	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468280	501.65636	FEXOFENADINE	FEXOFENADINE | FEXOFENADINE HYDROCHLORIDE | FEXOFENADINE HCL | FEXOFENADINE | FEXOFENADINE HYDROCHLORIDE | FEXOFENADINE HCL			MOABOX:2452	HRH1	Histamine H1 Receptor Antagonists
SJ000565173-9	SJ000565173	9	MOABOX:2454	JAUOIFJMECXRGI-UHFFFAOYSA-N	Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1	100643-71-8	Histamine H1 Receptor Antagonists	HRH1																																																															CHEMBL1172											124087	9801598	9891141	9932266	10278785	member																																																																																																																																																																15482930	31274307																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.74432																																0.21804																																8																																HY-B0539	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Inflammation/Immunology; Endocrinology|MOABOX:2454|HRH1|Histamine H1 Receptor Antagonists	Clc1ccc2C(=C3CCNCC3)c4ncccc4CCc2c1	100643-71-8	16362	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469303	310.82056	DESLORATADINE	DESLORATADINE | DESLORATIDINE | DESLORATADINE | DESLORATIDINE	Pathway: GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Inflammation/Immunology; Endocrinology	MOABOX:2454	HRH1	Histamine H1 Receptor Antagonists
SJ000285749-10	SJ000285749	10	MOABOX:2456	ODQWQRRAPPTVAG-BOPFTXTBSA-N	CN(C)CC/C=C1/c2ccccc2COc2ccccc21	1229-29-4	Histamine H1 Receptor Antagonists;Histamine H2 Receptor Antagonists;5-HT Reuptake Inhibitors;Norepinephrine Reuptake Inhibitors	HRH1																																																															CHEMBL101740	CHEMBL1256774										667468	5281088	20839476	45114061	73417172	member																																																																																																																																																																27643714																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.21208																																0.15151																																8																																HY-B0725	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2456|HRH1|Histamine H1 Receptor Antagonists;Histamine H2 Receptor Antagonists;5-HT Reuptake Inhibitors;Norepinephrine Reuptake Inhibitors	CN(C)CC\C=C\1/c2ccccc2COc3ccccc13	1229-29-4	16625	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469884	279.37614	DOXEPIN HYDROCHLORIDE	DOXEPIN HYDROCHLORIDE | DOXEPIN HCL | DOXEPIN HYDROCHLORIDE | DOXEPIN HCL	Pathway: GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2456	HRH1	Histamine H1 Receptor Antagonists;Histamine H2 Receptor Antagonists;5-HT Reuptake Inhibitors;Norepinephrine Reuptake Inhibitors
SJ000285344-9	SJ000285344	9	MOABOX:2458	UUQMNUMQCIQDMZ-UHFFFAOYSA-N	CNCCc1ccccn1	133206-34-5	Histamine H3 Receptor Antagonists;Histamine H1 Receptor Agonists	HRH1	HRH3																															11255																															CHEMBL1446813	CHEMBL1451277	CHEMBL1464589	CHEMBL24441								2366	68643	198334	203875	6420033	member	10.1124/jpet.110.168633																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0.41648																															0.0	0.05206																															8	8																															PS-4217	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CNCCc1ccccn1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466646	136.19428	BETAHISTINE HYDROCHLORIDE	BETAHISTINE HYDROCHLORIDE | BETAHISTINE MESYLATE | BETAHISTINE DIHYDROCHLORIDE | BETAHISTINE 2HCL | BETAHISTINE HYDROCHLORIDE | BETAHISTINE MESYLATE | BETAHISTINE DIHYDROCHLORIDE | BETAHISTINE 2HCL			MOABOX:2458	HRH1	Histamine H3 Receptor Antagonists;Histamine H1 Receptor Agonists
SJ001034845-1	SJ001034845	1	MOABOX:2462	FLTBEMVEAFMWDD-UHFFFAOYSA-N	CC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1	117796-52-8	Histamine H1 Receptor Antagonists;Platelet-Activating Factor Receptor (PAFR) Antagonists;Non-Steroidal Antiinflammatory Drugs	HRH1	PTAFR																															5724																															CHEMBL10971											60680	144798716				member	10.1016/S0960-894X(00)80290-5	10.1016/S0960-894X(98)00626-X	10.1016/S0968-0896(99)00075-9	10.1021/jm00105a069	10.2174/1568026033452104																																																																																																																																																											1671420	10465415	12769711	15544553	16220969	19075805																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.21144	-5.448e-002																															0.15143	-0.00681																															8	8																															Z3034437771	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-688-704|MOABOX:2462|HRH1|Histamine H1 Receptor Antagonists;Platelet-Activating Factor Receptor (PAFR) Antagonists;Non-Steroidal Antiinflammatory Drugs	CC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc4cccnc24)CC1	117796-52-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468089	352.85724	Z3034437771	Z3034437771 | Z3034437771			MOABOX:2462	HRH1	Histamine H1 Receptor Antagonists;Platelet-Activating Factor Receptor (PAFR) Antagonists;Non-Steroidal Antiinflammatory Drugs
SJ000287444-7	SJ000287444	7	MOABOX:2464	SGXXNSQHWDMGGP-IZZDOVSWSA-N	CN/C(=C\[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1	1246833-99-7	Histamine H2 Receptor Antagonists	HRH2																																																																										3033637	44123687	66608978	67364470	67396521	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																8																																HS-0083	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CN\C(=C/[N+](=O)[O-])\NCCSCc1csc(CN(C)C)n1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466658	331.45744	NIZATIDINE	"NIZATIDINE | ""NIZATIDINE | AXID"" | NIZATIDINE | ""NIZATIDINE | AXID"""			MOABOX:2464	HRH2	Histamine H2 Receptor Antagonists
SJ000855203-5	SJ000855203	5	MOABOX:2466	KMZQAVXSMUKBPD-DJWKRKHSSA-N	O=C(C[S+]([O-])Cc1ccco1)NC/C=C\COc1cc(CN2CCCCC2)ccn1	118288-08-7	Histamine H2 Receptor Antagonists	HRH2																																																															CHEMBL1742461											5282136	56838928				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-B0160	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling | Research Area: Metabolic Disease; Endocrinology|MOABOX:2466|HRH2|Histamine H2 Receptor Antagonists	O=C(CS(=O)Cc1occc1)NC\C=C/COc2cc(CN3CCCCC3)ccn2	118288-08-7	11964	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468841	431.54836	LAFUTIDINE	LAFUTIDINE | LAFUTIDINE	Pathway: GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Research Area: Metabolic Disease; Endocrinology	MOABOX:2466	HRH2	Histamine H2 Receptor Antagonists
SJ000285858-16	SJ000285858	16	MOABOX:2468	VMXUWOKSQNHOCA-UKTHLTGXSA-N	CN/C(=C\[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1	128345-62-0	Histamine H2 Receptor Antagonists	HRH2																																																															CHEMBL1092473	CHEMBL512										3001055	3033332	3033887	9809284	9810248	member																																																																																																																																																																15947036																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.92016																																0.11502																																8																																HY-B0281A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Infection; Endocrinology; Metabolic Disease|MOABOX:2468|HRH2|Histamine H2 Receptor Antagonists	CN\C(=C/[N+](=O)[O-])\NCCSCc1oc(CN(C)C)cc1	66357-59-3	16550	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469380	314.40378	RANITIDINE	RANITIDINE | RANITIDINE HYDROCHLORIDE | RANITIDINE HCL | RANITIDINE | RANITIDINE HYDROCHLORIDE | RANITIDINE HCL	Pathway: Anti-infection; GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Infection; Endocrinology; Metabolic Disease	MOABOX:2468	HRH2	Histamine H2 Receptor Antagonists
SJ001035242-1	SJ001035242	1	MOABOX:2470	WROHEWWOCPRMIA-UHFFFAOYSA-N	CNC(=O)c1ccc(Oc2ccc3c(c2)CCN(C2CCC2)CC3)nc1	720690-73-3	Histamine H3 Receptor Inverse Agonists;Histamine H3 Receptor Antagonists	HRH3																																																															CHEMBL517140											9798547	24768876				member	10.1021/jm800569w																																																																																																																																																															17371699	18673168	18841880	19043195	19456097	20864505	20930404	20945906	21062081	21261594	21510840	22687746	23205610	24269482																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								3.36488																																0.42061																																8																																HY-14111	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling | Research Area: Neurological Disease; Endocrinology|MOABOX:2470|HRH3|Histamine H3 Receptor Inverse Agonists;Histamine H3 Receptor Antagonists	CNC(=O)c1ccc(Oc2ccc3CCN(CCc3c2)C4CCC4)nc1	720690-73-3	23452	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469265	351.4421	GSK189254A | GSK189254	"""GSK189254A | GSK189254"" | ""GSK189254A | GSK189254"""	Pathway: GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Research Area: Neurological Disease; Endocrinology	MOABOX:2470	HRH3	Histamine H3 Receptor Inverse Agonists;Histamine H3 Receptor Antagonists
SJ000287445-6	SJ000287445	6	MOABOX:2472	QKDDJDBFONZGBW-UHFFFAOYSA-N	S=C(NC1CCCCC1)N1CCC(c2c[nH]cn2)CC1	106243-16-7	Histamine H3 Receptor Inverse Agonists;Histamine H3 Receptor Antagonists	HRH3																																																															CHEMBL12294	CHEMBL1256702	CHEMBL18998	CHEMBL260374								3035905	9894200	11211984	11953366	44267933	member	10.1006/bbrc.2000.4008	10.1016/S0014-2999(02)02382-8	10.1016/j.bcp.2007.02.010	10.1016/j.bmc.2011.09.061	10.1016/j.bmc.2013.07.051	10.1016/j.bmcl.2017.08.060	10.1016/j.ejphar.2017.03.013	10.1021/acs.jmedchem.8b01280	10.1021/jm0603318																																																																																																																																																							2164693	10869375	11090094	11179434	11181941	11284713	11294398	11411576	11714875	11755145	12393057	12672253	12954048	15033391	15110854	15139761	15294456	15466448	15544557	15634000	15634025	15771465	15947036	16263297	16366610	16402096	16432504	16466921	16713264	16918455	16942032	17371699	18683917	19009544	19043195	19101971	19252322	19317445	19405064	19414267	19524331	19577344	19773175	19791743	19846299	20043314	20045649	20166942	20397706	20864504	20930404	21062081	21261593	21261594	21348462	21498080	21510840	21761567	22019465	22120611	23042668	23891186	23978359	24650714	27007611	28888822	29401659	29681486	30385161																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	4.728e-002																																0.00591																																8																																10011127	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-009-019-463|MOABOX:2472|HRH3|Histamine H3 Receptor Inverse Agonists;Histamine H3 Receptor Antagonists	S=C(NC1CCCCC1)N2CCC(CC2)c3c[nH]cn3	148440-81-7	NA	GENERAL	MALEATE	1	NO_SOLVATE	0	1468329	292.44286	THIOPERAMIDE MALEATE	THIOPERAMIDE MALEATE | SJ000288247 | THIOPERAMIDE MALEATE | SJ000288247			MOABOX:2472	HRH3	Histamine H3 Receptor Inverse Agonists;Histamine H3 Receptor Antagonists
SJ000821693-3	SJ000821693	3	MOABOX:2474	NNACHAUCXXVJSP-UHFFFAOYSA-N	Clc1ccc(CCCOCCCN2CCCCC2)cc1	362665-56-3	Histamine H3 Receptor Inverse Agonists;Histamine H3 Receptor Antagonists	HRH3																																																															CHEMBL462605											9948102	11551689	11598405	23137286	23658543	member	10.1016/j.bmc.2009.03.014	10.1016/j.bmcl.2017.08.060	10.1021/jm800569w	10.1111/bph.14185	10.1124/jpet.106.111039	10.1124/jpet.110.170928	10.2174/156802611795860906																																																																																																																																																									16263297	17005916	17371699	18673168	18774720	18841880	19286376	19329325	19456097	19577344	20727744	20728354	20864504	20864505	20930404	21261594	21510840	24650714	25218907	28797771	28888822	29681486																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																3.94536																																0.49317																																8																																HY-12199B	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling | Research Area: Neurological Disease; Endocrinology|MOABOX:2474|HRH3|Histamine H3 Receptor Inverse Agonists;Histamine H3 Receptor Antagonists	Clc1ccc(CCCOCCCN2CCCCC2)cc1	903576-44-3	14715	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468895	295.84744	PITOLISANT HYDROCHLORIDE | BF-2649 HYDROCHLORIDE	"""PITOLISANT HYDROCHLORIDE | BF-2649 HYDROCHLORIDE"" | ""PITOLISANT HYDROCHLORIDE | BF-2649 HYDROCHLORIDE"""	Pathway: GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Research Area: Neurological Disease; Endocrinology	MOABOX:2474	HRH3	Histamine H3 Receptor Inverse Agonists;Histamine H3 Receptor Antagonists
SJ001035075-1	SJ001035075	1	MOABOX:2476	SDTRYHWIXVHTLM-GFCCVEGCSA-N	Nc1nc2c(c(N3CC[C@@H](N)C3)n1)CCCc1ccccc1-2	1027330-97-7	HRH4 antagonist;Histamine H4 Receptor Antagonists	HRH4																																																															CHEMBL502347											25068753	56972240	131865471	139025045		member																																																																																																																																																																18817367	22153663	30998358																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.84408																																0.10551																																8																																1990	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-035-936-414|MOABOX:2476|HRH4|HRH4 antagonist;Histamine H4 Receptor Antagonists	N[C@@H]1CCN(C1)c2nc(N)nc3c2CCCc4ccccc34	1027330-97-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468606	295.38214	A 943931	A 943931 | A 943931			MOABOX:2476	HRH4	HRH4 antagonist;Histamine H4 Receptor Antagonists
SJ001035084-1	SJ001035084	1	MOABOX:2482	VFTQRHWULYJKCI-UHFFFAOYSA-N	C1CCc2nnc(C34CC5CC(CC(C5)C3)C4)n2CC1	327093-42-5	11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors	HSD11B1																																																															CHEMBL256777											3630776					member	10.1002/cmdc.201000081	10.1016/j.bmc.2012.08.056	10.1016/j.bmcl.2005.06.040	10.1016/j.bmcl.2008.04.013	10.1016/j.bmcl.2008.04.014	10.1016/j.bmcl.2010.01.082	10.1021/jm800369f	10.2174/092986708783885264	10.2174/156802608786413528																																																																																																																																																							16039856	18336279	18440811	18440812	18652443	19075762	20149650	20486152	23040895	23747808	24294985																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											3.0176																																0.3772																																8																																EN300-16437	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-009-215-910|MOABOX:2482|HSD11B1|11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors	C1CCc2nnc(n2CC1)C34CC5CC(CC(C5)C3)C4	327093-42-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468629	271.4005	EN300-16437	EN300-16437 | EN300-16437			MOABOX:2482	HSD11B1	11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors
SJ000286303-6	SJ000286303	6	MOABOX:2484	AURFZBICLPNKBZ-FZCSVUEKSA-N	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	516-55-2	GABA(A) Receptor Antagonists;11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors	HSD11B1																																																															CHEMBL2057301											92787	66755868				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																3652	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-162-706|MOABOX:2484|HSD11B1|GABA(A) Receptor Antagonists;11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	128-20-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468507	318.49346	ALLOPREGNANOLONE	"ALLOPREGNANOLONE | 5ALPHA-PREGNAN-3ALPHA-OL-20-ONE | (3A,5B)-3-HYDROXY-PREGNAN-20-ONE | ALLOPREGNANOLONE | 5ALPHA-PREGNAN-3ALPHA-OL-20-ONE | (3A,5B)-3-HYDROXY-PREGNAN-20-ONE"			MOABOX:2484	HSD11B1	GABA(A) Receptor Antagonists;11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors
SJ000286353-9	SJ000286353	9	MOABOX:2486	FMGSKLZLMKYGDP-USOAJAOKSA-N	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CCC2=O	105597-37-3	HSD11B1 Expression Inhibitors	HSD11B1																																																															CHEMBL90593											5881	451771	9843174	9915706	9959540	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																GS-0906	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466764	288.42442	DEHYDROEPIANDROSTERONE	DEHYDROEPIANDROSTERONE | TRANS-DEHYDROANDROSTERONE | DEHYDROEPIANDROSTERONE (DHEA) | DEHYDROEPIANDROSTERONE | TRANS-DEHYDROANDROSTERONE | DEHYDROEPIANDROSTERONE (DHEA)			MOABOX:2486	HSD11B1	HSD11B1 Expression Inhibitors
SJ000286575-13	SJ000286575	13	MOABOX:2488	MPDGHEJMBKOTSU-YKLVYJNSSA-N	CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C	107420-91-7	11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors;11-beta-Hydroxysteroid Dehydrogenase Type 2 (11beta-HSD2) Inhibitors;17beta-Hydroxysteroid Dehydrogenase Type 3 (17beta-HSD3) Inhibitors	HSD11B1	HSD11B2	HSD17B3																														3291	3293																														CHEMBL230006											10114	9831742	9874646	9961800	25126458	member	10.1016/j.bmc.2010.08.046	10.1016/j.bmc.2011.02.005	10.1016/j.bmcl.2008.01.020	10.1016/j.bmcl.2011.08.019	10.1016/j.bmcl.2014.10.036	10.1016/j.ejmech.2013.05.010	10.1016/j.ejmech.2017.04.059	10.1021/acs.jnatprod.5b00952	10.1021/jm058228q	10.1021/np500896n																																																																																																																																																						18242087	18653260	20851614	20939816	21376605	21873057	23747808	25453795	25590374	26936592	28458137																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											1.5412	1.46592	-0.56245																														0.19265	0.18324	-0.08035																														8	8	7																														KS-1262	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]3(C)[C@@H]2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]34C)C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466717	470.68384	18ALPHA-GLYCYRRHETINIC ACID	18ALPHA-GLYCYRRHETINIC ACID | ENOXOLONE | GLYCYRRHETINIC ACID | 18-BETA-GLYCYRRHETINIC ACID | 18ALPHA-GLYCYRRHETINIC ACID | ENOXOLONE | GLYCYRRHETINIC ACID | 18-BETA-GLYCYRRHETINIC ACID			MOABOX:2488	HSD11B1	11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors;11-beta-Hydroxysteroid Dehydrogenase Type 2 (11beta-HSD2) Inhibitors;17beta-Hydroxysteroid Dehydrogenase Type 3 (17beta-HSD3) Inhibitors
SJ000285611-19	SJ000285611	19	MOABOX:2490	RUDATBOHQWOJDD-BSWAIDMHSA-N	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O	24404-86-2	11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors;Farnesoid X Receptor (FXR) Agonists	HSD11B1	NR1H4																															9971																															CHEMBL240597											10133	3081485	16069300	20848999	66644638	virtual																																																																																																																																																																19941473																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.23191	1.17904																															0.03313	0.14738																															7	8																															AS-13636	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466810	392.572	URSODIOL	URSODIOL | CHENODIOL | UROSIOL | URSODEOXYCHOLIC ACID | CHENODEOXYCHOLIC ACID | URSODIOL | CHENODIOL | UROSIOL | URSODEOXYCHOLIC ACID | CHENODEOXYCHOLIC ACID			MOABOX:2490	HSD11B1	11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors;Farnesoid X Receptor (FXR) Agonists
SJ000285611-20	SJ000285611	20	MOABOX:2490	RUDATBOHQWOJDD-BSWAIDMHSA-N	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O	24404-86-2	11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors;Farnesoid X Receptor (FXR) Agonists	HSD11B1	NR1H4																															9971																															CHEMBL240597											10133	3081485	16069300	20848999	66644638	virtual																																																																																																																																																																19941473																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.23191	1.17904																															0.03313	0.14738																															7	8																															KS-5243	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466811	392.572	URSODIOL	URSODIOL | CHENODIOL | UROSIOL | URSODEOXYCHOLIC ACID | CHENODEOXYCHOLIC ACID | URSODIOL | CHENODIOL | UROSIOL | URSODEOXYCHOLIC ACID | CHENODEOXYCHOLIC ACID			MOABOX:2490	HSD11B1	11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors;Farnesoid X Receptor (FXR) Agonists
SJ000287437-4	SJ000287437	4	MOABOX:2492	FJLBFSROUSIWMA-UHFFFAOYSA-N	CC(C)(C(=O)c1cccnc1)c1cccnc1	22752-91-6	11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors;Mineralocorticoid Receptor (MR) Antagonists;Cytochrome P450 CYP11B1 (Steroid 11-beta Hydroxylase) Inhibitors	CYP11B1	HSD11B1	NR3C2																														3290	4306																														CHEMBL3989720	CHEMBL934										4174	120837	3084377	20055496	20057112	member	10.1016/j.bmcl.2010.11.040	10.1016/j.ejmech.2014.10.021	10.1016/j.ejmech.2015.04.013	10.1016/j.ejmech.2017.11.018	10.1021/acs.jmedchem.7b00437	10.1021/jm100317b	10.1021/jm3003872	10.1021/jm400240r	10.1021/jm501004t	10.1021/ml100283h	10.2174/1568026611313120003																																																																																																																																																					20684610	21129965	22788843	23688131	23869452	24422519	24900247	24900349	25176013	25462231	25874338	28570067	29207342																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									3.87256	-0.77014	0																														0.48407	-0.11002	0.0																														8	7	7																														AG00D9QW	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-794-644|MOABOX:2492|CYP11B1|11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors;Mineralocorticoid Receptor (MR) Antagonists;Cytochrome P450 CYP11B1 (Steroid 11-beta Hydroxylase) Inhibitors	CC(C)(C(=O)c1cccnc1)c2cccnc2	54-36-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468671	226.27376	METYRAPONE	"METYRAPONE | ""METYRAPONE | METOPIRONE |"" | METYRAPONE | ""METYRAPONE | METOPIRONE |"""			MOABOX:2492	CYP11B1	11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors;Mineralocorticoid Receptor (MR) Antagonists;Cytochrome P450 CYP11B1 (Steroid 11-beta Hydroxylase) Inhibitors
SJ000287141-9	SJ000287141	9	MOABOX:2494	IIBYAHWJQTYFKB-UHFFFAOYSA-N	CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O	41859-67-0	11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors;HSD11B1 Expression Inhibitors;PPARalpha Agonists;PPARdelta Agonists;PPARgamma Agonists	HSD11B1	PPARA	PPARD	PPARG																													5465	5467	5468																													CHEMBL264374											39042	9870221	11204390	11570797	66709465	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0.35544	0.96352	0.32488																													0.0	0.04443	0.12044	0.04061																													7	8	8	8																													HY-B0637	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Metabolic Disease; Cardiovascular Disease|MOABOX:2494|HSD11B1|11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors;HSD11B1 Expression Inhibitors;PPARalpha Agonists;PPARdelta Agonists;PPARgamma Agonists	CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O	41859-67-0	14099	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468945	361.8194	BEZAFIBRATE	"BEZAFIBRATE | ""BEZAFIBRATE | BM-15075 |"" | BEZAFIBRATE | ""BEZAFIBRATE | BM-15075 |"""	Pathway: Cell Cycle/DNA Damage	Research Area: Metabolic Disease; Cardiovascular Disease	MOABOX:2494	HSD11B1	11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors;HSD11B1 Expression Inhibitors;PPARalpha Agonists;PPARdelta Agonists;PPARgamma Agonists
SJ000862608-2	SJ000862608	2	MOABOX:2498	NGHOLYJTSCBCGC-VAWYXSNFSA-N	O=C(/C=C/c1ccccc1)OCc1ccccc1	103-41-3	17beta-Hydroxysteroid Dehydrogenase (17beta-HSD)  Inhibitors	HSD17B1	HSD17B2	HSD17B7	HSD17B10	HSD17B8	HSD17B6	HSD17B12	HSD17B11	HSD17B14	HSD17B13																							3294	51478	3028	7923	8630	51144	51170	51171	345275																							CHEMBL361197											5273469	17891070	66836228	68422384	87448814	virtual	10.1016/j.bmcl.2004.05.069																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0	0	0	0	0	0	0	0	0																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0																							7	7	7	7	7	7	7	7	7	7																							HY-N7090	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Others|MOABOX:2498|HSD17B1|17beta-Hydroxysteroid Dehydrogenase (17beta-HSD) Inhibitors	O=C(OCc1ccccc1)\C=C\c2ccccc2	103-41-3	95051	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469740	238.28116	BENZYL CINNAMATE(P)	BENZYL CINNAMATE(P) | BENZYL CINNAMATE(P)	Pathway: Others	Research Area: Others	MOABOX:2498	HSD17B1	17beta-Hydroxysteroid Dehydrogenase (17beta-HSD) Inhibitors
SJ000003682-4	SJ000003682	4	MOABOX:2502	IDFOCEQDKOOOER-UHFFFAOYSA-N	Cc1c(Cc2ccccc2)c(=O)oc2cc(O)ccc12	86-44-2	17beta-Hydroxysteroid Dehydrogenase Type 3 (17beta-HSD3) Inhibitors	HSD17B3																																																															CHEMBL592042											5338538					member	10.1016/j.bmcl.2009.10.111																																																																																																																																																															19954971																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.3608																																0.1701																																8																																PS-7311	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC1=C(Cc2ccccc2)C(=O)Oc3cc(O)ccc13	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466642	266.29126					MOABOX:2502	HSD17B3	17beta-Hydroxysteroid Dehydrogenase Type 3 (17beta-HSD3) Inhibitors
SJ001033070-2	SJ001033070	2	MOABOX:2506	VAPSMQAHNAZRKC-BMRKFEMSSA-N	CC(C)(C)NC(=O)[C@H]1CCC2C3CC=C4C=C(C(=O)O)CC[C@]4(C)C3CC[C@@]21C		hydroxy-delta-5-steroid dehydrogenase inhibitors	HSD3B1	SRD5A2	HSD3B2	SRD5A1	HSD3B7																												6716	3284	6715	80270																																							9801084					virtual	10.1016/0039-128X(95)00021-H	10.1016/S0960-894X(99)00234-6	10.1021/jm00014a015	10.1021/jm00055a014	10.1080/1475636021000059092																																																																																																																																																											7629802	7676475	8381185	10386944	12683747	22776417																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																-0.28798	0	-0.59836	3.40208	0																												-0.04114	0.0	-0.08548	0.42526	0.0																												7	7	7	8	7																												CS-7978	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-027-720-486|MOABOX:2506|HSD3B1|hydroxy-delta-5-steroid dehydrogenase inhibitors	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C=C(CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)O	119169-78-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468479	399.56618	EPRISTERIDE | ONO-9302 | SKF105657	"""EPRISTERIDE | ONO-9302 | SKF105657"" | ""EPRISTERIDE | ONO-9302 | SKF105657"""			MOABOX:2506	HSD3B1	hydroxy-delta-5-steroid dehydrogenase inhibitors
SJ000784284-11	SJ000784284	11	MOABOX:2508	AYUNIORJHRXIBJ-TXHRRWQRSA-N	C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O	106-95-6	CHK1 Expression Inhibitors;Inhibitors of Signal Transduction Pathways;Heat Shock Protein 90 (hsp90) Inhibitors	HSP90AA1																																																															CHEMBL109480											6505803	11378126	11949685	15950378	49834951	virtual	10.1002/anie.200800233	10.1016/j.bmcl.2003.08.065	10.1016/j.bmcl.2009.04.030	10.1021/jm0603116	10.1021/jm900098v	10.1073/pnas.0608372103																																																																																																																																																										11294389	14592488	16621545	16797988	16854066	17488003	19168355	19231864	19410458	19552433	20055425	21106457	21875802	22938030	23362862	23520985	23965125	24499352	25105924	25277067	25677667	27914802	28426997																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															1.32136																																0.16517																																8																																T6290	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-836|MOABOX:2508|HSP90AA1|CHK1 Expression Inhibitors;Inhibitors of Signal Transduction Pathways;Heat Shock Protein 90 (hsp90) Inhibitors	CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=O)C=C(NC(=O)\C(=C\C=C/[C@H](OC)[C@@H](OC(=O)N)\C(=C\[C@H](C)[C@H]1O)\C)\C)C2=O	75747-14-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468131	585.68842	TANESPIMYCIN	"TANESPIMYCIN | ""17-AAG | BMS-722782 | CNF-101 | CP-127374 | KOS-953 | NSC-330507 | NSC-330507D | NSC-704057 |"" | 17-AAG | 17-AAG (TANESPIMYCIN) | TANESPIMYCIN | ""17-AAG | BMS-722782 | CNF-101 | CP-127374 | KOS-953 | NSC-330507 | NSC-330507D | NSC-704057 |"" | 17-AAG | 17-AAG (TANESPIMYCIN)"			MOABOX:2508	HSP90AA1	CHK1 Expression Inhibitors;Inhibitors of Signal Transduction Pathways;Heat Shock Protein 90 (hsp90) Inhibitors
SJ000841259-4	SJ000841259	4	MOABOX:2510	WSMQUUGTQYPVPD-OAHLLOKOSA-N	COc1cccc(-c2cc(F)ccc2[C@H]2Cc3nc(N)nc(C)c3C(=O)N2)n1	934343-74-5	Heat Shock Protein 90 (hsp90) Inhibitors	HSP90AA1																																																															CHEMBL3360305											46216556	67065358				virtual																																																																																																																																																																25368984																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-4.456e-002																																-0.00557																																8																																HY-15190	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:2510|HSP90AA1|Heat Shock Protein 90 (hsp90) Inhibitors	COc1cccc(n1)c2cc(F)ccc2[C@H]3Cc4nc(N)nc(C)c4C(=O)N3	934343-74-5	81086	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469128	379.38762	HSP-990 | NVP-HSP990 |	"""HSP-990 | NVP-HSP990 |"" | ""HSP-990 | NVP-HSP990 |"""	Pathway: Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:2510	HSP90AA1	Heat Shock Protein 90 (hsp90) Inhibitors
SJ000796058-6	SJ000796058	6	MOABOX:2516	NDAZATDQFDPQBD-UHFFFAOYSA-N	CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1	747412-49-3	Heat Shock Protein 90 (hsp90) Inhibitors	HSP90AA1	HSP90AB1	HSP90B1																														3326	7184																														CHEMBL252164	CHEMBL3137334										135539077	135565012	135565057	135869596	135910288	virtual	10.1016/j.bmcl.2015.06.009	10.1016/j.ejmech.2014.01.056	10.1021/ci100222k	10.1021/jm401536b	10.1021/jm701018h	10.1158/0008-5472.CAN-07-5256																																																																																																																																																										18020435	18413753	18430202	19860735	20055425	20608738	21459002	21838681	22066525	22112537	22123826	22938030	23965125	24332488	24565573	24588105	24673104	24751441	25313505	25383915	26112442	27688186	27996253	29698859																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														0.3812	0.42936	0.46872																														0.04765	0.05367	0.05859																														8	8	8																														HY-10215	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:2516|HSP90AA1|Heat Shock Protein 90 (hsp90) Inhibitors	CCNC(=O)c1noc(c2cc(C(C)C)c(O)cc2O)c1c3ccc(CN4CCOCC4)cc3	747412-49-3	43220	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469569	465.54144	NVP-AUY922	"NVP-AUY922 | ""VER-52296 | AUY-922"" | Luminespib | AUY922 (NVP-AUY922) | NVP-AUY922 | ""VER-52296 | AUY-922"" | Luminespib | AUY922 (NVP-AUY922)"	Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:2516	HSP90AA1	Heat Shock Protein 90 (hsp90) Inhibitors
SJ000796085-7	SJ000796085	7	MOABOX:2518	WJUNQSYQHHIVFX-UHFFFAOYSA-N	CCNC(=O)c1cc2c(-c3cc(OCCN4CCCC4)c(Cl)cc3Cl)nc(N)nc2s1	847559-80-2	Heat Shock Protein 90 (hsp90) Inhibitors	HSP90AA1	HSP90B1																															7184																															CHEMBL563327											25210273					member																																																																																																																																																																21838681	22112537																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.69432	0.56																															0.08679	0.08																															8	7																															HY-10942	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Metabolic Enzyme/Protease | Research Area: Cancer | DISSOLVED IN H2O|MOABOX:2518|HSP90AA1|Heat Shock Protein 90 (hsp90) Inhibitors	CCNC(=O)c1cc2c(nc(N)nc2s1)c3cc(OCCN4CCCC4)c(Cl)cc3Cl	847559-80-2	21397	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469748	480.41062	NVP-BEP800	NVP-BEP800 | VER-82576 | NVP-BEP800 | VER-82576	Pathway: Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:2518	HSP90AA1	
SJ001035130-1	SJ001035130	1	MOABOX:2528	ZXGGCBQORXDVTE-UMCMBGNQSA-N	N#Cc1ccc(COC[C@H]2O[C@@H](n3c(NCc4ccc(Cl)c(Cl)c4)nc4c(N)ncnc43)[C@H](O)[C@@H]2O)cc1	1134156-31-2	Heat Shock Protein 70 (hsp70) Inhibitors	HSPA2																																																															CHEMBL470334											25195348					member																																																																																																																																																																19256508	20608738	21526763	21838681																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.30422																																0.04346																																7																																HY-10941	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease | Research Area: Neurological Disease; Cancer|MOABOX:2528|HSPA2|Heat Shock Protein 70 (hsp70) Inhibitors	Nc1ncnc2c1nc(NCc3ccc(Cl)c(Cl)c3)n2[C@@H]4O[C@H](COCc5ccc(cc5)C#N)[C@@H](O)[C@H]4O	1134156-31-2	16576	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468792	556.40062	VER-155008	VER-155008 | VER-155008	Pathway: Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Research Area: Neurological Disease; Cancer	MOABOX:2528	HSPA2	Heat Shock Protein 70 (hsp70) Inhibitors
SJ000988692-3	SJ000988692	3	MOABOX:2536	CEIJFEGBUDEYSX-FZDBZEDMSA-N	O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2ncccn2)CC1	112457-95-1	5-HT1A Receptor Agonists	HTR1A																																																															CHEMBL1628275	CHEMBL2103888	CHEMBL274047									60558	91273	11377383	13422623	66691501	member	10.1016/S0014-2999(98)00483-X																																																																																																																																																															11354362	17897004	21087971	21467172																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.37576																																0.17197																																8																																HY-B0061	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2536|HTR1A|5-HT1A Receptor Agonists	O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN4CCN(CC4)c5ncccn5	112457-95-1	80128	GENERAL	CITRATE	1	NO_SOLVATE	0	1468762	383.48726	TANDOSPIRONE CITRATE | SM-3997 CITRATE	"""TANDOSPIRONE CITRATE | SM-3997 CITRATE"" | ""TANDOSPIRONE CITRATE | SM-3997 CITRATE"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2536	HTR1A	5-HT1A Receptor Agonists
SJ000126675-10	SJ000126675	10	MOABOX:2538	QWCRAEMEVRGPNT-UHFFFAOYSA-N	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1	116753-41-4	5-HT1A Receptor Agonists;ADRA1B partial agonist	ADRA1B	HTR1A																															3350																															CHEMBL1200399	CHEMBL49										2477	36431	9871873	9872896	9876428	virtual	10.1016/S0014-2999(98)00483-X	10.1016/j.bmcl.2004.01.045	10.1016/j.bmcl.2008.12.087	10.1021/jm0508641	10.1111/jphp.12762	10.1124/jpet.114.213793																																																																																																																																																										1348089	7731013	8101876	9083484	11354671	11472239	11945120	15026055	16029144	16677812	16722631	17897004	19147349	19754201	19854053	20041669	21486038	23544602	23787101	24691057	25435254	26900658	27753488	28435524	28850227	29425815	29439902	29748476	30282913	30721053	30904783																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							-0.15088	2.288																															-0.01886	0.286																															8	8																															PHAR046334	PHARMEKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-733-642|MOABOX:2538|ADRA1B|5-HT1A Receptor Agonists;ADRA1B partial agonist	O=C1CC2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)c4ncccn4	116753-41-4	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468550	385.50314	BUSPIRONE HYDROCHLORIDE	"BUSPIRONE HYDROCHLORIDE | ""BUSPIRONE HYDROCHLORIDE | BUSPAR"" | BUSPIRONE HCL | BUSPIRONE HYDROCHLORIDE | ""BUSPIRONE HYDROCHLORIDE | BUSPAR"" | BUSPIRONE HCL"			MOABOX:2538	ADRA1B	5-HT1A Receptor Agonists;ADRA1B partial agonist
SJ000833141-3	SJ000833141	3	MOABOX:2542	KRVMLPUDAOWOGN-UHFFFAOYSA-N	COc1ccc2[nH]cc(C3=CCNCC3)c2c1	107008-28-6	5-HT1A Receptor Agonists;5-HT1B Agonists	HTR1A	HTR1B																															3351																															CHEMBL18785											108028	108029	3050530	21152573	126455905	virtual	10.1007/BF00168751	10.1016/0006-2952(93)90073-6	10.1016/S0014-2999(98)00483-X																																																																																																																																																													1359584	10471417	16029144																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.764	0.65624																															0.0955	0.08203																															8	8																															HY-16688	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2542|HTR1A|5-HT1A Receptor Agonists;5-HT1B Agonists	COc1ccc2[nH]cc(C3=CCNCC3)c2c1	66611-26-5	21494	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469418	228.28964	RU 24969 HEMISUCCINATE	RU 24969 HEMISUCCINATE | RU 24969 HEMISUCCINATE	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2542	HTR1A	5-HT1A Receptor Agonists;5-HT1B Agonists
SJ000312325-8	SJ000312325	8	MOABOX:2548	CEUORZQYGODEFX-UHFFFAOYSA-N	O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1	1026778-41-5	Dopamine D2 Receptor Partial Agonists;5-HT1A Receptor Partial Agonists;ADRA1B gene inhibitor;HTR2A gene inhibitor	ADRA1B	DRD2	HTR1A	HTR2A	SRC																												1813	3350	3356	6714																												CHEMBL1112											60795	9875507	11377780	11408688	11454446	member	10.1016/S0014-2999(02)01532-7	10.1016/j.bcp.2005.11.007	10.1016/j.bmcl.2012.11.023	10.1021/acs.jmedchem.6b01208	10.1124/jpet.102.033175	10.1124/jpet.109.160432	10.1124/jpet.114.213793	10.1124/jpet.114.220293																																																																																																																																																								12065741	15180482	16336943	16613551	16918396	16921389	17242925	17266201	17880057	18537627	20155917	20166946	20481570	20637635	20801650	21353774	21536445	21823597	22025698	22845053	23157637	23237836	23279866	23544602	24295064	24697360	24827597	24831693	25343529	25826710	26227779	26299826	27173799	27312422	27805392	28248104	28300398	28489379	28870802	29395980																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														-0.25712	3.0628	2.33104	0.5528	0																												-0.03214	0.38285	0.29138	0.0691	0.0																												8	8	8	8	7																												KS-1030	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466710	448.38538	ARIPIPRAZOLE	"ARIPIPRAZOLE | ARIPIPRAZOLE| ABILIFY | ""ARIPIPRAZOLE | 7-(4-(4-(2,3-DICHLOROPHENYL)PIPERAZIN-1-YL)BUTOXY)-3,4-DIHYDROQUINOLIN-2(1H)-ONE | ARIPIPRAZOLE| ABILIFY"" | ARIPIPRAZOLE | ARIPIPRAZOLE| ABILIFY | ""ARIPIPRAZOLE | 7-(4-(4-(2,3-DICHLOROPHENYL)PIPERAZIN-1-YL)BUTOXY)-3,4-DIHYDROQUINOLIN-2(1H)-ONE | ARIPIPRAZOLE| ABILIFY"""			MOABOX:2548	ADRA1B	Dopamine D2 Receptor Partial Agonists;5-HT1A Receptor Partial Agonists;ADRA1B gene inhibitor;HTR2A gene inhibitor
SJ001034876-1	SJ001034876	1	MOABOX:2552	HGEYJZMMUGWEOT-UHFFFAOYSA-N	Oc1ccc2[nH]cc(CCCCN3CC=C(c4ccccc4)CC3)c2c1	108050-82-4	Dopamine Autoreceptor Agonists	HTR1A	PRL	SLC6A4																														5617	6532																														CHEMBL431367											219050	3035894	9886286	69503370	145859086	member	10.1021/jm040792y																																																																																																																																																															2565817	10431754	20022748																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.6736	0	0.3876																														0.0842	0.0	0.04845																														8	7	8																														1559	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-674|MOABOX:2552|HTR1A|Dopamine Autoreceptor Agonists	Oc1ccc2[nH]cc(CCCCN3CCC(=CC3)c4ccccc4)c2c1	108050-82-4	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468168	346.46534	ROXINDOLE HCL	ROXINDOLE HCL | ROXINDOLE HCL			MOABOX:2552	HTR1A	Dopamine Autoreceptor Agonists
SJ000287778-5	SJ000287778	5	MOABOX:2556	LXFHSCDLMBZYKY-UHFFFAOYSA-N	CN1CCN(c2nc3cc(C(F)(F)F)ccc3n3cccc23)CC1	109028-09-3	5-HT1B Agonists	HTR1B																																																															CHEMBL1256689	CHEMBL27403										2689	123945	6438352	9915956	10070972	member	10.1007/BF00168751																																																																																																																																																															3496228																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.62392																																0.07799																																8																																30623	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-724|MOABOX:2556|HTR1B|5-HT1B Agonists	CN1CCN(CC1)c2nc3cc(ccc3n4cccc24)C(F)(F)F	109028-10-6	NA	GENERAL	MALEATE	1	NO_SOLVATE	0	1468331	334.33889	CGS-12066A MALEATE	CGS-12066A MALEATE | CGS 12066B DIMALEATE | CGS-12066A MALEATE | CGS 12066B DIMALEATE			MOABOX:2556	HTR1B	5-HT1B Agonists
SJ001035066-1	SJ001035066	1	MOABOX:2558	QNLSCNDZNSALTM-OYRHEFFESA-N	COc1cc2c(cc1N1C[C@H](C)N[C@H](C)C1)N(C(=O)c1ccc(-c3ccc(-c4noc(C)n4)cc3C)cc1)CC2	332397-72-5	5-HT1B Antagonists	HTR1B																																																															CHEMBL196666											11591924	11685613				member																																																																																																																																																																16153839	16546225																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.25176																																0.15647																																8																																CS-6686	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-418-420|MOABOX:2558|HTR1B|5-HT1B Antagonists	COc1cc2CCN(C(=O)c3ccc(cc3)c4ccc(cc4C)c5noc(C)n5)c2cc1N6C[C@@H](C)N[C@@H](C)C6	908601-49-0	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468574	537.652	SB-616234-A	SB-616234-A | SB-616234-A			MOABOX:2558	HTR1B	5-HT1B Antagonists
SJ000312337-9	SJ000312337	9	MOABOX:2562	KQKPFRSPSRPDEB-UHFFFAOYSA-N	CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1	103628-46-2	5-HT1B Agonists;5-HT1D Agonists	HTR1B	HTR1D	HTR1F																														3352	3355																														CHEMBL1201150	CHEMBL128										5358	59772	9806872	9808656	9850468	member	10.1007/BF00167231	10.1007/BF00168751	10.1007/BF00178713	10.1007/PL00005058	10.1016/0014-2999(95)00876-4	10.1016/0960-894X(95)00091-7	10.1016/S0014-2999(00)00876-1	10.1016/S0223-5234(97)87539-3	10.1016/S0960-894X(98)00090-0	10.1016/j.bmcl.2003.09.025	10.1016/j.bmcl.2012.05.074	10.1021/jm0155190	10.1021/jm960552l	10.1021/jm9704558	10.1021/jm9704560	10.1021/jm9805687	10.1021/jm980569z	10.1021/jm9805945	10.1021/jm9910021	10.1038/sj.bjp.0701766	10.1073/pnas.89.8.3630	10.1111/bph.14547																																																																																																																																										1359584	1663621	7658447	7752204	8040078	8071931	8568822	8941384	8960551	9357514	9357515	9525090	9632349	9632357	9801818	9871581	9986723	10052975	10052976	10585208	10853656	10937729	11262079	11310595	11708905	14505640	14643336	14741277	16880765	18507369	20235265	21422162	29570292																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.73072	4.47928	-0.11784																														0.09134	0.55991	-0.01473																														8	8	8																														HY-B0121	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2562|HTR1B|5-HT1B Agonists;5-HT1D Agonists	CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1	103628-48-4	13900	GENERAL	SUCCINATE	1	NO_SOLVATE	0	1469359	295.40044	SUMATRIPTAN SUCCINATE	"SUMATRIPTAN SUCCINATE | SUMATRIPTAN SUCCINATE| IMITREX | ""SUMATRIPTAN SUCCINATE | 1-(3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-5-YL)-N-METHYLMETHANESULFONAMIDE | SUMATRIPTAN SUCCINATE| IMITREX"" | SUMATRIPTAN SUCCINATE | SUMATRIPTAN SUCCINATE| IMITREX | ""SUMATRIPTAN SUCCINATE | 1-(3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-5-YL)-N-METHYLMETHANESULFONAMIDE | SUMATRIPTAN SUCCINATE| IMITREX"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2562	HTR1B	5-HT1B Agonists;5-HT1D Agonists
SJ001035105-1	SJ001035105	1	MOABOX:2564	QUSLYAPLTMMCFE-UHFFFAOYSA-N	CC(C)N1Cc2cc(S(C)(=O)=O)ccc2N(CCN2CC=C(c3c[nH]c4cc(F)ccc34)CC2)S1(=O)=O	271780-64-4	5-HT1B Antagonists;5-HT1D Antagonists;5-HT2A Antagonists;5-HT2B Antagonists;5-HT Reuptake Inhibitors	HTR1B	HTR1D	HTR2A	HTR2B																													3352	3356	3357																																								10347428					virtual																																																																																																																																																																18691129																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0.7472	-0.17688																													0.0	0.0	0.0934	-0.02211																													7	7	8	8																													32775	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-769|MOABOX:2564|HTR1B|5-HT1B Antagonists;5-HT1D Antagonists;5-HT2A Antagonists;5-HT2B Antagonists;5-HT Reuptake Inhibitors	CC(C)N1Cc2cc(ccc2N(CCN3CCC(=CC3)c4c[nH]c5cc(F)ccc45)S1(=O)=O)S(=O)(=O)C	271780-64-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468696	546.67714	LY393558	LY393558 | LY393558			MOABOX:2564	HTR1B	5-HT1B Antagonists;5-HT1D Antagonists;5-HT2A Antagonists;5-HT2B Antagonists;5-HT Reuptake Inhibitors
SJ001033528-2	SJ001033528	2	MOABOX:2574	AXKPFOAXAHJUAG-UHFFFAOYSA-N	NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1	1893-33-0	5-HT2 Antagonists;Dopamine D2 Antagonists	HTR1E	HTR1F																															3355																															CHEMBL2361301	CHEMBL440294										4830	3046521	11705034	18533582	20200028	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-2.87e-003	-2.87e-003																															-0.00041	-0.00041																															7	7																															KS-1380	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-114-372|MOABOX:2574|HTR1E|5-HT2 Antagonists;Dopamine D2 Antagonists	NC(=O)C1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)N3CCCCC3	2448-68-2	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468289	375.4802	PIPAMPERONE; FLOROPIPAMIDE; MCN-JR 3345; R 3345	PIPAMPERONE; FLOROPIPAMIDE; MCN-JR 3345; R 3345 | PIPAMPERONE; FLOROPIPAMIDE; MCN-JR 3345; R 3345			MOABOX:2574	HTR1E	5-HT2 Antagonists;Dopamine D2 Antagonists
SJ000288230-5	SJ000288230	5	MOABOX:2578	VNICFCQJUVFULD-UHFFFAOYSA-N	c1ccc2c(N3CCNCC3)cccc2c1	104113-71-5		HTR1E	HTR1F																															3355																															CHEMBL1256192	CHEMBL277120										1342	2737391	6446344	20840429	44119130	virtual	10.1007/BF00167231																																																																																																																																																															3543362																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.14805	0.8928																															0.02115	0.1116																															7	8																															AT-057/41429159	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-344-189|MOABOX:2578|HTR1E|	C1CN(CCN1)c2cccc3ccccc23	104113-71-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468098	212.29024	1-(1-NAPHTHYL)PIPERAZINE HYDROCHLORIDE	1-(1-NAPHTHYL)PIPERAZINE HYDROCHLORIDE | 1-(1-NAPHTHYL)PIPERAZINE HCL | 1-(1-NAPHTHYL)PIPERAZINE HYDROCHLORIDE | 1-(1-NAPHTHYL)PIPERAZINE HCL			MOABOX:2578	HTR1E	
SJ000285363-8	SJ000285363	8	MOABOX:2580	RLJFTICUTYVZDG-UHFFFAOYSA-N	CSc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2	19728-88-2		HTR1E	HTR1F																															3355																															CHEMBL1256737	CHEMBL1358918	CHEMBL93240									4106	323077	3039995	5358812	6510954	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.14847	-0.50141																															-0.02121	-0.07163																															7	7																															HY-107836	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2580|HTR1E|	CSc1ccc2Sc3ccccc3CC(N4CCN(C)CC4)c2c1	74611-28-2	89401	GENERAL	METHANESULFONATE	1	NO_SOLVATE	0	1469189	356.54796	METHIOTHEPIN MALEATE	METHIOTHEPIN MALEATE | METHIOTHEPIN MESYLATE | METHIOTHEPIN MALEATE | METHIOTHEPIN MESYLATE	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2580	HTR1E	
SJ000287440-9	SJ000287440	9	MOABOX:2586	QOYHHIBFXOOADH-UHFFFAOYSA-N	O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2	1841-19-6	Dopamine D2 Antagonists	DRD2	HTR1E	HTR1F																														3354	3355																														CHEMBL46516											3396	87563419	89695309	90239285	137523842	virtual																																																																																																																																																																11561089	16613551																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.26992	0	0																														0.15874	0.0	0.0																														8	7	7																														HY-B1655	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2586|DRD2|Dopamine D2 Antagonists	Fc1ccc(cc1)C(CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4)c5ccc(F)cc5	1841-19-6	79039	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469493	475.57275	FLUSPIRILEN	"FLUSPIRILEN | FLUSPIRILENE | ""FLUSPIRILENE | R-6218 | IMAP |"" | FLUSPIRILEN | FLUSPIRILENE | ""FLUSPIRILENE | R-6218 | IMAP |"""	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2586	DRD2	Dopamine D2 Antagonists
SJ000288004-5	SJ000288004	5	MOABOX:2588	LLBLNMUONVVVPG-UHFFFAOYSA-N	OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1	81226-60-0	Dopamine D2 Antagonists	DRD2	HTR1E	HTR1F																														3354	3355																														CHEMBL445102											133633					member	10.1016/j.bmcl.2006.10.076																																																																																																																																																															8642550	16288878	16613551	17095222	18774793	19155177	20542439	20855444	24666157																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3.07336	0	0																														0.38417	0.0	0.0																														8	7	7																														HY-101348	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2588|DRD2|Dopamine D2 Antagonists	OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4	81226-60-0	84655	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469217	340.84654	"L-741,626"	"L-741,626 | L-741,626"	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2588	DRD2	Dopamine D2 Antagonists
SJ000110842-11	SJ000110842	11	MOABOX:2590	QZAYGJVTTNCVMB-UHFFFAOYSA-N	NCCc1c[nH]c2ccc(O)cc12	1094000-36-8	Serotonin receptor agonist	HTR1A	HTR1B	HTR1D	HTR1E	HTR1F	HTR2A	HTR2B	HTR2C	HTR3A	HTR4	HTR5A	HTR6	HTR7	HTR3B	HTR3C	HTR3D	HTR3E																3351	3352	3354	3355	3356	3357	3358	3359	3360	3361	3362	3363	9177	170572	200909	285242																CHEMBL39	CHEMBL535832										5202	160436	164531	202856	245870	member	10.1002/cmdc.201000186	10.1002/cmdc.201000444	10.1002/syn.10157	10.1006/bbrc.1996.0322	10.1007/BF00167231	10.1007/BF00168751	10.1007/BF00178713	10.1007/PL00005058	10.1007/s00213-013-3303-6	10.1007/s00213-018-5055-9	10.1007/s00259-006-0324-y	10.1016/0006-291X(92)90654-4	10.1016/0006-2952(93)90073-6	10.1016/S0014-2999(00)00876-1	10.1016/S0014-2999(98)00483-X	10.1016/S0028-3908(03)00305-8	10.1016/S0960-894X(98)00222-4	10.1016/j.bbr.2017.06.032	10.1016/j.bcp.2005.11.007	10.1016/j.bcp.2006.12.009	10.1016/j.bcp.2018.09.024	10.1016/j.bmc.2007.10.100	10.1016/j.bmc.2012.12.016	10.1016/j.bmc.2013.03.016	10.1016/j.bmc.2013.09.028	10.1016/j.bmcl.2003.05.001	10.1016/j.bmcl.2005.10.029	10.1016/j.bmcl.2006.01.052	10.1016/j.bmcl.2009.07.063	10.1016/j.bmcl.2010.11.080	10.1016/j.bmcl.2018.02.058	10.1016/j.bmcl.2018.03.093	10.1016/j.ejmech.2016.07.029	10.1016/j.ejmech.2018.01.002	10.1016/j.ejmech.2019.111596	10.1016/j.ejphar.2003.10.004	10.1016/j.ejphar.2003.11.019	10.1016/j.ejphar.2007.10.017	10.1016/j.ejphar.2009.03.006	10.1016/j.ejphar.2009.04.035	10.1016/j.ejphar.2011.04.028	10.1016/j.jphs.2019.02.004	10.1016/j.neuropharm.2006.02.002	10.1016/j.pbb.2008.07.015	10.1021/acs.jmedchem.5b01153	10.1021/acs.jmedchem.7b00584	10.1021/acs.jmedchem.8b01096	10.1021/acs.jmedchem.8b01759	10.1021/acschemneuro.6b00439	10.1021/bi00094a032	10.1021/ci400481p	10.1021/cn5001606	10.1021/jm030205t	10.1021/jm050725j	10.1021/jm070574f	10.1021/jm200536d	10.1021/jm5003759	10.1021/jm5019274	10.1021/jm801354e	10.1021/jm8014553	10.1021/jm960552l	10.1021/ml200206z	10.1021/np0205102	10.1021/np050301s	10.1038/sj.bjp.0705058	10.1038/sj.bjp.0707005	10.1073/pnas.89.8.3630	10.1074/jbc.270.28.16683	10.1074/jbc.M200195200	10.1111/bph.14547	10.1111/j.1476-5381.1995.tb16318.x	10.1124/jpet.102.034249	10.1124/jpet.103.049528	10.1124/jpet.106.116657	10.1124/jpet.107.133348	10.1124/jpet.108.141572	10.1124/jpet.110.171892	10.1124/jpet.110.173245	10.1124/jpet.111.179572	10.1124/jpet.111.185306	10.1124/jpet.114.213793	10.1124/jpet.117.239905	10.1124/mol.106.028720	10.1124/mol.109.059204	10.1124/mol.63.1.36	10.1124/mol.64.1.78	10.1371/journal.pone.0209804	10.2174/0929867043455828	10.2174/1568007023339508	10.2174/156802606778249766	10.3390/md17020108	10.3390/md17060377																																																																				1447752	2299641	2374139	2918500	3543362	7658447	8071931	8568822	8960551	9871775	9986723	10715164	11055342	11708905	11975483	12217367	12519065	12713409	12825922	12954071	14613313	15081042	15357994	16257207	16392798	16392816	16458504	17067154	17722904	17803293	18033297	18035544	18095642	18433113	18468904	18507369	18588282	18983139	19223092	19284718	19326916	19334715	19559623	19646865	20041669	20170099	20363635	21146988	21726069	22381048	22738316	22748706	22778800	23301527	23332346	23466604	23582449	23602445	23675993	24161678	24365159	24582985	24763360	24805037	25073094	25128671	25308766	25557493	25583099	25633969	26081758	26988801	26996373	27475109	27487565	27876250	27997171	28657744	28763213																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							1.65816	0.63208	0.94856	3.576e-002	6.52e-002	0.46352	1.36424	2.91896	-0.44704	-0.23064	-0.40016	-0.33192	2.32472	-0.39392	-0.34461	-0.34461	-0.34461																0.20727	0.07901	0.11857	0.00447	0.00815	0.05794	0.17053	0.36487	-0.05588	-0.02883	-0.05002	-0.04149	0.29059	-0.04924	-0.04923	-0.04923	-0.04923																8	8	8	8	8	8	8	8	8	8	8	8	8	8	7	7	7																AG00HY3J	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-933-638|MOABOX:2590|HTR1A|Serotonin receptor agonist	NCCc1c[nH]c2ccc(O)cc12	153-98-0	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468628	176.21508	SEROTONIN HYDROCHLORIDE	SEROTONIN HYDROCHLORIDE | SEROTONIN HCL | SEROTONIN HYDROCHLORIDE | SEROTONIN HCL			MOABOX:2590	HTR1A	Serotonin receptor agonist
SJ000288042-5	SJ000288042	5	MOABOX:2592	WYWNEDARFVJQSG-UHFFFAOYSA-N	Cc1[nH]c2ccc(O)cc2c1CCN	78263-90-8		HTR1F																																																															CHEMBL1491258	CHEMBL266591										1574	9836150	11492320	22227344	25162977	virtual																																																																																																																																																																21422162																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.56427																																0.08061																																7																																HY-19358	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2592|HTR1F|	Cc1[nH]c2ccc(O)cc2c1CCN	78263-90-8	48246	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469010	190.24166	2-METHYL-5-HYDROXYTRYPTAMINE MALEATE	2-METHYL-5-HYDROXYTRYPTAMINE MALEATE | 2-METHYLSEROTONIN HCL | 2-METHYL-5-HYDROXYTRYPTAMINE MALEATE | 2-METHYLSEROTONIN HCL	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2592	HTR1F	
SJ000312340-10	SJ000312340	10	MOABOX:2600	RONZAEMNMFQXRA-UHFFFAOYSA-N	CN1CCN2c3ncccc3Cc3ccccc3C2C1	207516-99-2	5-HT2A Antagonists;5-HT3 Antagonists;alpha2-Adrenoceptor Antagonists	HTR2A																																																															CHEMBL654											4205	9818488	9826047	9882242	9884236	member																																																																																																																																																																15771415	16517171	18673166	20922744																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.82136																																0.10267																																8																																KS-1086	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CN1CCN2C(C1)c3ccccc3Cc4cccnc24	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466706	265.35286	MIRTAZAPINE	"MIRTAZAPINE | ZISPIN | REMERON | ""MIRTAZAPINE|REMERON|ZISPIN | 2-METHYL-1,2,3,4,10,14B-HEXAHYDROBENZO[C]PYRAZINO[1,2-A]PYRIDO[3,2-F]AZEPINE | MIRTAZAPINE | MIRTAZEPINE"" | MIRTAZAPINE | ZISPIN | REMERON | ""MIRTAZAPINE|REMERON|ZISPIN | 2-METHYL-1,2,3,4,10,14B-HEXAHYDROBENZO[C]PYRAZINO[1,2-A]PYRIDO[3,2-F]AZEPINE | MIRTAZAPINE | MIRTAZEPINE"""			MOABOX:2600	HTR2A	5-HT2A Antagonists;5-HT3 Antagonists;alpha2-Adrenoceptor Antagonists
SJ000285983-10	SJ000285983	10	MOABOX:2602	FPCCSQOGAWCVBH-UHFFFAOYSA-N	O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1	74050-98-9	5-HT2 Antagonists	HTR2A																																																															CHEMBL1256709	CHEMBL1724541	CHEMBL2062337	CHEMBL51								3822	135348	6420005	6604164	6604580	member	10.1002/cmdc.201800199	10.1016/S0028-3908(03)00305-8	10.1016/j.bmc.2010.07.034	10.1016/j.bmc.2013.03.016	10.1016/j.bmcl.2018.03.093	10.1016/j.ejmech.2013.02.020	10.1016/j.ejphar.2009.03.006	10.1016/j.ejphar.2017.10.053	10.1016/j.neuropharm.2006.02.002	10.1016/j.physbeh.2013.05.042	10.1021/acs.jmedchem.8b01759	10.1021/acschemneuro.8b00637	10.1021/cn5001606	10.1021/jm200536d	10.1038/sj.bjp.0707005	10.1124/jpet.108.141572	10.1124/jpet.110.173245	10.1124/mol.64.5.1239	10.1248/cpb.48.245	10.1248/cpb.48.623	10.2174/1568007023339508																																																																																																																																											9525090	11512275	11642330	11738486	12052193	12052195	12446043	12769637	16722655	17220913	17763374	18588282	18847250	18983139	19328689	20621490	20855444	20875743	21084390	21366526	21558436	21726069	21777010	22694093	23023262	23301527	23466604	23537943	23582449	23675993	24805037	25557493	26348247	26475518	26988801	27876250	27997171	28106992	28471663	28947942	29631962	30240563	30383372	30810314	31112891																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									1.50648																																0.18831																																8																																HY-10562	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2602|HTR2A|5-HT2 Antagonists	Fc1ccc(cc1)C(=O)C2CCN(CCN3C(=O)Nc4ccccc4C3=O)CC2	74050-98-9	58975	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469734	395.42678	KETANSERIN	KETANSERIN | KETANSERIN TARTRATE HYDRATE | KETANSERIN TARTRATE  | KETANSERIN | KETANSERIN TARTRATE HYDRATE | KETANSERIN TARTRATE 	Pathway: Autophagy; GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2602	HTR2A	5-HT2 Antagonists
SJ000312344-6	SJ000312344	6	MOABOX:2604	VRBKIVRKKCLPHA-UHFFFAOYSA-N	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	82752-99-6	5-HT2A Antagonists;5-HT Reuptake Inhibitors;ADRA1B gene modulator	ADRA1B	HTR2A																															3356																															CHEMBL1200492	CHEMBL623										4449	54911	9872051	9873574	9894172	virtual																																																																																																																																																																14683466	15180481	20637635	21823597																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.37672	1.31568																															0.04709	0.16446																															8	8																															HY-B1396	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease; Endocrinology|MOABOX:2604|ADRA1B|5-HT2A Antagonists;5-HT Reuptake Inhibitors;ADRA1B gene modulator	CCC1=NN(CCCN2CCN(CC2)c3cccc(Cl)c3)C(=O)N1CCOc4ccccc4	82752-99-6	17538	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469346	470.00688	NEFAZODONE	"NEFAZODONE | NEFAZODONE HYDROCHLORIDE | ""NEFAZODONE | 1-(3-(4-(3-CHLOROPHENYL)PIPERAZIN-1-YL)PROPYL)-3-ETHYL-4-(2-PHENOXYETHYL)-1H-1,2,4-TRIAZOL-5(4H)-ONE | NEFAZODONE HYDROCHLORIDE"" | NEFAZODONE | NEFAZODONE HYDROCHLORIDE | ""NEFAZODONE | 1-(3-(4-(3-CHLOROPHENYL)PIPERAZIN-1-YL)PROPYL)-3-ETHYL-4-(2-PHENOXYETHYL)-1H-1,2,4-TRIAZOL-5(4H)-ONE | NEFAZODONE HYDROCHLORIDE"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease; Endocrinology	MOABOX:2604	ADRA1B	5-HT2A Antagonists;5-HT Reuptake Inhibitors;ADRA1B gene modulator
SJ000312342-9	SJ000312342	9	MOABOX:2612	KVWDHTXUZHCGIO-UHFFFAOYSA-N	Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1	132539-06-1	Dopamine D2 Antagonists;5-HT2A Inverse Agonist;ADRA1B gene inhibitor	ADRA1B	CHRM5	DRD2	HTR2A																													1133	1813	3356																													CHEMBL715											135398745	135422991	135430168	135446207	135456013	virtual	10.1016/j.bcp.2005.11.007	10.1124/jpet.109.160432																																																																																																																																																														8822531	8831770	10087034	10192829	10464021	10604931	11170639	11171942	11259537	11561089	11945123	12021408	12490615	14998318	15180482	15771415	16336943	17880057	18537627	18595716	19836247	20155917	20166946	20481570	21366526	22680630	22926225	23410162	23466228	24559051	24631727	24805037	25070422	25343529	26227779	26900658	28435524	29425815	29748476	30282913	30703658	30904783																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												2.81664	0.1728	-4.632e-002	0.3776																													0.35208	0.0216	-0.00579	0.0472																													8	8	8	8																													HY-14541	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease; Cancer|MOABOX:2612|ADRA1B|Dopamine D2 Antagonists;5-HT2A Inverse Agonist;ADRA1B gene inhibitor	CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24	132539-06-1	8959	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469320	312.4325	OLANZAPINE	"OLANZAPINE | ""OLANZAPINE| ZYPREXA | (E)-2-METHYL-4-(4-METHYLPIPERAZIN-1-YL)-10H-BENZO[B]THIENO[2,3-E][1,4]DIAZEPINE"" | OLANZAPINE | OLANZAPINE | ""OLANZAPINE| ZYPREXA | (E)-2-METHYL-4-(4-METHYLPIPERAZIN-1-YL)-10H-BENZO[B]THIENO[2,3-E][1,4]DIAZEPINE"""	Pathway: Apoptosis; Autophagy; GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease; Cancer	MOABOX:2612	ADRA1B	Dopamine D2 Antagonists;5-HT2A Inverse Agonist;ADRA1B gene inhibitor
SJ000833148-3	SJ000833148	3	MOABOX:2616	JNNOSTQEZICQQP-UHFFFAOYSA-N	Clc1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2	6104-71-8	Muscarinic M1 Agonists;5-HT2A Inverse Agonists;Dopamine D3 Partial Agonists;Dopamine D2 Receptor Partial Agonists	CHRM1	DRD2	DRD3	HTR2A																													1813	1814	3356																													CHEMBL845											135409468	143453801	145190567	145791947		member	10.1016/j.ejphar.2011.07.020	10.1021/jm100697g	10.1073/pnas.1835612100																																																																																																																																																													20684563	22329602																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.1516	0	-0.14736	0																													0.14395	0.0	-0.01842	0.0																													8	8	8	8																													HY-G0021	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Infection|MOABOX:2616|CHRM1|Muscarinic M1 Agonists;5-HT2A Inverse Agonists;Dopamine D3 Partial Agonists;Dopamine D2 Receptor Partial Agonists	Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCNCC4	6104-71-8	22854	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469271	312.79668	N-DESMETHYLCLOZAPINE	N-DESMETHYLCLOZAPINE | N-DESMETHYLCLOZAPINE	Pathway: Anti-infection; GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Infection	MOABOX:2616	CHRM1	Muscarinic M1 Agonists;5-HT2A Inverse Agonists;Dopamine D3 Partial Agonists;Dopamine D2 Receptor Partial Agonists
SJ001035019-1	SJ001035019	1	MOABOX:2618	VGIGHGMPMUCLIQ-UHFFFAOYSA-N	O=S1(=O)c2cccc3cccc(c23)N1CCCN1CCN(c2ccc(F)cc2)CC1	127625-29-0	Dopamine D4 Antagonists;5-HT2A Antagonists	DRD4	HTR2A																															3356																															CHEMBL83894											60785	69562800				member																																																																																																																																																																1596688	8957240	9223553	11170639	11784153	16168646	16256354	21366526	23544602	31253535																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												-0.23952	1.02416																															-0.02994	0.12802																															8	8																															CS-0024310	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-525|MOABOX:2618|DRD4|Dopamine D4 Antagonists;5-HT2A Antagonists	Fc1ccc(cc1)N2CCN(CCCN3c4cccc5cccc(c45)S3(=O)=O)CC2	127625-29-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468489	425.51896	FANANSERIN	FANANSERIN | FANANSERIN			MOABOX:2618	DRD4	Dopamine D4 Antagonists;5-HT2A Antagonists
SJ000287449-5	SJ000287449	5	MOABOX:2620	JOAHPSVPXZTVEP-YXJHDRRASA-N	CCN(CC)C(=O)N[C@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1	106347-60-8	5-HT2A Antagonists;5-HT2B Antagonists;Prolactin Secretion Inhibitors	DRD2	HTR2A	HTR2B	PRL																													3356	3357	5617																													CHEMBL73151											443951	9896187	20839521	21154252	69445599	member	10.1016/S0968-0896(02)00214-6																																																																																																																																																															22697513																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.93568	-0.54072	-0.564	0																													0.11696	-0.06759	-0.0705	0.0																													8	8	8	7																													KS-1464	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCN(CC)C(=O)N[C@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466656	340.46252	S(-)-TERGURIDE HYDROGEN MALEATE	S(-)-TERGURIDE HYDROGEN MALEATE | R(+)-TERGURIDE | S(-)-TERGURIDE HYDROGEN MALEATE | R(+)-TERGURIDE			MOABOX:2620	DRD2	5-HT2A Antagonists;5-HT2B Antagonists;Prolactin Secretion Inhibitors
SJ000286121-11	SJ000286121	11	MOABOX:2626	QWGDMFLQWFTERH-UHFFFAOYSA-N	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	14028-44-5	5-HT2A Antagonists;5-HT Reuptake Inhibitors;Norepinephrine Reuptake Inhibitors	HTR2A	SLC6A2	SLC6A4																														6530	6532																														CHEMBL1113											2170	53339189	53339308	67175832	67679995	member																																																																																																																																																																11561089	22268448																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.28744	0.58688	0.44064																														0.16093	0.07336	0.05508																														8	8	8																														HY-B0991	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Neurological Disease|MOABOX:2626|HTR2A|5-HT2A Antagonists;5-HT Reuptake Inhibitors;Norepinephrine Reuptake Inhibitors	Clc1ccc2Oc3ccccc3N=C(N4CCNCC4)c2c1	14028-44-5	26675	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468988	313.78144	AMOXEPINE	AMOXEPINE | AMOXAPINE | AMOXEPINE | AMOXAPINE	Pathway: Others	Research Area: Neurological Disease	MOABOX:2626	HTR2A	5-HT2A Antagonists;5-HT Reuptake Inhibitors;Norepinephrine Reuptake Inhibitors
SJ000855496-3	SJ000855496	3	MOABOX:2628	IENZFHBNCRQMNP-UHFFFAOYSA-N	N#Cc1cc(CN2CCC(Nc3ncnc4sc(Cl)cc34)CC2)ccc1F	866206-54-4	5-HT2B Antagonists	HTR2B																																																															CHEMBL513994											11502243	51348292	51348293	75306359	76972919	member	10.1124/jpet.109.165001																																																																																																																																																															19307114	20166944																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.11152																																0.38894																																8																																HY-15472	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Cardiovascular Disease|MOABOX:2628|HTR2B|5-HT2B Antagonists	Fc1ccc(CN2CCC(CC2)Nc3ncnc4sc(Cl)cc34)cc1C#N	866206-54-4	21414	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468968	401.88818	PRX-08066 MALEIC ACID	PRX-08066 MALEIC ACID | PRX-08066 MALEIC ACID	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Cardiovascular Disease	MOABOX:2628	HTR2B	5-HT2B Antagonists
SJ000147917-2	SJ000147917	2	MOABOX:2632	NBQUWOCIFFHZTM-UHFFFAOYSA-N	N=c1[nH]c(-c2cccc3ccccc23)cs1	56503-96-9	5-HT2B Antagonists	HTR2B																																																																										151342	21845604				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-8.12e-002																																-0.0116																																7																																F0777-0558	LIFE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-147-484|MOABOX:2632|HTR2B|5-HT2B Antagonists	Nc1nc(cs1)c2cccc3ccccc23	56503-96-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468731	226.2969					MOABOX:2632	HTR2B	5-HT2B Antagonists
SJ000287180-13	SJ000287180	13	MOABOX:2634	JJCFRYNCJDLXIK-UHFFFAOYSA-N	CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1	129-03-3	Histamine H1 Receptor Antagonists;5-HT2B Antagonists	HRH1	HTR2B																															3357																															CHEMBL1716	CHEMBL516										2913	13770	481767	657241	6441505	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.51888	0.16																															0.06486	0.02																															8	8																															HY-B0366A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease; Cardiovascular Disease|MOABOX:2634|HRH1|Histamine H1 Receptor Antagonists;5-HT2B Antagonists	CN1CCC(=C2c3ccccc3C=Cc4ccccc24)CC1	969-33-5	16122	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468816	287.39814	CYPROHEPTADINE HYDROCHLORIDE	"CYPROHEPTADINE HYDROCHLORIDE | ""CYPROHEPTADINE HYDROCHLORIDE SESQUIHYDRATE | CYPROHEPTADINE HCL |"" | CYPROHEPTADINE HCL | CYPROHEPTADINE HYDROCHLORIDE | ""CYPROHEPTADINE HYDROCHLORIDE SESQUIHYDRATE | CYPROHEPTADINE HCL |"" | CYPROHEPTADINE HCL"	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease; Cardiovascular Disease	MOABOX:2634	HRH1	Histamine H1 Receptor Antagonists;5-HT2B Antagonists
SJ000833132-2	SJ000833132	2	MOABOX:2638	YASBOGFWAMXINH-JSGCOSHPSA-N	CN1CC[C@H]2CN3CCc4cccc(c43)[C@H]2C1		5-HT2B Antagonists;5-HT2C Antagonists	HTR2B	HTR2C																															3358																																										14988831	131699101				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															1255	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-826|MOABOX:2638|HTR2B|5-HT2B Antagonists;5-HT2C Antagonists	CN1CC[C@@H]2CN3CCc4cccc([C@@H]2C1)c34	1417343-80-6	NA	GENERAL	FUMARATE	1	NO_SOLVATE	0	1468617	228.3327	SDZ SER 082 FUMARATE	SDZ SER 082 FUMARATE | SDZ SER 082 FUMARATE			MOABOX:2638	HTR2B	5-HT2B Antagonists;5-HT2C Antagonists
SJ001034824-1	SJ001034824	1	MOABOX:2642	ZJIUEDYXZUIMNV-UHFFFAOYSA-N	Clc1ccc2c(c1)CCNCC2	25174-38-3	5-HT2C Agonists	HTR2C																																																															CHEMBL180668											17954203	17954204	144956467	144971501	144971505	member	10.1016/j.bmcl.2004.12.080	10.1021/jm058240i																																																																																																																																																														15713408	16821762	18095642																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.47112																																0.30889																																8																																EN300-1581427	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-024-812|MOABOX:2642|HTR2C|5-HT2C Agonists	Clc1ccc2CCNCCc2c1	23166-82-7	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468065	181.66198	EN300-1581427	EN300-1581427 | EN300-1581427			MOABOX:2642	HTR2C	5-HT2C Agonists
SJ000855139-5	SJ000855139	5	MOABOX:2646	YJYPHIXNFHFHND-UHFFFAOYSA-N	COc1ccc2cccc(CCNC(C)=O)c2c1	1176316-99-6	melatonergic antidepressant;5-HT2C Antagonists;Melatonin MT1 Agonists;Melatonin MT2 Agonists	HTR2C	MTNR1A	MTNR1B																														4543	4544																														CHEMBL10878											82148	15984005	24759802	53373578	53373579	member	10.1016/j.ejmech.2017.10.025																																																																																																																																																															7932550	11063602	12646022	12750432	14683466	18384758	18673165	18778943	20444610	21476953	22301214	22680635	22709004	23265885	24228714	25528336	26820449	28131094	29102176																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			-0.91504	1.10632	1.8996																														-0.11438	0.13829	0.23745																														8	8	8																														HY-17038A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2646|HTR2C|melatonergic antidepressant;5-HT2C Antagonists;Melatonin MT1 Agonists;Melatonin MT2 Agonists	COc1ccc2cccc(CCNC(=O)C)c2c1	1176316-99-6	32072	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468797	243.30098	AGOMELATINE	AGOMELATINE | AGOMELATINE	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2646	HTR2C	melatonergic antidepressant;5-HT2C Antagonists;Melatonin MT1 Agonists;Melatonin MT2 Agonists
SJ000518941-5	SJ000518941	5	MOABOX:2648	CPZBLNMUGSZIPR-NVXWUHKLSA-N	O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2	1021481-16-2	5-HT3 Antagonists	HTR3A																																																															CHEMBL1189679	CHEMBL1720										6337614	6918303	44206764	44206765	44322545	member	10.1016/j.bmc.2013.09.028	10.1111/bph.12204																																																																																																																																																														20724042	24128813																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.82744																																0.35343																																8																																AS-75066	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-005-932-622|MOABOX:2648|HTR3A|5-HT3 Antagonists	O=C1N(C[C@H]2CCCc3cccc1c23)[C@@H]4CN5CCC4CC5	135729-62-3	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468242	296.40666	PALONOSETRON HYDROCHLORIDE	PALONOSETRON HYDROCHLORIDE | PALONOSETRON HYDROCHLORIDE| ALOXI | PALONOSETRON HYDROCHLORIDE | PALONOSETRON HYDROCHLORIDE| ALOXI			MOABOX:2648	HTR3A	5-HT3 Antagonists
SJ000287533-10	SJ000287533	10	MOABOX:2652	FELGMEQIXOGIFQ-UHFFFAOYSA-N	Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O	103639-04-9	5-HT3 receptor antagonist	HTR3A	HTR3B	HTR3C	HTR3D	HTR3E																												9177	170572	200909	285242																												CHEMBL1201111	CHEMBL1487310	CHEMBL3186492	CHEMBL46								4595	59774	68647	2828191	9799259	member	10.1021/jm101459g	10.1124/mol.106.032144																																																																																																																																																														1359584	2145434	2213824	2342053	8230119	8246239	9341912	9918193	11212100	15450944	20889341	21486038																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										1.22976	0.4172	0.4172	0.4172	0.4172																												0.15372	0.05215	0.05215	0.05215	0.05215																												8	8	8	8	8																												HY-B0002B	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2652|HTR3A|5-HT3 receptor antagonist	Cc1nccn1CC2CCc3c(C2=O)c4ccccc4n3C	99614-02-5	16985	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469496	293.36296	ONDANSETRON HYDROCHLORIDE	ONDANSETRON HYDROCHLORIDE | ONDANSETRON | ONDANSETRON HCL | ONDANSETRON HYDROCHLORIDE | ONDANSETRON | ONDANSETRON HCL	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2652	HTR3A	5-HT3 receptor antagonist
SJ001035063-1	SJ001035063	1	MOABOX:2658	PXNBOFBSFXZTES-UHFFFAOYSA-N	N=C(N)Nc1cc(Cl)cc(Cl)c1	46113-33-1	5-HT3 Receptor agonist ligands	HTR3B	HTR3C	HTR3D	HTR3E																													170572	200909	285242																													CHEMBL288055											12253688	12253689	75525945			virtual																																																																																																																																																																11412989	13129581																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.53336	0.53336	0.53336	0.53336																													0.06667	0.06667	0.06667	0.06667																													8	8	8	8																													EN300-177414	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-029-939-558|MOABOX:2658|HTR3B|5-HT3 Receptor agonist ligands	NC(=N)Nc1cc(Cl)cc(Cl)c1	76635-15-9	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468570	204.05658	EN300-177414	EN300-177414 | EN300-177414			MOABOX:2658	HTR3B	5-HT3 Receptor agonist ligands
SJ001035098-1	SJ001035098	1	MOABOX:2660	ZJAWVBLMRPEUPW-UHFFFAOYSA-N	N=C(N)NC(=N)Nc1ccc(Cl)c(Cl)c1	15233-34-8	5-HT3 Receptor agonist;Cell Adhesion Inhibitors	HTR3B	HTR3C	HTR3D	HTR3E																													170572	200909	285242																													CHEMBL41433											151947	293769	2730261	45108627	50938835	virtual																																																																																																																																																																11412989	13129581	17073663																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.76872	0.76872	0.76872	0.76872																													0.09609	0.09609	0.09609	0.09609																													8	8	8	8																													7934027	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-471-492|MOABOX:2660|HTR3B|5-HT3 Receptor agonist;Cell Adhesion Inhibitors	NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1	15233-34-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468685	246.09656	7934027	7934027 | 7934027			MOABOX:2660	HTR3B	5-HT3 Receptor agonist;Cell Adhesion Inhibitors
SJ000518984-6	SJ000518984	6	MOABOX:2664	MFWNKCLOYSRHCJ-UHFFFAOYSA-N	CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2	107007-99-8	5-HT3 receptor antagonist	HTR3A	HTR3B	HTR3C	HTR3D	HTR3E																												9177	170572	200909	285242																												CHEMBL1237080	CHEMBL289469										3510	65264	9946258	57516016		member																																																																																																																																																																2342053	8230119	9341912	9918193	11212100	11472239	20146481	20724042	22189135	24128813																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												0.40064	0.46128	0.3992	0.3992	0.3992																												0.05008	0.05766	0.0499	0.0499	0.0499																												8	8	8	8	8																												HY-B0071A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2664|HTR3A|5-HT3 receptor antagonist	CN1[C@@H]2CCC[C@H]1C[C@H](C2)NC(=O)c3nn(C)c4ccccc34	107007-99-8	11792	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469174	312.40936	GRANISETRON HYDROCHLORIDE	GRANISETRON HYDROCHLORIDE | GRANISETRON HCL | GRANISETRON HYDROCHLORIDE | GRANISETRON HCL	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2664	HTR3A	5-HT3 receptor antagonist
SJ001034867-1	SJ001034867	1	MOABOX:2666	HTYFFCPFVMJTKM-UHFFFAOYSA-N	N=C(N)NC(=N)Nc1ccc(Cl)cc1	4022-81-5	5-HT3 receptor agonist	HTR3B	HTR3C	HTR3D	HTR3E																													170572	200909	285242																													CHEMBL840											19933	225403	458746	25021418	45108638	virtual																																																																																																																																																																8831767	11412989	13129581	17073663																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.59568	0.59568	0.59568	0.59568																													0.07446	0.07446	0.07446	0.07446																													8	8	8	8																													17146	FLUOROCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-759-175|MOABOX:2666|HTR3B|5-HT3 receptor agonist	NC(=N)NC(=N)Nc1ccc(Cl)cc1	4022-81-5	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468122	211.6515	17146	17146 | 17146			MOABOX:2666	HTR3B	5-HT3 receptor agonist
SJ001034900-1	SJ001034900	1	MOABOX:2668	MKWFJPZMYHPQIA-UHFFFAOYSA-N	N=C(N)NC(=N)Nc1ccccc1Cl	137588-53-5	5-HT3 receptor agonist	HTR3B	HTR3C	HTR3D	HTR3E																													170572	200909	285242																													CHEMBL42752											29669	2730222	45108626			virtual																																																																																																																																																																8831767	11412989	13129581	17073663																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.57344	0.57344	0.57344	0.57344																													0.07168	0.07168	0.07168	0.07168																													8	8	8	8																													OR3912	APOLLO_SCI	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-761-258|MOABOX:2668|HTR3B|5-HT3 receptor agonist	NC(=N)NC(=N)Nc1ccccc1Cl	19579-44-3	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468206	211.6515	OR3912	OR3912 | OR3912			MOABOX:2668	HTR3B	5-HT3 receptor agonist
SJ001035069-1	SJ001035069	1	MOABOX:2672	LWLBVIFUVSUSAY-UHFFFAOYSA-N	c1ccc2cc(N3CCNCC3)ccc2c1	104090-87-1	5-HT3 receptor agonist	HTR3B	HTR3C	HTR3D	HTR3E																													170572	200909	285242																													CHEMBL278509											2760171	2760172	6446348	20840433	86719466	virtual																																																																																																																																																																8831767																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.48728	0.48728	0.48728	0.48728																													0.06091	0.06091	0.06091	0.06091																													8	8	8	8																													19970	FLUOROCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-157-701|MOABOX:2672|HTR3B|5-HT3 receptor agonist	C1CN(CCN1)c2ccc3ccccc3c2	57536-91-1	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468577	212.29024	19970	19970 | 19970			MOABOX:2672	HTR3B	5-HT3 receptor agonist
SJ000285381-8	SJ000285381	8	MOABOX:2674	XRXDAJYKGWNHTQ-UHFFFAOYSA-N	c1ccc2nc(N3CCNCC3)ccc2c1	1245646-84-7	5-HT3 receptor agonist selective against 5-HT1B	HTR3B	HTR3C	HTR3D	HTR3E																													170572	200909	285242																													CHEMBL1256794	CHEMBL1315073	CHEMBL18772									5011	22027	5702242	6420043	6507948	member																																																																																																																																																																8831767	9191957	10543880	11472239	12217367	17073663	20166948																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															0.25504	0.25504	0.25504	0.25504																													0.03188	0.03188	0.03188	0.03188																													8	8	8	8																													BD14730	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-006-267|MOABOX:2674|HTR3B|5-HT3 receptor agonist selective against 5-HT1B	C1CN(CCN1)c2ccc3ccccc3n2	4774-24-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468348	213.2783	QUIPAZINE	QUIPAZINE | QUIPAZINE MALEATE | QUIPAZINE DIMALEATE | QUIPAZINE | QUIPAZINE MALEATE | QUIPAZINE DIMALEATE			MOABOX:2674	HTR3B	5-HT3 receptor agonist selective against 5-HT1B
SJ001034985-1	SJ001034985	1	MOABOX:2676	LIIRNJNGOKYCIP-UHFFFAOYSA-N	Cc1ccc(NC(=N)NC(=N)N)cc1Cl	114133-93-6	5-HT3 receptor agonist	HTR3B	HTR3C	HTR3D	HTR3E																													170572	200909	285242																													CHEMBL40190											2730268	2730269	45108640			virtual																																																																																																																																																																8831767	11412989	13129581																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.53336	0.53336	0.53336	0.53336																													0.06667	0.06667	0.06667	0.06667																													8	8	8	8																													7932882	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-471-501|MOABOX:2676|HTR3B|5-HT3 receptor agonist	Cc1ccc(NC(=N)NC(=N)N)cc1Cl	114133-93-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468428	225.67808	7932882	7932882 | 7932882			MOABOX:2676	HTR3B	5-HT3 receptor agonist
SJ001034881-1	SJ001034881	1	MOABOX:2678	RDLIBCPWPNCFBW-UHFFFAOYSA-N	N=C(N)NC(=N)Nc1ccc2ccccc2c1	1215-36-7	5-HT3 receptoe agonist	HTR3B	HTR3C	HTR3D	HTR3E																													170572	200909	285242																													CHEMBL43078											14623	71355859				virtual																																																																																																																																																																8831767	11412989	12217367	13129581																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.60424	0.60424	0.60424	0.60424																													0.07553	0.07553	0.07553	0.07553																													8	8	8	8																													STK102821	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-256-939|MOABOX:2678|HTR3B|5-HT3 receptoe agonist	NC(=N)NC(=N)Nc1ccc2ccccc2c1	1215-36-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468181	227.26512	STK102821	STK102821 | STK102821			MOABOX:2678	HTR3B	5-HT3 receptoe agonist
SJ001034882-1	SJ001034882	1	MOABOX:2680	CFHPNABTZSOBQJ-UHFFFAOYSA-N	Cc1cccc(NC(=N)NC(=N)N)c1	19579-42-1	5-HT3 receptor agonist	HTR3B	HTR3C	HTR3D	HTR3E																													170572	200909	285242																													CHEMBL289319											29667	16246060	130236165			member																																																																																																																																																																8831767	11412989	13129581																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.516	0.516	0.516	0.516																													0.0645	0.0645	0.0645	0.0645																													8	8	8	8																													STK101567	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-471-474|MOABOX:2680|HTR3B|5-HT3 receptor agonist	Cc1cccc(NC(=N)NC(=N)N)c1	19579-42-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468182	191.23302	STK101567	STK101567 | STK101567			MOABOX:2680	HTR3B	5-HT3 receptor agonist
SJ000287784-5	SJ000287784	5	MOABOX:2680	CFHPNABTZSOBQJ-UHFFFAOYSA-N	Cc1cccc(NC(=N)NC(=N)N)c1	19579-42-1	5-HT3 receptor agonist	HTR3B	HTR3C	HTR3D	HTR3E																													170572	200909	285242																													CHEMBL289319											29667	16246060	130236165			member																																																																																																																																																																8831767	11412989	13129581																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.516	0.516	0.516	0.516																													0.0645	0.0645	0.0645	0.0645																													8	8	8	8																													AA002L7B	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-756-912|MOABOX:2680|HTR3B|5-HT3 receptor agonist	NC(=N)NC(=N)Nc1cccc(Cl)c1	2113-05-05	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468642	211.6515	1-(M-CHLOROPHENYL)-BIGUANIDE HYDROCHLORIDE	1-(M-CHLOROPHENYL)-BIGUANIDE HYDROCHLORIDE | M-CHLOROPHENYLBIGUANIDE HCL | 1-(M-CHLOROPHENYL)-BIGUANIDE HYDROCHLORIDE | M-CHLOROPHENYLBIGUANIDE HCL			MOABOX:2680	HTR3B	5-HT3 receptor agonist
SJ001034857-1	SJ001034857	1	MOABOX:2684	WEOIHIYCKWSSBW-UHFFFAOYSA-N	N=C(N)NC(=N)Nc1cccc([N+](=O)[O-])c1	10441-20-0	5-HT3 receptor agonist	HTR3B	HTR3C	HTR3D	HTR3E																													170572	200909	285242																													CHEMBL42538											20882	2730560				virtual																																																																																																																																																																8831767	11412989																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.53336	0.53336	0.53336	0.53336																													0.06667	0.06667	0.06667	0.06667																													8	8	8	8																													PHAR073206	PHARMEKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-471-791|MOABOX:2684|HTR3B|5-HT3 receptor agonist	NC(=N)NC(=N)Nc1cccc(c1)[N+](=O)[O-]	10441-20-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468108	222.204	PHAR073206	PHAR073206 | PHAR073206			MOABOX:2684	HTR3B	5-HT3 receptor agonist
SJ000855367-4	SJ000855367	4	MOABOX:2688	ZPMNHBXQOOVQJL-UHFFFAOYSA-N	COCCCN1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1	179474-80-7	5-HT4 Agonists	HTR4																																																															CHEMBL117287	CHEMBL2105748										3052762	9870009	9931054	11600079	18360799	member	10.1016/j.ejmech.2015.08.051	10.1111/bph.12397																																																																																																																																																														12540230	14965243	17293885	17325649	19261477	20299822	26363507	29763304																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														2.24224																																0.28028																																8																																BD305654	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-020-313-414|MOABOX:2688|HTR4|5-HT4 Agonists	COCCCN1CCC(CC1)NC(=O)c2cc(Cl)c(N)c3CCOc23	179474-85-2	NA	GENERAL	SUCCINATE	1	NO_SOLVATE	0	1468349	367.87034	PRUCALOPRIDE	PRUCALOPRIDE | PRUCALOPRIDE SUCCINAT | PRUCALOPRIDE | PRUCALOPRIDE SUCCINAT			MOABOX:2688	HTR4	5-HT4 Agonists
SJ001034855-1	SJ001034855	1	MOABOX:2692	JBHLYIVFFLNISJ-UHFFFAOYSA-N	CCCCN1CCC(CCC(=O)c2cc(Cl)c(N)cc2OC)CC1	160845-95-4	5-HT4 Partial Agonists	HTR4																																																															CHEMBL85251											183782	9800491	9874494	9876382	71297038	member	10.1016/j.ejmech.2015.08.051																																																																																																																																																															14965243	17293885	20166943	25793650	26363507	29763304																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																2.74376																																0.34297																																8																																989	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-019-879-226|MOABOX:2692|HTR4|5-HT4 Partial Agonists	CCCCN1CCC(CCC(=O)c2cc(Cl)c(N)cc2OC)CC1	168986-60-5	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468106	352.89876	RS 67333 HCL	RS 67333 HCL | RS 67333 HCL			MOABOX:2692	HTR4	5-HT4 Partial Agonists
SJ000534456-3	SJ000534456	3	MOABOX:2700	JNODQFNWMXFMEV-UHFFFAOYSA-N	Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1	1186653-04-2	NMDA Antagonists;5-HT6 Antagonists	HTR6																																																															CHEMBL2105703	CHEMBL589390										197033	23729232	24880041	44126378	44126379	member	10.1016/j.bmcl.2009.04.128																																																																																																																																																															19443217	19549510	19939513	19945877	20166958	20194526	24850589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															1.25504																																0.15688																																8																																CS-5771	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-019-939-221|MOABOX:2700|HTR6|NMDA Antagonists;5-HT6 Antagonists	CN1CCc2c(C1)c3cc(C)ccc3n2CCc4ccc(C)nc4	97657-92-6	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468476	319.4433	DIMEBOLIN HYDROCHLORIDE| DIMEBON	DIMEBOLIN HYDROCHLORIDE| DIMEBON | DIMEBOLIN HYDROCHLORIDE| DIMEBON			MOABOX:2700	HTR6	NMDA Antagonists;5-HT6 Antagonists
SJ000288155-6	SJ000288155	6	MOABOX:2702	HWKROQUZSKPIKQ-MRXNPFEDSA-N	CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1	201038-74-6	5-HT7 Antagonists	HTR5A	HTR7																															3363																															CHEMBL1256844	CHEMBL282199										6604889	11957684	23725111	51371255	145569779	member	10.1016/j.ejmech.2016.07.029	10.1124/mol.108.052084	10.1371/journal.pone.0142499																																																																																																																																																													10669560	12161155	12392747	12825922	14667218	15032609	15816047	17897083	19560916	20166946	21159507	21620533	22001327	22926225	23541835	24805037	25127461	25128671	25759032	26348247	26698537	26706111	26852005	27396505	27475109	27717652	28063784	29730027	30028132																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									-0.4552	3.73624																															-0.0569	0.46703																															8	8																															HY-15370A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2702|HTR5A|5-HT7 Antagonists	CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c3cccc(O)c3)CC1	261901-57-9	19547	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468817	352.49152	SB 269970 HYDROCHLORIDE	SB 269970 HYDROCHLORIDE | SB 269970 | SB269970 HCL | SB 269970 HYDROCHLORIDE | SB 269970 | SB269970 HCL	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2702	HTR5A	5-HT7 Antagonists
SJ001035355-1	SJ001035355	1	MOABOX:2708	HOFGTYCLOKDAES-UHFFFAOYSA-N	Cc1c(C(=O)NCCCO)cnn1-c1nc(-c2cccc(C(F)(F)F)c2)cs1	162112-37-0	LFA-1/ICAM-1 Interaction Inhibitors	ICAM1																																																															CHEMBL9453											9953357					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.16296																																-0.02328																																7																																HY-110086	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cytoskeleton | Research Area: Inflammation/Immunology|MOABOX:2708|ICAM1|LFA-1/ICAM-1 Interaction Inhibitors	Cc1c(cnn1c2nc(cs2)c3cccc(c3)C(F)(F)F)C(=O)NCCCO	162112-37-0	79572	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469688	410.41339	RWJ 50271	RWJ 50271 | RWJ 50271	Pathway: Cytoskeleton	Research Area: Inflammation/Immunology	MOABOX:2708	ICAM1	LFA-1/ICAM-1 Interaction Inhibitors
SJ000841741-4	SJ000841741	4	MOABOX:2716	KTXXYZBSQYXMPO-UHFFFAOYSA-N	N=C(N)SCc1ccc(Cl)cc1Cl	1073-70-7	MreB Polymerization Inhibitors;Angiogenesis Inhibitors	IDO1																																																															CHEMBL1224483	CHEMBL1229058	CHEMBL1416389									234810	234811	12526767	15945669	21139633	member																																																																																																																																																																20688518	22112538																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.39616																																0.17452																																8																																Z48820397	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-529-532|MOABOX:2716|IDO1|MreB Polymerization Inhibitors;Angiogenesis Inhibitors	NC(=N)SCc1ccc(Cl)cc1Cl	1073-70-7	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468092	235.13352	RB/RAF-1 DISRUPTOR 251 | RRD-251 | DPC-251 |	"""RB/RAF-1 DISRUPTOR 251 | RRD-251 | DPC-251 |"" | RRD-251 | ""RB/RAF-1 DISRUPTOR 251 | RRD-251 | DPC-251 |"" | RRD-251"			MOABOX:2716	IDO1	MreB Polymerization Inhibitors;Angiogenesis Inhibitors
SJ000796015-5	SJ000796015	5	MOABOX:2718	XGOYIMQSIKSOBS-UHFFFAOYSA-N	Cc1ccc2c(=O)c3cccc(CC(=O)O)c3oc2c1C	117570-53-3	Mouse STING agonist;Interferon Inducers;Vascular Disrupting Agents (VDA)	STING1																																																															CHEMBL71263											123964	9894471	91387536			virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.33383																																0.04769																																7																																HY-10964	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Immunology/Inflammation | Research Area: Cancer; Infection|MOABOX:2718|STING1|Mouse STING agonist;Interferon Inducers;Vascular Disrupting Agents (VDA)	Cc1ccc2C(=O)c3cccc(CC(=O)O)c3Oc2c1C	117570-53-3	33205	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469523	282.29066	"DMXAA | ASA-404 | 5,6-MEXAA | AS-1404 | NSC-640488 | R-1564 | VADIMEZAN |"	"""DMXAA | ASA-404 | 5,6-MEXAA | AS-1404 | NSC-640488 | R-1564 | VADIMEZAN |"" | (5,6-DIMETHYL-9-OXO-XANTHEN)-4-ACETIC ACID | DMXAA (VADIMEZAN) | ""DMXAA | ASA-404 | 5,6-MEXAA | AS-1404 | NSC-640488 | R-1564 | VADIMEZAN |"" | (5,6-DIMETHYL-9-OXO-XANTHEN)-4-ACETIC ACID | DMXAA (VADIMEZAN)"	Pathway: Anti-infection; Immunology/Inflammation	Research Area: Cancer; Infection	MOABOX:2718	STING1	Mouse STING agonist;Interferon Inducers;Vascular Disrupting Agents (VDA)
SJ000288326-12	SJ000288326	12	MOABOX:2720	DOUYETYNHWVLEO-UHFFFAOYSA-N	CC(C)Cn1cnc2c(N)nc3ccccc3c21	9050-31-1	TLR7 Receptor Agonists;Interferon Inducers	NQO2	TLR7																															51284																															CHEMBL1282											57469	11210943	11595577	11646112	11716927	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0.59584																															0.0	0.07448																															7	8																															KS-5218	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)Cn1cnc2c(N)nc3ccccc3c12	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466833	240.30364	IMIQUIMOD	IMIQUIMOD | IMIQUIMOD| ALDARA | IMIQUIMOD | IMIQUIMOD| ALDARA			MOABOX:2720	NQO2	TLR7 Receptor Agonists;Interferon Inducers
SJ000784304-7	SJ000784304	7	MOABOX:2722	LQVXSNNAFNGRAH-QHCPKHFHSA-N	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1	1001350-96-4	IGF-1R Inhibitors	IGF1R																																																															CHEMBL575448											24785538	53341134				member	10.1016/j.bmc.2011.10.090	10.1158/1535-7163.MCT-09-0499																																																																																																																																																														19778024	20675137	22137930	23373648	29191878	30754629																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																2.66096																																0.33262																																8																																HY-10200	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer; Endocrinology|MOABOX:2722|IGF1R|IGF-1R Inhibitors	C[C@]1(CCCN1c2nc(Nc3cc([nH]n3)C4CC4)c5cccn5n2)C(=O)Nc6ccc(F)nc6	1001350-96-4	8106	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469647	461.49476	BMS-754807	BMS-754807 | BMS-754807	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer; Endocrinology	MOABOX:2722	IGF1R	IGF-1R Inhibitors
SJ000796079-5	SJ000796079	5	MOABOX:2724	LSFLAQVDISHMNB-AFARHQOCSA-N	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](CN2CCCC2)C1	475488-23-4	IGF-1R Inhibitors;Inhibitors of Signal Transduction Pathways;Angiogenesis Inhibitors	IGF1R																																																															CHEMBL399021																member	10.1016/j.bmcl.2007.07.037																																																																																																																																																															17089440	17689078																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.03224																																0.37903																																8																																HY-10252	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Protein Tyrosine Kinase/RTK | Research Area: Cancer; Endocrinology|MOABOX:2724|IGF1R|IGF-1R Inhibitors;Inhibitors of Signal Transduction Pathways;Angiogenesis Inhibitors	Nc1ncnc2c1c(cn2[C@@H]3C[C@@H](CN4CCCC4)C3)c5cccc(OCc6ccccc6)c5	475488-23-4	58333	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469458	453.57864	NVP-ADW-742 | ADW-742 | ADW | GSK-552602-A |	"""NVP-ADW-742 | ADW-742 | ADW | GSK-552602-A |"" | NVP-ADW742 | ""NVP-ADW-742 | ADW-742 | ADW | GSK-552602-A |"" | NVP-ADW742"	Pathway: Apoptosis; Protein Tyrosine Kinase/RTK	Research Area: Cancer; Endocrinology	MOABOX:2724	IGF1R	IGF-1R Inhibitors;Inhibitors of Signal Transduction Pathways;Angiogenesis Inhibitors
SJ000571301-19	SJ000571301	19	MOABOX:2732	PKCDDUHJAFVJJB-VLZXCDOPSA-N	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1	1356958-77-4	IGF-1R Inhibitors;Insulin Receptor Antagonists	IGF1R	INSR																															3643																															CHEMBL1091644																member	10.1007/s13402-018-0370-z	10.1016/j.bmcl.2010.03.015	10.1016/j.bmcl.2010.12.094	10.1021/ml400160a	10.2174/138161212800672723	10.4155/fmc.09.89																																																																																																																																																										20346655	21251824	21425998	22571659	23373648	24900721	24900830	25559205	26951753	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												3.20688	1.2312																															0.40086	0.1539																															8	8																															AS-16999	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	C[C@@]1(O)C[C@@H](C1)c2nc(c3ccc4ccc(nc4c3)c5ccccc5)c6c(N)nccn26	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466824	421.49372	LINSITINIB	"LINSITINIB | ""OSI-906 | ASP-7487 | OSI-906AA"" | OSI-906 (LINSITINIB) | LINSITINIB | ""OSI-906 | ASP-7487 | OSI-906AA"" | OSI-906 (LINSITINIB)"			MOABOX:2732	IGF1R	IGF-1R Inhibitors;Insulin Receptor Antagonists
SJ000806159-10	SJ000806159	10	MOABOX:2738	WPTTVJLTNAWYAO-KPOXMGGZSA-N	COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@](C)(CC[C@H]4C(C)(C)C(=O)C(C#N)=C[C@]34C)[C@]1(C)CC2	218600-53-4	"Angiogenesis Inhibitors;Antiinflammatory Drugs;Apoptosis Inducers;Bcl-2 Inhibitors;Glutathione Reductase (NADPH) Activators;Heme Oxygenase Activators;IKK-1 (IKK-alpha) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Nitric Oxide Production Inhibitors;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators;PPARgamma Agonists"	KEAP1	IKBKB																															3551																															CHEMBL1762621											400769	9962751	25164142			member	10.1371/journal.pone.0098896																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0																															0.0	0.0																															7	7																															HY-13324	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; NF-?B | Research Area: Cancer|MOABOX:2738|KEAP1|Angiogenesis Inhibitors;Antiinflammatory Drugs;Apoptosis Inducers;Bcl-2 Inhibitors;Glutathione Reductase (NADPH) Activators;Heme Oxygenase Activators;IKK-1 (IKK-alpha) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Nitric Oxide Production Inhibitors;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators;PPARgamma Agonists"	COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]3C(=O)C=C4[C@@](C)(CC[C@H]5C(C)(C)C(=O)C(=C[C@]45C)C#N)[C@]3(C)CC2	218600-53-4	79585	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468759	505.68812	BARDOXOLONE METHYL	"BARDOXOLONE METHYL | ""CDDO METHYL ESTER | BARD | CDDO-ME | METHYL-CDDO | NSC-713200 | RTA-402 | TP-155C |"" | ""BARDOXOLONE METHYL | BARD | CDDO-ME | METHYL-CDDO | NSC-713200 | RTA-402 | TP-155C |"" | BARDOXOLONE METHYL | ""CDDO METHYL ESTER | BARD | CDDO-ME | METHYL-CDDO | NSC-713200 | RTA-402 | TP-155C |"" | ""BARDOXOLONE METHYL | BARD | CDDO-ME | METHYL-CDDO | NSC-713200 | RTA-402 | TP-155C |"""	Pathway: Apoptosis; Autophagy; NF-?B	Research Area: Cancer	MOABOX:2738	KEAP1	"Angiogenesis Inhibitors;Antiinflammatory Drugs;Apoptosis Inducers;Bcl-2 Inhibitors;Glutathione Reductase (NADPH) Activators;Heme Oxygenase Activators;IKK-1 (IKK-alpha) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Nitric Oxide Production Inhibitors;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators;PPARgamma Agonists"
SJ000773174-6	SJ000773174	6	MOABOX:2740	CHILCFMQWMQVAL-UHFFFAOYSA-N	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O	634914-41-3	IKK-2 (IKK-beta) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors	IKBKB																																																															CHEMBL536151											5081913	141745925				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.67438																																-0.09634																																7																																T6141	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-941-805|MOABOX:2740|IKBKB|IKK-2 (IKK-beta) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors	Oc1ccc(Cl)cc1C(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F	978-62-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468580	383.67294	IMD-0354	IMD-0354 | IKK-2 INHIBITOR V | IMD 0354 | IMD-0354 | IKK-2 INHIBITOR V | IMD 0354			MOABOX:2740	IKBKB	IKK-2 (IKK-beta) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors
SJ000806476-5	SJ000806476	5	MOABOX:2744	SAYGKHKXGCPTLX-UHFFFAOYSA-N	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O	507475-17-4	IKK-2 (IKK-beta) Inhibitors	CHUK	IKBKB																															3551																															CHEMBL257167											9903786					member	10.1016/j.bmc.2009.02.041	10.1124/jpet.104.074484	10.2174/138955711793564079	10.2174/156802609789007336																																																																																																																																																												17896971	18088098	19035792	19285872	19689370	19834513	20044255	21034406	21429745	23501112																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												0.31332	2.31816																															0.04476	0.28977																															7	8																															HY-10074	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; JAK/STAT Signaling; NF-?B; Stem Cell/Wnt | Research Area: Inflammation/Immunology; Cancer|MOABOX:2744|CHUK|IKK-2 (IKK-beta) Inhibitors	NC(=O)Nc1sc(cc1C(=O)N)c2ccc(F)cc2	507475-17-4	7170	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469119	279.2901	TPCA-1	TPCA-1 | U19690/37/2 | TPCA-1 | U19690/37/2	Pathway: Apoptosis; JAK/STAT Signaling; NF-?B; Stem Cell/Wnt	Research Area: Inflammation/Immunology; Cancer	MOABOX:2744	CHUK	IKK-2 (IKK-beta) Inhibitors
SJ001034831-1	SJ001034831	1	MOABOX:2748	SCAZVAQQRCZSRZ-UHFFFAOYSA-N	CCOC(=O)Cc1c[nH]cn1	28782-45-8	IL-10 Production Enhancers	IL10																																																																										13190584	13190585				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																EN300-7431019	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-755-634|MOABOX:2748|IL10|IL-10 Production Enhancers	CCOC(=O)Cc1c[nH]cn1	51718-81-1	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468072	154.1665	EN300-7431019	EN300-7431019 | EN300-7431019			MOABOX:2748	IL10	IL-10 Production Enhancers
SJ001010143-3	SJ001010143	3	MOABOX:2754	HSKAZIJJKRAJAV-KOEQRZSOSA-N	Cc1cccc(/C=N/Nc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1	541550-19-0	PIKFYVE inhibitor;IL-12 Production Inhibitor;PIKFYVE enzyme inhibitor	PIKFYVE																																																																										10173277	11527330	11612848	11657114	139050527	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.63072																																0.07884																																8																																HY-14644	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation; PI3K/Akt/mTOR | Research Area: Inflammation/Immunology|MOABOX:2754|PIKFYVE|PIKFYVE inhibitor;IL-12 Production Inhibitor;PIKFYVE enzyme inhibitor	Cc1cccc(\C=N\Nc2cc(nc(OCCc3ccccn3)n2)N4CCOCC4)c1	541550-19-0	11690	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468821	418.49154	APILIMOD | STA 5326	"""APILIMOD | STA 5326"" | ""APILIMOD | STA 5326"""	Pathway: Immunology/Inflammation; PI3K/Akt/mTOR	Research Area: Inflammation/Immunology	MOABOX:2754	PIKFYVE	PIKFYVE inhibitor;IL-12 Production Inhibitor;PIKFYVE enzyme inhibitor
SJ000285895-7	SJ000285895	7	MOABOX:2760	TYNLGDBUJLVSMA-UHFFFAOYSA-N	CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O	112118-18-0	IL-1 Inhibitors	IL1B																																																															CHEMBL41286											26248	19384684	20527646	23036595	46931245	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																KS-5088	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(=O)Oc1cccc2C(=O)c3cc(cc(OC(=O)C)c3C(=O)c12)C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466695	368.29378	DIACERIN	DIACERIN | DIACEREIN | DIACERIN | DIACEREIN			MOABOX:2760	IL1B	IL-1 Inhibitors
SJ000866922-2	SJ000866922	2	MOABOX:2762	PSZDOEIIIJFCFE-OSQDELBUSA-N	CC1(C)CC[C@]2(CO)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1	118204-21-0	IL-6 Production Inhibitors;IL-1beta Production Inhibitors	IL1B	IL6																															3569																															CHEMBL400074											101761	87814024				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															30135	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-925-627|MOABOX:2762|IL1B|IL-6 Production Inhibitors;IL-1beta Production Inhibitors	CC1(C)CC[C@]2(CO)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2C1	545-48-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468332	442.7168	ERYTHRODIOL(P)	ERYTHRODIOL(P) | ERYTHRODIOL(P)			MOABOX:2762	IL1B	IL-6 Production Inhibitors;IL-1beta Production Inhibitors
SJ001035042-1	SJ001035042	1	MOABOX:2776	LAHVQXKWWOOVLX-UHFFFAOYSA-N	Cc1noc(C)c1C(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1		IL-4 Production Inhibitors;IL-2 Production Inhibitors;IL-5 Production Inhibitors	IL2	IL4	IL5																														3565	3567																														CHEMBL101176											2740686					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0																														0.0	0.0	0.0																														7	7	7																														SEW04224	MAYBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-921-506|MOABOX:2776|IL2|IL-4 Production Inhibitors;IL-2 Production Inhibitors;IL-5 Production Inhibitors	Cc1onc(C)c1C(=O)Nc2ccc(cc2)n3nc(cc3C(F)(F)F)C(F)(F)F	245747-10-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468542	418.2932	SEW04224	SEW04224 | SEW04224			MOABOX:2776	IL2	IL-4 Production Inhibitors;IL-2 Production Inhibitors;IL-5 Production Inhibitors
SJ001011122-2	SJ001011122	2	MOABOX:2780	ZMNWFTYYYCSSTF-SOAUALDESA-N	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		IL-2 Production Inhibitors;Inhibitors of Signal Transduction Pathways;Lck Kinase Inhibitors	IL2	LCK																															3932																															CHEMBL197603																member	10.1016/j.bmcl.2005.09.039	10.1124/jpet.105.089169																																																																																																																																																														16014572	16216497	18537718																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0	1.72136																															0.0	0.21517																															7	8																															AA00GTXP	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-702-193|MOABOX:2780|IL2|IL-2 Production Inhibitors;Inhibitors of Signal Transduction Pathways;Lck Kinase Inhibitors	COc1cc(ccc1NC(=O)c2cc3ccccc3n2C)c4nn([C@@H]5CC[C@H](CC5)N6CCN(CC6)C(=O)C)c7ncnc(N)c47	869748-10-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468638	621.73196	A-770041	A-770041 | A-770041			MOABOX:2780	IL2	IL-2 Production Inhibitors;Inhibitors of Signal Transduction Pathways;Lck Kinase Inhibitors
SJ001035161-1	SJ001035161	1	MOABOX:2792	INBGSXNNRGWLJU-ZHHJOTBYSA-N	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C	2140-46-7	Apoptosis Inducers;IL-8 Modulators;TNF-alpha Release Inhibitors;Cholesterol Biosynthesis Inhibitors;3-hydroxy-3-methylglutaryl-CoA reductase Inhibitors	HMGCR	RORC	RORA																														6097	6095																														CHEMBL169046											65094	67008013	68673087	90233942		member																																																																																																																																																																8057282	25453817																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.20398	0	1.03864																														0.02914	0.0	0.12983																														7	7	8																														HY-113134	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:2792|HMGCR|Apoptosis Inducers;IL-8 Modulators;TNF-alpha Release Inhibitors;Cholesterol Biosynthesis Inhibitors;3-hydroxy-3-methylglutaryl-CoA reductase Inhibitors	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	2140-46-7	88869	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468967	402.65294	25-HYDROXYCHOLESTEROL	25-HYDROXYCHOLESTEROL | 25-HYDROXYCHOLESTEROL	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:2792	HMGCR	Apoptosis Inducers;IL-8 Modulators;TNF-alpha Release Inhibitors;Cholesterol Biosynthesis Inhibitors;3-hydroxy-3-methylglutaryl-CoA reductase Inhibitors
SJ000285280-10	SJ000285280	10	MOABOX:2794	HZQDCMWJEBCWBR-UUOKFMHZSA-N	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1O	50524-49-7	Immunosuppressive	ATIC	IMPDH1	IMPDH2	GMPS																													3614	3615	8833																													CHEMBL245019											104762	21120439	67740331	69414296	90205849	member	10.1021/bi0271401																																																																																																																																																															15083807	15279547																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0.99792	1.13484	-0.6146																													0.0	0.14256	0.16212	-0.0878																													7	7	7	7																													HS-0046	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466671	259.21602	MIZORIBINE	MIZORIBINE | MIZORIBINE			MOABOX:2794	ATIC	Immunosuppressive
SJ000285347-16	SJ000285347	16	MOABOX:2796	IWUCXVSUMQZMFG-AFCXAGJDSA-N	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1	252269-50-4	Hepatitis C virus inhibitor;Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors	IMPDH1																																																															CHEMBL1643											37542	451753	451754	451798	469589	member																																																																																																																																																																22037469																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.73472																																0.09184																																8																																AS-34178	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466852	244.20468	RIBAVIRIN	RIBAVIRIN | AB00430481_14 | RIBAVIRIN | AB00430481_14			MOABOX:2796	IMPDH1	Hepatitis C virus inhibitor;Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors
SJ000285197-12	SJ000285197	12	MOABOX:2798	HPNSFSBZBAHARI-RUDMXATFSA-N	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2	1162256-90-7	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors;Immunosuppressant;IMPDH inhibitor;antiviral	IMPDH1	IMPDH2																															3615																															CHEMBL866											446541	5279619	6475070	6475541	6475542	virtual	10.1016/S0960-894X(02)00351-7	10.1016/S0960-894X(02)00600-5	10.1016/S0960-894X(02)00641-8	10.1016/S0960-894X(02)00944-7	10.1016/S0960-894X(02)00945-9	10.1016/S0960-894X(03)00757-1	10.1016/j.bmc.2010.09.004	10.1016/j.bmc.2018.09.004	10.1016/j.bmcl.2006.03.097	10.1016/j.bmcl.2013.07.016	10.1016/j.ejmech.2018.09.016	10.1021/ac202404y	10.1021/jm00164a057	10.1021/jm9603633	10.1080/14756366.2018.1474211	10.3390/md11051718																																																																																																																																																1967654	8863796	9484510	11806722	12014950	12127522	12270177	12372516	12392738	12565968	12565969	14505670	16621550	17585753	17958343	18038969	18583139	18809333	20934342	21324702	22464133																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.92408	3.90704																															0.11551	0.48838																															8	8																															DS-1638	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466733	320.3371	MYCOPHENOLIC ACID	MYCOPHENOLIC ACID | MYCOPHENOLATE SODIUM | MYCOPHENOLIC ACID | MYCOPHENOLATE SODIUM			MOABOX:2798	IMPDH1	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors;Immunosuppressant;IMPDH inhibitor;antiviral
SJ000785923-2	SJ000785923	2	MOABOX:2802	RFZPGNRLOKVZJY-AWEZNQCLSA-N	C[C@H](NC(=O)c1sccc1OCc1ccc(Cl)cc1)c1ccccc1	1203680-76-5	SH2 Containing Inositol Phosphatase (SHIP) Inhibitors	INPPL1																																																															CHEMBL2337806											44473434					member																																																																																																																																																																23434638																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.336e-002																																0.00167																																8																																HY-18686	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:2802|INPPL1|SH2 Containing Inositol Phosphatase (SHIP) Inhibitors	C[C@H](NC(=O)c1sccc1OCc2ccc(Cl)cc2)c3ccccc3	1203680-76-5	95607	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469774	371.88042	AS 1949490	AS 1949490 | AS 1949490	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:2802	INPPL1	SH2 Containing Inositol Phosphatase (SHIP) Inhibitors
SJ000287528-8	SJ000287528	8	MOABOX:2804	FAEKWTJYAYMJKF-QHCPKHFHSA-N	CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O	135062-02-1	Insulin Secretagogues	ABCC8																																																															CHEMBL1272											65981	9918264	9938218	9962600	11398741	member																																																																																																																																																																10773014	15380228	15678092																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.95776																																0.24472																																8																																HY-15209	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Metabolic Disease|MOABOX:2804|ABCC8|Insulin Secretagogues	CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3)ccc1C(=O)O	135062-02-1	8958	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469294	452.58574	REPAGLINIDE	REPAGLINIDE | REPAGLINIDE	Pathway: Others	Research Area: Metabolic Disease	MOABOX:2804	ABCC8	Insulin Secretagogues
SJ000861348-4	SJ000861348	4	MOABOX:2806	WPGGHFDDFPHPOB-BBWFWOEESA-N	O=C(O)[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)Cc1ccccc1	145375-43-5	Insulin Secretagogues	ABCC8																																																															CHEMBL471498											121891	9884997	11859092	16756691	20843182	member																																																																																																																																																																11716850	24842616																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.14273																																-0.02039																																7																																HY-17398	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Metabolic Disease|MOABOX:2806|ABCC8|Insulin Secretagogues	OC(=O)[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)Cc3ccccc3	145525-41-3	9713	GENERAL	CALCIUM(II)	0.5	NO_SOLVATE	0	1469296	315.4067	MITIGLINIDE CALCIUM	MITIGLINIDE CALCIUM | MITIGLINIDE CALCIUM	Pathway: Membrane Transporter/Ion Channel	Research Area: Metabolic Disease	MOABOX:2806	ABCC8	Insulin Secretagogues
SJ000285593-10	SJ000285593	10	MOABOX:2808	OELFLUMRDSZNSF-BRWVUGGUSA-N	CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1	105816-04-4	K(ir) 6.2/SUR1 Blockers;Insulin Secretagogues	KCNJ11	ABCC8																															6833																															CHEMBL783																member																																																																																																																																																																10773014																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	1.31512																															0.0	0.16439																															7	8																															HY-B0422	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:2808|KCNJ11|K(ir) 6.2/SUR1 Blockers;Insulin Secretagogues	CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@H](Cc2ccccc2)C(=O)O	105816-04-4	16196	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469640	317.42258	NATEGLINIDE	NATEGLINIDE | STARLIX | NATEGLINIDE | STARLIX	Pathway: Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:2808	KCNJ11	K(ir) 6.2/SUR1 Blockers;Insulin Secretagogues
SJ001035263-1	SJ001035263	1	MOABOX:2810	KINMYBBFQRSVLL-UHFFFAOYSA-N	O=c1ccc2c(OCCCCOc3ccccc3)c3ccoc3cc2o1	870653-45-5	K(V)1.3 Channel Blockers	KCNA1	KCNA2	KCNA3	KCNA4	KCNA5	KCNA6	KCNA7																										3737	3738	3739	3741	3742	3743																										CHEMBL444449											11302540					virtual	10.1016/j.bmcl.2010.09.131	10.1016/j.bmcl.2010.09.132	10.1124/mol.105.015669																																																																																																																																																													16099841	19056148	19282171	20858170	20971642	20974533	23084278	28802123																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														0.31328	-0.10744	2.3532	6.776e-002	0.4768	0.25104	1.248e-002																										0.03916	-0.01343	0.29415	0.00847	0.0596	0.03138	0.00156																										8	8	8	8	8	8	8																										HY-10015	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Inflammation/Immunology|MOABOX:2810|KCNA1|K(V)1.3 Channel Blockers	O=C1Oc2cc3occc3c(OCCCCOc4ccccc4)c2C=C1	870653-45-5	7161	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469402	350.36462	PAP-1 | 5-(4-PHENOXYBUTOXY)PSORALEN	"""PAP-1 | 5-(4-PHENOXYBUTOXY)PSORALEN"" | ""PAP-1 | 5-(4-PHENOXYBUTOXY)PSORALEN"""	Pathway: Membrane Transporter/Ion Channel	Research Area: Inflammation/Immunology	MOABOX:2810	KCNA1	K(V)1.3 Channel Blockers
SJ000286950-18	SJ000286950	18	MOABOX:2814	PMATZTZNYRCHOR-CGLBZJNRSA-N	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C	104250-72-8	binds to cyclophilin;Calcineurin inhibitor;Cyclophilin modulator;Cyclophilin D Inhibitors;Cyclphilin A Inhibitors	PPIA	PPID	PPP3CA	PPP3CB	PPP3CC	PPP3R1	PPP3R2																										5481	5530	5532	5533	5534	5535																										CHEMBL160											5284373	6475771	6476816	6479218	6479219	member	10.1016/j.ejmech.2011.09.019	10.1021/acs.jmedchem.8b00802	10.1021/jm9903139																																																																																																																																																													7650689	7966126	11472213	11881984	12593646	14643337	15357990	18212100	18571405	19601846	19691347	19734911	19933795	20943390	21396746	21963115	22316150	23225707	23964991	24900244	24900335	26564266	26613291	26905826	26950392	26985318	27687672	28075591																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										0	0	3.37088	1.08128	0.66416	0	0																										0.0	0.0	0.42136	0.13516	0.08302	0.0	0.0																										7	7	8	8	8	7	7																										KS-1257	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466726	1202.61124	CYCLOSPORINE	CYCLOSPORINE | CYCLOSPORIN A | SJ000518936 | CYCLOSPORINE | CYCLOSPORIN A | SJ000518936			MOABOX:2814	PPIA	binds to cyclophilin;Calcineurin inhibitor;Cyclophilin modulator;Cyclophilin D Inhibitors;Cyclphilin A Inhibitors
SJ001035204-1	SJ001035204	1	MOABOX:2816	VBIYDORVDCFKHM-UHFFFAOYSA-N	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		Interleukin-1 Receptor-Associated Kinase (IRAK) Inhibitors	IRAK1	IRAK2																															3656																															CHEMBL210887											44412343					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.84344	0																															0.10543	0.0																															8	7																															HY-77048	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Inflammation/Immunology|MOABOX:2816|IRAK1|Interleukin-1 Receptor-Associated Kinase (IRAK) Inhibitors	[O-][N+](=O)c1cccc(c1)C(=O)Nc2nc3ccccc3[nH]2	301675-24-1	5367	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469090	282.2542	IRAK-4 PROTEIN KINASE INHIBITOR 2	IRAK-4 PROTEIN KINASE INHIBITOR 2 | IRAK-4 PROTEIN KINASE INHIBITOR 2	Pathway: Immunology/Inflammation	Research Area: Inflammation/Immunology	MOABOX:2816	IRAK1	Interleukin-1 Receptor-Associated Kinase (IRAK) Inhibitors
SJ001033419-2	SJ001033419	2	MOABOX:2828	YLFZHHDVRSYTKT-NRFANRHFSA-N	CCOCc1cc(OC)c(-c2ccc(C[C@H](NC(=O)c3c(F)cccc3F)C(=O)O)cc2)c(OC)c1	402567-16-2	Integrin alpha4beta7 (LPAM-1) Antagonists;Integrin alpha4beta1 (VLA-4) Antagonists	ITGA4																																																															CHEMBL2104967											9935681	52917927				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.16669																																0.16667																																7																																HY-14951	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cytoskeleton | Research Area: Neurological Disease|MOABOX:2828|ITGA4|Integrin alpha4beta7 (LPAM-1) Antagonists;Integrin alpha4beta1 (VLA-4) Antagonists	CCOCc1cc(OC)c(c(OC)c1)c2ccc(C[C@H](NC(=O)c3c(F)cccc3F)C(=O)O)cc2	402567-16-2	10186	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468824	499.50319	FIRATEGRAST; SB 683699	FIRATEGRAST; SB 683699 | FIRATEGRAST; SB 683699	Pathway: Cytoskeleton	Research Area: Neurological Disease	MOABOX:2828	ITGA4	Integrin alpha4beta7 (LPAM-1) Antagonists;Integrin alpha4beta1 (VLA-4) Antagonists
SJ001035021-1	SJ001035021	1	MOABOX:2834	ZRVZOBGMZWVJOS-VMXHOPILSA-N	N=C(N)NCCC[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O	111119-28-9	Integrin alphavbeta3 (Vitronectin) Antagonists	ITGAV	ITGB3																															3690																															CHEMBL58763											130667	131698143	145707436			virtual																																																																																																																																																																9784861	10447947	11384239	21269250																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.17952	1.164																															0.14744	0.1455																															8	8																															CS-7071	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-941-423|MOABOX:2834|ITGAV|Integrin alphavbeta3 (Vitronectin) Antagonists	NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)O	111119-28-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468494	715.75576	GRGDSPK	GRGDSPK | GRGDSPK			MOABOX:2834	ITGAV	Integrin alphavbeta3 (Vitronectin) Antagonists
SJ001035017-1	SJ001035017	1	MOABOX:2836	YYQUWEHEBOMRPH-NYUBLWNDSA-N	CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC1=O	137813-35-5	Integrin binder;Integrin alphavbeta3 (Vitronectin) Antagonists	ITGAV	ITGB3	ITGB5																														3690	3693																														CHEMBL411941											9851104	131698036				member	10.1016/S0968-0896(98)00090-X	10.1021/acsmedchemlett.7b00234	10.1021/jm050698x																																																																																																																																																													8893849	9784861	12370049	15134515	15863003	16302808	16509596	16722662	16982193	18343671	19212960	20166941	21349709	21392860	23140358	23657523	27726366	27997164	29348803	31306009																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.77224	0.94336	0.87112																														0.09653	0.11792	0.10889																														8	8	8																														CS-0062738	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-683-514|MOABOX:2836|ITGAV|Integrin binder;Integrin alphavbeta3 (Vitronectin) Antagonists	CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC1=O	199807-33-5	NA	GENERAL	"2,2,2-TRIFLUOROACETATE"	1	NO_SOLVATE	0	1468485	574.62932	CYCLO(ARG-GLY-ASP-D-PHE-VAL) TFA	CYCLO(ARG-GLY-ASP-D-PHE-VAL) TFA | CYCLO(ARG-GLY-ASP-D-PHE-VAL) TFA			MOABOX:2836	ITGAV	Integrin binder;Integrin alphavbeta3 (Vitronectin) Antagonists
SJ001033000-2	SJ001033000	2	MOABOX:2840	DRSJLVGDSNWQBI-SFHVURJKSA-N	COc1cccc(OC)c1-c1ccc(C[C@H](NC(=O)c2c(Cl)cccc2Cl)C(=O)O)cc1	232271-19-1	Integrin binder;Integrin alpha4beta1 (VLA-4) Antagonists;Integrin alpha4beta7 (LPAM-1) Antagonists	ITGB1																																																															CHEMBL91485											9912743					member	10.1016/S0960-894X(01)00544-3																																																																																																																																																															11591507	11937364	12052218	12065712	12161146	15582442	16432509	16722660	17035017																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0.98968																																0.12371																																8																																HY-15770	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cytoskeleton | Research Area: Inflammation/Immunology|MOABOX:2840|ITGB1|Integrin binder;Integrin alpha4beta1 (VLA-4) Antagonists;Integrin alpha4beta7 (LPAM-1) Antagonists	COc1cccc(OC)c1c2ccc(C[C@H](NC(=O)c3c(Cl)cccc3Cl)C(=O)O)cc2	232271-19-1	12462	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469503	474.33324	TR14035	TR14035 | TR14035	Pathway: Cytoskeleton	Research Area: Inflammation/Immunology	MOABOX:2840	ITGB1	Integrin binder;Integrin alpha4beta1 (VLA-4) Antagonists;Integrin alpha4beta7 (LPAM-1) Antagonists
SJ001010738-2	SJ001010738	2	MOABOX:2844	ZHXNIYGJAOPMSO-UHFFFAOYSA-N	COc1cc(C)c(Sc2cnc(NC(=O)c3ccc(CNC(C)C(C)(C)C)cc3)s2)cc1C(=O)N1CCN(C(C)=O)CC1	439575-02-7	ITK (EMT) Kinase Inhibitors	ITK																																																															CHEMBL209148											11467730	72193875	145095095			member	10.1021/bi049428r																																																																																																																																																															15323564	15975507	16682193	20545945	21391610	22820564	26258521																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															2.77912																																0.34739																																8																																HY-11092	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Inflammation/Immunology|MOABOX:2844|ITK|ITK (EMT) Kinase Inhibitors	COc1cc(C)c(Sc2cnc(NC(=O)c3ccc(CNC(C)C(C)(C)C)cc3)s2)cc1C(=O)N4CCN(CC4)C(=O)C	439575-02-7	14806	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468975	623.82904	BMS-509744	BMS-509744 | BMS-509744	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Inflammation/Immunology	MOABOX:2844	ITK	ITK (EMT) Kinase Inhibitors
SJ000785960-2	SJ000785960	2	MOABOX:2846	BLZVCIGGICSWIG-UHFFFAOYSA-N	NCCOB(c1ccccc1)c1ccccc1	524-95-8	Inositol Triphosphate IP3 Receptor Antagonists;Gap junction modulators	ITPR2	ITPR3	ITPR1																														3710	3708																														CHEMBL169233											1598	60143309				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.13524	-0.13524	-0.1372																														-0.01932	-0.01932	-0.0196																														7	7	7																														HY-W009724	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Infection|MOABOX:2846|ITPR2|Inositol Triphosphate IP3 Receptor Antagonists;Gap junction modulators	NCCOB(c1ccccc1)c2ccccc2	524-95-8	58548	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469695	225.09394	2-APB | 2-AMINOETHOXYDIPHENYLBORANE |	"""2-APB | 2-AMINOETHOXYDIPHENYLBORANE |"" | ""2-APB | 2-AMINOETHOXYDIPHENYLBORANE |"""	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Infection	MOABOX:2846	ITPR2	Inositol Triphosphate IP3 Receptor Antagonists;Gap junction modulators
SJ000784312-10	SJ000784312	10	MOABOX:2850	ZVHNDZWQTBEVRY-UHFFFAOYSA-N	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1	1056634-68-4	Jak2 Inhibitors;Jak1 Inhibitors;Tyk2 Inhibitors	JAK1	JAK2	TYK2																														3717	7297																														CHEMBL1078178	CHEMBL2219411										25062766	57345482	60202752	66576992	78357762	member	10.1016/j.bmcl.2009.08.071																																																																																																																																																															19295546	19762238	21062251	22583424	23317159	26258521	29191878	29940115																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														1.48232	1.93848	0.76592																														0.18529	0.24231	0.09574																														8	8	8																														HY-10961	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Epigenetics; JAK/STAT Signaling; Stem Cell/Wnt | Research Area: Cancer|MOABOX:2850|JAK1|Jak2 Inhibitors;Jak1 Inhibitors;Tyk2 Inhibitors	O=C(NCC#N)c1ccc(cc1)c2ccnc(Nc3ccc(cc3)N4CCOCC4)n2	1056634-68-4	16392	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468868	414.45978	Momelotinib	"Momelotinib | CYT387 | ""Momelotinib dihydrochloride | CYT-387"" | Momelotinib | CYT387 | ""Momelotinib dihydrochloride | CYT-387"""	Pathway: Apoptosis; Autophagy; Epigenetics; JAK/STAT Signaling; Stem Cell/Wnt	Research Area: Cancer	MOABOX:2850	JAK1	Jak2 Inhibitors;Jak1 Inhibitors;Tyk2 Inhibitors
SJ000790171-7	SJ000790171	7	MOABOX:2852	JVDOKQYTTYUYDV-UHFFFAOYSA-N	Cc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1	936091-14-4	Apoptosis Inducers;Jak2 Inhibitors	JAK2																																																															CHEMBL1995703											16722832					member	10.1038/sj.leu.2404750																																																																																																																																																															22286129	23317159	27668758	28195723	28280261																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.83704																																0.22963																																8																																HY-10410	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt | Research Area: Cancer|MOABOX:2852|JAK2|Apoptosis Inducers;Jak2 Inhibitors	CN1CCN(CC1)c2ccc(Nc3ncc(C)c(Nc4cccc(c4)S(=O)(=O)NC(C)(C)C)n3)cc2	936091-14-4	15048	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469134	509.6668	TG101209	TG101209 | TG101209	Pathway: Apoptosis; Autophagy; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Research Area: Cancer	MOABOX:2852	JAK2	Apoptosis Inducers;Jak2 Inhibitors
SJ000833886-5	SJ000833886	5	MOABOX:2854	PDOQBOJDRPLBQU-QMMMGPOBSA-N	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)n[nH]1	935666-88-9	Jak2 Inhibitors	JAK1	JAK2																															3717																															CHEMBL1231124											16659841	50993952				member	10.1021/jm1011319	10.1021/jm401546n																																																																																																																																																														21138246	23317159	24359159	30227617																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.42752	1.84024																															0.17844	0.23003																															8	8																															HY-10193	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics; JAK/STAT Signaling; Stem Cell/Wnt | Research Area: Cancer|MOABOX:2854|JAK1|Jak2 Inhibitors	C[C@H](Nc1ncc(Cl)c(Nc2cc(C)[nH]n2)n1)c3ncc(F)cn3	935666-88-9	3803	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469723	348.76596	AZD-1480	AZD-1480 | AZD-1480	Pathway: Epigenetics; JAK/STAT Signaling; Stem Cell/Wnt	Research Area: Cancer	MOABOX:2854	JAK1	Jak2 Inhibitors
SJ000852322-6	SJ000852322	6	MOABOX:2856	IBPVXAOOVUAOKJ-UHFFFAOYSA-N	Fc1cc(-c2cccc3ncc(-c4cnn(C5CCNCC5)c4)nc23)cc(F)c1CN1CCOCC1	1092499-93-8	Jak2 Inhibitors	JAK1	JAK2	JAK3	TYK2																													3717	3718	7297																													CHEMBL1092926											46398810	57339395	71558788	86346671	129010444	member	10.1016/j.bmcl.2010.02.056	10.1158/1535-7163.MCT-10-0053																																																																																																																																																														20231096	20587663	23317159																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.81696	2.03168	0.62128	0.71936																													0.10212	0.25396	0.07766	0.08992																													8	8	8	8																													HY-14722A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics; JAK/STAT Signaling; Stem Cell/Wnt | Research Area: Cancer|MOABOX:2856|JAK1|Jak2 Inhibitors	Fc1cc(cc(F)c1CN2CCOCC2)c3cccc4ncc(nc34)c5cnn(c5)C6CCNCC6	1942919-79-0	90882	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468785	490.54763	NVP-BSK805	NVP-BSK805 | NVP-BSK805 2HCL | NVP-BSK805 | NVP-BSK805 2HCL	Pathway: Epigenetics; JAK/STAT Signaling; Stem Cell/Wnt	Research Area: Cancer	MOABOX:2856	JAK1	Jak2 Inhibitors
SJ000288217-7	SJ000288217	7	MOABOX:2860	TUCIOBMMDDOEMM-RIYZIHGNSA-N	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1	133550-30-8	Jak3 Inhibitors;STAT-3 Inhibitors;Jak2 Inhibitors;Antiinflammatory Drugs	JAK2	JAK3	STAT3																														3718	6774																														CHEMBL56543											5328779	21159216				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.11064	0.23896	-0.16247																														0.01383	0.02987	-0.02321																														8	8	7																														HY-12000	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt | Research Area: Cancer|MOABOX:2860|JAK2|Jak3 Inhibitors;STAT-3 Inhibitors;Jak2 Inhibitors;Antiinflammatory Drugs	Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O	133550-30-8	18826	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469526	294.30466	TYRPHOSTIN AG 490	"TYRPHOSTIN AG 490 | ""TYRPHOSTIN AG 490 | AG 490 | TYRPHOSTIN B42 | JAK2 INHIBITORS | JAK3 INHIBITORS | STAT-3 INHIBITORS |"" | AG-490 (TYRPHOSTIN B42) | TYRPHOSTIN AG 490 | ""TYRPHOSTIN AG 490 | AG 490 | TYRPHOSTIN B42 | JAK2 INHIBITORS | JAK3 INHIBITORS | STAT-3 INHIBITORS |"" | AG-490 (TYRPHOSTIN B42)"	Pathway: Autophagy; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Research Area: Cancer	MOABOX:2860	JAK2	Jak3 Inhibitors;STAT-3 Inhibitors;Jak2 Inhibitors;Antiinflammatory Drugs
SJ000286180-15	SJ000286180	15	MOABOX:2876	FTALBRSUTCGOEG-UHFFFAOYSA-N	Nc1nc2ccc(OC(F)(F)F)cc2s1	1744-22-5	Glutamate Release Inhibitors;K(V)4.3 Channel Blockers;Sodium Channel  Blockers;Cystine Glutamate Transporter Inducer	SCN5A	SLC1A1	SLC1A3	SLC7A11	KCND3																												6505	6507	23657	3752																												CHEMBL1531817	CHEMBL744										5070	6419992	45114216	71406484	86045007	member	10.1016/j.ejphar.2007.10.023	10.1016/j.ijdevneu.2013.06.002	10.1016/j.neuint.2011.10.017																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0	0.15666	0	0	0																												0.0	0.02238	0.0	0.0	0.0																												7	7	7	7	7																												HY-B0211	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:2876|SCN5A|Glutamate Release Inhibitors;K(V)4.3 Channel Blockers;Sodium Channel Blockers;Cystine Glutamate Transporter Inducer	Nc1nc2ccc(OC(F)(F)F)cc2s1	1744-22-5	16556	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468944	234.19831	RILUZOLE HYDROCHLORIDE	RILUZOLE HYDROCHLORIDE | RILUZOLE | RILUZOLE HCL | RILUZOLE HYDROCHLORIDE | RILUZOLE | RILUZOLE HCL	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:2876	SCN5A	Glutamate Release Inhibitors;K(V)4.3 Channel Blockers;Sodium Channel Blockers;Cystine Glutamate Transporter Inducer
SJ000555707-6	SJ000555707	6	MOABOX:2880	IXTMWRCNAAVVAI-UHFFFAOYSA-N	CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1	115256-11-6	K(V)11.1 (erg1) Channel Blockers	KCNH2	KCNJ12	KCNK2																														3768	3776																														CHEMBL473											71329	9854080	67238435	67564144	69664960	member	10.1002/cmdc.200900203	10.1007/s004240100720	10.1016/S0008-6363(02)00774-5	10.1016/S0014-5793(97)01249-0	10.1016/S0960-894X(03)00196-3	10.1016/j.ejphar.2004.04.015	10.1016/j.ejphar.2014.12.012	10.1021/acs.jmedchem.6b01217	10.1021/jm0208875	10.1021/jm0700565	10.1021/jm301564f	10.1038/bjp.2008.191	10.1038/sj.bjp.0704859	10.1113/jphysiol.2001.013296	10.1124/jpet.103.062182	10.1124/mol.64.1.59	10.1128/AAC.00156-18	10.1161/01.CIR.94.10.2572	10.1161/01.RES.82.3.386	10.2174/092986707782794087	10.2174/1568016033477414	10.2174/156802608785700007																																																																																																																																										9694935	12190308	12729675	12873512	14711935	15132818	15324906	15326913	15911273	16616004	16782336	16892366	17331468	17536794	18220737	18262683	18448342	18493243	18782009	19061955	19110341	19152631	19725081	20349498	21205913	21300721	22455383	23473309	25087753	27709945																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								4.20072	0	0																														0.52509	0.0	0.0																														8	7	7																														HY-B0232	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Cardiovascular Disease|MOABOX:2880|KCNH2|K(V)11.1 (erg1) Channel Blockers	CN(CCOc1ccc(NS(=O)(=O)C)cc1)CCc2ccc(NS(=O)(=O)C)cc2	115256-11-6	15898	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469078	441.56478	DOFETILIDE	DOFETILIDE | DOFETILIDE	Pathway: Membrane Transporter/Ion Channel	Research Area: Cardiovascular Disease	MOABOX:2880	KCNH2	K(V)11.1 (erg1) Channel Blockers
SJ001035178-1	SJ001035178	1	MOABOX:2882	NJFVQMRYJZHGME-UHFFFAOYSA-N	O=C(Nc1cc(C(F)(F)F)ccc1O)Nc1cc(C(F)(F)F)ccc1O	448895-37-2	Voltage-Gated K(V)11.1 (erg1) Channel Activators	KCNH2																																																															CHEMBL1514181											10177784					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.76482																																0.10926																																7																																HY-16916	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Membrane Transporter/Ion Channel | Research Area: Others|MOABOX:2882|KCNH2|Voltage-Gated K(V)11.1 (erg1) Channel Activators	Oc1ccc(cc1NC(=O)Nc2cc(ccc2O)C(F)(F)F)C(F)(F)F	448895-37-2	20535	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469003	380.24192	NS1643	NS1643 | NS1643	Pathway: Autophagy; Membrane Transporter/Ion Channel	Research Area: Others	MOABOX:2882	KCNH2	Voltage-Gated K(V)11.1 (erg1) Channel Activators
SJ001035252-1	SJ001035252	1	MOABOX:2884	ZCQOSCDABPVAFB-UHFFFAOYSA-N	O=C(O)c1ccccc1Nc1ccc(CCc2ccc(Cl)c(Cl)c2)cc1	313674-97-4	Voltage-Gated K(V)11.1 (erg1) Channel Activators;Antiamyloidogenic Agents	KCNH2																																																															CHEMBL521083											9864959	69793118				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-6.902e-002																																-0.00986																																7																																HY-108594	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Metabolic Disease|MOABOX:2884|KCNH2|Voltage-Gated K(V)11.1 (erg1) Channel Activators;Antiamyloidogenic Agents	OC(=O)c1ccccc1Nc2ccc(CCc3ccc(Cl)c(Cl)c3)cc2	313674-97-4	58965	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469318	386.27118	PD-118057	PD-118057 | PD-118057	Pathway: Membrane Transporter/Ion Channel	Research Area: Metabolic Disease	MOABOX:2884	KCNH2	Voltage-Gated K(V)11.1 (erg1) Channel Activators;Antiamyloidogenic Agents
SJ000285675-10	SJ000285675	10	MOABOX:2888	PHVGLTMQBUFIQQ-UHFFFAOYSA-N	CNCCC=C1c2ccccc2CCc2ccccc21	203784-52-5	K(ir) 4.1 Blockers	KCNJ10																																																															CHEMBL1201156	CHEMBL445										4543	441358	657214	5458370	19786253	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																AG00880N	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-959-040|MOABOX:2888|KCNJ10|K(ir) 4.1 Blockers	CNCCC=C1c2ccccc2CCc3ccccc13	894-71-3	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468246	263.37674	NORTRIPTYLINE	NORTRIPTYLINE | NORTRIPTYLINE HYDROCHLORIDE | AVENTYL HYDROCHLORIDE | NORTRIPTYLINE | NORTRIPTYLINE HYDROCHLORIDE | AVENTYL HYDROCHLORIDE			MOABOX:2888	KCNJ10	K(ir) 4.1 Blockers
SJ001035394-1	SJ001035394	1	MOABOX:2890	CVOUSAVHMDXCKG-UHFFFAOYSA-N	O=C1Nc2c(ccc(Cl)c2Cl)/C1=N/O	18711-16-5	"Intermediate Conductance K(Ca) 3.1 (IKCa1;Gardos channel, SK41, IK1) Channel Activators;Small Conductance SK(Ca) 2.1 (SK1, SKCa1) Channel Activators;Small Conductance SK(Ca) 2.2 (SK2, SKCa2) Channel Activators;Small Conductance SK(Ca) 2.3 (SK3, SKCa3, hKCa3) Channel Activators"	KCNN1	KCNN2	KCNN3																														3781	3782																														CHEMBL499968																member																																																																																																																																																																17486140	17584055	19149539	22204342	23102227																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.2776	-0.23656	1.26944																														0.0347	-0.02957	0.15868																														8	8	8																														HY-15416	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Neurological Disease; Cardiovascular Disease|MOABOX:2890|KCNN1|Intermediate Conductance K(Ca) 3.1 (IKCa1;Gardos channel, SK41, IK1) Channel Activators;Small Conductance SK(Ca) 2.1 (SK1, SKCa1) Channel Activators;Small Conductance SK(Ca) 2.2 (SK2, SKCa2) Channel Activators;Small Conductance SK(Ca) 2.3 (SK3, SKCa3, hKCa3) Channel Activators"	O\N=C\1/C(=O)Nc2c(Cl)c(Cl)ccc12	18711-16-5	10947	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469894	231.03556	NS309	NS309 | NS309	Pathway: Membrane Transporter/Ion Channel	Research Area: Neurological Disease; Cardiovascular Disease	MOABOX:2890	KCNN1	"Intermediate Conductance K(Ca) 3.1 (IKCa1;Gardos channel, SK41, IK1) Channel Activators;Small Conductance SK(Ca) 2.1 (SK1, SKCa1) Channel Activators;Small Conductance SK(Ca) 2.2 (SK2, SKCa2) Channel Activators;Small Conductance SK(Ca) 2.3 (SK3, SKCa3, hKCa3) Channel Activators"
SJ001035025-1	SJ001035025	1	MOABOX:2892	USEMRPYUFJNFQN-UHFFFAOYSA-N	Cc1cc(NC2CCCCC2)nc(-n2nc(C)cc2C)n1	73029-73-9	"Small Conductance SK(Ca) 2.3 (SK3, SKCa3, hKCa3) Channel Activators"	KCNN2	KCNN3																															3782																															CHEMBL453730											909822					member																																																																																																																																																																17486140																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-8.715e-002	1.85448																															-0.01245	0.23181																															7	8																															2953	TOCRIS	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-762-862|MOABOX:2892|KCNN2|Small Conductance SK(Ca) 2.3 (SK3, SKCa3, hKCa3) Channel Activators"	Cc1cc(NC2CCCCC2)nc(n1)n3nc(C)cc3C	73029-73-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468508	285.38732	CYPPA	CYPPA | CYPPA			MOABOX:2892	KCNN2	"Small Conductance SK(Ca) 2.3 (SK3, SKCa3, hKCa3) Channel Activators"
SJ001035131-1	SJ001035131	1	MOABOX:2894	KBFUQFVFYYBHBT-UHFFFAOYSA-N	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1cccn1	289905-88-0	"Intermediate Conductance K(Ca) 3.1 (IKCa1;Gardos channel, SK41, IK1) Channel Blockers"	KCNN4																																																															CHEMBL498270											656734					member	10.1016/j.bmcl.2009.02.077	10.1124/mol.110.069807	10.2174/092986707780831186																																																																																																																																																													17584055	19282171	21363929	23667566																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		3.18768																																0.39846																																8																																HY-13519	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Neurological Disease|MOABOX:2894|KCNN4|Intermediate Conductance K(Ca) 3.1 (IKCa1;Gardos channel, SK41, IK1) Channel Blockers"	Clc1ccccc1C(c2ccccc2)(c3ccccc3)n4cccn4	289905-88-0	10588	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468800	344.83678	TRAM-34	TRAM-34 | TRAM-34	Pathway: Membrane Transporter/Ion Channel	Research Area: Neurological Disease	MOABOX:2894	KCNN4	"Intermediate Conductance K(Ca) 3.1 (IKCa1;Gardos channel, SK41, IK1) Channel Blockers"
SJ001033209-2	SJ001033209	2	MOABOX:2896	SCTZUZTYRMOMKT-UHFFFAOYSA-N	NC(=O)C(c1ccccc1)(c1ccc(F)cc1)c1ccc(F)cc1	289656-45-7	"Intermediate Conductance K(Ca) 3.1 (IKCa1;Gardos channel, SK41, IK1) Channel Blockers"	KCNN4																																																															CHEMBL405821											216327					member	10.1007/s11064-017-2223-y																																																																																																																																																															17584055	18232633	23121096																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.75896																																0.34487																																8																																HY-50694	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Others|MOABOX:2896|KCNN4|Intermediate Conductance K(Ca) 3.1 (IKCa1;Gardos channel, SK41, IK1) Channel Blockers"	NC(=O)C(c1ccccc1)(c2ccc(F)cc2)c3ccc(F)cc3	289656-45-7	1520	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469088	323.33601	SENICAPOC; ICA-17043	SENICAPOC; ICA-17043 | SENICAPOC; ICA-17043	Pathway: Membrane Transporter/Ion Channel	Research Area: Others	MOABOX:2896	KCNN4	"Intermediate Conductance K(Ca) 3.1 (IKCa1;Gardos channel, SK41, IK1) Channel Blockers"
SJ000285713-14	SJ000285713	14	MOABOX:2898	VNFPBHJOKIVQEB-UHFFFAOYSA-N	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1	117829-71-7	"Intermediate Conductance K(Ca) 3.1 (IKCa1;Gardos channel, SK41, IK1) Channel Blockers;Lanosterol 14alpha-demethylase Inhibitors;Angiogenesis Inhibitors"	CYP51A1	KCNN4																															3783																															CHEMBL104											2812	133951	492173	6476803	9810286	member	10.1016/j.bmcl.2009.02.077	10.1021/jm070663s	10.1124/dmd.106.013888	10.2174/092986707780831186																																																																																																																																																												12678783	17194716	18232633	19282171																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.16016	2.93624																															0.02002	0.36703																															8	8																															AG00393K	ANGENE	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-557-756|MOABOX:2898|CYP51A1|Intermediate Conductance K(Ca) 3.1 (IKCa1;Gardos channel, SK41, IK1) Channel Blockers;Lanosterol 14alpha-demethylase Inhibitors;Angiogenesis Inhibitors"	Clc1ccccc1C(c2ccccc2)(c3ccccc3)n4ccnc4	23593-75-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468124	344.83678	CLOTRIMAZOLE	"CLOTRIMAZOLE | ""CLOTRIMAZOLE | AES-210 | BAY-5097 | EVP-3546 | EVPK-0003546 |"" | CLOTRIMAZOLE | ""CLOTRIMAZOLE | AES-210 | BAY-5097 | EVP-3546 | EVPK-0003546 |"""			MOABOX:2898	CYP51A1	"Intermediate Conductance K(Ca) 3.1 (IKCa1;Gardos channel, SK41, IK1) Channel Blockers;Lanosterol 14alpha-demethylase Inhibitors;Angiogenesis Inhibitors"
SJ001034951-1	SJ001034951	1	MOABOX:2900	MCBBKIXEHFOEKH-UHFFFAOYSA-N	CCCCCC(=O)Nc1c(C)cc(Br)cc1C		Voltage-Gated K(V) 7.2 (KCNQ2) Channel Activators	KCNQ2	KCNQ3																															3786																																										3601868					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.92127	0																															-0.13161	0.0																															7	7																															STK155799	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-958-943|MOABOX:2900|KCNQ2|Voltage-Gated K(V) 7.2 (KCNQ2) Channel Activators	CCCCCC(=O)Nc1c(C)cc(Br)cc1C	462617-36-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468346	298.2187	STK155799	STK155799 | STK155799			MOABOX:2900	KCNQ2	Voltage-Gated K(V) 7.2 (KCNQ2) Channel Activators
SJ000574281-9	SJ000574281	9	MOABOX:2906	YCOYDOIWSSHVCK-UHFFFAOYSA-N	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1	212141-51-0	Angiogenesis Inhibitors;Aromatase Inhibitors;Inhibitors of Signal Transduction Pathways;KIT (C-KIT) Inhibitors;PDGFRbeta Inhibitors;VEGFR-1 (Flt-1) Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;VEGFR-3 (FLT4) Inhibitors	FLT1	KDR	KIT																														3791	3815																														CHEMBL101253	CHEMBL2142861	CHEMBL75232									151193	151194	9872019	9886292	15604672	virtual	10.1016/j.bmc.2007.03.055	10.1016/j.ejmech.2010.09.002	10.1021/acs.jmedchem.5b01582	10.1021/jm020899q	10.1021/jm0301641	10.1021/jm049538w	10.1021/jm0504151	10.1021/jm050559f	10.1021/jm9909443	10.1158/0008-5472.CAN-04-4409	10.1158/1078-0432.CCR-05-2028	10.2174/0929867043455756	10.2174/1389557043487349																																																																																																																																																			10882357	11607931	12171522	12171566	12477352	12941313	14640546	15032674	15032727	15711537	15742376	15743202	16107139	16275072	16302797	16321531	16364640	16460936	16565716	17064911	17177884	17177892	17188873	17253678	17416531	17481893	17539825	17692027	17869515	17979703	18183025	18420406	18991750	19124243	19188066	20629625	20869793	21034401	21429632	21447431	21762098	22037378	22196268	22571661	23098265	23937569	25462265	26590508	26629594	26922228																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.69288	4.67336	0.54048																														0.08661	0.58417	0.06756																														8	8	8																														HY-12018	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:2906|FLT1|Angiogenesis Inhibitors;Aromatase Inhibitors;Inhibitors of Signal Transduction Pathways;KIT (C-KIT) Inhibitors;PDGFRbeta Inhibitors;VEGFR-1 (Flt-1) Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;VEGFR-3 (FLT4) Inhibitors	Clc1ccc(Nc2nnc(Cc3ccncc3)c4ccccc24)cc1	212141-51-0	18805	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469882	346.8129	VATALANIB DIHYDROCHLORIDE| PTK-787 | ZK 222584	"""VATALANIB DIHYDROCHLORIDE| PTK-787 | ZK 222584"" | ""VATALANIB DIHYDROCHLORIDE | PTK-787 | ZK-222584 | CGP-79787D | PTK/ZK |"" | VATALANIB (PTK787) 2HCL | VATALANIB 2 HCL | ""VATALANIB DIHYDROCHLORIDE| PTK-787 | ZK 222584"" | ""VATALANIB DIHYDROCHLORIDE | PTK-787 | ZK-222584 | CGP-79787D | PTK/ZK |"" | VATALANIB (PTK787) 2HCL | VATALANIB 2 HCL"	Pathway: Apoptosis; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:2906	FLT1	Angiogenesis Inhibitors;Aromatase Inhibitors;Inhibitors of Signal Transduction Pathways;KIT (C-KIT) Inhibitors;PDGFRbeta Inhibitors;VEGFR-1 (Flt-1) Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;VEGFR-3 (FLT4) Inhibitors
SJ001010645-2	SJ001010645	2	MOABOX:2908	GXWKSXUPEFVUOO-UHFFFAOYSA-N	Cc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1Br	300842-64-2	Angiogenesis Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-2 (FLK-1/KDR) Inhibitors	KDR																																																																										6918616					virtual																																																																																																																																																																17979703	25462265																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.65056																																0.20632																																8																																HY-19624	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:2908|KDR|Angiogenesis Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-2 (FLK-1/KDR) Inhibitors	Cc1ccc(Nc2nnc(Cc3ccncc3)c4ccccc24)cc1Br	300842-64-2	28528	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469064	405.29048	NVP-ACC789	NVP-ACC789 | NVP-ACC789	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:2908	KDR	Angiogenesis Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-2 (FLK-1/KDR) Inhibitors
SJ001010676-2	SJ001010676	2	MOABOX:2914	MLLQJNIKDWEEFT-UHFFFAOYSA-N	Nc1nccc(Oc2ccc3c(C(=O)Nc4cccc(C(F)(F)F)c4)cccc3c2)n1	861875-60-7	Inhibitors of Signal Transduction Pathways;Protein Kinase Inhibitors	KDR																																																															CHEMBL4104297											16004702					virtual	10.1021/acs.jmedchem.5b01582	10.1021/acs.jmedchem.7b01731																																																																																																																																																														26629594	29400470																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.52552																																0.19069																																8																																HY-100394	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Endocrinology; Cancer|MOABOX:2914|KDR|Inhibitors of Signal Transduction Pathways;Protein Kinase Inhibitors	Nc1nccc(Oc2ccc3c(cccc3c2)C(=O)Nc4cccc(c4)C(F)(F)F)n1	861875-60-7	21298	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469915	424.37531	NVP-BAW2881	NVP-BAW2881 | NVP-BAW2881	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Endocrinology; Cancer	MOABOX:2914	KDR	Inhibitors of Signal Transduction Pathways;Protein Kinase Inhibitors
SJ001034940-1	SJ001034940	1	MOABOX:2934	BLAFVGLBBOPRLP-UHFFFAOYSA-N	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1	269390-77-4	VEGFR-2 (FLK-1/KDR) Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-3 (FLT4) Inhibitors;Angiogenesis Inhibitors	FLT4	KDR																															3791																															CHEMBL153843											6398883					member	10.1002/cmdc.200900373	10.1016/j.bmcl.2007.10.084	10.1016/j.bmcl.2008.03.068	10.1016/j.ejmech.2010.09.002	10.1021/acs.jmedchem.5b01582	10.1021/jm020899q																																																																																																																																																										12477352	16275072	16321531	16364640	16460936	16783341	16893647	17177884	17188873	17481893	17539825	17979703	17983745	18420406	19124243	19188066	19921722	20869793	21034401	21762098	26629594																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.72048	3.43784																															0.09006	0.42973																															8	8																															16351	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-660-068|MOABOX:2934|FLT4|VEGFR-2 (FLK-1/KDR) Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-3 (FLT4) Inhibitors;Angiogenesis Inhibitors	FC(F)(F)c1cccc(NC(=O)c2ccccc2NCc3ccncc3)c1	269390-77-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468318	371.35575	AAL-993 | VEGFR TYROSINE KINASE INHIBITOR VI | ZK 260253	"""AAL-993 | VEGFR TYROSINE KINASE INHIBITOR VI | ZK 260253"" | ""AAL-993 | VEGFR TYROSINE KINASE INHIBITOR VI | ZK 260253"""			MOABOX:2934	FLT4	VEGFR-2 (FLK-1/KDR) Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-3 (FLT4) Inhibitors;Angiogenesis Inhibitors
SJ000773201-2	SJ000773201	2	MOABOX:2948	GGPZCOONYBPZEW-UHFFFAOYSA-N	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1	269390-69-4	VEGFR-1 (Flt-1) Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;KIT (C-KIT) Inhibitors;Angiogenesis Inhibitors	FLT1	KDR	KIT																														3791	3815																														CHEMBL101683											9797919					virtual	10.1016/j.bmcl.2008.03.068																																																																																																																																																															12171566	12941313	17064911	17869515	18420406	21762098	30620194																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															0.82616	1.59568	3.488e-002																														0.10327	0.19946	0.00436																														8	8	8																														17654	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-561-457|MOABOX:2948|FLT1|VEGFR-1 (Flt-1) Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;KIT (C-KIT) Inhibitors;Angiogenesis Inhibitors	Clc1ccc(NC(=O)c2ccccc2NCc3ccncc3)cc1	269390-69-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468653	337.80284	VEGFR TKI INHIBITOR II | VEGF RECEPTOR TYROSINE KINASE INHIBITOR II  |	"""VEGFR TKI INHIBITOR II | VEGF RECEPTOR TYROSINE KINASE INHIBITOR II  |"" | ""VEGFR TKI INHIBITOR II | VEGF RECEPTOR TYROSINE KINASE INHIBITOR II  |"""			MOABOX:2948	FLT1	VEGFR-1 (Flt-1) Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;KIT (C-KIT) Inhibitors;Angiogenesis Inhibitors
SJ000796041-5	SJ000796041	5	MOABOX:2956	FGTCROZDHDSNIO-UHFFFAOYSA-N	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12	728033-96-3	VEGFR-2 (FLK-1/KDR) Inhibitors;PDGFRbeta Inhibitors;KIT (C-KIT) Inhibitors;Angiogenesis Inhibitors	ABL1	KDR	KIT	PDGFRB																													3791	3815	5159																													CHEMBL1614710											9868037	142482736				member	10.1158/0008-5472.CAN-05-2873	10.1158/1535-7163.MCT-05-0114																																																																																																																																																														16093434	16424037	17692027	17979703	21428893	21920748	23098265	23410165																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														0.34488	2.25248	2.55744	0.69768																													0.04311	0.28156	0.31968	0.08721																													8	8	8	8																													HY-10204	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:2956|ABL1|VEGFR-2 (FLK-1/KDR) Inhibitors;PDGFRbeta Inhibitors;KIT (C-KIT) Inhibitors;Angiogenesis Inhibitors	FC(F)(F)Oc1ccc(NC(=O)c2sccc2NCc3ccnc4ccccc34)cc1	728033-96-3	10516	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469312	443.44155	OSI-930	OSI-930 | OSI-930	Pathway: Apoptosis; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:2956	ABL1	VEGFR-2 (FLK-1/KDR) Inhibitors;PDGFRbeta Inhibitors;KIT (C-KIT) Inhibitors;Angiogenesis Inhibitors
SJ001034863-1	SJ001034863	1	MOABOX:2974	YKYCELLZOAVFCT-UHFFFAOYSA-N	Cc1ccc(S(=O)(=O)Nc2nnc(-c3ccccc3)s2)cc1	19948-89-1	Kynurenine 3-Monooxygenase Inhibitors	KMO																																																																										3797233					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																STK387551	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-324-123|MOABOX:2974|KMO|Kynurenine 3-Monooxygenase Inhibitors	Cc1ccc(cc1)S(=O)(=O)Nc2nnc(s2)c3ccccc3	19948-89-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468117	331.41262	STK387551	STK387551 | STK387551			MOABOX:2974	KMO	Kynurenine 3-Monooxygenase Inhibitors
SJ001035250-1	SJ001035250	1	MOABOX:2976	NDPBMCKQJOZAQX-UHFFFAOYSA-N	COc1ccc(S(=O)(=O)Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1OC	199666-03-0	Kynurenine 3-Monooxygenase Inhibitors	KMO																																																															CHEMBL134915											5282337	143631381	143631382			member																																																																																																																																																																22942319	26207924	27838184	28302400																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.9968																																0.1246																																8																																HY-12347	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Neurological Disease|MOABOX:2976|KMO|Kynurenine 3-Monooxygenase Inhibitors	COc1ccc(cc1OC)S(=O)(=O)Nc2nc(cs2)c3cccc(c3)[N+](=O)[O-]	199666-03-0	13123	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469304	421.4475	RO 61-8048	RO 61-8048 | RO 61-8048	Pathway: Others	Research Area: Neurological Disease	MOABOX:2976	KMO	Kynurenine 3-Monooxygenase Inhibitors
SJ001034847-1	SJ001034847	1	MOABOX:2988	ZFCPCFWCBDYWAI-UHFFFAOYSA-N	O=C(O)CSc1nsc(SCC(=O)O)n1		Lck Kinase SH2 domain Inhibitors	LCK																																																															CHEMBL323896											1713122					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																AG-664/25098006	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-801-823|MOABOX:2988|LCK|Lck Kinase SH2 domain Inhibitors	OC(=O)CSc1nsc(SCC(=O)O)n1	400877-99-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468091	266.31784	AG-664/25098006	AG-664/25098006 | AG-664/25098006			MOABOX:2988	LCK	Lck Kinase SH2 domain Inhibitors
SJ000285187-20	SJ000285187	20	MOABOX:2994	CMSMOCZEIVJLDB-UHFFFAOYSA-N	O=P1(N(CCCl)CCCl)NCCCO1	50-18-0	DNA alkylating agent prodrug;Apoptosis Inducers;BCL2 Expression Inhibitors;LGALS1 Expression Inhibitors	LGALS1																																																															CHEMBL1200796	CHEMBL88										2907	22420	311947	431989	434092	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																AG0039L8	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-739-014|MOABOX:2994|LGALS1|DNA alkylating agent prodrug;Apoptosis Inducers;BCL2 Expression Inhibitors;LGALS1 Expression Inhibitors	ClCCN(CCCl)P1(=O)NCCCO1	6055-19-2	NA	GENERAL	NO_SALT	0	H2O	1	1468364	261.08596	CYCLOPHOSPHAMIDE	"CYCLOPHOSPHAMIDE | ""CYCLOPHOSPHAMIDE HYDRATE | CYCLOPHOSPHAMIDE MONOHYDRATE | NSC-26271 | CYTOXAN"" | CYCLOPHOSPHAMIDE | ""CYCLOPHOSPHAMIDE HYDRATE | CYCLOPHOSPHAMIDE MONOHYDRATE | NSC-26271 | CYTOXAN"""			MOABOX:2994	LGALS1	DNA alkylating agent prodrug;Apoptosis Inducers;BCL2 Expression Inhibitors;LGALS1 Expression Inhibitors
SJ001035358-1	SJ001035358	1	MOABOX:2996	BIWQNIMLAISTBV-UHFFFAOYSA-N	Cc1ccc(B(O)O)cc1	5720-05-8	Endothelial Lipase (EL) Inhibitors	LIPG																																																															CHEMBL140780											79799	57367533	57416970	67240260	68626530	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-5.572e-002																																-0.00796																																7																																HY-21626	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: | Research Area: |MOABOX:2996|LIPG|Endothelial Lipase (EL) Inhibitors	Cc1ccc(cc1)B(O)O	5720-05-08	99301	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469732	135.95616	4-TOLUENEBORONIC ACID	4-TOLUENEBORONIC ACID | 4-TOLUENEBORONIC ACID	Pathway:	Research Area:	MOABOX:2996	LIPG	Endothelial Lipase (EL) Inhibitors
SJ001034834-1	SJ001034834	1	MOABOX:3000	ZGQHOOMVABRSSX-UHFFFAOYSA-N	CN(C)C(=O)On1nnc2ccccc21	39968-13-3	Triacylglycerol Lipase (Hormone-Sensitive Lipase) Inhibitors	LIPC	LIPE	LIPG	LIPF																													3991	9388	8513																																								3250344					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0																													0.0	0.0	0.0	0.0																													7	7	7	7																													EN300-7493741	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-815-735|MOABOX:3000|LIPC|Triacylglycerol Lipase (Hormone-Sensitive Lipase) Inhibitors	CN(C)C(=O)On1nnc2ccccc12	39968-13-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468076	206.2013	EN300-7493741	EN300-7493741 | EN300-7493741			MOABOX:3000	LIPC	Triacylglycerol Lipase (Hormone-Sensitive Lipase) Inhibitors
SJ001035256-1	SJ001035256	1	MOABOX:3002	JZXRLKWWVNUZRB-UHFFFAOYSA-N	NCCNC(=O)c1ccc(Cl)cn1	103878-83-7	MAO-B Inhibitors	MAOB																																																															CHEMBL2105029	CHEMBL279390										71307	163727	71297138	71312068	75420756	member	10.1002/ardp.201800309	10.1002/ddr.21576	10.1016/j.bioorg.2018.10.051	10.1016/j.bioorg.2018.12.030	10.1016/j.biopha.2018.06.064	10.1016/j.bmc.2018.09.032	10.1016/j.bmcl.2013.01.003	10.1016/j.bmcl.2014.04.021	10.1016/j.bmcl.2015.03.040	10.1016/j.bmcl.2015.09.049	10.1016/j.bmcl.2016.01.034	10.1016/j.bmcl.2018.01.049	10.1016/j.bmcl.2018.06.023	10.1016/j.bmcl.2019.01.016	10.1016/j.bmcl.2019.126677	10.1039/c8md00399h	10.1111/j.1365-2125.1994.tb04303.x	10.1111/jphp.12193	10.4014/jmb.1612.12025																																																																																																																																													7917773	16137882	22711801	23122934	23374869	24012182	24794105	24904963	25600407	25701250	25857942	26432037	26821818	27020523	28188065	28456030	29395970	29925480	30279044	30455149	30686752	30700029																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.56048																																0.07006																																8																																HY-14201	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Neuronal Signaling | Research Area: Neurological Disease|MOABOX:3002|MAOB|MAO-B Inhibitors	NCCNC(=O)c1ccc(Cl)cn1	103878-84-8	15810	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469357	199.6375	LAZABEMIDE | RO 19-6327	"""LAZABEMIDE | RO 19-6327"" | ""LAZABEMIDE | RO 19-6327"""	Pathway: Neuronal Signaling	Research Area: Neurological Disease	MOABOX:3002	MAOB	MAO-B Inhibitors
SJ000286964-6	SJ000286964	6	MOABOX:3008	QRYRORQUOLYVBU-VBKZILBWSA-N	CC(C)c1cc2c(c(O)c1O)[C@@]1(C(=O)O)CCCC(C)(C)[C@@H]1CC2	139236-75-2	PPARG agonist;Neurotrophic Factor Enhancers;Antioxidants;Triacylglycerol Lipase (Hormone-Sensitive Lipase) Inhibitors;Free Radical Scavengers	LIPC	LIPE	PPARG	LIPG	KEAP1	LIPF																											3991	5468	9388	9817	8513																											CHEMBL484853											65126	24802568				virtual	10.1111/j.1471-4159.2007.05039.x																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0	0	0	0	0																											0.0	0.0	0.0	0.0	0.0	0.0																											7	7	7	7	7	7																											BD105515	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-005-943-409|MOABOX:3008|LIPC|PPARG agonist;Neurotrophic Factor Enhancers;Antioxidants;Triacylglycerol Lipase (Hormone-Sensitive Lipase) Inhibitors;Free Radical Scavengers	CC(C)c1cc2CC[C@H]3C(C)(C)CCC[C@]3(C(=O)O)c2c(O)c1O	3650-09-07	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468663	332.43392	CARNOSIC ACID	CARNOSIC ACID | CARNOSIC ACID			MOABOX:3008	LIPC	PPARG agonist;Neurotrophic Factor Enhancers;Antioxidants;Triacylglycerol Lipase (Hormone-Sensitive Lipase) Inhibitors;Free Radical Scavengers
SJ000833854-2	SJ000833854	2	MOABOX:3012	LNDDRUPAICPXIN-GOSISDBHSA-N	Cc1noc(-c2ccc(-c3ccc(CC(=O)O)cc3)cc2)c1NC(=O)O[C@H](C)c1ccccc1	1228690-36-5	Lysophospholipid edg2 (LPA1) Receptor Antagonists	LPAR1																																																															CHEMBL2182052											46213949	56592848	56592849	56592850		virtual	10.1124/jpet.110.175901																																																																																																																																																															22894757																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.09648																																0.38706																																8																																HY-16040	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Inflammation/Immunology|MOABOX:3012|LPAR1|Lysophospholipid edg2 (LPA1) Receptor Antagonists	C[C@@H](OC(=O)Nc1c(C)noc1c2ccc(cc2)c3ccc(CC(=O)O)cc3)c4ccccc4	1228690-36-5	60668	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469061	456.48986	AM-095	AM-095 | AM-095	Pathway: GPCR/G Protein	Research Area: Inflammation/Immunology	MOABOX:3012	LPAR1	Lysophospholipid edg2 (LPA1) Receptor Antagonists
SJ000841718-3	SJ000841718	3	MOABOX:3016	LLIFMNUXGDHTRO-UHFFFAOYSA-N	Cc1noc(-c2ccc(CSCCC(=O)O)cc2)c1NC(=O)OC(C)c1ccccc1Cl	355025-24-0	Lysophospholipid edg2 (LPA1) Receptor Antagonists;Lysophospholipid edg7 (LPA3) Receptor Antagonists;LPAR1 antagonist;LPAR3 antagonist	LPAR1	LPAR3																															23566																															CHEMBL361501											10367662					member	10.1016/j.bmcl.2007.04.024	10.1124/jpet.110.175901																																																																																																																																																														14500756	16033271	16829511	17467986	20056548	21159750	22894757																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															0.72032	-0.12064																															0.09004	-0.01508																															8	8																															HY-13285	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Neurological Disease; Cancer|MOABOX:3016|LPAR1|Lysophospholipid edg2 (LPA1) Receptor Antagonists;Lysophospholipid edg7 (LPA3) Receptor Antagonists;LPAR1 antagonist;LPAR3 antagonist	CC(OC(=O)Nc1c(C)noc1c2ccc(CSCCC(=O)O)cc2)c3ccccc3Cl	355025-24-0	10172	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469417	474.95712	KI16425	KI16425 | KI16425	Pathway: GPCR/G Protein	Research Area: Neurological Disease; Cancer	MOABOX:3016	LPAR1	Lysophospholipid edg2 (LPA1) Receptor Antagonists;Lysophospholipid edg7 (LPA3) Receptor Antagonists;LPAR1 antagonist;LPAR3 antagonist
SJ001035087-1	SJ001035087	1	MOABOX:3020	KOZFSFOOLUUIGY-SOLYNIJKSA-N	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4	97161-97-2	"Leucine-Rich Repeat Kinase 2 (LRRK2;Dardarin) Inhibitors;""Leucine-Rich Repeat Kinase 2 (LRRK2;Dardarin) Inhibitors"""	CAMK2G	PRKCG	PRKCH	PRKCI	PRKCZ	PRKD3	LRRK2	CAMK2B	FYN																								5582	5583	5584	5590	23683	120892	816	2534																								CHEMBL281948											3035817					member	10.1016/j.bbrc.2008.11.048																																																																																																																																																															12270156	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				7.528e-002	6.488e-002	0	8.617e-002	0	3.696e-002	0	0.1628	0.11144																								0.00941	0.00811	0.0	0.01231	0.0	0.00528	0.0	0.02035	0.01393																								8	8	7	7	7	7	7	8	8																								11338	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-848-298|MOABOX:3020|CAMK2G|Leucine-Rich Repeat Kinase 2 (LRRK2;Dardarin) Inhibitors;\Leucine-Rich Repeat Kinase 2 (LRRK2;Dardarin) Inhibitors\	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35	99533-80-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468649	467.47274	K252A | SF 2370	"""K252A | SF 2370"" | ""K252A | SF 2370"""			MOABOX:3020	CAMK2G	Leucine-Rich Repeat Kinase 2 (LRRK2;Dardarin) Inhibitors;\Leucine-Rich Repeat Kinase 2 (LRRK2;Dardarin) Inhibitors\
SJ000287779-7	SJ000287779	7	MOABOX:3022	IYOZTVGMEWJPKR-IJLUTSLNSA-N	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1	129830-38-2	Calcium Sensitizers;Rho Kinase 2 (ROCK 2| ROCKalpha) Inhibitors;Rho Kinase 1 (ROCK 1| p160-ROCK) Inhibitors;Leucine-Rich Repeat Kinase 2 (LRRK2| Dardarin) Inhibitors	ROCK1	ROCK2	LRRK2																														9475	120892																														CHEMBL1605605	CHEMBL559147															member	10.1016/S0003-9861(02)00249-7	10.1016/j.bmcl.2010.04.070	10.1016/j.ejphar.2019.02.009	10.1021/jm9014263	10.1248/bpb.29.1138	10.2174/138161212800672688																																																																																																																																																										12023886	12171518	12672248	15892678	16249185	17018693	19689376	20000469	20462760	21145740	22571664	23275831	24119557	25248678	25898023	26039570																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						1.42744	1.4096	-0.27314																														0.17843	0.1762	-0.03902																														8	8	7																														HY-10583	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad | Research Area: Cancer|MOABOX:3022|ROCK1|Calcium Sensitizers;Rho Kinase 2 (ROCK 2| ROCKalpha) Inhibitors;Rho Kinase 1 (ROCK 1| p160-ROCK) Inhibitors;Leucine-Rich Repeat Kinase 2 (LRRK2| Dardarin) Inhibitors	C[C@@H](N)[C@@H]1CC[C@H](CC1)C(=O)Nc2ccncc2	129830-38-2	30536	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469354	247.33604	Y-27632 DIHYDROCHLORIDE	Y-27632 DIHYDROCHLORIDE | Y-27632 2HCL | Y-27632 DIHYDROCHLORIDE | Y-27632 2HCL	Pathway: Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad	Research Area: Cancer	MOABOX:3022	ROCK1	MOABOX:3022|ROCK1|Calcium Sensitizers;Rho Kinase 2 (ROCK 2|ROCKalpha) Inhibitors;Rho Kinase 1 (ROCK 1|p160-ROCK) Inhibitors;Leucine-Rich Repeat Kinase 2 (LRRK2|Dardarin) Inhibitors
SJ001035184-1	SJ001035184	1	MOABOX:3028	PVCTYSQBVIGZRU-KRWDZBQOSA-N	O=C(O)CCCN1CCC[C@H]1COc1ccc(Oc2ccc(Cl)cc2)cc1	929915-58-2	Leukotriene Synthesis Inhibitors;Leukotriene A4 Hydrolase Inhibitors	LTA4H																																																															CHEMBL565789											44537807	44818987	71738348	72199860	86611562	member																																																																																																																																																																19950900	20371179																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.05256																																0.25657																																8																																HY-10825	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:3028|LTA4H|Leukotriene Synthesis Inhibitors;Leukotriene A4 Hydrolase Inhibitors	OC(=O)CCCN1CCC[C@H]1COc2ccc(Oc3ccc(Cl)cc3)cc2	929915-58-2	22889	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469022	389.87256	DG051	DG051 | DG051	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:3028	LTA4H	Leukotriene Synthesis Inhibitors;Leukotriene A4 Hydrolase Inhibitors
SJ000287729-13	SJ000287729	13	MOABOX:3030	VGGGPCQERPFHOB-RDBSUJKOSA-N	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O	100992-60-7	Leukotriene A4 Hydrolase Inhibitors;Membrane Alanine Aminopeptidase (Aminopeptidase N) Inhibitors	ANPEP	LTA4H	LAP3																														4048	51056																														CHEMBL29292	CHEMBL538595										72172	6992132	11957481	44434006	78358331	member	10.1002/cmdc.201100298	10.1016/j.ejmech.2017.07.048																																																																																																																																																														2566685	3184126	8879550	11465152	12801228	16216010	17429823	20166950	21292493	21366301	23176597	27651294	28728898	28803047																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								0.5312	0.68848	1.8812																														0.0664	0.08606	0.23515																														8	8	8																														KS-5207	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466709	308.37276	BESTATIN HYDROCHLORIDE	BESTATIN HYDROCHLORIDE | EPIBESTATIN HYDROCHLORIDE | BESTATIN HCL | BESTATIN | BESTATIN HYDROCHLORIDE | EPIBESTATIN HYDROCHLORIDE | BESTATIN HCL | BESTATIN			MOABOX:3030	ANPEP	Leukotriene A4 Hydrolase Inhibitors;Membrane Alanine Aminopeptidase (Aminopeptidase N) Inhibitors
SJ001035172-1	SJ001035172	1	MOABOX:3038	SYZSSLLFRVDRHL-QPJJXVBHSA-N	COc1ccc(/C=C/CCCCOc2ccc(C(=O)c3cccc(C(=O)O)c3)cc2CCC(=O)O)cc1	117423-74-2	Leukotriene Antagonists;Leukotriene BLT (LTB4) Antagonists	LTB4R2																																																															CHEMBL49302											6444688					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.76e-003																																0.00022																																8																																HY-112737	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Inflammation/Immunology|MOABOX:3038|LTB4R2|Leukotriene Antagonists;Leukotriene BLT (LTB4) Antagonists	COc1ccc(\C=C\CCCCOc2ccc(cc2CCC(=O)O)C(=O)c3cccc(c3)C(=O)O)cc1	117423-74-2	81445	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468983	502.555	LY223982 | CGS23131 | SKF107324	"""LY223982 | CGS23131 | SKF107324"" | ""LY223982 | CGS23131 | SKF107324"""	Pathway: GPCR/G Protein	Research Area: Inflammation/Immunology	MOABOX:3038	LTB4R2	Leukotriene Antagonists;Leukotriene BLT (LTB4) Antagonists
SJ001010660-3	SJ001010660	3	MOABOX:3048	HJQILFPVRNHTIG-UHFFFAOYSA-N	Cc1cccc(Oc2cnc(O)nc2)c1	41964-07-2	Lyn Kinase Activators;Lyn kinase activator	LYN																																																															CHEMBL8030											39065					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.43328																																0.17916																																8																																HY-59047	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Metabolic Disease|MOABOX:3048|LYN|Lyn Kinase Activators;Lyn kinase activator	Cc1cccc(OC2=CNC(=O)N=C2)c1	41964-07-2	33510	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469864	202.2093	TOLIMIDONE	TOLIMIDONE | TOLIMIDONE	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Metabolic Disease	MOABOX:3048	LYN	Lyn Kinase Activators;Lyn kinase activator
SJ000285564-10	SJ000285564	10	MOABOX:3058	RMUCZJUITONUFY-UHFFFAOYSA-N	NNCCc1ccccc1	14847-47-3	MAO Inhibitors	MAOA																																																															CHEMBL1089	CHEMBL1200895										3675	28134	61100	154983	20976556	member	10.1016/j.bcp.2018.06.024																																																																																																																																																															27754693																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.72288																																0.09036																																8																																9080668	OTAVA	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-004-961-145|MOABOX:3058|MAOA|MAO Inhibitors	NNCCc1ccccc1	5470-36-0	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468541	136.19428	PHENELZINE SULFATE	PHENELZINE SULFATE | NARDIL | PHENELZINE SULFATE | NARDIL			MOABOX:3058	MAOA	MAO Inhibitors
SJ000855377-6	SJ000855377	6	MOABOX:3060	YHXISWVBGDMDLQ-UHFFFAOYSA-N	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	108375-13-9	MAO-A Inhibitors	MAOA																																																															CHEMBL86304											4235	9956208	20332355	68631135	70976853	member	10.1016/j.bmcl.2014.12.001																																																																																																																																																															21680183	22674756	24099995	24986657	25532905	25915461	26819666	28107736																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														0.84256																																0.10532																																8																																4348050	OTAVA	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-503-124|MOABOX:3060|MAOA|MAO-A Inhibitors	Clc1ccc(cc1)C(=O)NCCN2CCOCC2	108375-13-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468645	268.73928	MOCLOBEMIDE	MOCLOBEMIDE | RO 111163 | MOCLOBEMIDE | RO 111163			MOABOX:3060	MAOA	MAO-A Inhibitors
SJ001034933-1	SJ001034933	1	MOABOX:3062	WZXHSWVDAYOFPE-UHFFFAOYSA-N	COc1cc(Br)c2oc(C3CCNCC3)cc2c1	63638-90-4	MAO-A Inhibitors	MAOA																																																															CHEMBL160347											44570	44571	60210027	66920565	67920328	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.58224																																0.19778																																8																																AA00EIIY	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-418-097|MOABOX:3062|MAOA|MAO-A Inhibitors	COc1cc(Br)c2oc(cc2c1)C3CCNCC3	63638-91-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468284	310.18634	BROFAROMINE	BROFAROMINE | BROFAROMINE			MOABOX:3062	MAOA	MAO-A Inhibitors
SJ000285528-10	SJ000285528	10	MOABOX:3064	MXXWOMGUGJBKIW-YPCIICBESA-N	O=C(/C=C/C=C/c1ccc2c(c1)OCO2)N1CCCCC1	147030-08-8	ACAT Inhibitors;MAO-A Inhibitors;MAO-B Inhibitors	MAOA	MAOB	ACAT1																														4129	38																														CHEMBL43185											638024	9938483	87812288	88062316	88922935	member																																																																																																																																																																23102654																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-5.257e-002	-0.19705	0.42808																														-0.00751	-0.02815	0.05351																														7	7	8																														AS-17442	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466834	285.33766	PIPERINE	PIPERINE | PIPERINE			MOABOX:3064	MAOA	ACAT Inhibitors;MAO-A Inhibitors;MAO-B Inhibitors
SJ000312324-9	SJ000312324	9	MOABOX:3066	RUOKEQAAGRXIBM-GFCCVEGCSA-N	C#CCN[C@@H]1CCc2ccccc21	1204184-69-9	MAO-B Inhibitors	MAOB																																																															CHEMBL1201142	CHEMBL887										3052775	3052776	9794292	11679423	16660340	member	10.1002/cmdc.201100538	10.1002/cmdc.201500408	10.1007/s00044-019-02423-4	10.1016/j.bioorg.2019.03.043	10.1016/j.bmc.2013.08.019	10.1016/j.bmc.2016.04.012	10.1016/j.bmc.2016.11.048	10.1016/j.bmc.2016.12.013	10.1016/j.bmc.2017.02.027	10.1016/j.bmc.2017.03.070	10.1016/j.bmc.2018.01.030	10.1016/j.bmc.2018.02.037	10.1016/j.bmcl.2017.01.050	10.1016/j.bmcl.2017.09.055	10.1016/j.bmcl.2017.09.057	10.1016/j.bmcl.2018.10.048	10.1016/j.bmcl.2019.126625	10.1016/j.ejmech.2013.02.009	10.1016/j.ejmech.2016.12.009	10.1016/j.ejmech.2017.03.009	10.1016/j.ejmech.2018.01.029	10.1016/j.ejmech.2018.07.056	10.1016/j.ejmech.2019.04.016	10.1016/j.ejmech.2019.06.026	10.1021/acs.jmedchem.6b00527	10.1021/acs.jmedchem.7b00918	10.1021/acschemneuro.8b00530	10.1021/jm0310885	10.1021/jm300978h	10.1021/jm500729a	10.1039/c1md00176k	10.2174/092986711797379302																																																																																																																																15027867	15710600	16137882	16366596	18181565	21864289	22287164	22436387	22978824	23231395	23474901	24012376	24955776	25600407	27079124	27692996	27855360	27923535	27951485	28011206	28131710	28237559	28273563	28291352	28301816	28487125	28753307	29033232	29033233	29409707	29500132	30404719	30522087	31005056	31421966	31444085																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.7776																																0.3472																																8																																FS-3130	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	C#CCN[C@@H]1CCc2ccccc12	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466632	171.23832	RASAGILINE MESYLATE	"RASAGILINE MESYLATE | RASAGILINE MESYLATE | ""RASAGILINE MESYLATE| AGILECT| AZILECT | N-(PROP-2-YNYL)-2,3-DIHYDRO-1H-INDEN-1-AMINE | RASAGILINE MESYLATE"" | RASAGILINE MESYLATE | ""RASAGILINE MESYLATE| AGILECT| AZILECT | N-(PROP-2-YNYL)-2,3-DIHYDRO-1H-INDEN-1-AMINE | RASAGILINE MESYLATE"""			MOABOX:3066	MAOB	MAO-B Inhibitors
SJ000286555-3	SJ000286555	3	MOABOX:3070	AIFRHYZBTHREPW-UHFFFAOYSA-N	c1ccc2c(c1)[nH]c1cnccc12	244-63-3	"Indoleamine 2,3-dioxygenase Inhibitors;MAO-B Inhibitors"	IDO1	MAOB																															4129																															CHEMBL275224											64961	150184	21954263	53494985	53654567	member																																																																																																																																																																21269836	21992679																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.42384	0.21992																															-0.05298	0.02749																															8	8																															HY-W008566	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:3070|IDO1|Indoleamine 2,3-dioxygenase Inhibitors;MAO-B Inhibitors"	c1ccc2c(c1)[nH]c3cnccc23	244-63-3	63156	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469316	168.19462	NORHARMAN	NORHARMAN | NORHARMAN	Pathway: Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:3070	IDO1	"Indoleamine 2,3-dioxygenase Inhibitors;MAO-B Inhibitors"
SJ001010832-3	SJ001010832	3	MOABOX:3074	FIMYFEGKMOCQKT-UHFFFAOYSA-N	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F	874101-00-5	MEK1 Inhibitors;Inhibitors of Signal Transduction Pathways	MAP2K1																																																															CHEMBL1614766											11548630	71526743				member																																																																																																																																																																21316218	21898833	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.97056																																0.12132																																8																																HY-14719	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: MAPK/ERK Pathway | Research Area: Cancer|MOABOX:3074|MAP2K1|MEK1 Inhibitors;Inhibitors of Signal Transduction Pathways	OCCONC(=O)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc3ccc(I)cc3F	874101-00-5	12553	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469639	565.28164	RO4987655	RO4987655 | RO4987655	Pathway: MAPK/ERK Pathway	Research Area: Cancer	MOABOX:3074	MAP2K1	MEK1 Inhibitors;Inhibitors of Signal Transduction Pathways
SJ000784300-6	SJ000784300	6	MOABOX:3080	RDSACQWTXKSHJT-NSHDSACASA-N	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1	923032-36-4	MEK1 Inhibitors;MEK2 Inhibitors	MAP2K1	MAP2K2																															5605																															CHEMBL1236682											44182295	46894129	56962347	57336821		member	10.1158/0008-5472.CAN-09-0679																																																																																																																																																															29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.97264	3.304e-002																															0.12158	0.00413																															8	8																															T6636	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-293-525|MOABOX:3080|MAP2K1|MEK1 Inhibitors;MEK2 Inhibitors	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C3(C[C@H](O)CO)CC3	923032-37-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468129	572.33718	REFAMETINIB	"REFAMETINIB | ""RDEA-119 | AR-119 | BAY-86-9766 | BAY-869766"" | REFAMETINIB | ""RDEA-119 | AR-119 | BAY-86-9766 | BAY-869766"""			MOABOX:3080	MAP2K1	MEK1 Inhibitors;MEK2 Inhibitors
SJ000556682-16	SJ000556682	16	MOABOX:3082	CYOHGALHFOKKQC-UHFFFAOYSA-N	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21	606143-52-6	MEK1 Inhibitors;MEK2 Inhibitors;Inhibitors of Signal Transduction Pathways	MAP2K1	MAP2K2																															5605																															CHEMBL1614701	CHEMBL2105684										10127622	16214875	24778467	53393006	142808142	member	10.1002/cmdc.201000354	10.1073/pnas.0905833106																																																																																																																																																														16787382	19799530	20180757	21110380	21953275	22037378	22257058	23474388	26611920	29191878	29317148																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											0.45296	0.3912																															0.05662	0.0489																															8	8																															HY-50706	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; MAPK/ERK Pathway | Research Area: Cancer|MOABOX:3082|MAP2K1|MEK1 Inhibitors;MEK2 Inhibitors;Inhibitors of Signal Transduction Pathways	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(cc12)C(=O)NOCCO	606143-52-6	46103	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469028	457.6814	SELUMETINIB	"SELUMETINIB | ""ARRY-142886 | ARRY-886 | AZD-6244"" | AZD6244 | SELUMETINIB | ""ARRY-142886 | ARRY-886 | AZD-6244"" | AZD6244"	Pathway: Apoptosis; MAPK/ERK Pathway	Research Area: Cancer	MOABOX:3082	MAP2K1	MEK1 Inhibitors;MEK2 Inhibitors;Inhibitors of Signal Transduction Pathways
SJ000287864-9	SJ000287864	9	MOABOX:3084	ACPOUJIDANTYHO-UHFFFAOYSA-N	O=C1c2ccccc2-c2n[nH]c3cccc1c23	120093-15-4	"AP-1 Inhibitors;Inhibitors of Signal Transduction Pathways;Leucine-Rich Repeat Kinase 2 (LRRK2;Dardarin) Inhibitors;SAPK1a (JNK2) Inhibitors;SAPK1b (JNK3) Inhibitors;SAPK1c (JNK1) Inhibitors;""AP-1 Inhibitors;Inhibitors of Signal Transduction Pathways;Leucine-Rich Repeat Kinase 2 (LRRK2;Dardarin) Inhibitors;SAPK1a (JNK2) Inhibitors;SAPK1b (JNK3) Inhibitors;SAPK1c (JNK1) Inhibitors"""	MAPK8	MAPK9	MAPK10	MAP2K4	TTK	FLT3	GAK	CDK16	AAK1	BMP2K																							5601	5602	6416	7272	2322	2580	5127	22848	55589																							CHEMBL7064											8515	9906391	90729969	140968730		member	10.1002/anie.201300683	10.1016/j.bmc.2008.02.027	10.1021/bi901970c	10.1073/pnas.251194298																																																																																																																																																												11435459	11717429	12769633	12954329	15626722	15723614	15826602	15892678	16759099	16787380	17451961	17459703	17641674	18313304	21108268	23634759	25760409	30347329	31268308																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.19411	0	0	1.35952	1.65648	1.03176	-0.11158	-3.352e-002	0	0																							0.02773	0.0	0.0	0.16994	0.20706	0.12897	-0.01594	-0.00419	0.0	0.0																							7	7	7	8	8	8	7	8	7	7																							AS-14374	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	O=C1c2ccccc2c3n[nH]c4cccc1c34	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466767	220.22612	SP600125	"SP600125 | ""SP600125 | SAPK INHIBITOR II | JNK INHIBITOR II | ANTHRAPYRAZOLONE |"" | SP600125 | ""SP600125 | SAPK INHIBITOR II | JNK INHIBITOR II | ANTHRAPYRAZOLONE |"""			MOABOX:3084	MAPK8	"AP-1 Inhibitors;Inhibitors of Signal Transduction Pathways;Leucine-Rich Repeat Kinase 2 (LRRK2;Dardarin) Inhibitors;SAPK1a (JNK2) Inhibitors;SAPK1b (JNK3) Inhibitors;SAPK1c (JNK1) Inhibitors;""AP-1 Inhibitors;Inhibitors of Signal Transduction Pathways;Leucine-Rich Repeat Kinase 2 (LRRK2;Dardarin) Inhibitors;SAPK1a (JNK2) Inhibitors;SAPK1b (JNK3) Inhibitors;SAPK1c (JNK1) Inhibitors"""
SJ000574293-15	SJ000574293	15	MOABOX:3088	LIRYPHYGHXZJBZ-UHFFFAOYSA-N	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1	1187431-43-1	MEK inhibitor;MEK1 Inhibitors;MEK2 Inhibitors;Mitogen-Activated Protein (MAP) Kinase Kinase (MEK) Inhibitors;Inhibitors of Signal Transduction Pathways	MAP2K1	MAP2K2	MAP2K7																														5605	5609																														CHEMBL2103875	CHEMBL2105741										11707110	50992434	51039065	51039066	51039067	member	10.1158/1078-0432.CCR-10-2200																																																																																																																																																															22257058	29191878	30826508																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.88848	0.69784	0																														0.11106	0.08723	0.0																														8	8	7																														HY-10999A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; MAPK/ERK Pathway | Research Area: Cancer|MOABOX:3088|MAP2K1|MEK inhibitor;MEK1 Inhibitors;MEK2 Inhibitors;Mitogen-Activated Protein (MAP) Kinase Kinase (MEK) Inhibitors;Inhibitors of Signal Transduction Pathways	CN1C(=O)C(=C2N(C(=O)N(C3CC3)C(=O)C2=C1Nc4ccc(I)cc4F)c5cccc(NC(=O)C)c5)C	1187431-43-1	7379	GENERAL	NO_SALT	0	DIMETHYLSULFOXIDE	1	1469120	615.39479	TRAMETINIB	"TRAMETINIB | ""GSK-1120212B | JTP-74057 | 1120212 | GSK-1120212 | GSK1120212"" | TRAMETINIB (GSK1120212) | TRAMETINIB | ""GSK-1120212B | JTP-74057 | 1120212 | GSK-1120212 | GSK1120212"" | TRAMETINIB (GSK1120212)"	Pathway: Apoptosis; MAPK/ERK Pathway	Research Area: Cancer	MOABOX:3088	MAP2K1	MEK inhibitor;MEK1 Inhibitors;MEK2 Inhibitors;Mitogen-Activated Protein (MAP) Kinase Kinase (MEK) Inhibitors;Inhibitors of Signal Transduction Pathways
SJ000574301-12	SJ000574301	12	MOABOX:3108	CUHVIMMYOGQXCV-UHFFFAOYSA-N	Cc1cccc(C(C)c2cnc[nH]2)c1C	106807-72-1	Extracellular-regulated kinase (ERK) Activators;alpha2-Adrenoceptor Agonists;ADRA2A agonist;ADRA2B agonist;ADRA2C agonist	ADRA2B	ADRA2C	MAPK13																														152	5603																														CHEMBL537161	CHEMBL77921										68601	68602	44377741	57515975	66799797	member																																																																																																																																																																7914537																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.38773	0.3892	0																														0.05539	0.0556	0.0																														7	7	7																														AG00GRO4	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-394-853|MOABOX:3108|ADRA2B|Extracellular-regulated kinase (ERK) Activators;alpha2-Adrenoceptor Agonists;ADRA2A agonist;ADRA2B agonist;ADRA2C agonist	CC(c1c[nH]cn1)c2cccc(C)c2C	86347-14-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468389	200.27954	DEXMEDETOMIDINE	DEXMEDETOMIDINE | MEDETOMIDINE HCL | PRECEDEX | DEXMEDETOMIDINE | MEDETOMIDINE HCL | PRECEDEX			MOABOX:3108	ADRA2B	Extracellular-regulated kinase (ERK) Activators;alpha2-Adrenoceptor Agonists;ADRA2A agonist;ADRA2B agonist;ADRA2C agonist
SJ000512461-7	SJ000512461	7	MOABOX:3112	CDMGBJANTYXAIV-UHFFFAOYSA-N	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1	152121-47-6	Stress-Activated Protein (SAP/Jun) Kinase Inhibitors;Calcium Channel Activators;p38 MAPK Inhibitors	MAPK14	CSNK1D	GAK	MAPK11	MAPK12	RIPK2																											1453	2580	5600	6300	8767																											CHEMBL10											176155	11983196	16004703	16760644	18974352	member	10.1016/0014-5793(95)00357-F	10.1016/S0960-894X(98)00589-7	10.1016/S0968-0896(96)00212-X	10.1016/S1074-5521(98)90170-3	10.1016/j.bcp.2008.11.028	10.1016/j.bmc.2015.09.038	10.1016/j.bmcl.2004.07.024	10.1016/j.bmcl.2004.08.006	10.1016/j.bmcl.2004.08.007	10.1016/j.bmcl.2005.08.038	10.1016/j.bmcl.2008.02.033	10.1016/j.bmcl.2010.06.102	10.1016/j.bmcl.2011.05.114	10.1016/j.chembiol.2011.04.011	10.1016/j.ejmech.2019.111684	10.1016/j.ejphar.2010.01.011	10.1021/acs.jmedchem.6b00211	10.1021/bi981591x	10.1021/jm020873z	10.1021/jm049461b	10.1021/jm300327h	10.1021/jm300951u	10.1021/jm960415o	10.1038/sj.bjp.0706132	10.1073/pnas.2535024100	10.1124/jpet.119.259663	10.2174/156802606775270323	10.2174/1568026611313090005																																																																																																																																				8831759	9043657	9454815	9873604	9873730	10201821	10377223	10490895	10999467	10999468	11123361	11140741	11160612	11223862	11354358	11408558	11855979	12039561	12061876	12086485	12171518	12361396	12672248	12852754	12896977	15012994	15139749	15454231	15454232	15566301	15658855	15696598	15711537	15794933	15837310	15892678	15943486	15990304	16169718	16283677	16454763	16632356	16750367	16892352	17010605	17181176	17323937	17411025	17618114	17896971	18006306	18183025	18219408	18297096	18325768	18373337	18578517	19101521	19253982	19591487	19601892	19689286	19751974	20000735	20078117	20188577	20471255	20473979	20481631	20663667	21108268	21413808	21449619	21696951	21700206	22037378	22642504	22676210	22897496	22946527	23270382	23317165	23319368	23602399	23651481	23719673	24055074	24131218	24508134	24900264	25475894	25822739	26014481	26115577	26455654	27109867	27223276	28280261	28291685	28834431	29036906	29620886	30792101	31096153																																																																																																																																																																																																																																																																																																																																																																																																																																																														4.4592	0.45872	0.27104	0.46008	0.40754	0.99736																											0.5574	0.05734	0.03388	0.05751	0.05822	0.12467																											8	8	8	8	7	8																											HY-10256	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; MAPK/ERK Pathway | Research Area: Inflammation/Immunology; Cancer|MOABOX:3112|MAPK14|Stress-Activated Protein (SAP/Jun) Kinase Inhibitors;Calcium Channel Activators;p38 MAPK Inhibitors	CS(=O)c1ccc(cc1)c2nc(c3ccc(F)cc3)c([nH]2)c4ccncc4	152121-47-6	22898	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468876	377.43464	SB 203580	"SB 203580 | ""SB 203580 | PB 203580 | RWJ 64809"" | SB203580 | SB 203580 | ""SB 203580 | PB 203580 | RWJ 64809"" | SB203580"	Pathway: Autophagy; MAPK/ERK Pathway	Research Area: Inflammation/Immunology; Cancer	MOABOX:3112	MAPK14	Stress-Activated Protein (SAP/Jun) Kinase Inhibitors;Calcium Channel Activators;p38 MAPK Inhibitors
SJ000288250-10	SJ000288250	10	MOABOX:3114	DVEXZJFMOKTQEZ-JYFOCSDGSA-N	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N	109511-58-2	Apoptosis Inducers;Mitogen-Activated Protein (MAP) Kinase Kinase (MEK) Inhibitors;Extracellular-Regulated Kinase (ERK) Inhibitors;Jak2 Inhibitors	JAK2	MAP2K7	MAPK13																														5609	5603																														CHEMBL34704											3006531	16220066	71307532			virtual																																																																																																																																																																12769778	15853648																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0	0.2415																														0.0	0.0	0.0345																														7	7	7																														HY-12031	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Autophagy; MAPK/ERK Pathway | Research Area: Cancer|MOABOX:3114|JAK2|Apoptosis Inducers;Mitogen-Activated Protein (MAP) Kinase Kinase (MEK) Inhibitors;Extracellular-Regulated Kinase (ERK) Inhibitors;Jak2 Inhibitors	N\C(=C(\C#N)/C(=C(\N)/Sc1ccccc1N)/C#N)\Sc2ccccc2N	1173097-76-1	81383	GENERAL	NO_SALT	0	ETHANOL	1	1468950	380.48984	U0126	U0126 | U0126-ETOH | U0126 | U0126-ETOH	Pathway: Anti-infection; Autophagy; MAPK/ERK Pathway	Research Area: Cancer	MOABOX:3114	JAK2	Apoptosis Inducers;Mitogen-Activated Protein (MAP) Kinase Kinase (MEK) Inhibitors;Extracellular-Regulated Kinase (ERK) Inhibitors;Jak2 Inhibitors
SJ000556681-6	SJ000556681	6	MOABOX:3116	GFMMXOIFOQCCGU-UHFFFAOYSA-N	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl	212631-79-3	Mitogen-Activated Protein (MAP) Kinase Kinase (MEK) Inhibitors;Extracellular-Regulated Kinase (ERK) Inhibitors;Inhibitors of Signal Transduction Pathways	MAP2K7	MAPK13																															5603																															CHEMBL105442											6918454					member																																																																																																																																																																18056456	18952427	20586715	22257058																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0	0.17374																															0.0	0.02482																															7	7																															HY-50295	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; MAPK/ERK Pathway | Research Area: Cancer|MOABOX:3116|MAP2K7|Mitogen-Activated Protein (MAP) Kinase Kinase (MEK) Inhibitors;Extracellular-Regulated Kinase (ERK) Inhibitors;Inhibitors of Signal Transduction Pathways	Fc1ccc(C(=O)NOCC2CC2)c(Nc3ccc(I)cc3Cl)c1F	212631-79-3	24638	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468832	478.65954	PD-184352	PD-184352 | PD184352 (CI-1040) | PD-184352 | PD184352 (CI-1040)	Pathway: Apoptosis; MAPK/ERK Pathway	Research Area: Cancer	MOABOX:3116	MAP2K7	Mitogen-Activated Protein (MAP) Kinase Kinase (MEK) Inhibitors;Extracellular-Regulated Kinase (ERK) Inhibitors;Inhibitors of Signal Transduction Pathways
SJ000784294-7	SJ000784294	7	MOABOX:3118	MVCOAUNKQVWQHZ-UHFFFAOYSA-N	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1	1283526-53-3	SAPK2 (p38beta) Inhibitors;Inhibitors of Signal Transduction Pathways;p38 MAPK Inhibitors	MAPK14	MAPK11	MAPK13	MAPK12																													5600	5603	6300																													CHEMBL103667											156422	9854591	9941314	68107492	142274750	member	10.1016/j.bcp.2008.10.032	10.1016/j.bmc.2010.05.063	10.1016/j.bmcl.2006.10.044	10.1016/j.bmcl.2008.02.033	10.1016/j.bmcl.2010.06.102	10.1016/j.bmcl.2011.09.078	10.1016/j.chembiol.2011.04.011	10.1016/j.ejmech.2011.11.019	10.1016/j.ejphar.2010.01.011	10.1021/bi100070r	10.1021/jm048978k	10.1038/nsb770	10.1074/jbc.M414221200	10.1124/jpet.119.259663	10.3390/md17010053																																																																																																																																																	12086485	12941343	14561086	15711537	15975507	16178744	17095218	17181176	17482683	17541990	18183025	18325768	18602262	19027720	19356929	19799530	19928858	20471255	20621496	20655210	20663667	21413808	21700206	21888439	22014550	22037378	22154891	22642504	22749282	22946527	23270382	23937569	23941661	26800309	27223276	28834431	29133058	29620886	30642059																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															4.2148	1.01496	0.70288	1.10896																													0.52685	0.12687	0.08786	0.13862																													8	8	8	8																													T6277	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-168-795|MOABOX:3118|MAPK14|SAPK2 (p38beta) Inhibitors;Inhibitors of Signal Transduction Pathways;p38 MAPK Inhibitors	Cc1ccc(cc1)n2nc(cc2NC(=O)Nc3ccc(OCCN4CCOCC4)c5ccccc35)C(C)(C)C	285983-48-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468128	527.65718	DORAMAPIMOD | BIBR-796 | BIRB-0796 | BIRB-796 | BIRB-796 BS |	"""DORAMAPIMOD | BIBR-796 | BIRB-0796 | BIRB-796 | BIRB-796 BS |"" | R8104/65/1 | BIRB 796 (DORAMAPIMOD) | ""DORAMAPIMOD | BIBR-796 | BIRB-0796 | BIRB-796 | BIRB-796 BS |"" | R8104/65/1 | BIRB 796 (DORAMAPIMOD)"			MOABOX:3118	MAPK14	SAPK2 (p38beta) Inhibitors;Inhibitors of Signal Transduction Pathways;p38 MAPK Inhibitors
SJ000828659-4	SJ000828659	4	MOABOX:3120	IBCXZJCWDGCXQT-UHFFFAOYSA-N	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1	396129-53-6	Inhibitors of Signal Transduction Pathways;Activin Receptor Like Kinase 5 (ALK5;TbetaR-I) Inhibitors;p38 MAPK Inhibitors	TGFBR1	MAPK13																															5603																															CHEMBL261454											447966	145022278				member	10.1016/j.bmcl.2004.04.007																																																																																																																																																															12954047	14643325	15177479	16539403	18314943	19035792	19640613	21428893	23130626																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0	3.44096																															0.0	0.43012																															7	8																															HY-13462	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: TGF-beta/Smad | Research Area: Cancer|MOABOX:3120|TGFBR1|Inhibitors of Signal Transduction Pathways;Activin Receptor Like Kinase 5 (ALK5;TbetaR-I) Inhibitors;p38 MAPK Inhibitors	c1ccc(nc1)c2n[nH]cc2c3ccnc4ccccc34	396129-53-6	13708	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469913	272.30398	FUSI/7147	FUSI/7147 | LY364947 | FUSI/7147 | LY364947	Pathway: TGF-beta/Smad	Research Area: Cancer	MOABOX:3120	TGFBR1	Inhibitors of Signal Transduction Pathways;Activin Receptor Like Kinase 5 (ALK5;TbetaR-I) Inhibitors;p38 MAPK Inhibitors
SJ001010735-2	SJ001010735	2	MOABOX:3126	VGUSQKZDZHAAEE-UHFFFAOYSA-N	Cc1ccc(C(=O)NC2CC2)cc1-n1ncc(C(=O)c2cccc(C#N)c2)c1N	836683-15-9	p38 MAPK Inhibitors	MAPK14																																																																										11338127					virtual	10.1124/jpet.119.259663																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.16352																																0.27044																																8																																HY-16715	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; MAPK/ERK Pathway | Research Area: Inflammation/Immunology|MOABOX:3126|MAPK14|p38 MAPK Inhibitors	Cc1ccc(cc1n2ncc(C(=O)c3cccc(c3)C#N)c2N)C(=O)NC4CC4	836683-15-9	23320	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469115	385.41856	ACUMAPIMOD	ACUMAPIMOD | ACUMAPIMOD	Pathway: Autophagy; MAPK/ERK Pathway	Research Area: Inflammation/Immunology	MOABOX:3126	MAPK14	p38 MAPK Inhibitors
SJ000288145-11	SJ000288145	11	MOABOX:3136	QFWCYNPOPKQOKV-UHFFFAOYSA-N	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N	167869-21-8	ERK1 Inhibitors;MEK1 Inhibitors;MEK2 Inhibitors;MKK4 Inhibitors	MAPK3	MAP2K1	MAP2K2	MAP2K4																													5604	5605	6416																													CHEMBL35482											4713	22402502	46853726	67575625	71573454	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-7.623e-002	0.52976	0.1449	0.23492																													-0.01089	0.07568	0.0207	0.03356																													7	7	7	7																													HY-12028	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Immunology/Inflammation; MAPK/ERK Pathway; Stem Cell/Wnt | Research Area: Cancer|MOABOX:3136|MAPK3|ERK1 Inhibitors;MEK1 Inhibitors;MEK2 Inhibitors;MKK4 Inhibitors	COc1cccc(C2=CC(=O)c3ccccc3O2)c1N	167869-21-8	12764	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468829	267.27932	PD 98059	"PD 98059 | ""PD-98059 | PD 98,059"" | PD98059 | PD 98059 | ""PD-98059 | PD 98,059"" | PD98059"	Pathway: Autophagy; Immunology/Inflammation; MAPK/ERK Pathway; Stem Cell/Wnt	Research Area: Cancer	MOABOX:3136	MAPK3	ERK1 Inhibitors;MEK1 Inhibitors;MEK2 Inhibitors;MKK4 Inhibitors
SJ000773182-7	SJ000773182	7	MOABOX:3138	XVECMUKVOMUNLE-UHFFFAOYSA-N	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12	865362-74-9	ERK1 Inhibitors;ERK2 Inhibitors	MAPK1	MAPK3																															5595																															CHEMBL259551											11493598	53338808				member	10.1002/cmdc.201000354																																																																																																																																																															16139248	17896971	18077363	19689374	21110380	23419007																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.51504	1.75576																															0.18938	0.21947																															8	8																															HY-12275	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; MAPK/ERK Pathway; Stem Cell/Wnt | Research Area: Cancer|MOABOX:3138|MAPK1|ERK1 Inhibitors;ERK2 Inhibitors	Nc1n[nH]c2nnc(cc12)c3c(nn4ccccc34)c5ccccc5	865362-74-9	12769	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468823	327.34272	FR 180204	FR 180204 | FR 180204	Pathway: Apoptosis; MAPK/ERK Pathway; Stem Cell/Wnt	Research Area: Cancer	MOABOX:3138	MAPK1	ERK1 Inhibitors;ERK2 Inhibitors
SJ001034835-1	SJ001034835	1	MOABOX:3142	CXOCENPNQSXLGZ-UHFFFAOYSA-N	COC(=O)c1sccc1NC(=O)Cc1cccs1	676594-38-0	SAPK1a (JNK2) Inhibitors;SAPK1b (JNK3) Inhibitors;SAPK1c (JNK1) Inhibitors	MAPK8	MAPK9	MAPK10																														5601	5602																														CHEMBL1288895											2808202					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.77527	-0.26061	4.326e-002																														0.25361	-0.03723	0.00618																														7	7	7																														Z109088662	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-899-047|MOABOX:3142|MAPK8|SAPK1a (JNK2) Inhibitors;SAPK1b (JNK3) Inhibitors;SAPK1c (JNK1) Inhibitors	COC(=O)c1sccc1NC(=O)Cc2cccs2	676594-38-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468077	281.35064	Z109088662	Z109088662 | Z109088662			MOABOX:3142	MAPK8	SAPK1a (JNK2) Inhibitors;SAPK1b (JNK3) Inhibitors;SAPK1c (JNK1) Inhibitors
SJ001034952-1	SJ001034952	1	MOABOX:3158	RBTBFTRPCNLSDE-UHFFFAOYSA-N	CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1	1001913-24-1	Nitric Oxide Production Inhibitors;Tau Aggregation Inhibitors	MAPT																																																															CHEMBL191083	CHEMBL405110	CHEMBL550495									4139	6099	104827	11679141	11786557	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.3297																																0.0471																																7																																BD139888	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-110-157|MOABOX:3158|MAPT|Nitric Oxide Production Inhibitors;Tau Aggregation Inhibitors	CN(C)c1ccc2nc3ccc(cc3[s+]c2c1)N(C)C	61-73-4	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468350	284.39922	BD139888	BD139888 | BD139888			MOABOX:3158	MAPT	Nitric Oxide Production Inhibitors;Tau Aggregation Inhibitors
SJ001034666-1	SJ001034666	1	MOABOX:3160	VOJUXHHACRXLTD-UHFFFAOYSA-N	O=C(O)c1cc(O)c2ccccc2c1O	31519-22-9	Tau Aggregation Inhibitors	MAPT																																																															CHEMBL1232286											671	67924592	69078027	126466012		virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.78224																																0.09778																																8																																STR05294	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC(=O)c1cc(O)c2ccccc2c1O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466784	204.17882	STR05294	STR05294 | STR05294			MOABOX:3160	MAPT	Tau Aggregation Inhibitors
SJ000803700-4	SJ000803700	4	MOABOX:3164	XKPJTOHUPQWSOJ-HSZRJFAPSA-N	CCN(CC)Cc1ccc(C(=O)N(CCc2ccccc2OC)[C@@H]2CCNC2)cc1	947303-87-9	Site-1 Protease (S1P) Inhibitors	MBTPS1																																																															CHEMBL233611											23661637	90488837				member																																																																																																																																																																17583500																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.7312																																0.0914																																8																																HY-13447A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Metabolic Enzyme/Protease | Research Area: Infection; Metabolic Disease|MOABOX:3164|MBTPS1|Site-1 Protease (S1P) Inhibitors	CCN(CC)Cc1ccc(cc1)C(=O)N(CCc2ccccc2OC)[C@@H]3CCNC3	2248666-66-0	25017	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469901	409.5643	PF 429242	PF 429242 | PF 429242	Pathway: Anti-infection; Metabolic Enzyme/Protease	Research Area: Infection; Metabolic Disease	MOABOX:3164	MBTPS1	Site-1 Protease (S1P) Inhibitors
SJ001034999-1	SJ001034999	1	MOABOX:3166	GULVVTHHUIIMRL-WUFINQPMSA-N	CCCC(=O)C1(c2ccccc2)CCN(C(=O)[C@@H](Cc2ccc(OC)cc2)NC(=O)[C@@H](N)Cc2cncn2C)CC1	457893-92-4	Melanocortin MC1 Receptor Agonists	MC1R																																																															CHEMBL14642											9915813	60210130				member	10.1021/jm025600i	10.2174/1381612043382891																																																																																																																																																														12646021	15579046																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.27264																																0.40908																																8																																22231	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-277-051|MOABOX:3166|MC1R|Melanocortin MC1 Receptor Agonists	CCCC(=O)C1(CCN(CC1)C(=O)[C@@H](Cc2ccc(OC)cc2)NC(=O)[C@@H](N)Cc3cncn3C)c4ccccc4	457893-92-4	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468450	559.69904	BMS 470539 HCL	BMS 470539 HCL | BMS 470539 HCL			MOABOX:3166	MC1R	Melanocortin MC1 Receptor Agonists
SJ000841731-3	SJ000841731	3	MOABOX:3170	HLCHESOMJVGDSJ-LOYHVIPDSA-N	O=C(N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCC(Cn2cncn2)(C2CCCCC2)CC1)[C@H]1Cc2ccccc2CN1	312637-48-2	Melanocortin MC4 Receptor Agonists	MC3R	MC4R	MC5R																														4160	4161																														CHEMBL339053											9938402	127244276				member	10.1002/med.10064	10.1016/S0960-894X(03)00796-0	10.1016/j.bmc.2004.03.017	10.1016/j.bmcl.2003.09.036	10.1016/j.bmcl.2004.06.059	10.1016/j.bmcl.2005.01.060	10.1016/j.bmcl.2005.05.012	10.1016/j.bmcl.2005.11.095	10.1016/j.bmcl.2007.11.109	10.1016/j.bmcl.2011.02.090	10.1016/j.ygcen.2016.02.016	10.1021/bi0501840	10.1021/jm025539h	10.1021/jm049278i	10.2174/1381612043382891	10.2174/156802607780906609	10.2174/156802607780906663	10.2174/156802609788897826	10.2174/156802609788897871																																																																																																																																													12361385	14552781	14643322	14994367	15110848	15317471	15357964	15579046	15615531	15745810	15911261	15951175	16364639	16451057	16821763	17584127	17584130	17584133	18078748	19689363	19689364	21439820																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																-0.55288	5.70848	-0.58352																														-0.06911	0.71356	-0.07294																														8	8	8																														HY-10624	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Metabolic Disease|MOABOX:3170|MC3R|Melanocortin MC4 Receptor Agonists	Clc1ccc(C[C@@H](NC(=O)[C@H]2Cc3ccccc3CN2)C(=O)N4CCC(Cn5cncn5)(CC4)C6CCCCC6)cc1	312637-48-2	61409	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469117	589.17064	THIQ	THIQ | THIQ	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Metabolic Disease	MOABOX:3170	MC3R	Melanocortin MC4 Receptor Agonists
SJ001034869-1	SJ001034869	1	MOABOX:3176	WNWPRKWIJGVALY-UHFFFAOYSA-N	Cc1ccc2ccc(C(Nc3ccccn3)c3sccc3C)c(O)c2n1	430462-25-2	Apoptosis Inducers;Caspase Activators;Mcl-1 Inhibitors	MCL1																																																																										2907292					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.86584																																0.10823																																8																																STK509304	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-213-881|MOABOX:3176|MCL1|Apoptosis Inducers;Caspase Activators;Mcl-1 Inhibitors	Cc1ccc2ccc(C(Nc3ccccn3)c4sccc4C)c(O)c2n1	430462-25-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468142	361.46006	STK509304	STK509304 | STK509304			MOABOX:3176	MCL1	Apoptosis Inducers;Caspase Activators;Mcl-1 Inhibitors
SJ000784285-4	SJ000784285	4	MOABOX:3180	CEGSUKYESLWKJP-UHFFFAOYSA-N	c1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1	881202-16-0	MDM2 (hdm2) Inhibitors	MDM2																																																															CHEMBL2137530											11609586	92131146	122129986			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.28294																																-0.04042																																7																																AG008CDB	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-009-679-468|MOABOX:3180|MDM2|MDM2 (hdm2) Inhibitors	C(Cc1c[nH]c2ccccc12)Nc3ccc(Nc4ccncc4)cc3	881202-45-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468677	328.4103	SERDEMETAN	"SERDEMETAN | ""JNJ-26854165 | SERDEMETAN | JNJ-1 |"" | SERDEMETAN | ""JNJ-26854165 | SERDEMETAN | JNJ-1 |"""			MOABOX:3180	MDM2	MDM2 (hdm2) Inhibitors
SJ000857720-4	SJ000857720	4	MOABOX:3182	CLRSLRWKONPSRQ-IIPSPAQQSA-N	COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cc1)C(=O)C2	1313363-54-0	MDM2 (hdm2) Inhibitors	MDM2																																																															CHEMBL3601398																virtual																																																																																																																																																																26181851	28027532	30513790																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.9284																																0.24105																																8																																HY-15954	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:3182|MDM2|MDM2 (hdm2) Inhibitors	COc1cc2CC(=O)N([C@@H](c3ccc(Cl)cc3)c2cc1OC(C)C)c4ccc(cc4)N(C)C[C@@H]5CC[C@H](CC5)N6CCN(C)C(=O)C6	1313363-54-0	13866	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469087	659.25718	CGM-097	CGM-097 | CGM-097	Pathway: Apoptosis; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:3182	MDM2	MDM2 (hdm2) Inhibitors
SJ000855315-2	SJ000855315	2	MOABOX:3192	GLBZSOQDAOLMGC-UHFFFAOYSA-N	COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1	913376-83-7	c-Met) Inhibitors;HGFR (MET	MET																																																															CHEMBL460472											24764449					member	10.1021/jm201331s																																																																																																																																																															18553959	20015007	22320327	24320965	26717201																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.91688																																0.23961																																8																																SYN1144	AK_SCIENTIFIC	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-293-539|MOABOX:3192|MET|c-Met) Inhibitors;HGFR (MET	COc1ccc2c(Oc3ccc(NC(=O)C4=C(C)N(CC(C)(C)O)N(C4=O)c5ccccc5)nc3)ccnc2c1	913376-83-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468633	539.58176	AMG-458	AMG-458 | AMG-458			MOABOX:3192	MET	c-Met) Inhibitors;HGFR (MET
SJ000855133-4	SJ000855133	4	MOABOX:3194	JRWCBEOAFGHNNU-UHFFFAOYSA-N	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1	943540-75-8	Inhibitors of Signal Transduction Pathways;HGFR (MET;c-Met) Inhibitors	MET																																																															CHEMBL2133806											46911863	72715631				virtual	10.1016/j.ejmech.2016.03.076																																																																																																																																																															24320965	25745036	26005523	26717201	27061987	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																3.9216																																0.4902																																8																																HY-50683	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:3194|MET|Inhibitors of Signal Transduction Pathways;HGFR (MET;c-Met) Inhibitors	Cn1cc(cn1)c2ccc3nnc(n3n2)C(F)(F)c4ccc5ncccc5c4	943540-75-8	39744	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468995	377.35023	JNJ-38877605	JNJ-38877605 | JNJ-38877605	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:3194	MET	Inhibitors of Signal Transduction Pathways;HGFR (MET;c-Met) Inhibitors
SJ001034823-1	SJ001034823	1	MOABOX:3202	BKJXSQXZIOTRTP-UHFFFAOYSA-N	Brc1cccc(-c2c[nH]nn2)c1	35225-02-6	Methionine Aminopeptidase-2 (MetAP2) Inhibitors;Angiogenesis Inhibitors	METAP2																																																															CHEMBL382312											6400901					member																																																																																																																																																																16134930	22229417																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.338																																0.16725																																8																																Z1269168927	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-035-912-110|MOABOX:3202|METAP2|Methionine Aminopeptidase-2 (MetAP2) Inhibitors;Angiogenesis Inhibitors	Brc1cccc(c1)c2c[nH]nn2	35225-02-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468064	224.05734	Z1269168927	Z1269168927 | Z1269168927			MOABOX:3202	METAP2	Methionine Aminopeptidase-2 (MetAP2) Inhibitors;Angiogenesis Inhibitors
SJ000831480-3	SJ000831480	3	MOABOX:3204	MSHZHSPISPJWHW-PVDLLORBSA-N	CO[C@H]1[C@H]([C@@]2(C)O[C@@H]2CC=C(C)C)[C@]2(CC[C@H]1OC(=O)NC(=O)CCl)CO2	129298-91-5	Methionine Aminopeptidase-2 (MetAP2) Inhibitors;Angiogenesis Inhibitors	METAP2																																																															CHEMBL424278											369976					virtual	10.1016/S0968-0896(98)00078-9	10.1021/jo035065+	10.2174/092986712799320709																																																																																																																																																													9784858	14604668	16970390	17636946	19209899	22229417	22391578																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															3.96968																																0.49621																																8																																HY-101932	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer; Cardiovascular Disease|MOABOX:3204|METAP2|Methionine Aminopeptidase-2 (MetAP2) Inhibitors;Angiogenesis Inhibitors	CO[C@@H]1[C@@H](CC[C@]2(CO2)[C@H]1[C@@]3(C)O[C@@H]3CC=C(C)C)OC(=O)NC(=O)CCl	129298-91-5	87701	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469213	401.88172	TNP-470	TNP-470 | TNP-470	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer; Cardiovascular Disease	MOABOX:3204	METAP2	Methionine Aminopeptidase-2 (MetAP2) Inhibitors;Angiogenesis Inhibitors
SJ000556696-5	SJ000556696	5	MOABOX:3206	NGGMYCMLYOUNGM-CSDLUJIJSA-N	CO[C@H]1[C@H]([C@@]2(C)O[C@@H]2CC=C(C)C)[C@]2(CC[C@H]1OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)CO2	127913-45-5	Methionine Aminopeptidase-2 (MetAP2) Inhibitors;Angiogenesis Inhibitors	METAP2																																																															CHEMBL32838											6917655	76958970				virtual																																																																																																																																																																12877582	14684305	16134930	19209899																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		3.23968																																0.40496																																8																																T6841	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-199|MOABOX:3206|METAP2|Methionine Aminopeptidase-2 (MetAP2) Inhibitors;Angiogenesis Inhibitors	CO[C@@H]1[C@@H](CC[C@]2(CO2)[C@H]1[C@@]3(C)O[C@@H]3CC=C(C)C)OC(=O)\C=C\C=C\C=C\C=C\C(=O)O	23110-15-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468130	458.54396	FUMAGILLIN	FUMAGILLIN | FUMAGILLIN			MOABOX:3206	METAP2	Methionine Aminopeptidase-2 (MetAP2) Inhibitors;Angiogenesis Inhibitors
SJ000841248-4	SJ000841248	4	MOABOX:3210	RJIWZDNTCBHXAL-UHFFFAOYSA-N	O=[N+]([O-])c1ccc(O)c2ncccc12	4008-48-4	Antibiotic;Chelator;Methionine Aminopeptidase-2 (MetAP2) Inhibitors;Angiogenesis Inhibitors	METAP2	SIRT2	SIRT1																														22933	23411																														CHEMBL1454910	CHEMBL3251404										19910	417488	488236	498077	6338239	virtual	10.1002/cmdc.201100098.	10.1021/ml400034m	10.1039/c2ob06978d																																																																																																																																																													22229417	22391578	24376907	28089350																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.74296	-0.24472	-7.406e-002																														0.21787	-0.03496	-0.01058																														8	7	7																														HY-B1159	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Autophagy | Research Area: Infection; Cancer|MOABOX:3210|METAP2|Antibiotic;Chelator;Methionine Aminopeptidase-2 (MetAP2) Inhibitors;Angiogenesis Inhibitors	Oc1ccc(c2cccnc12)[N+](=O)[O-]	4008-48-4	17677	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469819	190.15554	8-HYDROXY-5-NITROQUINOLINE	8-HYDROXY-5-NITROQUINOLINE | 8-HYDROXY-5-NITROQUINOLINE	Pathway: Anti-infection; Autophagy	Research Area: Infection; Cancer	MOABOX:3210	METAP2	Antibiotic;Chelator;Methionine Aminopeptidase-2 (MetAP2) Inhibitors;Angiogenesis Inhibitors
SJ001035387-1	SJ001035387	1	MOABOX:3214	AIXMJTYHQHQJLU-UHFFFAOYSA-N	COC(=O)CC1CC(c2ccc(O)cc2)=NO1	478336-92-4	Macrophage Migration Inhibitory Factor (MIF) Inhibitors	MIF																																																															CHEMBL210858											4633677					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.18685																																0.16955																																7																																HY-16692	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Inflammation/Immunology|MOABOX:3214|MIF|Macrophage Migration Inhibitory Factor (MIF) Inhibitors	COC(=O)CC1CC(=NO1)c2ccc(O)cc2	478336-92-4	20437	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469873	235.23592	ISO-1 | MIF ANTAGONIST	"""ISO-1 | MIF ANTAGONIST"" | ""ISO-1 | MIF ANTAGONIST"""	Pathway: Others	Research Area: Inflammation/Immunology	MOABOX:3214	MIF	Macrophage Migration Inhibitory Factor (MIF) Inhibitors
SJ001034944-1	SJ001034944	1	MOABOX:3218	DDKGKOOLFLYZDL-UHFFFAOYSA-N	O=c1c(-c2ccc(O)c(O)c2)coc2cc(O)ccc12	485-63-2	Macrophage Migration Inhibitory Factor (MIF) Inhibitors;Tyrosinase Inhibitors;Melanin Inhibitors	MIF	TYR																															7299																															CHEMBL13486											5284648					member																																																																																																																																																																11170644	16420039	19090668	19275614	27156768																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	2.5456	-0.47586																															0.3182	-0.06798																															8	7																															20930	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-850-715|MOABOX:3218|MIF|Macrophage Migration Inhibitory Factor (MIF) Inhibitors;Tyrosinase Inhibitors;Melanin Inhibitors	Oc1ccc2C(=O)C(=COc2c1)c3ccc(O)c(O)c3	485-63-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468333	270.2369	"3',4',7-TRIHYDROXYISOFLAVONE | 3'-HYDROXY DAIDZEIN | 3',4',7-THIF"	"""3',4',7-TRIHYDROXYISOFLAVONE | 3'-HYDROXY DAIDZEIN | 3',4',7-THIF"" | ""3',4',7-TRIHYDROXYISOFLAVONE | 3'-HYDROXY DAIDZEIN | 3',4',7-THIF"""			MOABOX:3218	MIF	Macrophage Migration Inhibitory Factor (MIF) Inhibitors;Tyrosinase Inhibitors;Melanin Inhibitors
SJ001033557-2	SJ001033557	2	MOABOX:3220	RZKDEGZIFSJVNA-IBGZPJMESA-N	C[C@H]1CN(Cc2ccc(CC(=O)N3CCC(Nc4cccc(F)c4)CC3)cc2)CCN1	923565-21-3	Motilin Receptor Agonists	MLNR																																																															CHEMBL489095	CHEMBL489679										15984937	25222897				member																																																																																																																																																																19191554																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.538																																0.19225																																8																																HY-10922	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Metabolic Disease|MOABOX:3220|MLNR|Motilin Receptor Agonists	C[C@H]1CN(Cc2ccc(CC(=O)N3CCC(CC3)Nc4cccc(F)c4)cc2)CCN1	923565-21-3	11444	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469397	424.55412	CAMICINAL; GSK962040	CAMICINAL; GSK962040 | CAMICINAL; GSK962040	Pathway: GPCR/G Protein	Research Area: Metabolic Disease	MOABOX:3220	MLNR	Motilin Receptor Agonists
SJ000285823-11	SJ000285823	11	MOABOX:3222	ULGZDMOVFRHVEP-RWJQBGPGSA-N	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	114-07-8	Motilin Receptor Agonists;NF-kappaB (NFKB) Activation Inhibitors	MLNR																																																															CHEMBL1200476	CHEMBL1200506	CHEMBL1200510	CHEMBL3545060	CHEMBL3735423	CHEMBL3786307	CHEMBL532					12559	12560	71469	83935	83938	member	10.1016/j.jphs.2015.11.004	10.1021/jm0304865																																																																																																																																																														15027861	19006669	19191554	20869254	21570844																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.93536																																0.24192																																8																																HY-B0220	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Infection|MOABOX:3222|MLNR|Motilin Receptor Agonists;NF-kappaB (NFKB) Activation Inhibitors	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	114-07-8	15945	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469393	733.92678	ERYTHROMYCIN	"ERYTHROMYCIN | ""ERYTHROMYCIN GLUCEPTATE | ILOTYCIN GLUCEPTATE |"" | ERYTHROMYCIN | ""ERYTHROMYCIN GLUCEPTATE | ILOTYCIN GLUCEPTATE |"""	Pathway: Anti-infection	Research Area: Infection	MOABOX:3222	MLNR	Motilin Receptor Agonists;NF-kappaB (NFKB) Activation Inhibitors
SJ000287341-6	SJ000287341	6	MOABOX:3224	ODUOJXZPIYUATO-UHFFFAOYSA-N	CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1	81110-73-8	"Neprilysin (Enkephalinase, Neutral Endopeptidase, NEP) Inhibitors"	MME																																																															CHEMBL2103772											107751	11216080	89912776	90459334	90459473	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.87256																																0.10907																																8																																HY-17399	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:3224|MME|Neprilysin (Enkephalinase, Neutral Endopeptidase, NEP) Inhibitors"	CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc2ccccc2	81110-73-8	14560	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469638	385.47662	RACECADOTRIL	RACECADOTRIL | RACECADOTRIL	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:3224	MME	"Neprilysin (Enkephalinase, Neutral Endopeptidase, NEP) Inhibitors"
SJ000772411-4	SJ000772411	4	MOABOX:3240	OCSMOTCMPXTDND-OUAUKWLOSA-N	CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C	154039-60-8	"Matrix Metalloproteinase Inhibitors;Angiogenesis Inhibitors;""Matrix Metalloproteinase Inhibitors;Angiogenesis Inhibitors"""	MMP11	MMP14	MMP15	MMP16	MMP17	MMP19	MMP20	MMP27	MMP28	MMP21	MMP23A																						4323	4324	4325	4326	4327	9313	64066	79148	118856	8511																						CHEMBL279785											119031	88091600	88138983	88221345	88222634	virtual	10.1016/S0968-0896(02)00109-8	10.1016/j.ccr.2006.05.024	10.2174/187152009788451842																																																																																																																																																													9548812	11749499	12057646	12171558																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0	0.27128	-0.11432	-0.87206	0	0	0	-0.87206	0	0	0																						0.0	0.03391	-0.01429	-0.12458	0.0	0.0	0.0	-0.12458	0.0	0.0	0.0																						7	8	8	7	7	7	7	7	7	7	7																						HY-12169	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:3240|MMP11|Matrix Metalloproteinase Inhibitors;Angiogenesis Inhibitors;\Matrix Metalloproteinase Inhibitors;Angiogenesis Inhibitors\	CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C	154039-60-8	13636	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469264	331.40786	MARIMASTAT	MARIMASTAT | MARIMASTAT	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:3240	MMP11	Matrix Metalloproteinase Inhibitors;Angiogenesis Inhibitors;\Matrix Metalloproteinase Inhibitors;Angiogenesis Inhibitors\
SJ001033278-2	SJ001033278	2	MOABOX:3242	ROSNVSQTEGHUKU-UHFFFAOYSA-N	O=C(NO)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1	193022-04-7	"MMP-12 (Macrophage Elastase) Inhibitors;MMP-13 (Collagenase 3) Inhibitors;MMP-14 (Membrane-Type Matrix Metalloproteinase 1) Inhibitors;MMP-2 (Gelatinase A) Inhibitors;MMP-3 (Stromelysin 1) Inhibitors;MMP-8 (Neutrophil Collagenase) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;""MMP-12 (Macrophage Elastase) Inhibitors;MMP-13 (Collagenase 3) Inhibitors;MMP-14 (Membrane-Type Matrix Metalloproteinase 1) Inhibitors;MMP-2 (Gelatinase A) Inhibitors;MMP-3 (Stromelysin 1) Inhibitors;MMP-8 (Neutrophil Collagenase) Inhibitors;MMP-9 (Gelatinase B) Inhibitors"""	MMP14	MMP11	MMP15	MMP16	MMP17	MMP19	MMP23A	MMP20	MMP27	MMP28	MMP21																						4320	4324	4325	4326	4327	8511	9313	64066	79148	118856																						CHEMBL440498											3342298					member	10.1016/j.bmc.2014.07.025	10.1021/acs.jmedchem.6b01007	10.2174/187152009788451842																																																																																																																																																													19422229	25192810	25264600	27966948																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0	-0.1328	0	0	0	0	0	0	0	0	0																						0.0	-0.0166	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0																						7	8	7	7	7	7	7	7	7	7	7																						HY-10398	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:3242|MMP14|MMP-12 (Macrophage Elastase) Inhibitors;MMP-13 (Collagenase 3) Inhibitors;MMP-14 (Membrane-Type Matrix Metalloproteinase 1) Inhibitors;MMP-2 (Gelatinase A) Inhibitors;MMP-3 (Stromelysin 1) Inhibitors;MMP-8 (Neutrophil Collagenase) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;\MMP-12 (Macrophage Elastase) Inhibitors;MMP-13 (Collagenase 3) Inhibitors;MMP-14 (Membrane-Type Matrix Metalloproteinase 1) Inhibitors;MMP-2 (Gelatinase A) Inhibitors;MMP-3 (Stromelysin 1) Inhibitors;MMP-8 (Neutrophil Collagenase) Inhibitors;MMP-9 (Gelatinase B) Inhibitors\	ONC(=O)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1	193022-04-7	4076	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468894	425.8832	CTS-1027; RO 1130830; RS 130830	CTS-1027; RO 1130830; RS 130830 | CTS-1027; RO 1130830; RS 130830	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:3242	MMP14	MMP-12 (Macrophage Elastase) Inhibitors;MMP-13 (Collagenase 3) Inhibitors;MMP-14 (Membrane-Type Matrix Metalloproteinase 1) Inhibitors;MMP-2 (Gelatinase A) Inhibitors;MMP-3 (Stromelysin 1) Inhibitors;MMP-8 (Neutrophil Collagenase) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;\MMP-12 (Macrophage Elastase) Inhibitors;MMP-13 (Collagenase 3) Inhibitors;MMP-14 (Membrane-Type Matrix Metalloproteinase 1) Inhibitors;MMP-2 (Gelatinase A) Inhibitors;MMP-3 (Stromelysin 1) Inhibitors;MMP-8 (Neutrophil Collagenase) Inhibitors;MMP-9 (Gelatinase B) Inhibitors\
SJ001035232-1	SJ001035232	1	MOABOX:3268	YKPYIPVDTNNYCN-INIZCTEOSA-N	CC1(C)SCCN(S(=O)(=O)c2ccc(Oc3ccncc3)cc2)[C@H]1C(=O)NO	1435779-45-5	"MMP-2 (Gelatinase A) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;Angiogenesis Inhibitors;""MMP-2 (Gelatinase A) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;Angiogenesis Inhibitors"""	MMP2	MMP9	MMP14	MMP11	MMP15	MMP16	MMP17	MMP19	MMP23A	MMP20	MMP27	MMP28	MMP21																				4318	4323	4320	4324	4325	4326	4327	8511	9313	64066	79148	118856																				CHEMBL75094											466151	10321991	11757032	87984427	88091468	member	10.1002/cmdc.201800237	10.1002/stem.170237	10.1016/S0960-894X(00)00584-9	10.1016/S0960-894X(00)00646-6	10.1016/S0960-894X(01)00487-5	10.1016/j.bmc.2003.09.015	10.1016/j.bmc.2004.01.047	10.1016/j.bmcl.2005.01.024	10.1016/j.ejmech.2019.111563	10.1021/jm0307638	10.1021/jm990330y																																																																																																																																																					10437989	10579818	10669559	11133099	11212095	11549451	11749499	11754593	11814839	12217351	12678681	12713832	12789686	12930146	14642591	14711305	15080939	15544483	15713379	16483784	16611144	17251494	17267227	20196103																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														0	0	0	0	0	2.25832	0.59912	0	9.248e-002	0	0	0	0																				0.0	0.0	0.0	0.0	0.0	0.28229	0.07489	0.0	0.01156	0.0	0.0	0.0	0.0																				7	7	7	7	7	8	8	7	8	7	7	7	7																				HY-12170A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:3268|MMP2|MMP-2 (Gelatinase A) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;Angiogenesis Inhibitors;\MMP-2 (Gelatinase A) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;Angiogenesis Inhibitors\	CC1(C)SCCN([C@H]1C(=O)NO)S(=O)(=O)c2ccc(Oc3ccncc3)cc2	1435779-45-5	87869	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469225	423.50644	PRINOMASTAT HYDROCHLORIDE | AG3340 HYDROCHLORIDE | KB-R9896 HYDROCHLORIDE	"""PRINOMASTAT HYDROCHLORIDE | AG3340 HYDROCHLORIDE | KB-R9896 HYDROCHLORIDE"" | ""PRINOMASTAT HYDROCHLORIDE | AG3340 HYDROCHLORIDE | KB-R9896 HYDROCHLORIDE"""	Pathway: Apoptosis; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:3268	MMP2	MMP-2 (Gelatinase A) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;Angiogenesis Inhibitors;\MMP-2 (Gelatinase A) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;Angiogenesis Inhibitors\
SJ001035138-1	SJ001035138	1	MOABOX:3284	RSPDBEVKURKEII-ZCFIWIBFSA-N	O=c1[nH]c(=S)n(C[C@H]2CCCO2)c2nc[nH]c12	618913-30-7	Myeloperoxidase Inhibitors	MPO																																																																										10264211					member	10.1039/c7md00268h																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.20952																																0.40119																																8																																HY-111341	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Neurological Disease|MOABOX:3284|MPO|Myeloperoxidase Inhibitors	O=C1NC(=S)N(C[C@H]2CCCO2)c3[nH]cnc13	618913-30-7	28433	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468858	252.29288	AZD5904	AZD5904 | AZD5904	Pathway: Metabolic Enzyme/Protease	Research Area: Neurological Disease	MOABOX:3284	MPO	Myeloperoxidase Inhibitors
SJ000832240-2	SJ000832240	2	MOABOX:3290	WVVXBPKOIZGVNS-UHFFFAOYSA-N	CC(=O)NCCc1c(Cc2ccccc2)[nH]c2ccccc12	117946-91-5	Melatonin MT2 Antagonists	MTNR1B																																																															CHEMBL286615											122162	67779850				member																																																																																																																																																																9618428	10737738	12183692	14757166	17223160	17346859	24228714																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															1.65728																																0.20716																																8																																HY-101254	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:3290|MTNR1B|Melatonin MT2 Antagonists	CC(=O)NCCc1c(Cc2ccccc2)[nH]c3ccccc13	117946-91-5	65170	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469744	292.3749	LUZINDOLE	LUZINDOLE | LUZINDOLE	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:3290	MTNR1B	Melatonin MT2 Antagonists
SJ001035100-1	SJ001035100	1	MOABOX:3292	ISTCAWFMNVHHRU-UHFFFAOYSA-N	COc1cccc(Oc2ccc(NC(=O)C3CC3)cc2)c1		Melatonin MT2 Receptor Ligands	MTNR1B																																																															CHEMBL7673											18702059					member																																																																																																																																																																15013015																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.7268																																0.21585																																8																																63440885	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-045-949-052|MOABOX:3292|MTNR1B|Melatonin MT2 Receptor Ligands	COc1cccc(Oc2ccc(NC(=O)C3CC3)cc2)c1	244129-00-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468687	283.32178	63440885	63440885 | 63440885			MOABOX:3292	MTNR1B	Melatonin MT2 Receptor Ligands
SJ000571306-10	SJ000571306	10	MOABOX:3296	KVLFRAWTRWDEDF-IRXDYDNUSA-N	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO	1009298-09-2	mTOR Complex 1 (mTORC1) Inhibitors;mTOR Complex 2 (mTORC2) Inhibitors;catalytic mTOR inhibitor	MTOR																																																															CHEMBL1801204											25262965	44537932	69031900	69031901	69032038	member	10.1016/j.bmcl.2013.01.019	10.1158/0008-5472.CAN-09-1751																																																																																																																																																														20028854	20561789	21649581	21651476	22172063	23375793	25387153	28235701	29945756																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2.14776																																0.26847																																8																																HY-10422	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:3296|MTOR|mTOR Complex 1 (mTORC1) Inhibitors;mTOR Complex 2 (mTORC2) Inhibitors;catalytic mTOR inhibitor	COc1ccc(cc1CO)c2ccc3c(nc(nc3n2)N4CCOC[C@@H]4C)N5CCOC[C@@H]5C	1009298-09-2	3095	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469199	465.54474	1009298-09-2	1009298-09-2 | AZD8055 | | AZD8055 | 1009298-09-2 | AZD8055 | | AZD8055	Pathway: Apoptosis; Autophagy; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:3296	MTOR	mTOR Complex 1 (mTORC1) Inhibitors;mTOR Complex 2 (mTORC2) Inhibitors;catalytic mTOR inhibitor
SJ000784313-9	SJ000784313	9	MOABOX:3310	XDLYKKIQACFMJG-WKILWMFISA-N	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1	1013101-36-4	Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;Phosphatidylinositol 3-Kinase (PI3K) Inhibitors	MTOR	PIK3CA																															5290																															CHEMBL1234354																member																																																																																																																																																																23506825	23651303	24433860	24900269	25139570	29927604																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.53992	1.48328																															0.06749	0.18541																															8	8																															HY-15177	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:3310|MTOR|Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;Phosphatidylinositol 3-Kinase (PI3K) Inhibitors	COc1ccc(cn1)C2=Cc3c(C)nc(N)nc3N([C@@H]4CC[C@H](CC4)OCCO)C2=O	1013101-36-4	5623	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469275	425.48088	PF-04691502	"PF-04691502 | ""PF-4691502 | PF-502"" | PF-04691502 | ""PF-4691502 | PF-502"""	Pathway: Autophagy; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:3310	MTOR	Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;Phosphatidylinositol 3-Kinase (PI3K) Inhibitors
SJ000841704-9	SJ000841704	9	MOABOX:3316	GYLDXIAOMVERTK-UHFFFAOYSA-N	CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21	1224844-38-5	Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;Phosphatidylinositol 3-Kinase delta (PI3Kdelta) Inhibitors;Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors;Phosphatidylinositol 3-Kinase gamma (PI3Kgamma) Inhibitors	MTOR	PIK3CA	PIK3CD	PIK3CG																													5290	5293	5294																													CHEMBL3545097											45375953	91617494	91617593	91617907	91617945	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.14672	-0.30128	-0.33768	-0.45704																													-0.01834	-0.03766	-0.04221	-0.05713																													8	8	8	8																													HY-13328	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:3316|MTOR|Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;Phosphatidylinositol 3-Kinase delta (PI3Kdelta) Inhibitors;Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors;Phosphatidylinositol 3-Kinase gamma (PI3Kgamma) Inhibitors	CC(C)n1nc(c2ccc3oc(N)nc3c2)c4c(N)ncnc14	1224844-38-5	80768	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469866	309.3259	INK-128	INK-128 | MLN0128 | Sapanisertib | INK-128 | MLN0128 | Sapanisertib	Pathway: Autophagy; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:3316	MTOR	Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;Phosphatidylinositol 3-Kinase delta (PI3Kdelta) Inhibitors;Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors;Phosphatidylinositol 3-Kinase gamma (PI3Kgamma) Inhibitors
SJ000884139-2	SJ000884139	2	MOABOX:3318	MBBCVAKAJPKAKM-UHFFFAOYSA-N	O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1	182431-12-5	Microsomal Triglyceride Transfer Protein (MTTP) Inhibitors	MTTP																																																															CHEMBL2105662	CHEMBL354541										9853053	9854787	9941608	11274333	24849183	member																																																																																																																																																																11300866	15380200	22963620																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.30112																																0.41264																																8																																HY-14667	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cardiovascular Disease|MOABOX:3318|MTTP|Microsomal Triglyceride Transfer Protein (MTTP) Inhibitors	FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)c3ccccc3c4ccc(cc4)C(F)(F)F)c5ccccc5c6ccccc16	182431-12-5	13492	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468865	693.7204	AEGR-733 | BMS-201038 | LOMITAPIDE	"""AEGR-733 | BMS-201038 | LOMITAPIDE"" | ""AEGR-733 | BMS-201038 | LOMITAPIDE"""	Pathway: Others	Research Area: Cardiovascular Disease	MOABOX:3318	MTTP	Microsomal Triglyceride Transfer Protein (MTTP) Inhibitors
SJ000773186-2	SJ000773186	2	MOABOX:3326	KMJPYSQOCBYMCF-UHFFFAOYSA-N	O=[N+]([O-])c1ccc(Nc2ccccc2-c2ccccc2)c2nonc12	413611-93-5	c-Myc-Max protein-protein interaction inhibitor	MYC																																																															CHEMBL2312756											2836600	117599555				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.9604																																0.1372																																7																																HY-100996	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy | Research Area: Cancer|MOABOX:3326|MYC|c-Myc-Max protein-protein interaction inhibitor	[O-][N+](=O)c1ccc(Nc2ccccc2c3ccccc3)c4nonc14	413611-93-5	24168	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469623	332.31288	C-MYC INHIBITOR II | 10074-G5 |	"""C-MYC INHIBITOR II | 10074-G5 |"" | ""C-MYC INHIBITOR II | 10074-G5 |"""	Pathway: Apoptosis; Autophagy	Research Area: Cancer	MOABOX:3326	MYC	c-Myc-Max protein-protein interaction inhibitor
SJ000574299-6	SJ000574299	6	MOABOX:3338	KASDHRXLYQOAKZ-XDSKOBMDSA-N	CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@H](Cl)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC	1000802-56-1	"Calcineurin inhibitor;Rotamase (FKBP12) Inhibitors;""Calcineurin inhibitor;Rotamase (FKBP12) Inhibitors"""	FKBP1A	PPP3CB	PPP3CC	PPP3R1	PPP3R2	PPP3CA																											5532	5533	5534	5535	5530																											CHEMBL1200686											6509979	9833478	9833537	9854900	9898641	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.22168	0	0	0	0	0																											0.27771	0.0	0.0	0.0	0.0	0.0																											8	7	7	7	7	7																											HY-13723	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Inflammation/Immunology|MOABOX:3338|FKBP1A|Calcineurin inhibitor;Rotamase (FKBP12) Inhibitors;\Calcineurin inhibitor;Rotamase (FKBP12) Inhibitors\	CC[C@@H]1\C=C(/C)\C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)\C(=C\[C@@H]4CC[C@H](Cl)[C@@H](C4)OC)\C	137071-32-0	23420	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469150	810.45312	PIMECROLIMUS	"PIMECROLIMUS | ""PIMECROLIMUS | ASM-981 | ASM-998 | SDZ-ASM-981 |"" | PIMECROLIMUS | ""PIMECROLIMUS | ASM-981 | ASM-998 | SDZ-ASM-981 |"""	Pathway: Others	Research Area: Inflammation/Immunology	MOABOX:3338	FKBP1A	Calcineurin inhibitor;Rotamase (FKBP12) Inhibitors;\Calcineurin inhibitor;Rotamase (FKBP12) Inhibitors\
SJ000833841-2	SJ000833841	2	MOABOX:3342	CKNAQFVBEHDJQV-UHFFFAOYSA-N	Cc1c(-c2cnccn2)ssc1=S	64224-21-1	"AMPK Activator;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators;S6K1 Inhibitor"	NFE2L2																																																															CHEMBL178459											47318	44537868	87390416	88371484		member	"10.1111/bph.12057),"																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.4344																																0.3043																																8																																HY-12519	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Metabolic Enzyme/Protease; NF-?B | Research Area: Cancer|MOABOX:3342|NFE2L2|AMPK Activator;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators;S6K1 Inhibitor"	CC1=C(SSC1=S)c2cnccn2	64224-21-1	19640	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469147	226.34164	OLTIPRAZ	OLTIPRAZ | OLTIPRAZ	Pathway: Anti-infection; Metabolic Enzyme/Protease; NF-?B	Research Area: Cancer	MOABOX:3342	NFE2L2	"AMPK Activator;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators;S6K1 Inhibitor"
SJ001035134-1	SJ001035134	1	MOABOX:3348	ITFBYYCNYVFPKD-FMIDTUQUSA-N	CC1(C)CC[C@]2(C(=O)n3ccnc3)CC[C@]3(C)[C@H](C(=O)C=C4[C@@]3(C)CC[C@H]3C(C)(C)C(=O)C(C#N)=C[C@]43C)[C@@H]2C1	443104-02-7	"Apoptosis Inducers;Nitric Oxide Production Inhibitors;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators;Antiinflammatory Drugs;PPARgamma Agonists;""Apoptosis Inducers;Nitric Oxide Production Inhibitors;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators;Antiinflammatory Drugs;PPARgamma Agonists"""	NFE2L2	PPARG	KEAP1																														5468	9817																														CHEMBL1720855											9958995					member																																																																																																																																																																12855660																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.89272	0.27896	0																														0.23659	0.03487	0.0																														8	8	7																														HY-15725	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage; NF-?B | Research Area: Cancer|MOABOX:3348|NFE2L2|Apoptosis Inducers;Nitric Oxide Production Inhibitors;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators;Antiinflammatory Drugs;PPARgamma Agonists;\Apoptosis Inducers;Nitric Oxide Production Inhibitors;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators;Antiinflammatory Drugs;PPARgamma Agonists\"	CC1(C)CC[C@@]2(CC[C@]3(C)[C@@H]([C@@H]2C1)C(=O)C=C4[C@@]3(C)CC[C@H]5C(C)(C)C(=O)C(=C[C@]45C)C#N)C(=O)n6ccnc6	443104-02-7	16987	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468819	541.72352	CDDO-IM | RTA-403 | TP-235 | CDDO-IMIDAZOLIDE	"""CDDO-IM | RTA-403 | TP-235 | CDDO-IMIDAZOLIDE"" | ""CDDO-IM | RTA-403 | TP-235 | CDDO-IMIDAZOLIDE"""	Pathway: Apoptosis; Cell Cycle/DNA Damage; NF-?B	Research Area: Cancer	MOABOX:3348	NFE2L2	"Apoptosis Inducers;Nitric Oxide Production Inhibitors;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators;Antiinflammatory Drugs;PPARgamma Agonists;\Apoptosis Inducers;Nitric Oxide Production Inhibitors;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators;Antiinflammatory Drugs;PPARgamma Agonists\"
SJ000755098-9	SJ000755098	9	MOABOX:3352	TZYWCYJVHRLUCT-VABKMULXSA-N	CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1	1211877-36-9	Proteasome Inhibitors	NFKB1	PSMB1	PSMB2	PSMB5	PSMB9	PSMB10	PSMB8	PSMA1	PSMA2	PSMA3	PSMA4	PSMA5	PSMA6	PSMA7	PSMB3	PSMB4	PSMB6	PSMB7	PSMB11	PSMA8													5689	5690	5693	5698	5699	5696	5682	5683	5684	5685	5686	5687	5688	5691	5692	5694	5695	122706	143471													CHEMBL2447916	CHEMBL536336	CHEMBL64925									462382	464037	42623057	45263904	73352651	virtual	10.1016/S0968-0896(03)00438-3	10.1080/14756366.2017.1334649																																																																																																																																																														12927847	16686537	19577931	19726185	23181576	23540790	24321833	27158142	27318981	27889629	29292224	31312413																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										-0.30992	0	0	0	0	0	0	0	0.35656	-2.4e-002	0	0	1.46048	0	0	0	-0.10976	0.45024	0	0													-0.03874	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.04457	-0.003	0.0	0.0	0.18256	0.0	0.0	0.0	-0.01568	0.06432	0.0	0.0													8	7	7	7	7	7	7	7	8	8	7	7	8	7	7	7	7	7	7	7													HY-13259C	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:3352|NFKB1|Proteasome Inhibitors	CC(C)C[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O	1211877-36-9	91427	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469031	475.62084	MG 132	MG 132 | MG132 | MG-132 | MG 132 | MG132 | MG-132	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:3352	NFKB1	Proteasome Inhibitors
SJ000287478-7	SJ000287478	7	MOABOX:3356	CQXADFVORZEARL-UHFFFAOYSA-N	C1COC(NC(C2CC2)C2CC2)=N1	207572-68-7	Imidazoline I1 Receptor Agonists	NISCH																																																															CHEMBL1256674	CHEMBL289480										68712	198614	657225	5388964	21126765	member																																																																																																																																																																11334568	15224384	18621536	21688779	22512575	22750139																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.10176																																0.13772																																8																																HY-100490A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; GPCR/G Protein; Neuronal Signaling | Research Area: Cancer; Cardiovascular Disease|MOABOX:3356|NISCH|Imidazoline I1 Receptor Agonists	C1CN=C(NC(C2CC2)C3CC3)O1	207572-68-7	83997	GENERAL	FUMARATE	0.5	NO_SOLVATE	0	1469713	180.24684	RILMENIDINE HEMIFUMARATE	RILMENIDINE HEMIFUMARATE | RILMENIDINE | RILMENIDINE HEMIFUMARATE | RILMENIDINE	Pathway: Apoptosis; Autophagy; GPCR/G Protein; Neuronal Signaling	Research Area: Cancer; Cardiovascular Disease	MOABOX:3356	NISCH	Imidazoline I1 Receptor Agonists
SJ000287509-10	SJ000287509	10	MOABOX:3358	WPNJAUFVNXKLIM-UHFFFAOYSA-N	COc1nc(C)nc(Cl)c1NC1=NCCN1	1008754-16-2	Imidazoline I1 Receptor Agonists	NISCH																																																															CHEMBL1256287	CHEMBL19236										4810	6917782	11231255	18934261	45114196	member																																																																																																																																																																8632424	15224384	18621536	22512575																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.89472																																0.11184																																8																																AF-0062	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1nc(C)nc(Cl)c1NC2=NCCN2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466676	241.67748	MOXONIDINE	MOXONIDINE | MOXONIDINE HYDROCHLORIDE | MOXONIDINE | MOXONIDINE HYDROCHLORIDE			MOABOX:3358	NISCH	Imidazoline I1 Receptor Agonists
SJ001035251-1	SJ001035251	1	MOABOX:3378	WWVANQJRLPIHNS-ZKWXMUAHSA-N	N=C1N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]2N1	13395-35-2	Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Neuronal Nitric Oxide Synthase Inhibitors	NOS1	NOS2																															4843																															CHEMBL1233598											128878	131667834	135678104			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-118700A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Neurological Disease|MOABOX:3378|NOS1|Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Neuronal Nitric Oxide Synthase Inhibitors	OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=N)N[C@H]12	76985-52-9	62014	GENERAL	BROMIDE	1	NO_SOLVATE	0	1469314	243.32588	2-IMINOBIOTIN HYDROBROMIDE | GUANIDINOBIOTIN HYDROBROMIDE	"""2-IMINOBIOTIN HYDROBROMIDE | GUANIDINOBIOTIN HYDROBROMIDE"" | ""2-IMINOBIOTIN HYDROBROMIDE | GUANIDINOBIOTIN HYDROBROMIDE"""	Pathway: Immunology/Inflammation	Research Area: Neurological Disease	MOABOX:3378	NOS1	Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Neuronal Nitric Oxide Synthase Inhibitors
SJ000287958-4	SJ000287958	4	MOABOX:3382	NGVMVBQRKZPFLB-YFKPBYRVSA-N	CSC(=N)NCCC[C@H](N)C(=O)O	156719-39-0	Nitric Oxide Synthase Inhibitors	NOS3																																																															CHEMBL106516	CHEMBL1256475										107968	2733508	7048562	9835535	9964785	member	10.1016/j.bmc.2006.01.020	10.1016/j.bmcl.2005.03.078																																																																																																																																																														15911272	16466923																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.21208																																-0.02651																																8																																HY-12116	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Inflammation/Immunology|MOABOX:3382|NOS3|Nitric Oxide Synthase Inhibitors	CC(=N)NCCCC[C@H](N)C(=O)O	53774-63-3	61152	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469730	187.23948	L-N6-(1-IMINOETHYL)LYSINE HYDROCHLORIDE	L-N6-(1-IMINOETHYL)LYSINE HYDROCHLORIDE | L-N6-(1-IMINOETHYL)LYSINE HYDROCHLORIDE	Pathway: Immunology/Inflammation	Research Area: Inflammation/Immunology	MOABOX:3382	NOS3	Nitric Oxide Synthase Inhibitors
SJ001035097-1	SJ001035097	1	MOABOX:3388	WRIVUQGWNCNNGS-UHFFFAOYSA-N	O=C1C(=O)c2c(C(=O)c3ccccc3)coc2-c2ccccc21		"Inhibitors of Signal Transduction Pathways;CDC25A Inhibitors;CDC25B Inhibitors;CDC25C Inhibitors;""Inhibitors of Signal Transduction Pathways;CDC25A Inhibitors;CDC25B Inhibitors;CDC25C Inhibitors"""	CDC25C	NOS3																															4846																															CHEMBL1327816											1895639					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.18487	0																															0.02641	0.0																															7	7																															5169131	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-134-163|MOABOX:3388|CDC25C|Inhibitors of Signal Transduction Pathways;CDC25A Inhibitors;CDC25B Inhibitors;CDC25C Inhibitors;\Inhibitors of Signal Transduction Pathways;CDC25A Inhibitors;CDC25B Inhibitors;CDC25C Inhibitors\	O=C(c1ccccc1)c2coc3c4ccccc4C(=O)C(=O)c23	352553-53-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468683	302.2803	5169131	5169131 | 5169131			MOABOX:3388	CDC25C	Inhibitors of Signal Transduction Pathways;CDC25A Inhibitors;CDC25B Inhibitors;CDC25C Inhibitors;\Inhibitors of Signal Transduction Pathways;CDC25A Inhibitors;CDC25B Inhibitors;CDC25C Inhibitors\
SJ000572495-4	SJ000572495	4	MOABOX:3392	DFYRUELUNQRZTB-UHFFFAOYSA-N	COc1cc(C(C)=O)ccc1O	16522-48-8	NADPH Oxidase Inhibitors	NOX3	NOX1																															27035																															CHEMBL346919											2214	11842606	66599170	66694429	67189278	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	-0.27657																															0.0	-0.03951																															7	7																															FS-3673	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1cc(ccc1O)C(=O)C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466735	166.1739	APOCYNIN	APOCYNIN | APOCYNIN			MOABOX:3392	NOX3	NADPH Oxidase Inhibitors
SJ000286078-8	SJ000286078	8	MOABOX:3400	OLNTVTPDXPETLC-XPWALMASSA-N	O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1	163222-33-1	Niemann-Pick C1-like protein 1 (NPC1L1) Inhibitors;Cholesterol Absorption Inhibitors	NPC1L1																																																															CHEMBL1138											150311	9811273	9832090	9852148	9915011	member																																																																																																																																																																21824085																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.85576																																0.10697																																8																																HY-17376	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; NF-?B | Research Area: Cardiovascular Disease; Cancer|MOABOX:3400|NPC1L1|Niemann-Pick C1-like protein 1 (NPC1L1) Inhibitors;Cholesterol Absorption Inhibitors	O[C@@H](CC[C@@H]1[C@H](N(C1=O)c2ccc(F)cc2)c3ccc(O)cc3)c4ccc(F)cc4	163222-33-1	11713	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469726	409.42525	EZETIMIBE	EZETIMIBE | EZETIMIBE	Pathway: Autophagy; NF-?B	Research Area: Cardiovascular Disease; Cancer	MOABOX:3400	NPC1L1	Niemann-Pick C1-like protein 1 (NPC1L1) Inhibitors;Cholesterol Absorption Inhibitors
SJ001035151-1	SJ001035151	1	MOABOX:3416	UULIGRNKXHCLQN-WGSAOQKQSA-N	Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12	192322-50-2	NPY5R antagonist;Neuropeptide Y5 (NPY Y5) Antagonists;Reduced Feeding in mice	NPY5R																																																															CHEMBL17645																member	10.1016/S0960-894X(00)00177-3	10.1016/j.bmcl.2003.11.070	10.1016/j.bmcl.2005.03.052	10.1016/j.ejmech.2003.10.001	10.1021/jm011125x	10.1034/j.1399-3011.2001.00766.x	10.1172/JCI4188	10.2174/156802609788897853	10.2174/187152706777452236																																																																																																																																																							10866375	12769744	14741250	14987833	15863317	16787228	18781940	19689366																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														3.57056																																0.44632																																8																																HY-107723	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease; Endocrinology|MOABOX:3416|NPY5R|NPY5R antagonist;Neuropeptide Y5 (NPY Y5) Antagonists;Reduced Feeding in mice	Nc1nc(NC[C@@H]2CC[C@@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc5ccccc15	192322-50-2	32498	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468929	475.60576	CGP71683 HYDROCHLORIDE | CGP71683A	"""CGP71683 HYDROCHLORIDE | CGP71683A"" | ""CGP71683 HYDROCHLORIDE | CGP71683A"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease; Endocrinology	MOABOX:3416	NPY5R	NPY5R antagonist;Neuropeptide Y5 (NPY Y5) Antagonists;Reduced Feeding in mice
SJ000285189-9	SJ000285189	9	MOABOX:3418	DOBMPNYZJYQDGZ-UHFFFAOYSA-N	O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O	66-76-2	"NADPH Quinone Oxidoreductase 1 (NQO1) Inhibitors;Anticoagulant;Vitamin K Epoxide Reductase (VKER, VKOR) Inhibitors"	NQO1	VKORC1																															79001																															CHEMBL1466											54676038	54713228	54720819	73440755	88602470	member	10.1016/j.bmc.2009.11.059	10.1021/jm070472p	10.1021/jm9011609	10.2174/1381612811319210013																																																																																																																																																												17011189	17999461	18264564	19877692	22982531	23438968	27829520																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															3.0688	0																															0.3836	0.0																															8	7																															HY-N0645	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:3418|NQO1|NADPH Quinone Oxidoreductase 1 (NQO1) Inhibitors;Anticoagulant;Vitamin K Epoxide Reductase (VKER, VKOR) Inhibitors"	OC1=C(CC2=C(O)c3ccccc3OC2=O)C(=O)Oc4ccccc14	66-76-2	26918	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468964	336.29498	DICUMAROL	DICUMAROL | DICUMAROL	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:3418	NQO1	"NADPH Quinone Oxidoreductase 1 (NQO1) Inhibitors;Anticoagulant;Vitamin K Epoxide Reductase (VKER, VKOR) Inhibitors"
SJ000287073-23	SJ000287073	23	MOABOX:3420	LUKBXSAWLPMMSZ-OWOJBTEDSA-N	Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1	31100-06-8	Anti-inflammatory;Antioxidant	NQO2	TTR																															7276																															CHEMBL165											445154	6475497	9802478	9843315	9866144	member	10.1016/j.bmcl.2010.03.051	10.1021/jm801335z																																																																																																																																																														19149602	19265439	20036559	20356739	21261296	23953689	26854376	28920684	29567345																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1.19208	0.31927																															0.14901	0.04561																															8	7																															KS-5047	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466687	228.24328	RESVERATROL	"RESVERATROL | ""RM-1812 | SRT-501 | TRANS-RESVERATROL"" | RESVERATROL | ""RM-1812 | SRT-501 | TRANS-RESVERATROL"""			MOABOX:3420	NQO2	Anti-inflammatory;Antioxidant
SJ000855283-2	SJ000855283	2	MOABOX:3428	INASOKQDNHHMRE-UHFFFAOYSA-N	CC(C)OC(=O)C1=CN(C(=O)c2ccc(F)c(F)c2)CC(C)(C)c2c1[nH]c1ccccc21	629664-81-9	Farnesoid X Receptor (FXR) Agonists	NR1H4																																																															CHEMBL454138											10026128	145158514				member	10.1021/jm8014124	10.1194/jlr.M012542	10.2174/092986710790112666	10.2174/156802612799436678																																																																																																																																																												19159286	19683924	19941473	20095622	21464203	22242859	23040732	26878262																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														3.0472																																0.3809																																8																																HY-50911	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Metabolic Enzyme/Protease | Research Area: Metabolic Disease; Cancer|MOABOX:3428|NR1H4|Farnesoid X Receptor (FXR) Agonists	CC(C)OC(=O)C1=CN(CC(C)(C)c2c1[nH]c3ccccc23)C(=O)c4ccc(F)c(F)c4	629664-81-9	2853	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469278	438.46647	XL335	XL335 | XL335	Pathway: Autophagy; Metabolic Enzyme/Protease	Research Area: Metabolic Disease; Cancer	MOABOX:3428	NR1H4	Farnesoid X Receptor (FXR) Agonists
SJ001033118-2	SJ001033118	2	MOABOX:3430	ZXERDUOLZKYMJM-ZWECCWDJSA-N	CC[C@@H]1[C@@H]2C[C@H](O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]3[C@H](C)CCC(=O)O)[C@@H]2[C@@H]1O	459789-99-2	activates FXR directly in the liver and increases FGF19 hormone levels via intestinal FXR activation;Farnesoid X Receptor (FXR) Agonists	NR1H4																																																															CHEMBL566315											447715	11556819				member	10.1016/j.bmc.2011.03.004	10.1016/j.bmc.2014.02.053	10.1016/j.bmc.2015.04.035	10.1021/acs.jmedchem.7b00907	10.1021/acsmedchemlett.7b00318	10.1021/jm025529g	10.1021/jm049904b	10.1021/jm070633p	10.1124/mol.110.064501	10.2174/156802610790980576																																																																																																																																																						12166927	12749886	15317466	16107136	16821780	17685603	20014870	21459580	25255039	25934227	28252961	29148806																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										3.23168																																0.40396																																8																																HY-12222	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Metabolic Enzyme/Protease | Research Area: Others|MOABOX:3430|NR1H4|activates FXR directly in the liver and increases FGF19 hormone levels via intestinal FXR activation;Farnesoid X Receptor (FXR) Agonists	CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@H]([C@H](C)CCC(=O)O)[C@@]3(C)CC[C@@H]2[C@@]4(C)CC[C@@H](O)C[C@@H]14	459789-99-2	22753	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468869	420.62516	OBETICHOLIC ACID | INT-747 | 6-ECDCA | 6-ETHYLCHENODEOXYCHOLIC ACID	"""OBETICHOLIC ACID | INT-747 | 6-ECDCA | 6-ETHYLCHENODEOXYCHOLIC ACID"" | ""OBETICHOLIC ACID | INT-747 | 6-ECDCA | 6-ETHYLCHENODEOXYCHOLIC ACID"""	Pathway: Autophagy; Metabolic Enzyme/Protease	Research Area: Others	MOABOX:3430	NR1H4	activates FXR directly in the liver and increases FGF19 hormone levels via intestinal FXR activation;Farnesoid X Receptor (FXR) Agonists
SJ001034918-1	SJ001034918	1	MOABOX:3456	YCAACZFPADQMAR-UHFFFAOYSA-N	COCCOCc1ccc(-c2cc3onc(-c4ccccc4)c3c(=O)n2C)cc1		"Nuclear Receptor Subfamily 4 Group A Member 2 (NR4A2, NURR1) Agonists"	NR4A2																																																															CHEMBL401032											9908426					member																																																																																																																																																																17035009																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.176																																0.272																																8																																5699	TOCRIS	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-624-555|MOABOX:3456|NR4A2|Nuclear Receptor Subfamily 4 Group A Member 2 (NR4A2, NURR1) Agonists"	COCCOCc1ccc(cc1)C2=Cc3onc(c4ccccc4)c3C(=O)N2C	500164-74-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468231	390.43178	IP7E	IP7E | IP7E			MOABOX:3456	NR4A2	"Nuclear Receptor Subfamily 4 Group A Member 2 (NR4A2, NURR1) Agonists"
SJ000286433-5	SJ000286433	5	MOABOX:3460	COCYGNDCWFKTMF-UHFFFAOYSA-N	O=c1cc(-c2ccccc2)oc2c(O)c(O)ccc12	38183-03-8	TRKB Activators	NTRK2																																																															CHEMBL75267											1880	57514858				member																																																																																																																																																																20133810	24183588																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.6608																																0.2076																																8																																HY-W013372	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Neuronal Signaling; Protein Tyrosine Kinase/RTK | Research Area: Neurological Disease|MOABOX:3460|NTRK2|TRKB Activators	Oc1ccc2C(=O)C=C(Oc2c1O)c3ccccc3	38183-03-8	32429	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468756	254.2375	"7,8-DIHYDROXYFLAVONE"	"7,8-DIHYDROXYFLAVONE | 7,8-DIHYDROXYFLAVONE"	Pathway: Apoptosis; Neuronal Signaling; Protein Tyrosine Kinase/RTK	Research Area: Neurological Disease	MOABOX:3460	NTRK2	TRKB Activators
SJ000821689-3	SJ000821689	3	MOABOX:3464	DYLJVOXRWLXDIG-UHFFFAOYSA-N	COc1cccc(OC)c1-c1cc(C(=O)NC2(C(=O)O)C3CC4CC(C3)CC2C4)nn1-c1ccnc2cc(Cl)ccc12	146362-70-1	Carboxypeptidase A Inhibitors;Neurotensin NTS1 (NT1) Receptor Antagonists	NTSR1																																																															CHEMBL506981											119192					member	10.1016/S0196-9781(00)00362-4	10.1016/j.bmcl.2008.09.075																																																																																																																																																														11179604	11356931	11723247	18809332	18849166	19195889	19290594	21354674	22335510	23097347	23721919	24997685																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										0.2452																																0.03065																																8																																HY-105189	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:3464|NTSR1|Carboxypeptidase A Inhibitors;Neurotensin NTS1 (NT1) Receptor Antagonists	COc1cccc(OC)c1c2cc(nn2c3ccnc4cc(Cl)ccc34)C(=O)N[C@@]5([C@H]6C[C@@H]7C[C@@H](C[C@H]5C7)C6)C(=O)O	146362-70-1	90957	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469468	587.06534	MECLINERTANT | SR 48692	"""MECLINERTANT | SR 48692"" | SR 48692 | ""MECLINERTANT | SR 48692"" | SR 48692"	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:3464	NTSR1	Carboxypeptidase A Inhibitors;Neurotensin NTS1 (NT1) Receptor Antagonists
SJ000561072-10	SJ000561072	10	MOABOX:3472	OGQICQVSFDPSEI-UHFFFAOYSA-N	CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1	118292-40-3	Retinoid RARgamma Agonists;Ornithine Decarboxylase Inhibitors;Retinoid RARbeta Agonists	ODC1	RARB	RARG																														5915	5916																														CHEMBL1657											5381	57329809	66870691	66870911	69254897	member	10.1016/j.antiviral.2019.04.009																																																																																																																																																															19058965																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	1.90232	1.21224																														0.0	0.23779	0.15153																														7	8	8																														HY-15388	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology; Cancer|MOABOX:3472|ODC1|Retinoid RARgamma Agonists;Ornithine Decarboxylase Inhibitors;Retinoid RARbeta Agonists	CCOC(=O)c1ccc(nc1)C#Cc2ccc3SCCC(C)(C)c3c2	118292-40-3	16319	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469434	351.46194	TAZAROTENE	"TAZAROTENE | ""TAZAROTENE | AGN 190168 |"" | ""TAZAROTENE | AGN-190168 | CD-5789 |"" | ""TAZAROTENE | AGN-190168 |"" | TAZAROTENE | ""TAZAROTENE | AGN 190168 |"" | ""TAZAROTENE | AGN-190168 | CD-5789 |"" | ""TAZAROTENE | AGN-190168 |"""	Pathway: Autophagy; Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology; Cancer	MOABOX:3472	ODC1	Retinoid RARgamma Agonists;Ornithine Decarboxylase Inhibitors;Retinoid RARbeta Agonists
SJ001032996-3	SJ001032996	3	MOABOX:3478	JHLHNYVMZCADTC-LOSJGSFVSA-N	CN(C(=O)C(c1ccccc1)c1ccccc1)[C@H](CN1CC[C@H](O)C1)c1ccccc1	153205-46-0	kappa-Opioid Agonists	OPRK1																																																															CHEMBL1190199	CHEMBL540342										179340	9846614				member	10.1016/j.bmcl.2014.12.064	10.1016/j.ejphar.2010.08.012	10.2174/1381612043453036																																																																																																																																																													15032700	25599839																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.84208																																0.48026																																8																																HY-107384A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Metabolic Disease; Inflammation/Immunology; Neurological Disease|MOABOX:3478|OPRK1|kappa-Opioid Agonists	CN([C@H](CN1CC[C@H](O)C1)c2ccccc2)C(=O)C(c3ccccc3)c4ccccc4	185951-07-9	89934	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469378	414.5393	ASIMADOLINE HYDROCHLORIDE	ASIMADOLINE HYDROCHLORIDE | ASIMADOLINE HYDROCHLORIDE	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Metabolic Disease; Inflammation/Immunology; Neurological Disease	MOABOX:3478	OPRK1	kappa-Opioid Agonists
SJ000286107-14	SJ000286107	14	MOABOX:3488	RDOIQAHITMMDAJ-UHFFFAOYSA-N	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1	34552-83-5	mu-Opioid Agonists	OPRM1																																																															CHEMBL1707	CHEMBL841										3955	71420	9832599	9962211	15940227	member	10.1021/jm010877o	10.1021/jm030548r	10.1248/cpb.49.1314	10.2174/1381612043453036																																																																																																																																																												11585443	11605661	15032700	15454210	18284554																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	2.81016																																0.35127																																8																																HY-B0418A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; GPCR/G Protein; Neuronal Signaling | Research Area: Metabolic Disease; Neurological Disease|MOABOX:3488|OPRM1|mu-Opioid Agonists	CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4	34552-83-5	16110	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468833	477.03752	LOPERAMIDE	LOPERAMIDE | IMODIUM | LOPERAMIDE HCL | LOPERAMIDE | IMODIUM | LOPERAMIDE HCL	Pathway: Autophagy; GPCR/G Protein; Neuronal Signaling	Research Area: Metabolic Disease; Neurological Disease	MOABOX:3488	OPRM1	mu-Opioid Agonists
SJ001033303-2	SJ001033303	2	MOABOX:3498	WDPFJWLDPVQCAJ-UHFFFAOYSA-N	CCN(CC)CCN(Cc1ccc(-c2ccc(C(F)(F)F)cc2)cc1)C(=O)Cn1c(SCc2ccc(F)cc2)nc(=O)c2c1CCC2	356057-34-6	Lipoprotein Associated Phospholipase A2 (Lp-PLA2) Inhibitors	PLA2G7	OPTN																															10133																															CHEMBL204021	CHEMBL3793364										9939609	18768463	20601051	23135991	91827412	member	10.1016/S0960-894X(03)00058-1	10.1016/j.bmcl.2013.03.062	10.1021/acs.jmedchem.5b01930	10.1021/acs.jmedchem.6b00212	10.1021/acs.jmedchem.7b01530	10.2174/138161211798220936																																																																																																																																																										12643913	22074435	23575276	26479945	26927682	27078579	27167608	27933945	28105273	29193967	29336874	31097993																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										5.22144	0																															0.65268	0.0																															8	7																															HY-10521	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease|MOABOX:3498|PLA2G7|Lipoprotein Associated Phospholipase A2 (Lp-PLA2) Inhibitors	CCN(CC)CCN(Cc1ccc(cc1)c2ccc(cc2)C(F)(F)F)C(=O)CN3C4=C(CCC4)C(=O)N=C3SCc5ccc(F)cc5	356057-34-6	7802	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469587	666.77113	DARAPLADIB; SB-480848	DARAPLADIB; SB-480848 | DARAPLADIB; SB-480848	Pathway: Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease	MOABOX:3498	PLA2G7	Lipoprotein Associated Phospholipase A2 (Lp-PLA2) Inhibitors
SJ001034850-1	SJ001034850	1	MOABOX:3502	LWJKSVUJZBEXCH-UHFFFAOYSA-N	O=C(Nc1cnc(-c2cc(C(F)(F)F)ccc2Cl)cn1)c1c(F)cccc1F		Calcium Release-Activated Channels (CRAC) Blockers;IL-2 Production Inhibitors	ORAI1																																																																										11546102	86606870				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.43054																																0.34722																																7																																EN300-262408	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-768-491|MOABOX:3502|ORAI1|Calcium Release-Activated Channels (CRAC) Blockers;IL-2 Production Inhibitors	Fc1cccc(F)c1C(=O)Nc2cnc(cn2)c3cc(ccc3Cl)C(F)(F)F	903591-53-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468095	413.72858	EN300-262408	EN300-262408 | EN300-262408			MOABOX:3502	ORAI1	Calcium Release-Activated Channels (CRAC) Blockers;IL-2 Production Inhibitors
SJ001035346-1	SJ001035346	1	MOABOX:3504	XPRZIORDEVHURQ-UHFFFAOYSA-N	Cc1nnsc1C(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1	223499-30-7	Calcium channel inhibitor;TRPM4 agonist;IL-5 Production Inhibitors;Calcium Release-Activated Channels (CRAC) Blockers;TRPM4 Agonists;IL-4 Production Inhibitors;IL-2 Production Inhibitors	IL2	IL4	IL5	TRPM4	ORAI2	ORAI1	ORAI3																										3565	3567	54795	80228	84876	93129																										CHEMBL262766											2455					member																																																																																																																																																																16616503	17307161	18835179	21143109	22963562	25690784	29776832																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															0.29876	0	0.15785	0.48867	0.55524	1.20112	0.5705																										0.04268	0.0	0.02255	0.06981	0.07932	0.15014	0.0815																										7	7	7	7	7	8	7																										HY-100831	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Inflammation/Immunology|MOABOX:3504|IL2|Calcium channel inhibitor;TRPM4 agonist;IL-5 Production Inhibitors;Calcium Release-Activated Channels (CRAC) Blockers;TRPM4 Agonists;IL-4 Production Inhibitors;IL-2 Production Inhibitors	Cc1nnsc1C(=O)Nc2ccc(cc2)n3nc(cc3C(F)(F)F)C(F)(F)F	223499-30-7	22655	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469661	421.32028	YM-58483 | BTP2	"""YM-58483 | BTP2"" | ""YM-58483 | BTP2"""	Pathway: Membrane Transporter/Ion Channel	Research Area: Inflammation/Immunology	MOABOX:3504	IL2	Calcium channel inhibitor;TRPM4 agonist;IL-5 Production Inhibitors;Calcium Release-Activated Channels (CRAC) Blockers;TRPM4 Agonists;IL-4 Production Inhibitors;IL-2 Production Inhibitors
SJ000884162-2	SJ000884162	2	MOABOX:3508	VWXRQYYUEIYXCZ-OBIMUBPZSA-N	CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1	90779-69-4	Oxytocin (OT) Antagonists	AVPR1A	OXTR																															5021																															CHEMBL382301											5311010	87484500	87665603	87666255	89155159	member																																																																																																																																																																16302826	16821776	18032036	19095447	20027670	22239250	23205571	28505537																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														2.54224	0.35216																															0.31778	0.04402																															8	8																															HY-17572A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cancer; Endocrinology|MOABOX:3508|AVPR1A|Oxytocin (OT) Antagonists	CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(=O)N)NC(=O)C(NC(=O)[C@@H](NC2=O)[C@@H](C)CC)[C@@H](C)O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(=O)N)cc1	914453-95-5	64855	GENERAL	ACETATE	1	NO_SOLVATE	0	1469908	994.18858	ATOSIBAN ACETATE	ATOSIBAN ACETATE | ATOSIBAN ACETATE	Pathway: GPCR/G Protein	Research Area: Cancer; Endocrinology	MOABOX:3508	AVPR1A	Oxytocin (OT) Antagonists
SJ001035033-1	SJ001035033	1	MOABOX:3514	DJMHJHDYEXNPEH-UHFFFAOYSA-N	O=C1CN=C(c2ccccc2)c2oc3ccc(Br)cc3c2N1		P2X4 Receptor Antagonists	P2RX4																																																															CHEMBL1516524											649958					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																PHAR369909	PHARMEKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-014-889|MOABOX:3514|P2RX4|P2X4 Receptor Antagonists	Brc1ccc2oc3C(=NCC(=O)Nc3c2c1)c4ccccc4	296798-60-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468521	355.18544	PHAR369909	PHAR369909 | PHAR369909			MOABOX:3514	P2RX4	P2X4 Receptor Antagonists
SJ001035378-1	SJ001035378	1	MOABOX:3516	MMPAULQSJLVKHP-UHFFFAOYSA-N	Clc1cccc(-c2nnnn2Cc2cccnc2)c1Cl	899431-18-6	P2X7 Receptor Antagonists	P2RX7																																																															CHEMBL377219											11673921	11688742	71312015			member	10.1016/j.ejmech.2014.10.071	10.1038/sj.bjp.0707265																																																																																																																																																														16759108	17471177	17584060	18272366	19191585	19558545	21536435	22963440	25462266	29649742																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												1.536																																0.192																																8																																HY-15488A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Neurological Disease|MOABOX:3516|P2RX7|P2X7 Receptor Antagonists	Clc1cccc(c1Cl)c2nnnn2Cc3cccnc3	899431-18-6	9647	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469848	306.15006	A 438079 HYDROCHLORIDE	A 438079 HYDROCHLORIDE | A 438079 HYDROCHLORIDE	Pathway: Membrane Transporter/Ion Channel	Research Area: Neurological Disease	MOABOX:3516	P2RX7	P2X7 Receptor Antagonists
SJ000287167-8	SJ000287167	8	MOABOX:3522	PHWBOXQYWZNQIN-UHFFFAOYSA-N	Clc1ccccc1CN1CCc2sccc2C1	53885-35-1	P2Y12 (P2T) Antagonists	P2RY12																																																															CHEMBL1717	CHEMBL833										5472	65335	657310	20258300	42601769	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																8																																HY-B0153A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cardiovascular Disease|MOABOX:3522|P2RY12|P2Y12 (P2T) Antagonists	Clc1ccccc1CN2CCc3sccc3C2	53885-35-1	16715	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468751	263.78566	TICLOPIDINE HYDROCHLORIDE	TICLOPIDINE HYDROCHLORIDE | TICLOPIDINE HCL | TICLOPIDINE HYDROCHLORIDE | TICLOPIDINE HCL	Pathway: GPCR/G Protein	Research Area: Cardiovascular Disease	MOABOX:3522	P2RY12	P2Y12 (P2T) Antagonists
SJ000285478-10	SJ000285478	10	MOABOX:3524	GKTWGGQPFAXNFI-HNNXBMFYSA-N	COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1	113665-84-2	P2Y12 (P2T) Antagonists	P2RY12																																																															CHEMBL1083385	CHEMBL1771										60606	115366	9798860	9847991	9934036	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																8																																HY-15283	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cardiovascular Disease|MOABOX:3524|P2RY12|P2Y12 (P2T) Antagonists	COC(=O)[C@@H](N1CCc2sccc2C1)c3ccccc3Cl	113665-84-2	85793	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468770	321.82174	CLOPIDOGREL SULFATE	CLOPIDOGREL SULFATE | CLOPIDOGREL | CLOPIDOGREL SULFATE | CLOPIDOGREL	Pathway: GPCR/G Protein	Research Area: Cardiovascular Disease	MOABOX:3524	P2RY12	P2Y12 (P2T) Antagonists
SJ000285478-9	SJ000285478	9	MOABOX:3524	GKTWGGQPFAXNFI-HNNXBMFYSA-N	COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1	113665-84-2	P2Y12 (P2T) Antagonists	P2RY12																																																															CHEMBL1083385	CHEMBL1771										60606	115366	9798860	9847991	9934036	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																8																																AG003P0N	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-863|MOABOX:3524|P2RY12|P2Y12 (P2T) Antagonists	COC(=O)[C@@H](N1CCc2sccc2C1)c3ccccc3Cl	135046-48-9	NA	GENERAL	SULFATE	1	NO_SOLVATE	0	1468623	321.82174	CLOPIDOGREL SULFATE	CLOPIDOGREL SULFATE | CLOPIDOGREL | CLOPIDOGREL SULFATE | CLOPIDOGREL			MOABOX:3524	P2RY12	P2Y12 (P2T) Antagonists
SJ000285659-12	SJ000285659	12	MOABOX:3542	DYKFCLLONBREIL-KVUCHLLUSA-N	CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O	10118-90-8	Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors;30S Ribosomal Protein Inhibitors;Protein Arginine Deiminase Inhibitors	PARP1	PADI6																															353238																															CHEMBL1200881	CHEMBL1434															member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.43484	0																															-0.06212	0.0																															7	7																															HY-17412	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Infection|MOABOX:3542|PARP1|Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors;30S Ribosomal Protein Inhibitors;Protein Arginine Deiminase Inhibitors	CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)N(C)C	13614-98-7	28641	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469648	457.47638	MINOCYCLINE HYDROCHLORIDE	MINOCYCLINE HYDROCHLORIDE | DYNACIN | SJ000288037 | MINOCYCLINE HYDROCHLORIDE | DYNACIN | SJ000288037	Pathway: Anti-infection	Research Area: Infection	MOABOX:3542	PARP1	Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors;30S Ribosomal Protein Inhibitors;Protein Arginine Deiminase Inhibitors
SJ001033122-2	SJ001033122	2	MOABOX:3550	HMABYWSNWIZPAG-UHFFFAOYSA-N	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1	283173-50-2	Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors;Poly(ADP-ribose)polymerase-2 (PARP-2) Inhibitors;DNA Repair Inhibitors	PARP1	PARP2																															10038																															CHEMBL1173055	CHEMBL2105733	CHEMBL3833368									9931953	9931954	11504523	53344634	53356947	member	10.1016/j.bmcl.2018.02.008	10.1016/j.chembiol.2018.09.011																																																																																																																																																														17896912	19047122	20364863	20423312	22316152	24900770	25614115	25761096	26342868	26652717	27353531	28001384	29456106	31042381																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								3.35248	0.61424																															0.41906	0.07678																															8	8																															HY-10617A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:3550|PARP1|Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors;Poly(ADP-ribose)polymerase-2 (PARP-2) Inhibitors;DNA Repair Inhibitors	CNCc1ccc(cc1)c2[nH]c3cc(F)cc4C(=O)NCCc2c34	283173-50-2	64524	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469412	323.36412	RUCAPARIB (PHOSPHATE) | AG-014699 PHOSPHATE | PF-01367338 PHOSPHATE	"""RUCAPARIB (PHOSPHATE) | AG-014699 PHOSPHATE | PF-01367338 PHOSPHATE"" | ""RUCAPARIB (PHOSPHATE) | AG-014699 PHOSPHATE | PF-01367338 PHOSPHATE"""	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:3550	PARP1	Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors;Poly(ADP-ribose)polymerase-2 (PARP-2) Inhibitors;DNA Repair Inhibitors
SJ000285683-7	SJ000285683	7	MOABOX:3556	XQYZDYMELSJDRZ-UHFFFAOYSA-N	COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC	132-40-1	Phosphodiesterase PDE10A Inhibitors	PDE4C	PDE10A	ENPP6																														10846	133121																														CHEMBL19224	CHEMBL3833334	CHEMBL3833406	CHEMBL98123								4680	6084	74925	83856	83861	virtual	10.1016/j.bmc.2010.10.038	10.1016/j.bmcl.2012.01.046	10.1016/j.bmcl.2015.10.100	10.1016/j.ejmech.2011.05.072	10.1016/j.ejmech.2014.07.020	10.1016/j.ejmech.2015.10.028	10.1021/jm1002793	10.1021/jm3004976																																																																																																																																																								20450197	21087867	21602043	21705115	22321214	22834877	23978358	24721831	25592707																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0.27363	2.5784	0																														0.03909	0.3223	0.0																														7	8	7																														KS-5336	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466731	339.38504	PAPAVERINE HYDROCHLORIDE	PAPAVERINE HYDROCHLORIDE | PAPAVERINE HYDROCHLORIDE			MOABOX:3556	PDE4C	Phosphodiesterase PDE10A Inhibitors
SJ000782364-7	SJ000782364	7	MOABOX:3562	MNDBXUUTURYVHR-UHFFFAOYSA-N	O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1	162401-32-3	Phosphodiesterase IV Inhibitors	PDE4C	ENPP4	PDE2A																														22875	5138																														CHEMBL193240											449193	9895196	9962105	11628984	71569870	member	10.1124/jpet.103.064691	10.1124/jpet.114.220541	10.1248/bpb.b15-00652																																																																																																																																																													11259554	11470607	15082748	15887951	17336928	17704822	19256507	21205923	22297114	23375225	27933955																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											0	0.1508	5.901e-002																														0.0	0.01885	0.00843																														7	8	7																														HY-15455	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:3562|PDE4C|Phosphodiesterase IV Inhibitors	FC(F)Oc1ccc(cc1OCC2CC2)C(=O)Nc3c(Cl)cncc3Cl	162401-32-3	9153	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469781	403.20747	ROFLUMILAST	"ROFLUMILAST | ""ROFLUMILAST | BY-217 | APTA-2217 |"" | ROFLUMILAST | ""ROFLUMILAST | BY-217 | APTA-2217 |"""	Pathway: Anti-infection; Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:3562	PDE4C	Phosphodiesterase IV Inhibitors
SJ000287473-6	SJ000287473	6	MOABOX:3572	HJMQDJPMQIHLPB-UHFFFAOYSA-N	COc1cc(-c2ccc(=O)[nH]n2)ccc1OC(F)F	101975-10-4	Phosphodiesterase III Inhibitors;Phosphodiesterase IV Inhibitors	PDE3A	PDE3B																															5140																															CHEMBL313842											5723	69834960	89809132	137523786		member																																																																																																																																																																1648920	1665311	9400021	11472205	12723963	15125967	18686943																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															0.6232	0.53224																															0.0779	0.06653																															8	8																															HY-15485	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:3572|PDE3A|Phosphodiesterase III Inhibitors;Phosphodiesterase IV Inhibitors	COc1cc(ccc1OC(F)F)C2=NNC(=O)C=C2	101975-10-4	81831	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469838	268.21621	ZARDAVERINE	ZARDAVERINE | ZARDAVERINE	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:3572	PDE3A	Phosphodiesterase III Inhibitors;Phosphodiesterase IV Inhibitors
SJ000312334-8	SJ000312334	8	MOABOX:3574	OTBXOEAOVRKTNQ-UHFFFAOYSA-N	O=C1CN2Cc3c(ccc(Cl)c3Cl)NC2=N1	58579-51-4	PDE3A inhibitor	PDE3A	PDE3B	PDE4C																														5140	5143																														CHEMBL1200759	CHEMBL760										135409400	135413494	135565321	135714989	135860278	member	10.1021/jm00082a002	10.1021/jm00385a011																																																																																																																																																														1311763	1321910	1321911	1654430	2846839	3027338	16041400																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															1.04592	0.88728	1.23104																														0.13074	0.11091	0.15388																														8	8	8																														HY-B0523A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology; Cancer|MOABOX:3574|PDE3A|PDE3A inhibitor	Clc1ccc2NC3=NC(=O)CN3Cc2c1Cl	58579-51-4	14567	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468930	256.08808	ANAGRELIDE HYDROCHLORIDE	"ANAGRELIDE HYDROCHLORIDE | ANAGRELIDE HYDROCHLORIDE| AGRYLIN| XAGRID | ""ANAGRELIDE HYDROCHLORIDE| AGRYLIN| XAGRID | 6,7-DICHLORO-3,5-DIHYDROIMIDAZO[2,1-B]QUINAZOLIN-2(1H)-ONE | ANAGRELIDE HYDROCHLORIDE| AGRYLIN"" | ANAGRELIDE HCL | ANAGRELIDE HYDROCHLORIDE | ANAGRELIDE HYDROCHLORIDE| AGRYLIN| XAGRID | ""ANAGRELIDE HYDROCHLORIDE| AGRYLIN| XAGRID | 6,7-DICHLORO-3,5-DIHYDROIMIDAZO[2,1-B]QUINAZOLIN-2(1H)-ONE | ANAGRELIDE HYDROCHLORIDE| AGRYLIN"" | ANAGRELIDE HCL"	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology; Cancer	MOABOX:3574	PDE3A	PDE3A inhibitor
SJ001034658-1	SJ001034658	1	MOABOX:3576	XWVBOPKUSVZZPJ-UHFFFAOYSA-N	O=C(O)C1CCC(c2cc3cccnc3c(-c3cccc(F)c3)n2)CC1	524734-30-3	Phosphodiesterase IV Inhibitors	PDE4D																																																																										9924539					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.58328																																0.44791																																8																																EH-0718	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC(=O)C1CCC(CC1)c2cc3cccnc3c(n2)c4cccc(F)c4	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466763	350.38616	EH-0718	EH-0718 | EH-0718			MOABOX:3576	PDE4D	Phosphodiesterase IV Inhibitors
SJ000785990-5	SJ000785990	5	MOABOX:3592	CFBUZOUXXHZCFB-UHFFFAOYSA-N	COc1ccc(C2(C#N)CCC(C(=O)O)CC2)cc1OC1CCCC1	153259-65-5	Phosphodiesterase IV Inhibitors	PDE4C																																																															CHEMBL32854											151170	9804488	9822448	9853959	9937990	member																																																																																																																																																																9526558	9632360	11472206	12036360	12036361	12723963	15236836																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															5.348e-002																																0.00764																																7																																HY-10790	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:3592|PDE4C|Phosphodiesterase IV Inhibitors	COc1ccc(cc1OC2CCCC2)[C@@]3(CC[C@H](CC3)C(=O)O)C#N	153259-65-5	24569	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469195	343.4168	CILOMILAST | SB-207499 | ARIFLO |	"""CILOMILAST | SB-207499 | ARIFLO |"" | CILOMILAST | ""CILOMILAST | SB-207499 | ARIFLO |"" | CILOMILAST"	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:3592	PDE4C	Phosphodiesterase IV Inhibitors
SJ000785990-4	SJ000785990	4	MOABOX:3592	CFBUZOUXXHZCFB-UHFFFAOYSA-N	COc1ccc(C2(C#N)CCC(C(=O)O)CC2)cc1OC1CCCC1	153259-65-5	Phosphodiesterase IV Inhibitors	PDE4C																																																															CHEMBL32854											151170	9804488	9822448	9853959	9937990	member																																																																																																																																																																9526558	9632360	11472206	12036360	12036361	12723963	15236836																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															5.348e-002																																0.00764																																7																																1592	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-005-940-870|MOABOX:3592|PDE4C|Phosphodiesterase IV Inhibitors	COc1ccc(cc1OC2CCCC2)[C@@]3(CC[C@H](CC3)C(=O)O)C#N	153259-65-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468387	343.4168	CILOMILAST | SB-207499 | ARIFLO |	"""CILOMILAST | SB-207499 | ARIFLO |"" | CILOMILAST | ""CILOMILAST | SB-207499 | ARIFLO |"" | CILOMILAST"			MOABOX:3592	PDE4C	Phosphodiesterase IV Inhibitors
SJ000312349-9	SJ000312349	9	MOABOX:3598	WOXKDUGGOYFFRN-IIBYNOLFSA-N	CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3c(c2)OCO3)C1=O	1242099-07-5	Phosphodiesterase V (PDE5A) Inhibitors	PDE5A																																																															CHEMBL779											110635	11984525	16750211	24763647	46873020	member	10.1002/ardp.201000236	10.1016/S0960-894X(03)00159-8	10.1016/j.bmcl.2005.02.083	10.1016/j.bmcl.2017.12.019	10.1016/j.ejmech.2012.09.029	10.1021/jm0256068	10.1021/jm100842v	10.2174/092986707781389619																																																																																																																																																								12570368	12668004	15018924	15837326	15887951	16388517	17017941	17300160	17691956	18656371	20206015	20235539	20491634	21189023	21384413	23117589	23307609	23313637	27606546	29549837	30245400																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	5.49392																																0.68674																																8																																KS-1117	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c5ccc6OCOc6c5)C1=O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466653	389.40396	TADALAFIL	"TADALAFIL | TADALAFIL | ""TADALAFIL| CIALIS | TADALAFIL"" | TADALAFIL | ""TADALAFIL| CIALIS | TADALAFIL"""			MOABOX:3598	PDE5A	Phosphodiesterase V (PDE5A) Inhibitors
SJ000785893-4	SJ000785893	4	MOABOX:3602	AWIVHRPYFSSVOG-UHFFFAOYSA-N	Fc1ccc(CNc2ncnc3ccc(F)cc23)cc1	1262888-28-7	Autophagy Agonist;Phosphodiesterase V (PDE5A) Inhibitors	PDE5A																																																															CHEMBL2391504											51037431					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.52535																																0.07505																																7																																HY-12990	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy | Research Area: Cancer|MOABOX:3602|PDE5A|Autophagy Agonist;Phosphodiesterase V (PDE5A) Inhibitors	Fc1ccc(CNc2ncnc3ccc(F)cc23)cc1	1262888-28-7	17532	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469581	271.26475	SPAUTIN-1	SPAUTIN-1 | SPAUTIN-1	Pathway: Apoptosis; Autophagy	Research Area: Cancer	MOABOX:3602	PDE5A	Autophagy Agonist;Phosphodiesterase V (PDE5A) Inhibitors
SJ000285745-14	SJ000285745	14	MOABOX:3606	IZEKFCXSFNUWAM-UHFFFAOYSA-N	OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1	58-32-2	Adenosine Transporter Inhibitor;Phosphodiesterase III Inhibitors;Phosphodiesterase V (PDE5A) Inhibitors	ADA	SLC29A1	SLC29A2	PDE2A	PDE5A	ENPP6																											2030	3177	5138	8654	133121																											CHEMBL932											3108	137329	451734	451810	6452173	member	10.1016/j.bcp.2003.09.018	10.1016/j.bcp.2013.08.063	10.1021/jm070311l	10.1042/BJ20031880	10.1124/jpet.108.146241	10.2174/092986708784911524																																																																																																																																																										8254606	10891111	14556647	14759222	15037197	15081020	16336197	17636949	18673225	21291368	21401500	21688779	22711801																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									0	1.44488	1.50416	3.374e-002	0.8432	0.56238																											0.0	0.18061	0.18802	0.00482	0.1054	0.08034																											7	8	8	7	8	7																											HY-B0312	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease|MOABOX:3606|ADA|Adenosine Transporter Inhibitor;Phosphodiesterase III Inhibitors;Phosphodiesterase V (PDE5A) Inhibitors	OCCN(CCO)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCO)CCO	58-32-2	15979	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468781	504.6256	DIPYRIDAMOLE	DIPYRIDAMOLE | DIPYDRIDAMOLE | DIPYRIDAMOLE | DIPYDRIDAMOLE	Pathway: Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease	MOABOX:3606	ADA	Adenosine Transporter Inhibitor;Phosphodiesterase III Inhibitors;Phosphodiesterase V (PDE5A) Inhibitors
SJ000851906-4	SJ000851906	4	MOABOX:3640	BYWWNRBKPCPJMG-UHFFFAOYSA-N	CCCCCCCCCCCCc1ccc(S(=O)(=O)Nc2nncs2)cc1	1191951-57-1	Protein Kinase B (PKB/Akt) Inhibitors;Phosphoinositide dependent Kinase (PDK) 1 Inhibitors	PDPK1																																																															CHEMBL595583											44240850					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-5.019e-002																																-0.00717																																7																																HY-12063	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:3640|PDPK1|Protein Kinase B (PKB/Akt) Inhibitors;Phosphoinositide dependent Kinase (PDK) 1 Inhibitors	CCCCCCCCCCCCc1ccc(cc1)S(=O)(=O)Nc2nncs2	1191951-57-1	5946	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469861	409.60904	PHT-427	PHT-427 | PHT-427	Pathway: Apoptosis; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:3640	PDPK1	Protein Kinase B (PKB/Akt) Inhibitors;Phosphoinositide dependent Kinase (PDK) 1 Inhibitors
SJ001034921-1	SJ001034921	1	MOABOX:3642	GVPAGJWVBUZHNQ-UHFFFAOYSA-N	Cc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(C(C)(C)C#N)cc1	853910-02-8	"Phosphoinositide dependent Kinase (PDK) 1 Inhibitors;Phosphatidylinositol 3-Kinase (PI3K) Inhibitors;""Phosphoinositide dependent Kinase (PDK) 1 Inhibitors;Phosphatidylinositol 3-Kinase (PI3K) Inhibitors"""	AKT1	PDPK1	PIK3CA	PIK3CD	ATR																												5170	5290	5293	545																												CHEMBL2134545											24882589					virtual	10.1016/j.bmcl.2007.12.018																																																																																																																																																															18248814	18972468																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.49944	0	0.13936	0.38885	0.4445																												0.06243	0.0	0.01742	0.05555	0.0635																												8	7	8	7	7																												1282	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-021-804-924|MOABOX:3642|AKT1|Phosphoinositide dependent Kinase (PDK) 1 Inhibitors;Phosphatidylinositol 3-Kinase (PI3K) Inhibitors;\Phosphoinositide dependent Kinase (PDK) 1 Inhibitors;Phosphatidylinositol 3-Kinase (PI3K) Inhibitors\	Cc1nc2cnc3ccc(cc3c2n1c4ccc(cc4)C(C)(C)C#N)C#Cc5cccnc5	853910-02-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468243	427.49984	BAG 956 | NVP-BAG956	"""BAG 956 | NVP-BAG956"" | ""BAG 956 | NVP-BAG956"""			MOABOX:3642	AKT1	Phosphoinositide dependent Kinase (PDK) 1 Inhibitors;Phosphatidylinositol 3-Kinase (PI3K) Inhibitors;\Phosphoinositide dependent Kinase (PDK) 1 Inhibitors;Phosphatidylinositol 3-Kinase (PI3K) Inhibitors\
SJ000821624-3	SJ000821624	3	MOABOX:3646	XVWPFYDMUFBHBF-CLOONOSVSA-N	COC(=O)[C@H](CC(C)C)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1cccc2ccccc12	1217457-86-7	Farnesyl Transferase Inhibitors;Geranylgeranyl Transferase Type I (GGTase-I) Inhibitors	FNTA	PGGT1B																															5229																															CHEMBL282748											9811605	9811606	16078971	145709783		member																																																																																																																																																																15055985																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.80048	0.80048																															0.10006	0.10006																															8	8																															HY-15871	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; GPCR/G Protein | Research Area: Cancer|MOABOX:3646|FNTA|Farnesyl Transferase Inhibitors;Geranylgeranyl Transferase Type I (GGTase-I) Inhibitors	COC(=O)[C@H](CC(C)C)NC(=O)c1ccc(NC[C@@H](N)CS)cc1c2cccc3ccccc23	1217457-86-7	26256	GENERAL	"2,2,2-TRIFLUOROACETATE"	1	NO_SOLVATE	0	1469083	479.63422	GGTI 298	GGTI 298 | GGTI 298	Pathway: Apoptosis; GPCR/G Protein	Research Area: Cancer	MOABOX:3646	FNTA	Farnesyl Transferase Inhibitors;Geranylgeranyl Transferase Type I (GGTase-I) Inhibitors
SJ001035147-1	SJ001035147	1	MOABOX:3650	XBJWOGLKABXFJE-UHFFFAOYSA-N	CCOC(=O)N1CSCC1C(=O)O	127657-29-8	Elastase Inhibitors	PI3																																																																										11615393	70041565	70041566			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-108285	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Inflammation/Immunology|MOABOX:3650|PI3|Elastase Inhibitors	CCOC(=O)N1CSCC1C(=O)O	127657-29-8	58000	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468899	205.23154	(RAC)-TELMESTEINE	(RAC)-TELMESTEINE | (RAC)-TELMESTEINE	Pathway: Others	Research Area: Inflammation/Immunology	MOABOX:3650	PI3	Elastase Inhibitors
SJ000000850-18	SJ000000850	18	MOABOX:3656	JQXXHWHPUNPDRT-WLSIYKJHSA-N	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C	13292-46-1	DNA-Directed RNA Polymerase Inhibitors;Enzyme Inducers;RNA Polymerase (Bacterial) Inhibitors	NR1I2	SLCO1B1	POLRMT																														10599	5442																														CHEMBL374478											86278253	135398735	135401919	135415642	135431111	virtual	10.1002/jcph.79	10.1002/jps.22694	10.1007/s11095-005-8812-5	10.1016/j.ab.2010.06.012	10.1016/j.bcp.2012.11.020	10.1016/j.bcp.2014.08.025	10.1021/acs.molpharmaceut.5b00453	10.1021/bi0268753	10.1074/jbc.M001215200	10.1124/dmd.107.018689	10.1124/dmd.109.029637	10.1124/dmd.110.035105	10.1124/dmd.113.052290	10.1124/jpet.102.043026	10.1124/jpet.103.064329	10.1124/jpet.110.175927	10.1124/jpet.117.247296	10.1124/mol.108.049437	10.1172/JCI3703	10.1210/me.2004-0346																																																																																																																																												20966043	22587986	27145071																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0	2.33752	0.19264																														0.0	0.29219	0.02408																														7	8	8																														HY-B0272	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Infection|MOABOX:3656|NR1I2|DNA-Directed RNA Polymerase Inhibitors;Enzyme Inducers;RNA Polymerase (Bacterial) Inhibitors	CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)\C(=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@@H]1C)\C)c(\C=N\N5CCN(C)CC5)c(O)c4c3C2=O	13292-46-1	37144	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469447	822.94022	RIFAMPIN	RIFAMPIN | RIFAMPICIN | RIFAMPIN | RIFAMPICIN	Pathway: Anti-infection	Research Area: Infection	MOABOX:3656	NR1I2	DNA-Directed RNA Polymerase Inhibitors;Enzyme Inducers;RNA Polymerase (Bacterial) Inhibitors
SJ000574285-8	SJ000574285	8	MOABOX:3658	TUVCWJQQGGETHL-UHFFFAOYSA-N	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1	371935-74-9	Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors;Phosphatidylinositol 3-Kinase beta (PI3Kbeta) Inhibitors;Phosphatidylinositol 3-Kinase delta (PI3Kdelta) Inhibitors;Phosphatidylinositol 3-Kinase gamma (PI3Kgamma) Inhibitors	PIK3C2B																																																															CHEMBL538346	CHEMBL573339										9884685	16739368	44424681	127263066	145697643	member	10.1016/j.ejmech.2015.05.036	10.1158/0008-5472.CAN-06-4615																																																																																																																																																														17339109	17575152	17601739	22037378	25589915	26037808																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																-1.424e-002																																-0.00178																																8																																HY-10115	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:3658|PIK3C2B|Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors;Phosphatidylinositol 3-Kinase beta (PI3Kbeta) Inhibitors;Phosphatidylinositol 3-Kinase delta (PI3Kdelta) Inhibitors;Phosphatidylinositol 3-Kinase gamma (PI3Kgamma) Inhibitors	Oc1cccc(c1)c2nc(N3CCOCC3)c4oc5ncccc5c4n2	371935-74-9	37148	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468843	348.35534	PIK 103	PIK 103 | PI-103 | PIK 103 | PI-103	Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:3658	PIK3C2B	Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors;Phosphatidylinositol 3-Kinase beta (PI3Kbeta) Inhibitors;Phosphatidylinositol 3-Kinase delta (PI3Kdelta) Inhibitors;Phosphatidylinositol 3-Kinase gamma (PI3Kgamma) Inhibitors
SJ000571307-6	SJ000571307	6	MOABOX:3668	QDITZBLZQQZVEE-YBEGLDIGSA-N	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1	958852-01-2	Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors	PIK3CA																																																															CHEMBL3544966											23582824					member																																																																																																																																																																19689267	21428893	21649578																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.36824																																0.17103																																8																																HY-12036	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:3668|PIK3CA|Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors	O=C1NC(=O)\C(=C\c2ccc3nccc(c4ccncc4)c3c2)\S1	958852-01-2	14156	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469673	333.36384	GSK1059615	GSK1059615 | GSK 1059615 | 958852-01-1 | GSK1059615 | GSK 1059615 | 958852-01-1	Pathway: Apoptosis; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:3668	PIK3CA	Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors
SJ000571300-17	SJ000571300	17	MOABOX:3670	CWHUFRVAEUJCEF-UHFFFAOYSA-N	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1	1202777-78-3	Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors	PIK3CA																																																															CHEMBL2017974	CHEMBL2364604										16654980	66577015	66834029	72203606	76683417	virtual																																																																																																																																																																21649577	24900266	25387153	25765909	25911625	26731167	27427973	28829592	28835805	30034607	30655957	31117517																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										2.96712																																0.37089																																8																																AS-40568	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Nc1cc(c(cn1)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466768	410.39355	BUPARLISIB	"BUPARLISIB | ""NVP-BKM120 | BKM-120"" | NVP-BKM120 | BKM120 (NVP-BKM120, BUPARLISIB) | BUPARLISIB | ""NVP-BKM120 | BKM-120"" | NVP-BKM120 | BKM120 (NVP-BKM120, BUPARLISIB)"			MOABOX:3670	PIK3CA	Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors
SJ000821572-5	SJ000821572	5	MOABOX:3672	JEGHXKRHKHPBJD-UHFFFAOYSA-N	CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21	1007207-67-1	Phosphatidylinositol 3-Kinase beta (PI3Kbeta) Inhibitors;Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors;Phosphatidylinositol 3-Kinase gamma (PI3Kgamma) Inhibitors	PIK3CA	PIK3CB	PIK3CG																														5291	5294																														CHEMBL1684984											49784945	137331887				member	10.1158/1078-0432.CCR-10-2882																																																																																																																																																															21316229	25387153																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.52112	2.64e-002	0.69968																														0.19014	0.0033	0.08746																														8	8	8																														HY-15466	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:3672|PIK3CA|Phosphatidylinositol 3-Kinase beta (PI3Kbeta) Inhibitors;Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors;Phosphatidylinositol 3-Kinase gamma (PI3Kgamma) Inhibitors	CS(=O)(=O)N1CCc2c1nc(nc2c3cnc(N)nc3)N4CCOCC4	1007207-67-1	8869	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469327	377.42146	CH-5132799	CH-5132799 | CH5132799 | CH-5132799 | CH5132799	Pathway: PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:3672	PIK3CA	Phosphatidylinositol 3-Kinase beta (PI3Kbeta) Inhibitors;Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors;Phosphatidylinositol 3-Kinase gamma (PI3Kgamma) Inhibitors
SJ000981039-4	SJ000981039	4	MOABOX:3694	VRQXRVAKPDCRCI-ZNMIVQPWSA-N	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1	1210608-43-7	Pim-1 Kinase Inhibitors;Pim-2 Kinase Inhibitors;Pim-3 Kinase Inhibitors	PIM1																																																															CHEMBL3651966											44814409	90647156	122198133	126970584		virtual																																																																																																																																																																26505898																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.15976																																0.26997																																8																																HY-19322B	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; JAK/STAT Signaling | Research Area: Cancer|MOABOX:3694|PIM1|Pim-1 Kinase Inhibitors;Pim-2 Kinase Inhibitors;Pim-3 Kinase Inhibitors	C[C@@H]1C[C@H](N)C[C@@H](C1)c2ccncc2NC(=O)c3ccc(F)c(n3)c4c(F)cccc4F	1820565-69-2	23048	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469111	440.46083	PIM-477 DIHYDROCHLORIDE | SGH447 DIHYDROCHLORIDE	"""PIM-477 DIHYDROCHLORIDE | SGH447 DIHYDROCHLORIDE"" | ""PIM-477 DIHYDROCHLORIDE | SGH447 DIHYDROCHLORIDE"""	Pathway: Apoptosis; JAK/STAT Signaling	Research Area: Cancer	MOABOX:3694	PIM1	Pim-1 Kinase Inhibitors;Pim-2 Kinase Inhibitors;Pim-3 Kinase Inhibitors
SJ001034820-1	SJ001034820	1	MOABOX:3704	CRXJBISLCDTJDM-UHFFFAOYSA-N	O=C(C1CCCCC1)N1CCN(S(=O)(=O)c2cccc(C(F)(F)F)c2)CC1		Pyruvate Kinase Isozyme M2 (PKM2) Activators	PKM																																																															CHEMBL477867											2729560					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.21364																																-0.03052																																7																																RJC03087	MAYBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-915-911|MOABOX:3704|PKM|Pyruvate Kinase Isozyme M2 (PKM2) Activators	FC(F)(F)c1cccc(c1)S(=O)(=O)N2CCN(CC2)C(=O)C3CCCCC3	334668-69-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468061	404.44703	RJC03087	RJC03087 | RJC03087			MOABOX:3704	PKM	Pyruvate Kinase Isozyme M2 (PKM2) Activators
SJ001033306-2	SJ001033306	2	MOABOX:3714	GAMRBCZMOOMBSQ-CCEZHUSRSA-N	CCCCCc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1	110683-10-8	TRPM8 (TRP-p8| CMR1)  Antagonists;TRPM2 Antagonists;TRPC6 Inhibitors;Phospholipase A2 (PLA2) Inhibitors	TRPC6	TRPM2	TRPM8	PLA2G10																													7226	79054	8399																													CHEMBL173443											5353376					member																																																																																																																																																																29723786																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.45038	1.6816	0	-4.704e-002																													0.06434	0.2102	0.0	-0.00672																													7	8	7	7																													HY-118628	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Cardiovascular Disease|MOABOX:3714|TRPC6|TRPM8 (TRP-p8| CMR1) Antagonists;TRPM2 Antagonists;TRPC6 Inhibitors;Phospholipase A2 (PLA2) Inhibitors	CCCCCc1ccc(\C=C\C(=O)Nc2ccccc2C(=O)O)cc1	110683-10-8	39708	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469837	337.41222	N-(P-AMYLCINNAMOYL) ANTHRANILIC ACID; ACA	N-(P-AMYLCINNAMOYL) ANTHRANILIC ACID; ACA | N-(P-AMYLCINNAMOYL) ANTHRANILIC ACID; ACA	Pathway: Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Cardiovascular Disease	MOABOX:3714	TRPC6	TRPM8 (TRP-p8|CMR1) Antagonists;TRPM2 Antagonists;TRPC6 Inhibitors;Phospholipase A2 (PLA2) Inhibitors
SJ000852516-4	SJ000852516	4	MOABOX:3716	BHLXTPHDSZUFHR-UHFFFAOYSA-N	CCc1c(C(=O)C(N)=O)c2c(OCC(=O)O)cccc2n1Cc1ccccc1	172732-68-2	Secretory Phospholipase A2 (sPLA2) Inhibitors	PLA2G1B	PLA2G2A	PLA2G5	PLA2G2D	PLA2G2E	PLA2G7	PLA2G6	PLA2R1	PLA2G3	PLA2G12A	PLA2G12B	PLA2G4F	PLA2G2C																				5320	5322	26279	30814	7941	8398	22925	50487	81579	84647	255189	391013																				CHEMBL148674											155815	141951125	144292437			member	10.1016/S0223-5234(00)01183-1	10.1016/j.bmc.2016.02.040	10.1021/jm0401309	10.1021/jm060136t	10.1021/jm800422v	10.1021/jm960487f	10.2174/092986705774462860	10.2174/1381612053507521																																																																																																																																																								8978844	15689175	16686528	18605714																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.226	1.00664	-0.36862	0	0	0	0.67448	-0.11067	0	0	0	0	5.6e-004																				0.15325	0.12583	-0.05266	0.0	0.0	0.0	0.08431	-0.01581	0.0	0.0	0.0	0.0	8e-05																				8	8	7	7	7	7	8	7	7	7	7	7	7																				HY-13402	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:3716|PLA2G1B|Secretory Phospholipase A2 (sPLA2) Inhibitors	CCc1c(C(=O)C(=O)N)c2c(OCC(=O)O)cccc2n1Cc3ccccc3	172732-68-2	17019	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469668	380.3939	VARESPLADIB | LY315920	"""VARESPLADIB | LY315920"" | VARESPLADIB (LY315920) | ""VARESPLADIB | LY315920"" | VARESPLADIB (LY315920)"	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:3716	PLA2G1B	Secretory Phospholipase A2 (sPLA2) Inhibitors
SJ000285202-13	SJ000285202	13	MOABOX:3720	GPKJTRJOBQGKQK-UHFFFAOYSA-N	CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12	130-42-7	TP53 Expression Enhancers;Secretory Phospholipase A2 (sPLA2) Inhibitors;Cytokine Production Inhibitors;NF-kappaB (NFKB) Activation Inhibitors	PLA2G2A	PRNP	TP53	PLA2G2D																													5621	7157	26279																													CHEMBL2105615	CHEMBL3277743	CHEMBL546257	CHEMBL554190	CHEMBL556980	CHEMBL7568						237	6239	149640	192073	192151	member	10.1021/jm034093h																																																																																																																																																															12904059	15655516	17409533	20540064	21412985	21531054	24059335																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															-1.01906	1.13336	-8.96e-003	-1.01773																													-0.14558	0.14167	-0.00128	-0.14539																													7	8	7	7																													MS-1557	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc3ccc(OC)cc13	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466657	399.9568	QUINACRINE	"QUINACRINE | QUINACRINE DIHYDROCHLORIDE DIHYDRATE | QUINACRINE DIHYDROCHLORIDE | ""MEPACRINE HYDROCHLORIDE | QUINACRINE HYDROCHLORIDE"" | QUINACRINE 2HCL | QUINACRINE | QUINACRINE DIHYDROCHLORIDE DIHYDRATE | QUINACRINE DIHYDROCHLORIDE | ""MEPACRINE HYDROCHLORIDE | QUINACRINE HYDROCHLORIDE"" | QUINACRINE 2HCL"			MOABOX:3720	PLA2G2A	TP53 Expression Enhancers;Secretory Phospholipase A2 (sPLA2) Inhibitors;Cytokine Production Inhibitors;NF-kappaB (NFKB) Activation Inhibitors
SJ000285898-10	SJ000285898	10	MOABOX:3730	GYDJEQRTZSCIOI-LJGSYFOKSA-N	NC[C@H]1CC[C@H](C(=O)O)CC1	1197-18-8	Tissue-Type Plasminogen Activator (t-PA) Inhibitors	PLAT																																																															CHEMBL877																member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-B0149	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cardiovascular Disease|MOABOX:3730|PLAT|Tissue-Type Plasminogen Activator (t-PA) Inhibitors	NC[C@@H]1CC[C@H](CC1)C(=O)O	1197-18-8	16337	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469558	157.2102	TRANEXAMIC ACID	TRANEXAMIC ACID | TRANEXAMIC ACID	Pathway: Others	Research Area: Cardiovascular Disease	MOABOX:3730	PLAT	Tissue-Type Plasminogen Activator (t-PA) Inhibitors
SJ001035150-1	SJ001035150	1	MOABOX:3740	LHABRXRGDLASIH-UHFFFAOYSA-N	O=C(NCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1cc2cc(F)ccc2[nH]1	1781834-93-2	Phospholipase D1 (PLD1) Inhibitors;Phospholipase D2 (PLD2) Inhibitors	PLD1	PLD2																															5338																															CHEMBL398567											16739265	57347524	90488864			member	10.1038/nchembio.140	10.1111/cbdd.12319																																																																																																																																																														17317170	19136975																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.93728	-3.288e-002																															0.24216	-0.00411																															8	8																															HY-12807	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:3740|PLD1|Phospholipase D1 (PLD1) Inhibitors;Phospholipase D2 (PLD2) Inhibitors	Fc1ccc2[nH]c(cc2c1)C(=O)NCCN3CCC(CC3)N4C(=O)Nc5ccccc45	939055-18-2	16871	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468928	421.46736	FIPI | 5-FLUORO-2-INDOLYL DESCHLOROHALOPEMIDE	"""FIPI | 5-FLUORO-2-INDOLYL DESCHLOROHALOPEMIDE"" | ""FIPI | 5-FLUORO-2-INDOLYL DESCHLOROHALOPEMIDE"""	Pathway: Autophagy; Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:3740	PLD1	Phospholipase D1 (PLD1) Inhibitors;Phospholipase D2 (PLD2) Inhibitors
SJ001035243-1	SJ001035243	1	MOABOX:3742	NBHPRWLFLUBAIE-UHFFFAOYSA-N	O=C(NCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1)c1ccc(F)cc1	59831-65-1	Dopamine Receptor Antagonists;Phospholipase D2 (PLD2) Inhibitors	PLD2																																																															CHEMBL245621											65490					member	10.1021/jm100814g	10.1021/jm301782e	10.1038/nchembio.140																																																																																																																																																													19136975	19268584	20735042	23445448	25180768	25466173	27104509	30528979																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														-7.592e-002																																-0.00949																																8																																HY-119093	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Cancer; Neurological Disease|MOABOX:3742|PLD2|Dopamine Receptor Antagonists;Phospholipase D2 (PLD2) Inhibitors	Fc1ccc(cc1)C(=O)NCCN2CCC(CC2)N3C(=O)Nc4cc(Cl)ccc34	59831-65-1	66075	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469283	416.87638	HALOPEMIDE	HALOPEMIDE | HALOPEMIDE	Pathway: GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Cancer; Neurological Disease	MOABOX:3742	PLD2	Dopamine Receptor Antagonists;Phospholipase D2 (PLD2) Inhibitors
SJ000287723-4	SJ000287723	4	MOABOX:3748	PXXJHWLDUBFPOL-UHFFFAOYSA-N	N=C(N)c1ccccc1	125772-71-6		PLG																																																															CHEMBL1528282	CHEMBL20936	CHEMBL537204									2332	80289	229072	12238985	12238987	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.54824																																0.07832																																7																																BS-3750	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NC(=N)c1ccccc1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466755	120.15182	BENZAMIDINE HYDROCHLORIDE	BENZAMIDINE HYDROCHLORIDE | BENZAMIDINE HYDROCHLORIDE			MOABOX:3748	PLG	
SJ000560619-16	SJ000560619	16	MOABOX:3752	XQVVPGYIWAGRNI-JOCHJYFZSA-N	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1	755038-02-9	Antimitotic Drugs;Polo-like Kinase-1 (Plk-1) Inhibitors	PLK1	BRD4																															23476																															CHEMBL513909											11364421	73388378	81689938	86306092	91826268	member	10.1002/anie.201103273	10.1016/j.bmc.2019.05.006	10.1016/j.cub.2006.12.037	10.1016/j.ejmech.2017.05.049	10.1021/acsmedchemlett.8b00380	10.1111/j.1747-0285.2007.00594.x																																																																																																																																																										18005335	18762425	19474163	19568282	22037378	22583481	22607148	22709006	23103095	23651485	26191363	26985285	28195723	28280261	28586718	28792760	29220793	29525435	30125504	30253095	30613326	30613330	30789735	31079968																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														2.49848	0.24504																															0.31231	0.03063																															8	8																															HY-50698	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:3752|PLK1|Antimitotic Drugs;Polo-like Kinase-1 (Plk-1) Inhibitors	CC[C@H]1N(C2CCCC2)c3nc(Nc4ccc(cc4OC)C(=O)NC5CCN(C)CC5)ncc3N(C)C1=O	755038-02-9	28602	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469568	521.65436	BI-2536	BI-2536 | BI-2536	Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:3752	PLK1	Antimitotic Drugs;Polo-like Kinase-1 (Plk-1) Inhibitors
SJ000285188-27	SJ000285188	27	MOABOX:3764	UHDGCWIWMRVCDJ-CCXZUQQUSA-N	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1	147-94-4	Antimetabolites;DNA Polymerase Inhibitors	POLB	REV3L																															5980																															CHEMBL1256472	CHEMBL3350527	CHEMBL803									6252	6253	456559	490257	9911953	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.68628	0																															-0.09804	0.0																															7	7																															HY-13605	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease | Research Area: Cancer; Infection|MOABOX:3764|POLB|Antimetabolites;DNA Polymerase Inhibitors	NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O	147-94-4	11637	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468828	243.21662	CYTARABINE	"CYTARABINE | CYTIDINE | CYTOSINE-1-BETA-D-ARABINOFURANOSIDE HYDROCHLORIDE | CYTOSINE BETA-D-ARABINOFURANOSIDE | CYTOSINE ARABINOSIDE | ""CYTARABINE | ARA-C | ARAC | CHX-3311 | NSC-63878 | U-19920A |"" | |OSSL_144797 | CYTARABINE | CYTIDINE | CYTOSINE-1-BETA-D-ARABINOFURANOSIDE HYDROCHLORIDE | CYTOSINE BETA-D-ARABINOFURANOSIDE | CYTOSINE ARABINOSIDE | ""CYTARABINE | ARA-C | ARAC | CHX-3311 | NSC-63878 | U-19920A |"" | |OSSL_144797"	Pathway: Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Research Area: Cancer; Infection	MOABOX:3764	POLB	Antimetabolites;DNA Polymerase Inhibitors
SJ000285775-11	SJ000285775	11	MOABOX:3780	HEMJJKBWTPKOJG-UHFFFAOYSA-N	Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1	114413-98-8	PPARalpha Agonists	PPARA																																																															CHEMBL457											3463	19030122	42635917	66715394	67175568	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.17592																																-0.02199																																8																																KS-5192	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466664	250.33338	GEMFIBROZIL	GEMFIBROZIL | GEMFIBROZIL			MOABOX:3780	PPARA	PPARalpha Agonists
SJ000951747-3	SJ000951747	3	MOABOX:3792	YDBLKRPLXZNVNB-UHFFFAOYSA-N	Cc1cc(SCc2sc(-c3ccc(C(F)(F)F)cc3)nc2C)ccc1OCC(=O)O	317318-70-0	Insulin Sensitizers;PPARdelta Agonists	PPARD																																																															CHEMBL38943											9803963	142842234	143721236			virtual	10.1016/S0960-894X(03)00207-5	10.1016/j.bmc.2007.05.023	10.1016/j.bmc.2010.12.023	10.1016/j.bmc.2013.02.003	10.1016/j.bmc.2018.06.044	10.1016/j.bmcl.2005.06.023	10.1016/j.bmcl.2007.04.047	10.1016/j.bmcl.2007.05.007	10.1016/j.bmcl.2012.04.062	10.1016/j.ejmech.2012.03.055	10.1021/jm070511x	10.1021/jm9007399	10.1038/415813a	10.2174/0929867033368295	10.2174/0929867043364513	10.2174/1568026033451673																																																																																																																																																12699745	16750626	16797985	17243659	17343371	17512197	17524643	17532641	17553681	17560785	18722772	19275963	19928766	20128594	21094606	21112784	21215640	21414782	21515063	22051054	22534184	22564380	22579420	25305688	25768705	27591006	28539218	28799755																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										6.1036																																0.76295																																8																																6T-0058	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Cc1cc(SCc2sc(nc2C)c3ccc(cc3)C(F)(F)F)ccc1OCC(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466692	453.49773	GW-501516 | 501516 | GSK-516 | GW-516	"""GW-501516 | 501516 | GSK-516 | GW-516"" | ""GW-501516 | 501516 | GSK-516 | GW-516"""			MOABOX:3792	PPARD	Insulin Sensitizers;PPARdelta Agonists
SJ000286067-15	SJ000286067	15	MOABOX:3806	YASAKCUCGLMORW-UHFFFAOYSA-N	CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1	1217260-35-9	Insulin Sensitizers;PPARgamma Agonists	PPARA	PPARG																															5468																															CHEMBL121	CHEMBL1704605	CHEMBL843									77998	77999	5281055	6445783	6537720	member	10.1006/bbrc.2000.3868	10.1016/S0960-894X(03)00115-X	10.1016/S0960-894X(03)00505-5	10.1016/j.bmc.2011.11.035	10.1016/j.bmc.2018.10.033	10.1016/j.ejphar.2004.05.020	10.1016/j.jhazmat.2019.120794	10.1124/jpet.104.068254	10.1124/mol.104.008409	10.3390/md12020926																																																																																																																																																						8539218	9454824	9836620	10612594	10691680	10714503	11405642	11607934	11720854	11831892	12482434	12570700	12617924	12657263	12672231	12729668	12824034	12873517	12927868	12951090	14584939	14695833	15003718	15080938	15163205	15177462	15293980	15379708	15582409	15603954	15713415	15715931	15771468	15801817	15863293	16107150	16137885	16153845	16249089	16300944	16366601	16451087	16454728	16508139	16650995	16696951	16821769	16854085	16887353	16919947	16970391	16973358	16979341	17005393	17005394	17034149	17066499	17129725	17157019	17211457	17292606	17343371	17357171	17379517	17403688	17507225	17553681	17560785	17624777	18029176	18029178	18086153	18255290	18291645	18329751	18394907	18625559	18771917	18826205	18835719	19053776	19275963	19301897	19326383	19349176	19471887	19507861	19530681	19574056	19719236	19775169	19783444	19879669	20138762	20219371	20299214	20436486	20444603	20462215	20518620	20527969	20973122	21030263	21112784	21128600	21218783	21400663	21450468	21482446	21511917	21515063	21720040	21824085	21873070	21963632	22039047	22051054	22070604	22081932	22172067	22197396	22200596	22225641	22242855	22489042	22509006	22582973	22727448	22934537	23023262	23047286	23171045	23186307	23286787	23294830	23466604	23490155	23502212	23582449	24075729	24955889	25305688	25462281	25497132	25978962	26226490	26708109	26774923	26988801	27591006	27622746	27876250	28076827	28117121	28208577	28539218	28609708	28667876	28720328	28735214	29389121	29446942	29615345	29628329	29940464	30199253	30241907	30429097	30702885	30783504	30996794																																																																																																																																																																																																																																																																																																																																																																																											-0.39968	5.4936																															-0.04996	0.6867																															8	8																															6P-065	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c3ccccn3	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466649	357.42676	ROSIGLITAZONE	"ROSIGLITAZONE | ROSIGLITAZONE MALEATE| AVANDIA | ""ROSIGLITAZONE MALEATE | BRL-49653C |"" | ROSIGLITAZONE MALEATE | ROSIGLITAZONE | ROSIGLITAZONE MALEATE| AVANDIA | ""ROSIGLITAZONE MALEATE | BRL-49653C |"" | ROSIGLITAZONE MALEATE"			MOABOX:3806	PPARA	Insulin Sensitizers;PPARgamma Agonists
SJ000286074-17	SJ000286074	17	MOABOX:3808	HYAFETHFCAUJAY-UHFFFAOYSA-N	CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1	105355-27-9	Insulin Sensitizers;PPARgamma Agonists	PPARG	ADIPOR2																															79602																															CHEMBL1715	CHEMBL595										4829	60560	9805398	9847622	9850722	member	10.1002/minf.201700153	10.1006/bbrc.2000.3868	10.1016/S0014-2999(01)00907-4	10.1021/acs.jnatprod.8b00439	10.1124/jpet.104.068254																																																																																																																																																											9836620	10612594	10691680	11720854	11831892	11906293	12372861	12570700	14584939	15003718	15379708	16454728	16508139	16650995	16821769	16887353	17574414	17610302	18275039	19067454	19504532	20073471	20219371	20222852	20307981	20656494	21030263	21130649	21377875	21720040	21873070	22242855	22341573	22489042	22509006	23102891	23130964	25333853	26048793	26595749	27560282	27569195	27918994	30362739	30429097	30672698	30676741	30889916																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						2.66968	0																															0.33371	0.0																															8	7																															HS-0047	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466672	356.4387	PIOGLITAZONE	"PIOGLITAZONE | PIOGLITAZONE HYDROCHLORIDE | ""PIOGLITAZONE 2-IMINE | AD-4833 | U-72107 | AA-10090 | U-72107A | U-72107E"" | PIOGLITAZONE HCL | PIOGLITAZONE | PIOGLITAZONE HYDROCHLORIDE | ""PIOGLITAZONE 2-IMINE | AD-4833 | U-72107 | AA-10090 | U-72107A | U-72107E"" | PIOGLITAZONE HCL"			MOABOX:3808	PPARG	Insulin Sensitizers;PPARgamma Agonists
SJ001035377-1	SJ001035377	1	MOABOX:3810	VQHUQHAPWMNBLP-UHFFFAOYSA-N	COP(=O)(OC)OC(c1ccc(Cl)cc1)P(=O)(OC)OC	76541-72-5	PPARgamma Antagonists	PPARG																																																															CHEMBL284768											60910					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.26005																																-0.03715																																7																																HY-100277	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Metabolic Disease|MOABOX:3810|PPARG|PPARgamma Antagonists	COP(=O)(OC)OC(c1ccc(Cl)cc1)P(=O)(OC)OC	76541-72-5	85623	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469846	358.649	MIFOBATE | SR-202	"""MIFOBATE | SR-202"" | ""MIFOBATE | SR-202"""	Pathway: Cell Cycle/DNA Damage	Research Area: Metabolic Disease	MOABOX:3810	PPARG	PPARgamma Antagonists
SJ000286706-8	SJ000286706	8	MOABOX:3816	RMMXLENWKUUMAY-UHFFFAOYSA-N	CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1	144701-48-4	Angiotensin AT1 Antagonists;PPARgamma partial agonist;PPARalpha Partial Agonists	AGTR1	PPARA	PPARG																														5465	5468																														CHEMBL1017											65999	216293	9832849	9854421	9963098	member	10.1016/j.bmcl.2012.11.088	10.1016/j.bmcl.2014.01.004	10.1038/sj.bjp.0707323	10.1124/jpet.110.176636	10.1248/bpb.b16-00987																																																																																																																																																											20079636	21557540	22309912	22727371	23265881	24007859	24462665	27560282																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														3.34136	5.67e-003	-0.1692																														0.41767	0.00081	-0.02115																														8	7	8																														HY-13955	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; GPCR/G Protein | Research Area: Cardiovascular Disease; Endocrinology|MOABOX:3816|AGTR1|Angiotensin AT1 Antagonists;PPARgamma partial agonist;PPARalpha Partial Agonists	CCCc1nc2c(C)cc(cc2n1Cc3ccc(cc3)c4ccccc4C(=O)O)c5nc6ccccc6n5C	144701-48-4	10104	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469467	514.6169	TELMISARTAN	"TELMISARTAN | ""TELMISARTAN | MICARDIS"" | SJ000803704 | TELMISARTAN | ""TELMISARTAN | MICARDIS"" | SJ000803704"	Pathway: Autophagy; GPCR/G Protein	Research Area: Cardiovascular Disease; Endocrinology	MOABOX:3816	AGTR1	Angiotensin AT1 Antagonists;PPARgamma partial agonist;PPARalpha Partial Agonists
SJ001035262-1	SJ001035262	1	MOABOX:3824	GDOVFSONSLOIAK-KRWDZBQOSA-N	O=C([C@@H]1CSCN1C(=O)CC1Cc2ccccc2C1)N1CCCC1	130849-58-0	Prolyl Endopeptidase (prolyl oligopeptidase;POP) Inhibitors	PREP																																																															CHEMBL62960											9798234	87282783				member																																																																																																																																																																8027988																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.44216																																0.18027																																8																																HY-19123	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Neurological Disease|MOABOX:3824|PREP|Prolyl Endopeptidase (prolyl oligopeptidase;POP) Inhibitors	O=C(CC1Cc2ccccc2C1)N3CSC[C@H]3C(=O)N4CCCC4	130849-58-0	64520	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469394	344.47106	Z-321	Z-321 | Z-321	Pathway: Others	Research Area: Neurological Disease	MOABOX:3824	PREP	Prolyl Endopeptidase (prolyl oligopeptidase;POP) Inhibitors
SJ000855301-3	SJ000855301	3	MOABOX:3832	BPNUQXPIQBZCMR-IBGZPJMESA-N	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12	552325-73-2	cAMP-Dependent Protein Kinase (PKA) Inhibitors;Inhibitors of Signal Transduction Pathways;PKB alpha/Akt1 Inhibitors	PRKACA	PRKACB	PRKACG																														5567	5568																														CHEMBL379218											11314340	73357690				member																																																																																																																																																																16678413	17692025	19149480	20180757	22037378	22353219																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.61656	0.3514	0.30723																														0.07707	0.0502	0.04389																														8	7	7																														HY-13254A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:3832|PRKACA|cAMP-Dependent Protein Kinase (PKA) Inhibitors;Inhibitors of Signal Transduction Pathways;PKB alpha/Akt1 Inhibitors	Cc1n[nH]c2ccc(cc12)c3cncc(OC[C@@H](N)Cc4ccccc4)c3	NA	18910	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469398	358.43628	A-674563	A-674563 | A-674563	Pathway: PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:3832	PRKACA	cAMP-Dependent Protein Kinase (PKA) Inhibitors;Inhibitors of Signal Transduction Pathways;PKB alpha/Akt1 Inhibitors
SJ000287647-11	SJ000287647	11	MOABOX:3834	ZKZXNDJNWUTGDK-NSCUHMNNSA-N	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12	127243-85-0	cAMP-Dependent Protein Kinase (PKA) Inhibitors;Protein Kinase B (PKB/Akt) Inhibitors;Voltage-Gated K(V) Channel Blockers	PRKACA	PRKACB	PRKACG																														5567	5568																														CHEMBL104264	CHEMBL1315166										449241	5702541	9848107	16078954	68606940	member																																																																																																																																																																12171518	12171565	15853641	16249095	17125267	17451235	17457815	17692025	19143565	19149480	20180757	22512570	22607148																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									1.77968	0.3556	0.3556																														0.22246	0.0508	0.0508																														8	7	7																														HY-15979A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt | Research Area: Others|MOABOX:3834|PRKACA|cAMP-Dependent Protein Kinase (PKA) Inhibitors;Protein Kinase B (PKB/Akt) Inhibitors;Voltage-Gated K(V) Channel Blockers	Brc1ccc(\C=C\CNCCNS(=O)(=O)c2cccc3cnccc23)cc1	130964-39-5	26506	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468922	446.3607	H-89	H-89 | H-89 DIHYDROCHLORIDE SALT | H 89 2HCL | H-89 | H-89 DIHYDROCHLORIDE SALT | H 89 2HCL	Pathway: Autophagy; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Research Area: Others	MOABOX:3834	PRKACA	cAMP-Dependent Protein Kinase (PKA) Inhibitors;Protein Kinase B (PKB/Akt) Inhibitors;Voltage-Gated K(V) Channel Blockers
SJ000866915-2	SJ000866915	2	MOABOX:3836	AFSDNFLWKVMVRB-UHFFFAOYSA-N	O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23	122328-15-8	cAMP-Dependent Protein Kinase (PKA) Inhibitors;Inhibitors of Signal Transduction Pathways;PKB alpha/Akt1 Inhibitors;LOXL2-dependent prodrug inhibitor of TGFBR	LOXL2	PRKACA	PRKACB	PRKACG	CARM1																												5566	5567	5568	10498																												CHEMBL6246											5281855	16212384	16760409	46238599	46238600	virtual	10.1172/JCI94624																																																																																																																																																															7518523	15032721																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.37086	0	2.28e-002	1.995e-002	1.995e-002																												-0.05298	0.0	0.00285	0.00285	0.00285																												7	7	8	7	7																												AS-35095	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Oc1cc2C(=O)Oc3c(O)c(O)cc4C(=O)Oc(c1O)c2c34	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466832	302.19264	ELLAGIC ACID(P)	ELLAGIC ACID(P) | ELLAGIC ACID(P)			MOABOX:3836	LOXL2	cAMP-Dependent Protein Kinase (PKA) Inhibitors;Inhibitors of Signal Transduction Pathways;PKB alpha/Akt1 Inhibitors;LOXL2-dependent prodrug inhibitor of TGFBR
SJ000784314-9	SJ000784314	9	MOABOX:3854	AXRCEOKUDYDWLF-UHFFFAOYSA-N	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21	170364-57-5	Inhibitors of Signal Transduction Pathways;Protein Kinase PKC beta Inhibitors;Angiogenesis Inhibitors	PRKCB	PRKCH	PRKCZ	RPS6KB1																													5583	5590	6198																													CHEMBL2107337	CHEMBL300138										176166	176167	11261807	11983300	16004694	member	10.1016/S0960-894X(03)00286-5																																																																																																																																																															12749884	17389337	18972468	22037378																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.87384	9.288e-002	-0.37548	-5.383e-002																													0.23423	0.01161	-0.05364	-0.00769																													8	8	7	7																													HY-10342	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Epigenetics; TGF-beta/Smad | Research Area: Cancer|MOABOX:3854|PRKCB|Inhibitors of Signal Transduction Pathways;Protein Kinase PKC beta Inhibitors;Angiogenesis Inhibitors	Cn1cc(C2=C(C(=O)NC2=O)c3cn(C4CCN(Cc5ccccn5)CC4)c6ccccc36)c7ccccc17	170364-57-5	7196	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469268	515.60496	ENZASTAURIN	"ENZASTAURIN | ""LY-317615 | 317615"" | ENZASTAURIN (LY317615) | ENZASTAURIN | ""LY-317615 | 317615"" | ENZASTAURIN (LY317615)"	Pathway: Apoptosis; Autophagy; Epigenetics; TGF-beta/Smad	Research Area: Cancer	MOABOX:3854	PRKCB	Inhibitors of Signal Transduction Pathways;Protein Kinase PKC beta Inhibitors;Angiogenesis Inhibitors
SJ000834137-6	SJ000834137	6	MOABOX:3876	JAMULYFATHSZJM-UHFFFAOYSA-N	O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12	503468-95-9	"Inhibitors of Signal Transduction Pathways;DNA-Dependent Protein Kinase (DNA-PK) Inhibitors;DNA Repair Inhibitors;""Inhibitors of Signal Transduction Pathways;DNA-Dependent Protein Kinase (DNA-PK) Inhibitors;DNA Repair Inhibitors"""	PRKDC	XRCC6																															2547																															CHEMBL188678											11327430					member	10.1016/j.ejmech.2016.01.042	10.1021/jm100608j	10.1039/b705095j	10.1039/c1ob05282a																																																																																																																																																												15546735	16302822	16707462	17371003	18019542	18678488	19149561	20423312	20449499	20472428	21080722	21216595	21748189	22814419	22835870	23059543	23855836	25387153	26854431	27177826	28280261																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0	2.55928																															0.0	0.31991																															7	8																															HY-11006	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:3876|PRKDC|Inhibitors of Signal Transduction Pathways;DNA-Dependent Protein Kinase (DNA-PK) Inhibitors;DNA Repair Inhibitors;\Inhibitors of Signal Transduction Pathways;DNA-Dependent Protein Kinase (DNA-PK) Inhibitors;DNA Repair Inhibitors\	O=C1C=C(Oc2c1cccc2c3cccc4c5ccccc5sc34)N6CCOCC6	503468-95-9	79914	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468777	413.48826	NU 7441	NU 7441 | NU7441 | NU7441 (KU-57788) | NU 7441 | NU7441 | NU7441 (KU-57788)	Pathway: Cell Cycle/DNA Damage; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:3876	PRKDC	Inhibitors of Signal Transduction Pathways;DNA-Dependent Protein Kinase (DNA-PK) Inhibitors;DNA Repair Inhibitors;\Inhibitors of Signal Transduction Pathways;DNA-Dependent Protein Kinase (DNA-PK) Inhibitors;DNA Repair Inhibitors\
SJ000988526-4	SJ000988526	4	MOABOX:3892	VFCRKLWBYMDAED-REWPJTCUSA-N	CCC[C@H](N[C@H]1CCc2cc(F)cc(F)c2C1)C(=O)Nc1cn(C(C)(C)CNCC(C)(C)C)cn1	1290543-63-3	Apoptosis Inducers;gamma-Secretase Inhibitors	PSEN1	PSEN2	APH1A	PSENEN	APH1B																												5664	51107	55851	83464																												CHEMBL1770916											46224413	121513889				member																																																																																																																																																																21269827																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.43264	0.38647	0.38647	0.38647	0.38647																												0.05408	0.05521	0.05521	0.05521	0.05521																												8	7	7	7	7																												HY-15185	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Neuronal Signaling; Stem Cell/Wnt | Research Area: Cancer|MOABOX:3892|PSEN1|Apoptosis Inducers;gamma-Secretase Inhibitors	CCC[C@H](N[C@H]1CCc2cc(F)cc(F)c2C1)C(=O)Nc3cn(cn3)C(C)(C)CNCC(C)(C)C	1290543-63-3	24515	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468844	489.64415	NIROGACESTAT | PF-3084014	"""NIROGACESTAT | PF-3084014"" | ""NIROGACESTAT | PF-3084014"""	Pathway: Apoptosis; Neuronal Signaling; Stem Cell/Wnt	Research Area: Cancer	MOABOX:3892	PSEN1	Apoptosis Inducers;gamma-Secretase Inhibitors
SJ000786027-6	SJ000786027	6	MOABOX:3898	XEAOPVUAMONVLA-QGZVFWFLSA-N	NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(-c2ncon2)cc1F)S(=O)(=O)c1ccc(Cl)cc1	1146699-66-2	gamma-Secretase Inhibitors	PSEN1	PSEN2	APH1A	PSENEN	APH1B																												5664	51107	55851	83464																												CHEMBL1090771											46883536	91180145				member																																																																																																																																																																19694467	22420884	23312944	23713656																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.47648	0.50379	0.50379	0.50379	0.50379																												0.05956	0.07197	0.07197	0.07197	0.07197																												8	7	7	7	7																												HY-50845	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Neuronal Signaling; Stem Cell/Wnt | Research Area: Cancer|MOABOX:3898|PSEN1|gamma-Secretase Inhibitors	NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(cc1F)c2nocn2)S(=O)(=O)c3ccc(Cl)cc3	1146699-66-2	1725	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469792	520.88499	BMS-708163	BMS-708163 | AVAGACESTAT (BMS-708163) | BMS-708163 | AVAGACESTAT (BMS-708163)	Pathway: Neuronal Signaling; Stem Cell/Wnt	Research Area: Cancer	MOABOX:3898	PSEN1	gamma-Secretase Inhibitors
SJ000855292-2	SJ000855292	2	MOABOX:3900	ULSSJYNJIZWPSB-CVRXJBIPSA-N	C[C@H](NC(=O)[C@@H](O)c1cc(F)cc(F)c1)C(=O)N[C@@H]1C(=O)N(C)c2ccccc2-c2ccccc21	209984-57-6	gamma-Secretase Inhibitors;Antiamyloidogenic Agents	PSEN1	PSEN2	APH1A	PSENEN	APH1B																												5664	51107	55851	83464																												CHEMBL392068											10435235	24752902				member																																																																																																																																																																17573346	19694467																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.34456	0.92424	0.29834	0.29834	0.29834																												0.16807	0.11553	0.04262	0.04262	0.04262																												8	8	7	7	7																												HY-50752	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Neuronal Signaling; Stem Cell/Wnt | Research Area: Neurological Disease|MOABOX:3900|PSEN1|gamma-Secretase Inhibitors;Antiamyloidogenic Agents	C[C@H](NC(=O)[C@@H](O)c1cc(F)cc(F)c1)C(=O)N[C@@H]2C(=O)N(C)c3ccccc3c4ccccc24	209984-57-6	9004	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469284	479.47533	LY411575	LY411575 | LY411575	Pathway: Apoptosis; Neuronal Signaling; Stem Cell/Wnt	Research Area: Neurological Disease	MOABOX:3900	PSEN1	gamma-Secretase Inhibitors;Antiamyloidogenic Agents
SJ001035191-1	SJ001035191	1	MOABOX:3902	IZAOBRWCUGOKNH-OAHLLOKOSA-N	C[C@H](c1ccc(F)cc1CCCC(=O)O)N(c1cc(F)ccc1F)S(=O)(=O)c1ccc(Cl)cc1	290315-45-6	gamma-Secretase Inhibitors;Antiamyloidogenic Agents	PSEN1	PSEN2	APH1A	PSENEN	APH1B																												5664	51107	55851	83464																												CHEMBL247471											11249248					member																																																																																																																																																																17035010	17932033	19694467																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.39168	0.34314	0.34314	0.34314	0.34314																												0.04896	0.04902	0.04902	0.04902	0.04902																												8	7	7	7	7																												HY-50883	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Neuronal Signaling; Stem Cell/Wnt | Research Area: Neurological Disease|MOABOX:3902|PSEN1|gamma-Secretase Inhibitors;Antiamyloidogenic Agents	C[C@@H](N(c1cc(F)ccc1F)S(=O)(=O)c2ccc(Cl)cc2)c3ccc(F)cc3CCCC(=O)O	290315-45-6	22551	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469044	511.94105	BMS 299897	BMS 299897 | BMS 299897	Pathway: Neuronal Signaling; Stem Cell/Wnt	Research Area: Neurological Disease	MOABOX:3902	PSEN1	gamma-Secretase Inhibitors;Antiamyloidogenic Agents
SJ000784319-4	SJ000784319	4	MOABOX:3904	PKXWXXPNHIWQHW-RCBQFDQVSA-N	CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1C(=O)N(C)CCc2ccccc21	425386-60-3	gamma-Secretase Inhibitors;Antiamyloidogenic Agents	PSEN1	PSEN2	APH1A	PSENEN	APH1B																												5664	51107	55851	83464																												CHEMBL520733											9843749	9843750				member																																																																																																																																																																19694467	20056541	23713656																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.94632	0.81776	0.15505	0.15505	0.15505																												0.11829	0.10222	0.02215	0.02215	0.02215																												8	8	7	7	7																												HY-10009	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Neuronal Signaling; Stem Cell/Wnt | Research Area: Neurological Disease|MOABOX:3904|PSEN1|gamma-Secretase Inhibitors;Antiamyloidogenic Agents	CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1C(=O)N(C)CCc2ccccc12	425386-60-3	2048	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469198	361.43538	SEMAGACESTAT | LY-450139 |	"""SEMAGACESTAT | LY-450139 |"" | SEMAGACESTAT (LY450139) | ""SEMAGACESTAT | LY-450139 |"" | SEMAGACESTAT (LY450139)"	Pathway: Neuronal Signaling; Stem Cell/Wnt	Research Area: Neurological Disease	MOABOX:3904	PSEN1	gamma-Secretase Inhibitors;Antiamyloidogenic Agents
SJ000285770-13	SJ000285770	13	MOABOX:3906	SYTBZMRGLBWNTM-SNVBAGLBSA-N	C[C@@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1	5104-49-4	gamma-Secretase Inhibitors;NF-kappaB (NFKB) Modulators;Antiamyloidogenic Agents	PTGS1	PTGS2	APP																														5743	351																														CHEMBL190083											92337	10341360	24759764	46848031	66706549	member	10.1139/y97-130																																																																																																																																																															10091674	11311743	12511226	14510637	15279594	17341061	17640617	20858219	22471981	22571790	26774927																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											-0.6916	1.63784	0.67942																														-0.0988	0.20473	0.09706																														7	8	7																														HY-10582	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Immunology/Inflammation | Research Area: Inflammation/Immunology; Cancer|MOABOX:3906|PTGS1|gamma-Secretase Inhibitors;NF-kappaB (NFKB) Modulators;Antiamyloidogenic Agents	CC(C(=O)O)c1ccc(c(F)c1)c2ccccc2	5104-49-4	12040	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468791	244.26092	FLURBIPROFEN	"FLURBIPROFEN | ""BTS-18322 | MKS-11 | MU-27182 | ANMETARIN | (+/-)-FLURBIPROFEN"" | FLURBIPROFEN | ""BTS-18322 | MKS-11 | MU-27182 | ANMETARIN | (+/-)-FLURBIPROFEN"""	Pathway: Apoptosis; Immunology/Inflammation	Research Area: Inflammation/Immunology; Cancer	MOABOX:3906	PTGS1	gamma-Secretase Inhibitors;NF-kappaB (NFKB) Modulators;Antiamyloidogenic Agents
SJ000285770-12	SJ000285770	12	MOABOX:3906	SYTBZMRGLBWNTM-SNVBAGLBSA-N	C[C@@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1	5104-49-4	gamma-Secretase Inhibitors;NF-kappaB (NFKB) Modulators;Antiamyloidogenic Agents	PTGS1	PTGS2	APP																														5743	351																														CHEMBL190083											92337	10341360	24759764	46848031	66706549	member	10.1139/y97-130																																																																																																																																																															10091674	11311743	12511226	14510637	15279594	17341061	17640617	20858219	22471981	22571790	26774927																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											-0.6916	1.63784	0.67942																														-0.0988	0.20473	0.09706																														7	8	7																														AJP02233	ALDLAB	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-936-370|MOABOX:3906|PTGS1|gamma-Secretase Inhibitors;NF-kappaB (NFKB) Modulators;Antiamyloidogenic Agents	CC(C(=O)O)c1ccc(c(F)c1)c2ccccc2	51543-40-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468254	244.26092	FLURBIPROFEN	"FLURBIPROFEN | ""BTS-18322 | MKS-11 | MU-27182 | ANMETARIN | (+/-)-FLURBIPROFEN"" | FLURBIPROFEN | ""BTS-18322 | MKS-11 | MU-27182 | ANMETARIN | (+/-)-FLURBIPROFEN"""			MOABOX:3906	PTGS1	gamma-Secretase Inhibitors;NF-kappaB (NFKB) Modulators;Antiamyloidogenic Agents
SJ000772434-5	SJ000772434	5	MOABOX:3908	DWJXYEABWRJFSP-XOBRGWDASA-N	C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@H](C(=O)OC(C)(C)C)c1ccccc1	208255-80-5	gamma-Secretase Inhibitors;Notch Signaling Inhibitors;Antiamyloidogenic Agents	PSEN1	PSEN2	APH1A	PSENEN	APH1B																												5664	51107	55851	83464																												CHEMBL255682											5311272					member																																																																																																																																																																17932033																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.5952	0.5952	0.35371	0.35371	0.35371																												0.0744	0.0744	0.05053	0.05053	0.05053																												8	8	7	7	7																												HY-13027	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Neuronal Signaling; Stem Cell/Wnt | Research Area: Cancer; Inflammation/Immunology; Neurological Disease|MOABOX:3908|PSEN1|gamma-Secretase Inhibitors;Notch Signaling Inhibitors;Antiamyloidogenic Agents	C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@H](C(=O)OC(C)(C)C)c2ccccc2	208255-80-5	33812	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469573	432.46035	DAPT	DAPT | DAPT (GSI-IX) | DAPT | DAPT (GSI-IX)	Pathway: Apoptosis; Autophagy; Neuronal Signaling; Stem Cell/Wnt	Research Area: Cancer; Inflammation/Immunology; Neurological Disease	MOABOX:3908	PSEN1	gamma-Secretase Inhibitors;Notch Signaling Inhibitors;Antiamyloidogenic Agents
SJ000821695-2	SJ000821695	2	MOABOX:3916	JGPJQFOROWSRRS-UHFFFAOYSA-N	Cc1nnc2n1-c1sc(CCC(=O)N3CCOCC3)cc1C(c1ccccc1Cl)=NC2	105219-56-5	PTAFR antagonist;Platelet-Activating Factor Receptor (PAFR) Antagonists	PTAFR																																																															CHEMBL280164											65889	66936084				member	10.1016/0223-5234(96)85877-6	10.1016/S0960-894X(01)81205-1	10.1016/S0960-894X(98)00626-X	10.1021/jm00105a069	10.1021/jm980046r	10.1124/jpet.107.122010	10.1124/jpet.108.141572	10.1248/cpb.39.3215																																																																																																																																																								1671420	2002463	2016721	2754709	9599246	16722655																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.87808																																0.23476																																8																																HY-108634	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Inflammation/Immunology|MOABOX:3916|PTAFR|PTAFR antagonist;Platelet-Activating Factor Receptor (PAFR) Antagonists	Cc1nnc2CN=C(c3ccccc3Cl)c4cc(CCC(=O)N5CCOCC5)sc4n12	105219-56-5	90385	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469729	455.96038	APAFANT | WEB 2086	"""APAFANT | WEB 2086"" | ""APAFANT | WEB 2086"""	Pathway: Others	Research Area: Inflammation/Immunology	MOABOX:3916	PTAFR	PTAFR antagonist;Platelet-Activating Factor Receptor (PAFR) Antagonists
SJ000784288-8	SJ000784288	8	MOABOX:3920	VZZJRYRQSPEMTK-CALCHBBNSA-N	Cc1c(C(=O)Nc2ccc(N3C[C@H](C)O[C@H](C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1	1218778-76-7	Smo Receptor Antagonists	PTCH1	SMO																															6608																															CHEMBL2105737	CHEMBL3137317										24775005	45136862	45138697	45138698	45138699	virtual	10.1021/ml1000307																																																																																																																																																															23063522	27810591																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	2.02856																															0.0	0.25357																															7	8																															EE-0005	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	C[C@@H]1CN(C[C@H](C)O1)c2ccc(NC(=O)c3cccc(c3C)c4ccc(OC(F)(F)F)cc4)cn2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466668	485.49815	Sonidegib	"Sonidegib | ERISMODEGIB | ""NVP-LDE-225 | LDE-225"" | Sonidegib | ERISMODEGIB | ""NVP-LDE-225 | LDE-225"""			MOABOX:3920	PTCH1	Smo Receptor Antagonists
SJ000796120-3	SJ000796120	3	MOABOX:3922	NXFFJDQHYLNEJK-CYBMUJFWSA-N	CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3	571170-77-9	Prostanoid DP (DP1) Antagonists	PTGDR																																																															CHEMBL426559											9867642	11534075	11948701			member	10.1021/jm0603668																																																																																																																																																															16918458	17300164	17963209	19307115	20158474	20235539																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																3.37296																																0.42162																																8																																HY-50175	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Inflammation/Immunology; Endocrinology|MOABOX:3922|PTGDR|Prostanoid DP (DP1) Antagonists	CS(=O)(=O)c1cc(F)cc2c3CC[C@H](CC(=O)O)c3n(Cc4ccc(Cl)cc4)c12	571170-77-9	4492	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468771	435.89626	LAROPIPRANT | MK-0524 | L-888839 |	"""LAROPIPRANT | MK-0524 | L-888839 |"" | ""LAROPIPRANT | MK-0524 | L-888839 |"""	Pathway: GPCR/G Protein	Research Area: Inflammation/Immunology; Endocrinology	MOABOX:3922	PTGDR	Prostanoid DP (DP1) Antagonists
SJ000831457-5	SJ000831457	5	MOABOX:3924	XEYBRNLFEZDVAW-ARSRFYASSA-N	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O	363-24-6		PTGER1	PTGER2	PTGER3	PTGER4																													5732	5733	5734																													CHEMBL548											5280360	9874095	9917216	45380708	66630004	member	10.1016/0006-2952(95)02035-7	10.1016/S0014-2999(98)00522-6	10.1016/S0960-894X(03)00042-8	10.1016/j.bmc.2013.03.016	10.1016/j.bmcl.2004.01.063	10.1016/j.bmcl.2007.05.025	10.1016/j.bmcl.2013.01.025	10.1021/acs.jmedchem.8b00808	10.1021/acschemneuro.7b00486	10.1021/acsmedchemlett.5b00455	10.1021/jm401158e	10.1021/jm501203v	10.1042/BJ20031820	10.1111/j.1743-6109.2007.00676.x	10.1124/jpet.109.156398	10.1124/mol.56.3.545	10.1124/mol.59.6.1446																																																																																																																																															12643927	17531488	17931866	18039575	18983139	20218623	23403082	23466604	23582449	24279689	26985320	26988801	27876250																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									-7.216e-002	3.096e-002	0.65824	2.77344																													-0.00902	0.00387	0.08228	0.34668																													8	8	8	8																													HY-101952	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease; Endocrinology|MOABOX:3924|PTGER1|	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(=O)O	363-24-6	63588	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468947	352.46508	PGE2	"PGE2 | PROSTAGLANDIN E2 | ""PROSTAGLANDIN E2 | DINOPROSTONE | PGE2 | U-12062 |"" | PGE2 | PROSTAGLANDIN E2 | ""PROSTAGLANDIN E2 | DINOPROSTONE | PGE2 | U-12062 |"""	Pathway: GPCR/G Protein; Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease; Endocrinology	MOABOX:3924	PTGER1	
SJ001034640-1	SJ001034640	1	MOABOX:3932	BLTGDXMNAWRERE-UHFFFAOYSA-N	Cc1ccc(Oc2nc(-c3ccccc3)nc3ccsc23)cc1	691869-12-2	Prostanoid EP4 Agonists	PTGER4																																																																										2768262					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																11R-1301	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Cc1ccc(Oc2nc(nc3ccsc23)c4ccccc4)cc1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466638	318.39226	11R-1301	11R-1301 | 11R-1301			MOABOX:3932	PTGER4	Prostanoid EP4 Agonists
SJ000312391-4	SJ000312391	4	MOABOX:3940	MKPLKVHSHYCHOC-AHTXBMBWSA-N	CC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1cccc(C(F)(F)F)c1	157283-68-6	Prostanoid FP Agonists	PTGFR																																																															CHEMBL1200799											5282226	9876019	9940700	11228323	16034857	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.50208																																0.31276																																8																																HY-B0584	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Endocrinology|MOABOX:3940|PTGFR|Prostanoid FP Agonists	CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COc2cccc(c2)C(F)(F)F	157283-68-6	42692	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469912	500.54771	TRAVOPROST	"TRAVOPROST | ""TRAVOPROST | (E)-ISOPROPYL 7-(3,5-DIHYDROXY-2-((E)-3-HYDROXY-4-(3-(TRIFLUOROMETHYL)PHENOXY)BUT-1-ENYL)CYCLOPENTYL)HEPT-5-ENOATE"" | TRAVOPROST | ""TRAVOPROST | (E)-ISOPROPYL 7-(3,5-DIHYDROXY-2-((E)-3-HYDROXY-4-(3-(TRIFLUOROMETHYL)PHENOXY)BUT-1-ENYL)CYCLOPENTYL)HEPT-5-ENOATE"""	Pathway: GPCR/G Protein	Research Area: Endocrinology	MOABOX:3940	PTGFR	Prostanoid FP Agonists
SJ001033181-2	SJ001033181	2	MOABOX:3942	QXWZQTURMXZVHJ-UHFFFAOYSA-N	CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1	475086-01-2	Prostanoid IP Agonists	PTGIR																																																															CHEMBL238804											9913767	44623966	50942970	50942971	145289705	member	10.1021/acs.jmedchem.6b00871	10.1124/jpet.107.124248	10.1124/jpet.116.239665																																																																																																																																																													26291199	28072531																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.48536																																0.31067																																8																																HY-14870	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cardiovascular Disease; Endocrinology|MOABOX:3942|PTGIR|Prostanoid IP Agonists	CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)c1cnc(c2ccccc2)c(n1)c3ccccc3	475086-01-2	61935	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468827	496.62168	SELEXIPAG | NS-304 | ACT-293987	"""SELEXIPAG | NS-304 | ACT-293987"" | ""SELEXIPAG | NS-304 | ACT-293987"""	Pathway: GPCR/G Protein	Research Area: Cardiovascular Disease; Endocrinology	MOABOX:3942	PTGIR	Prostanoid IP Agonists
SJ000288168-4	SJ000288168	4	MOABOX:3948	PQUGCKBLVKJMNT-UHFFFAOYSA-N	COc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(Cl)cc2)cc1	188817-13-2	Cyclooxygenase-1 Inhibitors;Non-Steroidal Antiinflammatory Drugs	PTGS1	PTGS2																															5743																															CHEMBL26915											4306515					member	10.1002/ardp.201200193	10.1002/med.20182	10.1016/j.bcp.2007.03.030	10.1016/j.bcp.2008.05.005	10.1016/j.bmc.2013.01.058	10.1021/acs.jmedchem.6b01484	10.1021/jm960803q	10.2174/0929867003374336	10.2174/092986710793205408																																																																																																																																																							9135032	11032965	17069767	17499219	18571623	19967720	20388115	20436487	20540535	20858219	21106277	22263894	22475926	23473947	24531199	24983538	25768707	28475316																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.41176	-0.43616																															0.42647	-0.05452																															8	8																															HY-59105	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Cancer|MOABOX:3948|PTGS1|Cyclooxygenase-1 Inhibitors;Non-Steroidal Antiinflammatory Drugs	COc1ccc(cc1)n2nc(cc2c3ccc(Cl)cc3)C(F)(F)F	188817-13-2	26530	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469720	352.73819	SC-560	SC-560 | SC-560	Pathway: Immunology/Inflammation	Research Area: Cancer	MOABOX:3948	PTGS1	Cyclooxygenase-1 Inhibitors;Non-Steroidal Antiinflammatory Drugs
SJ000285802-7	SJ000285802	7	MOABOX:3950	RZVAJINKPMORJF-UHFFFAOYSA-N	CC(=O)Nc1ccc(O)cc1	103-90-2	Cyclooxygenase-3 Inhibitors	PTGS1																																																															CHEMBL112	CHEMBL144040	CHEMBL145467	CHEMBL423929								1983	127238	9904930	9932573	10198442	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.20464																																-0.02558																																8																																AG0033VV	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-150-777|MOABOX:3950|PTGS1|Cyclooxygenase-3 Inhibitors	CC(=O)Nc1ccc(O)cc1	103-90-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468630	151.16256	ACETAMINOPHEN	ACETAMINOPHEN | ACETAMINOPHEN			MOABOX:3950	PTGS1	Cyclooxygenase-3 Inhibitors
SJ000285320-22	SJ000285320	22	MOABOX:3952	DCOPUUMXTXDBNB-UHFFFAOYSA-N	O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl	128402-48-2	Cyclooxygenase-3 Inhibitors;Cyclooxygenase-1 Inhibitors;Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs;Voltage-Gated K(V) 7.2 (KCNQ2) Channel Activators	CXCR1	KCNQ2	KCNQ3	PTGS1	PTGS2																												3785	3786	5742	5743																												CHEMBL1201180	CHEMBL1205596	CHEMBL139	CHEMBL3350449								3033	114753	115087	154924	9549309	virtual	10.1007/s10787-017-0428-y	10.1016/S0223-5234(00)00150-1	10.1016/S0223-5234(01)01197-7	10.1016/S0223-5234(01)01330-7	10.1016/S0223-5234(02)01418-6	10.1016/S0960-894X(99)00288-7	10.1016/j.bcp.2008.06.025	10.1016/j.bmc.2008.11.074	10.1016/j.bmc.2017.06.027	10.1016/j.bmcl.2009.06.027	10.1016/j.bmcl.2013.11.080	10.1016/j.ejmech.2015.04.044	10.1021/acs.jmedchem.6b00134	10.1021/jm050619h	10.1021/np0502342	10.1042/bj20030969	10.1073/pnas.1008255107	10.1074/jbc.M609883200	10.1124/jpet.108.146241	10.1139/y97-130	10.2174/138161206776055949																																																																																																																																											10406640	16250658	16252917	17341061	17434872	18095641	18588282	18811132	19097798	19191553	19560921	22236250	24332492	25956953	27019010	28669741																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						0.61296	2.422e-002	2.422e-002	2.32728	3.02632																												0.07662	0.00346	0.00346	0.29091	0.37829																												8	7	7	8	8																												KS-1258	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC(=O)Cc1ccccc1Nc2c(Cl)cccc2Cl	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466716	296.14864	DICLOFENAC SODIUM	DICLOFENAC SODIUM | DICLOFENAC | SOLARAZE | SJ000287840 | DICLOFENAC POTASSIUM | DICLOFENAC DIETHYLAMINE | DICLOFENAC SODIUM | DICLOFENAC | SOLARAZE | SJ000287840 | DICLOFENAC POTASSIUM | DICLOFENAC DIETHYLAMINE			MOABOX:3952	CXCR1	Cyclooxygenase-3 Inhibitors;Cyclooxygenase-1 Inhibitors;Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs;Voltage-Gated K(V) 7.2 (KCNQ2) Channel Activators
SJ000285630-21	SJ000285630	21	MOABOX:3954	HEFNNWSXXWATRW-UHFFFAOYSA-N	CC(C)Cc1ccc(C(C)C(=O)O)cc1	1010396-31-2	Cyclooxygenase-3 Inhibitors;Cyclooxygenase-1 Inhibitors;Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs;NF-kappaB (NFKB) Activation Inhibitors	PTGS1	PTGS2																															5743																															CHEMBL1201141	CHEMBL121313	CHEMBL521									3672	158013	6328339	6612152	9797228	virtual	10.1002/cmdc.201000397	10.1021/jm301905a	10.1021/np980501m	10.1042/bj20030969	10.1139/y97-130																																																																																																																																																											9057869	23651359																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.07032	1.9116																															0.13379	0.23895																															8	8																															KS-5029	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)Cc1ccc(cc1)C(C)C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466694	206.28082	IBUPROFEN	"IBUPROFEN | S-(+)-IBUPROFEN | S(+)-IBUPROFEN | (±)-IBUPROFEN | IBUPROFEN| ADVIL LIQUI-GELS | ""IBUPROFEN | ST-1482 | ZAG-1701 |"" | IBUPROFEN | S-(+)-IBUPROFEN | S(+)-IBUPROFEN | (±)-IBUPROFEN | IBUPROFEN| ADVIL LIQUI-GELS | ""IBUPROFEN | ST-1482 | ZAG-1701 |"""			MOABOX:3954	PTGS1	Cyclooxygenase-3 Inhibitors;Cyclooxygenase-1 Inhibitors;Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs;NF-kappaB (NFKB) Activation Inhibitors
SJ000285633-14	SJ000285633	14	MOABOX:3956	CGIGDMFJXJATDK-UHFFFAOYSA-N	COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1	28751-45-3	Cyclooxygenase-3 Inhibitors;Cyclooxygenase-1 Inhibitors;Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs	PTGER2	PTGS1	PTGS2	SC5D																													5742	5743	6309																													CHEMBL121356	CHEMBL6										3715	93194	177844	181466	9830872	member	10.1002/ardp.200300723	10.1002/ardp.201500274	10.1002/cmdc.201200403	10.1016/0006-2952(96)00462-5	10.1016/0960-894X(95)00131-C	10.1016/0960-894X(96)00100-X	10.1016/0960-894X(96)00101-1	10.1016/S0223-5234(00)00150-1	10.1016/S0223-5234(01)01197-7	10.1016/S0223-5234(01)01258-2	10.1016/S0223-5234(01)01330-7	10.1016/S0223-5234(02)00009-0	10.1016/S0223-5234(02)01418-6	10.1016/S0960-894X(00)00329-2	10.1016/S0960-894X(01)00212-8	10.1016/S0960-894X(01)00534-0	10.1016/S0960-894X(01)00670-9	10.1016/S0960-894X(96)00501-X	10.1016/S0960-894X(96)00582-3	10.1016/S0960-894X(98)00499-5	10.1016/S0960-894X(99)00264-4	10.1016/S0960-894X(99)00288-7	10.1016/S0960-894X(99)00365-0	10.1016/S0960-894X(99)00559-4	10.1016/S0960-894X(99)00560-0	10.1016/S0968-0896(02)00562-X	10.1016/j.bcp.2007.03.030	10.1016/j.bmc.2004.01.037	10.1016/j.bmc.2010.04.034	10.1016/j.bmc.2017.08.039	10.1016/j.bmc.2018.06.038	10.1016/j.bmcl.2003.12.047	10.1016/j.bmcl.2006.06.036	10.1016/j.bmcl.2008.11.045	10.1016/j.bmcl.2011.06.029	10.1016/j.bmcl.2012.06.012	10.1016/j.bmcl.2012.08.082	10.1016/j.bmcl.2013.11.080	10.1016/j.ejmech.2005.08.003	10.1016/j.ejmech.2010.10.001	10.1016/j.ejmech.2011.08.009	10.1016/j.ejmech.2014.03.003	10.1016/j.ejmech.2015.04.044	10.1016/j.ejmech.2017.08.046	10.1016/j.ejmech.2017.12.065	10.1016/j.ejmech.2019.02.034	10.1016/j.ejmech.2019.03.036	10.1016/j.expneurol.2018.11.010	10.1021/acsmedchemlett.8b00484	10.1021/ja4056905	10.1021/jm000004e	10.1021/jm0000719	10.1021/jm00022a023	10.1021/jm00049a005	10.1021/jm0009383	10.1021/jm010458r	10.1021/jm010484p	10.1021/jm030765s	10.1021/jm0611861	10.1021/jm1003073	10.1021/jm950878e	10.1021/jm9606150	10.1021/jm9805081	10.1021/jm980570y	10.1021/jm9906015	10.1021/jm991106b	10.1021/ml400066a	10.1021/np0605539	10.1042/bj20030969	10.1073/pnas.97.2.925	10.1124/dmd.32.1.113	10.1139/y97-130	10.1248/bpb.32.1032	10.1248/cpb.55.64	10.1371/journal.pone.0139147	10.2174/0929867003374336	10.2174/092986710793205408	10.2174/138161206776055949																																																																																		688724	2113949	2491889	3104589	7473585	7966148	8627608	9057869	9171873	9873621	10197959	10197960	10397507	10406640	10411562	10465547	10576684	10576685	10639181	10649977	10889329	10937738	10956194	10956225	11032965	11160644	11311743	11392547	11430933	11462976	11602656	11672885	11738574	11824534	11858847	11906281	11906292	11965379	11966455	12511226	12593914	12614871	12660020	12877584	12916060	14510637	14531936	14980665	15051061	15210061	15279594	15679320	15790308	15943479	16038536	16225966	16529558	16533164	16562850	16581252	16791316	16814546	17079150	17202703	17328244	17341061	17378609	17499219	17509888	17532544	17555711	17994684	18061444	18363350	19056264	19075771	19084295	19378317	19419861	19427206	19483310	19540763	20451397	20503989	20576329	20692174	20727750	20800934	20858219	20970223	21319773	21345672	21499265	21524587	21752640	21804236	21868137	21873070	22263894	22361134	22571790	22652053	22748709	22749420	22830339	22916727	23010270	23225780	23432095	23687559	23769654	24332492	24531199	24631895	24631898	24763362	24900317	24938495	25219899	25868745	25956953	26122769	26204057	26455657	26487917	26867188	27325447	27541263	27916468	28057407	28881288	28916158	29031075	29289887	29980364	30095904	30771604	30818268	30904755	31244108																																																																																																																																																																																																																																																																																																																																																																																																																										0.26565	3.85872	0.50096	-8.008e-002																													0.03795	0.48234	0.06262	-0.01144																													7	8	8	7																													KS-5255	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466665	357.78764	INDOMETHACIN	INDOMETHACIN | INDOMETHACIN SODIUM| INDOCIN I.V. | INDOMETHACIN | INDOMETHACIN SODIUM| INDOCIN I.V.			MOABOX:3956	PTGER2	Cyclooxygenase-3 Inhibitors;Cyclooxygenase-1 Inhibitors;Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs
SJ000285665-15	SJ000285665	15	MOABOX:3958	CMWTZPSULFXXJA-VIFPVBQESA-N	COc1ccc2cc([C@H](C)C(=O)O)ccc2c1	131991-52-1	Non-Steroidal Antiinflammatory Drugs	PTGS1	PTGS2																															5743																															CHEMBL154											156390	156391	185019	9887301	9915846	member	10.1002/1521-4184(200103)334:3<104::AID-ARDP104>3.0.CO;2-R	10.1002/1521-4184(200211)335:8<363::AID-ARDP363>3.0.CO;2-S	10.1016/0960-894X(96)00412-X	10.1021/np980501m	10.1139/y97-130																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.73248	-4.664e-002																															0.21656	-0.00583																															8	8																															ME-0100	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1ccc2cc(ccc2c1)[C@H](C)C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466650	230.25916	NAPROXEN	"NAPROXEN | (R)-NAPROXEN SODIUM SALT | (-)-NAPROXEN SODIUM | ""NAPROXEN SODIUM | BAY-H-6689 | PL-3100 | RS-3650 |"" | NAPROXEN | (R)-NAPROXEN SODIUM SALT | (-)-NAPROXEN SODIUM | ""NAPROXEN SODIUM | BAY-H-6689 | PL-3100 | RS-3650 |"""			MOABOX:3958	PTGS1	Non-Steroidal Antiinflammatory Drugs
SJ000286844-13	SJ000286844	13	MOABOX:3962	BSYNRYMUTXBXSQ-UHFFFAOYSA-N	CC(=O)Oc1ccccc1C(=O)O	11126-35-5	Cyclooxygenase-2 Inhibitors;TP53 Expression Enhancers;Cyclooxygenase-1 Inhibitors;Nitric Oxide Donors;Non-Steroidal Antiinflammatory Drugs	PTGS1	PTGS2	TP53																														5743	7157																														CHEMBL25	CHEMBL3833404										2244	83966	162666	162733	171511	member	10.1002/cmdc.201000397	10.1002/cmdc.201100460																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			7.584e-002	0.21864	0																														0.00948	0.02733	0.0																														8	8	8																														STR01551	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(=O)Oc1ccccc1C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466808	180.15742	ASPIRIN	ASPIRIN | ACETYLSALICYLIC ACID | ASPIRIN| O-ACETYLSALICYCLIC ACID | ASPIRIN | ACETYLSALICYLIC ACID | ASPIRIN| O-ACETYLSALICYCLIC ACID			MOABOX:3962	PTGS1	Cyclooxygenase-2 Inhibitors;TP53 Expression Enhancers;Cyclooxygenase-1 Inhibitors;Nitric Oxide Donors;Non-Steroidal Antiinflammatory Drugs
SJ000358703-4	SJ000358703	4	MOABOX:3966	KHPKQFYUPIUARC-UHFFFAOYSA-N	Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1	220991-20-8	Cyclooxygenase-2 Inhibitors	PTGS2																																																															CHEMBL404108											151166	9807502	9872149	11627916	16045291	member	10.1002/cmdc.201200272	10.1016/j.bcp.2008.06.025	10.1016/j.ejps.2005.01.014	10.1038/sj.bjp.0706078	10.1074/jbc.M609883200																																																																																																																																																											15655513	15854797	17341061	17434872	18674517	22865828	26898334	30762371																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														2.22232																																0.27779																																8																																KS-1302	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466655	293.72062	LUMIRACOXIB | COX-189 |	"""LUMIRACOXIB | COX-189 |"" | LUMIRACOXIB | ""LUMIRACOXIB | COX-189 |"" | LUMIRACOXIB"			MOABOX:3966	PTGS2	Cyclooxygenase-2 Inhibitors
SJ001033065-2	SJ001033065	2	MOABOX:3968	MNJVRJDLRVPLFE-UHFFFAOYSA-N	Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1	202409-33-4	Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs	PTGS2																																																															CHEMBL416146											123619	17895326	53447335	56599997	56600187	member	10.1002/ardp.201500336	10.1016/S0960-894X(98)00499-5	10.1016/j.bmcl.2004.07.089	10.1016/j.bmcl.2006.03.052	10.1016/j.bmcl.2006.03.101	10.1016/j.bmcl.2009.02.085	10.1016/j.ejphar.2007.08.034	10.1021/jm049882t	10.2174/1381612043453108																																																																																																																																																							9873621	14965322	15239665	15454242	16054359	16616494	16647258	17920584	19520573	20166930	20800934	30762371																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										3.36208																																0.42026																																8																																HY-15321	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Inflammation/Immunology; Cancer|MOABOX:3968|PTGS2|Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs	Cc1ccc(cn1)c2ncc(Cl)cc2c3ccc(cc3)S(=O)(=O)C	202409-33-4	15036	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469291	358.8419	ETORICOXIB | MK-0663 | L-791456	"""ETORICOXIB | MK-0663 | L-791456"" | ""ETORICOXIB | MK-0663 | L-791456"""	Pathway: Immunology/Inflammation	Research Area: Inflammation/Immunology; Cancer	MOABOX:3968	PTGS2	Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs
SJ001034966-1	SJ001034966	1	MOABOX:3980	FQZSMTSTFMNWQF-UHFFFAOYSA-N	CCCCc1nc(Cl)c(C=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1	114798-36-6	Cyclooxygenase-2 Inhibitors;Angiotensin AT1 Antagonists	AGTR1	PTGS2																															5743																															CHEMBL308493											9802264	20832967				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															AG000F82	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-848-419|MOABOX:3980|AGTR1|Cyclooxygenase-2 Inhibitors;Angiotensin AT1 Antagonists	CCCCc1nc(Cl)c(C=O)n1Cc2ccc(cc2)c3ccccc3c4nn[nH]n4	114798-36-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468391	420.89474	AG000F82	AG000F82 | AG000F82			MOABOX:3980	AGTR1	Cyclooxygenase-2 Inhibitors;Angiotensin AT1 Antagonists
SJ000286947-11	SJ000286947	11	MOABOX:3984	HYWYRSMBCFDLJT-UHFFFAOYSA-N	CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1	1364966-82-4	Cyclooxygenase-2 Inhibitors	PTGS2	SC5D																															6309																															CHEMBL56367											4495	9805259	9825177	9862435	9914022	virtual	10.1016/S0960-894X(98)00068-7	10.1016/j.bmcl.2005.05.093	10.1016/j.ejmech.2013.12.033	10.1021/jm049480l	10.1021/jm900702b	10.1042/bj20030969	10.2174/138161206776055949																																																																																																																																																									9871612	11160644	14510637	15615524	15993594	16529558	16533164	17640617	19378317	19791801	21349729	21413808	21542630	22680630	24440378																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							3.14816	0.85659																															0.39352	0.12237																															8	7																															KS-1277	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CS(=O)(=O)Nc1ccc(cc1Oc2ccccc2)[N+](=O)[O-]	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466792	308.30978	NIMESULIDE	NIMESULIDE | NIMESULIDE			MOABOX:3984	PTGS2	Cyclooxygenase-2 Inhibitors
SJ000822451-6	SJ000822451	6	MOABOX:3990	UYJNQQDJUOUFQJ-UHFFFAOYSA-N	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl	761437-28-9	Focal Adhesion Kinase (FAK) Inhibitors;IGF-1R Inhibitors	PTK2																																																															CHEMBL458997											9934347	117074328	118905482			virtual	10.1016/j.bmcl.2017.02.072																																																																																																																																																															18006843	21787276	23845217	25180654	28284808	28576633	29102081	30978560	31129452																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1.59664																																0.19958																																8																																HY-13203	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Protein Tyrosine Kinase/RTK | Research Area: Cancer; Endocrinology|MOABOX:3990|PTK2|Focal Adhesion Kinase (FAK) Inhibitors;IGF-1R Inhibitors	CNC(=O)c1ccccc1Nc2nc(Nc3ccc(cc3OC)N4CCOCC4)ncc2Cl	761437-28-9	5352	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469231	468.936	NVP-TAE226	NVP-TAE226 | TAE226 (NVP-TAE226) | NVP-TAE226 | TAE226 (NVP-TAE226)	Pathway: Apoptosis; Protein Tyrosine Kinase/RTK	Research Area: Cancer; Endocrinology	MOABOX:3990	PTK2	Focal Adhesion Kinase (FAK) Inhibitors;IGF-1R Inhibitors
SJ000286499-5	SJ000286499	5	MOABOX:3998	YWJXCIXBAKGUKZ-HJJNZUOJSA-N	COc1c(O)cc2c(c1O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1OC2=O	108032-11-7	Protein Tyrosine Phosphatase PTP-1B Inhibitors	PTPN1																																																															CHEMBL273019	CHEMBL3181911										66065	201412				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.67081																																-0.09583																																7																																HY-N0017	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Apoptosis; Autophagy | Research Area: Cancer; Infection; Inflammation/Immunology|MOABOX:3998|PTPN1|Protein Tyrosine Phosphatase PTP-1B Inhibitors	COc1c(O)cc2C(=O)O[C@@H]3[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]3c2c1O	477-90-7	26507	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468809	328.27144	BERGENIN	BERGENIN | BERGENIN MONOHYDRATE | BERGENIN | BERGENIN MONOHYDRATE	Pathway: Anti-infection; Apoptosis; Autophagy	Research Area: Cancer; Infection; Inflammation/Immunology	MOABOX:3998	PTPN1	Protein Tyrosine Phosphatase PTP-1B Inhibitors
SJ000785940-4	SJ000785940	4	MOABOX:4028	DEFBCZWQLILOJF-UHFFFAOYSA-N	CCN(CC)CCCC(C)Nc1nc(C)cc(Nc2ccc3nc(C)cc(N)c3c2)n1	1177865-17-6	Rac1 GTPase Inhibitors	RAC1																																																															CHEMBL1535331	CHEMBL257119	CHEMBL3113208									409805	16759159	16760632	54603599	71297115	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-4.13e-002																																-0.0059																																7																																HY-15723A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; GPCR/G Protein | Research Area: Cancer|MOABOX:4028|RAC1|Rac1 GTPase Inhibitors	CCN(CC)CCCC(C)Nc1nc(C)cc(Nc2ccc3nc(C)cc(N)c3c2)n1	1177865-17-6	23268	GENERAL	CHLORIDE	3	NO_SOLVATE	0	1468888	421.5816	RAC1 INHIBITOR | NSC-23766	"""RAC1 INHIBITOR | NSC-23766"" | NSC 23766 | ""RAC1 INHIBITOR | NSC-23766"" | NSC 23766"	Pathway: Apoptosis; GPCR/G Protein	Research Area: Cancer	MOABOX:4028	RAC1	Rac1 GTPase Inhibitors
SJ000288227-8	SJ000288227	8	MOABOX:4040	FOIVPCKZDPCJJY-JQIJEIRASA-N	C/C(=C\c1ccc(C(=O)O)cc1)c1ccc2c(c1)C(C)(C)CCC2(C)C	71441-28-6	Retinoid RAR Agonists	RARA																																																															CHEMBL275311	CHEMBL349864										5289501	44377454	44596197	68446970	139556767	member	10.1016/0960-894X(95)00455-3	10.1016/S0006-291X(05)81062-9	10.1021/jm00029a013	10.1124/mol.109.060038																																																																																																																																																												7636843	8308867	8410972	8544175	10637371	10890153	25305688																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															5.872e-002																																0.00734																																8																																HY-15682	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:4040|RARA|Retinoid RAR Agonists	C\C(=C/c1ccc(cc1)C(=O)O)\c2ccc3c(c2)C(C)(C)CCC3(C)C	71441-28-6	79095	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469179	348.47792	TTNPB	TTNPB | TTNPB (AROTINOID ACID) | TTNPB | TTNPB (AROTINOID ACID)	Pathway: Apoptosis; Autophagy; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:4040	RARA	Retinoid RAR Agonists
SJ001034637-1	SJ001034637	1	MOABOX:4042	GWHSPAGSUKYSEY-UHFFFAOYSA-N	O=C(O)c1ccc(-c2nc(-c3cccc(C(F)(F)F)c3)cs2)cc1		Retinoid RXRalpha Agonists;Retinoid RARalpha Agonists	RARA	RXRA																															6256																															CHEMBL1460458											1483724					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					4.592e-002	1.70848																															0.00656	0.21356																															7	8																															1G-433S	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC(=O)c1ccc(cc1)c2nc(cs2)c3cccc(c3)C(F)(F)F	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466634	349.32701	1G-433S	1G-433S | 1G-433S			MOABOX:4042	RARA	Retinoid RXRalpha Agonists;Retinoid RARalpha Agonists
SJ001034990-1	SJ001034990	1	MOABOX:4074	VDWFDMKVYHLWRD-UHFFFAOYSA-N	O=C1CCCC2=C1C(c1cccc(Br)c1)Nc1ccc3ccccc3c12		Rho C GTPase Inhibitors	RHOC																																																																										619137					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																5213678	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-136-357|MOABOX:4074|RHOC|Rho C GTPase Inhibitors	Brc1cccc(c1)C2Nc3ccc4ccccc4c3C5=C2C(=O)CCC5	247138-33-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468434	404.29912	5213678	5213678 | 5213678			MOABOX:4074	RHOC	Rho C GTPase Inhibitors
SJ000286930-4	SJ000286930	4	MOABOX:4082	RSWGJHLUYNHPMX-ONCXSQPRSA-N	CC(C)C1=CC2=CC[C@H]3[C@](C)(C(=O)O)CCC[C@]3(C)[C@H]2CC1	10248-55-2	HSD11B1 expression inhibitor;Antibacterial;Antiinflammatory	HSD11B1	HSD11B2																															3291																															CHEMBL71893											10569	102116	11498360	11578065	11657569	member	10.1016/s0014-5793(03)00859-7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.18585	0																															-0.02655	0.0																															7	7																															AS-35301	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)C1=CC2=CC[C@@H]3[C@](C)(CCC[C@@]3(C)C(=O)O)[C@H]2CC1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466850	302.451	ABIETIC ACID	ABIETIC ACID | ABIETIC ACID			MOABOX:4082	HSD11B1	HSD11B1 expression inhibitor;Antibacterial;Antiinflammatory
SJ000852788-5	SJ000852788	5	MOABOX:4086	JTVBXQAYBIJXRP-SNVBAGLBSA-N	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1	173897-44-4	Rho Kinase Inhibitors	ROCK1	ROCK2																															9475																															CHEMBL3794409	CHEMBL571948										9810884	11507964	20601328	49868485	73013358	member	10.1016/j.bmcl.2014.03.017																																																																																																																																																															17591891	19689376	20434334	24684843	26486225	27072905	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															1.24712	2.13312																															0.15589	0.26664																															8	8																															HY-10069	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad | Research Area: Cancer|MOABOX:4086|ROCK1|Rho Kinase Inhibitors	C[C@@H](N)c1ccc(cc1)C(=O)Nc2ccnc3[nH]ccc23	173897-44-4	7678	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469167	280.32444	Y-39983	Y-39983 | Y-39983	Pathway: Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad	Research Area: Cancer	MOABOX:4086	ROCK1	Rho Kinase Inhibitors
SJ000520508-7	SJ000520508	7	MOABOX:4088	NGOGFTYYXHNFQH-UHFFFAOYSA-N	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1	103745-39-7	Calcium Sensitizers;Rho Kinase Inhibitors	PKN2	ROCK1	ROCK2																														6093	9475																														CHEMBL38380	CHEMBL541388										3547	163751	657249	11954307	16219471	member	10.1007/s00044-015-1463-0	10.1016/j.bmc.2004.02.025	10.1016/j.bmcl.2010.04.070	10.1016/j.ejphar.2019.02.009	10.1016/j.jns.2005.06.003	10.1021/jm9014263	10.1124/jpet.110.167924	10.2174/138161212800672688																																																																																																																																																								12672248	15864268	16005902	16249185	17018693	17046269	17084087	17368019	17482681	17934515	18710211	19355891	19689376	20000469	20214566	20347188	20462760	21145740	22521647	22571664	23275831	24211637	26039570	26356532	26486225	29048389	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											-7.176e-002	1.40184	1.58056																														-0.00897	0.17523	0.19757																														8	8	8																														HY-10341	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Autophagy; Cell Cycle/DNA Damage; Cytoskeleton; Epigenetics; Membrane Transporter/Ion Channel; Neuronal Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt; TGF-beta/Smad | Research Area: Cancer|MOABOX:4088|PKN2|Calcium Sensitizers;Rho Kinase Inhibitors	O=S(=O)(N1CCCNCC1)c2cccc3cnccc23	105628-07-7	19812	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468912	291.36868	FASUDIL	FASUDIL | FASUDIL (HA-1077) HCL | FASUDIL | FASUDIL (HA-1077) HCL	Pathway: Anti-infection; Autophagy; Cell Cycle/DNA Damage; Cytoskeleton; Epigenetics; Membrane Transporter/Ion Channel; Neuronal Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt; TGF-beta/Smad	Research Area: Cancer	MOABOX:4088	PKN2	Calcium Sensitizers;Rho Kinase Inhibitors
SJ001035176-1	SJ001035176	1	MOABOX:4094	OZBSSKGBKHOLGA-UHFFFAOYSA-N	CC(=O)Nc1nc(C)c(S(=O)(=O)Nc2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)s1	1335106-03-0	Retinoid RORalpha Inverse Agonists;Retinoid RORgamma Inverse Agonists	RORA																																																															CHEMBL3094388											44241473					member																																																																																																																																																																22284354	24502334																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.2012																																0.15015																																8																																HY-13421	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:4094|RORA|Retinoid RORalpha Inverse Agonists;Retinoid RORgamma Inverse Agonists	CC(=O)Nc1nc(C)c(s1)S(=O)(=O)Nc2ccc(cc2)C(O)(C(F)(F)F)C(F)(F)F	1335106-03-0	15471	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469001	477.40184	SR1001	SR1001 | SR1001	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:4094	RORA	Retinoid RORalpha Inverse Agonists;Retinoid RORgamma Inverse Agonists
SJ000312313-14	SJ000312313	14	MOABOX:4108	WDDPHFBMKLOVOX-AYQXTPAHSA-N	Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F	123318-82-1	DNA Polymerase Inhibitors;Ribonucleoside-Diphosphate Reductase Inhibitors	POLA1	RRM1																															6240																															CHEMBL1750											119182	11981045	142302848			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-A0005	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage | Research Area: Metabolic Disease; Cancer|MOABOX:4108|POLA1|DNA Polymerase Inhibitors;Ribonucleoside-Diphosphate Reductase Inhibitors	Nc1nc(Cl)nc2c1ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F	123318-82-1	11534	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469384	303.67744	CLOFARABINE	CLOFARABINE | CLOLAR | 2-CL-2-F-ARAA | SAR-393590 | CAFDA | CLOFARABINE | CLOLAR | 2-CL-2-F-ARAA | SAR-393590 | CAFDA	Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage	Research Area: Metabolic Disease; Cancer	MOABOX:4108	POLA1	DNA Polymerase Inhibitors;Ribonucleoside-Diphosphate Reductase Inhibitors
SJ000519028-30	SJ000519028	30	MOABOX:4112	SDUQYLNIPVEERB-QPPQHZFASA-N	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1	103882-84-4	Ribonucleotide Reductase inhibitor;DNA Damaging Agent	SLC29A1	SLC29A2	RRM1	RRM2	TYMS	SLC29A3																											3177	6240	6241	7298	55315																											CHEMBL1637	CHEMBL888										60749	60750	9869569	9871557	11223137	member	10.1016/j.bcp.2003.12.026																																																																																																																																																															15041467																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.26992	0.26992	-0.48344	-0.39543	0	0.26992																											0.03856	0.03856	-0.06043	-0.05649	0.0	0.03856																											7	7	8	7	7	7																											GS-3582	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466815	263.19815	GEMCITABINE	GEMCITABINE | LY-188011 | GEMCITABINE HCL | GEMCITABINE | LY-188011 | GEMCITABINE HCL			MOABOX:4112	SLC29A1	Ribonucleotide Reductase inhibitor;DNA Damaging Agent
SJ001035167-1	SJ001035167	1	MOABOX:4124	SLXTWXQUEZSSTJ-UHFFFAOYSA-N	Cc1cc2c(cc1C1(c3ccc(C(=O)O)cn3)CC1)C(C)(C)CCC2(C)C	153559-76-3	ABCA1 Expression Enhancers;Angiogenesis Inhibitors;Antiinflammatory Drugs;Insulin Sensitizers;Retinoid RXR Agonists	RXRB	RXRG																															6258																															CHEMBL288436											3922	9874878	9875104	9940102	91317632	member																																																																																																																																																																10637371	14592510	15006411	18855890																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.52304	0.71856																															0.06538	0.08982																															8	8																															HY-15340	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:4124|RXRB|ABCA1 Expression Enhancers;Angiogenesis Inhibitors;Antiinflammatory Drugs;Insulin Sensitizers;Retinoid RXR Agonists	Cc1cc2c(cc1C3(CC3)c4ccc(cn4)C(=O)O)C(C)(C)CCC2(C)C	153559-76-3	80582	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468974	363.49256	LG100268 | LG268	"""LG100268 | LG268"" | ""LG100268 | LG268"""	Pathway: Autophagy; Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:4124	RXRB	ABCA1 Expression Enhancers;Angiogenesis Inhibitors;Antiinflammatory Drugs;Insulin Sensitizers;Retinoid RXR Agonists
SJ001035283-1	SJ001035283	1	MOABOX:4128	BGVCEGVSQDOGSB-UHFFFAOYSA-N	COc1ccc2c(c1)CN(C)CCS2	1357476-46-0	Ryanodine receptor modulator;RyR1/FKBP12 Complex Stabilzer;Drugs Acting on Ryanodine Receptor (RyR) Channels	RYR1	RYR2																															6262																															CHEMBL2440854	CHEMBL2440855										24763624	53311704	143416822			member	10.1073/pnas.0711074105.																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0.9																															0.0	0.1125																															7	8																															HY-15292A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cardiovascular Disease|MOABOX:4128|RYR1|Ryanodine receptor modulator;RyR1/FKBP12 Complex Stabilzer;Drugs Acting on Ryanodine Receptor (RyR) Channels	COc1ccc2SCCN(C)Cc2c1	1357476-46-0	31119	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469487	209.3079	S107 HYDROCHLORIDE	S107 HYDROCHLORIDE | S107 HYDROCHLORIDE	Pathway: Others	Research Area: Cardiovascular Disease	MOABOX:4128	RYR1	Ryanodine receptor modulator;RyR1/FKBP12 Complex Stabilzer;Drugs Acting on Ryanodine Receptor (RyR) Channels
SJ001033146-2	SJ001033146	2	MOABOX:4132	KIHYPELVXPAIDH-HNSNBQBZSA-N	CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CN1CC(C(=O)O)C1	1230487-00-9	Angiogenesis Inhibitors;Lysophospholipid edg1 (S1P1) Receptor Agonists;Lysophospholipid edg1 (S1P1) Receptor Ligands;Lysophospholipid edg8 (S1P5) Receptor Ligands	S1PR1	S1PR5																															53637																															CHEMBL2336071											44599207	46700776	46700777	46836791	46836857	virtual	10.1016/j.bmcl.2013.09.058	10.1111/j.1476-5381.2012.02061.x																																																																																																																																																														21261590	24125884	24900670																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.03048	0.83872																															0.37881	0.10484																															8	8																															HY-12355	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Others|MOABOX:4132|S1PR1|Angiogenesis Inhibitors;Lysophospholipid edg1 (S1P1) Receptor Agonists;Lysophospholipid edg1 (S1P1) Receptor Ligands;Lysophospholipid edg8 (S1P5) Receptor Ligands	CCc1cc(ccc1CN2CC(C2)C(=O)O)\C(=N\OCc3ccc(C4CCCCC4)c(c3)C(F)(F)F)\C	1230487-00-9	24121	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469875	516.59501	SIPONIMOD | BAF-312	"""SIPONIMOD | BAF-312"" | ""SIPONIMOD | BAF-312"""	Pathway: GPCR/G Protein	Research Area: Others	MOABOX:4132	S1PR1	Angiogenesis Inhibitors;Lysophospholipid edg1 (S1P1) Receptor Agonists;Lysophospholipid edg1 (S1P1) Receptor Ligands;Lysophospholipid edg8 (S1P5) Receptor Ligands
SJ001035401-1	SJ001035401	1	MOABOX:4134	OYMNPJXKQVTQTR-UHFFFAOYSA-N	FC(F)(F)c1cccc(-c2noc(-c3cc(-c4ccccc4)c(C(F)(F)F)s3)n2)c1	256414-75-2	Lysophospholipid edg1 (S1P1) Receptor Agonists;S1PR1 agonist	S1PR1																																																															CHEMBL224720											4077460					member	10.1016/j.bmcl.2011.10.085	10.1021/jm0492507	10.1038/nchembio804	10.1074/jbc.M311743200	10.1124/mol.117.109140																																																																																																																																																											15615513	16829954	18321471	21261590	22104144	24900286																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																3.6768																																0.4596																																8																																HY-W008947	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Inflammation/Immunology; Neurological Disease|MOABOX:4134|S1PR1|Lysophospholipid edg1 (S1P1) Receptor Agonists;S1PR1 agonist	FC(F)(F)c1cccc(c1)c2noc(n2)c3cc(c4ccccc4)c(s3)C(F)(F)F	256414-75-2	85148	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469920	440.36162	SEW2871	SEW2871 | SEW2871	Pathway: GPCR/G Protein	Research Area: Inflammation/Immunology; Neurological Disease	MOABOX:4134	S1PR1	Lysophospholipid edg1 (S1P1) Receptor Agonists;S1PR1 agonist
SJ001035362-1	SJ001035362	1	MOABOX:4150	LRFKWQGGENFBFO-LJQANCHMSA-N	CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1	402616-23-3	Lysophospholipid edg3 (S1P3) Receptor Antagonists;Lysophospholipid edg1 (S1P1) Receptor Agonists;Lysophospholipid edg6 (S1P4) Receptor Agonists	S1PR1	S1PR3	S1PR4																														1903	8698																														CHEMBL190006											11222939	44438254				virtual	10.1016/j.bmc.2004.07.020	10.1016/j.bmc.2014.05.035	10.1016/j.bmcl.2006.10.014	10.1016/j.bmcl.2010.02.006	10.1016/j.ejmech.2012.02.022	10.1021/jm050242f																																																																																																																																																										15336258	15598563	16078855	17070046	20153186	20188554	21261590																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															1.3616	1.124	0.12792																														0.1702	0.1405	0.01599																														8	8	8																														HY-15382	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Inflammation/Immunology|MOABOX:4150|S1PR1|Lysophospholipid edg3 (S1P3) Receptor Antagonists;Lysophospholipid edg1 (S1P1) Receptor Agonists;Lysophospholipid edg6 (S1P4) Receptor Agonists	CCCCCCCCc1ccc(CC[C@](N)(CO)COP(=O)(O)O)cc1	402616-26-6	62051	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469745	387.45072	FTY720 (S)-PHOSPHATE | (S)-FTY720P | (S)-FTY720 PHOSPHATE	"""FTY720 (S)-PHOSPHATE | (S)-FTY720P | (S)-FTY720 PHOSPHATE"" | ""FTY720 (S)-PHOSPHATE | (S)-FTY720P | (S)-FTY720 PHOSPHATE"""	Pathway: GPCR/G Protein	Research Area: Inflammation/Immunology	MOABOX:4150	S1PR1	Lysophospholipid edg3 (S1P3) Receptor Antagonists;Lysophospholipid edg1 (S1P1) Receptor Agonists;Lysophospholipid edg6 (S1P4) Receptor Agonists
SJ000796092-2	SJ000796092	2	MOABOX:4166	RNSLRQNDXRSASX-UHFFFAOYSA-N	Cc1nn(C)c2nc(NNC(=O)Nc3cc(Cl)nc(Cl)c3)cc(C(C)C)c12	383150-41-2	S1PR2 antagonist;Lysophospholipid edg5 (S1P2) Receptor Antagonists	S1PR2																																																															CHEMBL1368758											10223146					member	10.1016/S0008-6363(03)00260-8	10.1016/j.bmc.2013.06.012	10.1016/j.bmcl.2017.12.010																																																																																																																																																													12667959	23849205	25746814	29249563	31279524																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	3.10288																																0.38786																																8																																HY-100675	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; GPCR/G Protein | Research Area: Cancer|MOABOX:4166|S1PR2|S1PR2 antagonist;Lysophospholipid edg5 (S1P2) Receptor Antagonists	CC(C)c1cc(NNC(=O)Nc2cc(Cl)nc(Cl)c2)nc3c1c(C)nn3C	383150-41-2	49951	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469842	408.28506	JTE 013	JTE 013 | JTE 013	Pathway: Apoptosis; GPCR/G Protein	Research Area: Cancer	MOABOX:4166	S1PR2	S1PR2 antagonist;Lysophospholipid edg5 (S1P2) Receptor Antagonists
SJ001035201-1	SJ001035201	1	MOABOX:4172	NSQNZEUFHPTJME-UHFFFAOYSA-N	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(Cl)cc2)cc1	170569-86-5	Cyclooxygenase-2 Inhibitors	SC5D																																																															CHEMBL282093											9865808	9874958	69625967			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.53809																																0.07687																																7																																HY-W010983	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage; Immunology/Inflammation | Research Area: Cancer; Inflammation/Immunology; Cardiovascular Disease|MOABOX:4172|SC5D|Cyclooxygenase-2 Inhibitors	NS(=O)(=O)c1ccc(cc1)n2nc(cc2c3ccc(Cl)cc3)C(F)(F)F	170569-86-5	85886	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469067	401.79065	SC-236	SC-236 | SC-236	Pathway: Apoptosis; Cell Cycle/DNA Damage; Immunology/Inflammation	Research Area: Cancer; Inflammation/Immunology; Cardiovascular Disease	MOABOX:4172	SC5D	Cyclooxygenase-2 Inhibitors
SJ000000133-2	SJ000000133	2	MOABOX:4174	KTDZCOWXCWUPEO-UHFFFAOYSA-N	CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1OC1CCCCC1	123653-11-2	Cyclooxygenase-2 Inhibitors	SC5D																																																															CHEMBL7162											4553	19838424	23717400	91291673		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.45409																																0.06487																																7																																HY-13913	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Inflammation/Immunology; Cancer|MOABOX:4174|SC5D|Cyclooxygenase-2 Inhibitors	CS(=O)(=O)Nc1ccc(cc1OC2CCCCC2)[N+](=O)[O-]	123653-11-2	19277	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469377	314.35742	CBT-000000133	CBT-000000133 | CBT-000000133	Pathway: Immunology/Inflammation	Research Area: Inflammation/Immunology; Cancer	MOABOX:4174	SC5D	Cyclooxygenase-2 Inhibitors
SJ000286072-8	SJ000286072	8	MOABOX:4178	LNPDTQAFDNKSHK-UHFFFAOYSA-N	Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1	181695-72-7	Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs	SC5D																																																															CHEMBL865											119607	9957034	10404893	11238177	11444472	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					8.68e-003																																0.00124																																7																																HY-15762	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Inflammation/Immunology|MOABOX:4178|SC5D|Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs	Cc1onc(c2ccccc2)c1c3ccc(cc3)S(=O)(=O)N	181695-72-7	23058	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469260	314.35896	VALDECOXIB	VALDECOXIB | VALDECOXIB| BEXTRA | VALDECOXIB | VALDECOXIB| BEXTRA	Pathway: Immunology/Inflammation	Research Area: Inflammation/Immunology	MOABOX:4178	SC5D	Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs
SJ000285362-8	SJ000285362	8	MOABOX:4186	RZJQGNCSTQAWON-UHFFFAOYSA-N	CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1	162011-90-7		SC5D																																																															CHEMBL122											5090	9873157	9915135	9935490	9956143	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.62048																																0.08864																																7																																HY-17372	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Inflammation/Immunology; Cancer|MOABOX:4186|SC5D|	CS(=O)(=O)c1ccc(cc1)C2=C(C(=O)OC2)c3ccccc3	162011-90-7	28805	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469382	314.35566	ROFECOXIB	ROFECOXIB | VIOXX | ROFECOXIB | VIOXX	Pathway: Immunology/Inflammation	Research Area: Inflammation/Immunology; Cancer	MOABOX:4186	SC5D	
SJ001034651-1	SJ001034651	1	MOABOX:4188	QMZSSLLJQUFMHM-UHFFFAOYSA-N	O=C(NCCC1CC1)c1ccc(N2CCN(C(=O)c3cc(F)ccc3C(F)(F)F)CC2)nn1	840489-44-3	Stearoyl-CoA Desaturase (delta-9 Desaturase;SCD;SCD1) Inhibitors	SCD																																																															CHEMBL2315130											16035876					virtual	10.1021/jm301661h																																																																																																																																																															23245208																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.09512																																0.13689																																8																																DH-0070	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Fc1ccc(c(c1)C(=O)N2CCN(CC2)c3ccc(nn3)C(=O)NCCC4CC4)C(F)(F)F	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466693	465.44393	DH-0070	DH-0070 | DH-0070			MOABOX:4188	SCD	Stearoyl-CoA Desaturase (delta-9 Desaturase;SCD;SCD1) Inhibitors
SJ001035332-1	SJ001035332	1	MOABOX:4192	HRAQDVZJYIAWOV-UHFFFAOYSA-N	Cc1nc2ccc(NCc3cccc(C(F)(F)F)c3)cc2n(CCNC(=O)CO)c1=O	1018675-35-8	Stearoyl-CoA Desaturase (delta-9 Desaturase;SCD;SCD1) Inhibitors	SCD																																																															CHEMBL573829											25195516					member	10.1016/S0065-7743(10)45007-1	10.1016/j.bmcl.2009.06.017																																																																																																																																																														19577469																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.23864																																0.15483																																8																																HY-11034	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:4192|SCD|Stearoyl-CoA Desaturase (delta-9 Desaturase;SCD;SCD1) Inhibitors	CC1=Nc2ccc(NCc3cccc(c3)C(F)(F)F)cc2N(CCNC(=O)CO)C1=O	1018675-35-8	34868	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469607	434.41165	CVT-12012	CVT-12012 | CVT-12012	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:4192	SCD	Stearoyl-CoA Desaturase (delta-9 Desaturase;SCD;SCD1) Inhibitors
SJ001035349-1	SJ001035349	1	MOABOX:4200	SKFRRNOLFFQBQU-AOOOYVTPSA-N	C[C@H]1CN(c2ncc(-c3cccc(Cl)c3Cl)c(N)n2)C[C@@H](C)N1		Nav1.8 (SNS/PN3) Sodium Channel Blockers	SCN10A																																																																										76966642					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-121879	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:4200|SCN10A|Nav1.8 (SNS/PN3) Sodium Channel Blockers	C[C@@H]1CN(C[C@H](C)N1)c2ncc(c(N)n2)c3cccc(Cl)c3Cl	1957276-35-5	67081	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469667	352.26156	SHP836	SHP836 | SHP836	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:4200	SCN10A	Nav1.8 (SNS/PN3) Sodium Channel Blockers
SJ000285954-10	SJ000285954	10	MOABOX:4204	DDNCQMVWWZOMLN-IRLDBZIGSA-N	CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32	115986-87-3	Nav1.8 (SNS/PN3) Sodium Channel Blockers;Phosphodiesterase I Inhibitors	SCN10A																																																															CHEMBL71752											443955	9930104	23642311	53344607	60151428	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																AS-13868	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c([C@H]23)n1c5ccccc45	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466816	350.45404	VINPOCETINE	VINPOCETINE | VINPOCETINE			MOABOX:4204	SCN10A	Nav1.8 (SNS/PN3) Sodium Channel Blockers;Phosphodiesterase I Inhibitors
SJ000285999-16	SJ000285999	16	MOABOX:4208	LEBVLXFERQHONN-UHFFFAOYSA-N	CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C	119427-31-5	"""Sodium Channel Blocker; anaesthetic"";""""""Sodium Channel Blocker; anaesthetic"""""""	SCN2A	SCN2B	SCN1A	SCN3A	SCN1B	SCN7A	SCN8A	SCN3B																									6327	6323	6328	6324	6332	6334	55800																									CHEMBL1098	CHEMBL1200396										2474	64737	181810	5282419	9850178	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.36211	0	0.70609	0.48027	0.36211	0	0	0																									0.05173	0.0	0.10087	0.06861	0.05173	0.0	0.0	0.0																									7	7	7	7	7	7	7	7																									BS-5224	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCCCN1CCCCC1C(=O)Nc2c(C)cccc2C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466757	288.42772	BUPIVACAINE HYDROCHLORIDE	"BUPIVACAINE HYDROCHLORIDE | ""LEVOBUPIVACAINE HYDROCHLORIDE | CAIROCAINE"" | LEVOBUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HCL | BUPIVACAINE HYDROCHLORIDE | ""LEVOBUPIVACAINE HYDROCHLORIDE | CAIROCAINE"" | LEVOBUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HCL"			MOABOX:4208	SCN2A	"""Sodium Channel Blocker; anaesthetic"";""""""Sodium Channel Blocker; anaesthetic"""""""
SJ001034657-1	SJ001034657	1	MOABOX:4212	QNJVELOLCDKQBN-UHFFFAOYSA-N	CC(C)c1cc(Br)cc(C(C)C)c1O	2432-03-3	Nav1.2 (Brain Type II) Sodium Channel Blockers;Nav1.4 (SkM1) Sodium Channel Blockers	SCN2A	SCN4A																															6329																															CHEMBL54497											10422572					member	10.1038/bjp.2008.255																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0.53704																															0.0	0.06713																															7	8																															AS-3289	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)c1cc(Br)cc(C(C)C)c1O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466762	257.16678	AS-3289	AS-3289 | AS-3289			MOABOX:4212	SCN2A	Nav1.2 (Brain Type II) Sodium Channel Blockers;Nav1.4 (SkM1) Sodium Channel Blockers
SJ001032962-2	SJ001032962	2	MOABOX:4240	ODXQFEWQSHNQNI-UHFFFAOYSA-N	O=C(O)C(=O)c1cn(Cc2ccccc2)c2ccc(-c3ccc(OC(F)(F)F)cc3)cc12	393105-53-8	Plasminogen Activator Inhibitor (PAI-1) Inhibitors	SERPINE1																																																															CHEMBL325441											6450819					member																																																																																																																																																																15982877																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.73696																																0.21712																																8																																HY-15253	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease | Research Area: Metabolic Disease; Cancer|MOABOX:4240|SERPINE1|Plasminogen Activator Inhibitor (PAI-1) Inhibitors	OC(=O)C(=O)c1cn(Cc2ccccc2)c3ccc(cc13)c4ccc(OC(F)(F)F)cc4	393105-53-8	15606	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469018	439.38335	TIPLAXTININ	TIPLAXTININ | TIPLAXTININ	Pathway: Apoptosis; Metabolic Enzyme/Protease	Research Area: Metabolic Disease; Cancer	MOABOX:4240	SERPINE1	Plasminogen Activator Inhibitor (PAI-1) Inhibitors
SJ001033508-2	SJ001033508	2	MOABOX:4250	UVSWWUWQVAQPJR-UHFFFAOYSA-N	COc1ccc(CCN2CCN(CCCc3ccccc3)CC2)cc1OC	165377-43-5	Acetylcholine Release Enhancers;sigma1 Receptor Agonists	SIGMAR1																																																															CHEMBL3216524	CHEMBL408867										9907323	9954941	56675569			member																																																																																																																																																																16250835	17015942	17073684	21732626	22288408	22288410																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.47568																																0.05946																																8																																HY-13510	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:4250|SIGMAR1|Acetylcholine Release Enhancers;sigma1 Receptor Agonists	COc1ccc(CCN2CCN(CCCc3ccccc3)CC2)cc1OC	165377-44-6	13606	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469290	368.51238	CUTAMESINE DIHYDROCHLORIDE; SA4503 (DIHYDROCHLORIDE); AGY94806 DIHYDROCHLORIDE	CUTAMESINE DIHYDROCHLORIDE; SA4503 (DIHYDROCHLORIDE); AGY94806 DIHYDROCHLORIDE | CUTAMESINE DIHYDROCHLORIDE; SA4503 (DIHYDROCHLORIDE); AGY94806 DIHYDROCHLORIDE	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:4250	SIGMAR1	Acetylcholine Release Enhancers;sigma1 Receptor Agonists
SJ001035350-1	SJ001035350	1	MOABOX:4254	MYKJVLTXPNIGOV-KTKRTIGZSA-N	CCN(C/C=C\c1ccc(C2CCCCC2)c(Cl)c1)C1CCCCC1	132173-06-9	sigma1 Receptor Ligands;sigma2 Receptor Ligands	SIGMAR1																																																																										6439330	6913112	67108491			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-13751	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Inflammation/Immunology|MOABOX:4254|SIGMAR1|sigma1 Receptor Ligands;sigma2 Receptor Ligands	CCN(C\C=C/c1ccc(C2CCCCC2)c(Cl)c1)C3CCCCC3	132173-07-0	60486	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469670	359.97576	SR-31747	SR-31747 | SR-31747	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Inflammation/Immunology	MOABOX:4254	SIGMAR1	sigma1 Receptor Ligands;sigma2 Receptor Ligands
SJ000784238-7	SJ000784238	7	MOABOX:4256	IASPBORHOMBZMY-UHFFFAOYSA-N	O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1cnc2ccccc2n1	1001645-58-4	SIRT1;Histone Deacetylase SIRT1 Activators	SIRT1																																																															CHEMBL257991											24180125	25232708	91826485	129010356	129908760	member																																																																																																																																																																18046409	18800048	19199480	23316803																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.4548																																0.05685																																8																																CS-0509	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-016-633-182|MOABOX:4256|SIRT1|SIRT1;Histone Deacetylase SIRT1 Activators	O=C(Nc1ccccc1c2cn3c(CN4CCNCC4)csc3n2)c5cnc6ccccc6n5	2060259-60-9	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468481	469.56142	SRT1720	SRT1720 | SRT1720			MOABOX:4256	SIRT1	SIRT1;Histone Deacetylase SIRT1 Activators
SJ000784267-6	SJ000784267	6	MOABOX:4258	FUZYTVDVLBBXDL-VIFPVBQESA-N	NC(=O)[C@H]1CCCc2c1[nH]c1ccc(Cl)cc21	848193-68-0	SIRT1;Histone Deacetylase SIRT1 Inhibitors	SIRT1																																																															CHEMBL597477											707029					member	10.1039/c2ob06695e																																																																																																																																																															20041717	22039877	22286328	25971769																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		3.24584																																0.40573																																8																																HY-15452	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer; Inflammation/Immunology|MOABOX:4258|SIRT1|SIRT1;Histone Deacetylase SIRT1 Inhibitors	NC(=O)C1CCCc2c1[nH]c3ccc(Cl)cc23	49843-98-3	68387	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469775	248.70812	SELISISTAT	"SELISISTAT | ""EX 527 | SIRT1 INHIBITOR III | SEN-0014196"" | EX 527 (SELISISTAT) | SELISISTAT | ""EX 527 | SIRT1 INHIBITOR III | SEN-0014196"" | EX 527 (SELISISTAT)"	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer; Inflammation/Immunology	MOABOX:4258	SIRT1	SIRT1;Histone Deacetylase SIRT1 Inhibitors
SJ000784267-7	SJ000784267	7	MOABOX:4258	FUZYTVDVLBBXDL-VIFPVBQESA-N	NC(=O)[C@H]1CCCc2c1[nH]c1ccc(Cl)cc21	848193-68-0	SIRT1;Histone Deacetylase SIRT1 Inhibitors	SIRT1																																																															CHEMBL597477											707029					member	10.1039/c2ob06695e																																																																																																																																																															20041717	22039877	22286328	25971769																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		3.24584																																0.40573																																8																																HY-15452A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:4258|SIRT1|SIRT1;Histone Deacetylase SIRT1 Inhibitors	NC(=O)[C@H]1CCCc2c1[nH]c3ccc(Cl)cc23	848193-68-0	21163	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469799	248.70812	SELISISTAT	"SELISISTAT | ""EX 527 | SIRT1 INHIBITOR III | SEN-0014196"" | EX 527 (SELISISTAT) | SELISISTAT | ""EX 527 | SIRT1 INHIBITOR III | SEN-0014196"" | EX 527 (SELISISTAT)"	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:4258	SIRT1	SIRT1;Histone Deacetylase SIRT1 Inhibitors
SJ001035168-1	SJ001035168	1	MOABOX:4264	ISFPDBUKMJDAJH-UHFFFAOYSA-N	O=C1CCc2c(ccc3ccccc23)O1	5690-03-9	Histone Deacetylase SIRT2 Inhibitors	SIRT2																																																															CHEMBL86537											5269					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					4.102e-002																																0.00586																																7																																HY-100585	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:4264|SIRT2|Histone Deacetylase SIRT2 Inhibitors	O=C1CCc2c(O1)ccc3ccccc23	5690-03-09	84218	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468976	198.2173	SPLITOMICIN | SPLITOMYCIN	"""SPLITOMICIN | SPLITOMYCIN"" | ""SPLITOMICIN | SPLITOMYCIN"""	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:4264	SIRT2	Histone Deacetylase SIRT2 Inhibitors
SJ000286085-10	SJ000286085	10	MOABOX:4266	NGBFQHCMQULJNZ-UHFFFAOYSA-N	Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1	56211-40-6	Drugs Acting on Potassium Channels	SLC12A1	SLC12A2																															6558																															CHEMBL1148											41781	9801583	9930540	9931295	9998308	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.8108	0.70945																															0.10135	0.10135																															8	7																															HY-B0247	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Metabolic Disease; Cardiovascular Disease|MOABOX:4266|SLC12A1|Drugs Acting on Potassium Channels	CC(C)NC(=O)NS(=O)(=O)c1cnccc1Nc2cccc(C)c2	56211-40-6	16023	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468790	348.42	TORSEMIDE	TORSEMIDE | TORSEMIDE	Pathway: Others	Research Area: Metabolic Disease; Cardiovascular Disease	MOABOX:4266	SLC12A1	Drugs Acting on Potassium Channels
SJ000286551-5	SJ000286551	5	MOABOX:4268	AFVLVVWMAFSXCK-VMPITWQZSA-N	N#C/C(=C\c1ccc(O)cc1)C(=O)O	122520-77-8	Monocarboxylate Transporter 1 (MCT1) Inhibitors	SLC16A1																																																															CHEMBL1885958	CHEMBL1889713	CHEMBL76602									5328791	16217123	16218262	18539544	66960045	member																																																																																																																																																																22684868																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.95024																																0.11878																																8																																BS-16413	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC(=O)\C(=C\c1ccc(O)cc1)\C#N	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466847	189.16748	ALPHA-CYANO-4-HYDROXYCINNAMIC ACID	"ALPHA-CYANO-4-HYDROXYCINNAMIC ACID | ""ACCA | CHC | CHCA |"" | ALPHA-CYANO-4-HYDROXYCINNAMIC ACID | ""ACCA | CHC | CHCA |"""			MOABOX:4268	SLC16A1	Monocarboxylate Transporter 1 (MCT1) Inhibitors
SJ000287226-7	SJ000287226	7	MOABOX:4274	QVZCXCJXTMIDME-UHFFFAOYSA-N	COc1cc(C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2)cc(OC)c1OC	20153-98-4	Adenosine Reuptake Inhibitor	SLC29A1	SLC29A2																															3177																															CHEMBL1256327	CHEMBL126075	CHEMBL1603820									3074	6419915	9898150	11954260	12834837	member	10.1016/j.bcp.2003.09.018	10.1016/j.bmcl.2014.10.026	10.1042/BJ20031880																																																																																																																																																													19883461	25454272																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.71896	0.85225																															0.21487	0.12175																															8	7																															HY-100957	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cardiovascular Disease|MOABOX:4274|SLC29A1|Adenosine Reuptake Inhibitor	COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2	20153-98-4	81291	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469373	604.68846	DILAZEP DIHYDROCHLORIDE	DILAZEP DIHYDROCHLORIDE | DILAZEP HYDROCHLORIDE | DILAZEP HCL | DILAZEP DIHYDROCHLORIDE | DILAZEP HYDROCHLORIDE | DILAZEP HCL	Pathway: Others	Research Area: Cardiovascular Disease	MOABOX:4274	SLC29A1	Adenosine Reuptake Inhibitor
SJ001035400-1	SJ001035400	1	MOABOX:4276	FZOFDZMKSAUTHT-NRFANRHFSA-N	O=C1Nc2ccccc2C2(CCN(C[C@H](Cc3ccccc3)Nc3nc4ccc(F)cc4s3)CC2)N1		Notch Pathway Antagonist;ER Stress Inducer;ZIP7 modulator	SLC39A7																																																																										134823928					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.2104																																0.2763																																8																																HY-114395	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Inflammation/Immunology|MOABOX:4276|SLC39A7|Notch Pathway Antagonist;ER Stress Inducer;ZIP7 modulator	Fc1ccc2nc(N[C@H](CN3CCC4(CC3)NC(=O)Nc5ccccc45)Cc6ccccc6)sc2c1	2349367-89-9	43197	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469918	501.61822	NVS-ZP7-4	NVS-ZP7-4 | NVS-ZP7-4	Pathway: Others	Research Area: Inflammation/Immunology	MOABOX:4276	SLC39A7	Notch Pathway Antagonist;ER Stress Inducer;ZIP7 modulator
SJ000286793-3	SJ000286793	3	MOABOX:4284	IOUVKUPGCMBWBT-QNDFHXLGSA-N	O=C(CCc1ccc(O)cc1)c1c(O)cc(O)cc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O	112318-65-7	SGLT-1 Inhibitors;SGLT-2 Inhibitors	SLC5A1	SLC5A2																															6524																															CHEMBL241384	CHEMBL245067										6072	9912668	21159083	24856303	68766996	member	10.1016/j.bioorg.2018.11.006	10.1016/j.bmc.2011.08.005	10.1016/j.bmc.2012.04.053	10.1016/j.bmc.2012.09.037	10.1016/j.bmc.2013.08.067	10.1016/j.bmc.2016.03.058	10.1016/j.bmcl.2008.08.036	10.1016/j.bmcl.2010.01.075	10.1016/j.bmcl.2014.01.077	10.1016/j.ejmech.2017.11.019	10.1021/acs.jmedchem.6b01134	10.1021/jm101072y	10.1021/jm300884k	10.1021/jm900951n	10.1124/jpet.116.232025	10.2174/156802611795860915																																																																																																																																																10720650	10794686	17374486	18260618	18707880	18755586	19243175	19785435	20149653	20192242	20302302	21128592	21398124	21510836	21873071	22652255	22889351	23062824	24071445	24556379	27075813	28098449	29216560																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															5.824e-002	3.4416																															0.00728	0.4302																															8	8																															AS-15724	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC[C@H]1O[C@@H](Oc2cc(O)cc(O)c2C(=O)CCc3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]1O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466812	436.40926	PHLORIDZIN	PHLORIDZIN | PHLORIZIN | PHLORIDZIN | PHLORIZIN			MOABOX:4284	SLC5A1	SGLT-1 Inhibitors;SGLT-2 Inhibitors
SJ001035374-1	SJ001035374	1	MOABOX:4286	XFJAMQQAAMJFGB-ZQGJOIPISA-N	CCc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc2c(c1)OCCO2	1291094-73-9	SGLT-1 Inhibitors;SGLT-2 Inhibitors	SLC5A2																																																																										52913524	52913744	75203148			virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.2044																																0.40055																																8																																HY-109092	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Metabolic Disease; Inflammation/Immunology|MOABOX:4286|SLC5A2|SGLT-1 Inhibitors;SGLT-2 Inhibitors	CCc1ccc(cc1Cc2ccc3OCCOc3c2)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O	1291094-73-9	29588	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469829	416.46422	LICOGLIFLOZIN | LIK066	"""LICOGLIFLOZIN | LIK066"" | ""LICOGLIFLOZIN | LIK066"""	Pathway: Membrane Transporter/Ion Channel	Research Area: Metabolic Disease; Inflammation/Immunology	MOABOX:4286	SLC5A2	SGLT-1 Inhibitors;SGLT-2 Inhibitors
SJ000855163-3	SJ000855163	3	MOABOX:4294	JVHXJTBJCFBINQ-ADAARDCZSA-N	CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1	461432-26-8	SGLT-2 Inhibitors	SLC5A2																																																															CHEMBL2103802	CHEMBL429910										9887712	23727726	24906252	24936221	25030873	member	10.1002/cmdc.201000051	10.1016/B978-0-12-386009-5.00020-5	10.1016/j.bioorg.2018.11.006	10.1016/j.bmc.2010.01.073	10.1016/j.bmc.2010.04.088	10.1016/j.bmc.2010.06.076	10.1016/j.bmc.2011.08.014	10.1016/j.bmc.2012.04.053	10.1016/j.bmc.2014.04.036	10.1016/j.bmc.2018.06.017	10.1016/j.bmcl.2009.08.030	10.1016/j.bmcl.2009.10.088	10.1016/j.bmcl.2010.04.006	10.1016/j.bmcl.2010.11.115	10.1016/j.bmcl.2011.02.056	10.1016/j.bmcl.2011.04.063	10.1016/j.bmcl.2011.06.032	10.1016/j.bmcl.2014.01.077	10.1016/j.bmcl.2015.01.016	10.1016/j.bmcl.2015.05.040	10.1016/j.bmcl.2018.04.070	10.1016/j.bmcl.2018.09.025	10.1016/j.ejmech.2011.03.052	10.1016/j.ejmech.2017.11.019	10.1016/j.ejmech.2019.07.032	10.1021/acs.jmedchem.6b01134	10.1021/jm300884k	10.1021/jm401780b	10.1021/jm8013019	10.1021/jm900951n	10.1021/ml100256c	10.1111/jphp.13130	10.2174/156802611795860915																																																																																																																															18260618	19243175	19700318	19785435	19896374	20149653	20181486	20414917	20434909	20576578	20637636	20952196	21128592	21193308	21398124	21510836	21514014	21565497	21592794	21737266	21868239	21906953	22652255	22818040	22889351	24456245	24556379	24842618	24900297	25650254	26026363	28447791	28731335	29216560	29764742	29954682	30268701																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	4.74752																																0.59344																																8																																HY-10450	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Metabolic Disease; Cancer|MOABOX:4294|SLC5A2|SGLT-2 Inhibitors	CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc1	461432-26-8	9791	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469262	408.8726	DAPAGLIFLOZIN	DAPAGLIFLOZIN | DAPAGLIFLOZIN	Pathway: Membrane Transporter/Ion Channel	Research Area: Metabolic Disease; Cancer	MOABOX:4294	SLC5A2	SGLT-2 Inhibitors
SJ000288206-6	SJ000288206	6	MOABOX:4298	TXQKSMSLZVKQBI-UHFFFAOYSA-N	O=C(O)C1CCCN(CCC=C(c2ccccc2)c2ccccc2)C1	85375-15-1	GAT-1 Inhibitors	SLC6A1	SLC6A12																															6539																															CHEMBL38686	CHEMBL543557										92409	6917797	44293354			member	10.1016/S0960-894X(96)00268-5	10.2174/0929867003374363	10.2174/0929867003375380																																																																																																																																																													10637362	10911018	18855736	20219271	22689508																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.87544	1.01843																															0.10943	0.14549																															8	7																															HY-100228A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:4298|SLC6A1|GAT-1 Inhibitors	OC(=O)C1CCCN(CCC=C(c2ccccc2)c3ccccc3)C1	85375-15-1	22632	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468946	335.4394	SKF 89976A	SKF 89976A | SKF 89976A HYDROCHLORIDE | SKF 89976A | SKF 89976A HYDROCHLORIDE	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:4298	SLC6A1	GAT-1 Inhibitors
SJ000782354-8	SJ000782354	8	MOABOX:4314	GJJFMKBJSRMPLA-HIFRSBDPSA-N	CCN(CC)C(=O)[C@]1(c2ccccc2)C[C@@H]1CN	101152-94-7	5-HT Reuptake Inhibitors;Norepinephrine Reuptake Inhibitors	SLC6A2	SLC6A4																															6532																															CHEMBL1237129	CHEMBL252923										65833	163701	23729143	25173688	25173689	member	10.1016/j.bmc.2016.10.034	10.1016/j.bmcl.2008.04.025	10.2174/092986708784872357	10.2174/1381612053764805																																																																																																																																																												11966445	15892657	16220969	17350257	17430151	17471183	18468895	18673223	23347683	24900709	27865645																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											0.70368	1.36456																															0.08796	0.17057																															8	8																															HY-B0168A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Neuronal Signaling | Research Area: Neurological Disease|MOABOX:4314|SLC6A2|5-HT Reuptake Inhibitors;Norepinephrine Reuptake Inhibitors	CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)c2ccccc2	101152-94-7	11706	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468993	246.34798	MILNACIPRAN HYDROCHLORIDE	"MILNACIPRAN HYDROCHLORIDE | ""MIDALCIPRAN HYDROCHLORE | F-2207 | TN-91"" | MILNACIPRAN HYDROCHLORIDE | ""MIDALCIPRAN HYDROCHLORE | F-2207 | TN-91"""	Pathway: Neuronal Signaling	Research Area: Neurological Disease	MOABOX:4314	SLC6A2	5-HT Reuptake Inhibitors;Norepinephrine Reuptake Inhibitors
SJ000855505-6	SJ000855505	6	MOABOX:4324	JICJBGPOMZQUBB-UHFFFAOYSA-N	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	1159812-13-1	5-HT Reuptake Enhancers	SLC6A4																																																															CHEMBL1289110											68870	22734988	45375836	46190761	66524473	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.33852																																0.04836																																7																																KS-5099	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CN1c2ccccc2C(NCCCCCCC(=O)O)c3ccc(Cl)cc3S1(=O)=O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466696	436.9522	TIANEPTINE SODIUM	TIANEPTINE SODIUM | TIANEPTINE SODIUM			MOABOX:4324	SLC6A4	5-HT Reuptake Enhancers
SJ000285523-15	SJ000285523	15	MOABOX:4326	GDLIGKIOYRNHDA-UHFFFAOYSA-N	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	17321-77-6	Serotonin Transporter (SERT) Inhibitors	SLC6A4																																																															CHEMBL1200710	CHEMBL415										2801	68539	481773	657299	9939942	member	10.2174/1381612053764805																																																																																																																																																															7452682	11472239	15892657	17471183	21793219	26372073																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.95224																																0.24403																																8																																HY-B0457	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:4326|SLC6A4|Serotonin Transporter (SERT) Inhibitors	CN(C)CCCN1c2ccccc2CCc3ccc(Cl)cc13	17321-77-6	16622	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469374	314.85232	CLOMIPRAMINE HYDROCHLORIDE	"CLOMIPRAMINE HYDROCHLORIDE | ANAFRANIL | ""CLOMIPRAMINE HYDROCHLORIDE | G-34586 | VR-776 | CHLORIMIPRAMINE HYDROCHLORIDE |"" | CLOMIPRAMINE HCL | CLOMIPRAMINE HYDROCHLORIDE | ANAFRANIL | ""CLOMIPRAMINE HYDROCHLORIDE | G-34586 | VR-776 | CHLORIMIPRAMINE HYDROCHLORIDE |"" | CLOMIPRAMINE HCL"	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:4326	SLC6A4	Serotonin Transporter (SERT) Inhibitors
SJ000518949-8	SJ000518949	8	MOABOX:4332	ZEUITGRIYCTCEM-KRWDZBQOSA-N	CNCC[C@H](Oc1cccc2ccccc12)c1cccs1	116539-58-3	Norepinephrine Transporter (NET) Inhibitors;Serotonin Transporter (SERT) Inhibitors	CYP2D6	SLC6A2	SLC6A4																														6530	6532																														CHEMBL1175	CHEMBL1200328										60834	60835	9870739	11639633	16738712	member	10.1016/j.bmc.2006.08.039	10.1016/j.bmcl.2006.05.049	10.1016/j.bmcl.2006.05.051	10.1016/j.bmcl.2007.01.020	10.1016/j.bmcl.2008.01.011	10.1016/j.bmcl.2009.03.054	10.1016/j.bmcl.2009.03.090	10.1016/j.bmcl.2009.06.076	10.1016/j.bmcl.2010.03.059	10.1016/j.bmcl.2014.06.026	10.1021/jm8009537	10.1021/ml400049p	10.1021/ml500187a	10.1111/j.1476-5381.2010.00690.x	10.1124/dmd.111.043158	10.1124/jpet.106.109728	10.1124/jpet.113.208686	10.1124/jpet.118.248039	10.1177/0269881116681456	10.1371/journal.pone.0217371	10.2174/092986708784872357	10.2174/1381612053764805																																																																																																																																										11966445	14643350	15177457	15454233	15892657	16220969	16750359	16750363	16884308	16973367	17267217	17430151	17471183	18207394	18387300	18672364	18673223	18771916	18954038	19199984	19329313	19359175	19592243	19647430	20235539	20378347	20471260	20945906	22680630	23084899	23347683	24900709	24974340	25221656																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.54584	1.34472	4.34464																														-0.06823	0.16809	0.54308																														8	8	8																														AG0070YP	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-028-751-527|MOABOX:4332|CYP2D6|Norepinephrine Transporter (NET) Inhibitors;Serotonin Transporter (SERT) Inhibitors	CNCC[C@H](Oc1cccc2ccccc12)c3cccs3	136434-34-9	NA	GENERAL	CHLORIDE	1	H2O	1	1468137	297.41456	DULOXETINE HYDROCHLORIDE 	"DULOXETINE HYDROCHLORIDE  | ""CYMBALTA | LY-264453 | LY-248686 "" | DULOXETINE HCL | DULOXETINE HYDROCHLORIDE  | ""CYMBALTA | LY-264453 | LY-248686 "" | DULOXETINE HCL"			MOABOX:4332	CYP2D6	Norepinephrine Transporter (NET) Inhibitors;Serotonin Transporter (SERT) Inhibitors
SJ001035331-1	SJ001035331	1	MOABOX:4334	BQNXBSYSQXSXPT-UHFFFAOYSA-N	Clc1cccc(Cl)c1CSc1nnc(-c2cnccn2)s1	448947-81-7	Piezo1 channel activator;GlyT-2 Inhibitors	SLC6A5	PIEZO1																															9780																																										2746822					member	10.1111/bph.14188																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0.40736																															0.0	0.05092																															7	8																															HY-18723	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cardiovascular Disease|MOABOX:4334|SLC6A5|Piezo1 channel activator;GlyT-2 Inhibitors	Clc1cccc(Cl)c1CSc2nnc(s2)c3cnccn3	448947-81-7	20381	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469604	355.26542	YODA 1	YODA 1 | YODA 1	Pathway: Others	Research Area: Cardiovascular Disease	MOABOX:4334	SLC6A5	Piezo1 channel activator;GlyT-2 Inhibitors
SJ001035294-1	SJ001035294	1	MOABOX:4342	YSUBLPUJDOWYDP-UHFFFAOYSA-N	CCOc1ccc(Oc2ccc(OCc3cc(F)ccc3F)cc2)c(N)c1	223104-29-8	Na+/Ca2+ Exchanger type 1 (NCX1) Inhibitors	SLC8A2																																																															CHEMBL332214											644100	22117683	143085276			member																																																																																																																																																																15602012																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.23296																																-0.03328																																7																																HY-15515	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Cardiovascular Disease|MOABOX:4342|SLC8A2|Na+/Ca2+ Exchanger type 1 (NCX1) Inhibitors	CCOc1ccc(Oc2ccc(OCc3cc(F)ccc3F)cc2)c(N)c1	223104-29-8	9215	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469520	371.37727	SEA0400	SEA0400 | SEA0400	Pathway: Membrane Transporter/Ion Channel	Research Area: Cardiovascular Disease	MOABOX:4342	SLC8A2	Na+/Ca2+ Exchanger type 1 (NCX1) Inhibitors
SJ001033562-2	SJ001033562	2	MOABOX:4350	POERAARDVFVDLO-QGZVFWFLSA-N	Cc1c(Cc2ccccc2)nnc(N2CCN(c3cnc(C(C)(C)O)cn3)[C@H](C)C2)c1C	1204975-42-7	Smoothened receptor antagonist;Hedgehog Signaling Inhibitors	SMO																																																															CHEMBL3133037											45100669					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.8744																																0.2343																																8																																HY-18636	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Stem Cell/Wnt | Research Area: Cancer|MOABOX:4350|SMO|Smoothened receptor antagonist;Hedgehog Signaling Inhibitors	C[C@@H]1CN(CCN1c2cnc(cn2)C(C)(C)O)c3nnc(Cc4ccccc4)c(C)c3C	1204975-42-7	35134	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469832	432.56118	LEQ506; NVP-LEQ506	LEQ506; NVP-LEQ506 | LEQ506; NVP-LEQ506	Pathway: Stem Cell/Wnt	Research Area: Cancer	MOABOX:4350	SMO	Smoothened receptor antagonist;Hedgehog Signaling Inhibitors
SJ001034642-1	SJ001034642	1	MOABOX:4354	NORNNMHDCZHPNP-UHFFFAOYSA-N	Sc1nnc(Cc2ccccc2)n1-c1ccccc1	22478-90-6	Neutral Sphingomyelinase (N-SMase) Inhibitors	SMPD2																																																															CHEMBL1491185											667526	126476475				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																JS-140C	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Sc1nnc(Cc2ccccc2)n1c3ccccc3	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466640	267.34882	JS-140C	JS-140C | JS-140C			MOABOX:4354	SMPD2	Neutral Sphingomyelinase (N-SMase) Inhibitors
SJ000286498-6	SJ000286498	6	MOABOX:4358	FVWJYYTZTCVBKE-ROUWMTJPSA-N	C=C(C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12	473-98-3	ACAT 1 Inhibitors;Antioxidants	SOAT1																																																															CHEMBL23236											72326	20598936	54589419	66621739	66633174	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																J10870	AK_SCIENTIFIC	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-742-486|MOABOX:4358|SOAT1|ACAT 1 Inhibitors;Antioxidants	CC(=C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12	473-98-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468715	442.7168	BETULIN	"BETULIN | ""BETULIN | NSC-4644 | BETULINIC ALCOHOL | BETULINOL | TROCHOL |"" | BETULIN | ""BETULIN | NSC-4644 | BETULINIC ALCOHOL | BETULINOL | TROCHOL |"""			MOABOX:4358	SOAT1	ACAT 1 Inhibitors;Antioxidants
SJ001034879-1	SJ001034879	1	MOABOX:4368	WZFCZVJGQHEBMO-ZSOIEALJSA-N	O=C1/C(=C/c2ccc(O)c(O)c2)Sc2ccccc21		Sphingosine Kinase Inhibitors	SPHK1																																																																										5403603					member																																																																																																																																																																14522923																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.81347																																0.11621																																7																																STL380978	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-011-293|MOABOX:4368|SPHK1|Sphingosine Kinase Inhibitors	Oc1ccc(\C=C\2/Sc3ccccc3C2=O)cc1O	24388-08-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468178	270.3031	STL380978	STL380978 | STL380978			MOABOX:4368	SPHK1	Sphingosine Kinase Inhibitors
SJ000831436-4	SJ000831436	4	MOABOX:4370	CAOTVXGYTWCKQE-UHFFFAOYSA-N	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2	915385-81-8	Sphingosine Kinase 2 (SphK2) Inhibitors;Angiogenesis Inhibitors	SPHK2																																																															CHEMBL2158685											15604015	73438894				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.11729																																0.30247																																7																																T6750	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-560-286|MOABOX:4370|SPHK2|Sphingosine Kinase 2 (SphK2) Inhibitors;Angiogenesis Inhibitors	Clc1ccc(cc1)C23CC4CC(CC(C4)(C2)C(=O)NCc5ccncc5)C3	915385-81-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468149	380.9104	ABC294640 HCL	ABC294640 HCL | ABC294640 | ABC294640 HCL | ABC294640			MOABOX:4370	SPHK2	Sphingosine Kinase 2 (SphK2) Inhibitors;Angiogenesis Inhibitors
SJ000286148-7	SJ000286148	7	MOABOX:4378	FUSNMLFNXJSCDI-UHFFFAOYSA-N	Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1	2398-96-1	Fungal Squalene Monooxygenase Inhibitors	SQLE																																																															CHEMBL83668											5510	73949569	87172967	87348551	87843059	member																																																																																																																																																																8834895																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.89397																																0.12771																																7																																HY-B0370	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Infection|MOABOX:4378|SQLE|Fungal Squalene Monooxygenase Inhibitors	CN(C(=S)Oc1ccc2ccccc2c1)c3cccc(C)c3	2398-96-1	16123	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469139	307.40938	TOLNAFTATE	TOLNAFTATE | TOLNAFTATE	Pathway: Anti-infection	Research Area: Infection	MOABOX:4378	SQLE	Fungal Squalene Monooxygenase Inhibitors
SJ001035312-1	SJ001035312	1	MOABOX:4382	WUPXZZWTHIZICK-UHFFFAOYSA-N	COc1cccc(-c2cn(-c3ccc(CCN4CCC(O)CC4)cc3)c3ncnc(N)c23)c1	234772-64-6	Src Kinase Inhibitors	SRC																																																															CHEMBL475584											5311381					member	10.1016/S8756-3282(99)00020-4																																																																																																																																																															10321903	10608920	12171518	15087474	17627544	18045061	18473810	18722033																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														2.08784																																0.26098																																8																																HY-W062835	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:4382|SRC|Src Kinase Inhibitors	COc1cccc(c1)c2cn(c3ccc(CCN4CCC(O)CC4)cc3)c5ncnc(N)c25	234772-64-6	67082	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469550	443.54076	CGP77675	CGP77675 | CGP77675	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:4382	SRC	Src Kinase Inhibitors
SJ000286970-4	SJ000286970	4	MOABOX:4398	URFCJEUYXNAHFI-UHFFFAOYSA-N	O=C1CC(c2ccccc2)Oc2cc(O)cc(O)c21	480-39-7	"Androgen Receptor Ligands;Steroid 5alpha-Reductase Inhibitors;""Androgen Receptor Ligands;Steroid 5alpha-Reductase Inhibitors"""	AR	SRD5A1	SRD5A2																														6715	6716																														CHEMBL70518											238782	66690004	67327532	67425260	67877722	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0																														0.0	0.0	0.0																														7	7	7																														HY-N0575	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?B | Research Area: Infection; Inflammation/Immunology; Cancer|MOABOX:4398|AR|Androgen Receptor Ligands;Steroid 5alpha-Reductase Inhibitors;\Androgen Receptor Ligands;Steroid 5alpha-Reductase Inhibitors\	Oc1cc(O)c2C(=O)C[C@H](Oc2c1)c3ccccc3	480-39-7	65818	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469844	256.25338	PINOCEMBRIN	PINOCEMBRIN | PINOCEMBRIN	Pathway: Anti-infection; Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?B	Research Area: Infection; Inflammation/Immunology; Cancer	MOABOX:4398	AR	Androgen Receptor Ligands;Steroid 5alpha-Reductase Inhibitors;\Androgen Receptor Ligands;Steroid 5alpha-Reductase Inhibitors\
SJ000286709-7	SJ000286709	7	MOABOX:4400	WUADCCWRTIWANL-UHFFFAOYSA-N	COc1ccc(-c2coc3cc(O)cc(O)c3c2=O)cc1	491-80-5	Androgen Receptor Antagonists;Steroid 5alpha-Reductase Inhibitors;PPARalpha Agonists;PPARgamma Agonists	AR	PPARA	PPARG	SRD5A1	SRD5A2																												5465	5468	6715	6716																												CHEMBL131921											5280373	145317670				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.66479	0	-0.12509	0	0																												-0.09497	0.0	-0.01787	0.0	0.0																												7	7	7	7	7																												HY-14595	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Neurological Disease; Cancer|MOABOX:4400|AR|Androgen Receptor Antagonists;Steroid 5alpha-Reductase Inhibitors;PPARalpha Agonists;PPARgamma Agonists	COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	491-80-5	13480	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469657	284.26348	BIOCHANIN A	BIOCHANIN A | BIOCHANIN A	Pathway: Autophagy; Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Neurological Disease; Cancer	MOABOX:4400	AR	Androgen Receptor Antagonists;Steroid 5alpha-Reductase Inhibitors;PPARalpha Agonists;PPARgamma Agonists
SJ001035095-1	SJ001035095	1	MOABOX:4426	GSWZMFDCPMPHDL-FZBBBUCASA-N	COc1ccc([C@@H](O)[C@@H](C)Oc2ccc([C@H]3O[C@H](c4ccc(O[C@H](C)[C@H](O)c5ccc6c(c5)OCO6)c(OC)c4)[C@H](C)[C@H]3C)cc2OC)cc1OC		Hypoxia Inducible Factor 1-alpha (HIF-1alpha) Inhibitors;Angiogenesis Inhibitors	HIF1A																																																															CHEMBL461308											10439828					member	10.1016/j.bbrc.2005.05.191	10.1021/np030514m																																																																																																																																																														15165135	15967416																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.41976																																0.30247																																8																																CFN70466	CHEMFACES	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-581-995|MOABOX:4426|HIF1A|Hypoxia Inducible Factor 1-alpha (HIF-1alpha) Inhibitors;Angiogenesis Inhibitors	COc1ccc(cc1OC)[C@@H](O)[C@@H](C)Oc2ccc(cc2OC)[C@H]3O[C@@H]([C@H](C)[C@H]3C)c4ccc(O[C@H](C)[C@H](O)c5ccc6OCOc6c5)c(OC)c4	88497-88-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468681	716.81322	MANASSANTIN B	MANASSANTIN B | MANASSANTIN B			MOABOX:4426	HIF1A	Hypoxia Inducible Factor 1-alpha (HIF-1alpha) Inhibitors;Angiogenesis Inhibitors
SJ001034647-1	SJ001034647	1	MOABOX:4428	MNPXTRXFUMGQLK-UHFFFAOYSA-N	O=C(Nc1nnc(-c2ccco2)o1)c1cc(-c2ccccc2)nc2ccccc12	851095-32-4	STAT-3 Inhibitors	STAT3																																																															CHEMBL1687979											4253236					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.2989																																-0.0427																																7																																ME-0153	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	O=C(Nc1oc(nn1)c2occc2)c3cc(nc4ccccc34)c5ccccc5	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466666	382.37156	ME-0153	ME-0153 | ME-0153			MOABOX:4428	STAT3	STAT-3 Inhibitors
SJ000121372-2	SJ000121372	2	MOABOX:4430	POOOQPHNOURAEX-UHFFFAOYSA-N	Clc1ccc(-c2cn3c(n2)sc2ccccc23)cc1	7025-32-3	STAT-6 Inhibitors	STAT6																																																															CHEMBL340962											667714	16236244	21203712			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																4T-0661	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Clc1ccc(cc1)c2cn3c4ccccc4sc3n2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466637	284.76336					MOABOX:4430	STAT6	STAT-6 Inhibitors
SJ000000854-19	SJ000000854	19	MOABOX:4442	REFJWTPEDVJJIY-UHFFFAOYSA-N	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12	117-39-5		SULT1A1																																																															CHEMBL1173475	CHEMBL1520590	CHEMBL50									5280343	5284452	5492759	9938691	11409987	virtual	10.1002/anie.200300631	10.1080/00498250110069159	10.1080/00498250110119108	10.2174/138920006774832596																																																																																																																																																												15293241	16454694	17584021																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.57208																																0.19651																																8																																HY-18085	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?B; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:4442|SULT1A1|	OC1=C(Oc2cc(O)cc(O)c2C1=O)c3ccc(O)c(O)c3	117-39-5	25265	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469136	302.2357	QUERCETIN	"QUERCETIN | QUERCETIN DIHYDRATE | QUERCETINE DIHYDRATE | ""QUERCETIN | LIM-5662 | LNS-5662 | QUER |"" | ""QUERCETIN DIHYDRATE | LIM-5662 | LNS-5662 | QUER |"" | ""LIM-566 | LNS-5662 | QUER | QUERCETIN |"" | QUERCETIN | QUERCETIN DIHYDRATE | QUERCETINE DIHYDRATE | ""QUERCETIN | LIM-5662 | LNS-5662 | QUER |"" | ""QUERCETIN DIHYDRATE | LIM-5662 | LNS-5662 | QUER |"" | ""LIM-566 | LNS-5662 | QUER | QUERCETIN |"""	Pathway: Apoptosis; Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?B; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:4442	SULT1A1	
SJ000785950-8	SJ000785950	8	MOABOX:4446	JWQOJVOKBAAAAR-UHFFFAOYSA-N	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC	648903-57-5	Syk Kinase Inhibitors	SYK																																																															CHEMBL1190711	CHEMBL1242100	CHEMBL541400									10200390	11784504	16760671	52949496	71311850	member																																																																																																																																																																12766258	15975507	18077363	22257213	22607148	25891105																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.96928																																0.24616																																8																																HY-14985	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Protein Tyrosine Kinase/RTK | Research Area: Inflammation/Immunology; Cancer|MOABOX:4446|SYK|Syk Kinase Inhibitors	COc1ccc(cc1OC)c2cc3nccn3c(Nc4ncccc4C(=O)N)n2	648903-57-5	4341	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468963	390.39532	BAY 61-3606 HYDROCHLORIDE | SYK INHIBITOR |	"""BAY 61-3606 HYDROCHLORIDE | SYK INHIBITOR |"" | BAY 61-3606 | ""BAY 61-3606 HYDROCHLORIDE | SYK INHIBITOR |"" | BAY 61-3606"	Pathway: Apoptosis; Protein Tyrosine Kinase/RTK	Research Area: Inflammation/Immunology; Cancer	MOABOX:4446	SYK	Syk Kinase Inhibitors
SJ001033397-2	SJ001033397	2	MOABOX:4456	XILNRORTJVDYRH-HKUYNNGSSA-N	COc1ccc(-n2nnnc2C(F)(F)F)cc1CN[C@H]1CCCN[C@H]1c1ccccc1	168266-51-1	Tachykinin NK1 Antagonists	CYP2D6	TACR1																															6869																															CHEMBL522302	CHEMBL557983										6918330	6918331	9896976	24864090	24864091	member	10.1021/jm980299k																																																																																																																																																															9804700	11562281	11961054	19388677	21944973																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	-1.01888	3.43832																															-0.12736	0.42979																															8	8																															HY-12143	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Cancer; Neurological Disease; Endocrinology|MOABOX:4456|CYP2D6|Tachykinin NK1 Antagonists	COc1ccc(cc1CN[C@H]2CCCN[C@H]2c3ccccc3)n4nnnc4C(F)(F)F	168266-51-1	80446	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469484	432.44213	VOFOPITANT; GR 205171	VOFOPITANT; GR 205171 | VOFOPITANT; GR 205171	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Cancer; Neurological Disease; Endocrinology	MOABOX:4456	CYP2D6	Tachykinin NK1 Antagonists
SJ001035351-1	SJ001035351	1	MOABOX:4466	PGKXDIMONUAMFR-AREMUKBSSA-N	CC(=O)NC1(c2ccccc2)CCN(CC[C@H](CN(C)C(=O)c2ccccc2)c2ccc(Cl)c(Cl)c2)CC1	142001-63-6	Tachykinin NK2 Antagonists	TACR2																																																															CHEMBL308148											104974	9854999	11534823	23729323	57370643	member	10.1016/0014-2999(93)90927-A	10.1016/0960-894X(96)00148-5	10.1016/S0006-2952(98)00373-6	10.1016/S0014-2999(02)02124-6	10.1016/S0960-894X(98)00395-3	10.1021/bi00031a029	10.1021/bi00176a033	10.1074/jbc.M106330200	10.1124/jpet.108.150201	10.1124/jpet.300.1.314	10.1177/108705719800300103																																																																																																																																																					7922121	8846425	9190866	9873524	11055349	11302484	11752131	15032679	15381044																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3.22824																																0.40353																																8																																HY-106910	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease; Endocrinology|MOABOX:4466|TACR2|Tachykinin NK2 Antagonists	CN(C[C@@H](CCN1CCC(CC1)(NC(=O)C)c2ccccc2)c3ccc(Cl)c(Cl)c3)C(=O)c4ccccc4	142001-63-6	56720	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469671	552.5345	SAREDUTANT | SR 48968 | SR 48968C	"""SAREDUTANT | SR 48968 | SR 48968C"" | ""SAREDUTANT | SR 48968 | SR 48968C"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease; Endocrinology	MOABOX:4466	TACR2	Tachykinin NK2 Antagonists
SJ001035315-1	SJ001035315	1	MOABOX:4468	DZOJBGLFWINFBF-UMSFTDKQSA-N	CC(=O)N(C)C1(c2ccccc2)CCN(CCC[C@]2(c3ccc(Cl)c(Cl)c3)CCCN(C(=O)c3ccccc3)C2)CC1	160492-56-8	Tachykinin NK3 Antagonists	TACR3																																																															CHEMBL346178											219077	9874213	87189833	87875214		member																																																																																																																																																																8691422	9190866	10090788	10992004	11302484	11472238	19117759	19817444	21047106	21376585	22574973	24374277	25738882																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									3.35632																																0.41954																																8																																HY-14551	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:4468|TACR3|Tachykinin NK3 Antagonists	CN(C(=O)C)C1(CCN(CCC[C@@]2(CCCN(C2)C(=O)c3ccccc3)c4ccc(Cl)c(Cl)c4)CC1)c5ccccc5	160492-56-8	57496	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469554	606.62494	OSANETANT | SR142801	"""OSANETANT | SR142801"" | ""OSANETANT | SR142801"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:4468	TACR3	Tachykinin NK3 Antagonists
SJ000287623-6	SJ000287623	6	MOABOX:4470	MQNYRKWJSMQECI-QFIPXVFZSA-N	CC[C@H](NC(=O)c1c(C)c(-c2ccccc2)nc2ccccc12)c1ccccc1	174635-69-9	Tachykinin NK3 Antagonists	TACR3																																																															CHEMBL10284											6604009					member	10.1016/j.bmc.2013.03.016	10.1021/cn5001606	10.1021/jm200536d	10.1124/jpet.108.146241	10.1124/jpet.110.173245																																																																																																																																																											8691422	10090788	10992004	15049675	17319724	18983139	19117759	21084390	21777010	23023262	23466604	23582449	26988801	27876250	28106992	28471663	28947942	29631962																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.82816																																0.47852																																8																																HY-15722	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease; Endocrinology|MOABOX:4470|TACR3|Tachykinin NK3 Antagonists	CC[C@H](NC(=O)c1c(C)c(nc2ccccc12)c3ccccc3)c4ccccc4	174635-69-9	9837	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468875	380.48156	SB 222200	SB 222200 | SB 222200	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease; Endocrinology	MOABOX:4470	TACR3	Tachykinin NK3 Antagonists
SJ001035076-1	SJ001035076	1	MOABOX:4472	QLOCSAUIBGQZLC-UHFFFAOYSA-N	COc1ccc2nc(NC(=O)COC(=O)CC(NC(=O)c3ccccc3)c3ccccc3)sc2c1			TAOK2	TAOK3	TAOK1																														51347	57551																														CHEMBL3717998											5030787					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.35126	1.31312	1.49872																														0.05018	0.16414	0.18734																														7	8	8																														STK758353	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-702-615|MOABOX:4472|TAOK2|	COc1ccc2nc(NC(=O)COC(=O)CC(NC(=O)c3ccccc3)c4ccccc4)sc2c1	312496-33-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468607	489.54292	STK758353	STK758353 | STK758353			MOABOX:4472	TAOK2	
SJ000008768-2	SJ000008768	2	MOABOX:4474	ZZIVMEREMOBTBA-UHFFFAOYSA-N	COC(=O)c1ccc(NC(=O)c2c(Cl)ccc(Cl)c2OC)cc1			TAS1R1																																																															CHEMBL3715874											986287					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.57904																																0.19738																																8																																6048706	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-650-151|MOABOX:4474|TAS1R1|	COC(=O)c1ccc(NC(=O)c2c(Cl)ccc(Cl)c2OC)cc1	301680-46-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468688	354.18472					MOABOX:4474	TAS1R1	
SJ001034982-1	SJ001034982	1	MOABOX:4476	QGWHBHBJGPJINC-UHFFFAOYSA-N	O=C(NC1CCCc2ccccc21)c1ccc2c(c1)OCO2		TAS1R1 gene antagonist	TAS1R1																																																															CHEMBL1348080											2971453					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.63944																																0.32993																																8																																7948972	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-097-003|MOABOX:4476|TAS1R1|TAS1R1 gene antagonist	O=C(NC1CCCc2ccccc12)c3ccc4OCOc4c3	791093-41-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468425	295.33248	7948972	7948972 | 7948972			MOABOX:4476	TAS1R1	TAS1R1 gene antagonist
SJ000806137-3	SJ000806137	3	MOABOX:4500	VILCJCGEZXAXTO-UHFFFAOYSA-N	NCCNCCNCCN	105821-86-1	Chelating Agents;Telomerase Inhibitors	TERT																																																															CHEMBL1200783	CHEMBL3989777	CHEMBL609									5565	30081	56835	61912	71433	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.73808																																0.10544																																7																																STR03562	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NCCNCCNCCN	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466785	146.23392	TRIENTINE HYDROCHLORIDE | MK-0681 | MK-681 | TECZA | TETA | TJA-250 |	"""TRIENTINE HYDROCHLORIDE | MK-0681 | MK-681 | TECZA | TETA | TJA-250 |"" | TRIENTINE HYDROCHLORIDE | ""TRIENTINE HYDROCHLORIDE | MK-0681 | MK-681 | TECZA | TETA | TJA-250 |"" | TRIENTINE HYDROCHLORIDE"			MOABOX:4500	TERT	Chelating Agents;Telomerase Inhibitors
SJ000834154-11	SJ000834154	11	MOABOX:4508	IVRXNBXKWIJUQB-UHFFFAOYSA-N	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1	700874-72-2	Inhibitors of Signal Transduction Pathways;Activin Receptor Like Kinase 5 (ALK5;TbetaR-I) Inhibitors	TGFBR1																																																															CHEMBL2364611											10090485	15945857				member	10.1016/j.bmcl.2015.09.058	10.1016/j.bmcl.2019.07.015	10.1016/j.ejmech.2019.07.013	10.1021/jm500115w																																																																																																																																																												26483198	28135685	29191878	29422332	30572609	31303386																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.67064																																0.20883																																8																																HY-13226	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: TGF-beta/Smad | Research Area: Cancer|MOABOX:4508|TGFBR1|Inhibitors of Signal Transduction Pathways;Activin Receptor Like Kinase 5 (ALK5;TbetaR-I) Inhibitors	Cc1cccc(n1)c2nn3CCCc3c2c4ccnc5ccc(cc45)C(=O)N	700874-72-2	15856	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468861	369.41916	LY2157299	LY2157299 | LY2157299	Pathway: TGF-beta/Smad	Research Area: Cancer	MOABOX:4508	TGFBR1	Inhibitors of Signal Transduction Pathways;Activin Receptor Like Kinase 5 (ALK5;TbetaR-I) Inhibitors
SJ001033276-2	SJ001033276	2	MOABOX:4524	BXNMTOQRYBFHNZ-UHFFFAOYSA-N	CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O	144875-48-9	Interferon Inducers;TLR7 Receptor Agonists;TLR8 Receptor Agonists;TNF-alpha Production Inducers	TLR7	TLR8																															51311																															CHEMBL383322											159603	11656870	53302814	67339109	67340588	member	10.1007/s00726-016-2190-7	10.1021/jm100070n																																																																																																																																																														20232824	26007168																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.7316	-0.19512																															0.21645	-0.02439																															8	8																															HY-13740	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Immunology/Inflammation | Research Area: Inflammation/Immunology; Cancer|MOABOX:4524|TLR7|Interferon Inducers;TLR7 Receptor Agonists;TLR8 Receptor Agonists;TNF-alpha Production Inducers	CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O	144875-48-9	86482	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468845	314.38218	RESIQUIMOD; R848; S28463	RESIQUIMOD; R848; S28463 | RESIQUIMOD; R848; S28463	Pathway: Anti-infection; Immunology/Inflammation	Research Area: Inflammation/Immunology; Cancer	MOABOX:4524	TLR7	Interferon Inducers;TLR7 Receptor Agonists;TLR8 Receptor Agonists;TNF-alpha Production Inducers
SJ000518970-8	SJ000518970	8	MOABOX:4526	GOTYRUGSSMKFNF-UHFFFAOYSA-N	Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O	1243329-97-6	DDB1-CRBN modulator;Angiogenesis Inhibitors;TNF-alpha Production Inhibitors	CRBN																																																															CHEMBL848											216326	24795083	25135307	44234575	44234576	member																																																																																																																																																																2924041																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.50704																																0.06338																																8																																HY-A0003	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; PROTAC | Research Area: Cancer; Inflammation/Immunology|MOABOX:4526|CRBN|DDB1-CRBN modulator;Angiogenesis Inhibitors;TNF-alpha Production Inhibitors	Nc1cccc2C(=O)N(Cc12)C3CCC(=O)NC3=O	191732-72-6	20918	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469888	259.26062	LENALIDOMIDE	"LENALIDOMIDE | ""LENALIDOMIDE | REVLIMID | CC-5013"" | LENALIDOMIDE | ""LENALIDOMIDE | REVLIMID | CC-5013"""	Pathway: Apoptosis; PROTAC	Research Area: Cancer; Inflammation/Immunology	MOABOX:4526	CRBN	DDB1-CRBN modulator;Angiogenesis Inhibitors;TNF-alpha Production Inhibitors
SJ001034980-1	SJ001034980	1	MOABOX:4536	DHKKONBXGAAFTB-OTYYAQKOSA-N	COc1cc(/C=C2\CCC/C(=C\c3ccc(O)c(OC)c3)C2=O)ccc1O	579-23-7	TNF Expression Inhibitors;Antiinflammatory Drugs;Breast Cancer-Resistant Protein (BCRP;ABCG2) Inhibitors	ABCG2																																																															CHEMBL17205											1550234					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																1310-0298	CHEMDIV	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-783-431|MOABOX:4536|ABCG2|TNF Expression Inhibitors;Antiinflammatory Drugs;Breast Cancer-Resistant Protein (BCRP;ABCG2) Inhibitors	COc1cc(\C=C\2/CCC\C(=C/c3ccc(O)c(OC)c3)\C2=O)ccc1O	579-23-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468422	366.40708	1310-0298	1310-0298 | 1310-0298			MOABOX:4536	ABCG2	TNF Expression Inhibitors;Antiinflammatory Drugs;Breast Cancer-Resistant Protein (BCRP;ABCG2) Inhibitors
SJ000784277-5	SJ000784277	5	MOABOX:4538	KLGQSVMIPOVQAX-UHFFFAOYSA-N	Oc1nc(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2	284028-89-3	Tankyrase 1 (TNKS1) Inhibitors;Tankyrase 2 (TNKS2) Inhibitors	TNKS	TNKS2																															80351																															CHEMBL1086580											135418940					member	10.1016/j.bmc.2015.05.005	10.1016/j.ejmech.2014.10.007	10.1021/jm201510p	10.1021/jm301607v	10.1021/ml400260b	10.1021/ml400292s																																																																																																																																																										20565110	22233320	22260203	23316926	23672613	23844574	23879431	24018190	24294969	24527792	24900625	25299683	25815142	26026769	27163581	27983846	28001384	28591512	29934219	30883102	31042381																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.32776	3.62184																															0.04097	0.45273																															8	8																															HY-15147	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics; Stem Cell/Wnt | Research Area: Cancer|MOABOX:4538|TNKS|Tankyrase 1 (TNKS1) Inhibitors;Tankyrase 2 (TNKS2) Inhibitors	FC(F)(F)c1ccc(cc1)C2=NC3=C(CSCC3)C(=O)N2	284028-89-3	45278	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468753	312.31015	XAV939	"XAV939 | ""XAV-939 | NVP-XAV-939 |"" | XAV-939 | XAV939 | ""XAV-939 | NVP-XAV-939 |"" | XAV-939"	Pathway: Cell Cycle/DNA Damage; Epigenetics; Stem Cell/Wnt	Research Area: Cancer	MOABOX:4538	TNKS	Tankyrase 1 (TNKS1) Inhibitors;Tankyrase 2 (TNKS2) Inhibitors
SJ000796090-10	SJ000796090	10	MOABOX:4540	ZGSXEXBYLJIOGF-ALFLXDJESA-N	O=C(Nc1cccc2cccnc12)c1ccc(N2C(=O)[C@H]3[C@H]4C=C[C@H](C4)[C@H]3C2=O)cc1	1127442-82-3	Wnt Signaling Inhibitors	TNKS2																																																															CHEMBL562310											44483163	90488854				member	10.1021/jm201510p	10.1021/jm301607v	10.1021/jm4000038	10.1021/jm401356t																																																																																																																																																												22233320	23316926	23701517	24527792	27983846	28001384																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																2.91512																																0.36439																																8																																HY-12238	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Stem Cell/Wnt | Research Area: Cancer|MOABOX:4540|TNKS2|Wnt Signaling Inhibitors	O=C(Nc1cccc2cccnc12)c3ccc(cc3)N4C(=O)[C@@H]5[C@H]6C[C@H](C=C6)[C@@H]5C4=O	1127442-82-3	12245	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469350	409.43666	IWR-1	"IWR-1 | ""WNT ANTAGONIST I | TNKS1/2 INHIBITOR II"" | IWR-1-ENDO | IWR-1 | ""WNT ANTAGONIST I | TNKS1/2 INHIBITOR II"" | IWR-1-ENDO"	Pathway: Stem Cell/Wnt	Research Area: Cancer	MOABOX:4540	TNKS2	Wnt Signaling Inhibitors
SJ000311679-11	SJ000311679	11	MOABOX:4544	FJHBVJOVLFPMQE-QFIPXVFZSA-N	CCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC	110714-48-2	Apoptosis Inducers;DNA Topoisomerase I Inhibitors	TOP1																																																															CHEMBL837											104842	11656465	67040460	131740141	131740142	member	10.1016/j.bmcl.2004.08.010	10.1016/j.bmcl.2018.12.059																																																																																																																																																														1846923	15454230																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.54584																																-0.06823																																8																																AS-13533	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCc1c2CN3C(=O)C4=C(C=C3c2nc5ccc(O)cc15)[C@@](O)(CC)C(=O)OC4	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466820	392.4046	SN-38	"SN-38 | ""7-ETHYL-10-HYDROXYCAMPTOTHECIN | NSC-673596"" | SN-38 | ""7-ETHYL-10-HYDROXYCAMPTOTHECIN | NSC-673596"""			MOABOX:4544	TOP1	Apoptosis Inducers;DNA Topoisomerase I Inhibitors
SJ000312345-17	SJ000312345	17	MOABOX:4546	UWKQSNNFCGGAFS-XIFFEERXSA-N	CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC	100286-90-6	DNA Topoisomerase I Inhibitors	TOP1																																																															CHEMBL1200512	CHEMBL3989514	CHEMBL481	CHEMBL541887								60837	60838	74990	9811268	9832506	member	10.1038/s41388-019-0965-5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-1.6e-003																																-0.0002																																8																																HY-16562A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:4546|TOP1|DNA Topoisomerase I Inhibitors	CCc1c2CN3C(=O)C4=C(C=C3c2nc5ccc(OC(=O)N6CCC(CC6)N7CCCCC7)cc15)[C@@](O)(CC)C(=O)OC4	100286-90-6	86874	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469156	586.67802	IRINOTECAN	"IRINOTECAN | ""CPT-11 | DQ-2805 | NSC-616348 | IRINOTECAN HYDROCHLORIDE TRIHYDRATE | CAMPTOSAR | IRINOTECAN HYDROCHLORIDE"" | IRINOTECAN HCL TRIHYDRATE | IRINOTECAN | ""CPT-11 | DQ-2805 | NSC-616348 | IRINOTECAN HYDROCHLORIDE TRIHYDRATE | CAMPTOSAR | IRINOTECAN HYDROCHLORIDE"" | IRINOTECAN HCL TRIHYDRATE"	Pathway: Autophagy; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:4546	TOP1	DNA Topoisomerase I Inhibitors
SJ000287149-21	SJ000287149	21	MOABOX:4548	UCFGDBYHRUNTLO-QHCPKHFHSA-N	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1	119413-54-6	DNA Topoisomerase I Inhibitors	TOP1																																																															CHEMBL1607	CHEMBL84										60699	60700	9810495	11489692	14761101	member	10.1021/jm00070a013	10.1021/jm049146p																																																																																																																																																														8410981	15801827	21542600	22305612	30897325																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.36e-003																																0.00017																																8																																HY-13768A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:4548|TOP1|DNA Topoisomerase I Inhibitors	CC[C@@]1(O)C(=O)OCC2=C1C=C3N(Cc4cc5c(CN(C)C)c(O)ccc5nc34)C2=O	119413-54-6	15428	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469019	421.44582	TOPOTECAN	TOPOTECAN | TOPOTECAN HYDROCHLORIDE | NSC-609699 | TOPOTECAN HCL | TOPOTECAN | TOPOTECAN HYDROCHLORIDE | NSC-609699 | TOPOTECAN HCL	Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:4548	TOP1	DNA Topoisomerase I Inhibitors
SJ001035233-1	SJ001035233	1	MOABOX:4552	UIVFUQKYVFCEKJ-OPTOVBNMSA-N	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2/C=N/OC(C)(C)C	292618-32-7	DNA-Intercalating Drugs;DNA Topoisomerase I Inhibitors	TOP1																																																															CHEMBL113051											9577124					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																8																																HY-B0063	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:4552|TOP1|DNA-Intercalating Drugs;DNA Topoisomerase I Inhibitors	CC[C@@]1(O)C(=O)OCC2=C1C=C3N(Cc4c(\C=N\OC(C)(C)C)c5ccccc5nc34)C2=O	292618-32-7	93632	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469235	447.4831	GIMATECAN | ST1481	"""GIMATECAN | ST1481"" | ""GIMATECAN | ST1481"""	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:4552	TOP1	DNA-Intercalating Drugs;DNA Topoisomerase I Inhibitors
SJ000285410-22	SJ000285410	22	MOABOX:4554	VSJKWCGYPAHWDS-FQEVSTJZSA-N	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1	72517-83-0	topoisomerase I	TOP1																																																															CHEMBL65											24360	153546	21141138	21141139	21141140	member	10.1016/j.bmcl.2004.08.010	10.1016/j.bmcl.2018.12.059	10.1021/jm00070a013	10.1021/jm049146p																																																																																																																																																												1846923	2537428	7707314	7853331	8246238	8410981	9003520	15454230	15801827	18676151																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												-7.208e-002																																-0.00901																																8																																KS-5235	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC[C@@]1(O)C(=O)OCC2=C1C=C3N(Cc4cc5ccccc5nc34)C2=O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466699	348.35204	CAMPTOTHECIN	"CAMPTOTHECIN | (S)-(+)-CAMPTOTHECIN | NSC-94600 | ""CAMPTOTHECIN | NSC-94600 | CAMPTOTHECINE |"" | CAMPTOTHECIN | (S)-(+)-CAMPTOTHECIN | NSC-94600 | ""CAMPTOTHECIN | NSC-94600 | CAMPTOTHECINE |"""			MOABOX:4554	TOP1	topoisomerase I
SJ000784260-3	SJ000784260	3	MOABOX:4562	WOWJIWFCOPZFGV-UHFFFAOYSA-N	CC(=O)Nc1ccc(NC(=S)NC(=O)c2ccc(C(C)(C)C)cc2)cc1	380315-80-0	p53	TP53																																																															CHEMBL1436543											1013376					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-13423	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:4562|TP53|p53	CC(=O)Nc1ccc(NC(=S)NC(=O)c2ccc(cc2)C(C)(C)C)cc1	380315-80-0	13997	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468898	369.48052	TENOVIN-1	TENOVIN-1 | TENOVIN-1	Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:4562	TP53	p53
SJ001035279-1	SJ001035279	1	MOABOX:4564	JZWUKILTKYJLCN-XEGCMXMBSA-N	Nc1nc(OC(c2ccc(-c3cccc(F)c3)cc2)C(F)(F)F)cc(-c2ccc(C[C@H](N)C(=O)O)cc2)n1	1040526-12-2	Tryptophan Hydroxylase 1 (TPH1) Inhibitors;Tryptophan Hydroxylase 2 (TPH2) Inhibitors	TPH1	TPH2																															121278																															CHEMBL511275											44560455	57330118	102602704			member	10.1021/jm5002293																																																																																																																																																															18192499	24844139	27146606																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.40984	0.78992																															0.17623	0.09874																															8	8																															HY-15849A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease; Cardiovascular Disease|MOABOX:4564|TPH1|Tryptophan Hydroxylase 1 (TPH1) Inhibitors;Tryptophan Hydroxylase 2 (TPH2) Inhibitors	N[C@@H](Cc1ccc(cc1)c2cc(OC(c3ccc(cc3)c4cccc(F)c4)C(F)(F)F)nc(N)n2)C(=O)O	1040526-12-2	36615	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469475	526.48219	LP-533401 HYDROCHLORIDE	LP-533401 HYDROCHLORIDE | LP-533401 HYDROCHLORIDE	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease; Cardiovascular Disease	MOABOX:4564	TPH1	Tryptophan Hydroxylase 1 (TPH1) Inhibitors;Tryptophan Hydroxylase 2 (TPH2) Inhibitors
SJ001035156-1	SJ001035156	1	MOABOX:4570	HKROEBDHHKMNBZ-CHBKHGQFSA-N	CCC(=N\O)/C(C)=C/c1ccc(F)cc1	1170613-55-4	TRPA1 Antagonists	TRPA1																																																															CHEMBL3697701											42641861					member	10.1016/S0065-7743(10)45003-4	10.1186/1744-8069-6-14	10.2174/156802611796904915																																																																																																																																																													20205719	21671872	30878828																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.52736																																0.44092																																8																																HY-108463	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Inflammation/Immunology|MOABOX:4570|TRPA1|TRPA1 Antagonists	CC\C(=N/O)\C(=C\c1ccc(F)cc1)\C	1170613-55-4	66615	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468941	207.24406	A-967079	A-967079 | A-967079	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Inflammation/Immunology	MOABOX:4570	TRPA1	TRPA1 Antagonists
SJ000024436-3	SJ000024436	3	MOABOX:4572	HEQDZPHDVAOBLN-UHFFFAOYSA-N	CC(C)c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1	349085-38-7	TRPA1 Antagonists	TRPA1																																																															CHEMBL1086310											1150897					member	10.1021/jm100062h	10.1073/pnas.0705924104	10.2174/156802611796904915																																																																																																																																																													20356305	21671872																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.74416																																0.34302																																8																																HY-15064	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:4572|TRPA1|TRPA1 Antagonists	CC(C)c1ccc(NC(=O)Cn2cnc3N(C)C(=O)N(C)C(=O)c23)cc1	349085-38-7	7553	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469361	355.39104	HC-030031	HC-030031 | HC-030031	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:4572	TRPA1	TRPA1 Antagonists
SJ000755093-7	SJ000755093	7	MOABOX:4578	ROFVXGGUISEHAM-UHFFFAOYSA-N	NC(=O)c1cccc(-c2cccc(OC(=O)NC3CCCCC3)c2)c1	546141-08-6	Fatty Acid Amide Hydrolase (FAAH) Inhibitors;TRPA1 Agonists	FAAH	TRPA1																															8989																															CHEMBL184238											1383884	24860574	53255265	143914909	144944550	virtual	10.1002/cmdc.200900120	10.1016/j.bmc.2011.04.057	10.1016/j.bmcl.2009.05.097	10.1016/j.bmcl.2011.02.052	10.1016/j.bmcl.2014.01.056	10.1016/j.bmcl.2016.04.004	10.1016/j.ejmech.2012.11.035	10.1016/j.ejmech.2015.04.064	10.1016/j.ejmech.2019.02.074	10.1016/j.fitote.2018.02.027	10.1021/jm061414r	10.1021/jm200723m	10.1021/jm400923s	10.1021/jm801042a	10.1021/jm9008532	10.1021/ml200313p	10.1039/c2md00307d	10.1039/c2md20146a	10.1039/c4cc00967c	10.1073/pnas.1016167108	10.1111/bph.12410	10.2174/156802608783498005	10.3109/14756366.2013.837900																																																																																																																																									16375687	16472164	16918457	17279090	17559203	18289091	18693015	18983142	19072118	19515560	19554599	19877691	21392988	21502526	21612933	21764305	21830831	21899370	22779702	23218778	23287055	23455058	24083878	24508127	24900454	25565044	26002335	27117424	27130358	30878828																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								0.81392	-1.00328																															0.10174	-0.12541																															8	8																															HY-10864	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:4578|FAAH|Fatty Acid Amide Hydrolase (FAAH) Inhibitors;TRPA1 Agonists	NC(=O)c1cccc(c1)c2cccc(OC(=O)NC3CCCCC3)c2	546141-08-6	4181	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469893	338.40028	URB-597|3-(3-CARBAMOYLPHENYL)PHENYL N-CYCLOHEXYLCARBAMATE	"URB-597|3-(3-CARBAMOYLPHENYL)PHENYL N-CYCLOHEXYLCARBAMATE | ""FAAH INHIBITOR II | URB597 | KDS-4103 | UCM-597 |"" | URB-597 | URB597 | URB-597|3-(3-CARBAMOYLPHENYL)PHENYL N-CYCLOHEXYLCARBAMATE | ""FAAH INHIBITOR II | URB597 | KDS-4103 | UCM-597 |"" | URB-597 | URB597"	Pathway: Autophagy; Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:4578	FAAH	Fatty Acid Amide Hydrolase (FAAH) Inhibitors;TRPA1 Agonists
SJ000287830-4	SJ000287830	4	MOABOX:4580	RCEFMOGVOYEGJN-UHFFFAOYSA-N	O=C1NC(c2cccc([N+](=O)[O-])c2)=CCN1c1ccccc1O	36945-98-9	TRPA1 Agonists;TRPM8 agonist;Induction of Brown Adipose Tissue (BAT) thermogenesis	TRPA1	TRPM8																															79054																															CHEMBL258405											161930					member	10.1016/j.bmcl.2013.09.016	10.2174/092986710790980078	10.2174/156802611796904933																																																																																																																																																													16408004	20166923	20356305	21671871	24080460	27437828	27964995																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															-0.52048	0.67224																															-0.06506	0.08403																															8	8																															HY-11062	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Cancer; Neurological Disease|MOABOX:4580|TRPA1|TRPA1 Agonists;TRPM8 agonist;Induction of Brown Adipose Tissue (BAT) thermogenesis	Oc1ccccc1N2CC=C(NC2=O)c3cccc(c3)[N+](=O)[O-]	36945-98-9	11034	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469366	311.29212	ICILIN	ICILIN | ICILIN	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Cancer; Neurological Disease	MOABOX:4580	TRPA1	TRPA1 Agonists;TRPM8 agonist;Induction of Brown Adipose Tissue (BAT) thermogenesis
SJ000286216-6	SJ000286216	6	MOABOX:4586	NOOLISFMXDJSKH-KXUCPTDWSA-N	CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O	114376-98-6	TRPM8 (TRP-p8;CMR1) Agonists	TRPM8																																																															CHEMBL470670											16666	9796153	9796733	9797203	9818093	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.16056																																0.27007																																8																																BS-3863	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466759	156.2652	MENTHOL(-)	MENTHOL(-) | (L)-MENTHOL | MENTHOL(-) | (L)-MENTHOL			MOABOX:4586	TRPM8	TRPM8 (TRP-p8;CMR1) Agonists
SJ000287452-8	SJ000287452	8	MOABOX:4588	OLBCVFGFOZPWHH-UHFFFAOYSA-N	CC(C)c1cccc(C(C)C)c1O	113981-41-2	TRPV1 (Vanilloid VR1 Receptor) Agonists	TRPV1																																																															CHEMBL526											4943	4867568	5148215	5231492	10866007	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																AS-13299	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)c1cccc(C(C)C)c1O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466778	178.27072	PROPOFOL	PROPOFOL | PROPOFOL| DIPRIVAN | PROPOFOL | PROPOFOL| DIPRIVAN			MOABOX:4588	TRPV1	TRPV1 (Vanilloid VR1 Receptor) Agonists
SJ000285284-11	SJ000285284	11	MOABOX:4590	YKPUWZUDDOIDPM-VURMDHGXSA-N	COc1cc(CNC(=O)CCCC/C=C\C(C)C)ccc1O	25775-90-0	TRPV1 (Vanilloid VR1 Receptor) Agonists	TRPV1																																																															CHEMBL313971											1548942	66644840	145358624	145358629		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-B1583	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:4590|TRPV1|TRPV1 (Vanilloid VR1 Receptor) Agonists	COc1cc(CNC(=O)CCCC\C=C/C(C)C)ccc1O	25775-90-0	35607	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469161	305.41188	(E)-CAPSAICIN | MR3H3 | NGX-1998 | NGX-3781 | NGX-4010 | NGX-7325 | TQ-1018 | CAPSAICIN | TRANS-CAPSAICIN |	"""(E)-CAPSAICIN | MR3H3 | NGX-1998 | NGX-3781 | NGX-4010 | NGX-7325 | TQ-1018 | CAPSAICIN | TRANS-CAPSAICIN |"" | CAPSAICIN | ""(E)-CAPSAICIN | MR3H3 | NGX-1998 | NGX-3781 | NGX-4010 | NGX-7325 | TQ-1018 | CAPSAICIN | TRANS-CAPSAICIN |"" | CAPSAICIN"	Pathway: Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:4590	TRPV1	TRPV1 (Vanilloid VR1 Receptor) Agonists
SJ000285284-12	SJ000285284	12	MOABOX:4590	YKPUWZUDDOIDPM-VURMDHGXSA-N	COc1cc(CNC(=O)CCCC/C=C\C(C)C)ccc1O	25775-90-0	TRPV1 (Vanilloid VR1 Receptor) Agonists	TRPV1																																																															CHEMBL313971											1548942	66644840	145358624	145358629		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-10448	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Cancer|MOABOX:4590|TRPV1|TRPV1 (Vanilloid VR1 Receptor) Agonists	COc1cc(CNC(=O)CCCC\C=C\C(C)C)ccc1O	404-86-4	94868	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469737	305.41188	(E)-CAPSAICIN | MR3H3 | NGX-1998 | NGX-3781 | NGX-4010 | NGX-7325 | TQ-1018 | CAPSAICIN | TRANS-CAPSAICIN |	"""(E)-CAPSAICIN | MR3H3 | NGX-1998 | NGX-3781 | NGX-4010 | NGX-7325 | TQ-1018 | CAPSAICIN | TRANS-CAPSAICIN |"" | CAPSAICIN | ""(E)-CAPSAICIN | MR3H3 | NGX-1998 | NGX-3781 | NGX-4010 | NGX-7325 | TQ-1018 | CAPSAICIN | TRANS-CAPSAICIN |"" | CAPSAICIN"	Pathway: Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Cancer	MOABOX:4590	TRPV1	TRPV1 (Vanilloid VR1 Receptor) Agonists
SJ000287803-4	SJ000287803	4	MOABOX:4594	DRCMAZOSEIMCHM-UHFFFAOYSA-N	Oc1cc2c(cc1O)CN(C(=S)NCCc1ccc(Cl)cc1)CCC2	138977-28-3	TRPV1 (Vanilloid VR1 Receptor) Antagonists	TRPV1																																																															CHEMBL391997											2733484					member	10.1002/ardp.200390008	10.1016/j.bmcl.2003.09.090	10.1016/j.bmcl.2004.04.038	10.1016/j.ejmech.2015.05.041	10.1016/j.neulet.2004.07.058	10.1021/acs.jnatprod.7b01067	10.1021/jm049485i	10.1021/jm0495071	10.1021/jm050139q	10.1021/jm051058x	10.1021/jm060637e	10.1021/np400885u	10.1021/np500235b	10.1038/sj.bjp.0705110	10.1038/sj.bjp.0705387	10.1038/sj.bjp.0707145	10.1124/jpet.104.079855	10.1124/jpet.105.084103	10.1124/jpet.108.138511	10.1124/mol.105.019786	10.1124/mol.108.051292	10.2174/156802608786264254																																																																																																																																										14529514	14698197	15149643	15634002	15771431	16000002	16420034	17279090	17489570	17828286	18991729	19442045	21671876	24484240	25052206	26079089	30507122	31104785																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				4.88992																																0.61124																																8																																HY-15640	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Cancer|MOABOX:4594|TRPV1|TRPV1 (Vanilloid VR1 Receptor) Antagonists	Oc1cc2CCCN(Cc2cc1O)C(=S)NCCc3ccc(Cl)cc3	138977-28-3	14422	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469300	376.90024	CAPSAZEPINE	CAPSAZEPINE | CAPSAZEPINE	Pathway: Apoptosis; Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Cancer	MOABOX:4594	TRPV1	TRPV1 (Vanilloid VR1 Receptor) Antagonists
SJ001034885-1	SJ001034885	1	MOABOX:4600	XLIFGFJGRRUPNT-CCEZHUSRSA-N	COc1cccc(/C=C/c2nc3ccccc3c(=O)n2-c2ccccc2)c1O		TRPV3 Inhibitors	TRPV3																																																																										135446750					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.12912																																0.26614																																8																																STK805488	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-965-785|MOABOX:4600|TRPV3|TRPV3 Inhibitors	COc1cccc(\C=C\C2=Nc3ccccc3C(=O)N2c4ccccc4)c1O	304876-83-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468185	370.40062	STK805488	STK805488 | STK805488			MOABOX:4600	TRPV3	TRPV3 Inhibitors
SJ001033215-2	SJ001033215	2	MOABOX:4608	NBMBIEOUVBHEBM-UHFFFAOYSA-N	CCN(Cc1ccccc1)C(=O)Cn1c(=O)n(C)c2cnc(-c3ccccc3)nc21	226954-04-7	Peripheral Benzodiazepine Receptor (PBR) Ligands	TSPO																																																															CHEMBL513922											6433109	22617787				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-1.21032																																-0.15129																																8																																HY-15527	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Metabolic Disease; Neurological Disease|MOABOX:4608|TSPO|Peripheral Benzodiazepine Receptor (PBR) Ligands	CCN(Cc1ccccc1)C(=O)CN2C(=O)N(C)c3cnc(nc23)c4ccccc4	226954-04-7	13909	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469603	401.46102	EMAPUNIL; AC-5216; XBD-173	EMAPUNIL; AC-5216; XBD-173 | EMAPUNIL; AC-5216; XBD-173	Pathway: Others	Research Area: Metabolic Disease; Neurological Disease	MOABOX:4608	TSPO	Peripheral Benzodiazepine Receptor (PBR) Ligands
SJ000287376-4	SJ000287376	4	MOABOX:4612	DANYIYRPLHHOCZ-UHFFFAOYSA-N	COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1	480-44-4	Xanthine Oxidase Inhibitors;Melanin Inhibitors	XDH																																																															CHEMBL243664											5280442	66831639	67294050	70341687	88277664	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					6.552e-002																																0.00819																																8																																HY-N0451	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy | Research Area: Cancer; Inflammation/Immunology; Neurological Disease|MOABOX:4612|XDH|Xanthine Oxidase Inhibitors;Melanin Inhibitors	COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2	480-44-4	24251	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469388	284.26348	ACACETIN	ACACETIN | AB00052639_09 | ACACETIN | AB00052639_09	Pathway: Apoptosis; Autophagy	Research Area: Cancer; Inflammation/Immunology; Neurological Disease	MOABOX:4612	XDH	Xanthine Oxidase Inhibitors;Melanin Inhibitors
SJ001010866-2	SJ001010866	2	MOABOX:4616	KYRVNWMVYQXFEU-UHFFFAOYSA-N	COC(=O)Nc1nc2ccc(C(=O)c3cccs3)cc2[nH]1	31430-18-9	"Tubulin polymerization inhibitor;Antimitotic Drugs;Tubulin polymerization inhibitors;Tubulin modulator;""Tubulin polymerization inhibitor;Antimitotic Drugs;Tubulin polymerization inhibitors;Tubulin modulator"""	TUBA4A	TUBB2A	TUBA1A	TUBA1B	TUBB3	TUBB4A	TUBB4B	TUBB1	TUBB6	TUBA1C	TUBA3E	TUBA3D	TUBB8	TUBB2B	TUBA3C	TUBG1	TUBG2	TUBD1	TUBA8														7280	7846	10376	10381	10382	10383	81027	84617	84790	112714	113457	347688	347733	7278	7283	27175	51174	51807														CHEMBL9514											4122	18462163	68662099	70253995	70297256	member																																																																																																																																																																20546980	24530033																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.11004	-0.11004	-0.11004	-0.11935	-0.11935	-0.11004	0	-0.11935	0	-0.11004	-0.11004	-0.11935	-0.11935	-0.11935	0	0	0	-0.11935	-0.11935														-0.01572	-0.01572	-0.01572	-0.01705	-0.01705	-0.01572	0.0	-0.01705	0.0	-0.01572	-0.01572	-0.01705	-0.01705	-0.01705	0.0	0.0	0.0	-0.01705	-0.01705														7	7	7	7	7	7	7	7	7	7	7	7	7	7	7	7	7	7	7														HY-13520	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage; Cytoskeleton; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:4616|TUBA4A|Tubulin polymerization inhibitor;Antimitotic Drugs;Tubulin polymerization inhibitors;Tubulin modulator;\Tubulin polymerization inhibitor;Antimitotic Drugs;Tubulin polymerization inhibitors;Tubulin modulator\	COC(=O)Nc1nc2ccc(cc2[nH]1)C(=O)c3cccs3	31430-18-9	10555	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469317	301.32044	NOCODAZOLE	NOCODAZOLE | NOCODAZOLE	Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage; Cytoskeleton; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:4616	TUBA4A	Tubulin polymerization inhibitor;Antimitotic Drugs;Tubulin polymerization inhibitors;Tubulin modulator;\Tubulin polymerization inhibitor;Antimitotic Drugs;Tubulin polymerization inhibitors;Tubulin modulator\
SJ000285238-18	SJ000285238	18	MOABOX:4620	IAKHMKGGTNLKSZ-INIZCTEOSA-N	COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2	30512-31-3	Tubulin Polymerase Inhibitors	TUBA4A	TUBB2A	TUBA1A	TUBA1B	TUBB3	TUBB4A	TUBB4B	TUBB1	TUBB6	TUBA1C	TUBA3E	TUBA3D	TUBB	TUBB8	TUBB2B	TUBA3C	TUBG1	TUBG2	TUBD1	TUBA8													7280	7846	10376	10381	10382	10383	81027	84617	84790	112714	113457	203068	347688	347733	7278	7283	27175	51174	51807													CHEMBL107											6167	479492	9811415	9963222	11999755	member	10.1016/j.ejmech.2018.11.004																																																																																																																																																															11741473	16970401	25659770																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			-0.14864	-0.14864	-0.12971	-0.12971	-0.12971	-0.1156	-0.14864	-0.14864	-0.12971	0	-0.14864	0	-0.13069	-0.13069	-0.14864	-0.14864	-0.14864	0	0	0													-0.01858	-0.01858	-0.01853	-0.01853	-0.01853	-0.01445	-0.01858	-0.01858	-0.01853	0.0	-0.01858	0.0	-0.01867	-0.01867	-0.01858	-0.01858	-0.01858	0.0	0.0	0.0													8	8	7	7	7	8	8	8	7	7	8	7	7	7	8	8	8	7	7	7													AS-14691	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COC1=CC=C2C(=CC1=O)[C@H](CCc3cc(OC)c(OC)c(OC)c23)NC(=O)C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466797	399.437	COLCHICINE	"COLCHICINE | ""MPC-004 | COLSTAT"" | ""COLCHICINE | MPC-004 |"" | COLCHICINE | ""MPC-004 | COLSTAT"" | ""COLCHICINE | MPC-004 |"""			MOABOX:4620	TUBA4A	Tubulin Polymerase Inhibitors
SJ001033279-2	SJ001033279	2	MOABOX:4622	HVXBOLULGPECHP-WAYWQWQTSA-N	COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1O	117048-59-6	Microtubule Polymerization Inhibitors	TUBA4A	TUBB2A	TUBA1A	TUBA1B	TUBB3	TUBB4A	TUBB4B	TUBB1	TUBB6	TUBA1C	TUBA3E	TUBA3D	TUBB8	TUBB2B	TUBA3C	TUBG1	TUBG2	TUBD1	TUBA8														7280	7846	10376	10381	10382	10383	81027	84617	84790	112714	113457	347688	347733	7278	7283	27175	51174	51807														CHEMBL41041	CHEMBL67										5351344	49796122	54608929	67409278	68539664	member																																																																																																																																																																8387598	15658859	16198562	16377187	16722633	17174089	20973488	23214452	23332369	23353744	23369686	23867604	23895532	24087857	24106982	24502232	25025991	25462279	26132075	26602281	27918450	28610978																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																9.345e-002	0	0.12296	0	9.345e-002	9.345e-002	1.06448	0.12296	0.12296	0	0	0	0.13488	0.12296	9.345e-002	9.345e-002	9.345e-002	0.12296	0.12296														0.01335	0.0	0.01537	0.0	0.01335	0.01335	0.13306	0.01537	0.01537	0.0	0.0	0.0	0.01686	0.01537	0.01335	0.01335	0.01335	0.01537	0.01537														7	7	8	7	7	7	8	8	8	7	7	7	8	8	7	7	7	8	8														HY-N2146	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Cytoskeleton | Research Area: Cancer|MOABOX:4622|TUBA4A|Microtubule Polymerization Inhibitors	COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)cc1O	117048-59-6	24623	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469811	316.3484	COMBRETASTATIN A4; CRC 87-09	COMBRETASTATIN A4; CRC 87-09 | COMBRETASTATIN A4; CRC 87-09	Pathway: Cell Cycle/DNA Damage; Cytoskeleton	Research Area: Cancer	MOABOX:4622	TUBA4A	Microtubule Polymerization Inhibitors
SJ000312363-16	SJ000312363	16	MOABOX:4626	GBABOYUKABKIAF-IELIFDKJSA-N	CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2	71486-22-1	Antimitotic Drugs;Tubulin polymerization inhibitors	TUBB																																																															CHEMBL538943	CHEMBL553025										5311497	11491495	11607738	16051941	16079018	virtual																																																																																																																																																																25804719																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					8.498e-002																																0.01214																																7																																HY-12053A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Cell Cycle/DNA Damage; Cytoskeleton | Research Area: Cancer|MOABOX:4626|TUBB|Antimitotic Drugs;Tubulin polymerization inhibitors	CCC1=CC2CN(C1)Cc3c([nH]c4ccccc34)[C@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC	125317-39-7	86067	GENERAL	TARTRATE	2	NO_SOLVATE	0	1468818	778.93226	VINORELBINE	"VINORELBINE | ""VINORELBINE DITARTRATE | ANX-530 | KW-2307 | NVB | SDP-012 | NAVELBINE | VINORELBINE TARTRATE | VINORELBINE DITARTRATE SALT HYDRATE"" | VINORELBINE | ""VINORELBINE DITARTRATE | ANX-530 | KW-2307 | NVB | SDP-012 | NAVELBINE | VINORELBINE TARTRATE | VINORELBINE DITARTRATE SALT HYDRATE"""	Pathway: Autophagy; Cell Cycle/DNA Damage; Cytoskeleton	Research Area: Cancer	MOABOX:4626	TUBB	Antimitotic Drugs;Tubulin polymerization inhibitors
SJ000855320-4	SJ000855320	4	MOABOX:4638	KZENBFUSKMWCJF-UHFFFAOYSA-N	OCc1ccc(-c2ccc(-c3ccc(CO)s3)o2)s1	213261-59-7	"Antiinflammatory Drugs;Cytokine Production Inhibitors;SULT1A1 prodrug;Chemical crosslinker;""Antiinflammatory Drugs;Cytokine Production Inhibitors;SULT1A1 prodrug;Chemical crosslinker"""	MDM2	TXNRD1	TXNRD2																														7296	10587																														CHEMBL1555354											374536					member	10.1038/nchembio.1986																																																																																																																																																															21254973	22830335																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.3608	0	0																														0.1701	0.0	0.0																														8	7	7																														HY-13424	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:4638|MDM2|Antiinflammatory Drugs;Cytokine Production Inhibitors;SULT1A1 prodrug;Chemical crosslinker;\Antiinflammatory Drugs;Cytokine Production Inhibitors;SULT1A1 prodrug;Chemical crosslinker\	OCc1ccc(s1)c2oc(cc2)c3ccc(CO)s3	213261-59-7	10476	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469192	292.37328	RITA	RITA | NSC 652287 | RITA | NSC 652287	Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:4638	MDM2	Antiinflammatory Drugs;Cytokine Production Inhibitors;SULT1A1 prodrug;Chemical crosslinker;\Antiinflammatory Drugs;Cytokine Production Inhibitors;SULT1A1 prodrug;Chemical crosslinker\
SJ001034674-1	SJ001034674	1	MOABOX:4640	FZDHVUVGQXVYOP-JIMJEQGWSA-N	Cc1cn([C@H]2C[C@H](O)[C@@H](COC(c3ccccc3)(c3ccccc3)c3ccccc3)O2)c(=O)[nH]c1=O	7791-71-1	Thymidine Phosphorylase Inhibitors;Angiogenesis Inhibitors	TYMP																																																															CHEMBL2403290											514178	67652843				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.84525																																0.12075																																7																																DS-2683	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC1=CN([C@H]2C[C@H](O)[C@@H](COC(c3ccccc3)(c4ccccc4)c5ccccc5)O2)C(=O)NC1=O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466849	484.54302	DS-2683	DS-2683 | DS-2683			MOABOX:4640	TYMP	Thymidine Phosphorylase Inhibitors;Angiogenesis Inhibitors
SJ000285219-13	SJ000285219	13	MOABOX:4642	ZWAOHEXOSAUJHY-ZIYNGMLESA-N	C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O	003094-09-5	Pyrimidine Antagonists;Apoptosis Inducers;Thymidylate Synthase Inhibitors	TYMS																																																															CHEMBL1130											18343	67362589	67365413	67450366	68545855	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																KS-5065	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=C(F)C(=O)NC2=O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466708	246.19244	5-FLUORO-5'-DEOXYURIDINE	5-FLUORO-5'-DEOXYURIDINE | DOXIFLURIDINE | 5-DEOXY-5-FLUOROURIDINE | 5-FLUORO-5'-DEOXYURIDINE | DOXIFLURIDINE | 5-DEOXY-5-FLUOROURIDINE			MOABOX:4642	TYMS	Pyrimidine Antagonists;Apoptosis Inducers;Thymidylate Synthase Inhibitors
SJ000285315-10	SJ000285315	10	MOABOX:4644	AOCCBINRVIKJHY-UHFFFAOYSA-N	CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O	61422-45-5	Pyrimidine Antagonists;Thymidylate Synthase Inhibitors	TYMS																																																															CHEMBL460499											2577	89876051	145209823	145209824	145209839	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-B0182	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:4644|TYMS|Pyrimidine Antagonists;Thymidylate Synthase Inhibitors	CCCCCCNC(=O)N1C=C(F)C(=O)NC1=O	61422-45-5	83696	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469352	257.26144	CARMOFUR	"CARMOFUR | ""CARMOFUR | HCFU |"" | CARMOFUR  | CARMOFUR | ""CARMOFUR | HCFU |"" | CARMOFUR "	Pathway: Anti-infection; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:4644	TYMS	Pyrimidine Antagonists;Thymidylate Synthase Inhibitors
SJ000285190-23	SJ000285190	23	MOABOX:4646	GHASVSINZRGABV-UHFFFAOYSA-N	O=c1[nH]cc(F)c(=O)[nH]1	1004-03-1	thymidylate synthase	TYMS																																																															CHEMBL185											3385	11402229	11579187	11644269	11651502	member																																																																																																																																																																18473929																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.34568																																-0.04321																																8																																KS-5129	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	FC1=CNC(=O)NC1=O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466697	130.07722	5-FLUOROURACIL	"5-FLUOROURACIL | FLUOROURACIL | ""5-FU | NSC-19893 | RO-29757"" | SJ000822492 | FLUOROURACIL (5-FLUORACIL, 5-FU) | 5-FLUOROURACIL | FLUOROURACIL | ""5-FU | NSC-19893 | RO-29757"" | SJ000822492 | FLUOROURACIL (5-FLUORACIL, 5-FU)"			MOABOX:4646	TYMS	thymidylate synthase
SJ000782384-8	SJ000782384	8	MOABOX:4648	MPUQHZXIXSTTDU-QXGSTGNESA-N	NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O	1160295-21-5	NEDD8-Activating Enzyme (NAE) Inhibitors	NAE1	UBA3																															9039																															CHEMBL1231160	CHEMBL2364622										16720766	66576990	71523682	86280022	122668087	member																																																																																																																																																																23360215																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.25928	0.33957																															0.15741	0.04851																															8	7																															HY-10484	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:4648|NAE1|NEDD8-Activating Enzyme (NAE) Inhibitors	NS(=O)(=O)OC[C@@H]1C[C@H](C[C@@H]1O)n2ccc3c(N[C@H]4CCc5ccccc45)ncnc23	1160295-21-5	15714	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469219	443.5193	Pevonedistat	Pevonedistat | MLN 4924 | Pevonedistat | MLN 4924	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:4648	NAE1	NEDD8-Activating Enzyme (NAE) Inhibitors
SJ000782384-9	SJ000782384	9	MOABOX:4648	MPUQHZXIXSTTDU-QXGSTGNESA-N	NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O	1160295-21-5	NEDD8-Activating Enzyme (NAE) Inhibitors	NAE1	UBA3																															9039																															CHEMBL1231160	CHEMBL2364622										16720766	66576990	71523682	86280022	122668087	member																																																																																																																																																																23360215																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.25928	0.33957																															0.15741	0.04851																															8	7																															HY-70062	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:4648|NAE1|NEDD8-Activating Enzyme (NAE) Inhibitors	NS(=O)(=O)OC[C@@H]1C[C@H](C[C@@H]1O)n2ccc3c(N[C@H]4CCc5ccccc45)ncnc23	905579-51-3	89626	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469652	443.5193	Pevonedistat	Pevonedistat | MLN 4924 | Pevonedistat | MLN 4924	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:4648	NAE1	NEDD8-Activating Enzyme (NAE) Inhibitors
SJ000574312-4	SJ000574312	4	MOABOX:4650	UQRORFVVSGFNRO-XFWSIPNHSA-N	CCCCN1C[C@H](O)[C@@H](O)[C@@H](O)[C@H]1CO	141206-42-0	Ceramide Glucosyltransferase Inhibitors	UGCG																																																															CHEMBL1086997											501391					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-9.625e-002																																-0.01375																																7																																CS-2777	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-940-536|MOABOX:4650|UGCG|Ceramide Glucosyltransferase Inhibitors	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	210110-90-0	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468484	219.27804	MIGLUSTAT HYDROCHLORIDE | ZAVESCA	"""MIGLUSTAT HYDROCHLORIDE | ZAVESCA"" | N-(N-BUTYL) DEOXYGALACTONOJIRIMYCIN | ""MIGLUSTAT HYDROCHLORIDE | ZAVESCA"" | N-(N-BUTYL) DEOXYGALACTONOJIRIMYCIN"			MOABOX:4650	UGCG	Ceramide Glucosyltransferase Inhibitors
SJ000855462-3	SJ000855462	3	MOABOX:4654	JUWDSDKJBMFLHE-UHFFFAOYSA-N	Cc1cc(C(=O)CN2CCCC2)c(C)n1-c1ccc(F)cc1	314245-33-5	Ubiquitin C-terminal Hydrolase 14 (USP14) Inhibitors	USP14																																																															CHEMBL1410015											675434					member	10.1038/nature09299																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.24943																																0.17849																																7																																HY-13817	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Cell Cycle/DNA Damage | Research Area: Cardiovascular Disease|MOABOX:4654|USP14|Ubiquitin C-terminal Hydrolase 14 (USP14) Inhibitors	Cc1cc(C(=O)CN2CCCC2)c(C)n1c3ccc(F)cc3	314245-33-5	57428	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469669	300.37054	IU1	IU1 | IU1	Pathway: Autophagy; Cell Cycle/DNA Damage	Research Area: Cardiovascular Disease	MOABOX:4654	USP14	Ubiquitin C-terminal Hydrolase 14 (USP14) Inhibitors
SJ000855451-3	SJ000855451	3	MOABOX:4656	LKZLGMAAKNEGCH-UHFFFAOYSA-N	CC(=O)c1cc([N+](=O)[O-])c(Sc2cccc(Cl)c2Cl)s1	882257-11-6	Ubiquitin C-terminal Hydrolase Inhibitors 7 (USP7| HAUSP) Inhibitors	USP7																																																															CHEMBL2159495											2819993					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.31509																																0.18787																																7																																HY-15667	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:4656|USP7|Ubiquitin C-terminal Hydrolase Inhibitors 7 (USP7| HAUSP) Inhibitors	CC(=O)c1cc(c(Sc2cccc(Cl)c2Cl)s1)[N+](=O)[O-]	882257-11-6	9168	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469687	348.22488	P5091	P5091 | P005091 | P5091 | P005091	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:4656	USP7	Ubiquitin C-terminal Hydrolase Inhibitors 7 (USP7|HAUSP) Inhibitors
SJ000286691-6	SJ000286691	6	MOABOX:4662	VGEREEWJJVICBM-UHFFFAOYSA-N	O=C(CCc1ccc(O)cc1)c1c(O)cc(O)cc1O	60-82-2	VCAM1 Expression Inhibitors;ICAM1 Expression Inhibitors;Antioxidants	ICAM1	VCAM1																															7412																															CHEMBL45068											4788	24770	57349664	67057667	67830212	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-N0142	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease | Research Area: Metabolic Disease; Cancer|MOABOX:4662|ICAM1|VCAM1 Expression Inhibitors;ICAM1 Expression Inhibitors;Antioxidants	Oc1ccc(CCC(=O)c2c(O)cc(O)cc2O)cc1	60-82-2	16885	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469116	274.26866	PHLORETIN	PHLORETIN | PHLORETIN	Pathway: Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease	Research Area: Metabolic Disease; Cancer	MOABOX:4662	ICAM1	VCAM1 Expression Inhibitors;ICAM1 Expression Inhibitors;Antioxidants
SJ001010752-2	SJ001010752	2	MOABOX:4668	XXSDLQLNIVFIJI-UHFFFAOYSA-N	Nc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1	1383716-40-2	Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 (PIK3C3;Vps34) Inhibitors	PIK3C3																																																															CHEMBL3781415											67983123					member																																																																																																																																																																26819669	27644332																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.48664																																0.18583																																8																																HY-12794	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; PI3K/Akt/mTOR | Research Area: Neurological Disease|MOABOX:4668|PIK3C3|Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 (PIK3C3;Vps34) Inhibitors	Nc1ncc(c(CC2CC2)n1)c3ccnc(Nc4ccncc4)n3	1383716-40-2	24001	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469501	319.36378	VPS34-PIK-III	VPS34-PIK-III | VPS34-PIK-III	Pathway: Autophagy; PI3K/Akt/mTOR	Research Area: Neurological Disease	MOABOX:4668	PIK3C3	Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 (PIK3C3;Vps34) Inhibitors
SJ001035321-1	SJ001035321	1	MOABOX:4670	HWSHOMMVLGBIDN-UHFFFAOYSA-N	CC(C)(C)NC(=O)c1cncn1C1CCN(c2ccc(-c3nnc(C(F)(F)F)o3)cn2)CC1		WNK1/2/3/4 inhibitor;WNK1 gene inhibitor	WNK1	WNK4	WNK3	WNK2																													65266	65267	65268																																								121487936					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.78288	0.74328	0.77992	1.02352																													0.09786	0.09291	0.09749	0.12794																													8	8	8	8																													HY-100626	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:4670|WNK1|WNK1/2/3/4 inhibitor;WNK1 gene inhibitor	CC(C)(C)NC(=O)c1cncn1C2CCN(CC2)c3ccc(cn3)c4oc(nn4)C(F)(F)F	2012607-27-9	22065	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469565	463.45617	WNK463	WNK463 | WNK463	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:4670	WNK1	WNK1/2/3/4 inhibitor;WNK1 gene inhibitor
SJ000855273-3	SJ000855273	3	MOABOX:4672	HSTZMXCBWJGKHG-CUYWLFDKSA-N	OC[C@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O	148766-36-3	VCAM1 Expression Inhibitors;ICAM1 Expression Inhibitors;Xanthine Oxidase Inhibitors	XDH																																																															CHEMBL142652											5281718	44156899	46176146	46176147	46176148	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																KS-5384	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC[C@H]1O[C@@H](Oc2cc(O)cc(\C=C\c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466747	390.38388	POLYDATIN	POLYDATIN | POLYDATIN			MOABOX:4672	XDH	VCAM1 Expression Inhibitors;ICAM1 Expression Inhibitors;Xanthine Oxidase Inhibitors
SJ000287487-11	SJ000287487	11	MOABOX:4696	CJOFXWAVKWHTFT-XSFVSMFZSA-N	COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1	54739-18-3	5-HT Reuptake Inhibitors	SLC6A4																																																															CHEMBL1409	CHEMBL814										5324346	9560989	11237102	13373005	24848756	member	10.2174/092986708784872357																																																																																																																																																															10691690	12620070	18673223	20583995	22711801																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	2.39336																																0.29917																																8																																HY-B0103A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Neuronal Signaling | Research Area: Neurological Disease|MOABOX:4696|SLC6A4|5-HT Reuptake Inhibitors	COCCCC\C(=N/OCCN)\c1ccc(cc1)C(F)(F)F	61718-82-9	15627	GENERAL	MALEATE	1	NO_SOLVATE	0	1469110	318.33465	FLUVOXAMINE MALEATE	FLUVOXAMINE MALEATE | FLUVOXAMINE MALEATE	Pathway: Neuronal Signaling	Research Area: Neurological Disease	MOABOX:4696	SLC6A4	5-HT Reuptake Inhibitors
SJ000285631-12	SJ000285631	12	MOABOX:4702	BCGWQEUPMDMJNV-UHFFFAOYSA-N	CN(C)CCCN1c2ccccc2CCc2ccccc21	113-52-0	5-HT Reuptake Inhibitors;Sodium Channel  Blockers;Norepinephrine Reuptake Inhibitors	ADRA1A	HRH1	HTR2A	SLC6A2	SLC6A4																												3269	3356	6530	6532																												CHEMBL11	CHEMBL1692										3696	8228	115863	657207	9873569	member	10.1016/S0960-894X(97)10053-1	10.1016/j.bmc.2010.07.034	10.1016/j.bmc.2013.03.016	10.1016/j.bmc.2016.10.034	10.1016/j.bmcl.2013.01.020	10.1016/j.bmcl.2013.08.062	10.1016/j.bmcl.2018.03.093	10.1016/j.ejphar.2009.03.006	10.1021/acs.jmedchem.8b01759	10.1124/jpet.107.122010	10.1124/jpet.108.141572	10.1124/jpet.108.146241	10.1128/AAC.00669-07																																																																																																																																																			8496700	11266163	15081025	17846138	18983139	19791802	20875743	21726069	23385211	23466604	23582449	23919353	24012181	24805037	25557493	26988801	27160055	27865645	27876250	28763213																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		3.952e-002	0.3832	2.984e-002	0.36368	2.96328																												0.00494	0.0479	0.00373	0.04546	0.37041																												8	8	8	8	8																												HY-B1490	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Neuronal Signaling | Research Area: Neurological Disease|MOABOX:4702|ADRA1A|5-HT Reuptake Inhibitors;Sodium Channel Blockers;Norepinephrine Reuptake Inhibitors	CN(C)CCCN1c2ccccc2CCc3ccccc13	113-52-0	23298	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469567	280.40726	IMIPRAMINE HYDROCHLORIDE	IMIPRAMINE HYDROCHLORIDE | IMIPRAMINE HCL | IMIPRAMINE HYDROCHLORIDE | IMIPRAMINE HCL	Pathway: Neuronal Signaling	Research Area: Neurological Disease	MOABOX:4702	ADRA1A	5-HT Reuptake Inhibitors;Sodium Channel Blockers;Norepinephrine Reuptake Inhibitors
SJ000287999-4	SJ000287999	4	MOABOX:4708	YEJCDKJIEMIWRQ-UHFFFAOYSA-N	O=C1N(c2ccccc2)c2ccccc2C1(Cc1ccncc1)Cc1ccncc1	105431-72-9	Acetylcholine Release Enhancers	KCNQ1																																																															CHEMBL1612640	CHEMBL319111										3932	14209557	23581818	45114239	71297075	member																																																																																																																																																																22793372																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.10955																																0.01565																																7																																HY-W020468	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:4708|KCNQ1|Acetylcholine Release Enhancers	O=C1N(c2ccccc2)c3ccccc3C1(Cc4ccncc4)Cc5ccncc5	105431-72-9	67904	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469396	391.46444	LINOPIRDINE	LINOPIRDINE | LINOPIRDINE	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:4708	KCNQ1	Acetylcholine Release Enhancers
SJ000285306-5	SJ000285306	5	MOABOX:4710	SDZRWUKZFQQKKV-CAPWMPRDSA-N	C=C1[C@@H](O)[C@@H]2/C=C/C[C@H](C)C(=O)[C@](C)(O)/C=C/C(OC(C)=O)[C@]23C(=O)N[C@@H](Cc2ccccc2)[C@@H]3[C@@H]1C	22144-77-0	actin polymerization	ACTA1																																																																										6419417					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																AA00I4A3	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-590-298|MOABOX:4710|ACTA1|actin polymerization	C[C@H]1C\C=C/[C@H]2[C@H](O)C(=C)[C@@H](C)[C@H]3[C@H](Cc4ccccc4)NC(=O)[C@@]23[C@H](OC(=O)C)\C=C/[C@@](C)(O)C1=O	22144-77-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468639	507.61788	CYTOCHALASIN D	"CYTOCHALASIN D | ""CYTOCHALASIN D | ZYGOSPORIN A |"" | ""CYTOCHALASIN D | ZYGOSPORIN A | ZYGUSPORIUM MANSONII |"" | CYTOCHALASIN D | ""CYTOCHALASIN D | ZYGOSPORIN A |"" | ""CYTOCHALASIN D | ZYGOSPORIN A | ZYGUSPORIUM MANSONII |"""			MOABOX:4710	ACTA1	actin polymerization
SJ000126358-7	SJ000126358	7	MOABOX:4712	JADDQZYHOWSFJD-FLNNQWSLSA-N	CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O	100111-00-0	Adenosine Receptor Agonists	ADORA2A																																																															CHEMBL464859											448222					member	10.1016/S0006-2952(98)00298-6	10.1016/S0028-3908(03)00305-8	10.1016/j.bmc.2010.07.034	10.1016/j.bmc.2012.11.021	10.1016/j.bmc.2013.03.016	10.1016/j.bmcl.2009.11.131	10.1016/j.bmcl.2018.03.093	10.1016/j.ejphar.2007.10.017	10.1016/j.ejphar.2009.03.006	10.1016/j.neuropharm.2006.02.002	10.1021/acs.jmedchem.8b01759	10.1021/cn5001606	10.1021/jm010952v	10.1021/jm031143+	10.1021/jm061278q	10.1021/jm200536d	10.1038/sj.bjp.0701119	10.1124/jpet.107.122010	10.1124/jpet.108.141572	10.1124/jpet.108.146241	10.1124/jpet.110.173245	10.1124/mol.104.009225																																																																																																																																										1619615	2016707	3018244	3373486	9258366	9572897	10714510	10956189	11459663	11462973	11714602	11784146	11976268	12672250	14584936	15239649	15267242	15481989	15743197	16366607	16487705	17201410	17228880	17249651	17306548	17378544	17927167	17967536	18269230	18588282	18983139	19041853	20018509	20031406	20408530	20875743	21084390	21428896	21688779	21777010	21796795	22104008	22257095	22486652	22921089	23023262	23181587	23200243	23245803	23466604	23582449	23602401	24077183	24164628	24900277	25780876	26756468	26988801	27227326	27876250	27933810	28106992	28471663	28590753	28626529	28947942	29446948	29631962	30415894																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.68024																																0.08503																																8																																21420	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-795-598|MOABOX:4712|ADORA2A|Adenosine Receptor Agonists	CCNC(=O)C1OC(C(O)C1O)n2cnc3c(N)ncnc23	35920-39-9	NA	GENERAL	NO_SALT	0	H2O	1	1468702	308.29324	NECA	NECA | 5-N-ETHYLCARBOXAMIDOADENOSINE | NECA | 5-N-ETHYLCARBOXAMIDOADENOSINE			MOABOX:4712	ADORA2A	Adenosine Receptor Agonists
SJ000285615-24	SJ000285615	24	MOABOX:4714	OIRDTQYFTABQOQ-KQYNXXCUSA-N	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	142796-17-6	Adenosine Receptor Agonists	ADORA1	ADORA2A	ADORA2B	ADORA3																													135	136	140																													CHEMBL477											60961	5287674	6320389	6483565	10408551	virtual	10.1016/S0006-2952(98)00298-6	10.1016/j.bcp.2008.11.002	10.1016/j.bmcl.2006.04.074	10.1016/j.bmcl.2010.05.056	10.1016/j.cellsig.2016.02.010	10.1021/jm3004834	10.2174/0929867003374101	10.2174/092986711796011274																																																																																																																																																								2016707	2016708	6279840	11032971	12570759	16289820	16697192	19041853	20541935	21388809	21649583	22104008	22738238	24164628	26356532	26756468	27227326	30359014																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.08896	0.5784	-0.39456	0.462																													0.13612	0.0723	-0.04932	0.05775																													8	8	8	8																													AS-12664	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Nc1ncnc2c1ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466851	267.24132	VIDARABINE	"VIDARABINE | ADENOSINE | ADENOSINE| ADENOCARD | ""VIDARABINE | CI-673 | ARASENA-A | VIRA-A | 9-BETA-D-ARABINOSYLADENINE |"" | ""ADENOSINE | MEDR-640 | SR-96225 | SUN-Y4001 |"" | VIDARABINE | ADENOSINE | ADENOSINE| ADENOCARD | ""VIDARABINE | CI-673 | ARASENA-A | VIRA-A | 9-BETA-D-ARABINOSYLADENINE |"" | ""ADENOSINE | MEDR-640 | SR-96225 | SUN-Y4001 |"""			MOABOX:4714	ADORA1	Adenosine Receptor Agonists
SJ000288236-5	SJ000288236	5	MOABOX:4722	UKHMZCMKHPHFOT-UHFFFAOYSA-N	Nc1ncnc2c1ncn2C1CCCO1	17318-31-9	Adenylate Cyclase Inhibitors	ADCY5																																																															CHEMBL64239											5270					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.24626																																-0.03518																																7																																HY-100396	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Metabolic Disease|MOABOX:4722|ADCY5|Adenylate Cyclase Inhibitors	Nc1ncnc2c1ncn2C3CCCO3	17318-31-9	22969	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469629	205.21654	SQ 22536	SQ 22536 | SQ 22536	Pathway: GPCR/G Protein	Research Area: Metabolic Disease	MOABOX:4722	ADCY5	Adenylate Cyclase Inhibitors
SJ000286224-10	SJ000286224	10	MOABOX:4746	SGUAFYQXFOLMHL-UHFFFAOYSA-N	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(=N)O)c1	32780-40-8	alpha-Adrenoceptor Antagonists;beta-Adrenoceptor Antagonists	ADRA1B	ADRA1A	ADRB1																														148	153																														CHEMBL1200323	CHEMBL429										3869	71412	657196	12595692	22295547	member																																																																																																																																																																3012084	6124636																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.3564	0.3564	0.79456																														0.04455	0.04455	0.09932																														8	8	8																														AA0038QZ	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-813|MOABOX:4746|ADRA1B|alpha-Adrenoceptor Antagonists;beta-Adrenoceptor Antagonists	CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N	32780-64-6	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468637	328.40546	LABETALOL	LABETALOL | LABETALOL HYDROCHLORIDE | LABETALOL | LABETALOL HYDROCHLORIDE			MOABOX:4746	ADRA1B	alpha-Adrenoceptor Antagonists;beta-Adrenoceptor Antagonists
SJ000785958-5	SJ000785958	5	MOABOX:4748	CTESJDQKVOEUOY-UHFFFAOYSA-N	N#Cc1c(O)c2c(-c3ccc(-c4ccccc4O)cc3)csc2[nH]c1=O	844499-71-4	AMP-Activated Protein Kinase (AMPK) Activators	PRKAA1	PRKAA2	PRKAB1																														5563	5564																														CHEMBL512504											54708532	71763008				member	10.1002/ardp.201900066																																																																																																																																																															20154666	25122135	26471090	26510622	27132866	27727125	31358465																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															-0.13672	1.19048	0.9312																														-0.01709	0.14881	0.1164																														8	8	8																														HY-50662	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:4748|PRKAA1|AMP-Activated Protein Kinase (AMPK) Activators	Oc1ccccc1c2ccc(cc2)c3csc4NC(=O)C(C#N)C(=O)c34	844499-71-4	45877	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469857	360.38588	A-769662	A-769662 | A-769662	Pathway: Epigenetics; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:4748	PRKAA1	AMP-Activated Protein Kinase (AMPK) Activators
SJ000287153-11	SJ000287153	11	MOABOX:4750	XZWYZXLIPXDOLR-UHFFFAOYSA-N	CN(C)C(=N)N=C(N)N	1115-70-4	inhibitor of mitochondrial complex I of the electron transport chain;AMP-Activated Protein Kinase (AMPK) Activators;MTTP Inhibitor;mitochondrial repiratory chain 1 inhibitors;adenine deaminase inhibitor;GPD2 gene modulator	GPD2	MT-ND1																															4535																															CHEMBL1431	CHEMBL1703	CHEMBL2348412									4091	14219	62988	124097	499356	member	10.1038/nature13270																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0																															0.0	0.0																															7	7																															HY-17471A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Epigenetics; PI3K/Akt/mTOR | Research Area: Metabolic Disease; Cardiovascular Disease|MOABOX:4750|GPD2|inhibitor of mitochondrial complex I of the electron transport chain;AMP-Activated Protein Kinase (AMPK) Activators;MTTP Inhibitor;mitochondrial repiratory chain 1 inhibitors;adenine deaminase inhibitor;GPD2 gene modulator	CN(C)C(=N)NC(=N)N	1115-70-4	10550	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469439	129.16364	METFORMIN HYDROCHLORIDE	"METFORMIN HYDROCHLORIDE | ""METFORMIN HYDROCHLORIDE | ADX-155 | LA-6023 | SMP-862 |"" | METFORMIN HCL | METFORMIN HYDROCHLORIDE | ""METFORMIN HYDROCHLORIDE | ADX-155 | LA-6023 | SMP-862 |"" | METFORMIN HCL"	Pathway: Autophagy; Epigenetics; PI3K/Akt/mTOR	Research Area: Metabolic Disease; Cardiovascular Disease	MOABOX:4750	GPD2	inhibitor of mitochondrial complex I of the electron transport chain;AMP-Activated Protein Kinase (AMPK) Activators;MTTP Inhibitor;mitochondrial repiratory chain 1 inhibitors;adenine deaminase inhibitor;GPD2 gene modulator
SJ000285691-11	SJ000285691	11	MOABOX:4766	GIJXKZJWITVLHI-YOFSQIOKSA-N	CN1[C@H]2CC[C@@H]1CC(OC(c1ccccc1)c1ccccc1)C2	132-17-2	Anticholinergics	CHRM1	SLC6A2	SLC6A7	SLC6A3																													6530	6534	574143																													CHEMBL1442985	CHEMBL438151										1201549	3057774	3246155	21139675	66632049	virtual																																																																																																																																																																8027983	8558504	11502876	15455161	19159658																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0	-7.994e-002	-0.15806	-7.959e-002																													0.0	-0.01142	-0.02258	-0.01137																													7	7	7	7																													HY-B0520A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling | Research Area: Cancer; Neurological Disease|MOABOX:4766|CHRM1|Anticholinergics	CN1[C@@H]2CC[C@H]1CC(C2)OC(c3ccccc3)c4ccccc4	132-17-2	13242	GENERAL	METHANESULFONATE	1	NO_SOLVATE	0	1469336	307.4293	BENZTROPINE	BENZTROPINE | BENZTROPINE MESYLATE | BENZTROPINE MESYLATE| COGENTIN | BENZTROPINE | BENZTROPINE MESYLATE | BENZTROPINE MESYLATE| COGENTIN	Pathway: GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Research Area: Cancer; Neurological Disease	MOABOX:4766	CHRM1	Anticholinergics
SJ000285497-15	SJ000285497	15	MOABOX:4768	BGDKAVGWHJFAGW-UHFFFAOYSA-N	CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1	1508-75-4	CHRM4 antagonist;Anticholinergics;CHRM4 Antagonists	CHRM4																																																															CHEMBL1200604											5593	149078	10125724	10193793	20263732	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.04048																																0.13006																																8																																HY-B0321	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:4768|CHRM4|CHRM4 antagonist;Anticholinergics;CHRM4 Antagonists	CCN(Cc1ccncc1)C(=O)C(CO)c2ccccc2	1508-75-4	16055	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468810	284.3529	TROPICAMIDE	"TROPICAMIDE | ""TROPICAMIDE | MYDRIACYL"" | ""TROPICAMIDE | NH-004 |"" | TROPICAMIDE | ""TROPICAMIDE | MYDRIACYL"" | ""TROPICAMIDE | NH-004 |"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:4768	CHRM4	CHRM4 antagonist;Anticholinergics;CHRM4 Antagonists
SJ000287199-7	SJ000287199	7	MOABOX:4770	YSXKPIUOCJLQIE-UHFFFAOYSA-N	OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2	1235-82-1	Anticholinergics	CHRM1	CHRNA2																															1135																															CHEMBL1101	CHEMBL1201035	CHEMBL1201067									2381	92151	197083	24189163	44148444	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.85376	0																															0.23172	0.0																															8	7																															HY-13204	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:4770|CHRM1|Anticholinergics	OC(CCN1CCCCC1)(C2CC3CC2C=C3)c4ccccc4	1235-82-1	16840	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469592	311.46106	BIPERIDEN HYDROCHLORIDE	"BIPERIDEN HYDROCHLORIDE | ""BIPERIDEN HYDROCHLORIDE | AKINETON"" | BIPERIDEN HCL | BIPERIDEN HYDROCHLORIDE | ""BIPERIDEN HYDROCHLORIDE | AKINETON"" | BIPERIDEN HCL"	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:4770	CHRM1	Anticholinergics
SJ000285692-28	SJ000285692	28	MOABOX:4774	UREBDLICKHMUKA-CXSFZGCWSA-N	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	1050677-47-8	Antiinflammatory Drugs	NR3C1																																																															CHEMBL3350489	CHEMBL384467										5743	656863	9830956	9875312	9896224	member	10.1016/0960-0760(92)90414-E	10.1016/j.bmc.2010.07.034	10.1016/j.bmc.2013.03.016	10.1016/j.bmcl.2004.07.052	10.1016/j.bmcl.2005.07.025	10.1016/j.bmcl.2006.04.008	10.1016/j.bmcl.2006.10.058	10.1016/j.bmcl.2007.07.031	10.1016/j.bmcl.2009.03.006	10.1016/j.bmcl.2011.09.018	10.1016/j.bmcl.2013.01.025	10.1016/j.bmcl.2013.06.089	10.1016/j.bmcl.2013.10.052	10.1016/j.bmcl.2014.03.005	10.1016/j.bmcl.2014.06.010	10.1016/j.cclet.2014.03.017	10.1016/j.ejphar.2009.03.006	10.1016/j.ejphar.2013.12.031	10.1016/j.jsbmb.2004.10.014	10.1016/j.jsbmb.2012.10.015	10.1016/j.steroids.2006.02.002	10.1016/j.steroids.2011.02.043	10.1016/j.steroids.2014.12.016	10.1021/jm061273t	10.1021/jm070370z	10.1021/jm100447c	10.1021/jm100957a	10.1021/jm401158e	10.1021/jm401616g	10.1021/jm501203v	10.1021/jm501601b	10.1021/jm9002999	10.1021/jm901452y	10.1021/jm901551w	10.1021/np050528n	10.1021/np070073x	10.1073/pnas.0300372101	10.1111/j.1432-1033.2004.04342.x	10.1124/jpet.104.074146	10.1124/jpet.105.085217	10.1124/jpet.107.122010	10.1124/jpet.108.141572	10.1124/jpet.108.146241	10.1124/mol.106.025841	10.1124/mol.113.085860	10.1124/mol.62.2.297	10.1210/endo.136.12.7588320	10.1289/ehp.98106769																																																																																																																8627601	15999989	16112571	16643060	16821781	17118655	17181172	17583952	17616395	17692519	17705362	18032610	18038970	18412397	18490170	18983139	19009570	19321341	19592245	19592247	19610652	19863083	20047280	20334371	20355713	20727743	20735001	20812681	20875743	20977419	21073190	21257309	21688779	21963986	23023262	23199485	23403082	23466604	23582449	23916594	23953070	24011644	24215891	24446728	24656565	24980053	25305688	25516791	25706100	25905990	26478787	26988801	27810243	27876250	28043796	29741891	30144697	31018484																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												5.18296																																0.64787																																8																																KS-1451	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466802	392.46106	BETAMETHASONE	"BETAMETHASONE | DEXAMETHASONE | DEXAMETHASONE| AEROSEB-DEX | ""DEXAMETHASONE | IBI-10090 | ISV-305 | OTO-104 |"" | DEXAMETHASONE (DHAP) | BETAMETHASONE | DEXAMETHASONE | DEXAMETHASONE| AEROSEB-DEX | ""DEXAMETHASONE | IBI-10090 | ISV-305 | OTO-104 |"" | DEXAMETHASONE (DHAP)"			MOABOX:4774	NR3C1	Antiinflammatory Drugs
SJ001033214-2	SJ001033214	2	MOABOX:4786	PHEZJEYUWHETKO-UHFFFAOYSA-N	Cc1c(-c2ccc(-c3ccccc3F)cc2)nc2ccc(F)cc2c1C(=O)O	96187-53-0	Dihydroorotate Dehydrogenase (DHODH) Inhibitors	DHODH																																																															CHEMBL38434											57030	513434	23223059	59081448	68877642	member	10.1002/2211-5463.12658	10.1002/cmdc.200900454	10.1016/j.bmcl.2005.10.011	10.1016/j.bmcl.2010.01.115	10.1016/j.bmcl.2019.01.038	10.1016/j.ejmech.2017.02.017	10.1021/acs.jmedchem.5b00606	10.1021/acs.jmedchem.7b01862	10.1021/acs.jmedchem.8b00373	10.1021/jm301848w	10.2174/138955711797247707																																																																																																																																																					16246558	20153645	20183850	23452331	23930152	25558988	26079043	26088338	27994748																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3.53184																																0.44148																																8																																HY-108325	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease | Research Area: Cancer; Infection; Inflammation/Immunology|MOABOX:4786|DHODH|Dihydroorotate Dehydrogenase (DHODH) Inhibitors	Cc1c(C(=O)O)c2cc(F)ccc2nc1c3ccc(cc3)c4ccccc4F	96187-53-0	61990	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469605	375.36751	BREQUINAR; DUP785; NSC 368390	BREQUINAR; DUP785; NSC 368390 | BREQUINAR; DUP785; NSC 368390	Pathway: Anti-infection; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Research Area: Cancer; Infection; Inflammation/Immunology	MOABOX:4786	DHODH	Dihydroorotate Dehydrogenase (DHODH) Inhibitors
SJ000285227-22	SJ000285227	22	MOABOX:4788	NMUSYJAQQFHJEW-KVTDHHQDSA-N	Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1	1401238-97-8	"DNMT1;Antimetabolites;Apoptosis Inducers;DNA Methyltransferase (DNMT) Inhibitors;""DNMT1;Antimetabolites;Apoptosis Inducers;DNA Methyltransferase (DNMT) Inhibitors"""	DNMT1	DTYMK	UHRF1																														1841	29128																														CHEMBL1489											9444	11702858	46180886	46180887	46180888	member																																																																																																																																																																29890830	29953809	30544967																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.48872	0	0																														0.06109	0.0	0.0																														8	7	7																														AS-13697	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NC1=NC(=O)N(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466732	244.20468	5-AZACYTIDINE	"5-AZACYTIDINE | VIDAZA | NSC-102816 | ""5-AZACYTIDINE | 5-AZA-CR | NS-17 | NSC-102816 | U-18496 | AZACITIDINE | AZACYTIDINE | LADAKAMYCIN |"" | ""5-AZACYTIDINE | NS-17 | NSC-102816 | U-18496 | 5-AZA-CR | AZACITIDINE | AZACYTIDINE | LADAKAMYCIN |"" | ""AZACYTIDINE | 5-AZA-CR | NS-17 | NSC-102816 | U-18496 | 5-AZACYTIDINE | AZACITIDINE | LADAKAMYCIN |"" | AZACITIDINE | 5-AZACYTIDINE | VIDAZA | NSC-102816 | ""5-AZACYTIDINE | 5-AZA-CR | NS-17 | NSC-102816 | U-18496 | AZACITIDINE | AZACYTIDINE | LADAKAMYCIN |"" | ""5-AZACYTIDINE | NS-17 | NSC-102816 | U-18496 | 5-AZA-CR | AZACITIDINE | AZACYTIDINE | LADAKAMYCIN |"" | ""AZACYTIDINE | 5-AZA-CR | NS-17 | NSC-102816 | U-18496 | 5-AZACYTIDINE | AZACITIDINE | LADAKAMYCIN |"" | AZACITIDINE"			MOABOX:4788	DNMT1	"DNMT1;Antimetabolites;Apoptosis Inducers;DNA Methyltransferase (DNMT) Inhibitors;""DNMT1;Antimetabolites;Apoptosis Inducers;DNA Methyltransferase (DNMT) Inhibitors"""
SJ000312371-27	SJ000312371	27	MOABOX:4790	XAUDJQYHKZQPEU-KVQBGUIXSA-N	Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1	105597-46-4	DNMT1;Antimetabolites;DNA Methyltransferase (DNMT) Inhibitors	DNMT1	DCK																															1633																															CHEMBL1201129											451668	11631196	23617907	50922665	53241319	member																																																																																																																																																																29890830	29953809																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0.90744																															0.0	0.11343																															7	8																															AG002NLT	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-925-958|MOABOX:4790|DNMT1|DNMT1;Antimetabolites;DNA Methyltransferase (DNMT) Inhibitors	NC1=NC(=O)N(C=N1)[C@H]2C[C@H](O)[C@@H](CO)O2	2353-33-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468239	228.20528	DECITABINE	"DECITABINE | DACOGEN | ""5-AZA-2-DEOXYCYTIDINE | 5-AZA-CDR | AZADC | DAC | E-7373 | NSC-127716 | DEZOCITIDINE |"" | ""5-AZA-2-DEOXYCYTIDINE | 5-AZA-CDR | AZADC | DAC | E-7373 | NSC-127716 | DEZOCITIDINE | DECITABINE"" | DECITABINE | DACOGEN | ""5-AZA-2-DEOXYCYTIDINE | 5-AZA-CDR | AZADC | DAC | E-7373 | NSC-127716 | DEZOCITIDINE |"" | ""5-AZA-2-DEOXYCYTIDINE | 5-AZA-CDR | AZADC | DAC | E-7373 | NSC-127716 | DEZOCITIDINE | DECITABINE"""			MOABOX:4790	DNMT1	DNMT1;Antimetabolites;DNA Methyltransferase (DNMT) Inhibitors
SJ000285839-10	SJ000285839	10	MOABOX:4796	FYPMFJGVHOHGLL-UHFFFAOYSA-N	CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1	23288-49-5	Antioxidants;ABCA1-mediated cellular lipid efflux inhibitor;Serine Protease Hepsin Inhibitors	ABCA1	HPN																															3249																															CHEMBL608											4912	16004705	23146893	58961681	78321662	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	1.12712																															0.0	0.14089																															7	8																															HY-B0388	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Metabolic Disease|MOABOX:4796|ABCA1|Antioxidants;ABCA1-mediated cellular lipid efflux inhibitor;Serine Protease Hepsin Inhibitors	CC(C)(C)c1cc(SC(C)(C)Sc2cc(c(O)c(c2)C(C)(C)C)C(C)(C)C)cc(c1O)C(C)(C)C	23288-49-5	65408	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468943	516.84162	PROBUCOL	"PROBUCOL | ""PROBUCOL  | DH-581 | DE-3872 |"" | PROBUCOL | ""PROBUCOL  | DH-581 | DE-3872 |"""	Pathway: Anti-infection	Research Area: Metabolic Disease	MOABOX:4796	ABCA1	Antioxidants;ABCA1-mediated cellular lipid efflux inhibitor;Serine Protease Hepsin Inhibitors
SJ000852801-3	SJ000852801	3	MOABOX:27103	WWONFUQGBVOKOF-UHFFFAOYSA-N	O=C(NS(=O)(=O)c1ccc(Br)s1)c1ccc(Cl)cc1Cl	519055-62-0	Apoptosis Inducers	RBM39	DCAF15																															90379																															CHEMBL2110587											10160238	22019521				member	10.1126/science.aal3755																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.26782	0																															-0.03826	0.0																															7	7																															HY-14804	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis | Research Area: Cancer|MOABOX:27103|RBM39|Apoptosis Inducers	Clc1ccc(C(=O)NS(=O)(=O)c2ccc(Br)s2)c(Cl)c1	519055-62-0	66870	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468848	415.11024	LY 573636	LY 573636 | TASISULAM | LY 573636 | TASISULAM	Pathway: Apoptosis	Research Area: Cancer	MOABOX:27103	RBM39	Apoptosis Inducers
SJ001032985-2	SJ001032985	2	MOABOX:4850	SCVHJVCATBPIHN-SJCJKPOMSA-N	C[C@H](NC(=O)C(=O)Nc1ccccc1C(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)COc1c(F)c(F)cc(F)c1F	254750-02-2	Apoptosis Inhibitors;Caspase Inhibitors	CASP1	CASP3	CASP8																														836	841																														CHEMBL197672											12000240	24893952				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.30008	8.952e-002	0.97632																														0.16251	0.01119	0.12204																														8	8	8																														HY-10396	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Apoptosis | Research Area: Cancer; Infection; Neurological Disease|MOABOX:4850|CASP1|Apoptosis Inhibitors;Caspase Inhibitors	C[C@H](NC(=O)C(=O)Nc1ccccc1C(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)COc2c(F)c(F)cc(F)c2F	254750-02-2	5643	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469601	569.50209	EMRICASAN	EMRICASAN | EMRICASAN	Pathway: Anti-infection; Apoptosis	Research Area: Cancer; Infection; Neurological Disease	MOABOX:4850	CASP1	Apoptosis Inhibitors;Caspase Inhibitors
SJ000285637-25	SJ000285637	25	MOABOX:4862	JWZZKOKVBUJMES-UHFFFAOYSA-N	CC(C)NCC(O)c1ccc(O)c(O)c1	114-45-4	beta-Adrenoceptor Agonists	ADRB1	ADRB2	ADRB3																														154	155																														CHEMBL166514	CHEMBL168039	CHEMBL1711	CHEMBL349178	CHEMBL350734	CHEMBL352606	CHEMBL3989521	CHEMBL434				3779	5807	8239	26792	160420	member	10.1007/s00210-011-0655-5	10.1007/s00249-018-1336-9	10.1016/0006-291X(89)91063-2	10.1016/S0960-894X(96)00603-8	10.1016/j.bcp.2007.02.015	10.1016/j.bioorg.2018.04.017	10.1016/j.bmc.2007.11.060	10.1016/j.bmc.2009.03.044	10.1016/j.bmc.2009.06.031	10.1016/j.bmc.2011.11.054	10.1016/j.bmc.2013.11.030	10.1016/j.bmc.2016.04.028	10.1016/j.bmcl.2004.11.001	10.1016/j.bmcl.2008.08.009	10.1016/j.bmcl.2009.06.083	10.1016/j.ejmech.2009.01.022	10.1021/acs.jmedchem.6b01197	10.1021/bi00047a003	10.1021/jm701324c	10.1021/jm800222k	10.1021/jm9000709	10.1073/pnas.88.8.2979	10.1074/jbc.270.47.28268	10.1074/jbc.M207968200	10.1124/jpet.114.216861	10.1124/jpet.116.237313	10.1126/science.2836950	10.1248/bpb.27.718	10.1248/cpb.58.533	10.1248/cpb.60.647																																																																																																																																		2999409	6124637	10377236	11806709	12502364	15603933	16640337	18083578	18307290	18553954	18651730	18752946	19168263	19232786	19317397	19362005	19366244	19581100	19608416	20462258	21652207	21696967	21925889	22182578	23954364	24326276	26125514	27132867	28355078																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									1.96696	1.41832	0.68592																														0.24587	0.17729	0.08574																														8	8	8																														AG003R4B	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-212|MOABOX:4862|ADRB1|beta-Adrenoceptor Agonists	CC(C)NCC(O)c1ccc(O)c(O)c1	51-30-9	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468396	211.25758	ISOPROTERENOL HYDROCHLORIDE	ISOPROTERENOL HYDROCHLORIDE | (-)-ISOPROTERENOL HYDROCHLORIDE | (R)-(-)-ISOPROTERENOL (+)-BITARTRATE | (S)-(+)-ISOPROTERENOL (+)-BITARTRATE | (±)-ISOPROTERENOL HYDROCHLORIDE | (±)-ISOPROTERENOL HCL | ISOPRENALINE HCL | ISOPROTERENOL HYDROCHLORIDE | (-)-ISOPROTERENOL HYDROCHLORIDE | (R)-(-)-ISOPROTERENOL (+)-BITARTRATE | (S)-(+)-ISOPROTERENOL (+)-BITARTRATE | (±)-ISOPROTERENOL HYDROCHLORIDE | (±)-ISOPROTERENOL HCL | ISOPRENALINE HCL			MOABOX:4862	ADRB1	beta-Adrenoceptor Agonists
SJ000285537-15	SJ000285537	15	MOABOX:4864	JZQKKSLKJUAGIC-UHFFFAOYSA-N	CC(C)NCC(O)COc1cccc2[nH]ccc12	13523-86-9	beta-Adrenoceptor Antagonists	ADRB1																																																															CHEMBL500											4828	127085	162634	177282	177283	member																																																																																																																																																																17804228	21870877																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.36096																																0.17012																																8																																HY-B0982	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease; Endocrinology|MOABOX:4864|ADRB1|beta-Adrenoceptor Antagonists	CC(C)NCC(O)COc1cccc2[nH]ccc12	13523-86-9	42258	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469375	248.3208	PINDOLOL	PINDOLOL | S(-)-PINDOLOL | (S)-(-)-PINDOLOL | PINDOLOL | S(-)-PINDOLOL | (S)-(-)-PINDOLOL	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease; Endocrinology	MOABOX:4864	ADRB1	beta-Adrenoceptor Antagonists
SJ000126164-29	SJ000126164	29	MOABOX:4866	AQHHHDLHHXJYJD-UHFFFAOYSA-N	CC(C)NCC(O)COc1cccc2ccccc12	13013-17-7	beta-Adrenoceptor Antagonists	ADRB1	ADRB2	ADRB3																														154	155																														CHEMBL1671	CHEMBL27										4946	62882	172393	3036087	3084469	member	10.1006/bbrc.2000.3507	10.1016/0006-2952(91)90502-V																																																																																																																																																														1976812	2878080	3560162	6115059	6146718	6147415	8093626	19168263	21870877	24326276	26565745																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											1.43424	2.02104	0.78848																														0.17928	0.25263	0.09856																														8	8	8																														FE-0204	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)NCC(O)COc1cccc2ccccc12	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466669	259.34344	PROPRANOLOL HYDROCHLORIDE	"PROPRANOLOL HYDROCHLORIDE | (R)-PROPRANOLOL HYDROCHLORIDE | (S)-PROPRANOLOL HYDROCHLORIDE | (±)-PROPRANOLOL HYDROCHLORIDE | ""DL-PROPRANOLOL HYDROCHLORIDE | NSC-91523"" | R-(+)-PROPRANOLOL HCL | PROPRANOLOL HCL | (S)-(-)-PROPRANOLOL HCL | PROPRANOLOL HYDROCHLORIDE | (R)-PROPRANOLOL HYDROCHLORIDE | (S)-PROPRANOLOL HYDROCHLORIDE | (±)-PROPRANOLOL HYDROCHLORIDE | ""DL-PROPRANOLOL HYDROCHLORIDE | NSC-91523"" | R-(+)-PROPRANOLOL HCL | PROPRANOLOL HCL | (S)-(-)-PROPRANOLOL HCL"			MOABOX:4866	ADRB1	beta-Adrenoceptor Antagonists
SJ000287532-3	SJ000287532	3	MOABOX:4868	CEMAWMOMDPGJMB-UHFFFAOYSA-N	C=CCOc1ccccc1OCC(O)CNC(C)C	22972-96-9	beta-Adrenoceptor Antagonists	ADRB1	ADRB2																															154																															CHEMBL1200745	CHEMBL3245937	CHEMBL546									4631	71172	146280	176633	194383	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.90408	0.97264																															0.11301	0.12158																															8	8																															KS-1152	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-770-529|MOABOX:4868|ADRB1|beta-Adrenoceptor Antagonists	CC(C)NCC(O)COc1ccccc1OCC=C	6452-73-9	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468359	265.34802	OXPRENOLOL HYDROCHLORIDE	"OXPRENOLOL HYDROCHLORIDE | ""OXPRENOLOL HYDROCHLORIDE | BA-39089 |"" | OXPRENOLOL HYDROCHLORIDE | ""OXPRENOLOL HYDROCHLORIDE | BA-39089 |"""			MOABOX:4868	ADRB1	beta-Adrenoceptor Antagonists
SJ000285845-17	SJ000285845	17	MOABOX:4880	ZBBHBTPTTSWHBA-UHFFFAOYSA-N	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1	106664-28-2	Calcium Channel Blockers	CACNA1C	CACNA1D	CACNA2D1	CACNB2																													776	781	783																													CHEMBL1200326	CHEMBL1484										4474	41114	177986	3017937	18770505	member																																																																																																																																																																22761000																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.31424	0	0	0																													0.03928	0.0	0.0	0.0																													8	7	7	7																													AA00DDRJ	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-362|MOABOX:4880|CACNA1C|Calcium Channel Blockers	COC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OCCN(C)Cc3ccccc3)C	54527-84-3	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468273	479.52496	NICARDIPINE	"NICARDIPINE | CARDENE | ""NERDIPINE | PERDIPINE | PERPIDINE"" | NICARDIPINE HYDROCHLORIDE | NICARDIPINE | CARDENE | ""NERDIPINE | PERDIPINE | PERPIDINE"" | NICARDIPINE HYDROCHLORIDE"			MOABOX:4880	CACNA1C	Calcium Channel Blockers
SJ000287510-8	SJ000287510	8	MOABOX:4882	HMJIYCCIJYRONP-UHFFFAOYSA-N	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12	131970-21-3	Calcium Channel Blockers	CACNA1C	CACNA1D	CACNA1S	CACNA2D1	CACNB2	CACNA1H	CACNA2D2																										776	779	781	783	8912	9254																										CHEMBL1648											3784	11479409	51001905	66931421	68500761	member																																																																																																																																																																22761000																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.37088	0	0	0	0	6.132e-002	0																										0.17136	0.0	0.0	0.0	0.0	0.00876	0.0																										8	7	7	7	7	7	7																										HS-0085	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COC(=O)C1=C(C)NC(=C(C1c2cccc3nonc23)C(=O)OC(C)C)C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466659	371.38714	ISRADIPINE	ISRADIPINE | ISRADIPINE			MOABOX:4882	CACNA1C	Calcium Channel Blockers
SJ000285737-9	SJ000285737	9	MOABOX:4916	RGLYKWWBQGJZGM-ISLYRVAYSA-N	CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1	22610-99-7	Chloride Channel Blockers;Estrogen Receptor (ER) Agonists	ESR1	ESR2																															2100																															CHEMBL411											448537	5473687	20980228	21150982	21151300	member	10.1016/S0039-128X(01)00194-5	10.1016/S0043-1354(02)00378-0	10.1016/S0278-6915(01)00073-4	10.1016/S0300-483X(01)00437-1	10.1016/S0960-0760(00)00126-6	10.1016/j.bcp.2006.01.004	10.1016/j.bmcl.2013.01.025	10.1016/j.cca.2005.07.002	10.1016/j.jsbmb.2004.03.118	10.1016/j.jsbmb.2004.09.004	10.1016/j.steroids.2006.02.002	10.1021/ac020088u	10.1021/jm010086m	10.1021/jm015577l	10.1021/jm401158e	10.1021/jm501203v	10.1039/b303985d	10.1074/jbc.M203578200	10.1210/en.2006-0113	10.2174/0929867053764662																																																																																																																																												9216828	11356100	11906280	11965371	12672240	15892637	16480962	22652053	23403082	26478787	30940565																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											4.34144	2.4816																															0.54268	0.3102																															8	8																															AS-13377	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC\C(=C(\CC)/c1ccc(O)cc1)\c2ccc(O)cc2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466828	268.3502	DIETHYLSTILBESTROL	DIETHYLSTILBESTROL | DIETHYLSTILBESTROL| STILBESTROL | DIETHYLSTILBESTROL | DIETHYLSTILBESTROL| STILBESTROL			MOABOX:4916	ESR1	Chloride Channel Blockers;Estrogen Receptor (ER) Agonists
SJ000831505-2	SJ000831505	2	MOABOX:4928	CMCWWLVWPDLCRM-UHFFFAOYSA-N	O=C1CCN(c2ccccc2)N1	14776-33-1	Cyclooxygenase (COX) Inhibitors;Lipoxygenase Inhibitors;Antioxidants	ALOX5	PTGS1	PTGS2																														5742	5743																														CHEMBL7660											7090	11708832	19104456	20493950	21088074	virtual	10.1021/jm960372b																																																																																																																																																															8831760																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.86208	-0.31801	-0.31801																														0.10776	-0.04543	-0.04543																														8	7	7																														FS-4504	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	O=C1CCN(N1)c2ccccc2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466819	162.1885	PHENIDONE	PHENIDONE | PHENIDONE			MOABOX:4928	ALOX5	Cyclooxygenase (COX) Inhibitors;Lipoxygenase Inhibitors;Antioxidants
SJ000855531-4	SJ000855531	4	MOABOX:4936	MUXFZBHBYYYLTH-UHFFFAOYSA-N	CC(C(=O)O)c1ccc2c(c1)CC(=O)c1ccccc1S2	1166864-09-0	Cyclooxygenase (COX) Inhibitors;Non-Steroidal Antiinflammatory Drugs	PTGS2																																																															CHEMBL1765291											5720	44159207	67364326	67365089	69858954	virtual	10.1016/S0014-2999(98)00078-8																																																																																																																																																															9650852																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.98032																																0.24754																																8																																GS-3949	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C(=O)O)c1ccc2Sc3ccccc3C(=O)Cc2c1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466831	298.35626	ZALTOPROFEN	ZALTOPROFEN | ZALTOPROFEN			MOABOX:4936	PTGS2	Cyclooxygenase (COX) Inhibitors;Non-Steroidal Antiinflammatory Drugs
SJ000285630-20	SJ000285630	20	MOABOX:4938	HEFNNWSXXWATRW-JTQLQIEISA-N	CC(C)Cc1ccc([C@H](C)C(=O)O)cc1	113403-10-4	Cyclooxygenase (COX) Inhibitors;Non-Steroidal Antiinflammatory Drugs	PTGS1	PTGS2																															5743																															CHEMBL175											39912	9800021	9819903	11258241	11954362	virtual	10.1016/j.bmcl.2011.04.114																																																																																																																																																															21602044																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.44336	0.24885																															0.18042	0.03555																															8	7																															HS-0088	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466660	206.28082	IBUPROFEN	"IBUPROFEN | S-(+)-IBUPROFEN | S(+)-IBUPROFEN | (±)-IBUPROFEN | IBUPROFEN| ADVIL LIQUI-GELS | ""IBUPROFEN | ST-1482 | ZAG-1701 |"" | IBUPROFEN | S-(+)-IBUPROFEN | S(+)-IBUPROFEN | (±)-IBUPROFEN | IBUPROFEN| ADVIL LIQUI-GELS | ""IBUPROFEN | ST-1482 | ZAG-1701 |"""			MOABOX:4938	PTGS1	Cyclooxygenase (COX) Inhibitors;Non-Steroidal Antiinflammatory Drugs
SJ000285581-11	SJ000285581	11	MOABOX:5000	TTWJBBZEZQICBI-UHFFFAOYSA-N	CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC	2576-84-3	Dopamine Receptor Antagonists	DRD2																																																															CHEMBL1200940	CHEMBL1256771	CHEMBL327094	CHEMBL86								4168	21761	23659	156411	192710	member																																																																																																																																																																8746557	9808703	10722154																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.83144																																0.10393																																8																																KS-5055	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466719	299.79638	METOCLOPRAMIDE HYDROCHLORIDE	METOCLOPRAMIDE HYDROCHLORIDE | METOCLOPRAMIDE HCL | METOCLOPRAMIDE HYDROCHLORIDE | METOCLOPRAMIDE HCL			MOABOX:5000	DRD2	Dopamine Receptor Antagonists
SJ000287283-12	SJ000287283	12	MOABOX:5002	FGXWKSZFVQUSTL-UHFFFAOYSA-N	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1	57808-66-9	Dopamine Receptor Antagonists	DRD2	DRD3																															1814																															CHEMBL219916	CHEMBL3436365										3151	188548	6443236	6604595	9808295	member	10.1016/0922-4106(92)90164-Q	10.1016/j.bcp.2004.05.019																																																																																																																																																														11259537	14521403	15276084	16854052																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.27864	1.40632																															0.15983	0.17579																															8	8																															HY-B0411	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:5002|DRD2|Dopamine Receptor Antagonists	Clc1ccc2N(C3CCN(CCCN4C(=O)Nc5ccccc45)CC3)C(=O)Nc2c1	57808-66-9	11944	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469292	425.91126	DOMPERIDONE MALEATE	DOMPERIDONE MALEATE | DOMPERIDONE | DOMPERIDONE MALEATE | DOMPERIDONE	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:5002	DRD2	Dopamine Receptor Antagonists
SJ000286016-10	SJ000286016	10	MOABOX:5004	RGCVKNLCSQQDEP-UHFFFAOYSA-N	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1	130-69-8	Dopamine Receptor Antagonists	DRD2																																																															CHEMBL567											4748	74835	165659	168090	6442084	virtual																																																																																																																																																																18757185	23675993	24088053																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.46192																																0.18274																																8																																KS-5105	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OCCN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466737	403.96864	PERPHENAZINE	PERPHENAZINE | PERPHENAZINE			MOABOX:5004	DRD2	Dopamine Receptor Antagonists
SJ000285628-9	SJ000285628	9	MOABOX:5006	MXYUKLILVYORSK-HBMCJLEFSA-N	CN1[C@H](C[C@H](O)c2ccccc2)CCC[C@@H]1CC(=O)c1ccccc1	134-63-4	Dopamine Receptor Modulators;alpha4beta2 nicotinic acid receptor partial agonist	CHRNA4	CHRNB2	SLC18A2																														1141	6571																														CHEMBL122270	CHEMBL1257005										101615	101616	120636	657330	9932695	member	10.1124/mol.64.6.1283																																																																																																																																																															11281847	15003719	19691331	20805303	21050177	22243960	30240563																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															0.8504	0.92008	-0.23632																														0.1063	0.11501	-0.02954																														8	8	8																														HY-B0979	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:5006|CHRNA4|Dopamine Receptor Modulators;alpha4beta2 nicotinic acid receptor partial agonist	CN1[C@H](C[C@H](O)c2ccccc2)CCC[C@@H]1CC(=O)c3ccccc3	134-63-4	60765	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469616	337.45528	LOBELINE HYDROCHLORIDE	LOBELINE HYDROCHLORIDE | LOBELINE ALPHA (-) HYDROCHORIDE | ALPHA-LOBELINE HYDROCHLORIDE | LOBELINE HCL | LOBELINE HYDROCHLORIDE | LOBELINE ALPHA (-) HYDROCHORIDE | ALPHA-LOBELINE HYDROCHLORIDE | LOBELINE HCL	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:5006	CHRNA4	Dopamine Receptor Modulators;alpha4beta2 nicotinic acid receptor partial agonist
SJ000285720-7	SJ000285720	7	MOABOX:5024	UVKZSORBKUEBAZ-UHFFFAOYSA-N	CN1CCN(C(c2ccccc2)c2ccccc2)CC1	303-25-3	Drugs Acting on Histamine Receptors	HRH1	SULT1E1																															6783																															CHEMBL1200497	CHEMBL1324714	CHEMBL3189137	CHEMBL648								6726	67533	71473	6420019	18523477	virtual	10.2174/138920006774832596																																																																																																																																																															16454694																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.01792	0.434																															0.12724	0.05425																															8	8																															T4056	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-111-171|MOABOX:5024|HRH1|Drugs Acting on Histamine Receptors	CN1CCN(CC1)C(c2ccccc2)c3ccccc3	303-25-3	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468548	266.38068	CYCLIZINE	CYCLIZINE | CYCLIZINE HYDROCHLORIDE | CYCLIZINE HYDROCHLORIDE | | CYCLIZINE HCL | CYCLIZINE 2HCL | CYCLIZINE | CYCLIZINE HYDROCHLORIDE | CYCLIZINE HYDROCHLORIDE | | CYCLIZINE HCL | CYCLIZINE 2HCL			MOABOX:5024	HRH1	Drugs Acting on Histamine Receptors
SJ000286231-8	SJ000286231	8	MOABOX:5026	ATHGHQPFGPMSJY-UHFFFAOYSA-N	NCCCCNCCCN	1122077-27-3	Protein tyrosine phophatase N-like stimulator;Drugs Acting on NMDA Receptors	GRIN2A	GRIN2B	PTPN2																														2904	5771																														CHEMBL1256356	CHEMBL1473196	CHEMBL19612									1102	9539	449185	517450	9823618	member	10.1016/j.ejphar.2012.03.046	10.1371/journal.pone.0073703																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0	0	0																														0.0	0.0	0.0																														7	7	7																														AG000LDG	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-761-230|MOABOX:5026|GRIN2A|Protein tyrosine phophatase N-like stimulator;Drugs Acting on NMDA Receptors	NCCCCNCCCN	124-20-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468244	145.24586	SPERMIDINE TRIHYDROCHLORIDE	SPERMIDINE TRIHYDROCHLORIDE | SPERMIDINE | SPERMIDINE HCL | SPERMIDINE TRIHYDROCHLORIDE | SPERMIDINE | SPERMIDINE HCL			MOABOX:5026	GRIN2A	Protein tyrosine phophatase N-like stimulator;Drugs Acting on NMDA Receptors
SJ001035208-1	SJ001035208	1	MOABOX:5034	ZNXOKLWCOWOECF-UHFFFAOYSA-N	COc1cccc(Oc2c(NS(=O)(=O)c3ccc(C(C)(C)C)cc3)ncnc2OCCO)c1	150725-87-4	Endothelin Receptor Antagonists	EDNRA	EDNRB																															1910																															CHEMBL115951											122044	17887389				member	10.1002/(SICI)1098-1128(199701)17:1<17::AID-MED2>3.0.CO;2-W	10.2174/138161211797416101																																																																																																																																																														8413655	8979248	15279581	21728984	27321813																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.166	0.7816																															0.14575	0.0977																															8	8																															HY-19529	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cardiovascular Disease; Endocrinology|MOABOX:5034|EDNRA|Endothelin Receptor Antagonists	COc1cccc(Oc2c(NS(=O)(=O)c3ccc(cc3)C(C)(C)C)ncnc2OCCO)c1	150725-87-4	18940	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469107	473.54198	RO 46-2005	RO 46-2005 | RO 46-2005	Pathway: GPCR/G Protein	Research Area: Cardiovascular Disease; Endocrinology	MOABOX:5034	EDNRA	Endothelin Receptor Antagonists
SJ000286147-12	SJ000286147	12	MOABOX:5036	NHUHCSRWZMLRLA-UHFFFAOYSA-N	Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C	127-69-5	Endothelin Receptor Antagonists	EDNRA																																																															CHEMBL1200321	CHEMBL453										5344	20287	9797497	18354024	23617685	member	10.1006/bbrc.1994.1693	10.1016/0960-894X(96)00441-6																																																																																																																																																														8308857	8979248	11860362	11945124	14998318	20235539																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.22032																																0.15254																																8																																HY-B0323	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; GPCR/G Protein | Research Area: Cancer; Infection; Endocrinology|MOABOX:5036|EDNRA|Endothelin Receptor Antagonists	Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C	127-69-5	17004	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469449	267.30422	SULFISOXAZOLE	SULFISOXAZOLE | SULFISOXAZOLE	Pathway: Anti-infection; GPCR/G Protein	Research Area: Cancer; Infection; Endocrinology	MOABOX:5036	EDNRA	Endothelin Receptor Antagonists
SJ000855400-3	SJ000855400	3	MOABOX:5038	OWEGWHBOCFMBLP-UHFFFAOYSA-N	CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1	38083-17-9	Cyp Enzyme Inducers;Antifungal	CYP3A4																																																															CHEMBL1437764											37907	19849519	67379518	69942531	69942861	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.06168																																0.38271																																8																																HY-B1151	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Infection|MOABOX:5038|CYP3A4|Cyp Enzyme Inducers;Antifungal	CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n2ccnc2	38083-17-9	17267	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469404	292.76068	CLIMBAZOLE	CLIMBAZOLE | CLIMBAZOLE	Pathway: Anti-infection	Research Area: Infection	MOABOX:5038	CYP3A4	Cyp Enzyme Inducers;Antifungal
SJ000287092-7	SJ000287092	7	MOABOX:5040	MNULEGDCPYONBU-OQHYSAPWSA-N	CC[C@@H]1C=C/C=C/C[C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)/C=C/C(=O)O[C@H]2[C@@H](C)[C@@H](CC1)O[C@@]1(CC[C@@H](C)[C@@H](C[C@H](C)O)O1)[C@@H]2C	579-13-5	F-ATPase;Electron Transport Chain Inhibitors	ATP5MC1	ATP5MC2	ATP5MC3	MT-ATP6																													517	518	4508																																								66649023					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0																													0.0	0.0	0.0	0.0																													7	7	7	7																													HY-16589	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Membrane Transporter/Ion Channel | Research Area: Cancer; Infection|MOABOX:5040|ATP5MC1|F-ATPase;Electron Transport Chain Inhibitors	CC[C@@H]1CC[C@@H]2O[C@]3(CC[C@H](C)[C@H](C[C@@H](C)O)O3)[C@@H](C)[C@H](OC(=O)\C=C\[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@](C)(O)[C@@H](O)[C@H](C)C\C=C\C=C\1)[C@@H]2C	579-13-5	97291	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469739	791.06246	OLIGOMYCIN A	OLIGOMYCIN A | OLIGOMYCIN | | OLIGOMYCIN A | OLIGOMYCIN |	Pathway: Anti-infection; Membrane Transporter/Ion Channel	Research Area: Cancer; Infection	MOABOX:5040	ATP5MC1	F-ATPase;Electron Transport Chain Inhibitors
SJ001034653-1	SJ001034653	1	MOABOX:5046	GOLXRNDWAUTYKT-UHFFFAOYSA-N	O=C(O)CCc1c[nH]c2ccccc12	10265-77-7	Free Radical Scavengers;beta-Amyloid (Abeta) Protein Neurotoxicity Inhibitors	APP																																																															CHEMBL207225											3744	499067	66618988	86639123	88252448	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																FS-3158	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC(=O)CCc1c[nH]c2ccccc12	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466734	189.21054	FS-3158	FS-3158 | FS-3158			MOABOX:5046	APP	Free Radical Scavengers;beta-Amyloid (Abeta) Protein Neurotoxicity Inhibitors
SJ000287891-5	SJ000287891	5	MOABOX:5060	QMCOPDWHWYSJSA-UHFFFAOYSA-N	CNC(=O)c1cc2c(cn1)[nH]c1ccccc12	78538-74-6	GABA(A) BZ Site Receptor Inverse Agonists	GABRA1	GABRA2	GABRA3	GABRG2	GABRA5	GABRA4	GABRA6	GABRG1	GABRG3																								2555	2556	2566	2558	2557	2559	2565	2567																																			4375					member	10.1038/sj.bjp.0706056																																																																																																																																																															15655523																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.1128	-4.728e-002	-0.11564	0	-0.23737	0	0	0.75968	0																								0.1391	-0.00591	-0.01652	0.0	-0.03391	0.0	0.0	0.09496	0.0																								8	8	7	7	7	7	7	8	7																								HY-100991	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:5060|GABRA1|GABA(A) BZ Site Receptor Inverse Agonists	CNC(=O)c1cc2c(cn1)[nH]c3ccccc23	78538-74-6	58555	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469606	225.24594	N-METHYL-BETA-CARBOLINE-3-CARBOXAMIDE	N-METHYL-BETA-CARBOLINE-3-CARBOXAMIDE | FG 7142 | N-METHYL-BETA-CARBOLINE-3-CARBOXAMIDE | FG 7142	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:5060	GABRA1	GABA(A) BZ Site Receptor Inverse Agonists
SJ000288281-4	SJ000288281	4	MOABOX:5064	GBBSUAFBMRNDJC-INIZCTEOSA-N	CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1	1140433-81-3	GABA(A) Receptor Agonists	GABRA5																																																															CHEMBL1522											969472	11285133	11285284	11387982	11763916	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.46024																																0.05753																																8																																KS-1055	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CN1CCN(CC1)C(=O)O[C@@H]2N(C(=O)c3nccnc23)c4ccc(Cl)cn4	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466701	388.80828	ZOPICLONE	"ZOPICLONE | ""ESZOPICLONE | S-ZOPICLONE | ZOPICLONE | SEP-0227018 | SEP-0227108 | SEP-190 | SEP-225441 |  HSDB 7472 | SEP-190"" | ZOPICLONE | ""ESZOPICLONE | S-ZOPICLONE | ZOPICLONE | SEP-0227018 | SEP-0227108 | SEP-190 | SEP-225441 |  HSDB 7472 | SEP-190"""			MOABOX:5064	GABRA5	GABA(A) Receptor Agonists
SJ001035258-1	SJ001035258	1	MOABOX:5066	PCMORTLOPMLEFB-ONEGZZNKSA-N	COc1cc(/C=C/C(=O)O)cc(OC)c1O	530-59-6	GABA(A) Receptor Agonists;Antioxidants;Alleviation of Cartilage Destruction	KEAP1																																																															CHEMBL109341											637775	69474473	69476200	69565373	69869764	virtual	10.1155/2019/5689613																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-W009732	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?B | Research Area: Cancer; Metabolic Disease|MOABOX:5066|KEAP1|GABA(A) Receptor Agonists;Antioxidants;Alleviation of Cartilage Destruction	COc1cc(\C=C\C(=O)O)cc(OC)c1O	530-59-6	64385	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469365	224.20998	SINAPINIC ACID | SINAPIC ACID	"""SINAPINIC ACID | SINAPIC ACID"" | ""SINAPINIC ACID | SINAPIC ACID"""	Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?B	Research Area: Cancer; Metabolic Disease	MOABOX:5066	KEAP1	GABA(A) Receptor Agonists;Antioxidants;Alleviation of Cartilage Destruction
SJ000287888-11	SJ000287888	11	MOABOX:5078	WKGXYQFOCVYPAC-UHFFFAOYSA-N	NC(=O)OCC(COC(N)=O)c1ccccc1	1177501-39-1	GABA(A) Receptor Modulators	GRIN2A	GRIN2B	GRIN3A																														2904	116443																														CHEMBL1094	CHEMBL2130858										3331	23581812	66870886	66888374	67394670	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.83587	-0.83587	-0.83587																														-0.11941	-0.11941	-0.11941																														7	7	7																														HY-B0184	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:5078|GRIN2A|GABA(A) Receptor Modulators	NC(=O)OCC(COC(=O)N)c1ccccc1	25451-15-4	16867	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468959	238.23986	FELBAMATE	FELBAMATE | FELBAMATE| FELBATOL | FELBAMATE | FELBAMATE| FELBATOL	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:5078	GRIN2A	GABA(A) Receptor Modulators
SJ001035188-1	SJ001035188	1	MOABOX:5088	BDYHNCZIGYIOGJ-DUXPYHPUSA-N	C/C(=C\C(N)C(=O)O)CP(=O)(O)O	127910-31-0	Glutamate Ionotropic Antagonists;NMDA Antagonists	GRIN1	GRIN2A	GRIN2B	GRIN2C	GRIN2D																												2903	2904	2905	2906																												CHEMBL29811											5950212	88047607				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.46998	0.46998	0.46998	0.46998	0.46998																												0.06714	0.06714	0.06714	0.06714	0.06714																												7	7	7	7	7																												HY-107702	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:5088|GRIN1|Glutamate Ionotropic Antagonists;NMDA Antagonists	C\C(=C/C(N)C(=O)O)\CP(=O)(O)O	127910-31-0	55609	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469037	209.13694	CGP 37849	CGP 37849 | CGP 37849	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:5088	GRIN1	Glutamate Ionotropic Antagonists;NMDA Antagonists
SJ000111716-20	SJ000111716	20	MOABOX:5118	SOYKEARSMXGVTM-HNNXBMFYSA-N	CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1	113-92-8	Histamine Receptor Antagonists	HRH1																																																															CHEMBL1200927	CHEMBL1201353	CHEMBL3183101									33036	114921	5281070	16667442	20057063	member																																																																																																																																																																16460947	16782354																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.51288																																0.18911																																8																																HY-B0286A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling | Research Area: Inflammation/Immunology; Endocrinology|MOABOX:5118|HRH1|Histamine Receptor Antagonists	CN(C)CCC(c1ccc(Cl)cc1)c2ccccn2	113-92-8	15398	GENERAL	MALEATE	1	NO_SOLVATE	0	1469193	274.78846	(rac)-CHLORPHENIRAMINE	(rac)-CHLORPHENIRAMINE | (S)-CHLORPHENIRAMINE MALEATE | CHLORPHENIRAMINE MALEATE | (+)-CHLORPHENIRAMINE MALEATE | TELDRIN | CHLOR-TRIMETON | (rac)-CHLORPHENIRAMINE | (S)-CHLORPHENIRAMINE MALEATE | CHLORPHENIRAMINE MALEATE | (+)-CHLORPHENIRAMINE MALEATE | TELDRIN | CHLOR-TRIMETON	Pathway: GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Research Area: Inflammation/Immunology; Endocrinology	MOABOX:5118	HRH1	Histamine Receptor Antagonists
SJ000286027-17	SJ000286027	17	MOABOX:5120	ZDIGNSYAACHWNL-UHFFFAOYSA-N	CN(C)CCC(c1ccc(Br)cc1)c1ccccn1	132-21-8	Histamine Receptor Antagonists	HRH1																																																															CHEMBL1200961	CHEMBL811										6834	91495	5281067	9895607	9918711	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.82648																																0.10331																																8																																AG00H5Z8	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-220-382|MOABOX:5120|HRH1|Histamine Receptor Antagonists	CN(C)CCC(c1ccc(Br)cc1)c2ccccn2	980-71-2	NA	GENERAL	FUMARATE	1	NO_SOLVATE	0	1468627	319.23946	BROMPHENIRAMINE MALEATE	BROMPHENIRAMINE MALEATE | (±)-BROMPHENIRAMINE MALEATE | (+)-BROMPHENIRAMINE MALEATE | DEXBROMPHENIRAMINE MALEATE | | BROMPHENIRAMINE HYDROGEN MALEATE | BROMPHENIRAMINE MALEATE | (±)-BROMPHENIRAMINE MALEATE | (+)-BROMPHENIRAMINE MALEATE | DEXBROMPHENIRAMINE MALEATE | | BROMPHENIRAMINE HYDROGEN MALEATE			MOABOX:5120	HRH1	Histamine Receptor Antagonists
SJ000834147-6	SJ000834147	6	MOABOX:5138	WQAVPPWWLLVGFK-VTNASVEKSA-N	COc1ccc(C[C@H](NC(=O)[C@H](C)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]2(C)CO2)cc1	960374-59-8	Immunoproteasome Inhibitors	PSMB8																																																															CHEMBL3237875											23642227	134815203	134815204			member	10.1021/acs.jmedchem.8b01201	10.1021/acs.jmedchem.8b01884	10.1021/acsmedchemlett.6b00496																																																																																																																																																													24524217	25006746	28435528	30657666	31283222																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	2.04736																																0.25592																																8																																HY-13207	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:5138|PSMB8|Immunoproteasome Inhibitors	COc1ccc(C[C@H](NC(=O)[C@H](C)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)[C@@]4(C)CO4)cc1	960374-59-8	83505	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469452	580.6719	ONX-0914	ONX-0914 | ONX-0914 (PR-957) | ONX-0914 | ONX-0914 (PR-957)	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:5138	PSMB8	Immunoproteasome Inhibitors
SJ000518965-3	SJ000518965	3	MOABOX:5140	CZKPOZZJODAYPZ-LROMGURASA-N	N=C(N)NCCCC[C@@H]1NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O	1248559-53-6	"Inhibitors of Blood Coagulation Pathways;Integrin alphaIIbbeta3 (Fibrinogen gpIIb/IIIa) Antagonists;""Inhibitors of Blood Coagulation Pathways;Integrin alphaIIbbeta3 (Fibrinogen gpIIb/IIIa) Antagonists"""	ITGA2B	ITGA3																															3675																															CHEMBL1174	CHEMBL4068311										448812	11506293	12001375	54576062	54759262	member																																																																																																																																																																10999999																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.34384	0																															0.16798	0.0																															8	7																															HY-B0686	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cytoskeleton | Research Area: Cardiovascular Disease|MOABOX:5140|ITGA2B|Inhibitors of Blood Coagulation Pathways;Integrin alphaIIbbeta3 (Fibrinogen gpIIb/IIIa) Antagonists;\Inhibitors of Blood Coagulation Pathways;Integrin alphaIIbbeta3 (Fibrinogen gpIIb/IIIa) Antagonists\	NC(=N)NCCCC[C@@H]1NC(=O)CCSSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O)C(=O)N	188627-80-7	80269	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469608	831.96186	EPTIFIBATIDE| INTEGRILIN	EPTIFIBATIDE| INTEGRILIN | EPTIFIBATIDE| INTEGRILIN	Pathway: Cytoskeleton	Research Area: Cardiovascular Disease	MOABOX:5140	ITGA2B	Inhibitors of Blood Coagulation Pathways;Integrin alphaIIbbeta3 (Fibrinogen gpIIb/IIIa) Antagonists;\Inhibitors of Blood Coagulation Pathways;Integrin alphaIIbbeta3 (Fibrinogen gpIIb/IIIa) Antagonists\
SJ001034862-1	SJ001034862	1	MOABOX:5162	FECQXVPRUCCUIL-UHFFFAOYSA-N	Nc1nc2c(ccc3ccccc32)s1	111886-81-8	"Intermediate Conductance K(Ca) 3.1 (IKCa1| Gardos channel, SK41, IK1) Channel Activators;Small Conductance SK(Ca) Channel Activators"	KCNN4																																																															CHEMBL1709719											94880	87756117	135502117	135539829	135539833	member	10.1124/mol.108.051425																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.14																																0.1425																																8																																STK396352	VITASM	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-834-490|MOABOX:5162|KCNN4|Intermediate Conductance K(Ca) 3.1 (IKCa1| Gardos channel, SK41, IK1) Channel Activators;Small Conductance SK(Ca) Channel Activators"	Nc1nc2c(ccc3ccccc23)s1	111886-81-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468115	200.25962	STK396352	STK396352 | STK396352			MOABOX:5162	KCNN4	"Intermediate Conductance K(Ca) 3.1 (IKCa1|Gardos channel, SK41, IK1) Channel Activators;Small Conductance SK(Ca) Channel Activators"
SJ000288164-4	SJ000288164	4	MOABOX:5178	LMPZHLXYBWGGNT-UHFFFAOYSA-N	O=C(O)c1ccccc1Nc1cccc(OCc2ccc3ccccc3n2)c1	105350-26-3	Leukotriene Antagonists	CYSLTR1																																																															CHEMBL18132											128355	45073453	71297093			member																																																																																																																																																																8709092																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.70959																																0.10137																																7																																1804	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-691|MOABOX:5178|CYSLTR1|Leukotriene Antagonists	OC(=O)c1ccccc1Nc2cccc(OCc3ccc4ccccc4n3)c2	146662-42-2	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468621	370.40062	SR 2640	SR 2640 | SR 2640			MOABOX:5178	CYSLTR1	Leukotriene Antagonists
SJ001035079-1	SJ001035079	1	MOABOX:5182	LMQBMWHHGVZWMR-UHFFFAOYSA-N	CCCc1c(OCC(O)COc2ccc3c(=O)cc(C(=O)O)oc3c2CCC)ccc(C(C)=O)c1O	40785-97-5	Leukotriene Antagonists;Leukotriene Synthesis Inhibitors	CYSLTR1	CYSLTR2																															57105																															CHEMBL267475											105007	70592699	70605061	131711403		member																																																																																																																																																																2157009	2170649	3027332	3033245																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.88417	0.92673																															0.12631	0.13239																															7	7																															2276	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-382|MOABOX:5182|CYSLTR1|Leukotriene Antagonists;Leukotriene Synthesis Inhibitors	CCCc1c(O)c(ccc1OCC(O)COc2ccc3C(=O)C=C(Oc3c2CCC)C(=O)O)C(=O)C	40785-97-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468613	498.5217	FPL 55712	FPL 55712 | FPL 55712			MOABOX:5182	CYSLTR1	Leukotriene Antagonists;Leukotriene Synthesis Inhibitors
SJ000286713-7	SJ000286713	7	MOABOX:5212	AIONOLUJZLIMTK-AWEZNQCLSA-N	COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1O	41001-90-5	Lipid Lowering Agents;Antioxidants;Triglyceride Lowering Agents;Cytochrome P450 CYP1B1 Inhibitors;TRPM3 Antagonists	CYP1B1	TRPM3																															80036																															CHEMBL399121											72281	9851098	16066671	66780498	69351729	member																																																																																																																																																																20696580																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.63096	0																															0.07887	0.0																															8	7																															KS-5307	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1ccc(cc1O)[C@@H]2CC(=O)c3c(O)cc(O)cc3O2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466817	302.27876	HESPERETIN	HESPERETIN | HESPERETIN			MOABOX:5212	CYP1B1	Lipid Lowering Agents;Antioxidants;Triglyceride Lowering Agents;Cytochrome P450 CYP1B1 Inhibitors;TRPM3 Antagonists
SJ000287585-5	SJ000287585	5	MOABOX:5222	WDEABJKSGGRCQA-UHFFFAOYSA-N	CC1=C(C)C(=O)C(CCCCC#CCCCC#CCO)=C(C)C1=O	80809-81-0	Lipoxygenase Inhibitors	ALOX5																																																															CHEMBL304818											1967					member	10.1016/S0960-894X(01)00003-8																																																																																																																																																															20222852																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.53672																																0.19209																																8																																HY-12886	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:5222|ALOX5|Lipoxygenase Inhibitors	CC1=C(C)C(=O)C(=C(C)C1=O)CCCCC#CCCCC#CCO	80809-81-0	65740	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469664	326.42934	AA-861	AA-861 | AA-861	Pathway: Apoptosis; Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:5222	ALOX5	Lipoxygenase Inhibitors
SJ001035375-1	SJ001035375	1	MOABOX:5224	IFWMVQUGSGWCRP-UHFFFAOYSA-N	COc1c(OC)c(OC(C)=O)c2cc(Cl)ccc2c1OC(C)=O	91431-42-4	Lipoxygenase Inhibitors	ALOX5																																																															CHEMBL36648											56237					virtual	10.1111/1523-1747																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-U00156	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:5224|ALOX5|Lipoxygenase Inhibitors	COc1c(OC)c(OC(=O)C)c2cc(Cl)ccc2c1OC(=O)C	91431-42-4	79435	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469830	338.7397	LONAPALENE | RS4317	"""LONAPALENE | RS4317"" | ""LONAPALENE | RS4317"""	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:5224	ALOX5	Lipoxygenase Inhibitors
SJ000312329-6	SJ000312329	6	MOABOX:5250	SGRYPYWGNKJSDL-UHFFFAOYSA-N	CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1	68302-57-8	Mediator Release Inhibitors	S100A12	S100A13																															6284																															CHEMBL1096											2161	16755358	56834945	69296548	89157691	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-B0713	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: NF-?B | Research Area: Metabolic Disease|MOABOX:5250|S100A12|Mediator Release Inhibitors	CC(C)c1ccc2Oc3nc(N)c(cc3C(=O)c2c1)C(=O)O	68302-57-8	15060	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469127	298.29336	AMLEXANOX| APHTHASOL| AA-673| CHX-3673	"AMLEXANOX| APHTHASOL| AA-673| CHX-3673 | ""AMLEXANOX| APHTHASOL| AA-673| CHX-3673 | 2-AMINO-7-ISOPROPYL-5-OXO-5H-CHROMENO[2,3-B]PYRIDINE-3-CARBOXYLIC ACID"" | AMLEXANOX| APHTHASOL| AA-673| CHX-3673 | ""AMLEXANOX| APHTHASOL| AA-673| CHX-3673 | 2-AMINO-7-ISOPROPYL-5-OXO-5H-CHROMENO[2,3-B]PYRIDINE-3-CARBOXYLIC ACID"""	Pathway: NF-?B	Research Area: Metabolic Disease	MOABOX:5250	S100A12	Mediator Release Inhibitors
SJ000518934-9	SJ000518934	9	MOABOX:5264	QJJXYPPXXYFBGM-LFZNUXCKSA-N	C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC	104987-11-3	Calcineurin inhibitor;FKBP12 gene modulator	FKBP1A	PPP3CA	PPP3CB	PPP3CC	PPP3R1	PPP3R2																											5530	5532	5533	5534	5535																											CHEMBL269732	CHEMBL3989887										445643	5282315	9812351	9876789	9898385	member																																																																																																																																																																7241506	9599228	9857082	10425089	10450987	10543889	11881984	15369399	28412204																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2.51568	0.96256	0	0	0	0																											0.31446	0.12032	0.0	0.0	0.0	0.0																											8	8	7	7	7	7																											HY-13756A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Apoptosis; Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease | Research Area: Cancer; Infection; Inflammation/Immunology|MOABOX:5264|FKBP1A|Calcineurin inhibitor;FKBP12 gene modulator	CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)\[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)C\C(=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)\C)OC)[C@H](C[C@H]4C)OC	109581-93-3	39160	GENERAL	NO_SALT	0	Water	1	1469679	804.01816	TACROLIMUS	"TACROLIMUS | ""TACROLIMUS | FUJIMYCIN | FK-506 | FR-900506 | L-679934 | LCP-TACRO |"" | ""FK-506 | TACROLIMUS | FUJIMYCIN | FR-900506 | L-679934 | LCP-TACRO |"" | FK506 | TACROLIMUS | ""TACROLIMUS | FUJIMYCIN | FK-506 | FR-900506 | L-679934 | LCP-TACRO |"" | ""FK-506 | TACROLIMUS | FUJIMYCIN | FR-900506 | L-679934 | LCP-TACRO |"" | FK506"	Pathway: Anti-infection; Apoptosis; Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease	Research Area: Cancer; Infection; Inflammation/Immunology	MOABOX:5264	FKBP1A	Calcineurin inhibitor;FKBP12 gene modulator
SJ000285536-17	SJ000285536	17	MOABOX:5268	QCHFTSOMWOSFHM-WPRPVWTQSA-N	CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C	102282-25-7	Muscarinic Agonists	CHRM1	CHRM2	CHRM3																														1129	1131																														CHEMBL1200330	CHEMBL1213136	CHEMBL550									5909	5910	185052	191806	194118	virtual	10.1016/j.bmcl.2015.02.012	10.1021/acschemneuro.6b00334																																																																																																																																																														2724302	25478907	25765911																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.66392	-0.27944	0.5124																														0.08299	-0.03493	0.06405																														8	8	8																														AG003BD9	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-939-125|MOABOX:5268|CHRM1|Muscarinic Agonists	CC[C@H]1[C@@H](Cc2cncn2C)COC1=O	54-71-7	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468673	208.25694	PILOCARPINE NITRATE	PILOCARPINE NITRATE | ISOPILOCARPINE NITRATE | (+)-PILOCARPINE HYDROCHLORIDE | PILOCARPINE | PILOCARPINE HYDROCHLORIDE | PILOCARPINE HCL | PILOCARPINE NITRATE | ISOPILOCARPINE NITRATE | (+)-PILOCARPINE HYDROCHLORIDE | PILOCARPINE | PILOCARPINE HYDROCHLORIDE | PILOCARPINE HCL			MOABOX:5268	CHRM1	Muscarinic Agonists
SJ000287233-12	SJ000287233	12	MOABOX:5272	XIQVNETUBQGFHX-UHFFFAOYSA-N	CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1	119579-36-1	Muscarinic Antagonists	CHRM1	CHRM2	CHRM3																														1129	1131																														CHEMBL1133	CHEMBL1231										4634	91505	657224	9802234	9849867	member																																																																																																																																																																1447741	9873438	16275087	17188867	22243489																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.22912	0.90224	1.29624																														0.15364	0.11278	0.16203																														8	8	8																														KS-5221	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466739	357.48644	OXYBUTYNIN	OXYBUTYNIN | OXYBUTYNIN CHLORIDE | OXYBUTYNIN | OXYBUTYNIN CHLORIDE			MOABOX:5272	CHRM1	Muscarinic Antagonists
SJ000287387-4	SJ000287387	4	MOABOX:5276	ANGKOCUUWGHLCE-UHFFFAOYSA-N	C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1	13283-82-4	Muscarinic Antagonists	CHRM1	CHRM2	CHRM3																														1129	1131																														CHEMBL1201027	CHEMBL1201335	CHEMBL3707243									3494	11693	429230	521843	9874836	member	10.1002/cmdc.201700189																																																																																																																																																															10385241	16565730	20805306	21036043	22047691	24144851	31204225																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															0.70472	0.55	1.25168																														0.08809	0.06875	0.15646																														8	8	8																														AI68762	A2BCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-112-011|MOABOX:5276|CHRM1|Muscarinic Antagonists	C[N+]1(C)CCC(C1)OC(=O)C(O)(C2CCCC2)c3ccccc3	13283-82-4	NA	GENERAL	BROMIDE	1	NO_SOLVATE	0	1468288	318.43052	GLYCOPYRROLATE	GLYCOPYRROLATE | GLYCOPYRROLATE			MOABOX:5276	CHRM1	Muscarinic Antagonists
SJ000287590-4	SJ000287590	4	MOABOX:5280	QDERNBXNXJCIQK-UHFFFAOYSA-N	CCN(c1nc(N)c(C(=O)N=C(N)N)nc1Cl)C(C)C	1154-25-2	Na+/H+ Exchanger (NHE) Inhibitors	SLC9A1	SLC9A5	SLC9A3	SLC9A2																													6553	6550	6549																													CHEMBL1909809	CHEMBL517986										1795	56935648	86296915	131847012	135565707	member	10.1016/S0968-0896(02)00022-6																																																																																																																																																															11937337	12832126	17493937																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.92088	0	-0.16604	0.68632																													0.11511	0.0	-0.02372	0.08579																													8	7	7	8																													HY-101840	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Cancer; Inflammation/Immunology|MOABOX:5280|SLC9A1|Na+/H+ Exchanger (NHE) Inhibitors	CCN(C(C)C)c1nc(N)c(nc1Cl)C(=O)NC(=N)N	1154-25-2	41701	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468812	299.75992	5-(N-ETHYL-N-ISOPROPYL)AMILORIDE	5-(N-ETHYL-N-ISOPROPYL)AMILORIDE | 5-(N-ETHYL-N-ISOPROPYL)AMILORIDE	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Cancer; Inflammation/Immunology	MOABOX:5280	SLC9A1	Na+/H+ Exchanger (NHE) Inhibitors
SJ000784265-5	SJ000784265	5	MOABOX:5284	UYJZZVDLGDDTCL-UHFFFAOYSA-N	CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1	344458-15-7	NAD+ ADP-Ribosyltransferase (poly(ADP-ribose)polymerase PARP) Inhibitors;poly(ADP-ribose) Glycohydrolase (PARG) Inhibitors	PARP1	P2RY12																															64805																															CHEMBL3233481	CHEMBL372303										4858	16219859	16760621	129010320		member	10.1021/jm100012m	10.1371/journal.pone.0110776	10.2174/0929867033368376																																																																																																																																																													12223530	15982573	16098744	16181138	17449015	17896912	18713665	19125579	19354255	20364863	22177599	22365563	24503274	24900770	25614115	28001384																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						3.16248	0																															0.39531	0.0																															8	7																															HY-13688	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:5284|PARP1|NAD+ ADP-Ribosyltransferase (poly(ADP-ribose)polymerase PARP) Inhibitors;poly(ADP-ribose) Glycohydrolase (PARG) Inhibitors	CN(C)CC(=O)Nc1ccc2NC(=O)c3ccccc3c2c1	344458-15-7	9772	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468994	295.33578	PJ34	PJ34 | PARP INHIBITOR VIII | PJ34 | PARP INHIBITOR VIII	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:5284	PARP1	NAD+ ADP-Ribosyltransferase (poly(ADP-ribose)polymerase PARP) Inhibitors;poly(ADP-ribose) Glycohydrolase (PARG) Inhibitors
SJ000285477-8	SJ000285477	8	MOABOX:5288	GSCPDZHWVNUUFI-UHFFFAOYSA-N	NC(=O)c1cccc(N)c1	3544-24-9	NAD+ ADP-Ribosyltransferase (poly(ADP-ribose)polymerase;PARP) Inhibitors;Free Radical Scavengers	PARP1																																																															CHEMBL81977											1645	19698341	68089316	70306160	121332164	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.39617																																0.34231																																7																																HY-12022	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:5288|PARP1|NAD+ ADP-Ribosyltransferase (poly(ADP-ribose)polymerase;PARP) Inhibitors;Free Radical Scavengers	NC(=O)c1cccc(N)c1	3544-24-9	20762	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469319	136.15122	3-AMINOBENZAMIDE	"3-AMINOBENZAMIDE | ""3-AMIDO BENZAMIDE | 3-ABA | PARP INHIBITOR 1 | NSC 36962 | SR 4294 |"" | INO-1001 | 3-AMINOBENZAMIDE | ""3-AMIDO BENZAMIDE | 3-ABA | PARP INHIBITOR 1 | NSC 36962 | SR 4294 |"" | INO-1001"	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:5288	PARP1	NAD+ ADP-Ribosyltransferase (poly(ADP-ribose)polymerase;PARP) Inhibitors;Free Radical Scavengers
SJ000286225-25	SJ000286225	25	MOABOX:5306	HLFSDGLLUJUHTE-SNVBAGLBSA-N	c1ccc([C@H]2CN3CCSC3=N2)cc1	14769-73-4	Nicotinic Receptor Agonists	CHRNA3																																																															CHEMBL1454	CHEMBL1770										26879	27944	192115	198119	21126691	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																AG00388J	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-467|MOABOX:5306|CHRNA3|Nicotinic Receptor Agonists	C1CN2C[C@@H](N=C2S1)c3ccccc3	16595-80-5	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468631	204.29138	LEVAMISOLE HYDROCHLORIDE	"LEVAMISOLE HYDROCHLORIDE | TETRAMISOLE HYDROCHLORIDE | (-)-TETRAMISOLE HYDROCHLORIDE | ""6-PHENYL-2,3,5,6-TETRAHYDROIMIDAZO[2,1-B]THIAZOLE | ERGAMISOL | KW-2299 | R-12,564 |"" | LEVAMISOLE HCL | TETRAMISOLE HCL | (-)-TETRAMISOLE | LEVAMISOLE HYDROCHLORIDE | TETRAMISOLE HYDROCHLORIDE | (-)-TETRAMISOLE HYDROCHLORIDE | ""6-PHENYL-2,3,5,6-TETRAHYDROIMIDAZO[2,1-B]THIAZOLE | ERGAMISOL | KW-2299 | R-12,564 |"" | LEVAMISOLE HCL | TETRAMISOLE HCL | (-)-TETRAMISOLE"			MOABOX:5306	CHRNA3	Nicotinic Receptor Agonists
SJ001035367-1	SJ001035367	1	MOABOX:5308	MKTAGSRKQIGEBH-SSDOTTSWSA-N	Clc1ccc(OC[C@H]2CCN2)cn1	198283-73-7	Nicotinic Receptor Agonists	CHRNA3	CHRNA4																															1137																															CHEMBL2104964	CHEMBL430497										3075702	9907432	72193963	122714148		virtual	10.1016/j.bmcl.2009.01.099																																																																																																																																																															9484491	15003719	19232492	20109141																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		-0.93616	0.26136																															-0.11702	0.03267																															8	8																															HY-14316A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:5308|CHRNA3|Nicotinic Receptor Agonists	Clc1ccc(OC[C@H]2CCN2)cn1	209326-19-2	24257	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469801	198.64944	TEBANICLINE DIHYDROCHLORIDE | EBANICLINE DIHYDROCHLORIDE | ABT-594 DIHYDROCHLORIDE	"""TEBANICLINE DIHYDROCHLORIDE | EBANICLINE DIHYDROCHLORIDE | ABT-594 DIHYDROCHLORIDE"" | ""TEBANICLINE DIHYDROCHLORIDE | EBANICLINE DIHYDROCHLORIDE | ABT-594 DIHYDROCHLORIDE"""	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:5308	CHRNA3	Nicotinic Receptor Agonists
SJ001034856-1	SJ001034856	1	MOABOX:5310	YRVIKLBSVVNSHF-JTQLQIEISA-N	Cc1ncccc1OC[C@@H]1CCCN1	161417-03-4	Nicotinic Receptor Partial Agonists	CHRNA4	CHRNB2																															1141																															CHEMBL127071	CHEMBL2105650										178052	23729426	24906253	70685112	129718535	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.88088	-0.8757																															-0.12584	-0.1251																															7	7																															5079	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-052-190|MOABOX:5310|CHRNA4|Nicotinic Receptor Partial Agonists	Cc1ncccc1OC[C@@H]2CCCN2	161416-61-1	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468107	192.25754	ABT 089 DIHCL	ABT 089 DIHCL | ABT 089 DIHCL			MOABOX:5310	CHRNA4	Nicotinic Receptor Partial Agonists
SJ000285465-17	SJ000285465	17	MOABOX:5328	BUGYDGFZZOZRHP-UHFFFAOYSA-N	CC12CC3CC(C)(C1)CC(N)(C3)C2	19982-08-2	NMDA Antagonists	GRIN2A	GRIN2B																															2904																															CHEMBL1699	CHEMBL1882685	CHEMBL807									4054	181458	2842572	9807225	9866201	member	10.1016/S0028-3908(98)00007-0	10.1016/j.bmcl.2007.06.069																																																																																																																																																														9464369	17624774	23692871																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.33456	0.20832																															0.04182	0.02604																															8	8																															HY-B0365A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:5328|GRIN2A|NMDA Antagonists	C[C@]12C[C@@H]3C[C@](C)(C1)C[C@@](N)(C3)C2	41100-52-1	13243	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468885	179.30184	MEMANTINE	MEMANTINE | NAMENDA | MEMANTINE HYDROCHLORIDE | MEMANTINE HCL | MEMANTINE | NAMENDA | MEMANTINE HYDROCHLORIDE | MEMANTINE HCL	Pathway: Autophagy; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:5328	GRIN2A	NMDA Antagonists
SJ000287238-11	SJ000287238	11	MOABOX:5332	UYNVMODNBIQBMV-UHFFFAOYSA-N	CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1	136172-79-7	NMDA Antagonists;alpha-Adrenoceptor Antagonists	GRIN2B																																																															CHEMBL1256662	CHEMBL1372983	CHEMBL1597876	CHEMBL1886888	CHEMBL305187							3689	198499	656586	6419987	9851877	virtual																																																																																																																																																																18434149	20692832	20965739	21453995	23458846	24411196	25458498																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															0.47512																																0.05939																																8																																17201	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-665-654|MOABOX:5332|GRIN2B|NMDA Antagonists;alpha-Adrenoceptor Antagonists	CC(C(O)c1ccc(O)cc1)N2CCC(Cc3ccccc3)CC2	23210-58-4	NA	GENERAL	TARTRATE	0.5	NO_SOLVATE	0	1468324	325.44458	IFENPRODIL	IFENPRODIL | IFENPRODIL TARTRATE | IFENPRODIL HEMITARTRATE | IFENPRODIL | IFENPRODIL TARTRATE | IFENPRODIL HEMITARTRATE			MOABOX:5332	GRIN2B	NMDA Antagonists;alpha-Adrenoceptor Antagonists
SJ000288170-5	SJ000288170	5	MOABOX:5346	MTCFGRXMJLQNBG-UWTATZPHSA-N	N[C@H](CO)C(=O)O	13095-79-9	NMDA Glycine-Site Agonists	GRIN1																																																															CHEMBL285123											71077	6857549	9794050	11386072	56845479	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.24983																																-0.03569																																7																																AS-11730	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	N[C@H](CO)C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466836	105.09258	D-SERINE	D-SERINE | D-SERINE			MOABOX:5346	GRIN1	NMDA Glycine-Site Agonists
SJ000285889-12	SJ000285889	12	MOABOX:5356	DKYWVDODHFEZIM-UHFFFAOYSA-N	CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1	154907-35-4	Non-Steroidal Antiinflammatory Drugs	PTGS2																																																															CHEMBL124412	CHEMBL571										3825	119285	177976	9817603	9831785	virtual	10.1016/S0223-5234(01)01330-7	10.1016/S0960-894X(01)00800-9	10.1016/j.bmc.2018.06.038	10.1016/j.bmcl.2008.07.018	10.1021/jm9906217	10.1042/bj20030969																																																																																																																																																										11844666	18667313	26487917																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.25456																																0.28182																																8																																KS-5031	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466686	254.28056	KETOPROFEN	KETOPROFEN | KETOPROFEN			MOABOX:5356	PTGS2	Non-Steroidal Antiinflammatory Drugs
SJ000286394-6	SJ000286394	6	MOABOX:5360	WVYADZUPLLSGPU-UHFFFAOYSA-N	O=C(Oc1ccccc1C(=O)O)c1ccccc1O	552-94-3	inhibition of p300-induced Tau acetylation;Non-Steroidal Antiinflammatory Drugs;NF-kappaB (NFKB) Activation Inhibitors	PTGS1	PTGS2																															5743																															CHEMBL154111											5161	66665140	67166469	67252322	67943960	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-B1245	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?B | Research Area: Inflammation/Immunology|MOABOX:5360|PTGS1|inhibition of p300-induced Tau acetylation;Non-Steroidal Antiinflammatory Drugs;NF-kappaB (NFKB) Activation Inhibitors	OC(=O)c1ccccc1OC(=O)c2ccccc2O	552-94-3	84318	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469631	258.2262	SALSALATE	"SALSALATE | ""SALSALATE | NSC-49171 | 2-CARBOXYPHENYL SALICYLATE |"" | SASAPYRINE | SALSALATE | ""SALSALATE | NSC-49171 | 2-CARBOXYPHENYL SALICYLATE |"" | SASAPYRINE"	Pathway: Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?B	Research Area: Inflammation/Immunology	MOABOX:5360	PTGS1	inhibition of p300-induced Tau acetylation;Non-Steroidal Antiinflammatory Drugs;NF-kappaB (NFKB) Activation Inhibitors
SJ001033339-2	SJ001033339	2	MOABOX:5384	ZJXIUGNEAIHSBI-IBGZPJMESA-N	Cc1nc(C(=O)N2CCCC[C@H]2CNC(=O)c2cccc3occc23)c(-c2ccc(F)cc2)s1	380899-24-1	Orexin Receptor Antagonists	HCRTR1	HCRTR2																															3062																															CHEMBL1272307											25195495					member																																																																																																																																																																20933413	21831639	23891187	25267004																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.27224	1.11888																															0.15903	0.13986																															8	8																															HY-10806	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Metabolic Disease; Endocrinology|MOABOX:5384|HCRTR1|Orexin Receptor Antagonists	Cc1nc(C(=O)N2CCCC[C@H]2CNC(=O)c3cccc4occc34)c(s1)c5ccc(F)cc5	380899-24-1	25952	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469485	477.55046	SB-649868; GSK649868	SB-649868; GSK649868 | SB-649868; GSK649868	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Metabolic Disease; Endocrinology	MOABOX:5384	HCRTR1	Orexin Receptor Antagonists
SJ001034946-1	SJ001034946	1	MOABOX:5414	NIDVDYQCGWISJZ-UHFFFAOYSA-N	Cn1c(=O)c2c(ncn2CCN2CCN(c3ccccc3Cl)CC2)n(C)c1=O	1254041-13-8	Potassium Channel Activators;Phosphodiesterase Inhibitors;Guanylate Cyclase Activators	HTR2A	HTR2B	HTR2C																														3357	3358																																									10453764	46946658	49779612	49783485	49783486	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-7.456e-002	3.08376	-0.1872																														-0.00932	0.38547	-0.0234																														8	8	8																														Z104874704	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-747-810|MOABOX:5414|HTR2A|Potassium Channel Activators;Phosphodiesterase Inhibitors;Guanylate Cyclase Activators	CN1C(=O)N(C)c2ncn(CCN3CCN(CC3)c4ccccc4Cl)c2C1=O	1254041-13-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468339	402.87792	Z104874704	Z104874704 | Z104874704			MOABOX:5414	HTR2A	Potassium Channel Activators;Phosphodiesterase Inhibitors;Guanylate Cyclase Activators
SJ000556760-6	SJ000556760	6	MOABOX:5416	ALOBUEHUHMBRLE-UHFFFAOYSA-N	CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1	100632-81-3	Potassium Channel Blockers;Antiarrhythmic	CACNA1C	CACNA2D1	CACNB1	CACNG1	KCNJ11	KCNK1	KCNK6	KCNH6	KCNH7																								781	782	786	3767	3775	9424	81033	90134																								CHEMBL2355456	CHEMBL3187455	CHEMBL533									60752	60753	5281065	6437366	9874634	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.8155	0	0	0	0	0	0	0	0																								-0.1165	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0																								7	7	7	7	7	7	7	7	7																								15011	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-019-991-026|MOABOX:5416|CACNA1C|Potassium Channel Blockers;Antiarrhythmic	CCCCCCCN(CC)CCCC(O)c1ccc(NS(=O)(=O)C)cc1	122647-32-9	NA	GENERAL	FUMARATE	0.5	NO_SOLVATE	0	1468304	384.57644	IBUTILIDE FUMARATE	IBUTILIDE FUMARATE | IBUTILIDE FUMARATE			MOABOX:5416	CACNA1C	Potassium Channel Blockers;Antiarrhythmic
SJ001034870-1	SJ001034870	1	MOABOX:5418	OEBPANQZQGQPHF-UHFFFAOYSA-N	Cn1c(NCCN(CCO)CCCc2ccc([N+](=O)[O-])cc2)cc(=O)n(C)c1=O	130636-43-0	Potassium Channel Blockers;K(V)11.1 (erg1) Channel Blockers	KCNH2																																																															CHEMBL360861	CHEMBL553090										4486	122188	44341031	57516083	70364434	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.1124																																0.01405																																8																																T2712	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-005-938-250|MOABOX:5418|KCNH2|Potassium Channel Blockers;K(V)11.1 (erg1) Channel Blockers	CN1C(=O)C=C(NCCN(CCO)CCCc2ccc(cc2)[N+](=O)[O-])N(C)C1=O	130656-51-8	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468150	405.44818	NIFEKALANT HCL	NIFEKALANT HCL | NIFEKALANT HCL			MOABOX:5418	KCNH2	Potassium Channel Blockers;K(V)11.1 (erg1) Channel Blockers
SJ000288111-5	SJ000288111	5	MOABOX:5420	LZMHWZHOZLVYDL-UHFFFAOYSA-N	O=c1onc2cnc3ccccc3n12	41443-28-1	Potassium Channel Blockers;Soluble Guanylyl Cyclase (sGC) Inhibitors	GUCY1A2	GUCY1A1	GUCY1B1																														2982	2983																														CHEMBL598952											1456					member																																																																																																																																																																12459038																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.67767	0.67767	0.67767																														0.09681	0.09681	0.09681																														7	7	7																														HY-101255	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; GPCR/G Protein | Research Area: Cancer|MOABOX:5420|GUCY1A2|Potassium Channel Blockers;Soluble Guanylyl Cyclase (sGC) Inhibitors	O=C1ON=C2C=Nc3ccccc3N12	41443-28-1	78869	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468794	187.1549	ODQ	ODQ | ODQ	Pathway: Apoptosis; GPCR/G Protein	Research Area: Cancer	MOABOX:5420	GUCY1A2	Potassium Channel Blockers;Soluble Guanylyl Cyclase (sGC) Inhibitors
SJ001033086-2	SJ001033086	2	MOABOX:5426	PAJMKGZZBBTTOY-ZFORQUDYSA-N	CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O	289480-64-4	Prostacyclin Analogs	PTGIR																																																															CHEMBL1237119	CHEMBL2107815										6918140	11179459	24771830	44462752	56602585	member	10.1016/j.bcp.2012.03.012	10.1124/jpet.116.239665	10.1124/jpet.117.242099	10.3390/ijms19082372																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.18368																																0.14796																																8																																HY-16504	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Inflammation/Immunology; Endocrinology|MOABOX:5426|PTGIR|Prostacyclin Analogs	CCCCC[C@H](O)CC[C@H]1[C@H](O)C[C@@H]2Cc3c(C[C@H]12)cccc3OCC(=O)O	289480-64-4	23239	GENERAL	SODIUM(I)	1	NO_SOLVATE	0	1469185	390.51306	TREPROSTINIL (SODIUM) | UT-15	"""TREPROSTINIL (SODIUM) | UT-15"" | ""TREPROSTINIL (SODIUM) | UT-15"""	Pathway: GPCR/G Protein	Research Area: Inflammation/Immunology; Endocrinology	MOABOX:5426	PTGIR	Prostacyclin Analogs
SJ000312219-9	SJ000312219	9	MOABOX:5438	OGSPWJRAVKPPFI-UHFFFAOYSA-N	NCCCC(O)(P(=O)(O)O)P(=O)(O)O	121268-17-5	"Protein Tyrosine Phosphatase (PTP) Inhibitors;Farnesyl Pyrophosphate Synthase Inhibitors;""Protein Tyrosine Phosphatase (PTP) Inhibitors;Farnesyl Pyrophosphate Synthase Inhibitors"""	FDPS	FDFT1																															2222																															CHEMBL870											2088	441400	450356	9816926	9817396	member	10.1021/jm010412y	10.1021/jm200587f	10.1021/jm7015733	10.1038/nchembio.421	10.2174/092986708784310468	10.2174/092986711794088335	10.2174/1381612033453640																																																																																																																																																									12014956	14613320	18327899	21780776																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0	3.3136																															0.0	0.4142																															7	8																															HY-11101	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:5438|FDPS|Protein Tyrosine Phosphatase (PTP) Inhibitors;Farnesyl Pyrophosphate Synthase Inhibitors;\Protein Tyrosine Phosphatase (PTP) Inhibitors;Farnesyl Pyrophosphate Synthase Inhibitors\	NCCCC(O)(P(=O)(O)O)P(=O)(O)O	121268-17-5	3301	GENERAL	SODIUM(I)	1	H2O	3	1469236	249.09604	ALENDRONATE 	ALENDRONATE  | ALENDRONATE MONOSODIUM TRIHYDRATE| ALENDRONIC ACID | ALENDRONATE  | ALENDRONATE MONOSODIUM TRIHYDRATE| ALENDRONIC ACID	Pathway: Others	Research Area: Cancer	MOABOX:5438	FDPS	Protein Tyrosine Phosphatase (PTP) Inhibitors;Farnesyl Pyrophosphate Synthase Inhibitors;\Protein Tyrosine Phosphatase (PTP) Inhibitors;Farnesyl Pyrophosphate Synthase Inhibitors\
SJ000518933-13	SJ000518933	13	MOABOX:5440	GIUYCYHIANZCFB-FJFJXFQQSA-N	Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]1O	75607-67-9	Purine Antagonists	DCK	POLA1	RRM1																														5422	6240																														CHEMBL1096882											30751	9809441	9830610	11262278	23615731	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0																														0.0	0.0	0.0																														7	7	7																														HY-B0028	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:5440|DCK|Purine Antagonists	Nc1nc(F)nc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]3O	75607-67-9	11876	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469717	365.21168	FLUDARABINE PHOSPHATE	"FLUDARABINE PHOSPHATE | ""FLUDARA | 2-F-ARA-AMP | 2-FLUORO-ARA-AMP | NSC-312887 | SHT-586 |"" | FLUDARABINE PHOSPHATE | ""FLUDARA | 2-F-ARA-AMP | 2-FLUORO-ARA-AMP | NSC-312887 | SHT-586 |"""	Pathway: Apoptosis; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:5440	DCK	Purine Antagonists
SJ000285272-18	SJ000285272	18	MOABOX:5442	ODKNJVUHOIMIIZ-RRKCRQDMSA-N	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F	136353-77-0	Pyrimidine Antagonists	TYMS																																																															CHEMBL917											5790	467504	11342548	66677927	66856926	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.73224																																0.09153																																8																																PS-7520	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(F)C(=O)NC2=O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466807	246.19244	FLOXURIDINE	"FLOXURIDINE | 5-FLUORO-2'-DEOXYURIDINE | ""5-FUDR | FUDR | NSC-27640"" | ""FLOXURIDINE | 5-FUDR | 5-FDU | FUDR | FDURD | FUDR | NSC-27640 |"" | ""FLOXURIDINE | NSC-27640 | FUDR | 5-FUDR | 5-FDU | FDURD | FUDR |"" | FLOXURIDINE | 5-FLUORO-2'-DEOXYURIDINE | ""5-FUDR | FUDR | NSC-27640"" | ""FLOXURIDINE | 5-FUDR | 5-FDU | FUDR | FDURD | FUDR | NSC-27640 |"" | ""FLOXURIDINE | NSC-27640 | FUDR | 5-FUDR | 5-FDU | FDURD | FUDR |"""			MOABOX:5442	TYMS	Pyrimidine Antagonists
SJ000287838-4	SJ000287838	4	MOABOX:5450	PYKJFEPAUKAXNN-UHFFFAOYSA-N	Cc1nc2c(OCc3ccccc3)cccn2c1CC#N	76081-98-6	Reversible H+/K+-ATPase Inhibitors	ATP4A	ATP4B																															496																															CHEMBL47529											108137					member																																																																																																																																																																9046332																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.61474	0.63504																															0.08782	0.09072																															7	7																															17885	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-678|MOABOX:5450|ATP4A|Reversible H+/K+-ATPase Inhibitors	Cc1nc2c(OCc3ccccc3)cccn2c1CC#N	76081-98-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468648	277.3205	SCH-28080	SCH-28080 | SCH-28080			MOABOX:5450	ATP4A	Reversible H+/K+-ATPase Inhibitors
SJ000862699-4	SJ000862699	4	MOABOX:5458	XDJCLCLBSGGNKS-UHFFFAOYSA-N	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1	1438391-30-0	SAPK1 (JNK) Inhibitors;Inhibitors of Signal Transduction Pathways	MAPK9																																																															CHEMBL1614713											10430360	56965904	66576998	69620732	117074075	member																																																																																																																																																																29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.24096																																0.03012																																8																																HY-13022	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: MAPK/ERK Pathway | Research Area: Cancer|MOABOX:5458|MAPK9|SAPK1 (JNK) Inhibitors;Inhibitors of Signal Transduction Pathways	C(CN1CCCCC1)Oc2cccc(c2)c3n[nH]c4ccc(cc34)c5ncn[nH]5	1438391-30-0	10514	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468856	388.46556	CC-401 HYDROCHLORIDE | JNK-401 | CC-401 |	"""CC-401 HYDROCHLORIDE | JNK-401 | CC-401 |"" | ""CC-401 HYDROCHLORIDE | JNK-401 | CC-401 |"""	Pathway: MAPK/ERK Pathway	Research Area: Cancer	MOABOX:5458	MAPK9	SAPK1 (JNK) Inhibitors;Inhibitors of Signal Transduction Pathways
SJ000286236-8	SJ000286236	8	MOABOX:5472	CTRLABGOLIVAIY-UHFFFAOYSA-N	NC(=O)N1c2ccccc2CC(=O)c2ccccc21	28721-07-5	Sodium Channel  Blockers	AQP4	SCN5A																															6331																															CHEMBL1068											34312	9935222	11466316	66646552	66646612	member	10.1016/j.bmc.2007.12.038																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0																															0.0	0.0																															7	7																															HY-B0114	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Neurological Disease|MOABOX:5472|AQP4|Sodium Channel Blockers	NC(=O)N1c2ccccc2CC(=O)c3ccccc13	28721-07-5	15707	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469778	252.26798	OXCARBAZEPINE	OXCARBAZEPINE | OXCARBAZEPINE| TRILEPTAL | OXCARBAZEPINE | OXCARBAZEPINE| TRILEPTAL	Pathway: Membrane Transporter/Ion Channel	Research Area: Neurological Disease	MOABOX:5472	AQP4	Sodium Channel Blockers
SJ000285696-15	SJ000285696	15	MOABOX:5474	FFGPTBGBLSHEPO-UHFFFAOYSA-N	NC(=O)N1c2ccccc2C=Cc2ccccc21	298-46-4	Sodium Channel  Blockers	SCN5A	SCN10A																															6336																															CHEMBL108											2554	158856	14181404	19925940	22229155	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.49832	1.47008																															0.06229	0.18376																															8	8																															HY-B0246	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Membrane Transporter/Ion Channel | Research Area: Neurological Disease; Cancer|MOABOX:5474|SCN5A|Sodium Channel Blockers	NC(=O)N1c2ccccc2C=Cc3ccccc13	298-46-4	16410	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469619	236.26858	CARBAMAZEPINE	CARBAMAZEPINE | CARBAMAZEPINE| CARBATROL | CARBAMAZEPINE | CARBAMAZEPINE| CARBATROL	Pathway: Autophagy; Membrane Transporter/Ion Channel	Research Area: Neurological Disease; Cancer	MOABOX:5474	SCN5A	Sodium Channel Blockers
SJ000288157-13	SJ000288157	13	MOABOX:5476	XKLMZUWKNUAPSZ-UHFFFAOYSA-N	COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1	1080496-58-7	Sodium Channel  Blockers	SCN5A	SCN9A																															6335																															CHEMBL1404	CHEMBL1526084	CHEMBL537649									56959	71279	11700894	18364999	18365000	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.38157	-0.17983																															0.05451	-0.02569																															7	7																															KS-1244	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1ccccc1OCC(O)CN2CCN(CC(=O)Nc3c(C)cccc3C)CC2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466715	427.53652	RANOLAZINE DIHYDROCHLORIDE	"RANOLAZINE DIHYDROCHLORIDE | ""RANOLAZINE | CVT-303 | RS-43285 | KEG-1295 |"" | RANOLAZINE | RANOLAZINE 2HCL | RANOLAZINE DIHYDROCHLORIDE | ""RANOLAZINE | CVT-303 | RS-43285 | KEG-1295 |"" | RANOLAZINE | RANOLAZINE 2HCL"			MOABOX:5476	SCN5A	Sodium Channel  Blockers
SJ001035295-1	SJ001035295	1	MOABOX:5494	OMHZFEWYVFWVLI-UHFFFAOYSA-N	O=C1C(=Cc2cccnc2)C(=O)c2ccccc21	31083-55-3	Ubiquitin Protein Ligase E3 Inhibitors	RNF2	BMI1	RING1																														648	6015																																									207893					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0																														0.0	0.0	0.0																														7	7	7																														HY-19817	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:5494|RNF2|Ubiquitin Protein Ligase E3 Inhibitors	O=C1C(=Cc2cccnc2)C(=O)c3ccccc13	31083-55-3	19746	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469521	235.23746	PRT4165 | NSC600157	"""PRT4165 | NSC600157"" | ""PRT4165 | NSC600157"""	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:5494	RNF2	Ubiquitin Protein Ligase E3 Inhibitors
SJ001033112-2	SJ001033112	2	MOABOX:5500	IWCWQNVIUXZOMJ-MISYRCLQSA-N	CC(C)c1cc2c(cc1S(=O)(=O)O)[C@@]1(C)CCC[C@@](C)(C(=O)O)[C@@H]1CC2	33159-27-2	"Urease Inhibitors;Mucin Production, Enhancers"	NOXO1																																																															CHEMBL2104585											65781	22298948	73554418			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-B0691A	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?B | Research Area: Infection|MOABOX:5500|NOXO1|Urease Inhibitors;Mucin Production, Enhancers"	CC(C)c1cc2CC[C@H]3[C@@](C)(CCC[C@]3(C)c2cc1S(=O)(=O)O)C(=O)O	86408-72-2	46048	GENERAL	SODIUM(I)	1	NO_SOLVATE	0	1469818	380.49832	ECABET (SODIUM) | TA-2711	"""ECABET (SODIUM) | TA-2711"" | ""ECABET (SODIUM) | TA-2711"""	Pathway: Anti-infection; Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?B	Research Area: Infection	MOABOX:5500	NOXO1	"Urease Inhibitors;Mucin Production, Enhancers"
SJ000287897-7	SJ000287897	7	MOABOX:5518	JUUFBMODXQKSTD-UHFFFAOYSA-N	CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N	1198579-27-9	Voltage-Gated K(V) 7 (KCNQ) Channel Activators	KCNQ2	KCNQ3	KCNQ4																														3786	9132																														CHEMBL1256752	CHEMBL255044	CHEMBL543869									53275	53276	198127	6435335	6536833	member	10.1002/cmdc.201900112																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.4473	0.4473	0																														0.0639	0.0639	0.0																														7	7	7																														J10053	AK_SCIENTIFIC	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-941-407|MOABOX:5518|KCNQ2|Voltage-Gated K(V) 7 (KCNQ) Channel Activators	CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N	75507-68-5	NA	GENERAL	MALEATE	1	NO_SOLVATE	0	1468634	304.31948	FLUPIRTINE MALEATE	FLUPIRTINE MALEATE | FLUPIRTINE MALEATE			MOABOX:5518	KCNQ2	Voltage-Gated K(V) 7 (KCNQ) Channel Activators
SJ000011933-2	SJ000011933	2	MOABOX:5524	PENIBPKELSMGQC-ZSOIEALJSA-N	O=C1/C(=C/c2cc([N+](=O)[O-])ccc2O)Sc2ccccc21		Palmitoyl Acyltransferase Inhibitors	ZDHHC17																																																																										1908906					member	10.1158/1535-7163.MCT-06-0114																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																PHAR151448	PHARMEKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-814-979|MOABOX:5524|ZDHHC17|Palmitoyl Acyltransferase Inhibitors	Oc1ccc(cc1\C=C\2/Sc3ccccc3C2=O)[N+](=O)[O-]	326611-00-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468572	299.30126					MOABOX:5524	ZDHHC17	Palmitoyl Acyltransferase Inhibitors
SJ001010597-2	SJ001010597	2	MOABOX:5530	IVQVBMWPWPTSNO-UHFFFAOYSA-N	CN1CCN(C(=O)c2ccc(-c3ccc4c(C=O)c(O)ccc4c3)s2)CC1	1093119-54-0	IRE1 protein kinase inhibitor	ERN1																																																															CHEMBL3665060											59599728					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.5244																																0.31555																																8																																HY-19710	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:5530|ERN1|IRE1 protein kinase inhibitor	CN1CCN(CC1)C(=O)c2ccc(s2)c3ccc4c(C=O)c(O)ccc4c3	1093119-54-0	27087	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469771	380.4601	MKC3946	MKC3946 | MKC3946	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:5530	ERN1	IRE1 protein kinase inhibitor
SJ001035280-1	SJ001035280	1	MOABOX:5531	HDZWHJYZJWLTAG-UHFFFAOYSA-N	CCOC(=O)c1ccc(CN(Cc2ccc(-c3cccc(S(C)(=O)=O)c3)cc2)S(=O)(=O)c2c(C)cc(C)cc2C)o1	1416153-62-2	LXR inverse agonist;Inverse agonist of LXR;NR1H3 gene modulator	NR1H2	NR1H3																															10062																																										71478195					member																																																																																																																																																																31202993																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.73392	0.72984																															0.21674	0.09123																															8	8																															HY-101442	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:5531|NR1H2|LXR inverse agonist;Inverse agonist of LXR;NR1H3 gene modulator	CCOC(=O)c1oc(CN(Cc2ccc(cc2)c3cccc(c3)S(=O)(=O)C)S(=O)(=O)c4c(C)cc(C)cc4C)cc1	1416153-62-2	36449	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469479	595.72622	SR9238	SR9238 | SR9238	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:5531	NR1H2	LXR inverse agonist;Inverse agonist of LXR;NR1H3 gene modulator
SJ001035339-1	SJ001035339	1	MOABOX:5533	TZUYDLKHNQUNKS-UHFFFAOYSA-N	Cc1occ2c1C(=O)c1c(O)ccc(O)c1C2	150045-18-4	ELAVL1 gene inhibitor	ELAVL1	MYLK																															4638																															CHEMBL1240928											132904					member																																																																																																																																																																17632515																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.74544	-0.23737																															0.21818	-0.03391																															8	7																															HY-100685	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cytoskeleton | Research Area: Cancer|MOABOX:5533|ELAVL1|ELAVL1 gene inhibitor	Cc1occ2Cc3c(O)ccc(O)c3C(=O)c12	150045-18-4	90183	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469650	230.2161	MS-444 | BE-34776	"""MS-444 | BE-34776"" | ""MS-444 | BE-34776"""	Pathway: Cytoskeleton	Research Area: Cancer	MOABOX:5533	ELAVL1	ELAVL1 gene inhibitor
SJ000986086-2	SJ000986086	2	MOABOX:5534	YGUFCDOEKKVKJK-UHFFFAOYSA-N	CC1(N)CCN(c2cnc(-c3cccc(Cl)c3Cl)c(N)n2)CC1		PTPN11 gene inhibitor	PTPN11																																																															CHEMBL4060033											118238298	121241170	131709239	144887375		virtual	10.1021/acs.jmedchem.6b00680	10.1021/acs.jmedchem.8b01726																																																																																																																																																														27347692	27539118	28412041	29155585	29304282	30688459	30688462																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															2.73512																																0.34189																																8																																HY-100388	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:5534|PTPN11|PTPN11 gene inhibitor	CC1(N)CCN(CC1)c2cnc(c(N)n2)c3cccc(Cl)c3Cl	1801747-42-1	47911	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469227	352.26156	SHP099 HYDROCHLORIDE	SHP099 HYDROCHLORIDE | SHP099 HYDROCHLORIDE	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:5534	PTPN11	PTPN11 gene inhibitor
SJ001035268-1	SJ001035268	1	MOABOX:5538	FUHCEERDBRGPQZ-LBNVMWSVSA-N	COc1ccc([C@H]2N[C@H](C(=O)O)Cc3c2[nH]c2ccccc32)cc1CN1CCN(c2ccccc2F)CC1	1354235-96-3	Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Antagonists	TPCN1	TPCN2																															219931																															CHEMBL1222013											1427628					member	10.1038/nature17194	10.1038/nchembio.150	10.1074/jbc.M109.016519	10.1152/ajprenal.00116.2009																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0	0																															0.0	0.0																															7	7																															HY-103316	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Cardiovascular Disease|MOABOX:5538|TPCN1|Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Antagonists	COc1ccc(cc1CN2CCN(CC2)c3ccccc3F)[C@H]4N[C@@H](Cc5c4[nH]c6ccccc56)C(=O)O	1354235-96-3	67094	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469429	514.59054	TRANS-NED 19	TRANS-NED 19 | TRANS-NED 19	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Cardiovascular Disease	MOABOX:5538	TPCN1	Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Antagonists
SJ001035345-1	SJ001035345	1	MOABOX:5540	JFUAWXPBHXKZGA-IBGZPJMESA-N	CC(C)(C[C@@](O)(Cc1cc2ccncc2[nH]1)C(F)(F)F)c1cc(F)ccc1O	1245526-82-2	Glucocorticoid Receptor (GR) Ligands;TNF-alpha Production Inhibitors	NR3C1																																																															CHEMBL1253898											46937290					member																																																																																																																																																																18397173	20735001																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.01048																																0.25131																																8																																HY-14234	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Metabolic Disease; Endocrinology|MOABOX:5540|NR3C1|Glucocorticoid Receptor (GR) Ligands;TNF-alpha Production Inhibitors	CC(C)(C[C@@](O)(Cc1cc2ccncc2[nH]1)C(F)(F)F)c3cc(F)ccc3O	1245526-82-2	5323	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469658	396.37861	GLUCOCORTICOID RECEPTOR AGONIST	GLUCOCORTICOID RECEPTOR AGONIST | GLUCOCORTICOID RECEPTOR AGONIST	Pathway: GPCR/G Protein	Research Area: Metabolic Disease; Endocrinology	MOABOX:5540	NR3C1	Glucocorticoid Receptor (GR) Ligands;TNF-alpha Production Inhibitors
SJ000855310-4	SJ000855310	4	MOABOX:5546	BZCALJIHZVNMGJ-HSZRJFAPSA-N	Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc3c(c2)OC[C@H]3CC(=O)O)c1	1000413-72-8	"""Free Fatty Acid Receptor 1 (FFAR1; GPR40) Agonists"""	FFAR1																																																															CHEMBL1829174	CHEMBL2047159										24857286	46869922	57339446	72722194		member	10.1016/j.bmc.2016.03.014	10.1016/j.bmc.2017.10.040	10.1016/j.bmc.2017.12.030	10.1016/j.bmc.2018.10.019	10.1016/j.bmcl.2013.03.060	10.1016/j.ejmech.2016.02.040	10.1016/j.ejmech.2016.03.054	10.1016/j.ejmech.2018.08.075	10.1016/j.ejmech.2018.12.069	10.1021/acs.jmedchem.6b00892	10.1021/acs.jmedchem.6b01357	10.1021/acs.jmedchem.7b00982	10.1021/acsmedchemlett.6b00331	10.1021/acsmedchemlett.7b00460	10.1021/acsmedchemlett.8b00444	10.1021/jm300170m	10.1021/ml1000855	10.1038/nature13494	10.1074/jbc.RA117.001297	10.1111/cbdd.13480	10.1124/jpet.111.183772	10.1124/mol.117.111369																																																																																																																																										21854074	22490067	23582779	24900210	25481394	26420383	26482570	26945112	27020683	27054485	27074625	27229618	27624524	27749056	27994752	28277660	28285923	29100735	29259758	29291938	29316397	30082106	30212763	30392954	30605833	30655940	30685095	30992164	31104992																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									3.30632																																0.41329																																8																																HY-10480	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Metabolic Disease|MOABOX:5546|FFAR1|\Free Fatty Acid Receptor 1 (FFAR1; GPR40) Agonists\	Cc1cc(OCCCS(=O)(=O)C)cc(C)c1c2cccc(COc3ccc4[C@H](CC(=O)O)COc4c3)c2	1000413-72-8	16917	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469625	524.62518	TAK-875	TAK-875 | TAK-875	Pathway: GPCR/G Protein	Research Area: Metabolic Disease	MOABOX:5546	FFAR1	\Free Fatty Acid Receptor 1 (FFAR1; GPR40) Agonists\
SJ000287496-2	SJ000287496	2	MOABOX:5547	JTLXCMOFVBXEKD-FOWTUZBSSA-N	C/C(=C(/CCO)SSCC1CCCO1)N(C=O)Cc1cnc(C)nc1N	10238-39-8	Hepcidin antagonist	SLC40A1																																																															CHEMBL1705673	CHEMBL1740659										3002119	9845819	9890507	51371443	56848894	member	10.1124/mol.112.083428																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																AS-14765	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	C\C(=C(\CCO)/SSCC1CCCO1)\N(Cc2cnc(C)nc2N)C=O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466844	398.54334	FURSULTIAMINE HYDROCHLORIDE	FURSULTIAMINE HYDROCHLORIDE | FURSULTIAMINE HYDROCHLORIDE			MOABOX:5547	SLC40A1	Hepcidin antagonist
SJ000286101-9	SJ000286101	9	MOABOX:5549	KXDROGADUISDGY-UHFFFAOYSA-N	N/C(=N\C(=O)c1nc(Cl)c(N)nc1N)NCc1ccccc1	161804-20-2	"PKD2L2 gene inhibitor;Sodium calcium exchanger 1 inhibitor;;""PKD2L2 gene inhibitor;Sodium calcium exchanger 1 inhibitor;"""	SCNN1A	SCNN1B	SCNN1D	SCNN1G	PKD2L2																												6338	6339	6340	27039																												CHEMBL1256878	CHEMBL212579	CHEMBL579086									108107	5702295	45489143	46864226	71308783	member																																																																																																																																																																16821771	22197144																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.90432	0.78504	0.78504	0.78504	0																												0.11304	0.09813	0.09813	0.09813	0.0																												8	8	8	8	7																												HY-B1546A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Neurological Disease|MOABOX:5549|SCNN1A|PKD2L2 gene inhibitor;Sodium calcium exchanger 1 inhibitor;;\PKD2L2 gene inhibitor;Sodium calcium exchanger 1 inhibitor;\	Nc1nc(N)c(nc1Cl)C(=O)NC(=N)NCc2ccccc2	161804-20-2	26259	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468854	319.74956	BENZAMIL HYDROCHLORIDE	BENZAMIL HYDROCHLORIDE | BENZAMIL | BENZAMIL HYDROCHLORIDE | BENZAMIL	Pathway: Membrane Transporter/Ion Channel	Research Area: Neurological Disease	MOABOX:5549	SCNN1A	PKD2L2 gene inhibitor;Sodium calcium exchanger 1 inhibitor;;\PKD2L2 gene inhibitor;Sodium calcium exchanger 1 inhibitor;\
SJ000288278-10	SJ000288278	10	MOABOX:5553	IXFPJGBNCFXKPI-FSIHEZPISA-N	C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(O)[C@@H](OC(=O)CCC)C[C@](C)(OC(C)=O)[C@H]2[C@@H]1OC(=O)CCCCCCC	123269-03-4	ER stress inducer;Calcium ATPase inhibitor	ATP2A1	ATP2A2	ATP2A3																														488	489																														CHEMBL96926											446378	60202644	86298461	87878022	137523550	member																																																																																																																																																																7830270	10465403	29292225	29636219																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.21812	0.16961	0.16961																														0.03116	0.02423	0.02423																														7	7	7																														CS-0006886	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-959-790|MOABOX:5553|ATP2A1|ER stress inducer;Calcium ATPase inhibitor	CCCCCCCC(=O)O[C@@H]1[C@@H](OC(=O)\C(=C/C)\C)C(=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(O)[C@H](C[C@](C)(OC(=O)C)[C@@H]12)OC(=O)CCC)C	67526-95-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468599	650.7536	THAPSIGARGIN	THAPSIGARGIN | THAPSIGARGIN			MOABOX:5553	ATP2A1	ER stress inducer;Calcium ATPase inhibitor
SJ000285572-32	SJ000285572	32	MOABOX:5557	LOUPRKONTZGTKE-LHHVKLHASA-N	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12	101143-86-6	P-Glycoprotein (MDR-1) Inhibitors;Sodium channel inhibitor	CYP2D6	CYP3A4	ABCB1	SCN1A	SCN2A																												1576	5243	6323	6326																												CHEMBL1200437	CHEMBL1294	CHEMBL1435413	CHEMBL2068675	CHEMBL2165709	CHEMBL3707183	CHEMBL506921					94328	441074	441326	441327	656862	member	10.1007/s00204-014-1412-6	10.1007/s00210-017-1431-y	10.1016/j.bmc.2016.11.051	10.1016/j.bmc.2017.07.058	10.1016/j.bmc.2018.02.022	10.1016/j.bmc.2018.04.054	10.1016/j.bmc.2018.05.006	10.1016/j.bmcl.2014.07.026	10.1016/j.dmpk.2016.04.002	10.1016/j.ejphar.2015.12.009	10.1016/j.ejps.2019.02.016	10.1016/j.fct.2017.09.007	10.1016/j.jpba.2018.06.047	10.1021/acs.jmedchem.5b01891	10.1021/acs.jmedchem.6b00030	10.1021/acs.jmedchem.7b01279	10.1021/acs.jmedchem.8b00808	10.1021/acs.jmedchem.8b01464	10.1021/acs.jmedchem.9b00352	10.1021/acs.molpharmaceut.8b00654	10.1021/acsmedchemlett.6b00491	10.1021/acsmedchemlett.8b00167	10.1021/jm3012917	10.1021/jm500109z	10.1021/jm800377h	10.1021/jm800888q	10.1038/aps.2013.74	10.1080/00498254.2019.1581301	10.1080/14756366.2017.1375483	10.1124/dmd.114.063016	10.1128/AAC.00762-18	10.1128/AAC.01217-16	10.1248/cpb.59.249	10.1371/journal.pone.0191295	10.2174/138920005774330602	10.2174/138920006775541534	10.2174/138920011795495286	10.3109/14756366.2015.1004057																																																																																																																										8487254	11716514	12502361	12636153	15270556	15481972	15679319	16220979	16570918	16610785	17249648	18324762	18672861	18763754	19117415	21138310	21189020	21384875	24050112	24793360	25082126	25300820	26204510	26355532	26962886	27105029	27145071	27606885	27955926	28337324																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								4.90816	-0.17376	-0.41125	-0.39725	-0.39725																												0.61352	-0.02172	-0.05875	-0.05675	-0.05675																												8	8	7	7	7																												AS-30538	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466776	324.41676	QUININE SULFATE	QUININE SULFATE | QUINIDINE GLUCONATE | QUINIDINE HYDROCHLORIDE MONOHYDRATE | QUINIDINE SULFATE | QUININE | QUINIDINE | QUININE HCL HYDRATE | QUINIDINE HCL HYDRATE | QUININE HCL DIHYDRATE | QUININE SULFATE | QUINIDINE GLUCONATE | QUINIDINE HYDROCHLORIDE MONOHYDRATE | QUINIDINE SULFATE | QUININE | QUINIDINE | QUININE HCL HYDRATE | QUINIDINE HCL HYDRATE | QUININE HCL DIHYDRATE			MOABOX:5557	CYP2D6	P-Glycoprotein (MDR-1) Inhibitors;Sodium channel inhibitor
SJ001035389-1	SJ001035389	1	MOABOX:5560	ZVYIJXLMBWCGHP-UHFFFAOYSA-N	CCOC(=O)C1CSC(Cc2ccc(OCc3ccc([N+](=O)[O-])cc3)cc2)N1	415697-08-4	Sodium calcium exchanger 1 inhibitor	SLC8A1																																																															CHEMBL1318259											10222761					member																																																																																																																																																																15213295																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.64969																																0.23567																																7																																HY-107658	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Cardiovascular Disease|MOABOX:5560|SLC8A1|Sodium calcium exchanger 1 inhibitor	CCOC(=O)C1CSC(Cc2ccc(OCc3ccc(cc3)[N+](=O)[O-])cc2)N1	415697-08-4	33625	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469877	402.46408	SN 6	SN 6 | SN 6	Pathway: Membrane Transporter/Ion Channel	Research Area: Cardiovascular Disease	MOABOX:5560	SLC8A1	Sodium calcium exchanger 1 inhibitor
SJ000287793-5	SJ000287793	5	MOABOX:5566	YAORIDZYZDUZCM-UHFFFAOYSA-N	c1ccc(C2CC2)c(OCC2=NCCN2)c1	40600-13-3	ADRA1B agonist;ADRA1D agonist	ADRA1D	ADRA1B																															147																															CHEMBL1255646	CHEMBL13852										2765	11957512	51371160	68738353	69812391	member																																																																																																																																																																11597419	11814822	11844675	12419381																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		-0.12104	0.88608																															-0.01513	0.11076																															8	8																															HY-101300	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Neurological Disease|MOABOX:5566|ADRA1D|ADRA1B agonist;ADRA1D agonist	C(Oc1ccccc1C2CC2)C3=NCCN3	40600-13-3	85215	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469541	216.27894	CIRAZOLINE HYDROCHLORIDE	CIRAZOLINE HYDROCHLORIDE | CIRAZOLINE HCL | CIRAZOLINE HYDROCHLORIDE | CIRAZOLINE HCL	Pathway: GPCR/G Protein	Research Area: Neurological Disease	MOABOX:5566	ADRA1D	ADRA1B agonist;ADRA1D agonist
SJ000287876-13	SJ000287876	13	MOABOX:5569	BPZSYCZIITTYBL-UHFFFAOYSA-N	COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1	126587-85-7	ADRB2 agonist	ADRB2																																																															CHEMBL1256786	CHEMBL1893395	CHEMBL2133469	CHEMBL3989798								3410	443956	5282416	9912089	9919001	virtual																																																																																																																																																																15324892	19317397	20096576	20655218	21310610	21652207	21723724	22079756	23954364	24813741	24835980	24900851	25065493																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									2.43128																																0.30391																																8																																PHAR344930	PHARMEKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-833|MOABOX:5569|ADRB2|ADRB2 agonist	COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1	1254575-18-2	NA	GENERAL	FUMARATE	1	NO_SOLVATE	0	1468110	344.40486	FORMOTEROL	FORMOTEROL | FORMOTEROL FUMARATE DIHYDRATE| FORADIL | SJ000556753 | FORMOTEROL HEMIFUMARATE | FORMOTEROL | FORMOTEROL FUMARATE DIHYDRATE| FORADIL | SJ000556753 | FORMOTEROL HEMIFUMARATE			MOABOX:5569	ADRB2	ADRB2 agonist
SJ000287876-14	SJ000287876	14	MOABOX:5569	BPZSYCZIITTYBL-UHFFFAOYSA-N	COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1	126587-85-7	ADRB2 agonist	ADRB2																																																															CHEMBL1256786	CHEMBL1893395	CHEMBL2133469	CHEMBL3989798								3410	443956	5282416	9912089	9919001	virtual																																																																																																																																																																15324892	19317397	20096576	20655218	21310610	21652207	21723724	22079756	23954364	24813741	24835980	24900851	25065493																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									2.43128																																0.30391																																8																																STL450992	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-005-934-219|MOABOX:5569|ADRB2|ADRB2 agonist	COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1	73573-87-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468192	344.40486	FORMOTEROL	FORMOTEROL | FORMOTEROL FUMARATE DIHYDRATE| FORADIL | SJ000556753 | FORMOTEROL HEMIFUMARATE | FORMOTEROL | FORMOTEROL FUMARATE DIHYDRATE| FORADIL | SJ000556753 | FORMOTEROL HEMIFUMARATE			MOABOX:5569	ADRB2	ADRB2 agonist
SJ000285856-13	SJ000285856	13	MOABOX:5571	IOVGROKTTNBUGK-SJCJKPOMSA-N	C[C@H](NCCc1ccc(O)cc1)[C@H](O)c1ccc(O)cc1	23239-51-2	ADRB3 agonist	ADRB3																																																															CHEMBL1201160	CHEMBL785										31728	33572	179602	46911860	51371387	member																																																																																																																																																																11311067																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.36435																																0.05205																																7																																HY-B0452	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Endocrinology|MOABOX:5571|ADRB3|ADRB3 agonist	C[C@@H](NCCc1ccc(O)cc1)[C@@H](O)c2ccc(O)cc2	23239-51-2	16820	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469080	287.35354	RITODRINE HYDROCHLORIDE	RITODRINE HYDROCHLORIDE | RITODRINE HCL | RITODRINE HYDROCHLORIDE | RITODRINE HCL	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Endocrinology	MOABOX:5571	ADRB3	ADRB3 agonist
SJ001035110-1	SJ001035110	1	MOABOX:5574	ZVQUCWXZCKWZBP-CQSZACIVSA-N	COc1cccc([C@@H](C)NCCCc2ccccc2Cl)c1	148717-49-1	Calcium-Sensing Receptor (CaSR) Agonists	CASR																																																															CHEMBL2107572	CHEMBL292376										158796	158797				member	10.1016/j.bmcl.2013.01.077	10.1016/j.bmcl.2013.01.078	10.1021/jm9012278																																																																																																																																																													19835382	21969374	23465611	23499504	29724589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	2.36																																0.295																																8																																CS-0002492	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-943|MOABOX:5574|CASR|Calcium-Sensing Receptor (CaSR) Agonists	COc1cccc(c1)[C@@H](C)NCCCc2ccccc2Cl	177172-49-5	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468709	303.82638	TECALCET HCL	TECALCET HCL | TECALCET HCL			MOABOX:5574	CASR	Calcium-Sensing Receptor (CaSR) Agonists
SJ000312332-4	SJ000312332	4	MOABOX:5576	WUTYZMFRCNBCHQ-UHFFFAOYSA-N	CC1OC2(CS1)CN1CCC2CC1	107220-28-0	CHRM1 agonist	CHRM1																																																															CHEMBL168815	CHEMBL2218917										2684	6850802	9837584	66577068	71280800	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.57408																																-0.07176																																8																																HY-76772	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:5576|CHRM1|CHRM1 agonist	C[C@@H]1O[C@@]2(CS1)CN3CCC2CC3	153504-70-2	4227	GENERAL	CHLORIDE	1	H2O	0.5	1469707	199.31308	CEVIMELINE HYDROCHLORIDE	"CEVIMELINE HYDROCHLORIDE | CEVIMELINE HYDROCHLORIDE SALT | ""CEVIMELINE HYDROCHLORIDE | 2-METHYL-1'-AZASPIRO[[1,3]OXATHIOLANE-5,3'-BICYCLO[2.2.2]OCTANE] | CEVIMELINE HYDROCHLORIDE SALT"" | CEVIMELINE HYDROCHLORIDE | CEVIMELINE HYDROCHLORIDE SALT | ""CEVIMELINE HYDROCHLORIDE | 2-METHYL-1'-AZASPIRO[[1,3]OXATHIOLANE-5,3'-BICYCLO[2.2.2]OCTANE] | CEVIMELINE HYDROCHLORIDE SALT"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:5576	CHRM1	CHRM1 agonist
SJ000287643-6	SJ000287643	6	MOABOX:5578	SPHRJZBOFYIKMC-UHFFFAOYSA-N	C#CCOC(=O)C1=CCCN(C)C1	116511-28-5	CHRM2 agonist;CHRM3 agonist;CHRM4 agonist;CHRM5 agonist	CHRM2	CHRM3	CHRM4	CHRM5																													1131	1132	1133																													CHEMBL1255649	CHEMBL128365	CHEMBL1475038									2229	189406	3038781	6604936	51371125	member																																																																																																																																																																16539379																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.8456	0.23828	2.324e-002	3.689e-002																													0.1057	0.03404	0.00332	0.00527																													8	7	7	7																													383	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-518|MOABOX:5578|CHRM2|CHRM2 agonist;CHRM3 agonist;CHRM4 agonist;CHRM5 agonist	CN1CCC=C(C1)C(=O)OCC#C	147202-94-6	NA	GENERAL	4-METHYLBENZENESULFONATE	1	NO_SOLVATE	0	1468620	179.21572	ARECAIDINE PROPARGYL ESTER HYDROBROMIDE	ARECAIDINE PROPARGYL ESTER HYDROBROMIDE | ARECAIDINE PROPARGYL ESTER TOSYLATE | ARECAIDINE PROPARGYL ESTER HYDROBROMIDE | ARECAIDINE PROPARGYL ESTER TOSYLATE			MOABOX:5578	CHRM2	CHRM2 agonist;CHRM3 agonist;CHRM4 agonist;CHRM5 agonist
SJ000288214-4	SJ000288214	4	MOABOX:5580	GHWJEDJMOVUXEC-UHFFFAOYSA-N	Oc1cc2c(c(Cl)c1O)CCNCC2c1ccccc1	67287-39-2	DRD1 agonist	DRD1																																																															CHEMBL353335	CHEMBL553503										1218	9927337	11957706	44314434		virtual	10.1016/j.bmcl.2015.03.079	10.1016/j.ejphar.2003.11.077	10.1074/jbc.M611485200																																																																																																																																																													1684995	25881819	31098001																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.0696																																0.2587																																8																																15067	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-959-499|MOABOX:5580|DRD1|DRD1 agonist	Oc1cc2C(CNCCc2c(Cl)c1O)c3ccccc3	67287-39-2	NA	GENERAL	BROMIDE	1	NO_SOLVATE	0	1468311	289.75674	(±)-6-CHLORO-PB HYDROBROMIDE	(±)-6-CHLORO-PB HYDROBROMIDE | (±)-6-CHLORO-PB HYDROBROMIDE			MOABOX:5580	DRD1	DRD1 agonist
SJ000519030-3	SJ000519030	3	MOABOX:5581	KFQYTPMOWPVWEJ-UHFFFAOYSA-N	CCCN(CCc1cccs1)C1CCc2c(O)cccc2C1	102120-99-0	DRD2 agonist	DRD2																																																																										57537	6917969	75236004			virtual																																																																																																																																																																8863800	12086487	18704368	22697513																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.3956																																0.17445																																8																																HY-15394	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Endocrinology; Neurological Disease|MOABOX:5581|DRD2|DRD2 agonist	CCCN(CCc1cccs1)C2CCc3c(O)cccc3C2	102120-99-0	2080	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469840	315.4729	ROTIGOTINE| NEUPRO	ROTIGOTINE| NEUPRO | ROTIGOTINE| NEUPRO	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Endocrinology; Neurological Disease	MOABOX:5581	DRD2	DRD2 agonist
SJ000287637-6	SJ000287637	6	MOABOX:5582	QLJOSZATCBCBDR-DFKUFRTHSA-N	NC[C@@H]1O[C@H](C23CC4CC(CC(C4)C2)C3)Cc2c1ccc(O)c2O	145307-34-2	DRD5 agonist;D1 agonist	DRD1	DRD5																															1816																															CHEMBL1256876	CHEMBL291143										6603703	9951033	51371118	68671454		member	10.1021/jm00018a002	10.1124/mol.105.012153																																																																																																																																																														7658429	9171869																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.60552	0																															0.32569	0.0																															8	7																															24316	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-426-419|MOABOX:5582|DRD1|DRD5 agonist;D1 agonist	NCC1OC(Cc2c(O)c(O)ccc12)C34CC5CC(CC(C5)C3)C4	145307-34-2	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468310	329.43328	A-77636 HYDROCHLORIDE	A-77636 HYDROCHLORIDE | A-77636 HCL HYDRATE | A-77636 HYDROCHLORIDE | A-77636 HCL HYDRATE			MOABOX:5582	DRD1	DRD5 agonist;D1 agonist
SJ001035128-1	SJ001035128	1	MOABOX:5584	SGPMJRPYYIJZPC-JYAZKYGWSA-N	CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(N)=O	171436-38-7	F2RL1 agonist	F2RL1																																																															CHEMBL238078											9831050	126456187				member	10.1124/jpet.103.061010																																																																																																																																																															24175626																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.1144																																0.1393																																8																																HY-P1308	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Inflammation/Immunology|MOABOX:5584|F2RL1|F2RL1 agonist	CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N	171436-38-7	98049	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468782	656.81774	SLIGRL-NH2 | PROTEASE-ACTIVATED RECEPTOR-2 ACTIVATING PEPTIDE	"""SLIGRL-NH2 | PROTEASE-ACTIVATED RECEPTOR-2 ACTIVATING PEPTIDE"" | ""SLIGRL-NH2 | PROTEASE-ACTIVATED RECEPTOR-2 ACTIVATING PEPTIDE"""	Pathway: GPCR/G Protein	Research Area: Inflammation/Immunology	MOABOX:5584	F2RL1	F2RL1 agonist
SJ001035324-1	SJ001035324	1	MOABOX:5588	PAEBEUZTAPIOIO-UHFFFAOYSA-N	CC(C)c1c(NC(=O)Nc2ccc(Cl)cc2)c(=O)n(-c2ccccc2)n1C	903895-98-7	FPR1 agonist;FPR2 agonist	FPR1	FPR2																															2358																															CHEMBL379761											24776341					member	10.1016/j.bmcl.2006.04.068	10.1016/j.bmcl.2007.09.043	10.1021/jm501051x																																																																																																																																																													16697190	17920884	25365541																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.2992	2.69336																															0.0374	0.33667																															8	8																															HY-19574	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Inflammation/Immunology|MOABOX:5588|FPR1|FPR1 agonist;FPR2 agonist	CC(C)C1=C(NC(=O)Nc2ccc(Cl)cc2)C(=O)N(N1C)c3ccccc3	903895-98-7	42255	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469578	384.85934	FPR AGONIST 43	FPR AGONIST 43 | FPR AGONIST 43	Pathway: Others	Research Area: Inflammation/Immunology	MOABOX:5588	FPR1	FPR1 agonist;FPR2 agonist
SJ000785961-2	SJ000785961	2	MOABOX:5595	DFDGRKNOFOJBAJ-UHFFFAOYSA-N	CC1(c2ccccc2)OC(C(=O)O)=CC1=O	72420-38-3	GPR109A agonist	HCAR2																																																															CHEMBL278488											51576	67196974	69295541	70580448	124136486	member	10.1016/j.ejphar.2015.11.052	10.1021/jm070022x	10.1074/jbc.M210695200																																																																																																																																																													12522134	17358052	18983141	25737085																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.83496																																0.35437																																8																																1762	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-847|MOABOX:5595|HCAR2|GPR109A agonist	CC1(OC(=CC1=O)C(=O)O)c2ccccc2	72420-38-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468713	218.2054	ACIFRAN | AY 25712 |	"""ACIFRAN | AY 25712 |"" | ""ACIFRAN | AY 25712 |"""			MOABOX:5595	HCAR2	GPR109A agonist
SJ001035065-1	SJ001035065	1	MOABOX:5599	BQMSKLCEWBSPPY-IKVTXIKFSA-N	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C	64907-22-8	GPR183 activator;GPR183 Agonist;GPR183 agonist	GPR183																																																																										11954197					member	10.1021/jm4019355	10.1038/nature10226	10.1038/nature10280																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.3076																																0.28845																																8																																AA00EF0D	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-561-082|MOABOX:5599|GPR183|GPR183 activator;GPR183 Agonist;GPR183 agonist	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	64907-22-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468573	418.65234	AA00EF0D	AA00EF0D | AA00EF0D			MOABOX:5599	GPR183	GPR183 activator;GPR183 Agonist;GPR183 agonist
SJ000288149-5	SJ000288149	5	MOABOX:5603	ASNFTDCKZKHJSW-UWTATZPHSA-N	N[C@H](Cn1oc(=O)[nH]c1=O)C(=O)O		GRM1 agonist;GRM5 agonist	GRIA1	GRM1	GRM5																														2911	2915																														CHEMBL168279											6603978					virtual	10.1016/0028-3908(95)00070-M	10.1529/biophysj.106.084426																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0	0	0																														0.0	0.0	0.0																														7	7	7																														20211	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-939-212|MOABOX:5603|GRIA1|GRM1 agonist;GRM5 agonist	N[C@@H](CN1OC(=O)NC1=O)C(=O)O	52809-07-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468472	189.12618	(+)-QUISQUALIC ACID	(+)-QUISQUALIC ACID | L-QUISQUALIC ACID | (+)-QUISQUALIC ACID | L-QUISQUALIC ACID			MOABOX:5603	GRIA1	GRM1 agonist;GRM5 agonist
SJ000796115-2	SJ000796115	2	MOABOX:5606	PMKJGGBYYNEYPA-UHFFFAOYSA-N	CC(CCCCC(=O)Nc1ccc(C(F)(F)F)cc1)NCCc1c[nH]cn1	103827-16-3	HRH1 agonist	HRH1																																																															CHEMBL1698287	CHEMBL67601										124846	23581821	45073433	56846196	71296934	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																29018	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-857-298|MOABOX:5606|HRH1|HRH1 agonist	CC(CCCCCC(=O)Nc1ccc(cc1)C(F)(F)F)NCCc2c[nH]cn2	195867-54-0	NA	GENERAL	MALEATE	1	NO_SOLVATE	0	1468328	396.44979	HTMT DIMALEATE | HISTAMINE TRIFLUOROMETHYL TOLUIDIDE |	"""HTMT DIMALEATE | HISTAMINE TRIFLUOROMETHYL TOLUIDIDE |"" | ""HTMT DIMALEATE | HISTAMINE TRIFLUOROMETHYL TOLUIDIDE |"""			MOABOX:5606	HRH1	HRH1 agonist
SJ000287479-4	SJ000287479	4	MOABOX:5607	OLHQOJYVQUNWPL-UHFFFAOYSA-N	CN(C)CCCSC(=N)N	23256-33-9	HRH2 agonist	HRH2																																																															CHEMBL12344	CHEMBL2311029										3077	90045	24871266	51371436	71717291	virtual																																																																																																																																																																11181941	15947036																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-1.652e-002																																-0.00236																																7																																AE-641/25069014	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-556|MOABOX:5607|HRH2|HRH2 agonist	CN(C)CCCSC(=N)N	23256-33-9	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468520	161.2684	DIMAPRIT DIHYDROCHLORIDE	DIMAPRIT DIHYDROCHLORIDE | DIMAPRIT HCL | DIMAPRIT 2HCL | DIMAPRIT DIHYDROCHLORIDE | DIMAPRIT HCL | DIMAPRIT 2HCL			MOABOX:5607	HRH2	HRH2 agonist
SJ000287946-5	SJ000287946	5	MOABOX:5608	PEHSVUKQDJULKE-UHFFFAOYSA-N	N=C(N)SCCc1c[nH]cn1	102203-18-9	HRH3 agonist	HRH3																																																															CHEMBL1490875	CHEMBL19439	CHEMBL544911									3692	11957573	25102741	44274054	51371199	virtual	10.1006/bbrc.2000.4008	10.1016/S0014-2999(02)02382-8	10.1016/S0014-2999(03)01635-2	10.1016/S0028-3908(02)00041-2	10.1016/j.ejphar.2017.03.013	10.1021/jm020415q	10.1021/jm901890s	10.1111/febs.14484	10.1124/jpet.106.111039																																																																																																																																																							10869375	11118334	11181941	11284713	11714875	11755145	11961043	12393057	12706455	12723960	15544556	15947036	16213736	17005916	19009544	19414267	20384344	20864504	21044842	21261593	21498080	22003888	29704723																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															1.8308																																0.22885																																8																																29517	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-857-326|MOABOX:5608|HRH3|HRH3 agonist	NC(=N)SCCc1c[nH]cn1	32385-58-3	NA	GENERAL	BROMIDE	2	NO_SOLVATE	0	1468330	170.2354	IMETIT DIHYDROBROMIDE	IMETIT DIHYDROBROMIDE | IMETIT HBR | IMETIT DIHYDROBROMIDE | IMETIT HBR			MOABOX:5608	HRH3	HRH3 agonist
SJ001035089-1	SJ001035089	1	MOABOX:5609	UGYXPZQILZRKJJ-UHFFFAOYSA-N	Cc1nc[nH]c1CCN	36376-47-3	HRH4 agonist	HRH4																																																															CHEMBL1411701	CHEMBL275443	CHEMBL3272580									37463	215819	12456195	71297116		member	10.1002/ardp.201300316	10.1016/j.ejphar.2010.12.033	10.1016/j.ejphar.2016.02.061																																																																																																																																																													16432504	16918455	19791743	21044842	21261593	27007611																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																3.10432																																0.38804																																8																																VS-0251	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-020-168-020|MOABOX:5609|HRH4|HRH4 agonist	Cc1[nH]cnc1CCN	84103-51-5	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468665	125.17164	VS-0251	VS-0251 | VS-0251			MOABOX:5609	HRH4	HRH4 agonist
SJ001035103-1	SJ001035103	1	MOABOX:5612	KWQWBZIGHIOKIO-UHFFFAOYSA-N	CCCOc1ccc2[nH]cc(C3=CCNCC3)c2n1	131084-35-0	HTR1B agonist	HTR1B																																																															CHEMBL1570196											4029677	11652258	71297049	117065030		virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.73696																																0.21712																																8																																29486	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-541|MOABOX:5612|HTR1B|HTR1B agonist	CCCOc1ccc2[nH]cc(C3=CCNCC3)c2n1	845861-39-4	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468694	257.33086	"CP 94,253 HCL"	"CP 94,253 HCL | CP 94,253 HCL"			MOABOX:5612	HTR1B	HTR1B agonist
SJ000287605-4	SJ000287605	4	MOABOX:5613	LBVZWEWTNUDWNS-YRNVUSSQSA-N	COc1ccc(CNC(=O)/C=C/c2ccc3[nH]cc(CCN(C)C)c3c2)cc1	185259-85-2	HTR1D agonist	HTR1D																																																															CHEMBL344127											6160690					virtual																																																																																																																																																																8941384																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.88776																																0.23597																																8																																864	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-941-553|MOABOX:5613|HTR1D|HTR1D agonist	COc1ccc(CNC(=O)\C=C\c2ccc3[nH]cc(CCN(C)C)c3c2)cc1	185259-85-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468510	377.47938	GR 4661	GR 4661 | GR 4661			MOABOX:5613	HTR1D	HTR1D agonist
SJ000287726-7	SJ000287726	7	MOABOX:5615	WKNFADCGOAHBPG-UHFFFAOYSA-N	CN1CCC(c2c[nH]c3ccc(O)cc23)CC1	1197333-54-2	HTR1E agonist;HTR1F agonist	HTR1E	HTR1F																															3355																															CHEMBL1256797	CHEMBL1371156										2438	11957480	45479725	53399087	77519811	virtual																																																																																																																																																																15178373	21422162																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.30888	1.36128																															0.16361	0.17016																															8	8																															HY-13221	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Cardiovascular Disease|MOABOX:5615|HTR1E|HTR1E agonist;HTR1F agonist	CN1CCC(CC1)c2c[nH]c3ccc(O)cc23	57477-39-1	10814	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469440	230.30552	BRL 54443 MALEATE	BRL 54443 MALEATE | BRL 54443 | BRL-54443 | BRL 54443 MALEATE | BRL 54443 | BRL-54443	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Cardiovascular Disease	MOABOX:5615	HTR1E	HTR1E agonist;HTR1F agonist
SJ000287732-5	SJ000287732	5	MOABOX:5616	ALFGDCNSEBJYSP-UHFFFAOYSA-N	CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12	160521-72-2	HTR2B agonist	HTR2B																																																															CHEMBL1255834	CHEMBL1600780										4284720	5311036	51371221			virtual	10.1016/j.bcp.2005.11.007	10.1124/jpet.107.133348																																																																																																																																																														15131246	16336943																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.05456																																0.38182																																8																																70090	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-849-106|MOABOX:5616|HTR2B|HTR2B agonist	CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12	160521-72-2	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468732	286.39192	BW 723C86	BW 723C86 | BW 723C86 HCL | BW 723C86 | BW 723C86 HCL			MOABOX:5616	HTR2B	HTR2B agonist
SJ000855151-6	SJ000855151	6	MOABOX:5618	YPELFRMCRYSPKZ-UHFFFAOYSA-N	CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1	112885-41-3	5-HT4 Agonists	HTR4																																																															CHEMBL1733174	CHEMBL60889										119583	119584	3076464	6918047	9853834	member	10.1124/jpet.107.133850																																																																																																																																																															9918193	12593651	14965243	17293885	17928736	20166943	21123674																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															1.13016																																0.14127																																8																																HY-B0189A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:5618|HTR4|5-HT4 Agonists	CCOc1cc(N)c(Cl)cc1C(=O)NCC2CN(Cc3ccc(F)cc3)CCO2	112885-42-4	16413	GENERAL	CITRATE	1	NO_SOLVATE	0	1469641	421.8929	MOSAPRIDE CITRATE	MOSAPRIDE CITRATE | MOSAPRIDE CITRATE	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:5618	HTR4	5-HT4 Agonists
SJ001034846-1	SJ001034846	1	MOABOX:5620	KQLDNWDJVNJTQQ-UHFFFAOYSA-N	COc1ccc(C(C)C)cc1CN1CCN(c2cccc3[nH]ccc23)CC1	1206846-61-8	HTR7 agonist	HTR7																																																																										44610704					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.79752																																0.22469																																8																																Z3953631182	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-062-431|MOABOX:5620|HTR7|HTR7 agonist	COc1ccc(cc1CN2CCN(CC2)c3cccc4[nH]ccc34)C(C)C	1206846-61-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468090	363.49586	Z3953631182	Z3953631182 | Z3953631182			MOABOX:5620	HTR7	HTR7 agonist
SJ000287932-3	SJ000287932	3	MOABOX:5623	FJDDSMSDZHURBJ-UHFFFAOYSA-N	COc1ccc2[nH]c(I)c(CCNC(C)=O)c2c1	93515-00-5	MTNR1A agonist;MTNR1B agonist	MTNR1A	MTNR1B																															4544																															CHEMBL289233											115348					member	10.1021/np400478c																																																																																																																																																															8258829	8411005	9804685	11354661	11960497	14757166	18384758	23181587	24175626	24228714																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												1.62648	0.85808																															0.20331	0.10726																															8	8																															HY-101176	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Cancer|MOABOX:5623|MTNR1A|MTNR1A agonist;MTNR1B agonist	COc1ccc2[nH]c(I)c(CCNC(=O)C)c2c1	93515-00-5	66537	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469057	358.17487	2-IODOMELATONIN	2-IODOMELATONIN | 2-IODOMELATONIN	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Cancer	MOABOX:5623	MTNR1A	MTNR1A agonist;MTNR1B agonist
SJ000519020-4	SJ000519020	4	MOABOX:5628	XNOPRXBHLZRZKH-DSZYJQQASA-N	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O	50-56-6	OXTR agonist	OXTR																																																															CHEMBL3185709	CHEMBL395429										439302	9898543	12004215	42623062	72941595	member	10.1016/j.bmc.2016.05.062	10.1016/j.bmc.2018.03.019	10.1016/j.bmc.2019.06.018	10.1016/j.neuropharm.2018.10.036	10.1021/acs.jmedchem.8b01691	10.1021/jm1016208	10.1021/jm500365s	10.1111/bph.12699																																																																																																																																																								7507528	10201826	12036367	16158071	17316912	19095447	21117646	21428295	23181587	24175626	24874785	25642985	26741855	27297999	28438540	29273395	30896946																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.73448																																0.34181																																8																																HY-17571A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Endocrinology|MOABOX:5628|OXTR|OXTR agonist	CC[C@H](C)C1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N	6233-83-6	16893	GENERAL	ACETATE	1	NO_SOLVATE	0	1469305	1007.18734	OXYTOCIN	OXYTOCIN | OXYTOCIN	Pathway: GPCR/G Protein	Research Area: Endocrinology	MOABOX:5628	OXTR	OXTR agonist
SJ001035228-1	SJ001035228	1	MOABOX:5634	OJQMKCBWYCWFPU-UHFFFAOYSA-N	CC(C)N(CCCCOCC(=O)O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1	475085-57-5	PTGIR agonist;Prostacyclin agonist	PTGIR																																																															CHEMBL239226											9931891	145272199				member	10.1016/j.bmc.2007.08.010	10.1016/j.bmcl.2015.01.024	10.1016/j.ejphar.2016.11.057	10.1021/acs.jmedchem.5b00698	10.1021/acs.jmedchem.6b00871	10.1124/jpet.107.124248	10.1124/jpet.116.239665	10.3390/ijms19082372																																																																																																																																																								17881233	24736116	25666818	26291199	28072531																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	2.7016																																0.3377																																8																																HY-79593	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cardiovascular Disease; Endocrinology|MOABOX:5634|PTGIR|PTGIR agonist;Prostacyclin agonist	CC(C)N(CCCCOCC(=O)O)c1cnc(c2ccccc2)c(n1)c3ccccc3	475085-57-5	23354	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469191	419.51606	MRE-269 | ACT-333679	"""MRE-269 | ACT-333679"" | ""MRE-269 | ACT-333679"""	Pathway: GPCR/G Protein	Research Area: Cardiovascular Disease; Endocrinology	MOABOX:5634	PTGIR	PTGIR agonist;Prostacyclin agonist
SJ001035190-1	SJ001035190	1	MOABOX:5641	ACIMQXSSGMWVKG-UHFFFAOYSA-N	NCCc1c(Cl)cccc1Cl	14573-23-0	TAAR1 agonist	TAAR1																																																															CHEMBL510649											2734101	53420349	143299817			virtual	10.1016/j.bmc.2008.06.009																																																																																																																																																															18602830																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					4.078																																0.50975																																8																																HY-107374	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: | Research Area: |MOABOX:5641|TAAR1|TAAR1 agonist	NCCc1c(Cl)cccc1Cl	14573-23-0	26444	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469041	190.06976	"2,6-DICHLOROPHENETHYLAMINE | 2,6-DICHLORO-BETA-PHENYLETHYLAMINE | 2,6-DICHLOROPHENETHYLAMINE"	"""2,6-DICHLOROPHENETHYLAMINE | 2,6-DICHLORO-BETA-PHENYLETHYLAMINE | 2,6-DICHLOROPHENETHYLAMINE"" | ""2,6-DICHLOROPHENETHYLAMINE | 2,6-DICHLORO-BETA-PHENYLETHYLAMINE | 2,6-DICHLOROPHENETHYLAMINE"""	Pathway:	Research Area:	MOABOX:5641	TAAR1	TAAR1 agonist
SJ000831657-4	SJ000831657	4	MOABOX:5642	LQANGKSBLPMBTJ-BRSNVKEHSA-N	CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@H]2CO[C@@H]1C2	56985-40-1	TBXA2R agonist	TBXA2R																																																															CHEMBL521784											5311493					virtual	10.1016/j.thromres.2008.07.011	10.1038/sj.bjp.0707518	10.1111/j.1476-5381.1987.tb09002.x	10.1111/j.1476-5381.1991.tb12200.x	10.1111/j.1476-5381.1991.tb12220.x	10.1111/j.1476-5381.1996.tb16712.x																																																																																																																																																										8496700																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.3272																																0.0409																																8																																HY-108566	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cardiovascular Disease|MOABOX:5642|TBXA2R|TBXA2R agonist	CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](C\C=C/CCCC(=O)O)[C@H]2CO[C@@H]1C2	56985-40-1	87702	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469559	350.49226	U-46619	U-46619 | U 46619 | U-46619 | U 46619	Pathway: GPCR/G Protein	Research Area: Cardiovascular Disease	MOABOX:5642	TBXA2R	TBXA2R agonist
SJ001035003-1	SJ001035003	1	MOABOX:5650	KOCIMZNSNPOGOP-IWCJZZDYSA-N	CCCCC#Cc1nc(NC)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1	403842-38-6	ADORA3 agonist	ADORA3																																																															CHEMBL260563											10981286					virtual																																																																																																																																																																12109910																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.4156																																0.17695																																8																																21015	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-822-566|MOABOX:5650|ADORA3|ADORA3 agonist	CCCCC#Cc1nc(NC)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1	403842-38-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468455	361.39562	HEMADO	HEMADO | HEMADO			MOABOX:5650	ADORA3	ADORA3 agonist
SJ001035199-1	SJ001035199	1	MOABOX:5652	GGMAXEWLXWJGSF-PEWBXTNBSA-N	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O	217082-60-5	APLNR agonist	APLNR																																																															CHEMBL3184840											25085173	137700568				member	10.1002/cmdc.201100492	10.1016/j.phrs.2018.02.032																																																																																																																																																														21560248	24755525	25241924	25668242	26986036	29461833																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																2.30944																																0.28868																																8																																HY-P1033	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cardiovascular Disease|MOABOX:5652|APLNR|APLNR agonist	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]4CCC(=O)N4)C(=O)N5CCC[C@H]5C(=O)N[C@@H](Cc6ccccc6)C(=O)O	217082-60-5	25979	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469053	1533.79862	PYR1-APELIN-13 | PGLU1-APELIN-13	"""PYR1-APELIN-13 | PGLU1-APELIN-13"" | ""PYR1-APELIN-13 | PGLU1-APELIN-13"""	Pathway: Others	Research Area: Cardiovascular Disease	MOABOX:5652	APLNR	APLNR agonist
SJ000806152-4	SJ000806152	4	MOABOX:5653	KBZOIRJILGZLEJ-UHFFFAOYSA-N	N=C(N)NCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O	113-79-1	AVPR1A agonist	AVPR1A																																																																										8230	11979316	53395954	78069869		virtual																																																																																																																																																																21428295																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-5.397e-002																																-0.00771																																7																																HY-P0049	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Neurological Disease|MOABOX:5653|AVPR1A|AVPR1A agonist	N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc3ccc(O)cc3)NC1=O)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N	113-79-1	61924	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468806	1084.2316	VASOPRESSIN | AVP | ARGININE VASOPRESSIN | ARGIPRESSIN |	"""VASOPRESSIN | AVP | ARGININE VASOPRESSIN | ARGIPRESSIN |"" | ""VASOPRESSIN | AVP | ARGININE VASOPRESSIN | ARGIPRESSIN |"""	Pathway: GPCR/G Protein	Research Area: Neurological Disease	MOABOX:5653	AVPR1A	AVPR1A agonist
SJ000806152-3	SJ000806152	3	MOABOX:5653	KBZOIRJILGZLEJ-UHFFFAOYSA-N	N=C(N)NCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O	113-79-1	AVPR1A agonist	AVPR1A																																																																										8230	11979316	53395954	78069869		virtual																																																																																																																																																																21428295																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-5.397e-002																																-0.00771																																7																																SC-13590	LABSEEKER	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-559-933|MOABOX:5653|AVPR1A|AVPR1A agonist	N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc3ccc(O)cc3)NC1=O)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N	126828-97-5	NA	GENERAL	"2,2,2-TRIFLUOROACETATE"	1	NO_SOLVATE	0	1468265	1084.2316	VASOPRESSIN | AVP | ARGININE VASOPRESSIN | ARGIPRESSIN |	"""VASOPRESSIN | AVP | ARGININE VASOPRESSIN | ARGIPRESSIN |"" | ""VASOPRESSIN | AVP | ARGININE VASOPRESSIN | ARGIPRESSIN |"""			MOABOX:5653	AVPR1A	AVPR1A agonist
SJ000784287-10	SJ000784287	10	MOABOX:5661	DXPHNGAMYPPTBJ-TZMIJSMNSA-N	CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCC(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC	142569-99-1	EDNRB agonist	EDNRB																																																															CHEMBL3188091											16130933	16133819	23729131	25014902	56947141	virtual	10.1016/0014-2999(94)90156-2	10.1038/s41467-018-07094-0																																																																																																																																																														7957593																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.48296																																0.18537																																8																																HY-10358	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:5661|EDNRB|EDNRB agonist	NC1(CCC1)c2ccc(cc2)c3nc4C=CN5C(=O)NN=C5c4cc3c6ccccc6	1032350-13-2	18916	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469809	407.46714	MK-2206	MK-2206 | MK-2206 2HCL | MK-2206 | MK-2206 2HCL	Pathway: Apoptosis; Autophagy; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:5661	EDNRB	EDNRB agonist
SJ001034930-1	SJ001034930	1	MOABOX:5662	FKRCODPIKNYEAC-UHFFFAOYSA-N	CCOC(=O)CC	105-37-3	FFAR3 agonist	FFAR3																																																															CHEMBL44115											7749	6536829	18913666	19745170	20043139	virtual	10.1074/jbc.M211609200																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																AA003QE2	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-769-743|MOABOX:5662|FFAR3|FFAR3 agonist	CCOC(=O)CC	105-37-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468266	102.1317	ETHYL PROPIONATE	ETHYL PROPIONATE | ETHYL PROPIONATE			MOABOX:5662	FFAR3	FFAR3 agonist
SJ000796072-2	SJ000796072	2	MOABOX:5666	VTAARTQTOOYTES-UHFFFAOYSA-N	NC1(C(=O)O)CCC2C(C(=O)O)C21	176027-90-0	GRM2 agonist;GRM3 agonist	GRM2	GRM3																															2913																																										114827	71435939	145862596			virtual	10.1021/jm970719q																																																																																																																																																															9572889																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.16576	-9.832e-002																															0.39572	-0.01229																															8	8																															HY-18941	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:5666|GRM2|GRM2 agonist;GRM3 agonist	N[C@]1(CC[C@H]2[C@@H]([C@@H]12)C(=O)O)C(=O)O	176199-48-7	58523	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469233	185.17724	LY 354740 MONOHYDRATE | LY-314582 | EGLUMEGAD HYDRATE | EGLUMETAD HYDRATE |	"""LY 354740 MONOHYDRATE | LY-314582 | EGLUMEGAD HYDRATE | EGLUMETAD HYDRATE |"" | ""LY 354740 MONOHYDRATE | LY-314582 | EGLUMEGAD HYDRATE | EGLUMETAD HYDRATE |"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:5666	GRM2	GRM2 agonist;GRM3 agonist
SJ000285809-18	SJ000285809	18	MOABOX:5668	FERIKTBTNCSGJS-KIGHRTHISA-N	N[C@@]1(C(=O)O)C[C@H](C(=O)O)[C@H](C(=O)O)C1		GRM4 agonist;GRM6 agonist;GRM7 agonist;GRM8 agonist	GRM4	GRM6	GRM7	GRM8																													2916	2917	2918																													CHEMBL285043																member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.45171	-7.791e-002	-0.40593	0.29169																													0.06453	-0.01113	-0.05799	0.04167																													7	7	7	7																													STR04703	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NC12C[C@@H]3C[C@@H](C[C@@H](C3)C1)C2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466743	151.24868	AMANTADINE HYDROCHLORIDE	"AMANTADINE HYDROCHLORIDE | ADAMANTAMINE FUMARATE | ""AM-102 | AMANTADINE HYDROCHLORIDE |"" | AMANTIDINE HCL | AMANTADINE HCL | AMANTADINE HYDROCHLORIDE | ADAMANTAMINE FUMARATE | ""AM-102 | AMANTADINE HYDROCHLORIDE |"" | AMANTIDINE HCL | AMANTADINE HCL"			MOABOX:5668	GRM4	GRM4 agonist;GRM6 agonist;GRM7 agonist;GRM8 agonist
SJ001035022-1	SJ001035022	1	MOABOX:5670	JDKLPDJLXHXHNV-MFVUMRCOSA-N	CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O	121062-08-6	MC1R agonist;MC3R agonist;MC4R agonist;MC5R agonist	MC1R	MC3R	MC4R	MC5R																													4159	4160	4161																													CHEMBL430239											92432	57327170	91971817	135537075		member	10.1021/acs.jmedchem.5b00102	10.1021/acs.jmedchem.5b01285	10.1021/acs.jmedchem.7b00353	10.1021/acs.jmedchem.8b00238	10.1021/acs.jmedchem.8b00488	10.1021/ja101428m	10.1021/jm201489a	10.1021/jm9017866																																																																																																																																																								7473600	9171884	9276019	12657270	13678399	16539382	16931008	17154518	17314042	17455928	18088090	19473029	20329799	21486697	22335602	23790489	24175626	25699148	26218460	26599352	28972753	29605997	29660981	29679901																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														0.49008	-0.24264	0.19224	-0.35048																													0.06126	-0.03033	0.02403	-0.04381																													8	8	8	8																													AA01DQ73	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-009-194-179|MOABOX:5670|MC1R|MC1R agonist;MC3R agonist;MC4R agonist;MC5R agonist	CCCC[C@H](NC(=O)C)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc4ccccc4)NC(=O)[C@H](Cc5c[nH]cn5)NC1=O)C(=O)N	121062-08-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468499	1024.17796	MELANOTAN II	MELANOTAN II | MELANOTAN II			MOABOX:5670	MC1R	MC1R agonist;MC3R agonist;MC4R agonist;MC5R agonist
SJ001034664-1	SJ001034664	1	MOABOX:5674	OUYCCCASQSFEME-QMMMGPOBSA-N	N[C@@H](Cc1ccc(O)cc1)C(=O)O	1189756-47-5	Tyrosine hydroxylase inhibitor	TH																																																															CHEMBL925											6057	36210	65370	65383	65384	member																																																																																																																																																																17451064																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																AS-11772	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	N[C@@H](Cc1ccc(O)cc1)C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466777	181.18854	AS-11772	AS-11772 | AS-11772			MOABOX:5674	TH	Tyrosine hydroxylase inhibitor
SJ000832245-2	SJ000832245	2	MOABOX:5682	TWWFAXQOKNBUCR-UHFFFAOYSA-N	O=C(Cc1ccccc1)Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12	183721-15-5	ADORA3 antagonist	ADORA3																																																															CHEMBL88147											393595	9808770				virtual	10.1016/S0028-3908(97)00104-4	10.1021/jm300087j																																																																																																																																																														8863790	9258367	9667972	10579811	10636237	12166943	12238926	16821770	20202853	21511471	22468757	23200243	25497490																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									1.39136																																0.17392																																8																																1217	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-958-674|MOABOX:5682|ADORA3|ADORA3 antagonist	Clc1ccc2nc(NC(=O)Cc3ccccc3)n4nc(nc4c2c1)c5occc5	183721-15-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468119	403.82116	MRS 1220	MRS 1220 | MRS 1220			MOABOX:5682	ADORA3	ADORA3 antagonist
SJ000287797-5	SJ000287797	5	MOABOX:5687	GKJZEKSHCJELPL-UHFFFAOYSA-N	Cn1cc(C(F)(F)F)nc1-c1ccc(OCC(O)CNCCOc2ccc(O)c(C(N)=O)c2)cc1	105737-62-0	ADRB1 antagonist	ADRB1																																																															CHEMBL1256955	CHEMBL280822										2685	10008573	56972164	71297053		virtual	10.1016/0006-2952(91)90502-V																																																																																																																																																															11858844	11864632	17196553	17266607	21357659	23614528	28523097																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															2.3408																																0.2926																																8																																NB-48-0240-10MG	BIOTREND	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-940-677|MOABOX:5687|ADRB1|ADRB1 antagonist	Cn1cc(nc1c2ccc(OCC(O)CNCCOc3ccc(O)c(c3)C(=O)N)cc2)C(F)(F)F	105737-62-0	NA	GENERAL	METHANESULFONATE	1	NO_SOLVATE	0	1468355	494.46361	CGP 20712A METHANESULFONATE	CGP 20712A METHANESULFONATE | CGP 20712A HCL | CGP 20712A METHANESULFONATE | CGP 20712A HCL			MOABOX:5687	ADRB1	ADRB1 antagonist
SJ000287988-6	SJ000287988	6	MOABOX:5688	VFIDUCMKNJIJTO-CZUORRHYSA-N	Cc1ccc(OC[C@@H](O)[C@@H](C)NC(C)C)c2c1CCC2	72795-19-8	ADRB2 antagonist	ADRB2																																																																										6324629	56972148	76963609			virtual																																																																																																																																																																7938162	11356949	11454950	11864632	12606629	17266601	17266607	21688779	21726069	23023262	23466604	26988801	28471663																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									2.62552																																0.32819																																8																																BD630839	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-561-284|MOABOX:5688|ADRB2|ADRB2 antagonist	CC(C)N[C@H](C)[C@@H](O)COc1ccc(C)c2CCCc12	72795-19-8	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468658	277.40178	"ICI 118,551 HYDROCHLORIDE"	"ICI 118,551 HYDROCHLORIDE | ICI 118,551 HYDROCHLORIDE | | ICI-118,551 HCL | ICI 118,551 HYDROCHLORIDE | ICI 118,551 HYDROCHLORIDE | | ICI-118,551 HCL"			MOABOX:5688	ADRB2	ADRB2 antagonist
SJ001034967-1	SJ001034967	1	MOABOX:5689	UJTNRXYTECQKFO-QHCPKHFHSA-N	CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@H](C(=O)OC)C(C)C	137863-17-3	AGTR1 antagonist	AGTR1																																																															CHEMBL326349											11561462					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.23128																																0.15391																																8																																AG0013YW	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-038-941-697|MOABOX:5689|AGTR1|AGTR1 antagonist	CCCCC(=O)N(Cc1ccc(cc1)c2ccccc2c3nn[nH]n3)[C@@H](C(C)C)C(=O)OC	137863-17-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468393	449.54534	AG0013YW	AG0013YW | AG0013YW			MOABOX:5689	AGTR1	AGTR1 antagonist
SJ000855440-2	SJ000855440	2	MOABOX:5690	YSTVFDAKLDMYCR-NDEPHWFRSA-N	Cc1cc(Cn2cnc3c2C[C@@H](C(=O)O)N(C(=O)C(c2ccccc2)c2ccccc2)C3)ccc1N(C)C	130663-39-7	AGTR2 antagonist	AGTR2																																																															CHEMBL157946	CHEMBL321820										5311345	6604951	71308630	71751471		member	10.1152/ajpregu.00008.2003																																																																																																																																																															15537354																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.83632																																0.10454																																8																																HY-10259A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cardiovascular Disease; Endocrinology|MOABOX:5690|AGTR2|AGTR2 antagonist	CN(C)c1ccc(Cn2cnc3CN([C@@H](Cc23)C(=O)O)C(=O)C(c4ccccc4)c5ccccc5)cc1C	136676-91-0	10017	GENERAL	"2,2,2-TRIFLUOROACETATE"	2	NO_SOLVATE	0	1468842	508.61078	PD123319	PD123319 | PD123319	Pathway: GPCR/G Protein	Research Area: Cardiovascular Disease; Endocrinology	MOABOX:5690	AGTR2	AGTR2 antagonist
SJ000840394-2	SJ000840394	2	MOABOX:5694	UKMJWGFHXMGRNG-VZUYHUTRSA-O	CCCC[P+](CCCC)(CCCC)Cc1ccc(NC(=O)[C@@H](Cc2ccc3ccccc3c2)N/C(=N/C2CCCCC2)NC2CCCCC2)cc1		BDKRB2 antagonist	BDKRB2																																																															CHEMBL1315207	CHEMBL299701	CHEMBL555236									6604942	6604943	45266253	71297005	126479988	member	10.1177/1074248412437586																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																1057	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-710|MOABOX:5694|BDKRB2|BDKRB2 antagonist	CCCC[P](CCCC)(CCCC)Cc1ccc(NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=NC4CCCCC4)NC5CCCCC5)cc1	163727-74-0	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468197	712.02138	WIN 64338	WIN 64338 | WIN 64338			MOABOX:5694	BDKRB2	BDKRB2 antagonist
SJ001034891-1	SJ001034891	1	MOABOX:5698	UGMPOJSWOINMDE-UHFFFAOYSA-N	Nc1cc2c(cn1)[nH]c1ccccc12	114819-72-6	CCKAR antagonist	CCKAR																																																															CHEMBL2171526											119537	12858791	131844876			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																WXCD02506780	WUXI_APPTECH	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-004-948-228|MOABOX:5698|CCKAR|CCKAR antagonist	Nc1cc2c(cn1)[nH]c3ccccc23	114819-72-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468194	183.20926	WXCD02506780	WXCD02506780 | WXCD02506780			MOABOX:5698	CCKAR	CCKAR antagonist
SJ001034852-1	SJ001034852	1	MOABOX:5700	MEEJEEVTIVAOJP-UHFFFAOYSA-N	N#CC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1	193542-65-3	CCR1 antagonist;Chemokine US28 Receptor Inverse Agonists	CCR1																																																															CHEMBL34166											9889700	56972186				member	10.1016/S0014-2999(99)00863-8	10.1021/jm0004244	10.1358/dof.2001.026.02.609009	10.2174/1381612033454937																																																																																																																																																												9624164	10579830	11311066	12166951	12574358	12769747	16178722																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															1.58048																																0.19756																																8																																2769	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-572|MOABOX:5700|CCR1|CCR1 antagonist;Chemokine US28 Receptor Inverse Agonists	OC1(CCN(CCCC(C#N)(c2ccccc2)c3ccccc3)CC1)c4ccc(Cl)cc4	1216540-18-9	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468100	444.99566	BX 513 HCL | VUF 2274	"""BX 513 HCL | VUF 2274"" | ""BX 513 HCL | VUF 2274"""			MOABOX:5700	CCR1	CCR1 antagonist;Chemokine US28 Receptor Inverse Agonists
SJ000796116-2	SJ000796116	2	MOABOX:5702	VQHKDCUXFKNNMT-ODCIPOBUSA-O	CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1	202796-41-6	CCR3 antagonist	CCR1	CCR3																															1232																															CHEMBL277930	CHEMBL331897										6918496	6918497	23283025	70297949	70297950	member	10.1358/dof.2001.026.02.609009																																																																																																																																																															11311066	11354381	14505678																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.53296	0.80936																															0.31662	0.10117																															8	8																															CS-0027742	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-152-781|MOABOX:5702|CCR1|CCR3 antagonist	CC[N+]1(C\C\2=C\CCCCCC2)CCC(CC1)NC(=O)C3c4cc(Cl)ccc4Oc5ccc(Cl)cc35	353791-85-2	NA	GENERAL	IODIDE	1	NO_SOLVATE	0	1468488	528.53298	J 113863	J 113863 | J 113863			MOABOX:5702	CCR1	CCR3 antagonist
SJ000286049-8	SJ000286049	8	MOABOX:5706	VSWPGAIWKHPTKX-UHFFFAOYSA-N	Cc1scc2c1N(C(=O)CN1CCN(C)CC1)c1ccccc1NC2=O	127519-18-0	CHRM1 antagonist	CHRM1																																																															CHEMBL1256762	CHEMBL1257109	CHEMBL253978									5387	182856	6419995	20836617	20836618	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.22032																																0.15254																																8																																1122	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-959-660|MOABOX:5706|CHRM1|CHRM1 antagonist	CN1CCN(CC(=O)N2c3ccccc3NC(=O)c4csc(C)c24)CC1	147416-96-4	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468230	370.46858	TELENZEPINE HYDROCHLORIDE	TELENZEPINE HYDROCHLORIDE | TELENZEPINE DIHYDROCHLORIDE | TELENZEPINE HCL | TELENZEPINE HYDROCHLORIDE | TELENZEPINE DIHYDROCHLORIDE | TELENZEPINE HCL			MOABOX:5706	CHRM1	CHRM1 antagonist
SJ000287683-5	SJ000287683	5	MOABOX:5708	HYJRTXSYDAFGJK-UHFFFAOYSA-N	C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1	106458-69-9	CHRM3 antagonist	CHRM3																																																															CHEMBL168067	CHEMBL76897										1734	157949	3014059	24809663	53426078	virtual	10.1016/j.bmc.2010.07.034	10.1016/j.bmc.2013.03.016	10.1016/j.bmcl.2013.01.025	10.1016/j.bmcl.2018.03.093	10.1016/j.ejphar.2007.10.017	10.1016/j.ejphar.2009.03.006	10.1016/j.neuropharm.2006.02.002	10.1021/acs.jmedchem.8b01759	10.1021/cn5001606	10.1021/jm200536d	10.1021/jm401158e	10.1021/jm501203v	10.1124/jpet.110.173245																																																																																																																																																			15723094	16290166	16981004	17889543	18588282	18983139	20345348	20875743	21084390	21688779	21777010	23023262	23403082	23466604	23582449	24805037	25650309	26478787	26988801	27876250	27997171	28106992	28471663	28947942	29631962	30810314																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												1.49112																																0.18639																																8																																14574	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-940-940|MOABOX:5708|CHRM3|CHRM3 antagonist	C[N+]1(C)CCC(CC1)OC(=O)C(c2ccccc2)c3ccccc3	1952-15-4	NA	GENERAL	IODIDE	1	NO_SOLVATE	0	1468308	324.43664	4-DAMP METHIODIDE	4-DAMP METHIODIDE | 4-DIPHENYLACETOXY-N-METHYLPIPERIDINE IODIDE | 4-DAMP METHIODIDE | 4-DIPHENYLACETOXY-N-METHYLPIPERIDINE IODIDE			MOABOX:5708	CHRM3	CHRM3 antagonist
SJ000287224-2	SJ000287224	2	MOABOX:5711	GSYQNAMOFFWAPF-PPOBMCMBSA-N	C[N+]1([O-])[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21	56362-75-5	CHRM5 antagonist	CHRM5																																																															CHEMBL1731448	CHEMBL1740879															virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																T2181	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-337-900|MOABOX:5711|CHRM5|CHRM5 antagonist	C[N+]1([O-])[C@@H]2C[C@H](C[C@H]1[C@@H]3O[C@H]23)OC(=O)[C@H](CO)c4ccccc4	6106-81-6	NA	GENERAL	BROMIDE	1	NO_SOLVATE	0	1468138	319.35234	SCOPOLAMIN-N-OXIDE HYDROBROMIDE	SCOPOLAMIN-N-OXIDE HYDROBROMIDE | SCOPOLAMIN-N-OXIDE HYDROBROMIDE			MOABOX:5711	CHRM5	CHRM5 antagonist
SJ001035272-1	SJ001035272	1	MOABOX:5713	JHOTYHDSLIUKCJ-UHFFFAOYSA-N	COc1ccc(C(=O)c2c(C)n(CCN3CCOCC3)c3cc(I)ccc23)cc1	164178-33-0	CNR2 antagonist	CNR2																																																															CHEMBL181633											4302963					virtual	10.1016/S0014-5793(03)00048-6	10.1016/j.bmc.2014.06.008	10.1016/j.ejmech.2018.05.019	10.1021/acsmedchemlett.7b00396	10.1021/jm801353p	10.1038/sj.bjp.0702351	10.1038/sj.bjp.0707347	10.2174/156802608783498014																																																																																																																																																								10188977	15664857	15892633	15974990	16026310	16712486	16918457	17828286	17942307	17982478	18026124	18038967	18289088	18537620	19115816	20166927	20218623	21183257	21867920	24984935	27560280	28626532	29259753	29360044	29407590	29793210	30359820																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											3.02584																																0.37823																																8																																HY-15421	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:5713|CNR2|CNR2 antagonist	COc1ccc(cc1)C(=O)c2c(C)n(CCN3CCOCC3)c4cc(I)ccc24	164178-33-0	19243	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469446	504.36067	6-IODOPRAVADOLINE | AM630	"""6-IODOPRAVADOLINE | AM630"" | ""6-IODOPRAVADOLINE | AM630"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:5713	CNR2	CNR2 antagonist
SJ001034963-1	SJ001034963	1	MOABOX:5714	IXPROWGEHNVJOY-UHFFFAOYSA-N	CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C	157284-96-3	CRHR1 antagonist	CRHR1																																																															CHEMBL296641											177990	11787563	16078945			virtual	10.1016/j.bmcl.2004.05.019	10.1016/j.bmcl.2004.05.056																																																																																																																																																														10072681	16078829	16134945	16378503	16712469	16750175	17073626	22104142	26335976																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0.8824																																0.1103																																8																																1321	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-575|MOABOX:5714|CRHR1|CRHR1 antagonist	CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2c3c(C)cc(C)cc3C	220953-69-5	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468380	378.55356	ANTALARMIN HCL	ANTALARMIN HCL | ANTALARMIN HCL			MOABOX:5714	CRHR1	CRHR1 antagonist
SJ000840355-2	SJ000840355	2	MOABOX:5715	MQBZVUNNWUIPMK-UHFFFAOYSA-N	O=C(Nc1ccc([N+](=O)[O-])cc1O)Nc1ccccc1Br	182498-32-4	CXCR2 antagonist	CXCR2																																																															CHEMBL239767											3854666	88063432	88157582			virtual	10.1002/(SICI)1098-1128(200003)20:2<155::AID-MED3>3.0.CO;2-G	10.1016/S0006-2952(02)01619-2	10.1016/S0968-0896(03)00399-7	10.1016/j.bmc.2005.08.026	10.1016/j.bmcl.2006.12.067	10.1021/jm300682j	10.1074/jbc.273.17.10095																																																																																																																																																									10723026	12901923	16182534	17236763	19200021	22931505	25254640	25933594	26153616																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3.97072																																0.49634																																8																																HY-16711	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation | Research Area: Inflammation/Immunology; Endocrinology; Cancer|MOABOX:5715|CXCR2|CXCR2 antagonist	Oc1cc(ccc1NC(=O)Nc2ccccc2Br)[N+](=O)[O-]	182498-32-4	14352	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469724	352.1402	SB 225002	SB 225002 | SB 225002	Pathway: GPCR/G Protein; Immunology/Inflammation	Research Area: Inflammation/Immunology; Endocrinology; Cancer	MOABOX:5715	CXCR2	CXCR2 antagonist
SJ000833153-3	SJ000833153	3	MOABOX:5723	DKMFBWQBDIGMHM-UHFFFAOYSA-N	CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1	1622-79-3	DRD2 antagonist	DRD2																																																															CHEMBL1531134											15387	9926325	23617544	124159960	141920116	virtual																																																																																																																																																																16613551																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.67448																																0.08431																																8																																19770	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-019-939-228|MOABOX:5723|DRD2|DRD2 antagonist	CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1	1622-79-3	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468312	263.35038	MELPERONE HCL	MELPERONE HCL | MELPERONE HCL			MOABOX:5723	DRD2	DRD2 antagonist
SJ001035059-1	SJ001035059	1	MOABOX:5724	PCIWCYUKRZFCMF-UHFFFAOYSA-N	COc1cccc(C(=O)NC2CC3CCC(C2)N3Cc2ccccc2)c1OC	109021-66-1	DRD2 antagonist	DRD2																																																															CHEMBL75876											3065827	3065828	131954720			virtual																																																																																																																																																																15816047																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.58216																																0.36888																																7																																Z1173261445	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-464-481|MOABOX:5724|DRD2|DRD2 antagonist	COc1cccc(C(=O)NC2CC3CCC(C2)N3Cc4ccccc4)c1OC	109021-66-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468565	380.48002	Z1173261445	Z1173261445 | Z1173261445			MOABOX:5724	DRD2	DRD2 antagonist
SJ000288243-5	SJ000288243	5	MOABOX:5725	UOLJKAPABHXFRE-UHFFFAOYSA-N	CCCN(CCC)C1Cc2cc(OC)c(OC)cc2C1	1217227-99-0	DRD3 antagonist	DRD3																																																															CHEMBL1256838	CHEMBL16410	CHEMBL543760									5626	119195	11957713	24848644	53447313	virtual																																																																																																																																																																9353400	12362359	12369994	16613551	16613552																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.4452																																0.18065																																8																																1069	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-959-849|MOABOX:5725|DRD3|DRD3 antagonist	CCCN(CCC)C1Cc2cc(OC)c(OC)cc2C1	234757-41-6	NA	GENERAL	MALEATE	1	NO_SOLVATE	0	1468386	277.40178	U-99194A MALEATE	U-99194A MALEATE | U-99194A MALEATE			MOABOX:5725	DRD3	DRD3 antagonist
SJ001034838-1	SJ001034838	1	MOABOX:5727	BRLVOVGBNYPHBQ-UHFFFAOYSA-N	Clc1cccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)c1		DRD4 antagonist	DRD4																																																															CHEMBL77151											2099556					virtual																																																																																																																																																																15084133	17073641																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				4.27136																																0.53392																																8																																Z55621860	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-728-587|MOABOX:5727|DRD4|DRD4 antagonist	Clc1cccc(c1)N2CCN(Cc3nc4ccccc4[nH]3)CC2	444724-92-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468080	326.82326	Z55621860	Z55621860 | Z55621860			MOABOX:5727	DRD4	DRD4 antagonist
SJ000840375-2	SJ000840375	2	MOABOX:5731	AVXQPEKZIGPIJW-UHFFFAOYSA-N	CC(C)c1ccc(Cn2ccc3c4c(N)nc(NC5CC5)nc4ccc32)cc1	1216720-69-2	F2R antagonist;PAR1 antagonist	F2R																																																															CHEMBL63426											4259181	45073452	71297091	86346659		member	10.1016/S0006-2952(00)00460-3	10.1016/S0960-894X(99)00339-X	10.1111/j.1476-5381.2012.01974.x	10.1111/j.1742-7843.2007.00078.x	10.2174/092986706775476070	10.2174/1381612033453884	10.2174/138955708783955971	10.2174/1568016033356706	10.2174/1568026033452122																																																																																																																																																							10450984	12769712	14529396	15186843	15389730	16475935	16942011	17577318	18473926	25937878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												2.89464																																0.36183																																8																																1275	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-680|MOABOX:5731|F2R|F2R antagonist;PAR1 antagonist	CC(C)c1ccc(Cn2ccc3c2ccc4nc(NC5CC5)nc(N)c34)cc1	1216720-69-2	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468232	371.4781	SCH 79797 DIHYDROBROMIDE	SCH 79797 DIHYDROBROMIDE | SCH 79797 DIHYDROBROMIDE			MOABOX:5731	F2R	F2R antagonist;PAR1 antagonist
SJ001034978-1	SJ001034978	1	MOABOX:5736	LPAQYRVMHQPHSA-UHFFFAOYSA-N	CCN(CC)CCN1C(=O)C2C(C(=O)Nc3ccc(Cl)c(Cl)c3)C3C=CC2(O3)C1C(=O)NC1CCCCC1	1044597-57-0	GHSR antagonist	GHSR																																																																										46503924					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.5																																0.5																																7																																C073-3979	CHEMDIV	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-035-692-085|MOABOX:5736|GHSR|GHSR antagonist	CCN(CC)CCN1C(C(=O)NC2CCCCC2)C34O[C@@H](C=C3)C([C@H]4C1=O)C(=O)Nc5ccc(Cl)c(Cl)c5	1044597-57-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468420	563.51584	C073-3979	C073-3979 | C073-3979			MOABOX:5736	GHSR	GHSR antagonist
SJ001007685-2	SJ001007685	2	MOABOX:5737	OFHXXBRBGWUOHR-NYYWCZLTSA-N	COc1ccc(C(=O)N2CCN(C(=O)/C=C/c3ccc(Br)cc3)CC2)cc1	1599432-08-2	GPR183 antagonist	GPR183																																																															CHEMBL3262896											36295259					member	10.1021/jm4019355																																																																																																																																																															24678947																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.992																																0.374																																8																																HY-12336	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Inflammation/Immunology|MOABOX:5737|GPR183|GPR183 antagonist	COc1ccc(cc1)C(=O)N2CCN(CC2)C(=O)\C=C\c3ccc(Br)cc3	1599432-08-2	13616	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468961	429.30704	NIBR189	NIBR189 | NIBR189	Pathway: GPCR/G Protein	Research Area: Inflammation/Immunology	MOABOX:5737	GPR183	GPR183 antagonist
SJ001034998-1	SJ001034998	1	MOABOX:5738	CYNLZIBKERMMOA-AWQFTUOYSA-N	COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)NC(C)(C)C	264233-05-8	GPR35 antagonist	GPR35																																																															CHEMBL1708510											9581011					member																																																																																																																																																																23888932	27989666																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.7052																																0.33815																																8																																12046	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-925-739|MOABOX:5738|GPR35|GPR35 antagonist	COC(=O)c1cnn(c1\C=N\NC(=S)NC(C)(C)C)c2ccc(F)cc2F	264233-05-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468449	395.42687	CID-2745687 | ML-194	"""CID-2745687 | ML-194"" | ""CID-2745687 | ML-194"""			MOABOX:5738	GPR35	GPR35 antagonist
SJ001035175-1	SJ001035175	1	MOABOX:5742	HXPQWNPLNIEJOW-UHFFFAOYSA-N	CCc1nn2c(C)cc(C)nc2c1Cc1ccc(-c2nnc(C3CCNCC3)o2)cc1	1401728-56-0	GPR4 antagonist	GPR4																																																															CHEMBL3675743											68379135	144449081				member	10.1021/acs.jmedchem.6b01703																																																																																																																																																															28445047																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.44816																																0.43102																																8																																HY-101784	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Inflammation/Immunology|MOABOX:5742|GPR4|GPR4 antagonist	CCc1nn2c(C)cc(C)nc2c1Cc3ccc(cc3)c4oc(nn4)C5CCNCC5	1401728-56-0	64445	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468990	416.51872	NE 52-QQ57	NE 52-QQ57 | NE 52-QQ57	Pathway: Others	Research Area: Inflammation/Immunology	MOABOX:5742	GPR4	GPR4 antagonist
SJ001034984-1	SJ001034984	1	MOABOX:5749	WMCBPITWUUHVJB-UHFFFAOYSA-N	O=S(=O)(c1ccc(Cl)cc1)N1CCCC1c1cccs1		GRM1 antagonist	GRM1																																																															CHEMBL1076546											2805672					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.34664																																0.16833																																8																																9249735	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-896-852|MOABOX:5749|GRM1|GRM1 antagonist	Clc1ccc(cc1)S(=O)(=O)N2CCCC2c3cccs3	298689-98-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468427	327.84946	9249735	9249735 | 9249735			MOABOX:5749	GRM1	GRM1 antagonist
SJ000852515-2	SJ000852515	2	MOABOX:5752	NNFUWNLENRUDHR-HKBQPEDESA-N	COc1ccc(C2(CNC(=O)[C@](C)(Cc3c[nH]c4ccccc34)NC(=O)Nc3ccc([N+](=O)[O-])cc3)CCCCC2)nc1	204067-01-6	GRPR antagonist;NMBR antagonist;FPR agonist	FPR1	FPR2	GRPR	NMBR																													2358	2925	4829																													CHEMBL405908											9829828					member	10.1016/j.peptides.2009.05.007	10.1124/mol.110.068288																																																																																																																																																														9873586	20943772	22741605	27863916																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		-0.71168	-0.79968	0.37176	2.31488																													-0.08896	-0.09996	0.04647	0.28936																													8	8	8	8																													CS-0027145	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-822-704|MOABOX:5752|FPR1|GRPR antagonist;NMBR antagonist;FPR agonist	COc1ccc(nc1)C2(CNC(=O)[C@](C)(Cc3c[nH]c4ccccc34)NC(=O)Nc5ccc(cc5)[N+](=O)[O-])CCCCC2	204067-01-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468410	584.66544	PD 176252	PD 176252 | PD 176252			MOABOX:5752	FPR1	GRPR antagonist;NMBR antagonist;FPR agonist
SJ000852515-3	SJ000852515	3	MOABOX:5752	NNFUWNLENRUDHR-HKBQPEDESA-N	COc1ccc(C2(CNC(=O)[C@](C)(Cc3c[nH]c4ccccc34)NC(=O)Nc3ccc([N+](=O)[O-])cc3)CCCCC2)nc1	204067-01-6	GRPR antagonist;NMBR antagonist;FPR agonist	FPR1	FPR2	GRPR	NMBR																													2358	2925	4829																													CHEMBL405908											9829828					member	10.1016/j.peptides.2009.05.007	10.1124/mol.110.068288																																																																																																																																																														9873586	20943772	22741605	27863916																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		-0.71168	-0.79968	0.37176	2.31488																													-0.08896	-0.09996	0.04647	0.28936																													8	8	8	8																													AG007QFE	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-737-997|MOABOX:5752|FPR1|GRPR antagonist;NMBR antagonist;FPR agonist	COc1ccc(nc1)C2(CNC(=O)[C@](C)(Cc3c[nH]c4ccccc34)NC(=O)Nc5ccc(cc5)[N+](=O)[O-])CCCCC2	204067-01-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468632	584.66544	PD 176252	PD 176252 | PD 176252			MOABOX:5752	FPR1	GRPR antagonist;NMBR antagonist;FPR agonist
SJ000285491-10	SJ000285491	10	MOABOX:5755	CBEQULMOCCWAQT-WOJGMQOQSA-N	Cc1ccc(/C(=C\CN2CCCC2)c2ccccn2)cc1	10191-42-1	HRH1 antagonist	HRH1																																																															CHEMBL1200450	CHEMBL3188034	CHEMBL855									5282443	5284472	5702129	6437831	11497510	virtual																																																																																																																																																																8496700	10514483	16782354	21558436	22007643	23181587																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.21696																																0.15212																																8																																J10677	AK_SCIENTIFIC	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-303|MOABOX:5755|HRH1|HRH1 antagonist	Cc1ccc(cc1)\C(=C/CN2CCCC2)\c3ccccn3	550-70-9	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468259	278.39138	TRIPROLIDINE HYDROCHLORIDE	TRIPROLIDINE HYDROCHLORIDE | TRANS-TRIPROLIDINE HYDROCHLORIDE | | TRANS-TRIPROLIDINE HCL | TRIPROLIDINE HYDROCHLORIDE | TRANS-TRIPROLIDINE HYDROCHLORIDE | | TRANS-TRIPROLIDINE HCL			MOABOX:5755	HRH1	HRH1 antagonist
SJ000832233-2	SJ000832233	2	MOABOX:5757	YDDXVAXDYKBWDX-UHFFFAOYSA-N	C/N=C(\NC#N)NCCSCc1csc(N=C(N)N)n1	145066-38-2	HRH2 antagonist	HRH2																																																															CHEMBL269646											50287	18964639	88749896			virtual	10.1016/j.bmcl.2013.01.025	10.1021/jm501203v																																																																																																																																																														15947036	23181587	23403082	26478787																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.65408																																0.33176																																8																																826	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-275-939|MOABOX:5757|HRH2|HRH2 antagonist	CN=C(NCCSCc1csc(N=C(N)N)n1)NC#N	69014-14-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468716	312.41764	TIOTIDINE	TIOTIDINE | TIOTIDINE			MOABOX:5757	HRH2	HRH2 antagonist
SJ000855509-5	SJ000855509	5	MOABOX:5758	SMTZFNFIKUPEJC-UHFFFAOYSA-N	CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1	78628-28-1	HRH2 antagonist	HRH2																																																															CHEMBL2104871	CHEMBL46102										5105	56704	11503202	45114193	66700131	virtual																																																																																																																																																																16220969																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					6.64e-003																																0.00083																																8																																HY-B0305A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling | Research Area: Inflammation/Immunology|MOABOX:5758|HRH2|HRH2 antagonist	CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1	93793-83-0	16016	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469738	348.43662	ROXATIDINE ACETATE HCL	ROXATIDINE ACETATE HCL | ROXATIDINE ACETATE HCL	Pathway: GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Research Area: Inflammation/Immunology	MOABOX:5758	HRH2	HRH2 antagonist
SJ001035207-1	SJ001035207	1	MOABOX:5762	GUJLUPNSRRNJKP-UHFFFAOYSA-N	Cc1nc(N2CCN(C)CC2)c2oc3ccc(Cl)cc3c2n1	848217-00-5	HRH4 antagonist	HRH4																																																															CHEMBL1091558											3934857					member	10.1016/j.bmcl.2010.02.097																																																																																																																																																															20299215																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.0192																																0.3774																																8																																HY-114025	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling | Research Area: Neurological Disease; Endocrinology|MOABOX:5762|HRH4|HRH4 antagonist	CN1CCN(CC1)c2nc(C)nc3c2oc4ccc(Cl)cc34	848217-00-5	36847	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469104	316.78538	H4 RECEPTOR ANTAGONIST 1	H4 RECEPTOR ANTAGONIST 1 | H4 RECEPTOR ANTAGONIST 1	Pathway: GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Research Area: Neurological Disease; Endocrinology	MOABOX:5762	HRH4	HRH4 antagonist
SJ000833139-2	SJ000833139	2	MOABOX:5763	BVMYCHKQPGEOSI-UHFFFAOYSA-N	O=C1CC2(CCCC2)CC(=O)N1CCNCC1COc2ccccc2O1	102908-59-8	HTR1A antagonist	HTR1A																																																															CHEMBL1487115	CHEMBL2218891										60769	71346	23581829	45114244	56972149	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																8																																411	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-275-885|MOABOX:5763|HTR1A|HTR1A antagonist	O=C1CC2(CCCC2)CC(=O)N1CCNCC3COc4ccccc4O3	102908-60-1	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468717	358.43144	MDL 73005EF HCL	MDL 73005EF HCL | MDL 73005EF HCL			MOABOX:5763	HTR1A	HTR1A antagonist
SJ000288224-4	SJ000288224	4	MOABOX:5764	ATQMRMGXINTJHV-UHFFFAOYSA-N	Cc1nc(-c2ccc(-c3ccc(C(=O)N4CCc5cc6c(cc54)C4(CCN(C)CC4)CO6)cc3)c(C)c2)no1	180083-23-2	HTR1B antagonist	HTR1B																																																															CHEMBL1256869	CHEMBL281350										3378093	9895128	11226716	138756145		virtual																																																																																																																																																																9548813	9776361	12052194	12774693	15816047	16143528																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.64936																																0.20617																																8																																HY-101105A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:5764|HTR1B|HTR1B antagonist	CN1CCC2(CC1)COc3cc4CCN(C(=O)c5ccc(cc5)c6ccc(cc6C)c7noc(C)n7)c4cc23	180084-26-8	79040	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469438	520.62148	SB 224289 HYDROCHLORIDE	SB 224289 HYDROCHLORIDE | SB 224289 HYDROCHLORIDE	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:5764	HTR1B	HTR1B antagonist
SJ000288030-4	SJ000288030	4	MOABOX:5765	YDBCEBYHYKAFRX-UHFFFAOYSA-N	COc1ccc(NC(=O)c2ccc(-c3ccc(-c4noc(C)n4)cc3C)cc2)cc1N1CCN(C)CC1	1049739-35-6	HTR1D antagonist	HTR1D																																																															CHEMBL1256656	CHEMBL15928										107780	9811580	11497466	16219423	24848519	virtual	10.1007/BF00168751	10.1007/BF00178713	10.1007/PL00005058																																																																																																																																																													8057272	9548813	10669578	11472239	16143528	16465176																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																2.1972																																0.27465																																8																																RAM0238	RAMIDUS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-941-511|MOABOX:5765|HTR1D|HTR1D antagonist	COc1ccc(NC(=O)c2ccc(cc2)c3ccc(cc3C)c4noc(C)n4)cc1N5CCN(C)CC5	148672-13-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468533	497.58814	GR 127935 HYDROCHLORIDE	GR 127935 HYDROCHLORIDE | GR 127935 HYDROCHLORIDE			MOABOX:5765	HTR1D	HTR1D antagonist
SJ001034894-1	SJ001034894	1	MOABOX:5766	AFZLABYDOCWQBQ-WOJBJXKFSA-N	COc1cccc(CCc2ccccc2OCC[C@@H]2C[C@@H](O)CN2C)c1	167144-79-8	HTR2A antagonist	HTR2A																																																															CHEMBL1415927	CHEMBL1619948										10668211	16759150	71297062			virtual	10.1016/S0014-2999(02)02654-7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.27912																																-0.03489																																8																																1742	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-853|MOABOX:5766|HTR2A|HTR2A antagonist	COc1cccc(CCc2ccccc2OCC[C@@H]3C[C@@H](O)CN3C)c1	167144-80-1	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468199	355.47056	R-96544 HCL	R-96544 HCL | R-96544 HCL			MOABOX:5766	HTR2A	HTR2A antagonist
SJ000287744-6	SJ000287744	6	MOABOX:5768	USFUFHFQWXDVMH-UHFFFAOYSA-N	Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1	152239-46-8	HTR2B antagonist	HTR2B																																																															CHEMBL323356											3277600					virtual																																																																																																																																																																15131246																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.18168																																0.14771																																8																																AA00AK1D	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-959-484|MOABOX:5768|HTR2B|HTR2B antagonist	Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1	152239-46-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468641	286.35216	SB 204741	SB 204741 | SB 204741			MOABOX:5768	HTR2B	HTR2B antagonist
SJ000840357-2	SJ000840357	2	MOABOX:5769	HZZZZODVDSHQRG-UHFFFAOYSA-N	COc1cc(OC)c(C(=O)CCCCN2CCC3(CC2)NC(=O)NC3=O)cc1NS(=O)(=O)c1ccc(C(F)(F)F)cc1	185376-97-0	5-HT2C Antagonists;HTR2C antagonist	HTR2C																																																															CHEMBL88402											3693566	18931299	71297001	71312014		member	10.1016/j.bmc.2013.03.016																																																																																																																																																															18983139	23023262	23466604	23582449	24805037	25557493	26988801	27876250																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														3.61416																																0.45177																																8																																31543	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-219-195|MOABOX:5769|HTR2C|5-HT2C Antagonists;HTR2C antagonist	COc1cc(OC)c(cc1NS(=O)(=O)c2ccc(cc2)C(F)(F)F)C(=O)CCCCN3CCC4(CC3)NC(=O)NC4=O	187397-18-8	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468327	612.61785	RS 102221 HYDROCHLORIDE	RS 102221 HYDROCHLORIDE | RS 102221 HYDROCHLORIDE			MOABOX:5769	HTR2C	5-HT2C Antagonists;HTR2C antagonist
SJ001034909-1	SJ001034909	1	MOABOX:5771	BKVIWGRFRKLFIO-UHFFFAOYSA-N	COc1cc(COc2cc(N)c(Cl)cc2C(=O)CCC2CCN(CCNS(C)(=O)=O)CC2)cc(OC)c1	161362-65-8	HTR4 antagonist	HTR4																																																															CHEMBL586946	CHEMBL66114										5145950	19081934	56927923	71297040		virtual																																																																																																																																																																12052197	17293885																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																8																																991	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-275-971|MOABOX:5771|HTR4|HTR4 antagonist	COc1cc(COc2cc(N)c(Cl)cc2C(=O)CCC3CCN(CCNS(=O)(=O)C)CC3)cc(OC)c1	167710-87-4	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468218	554.09854	RS 39604 HCL	RS 39604 HCL | RS 39604 HCL			MOABOX:5771	HTR4	HTR4 antagonist
SJ001035020-1	SJ001035020	1	MOABOX:5773	AGVNHDNTFYHZNL-QGZVFWFLSA-N	Cc1cccc(S(=O)(=O)N(C)[C@H](C)CCN2CCC(C)CC2)c1	1217674-10-6	5-HT7 Antagonists	HTR7																																																															CHEMBL12264											5312148	56972181				member																																																																																																																																																																9513592	9720804	10821781	10843226	12070528	12161155	12825922	14667218	15032609	17897083	23541835	26706111																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										2.83784																																0.35473																																8																																CS-0035396	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-419-096|MOABOX:5773|HTR7|5-HT7 Antagonists	C[C@H](CCN1CCC(C)CC1)N(C)S(=O)(=O)c2cccc(C)c2	195199-95-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468492	338.508	SB 258719	SB 258719 | SB 258719			MOABOX:5773	HTR7	5-HT7 Antagonists
SJ000833864-2	SJ000833864	2	MOABOX:5776	WWQTWEWAPUCDDZ-QGZVFWFLSA-N	Cc1noc(-c2ccc(-c3ccc(CC(=O)O)cc3)cc2)c1NC(=O)O[C@H](C)c1ccccc1Cl	1228690-19-4	LPAR1 antagonist	LPAR1																																																															CHEMBL3621966											46240292					member	10.1111/j.1476-5381.2010.00828.x	10.1124/jpet.110.175901																																																																																																																																																														20649573	21159750																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.778																																0.34725																																8																																HY-15277	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Inflammation/Immunology|MOABOX:5776|LPAR1|LPAR1 antagonist	C[C@@H](OC(=O)Nc1c(C)noc1c2ccc(cc2)c3ccc(CC(=O)O)cc3)c4ccccc4Cl	1228690-19-4	7797	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469344	490.93492	AM-966	AM-966 | AM-966	Pathway: GPCR/G Protein	Research Area: Inflammation/Immunology	MOABOX:5776	LPAR1	LPAR1 antagonist
SJ000796142-2	SJ000796142	2	MOABOX:5778	WCGXJPFHTHQNJL-UHFFFAOYSA-N	CCc1cc(C(C)=O)c(O)cc1OCCCCCC(C)(C)c1nn[nH]n1	117690-79-6	LTB4R2 antagonist	LTB4R2																																																															CHEMBL15766											122023					virtual	10.1074/jbc.M109.083477																																																																																																																																																															7473568																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.74704																																0.09338																																8																																AA007QR4	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-938-975|MOABOX:5778|LTB4R2|LTB4R2 antagonist	CCc1cc(C(=O)C)c(O)cc1OCCCCCC(C)(C)c2nn[nH]n2	117690-79-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468285	360.45062	LY 255283	LY 255283 | LY 255283			MOABOX:5778	LTB4R2	LTB4R2 antagonist
SJ001034661-1	SJ001034661	1	MOABOX:5792	BVSGXWCTWBZFEV-UHFFFAOYSA-N	OCc1cccc2[nH]ccc12	1074-85-7	OPRL1 antagonist	OPRL1																																																																										2773457	70166038				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																SS-6026	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OCc1cccc2[nH]ccc12	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466772	147.17386	SS-6026	SS-6026 | SS-6026			MOABOX:5792	OPRL1	OPRL1 antagonist
SJ000287962-5	SJ000287962	5	MOABOX:5794	MWIASLNTAGRGGA-OTALZHNTSA-N	Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(CC2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1		OXTR antagonist	OXTR																																																															CHEMBL1450525	CHEMBL1621006										11957584	11957585	53313188	134695275		member	10.1021/jm00031a004																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																ST110573	TIMTEC	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-947-506|MOABOX:5794|OXTR|OXTR antagonist	Cc1ccccc1N2CCN(CC2)S(=O)(=O)C[C@]34CCC(CC3NC(=O)[C@@H](N)CCS(=O)(=O)C)C4(C)C	160312-62-9	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468513	554.76548	"L-368,899"	"L-368,899 | L-368,899"			MOABOX:5794	OXTR	OXTR antagonist
SJ000287586-5	SJ000287586	5	MOABOX:5809	BYYQYXVAWXAYQC-IBGZPJMESA-N	CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OCc1cc(C(F)(F)F)cc(C(F)(F)F)c1	148451-96-1	TACR1 antagonist	TACR1																																																															CHEMBL22870											132837					virtual	10.1016/S0960-894X(98)00395-3	10.1021/jm00006a011	10.1021/jm00006a012	10.1021/jm00035a006	10.1021/jm00066a015	10.2174/1389557043487376																																																																																																																																																										7509807	7513763	7535362	7699709	8393115	9733486	9873524	15032679	17516639	18266313	18821747	19762245	20560643	20617791	21366266	23899615	26212775																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					5.152																																0.644																																8																																HY-101249	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Cancer; Neurological Disease|MOABOX:5809|TACR1|TACR1 antagonist	CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OCc3cc(cc(c3)C(F)(F)F)C(F)(F)F	148451-96-1	67664	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469635	472.38034	"L-732,138"	"L-732,138 | L-732,138"	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Cancer; Neurological Disease	MOABOX:5809	TACR1	TACR1 antagonist
SJ001035376-1	SJ001035376	1	MOABOX:5815	ZKUCFFYOQOJLGT-UHFFFAOYSA-N	CCCn1c(=O)c2[nH]c(-c3ccc(OCC(=O)Nc4ccc(C(C)=O)cc4)cc3)nc2n(CCC)c1=O	264622-53-9	ADORA2B antagonist	ADORA2B																																																															CHEMBL17002											5139184					virtual																																																																																																																																																																10737749	16375751	16380972	16847822	20370659	20537438																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																2.94904																																0.36863																																8																																HY-103186	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Inflammation/Immunology|MOABOX:5815|ADORA2B|ADORA2B antagonist	CCCN1C(=O)N(CCC)c2nc([nH]c2C1=O)c3ccc(OCC(=O)Nc4ccc(cc4)C(=O)C)cc3	264622-53-9	36115	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469834	503.54966	MRS-1706	MRS-1706 | MRS-1706	Pathway: GPCR/G Protein	Research Area: Inflammation/Immunology	MOABOX:5815	ADORA2B	ADORA2B antagonist
SJ001035090-1	SJ001035090	1	MOABOX:5816	CEBYCSRFKCEUSW-UHFFFAOYSA-N	COc1ccc(S(=O)(=O)N2c3ccc(Cl)cc3C(O)(c3ccccc3Cl)C2C(=O)N2CCCC2C(N)=O)cc1OC		AVPR1A antagonist	AVPR1A																																																																										10168002					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.5																																0.5																																7																																SYN5553	AK_SCIENTIFIC	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-390|MOABOX:5816|AVPR1A|AVPR1A antagonist	COc1ccc(cc1OC)S(=O)(=O)N2[C@@H](C(=O)N3CCC[C@H]3C(=O)N)[C@@](O)(c4ccccc4Cl)c5cc(Cl)ccc25	150375-75-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468666	620.50088	RELCOVAPTAN	RELCOVAPTAN | RELCOVAPTAN			MOABOX:5816	AVPR1A	AVPR1A antagonist
SJ000840392-2	SJ000840392	2	MOABOX:5817	ILNRQFBVVQUOLP-UHFFFAOYSA-N	O=C(O)Cn1c(C(=O)Nc2nc(-c3ccccc3Cl)cs2)cc2ccccc21	136381-85-6	CCKAR antagonist	CCKAR																																																															CHEMBL249973											122077	71728480	145841876			virtual	10.1006/bbrc.1995.2206	10.1016/S0014-2999(99)00612-3	10.1016/S0014-2999(99)00894-8	10.2174/156802607780960519																																																																																																																																																												8397341	10581329	12110612	17584143	17933530	21728335																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																2.52744																																0.31593																																8																																HY-101764	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Metabolic Disease|MOABOX:5817|CCKAR|CCKAR antagonist	OC(=O)Cn1c(cc2ccccc12)C(=O)Nc3nc(cs3)c4ccccc4Cl	136381-85-6	59007	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469026	411.86146	SR 27897	SR 27897 | SR 27897	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Metabolic Disease	MOABOX:5817	CCKAR	CCKAR antagonist
SJ000786021-3	SJ000786021	3	MOABOX:5826	ZODSPDOOCZZEIM-BBRMVZONSA-N	C[C@H](NC[C@H](O)CP(=O)(O)Cc1ccccc1)c1ccc(Cl)c(Cl)c1	148056-42-2	GABBR1 antagonist	GABBR1																																																															CHEMBL455185											5311042	9954841				virtual																																																																																																																																																																7905214	11082110																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.19312																																0.14914																																8																																1248	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-019-939-009|MOABOX:5826|GABBR1|GABBR1 antagonist	C[C@H](NC[C@H](O)CP(=O)(O)Cc1ccccc1)c2ccc(Cl)c(Cl)c2	149184-22-5	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468644	402.25194	CGP 55845 HYDROCHLORIDE | CGP-55845A |	"""CGP 55845 HYDROCHLORIDE | CGP-55845A |"" | CGP 55845 HCL | ""CGP 55845 HYDROCHLORIDE | CGP-55845A |"" | CGP 55845 HCL"			MOABOX:5826	GABBR1	GABBR1 antagonist
SJ000796009-2	SJ000796009	2	MOABOX:5828	YOLTZIVRJAPVPH-UHFFFAOYSA-N	Brc1cc2c(cc1C1Nc3ccccc3C3C=CCC31)OCO2	1005086-82-7	GPER antagonist	GPER1																																																															CHEMBL1540742											3136844					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																CS-0027916	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-019-939-285|MOABOX:5828|GPER1|GPER antagonist	Brc1cc2OCOc2cc1[C@@H]3Nc4ccccc4[C@@H]5C=CC[C@H]35	1161002-05-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468171	370.23984	G-15	G-15 | G-15			MOABOX:5828	GPER1	GPER antagonist
SJ001034897-1	SJ001034897	1	MOABOX:5829	STCVFKBRXOEQRF-YBEGLDIGSA-N	Clc1cccc(Cl)c1/C(=C/n1cncn1)OC1CCCCCC1	246852-46-0	GRM2 antagonist	GRM2																																																															CHEMBL305406											10428048					member	10.1021/jm000007r																																																																																																																																																															10893301																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.424																																0.053																																8																																2913	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-599|MOABOX:5829|GRM2|GRM2 antagonist	Clc1cccc(Cl)c1\C(=C\n2cncn2)\OC3CCCCCC3	246852-46-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468203	352.25826	RO 64-5229	RO 64-5229 | RO 64-5229			MOABOX:5829	GRM2	GRM2 antagonist
SJ000840393-2	SJ000840393	2	MOABOX:5832	SEQAMPXQRKYYQF-UHFFFAOYSA-N	CN(C)CCN(Cc1ccc(-c2ccc(CNCCc3ccccc3)cc2)cc1)C(=O)CCC1CCCC1	791789-61-2	HTR5A antagonist	HTR1B	HTR5A																															3361																															CHEMBL1181770	CHEMBL191460	CHEMBL535371									11168182	11983346	44397670			member																																																																																																																																																																16002289	20166946																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.4712	0.92456																															0.0589	0.11557																															8	8																															1469	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-019-879-461|MOABOX:5832|HTR1B|HTR5A antagonist	CN(C)CCN(Cc1ccc(cc1)c2ccc(CNCCc3ccccc3)cc2)C(=O)CCC4CCCC4	791789-61-2	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468375	511.7406	SB 699551	SB 699551 | SB 699551			MOABOX:5832	HTR1B	HTR5A antagonist
SJ000288154-5	SJ000288154	5	MOABOX:5833	JELFWSXQTXRMAJ-UHFFFAOYSA-N	CNc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(NC)n1	1197333-95-1	HTR6 antagonist	HTR6																																																															CHEMBL1256675	CHEMBL1397139	CHEMBL433461	CHEMBL542806								5312145	11957681	17774509	20846175	51371250	virtual	10.1021/jm034142q																																																																																																																																																															9925723	10937732	12646038	12825922	14584934	15771424	15974573	18053713	19159187	19433358	21190848	24850589	28441580																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									3.53032																																0.44129																																8																																1330	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-665-676|MOABOX:5833|HTR6|HTR6 antagonist	CNc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(NC)n1	1197333-95-1	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468377	308.35944	RO 04-6790 DIHYDROCHLORIDE	RO 04-6790 DIHYDROCHLORIDE | RO 04-6790 | RO 04-6790 DIHYDROCHLORIDE | RO 04-6790			MOABOX:5833	HTR6	HTR6 antagonist
SJ000841733-2	SJ000841733	2	MOABOX:5834	UMKHUSRDQFQHAK-RNJMTYCLSA-N	N=C(N)NCCC[C@H](NC(=O)C12CC3CC(CC(C3)C1)C2)C(=O)N[C@@H](Cc1ccccc1)C(N)=O	876310-60-0	Neuropeptide FF Receptor Antagonists	NPFFR1																																																															CHEMBL1672380											53320361	71311841	71434320			member	10.1021/jm300535s																																																																																																																																																															22708927	23131340	30626554																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.96032																																0.12004																																8																																HY-107382	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Endocrinology; Neurological Disease; Cardiovascular Disease|MOABOX:5834|NPFFR1|Neuropeptide FF Receptor Antagonists	NC(=N)NCCC[C@H](NC(=O)C12C[C@@H]3C[C@@H](C[C@@H](C3)C1)C2)C(=O)N[C@@H](Cc4ccccc4)C(=O)N	876310-60-0	67661	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469024	482.61832	RF 9	RF 9 | RF 9	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Endocrinology; Neurological Disease; Cardiovascular Disease	MOABOX:5834	NPFFR1	Neuropeptide FF Receptor Antagonists
SJ000785922-2	SJ000785922	2	MOABOX:5837	AQFFXPQJLZFABJ-UHFFFAOYSA-N	CC(C)Oc1ccc2c(=O)c3cc(C(=O)O)ccc3oc2c1	33458-93-4	PTGER2 antagonist	PTGER2																																																															CHEMBL1317823											119461					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.24288																																0.15536																																8																																HY-10418	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Inflammation/Immunology; Endocrinology|MOABOX:5837|PTGER2|PTGER2 antagonist	CC(C)Oc1ccc2C(=O)c3cc(ccc3Oc2c1)C(=O)O	33458-93-4	27839	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469220	298.29006	AH 6809	AH 6809 | AH 6809	Pathway: GPCR/G Protein	Research Area: Inflammation/Immunology; Endocrinology	MOABOX:5837	PTGER2	PTGER2 antagonist
SJ000803722-4	SJ000803722	4	MOABOX:5844	FBLPQCAQRNSVHB-UHFFFAOYSA-N	CCc1cncnc1N1CCN(Cc2nc3cc(C(F)(F)F)ccc3[nH]2)CC1	1255517-76-0	Antagonist of S6K	RPS6KB1																																																															CHEMBL2134202											51371303					virtual	10.1042/BJ20101024																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.464																																0.308																																8																																HY-15773	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; MAPK/ERK Pathway | Research Area: Cancer|MOABOX:5844|RPS6KB1|Antagonist of S6K	CCc1cncnc1N2CCN(Cc3nc4ccc(cc4[nH]3)C(F)(F)F)CC2	1255517-76-0	10592	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469069	390.40545	PF 4708671	PF 4708671 | PF-4708671 | PF 4708671 | PF-4708671	Pathway: Autophagy; MAPK/ERK Pathway	Research Area: Cancer	MOABOX:5844	RPS6KB1	Antagonist of S6K
SJ001011107-2	SJ001011107	2	MOABOX:5850	WCIGMFCFPXZRMQ-UHFFFAOYSA-N	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1	1285515-21-0	LRRK2 gene inhibitor	LRRK2																																																															CHEMBL2204495											68107965					member	10.1016/j.bmcl.2012.06.104	10.1021/acs.jmedchem.7b01186																																																																																																																																																														22863203	23721803	25915084	26005538	28408230	28774425	29023112																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															2.16888																																0.27111																																8																																HY-13237	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy | Research Area: Neurological Disease|MOABOX:5850|LRRK2|LRRK2 gene inhibitor	Fc1cc(ccn1)c2ccc(OCc3ccccc3)c(c2)C(=O)Nc4cccnc4	1285515-21-0	14506	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469274	399.41702	GSK2578215A	GSK2578215A | GSK2578215A	Pathway: Autophagy	Research Area: Neurological Disease	MOABOX:5850	LRRK2	LRRK2 gene inhibitor
SJ001033140-2	SJ001033140	2	MOABOX:5855	KXGCNMMJRFDFNR-WDRJZQOASA-N	C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CSSC[C@H](N)C(=O)N[C@H]3CSSC[C@H](NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)CSSC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC3=O)C(=O)N2	851199-59-2	Guanylate cyclase receptor agonist	GUCY2C																																																															CHEMBL3301675	CHEMBL3301676										16158207	16158208				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-17584	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Others|MOABOX:5855|GUCY2C|Guanylate cyclase receptor agonist	C[C@@H](O)C1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)O)NC(=O)[C@H](Cc5ccc(O)cc5)NC(=O)[C@H](CCC(=O)O)NC3=O)C(=O)N[C@@H](CC(=O)N)C(=O)N6CCC[C@H]6C(=O)N[C@@H](C)C(=O)N2	851199-59-2	67378	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469243	1526.73646	LINACLOTIDE	LINACLOTIDE | LINACLOTIDE	Pathway: GPCR/G Protein	Research Area: Others	MOABOX:5855	GUCY2C	Guanylate cyclase receptor agonist
SJ001033386-2	SJ001033386	2	MOABOX:5856	CGDZXLJGHVKVIE-DNVCBOLYSA-N	O=C(N[C@@H]1CC[C@@H](c2cccc(F)c2F)CN(CC(F)(F)F)C1=O)N1CCC(n2c(O)nc3ncccc32)CC1	781649-09-0	"CGRP antagonist;Calcitonin gene peptide ligand inhibitor;""CGRP antagonist;Calcitonin gene peptide ligand inhibitor"""	CALCA	CALCB	CALCRL	RAMP1	CRCP																												797	10203	10267	27297																												CHEMBL236593											11319053	44595290	44595291	142761864		member	10.1016/j.bmcl.2009.06.057	10.1016/j.bmcl.2011.09.056	10.1021/ml900016y	10.1124/jpet.107.130344																																																																																																																																																												17929795	17963849	19557759	19577468	19818613	21251825	21982500	22607672	23153230	23632269	24900761	24960305																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										0.6684	0.41874	3.64768	0.45745	0																												0.08355	0.05982	0.45596	0.06535	0.0																												8	7	8	7	7																												HY-32709	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:5856|CALCA|CGRP antagonist;Calcitonin gene peptide ligand inhibitor;\CGRP antagonist;Calcitonin gene peptide ligand inhibitor\	Fc1cccc([C@@H]2CC[C@@H](NC(=O)N3CCC(CC3)N4C(=O)Nc5ncccc45)C(=O)N(CC(F)(F)F)C2)c1F	781649-09-0	16673	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469142	566.523	TELCAGEPANT; MK-0974	TELCAGEPANT; MK-0974 | TELCAGEPANT; MK-0974	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:5856	CALCA	CGRP antagonist;Calcitonin gene peptide ligand inhibitor;\CGRP antagonist;Calcitonin gene peptide ligand inhibitor\
SJ000828740-4	SJ000828740	4	MOABOX:5857	SIXVRXARNAVBTC-UHFFFAOYSA-N	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21	1337531-36-8	EIF2AK3 gene inhibitor	EIF2AK3																																																															CHEMBL2171124											53469448					member	10.1021/jm300713s	10.1021/ml400228e																																																																																																																																																														22827572	24900593																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.88744																																0.36093																																8																																HY-18072	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:5857|EIF2AK3|EIF2AK3 gene inhibitor	Cn1cc(c2ccc3N(CCc3c2)C(=O)Cc4cccc(c4)C(F)(F)F)c5c(N)ncnc15	1337531-36-8	22864	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469461	451.44371	N17498-20-A2	N17498-20-A2 | N17498-20-A2	Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:5857	EIF2AK3	EIF2AK3 gene inhibitor
SJ000562681-7	SJ000562681	7	MOABOX:5858	OTSOOHRUMBRSHZ-UHFFFAOYSA-N	COCC[n+]1c2c(n(Cc3cnccn3)c1C)C(=O)c1ccccc1C2=O	355406-09-6	BIRC5 gene inhibitor	BIRC5																																																															CHEMBL2105734	CHEMBL2110734										10126189	11178236	23108256	86298735	138391543	member	10.2174/092986710790979935																																																																																																																																																															20166933																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.22824																																0.27853																																8																																HY-10194	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy | Research Area: Cancer|MOABOX:5858|BIRC5|BIRC5 gene inhibitor	COCCn1c(C)[n+](Cc2cnccn2)c3C(=O)c4ccccc4C(=O)c13	781661-94-7	6914	GENERAL	BROMIDE	1	NO_SOLVATE	0	1469878	363.38986	YM-155	YM-155 | SEPANTRONIUM BROMIDE | SJ000832937 | YM155 (SEPANTRONIUM BROMIDE) | YM-155 | SEPANTRONIUM BROMIDE | SJ000832937 | YM155 (SEPANTRONIUM BROMIDE)	Pathway: Apoptosis; Autophagy	Research Area: Cancer	MOABOX:5858	BIRC5	BIRC5 gene inhibitor
SJ000287380-12	SJ000287380	12	MOABOX:5864	DBEPLOCGEIEOCV-WSBQPABSSA-N	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C	140375-21-9	Steroid 5alpha-Reductase Inhibitors	SRD5A1	SRD5A2																															6716																															CHEMBL710											57363	9831117	9875095	9875793	9896997	member	10.1002/1521-4184(200203)335:2/3<83::AID-ARDP83>3.0.CO;2-3	10.1002/ardp.200290006	10.1002/ardp.200390001	10.1016/0960-894X(96)00054-6	10.1016/0968-0896(95)00160-3	10.1016/S0039-128X(98)00020-8	10.1016/S0960-0760(96)00199-9	10.1016/S0960-894X(98)00505-8	10.1016/S0968-0896(01)00293-0	10.1016/S0968-0896(96)00241-6	10.1016/j.bmc.2017.01.018	10.1016/j.bmcl.2010.10.112	10.1016/j.steroids.2004.04.003	10.1016/j.steroids.2007.10.009	10.1016/j.steroids.2010.03.006	10.1021/jm00007a013	10.1021/jm00041a014	10.1021/jm00049a003	10.1021/jm00055a014	10.1021/jm00078a022	10.1021/jm000945r	10.1021/jm001008m	10.1021/jm031131o	10.1021/jm040202w	10.1021/jm050728w	10.1021/jm960697s	10.1080/14756360600748474	10.3109/14756366.2012.729827	10.3109/14756366.2015.1070843	10.3109/14756366.2015.1103235																																																																																																																																		7629802	7650670	7707319	7739004	7966146	8057283	8277514	8381185	8689240	8778238	9061195	9089333	9135028	9526564	9618802	9873639	11020287	11063622	11741792	12043459	12139451	12596217	12666251	15214782	15246775	15828836	16420060	16719800	17059168	17168713	17490876	18082864	19289282	21094046	22776417	23092389	25261928	26631442	26780831	28174065																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														2.52e-002	4.93152																															0.00315	0.61644																															8	8																															KS-1058	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466702	372.54414	FINASTERIDE	"FINASTERIDE | ""FINASTERIDE | MK-906 | YM-152 |"" | FINASTERIDE | ""FINASTERIDE | MK-906 | YM-152 |"""			MOABOX:5864	SRD5A1	Steroid 5alpha-Reductase Inhibitors
SJ000562696-3	SJ000562696	3	MOABOX:5865	OUBCNLGXQFSTLU-UHFFFAOYSA-N	O=C1CCCC(=O)C1C(=O)c1ccc(C(F)(F)F)cc1[N+](=O)[O-]	104206-65-7	4-Hydroxyphenylpyruvate Dioxygenase (4HPPD) Inhibitors	HPD																																																															CHEMBL1337											115355	90016752	118209022			member	10.1016/j.ejmech.2015.01.018	10.1016/j.ejmech.2019.01.032																																																																																																																																																														22711801	25182962	25590863	28598377																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.29792																																0.16224																																8																																HY-B0607	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?B | Research Area: Metabolic Disease|MOABOX:5865|HPD|4-Hydroxyphenylpyruvate Dioxygenase (4HPPD) Inhibitors	[O-][N+](=O)c1cc(ccc1C(=O)C2C(=O)CCCC2=O)C(F)(F)F	104206-65-7	14558	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469183	329.22811	NITISINONE | ORFADIN	"""NITISINONE | ORFADIN"" | ""NITISINONE | ORFADIN"""	Pathway: Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?B	Research Area: Metabolic Disease	MOABOX:5865	HPD	4-Hydroxyphenylpyruvate Dioxygenase (4HPPD) Inhibitors
SJ000859781-4	SJ000859781	4	MOABOX:5866	VUIRVWPJNKZOSS-UHFFFAOYSA-N	Cc1cnc(-c2ccccc2C(C)C)nc1NCc1ccc(-n2ccnn2)cc1	1572414-83-5	USP1âUAF1 inhibitor	USP1	WDR48																															57599																															CHEMBL3182437											60167849	71604296				member	10.1038/nchembio.1455																																																																																																																																																															25229643	25364867	27362876																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.21632	1.20184																															0.15204	0.15023																															8	8																															HY-17543	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:5866|USP1|USP1a UAF1 inhibitor	CC(C)c1ccccc1c2ncc(C)c(NCc3ccc(cc3)n4ccnn4)n2	1572414-83-5	11267	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469868	384.47686	ML 323	ML 323 | ML 323	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:5866	USP1	USP1a UAF1 inhibitor
SJ001035260-1	SJ001035260	1	MOABOX:5867	URWCXPXBBITYLR-UHFFFAOYSA-N	CNc1cc(-c2cccc(Cl)c2Cl)nc(N)n1	1609960-30-6	NUDT1 gene inhibitor	NUDT1																																																															CHEMBL3781316											73441664	91826506				member																																																																																																																																																																26898335	26924380	28280261																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.97232																																0.37154																																8																																HY-16965	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:5867|NUDT1|NUDT1 gene inhibitor	CNc1cc(nc(N)n1)c2cccc(Cl)c2Cl	1609960-30-6	16869	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469387	269.1299	TH287	TH287 | TH287	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:5867	NUDT1	NUDT1 gene inhibitor
SJ000834160-4	SJ000834160	4	MOABOX:5868	PNMYJIOQIAEYQL-UHFFFAOYSA-N	Nc1nc(NC2CC2)cc(-c2cccc(Cl)c2Cl)n1	1609960-31-7	NUDT1 gene inhibitor	NUDT1																																																															CHEMBL3782004											73389731	91826507				member	10.1038/s41419-019-1665-3																																																																																																																																																															26878898	26898335	26924380	28280261	29485874																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	3.5668																																0.44585																																8																																HY-12814	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:5868|NUDT1|NUDT1 gene inhibitor	Nc1nc(NC2CC2)cc(n1)c3cccc(Cl)c3Cl	1609960-31-7	17240	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469102	295.16718	TH588	TH588 | TH588 HYDROCHLORIDE | TH588 | TH588 HYDROCHLORIDE	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:5868	NUDT1	NUDT1 gene inhibitor
SJ001033401-2	SJ001033401	2	MOABOX:5875	NPFDWHQSDBWQLH-QZTJIDSGSA-N	Cc1ccc(-c2ncccn2)c(C(=O)N2C[C@H](COc3ccc(F)cn3)CC[C@H]2C)c1	1088991-73-4	"Orexin 1 receptor antagonist, Orexin 2 receptor antagonist"	HCRTR1	HCRTR2																															3062																															CHEMBL2107822											25128145					member	10.1002/cmdc.201200025	10.1016/j.bmcl.2014.12.056																																																																																																																																																														20544785	23891187	25577040	26045032	26317591																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.59584	2.07024																															0.07448	0.25878																															8	8																															HY-15653	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease; Endocrinology|MOABOX:5875|HCRTR1|Orexin 1 receptor antagonist, Orexin 2 receptor antagonist"	C[C@@H]1CC[C@@H](COc2ccc(F)cn2)CN1C(=O)c3cc(C)ccc3c4ncccn4	1088991-73-4	16781	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468979	420.4793	FILOREXANT; MK-6096	FILOREXANT; MK-6096 | FILOREXANT; MK-6096	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease; Endocrinology	MOABOX:5875	HCRTR1	"Orexin 1 receptor antagonist, Orexin 2 receptor antagonist"
SJ000855173-3	SJ000855173	3	MOABOX:5877	JTARFZSNUAGHRB-UHFFFAOYSA-N	Cc1cc(NC(=O)Nc2ccc(N(C)C)cc2)c2cc(F)cc(F)c2n1	1431697-90-3	Orexin 1 receptor antagonist	HCRTR1																																																															CHEMBL1334465	CHEMBL4082879										4331799	71576692	137645329			member	10.1124/mol.109.055152																																																																																																																																																															19199652	23891187	28051300																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.55312																																0.31914																																8																																HY-76612	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease; Endocrinology | DISSOLVED IN H2O|MOABOX:5877|HCRTR1|Orexin 1 receptor antagonist	CN(C)c1ccc(NC(=O)Nc2cc(C)nc3c(F)cc(F)cc23)cc1	1431697-90-3	3728	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469747	356.36923	SB408124	SB408124 | SB408124	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease; Endocrinology	MOABOX:5877	HCRTR1	
SJ000836416-8	SJ000836416	8	MOABOX:5879	LXFOLMYKSYSZQS-XKHGBIBOSA-N	CC(C)N(C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C1CC(CCc2nc3cc(C(C)(C)C)ccc3[nH]2)C1	1380288-87-8	Dot1L / KMT4;Dot1L inhibitor	DOT1L																																																															CHEMBL3087499											57345410	78425803	90461055	91617704	144720223	virtual																																																																																																																																																																23879463	25406944	28337327	29050780																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		4.45056																																0.55632																																8																																HY-15593	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:5879|DOT1L|Dot1L / KMT4;Dot1L inhibitor	CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(N)ncnc23)[C@@H]4C[C@H](CCc5nc6cc(ccc6[nH]5)C(C)(C)C)C4	1380288-87-8	90591	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469426	562.70628	Pinometostat	Pinometostat | EPZ-5676 | Pinometostat | EPZ-5676	Pathway: Epigenetics	Research Area: Cancer	MOABOX:5879	DOT1L	Dot1L / KMT4;Dot1L inhibitor
SJ000984349-4	SJ000984349	4	MOABOX:5880	AGBSXNCBIWWLHD-FQEVSTJZSA-N	COc1ncc(-c2nc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1	1448867-41-1	p53-HDM2 PPI inhibitor;p53-MDM2 PPI inhibitor	MDM2																																																															CHEMBL3653256											71678098	71678608	71678609	71678774	91820645	virtual	10.1002/cmdc.201900201																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.82384																																0.35298																																8																																HY-18658	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:5880|MDM2|p53-HDM2 PPI inhibitor;p53-MDM2 PPI inhibitor	COc1ncc(c(OC)n1)c2nc3C(=O)N([C@@H](c4ccc(Cl)cc4)c3n2C(C)C)C5=CC(=CN(C)C5=O)Cl	1448867-41-1	28531	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468775	555.41256	HDM-201	"HDM-201 | ""NVP-HDM201 | HDM-201"" | HDM-201 | ""NVP-HDM201 | HDM-201"""	Pathway: Apoptosis; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:5880	MDM2	p53-HDM2 PPI inhibitor;p53-MDM2 PPI inhibitor
SJ001034943-1	SJ001034943	1	MOABOX:5890	WJQBOBGVBBZLJU-OAHLLOKOSA-N	O=C(N[C@@H]1CCCc2c1[nH]c1ccc(Cl)cc21)c1ccccn1	827591-02-6	Inhibitor of pyrimidine biosynthesis	DHODH																																																															CHEMBL551051											11416123					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.16416																																-0.02052																																8																																PHAR327678	PHARMEKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-028-851-991|MOABOX:5890|DHODH|Inhibitor of pyrimidine biosynthesis	Clc1ccc2[nH]c3C(CCCc3c2c1)NC(=O)c4ccccn4	827591-02-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468326	325.79214	PHAR327678	PHAR327678 | PHAR327678			MOABOX:5890	DHODH	Inhibitor of pyrimidine biosynthesis
SJ000796047-7	SJ000796047	7	MOABOX:5897	WXCXUHSOUPDCQV-UHFFFAOYSA-N	CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F	915087-33-1	Androgen Receptor Antagonists	AR																																																															CHEMBL1082407											15951529	86275860	91667498	91668279	117968220	member	10.1002/cmdc.201200549	10.1007/s00210-019-01622-5	10.1016/j.ejmech.2019.03.041	10.1016/j.ejmech.2019.111608	10.1074/jbc.M114.553818	10.1158/0008-5472.CAN-11-3948																																																																																																																																																										23436650	23713567	26046313	27131065	27301368	27437082	27717544	28011219	28385503	30193215	30525603	30925341																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										3.15248																																0.39406																																8																																HY-70002	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Others | Research Area: Cancer|MOABOX:5897|AR|Androgen Receptor Antagonists	CNC(=O)c1ccc(cc1F)N2C(=S)N(C(=O)C2(C)C)c3ccc(C#N)c(c3)C(F)(F)F	915087-33-1	87114	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469583	464.43595	ENZALUTAMIDE	"ENZALUTAMIDE | ""MDV-3100 | ASP-9785 | NC-54"" | ENZALUTAMIDE | ""MDV-3100 | ASP-9785 | NC-54"""	Pathway: Autophagy; Others	Research Area: Cancer	MOABOX:5897	AR	Androgen Receptor Antagonists
SJ001035390-1	SJ001035390	1	MOABOX:5898	VMZMNAABQBOLAK-DBILLSOUSA-N	NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O	396091-73-9	Somatostatin SRIF1B (sst5) inhibitor	SSTR3	SSTR5																															6755																															CHEMBL3349607											9941444	11982961	16725665	56946867	70788982	member	10.1159/000080741	10.1530/eje.0.1460707																																																																																																																																																														12773038	23410165																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.67232	1.5168																															0.08404	0.1896																															8	8																															HY-79135	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Endocrinology; Cancer|MOABOX:5898|SSTR3|Somatostatin SRIF1B (sst5) inhibitor	NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]4C[C@H](CN4C(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](Cc6ccc(OCc7ccccc7)cc6)NC1=O)OC(=O)NCCN)c8ccccc8	NA	15313	GENERAL	"2,2,2-TRIFLUOROACETATE"	2	NO_SOLVATE	0	1469879	1047.20624	PASIREOTIDE DITRIFLUOROACETATE | SOM230 DITRIFLUOROACETATE | PASIREOTIDE TFA SALT	"""PASIREOTIDE DITRIFLUOROACETATE | SOM230 DITRIFLUOROACETATE | PASIREOTIDE TFA SALT"" | ""PASIREOTIDE DITRIFLUOROACETATE | SOM230 DITRIFLUOROACETATE | PASIREOTIDE TFA SALT"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Endocrinology; Cancer	MOABOX:5898	SSTR3	Somatostatin SRIF1B (sst5) inhibitor
SJ001035327-1	SJ001035327	1	MOABOX:5899	AATPYXMXFBBKFO-UHFFFAOYSA-N	COc1cc(C(C)C)c(Oc2cnc(N)nc2N)cc1I	865305-30-2	P2RX2 and P2RX3 Purinergic Receptor Antagonist	P2RX2																																																															CHEMBL526307											15953802	46837686				member																																																																																																																																																																19231178	19231180	23121096																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			-5.92e-002																																-0.0074																																8																																HY-14483	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Cancer|MOABOX:5899|P2RX2|P2RX2 and P2RX3 Purinergic Receptor Antagonist	COc1cc(C(C)C)c(Oc2cnc(N)nc2N)cc1I	865305-30-2	17829	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469597	400.21485	AF-353 | RO-4	"""AF-353 | RO-4"" | ""AF-353 | RO-4"""	Pathway: Membrane Transporter/Ion Channel	Research Area: Cancer	MOABOX:5899	P2RX2	P2RX2 and P2RX3 Purinergic Receptor Antagonist
SJ001035218-1	SJ001035218	1	MOABOX:5907	BPRNMVDTWIHULJ-AWEZNQCLSA-N	Cc1csc2c(N[C@@H](C)CN3CCN(S(=O)(=O)c4ccc(Cl)c(Cl)c4)CC3)ncnc12	1017606-66-4	Lysophosphatidate-2 receptor antagonist	LPAR2																																																															CHEMBL256470											24882686					member																																																																																																																																																																18178086	18781939	22894757																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.16072																																0.27009																																8																																HY-18075	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cancer|MOABOX:5907|LPAR2|Lysophosphatidate-2 receptor antagonist	C[C@@H](CN1CCN(CC1)S(=O)(=O)c2ccc(Cl)c(Cl)c2)Nc3ncnc4c(C)csc34	1017606-66-4	12543	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469160	500.46492	LPA2 ANTAGONIST 1	LPA2 ANTAGONIST 1 | LPA2 ANTAGONIST 1	Pathway: GPCR/G Protein	Research Area: Cancer	MOABOX:5907	LPAR2	Lysophosphatidate-2 receptor antagonist
SJ000312294-8	SJ000312294	8	MOABOX:5909	COKMIXFXJJXBQG-NRFANRHFSA-N	CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O	1331911-68-2	Integrin binder;Integrin alpha-2/beta-3 antagonist	ITGA2B	ITGB3																															3690																															CHEMBL1704	CHEMBL3189072	CHEMBL916									60946	60947	64781	9897436	24883425	member	10.1016/j.bmc.2013.05.019	10.1016/j.bmcl.2016.02.011	10.1016/j.ejmech.2013.03.056	10.1021/jm2013826	10.1021/jm5004478																																																																																																																																																											1469694	8057299	9622548	10395482	10987423	10999999	14640540	15379638	15388165	20235539	22185640	22365562	23362923	23376251	23644213	23757209	24949551	26367138	26912112	27662032	27726366	31306009																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.53248	1.36688																															0.19156	0.17086																															8	8																															AG007X8H	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-823-927|MOABOX:5909|ITGA2B|Integrin binder;Integrin alpha-2/beta-3 antagonist	CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O	150915-40-5	NA	GENERAL	CHLORIDE	1	H2O	1	1468245	440.59664	TIROFIBAN HYDROCHLORIDE HYDRATE| AGGRASTAT	"TIROFIBAN HYDROCHLORIDE HYDRATE| AGGRASTAT | TIROFIBAN HYDROCHLORIDE | ""TIROFIBAN HYDROCHLORIDE HYDRATE | AGGRASTAT | 2-(BUTYLSULFONAMIDO)-3-(4-(4-(PIPERIDIN-4-YL)BUTOXY)PHENYL)PROPANOIC ACID | TIROFIBAN HYDROCHLORIDE |"" | TIROFIBAN HYDROCHLORIDE HYDRATE| AGGRASTAT | TIROFIBAN HYDROCHLORIDE | ""TIROFIBAN HYDROCHLORIDE HYDRATE | AGGRASTAT | 2-(BUTYLSULFONAMIDO)-3-(4-(4-(PIPERIDIN-4-YL)BUTOXY)PHENYL)PROPANOIC ACID | TIROFIBAN HYDROCHLORIDE |"""			MOABOX:5909	ITGA2B	Integrin binder;Integrin alpha-2/beta-3 antagonist
SJ000312341-8	SJ000312341	8	MOABOX:5910	HPHUVLMMVZITSG-LURJTMIESA-N	CC[C@@H](C(N)=O)N1CCCC1=O	102767-28-2	Synaptic vesicle glycoprotein 2A modulator	CACNA1B	SV2A																															9900																															CHEMBL1286											5284583	11288761	66873404	67363327	67365283	member																																																																																																																																																																20039359	23410162																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	-0.33936																															0.0	-0.04242																															7	8																															HY-B0106	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:5910|CACNA1B|Synaptic vesicle glycoprotein 2A modulator	CC[C@H](N1CCCC1=O)C(=O)N	102767-28-2	13420	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468811	170.20896	LEVETIRACETAM	"LEVETIRACETAM | LEVETIRACETAM| KEPPRA | ""LEVETIRACETAM| KEPPRA|SIB-S1 | (S)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE | LEVETIRACETAM| KEPPRA | 2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE"" | LEVETIRACETAM | LEVETIRACETAM | LEVETIRACETAM| KEPPRA | ""LEVETIRACETAM| KEPPRA|SIB-S1 | (S)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE | LEVETIRACETAM| KEPPRA | 2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:5910	CACNA1B	Synaptic vesicle glycoprotein 2A modulator
SJ000288082-6	SJ000288082	6	MOABOX:5913	BGVLELSCIHASRV-QPEQYQDCSA-N	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21	300801-52-9	CDC-like kinase-1 inhibitors	CLK1	CLK2	CLK4																														1196	57396																														CHEMBL408982											1893668					member	10.1016/j.chembiol.2010.11.009	10.1021/acs.jmedchem.7b00665																																																																																																																																																														19837585	21276940	23642479	25221649	28561591	28692292																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.13592	0.41736	0.69568																														0.14199	0.05217	0.08696																														8	8	8																														STK874212	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-914-774|MOABOX:5913|CLK1|CDC-like kinase-1 inhibitors	CCN1\C(=C\C(=O)C)\Sc2ccc(OC)cc12	300801-52-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468612	249.3287	TG003	TG003 | TG003			MOABOX:5913	CLK1	CDC-like kinase-1 inhibitors
SJ001035344-1	SJ001035344	1	MOABOX:5915	BXVNPOBNVRBOOV-UHFFFAOYSA-N	Cc1cc(N2CCOCC2)nc2ccc(NC(=O)C3CCCCC3)cc12	442898-34-2	Glucosylceramidase inhibitor	GBA																																																															CHEMBL403714											5067281					member																																																																																																																																																																17670938	17827006	19807664	22646221																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.85704																																0.35713																																8																																HY-114043	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:5915|GBA|Glucosylceramidase inhibitor	Cc1cc(nc2ccc(NC(=O)C3CCCCC3)cc12)N4CCOCC4	442898-34-2	90772	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469656	353.45798	NCGC00092410	NCGC00092410 | NCGC00092410	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:5915	GBA	Glucosylceramidase inhibitor
SJ000784259-4	SJ000784259	4	MOABOX:5916	JUJPKFNFCWJBCX-UHFFFAOYSA-N	Nc1nc(OCc2cc(Br)cs2)c2[nH]cnc2n1	192441-08-0	MGMT gene inhibitor	MGMT																																																															CHEMBL339133											3025944					member	10.1016/j.bmc.2011.01.038	10.1021/jm010006e	10.2174/1389557033487980																																																																																																																																																													11708909	12769698	16278661	21320783	27347909																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	2.15024																																0.26878																																8																																HY-13668	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:5916|MGMT|MGMT gene inhibitor	Nc1nc(OCc2cc(Br)cs2)c3nc[nH]c3n1	192441-08-0	12182	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469267	326.17242	LOMEGUATRIB	"LOMEGUATRIB | ""4-BTG | AZD-5896 | PATRIN-2"" | ""LOMEGUATRIB | 4-BTG | AZD-5896 | PATRIN-2 |"" | LOMEGUATRIB | ""4-BTG | AZD-5896 | PATRIN-2"" | ""LOMEGUATRIB | 4-BTG | AZD-5896 | PATRIN-2 |"""	Pathway: Epigenetics	Research Area: Cancer	MOABOX:5916	MGMT	MGMT gene inhibitor
SJ000833852-3	SJ000833852	3	MOABOX:5921	CDQUJZKBRAFWNG-UHFFFAOYSA-N	O=[N+]([O-])c1c(Nc2cc(F)cc(Cl)c2)ccc2nonc12	1422955-31-4	HIF-2;HIF-2 Inhibitor	EPAS1																																																															CHEMBL2311933											70697712					member																																																																																																																																																																23363003	23434853	30289716																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.88728																																0.23591																																8																																HY-18371	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:5921|EPAS1|HIF-2;HIF-2 Inhibitor	[O-][N+](=O)c1c(Nc2cc(F)cc(Cl)c2)ccc3nonc13	1422955-31-4	79605	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469000	308.65244	HIF-C2	HIF-C2 | HIF-2 ANTAGONIST 2 | HIF-C2 | HIF-2 ANTAGONIST 2	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:5921	EPAS1	HIF-2;HIF-2 Inhibitor
SJ000561071-2	SJ000561071	2	MOABOX:5926	UVVWQQKSNZLUQA-UHFFFAOYSA-N	CCCCCCCC(=O)c1c(O)cc(O)cc1CC(=O)OCC	321661-62-5	NR4A1 gene stimulator	NR4A1																																																															CHEMBL1221517											10687292					member																																																																																																																																																																18690216																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.9728																																0.3716																																8																																HY-N2148	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:5926|NR4A1|NR4A1 gene stimulator	CCCCCCCC(=O)c1c(O)cc(O)cc1CC(=O)OCC	321661-62-5	24920	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469510	322.39604	CYTOSPORONE B	CYTOSPORONE B | CYTOSPORONE B	Pathway: Others	Research Area: Cancer	MOABOX:5926	NR4A1	NR4A1 gene stimulator
SJ000782349-7	SJ000782349	7	MOABOX:5931	RPQZTTQVRYEKCR-WCTZXXKLSA-N	O=c1ncccn1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	3690-10-6	DNA Methyltransferase (DNMT) Inhibitors;Cytidine Deaminase (CDA) Inhibitors	CDA	DNMT1	DNMT3A																														1786	1788																														CHEMBL504567											100016	67280714	68963796	138674153		member																																																																																																																																																																21598398																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.14576	-0.41167	0																														0.14322	-0.05881	0.0																														8	7	7																														HY-13420	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Epigenetics | Research Area: Cancer|MOABOX:5931|CDA|DNA Methyltransferase (DNMT) Inhibitors;Cytidine Deaminase (CDA) Inhibitors	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=CC=NC2=O	3690-10-06	17355	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468997	228.20198	ZEBULARINE	ZEBULARINE | NSC-309132 | ZEBULARINE | NSC-309132	Pathway: Autophagy; Epigenetics	Research Area: Cancer	MOABOX:5931	CDA	DNA Methyltransferase (DNMT) Inhibitors;Cytidine Deaminase (CDA) Inhibitors
SJ000833857-4	SJ000833857	4	MOABOX:5932	WHMXDBPHBVLYRC-OFVILXPXSA-N	CC(C)Oc1ccc(C(=O)N[C@H](CNC(=O)CN(C)C)Cc2ccc(-c3cn4cccc([C@H](C)O)c4n3)cc2)cc1Cl	1088965-37-0	Centromere protein E inhibitor	CENPE																																																																										46898058					member																																																																																																																																																																20167803																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.192																																0.274																																8																																HY-10299	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton | Research Area: Cancer|MOABOX:5932|CENPE|Centromere protein E inhibitor	CC(C)Oc1ccc(cc1Cl)C(=O)N[C@H](CNC(=O)CN(C)C)Cc2ccc(cc2)c3cn4cccc([C@H](C)O)c4n3	1088965-37-0	41442	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469165	592.12822	GSK-923295	GSK-923295 | GSK-923295	Pathway: Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton	Research Area: Cancer	MOABOX:5932	CENPE	Centromere protein E inhibitor
SJ001033408-2	SJ001033408	2	MOABOX:5933	OUQVKRKGTAUJQA-UHFFFAOYSA-N	O=C(O)CNC(=O)c1nc(Cl)c2ccccc2c1O	223387-75-5	EGLN1 gene inhibitor	EGLN1	P4HA1	P4HB	P4HA2	P4HA3																												5033	5034	8974	283208																												CHEMBL426560											6914666	144866898				member	10.1021/jm301583m	10.1021/jm900285r	10.1021/jm901537q	10.1042/BSR20170275																																																																																																																																																												19364117	20025281	23234607	26713111																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0	0	0	2.82768	0																												0.0	0.0	0.0	0.35346	0.0																												7	7	7	8	7																												HY-15641	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:5933|EGLN1|EGLN1 gene inhibitor	OC(=O)CNC(=O)c1nc(Cl)c2ccccc2c1O	223387-75-5	16113	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469015	280.66386	FG-2216; IOX3; YM311	FG-2216; IOX3; YM311 | FG-2216; IOX3; YM311	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:5933	EGLN1	EGLN1 gene inhibitor
SJ001035185-1	SJ001035185	1	MOABOX:5934	IVYQPSHHYIAUFO-VXKWHMMOSA-N	CC(C)C[C@H](NC(=O)c1cc2ccccc2s1)C(=O)N1CCN(C(=O)[C@H](CO)NS(=O)(=O)c2ccc(Cl)cc2Cl)CC1	942206-85-1	TRPV4 gene stimulator	TRPV4																																																																										23630211					member	10.1124/jpet.107.134551	10.1124/jpet.108.139295	10.2174/156802611796904861																																																																																																																																																													21671873	30629441																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.4264																																0.1783																																8																																HY-19608	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Metabolic Disease; Cardiovascular Disease|MOABOX:5934|TRPV4|TRPV4 gene stimulator	CC(C)C[C@H](NC(=O)c1cc2ccccc2s1)C(=O)N3CCN(CC3)C(=O)[C@H](CO)NS(=O)(=O)c4ccc(Cl)cc4Cl	942206-85-1	64608	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469025	655.61288	GSK1016790A	GSK1016790A | GSK1016790A	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Metabolic Disease; Cardiovascular Disease	MOABOX:5934	TRPV4	TRPV4 gene stimulator
SJ001035135-1	SJ001035135	1	MOABOX:5935	NCZYSQOTAYFTNM-UHFFFAOYSA-N	Cc1c(C(=O)Nc2cccc(C(F)(F)F)c2)cc(-c2ccccc2)n1CCCN1CCOCC1	883031-03-6	TRPV4 gene inhibitor	TRPV4																																																															CHEMBL2133556											2742550	89894200				member	10.1016/j.bmc.2017.02.047	10.1016/j.bmcl.2016.09.013	10.1073/pnas.1005333107	10.2174/156802611796904861																																																																																																																																																												20956320	21671873	27634196	27637151	28284871	28523109	30507122																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															2.29832																																0.28729																																8																																HY-100208	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Cancer|MOABOX:5935|TRPV4|TRPV4 gene inhibitor	Cc1c(cc(c2ccccc2)n1CCCN3CCOCC3)C(=O)Nc4cccc(c4)C(F)(F)F	883031-03-6	21091	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468825	471.51463	HC-067047	HC-067047 | HC-067047	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Cancer	MOABOX:5935	TRPV4	TRPV4 gene inhibitor
SJ000796053-3	SJ000796053	3	MOABOX:5939	AZAANWYREOQRFB-SETSBSEESA-N	O=C(CN1C(=O)C2(CCCC2)NC[C@H]1c1cc(F)cc(F)c1)Nc1ccc2c(c1)C[C@@]1(C2)C(=O)Nc2ncccc21	957116-20-0	"highly potent calcitonin gene-related peptide (CGRP) receptor antagonist;CGRP antagonist;""highly potent calcitonin gene-related peptide (CGRP) receptor antagonist;CGRP antagonist"""	CALCA	CALCRL	RAMP1	CRCP																													10203	10267	27297																													CHEMBL1910936											25019940	49867927				member	10.1016/j.bmcl.2011.09.056	10.1021/ml900016y	10.1124/jpet.109.163816																																																																																																																																																													21982500	22607672	23632269	24900761	26231160																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.62136	1.60728	0.30002	0																													0.07767	0.20091	0.04286	0.0																													8	8	7	7																													HY-10302	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:5939|CALCA|highly potent calcitonin gene-related peptide (CGRP) receptor antagonist;CGRP antagonist;\highly potent calcitonin gene-related peptide (CGRP) receptor antagonist;CGRP antagonist\	Fc1cc(F)cc(c1)[C@@H]2CNC3(CCCC3)C(=O)N2CC(=O)Nc4ccc5C[C@]6(Cc5c4)C(=O)Nc7ncccc67	957116-20-0	9535	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469718	557.59047	MK3207 HYDROCHLORIDE	MK3207 HYDROCHLORIDE | MK3207 HYDROCHLORIDE	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:5939	CALCA	highly potent calcitonin gene-related peptide (CGRP) receptor antagonist;CGRP antagonist;\highly potent calcitonin gene-related peptide (CGRP) receptor antagonist;CGRP antagonist\
SJ001034970-1	SJ001034970	1	MOABOX:5940	JJQKICOADUKSNS-UHFFFAOYSA-N	NCCCCNS(=O)(=O)c1ccc2c(Cl)cccc2c1	81705-04-6	CYP2C19 gene modulator	CYP2C19																																																															CHEMBL1256392	CHEMBL1256657										4299	16760706	71296961			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.83624																																0.26232																																7																																AG0048JE	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-844-471|MOABOX:5940|CYP2C19|CYP2C19 gene modulator	NCCCCNS(=O)(=O)c1ccc2c(Cl)cccc2c1	88519-57-7	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468398	312.81498	AG0048JE	AG0048JE | AG0048JE			MOABOX:5940	CYP2C19	CYP2C19 gene modulator
SJ001035005-1	SJ001035005	1	MOABOX:5946	ZLQBZYKAQQWOTK-UHFFFAOYSA-N	O=C(NNS(=O)(=O)c1ccccc1C(F)(F)F)c1cc2cc(Cl)ccc2o1	406191-34-2	Branched amino acid aminotransferase 1 inhibitor	BCAT1																																																															CHEMBL1231666											6914573					member																																																																																																																																																																16143519	21840712																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				8.88e-003																																0.00111																																8																																9002002	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-561-935|MOABOX:5946|BCAT1|Branched amino acid aminotransferase 1 inhibitor	FC(F)(F)c1ccccc1S(=O)(=O)NNC(=O)c2oc3ccc(Cl)cc3c2	406191-34-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468457	418.77481	BCATC INHIBITOR 2	BCATC INHIBITOR 2 | BCATC INHIBITOR 2			MOABOX:5946	BCAT1	Branched amino acid aminotransferase 1 inhibitor
SJ001035245-1	SJ001035245	1	MOABOX:5947	LVPYVYFMCKYFCZ-UHFFFAOYSA-N	CCCc1c(O)c(O)c(C(=O)O)c2cc(Cc3ccccc3)c(C)cc12	213971-34-7	Lactate dehydrogenase inhibitor	LDHA	LDHB																															3945																															CHEMBL126519											10498042					virtual																																																																																																																																																																9748363	18473929	20088761	22741776	26340601																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.80232	0.85144																															0.10029	0.10643																															8	8																															HY-16214	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:5947|LDHA|Lactate dehydrogenase inhibitor	CCCc1c(O)c(O)c(C(=O)O)c2cc(Cc3ccccc3)c(C)cc12	213971-34-7	44183	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469287	350.40768	FX-11 | LDHA INHIBITOR FX11	"""FX-11 | LDHA INHIBITOR FX11"" | ""FX-11 | LDHA INHIBITOR FX11"""	Pathway: Apoptosis; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:5947	LDHA	Lactate dehydrogenase inhibitor
SJ000870800-3	SJ000870800	3	MOABOX:5950	QKKIWEILHCXECO-UHFFFAOYSA-N	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1	1229582-33-5	MAP3K11 gene inhibitor	MAP3K11																																																															CHEMBL2436978											54764565	144637027				member	10.1021/jm401094t																																																																																																																																																															24044867																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.74152																																0.09269																																8																																HY-12599	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; MAPK/ERK Pathway | Research Area: Neurological Disease; Cancer|MOABOX:5950|MAP3K11|MAP3K11 gene inhibitor	CN1CCN(Cc2ccc(cc2)c3cnc4[nH]cc(c5ccc6[nH]ccc6c5)c4c3)CC1	1229582-33-5	19448	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468859	421.53678	URMC-099	URMC-099 | URMC-099	Pathway: Autophagy; MAPK/ERK Pathway	Research Area: Neurological Disease; Cancer	MOABOX:5950	MAP3K11	MAP3K11 gene inhibitor
SJ001034945-1	SJ001034945	1	MOABOX:5952	MDZIRNPRVJEHHX-UHFFFAOYSA-N	O=C(O)c1cccc(Nc2ccc(C(F)(F)F)cc2)c1	1284180-11-5	AKR1C3 inhibitor	AKR1C3																																																															CHEMBL1682202											51346826					member	10.1016/j.bmcl.2012.03.085																																																																																																																																																															21277203	22263837	22507964	30836001																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		3.46008																																0.43251																																8																																BD281090	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-013-357-750|MOABOX:5952|AKR1C3|AKR1C3 inhibitor	OC(=O)c1cccc(Nc2ccc(cc2)C(F)(F)F)c1	1284180-11-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468337	281.22991	BD281090	BD281090 | BD281090			MOABOX:5952	AKR1C3	AKR1C3 inhibitor
SJ001005327-2	SJ001005327	2	MOABOX:5953	NUUSUAWULNXMGF-UHFFFAOYSA-N	O=C(Nc1ccc(Cl)c(Cl)c1)Nc1ccc2nnsc2c1	1257423-87-2	Eukaryotic Translation Initiation Factor 2-alpha Kinase 1 (HRI) Activators	EIF2AK1																																																																										49787174					member																																																																																																																																																																21765405																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.03992																																0.25499																																8																																HY-118266	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:5953|EIF2AK1|Eukaryotic Translation Initiation Factor 2-alpha Kinase 1 (HRI) Activators	Clc1ccc(NC(=O)Nc2ccc3nnsc3c2)cc1Cl	1257423-87-2	52047	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469511	339.19982	PJS_AC-028-2	PJS_AC-028-2 | PJS_AC-028-2	Pathway: Apoptosis; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:5953	EIF2AK1	Eukaryotic Translation Initiation Factor 2-alpha Kinase 1 (HRI) Activators
SJ000287968-5	SJ000287968	5	MOABOX:5955	PYEBKOFMWAMBFV-UHFFFAOYSA-O	CC[N+](CC)(CC)CC(=O)Nc1c(C)cccc1C	21306-56-9	BLMH gene inhibitor	BLM																																																															CHEMBL1180496	CHEMBL1255750	CHEMBL128028									3925	21462	135089	9884487		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.4329																																0.2047																																7																																10011032	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-009-019-414|MOABOX:5955|BLM|BLMH gene inhibitor	CC[N+](CC)(CC)CC(=O)Nc1c(C)cccc1C	24003-58-5	NA	GENERAL	BROMIDE	1	NO_SOLVATE	0	1468690	263.39838	LIDOCAINE N-ETHYL BROMIDE QUATERNARY SALT	LIDOCAINE N-ETHYL BROMIDE QUATERNARY SALT | QX-314 BROMIDE | LIDOCAINE N-ETHYL BROMIDE QUATERNARY SALT | QX-314 BROMIDE			MOABOX:5955	BLM	BLMH gene inhibitor
SJ001035320-1	SJ001035320	1	MOABOX:5956	RRKKJYBCPXAJAO-IBGZPJMESA-N	N=C(N)NCCC[C@H](NC(=O)COCC(c1ccccc1)c1ccccc1)C(=O)O	1140525-25-2	C3AR1 antagonist	C3AR1																																																															CHEMBL389348											5311120	16760645				member	10.1016/j.bmcl.2015.10.038	10.4049/jimmunol.166.10.6341																																																																																																																																																														17467987	20527893	25259874																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.23912																																0.27989																																8																																HY-101502A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Inflammation/Immunology|MOABOX:5956|C3AR1|C3AR1 antagonist	NC(=N)NCCC[C@H](NC(=O)COCC(c1ccccc1)c2ccccc2)C(=O)O	1140525-25-2	55990	GENERAL	"2,2,2-TRIFLUOROACETATE"	1	NO_SOLVATE	0	1469562	412.48212	SB290157 TRIFLUOROACETATE	SB290157 TRIFLUOROACETATE | SB290157 TRIFLUOROACETATE	Pathway: Immunology/Inflammation	Research Area: Inflammation/Immunology	MOABOX:5956	C3AR1	C3AR1 antagonist
SJ000855473-4	SJ000855473	4	MOABOX:5957	RTHHSXOVIJWFQP-UHFFFAOYSA-N	Cc1cc(=O)oc2c(C=O)c(O)ccc12	14003-96-4	ERN1 gene inhibitor	ERN1																																																															CHEMBL272357											12934390					member																																																																																																																																																																24749861																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.10176																																0.38772																																8																																HY-19707	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Metabolic Disease|MOABOX:5957|ERN1|ERN1 gene inhibitor	CC1=CC(=O)Oc2c(C=O)c(O)ccc12	14003-96-4	24310	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468902	204.17882	4U8C	4U8C | 4U8C	Pathway: Cell Cycle/DNA Damage	Research Area: Metabolic Disease	MOABOX:5957	ERN1	ERN1 gene inhibitor
SJ001035330-1	SJ001035330	1	MOABOX:5958	SFNLLCUAISZNRV-UHFFFAOYSA-N	O=C(NC(=O)c1c(F)cccc1Cl)NC1c2ccccc2-c2ccccc21	1186372-20-2	PPIA gene inhibitor	PPIA																																																															CHEMBL559525											44249042					member																																																																																																																																																																19691347	20222857	22087830	22316150	22430881	26950392																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																2.67272																																0.33409																																8																																HY-107635	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cardiovascular Disease|MOABOX:5958|PPIA|PPIA gene inhibitor	Fc1cccc(Cl)c1C(=O)NC(=O)NC2c3ccccc3c4ccccc24	1186372-20-2	78714	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469602	380.79946	TMN355	TMN355 | TMN355	Pathway: Others	Research Area: Cardiovascular Disease	MOABOX:5958	PPIA	PPIA gene inhibitor
SJ000798844-5	SJ000798844	5	MOABOX:5959	UCKYOOZPSJFJIZ-XVKVHKPRSA-N	O=C1NC(O)CCN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	18771-50-1	CDA gene inhibitor	CDA																																																															CHEMBL2311128											29243	452210	452212	3013329	46239866	member	10.1021/jm401856k	10.1124/dmd.32.7.762																																																																																																																																																														7401098	15689149	21598398	24520856																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.74872																																0.34359																																8																																16402	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-561-340|MOABOX:5959|CDA|CDA gene inhibitor	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2CCC(O)NC2=O	18771-50-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468293	248.23314	TETRAHYDROURIDINE | NSC-112907 | THU |	"""TETRAHYDROURIDINE | NSC-112907 | THU |"" | ""TETRAHYDROURIDINE | NSC112907 | THU"" | TETRAHYDROURIDINE | ""TETRAHYDROURIDINE | NSC-112907 | THU |"" | ""TETRAHYDROURIDINE | NSC112907 | THU"" | TETRAHYDROURIDINE"			MOABOX:5959	CDA	CDA gene inhibitor
SJ001035001-1	SJ001035001	1	MOABOX:5961	XXUFNNVFZFVKGP-UHFFFAOYSA-N	CCOC(=O)N1CCN(C(=O)Cn2sc3nc(C)cc(C)c3c2=O)CC1	902589-96-2	DTYMK inhibitor	DTYMK																																																																										49878590	144390052				member	10.2174/0929867311320100006																																																																																																																																																															23394555																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.51368																																0.31421																																8																																21981	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-019-262-335|MOABOX:5961|DTYMK|DTYMK inhibitor	CCOC(=O)N1CCN(CC1)C(=O)CN2Sc3nc(C)cc(C)c3C2=O	902589-96-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468452	378.44598	YMU1	YMU1 | YMU1			MOABOX:5961	DTYMK	DTYMK inhibitor
SJ001035194-1	SJ001035194	1	MOABOX:5962	YAOAMZOGXBMLFQ-UHFFFAOYSA-N	N=C(N)NCCCCCCCN	150333-69-0	DHPS inhibitor	DHPS																																																															CHEMBL229457											448393	24879516	131842088			member	10.1016/S0968-0896(97)10030-X	10.2174/138955706778742795																																																																																																																																																														9568280	17100634	17591443																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.82048																																0.35256																																8																																HY-108314A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:5962|DHPS|DHPS inhibitor	NCCCCCCCNC(=N)N	150417-90-6	29333	GENERAL	SULFATE	1	NO_SOLVATE	0	1469048	172.2712	GC7 SULFATE	GC7 SULFATE | GC7 SULFATE	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:5962	DHPS	DHPS inhibitor
SJ000832517-3	SJ000832517	3	MOABOX:5964	LTZKEDSUXKTTTC-KXQOOQHDSA-N	c1ccc(Cn2c(-c3ccc(OC[C@H](C4CCNCC4)n4c(-c5ccccc5)nc5ccccc54)cc3)nc3ccccc32)cc1	1440898-61-2	Inhibitor of Prenyl Binding Protein (PDE6d)	PDE6D																																																															CHEMBL3286929											73292904	78357804	91826089	131668633		member	10.1038/nature12205.																																																																																																																																																															24884780	28929751	30562696																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			4.18072																																0.52259																																8																																HY-15747	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:5964|PDE6D|Inhibitor of Prenyl Binding Protein (PDE6d)	C(Oc1ccc(cc1)c2nc3ccccc3n2Cc4ccccc4)[C@H](C5CCNCC5)n6c(nc7ccccc67)c8ccccc8	1440898-61-2	11332	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469705	603.75468	Deltarasin (S)-4	Deltarasin (S)-4 | Deltarasin (S)-4	Pathway: GPCR/G Protein; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:5964	PDE6D	Inhibitor of Prenyl Binding Protein (PDE6d)
SJ000191357-3	SJ000191357	3	MOABOX:5967	QBNZBMVRFYREHK-UHFFFAOYSA-N	COc1ccc(C2CC(c3ccccc3)=NN2c2ccc(S(N)(=O)=O)cc2)cc1	71203-35-5	CDC42 Rho GTPase inhibitor	CDC42																																																															CHEMBL1370630											2950007					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-12755	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; GPCR/G Protein | Research Area: Cancer|MOABOX:5967|CDC42|CDC42 Rho GTPase inhibitor	COc1ccc(cc1)C2CC(=NN2c3ccc(cc3)S(=O)(=O)N)c4ccccc4	71203-35-5	15437	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469630	407.48544	ML141	ML141 | ML141	Pathway: Apoptosis; GPCR/G Protein	Research Area: Cancer	MOABOX:5967	CDC42	CDC42 Rho GTPase inhibitor
SJ001010662-2	SJ001010662	2	MOABOX:5968	HXWARSZQGAFXJM-MGPUTAFESA-N	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2Cl)CCN1	1321924-70-2	Protein kinase C theta inhibitor	PRKCQ																																																															CHEMBL2326002											53354074					member	10.1021/jm301465a.																																																																																																																																																															23398373	25000588																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.7616																																0.2202																																8																																HY-112782	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics; TGF-beta/Smad | Research Area: Inflammation/Immunology|MOABOX:5968|PRKCQ|Protein kinase C theta inhibitor	CC(C)[C@@](C)(O)[C@@H]1CN(CCN1)c2nc(c(F)cc2Cl)c3n[nH]c4ncccc34	1321924-70-2	34673	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469085	418.89556	VTX-27	VTX-27 | VTX-27	Pathway: Epigenetics; TGF-beta/Smad	Research Area: Inflammation/Immunology	MOABOX:5968	PRKCQ	Protein kinase C theta inhibitor
SJ000843885-4	SJ000843885	4	MOABOX:5985	CAOSCCRYLYQBES-UHFFFAOYSA-N	O=C(O)CNC(=O)c1c(O)c2ccccc2n(Cc2ccccc2)c1=O	931398-72-0	"EGLN1 inhibitor;EGLN1 gene inhibitor;""EGLN1 inhibitor;EGLN1 gene inhibitor"""	EGLN1	EGLN2																															112398																															CHEMBL3186774											54685215					member																																																																																																																																																																30737136																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.10872	0																															0.38859	0.0																															8	7																															HY-15468	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:5985|EGLN1|EGLN1 inhibitor;EGLN1 gene inhibitor;\EGLN1 inhibitor;EGLN1 gene inhibitor\	OC(=O)CNC(=O)C1=C(O)c2ccccc2N(Cc3ccccc3)C1=O	931398-72-0	8316	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469014	352.34074	IOX2	IOX2 | IOX2	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:5985	EGLN1	EGLN1 inhibitor;EGLN1 gene inhibitor;\EGLN1 inhibitor;EGLN1 gene inhibitor\
SJ000826829-8	SJ000826829	8	MOABOX:5999	PQOOIERVZAXHBP-UHFFFAOYSA-N	O=C(c1ccc(C(=O)N2CCC(N3CCCC3)CC2)c(Nc2ccccc2)c1)N1CCC(N2CCCC2)CC1	1415800-43-9	L3MBTL3 inhibitor;L3MBTL3 reader domain inhibitor	L3MBTL3	L3MBTL1																															26013																															CHEMBL2426364											57339144					member																																																																																																																																																																23292653	24040942	24300735	24449612	24466405																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	-0.29512	3.07344																															-0.04216	0.38418																															7	8																															HY-15649	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Epigenetics | Research Area: Cancer|MOABOX:5999|L3MBTL3|L3MBTL3 inhibitor;L3MBTL3 reader domain inhibitor	O=C(N1CCC(CC1)N2CCCC2)c3ccc(C(=O)N4CCC(CC4)N5CCCC5)c(Nc6ccccc6)c3	1415800-43-9	9810	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469256	529.71612	UNC1215	UNC1215 | UNC1215	Pathway: Apoptosis; Epigenetics	Research Area: Cancer	MOABOX:5999	L3MBTL3	L3MBTL3 inhibitor;L3MBTL3 reader domain inhibitor
SJ001035264-1	SJ001035264	1	MOABOX:6000	NXCSEAQOKPSNJV-UHFFFAOYSA-N	Cc1cc(Cl)ccc1CN(Cc1ccc(Cl)cc1)Cc1ccc([N+](=O)[O-])s1	1438071-12-5	REV-ERB agonist	NR1D1																																																															CHEMBL2381196											71682479	139025326				member	10.1021/jm400458q																																																																																																																																																															23656296																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.1476																																0.39345																																8																																HY-117147A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:6000|NR1D1|REV-ERB agonist	Cc1cc(Cl)ccc1CN(Cc2ccc(Cl)cc2)Cc3ccc(s3)[N+](=O)[O-]	NA	79763	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469405	421.34012	GSK2945 HYDROCHLORIDE	GSK2945 HYDROCHLORIDE | GSK2945 HYDROCHLORIDE	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:6000	NR1D1	REV-ERB agonist
SJ000851859-7	SJ000851859	7	MOABOX:6003	DJOVLOYCGXNVPI-UHFFFAOYSA-N	CN1CCN(c2ccc(-c3cccc(CN4CCOCC4)c3)cc2NC(=O)c2c[nH]c(=O)cc2C(F)(F)F)CC1	1801787-56-3	WDR5 inhibitor;WDR5 Inhibitor	WDR5																																																															CHEMBL3798846											91623360					member																																																																																																																																																																26167872	26958703	27116709	27598236	29889518																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.76496																																0.22062																																8																																HY-16993	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:6003|WDR5|WDR5 inhibitor;WDR5 Inhibitor	CN1CCN(CC1)c2ccc(cc2NC(=O)C3=CNC(=O)C=C3C(F)(F)F)c4cccc(CN5CCOCC5)c4	1801787-56-3	21449	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469016	555.59129	OICR-9429	OICR-9429 | OICR-9429	Pathway: Epigenetics	Research Area: Cancer	MOABOX:6003	WDR5	WDR5 inhibitor;WDR5 Inhibitor
SJ001033341-2	SJ001033341	2	MOABOX:6008	JRWROCIMSDXGOZ-UHFFFAOYSA-N	CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(Cl)cc2C(=O)c2cc[n+]([O-])cc2)cc1	698394-73-9	CCR9 chemokine antagonist	CCR9																																																															CHEMBL2178578											10343454	90197147	90197380			member	10.1021/jm300682j																																																																																																																																																															22931505	26117562	26987013	27256913																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.9092																																0.11365																																8																																HY-15724	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation | Research Area: Inflammation/Immunology; Endocrinology|MOABOX:6008|CCR9|CCR9 chemokine antagonist	CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc2ccc(Cl)cc2C(=O)c3cc[n+]([O-])cc3	698394-73-9	18883	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469011	444.93114	VERCIRNON; GSK-1605786; CCX282-B; TRAFICET-EN	VERCIRNON; GSK-1605786; CCX282-B; TRAFICET-EN | VERCIRNON; GSK-1605786; CCX282-B; TRAFICET-EN	Pathway: GPCR/G Protein; Immunology/Inflammation	Research Area: Inflammation/Immunology; Endocrinology	MOABOX:6008	CCR9	CCR9 chemokine antagonist
SJ001034899-1	SJ001034899	1	MOABOX:6012	CLGRAWDGLMENOD-UHFFFAOYSA-N	CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1	1260181-14-3	Jak3 tyrosine kinase inhibitor	GSK3B	JAK3	PRKCA																														3718	5578																														CHEMBL1650951											50925411					member																																																																																																																																																																21155605	21439476	24461299	25217444	29852068	30615446																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.18376	2.25848	1.03224																														0.14797	0.28231	0.12903																														8	8	8																														4221	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-277-107|MOABOX:6012|GSK3B|Jak3 tyrosine kinase inhibitor	CC(C)(O)C(=O)N1CCN(CC1)c2ccc(c(c2)C3=C(C(=O)NC3=O)c4c[nH]c5ccccc45)C(F)(F)F	1260181-14-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468205	526.50701	TCS 21311 | NIBR3049	"""TCS 21311 | NIBR3049"" | ""TCS 21311 | NIBR3049"""			MOABOX:6012	GSK3B	Jak3 tyrosine kinase inhibitor
SJ000574288-15	SJ000574288	15	MOABOX:6013	UJLAWZDWDVHWOW-YPMHNXCESA-N	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12	1259404-17-5	Jak1 tyrosine kinase inhibitor;Jak3 tyrosine kinase inhibitor	JAK1	JAK2	JAK3	TYK2																													3717	3718	7297																													CHEMBL2103743	CHEMBL221959										9926791	10174505	66559269	70674156	71582640	member	10.1016/S0065-7743(09)04412-1	10.1016/j.bmc.2015.05.028	10.1016/j.bmc.2017.07.043	10.1016/j.bmc.2019.03.009	10.1016/j.bmcl.2006.08.022	10.1016/j.bmcl.2006.12.018	10.1016/j.bmcl.2009.08.071	10.1016/j.bmcl.2013.03.015	10.1021/acs.jmedchem.7b01598	10.1021/acs.jmedchem.8b00076	10.1021/acschembio.9b00188	10.1021/jm1004286	10.1021/jm200911r	10.1021/jm300438j	10.1021/jm4004895	10.1021/jm501262q	10.1124/jpet.119.256263	10.1182/blood-2007-09-115030	10.1248/cpb.c15-00036																																																																																																																																													14593182	15975507	16934457	17189692	18183025	19053756	19762238	21105711	21106455	21155605	21291394	21439476	22037378	22087750	22591402	22698084	23214979	23317159	23540648	23541670	23659214	23668484	24398382	24403205	24417533	24461299	25217444	25262541	25369270	26014481	26059596	26258521	26372653	26927423	27130359	27137359	27555284	27771180	28789911	29156136	29298069	29452839	29852068	29856615	30113844	30139575	30460842	30615446	30833158	30846405	30853331	30926315	30981576																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.99112	1.23936	4.04136	-0.12448																													0.24889	0.15492	0.50517	-0.01556																													8	8	8	8																													AR-270/43507983	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-393-346|MOABOX:6013|JAK1|Jak1 tyrosine kinase inhibitor;Jak3 tyrosine kinase inhibitor	C[C@@H]1CCN(C[C@@H]1N(C)c2ncnc3[nH]ccc23)C(=O)CC#N	1259404-17-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468726	312.3696	TOFACITINIB	"TOFACITINIB | ""TASOCITINIB | CP-690550"" | ""TASOCITINIB | CP-690550 | TOFACITINIB"" | TOFACITINIB (CP-690550,TASOCITINIB) | TOFACITINIB (CP-690550) CITRATE | TOFACITINIB | ""TASOCITINIB | CP-690550"" | ""TASOCITINIB | CP-690550 | TOFACITINIB"" | TOFACITINIB (CP-690550,TASOCITINIB) | TOFACITINIB (CP-690550) CITRATE"			MOABOX:6013	JAK1	Jak1 tyrosine kinase inhibitor;Jak3 tyrosine kinase inhibitor
SJ001033457-2	SJ001033457	2	MOABOX:6019	HZLAWYIBLZNRFZ-VXGBXAGGSA-N	O=C(O)[C@H]1CCCN1C(=O)CCCCC(=O)N1CCC[C@@H]1C(=O)O	224624-80-0	Antiamyloidogenic Agents;Anti-Human Serum Amyloid P (Anti-SAP)	APCS																																																															CHEMBL25263											125516	139088936				member																																																																																																																																																																14998318																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.7348																																-0.09185																																8																																HY-101861	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Neurological Disease|MOABOX:6019|APCS|Antiamyloidogenic Agents;Anti-Human Serum Amyloid P (Anti-SAP)	OC(=O)[C@H]1CCCN1C(=O)CCCCC(=O)N2CCC[C@@H]2C(=O)O	224624-80-0	41365	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469596	340.37156	MIRIDESAP; CPHPC; RO63-8695; GSK2315698	MIRIDESAP; CPHPC; RO63-8695; GSK2315698 | MIRIDESAP; CPHPC; RO63-8695; GSK2315698	Pathway: Others	Research Area: Neurological Disease	MOABOX:6019	APCS	Antiamyloidogenic Agents;Anti-Human Serum Amyloid P (Anti-SAP)
SJ000855469-2	SJ000855469	2	MOABOX:6022	PPAIMZHKIXDJRN-FMDGEEDCSA-N	CCNC1=N[C@H]2[C@H](O[C@H](CO)[C@@H](O)[C@@H]2O)S1	1009816-48-1	"N-Acetyl-beta-D-Glucosaminidase (O-GlcNAcase, OGA) Inhibitors;OGLcNACase inhibitor"	OGA																																																															CHEMBL1213603											24808478	135566354				member																																																																																																																																																																18587388	30713024																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.12224																																0.39028																																8																																HY-12588	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy | Research Area: Cancer|MOABOX:6022|OGA|N-Acetyl-beta-D-Glucosaminidase (O-GlcNAcase, OGA) Inhibitors;OGLcNACase inhibitor"	CCNC1=N[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]2S1	1009816-48-1	27300	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469415	248.29934	THIAMET G	THIAMET G | THIAMET G	Pathway: Autophagy	Research Area: Cancer	MOABOX:6022	OGA	"N-Acetyl-beta-D-Glucosaminidase (O-GlcNAcase, OGA) Inhibitors;OGLcNACase inhibitor"
SJ001035385-1	SJ001035385	1	MOABOX:6026	OQAHHWOPVDDWHD-INIZCTEOSA-N	CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(=O)OCCCc1cccnc1	186452-09-5	FK506-Binding Protein 12 (Peptidyl-Prolyl Cis-Trans Isomerase FKBP12) Inhibitors;Neurotrophic Agents;Rotamase (FKBP12) Inhibitors	FKBP1A																																																															CHEMBL6367											445501	9874568	141946753	143524200		member																																																																																																																																																																9767630	11992791	12139466	22087831																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.62384																																0.07798																																8																																HY-124619	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Apoptosis; Autophagy; Immunology/Inflammation | Research Area: Infection; Neurological Disease|MOABOX:6026|FKBP1A|FK506-Binding Protein 12 (Peptidyl-Prolyl Cis-Trans Isomerase FKBP12) Inhibitors;Neurotrophic Agents;Rotamase (FKBP12) Inhibitors	CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(=O)OCCCc2cccnc2	186452-09-5	89060	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469862	360.44732	GPI-1046	GPI-1046 | GPI-1046	Pathway: Anti-infection; Apoptosis; Autophagy; Immunology/Inflammation	Research Area: Infection; Neurological Disease	MOABOX:6026	FKBP1A	FK506-Binding Protein 12 (Peptidyl-Prolyl Cis-Trans Isomerase FKBP12) Inhibitors;Neurotrophic Agents;Rotamase (FKBP12) Inhibitors
SJ000832931-5	SJ000832931	5	MOABOX:6028	LSXUTRRVVSPWDZ-MKKUMYSQSA-N	CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CC(C)C)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O	1071992-57-8	Apoptosis Inducers;Inhibitor  of Apoptosis Protein 1 (IAP1) Inhibitors;Inhibitor  of Apoptosis Protein 2 (IAP2) Inhibitors;Signal Transduction Modulators;X-Chromosome-Linked Inhibitor of Apoptosis Protein (XIAP) Inhibitors	BIRC2	BIRC3	XIAP																														330	331																														CHEMBL2158051	CHEMBL2158055										25022339	25022340	52952684			member	10.1021/jm101505d																																																																																																																																																															21443232	26218264	28492317	29940121																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.73928	1.54216	-0.33408																														0.21741	0.19277	-0.04176																														8	8	8																														HY-15454	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis | Research Area: Cancer|MOABOX:6028|BIRC2|Apoptosis Inducers;Inhibitor of Apoptosis Protein 1 (IAP1) Inhibitors;Inhibitor of Apoptosis Protein 2 (IAP2) Inhibitors;Signal Transduction Modulators;X-Chromosome-Linked Inhibitor of Apoptosis Protein (XIAP) Inhibitors	CN[C@@H](C)C(=O)N[C@H]1CN(CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c3ccccc3)c4ccccc4)C(=O)CC(C)C	1071992-99-8	8456	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469230	561.71492	AT-406	AT-406 | AT-406	Pathway: Apoptosis	Research Area: Cancer	MOABOX:6028	BIRC2	Apoptosis Inducers;Inhibitor of Apoptosis Protein 1 (IAP1) Inhibitors;Inhibitor of Apoptosis Protein 2 (IAP2) Inhibitors;Signal Transduction Modulators;X-Chromosome-Linked Inhibitor of Apoptosis Protein (XIAP) Inhibitors
SJ001035159-1	SJ001035159	1	MOABOX:6031	XJDKPLZUXCIMIS-HMMYKYKNSA-N	O=C1/C(=C/c2ccccc2)C(NC2CCCCC2)c2ccccc21	1245792-51-1	Angiogenesis Inhibitors;MKP-3 Inhibitors;Signal Transduction Modulators	DUSP6																																																															CHEMBL1241589											6419844	69670465				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.76335																																0.10905																																7																																HY-115502	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer; Inflammation/Immunology|MOABOX:6031|DUSP6|Angiogenesis Inhibitors;MKP-3 Inhibitors;Signal Transduction Modulators	O=C1\C(=C\c2ccccc2)\C(NC3CCCCC3)c4ccccc14	1245792-51-1	48298	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468953	317.42412	BCI | (E)-BCI	"""BCI | (E)-BCI"" | ""BCI | (E)-BCI"""	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer; Inflammation/Immunology	MOABOX:6031	DUSP6	Angiogenesis Inhibitors;MKP-3 Inhibitors;Signal Transduction Modulators
SJ000852811-2	SJ000852811	2	MOABOX:6035	RXXJCNMVVRGOJB-UHFFFAOYSA-O	COCCOCCOCCOCCOC(=O)OC[n+]1ccc(N/C(=N\C#N)NCCCCCCOc2ccc(Cl)cc2)cc1	432037-57-5	"Glycerol-3-Phosphate Dehydrogenase (NAD+) Inhibitors;Inhibitory kappaB Kinase (IKK) Inhibitors;Nicotinamide Phosphoribosyltransferase (NMPRTase) Inhibitors;Signal Transduction Modulators;""Glycerol-3-Phosphate Dehydrogenase (NAD+) Inhibitors;Inhibitory kappaB Kinase (IKK) Inhibitors;Nicotinamide Phosphoribosyltransferase (NMPRTase) Inhibitors;Signal Transduction Modulators"""	GPD1	NAMPT	CHUK																														10135	1147																														CHEMBL1181731	CHEMBL190412										9961434	9961435	42611167	129894067	136845567	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0																														0.0	0.0	0.0																														7	7	7																														HY-10080	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:6035|GPD1|Glycerol-3-Phosphate Dehydrogenase (NAD+) Inhibitors;Inhibitory kappaB Kinase (IKK) Inhibitors;Nicotinamide Phosphoribosyltransferase (NMPRTase) Inhibitors;Signal Transduction Modulators;\Glycerol-3-Phosphate Dehydrogenase (NAD+) Inhibitors;Inhibitory kappaB Kinase (IKK) Inhibitors;Nicotinamide Phosphoribosyltransferase (NMPRTase) Inhibitors;Signal Transduction Modulators\	COCCOCCOCCOCCOC(=O)OC[n+]1ccc(N\C(=N/CCCCCCOc2ccc(Cl)cc2)\NC#N)cc1	432037-57-5	90720	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469911	637.14412	GMX-1777	GMX-1777 | GMX-1777	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:6035	GPD1	Glycerol-3-Phosphate Dehydrogenase (NAD+) Inhibitors;Inhibitory kappaB Kinase (IKK) Inhibitors;Nicotinamide Phosphoribosyltransferase (NMPRTase) Inhibitors;Signal Transduction Modulators;\Glycerol-3-Phosphate Dehydrogenase (NAD+) Inhibitors;Inhibitory kappaB Kinase (IKK) Inhibitors;Nicotinamide Phosphoribosyltransferase (NMPRTase) Inhibitors;Signal Transduction Modulators\
SJ001035398-1	SJ001035398	1	MOABOX:6037	XTHRTBCPBWJYRO-UHFFFAOYSA-N	COc1ccccc1-c1nc(=Nc2ccccc2)sn1-c1ccccc1OC	524923-88-4	Signal Transduction Modulators;Melanocortin MC5 Antagonists;Melanocortin MC1 Receptor Antagonists	MC1R	MC5R																															4161																																															member	10.1016/j.jdermsci.2011.04.001																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0																															0.0	0.0																															7	7																															HY-107139	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Endocrinology|MOABOX:6037|MC1R|Signal Transduction Modulators;Melanocortin MC5 Antagonists;Melanocortin MC1 Receptor Antagonists	COc1ccccc1N2S\C(=N/c3ccccc3)\N=C2c4ccccc4OC	524923-88-4	36473	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469903	389.47016	JNJ-10229570	JNJ-10229570 | JNJ-10229570	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Endocrinology	MOABOX:6037	MC1R	Signal Transduction Modulators;Melanocortin MC5 Antagonists;Melanocortin MC1 Receptor Antagonists
SJ001033138-2	SJ001033138	2	MOABOX:6039	NOZIJMHMKORZBA-KJCUYJGMSA-N	CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC	1110766-97-6	Signal Transduction Modulators;Thrombopoietin Receptor (c-MPL) agonist	MPL																																																															CHEMBL2107831											49843517					member	10.1007/s40265-015-0525-4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.35816																																0.16977																																8																																HY-19883	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Inflammation/Immunology|MOABOX:6039|MPL|Signal Transduction Modulators;Thrombopoietin Receptor (c-MPL) agonist	CCCCCCO[C@@H](C)c1cccc(c1OC)c2csc(NC(=O)c3cc(Cl)c(\C=C(/C)\C(=O)O)c(Cl)c3)n2	1110766-97-6	22971	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468960	591.54578	LUSUTROMBOPAG | S-888711	"""LUSUTROMBOPAG | S-888711"" | ""LUSUTROMBOPAG | S-888711"""	Pathway: Immunology/Inflammation	Research Area: Inflammation/Immunology	MOABOX:6039	MPL	Signal Transduction Modulators;Thrombopoietin Receptor (c-MPL) agonist
SJ001033121-2	SJ001033121	2	MOABOX:6040	OFZJKCQENFPZBH-UHFFFAOYSA-N	O=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1cnc(N2CCC(C(=O)O)CC2)c(Cl)c1	570406-98-3	Signal Transduction Modulators;Thrombopoietin Receptor (TpoR) Agonists	MPL																																																															CHEMBL2103883	CHEMBL2105758										9852519	9918581	87588882	90888239	134715627	member	10.1007/s40265-018-0949-8	10.1155/2016/1802932																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.57664																																0.44708																																8																																HY-13463B	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Cardiovascular Disease|MOABOX:6040|MPL|Signal Transduction Modulators;Thrombopoietin Receptor (TpoR) Agonists	OC(=O)C1CCN(CC1)c2ncc(cc2Cl)C(=O)Nc3nc(c4cc(Cl)cs4)c(s3)N5CCN(CC5)C6CCCCC6	570403-17-7	20014	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469232	649.65466	AVATROMBOPAG (HYDROCHLORIDE) | AKR-501 (HYDROCHLORIDE) | E5501 (HYDROCHLORIDE) | YM477 (HYDROCHLORIDE)	"""AVATROMBOPAG (HYDROCHLORIDE) | AKR-501 (HYDROCHLORIDE) | E5501 (HYDROCHLORIDE) | YM477 (HYDROCHLORIDE)"" | ""AVATROMBOPAG (HYDROCHLORIDE) | AKR-501 (HYDROCHLORIDE) | E5501 (HYDROCHLORIDE) | YM477 (HYDROCHLORIDE)"""	Pathway: Immunology/Inflammation	Research Area: Cardiovascular Disease	MOABOX:6040	MPL	Signal Transduction Modulators;Thrombopoietin Receptor (TpoR) Agonists
SJ000833881-6	SJ000833881	6	MOABOX:6041	QHADVLVFMKEIIP-UHFFFAOYSA-N	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1	1206799-15-6	"""""""Angiogenesis Inhibitors"";HGFR (MET;c-Met) Inhibitors;Macrophage Stimulating 1 Receptor (MST1R, RON) Inhibitors;""Signal Transduction Modulators"""""""	MET	MST1R																															4486																															CHEMBL3545307											44603533	66767273	71604306			member																																																																																																																																																																29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.33736	0																															0.16717	0.0																															8	8																															HY-15514	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:6041|MET|\\\Angiogenesis Inhibitors\;HGFR (MET;c-Met) Inhibitors;Macrophage Stimulating 1 Receptor (MST1R, RON) Inhibitors;\Signal Transduction Modulators\\\"	CC1=CC=C(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3c5cn[nH]c5)c(F)c2)C(=O)N1c6ccc(F)cc6	1206799-15-6	64967	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469407	552.53089	LY2801653	LY2801653 | LY2801653	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:6041	MET	"\\\Angiogenesis Inhibitors\;HGFR (MET;c-Met) Inhibitors;Macrophage Stimulating 1 Receptor (MST1R, RON) Inhibitors;\Signal Transduction Modulators\\\"
SJ001033245-2	SJ001033245	2	MOABOX:6047	TXCGMRVPXUBHAL-UHFFFAOYSA-N	O=C1C(=Nc2cccc(C(F)(F)F)c2)c2ccccc2N1c1ccccc1	1000273-85-7	Galanin GAL3 Antagonists;Signal Transduction Modulators	GALR3																																																																															virtual	10.1016/j.regpep.2010.08.009	10.1073/pnas.0508970102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.7175																																0.1025																																7																																T5455	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-795-902|MOABOX:6047|GALR3|Galanin GAL3 Antagonists;Signal Transduction Modulators	FC(F)(F)c1cccc(c1)\N=C\2/C(=O)N(c3ccccc3)c4ccccc24	303149-14-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468148	366.33593	HT-2157; SNAP 37889	HT-2157; SNAP 37889 | HT-2157; SNAP 37889			MOABOX:6047	GALR3	Galanin GAL3 Antagonists;Signal Transduction Modulators
SJ000840332-5	SJ000840332	5	MOABOX:6050	XXYGTCZJJLTAGH-UHFFFAOYSA-N	Cc1cc(-c2ncc(CC(=O)Nc3ccc(-c4cnccn4)cn3)cc2C)ccn1	1243244-14-5	Porcupine Antagonist	PORCN																																																															CHEMBL3188386											46926973					virtual																																																																																																																																																																26522946	27876319	28671458																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.4384																																0.1798																																8																																HY-17545	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Stem Cell/Wnt | Research Area: Cancer|MOABOX:6050|PORCN|Porcupine Antagonist	Cc1cc(ccn1)c2ncc(CC(=O)Nc3ccc(cn3)c4cnccn4)cc2C	1243244-14-5	41279	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469113	396.4445	LGK-974	LGK-974 | LGK974 | LGK-974 | LGK974	Pathway: Stem Cell/Wnt	Research Area: Cancer	MOABOX:6050	PORCN	Porcupine Antagonist
SJ000286190-11	SJ000286190	11	MOABOX:6052	NZHGWWWHIYHZNX-CSKARUKUSA-N	COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC	053902-12-8	"IL-10 Production Enhancers;IL-2 Production Inhibitors;IL-4 Modulators;Indoleamine 2,3-dioxygenase Activators;Signal Transduction Modulators;TNF-alpha Production Inhibitors;IFN-gamma Production Inhibitors;Urate Transporter 1 (URAT1) Inhibitors"	HEXB	IDO1	TRPV2	SLC22A12																													3620	51393	116085																													CHEMBL415324											5282230	9798249	11656990	46220561	71738858	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.33341	0	-3.458e-002	-0.25207																													0.04763	0.0	-0.00494	-0.03601																													7	7	7	7																													KS-1193	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1ccc(\C=C\C(=O)Nc2ccccc2C(=O)O)cc1OC	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466724	327.33128	TRANILAST	TRANILAST | TRANILAST			MOABOX:6052	HEXB	"IL-10 Production Enhancers;IL-2 Production Inhibitors;IL-4 Modulators;Indoleamine 2,3-dioxygenase Activators;Signal Transduction Modulators;TNF-alpha Production Inhibitors;IFN-gamma Production Inhibitors;Urate Transporter 1 (URAT1) Inhibitors"
SJ000773176-3	SJ000773176	3	MOABOX:6062	HLXSCTYHLQHQDJ-UHFFFAOYSA-N	COc1ccc(C(=O)CC2(O)C(=O)Nc3c(Cl)ccc(Cl)c32)cc1	1037184-44-3	EWS-FLI1 Inhibitors	EWSR1	FLI1																															2313																															CHEMBL2011500											44632017	145653649				member																																																																																																																																																																21320057	25432018																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.69568	0.40088																															0.08696	0.05011																															8	8																															HY-14507	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:6062|EWSR1|EWS-FLI1 Inhibitors	COc1ccc(cc1)C(=O)CC2(O)C(=O)Nc3c(Cl)ccc(Cl)c23	1037184-44-3	5920	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468755	366.19542	YK-4-279 | ESFTS INHIBITOR |	"""YK-4-279 | ESFTS INHIBITOR |"" | ""YK-4-279 | ESFTS INHIBITOR |"""	Pathway: Apoptosis; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:6062	EWSR1	EWS-FLI1 Inhibitors
SJ000285235-35	SJ000285235	35	MOABOX:6070	VJJPUSNTGOMMGY-MRVIYFEKSA-N	COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O	121471-01-0	"Topoisomerase II inhibitor;Tubulin modulator;""Topoisomerase II inhibitor;Tubulin modulator"""	TOP2A	TOP2B	TUBB																														7155	203068																														CHEMBL44657											36462	487697	9833516	9875998	9876118	member	10.1016/j.bioorg.2019.103131	10.1016/j.ejmech.2018.03.026	10.1016/j.ejmech.2018.07.003																																																																																																																																																													8246238	8410993	12369868	20854254	29547830	30025350																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.21544	0.65536	0																														0.02693	0.08192	0.0																														8	8	7																														AS-35312	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1cc(cc(OC)c1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)c6cc7OCOc7cc26	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466745	588.55658	ETOPOSIDE	"ETOPOSIDE | ""EPEG | NK-171 | NSC-141540 | VP-16 | VP-16-213"" | SJ000287827 | ""ETOPOSIDE | EPEG | NK-171 | NSC-141540 | VP-16 | VP-16-213 |"" | ETOPOSIDE | ""EPEG | NK-171 | NSC-141540 | VP-16 | VP-16-213"" | SJ000287827 | ""ETOPOSIDE | EPEG | NK-171 | NSC-141540 | VP-16 | VP-16-213 |"""			MOABOX:6070	TOP2A	"Topoisomerase II inhibitor;Tubulin modulator;""Topoisomerase II inhibitor;Tubulin modulator"""
SJ001034954-1	SJ001034954	1	MOABOX:6071	FLCMSIBUTPDBOT-UHFFFAOYSA-N	COc1ccc(N=c2oc3cc(O)ccc3cc2C(=O)Nc2cccc(C)n2)cc1OC	1228170-70-4	AKR1B10 inhibitor	AKR1B1	AKR1B10																															57016																																															member	10.1016/j.bmc.2010.02.050																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				8.295e-002	8.918e-002																															0.01185	0.01274																															7	7																															STK019842	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-931-151|MOABOX:6071|AKR1B1|AKR1B10 inhibitor	COc1ccc(cc1OC)\N=C\2/Oc3cc(O)ccc3C=C2C(=O)Nc4cccc(C)n4	1228170-70-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468363	431.44064	STK019842	STK019842 | STK019842			MOABOX:6071	AKR1B1	AKR1B10 inhibitor
SJ000556735-9	SJ000556735	9	MOABOX:6073	IQFYYKKMVGJFEH-XLPZGREQSA-N	Cc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O	1211376-53-2	Thymidine kinase 1 ligand;Thymidine kinase 2 ligand	TK1	TYMP	TK2																														1890	7084																														CHEMBL52609											5789	3013328	9903773	20849132	21124326	member																																																																																																																																																																3033244	8941385	11606136	12213066	14584954	16305527																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0	2.1245	0.34335																														0.0	0.3035	0.04905																														7	7	7																														STR05630	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466788	242.22856	TELBIVUDINE	TELBIVUDINE | TELBIVUDINE			MOABOX:6073	TK1	Thymidine kinase 1 ligand;Thymidine kinase 2 ligand
SJ001010835-2	SJ001010835	2	MOABOX:6074	IVUGBSGLHRJSSP-UHFFFAOYSA-N	CC(C)C(=O)Nc1ncc(-c2cc(C(F)F)nn2-c2c(Cl)cccc2Cl)s1	1338247-35-0	LIM kinase-1 inhibitor;LIM kinase-2 inhibitor	LIMK1	LIMK2																															3985																															CHEMBL2141887											56965901					member	10.1002/med.20230	10.1158/1535-7163.MCT-08-0826																																																																																																																																																														22886629																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.36824	1.28344																															0.17103	0.16043																															8	8																															HY-18305	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:6074|LIMK1|LIM kinase-1 inhibitor;LIM kinase-2 inhibitor	CC(C)C(=O)Nc1ncc(s1)c2cc(nn2c3c(Cl)cccc3Cl)C(F)F	1338247-35-0	20643	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469689	431.28707	BMS-5	BMS-5 | BMS-5	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:6074	LIMK1	LIM kinase-1 inhibitor;LIM kinase-2 inhibitor
SJ001035029-1	SJ001035029	1	MOABOX:6078	KPTMSQHTGZMEFU-UHFFFAOYSA-N	COc1cc(OC)cc(C(=O)NNC(=O)Nc2cccc3ccccc23)c1	444932-31-4	GPR139 agonist;Drugs Acting on Orphan G-Protein Coupled Receptors (GPR)	GPR139																																																															CHEMBL3633893											3376937					member	10.1021/jm201136z	10.1021/ml100293q																																																																																																																																																														22506484	26396690																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				4.10904																																0.51363																																8																																AK-968/15605400	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-676-660|MOABOX:6078|GPR139|GPR139 agonist;Drugs Acting on Orphan G-Protein Coupled Receptors (GPR)	COc1cc(OC)cc(c1)C(=O)NNC(=O)Nc2cccc3ccccc23	444932-31-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468516	365.38256	AK-968/15605400	AK-968/15605400 | AK-968/15605400			MOABOX:6078	GPR139	GPR139 agonist;Drugs Acting on Orphan G-Protein Coupled Receptors (GPR)
SJ001035114-1	SJ001035114	1	MOABOX:6079	OOBDBFPYJXJEHC-UHFFFAOYSA-N	CN1CCN(C(=S)SSC(=S)N2CCN(C)CC2)CC1	20231-01-0	Monoglyceride lipase inhibitor	MGLL																																																															CHEMBL571699											30054					virtual	10.1021/jm901323s	10.2174/092986710791859414																																																																																																																																																														19883085	20370710	20491633	23410152																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		3.60648																																0.45081																																8																																ST102783	TIMTEC	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-663-854|MOABOX:6079|MGLL|Monoglyceride lipase inhibitor	CN1CCN(CC1)C(=S)SSC(=S)N2CCN(C)CC2	20231-01-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468721	350.58988	ST102783	ST102783 | ST102783			MOABOX:6079	MGLL	Monoglyceride lipase inhibitor
SJ000796109-4	SJ000796109	4	MOABOX:6081	SEGYOKHGGFKMCX-UHFFFAOYSA-N	O=C(Oc1ccc([N+](=O)[O-])cc1)N1CCC(C(O)(c2ccc3c(c2)OCO3)c2ccc3c(c2)OCO3)CC1	1101854-58-3	Monoacylglycerol Lipase Inhibitors;Monoglyceride lipase inhibitor	MGLL																																																															CHEMBL576786											25021165	71312223				member	10.1002/cbic.200900621	10.1002/cmdc.201800388	10.1016/j.bmc.2010.01.034	10.1016/j.bmc.2012.09.011	10.1016/j.bmcl.2011.09.038	10.1016/j.bmcl.2012.05.101	10.1016/j.chembiol.2012.03.009	10.1016/j.jpba.2015.02.007	10.1021/acs.jmedchem.5b01812	10.1021/acs.jmedchem.6b01459	10.1021/acs.jmedchem.8b01483	10.1021/jm501371s	10.1038/nchembio.663	10.1080/14756366.2017.1375484	10.1111/j.1476-5381.2010.00974.x	10.1194/jlr.D058438	10.2174/156802610791164238	10.3109/14756366.2015.1010530																																																																																																																																														19029917	19583260	19957260	20370710	20491633	20735405	21982493	22053353	22542104	22738638	23036333	23410152	23455058	25011912	25565044	26888301	27267002	27809504	29148769	29309142	29498843	30715876																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																2.29616																																0.28702																																8																																HY-15249	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Neurological Disease|MOABOX:6081|MGLL|Monoacylglycerol Lipase Inhibitors;Monoglyceride lipase inhibitor	OC(C1CCN(CC1)C(=O)Oc2ccc(cc2)[N+](=O)[O-])(c3ccc4OCOc4c3)c5ccc6OCOc6c5	1101854-58-3	20417	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469645	520.48746	JZL 184	JZL 184 | JZL184 | JZL 184 | JZL184	Pathway: Metabolic Enzyme/Protease	Research Area: Neurological Disease	MOABOX:6081	MGLL	Monoacylglycerol Lipase Inhibitors;Monoglyceride lipase inhibitor
SJ000834158-8	SJ000834158	8	MOABOX:6085	DUIHHZKTCSNTGM-UHFFFAOYSA-N	CS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1	1232410-49-9	ATR gene inhibitor	ATR	ATRIP																															84126																															CHEMBL1766779											51000408					member	10.1021/jm101488z																																																																																																																																																															21413798	21490603	22835870	24893124	27177826	31074988																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																3.17536	0																															0.39692	0.0																															8	7																															HY-14731	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:6085|ATR|ATR gene inhibitor	CS(=O)(=O)c1ccc(cc1)c2cnc(N)c(n2)C(=O)Nc3ccccc3	1232410-49-9	4007	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469580	368.40964	VE-821	VE-821 | VE-821	Pathway: Cell Cycle/DNA Damage; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:6085	ATR	ATR gene inhibitor
SJ000840356-2	SJ000840356	2	MOABOX:6086	BNYDDAAZMBUFRG-ZDUSSCGKSA-N	N[C@@H](CC(=O)Nc1ccc(Oc2cc(F)c(F)cc2Br)cc1)C(=O)O	868359-05-1	Excitatory amino acid transporter 2 inhibitor	SLC1A2																																																															CHEMBL1628669											11531745	139290995				member	10.1016/j.bmcl.2005.08.003	10.1021/acs.jmedchem.8b00700	10.1124/mol.105.012005																																																																																																																																																													16014807	16165356	16368269	17017964	30011368																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.15032																																0.14379																																8																																HY-107523A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Neurological Disease|MOABOX:6086|SLC1A2|Excitatory amino acid transporter 2 inhibitor	N[C@@H](CC(=O)Nc1ccc(Oc2cc(F)c(F)cc2Br)cc1)C(=O)O	NA	46785	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468951	415.18623	WAY 213613	WAY 213613 | WAY 213613	Pathway: Membrane Transporter/Ion Channel	Research Area: Neurological Disease	MOABOX:6086	SLC1A2	Excitatory amino acid transporter 2 inhibitor
SJ001034643-1	SJ001034643	1	MOABOX:6087	CNJGWCQEGROXEE-UHFFFAOYSA-N	O=C(O)c1cc(Cl)cc(Cl)c1O	106086-54-8	Aldo keto reductase 1C1 inhibitor	AKR1C1																																																															CHEMBL449129											9445	139187305	145233531			member																																																																																																																																																																18620380	19397269	20850205	21414777	21568892																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	3.30344																																0.41293																																8																																PS-4183	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC(=O)c1cc(Cl)cc(Cl)c1O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466643	207.01086	PS-4183	PS-4183 | PS-4183			MOABOX:6087	AKR1C1	Aldo keto reductase 1C1 inhibitor
SJ000884178-2	SJ000884178	2	MOABOX:6090	CCAWRGNYALGPQH-UHFFFAOYSA-N	O=C(Nc1cccc(C(F)(F)F)c1)Nc1cc(S(=O)(=O)NC2CC2)ccc1-c1ccsc1	1432660-47-3	"Isocitrate Dehydrogenase (NADP+) (IDPm, IDH2) (Arg140Gln Mutant) Inhibitors"	IDH2																																																															CHEMBL3392845											71299339					member																																																																																																																																																																23558173																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.2496																																0.4062																																8																																HY-15734	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:6090|IDH2|Isocitrate Dehydrogenase (NADP+) (IDPm, IDH2) (Arg140Gln Mutant) Inhibitors"	FC(F)(F)c1cccc(NC(=O)Nc2cc(ccc2c3ccsc3)S(=O)(=O)NC4CC4)c1	1432660-47-3	10863	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468822	481.51113	AGI-6780	AGI-6780 | AGI-6780	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:6090	IDH2	"Isocitrate Dehydrogenase (NADP+) (IDPm, IDH2) (Arg140Gln Mutant) Inhibitors"
SJ000785906-3	SJ000785906	3	MOABOX:6091	QSYLKMKIVWJAAK-UHFFFAOYSA-N	Cc1cc(Nc2ccc(NC(=O)c3ccc(Nc4ccnc5ccccc45)cc3)cc2)nc(N)n1	1020086-21-8	DNA Methyltransferase I Inhibitors	DNMT1																																																															CHEMBL2336409											24858110	24858111	91826513			member	10.1021/jm4012627																																																																																																																																																															24387159																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.278																																0.03475																																8																																T1904	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-035-395-813|MOABOX:6091|DNMT1|DNA Methyltransferase I Inhibitors	Cc1cc(Nc2ccc(NC(=O)c3ccc(Nc4ccnc5ccccc45)cc3)cc2)nc(N)n1	1020149-73-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468136	461.51782	SGI-1027	"SGI-1027 | ""DNA METHYLTRANSFERASE INHIBITOR II | S-1027"" | SGI-1027 | ""DNA METHYLTRANSFERASE INHIBITOR II | S-1027"""			MOABOX:6091	DNMT1	DNA Methyltransferase I Inhibitors
SJ000785891-8	SJ000785891	8	MOABOX:6093	VUVUVNZRUGEAHB-CYBMUJFWSA-N	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12	1300031-49-5	BRD2/3/4/T BET familiy inhibitor;BRD4 gene inhibitor	BRD4																																																															CHEMBL2017291											52912189	90488961	121513850			member	10.1021/acs.jmedchem.7b00193	10.1039/c7md00083a																																																																																																																																																														22437115	23517011	24300735	24900758	25559428	25678016	25851940	26080064	26572217	26731490	26985289	28463487	28765013	29566488	29776834	30606676																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						1.88384																																0.23548																																8																																HY-13235	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:6093|BRD4|BRD2/3/4/T BET familiy inhibitor;BRD4 gene inhibitor	COc1cc2c3N([C@H](C)c4ccccn4)C(=O)Nc3cnc2cc1c5c(C)onc5C	1300031-49-5	9018	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468935	415.44454	I-BET151	I-BET151 | GSK1210151 | I-BET151 (GSK1210151A) | I-BET151 | GSK1210151 | I-BET151 (GSK1210151A)	Pathway: Epigenetics	Research Area: Cancer	MOABOX:6093	BRD4	BRD2/3/4/T BET familiy inhibitor;BRD4 gene inhibitor
SJ000833879-8	SJ000833879	8	MOABOX:6094	QECMENZMDBOLDR-AWEZNQCLSA-N	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(N)=O)c1nnc(C)n1-2	1446144-04-2	BRD4 gene inhibitor	BRD4																																																																										71291068	144280332	144280399			member																																																																																																																																																																22509028																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.776e-002																																0.00222																																8																																HY-15846	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Epigenetics | Research Area: Cancer|MOABOX:6094|BRD4|BRD4 gene inhibitor	Cc1sc2c(C(=N[C@@H](CC(=O)N)c3nnc(C)n23)c4ccc(Cl)cc4)c1C	1446144-04-2	11287	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469133	399.89712	CPI-203	CPI-203 | CPI-203	Pathway: Apoptosis; Epigenetics	Research Area: Cancer	MOABOX:6094	BRD4	BRD4 gene inhibitor
SJ000884180-5	SJ000884180	5	MOABOX:6095	RDONXGFGWSSFMY-UHFFFAOYSA-N	CCS(=O)(=O)Nc1ccc(Oc2ccc(F)cc2F)c(-c2cn(C)c(=O)c3[nH]ccc23)c1	1445993-26-9	"Bromodomain-Containing Protein 4 (Brd4, HUNK1) Inhibitors"	BRD4																																																															CHEMBL3987016											71600087					member	10.1016/j.bioorg.2019.103044	10.1158/1535-7163.MCT-16-0459																																																																																																																																																														24497428	28314513	28949521	29678460	30529546																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	2.23192																																0.27899																																8																																HY-100015	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Epigenetics | Research Area: Cancer|MOABOX:6095|BRD4|Bromodomain-Containing Protein 4 (Brd4, HUNK1) Inhibitors"	CCS(=O)(=O)Nc1ccc(Oc2ccc(F)cc2F)c(c1)C3=CN(C)C(=O)c4[nH]ccc34	1445993-26-9	21605	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469215	459.46577	MIVEBRESIB	MIVEBRESIB | ABBV-075 | MIVEBRESIB | ABBV-075	Pathway: Apoptosis; Epigenetics	Research Area: Cancer	MOABOX:6095	BRD4	"Bromodomain-Containing Protein 4 (Brd4, HUNK1) Inhibitors"
SJ000013086-2	SJ000013086	2	MOABOX:6096	IYAYHZZWYNXHEQ-UHFFFAOYSA-N	O=C(Nc1cccc(Br)c1)c1cccc(S(=O)(=O)N2CCCCCC2)c1	420831-40-9	SIRT2;SIRT2 gene inhibitor	SIRT2																																																															CHEMBL3222141											1328033					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.49476																																-0.07068																																7																																HY-16691	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Neurological Disease|MOABOX:6096|SIRT2|SIRT2;SIRT2 gene inhibitor	Brc1cccc(NC(=O)c2cccc(c2)S(=O)(=O)N3CCCCCC3)c1	420831-40-9	22450	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469273	437.35064			Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Neurological Disease	MOABOX:6096	SIRT2	SIRT2;SIRT2 gene inhibitor
SJ000843884-4	SJ000843884	4	MOABOX:6097	INAICWLVUAKEPB-QSTFCLMHSA-N	O=C(/C=C/N1C[C@H]2C[C@@H]1CN2c1ccccn1)c1ccccc1O		"SMARCA2/4;SMARCA2 gene inhibitor;""Protein Polybromo-1 (PBRM1; hPB1; BAF180) Inhibitors"""	SMARCA2	SMARCA4	PBRM1																														6597	55193																														CHEMBL3752911											78243717					member																																																																																																																																																																26139243	26572217	27115555	27119626																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		-6.872e-002	0.40408	2.056																														-0.00859	0.05051	0.257																														8	8	8																														HY-12409	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:6097|SMARCA2|SMARCA2/4;SMARCA2 gene inhibitor;\Protein Polybromo-1 (PBRM1; hPB1; BAF180) Inhibitors\	Oc1ccccc1C(=O)\C=C\N2C[C@H]3C[C@@H]2CN3c4ccccn4	1819363-80-8	15441	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469916	321.37306	PFI-3	PFI-3 | PFI-3	Pathway: Epigenetics	Research Area: Cancer	MOABOX:6097	SMARCA2	SMARCA2/4;SMARCA2 gene inhibitor;\Protein Polybromo-1 (PBRM1; hPB1; BAF180) Inhibitors\
SJ000852521-5	SJ000852521	5	MOABOX:6101	PMJIHLSCWIDGMD-UHFFFAOYSA-N	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1	865854-05-3	GSK3B gene inhibitor	GSK3B																																																															CHEMBL3545157											11313622					member	10.1074/jbc.M111.306472																																																																																																																																																															22102280	23931441	26486317	27131621	29208522	29541355																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																3.09984																																0.38748																																8																																HY-14872	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: PI3K/Akt/mTOR; Stem Cell/Wnt | Research Area: Neurological Disease|MOABOX:6101|GSK3B|GSK3B gene inhibitor	O=C1SN(C(=O)N1Cc2ccccc2)c3cccc4ccccc34	865854-05-3	13986	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469126	334.39166	TIDEGLUSIB	TIDEGLUSIB | TIDEGLUSIB	Pathway: PI3K/Akt/mTOR; Stem Cell/Wnt	Research Area: Neurological Disease	MOABOX:6101	GSK3B	GSK3B gene inhibitor
SJ001035341-1	SJ001035341	1	MOABOX:6109	HGFOOLONGOBCMP-IBGZPJMESA-N	COc1ccc([C@H](CC(=O)O)N2CCN(CCCc3ccc4c(n3)NCCC4)C2=O)cn1	227963-15-7	"Integrin alpha-V/beta-3 antagonist, Integrin alpha-V/beta-5 antagonist"	ITGAV	ITGB3	ITGB5																														3690	3693																														CHEMBL145085											9853558	9853559	10143103	10144314	10168012	member	10.1124/jpet.118.248427																																																																																																																																																															14561098	15357983	16918408	20218623	22572578																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.6376	1.26888	0																														0.0797	0.15861	0.0																														8	8	7																														HY-15102	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Cytoskeleton | Research Area: Inflammation/Immunology; Cancer|MOABOX:6109|ITGAV|Integrin alpha-V/beta-3 antagonist, Integrin alpha-V/beta-5 antagonist"	COc1ccc(cn1)[C@H](CC(=O)O)N2CCN(CCCc3ccc4CCCNc4n3)C2=O	227963-15-7	42905	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469653	439.50746	MK-0429 | L-000845704	"""MK-0429 | L-000845704"" | ""MK-0429 | L-000845704"""	Pathway: Cytoskeleton	Research Area: Inflammation/Immunology; Cancer	MOABOX:6109	ITGAV	"Integrin alpha-V/beta-3 antagonist, Integrin alpha-V/beta-5 antagonist"
SJ000826827-9	SJ000826827	9	MOABOX:6110	WBKCKEHGXNWYMO-UHFFFAOYSA-N	CCOC(=O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2ccccn2)n1	1373423-53-0	"pan-KDM6 family (KDM6A / KDM6B / UTY);Histone demethylation inhibitors;KDM6A gene inhibitor, KDM6B gene inhibitor"	KDM6A	KDM6B																															23135																															CHEMBL3183531											71729974	71729975	129010304			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	-3.416e-002																															0.0	-0.00488																															7	7																															HY-15648B	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Epigenetics | Research Area: Cancer|MOABOX:6110|KDM6A|pan-KDM6 family (KDM6A / KDM6B / UTY);Histone demethylation inhibitors;KDM6A gene inhibitor, KDM6B gene inhibitor"	CCOC(=O)CCNc1cc(nc(n1)c2ccccn2)N3CCc4ccccc4CC3	1373423-53-0	25055	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469311	417.50348	GSK-J4	GSK-J4 | GSK J4 HCL | GSK J4 | GSK-J4 | GSK J4 HCL | GSK J4	Pathway: Apoptosis; Epigenetics	Research Area: Cancer	MOABOX:6110	KDM6A	"pan-KDM6 family (KDM6A / KDM6B / UTY);Histone demethylation inhibitors;KDM6A gene inhibitor, KDM6B gene inhibitor"
SJ001035171-1	SJ001035171	1	MOABOX:6115	YVIJPELUPZUEJX-UHFFFAOYSA-N	COc1ccc(N2CCN(C(=O)c3cc4c(s3)-c3ccccc3S(=O)(=O)C4)CC2)cc1	890819-86-0	LYPLA2 gene inhibitor	LYPLA2																																																															CHEMBL1509398											16193817					member	10.1021/acsmedchemlett.6b00441																																																																																																																																																															25558349	28197315																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.37952																																0.42244																																8																																HY-100737	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:6115|LYPLA2|LYPLA2 gene inhibitor	COc1ccc(cc1)N2CCN(CC2)C(=O)c3cc4CS(=O)(=O)c5ccccc5c4s3	890819-86-0	89488	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468982	454.56178	ML349	ML349 | ML349	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:6115	LYPLA2	LYPLA2 gene inhibitor
SJ001035227-1	SJ001035227	1	MOABOX:6116	UTAJHKSGYJSZBR-UHFFFAOYSA-N	COc1ccccc1C(=O)Nc1cccc(NC(=O)c2cccc(C)c2)c1	947914-18-3	KCNK3 gene inhibitor	KCNK3																																																															CHEMBL1081188											46785920					member																																																																																																																																																																25017033																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.6976																																0.3372																																8																																HY-12345	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Cardiovascular Disease|MOABOX:6116|KCNK3|KCNK3 gene inhibitor	COc1ccccc1C(=O)Nc2cccc(NC(=O)c3cccc(C)c3)c2	947914-18-3	13869	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469187	360.4058	ML365	ML365 | ML365	Pathway: Membrane Transporter/Ion Channel	Research Area: Cardiovascular Disease	MOABOX:6116	KCNK3	KCNK3 gene inhibitor
SJ001034935-1	SJ001034935	1	MOABOX:6118	DYXYXTDIFMDJIR-UHFFFAOYSA-N	CNc1oc(-c2cccc3ccccc23)nc1C#N	847163-28-4	ALOX15 gene inhibitor	ALOX15																																																															CHEMBL1548353											664510					member	10.1021/acs.jmedchem.5b01121	10.1021/jm401915r																																																																																																																																																														24684213	26331552	26899595	27647374																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.506																																0.31325																																8																																4355573	OTAVA	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-618-078|MOABOX:6118|ALOX15|ALOX15 gene inhibitor	CNc1oc(nc1C#N)c2cccc3ccccc23	847163-28-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468291	249.26734	4355573	4355573 | 4355573			MOABOX:6118	ALOX15	ALOX15 gene inhibitor
SJ001035010-1	SJ001035010	1	MOABOX:6119	FVKOFZKSMMIUTL-UHFFFAOYSA-N	O=c1c2cc(F)ccc2sn1-c1cc(S(=O)(=O)N2CCOCC2)ccc1N1CCOCC1	1632125-79-1	Insulin degrading enzyme inhibitor	IDE																																																																										57390068					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																17633	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-181-411|MOABOX:6119|IDE|Insulin degrading enzyme inhibitor	Fc1ccc2SN(C(=O)c2c1)c3cc(ccc3N4CCOCC4)S(=O)(=O)N5CCOCC5	1632125-79-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468464	479.54488	ML-345	ML-345 | ML-345			MOABOX:6119	IDE	Insulin degrading enzyme inhibitor
SJ001035026-1	SJ001035026	1	MOABOX:6120	SSPYAPRDKNCABY-YQQQUEKLSA-N	COc1cc(C(=O)NC2C[C@@H]3CCC[C@H](C2)N3CC(=O)Nc2ccccc2Cl)cc(OC)c1OC		CXCR6 chemokine antagonist	CXCR6																																																																										71768224					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																5943	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-162-858|MOABOX:6120|CXCR6|CXCR6 chemokine antagonist	COc1cc(cc(OC)c1OC)C(=O)N[C@@H]2C[C@H]3CCC[C@@H](C2)N3CC(=O)Nc4ccccc4Cl	2080300-49-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468511	502.00238	ML 339	ML 339 | ML 339			MOABOX:6120	CXCR6	CXCR6 chemokine antagonist
SJ000855533-2	SJ000855533	2	MOABOX:6122	XDHBUMNIQRLHGO-UKTHLTGXSA-N	C/C(=N\NC(=S)N1CCC1)c1ccccn1	71555-25-4	p53 tumor suppressor protein inhibitor	TP53																																																															CHEMBL1976486											5351307					virtual																																																																																																																																																																22624712																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.73502																																0.24786																																7																																HY-18634	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis | Research Area: Cancer|MOABOX:6122|TP53|p53 tumor suppressor protein inhibitor	C\C(=N/NC(=S)N1CCC1)\c2ccccn2	71555-25-4	14128	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469162	234.32066	NSC 319726	NSC 319726 | NSC 319726	Pathway: Apoptosis	Research Area: Cancer	MOABOX:6122	TP53	p53 tumor suppressor protein inhibitor
SJ000855155-3	SJ000855155	3	MOABOX:6123	QJZRFPJCWMNVAV-HHHXNRCGSA-N	Cc1ccc(C(=O)N(CCCN)[C@@H](c2nc3cc(Cl)ccc3c(=O)n2Cc2ccccc2)C(C)C)cc1	336113-53-2	"Antimitotic Drugs;Kinesin-Like Spindle Protein  KIF11 (KSP, Eg5) Inhibitors"	KIF11																																																															CHEMBL228814	CHEMBL2347651										6450816	6851740	11629254			member	10.1016/j.bbrc.2008.05.074																																																																																																																																																															22248262	23394180	23434636	24184776	26396688																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.2044																																0.15055																																8																																HY-50759	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton | Research Area: Cancer|MOABOX:6123|KIF11|Antimitotic Drugs;Kinesin-Like Spindle Protein KIF11 (KSP, Eg5) Inhibitors"	CC(C)[C@@H](N(CCCN)C(=O)c1ccc(C)cc1)C2=Nc3cc(Cl)ccc3C(=O)N2Cc4ccccc4	336113-53-2	48253	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469072	517.06162	ISPINESIB (SB-715992)	ISPINESIB (SB-715992) | ISPINESIB (SB-715992)	Pathway: Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton	Research Area: Cancer	MOABOX:6123	KIF11	"Antimitotic Drugs;Kinesin-Like Spindle Protein KIF11 (KSP, Eg5) Inhibitors"
SJ000870801-3	SJ000870801	3	MOABOX:6125	TXJZRSRTYPUYRW-NQIIRXRSSA-N	COC(=O)c1ccc([C@H]2c3[nH]c4ccccc4c3C[C@H](C(=O)OC)N2C(=O)CCl)cc1		GPX4 covalent inhibitor	GPX4																																																																										1750826					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																CS-5650	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-560-322|MOABOX:6125|GPX4|GPX4 covalent inhibitor	COC(=O)[C@H]1Cc2c([nH]c3ccccc23)[C@@H](N1C(=O)CCl)c4ccc(cc4)C(=O)OC	1219810-16-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468679	440.87624	RSL3	RSL3 | RSL3			MOABOX:6125	GPX4	GPX4 covalent inhibitor
SJ000855286-3	SJ000855286	3	MOABOX:6128	RFUBTTPMWSKEIW-UHFFFAOYSA-N	COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1	873697-71-3	Cardiac Myosin Activators	MYH7																																																															CHEMBL1800955											11689883	78425816				member	10.1038/ncomms8974																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-14233	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cytoskeleton | Research Area: Cardiovascular Disease|MOABOX:6128|MYH7|Cardiac Myosin Activators	COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1	873697-71-3	5330	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469692	401.43466	OMECAMTIV MECARBIL (CK-1827452)	OMECAMTIV MECARBIL (CK-1827452) | OMECAMTIV MECARBIL (CK-1827452)	Pathway: Cytoskeleton	Research Area: Cardiovascular Disease	MOABOX:6128	MYH7	Cardiac Myosin Activators
SJ001010844-3	SJ001010844	3	MOABOX:6130	BHKDKKZMPODMIQ-UHFFFAOYSA-N	COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc32)ncc1C#N		Selective FGFR4 inhibitor;FGFR4 gene inhibitor	FGFR4																																																															CHEMBL3908979											118036971	133082760				virtual	10.1016/j.bmc.2019.04.018	10.1039/c9cc02052g																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.3992																																0.2999																																8																																T4235	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-756-212|MOABOX:6130|FGFR4|Selective FGFR4 inhibitor;FGFR4 gene inhibitor	COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc23)ncc1C#N	1708971-55-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468528	506.5569	ROBLITINIB	ROBLITINIB | ROBLITINIB			MOABOX:6130	FGFR4	Selective FGFR4 inhibitor;FGFR4 gene inhibitor
SJ001010830-2	SJ001010830	2	MOABOX:6133	IKUFKDGKRLMXEX-UHFFFAOYSA-N	CN1CCN(c2ccc(-c3ccncc3-c3cc(F)c(O)c(F)c3)cc2)CC1		Ribosomal protein S6 kinase inhibitor	RPS6KA1	RPS6KA2	RPS6KA3																														6196	6197																														CHEMBL3604793											73010393					member																																																																																																																																																																26270416	30170943																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.82	0.90256	2.44624																														0.1025	0.11282	0.30578																														8	8	8																														T6877	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-560-306|MOABOX:6133|RPS6KA1|Ribosomal protein S6 kinase inhibitor	CN1CCN(CC1)c2ccc(cc2)c3ccncc3c4cc(F)c(O)c(F)c4	1627710-50-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468143	381.41845	LJH685	LJH685 | LJH685			MOABOX:6133	RPS6KA1	Ribosomal protein S6 kinase inhibitor
SJ000855438-4	SJ000855438	4	MOABOX:6144	WXRGFPHDRFQODR-ICLZECGLSA-N	CC(C)N(CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)C[C@H]1O[C@@H](n2ccc3c(N)ncnc32)[C@H](O)[C@@H]1O	1338466-77-5	Dot1L / KMT4;Histone methyltransferase inhibitors	DOT1L																																																															CHEMBL2169919											56962336	67811385	73554302			virtual	10.1016/j.bmc.2013.01.049	10.1038/ncomms2304	10.1182/blood-2013-04-497644																																																																																																																																																													21741596	22510649	22975593	22978415	23433670	23795283	23879463	24300735	25406853	26914852	27485386																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											4.32152																																0.54019																																8																																HY-15227	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Epigenetics | Research Area: Cancer|MOABOX:6144|DOT1L|Dot1L / KMT4;Histone methyltransferase inhibitors	CC(C)N(CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc4c(N)ncnc34	1338466-77-5	11119	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469202	539.66964	EPZ004777	EPZ004777 | EPZ004777 HYDROCHLORIDE | EPZ004777 | EPZ004777 HYDROCHLORIDE	Pathway: Apoptosis; Epigenetics	Research Area: Cancer	MOABOX:6144	DOT1L	Dot1L / KMT4;Histone methyltransferase inhibitors
SJ001035361-1	SJ001035361	1	MOABOX:6148	CYPGNVSXMAUSJY-CXUHLZMHSA-N	N=C(N)N/N=C1\CCc2c(C(=N)N)cccc21	138794-73-7	SAMDC inhibitor	AMD1																																																															CHEMBL1202793	CHEMBL65789										9576789	10402702	16214899	135503026	145836962	member																																																																																																																																																																8205541																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.78504																																0.09813																																8																																HY-13746B	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:6148|AMD1|SAMDC inhibitor	NC(=N)N\N=C\1/CCc2c(cccc12)C(=N)N	138794-73-7	35031	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469743	230.26906	SARDOMOZIDE DIHYDROCHLORIDE | CGP 48664A	"""SARDOMOZIDE DIHYDROCHLORIDE | CGP 48664A"" | ""SARDOMOZIDE DIHYDROCHLORIDE | CGP 48664A"""	Pathway: Others	Research Area: Cancer	MOABOX:6148	AMD1	SAMDC inhibitor
SJ001035397-1	SJ001035397	1	MOABOX:6149	WILMXUAKQKGGCC-DJKKODMXSA-N	CC(Sc1nc2ccccc2[nH]1)C(=O)N/N=C/c1cc(Br)ccc1O	330676-02-3	soluble adenylyl cyclase inhibitor	ADCY10																																																																										135496218					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.53501																																0.07643																																7																																HY-103194	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Others|MOABOX:6149|ADCY10|soluble adenylyl cyclase inhibitor	CC(Sc1nc2ccccc2[nH]1)C(=O)N\N=C\c3cc(Br)ccc3O	330676-02-3	81417	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469898	419.2956	KH7	KH7 | KH7	Pathway: Others	Research Area: Others	MOABOX:6149	ADCY10	soluble adenylyl cyclase inhibitor
SJ000833873-5	SJ000833873	5	MOABOX:6151	ULNXAWLQFZMIHX-UHFFFAOYSA-N	CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccnc(N3CCN(C)CC3)c2)cc2c1cnn2C(C)C	1346704-33-3	PRC2/EZH2;EZH2 gene inhibitor	EZH2																																																															CHEMBL2204995											71268957					member																																																																																																																																																																24900432	26226379	28002961																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.47472																																0.18434																																8																																HY-13500	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Epigenetics | Research Area: Cancer|MOABOX:6151|EZH2|PRC2/EZH2;EZH2 gene inhibitor	CCCC1=C(CNC(=O)c2cc(cc3c2cnn3C(C)C)c4ccnc(c4)N5CCN(C)CC5)C(=O)NC(=C1)C	1346704-33-3	61598	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469186	541.68706	GSK343	GSK343 | GSK343	Pathway: Autophagy; Epigenetics	Research Area: Cancer	MOABOX:6151	EZH2	PRC2/EZH2;EZH2 gene inhibitor
SJ000286032-11	SJ000286032	11	MOABOX:6154	BNRNXUUZRGQAQC-UHFFFAOYSA-N	CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12	139755-83-2	phosphodiesterase PDE5A Inhibitors	PDE6A	PDE6G	PDE6H	PDE5A																													5148	5149	8654																													CHEMBL1737	CHEMBL192										135398744	135413523	135414327	135425271	135430942	member	10.1016/0960-894X(96)00323-X	10.1016/S0960-894X(01)00466-8	10.1016/S0960-894X(02)00030-6	10.1016/S0960-894X(02)00646-7	10.1016/S0968-0896(01)00095-5	10.1016/j.bcp.2008.01.019	10.1016/j.bioorg.2019.103022	10.1016/j.bmc.2015.03.005	10.1016/j.bmcl.2003.12.027	10.1016/j.bmcl.2003.12.090	10.1016/j.bmcl.2004.03.021	10.1016/j.bmcl.2005.02.083	10.1016/j.bmcl.2005.02.090	10.1016/j.bmcl.2005.03.102	10.1016/j.bmcl.2013.06.062	10.1021/acs.biochem.8b01073	10.1021/jm000081+	10.1021/jm000336j	10.1021/jm0155042	10.1021/jm0256068	10.1021/jm060113e	10.1021/jm060265+	10.1021/jm301159y	10.1021/jm3017877	10.1021/jm701400r	10.1021/np800049y	10.2174/092986707781389619	10.2174/156802607779941198																																																																																																																																				9736920	10753463	10891111	11125024	11150175	11297448	11405657	11425592	11549447	11958981	12213052	12372521	12540243	12570368	12639576	12774696	14736245	14980684	15006407	15018924	15080987	15125967	15294449	15780616	15837326	15837329	15878277	15887951	15993055	16336197	16388517	16759100	16913726	17017939	17017940	17017941	17168704	17305584	17691956	18346713	18393409	18656371	18778098	18951784	20235539	20400309	20491634	22100260	23137303	23313637	23409953	23867165	25442307	25801159	26908025	27606546	28686445	29549837	30148362	30245400	30509781	30646523	31021628																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							5.928e-002	7.464e-002	7.464e-002	5.06536																													0.00741	0.00933	0.00933	0.63317																													8	8	8	8																													HY-15025	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease; Cancer|MOABOX:6154|PDE6A|phosphodiesterase PDE5A Inhibitors	CCCc1nn(C)c2C(=O)NC(=Nc12)c3cc(ccc3OCC)S(=O)(=O)N4CCN(C)CC4	139755-83-2	39622	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469451	474.5764	SILDENAFIL	"SILDENAFIL | ""SILDENAFIL | REVATIO"" | SILDENAFIL CITRATE | SILDENAFIL | ""SILDENAFIL | REVATIO"" | SILDENAFIL CITRATE"	Pathway: Apoptosis; Autophagy; Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease; Cancer	MOABOX:6154	PDE6A	phosphodiesterase PDE5A Inhibitors
SJ000565182-12	SJ000565182	12	MOABOX:6156	INVTYAOGFAGBOE-UHFFFAOYSA-N	Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1	209783-80-2	HDAC1/3;Wnt pathway agonist;Histone deacetylase-1 inhibitor;Histone deacetylase-2 inhibitor	HDAC1	HDAC2	HDAC3																														3066	8841																														CHEMBL27759											4261	9832489	22598024	22598025	22598027	member	10.1002/cmdc.201200193	10.1016/j.bmc.2010.03.080	10.1016/j.bmc.2010.04.033	10.1016/j.bmc.2012.05.031	10.1016/j.bmc.2013.06.009	10.1016/j.bmc.2015.04.028	10.1016/j.bmcl.2003.08.083	10.1016/j.bmcl.2007.08.023	10.1016/j.bmcl.2008.03.055	10.1016/j.bmcl.2010.09.100	10.1016/j.bmcl.2010.11.063	10.1016/j.bmcl.2012.01.053	10.1016/j.ejmech.2010.02.030	10.1016/j.ejmech.2012.03.058	10.1016/j.ejmech.2016.12.032	10.1016/j.ejmech.2017.03.079	10.1016/j.ejmech.2019.04.017	10.1016/j.lfs.2008.03.004	10.1021/jm701079h	10.1021/jm800988r	10.1021/jm9004303	10.1042/BJ20070779	10.1124/jpet.103.055541	10.2174/138161208783885335	10.2174/138161208783885353	10.2174/187152012800228814																																																																																																																																						14684344	16305476	16987657	17325656	17456026	17941625	18060775	18247554	18308563	18336297	18336298	18370373	18381238	18537607	18568166	18701301	19301902	19317450	19350613	19441846	19457659	19519383	19751207	19966789	20139990	20223566	20452226	20472442	20616024	20947351	21145737	21742496	22172064	22263804	22321215	22541394	22607140	22628266	22705022	22827519	23672185	23820574	25565044	25874326	25953722	26140961	26613635	26681404	27142751	28340413	28395150	28511906	28629630	29202397	29289885	29787262	30476825	31003060	31181405																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											4.20672	1.26856	0.86032																														0.52584	0.15857	0.10754																														8	8	8																														HY-12163	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:6156|HDAC1|HDAC1/3;Wnt pathway agonist;Histone deacetylase-1 inhibitor;Histone deacetylase-2 inhibitor	Nc1ccccc1NC(=O)c2ccc(CNC(=O)OCc3cccnc3)cc2	209783-80-2	60686	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469769	376.4085	ENTINOSTAT	"ENTINOSTAT | ""MS-27-275 | MS-275 | NSC-706995 | SNDX-275"" | ""ENTINOSTAT | MS-27-275 | MS-275 | NSC-706995 | SNDX-275 |"" | ENTINOSTAT (MS-275) | ENTINOSTAT | ""MS-27-275 | MS-275 | NSC-706995 | SNDX-275"" | ""ENTINOSTAT | MS-27-275 | MS-275 | NSC-706995 | SNDX-275 |"" | ENTINOSTAT (MS-275)"	Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:6156	HDAC1	HDAC1/3;Wnt pathway agonist;Histone deacetylase-1 inhibitor;Histone deacetylase-2 inhibitor
SJ000891041-3	SJ000891041	3	MOABOX:6162	XVOOCQSWCCRVDY-UHFFFAOYSA-N	COc1cc(Br)c(Nc2nc(-c3c(C)nc4ncccn34)cs2)c(Br)c1	1217022-63-3	Polycomb Complex Protein BMI-1 Inhibitors	BMI1																																																															CHEMBL468984											1117196	76458124	129010325			member	10.1021/acsmedchemlett.8b00345	10.18632/oncotarget.6378																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.54456																																0.06807																																8																																T2345	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-958-955|MOABOX:6162|BMI1|Polycomb Complex Protein BMI-1 Inhibitors	COc1cc(Br)c(Nc2nc(cs2)c3c(C)nc4ncccn34)c(Br)c1	315704-66-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468162	495.19102	PTC-209	PTC-209 | PTC209 | PTC-209 | PTC209			MOABOX:6162	BMI1	Polycomb Complex Protein BMI-1 Inhibitors
SJ000833632-14	SJ000833632	14	MOABOX:6163	TVTXCJFHQKSQQM-LJQIRTBHSA-N	COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F	1229705-06-9	Mdm2 p53-binding protein inhibitor	MDM2																																																															CHEMBL2402737											53358942	71725132	72550240	86345921	86346006	member																																																																																																																																																																23808545	24456472	24997575																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.0048																																0.2506																																8																																HY-15676	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:6163|MDM2|Mdm2 p53-binding protein inhibitor	COc1cc(ccc1NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@@](C#N)([C@H]2c3cccc(Cl)c3F)c4ccc(Cl)cc4F)C(=O)O	1229705-06-9	23323	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469143	616.48247	RG7388	RG7388 | Idasanutlin | Idasanutlin + Copovidone | RG7388 | Idasanutlin | Idasanutlin + Copovidone	Pathway: Apoptosis; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:6163	MDM2	Mdm2 p53-binding protein inhibitor
SJ001035008-1	SJ001035008	1	MOABOX:6167	WVLHHLRVNDMIAR-IBGZPJMESA-N	NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21	558441-90-0	"CXCR4 antagonist, HIV attachment inhibitor"	CXCR4																																																															CHEMBL518924											11256587	71576687	78357868			member	10.1016/j.bcp.2011.11.020	10.1016/j.bmcl.2009.07.037	10.1021/acsmedchemlett.8b00030	10.1021/jm100073m	10.1124/mol.108.049775	10.2174/138161210794455003																																																																																																																																																										20088780	20297846	21128884	21143114	21158728	24936240	29795757	30052039																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														3.56376																																0.44547																																8																																28439	CAYMAN	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-332-827|MOABOX:6167|CXCR4|CXCR4 antagonist, HIV attachment inhibitor"	NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]3CCCc4cccnc34	558447-26-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468462	349.47258	MAVORIXAFOR | AMD 070 | AMD 11070 | X4P-001	"""MAVORIXAFOR | AMD 070 | AMD 11070 | X4P-001"" | ""MAVORIXAFOR | AMD 070 | AMD 11070 | X4P-001"""			MOABOX:6167	CXCR4	"CXCR4 antagonist, HIV attachment inhibitor"
SJ000821632-14	SJ000821632	14	MOABOX:6168	LQBVNQSMGBZMKD-UHFFFAOYSA-N	CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1	1257044-40-8	"Bcl-2 inhibtion, apoptosis inducer;BCL2 inhibitor"	BCL2																																																															CHEMBL3137309											49846579	91864614	91933812	130362164	130362165	member	10.1002/prp2.178	10.1021/acschembio.6b00962	10.1021/acsmedchemlett.6b00302																																																																																																																																																													26988306	27749061	27994761	29407973	30278333	30582811	30594434																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															3.56248																																0.44531																																8																																HY-15531	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy | Research Area: Cancer|MOABOX:6168|BCL2|Bcl-2 inhibtion, apoptosis inducer;BCL2 inhibitor"	CC1(C)CCC(=C(C1)c2ccc(Cl)cc2)CN3CCN(CC3)c4ccc(C(=O)NS(=O)(=O)c5ccc(NCC6CCOCC6)c(c5)[N+](=O)[O-])c(Oc7cnc8[nH]ccc8c7)c4	1257044-40-8	39403	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469068	868.4392	Venetoclax	Venetoclax | ABT-199 (GDC-0199) | Venetoclax | ABT-199 (GDC-0199)	Pathway: Apoptosis; Autophagy	Research Area: Cancer	MOABOX:6168	BCL2	"Bcl-2 inhibtion, apoptosis inducer;BCL2 inhibitor"
SJ000313027-23	SJ000313027	23	MOABOX:6176	KTEIFNKAUNYNJU-LBPRGKRZSA-N	C[C@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl	1374356-45-2	"NUDT1 gene inhibitor;ALK gene inhibitor,ROS1 gene inhibitor, MET gene inhibitor, NUDT1 gene inhibitor"	NUDT1																																																															CHEMBL1825141											56671814					member	10.2147/OTT.S94513																																																																																																																																																															26924380	28280261																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.24056																																0.15507																																8																																HY-100549	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:6176|NUDT1|NUDT1 gene inhibitor;ALK gene inhibitor,ROS1 gene inhibitor, MET gene inhibitor, NUDT1 gene inhibitor"	C[C@H](Oc1cc(cnc1N)c2cnn(c2)C3CCNCC3)c4c(Cl)ccc(F)c4Cl	1374356-45-2	49945	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469571	450.33668	CRIZOTINIB	"CRIZOTINIB | ""PF-02341066 | PF-2341066"" | (S)-CRIZOTINIB | CRIZOTINIB (PF-02341066) | CRIZOTINIB | ""PF-02341066 | PF-2341066"" | (S)-CRIZOTINIB | CRIZOTINIB (PF-02341066)"	Pathway: Apoptosis; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:6176	NUDT1	"NUDT1 gene inhibitor;ALK gene inhibitor,ROS1 gene inhibitor, MET gene inhibitor, NUDT1 gene inhibitor"
SJ001034953-1	SJ001034953	1	MOABOX:6178	WVHMNCOFPWFUMF-UHFFFAOYSA-N	CC(C)Nc1nc(Nc2ccccc2)nc(-c2ccccc2)n1	1446506-78-0	IDH2 mutant inhibitor	IDH2																																																																										71622454					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.48032																																-0.06004																																8																																CS-2395	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-137-721|MOABOX:6178|IDH2|IDH2 mutant inhibitor	CC(C)Nc1nc(Nc2ccccc2)nc(n1)c3ccccc3	1446506-78-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468354	305.37696	CS-2395	CS-2395 | CS-2395			MOABOX:6178	IDH2	IDH2 mutant inhibitor
SJ000870758-3	SJ000870758	3	MOABOX:6179	UYUHRKLITDJEHB-UHFFFAOYSA-N	COc1ccc(N(C(=O)Nc2c(C)cccc2C)c2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c(OC)c1		SIK1 gene inhibitor	SIK2	SIK3	SIK1																														23387	150094																																									78357808	145016549				member	10.1021/acschembio.6b00217																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.07504	-1.608e-002	1.23912																														0.13438	-0.00201	0.15489																														8	8	8																														HY-15776	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Inflammation/Immunology|MOABOX:6179|SIK2|SIK1 gene inhibitor	COc1ccc(N(C(=O)Nc2c(C)cccc2C)c3cc(Nc4ccc(cc4)N5CCN(C)CC5)ncn3)c(OC)c1	1456858-58-4	10582	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469907	567.68128	HG-9-91-01	HG-9-91-01 | HG-9-91-01	Pathway: Immunology/Inflammation	Research Area: Inflammation/Immunology	MOABOX:6179	SIK2	SIK1 gene inhibitor
SJ001035137-1	SJ001035137	1	MOABOX:6183	NOEGNKMFWQHSLB-UHFFFAOYSA-N	O=Cc1ccc(CO)o1	67-47-0	"Binds to hemoglobin, increases oxygen affinity thereby reducing sickling of cells"	HBB																																																															CHEMBL185885											237332	20697515	23295611	87087132	87193269	virtual	"10.1021/jm0498001

PMID: 15686467 
http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2004.05332.x/pdf"																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-Y0051	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Others|MOABOX:6183|HBB|Binds to hemoglobin, increases oxygen affinity thereby reducing sickling of cells"	OCc1oc(C=O)cc1	67-47-0	32263	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468847	126.11004	5-HYDROXYMETHYLFURFURAL | 2-HYDROXYMETHYL-5-FURFURAL | 2-FORMYL-5-HYDROXYMETHYLFURAN	"""5-HYDROXYMETHYLFURFURAL | 2-HYDROXYMETHYL-5-FURFURAL | 2-FORMYL-5-HYDROXYMETHYLFURAN"" | ""5-HYDROXYMETHYLFURFURAL | 2-HYDROXYMETHYL-5-FURFURAL | 2-FORMYL-5-HYDROXYMETHYLFURAN"""	Pathway: Anti-infection	Research Area: Others	MOABOX:6183	HBB	"Binds to hemoglobin, increases oxygen affinity thereby reducing sickling of cells"
SJ000843881-6	SJ000843881	6	MOABOX:6190	JCKGSPAAPQRPBW-OAQYLSRUSA-N	O=C([C@@H](Cc1cccc(C(F)(F)F)c1)NS(=O)(=O)c1cc(F)c2c(c1)CCNC2)N1CCCC1	1627607-87-7	Substrate competitive SET7/9 inhibitor;SET7/9 Inhibitor	SETD7																																																															CHEMBL3414622											71300326	78243738				member	10.1002/cmdc.201800242	10.10773/pnas.1407358111.																																																																																																																																																														25406853	26390175	29498708																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.21112																																0.27639																																8																																HY-18627A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:6190|SETD7|Substrate competitive SET7/9 inhibitor;SET7/9 Inhibitor	Fc1cc(cc2CCNCc12)S(=O)(=O)N[C@H](Cc3cccc(c3)C(F)(F)F)C(=O)N4CCCC4	1627607-87-7	28356	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469617	499.52151	PFI-2	PFI-2 | PFI-2 HCL | PFI-2 | PFI-2 HCL	Pathway: Epigenetics	Research Area: Cancer	MOABOX:6190	SETD7	Substrate competitive SET7/9 inhibitor;SET7/9 Inhibitor
SJ001010824-2	SJ001010824	2	MOABOX:6192	YYDUWLSETXNJJT-MTJSOVHGSA-N	Cc1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1	1033769-28-6	NTRK1 gene inhibitor	NTRK1	NTRK2	NTRK3																														4915	4916																														CHEMBL2037226											59397065					member																																																																																																																																																																24900443	27318978																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.86288	1.39008	1.0512																														0.23286	0.17376	0.1314																														8	8	8																														HY-13491	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Neuronal Signaling; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:6192|NTRK1|NTRK1 gene inhibitor	Cc1ccc(NC(=O)Nc2cc(ccc2F)C(F)(F)F)cc1Nc3ccc4\C(=C\c5ccc[nH]5)\C(=O)Nc4c3	1033769-28-6	21988	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469154	535.49225	GNF-5837	GNF-5837 | GNF-5837	Pathway: Neuronal Signaling; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:6192	NTRK1	NTRK1 gene inhibitor
SJ001035290-1	SJ001035290	1	MOABOX:6194	AFZWZVLPIMHLSE-UHFFFAOYSA-N	Cc1cc(C)c(S(=O)(=O)n2cc(C)cc2C)c(C)c1	885434-70-8	Guanine Nucleotide Exchange Factors (GEFs) Inhibitors	RAPGEF4																																																															CHEMBL2313646											22200891					member																																																																																																																																																																23286832	24256330																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.51968																																0.18996																																8																																HY-15702	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:6194|RAPGEF4|Guanine Nucleotide Exchange Factors (GEFs) Inhibitors	Cc1cc(C)c(c(C)c1)S(=O)(=O)n2cc(C)cc2C	885434-70-8	24644	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469513	277.38186	HJC0350	HJC0350 | HJC0350	Pathway: Others	Research Area: Cancer	MOABOX:6194	RAPGEF4	Guanine Nucleotide Exchange Factors (GEFs) Inhibitors
SJ000285508-23	SJ000285508	23	MOABOX:6199	RCINICONZNJXQF-MZXODVADSA-N	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C	1203669-79-7	Microtubule stabilizer	TUBB1																																																															CHEMBL428647											36314	177408	9811963	9812113	9812217	member																																																																																																																																																																16257201	17263521	17542572																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			-0.12872																																-0.01609																																8																																AG0037NN	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-742-627|MOABOX:6199|TUBB1|Microtubule stabilizer	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(=O)C)C2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c6ccccc6)c7ccccc7)C(=C1C5(C)C)C	33069-62-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468253	853.90614	PACLITAXEL	"PACLITAXEL | TAXOL | ""PACLITAXEL | ANX-513 | BMS-181339 | DHP-107 | DHP-208 | DTS-301 | EMPAC | NSC-125973 | NOVA-12005 | OAS-PAC-100 | SDP-013 | MPI-5018 | INTAXEL |"" | ""PACLITAXEL | INTAXEL | ANX-513 | BMS-181339 | DHP-107 | DHP-208 | DTS-301 | EMPAC | NSC-125973 | NOVA-12005 | OAS-PAC-100 | SDP-013 | MPI-5018 |"" | PACLITAXEL | TAXOL | ""PACLITAXEL | ANX-513 | BMS-181339 | DHP-107 | DHP-208 | DTS-301 | EMPAC | NSC-125973 | NOVA-12005 | OAS-PAC-100 | SDP-013 | MPI-5018 | INTAXEL |"" | ""PACLITAXEL | INTAXEL | ANX-513 | BMS-181339 | DHP-107 | DHP-208 | DTS-301 | EMPAC | NSC-125973 | NOVA-12005 | OAS-PAC-100 | SDP-013 | MPI-5018 |"""			MOABOX:6199	TUBB1	Microtubule stabilizer
SJ000285508-22	SJ000285508	22	MOABOX:6199	RCINICONZNJXQF-MZXODVADSA-N	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C	1203669-79-7	Microtubule stabilizer	TUBB1																																																															CHEMBL428647											36314	177408	9811963	9812113	9812217	member																																																																																																																																																																16257201	17263521	17542572																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			-0.12872																																-0.01609																																8																																GS-6554	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(=O)C)[C@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c6ccccc6)c7ccccc7)C(=C1C5(C)C)C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466721	853.90614	PACLITAXEL	"PACLITAXEL | TAXOL | ""PACLITAXEL | ANX-513 | BMS-181339 | DHP-107 | DHP-208 | DTS-301 | EMPAC | NSC-125973 | NOVA-12005 | OAS-PAC-100 | SDP-013 | MPI-5018 | INTAXEL |"" | ""PACLITAXEL | INTAXEL | ANX-513 | BMS-181339 | DHP-107 | DHP-208 | DTS-301 | EMPAC | NSC-125973 | NOVA-12005 | OAS-PAC-100 | SDP-013 | MPI-5018 |"" | PACLITAXEL | TAXOL | ""PACLITAXEL | ANX-513 | BMS-181339 | DHP-107 | DHP-208 | DTS-301 | EMPAC | NSC-125973 | NOVA-12005 | OAS-PAC-100 | SDP-013 | MPI-5018 | INTAXEL |"" | ""PACLITAXEL | INTAXEL | ANX-513 | BMS-181339 | DHP-107 | DHP-208 | DTS-301 | EMPAC | NSC-125973 | NOVA-12005 | OAS-PAC-100 | SDP-013 | MPI-5018 |"""			MOABOX:6199	TUBB1	Microtubule stabilizer
SJ000786005-4	SJ000786005	4	MOABOX:6202	JDVVGAQPNNXQDW-TVNFTVLESA-N	O[C@H]1CN2CC[C@H](O)[C@@H]2[C@@H](O)[C@@H]1O	107244-34-8	Alpha glucosidase inhibitor	GAA	GANC	MOGS																														2595	7841																														CHEMBL311226											54445	67835623	67835956	70299668		member																																																																																																																																																																19199917	22827178																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.13976	1.45649	0.44275																														0.01747	0.20807	0.06325																														8	7	7																														11313	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-845-673|MOABOX:6202|GAA|Alpha glucosidase inhibitor	O[C@H]1CCN2C[C@H](O)[C@@H](O)[C@H](O)[C@@H]12	79831-76-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468319	189.209	CASTANOSPERMINE | MDL-26190 |	"""CASTANOSPERMINE | MDL-26190 |"" | CASTANOSPERMINE | ""CASTANOSPERMINE | MDL-26190 |"" | CASTANOSPERMINE"			MOABOX:6202	GAA	Alpha glucosidase inhibitor
SJ000855444-4	SJ000855444	4	MOABOX:6204	AMLYAMJWYAIXIA-VWNVYAMZSA-N	CC(C)[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](Cc2ccccc2)C(=O)N1C	188968-51-6	"Integrin binder;Integrin alphavbeta3 (Vitronectin) Antagonists;Integrin alphavbeta5 Antagonists;""Integrin binder;Integrin alphavbeta3 (Vitronectin) Antagonists;Integrin alphavbeta5 Antagonists"""	ITGAV	ITGB3	ITGB5	ITGA6																													3690	3693	3655																													CHEMBL429876											176873	9897954	16655040	16655043	71954680	member	10.1016/j.bmcl.2019.01.043	10.1021/acs.bioconjchem.8b00682	10.1021/acs.jmedchem.8b00004	10.1021/jm500092w	10.1021/jm5004478	10.1021/jm701214z																																																																																																																																																										11855984	16214345	16302808	16509596	16697080	17184884	18303826	18343671	19195898	19929817	20166941	20218623	22650257	23362923	24095096	24568695	24654918	24949551	25384028	26753814	26818999	28351594	29489355	29775303	29883545	31306009																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												0	1.14648	1.06448	0.4188																													0.0	0.14331	0.13306	0.05235																													7	8	8	8																													HY-16141	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Cytoskeleton | Research Area: Cancer|MOABOX:6204|ITGAV|Integrin binder;Integrin alphavbeta3 (Vitronectin) Antagonists;Integrin alphavbeta5 Antagonists;\Integrin binder;Integrin alphavbeta3 (Vitronectin) Antagonists;Integrin alphavbeta5 Antagonists\	CC(C)[C@@H]1N(C)C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC1=O	188968-51-6	90135	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468933	588.6559	CILENGITIDE	CILENGITIDE | CILENGITIDE	Pathway: Autophagy; Cytoskeleton	Research Area: Cancer	MOABOX:6204	ITGAV	Integrin binder;Integrin alphavbeta3 (Vitronectin) Antagonists;Integrin alphavbeta5 Antagonists;\Integrin binder;Integrin alphavbeta3 (Vitronectin) Antagonists;Integrin alphavbeta5 Antagonists\
SJ000822450-3	SJ000822450	3	MOABOX:6209	ZWVZORIKUNOTCS-OAQYLSRUSA-N	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)nc12	468740-43-4	IGF-1R Inhibitors	IGF1R																																																															CHEMBL401930											135440465	135440466	135491799			member	10.1016/j.bmcl.2015.01.011	10.1021/jm050392q																																																																																																																																																														16134929	18258427	18572407	18763755	19610618	20153189	20399649	22680629	25648298																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2.45616																																0.30702																																8																																HY-10262	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Protein Tyrosine Kinase/RTK | Research Area: Cancer; Endocrinology|MOABOX:6209|IGF1R|IGF-1R Inhibitors	Cc1cc(cc2nc([nH]c12)C3=C(NC[C@@H](O)c4cccc(Cl)c4)C=CNC3=O)N5CCOCC5	468740-43-4	55634	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469543	479.95864	BMS-536924	BMS-536924 | BMS-536924	Pathway: Apoptosis; Protein Tyrosine Kinase/RTK	Research Area: Cancer; Endocrinology	MOABOX:6209	IGF1R	IGF-1R Inhibitors
SJ001035257-1	SJ001035257	1	MOABOX:6222	ZWKJWVSEDISQIS-UHFFFAOYSA-N	Cn1c2cc([S+](C)[O-])sc2c2cnn(Cc3cccc(N)c3)c(=O)c21	1221186-53-3	Pyruvate kinase 2 stimulator	PKM																																																															CHEMBL1085588											44246499	60138089				member	10.1016/j.bmcl.2010.04.015	10.1038/nchembio.1060																																																																																																																																																														20451379	22922757																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.2392																																0.4049																																8																																HY-18657	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:6222|PKM|Pyruvate kinase 2 stimulator	CS(=O)c1cc2c(s1)c3C=NN(Cc4cccc(N)c4)C(=O)c3n2C	1221186-53-3	24615	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469364	372.46454	TEPP-46 | ML-265	"""TEPP-46 | ML-265"" | ""TEPP-46 | ML-265"""	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:6222	PKM	Pyruvate kinase 2 stimulator
SJ000067352-4	SJ000067352	4	MOABOX:6231	QCIJLRJBZDBVDB-UHFFFAOYSA-N	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCC1)n(C)c(=O)n2C	900305-37-5	BRPF1B;BRPF1B inhibitor	BRPF1																																																															CHEMBL3356143											40642506					member	"10.1021/ml5002932
http://pubs.acs.org/doi/abs/10.1021/ml5002932"																																																																																																																																																															25408830	26572217	27326325	28402630																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.65088																																0.33136																																8																																HY-18664	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:6231|BRPF1|BRPF1B;BRPF1B inhibitor	COc1ccccc1C(=O)Nc2cc3N(C)C(=O)N(C)c3cc2N4CCCC4	900305-37-5	17657	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469624	380.44026	PFI-4	PFI-4 | PFI-4	Pathway: Epigenetics	Research Area: Cancer	MOABOX:6231	BRPF1	BRPF1B;BRPF1B inhibitor
SJ000859887-6	SJ000859887	6	MOABOX:6237	FAWSUKOIROHXAP-NPMXOYFQSA-N	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C	1300031-52-0	BET bromodomain inhibitor	BRDT	BRD2	BRD3	BRD4																													6046	8019	23476																													CHEMBL2177300											52912222					member	10.1021/jm5010539																																																																																																																																																															25249180	28765013	29170024	29656650																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		-9.176e-002	0.2628	1.58112	1.85968																													-0.01147	0.03285	0.19764	0.23246																													8	8	8	8																													HY-13960	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Epigenetics | Research Area: Cancer|MOABOX:6237|BRDT|BET bromodomain inhibitor	C[C@H]1C[C@@H](Nc2ccc(Cl)cc2)c3cc(ccc3N1C(=O)C)c4ccc(cc4)C(=O)O	1300031-52-0	11165	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469902	434.91472	I-BET726	I-BET726 | GSK1324726A | IBET726 | GSK726 | I-BET726 | GSK1324726A | IBET726 | GSK726	Pathway: Apoptosis; Epigenetics	Research Area: Cancer	MOABOX:6237	BRDT	BET bromodomain inhibitor
SJ001035384-1	SJ001035384	1	MOABOX:6239	NOHQEAFAESMMDX-UHFFFAOYSA-N	CC(C)(C)c1nc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)c3ccccc23)c2c(N)nccn12	1589527-65-0	IRE1 RNase Allosteric Inhibitor	ERN1																																																																										73425700					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.34408																																-0.04301																																8																																HY-19708	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer; Metabolic Disease; Inflammation/Immunology|MOABOX:6239|ERN1|IRE1 RNase Allosteric Inhibitor	CC(C)(C)c1nc(c2ccc(NC(=O)Nc3cccc(c3)C(F)(F)F)c4ccccc24)c5c(N)nccn15	1589527-65-0	27446	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469858	518.53291	KIRA6	KIRA6 | KIRA6	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer; Metabolic Disease; Inflammation/Immunology	MOABOX:6239	ERN1	IRE1 RNase Allosteric Inhibitor
SJ001034898-1	SJ001034898	1	MOABOX:6240	DBISXWCOHGUFSF-UHFFFAOYSA-N	c1ccc(Nc2nc3c(s2)CCCc2n[nH]cc2-3)nc1	1235325-16-2	MGLUR4 positive allosteric modulator	GRM4																																																															CHEMBL1830707											46836562					member	10.1021/jm200290z																																																																																																																																																															21688779																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.87128																																0.23391																																8																																4370	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-277-166|MOABOX:6240|GRM4|MGLUR4 positive allosteric modulator	C1Cc2n[nH]cc2c3nc(Nc4ccccn4)sc3C1	1314140-00-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468204	283.35152	TC-N 22A	TC-N 22A | TC-N 22A			MOABOX:6240	GRM4	MGLUR4 positive allosteric modulator
SJ000285257-14	SJ000285257	14	MOABOX:6245	DDUHZTYCFQRHIY-RBHXEPJQSA-N	COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O	107912-37-8	Keratin 12 modulator	KRT12																																																															CHEMBL562											441140	66617292	66889319	67096429	67363532	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																AS-13736	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COC1=CC(=O)C[C@@H](C)[C@]12Oc3c(Cl)c(OC)cc(OC)c3C2=O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466796	352.76628	GRISEOFULVIN	GRISEOFULVIN | (+)-GRISEOFULVIN | GRISEOFULVIN | (+)-GRISEOFULVIN			MOABOX:6245	KRT12	Keratin 12 modulator
SJ000821575-8	SJ000821575	8	MOABOX:6271	VRQMAABPASPXMW-HDICACEKSA-N	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)[nH]n2)cc(OC)c1	1035270-39-3	FGFR1 gene inhibitor	FGFR1																																																															CHEMBL3348846											51039095					member	10.1016/j.bmcl.2016.04.028	10.1016/j.bmcl.2017.06.068	10.1016/j.ejmech.2018.05.005	10.1016/j.ejmech.2018.12.015	10.1021/acs.jmedchem.7b00076																																																																																																																																																											23016864	23272905	25736993	26561719	27117427	27326339	27348537	27782099	27914362	28379191	28460311	28687204	28714692	29584670	29775937																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							2.39048																																0.29881																																8																																HY-13330	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:6271|FGFR1|FGFR1 gene inhibitor	COc1cc(CCc2cc(NC(=O)c3ccc(cc3)N4C[C@@H](C)N[C@@H](C)C4)n[nH]2)cc(OC)c1	1035270-39-3	29016	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469145	463.57192	AZD4547	AZD4547 | AZD4547	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:6271	FGFR1	FGFR1 gene inhibitor
SJ000870507-2	SJ000870507	2	MOABOX:6276	XLIBABIFOBYHSV-UHFFFAOYSA-N	Cc1ncccc1-c1cnc(NCc2c(F)ccc3c2CCO3)n2cnnc12		EED inhibitor	EED																																																																										121412508	138734886				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.04056																																0.13007																																8																																CS-8054	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-417-839|MOABOX:6276|EED|EED inhibitor	Cc1ncccc1c2cnc(NCc3c(F)ccc4OCCc34)n5cnnc25	1951408-58-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468172	376.38698	CPI26	CPI26 | CPI26			MOABOX:6276	EED	EED inhibitor
SJ000833870-11	SJ000833870	11	MOABOX:6277	NSQSAUGJQHDYNO-UHFFFAOYSA-N	CCN(c1cc(-c2ccc(CN3CCOCC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1	1403254-99-8	PRC2/EZH2;EZH2 inhibitor	EZH1	EZH2																															2146																															CHEMBL3414621											66558664	71761627	91617646	91617699	91617700	member	10.1158/1535-7163.MCT-13-0773																																																																																																																																																															25406853	26005520	26189078	26769278	27923618	28092155	29456795																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															-0.4472	2.7312																															-0.0559	0.3414																															8	8																															HY-13803	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:6277|EZH1|PRC2/EZH2;EZH2 inhibitor	CCN(C1CCOCC1)c2cc(cc(C(=O)NCC3=C(C)C=C(C)NC3=O)c2C)c4ccc(CN5CCOCC5)cc4	1403254-99-8	39010	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468916	572.73756	Tazemetostat	Tazemetostat | EPZ-6438 | Tazemetostat | EPZ-6438	Pathway: Epigenetics	Research Area: Cancer	MOABOX:6277	EZH1	PRC2/EZH2;EZH2 inhibitor
SJ001035393-1	SJ001035393	1	MOABOX:6282	WUJVPELCYCESAP-UHFFFAOYSA-N	O=C(O)CC1CCC2(CC1)CCN(c1cc(OC(F)(F)F)ccc1Cl)CC2	1599477-75-4	GPR120 agonist	FFAR4																																																															CHEMBL3919973											73777063	144606666				member	10.1021/acsmedchemlett.6b00360																																																																																																																																																															28105274	28105282																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-7.976e-002																																-0.00997																																8																																HY-101492	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Metabolic Disease|MOABOX:6282|FFAR4|GPR120 agonist	OC(=O)CC1CCC2(CC1)CCN(CC2)c3cc(OC(F)(F)F)ccc3Cl	1599477-75-4	24367	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469892	405.83903	GPR120-IN-1	GPR120-IN-1 | GPR120-IN-1	Pathway: GPCR/G Protein	Research Area: Metabolic Disease	MOABOX:6282	FFAR4	GPR120 agonist
SJ000561035-6	SJ000561035	6	MOABOX:6296	SJDDOCKBXFJEJB-MOKWFATOSA-N	CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1ccc(N)c(Cl)c1)C(C)(C)C	273404-37-8	Caspase 1 (IL-1beta Converting Enzyme) Inhibitors	CASP1																																																															CHEMBL2107819											11398092					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.09328																																0.26166																																8																																HY-13205	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis | Research Area: Inflammation/Immunology|MOABOX:6296|CASP1|Caspase 1 (IL-1beta Converting Enzyme) Inhibitors	CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)c3ccc(N)c(Cl)c3)C(C)(C)C	273404-37-8	60767	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469585	508.99502	VX-765	VX-765 | VX-765	Pathway: Apoptosis	Research Area: Inflammation/Immunology	MOABOX:6296	CASP1	Caspase 1 (IL-1beta Converting Enzyme) Inhibitors
SJ001034947-1	SJ001034947	1	MOABOX:6303	AASYYGYJPZBFKC-UHFFFAOYSA-N	O=C(O)Cc1c(C(=O)O)n(Cc2cccc3ccccc23)c2ccc(F)cc12	942191-15-3	Known Chymase inhibitor	CMA1																																																																										23582810					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.58712																																0.44839																																8																																BD213910	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-278-433|MOABOX:6303|CMA1|Known Chymase inhibitor	OC(=O)Cc1c(C(=O)O)n(Cc2cccc3ccccc23)c4ccc(F)cc14	942191-15-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468340	377.36514	BD213910	BD213910 | BD213910			MOABOX:6303	CMA1	Known Chymase inhibitor
SJ001034842-1	SJ001034842	1	MOABOX:6307	HDQZJWISFBAGPN-UHFFFAOYSA-N	O=c1oc(-c2ccccc2F)nc2sc3c(c12)CCCC3	342594-95-0	"Known Chymotrypsin, Kallikrein7 inhibitor"	KLK7																																																															CHEMBL600954											828421					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-3.904e-002																																-0.00488																																8																																AE-848/37174054	SPECS	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-568-431|MOABOX:6307|KLK7|Known Chymotrypsin, Kallikrein7 inhibitor"	Fc1ccccc1C2=Nc3sc4CCCCc4c3C(=O)O2	342594-95-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468085	301.33538	AE-848/37174054	AE-848/37174054 | AE-848/37174054			MOABOX:6307	KLK7	"Known Chymotrypsin, Kallikrein7 inhibitor"
SJ001035338-1	SJ001035338	1	MOABOX:6312	ZKIQFLSGMMYCGS-SANMLTNESA-N	N[C@@H](CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1		"Known DPP8, DPP9 inhibitor"	DPP8	DPP9																															91039																															CHEMBL1814633											56658139					member	10.1016/j.bmcl.2004.11.023	10.1021/jm200383j																																																																																																																																																														15664838	17352682	21711053	27820798																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.75632	0.75728																															0.34454	0.09466																															8	8																															HY-116304	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:6312|DPP8|Known DPP8, DPP9 inhibitor"	N[C@@H](CC(=O)N1CCN(CC1)C(c2ccc(F)cc2)c3ccc(F)cc3)C(=O)N4Cc5ccccc5C4	847928-32-9	67207	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469649	504.57091	1G244	1G244 | 1G244	Pathway: Apoptosis; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:6312	DPP8	"Known DPP8, DPP9 inhibitor"
SJ000785927-6	SJ000785927	6	MOABOX:6320	QNZCBYKSOIHPEH-UHFFFAOYSA-N	COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1	503612-47-3	Known FactorXa inhibitor	F10																																																															CHEMBL231779											10182969	69444683	71245064	90014785	134364122	virtual	10.2165/0003088-200948010-00001																																																																																																																																																															17588746	17630943	17914785	18424044	19046881	19071881	19297154	19967784	20100660	20503967	21171894	21955945	22680641	24951330	27663548	28389110																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						4.77536																																0.59692																																8																																HY-50667	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease|MOABOX:6320|F10|Known FactorXa inhibitor	COc1ccc(cc1)n2nc(C(=O)N)c3CCN(C(=O)c23)c4ccc(cc4)N5CCCCC5=O	503612-47-3	24129	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468901	459.4971	APIXABAN	"APIXABAN | ""APIXABAN | BMS-562247-01 | BMS-562247 |"" | APIXABAN | ""APIXABAN | BMS-562247-01 | BMS-562247 |"""	Pathway: Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease	MOABOX:6320	F10	Known FactorXa inhibitor
SJ000855227-5	SJ000855227	5	MOABOX:6327	KSGXQBZTULBEEQ-UHFFFAOYSA-N	CCCCCCOC(=O)/N=C(\N)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1	1019206-66-6	Known Thrombin inhibitor	F2																																																															CHEMBL1615369	CHEMBL539697										213023	6445226	9578572	10439877	11434065	virtual																																																																																																																																																																11960487	17313362	19071881	22680641	23043765	23466230	26690913																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															3.5348																																0.44185																																8																																BS-1001	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCCCCCOC(=O)NC(=N)c1ccc(NCc2nc3cc(ccc3n2C)C(=O)N(CCC(=O)OCC)c4ccccn4)cc1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466677	627.73324	DABIGATRAN ETEXILATE	DABIGATRAN ETEXILATE | DABIGATRAN ETEXILATE			MOABOX:6327	F2	Known Thrombin inhibitor
SJ000295834-2	SJ000295834	2	MOABOX:6332	JOPNHSIHFSZJMB-UHFFFAOYSA-N	CCOC(=O)C1=C(N)Oc2cc(O)ccc2C1c1cccnc1	332164-34-8	Known LNPEP	LNPEP																																																															CHEMBL1604159											655457					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.27386																																0.18198																																7																																STK860400	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-959-457|MOABOX:6332|LNPEP|Known LNPEP	CCOC(=O)C1=C(N)Oc2cc(O)ccc2C1c3cccnc3	332164-34-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468088	312.31994					MOABOX:6332	LNPEP	Known LNPEP
SJ001034636-1	SJ001034636	1	MOABOX:6334	JXAGDPXECXQWBC-UHFFFAOYSA-N	O=C(CC(CSc1ccccc1)C(=O)O)c1ccc(-c2ccc(Cl)cc2)cc1	179545-76-7	"Known MMP9, MMP2, MMP3 inhibitor"	MMP2	MMP3	MMP9																														4314	4318																														CHEMBL83616											177347					virtual	10.1021/jm015531s	10.2174/187152009788451842																																																																																																																																																														11472202	16682189	19519299																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.55132	-0.28616	3.50248																														0.07876	-0.03577	0.43781																														7	8	8																														12P-030	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC(=O)C(CSc1ccccc1)CC(=O)c2ccc(cc2)c3ccc(Cl)cc3	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466633	410.91316	12P-030	12P-030 | 12P-030			MOABOX:6334	MMP2	"Known MMP9, MMP2, MMP3 inhibitor"
SJ000803723-8	SJ000803723	8	MOABOX:6356	XTKLTGBKIDQGQL-UHFFFAOYSA-N	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F	1372540-25-4	PI3Kbeta inhibitor	PIK3CB																																																															CHEMBL3188551											56949517	66976666	86304356	91826489	122584246	virtual																																																																																																																																																																25387153																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.48032																																0.18504																																8																																HY-15245	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:6356|PIK3CB|PI3Kbeta inhibitor	Cc1c(Cn2c(C)nc3c(cc(cc23)N4CCOCC4)C(=O)O)cccc1C(F)(F)F	1372540-25-4	6557	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469481	433.42359	GSK-2636771	GSK-2636771 | GSK2636771 | GSK-2636771 | GSK2636771	Pathway: PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:6356	PIK3CB	PI3Kbeta inhibitor
SJ000796027-17	SJ000796027	17	MOABOX:6357	LHNIIDJUOCFXAP-UHFFFAOYSA-N	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1	957054-30-7	panPI3K inhibitor	PIK3CA	PIK3CB																															5291																															CHEMBL1922096	CHEMBL4097197	CHEMBL521851									17755052	23650072	23650073	23650074	23650222	member	10.1021/jm800295d	10.2174/09298673113209990124																																																																																																																																																														18754654	19275602	19519296	19689267	19689378	20050669	20081827	20154668	20334367	20346656	20939811	21636270	21649577	21649578	21981714	21985639	22037378	22325943	22877085	22946614	23360348	23540645	23568455	23651303	23662903	25086238	25387153	25440879	25911625	26086931	27043268	27353887	27384552	27644332	27809261	28128944	28409639	28829592	28835805	29088090	29360358	30053721	30655957																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											2.7176	-4.384e-002																															0.3397	-0.00548																															8	8																															HY-50094	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:6357|PIK3CA|panPI3K inhibitor	CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)c5cccc6[nH]ncc56)CC1	957054-30-7	66722	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469135	513.63558	PICTILISIB	"PICTILISIB | ""GDC-0941 | RG-7321 | PICTRELISIB"" | GDC-0941 | PICTILISIB | ""GDC-0941 | RG-7321 | PICTRELISIB"" | GDC-0941"	Pathway: Apoptosis; Autophagy; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:6357	PIK3CA	panPI3K inhibitor
SJ000784328-5	SJ000784328	5	MOABOX:6359	AECDBHGVIIRMOI-UHFFFAOYSA-N	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCC2)C1	475488-34-7	MTH1 inhibitor;IGF1R inhibitor	IGF1R	NUDT1																															4521																															CHEMBL3188172											11476171	132285141				member	10.1007/s00204-016-1871-z	10.1021/jacs.6b02895																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.75938	0																															0.25134	0.0																															7	7																															AA00DB4C	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-021-804-979|MOABOX:6359|IGF1R|MTH1 inhibitor;IGF1R inhibitor	Nc1ncnc2c1c(cn2[C@@H]3C[C@H](CN4CCC4)C3)c5cccc(OCc6ccccc6)c5	475489-16-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468282	439.55206	NVP-AEW541	"NVP-AEW541 | ""NVP-AEW541 | AEW-541 | NVP-AEW541-NX | NVP-AEW541-"" | NVP-AEW541 | ""NVP-AEW541 | AEW-541 | NVP-AEW541-NX | NVP-AEW541-"""			MOABOX:6359	IGF1R	MTH1 inhibitor;IGF1R inhibitor
SJ001010670-2	SJ001010670	2	MOABOX:6362	QLPHOXTXAKOFMU-WBVHZDCISA-N	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1	1227911-45-6	PDK1 inhibitor;PDK1/2 inhibitor	PDK1	PDPK1																															5170																															CHEMBL1765740											46215815					member	10.1021/jm101527u	10.1042/BJ20101732																																																																																																																																																														21341675	22040023	23448267	27123901	27217002																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0.7238	3.43696																															0.1034	0.42962																															7	8																															HY-14981	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:6362|PDK1|PDK1 inhibitor;PDK1/2 inhibitor	CNc1nc(cc(n1)c2ccc3c(N)n[nH]c3c2)N4C[C@H](CC[C@H]4C)C(=O)NC5CCCCC5	1227911-45-6	7284	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469512	462.59046	GSK2334470	GSK2334470 | GSK2334470	Pathway: PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:6362	PDK1	PDK1 inhibitor;PDK1/2 inhibitor
SJ000803731-7	SJ000803731	7	MOABOX:6363	CPRAGQJXBLMUEL-UHFFFAOYSA-N	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1	663619-89-4	PI3Kbeta inhibitor	PIK3CB																																																															CHEMBL1972466											9907093	24881138	144060209			virtual	10.1016/j.bmcl.2012.08.101	10.1016/j.bmcl.2014.07.007	10.1021/jm300241b	10.1021/jm401642q	10.1042/BJ20070003																																																																																																																																																											17362206	19176369	19351820	19689267	21349933	21649578	22524426	23010274	24387221	24992874	25042253	25890698	27387421	30655957	31083328																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							3.28216																																0.41027																																8																																HY-10114	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:6363|PIK3CB|PI3Kbeta inhibitor	CC(Nc1ccccc1)C2=CC(=CN3C(=O)C=C(N=C23)N4CCOCC4)C	663619-89-4	20235	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469282	364.44086	TGX-221	TGX-221 | TGX-221	Pathway: PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:6363	PIK3CB	PI3Kbeta inhibitor
SJ001035347-1	SJ001035347	1	MOABOX:6368	HKGJEZIGDHFJFL-UHFFFAOYSA-N	CC(Nc1nc(N2CCCC2)nc2ccccc12)c1ccccc1	662163-81-7	Importin beta inhibitor	KPNB1																																																															CHEMBL1498173											2949965					member	10.1021/cb2000296.																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-101091	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis | Research Area: Cancer|MOABOX:6368|KPNB1|Importin beta inhibitor	CC(Nc1nc(nc2ccccc12)N3CCCC3)c4ccccc4	662163-81-7	23313	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469663	318.41548	IMPORTAZOLE	IMPORTAZOLE | IMPORTAZOLE	Pathway: Apoptosis	Research Area: Cancer	MOABOX:6368	KPNB1	Importin beta inhibitor
SJ001035255-1	SJ001035255	1	MOABOX:6380	SWKAVEUTKGKHSR-UHFFFAOYSA-N	O=C(Nc1ccc(Br)cc1)c1ccc(Br)c(S(=O)(=O)NCc2ccccc2)c1	312756-74-4	RAD51 gene stimulator	RAD51																																																															CHEMBL1598912											1039737					member	10.1073/pnas.0808046105																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-19793	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:6380|RAD51|RAD51 gene stimulator	Brc1ccc(NC(=O)c2ccc(Br)c(c2)S(=O)(=O)NCc3ccccc3)cc1	312756-74-4	20757	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469329	524.22564	RS-1	RS-1 | RS-1	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:6380	RAD51	RAD51 gene stimulator
SJ001033609-2	SJ001033609	2	MOABOX:6401	KVHRYLNQDWXAGI-UHFFFAOYSA-N	COc1cn(-c2ccc(-n3cccn3)cc2F)nc(-c2ccnn2-c2ccccc2)c1=O	1238697-26-1	PDE10A inhibitor	PDE10A																																																															CHEMBL3989972											46848915					member	10.1016/j.bmc.2015.10.002	10.1021/jm5013648																																																																																																																																																														25384088	26494583	26908025	27301679	30888810																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	4.18616																																0.52327																																8																																HY-12472	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Neurological Disease|MOABOX:6401|PDE10A|PDE10A inhibitor	COC1=CN(N=C(C1=O)c2ccnn2c3ccccc3)c4ccc(cc4F)n5cccn5	1238697-26-1	15063	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469095	428.41848	BALIPODECT; TAK-063	BALIPODECT; TAK-063 | BALIPODECT; TAK-063	Pathway: Metabolic Enzyme/Protease	Research Area: Neurological Disease	MOABOX:6401	PDE10A	PDE10A inhibitor
SJ000870777-2	SJ000870777	2	MOABOX:6402	FYICDSWKKFSYOM-UHFFFAOYSA-N	C=CC(=O)Nc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1Oc1ccccc1	1603845-32-4	ERBB3 covalent inhibitor	ERBB3																																																																										78243752					member	10.1038/nchembio.1658																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																CS-0020496	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-426-174|MOABOX:6402|ERBB3|ERBB3 covalent inhibitor	CC(=O)N1CCN(CC1)C2CCC(CC2)n3nc(c4ccc(Oc5ccccc5)c(NC(=O)C=C)c4)c6c(N)ncnc36	1603845-32-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468104	580.68004	TX1-85-1	TX1-85-1 | TX1-85-1			MOABOX:6402	ERBB3	ERBB3 covalent inhibitor
SJ001035286-1	SJ001035286	1	MOABOX:6403	VVOXDJYPDCSQMI-UHFFFAOYSA-N	CC1(C)Oc2cc(O)ccc2C2C1=CCn1c(=O)n(-c3ccccc3)c(=O)n12	908568-01-4	HMGB2 gene inhibitor	HMGB1	HMGB2																															3148																															CHEMBL1801580											49857340					member	10.1038/nchembio.1669																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0																															0.0	0.0																															7	7																															HY-113772	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Inflammation/Immunology; Neurological Disease|MOABOX:6403|HMGB1|HMGB2 gene inhibitor	CC1(C)Oc2cc(O)ccc2C3N4N(CC=C13)C(=O)N(C4=O)c5ccccc5	908568-01-4	79743	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469491	377.39326	INFLACHROMENE	INFLACHROMENE | INFLACHROMENE	Pathway: Others	Research Area: Inflammation/Immunology; Neurological Disease	MOABOX:6403	HMGB1	HMGB2 gene inhibitor
SJ000833889-7	SJ000833889	7	MOABOX:6408	MCUJKPPARUPFJM-UWCCDQBKSA-N	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1	1204144-28-4	"PIM1, PIM2 and PIM3 inhibitor"	PIM1	PIM2	PIM3																														11040	415116																														CHEMBL2048872											58423153	76962885				member	10.1016/j.bmcl.2012.05.098	10.1182/blood-2013-04-495366																																																																																																																																																														22727640	24900629	26505898	28341403	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.99	0.972	1.50432																														0.24875	0.1215	0.18804																														8	8	8																														HY-15604	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; JAK/STAT Signaling | Research Area: Cancer|MOABOX:6408|PIM1|PIM1, PIM2 and PIM3 inhibitor"	N[C@@H]1CCCN(C1)c2c(\C=C\3/SC(=O)NC3=O)cccc2c4ccccc4	1204144-28-4	13429	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469896	379.47534	AZD-1208	AZD-1208 | AZD-1208	Pathway: Apoptosis; Autophagy; JAK/STAT Signaling	Research Area: Cancer	MOABOX:6408	PIM1	"PIM1, PIM2 and PIM3 inhibitor"
SJ001010628-2	SJ001010628	2	MOABOX:6410	DKZYXHCYPUVGAF-JCNLHEQBSA-N	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1	1431697-89-0	MELK inhibitor	MELK																																																															CHEMBL3688339																member																																																																																																																																																																29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.24208																																0.28026																																8																																HY-15512A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:6410|MELK|MELK inhibitor	CN(C)C[C@@H]1CC[C@H](CC1)Nc2c(cnc3ccc(nc23)c4cc(Cl)c(O)c(Cl)c4)C(=O)C	1431698-10-0	8380	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469660	487.42142	OTSSP167 (HYDROCHLORIDE)	OTSSP167 (HYDROCHLORIDE) | OTSSP167 (HYDROCHLORIDE)	Pathway: PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:6410	MELK	MELK inhibitor
SJ000986415-2	SJ000986415	2	MOABOX:6412	IXEPQJQQSLMESJ-UHFFFAOYSA-N	c1ccc(-c2ccc(CNCCNCc3ccc(-c4ccccn4)cc3)cc2)nc1	1507370-20-8	FBXO3 gene inhibitor	FBXO3																																																																										72201045					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-117937	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: PROTAC | Research Area: Inflammation/Immunology|MOABOX:6412|FBXO3|FBXO3 gene inhibitor	C(CNCc1ccc(cc1)c2ccccn2)NCc3ccc(cc3)c4ccccn4	1507370-20-8	47521	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469425	394.51144	BC-1215	BC-1215 | BC-1215	Pathway: PROTAC	Research Area: Inflammation/Immunology	MOABOX:6412	FBXO3	FBXO3 gene inhibitor
SJ001035148-1	SJ001035148	1	MOABOX:6413	IZPMWFSVTDOCDI-HAVVHWLPSA-N	O=C(O)c1ccc(N2N=C(Cc3ccccc3)/C(=C\c3ccc(-c4ccccc4F)o3)C2=O)cc1			BTRC																																																																										121513876					member	10.1016/j.bbrc.2008.01.166																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-110261	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease; NF-?B | Research Area: Inflammation/Immunology|MOABOX:6413|BTRC|	OC(=O)c1ccc(cc1)N2N=C(Cc3ccccc3)\C(=C/c4oc(cc4)c5ccccc5F)\C2=O	916232-21-8	81998	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468924	466.45986	GS143	GS143 | GS143	Pathway: Metabolic Enzyme/Protease; NF-?B	Research Area: Inflammation/Immunology	MOABOX:6413	BTRC	
SJ001035366-1	SJ001035366	1	MOABOX:6415	MMJJNHOIVCGAAP-UHFFFAOYSA-N	CCOC(=O)N1CCC(CN(Cc2ccc(Cl)cc2)Cc2ccc([N+](=O)[O-])s2)C1	1379686-30-2	REV-ERB agonist	NR1D1																																																															CHEMBL1961796											57394020					member																																																																																																																																																																22460951	22633688																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.87832																																0.35979																																8																																HY-16989	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy | Research Area: Cancer|MOABOX:6415|NR1D1|REV-ERB agonist	CCOC(=O)N1CCC(CN(Cc2ccc(Cl)cc2)Cc3ccc(s3)[N+](=O)[O-])C1	1379686-30-2	17241	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469798	437.94026	SR9009	SR9009 | SR9009	Pathway: Autophagy	Research Area: Cancer	MOABOX:6415	NR1D1	REV-ERB agonist
SJ001010621-2	SJ001010621	2	MOABOX:6418	ZTUJNJAKTLHBEX-UHFFFAOYSA-N	CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1	1242156-23-5	reversible BTK inhibitor	BTK																																																															CHEMBL2057918											46908026	91895224				member	10.1021/jm300035p																																																																																																																																																															22394077	24712864	25515957	25596757	26169764	28792217	30888232																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															3.9064																																0.4883																																8																																HY-18018	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Inflammation/Immunology|MOABOX:6418|BTK|reversible BTK inhibitor	CN1CCN(CC1)c2ccc(NC3=CC(=CN(C)C3=O)c4cccc(N5C=Cc6cc(cc(F)c6C5=O)C7CC7)c4CO)nc2	1242156-23-5	16267	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468966	606.6892	RN486	RN486 | RN486	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Inflammation/Immunology	MOABOX:6418	BTK	reversible BTK inhibitor
SJ000831453-4	SJ000831453	4	MOABOX:6425	DOKZLKDGUQWMSX-HKBQPEDESA-N	OC[C@H](Cc1ccccc1)Nc1nc(Oc2ccc3c(c2)CCC3)nc2c1ncn2Cc1ccc(-c2ccccc2)cc1	944328-88-5	ADP ribosylation factor 1 inhibitor	ARFGAP1																																																															CHEMBL259181											42623900	71311792				member	10.1073/pnas.0702136104																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-12762	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:6425|ARFGAP1|ADP ribosylation factor 1 inhibitor	OC[C@H](Cc1ccccc1)Nc2nc(Oc3ccc4CCCc4c3)nc5c2ncn5Cc6ccc(cc6)c7ccccc7	944328-88-5	25635	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469392	567.67952	QS-11	QS-11 | QS11 HYDRATE | QS-11 | QS11 HYDRATE	Pathway: Others	Research Area: Cancer	MOABOX:6425	ARFGAP1	ADP ribosylation factor 1 inhibitor
SJ000782377-8	SJ000782377	8	MOABOX:6426	NJZHEQOUHLZCOX-FTLRAWMYSA-N	Fc1cc(F)c2c(c1)[C@H]1C=CC[C@H]1C(c1cccnc1)N2	1139889-93-2	Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors	GBF1																																																															CHEMBL1256685											25113626					member	10.1038/nchembio.144																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-100540	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Cancer; Infection|MOABOX:6426|GBF1|Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors	Fc1cc(F)c2NC([C@@H]3CC=C[C@@H]3c2c1)c4cccnc4	1139889-93-2	62853	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469157	284.30327	GOLGICIDE A | GCA |	"""GOLGICIDE A | GCA |"" | GOLGICIDE | GOLGICIDE A | ""GOLGICIDE A | GCA |"" | GOLGICIDE | GOLGICIDE A"	Pathway: Anti-infection	Research Area: Cancer; Infection	MOABOX:6426	GBF1	Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors
SJ001035381-1	SJ001035381	1	MOABOX:6427	RXIUMAOXORBRCY-UHFFFAOYSA-N	OCCNC1CCCc2c1[nH]c1ccc(-c3ccccc3)cc21	425399-05-9	CDC42 Rho GTPase inhibitor	CDC42																																																																										2882155					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-12874	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cancer|MOABOX:6427|CDC42|CDC42 Rho GTPase inhibitor	OCCNC1CCCc2c1[nH]c3ccc(cc23)c4ccccc4	425399-05-9	27609	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469853	306.40148	CASIN	CASIN | CASIN	Pathway: GPCR/G Protein	Research Area: Cancer	MOABOX:6427	CDC42	CDC42 Rho GTPase inhibitor
SJ000110703-18	SJ000110703	18	MOABOX:6429	OVCDSSHSILBFBN-UHFFFAOYSA-N	CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O	1021496-19-4	Histamine Methyltransferase Inhibitor;Antimalarial	HNMT																																																															CHEMBL1357648	CHEMBL1630	CHEMBL1707005	CHEMBL3137745	CHEMBL3216010	CHEMBL682						2165	6246	64646	3647519	16051921	member																																																																																																																																																																18789706	22771008																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.09992																																0.13749																																8																																BD93089	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-005-935-533|MOABOX:6429|HNMT|Histamine Methyltransferase Inhibitor;Antimalarial	CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O	69-44-3	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468662	355.86118	AMODIAQUIN DIHYDROCHLORIDE DIHYDRATE	AMODIAQUIN DIHYDROCHLORIDE DIHYDRATE | SJ000285801 | CAMOQUIN HYDROCHLORIDE | AMODIAQUINE DIHYDROCHLORIDE | AMODIAQUIN DIHYDROCHLORIDE DIHYDRATE | SJ000285801 | CAMOQUIN HYDROCHLORIDE | AMODIAQUINE DIHYDROCHLORIDE			MOABOX:6429	HNMT	Histamine Methyltransferase Inhibitor;Antimalarial
SJ001032957-2	SJ001032957	2	MOABOX:6430	WPYWMXNXEZFMAK-UHFFFAOYSA-N	O=C(O)CCCCN(CCc1ccccc1OCc1ccc(CCc2ccccc2)cc1)Cc1ccc(C(=O)O)cc1	329773-35-5	Soluble guanylate cyclase activator;Soluble Guanylyl Cyclase (sGC) Activators	GUCY1A2	GUCY1A1	GUCY1B1																														2982	2983																														CHEMBL1236936											9808022	10031513	11389050	46700746	91518190	member																																																																																																																																																																20015042	29498522																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.66633	0.55744	0.55744																														0.09519	0.06968	0.06968																														7	8	8																														HY-14181	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cardiovascular Disease|MOABOX:6430|GUCY1A2|Soluble guanylate cyclase activator;Soluble Guanylyl Cyclase (sGC) Activators	OC(=O)CCCCN(CCc1ccccc1OCc2ccc(CCc3ccccc3)cc2)Cc4ccc(cc4)C(=O)O	329773-35-5	8313	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469905	565.69856	CINACIGUAT	CINACIGUAT | CINACIGUAT	Pathway: GPCR/G Protein	Research Area: Cardiovascular Disease	MOABOX:6430	GUCY1A2	Soluble guanylate cyclase activator;Soluble Guanylyl Cyclase (sGC) Activators
SJ000287842-11	SJ000287842	11	MOABOX:6431	LXBIFEVIBLOUGU-DPYQTVNSSA-N	OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O	108147-54-2	"an oral pharmacologic chaperone, stabilizes specific mutant forms of Î±-galactosidase, increasing enzyme trafficking to lysosomes;Pharmacological Chaperones"	GLA																																																															CHEMBL110458	CHEMBL2107355										176077	11644097				virtual																																																																																																																																																																15771446	17520141	19199995	20457528	20610152	20715263	22827178	27744182	27750150																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3.23616																																0.40452																																8																																HY-14929A	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Others|MOABOX:6431|GLA|an oral pharmacologic chaperone, stabilizes specific mutant forms of ??-galactosidase, increasing enzyme trafficking to lysosomes;Pharmacological Chaperones"	OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O	75172-81-5	67103	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469564	163.17172	MIGALASTAT	"MIGALASTAT | ""DGJ | 1-DEOXYGALACTONOJIRIMYCIN HYDROCHLORIDE | AT-1001 | GR-181413A | HGT-3310 | GALACTO-DNJ HCL | NSC-625109"" | MIGALASTAT | ""DGJ | 1-DEOXYGALACTONOJIRIMYCIN HYDROCHLORIDE | AT-1001 | GR-181413A | HGT-3310 | GALACTO-DNJ HCL | NSC-625109"""	Pathway: Others	Research Area: Others	MOABOX:6431	GLA	"an oral pharmacologic chaperone, stabilizes specific mutant forms of ??-galactosidase, increasing enzyme trafficking to lysosomes;Pharmacological Chaperones"
SJ000285967-5	SJ000285967	5	MOABOX:6433	CYXKNKQEMFBLER-UHFFFAOYSA-N	C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1	10118-35-1	Carnitine O-Palmitoyltransferase Inhibitors;NOX2 Inhibitors	CPT1A	CPT2	CYBB																														1376	1536																														CHEMBL1334033	CHEMBL75880										4746	71175	5284439	17854957	18770512	member	10.3109/14756366.2011.636360																																																																																																																																																															22136506																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.30093	-0.30177	1.29968																														-0.04299	-0.04311	0.16246																														7	7	8																														16982	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-460|MOABOX:6433|CPT1A|Carnitine O-Palmitoyltransferase Inhibitors;NOX2 Inhibitors	C(C(C1CCCCC1)C2CCCCC2)C3CCCCN3	6724-53-4	NA	GENERAL	MALEATE	1	NO_SOLVATE	0	1468701	277.4879	PERHEXILINE MALEATE	PERHEXILINE MALEATE | PERHEXILINE MALEATE			MOABOX:6433	CPT1A	Carnitine O-Palmitoyltransferase Inhibitors;NOX2 Inhibitors
SJ001035036-1	SJ001035036	1	MOABOX:6435	UWQXWOJVNASZLI-UHFFFAOYSA-N	CC1=C(C(=O)Nc2ccccc2C)C(c2cccc([N+](=O)[O-])c2)C2=C(CCCC2=O)N1	506417-09-0	GPR41 agonist	FFAR3																																																																										3142532					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.0176																																0.2522																																8																																AG-690/40699390	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-982-343|MOABOX:6435|FFAR3|GPR41 agonist	CC1=C(C(C2=C(CCCC2=O)N1)c3cccc(c3)[N+](=O)[O-])C(=O)Nc4ccccc4C	506417-09-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468524	417.45712	AG-690/40699390	AG-690/40699390 | AG-690/40699390			MOABOX:6435	FFAR3	GPR41 agonist
SJ000861825-8	SJ000861825	8	MOABOX:6439	OBJNFLYHUXWUPF-IZZDOVSWSA-N	CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1	1604810-83-4	CDK7 inhibitor	CDK7																																																															CHEMBL3603847											73602827	78358326	129896819			member	10.1002/jcb.27292	10.1038/s41388-019-0701-1																																																																																																																																																														25043025	26115571	28174091	31064851																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.33976																																0.16747																																8																																HY-80013	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:6439|CDK7|CDK7 inhibitor	CN(C)C\C=C\C(=O)Nc1ccc(cc1)C(=O)Nc2cccc(Nc3ncc(Cl)c(n3)c4c[nH]c5ccccc45)c2	1604810-83-4	30004	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469419	566.05272	THZ1	THZ1 | THZ1	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:6439	CDK7	CDK7 inhibitor
SJ001035214-1	SJ001035214	1	MOABOX:6440	AQTPWCUIYUOEMG-INIZCTEOSA-N	O=C(C1CC1)N1CC[C@@H](Cc2n[nH]c(=O)n2-c2ccc(-c3ccc4occc4c3)cc2)C1	1332331-08-4	FAS inhibitor	FASN																																																															CHEMBL3646801											67376285					member	10.1038/nchembio.1603																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.14808																																0.26851																																8																																HY-12325	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:6440|FASN|FAS inhibitor	O=C(C1CC1)N2CC[C@@H](CC3=NNC(=O)N3c4ccc(cc4)c5ccc6occc6c5)C2	1332331-08-4	15670	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469153	428.48306	GSK2194069	GSK2194069 | GSK2194069	Pathway: Others	Research Area: Cancer	MOABOX:6440	FASN	FAS inhibitor
SJ000855254-6	SJ000855254	6	MOABOX:6446	WIKGAEMMNQTUGL-SNVBAGLBSA-N	CN1C(=O)N[C@H](Cc2c[nH]c3c(Cl)cccc23)C1=O	852391-19-6	RIPK1 inhibitor	RIPK1																																																															CHEMBL370438											11288934					member	10.1021/acs.jmedchem.5b01898	10.1038/nchembio.83																																																																																																																																																														18408713	26854747	29437386																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.19536																																0.14942																																8																																HY-14622	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis | Research Area: Cancer|MOABOX:6446|RIPK1|RIPK1 inhibitor	CN1C(=O)N[C@H](Cc2c[nH]c3c(Cl)cccc23)C1=O	852391-19-6	9951	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469874	277.70628	7-CL-O-NEC1	7-CL-O-NEC1 | Nec-1s | 7-CL-O-NEC1 | Nec-1s	Pathway: Apoptosis	Research Area: Cancer	MOABOX:6446	RIPK1	RIPK1 inhibitor
SJ001035212-1	SJ001035212	1	MOABOX:6449	XERATECPNBWJFP-UHFFFAOYSA-N	O=C(O)Cn1nnc(-c2ccc(CN(CCCCOc3ccc(CN4CCCC4)cc3)CCc3ccccc3)cc2)n1		Tip60 (KAT5) inhibitor	KAT5																																																															CHEMBL3775396											91826511	91826512				member	10. 1038/srep05372																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-123604A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Epigenetics | Research Area: Cancer|MOABOX:6449|KAT5|Tip60 (KAT5) inhibitor	OC(=O)Cn1nnc(n1)c2ccc(CN(CCCCOc3ccc(CN4CCCC4)cc3)CCc5ccccc5)cc2	2108830-09-5	66148	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469151	568.7091	TH1834 DIHYDROCHLORIDE	TH1834 DIHYDROCHLORIDE | TH1834 DIHYDROCHLORIDE	Pathway: Apoptosis; Epigenetics	Research Area: Cancer	MOABOX:6449	KAT5	Tip60 (KAT5) inhibitor
SJ000784250-3	SJ000784250	3	MOABOX:6452	SVENPFFEMUOOGK-SDNWHVSQSA-N	N#C/C(=C\c1ccc(-c2cc(Cl)ccc2Cl)o1)C(=O)Nc1cccc2ncccc12	304896-28-4	SIRT2;SIRT inhibitor NAD dependent	SIRT2																																																															CHEMBL224864											2130404	132274335				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.3929																																0.4847																																7																																HY-100578	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:6452|SIRT2|SIRT2;SIRT inhibitor NAD dependent	Clc1ccc(Cl)c(c1)c2oc(\C=C(/C#N)\C(=O)Nc3cccc4ncccc34)cc2	304896-28-4	26520	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468992	434.27422	AGK 2	AGK 2 | AGK 2	Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:6452	SIRT2	SIRT2;SIRT inhibitor NAD dependent
SJ000833877-10	SJ000833877	10	MOABOX:6454	KHWCPNJRJCNVRI-UHFFFAOYSA-N	CCCOc1ccn2c(C(C)=O)cc(-c3ccccc3S(C)(=O)=O)c2c1	1619994-68-1	"BAZ2A, BAZ2B dual inhibitor;Dual BAZ2A/BAZ2B inhibitor;BAZ2A/B dual inhibitor"	BAZ2A	BAZ2B																															29994																															CHEMBL3739699											73010930					member																																																																																																																																																																25799074	26572217	26982797	27731638																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.57432	2.45216																															0.07179	0.30652																															8	8																															HY-15658	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Epigenetics | Research Area: Cancer|MOABOX:6454|BAZ2A|BAZ2A, BAZ2B dual inhibitor;Dual BAZ2A/BAZ2B inhibitor;BAZ2A/B dual inhibitor"	CCCOc1ccn2c(cc(c3ccccc3S(=O)(=O)C)c2c1)C(=O)C	1619994-68-1	18350	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469725	371.45004	GSK2801	GSK2801 | GSK2801	Pathway: Apoptosis; Epigenetics	Research Area: Cancer	MOABOX:6454	BAZ2A	"BAZ2A, BAZ2B dual inhibitor;Dual BAZ2A/BAZ2B inhibitor;BAZ2A/B dual inhibitor"
SJ000833875-8	SJ000833875	8	MOABOX:6455	GEPYBHCJBORHCE-SFHVURJKSA-N	COc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2C[C@H](C)N2CCOCC2)cc1Cl	1613695-14-9	CREBBP / CBP / KAT3A;N-Ac Lysine competitive CREBBP inhibitor	CREBBP	EP300																															2033																															CHEMBL3622373											72201027					member																																																																																																																																																																24497428	26043365	26086931	26572217	27673482	27682507	28375629	29448139	29758518																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2.84736	0.77992																															0.35592	0.09749																															8	8																															HY-15826	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer; Inflammation/Immunology|MOABOX:6455|CREBBP|CREBBP / CBP / KAT3A;N-Ac Lysine competitive CREBBP inhibitor	COc1ccc(CCc2nc3cc(ccc3n2C[C@H](C)N4CCOCC4)c5c(C)onc5C)cc1Cl	1613695-14-9	10829	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469495	509.03962	SGC-CBP30	SGC-CBP30 | SGC-CBP30	Pathway: Epigenetics	Research Area: Cancer; Inflammation/Immunology	MOABOX:6455	CREBBP	CREBBP / CBP / KAT3A;N-Ac Lysine competitive CREBBP inhibitor
SJ000833880-6	SJ000833880	6	MOABOX:6456	YKNAKDFZAWQEEO-IBGZPJMESA-N	CCC(=O)N1CCOc2c(cc(-c3ccc(OC)c(OC)c3)cc2OC[C@H]2CCCN(C)C2)C1		CREBBP / CBP / KAT3A;N-Ac Lysine competitive CREBBP inhibitor	CREBBP	EP300																															2033																															CHEMBL3774655											90488984	132285145				member																																																																																																																																																																24497428	26572217	26701186	27673482	27682507	29155580																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.87696	0.512																															0.23462	0.064																															8	8																															14468	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-561-214|MOABOX:6456|CREBBP|CREBBP / CBP / KAT3A;N-Ac Lysine competitive CREBBP inhibitor	CCC(=O)N1CCOc2c(C1)cc(cc2OC[C@H]3CCCN(C)C3)c4ccc(OC)c(OC)c4	2147701-33-3	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468299	468.58514	I-CBP112	I-CBP112 | I-CBP112			MOABOX:6456	CREBBP	CREBBP / CBP / KAT3A;N-Ac Lysine competitive CREBBP inhibitor
SJ000862690-2	SJ000862690	2	MOABOX:6458	LIBVHXXKHSODII-UHFFFAOYSA-N	O=C1COc2c(CCNCCN(C(=O)CCNCCc3ccc(Cl)c(Cl)c3)C3CCCCC3)ccc(O)c2N1	1035227-43-0	SMYD2 / KMT3C;SMYD2 gene inhibitor	SMYD2																																																															CHEMBL2169920											24961094	78357790				member																																																																																																																																																																22498752	22975593	24300735	25406853	26101576	27075367																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.71064																																0.21383																																8																																HY-15226	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:6458|SMYD2|SMYD2 / KMT3C;SMYD2 gene inhibitor	Oc1ccc(CCNCCN(C2CCCCC2)C(=O)CCNCCc3ccc(Cl)c(Cl)c3)c4OCC(=O)Nc14	1035227-43-0	57023	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469164	577.54242	AZ505	AZ505 | AZ505 DITRIFLUOROACETATE | AZ505 | AZ505 DITRIFLUOROACETATE	Pathway: Epigenetics	Research Area: Cancer	MOABOX:6458	SMYD2	SMYD2 / KMT3C;SMYD2 gene inhibitor
SJ001035336-1	SJ001035336	1	MOABOX:6461	LNENLABLFGGAFF-BHIFYINESA-N	O=C(O)[C@H]1CCCC[C@H]1C(=O)N1CCc2ccccc2[C@H]1CN1C(=O)c2ccccc2C1=O	1432500-66-7	"Inhibitor of KEAP1-nrf2 protein-protein interaction;Erythroid Derived 2, Like 2 (Nrf2) Activators;KEAP1 gene inhibitor;NRF2 Activator"	KEAP1																																																															CHEMBL2381968											56840728					member	10.1002/cmdc.201300525/)	10.1016/j.bmcl.2013.03.013)																																																																																																																																																														23562243	24131448	24417449	24512214	26258437																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.65456																																0.20682																																8																																HY-110258	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: NF-?B | Research Area: Cancer|MOABOX:6461|KEAP1|Inhibitor of KEAP1-nrf2 protein-protein interaction;Erythroid Derived 2, Like 2 (Nrf2) Activators;KEAP1 gene inhibitor;NRF2 Activator"	OC(=O)[C@H]1CCCC[C@H]1C(=O)N2CCc3ccccc3[C@H]2CN4C(=O)c5ccccc5C4=O	1432500-66-7	66177	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469628	446.49504	ML334 | LH601A	"""ML334 | LH601A"" | ""ML334 | LH601A"""	Pathway: NF-?B	Research Area: Cancer	MOABOX:6461	KEAP1	"Inhibitor of KEAP1-nrf2 protein-protein interaction;Erythroid Derived 2, Like 2 (Nrf2) Activators;KEAP1 gene inhibitor;NRF2 Activator"
SJ001034911-1	SJ001034911	1	MOABOX:6462	QOSIJVVNNGXEKE-INIZCTEOSA-N	O=C(O)C[C@H](Cc1ccc(C(F)(F)F)cc1)NC(=O)Cc1cccc(Cl)c1	1322598-09-3	GPR43 antagonist	FFAR2																																																																										53308747					member	10.3389/fendo.2012.00111																																																																																																																																																															28570808																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.25672																																-0.03209																																8																																5903	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-694-789|MOABOX:6462|FFAR2|GPR43 antagonist	OC(=O)C[C@H](Cc1ccc(cc1)C(F)(F)F)NC(=O)Cc2cccc(Cl)c2	1322598-09-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468221	399.79139	CATPB	CATPB | CATPB			MOABOX:6462	FFAR2	GPR43 antagonist
SJ001035395-1	SJ001035395	1	MOABOX:6463	MPMKMQHJHDHPBE-RUZDIDTESA-N	C[C@]1(C(=O)N(CCCC(=O)O)Cc2cccc(Cl)c2)CCN1C(=O)c1csc2ccccc12	1391076-61-1	GPR43 antagonist	FFAR2																																																															CHEMBL3353541											57520598					member	10.1021/jm5012885	10.3389/fendo.2012.00111																																																																																																																																																														25380412	30247908																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				4.27888																																0.53486																																8																																HY-12940	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Metabolic Disease|MOABOX:6463|FFAR2|GPR43 antagonist	C[C@@]1(CCN1C(=O)c2csc3ccccc23)C(=O)N(CCCC(=O)O)Cc4cccc(Cl)c4	1391076-61-1	84666	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469895	484.995	GLPG0974	GLPG0974 | GLPG0974	Pathway: Others	Research Area: Metabolic Disease	MOABOX:6463	FFAR2	GPR43 antagonist
SJ001033613-2	SJ001033613	2	MOABOX:6476	ORFLZNAGUTZRLQ-ZMBVWFSWSA-N	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(C)C	258818-34-7	Zonulin Receptor Antagonists	HP																																																															CHEMBL2103815	CHEMBL2105646										9810532	25230396	44146842			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-106268A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cytoskeleton | Research Area: Inflammation/Immunology|MOABOX:6476|HP|Zonulin Receptor Antagonists	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O	881851-50-9	58430	GENERAL	ACETATE	1	NO_SOLVATE	0	1469310	725.8334	LARAZOTIDE (ACETATE)	LARAZOTIDE (ACETATE) | LARAZOTIDE (ACETATE)	Pathway: Cytoskeleton	Research Area: Inflammation/Immunology	MOABOX:6476	HP	Zonulin Receptor Antagonists
SJ001035106-1	SJ001035106	1	MOABOX:6478	QIXBOOVPFRZHQQ-UHFFFAOYSA-N	CCCCCCCCn1cc(CC(N)=O)c2cc(-c3cccc(C)c3)ccc21	851636-83-4	Isoprenylcysteine Carboxyl Methyltransferase Inhibitors	ICMT																																																															CHEMBL240860											6918831					member	10.1021/jm200249a	10.1073/pnas.0408107102																																																																																																																																																														15784746	21661760																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.46552																																0.18319																																8																																14745	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-561-231|MOABOX:6478|ICMT|Isoprenylcysteine Carboxyl Methyltransferase Inhibitors	CCCCCCCCn1cc(CC(=O)N)c2cc(ccc12)c3cccc(C)c3	851636-83-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468698	376.53438	CYSMETHYNIL | ICMT INHIBITOR	"""CYSMETHYNIL | ICMT INHIBITOR"" | ""CYSMETHYNIL | ICMT INHIBITOR"""			MOABOX:6478	ICMT	Isoprenylcysteine Carboxyl Methyltransferase Inhibitors
SJ000288061-3	SJ000288061	3	MOABOX:6481	WZJKPXZLQTXALB-UHFFFAOYSA-N	C[N+](C)(C)CCC(=O)c1cccc2ccccc12	115066-04-1	"Chemokine-like Receptor 1 (CMKLR1, CHEMR23) Antagonists;ChAT inhibitor;Aldehyde dehydrogenase 1 inhibitor"	ALDH1A1	CHAT	CMKLR1																														1103	1240																														CHEMBL1255936	CHEMBL1358898										1518	11957648				virtual	10.1371/journal.pone.0112925.																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.97797	0	1.70776																														0.13971	0.0	0.21347																														7	7	8																														AA0097DI	AABLOCKS	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-016-580-870|MOABOX:6481|ALDH1A1|Chemokine-like Receptor 1 (CMKLR1, CHEMR23) Antagonists;ChAT inhibitor;Aldehyde dehydrogenase 1 inhibitor"	C[N+](C)(C)CCC(=O)c1cccc2ccccc12	115066-04-1	NA	GENERAL	IODIDE	1	NO_SOLVATE	0	1468277	242.3361	2-(ALPHA-NAPHTHOYL)ETHYLTRIMETHYLAMMONIUM IODIDE	2-(ALPHA-NAPHTHOYL)ETHYLTRIMETHYLAMMONIUM IODIDE | 2-(Î±-NAPHTHOYL)-ETHYLTRIMETHYLAMMONIUM IODIDE | 2-(ALPHA-NAPHTHOYL)ETHYLTRIMETHYLAMMONIUM IODIDE | 2-(Î±-NAPHTHOYL)-ETHYLTRIMETHYLAMMONIUM IODIDE			MOABOX:6481	ALDH1A1	"Chemokine-like Receptor 1 (CMKLR1, CHEMR23) Antagonists;ChAT inhibitor;Aldehyde dehydrogenase 1 inhibitor"
SJ001034656-1	SJ001034656	1	MOABOX:6483	YRGYYQCOWUULNF-UHFFFAOYSA-N	Cc1cc(O)nc(O)c1C#N	40401-47-6	Uridine Phosphorylase Inhibitors	UPP1																																																															CHEMBL3086510											79516	87617031	91664345	132647862	139061923	member																																																																																																																																																																24131420																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.13232																																0.39154																																8																																4T-0009	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Cc1cc(O)nc(O)c1C#N	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466760	150.13474	4T-0009	4T-0009 | 4T-0009			MOABOX:6483	UPP1	Uridine Phosphorylase Inhibitors
SJ001035328-1	SJ001035328	1	MOABOX:6484	JRVXFGNCHKHBPA-UHFFFAOYSA-N	COc1ccc(C2Nc3cccc(O)c3C(=O)N2Cc2ccccc2)cc1COc1ccc(NC(C)=O)cc1	1186649-91-1	Thyroid stimulating hormone receptor antagonist	TSHR																																																															CHEMBL1515891											25246343					member	10.1039/c1md00145k	10.1210/jc.2010-1935																																																																																																																																																														22408719																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.94456																																0.24307																																8																																HY-114116	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Metabolic Disease; Endocrinology|MOABOX:6484|TSHR|Thyroid stimulating hormone receptor antagonist	COc1ccc(cc1COc2ccc(NC(=O)C)cc2)C3Nc4cccc(O)c4C(=O)N3Cc5ccccc5	1186649-91-1	60056	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469598	523.57906	ML-109	ML-109 | ML-109	Pathway: GPCR/G Protein	Research Area: Metabolic Disease; Endocrinology	MOABOX:6484	TSHR	Thyroid stimulating hormone receptor antagonist
SJ001034907-1	SJ001034907	1	MOABOX:6485	JFBXEXDZHRGQKW-UHFFFAOYSA-N	COc1ccccc1N1CCN(c2ncnc3c2cnn3-c2ccccc2)CC1		GLUT1 Inhibitor	SLC2A1																																																															CHEMBL3781157											1977736					member																																																																																																																																																																26949183																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.1156																																0.38945																																8																																STL336112	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-582-541|MOABOX:6485|SLC2A1|GLUT1 Inhibitor	COc1ccccc1N2CCN(CC2)c3ncnc4c3cnn4c5ccccc5	393845-92-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468216	386.44968	STL336112	STL336112 | STL336112			MOABOX:6485	SLC2A1	GLUT1 Inhibitor
SJ001033394-2	SJ001033394	2	MOABOX:6491	PRAAPINBUWJLGA-UHFFFAOYSA-N	O=C(Cc1cccc(OC(F)(F)F)c1)Nc1ccc(CCCCc2nnc(NC(=O)Cc3ccccn3)s2)nn1	1439399-58-2	Glutaminase Inhibitors	GLS																																																															CHEMBL3639788											71577426	91886034	102593956	118867520	118867523	member	10.1016/j.bmc.2016.03.009	10.1021/acsmedchemlett.6b00060	10.1074/jbc.M117.810101	10.1158/1535-7163.MCT-13-0870																																																																																																																																																												26988803	27200176	30543285	31474484																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		3.59112																																0.44889																																8																																HY-12248	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:6491|GLS|Glutaminase Inhibitors	FC(F)(F)Oc1cccc(CC(=O)Nc2ccc(CCCCc3nnc(NC(=O)Cc4ccccn4)s3)nn2)c1	1439399-58-2	27505	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469098	571.57407	TELAGLENASTAT; CB-839	TELAGLENASTAT; CB-839 | TELAGLENASTAT; CB-839	Pathway: Autophagy; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:6491	GLS	Glutaminase Inhibitors
SJ000546510-2	SJ000546510	2	MOABOX:6500	VLQTUNDJHLEFEQ-KGENOOAVSA-N	COC(=O)/C=C/c1cccc(N(Cc2ccc(-c3ccc(N(C)C)cc3)cc2)C(=O)C2CCCCC2)c1	574013-66-4	Farnesoid X-receptor agonist	NR1H4																																																															CHEMBL192966											5326713	145278081				member	10.1016/S1097-2765(03)00104-7																																																																																																																																																															12929628	15892636	15893927	16134928	16178789	16408003	18855890	21383957	23040732																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2.25528																																0.28191																																8																																HY-10912	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Metabolic Enzyme/Protease | Research Area: Others|MOABOX:6500|NR1H4|Farnesoid X-receptor agonist	COC(=O)\C=C\c1cccc(c1)N(Cc2ccc(cc2)c3ccc(cc3)N(C)C)C(=O)C4CCCCC4	574013-66-4	15975	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469835	496.63984	FEXARAMINE	FEXARAMINE | FEXARAMINE	Pathway: Autophagy; Metabolic Enzyme/Protease	Research Area: Others	MOABOX:6500	NR1H4	Farnesoid X-receptor agonist
SJ001033652-2	SJ001033652	2	MOABOX:6503	YPPSMYLMSKHYAY-UHFFFAOYSA-N	Cc1ccc2cc(-c3c(C)ccc(C(=O)c4c(-c5ccccc5)n(C)n(-c5ccccc5)c4=O)c3N)ccc2n1		PERK kinase inhibitor	EIF2AK3																																																															CHEMBL3407862											86583045	121513867				member	10.1021/jm5017494																																																																																																																																																															25587754																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.596																																0.4495																																8																																HY-12661A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:6503|EIF2AK3|PERK kinase inhibitor	CN1N(C(=O)C(=C1c2ccccc2)C(=O)c3ccc(C)c(c3N)c4ccc5nc(C)ccc5c4)c6ccccc6	1883548-84-2	64599	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468905	524.61172	AMG PERK 44	AMG PERK 44 | AMG PERK 44	Pathway: Autophagy; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:6503	EIF2AK3	PERK kinase inhibitor
SJ000988625-3	SJ000988625	3	MOABOX:6514	KPWSJANDNDDRMB-QAQDUYKDSA-N	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1	1083076-69-0	Dopamine D2/3 receptor partial agonist	DRD3																																																															CHEMBL2024517	CHEMBL2028019															member	10.1016/j.ejphar.2011.07.020																																																																																																																																																															22537450	23361833	24831693	27487565	28421763	28495386																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.50216																																0.18777																																8																																HY-14763A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:6514|DRD3|Dopamine D2/3 receptor partial agonist	CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1	1083076-69-0	16398	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469800	427.41098	CARIPRAZINE | RGH-188	"""CARIPRAZINE | RGH-188"" | ""CARIPRAZINE | RGH-188"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:6514	DRD3	Dopamine D2/3 receptor partial agonist
SJ001035308-1	SJ001035308	1	MOABOX:6518	WKSHMJCYWFOADB-UHFFFAOYSA-N	CN(C(=O)Oc1nsnc1N1CCOCC1)C1CCCCCCC1		ABHD6 Inhibitor	ABHD6																																																															CHEMBL3613671											121513897					member	10.1002/cmdc.201402453	10.1016/j.bmc.2015.08.030																																																																																																																																																														26344596																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.44736																																0.43092																																8																																HY-101457	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:6518|ABHD6|ABHD6 Inhibitor	CN(C1CCCCCCC1)C(=O)Oc2nsnc2N3CCOCC3	1672691-74-5	41367	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469539	354.46764	JZP-430	JZP-430 | JZP-430	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:6518	ABHD6	ABHD6 Inhibitor
SJ000862668-2	SJ000862668	2	MOABOX:6520	IVDUVEGCMXCMSO-FQEVSTJZSA-N	Cc1ncc(Cl)cc1NCc1ccc(C(=O)N[C@@H](CC2CCCC2)C(=O)NC2CC2)s1	1404456-53-6	WIP1 inhibitor	PPM1D																																																															CHEMBL3613749											70983932					member																																																																																																																																																																26358280																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.46328																																-0.05791																																8																																HY-15832	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:6520|PPM1D|WIP1 inhibitor	Cc1ncc(Cl)cc1NCc2ccc(s2)C(=O)N[C@@H](CC3CCCC3)C(=O)NC4CC4	1404456-53-6	12822	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469209	461.01996	GSK2830371	GSK2830371 | GSK2830371	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:6520	PPM1D	WIP1 inhibitor
SJ001035340-1	SJ001035340	1	MOABOX:6524	LYNOGBKNFIHKLE-UHFFFAOYSA-N	CCCCc1ccc(N/C=N/O)c(C)c1	339068-25-6	20-HETE receptor antagonist	CYP4A11																																																															CHEMBL267865											2727594					member	10.1016/S0968-0896(01)00194-8	10.1016/j.bmcl.2003.11.005	10.1021/jm020557k	10.1038/sj.bjp.0704101	10.2174/092986709788803033																																																																																																																																																											14640550	14698153	19689286																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.73408																																0.21676																																8																																HY-124527	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease|MOABOX:6524|CYP4A11|20-HETE receptor antagonist	CCCCc1ccc(\N=C\NO)c(C)c1	339068-25-6	58008	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469651	206.28412	HET0016	HET0016 | HET0016	Pathway: Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease	MOABOX:6524	CYP4A11	20-HETE receptor antagonist
SJ001010948-2	SJ001010948	2	MOABOX:6525	REKSFCCYDQMSIN-UHFFFAOYSA-N	CC(C)n1cnc2c(NCc3cccc(C(F)(F)F)c3)ncnc21	1353867-91-0	Casein kinase-I alpha inhibitor;Casein kinase-I delta inhibitor	CSNK1A1	CSNK1D																															1453																																										49830252					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.8568	0.73605																															0.1224	0.10515																															7	7																															HY-18285	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; MAPK/ERK Pathway; Stem Cell/Wnt | Research Area: Cancer|MOABOX:6525|CSNK1A1|Casein kinase-I alpha inhibitor;Casein kinase-I delta inhibitor	CC(C)n1cnc2c(NCc3cccc(c3)C(F)(F)F)ncnc12	1353867-91-0	41163	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468862	335.32695	LONGDAYSIN	LONGDAYSIN | LONGDAYSIN	Pathway: Cell Cycle/DNA Damage; MAPK/ERK Pathway; Stem Cell/Wnt	Research Area: Cancer	MOABOX:6525	CSNK1A1	Casein kinase-I alpha inhibitor;Casein kinase-I delta inhibitor
SJ000803727-5	SJ000803727	5	MOABOX:6529	DTEKTGDVSARYDS-NSHDSACASA-N	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)[C@@H]1C		Ribosomal protein S6 kinase inhibitor	RPS6KA1	RPS6KA2	RPS6KA3	RPS6KA4	RPS6KA6																												6196	6197	8986	27330																																							44141268					member	10.1042/BJ20061088																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.72163	0.82082	0.66647	0	0.84238																												0.10309	0.11726	0.09521	0.0	0.12034																												7	7	7	7	7																												1528	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-008-266-821|MOABOX:6529|RPS6KA1|Ribosomal protein S6 kinase inhibitor	CC(C)CCN1C(C)C(=O)N(C)c2cnc(Nc3cc(F)c(O)c(F)c3)nc12	501437-28-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468385	391.41503	BI-D1870	BI-D1870 | BI-D1870			MOABOX:6529	RPS6KA1	Ribosomal protein S6 kinase inhibitor
SJ001034895-1	SJ001034895	1	MOABOX:6533	WQAGVQVBDHOHRD-UHFFFAOYSA-N	Cc1c[nH]c2ncnc(-c3ccc(NC(=O)N(CCO)c4ccccc4)cc3)c12	1219728-20-7	Limk1 inhibitor	LIMK1																																																															CHEMBL3410036											45381385					member	10.1016/j.bmc.2015.10.041	10.1021/jm501680m																																																																																																																																																														25621531	26545798																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.41336																																0.42667																																8																																5626	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-101-337|MOABOX:6533|LIMK1|Limk1 inhibitor	Cc1c[nH]c2ncnc(c3ccc(NC(=O)N(CCO)c4ccccc4)cc3)c12	1219728-20-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468201	387.43444	SR 7826	SR 7826 | SR 7826			MOABOX:6533	LIMK1	Limk1 inhibitor
SJ001033262-2	SJ001033262	2	MOABOX:6536	URWYQGVSPQJGGB-DHUJRADRSA-N	COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12	743461-65-6	"Muscarinic M3 receptor antagonist, Beta 2 adrenoceptor agonist"	ADRB2	CHRM3																															1131																															CHEMBL3039512	CHEMBL3039518										10372836	11629376	11858365	16718568	135905398	member	10.1021/jm501915g	10.1124/jpet.114.216861																																																																																																																																																														25629394																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.67728	0.9416																															0.20966	0.1177																															8	8																															HY-12980	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Inflammation/Immunology; Endocrinology|MOABOX:6536|ADRB2|Muscarinic M3 receptor antagonist, Beta 2 adrenoceptor agonist"	COc1cc(NC(=O)CCN2CCC(CC2)OC(=O)Nc3ccccc3c4ccccc4)c(Cl)cc1CNC[C@H](O)c5ccc(O)c6NC(=O)C=Cc56	743461-65-6	23839	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469097	740.24378	BATEFENTEROL; GSK961081; TD-5959	BATEFENTEROL; GSK961081; TD-5959 | BATEFENTEROL; GSK961081; TD-5959	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Inflammation/Immunology; Endocrinology	MOABOX:6536	ADRB2	"Muscarinic M3 receptor antagonist, Beta 2 adrenoceptor agonist"
SJ000288087-7	SJ000288087	7	MOABOX:6544	ISWRGOKTTBVCFA-UHFFFAOYSA-N	Cc1ccc(=O)n(-c2ccccc2)c1	53179-13-8	TNF alpha synthesis inhibitor;TGFb pathway inhibitor;antifibrotic	TNF																																																															CHEMBL1256391											40632	45375849	66874302	68279924	118917410	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-B0673	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation; Stem Cell/Wnt; TGF-beta/Smad | Research Area: Inflammation/Immunology; Cancer|MOABOX:6544|TNF|TNF alpha synthesis inhibitor;TGFb pathway inhibitor;antifibrotic	CC1=CN(C(=O)C=C1)c2ccccc2	53179-13-8	15738	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468908	185.22184	PIRFENIDONE	PIRFENIDONE | PIRFENIDONE	Pathway: GPCR/G Protein; Immunology/Inflammation; Stem Cell/Wnt; TGF-beta/Smad	Research Area: Inflammation/Immunology; Cancer	MOABOX:6544	TNF	TNF alpha synthesis inhibitor;TGFb pathway inhibitor;antifibrotic
SJ001035031-1	SJ001035031	1	MOABOX:6545	LUMCNRKHZRYQOV-UHFFFAOYSA-N	COc1cccc(C(=O)N2CCN(C(=O)COc3cccc(C)c3)CC2)c1OC	423748-02-1	antagonist of CBX7ChD/methyl-lysine binding by blocking H3K27me3 binding;CBX7ChD antagonist	CBX7																																																															CHEMBL3827954											1072048					member	10.1016/j.chembiol.2014.11.021																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.91207																																0.41601																																7																																AT-057/43316446	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-536-062|MOABOX:6545|CBX7|antagonist of CBX7ChD/methyl-lysine binding by blocking H3K27me3 binding;CBX7ChD antagonist	COc1cccc(C(=O)N2CCN(CC2)C(=O)COc3cccc(C)c3)c1OC	423748-02-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468518	398.45224	AT-057/43316446	AT-057/43316446 | AT-057/43316446			MOABOX:6545	CBX7	antagonist of CBX7ChD/methyl-lysine binding by blocking H3K27me3 binding;CBX7ChD antagonist
SJ001035270-1	SJ001035270	1	MOABOX:6546	LBFYQISQYCGDDW-UHFFFAOYSA-N	Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1		Wnt signalling inhibitor;Wnt Pathway Inhibitor;type I inhibitor of CDK8 and CDK19	CDK8	CDK19																															23097																															CHEMBL3408213											77050682					member																																																																																																																																																																26796641	26852363	27326329	28174091																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.83896	1.14392																															0.10487	0.14299																															8	8																															HY-12681	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Stem Cell/Wnt | Research Area: Cancer|MOABOX:6546|CDK8|Wnt signalling inhibitor;Wnt Pathway Inhibitor;type I inhibitor of CDK8 and CDK19	Cn1cc(cn1)c2ccc(cc2)c3cncc(Cl)c3N4CCC5(CCNC5=O)CC4	1661839-45-7	20068	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469436	421.92256	CCT251545	CCT251545 | CCT251545	Pathway: Stem Cell/Wnt	Research Area: Cancer	MOABOX:6546	CDK8	Wnt signalling inhibitor;Wnt Pathway Inhibitor;type I inhibitor of CDK8 and CDK19
SJ000773156-10	SJ000773156	10	MOABOX:6547	HQWTUOLCGKIECB-XZWHSSHBSA-N	O=C1[C@H](Cc2ccc(O)cc2)N2C(=O)CCN(C(=O)NCc3ccccc3)[C@H]2CN1Cc1cccc2ccccc12	780757-88-2	CREBBP - beta-catenin interaction inhibitor;Apoptosis Inducers;Wnt Signaling Inhibitors	CREBBP	CTNNB1																															1499																															CHEMBL2312139											11238147					member	10.1158/1535-7163.MCT-13-1005.																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-5.74e-002	0.63968																															-0.0082	0.07996																															7	8																															HY-14428	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Stem Cell/Wnt | Research Area: Cancer|MOABOX:6547|CREBBP|CREBBP - beta-catenin interaction inhibitor;Apoptosis Inducers;Wnt Signaling Inhibitors	Oc1ccc(C[C@@H]2N3[C@H](CN(Cc4cccc5ccccc45)C2=O)N(CCC3=O)C(=O)NCc6ccccc6)cc1	780757-88-2	4362	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469279	548.63158	ICG001	ICG001 | ICG-001 | ICG001 | ICG-001	Pathway: Apoptosis; Stem Cell/Wnt	Research Area: Cancer	MOABOX:6547	CREBBP	CREBBP - beta-catenin interaction inhibitor;Apoptosis Inducers;Wnt Signaling Inhibitors
SJ000518978-19	SJ000518978	19	MOABOX:6548	HKVAMNSJSFKALM-GKUWKFKPSA-N	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C	159351-69-6	Inhibitors of Signal Transduction Pathways;Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;Rotamase (FKBP12) Inhibitors;Angiogenesis Inhibitors;mTOR inhibitor	FKBP1A	MTOR																															2475																															CHEMBL1908360																member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.52768	-0.38176																															0.06596	-0.04772																															8	8																															HY-10218	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Immunology/Inflammation; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:6548|FKBP1A|Inhibitors of Signal Transduction Pathways;Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;Rotamase (FKBP12) Inhibitors;Angiogenesis Inhibitors;mTOR inhibitor	CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(/C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(/C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC)CC[C@H]1OCCO	159351-69-6	44976	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469424	958.22442	EVEROLIMUS	"EVEROLIMUS | ""NVP-RAD-001 | RAD-001 | RAD-001C | SDZ-RAD | CERTICAN"" | EVEROLIMUS (RAD001) | EVEROLIMUS | ""NVP-RAD-001 | RAD-001 | RAD-001C | SDZ-RAD | CERTICAN"" | EVEROLIMUS (RAD001)"	Pathway: Apoptosis; Autophagy; Immunology/Inflammation; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:6548	FKBP1A	Inhibitors of Signal Transduction Pathways;Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;Rotamase (FKBP12) Inhibitors;Angiogenesis Inhibitors;mTOR inhibitor
SJ001035157-1	SJ001035157	1	MOABOX:6555	ZDQSOHOQTUFQEM-NURRSENYSA-N	CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC	104987-12-4	"Calcineurin inhibitor;FKBP12 gene modulator;""Calcineurin inhibitor;FKBP12 gene modulator"""	FKBP1A	PPP3CB	PPP3CC	PPP3R1	PPP3R2	PPP3CA																											5532	5533	5534	5535	5530																											CHEMBL8597											5282071	24795064	87614595	87663412	87742981	member																																																																																																																																																																9599228	9873523	10450986	10543889	16724459																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	3.84032	0	0	0	0	0																											0.48004	0.0	0.0	0.0	0.0	0.0																											8	7	7	7	7	7																											HY-13557	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Apoptosis; Autophagy; Immunology/Inflammation | Research Area: Infection|MOABOX:6555|FKBP1A|Calcineurin inhibitor;FKBP12 gene modulator;\Calcineurin inhibitor;FKBP12 gene modulator\	CC[C@@H]1\C=C(/C)\C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)\C(=C\[C@@H]4CC[C@@H](O)[C@@H](C4)OC)\C	104987-12-4	16730	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468942	792.00746	ASCOMYCIN | IMMUNOMYCIN | FR-900520 | FK520	"""ASCOMYCIN | IMMUNOMYCIN | FR-900520 | FK520"" | ""ASCOMYCIN | IMMUNOMYCIN | FR-900520 | FK520"""	Pathway: Anti-infection; Apoptosis; Autophagy; Immunology/Inflammation	Research Area: Infection	MOABOX:6555	FKBP1A	Calcineurin inhibitor;FKBP12 gene modulator;\Calcineurin inhibitor;FKBP12 gene modulator\
SJ001010849-2	SJ001010849	2	MOABOX:6556	SPDQRCUBFSRAFI-DOMZBBRYSA-N	C[C@@H]1COCCN1c1cc(=O)n2c(n1)N(Cc1cncc(Cl)c1)[C@H](C(F)(F)F)CC2	1523406-39-4	VPS34 inhibitor	PIK3C3																																																															CHEMBL3622372											72709209					member	10.1038/nchembio.1681																																																																																																																																																															25402320	25905679	26086931	26093105	27644332																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	3.49168																																0.43646																																8																																HY-12481	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:6556|PIK3C3|VPS34 inhibitor	C[C@@H]1COCCN1C2=CC(=O)N3CC[C@H](N(Cc4cncc(Cl)c4)C3=N2)C(F)(F)F	1523406-39-4	24558	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469872	443.85055	SAR405	SAR405 | SAR405	Pathway: Autophagy; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:6556	PIK3C3	VPS34 inhibitor
SJ001034893-1	SJ001034893	1	MOABOX:6557	HYTRYTZFJVVZAF-UHFFFAOYSA-N	NC1Cc2ccccc2N(O)C1=O	25263-70-1	Kynurenine Aminotransferase II (KAT II) Inhibitors	AADAT																																																																										135742	23356831				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																WXCD00290155	WUXI_APPTECH	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-354-298|MOABOX:6557|AADAT|Kynurenine Aminotransferase II (KAT II) Inhibitors	N[C@@H]1Cc2ccccc2N(O)C1=O	25263-70-1	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468196	178.1879	WXCD00290155	WXCD00290155 | WXCD00290155			MOABOX:6557	AADAT	Kynurenine Aminotransferase II (KAT II) Inhibitors
SJ000870776-2	SJ000870776	2	MOABOX:6558	HUUSXLKCTQDPGL-UHFFFAOYSA-N	CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c1	210826-40-7	NRLP3 inflammasome inhibitor;inhibits NLRP3 inflammasome (exact target/mechanism unknown). Shows reduction of IL-1B in vivo in EAE expt models of MS.	NLRP3																																																															CHEMBL3183703											9910393	124082001				member	10.1016/j.bmcl.2017.12.054	10.1021/acsmedchemlett.6b00198	10.1038/nm.3806																																																																																																																																																													25686105	27994733	29338910																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.3668																																0.29585																																8																																HY-12815A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Inflammation/Immunology|MOABOX:6558|NLRP3|NRLP3 inflammasome inhibitor;inhibits NLRP3 inflammasome (exact target/mechanism unknown). Shows reduction of IL-1B in vivo in EAE expt models of MS.	CC(C)(O)c1coc(c1)S(=O)(=O)NC(=O)Nc2c3CCCc3cc4CCCc24	256373-96-3	61986	GENERAL	SODIUM(I)	1	NO_SOLVATE	0	1469455	404.47996	MCC950 | MCC-950 | MCC 950 | CRID-3 | CRID3 | CRID 3 | CP-456773 | CP 456773 | CP456773	"""MCC950 | MCC-950 | MCC 950 | CRID-3 | CRID3 | CRID 3 | CP-456773 | CP 456773 | CP456773"" | ""MCC950 | MCC-950 | MCC 950 | CRID-3 | CRID3 | CRID 3 | CP-456773 | CP 456773 | CP456773"""	Pathway: Immunology/Inflammation	Research Area: Inflammation/Immunology	MOABOX:6558	NLRP3	NRLP3 inflammasome inhibitor;inhibits NLRP3 inflammasome (exact target/mechanism unknown). Shows reduction of IL-1B in vivo in EAE expt models of MS.
SJ000773173-8	SJ000773173	8	MOABOX:6562	XHBVYDAKJHETMP-UHFFFAOYSA-N	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1	1219168-18-9	AMPK Inhibitor	PRKAA1																																																															CHEMBL478629											11524144	49761481	71296952	71497117	86346670	virtual																																																																																																																																																																20932747	26288266																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.17437																																0.02491																																7																																HY-13418	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Epigenetics; PI3K/Akt/mTOR; TGF-beta/Smad | Research Area: Cancer|MOABOX:6562|PRKAA1|AMPK Inhibitor	C(CN1CCCCC1)Oc2ccc(cc2)c3cnc4c(cnn4c3)c5ccncc5	1219168-18-9	40374	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468763	399.4882	DORSOMORPHIN | BML-275 | COMPOUND C |	"""DORSOMORPHIN | BML-275 | COMPOUND C |"" | DORSOMORPHIN | ""DORSOMORPHIN | BML-275 | COMPOUND C |"" | DORSOMORPHIN"	Pathway: Autophagy; Epigenetics; PI3K/Akt/mTOR; TGF-beta/Smad	Research Area: Cancer	MOABOX:6562	PRKAA1	AMPK Inhibitor
SJ001035183-1	SJ001035183	1	MOABOX:6563	LTQYSJKGRPGMPO-UHFFFAOYSA-N	C1Cc2[nH]nc(-c3nn[nH]n3)c2C1	851776-28-8	GPR109a partial agonist	HCAR2																																																															CHEMBL456145											11159621					member	10.1021/jm2010964																																																																																																																																																															18665582	20363624	22435740	25737085																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.00432																																0.12554																																8																																HY-13008	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cardiovascular Disease|MOABOX:6563|HCAR2|GPR109a partial agonist	C1Cc2[nH]nc(c2C1)c3nnn[nH]3	851776-28-8	16992	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469021	176.17862	MK-0354	MK-0354 | MK-0354	Pathway: GPCR/G Protein	Research Area: Cardiovascular Disease	MOABOX:6563	HCAR2	GPR109a partial agonist
SJ001035024-1	SJ001035024	1	MOABOX:6569	SYKKEBRXRXCNEC-AYSLTRBKSA-N	N=C(N)N/N=C/c1ccc(Cl)c(C(F)(F)F)c1		"NPFFR2 agonist, GIRK 1/4 blocker"	NPFFR2																																																															CHEMBL583068											44542177	44542178				member																																																																																																																																																																19803524																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.09736																																0.26217																																8																																Z1066237462	ENAMINE	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-460-237|MOABOX:6569|NPFFR2|NPFFR2 agonist, GIRK 1/4 blocker"	NC(=N)NN=Cc1ccc(Cl)c(c1)C(F)(F)F	849459-88-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468505	264.63483	Z1066237462	Z1066237462 | Z1066237462			MOABOX:6569	NPFFR2	"NPFFR2 agonist, GIRK 1/4 blocker"
SJ000286736-5	SJ000286736	5	MOABOX:6571	TZJALUIVHRYQQB-XLRXWWTNSA-N	COc1ccc(-c2oc3c(CC=C(C)C)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(O)c3c(=O)c2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)cc1	489-32-7	Sorbitol dehydrogenase inhibitor	SORD																																																															CHEMBL553204											5318997	139200762	139200763	139200764	139200765	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-N0014	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology; Cardiovascular Disease; Cancer|MOABOX:6571|SORD|Sorbitol dehydrogenase inhibitor	COc1ccc(cc1)C2=C(O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)C(=O)c4c(O)cc(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)c(CC=C(C)C)c4O2	489-32-7	34181	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468920	676.6617	ICARIIN	ICARIIN | ICARIIN	Pathway: Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology; Cardiovascular Disease; Cancer	MOABOX:6571	SORD	Sorbitol dehydrogenase inhibitor
SJ000841249-7	SJ000841249	7	MOABOX:6572	WFWLQNSHRPWKFK-UHFFFAOYSA-N	O=c1[nH]c(=O)n(C2CCCO2)cc1F	1189456-27-6	Cytochrome P450 CYP2A6 inhibitor	CYP2A6																																																															CHEMBL20883											5386	104747	9803378	9895794	9934128	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																AS-13528	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	FC1=CN(C2CCCO2)C(=O)NC1=O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466845	200.16706	Tegafur	Tegafur | NSC 148958 | 5-FLUORO-1-(TETRAHYDRO-2-FURFURYL)URACIL | Tegafur | NSC 148958 | 5-FLUORO-1-(TETRAHYDRO-2-FURFURYL)URACIL			MOABOX:6572	CYP2A6	Cytochrome P450 CYP2A6 inhibitor
SJ000862654-2	SJ000862654	2	MOABOX:6575	XMVAWGSQPHFXKU-UHFFFAOYSA-N	Cc1nn(C)c(COc2ccc(N3CCN(S(=O)(=O)N(C)C)CC3)cc2)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)n(CCN3CCOCC3)c12	1668553-26-1	Mcl-1 inhibitor	MCL1																																																															CHEMBL3417704											66575373	132470899				member																																																																																																																																																																25679114	25844895	29407973	31117518																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		4.05536																																0.50692																																8																																HY-12468	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis | Research Area: Cancer|MOABOX:6575|MCL1|Mcl-1 inhibitor	CN(C)S(=O)(=O)N1CCN(CC1)c2ccc(OCc3c(c(C)nn3C)c4cccc5c(CCCOc6cccc7ccccc67)c(C(=O)O)n(CCN8CCOCC8)c45)cc2	1668553-26-1	27278	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469163	850.0366	A-1210477	A-1210477 | A-1210477	Pathway: Apoptosis	Research Area: Cancer	MOABOX:6575	MCL1	Mcl-1 inhibitor
SJ001033129-2	SJ001033129	2	MOABOX:6576	RKEWSXXUOLRFBX-UHFFFAOYSA-N	CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1	706779-91-1	"SELECTIVE inverse agonist on the serotonin receptor subtype 5-HT2A;HTR2A (5HT2A) inverse agonist;""SELECTIVE inverse agonist on the serotonin receptor subtype 5-HT2A;HTR2A (5HT2A) inverse agonist"""	HTR2A	HTR5A																															3361																															CHEMBL2111101	CHEMBL2448613										10071196	11511907	11518792	11519684	11526023	virtual	10.2174/156802608784936700																																																																																																																																																															16469866	18673166	29730027																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.70224	0																															0.33778	0.0																															8	7																															HY-14557	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:6576|HTR2A|SELECTIVE inverse agonist on the serotonin receptor subtype 5-HT2A;HTR2A (5HT2A) inverse agonist;\SELECTIVE inverse agonist on the serotonin receptor subtype 5-HT2A;HTR2A (5HT2A) inverse agonist\	CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C3CCN(C)CC3)cc1	706779-91-1	25278	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469040	427.55476	PIMAVANSERIN | ACP-103	"""PIMAVANSERIN | ACP-103"" | ""PIMAVANSERIN | ACP-103"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:6576	HTR2A	SELECTIVE inverse agonist on the serotonin receptor subtype 5-HT2A;HTR2A (5HT2A) inverse agonist;\SELECTIVE inverse agonist on the serotonin receptor subtype 5-HT2A;HTR2A (5HT2A) inverse agonist\
SJ000862688-5	SJ000862688	5	MOABOX:6578	DMIDPTCQPIJYFE-UHFFFAOYSA-N	O=C(NCC(=O)N1CCCC1)Nc1ccc2cnccc2c1	1687736-54-4	protein arginine methyltransferase 3 inhibitor;PRMT3 inhibitor	PRMT3																																																															CHEMBL4072005											90642938					member	10.1002/anie.201412154																																																																																																																																																															29244490																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.77376																																0.22172																																8																																HY-19715	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:6578|PRMT3|protein arginine methyltransferase 3 inhibitor;PRMT3 inhibitor	O=C(NCC(=O)N1CCCC1)Nc2ccc3cnccc3c2	1687736-54-4	19747	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469254	298.33972	SGC-707	SGC-707 | SGC-707	Pathway: Epigenetics	Research Area: Cancer	MOABOX:6578	PRMT3	protein arginine methyltransferase 3 inhibitor;PRMT3 inhibitor
SJ001035215-1	SJ001035215	1	MOABOX:6579	UFAFCKVYKJIJTR-INIZCTEOSA-N	COc1cc(C(=O)O)c(NC(=O)N[C@@H](C)c2ccccc2OC)cc1OCCCC(C)C		C5 complement protein inhibitor	C5																																																																										138059708					member	10.1038/s41589-019-0303-9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.13344																																-0.01668																																8																																HY-128342	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Inflammation/Immunology|MOABOX:6579|C5|C5 complement protein inhibitor	COc1cc(C(=O)O)c(NC(=O)N[C@@H](C)c2ccccc2OC)cc1OCCCC(C)C	2365402-67-9	64161	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469155	444.52068	COMPLEMENT C5-IN-1	COMPLEMENT C5-IN-1 | COMPLEMENT C5-IN-1	Pathway: Immunology/Inflammation	Research Area: Inflammation/Immunology	MOABOX:6579	C5	C5 complement protein inhibitor
SJ000982876-2	SJ000982876	2	MOABOX:6588	CZCUSHJQJWKYTD-UHFFFAOYSA-N	Cc1nccc(-c2cn(Cc3ccccc3)c3cnccc23)n1		Dyrk1 inhibitor	DYRK1B																																																															CHEMBL3421980											118735338					member	10.1021/acs.jmedchem.5b00098)																																																																																																																																																															25738750																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.38696																																0.29837																																8																																5632	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-162-826|MOABOX:6588|DYRK1B|Dyrk1 inhibitor	Cc1nccc(n1)c2cn(Cc3ccccc3)c4cnccc24	1679330-37-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468233	300.35714	AZDYRK1B33	AZDYRK1B33 | AZDYRK1B33			MOABOX:6588	DYRK1B	Dyrk1 inhibitor
SJ001034919-1	SJ001034919	1	MOABOX:6589	VWWVDRUMIVMLNJ-HNNXBMFYSA-N	CCCn1c(NC(=O)[C@H]2CCCN(c3cnccn3)C2)nc2ccccc21		Selective allosteric inhibitor for HSPA1A/Hsp70i	HSPA1A																																																																										40009526					member	10.1016/j.chembiol.2014.10.016																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																Z324738070	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-009-266-086|MOABOX:6589|HSPA1A|Selective allosteric inhibitor for HSPA1A/Hsp70i	CCCn1c(NC(=O)C2CCCN(C2)c3cnccn3)nc4ccccc14	1118861-60-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468236	364.44416	Z324738070	Z324738070 | Z324738070			MOABOX:6589	HSPA1A	Selective allosteric inhibitor for HSPA1A/Hsp70i
SJ000865780-6	SJ000865780	6	MOABOX:6590	LVDRREOUMKACNJ-BKMJKUGQSA-N	Cc1cc(=O)n(C)c2cc(N3C(=O)CC[C@H](NS(=O)(=O)CC(C)C)[C@H]3c3ccc(Cl)cc3)ccc12	1808951-93-0	BRD7/9 inhbitor;BRD9 inhibitor;BRD7/9 Bromodomain Inhibitor	BRD7	BRD9																															65980																															CHEMBL3753082											91827372					member	10.1002/anie.201501394																																																																																																																																																															26572217	26914985	27120693	30824168																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		-0.25096	2.6492																															-0.03137	0.33115																															8	8																															5496	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-727-599|MOABOX:6590|BRD7|BRD7/9 inhbitor;BRD9 inhibitor;BRD7/9 Bromodomain Inhibitor	CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c2ccc(Cl)cc2)c3ccc4C(=CC(=O)N(C)c4c3)C	1808951-93-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468226	516.0521	LP-99	LP-99 | LP-99			MOABOX:6590	BRD7	BRD7/9 inhbitor;BRD9 inhibitor;BRD7/9 Bromodomain Inhibitor
SJ000067307-4	SJ000067307	4	MOABOX:6591	LTUGYAOMCKNTGG-UHFFFAOYSA-N	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(C)c(=O)n2C	901245-65-6	BRPF1 inhbitor;BRPF1 inhibitor	BRPF1																																																															CHEMBL1522313											15990224					member																																																																																																																																																																25408830	26572217	27326325																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.21144																																0.27643																																8																																HY-18665	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:6591|BRPF1|BRPF1 inhbitor;BRPF1 inhibitor	COc1ccccc1C(=O)Nc2cc3N(C)C(=O)N(C)c3cc2N4CCCCC4	901245-65-6	17651	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468765	394.46684	GSK-5959	GSK-5959 | GSK-5959	Pathway: Epigenetics	Research Area: Cancer	MOABOX:6591	BRPF1	BRPF1 inhbitor;BRPF1 inhibitor
SJ000862686-2	SJ000862686	2	MOABOX:6592	YUNQZQREIHWDQT-UHFFFAOYSA-N	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C	919973-83-4	BRPF1B and BRPF2 inhibitor	BRPF1	BRD1																															23774																															CHEMBL3770173											35397514	131721282	131738235			member																																																																																																																																																																25974391	26572217	28402630																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.90688	-0.166																															0.23836	-0.02075																															8	8																															HY-12518	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:6592|BRPF1|BRPF1B and BRPF2 inhibitor	COc1cc2N(C)C(=O)N(C)c2cc1NS(=O)(=O)c3ccc(Br)cc3C	919973-83-4	14717	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468831	440.31152	OF 1	OF 1 | OF 1	Pathway: Epigenetics	Research Area: Cancer	MOABOX:6592	BRPF1	BRPF1B and BRPF2 inhibitor
SJ000870728-2	SJ000870728	2	MOABOX:6593	XVECNLUKQDKOST-UHFFFAOYSA-N	CCCS(=O)(=O)c1nc(NC2CC2)cc(-c2ccc3c(ccn3C3CC(C)(C)NC(C)(C)C3)c2)n1		CECR2 inhibitor;CECR2 inhbitor	CECR2																																																															CHEMBL3785432											117072550					member																																																																																																																																																																26572217	28740608																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.39352																																0.17419																																8																																18316	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-624-562|MOABOX:6593|CECR2|CECR2 inhibitor;CECR2 inhbitor	CCCS(=O)(=O)c1nc(NC2CC2)cc(n1)c3ccc4c(ccn4C5CC(C)(C)NC(C)(C)C5)c3	1992047-61-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468471	495.67998	NVS-CECR2-1	NVS-CECR2-1 | NVS-CECR2-1			MOABOX:6593	CECR2	CECR2 inhibitor;CECR2 inhbitor
SJ000843883-6	SJ000843883	6	MOABOX:6595	IQCKJUKAQJINMK-HUBRGWSESA-N	CC(C)N(CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)C[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O	1561178-17-3	Dot1L inhibitor	DOT1L																																																															CHEMBL3087498											56962337					member																																																																																																																																																																23250418	23879463	24300735	25406853	26914852	27485386																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																3.68424																																0.46053																																8																																HY-15650	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:6595|DOT1L|Dot1L inhibitor	CC(C)N(CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cc(Br)c4c(N)ncnc34	1561178-17-3	58947	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468923	618.5657	SGC0946	SGC0946 | SGC 0946 | SGC0946 | SGC 0946	Pathway: Epigenetics	Research Area: Cancer	MOABOX:6595	DOT1L	Dot1L inhibitor
SJ000546522-2	SJ000546522	2	MOABOX:6597	KDDXOGDIPZSCTM-UHFFFAOYSA-N	COC(=O)c1csc(C(=O)c2c[nH]c3ccccc23)n1	448906-42-1	Aryl Hydrocarbon Receptor (AhR) Ligands	AHR																																																															CHEMBL1324296											4668801	142391653				member	10.1016/j.jsbmb.2007.10.001																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.24696																																0.03087																																8																																HY-19317	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Inflammation/Immunology; Cancer|MOABOX:6597|AHR|Aryl Hydrocarbon Receptor (AhR) Ligands	COC(=O)c1csc(n1)C(=O)c2c[nH]c3ccccc23	448906-42-1	18444	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468907	286.3058	ITE	ITE | ITE	Pathway: Immunology/Inflammation	Research Area: Inflammation/Immunology; Cancer	MOABOX:6597	AHR	Aryl Hydrocarbon Receptor (AhR) Ligands
SJ000565611-3	SJ000565611	3	MOABOX:6599	BGFHMYJZJZLMHW-UHFFFAOYSA-N	CC(C)n1cnc2c(NCCc3ccc(O)cc3)nc(-c3csc4ccccc34)nc21	1227633-49-9	Stem cell expansion;Aryl hydrocarbon receptor antagonist	AHR																																																																										46199207	86280697	89928937			virtual	10.1126/science.1191536																																																																																																																																																															20688981																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.9656																																0.2457																																8																																HY-15001	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Cancer|MOABOX:6599|AHR|Stem cell expansion;Aryl hydrocarbon receptor antagonist	CC(C)n1cnc2c(NCCc3ccc(O)cc3)nc(nc12)c4csc5ccccc45	1227633-49-9	9898	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468863	429.53732	SR1	SR1 | STEMREGENIN 1 (SR1) | SR1 | STEMREGENIN 1 (SR1)	Pathway: Immunology/Inflammation	Research Area: Cancer	MOABOX:6599	AHR	Stem cell expansion;Aryl hydrocarbon receptor antagonist
SJ000869993-2	SJ000869993	2	MOABOX:6600	NKUDGJUBIVEDTF-FYJGNVAPSA-N	C/C(=N\NC(=O)c1cccc(S(=O)(=O)N2CCOCC2)c1)c1cc(Cl)ccc1O	1423715-09-6	KDM1A (LSD1) inhibitor;KDM1A inhibitor	KDM1A																																																															CHEMBL3104250											135743577					virtual																																																																																																																																																																24237195	27524309	29037950	29247860	30739825																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	3.54496																																0.44312																																8																																HY-12635	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Epigenetics | Research Area: Cancer|MOABOX:6600|KDM1A|KDM1A (LSD1) inhibitor;KDM1A inhibitor	C\C(=N/NC(=O)c1cccc(c1)S(=O)(=O)N2CCOCC2)\c3cc(Cl)ccc3O	1423715-09-6	15043	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469815	437.8972	SP-2509	SP-2509 | SP-2509	Pathway: Apoptosis; Epigenetics	Research Area: Cancer	MOABOX:6600	KDM1A	KDM1A (LSD1) inhibitor;KDM1A inhibitor
SJ000826828-4	SJ000826828	4	MOABOX:6602	LQPGVGSKBNXQDU-UHFFFAOYSA-N	CCOC(=O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2cccnc2)n1	1394854-51-3	KDM6 inhibitor	KDM6A	UTY	KDM6B																														7404	23135																																									78243729	126456082				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0																														0.0	0.0	0.0																														7	7	7																														12074	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-561-130|MOABOX:6602|KDM6A|KDM6 inhibitor	CCOC(=O)CCNc1cc(nc(n1)c2cccnc2)N3CCc4ccccc4CC3	1797983-32-4	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468335	417.50348	GSK-J5	GSK-J5 | GSK-J5			MOABOX:6602	KDM6A	KDM6 inhibitor
SJ001035348-1	SJ001035348	1	MOABOX:6603	FUGQNAUKABUDQI-UHFFFAOYSA-N	CC(C)c1cc2c(N3CCN(C4=NCC(C)(C)S4)CC3)ncnc2s1	1271738-59-0	Inhibitor of MEN1 (Menin);MEN1 inhibitor	MEN1																																																															CHEMBL3696180											51001299					member																																																																																																																																																																22286128																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.31192																																-0.03899																																8																																HY-15223	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Epigenetics | Research Area: Cancer|MOABOX:6603|MEN1|Inhibitor of MEN1 (Menin);MEN1 inhibitor	CC(C)c1cc2c(ncnc2s1)N3CCN(CC3)C4=NCC(C)(C)S4	1271738-59-0	6400	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469665	375.5546	MI-3 | MENIN-MLL INHIBITOR 3	"""MI-3 | MENIN-MLL INHIBITOR 3"" | ""MI-3 | MENIN-MLL INHIBITOR 3"""	Pathway: Apoptosis; Epigenetics	Research Area: Cancer	MOABOX:6603	MEN1	Inhibitor of MEN1 (Menin);MEN1 inhibitor
SJ000785890-4	SJ000785890	4	MOABOX:6605	HEKJYZZSCQBJGB-UNOMPAQXSA-N	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)/C1=C\c1ccc(-c2cc(C)c(C)cc2[N+](=O)[O-])o1	328968-36-1	CBP;CBP/p300 inhibitor	CREBBP	EP300																															2033																															CHEMBL1797936											1285941					virtual																																																																																																																																																																20534345	21316248	22039877	22234972	26701186	26985290	28686912	30973727																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														0.25823	2.16128																															0.03689	0.27016																															7	8																															HY-13823	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Epigenetics | Research Area: Cancer|MOABOX:6605|CREBBP|CBP;CBP/p300 inhibitor	CC1=NN(C(=O)/C/1=C/c2oc(cc2)c3cc(C)c(C)cc3[N+](=O)[O-])c4ccc(cc4)C(=O)O	328968-36-1	15270	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469465	445.42416	C 646	C 646 | C 646	Pathway: Apoptosis; Autophagy; Epigenetics	Research Area: Cancer	MOABOX:6605	CREBBP	CBP;CBP/p300 inhibitor
SJ001034646-1	SJ001034646	1	MOABOX:6607	OBTSACXGWYGCPK-UHFFFAOYSA-N	O=C(Nc1cc(O)cc(-c2cccs2)c1)Nc1ccc2ccccc2c1	1680196-54-6	frizzled-4 anatagonist	FZD4																																																																										90478321					member	10.1038/nchembio.1770																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																AS-16918	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Oc1cc(NC(=O)Nc2ccc3ccccc3c2)cc(c1)c4cccs4	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466662	360.42894	AS-16918	AS-16918 | AS-16918			MOABOX:6607	FZD4	frizzled-4 anatagonist
SJ001035035-1	SJ001035035	1	MOABOX:6608	HMKZVAZQKOKXRZ-UHFFFAOYSA-N	O=S(=O)(Nc1cc(Cl)cc(Cl)c1)c1ccccc1	54129-15-6	Dedicator of cytokenesis protein 5 inhibitor	DOCK5																																																																										4985978	137528322	137528332	137528339		member	10.1038/ncomms7218																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																AN-652/11634462	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-194-019|MOABOX:6608|DOCK5|Dedicator of cytokenesis protein 5 inhibitor	Clc1cc(Cl)cc(NS(=O)(=O)c2ccccc2)c1	54129-15-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468523	302.17636	AN-652/11634462	AN-652/11634462 | AN-652/11634462			MOABOX:6608	DOCK5	Dedicator of cytokenesis protein 5 inhibitor
SJ000870790-2	SJ000870790	2	MOABOX:6610	BVQCFCYPFJOOAV-UHFFFAOYSA-N	CCCCNNC(=O)c1ccc(Br)cc1	537672-41-6	HDAC3 gene inhibitor	HDAC1	HDAC2	HDAC3																														3066	8841																																									4596836					member																																																																																																																																																																25699604	31201063																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.56424	0.84344	1.57888																														0.07053	0.10543	0.19736																														8	8	8																														HY-18976	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:6610|HDAC1|HDAC3 gene inhibitor	CCCCNNC(=O)c1ccc(Br)cc1	537672-41-6	18745	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469062	271.1536	UF-010 | UF010 | UF 010 | RLS-2-134	"""UF-010 | UF010 | UF 010 | RLS-2-134"" | ""UF-010 | UF010 | UF 010 | RLS-2-134"""	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:6610	HDAC1	HDAC3 gene inhibitor
SJ000841737-3	SJ000841737	3	MOABOX:6614	ARJCBSRIPGJMAD-LLVKDONJSA-N	NC(=O)c1noc([C@H](CCCC2CCCCC2)CC(=O)NO)n1	348622-88-8	Inhibitor of the BMP1/TLL1/TLL2 family of Proteases	BMP1																																																															CHEMBL226630											9818682	86583700				member	10.1002/2211-5463.12540	10.1016/j.bmcl.2008.10.036	10.1021/jm061010z																																																																																																																																																													17591762	18945617																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.96976																																0.37122																																8																																HY-13102	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Others|MOABOX:6614|BMP1|Inhibitor of the BMP1/TLL1/TLL2 family of Proteases	NC(=O)c1noc(n1)[C@H](CCCC2CCCCC2)CC(=O)NO	348622-88-8	81194	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469555	324.37546	UK 383367	UK 383367 | UK 383367	Pathway: Metabolic Enzyme/Protease	Research Area: Others	MOABOX:6614	BMP1	Inhibitor of the BMP1/TLL1/TLL2 family of Proteases
SJ001033583-2	SJ001033583	2	MOABOX:6619	QZXVLRCMAHJVIP-UHFFFAOYSA-N	CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21	920022-47-5	human vasopressin 1a (hV1a) receptor antagonist	AVPR1A																																																															CHEMBL3416885											59657596					virtual	10.1021/jm501745f																																																																																																																																																															25654260	28001064																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.22416																																0.40302																																8																																HY-12981	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Neurological Disease; Endocrinology|MOABOX:6619|AVPR1A|human vasopressin 1a (hV1a) receptor antagonist	CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc4ccccc34)c5ccc(Cl)cc15	920022-47-5	26831	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468926	437.96172	RG7713; RO5028442	RG7713; RO5028442 | RG7713; RO5028442	Pathway: GPCR/G Protein	Research Area: Neurological Disease; Endocrinology	MOABOX:6619	AVPR1A	human vasopressin 1a (hV1a) receptor antagonist
SJ000870724-3	SJ000870724	3	MOABOX:6624	OINGHOPGNMYCAB-INIZCTEOSA-N	CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1		PAK1 inhibitor	PAK1																																																															CHEMBL3609372											137125241					member																																																																																																																																																																26191365																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.37512																																0.42189																																8																																CS-6916	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-162-893|MOABOX:6624|PAK1|PAK1 inhibitor	CC(C)NC(=O)N1CC[C@@H](C1)NC2=Nc3cc(F)ccc3N(CC(F)F)c4ccc(Cl)cc24	1783816-74-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468170	479.92571	NVS-PAK1-1	NVS-PAK1-1 | NVS-PAK1-1			MOABOX:6624	PAK1	PAK1 inhibitor
SJ000862684-4	SJ000862684	4	MOABOX:6642	ZKXZLIFRWWKZRY-KRWDZBQOSA-N	O=C(NC[C@H](O)CN1CCc2ccccc2C1)c1cc(NC2COC2)ncn1	1616391-65-1	SAM-cooperative (uncompetitive) inhibition of methyltransferase function;Epizyme SAM cooperative PRMT5 inhibitor (aka EPZ01566 / GSK3235025);PRMT5 gene inhibitor	PRMT5																																																															CHEMBL4060831											90241673					member	10.1007/s10822-019-00214-y																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.79392																																0.34924																																8																																HY-12727	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:6642|PRMT5|SAM-cooperative (uncompetitive) inhibition of methyltransferase function;Epizyme SAM cooperative PRMT5 inhibitor (aka EPZ01566 / GSK3235025);PRMT5 gene inhibitor	O[C@@H](CNC(=O)c1cc(NC2COC2)ncn1)CN3CCc4ccccc4C3	1616391-65-1	16637	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469770	383.4442	EPZ015666	EPZ015666 | GSK-3235025 | EPZ015666 | GSK-3235025	Pathway: Epigenetics	Research Area: Cancer	MOABOX:6642	PRMT5	SAM-cooperative (uncompetitive) inhibition of methyltransferase function;Epizyme SAM cooperative PRMT5 inhibitor (aka EPZ01566 / GSK3235025);PRMT5 gene inhibitor
SJ000784255-5	SJ000784255	5	MOABOX:6646	JWOGUUIOCYMBPV-GMFLJSBRSA-N	CCC(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCCN2C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC1=O	183506-66-3	HDAC inhibitor	HDAC3	HDAC4																															9759																															CHEMBL430060											6918328	69987972	88089910	137523486	137523828	virtual	10.1016/j.bmc.2017.02.020	10.1016/j.bmcl.2017.06.027	10.1016/j.lfs.2008.03.004	10.1021/jm900850t	10.1021/ml300162r	10.1042/BJ20070779																																																																																																																																																										11124001	11206439	14613312	17956988	18308563	18430569	19705846	19751207	20139990	20472442	21984958	23276137	24900543	28648462																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								0.59144	0.45856																															0.07393	0.05732																															8	8																															HY-N6735	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer; Infection|MOABOX:6646|HDAC3|HDAC inhibitor	CC[C@H](C)C1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]4CCCCN4C1=O	183506-66-3	87580	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468989	623.78276	APICIDIN	APICIDIN | OSI-2040 | APICIDIN | OSI-2040	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer; Infection	MOABOX:6646	HDAC3	HDAC inhibitor
SJ001035085-1	SJ001035085	1	MOABOX:6656	JLSVDPQAIKFBTO-AYGDVHJDSA-N	COc1cc(=O)oc(/C=C/C=C/C=C/C(C)=C/[C@@]2(C)O[C@@H](C)[C@@](C)(O)[C@@H]2O)c1C	25425-12-1	Inhibitor of mitochondrial ATPase	ATP5F1B																																																																										12303281					member	10.1042/bj1700503																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																AA00C36V	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-336-887|MOABOX:6656|ATP5F1B|Inhibitor of mitochondrial ATPase	COC1=CC(=O)OC(=C1C)\C=C\C=C\C=C\C(=C\C2(C)OC(C)C(C)(O)C2O)\C	25425-12-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468635	402.4807	CITREOVIRIDIN	CITREOVIRIDIN | CITREOVIRIDIN			MOABOX:6656	ATP5F1B	Inhibitor of mitochondrial ATPase
SJ000534770-12	SJ000534770	12	MOABOX:6676	RTKIYFITIVXBLE-WKWSCTOISA-N	CC(/C=C/C(=O)NO)=C\C(C)C(=O)c1ccc(N(C)C)cc1	1208356-08-4	HDAC inhibitor	HDAC1	HDAC3	HDAC4	HDAC6	HDAC10																												8841	9759	10013	83933																												CHEMBL26159											6376322	9919462	144125784			virtual	10.1002/cmdc.201300372	10.1016/S0960-894X(01)00552-2	10.1016/j.bmc.2011.06.030	10.1016/j.bmcl.2004.08.016	10.1016/j.bmcl.2008.12.045	10.1016/j.bmcl.2009.02.029	10.1016/j.bmcl.2010.09.100	10.2174/1568011043352948																																																																																																																																																								15134505	15454224	16165353	18212103	19285395	20947351	21723733	24285590																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														1.56024	0.4576	-2.032e-002	5.232e-002	0.258																												0.19503	0.0572	-0.00254	0.00654	0.03225																												8	8	8	8	8																												T6270	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-959-819|MOABOX:6676|HDAC1|HDAC inhibitor	C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C	58880-19-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468163	302.36818	TRICHOSTATIN A	"TRICHOSTATIN A | ""TRICHOSTATIN A | TSA | TRICOSTATIN A |"" | TRICHOSTATIN A (TSA) | TRICHOSTATIN A | ""TRICHOSTATIN A | TSA | TRICOSTATIN A |"" | TRICHOSTATIN A (TSA)"			MOABOX:6676	HDAC1	HDAC inhibitor
SJ000285335-23	SJ000285335	23	MOABOX:6679	JXLYSJRDGCGARV-CFWMRBGOSA-N	CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1	132142-72-4	Tubulin modulator;Microtubule assembly inhibitor	TUBB																																																															CHEMBL159	CHEMBL378544										13342	5388983	24881112	51039257	66863080	virtual	10.1016/j.ejmech.2018.11.004																																																																																																																																																															2066973	15566300	16279766	20546980																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.23216																																0.02902																																8																																T1668	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-052-360|MOABOX:6679|TUBB|Tubulin modulator;Microtubule assembly inhibitor	CC[C@]1(O)CC2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1	143-67-9	NA	GENERAL	SULFATE	1	NO_SOLVATE	0	1468139	810.97412	VINBLASTINE	VINBLASTINE | NSC-49842 | 29060-LE | VINBLASTINE SULFATE | VINBLASTINE | NSC-49842 | 29060-LE | VINBLASTINE SULFATE			MOABOX:6679	TUBB	Tubulin modulator;Microtubule assembly inhibitor
SJ000288244-28	SJ000288244	28	MOABOX:6679	JXLYSJRDGCGARV-CFWMRBGOSA-N	CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1	132142-72-4	Tubulin modulator;Microtubule assembly inhibitor	TUBB																																																															CHEMBL159	CHEMBL378544										13342	5388983	24881112	51039257	66863080	virtual	10.1016/j.ejmech.2018.11.004																																																																																																																																																															2066973	15566300	16279766	20546980																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.23216																																0.02902																																8																																11764	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-939-859|MOABOX:6679|TUBB|Tubulin modulator;Microtubule assembly inhibitor	CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C=O)C7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1	2068-78-2	NA	GENERAL	SULFATE	1	NO_SOLVATE	0	1468647	824.95764	VINCRISTINE	VINCRISTINE | ONCOVIN | VINCRISTINE SULFATE | NSC-67574 | VINCRISTINE | ONCOVIN | VINCRISTINE SULFATE | NSC-67574			MOABOX:6679	TUBB	Tubulin modulator;Microtubule assembly inhibitor
SJ001033452-2	SJ001033452	2	MOABOX:6699	IWXUVYOOUMLUTQ-CZUORRHYSA-N	C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1nc2c(cnn2C2CCOCC2)c(=O)[nH]1	1082744-20-4	PDE9A gene inhibitor	PDE9A																																																															CHEMBL2179105											135564558					member	10.1021/jm3007799																																																																																																																																																															22780914	25532473	26908025																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.49968																																0.43746																																8																																HY-15441	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Neurological Disease|MOABOX:6699|PDE9A|PDE9A gene inhibitor	C[C@@H]1CN(Cc2ncccn2)C[C@H]1C3=Nc4c(cnn4C5CCOCC5)C(=O)N3	1082744-20-4	12115	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469012	395.4582	PF-04447943	PF-04447943 | PF-04447943	Pathway: Metabolic Enzyme/Protease	Research Area: Neurological Disease	MOABOX:6699	PDE9A	PDE9A gene inhibitor
SJ000862663-2	SJ000862663	2	MOABOX:6706	PSOXOVKYGWBTPB-UHFFFAOYSA-N	Cc1cc(C)c(S(=O)(=O)N(Cc2ccc(-c3cccc(S(C)(=O)=O)c3)cc2)Cc2ccc(C(F)(F)F)o2)c(C)c1	1221277-90-2	"LXRb antagonist, requested for use by Pierre Saint-Mezzard"	NR1H2																																																															CHEMBL1093266											46203250					virtual																																																																																																																																																																20345102	24832115																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.45																																0.30625																																8																																HY-108688	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:6706|NR1H2|LXRb antagonist, requested for use by Pierre Saint-Mezzard"	Cc1cc(C)c(c(C)c1)S(=O)(=O)N(Cc2oc(cc2)C(F)(F)F)Cc3ccc(cc3)c4cccc(c4)S(=O)(=O)C	1221277-90-2	28434	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469845	591.66153	GSK-2033	GSK-2033 | GSK-1440233A | GSK-2033 | GSK-1440233A	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:6706	NR1H2	"LXRb antagonist, requested for use by Pierre Saint-Mezzard"
SJ000870752-2	SJ000870752	2	MOABOX:6707	XQFINGFCBFHOPE-WXUXXXNLSA-N	CCN(c1cc(C#CCN2CCOCC2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)[C@H]1CC[C@H](N(C)CCOC)CC1	1598383-40-4	EZH2 inhibitor	EZH2																																																															CHEMBL3672841																virtual	10.1021/acsmedchemlett.5b00037																																																																																																																																																															26005520																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.69896																																0.46237																																8																																HY-16986	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:6707|EZH2|EZH2 inhibitor	CCN([C@@H]1CC[C@H](CC1)N(C)CCOC)c2cc(cc(C(=O)NCC3=C(C)C=C(C)NC3=O)c2C)C#CCN4CCOCC4	1598383-40-4	19557	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469173	605.81054	EPZ-011989	"EPZ-011989 | ""EPZ011989 | EPZ-011989 | EPZ 011989"" | EPZ-011989 | ""EPZ011989 | EPZ-011989 | EPZ 011989"""	Pathway: Epigenetics	Research Area: Cancer	MOABOX:6707	EZH2	EZH2 inhibitor
SJ000879498-3	SJ000879498	3	MOABOX:6710	SOYCFODXNRVBTI-UHFFFAOYSA-N	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1	1235034-55-5	Bcl2l1 inhibitor	BCL2L1																																																															CHEMBL3342332											59447577	139025440				member																																																																																																																																																																25313317	26988306																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.70264																																0.46283																																8																																HY-19725	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis | Research Area: Cancer|MOABOX:6710|BCL2L1|Bcl2l1 inhibitor	CN(C)CC#Cc1ccc(OCCCc2sc(nc2C(=O)O)N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)c(F)c1	1235034-55-5	23006	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468857	669.78808	A-1155463	A-1155463 | A-1155463	Pathway: Apoptosis	Research Area: Cancer	MOABOX:6710	BCL2L1	Bcl2l1 inhibitor
SJ001035226-1	SJ001035226	1	MOABOX:6712	DYGBNAYFDZEYBA-UHFFFAOYSA-N	COc1ccc(C(=O)C2CCN(CC(=O)N(Cc3nc4c(c(=O)[nH]3)COCC4)CC3CC3)CC2)cc1	1419949-20-4	Tankyrase 1 (TNKS1;PARP5A) Inhibitors;Tankyrase 2 (TNKS2;PARP5B) Inhibitors	TNKS	TNKS2																															80351																															CHEMBL2419706											136237316					member																																																																																																																																																																23844574	24054120																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.6892	2.05696																															0.08615	0.25712																															8	8																															HY-13990	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:6712|TNKS|Tankyrase 1 (TNKS1;PARP5A) Inhibitors;Tankyrase 2 (TNKS2;PARP5B) Inhibitors	COc1ccc(cc1)C(=O)C2CCN(CC(=O)N(CC3CC3)CC4=NC5=C(COCC5)C(=O)N4)CC2	1419949-20-4	13130	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469182	494.58266	NVP-TNKS656 | TNKS656	"""NVP-TNKS656 | TNKS656"" | ""NVP-TNKS656 | TNKS656"""	Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:6712	TNKS	Tankyrase 1 (TNKS1;PARP5A) Inhibitors;Tankyrase 2 (TNKS2;PARP5B) Inhibitors
SJ000833871-6	SJ000833871	6	MOABOX:6713	FKSFKBQGSFSOSM-QFIPXVFZSA-N	CC[C@H](C)n1cc(C)c2c(C(=O)NCc3c(C)cc(C)[nH]c3=O)cc(-c3ccc(N4CCNCC4)nc3)cc21	1346574-57-9	PRC2/EZH2;EZH2 gene inhibitor	EZH2																																																															CHEMBL3287735											68210102	137347167	144909323			virtual	10.1016/j.bmcl.2014.04.010	10.1038/nm.3799																																																																																																																																																														24767850	25406853	25923513	26189078																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		4.08272																																0.51034																																8																																HY-13470	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:6713|EZH2|PRC2/EZH2;EZH2 gene inhibitor	CC[C@H](C)n1cc(C)c2c(cc(cc12)c3ccc(nc3)N4CCNCC4)C(=O)NCC5=C(C)C=C(C)NC5=O	1346574-57-9	39829	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469466	526.67242	GSK126	GSK126 | GSK126	Pathway: Epigenetics	Research Area: Cancer	MOABOX:6713	EZH2	PRC2/EZH2;EZH2 gene inhibitor
SJ000796118-2	SJ000796118	2	MOABOX:6716	SAKOXVNKDMWWLF-UHFFFAOYSA-N	Nc1[nH]c(=S)[nH]c(=O)c1N=Cc1ccccc1	64232-83-3	DNA ligase inhibitor	LIG1	LIG3	LIG4																														3980	3981																																														virtual	10.1158/0008-5472																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0	0																														0.0	0.0	0.0																														7	7	7																														HY-15588	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:6716|LIG1|DNA ligase inhibitor	Nc1nc(S)nc(O)c1\N=C\c2ccccc2	64232-83-3	17811	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469589	246.2883	L189	L189 | L189	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:6716	LIG1	DNA ligase inhibitor
SJ001035292-1	SJ001035292	1	MOABOX:6718	AWOPBSAJHCUSAS-UHFFFAOYSA-N	CN(C)C(=O)Nc1cccc(-c2ccc(N(C)C)cc2)c1	1469924-27-3	Patatin like phospholipase protein inhibitor	PNPLA2																																																															CHEMBL3823931											71699712	132274338				member																																																																																																																																																																24096302	27155760																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.44048																																0.30506																																8																																HY-15859	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:6718|PNPLA2|Patatin like phospholipase protein inhibitor	CN(C)C(=O)Nc1cccc(c1)c2ccc(cc2)N(C)C	1469924-27-3	11458	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469518	283.36814	ATGLISTATIN	ATGLISTATIN | ATGLISTATIN	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:6718	PNPLA2	Patatin like phospholipase protein inhibitor
SJ000285925-11	SJ000285925	11	MOABOX:6721	TZFNLOMSOLWIDK-JTQLQIEISA-N	C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O	1426847-87-1	Dopa decarboxylase inhibitor	DDC																																																															CHEMBL1200748	CHEMBL1201236										34359	38101	104778	9824377	9866962	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																AS-16862	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466842	226.22916	CARBIDOPA	CARBIDOPA | S-(-)-CARBIDOPA | CARBIDOPA | S-(-)-CARBIDOPA			MOABOX:6721	DDC	Dopa decarboxylase inhibitor
SJ001033476-2	SJ001033476	2	MOABOX:6722	FQVLRGLGWNWPSS-BXBUPLCLSA-N	CC(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O	229971-81-7	N-cadherin Inhibitor	CDH2																																																															CHEMBL3818130											9916058	24203776				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-13541A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:6722|CDH2|N-cadherin Inhibitor	CC(C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N)NC(=O)C	1135237-88-5	14478	GENERAL	"2,2,2-TRIFLUOROACETATE"	1	NO_SOLVATE	0	1469611	570.68536	ADH-1 (TRIFLUOROACETATE)	ADH-1 (TRIFLUOROACETATE) | ADH-1 (TRIFLUOROACETATE)	Pathway: Others	Research Area: Cancer	MOABOX:6722	CDH2	N-cadherin Inhibitor
SJ000832271-4	SJ000832271	4	MOABOX:6725	WHSIXKUPQCKWBY-IOSLPCCCSA-N	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	24386-93-4	Adenosine kinase inhibitor	ADK	AK1	AK2	AK4	AK5	AK3	AK7	AK8	AK6																								203	204	205	26289	50808	122481	158067	102157402																								CHEMBL99203											97297					virtual	10.1021/acs.jmedchem.6b00689	10.1021/jm00074a024																																																																																																																																																														8230132	10956196	11958989	14561094	16190769	16620788	18077363	21291368	27410258	27595538																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												0.13904	0.3892	0.3892	0.3892	0.3892	0.3892	0.3892	0.40446	0.19712																								0.01738	0.0556	0.0556	0.0556	0.0556	0.0556	0.0556	0.05778	0.02816																								8	7	7	7	7	7	7	7	7																								HY-15424	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Cancer|MOABOX:6725|ADK|Adenosine kinase inhibitor	Nc1ncnc2c1c(I)cn2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O	24386-93-4	12956	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469166	392.14979	5-IODOTUBERICIDIN	5-IODOTUBERICIDIN | 5-IODOTUBERICIDIN	Pathway: Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Cancer	MOABOX:6725	ADK	Adenosine kinase inhibitor
SJ000290192-2	SJ000290192	2	MOABOX:6726	SMGZHCSEIBBFEJ-UHFFFAOYSA-N	Cc1nc2ccccc2n1S(=O)(=O)c1ccc(F)cc1	324777-01-7	Aldehyde dehydrogenase 3 inhibitor	ALDH3A1																																																															CHEMBL1378094											804705					member	10.1021/jm401508p																																																																																																																																																															24387105																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.52464																																0.19058																																8																																STK416816	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-491-609|MOABOX:6726|ALDH3A1|Aldehyde dehydrogenase 3 inhibitor	Cc1nc2ccccc2n1S(=O)(=O)c3ccc(F)cc3	324777-01-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468189	290.31274					MOABOX:6726	ALDH3A1	Aldehyde dehydrogenase 3 inhibitor
SJ000285604-6	SJ000285604	6	MOABOX:6728	MBGGBVCUIVRRBF-UHFFFAOYSA-N	O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1	57-96-5	URAT1 Inhibitors;OAT4 Inhibitors;Multidrug resistance-associated protein inhibitors	ABCC2	ABCC1	SLC22A1	SLC22A12																													4363	6580	116085																													CHEMBL832											5342	68755977	70187242	87244317	87431887	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	-9.646e-002	-0.3465	0																													0.0	-0.01378	-0.0495	0.0																													7	7	7	7																													HY-B1271	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Inflammation/Immunology|MOABOX:6728|ABCC2|URAT1 Inhibitors;OAT4 Inhibitors;Multidrug resistance-associated protein inhibitors	O=C1C(CCS(=O)c2ccccc2)C(=O)N(N1c3ccccc3)c4ccccc4	57-96-5	63993	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468931	404.4815	SULFINPYRAZONE	"SULFINPYRAZONE | ""SULFINPYRAZONE | SULPHINPYRAZONE |"" | SULFINPYRAZONE | ""SULFINPYRAZONE | SULPHINPYRAZONE |"""	Pathway: Others	Research Area: Inflammation/Immunology	MOABOX:6728	ABCC2	URAT1 Inhibitors;OAT4 Inhibitors;Multidrug resistance-associated protein inhibitors
SJ000840369-3	SJ000840369	3	MOABOX:6743	FRPJSHKMZHWJBE-UHFFFAOYSA-N	O=C(Nc1ccncc1)c1cc([N+](=O)[O-])ccc1Cl	313516-66-4	PPARgamma antagonist	PPARG																																																															CHEMBL510698											2777391	17848001				member																																																																																																																																																																11877444	15003718	17045164	18329752																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		3.53672																																0.44209																																8																																HY-13202	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:6743|PPARG|PPARgamma antagonist	[O-][N+](=O)c1ccc(Cl)c(c1)C(=O)Nc2ccncc2	313516-66-4	4465	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469886	277.66322	T 0070907	T 0070907 | T0070907 | T 0070907 | T0070907	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:6743	PPARG	PPARgamma antagonist
SJ000870520-3	SJ000870520	3	MOABOX:6745	QMDKVNSQXPVCRD-RQNOJGIXSA-N	CNCCN(C)Cc1c[nH]nc1-c1ccc(O[C@H]2C[C@H](OCCC3CCOCC3)C2)cc1		PRMT6 inhibitor;PRMT6 gene inhibitor	PRMT6																																																															CHEMBL3589039																member	10.1021/acsmedchemlett.5b00071																																																																																																																																																															26101569	27584694	31117515																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.45056																																0.30632																																8																																CS-5501	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-416-938|MOABOX:6745|PRMT6|PRMT6 inhibitor;PRMT6 gene inhibitor	CNCCN(C)Cc1c[nH]nc1c2ccc(O[C@@H]3C[C@H](C3)OCCC4CCOCC4)cc2	2070015-25-5	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468404	442.59422	CPI45	CPI45 | CPI45			MOABOX:6745	PRMT6	PRMT6 inhibitor;PRMT6 gene inhibitor
SJ001035386-1	SJ001035386	1	MOABOX:6750	ZEXHXVOGJFGTRX-UHFFFAOYSA-N	Cc1ncc([N+](=O)[O-])n1CCOC(=O)NC(Nc1ncccn1)C(Cl)(Cl)Cl	300815-04-7	CDC20 inhibitor	CDC20																																																																										2830389					member	10.1038/nature13660																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-110287	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:6750|CDC20|CDC20 inhibitor	Cc1ncc([N+](=O)[O-])n1CCOC(=O)NC(Nc2ncccn2)C(Cl)(Cl)Cl	300815-04-7	79272	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469863	438.65376	APCIN	APCIN | APCIN	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:6750	CDC20	CDC20 inhibitor
SJ001035342-1	SJ001035342	1	MOABOX:6763	VJQALSOBHVEJQM-QAQDUYKDSA-N	COCCO[C@H]1CC[C@H](Nc2cc(=O)n(C)c3ccc(-c4cncs4)cc23)CC1		CD38 gene inhibitor;CD38 inhibitor	CD38																																																															CHEMBL3426034																member	10.1021/jm502009h																																																																																																																																																															25828863																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.82656																																0.22832																																8																																HY-123999	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Metabolic Disease|MOABOX:6763|CD38|CD38 gene inhibitor;CD38 inhibitor	COCCO[C@@H]1CC[C@H](CC1)NC2=CC(=O)N(C)c3ccc(cc23)c4cncs4	1700637-55-3	83581	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469654	413.53308	CD38 INHIBITOR 1	CD38 INHIBITOR 1 | CD38 INHIBITOR 1	Pathway: Others	Research Area: Metabolic Disease	MOABOX:6763	CD38	CD38 gene inhibitor;CD38 inhibitor
SJ001034868-1	SJ001034868	1	MOABOX:6764	NDIKFKQBWGMLCA-DEOSSOPVSA-N	Cc1noc(C)c1Cn1cc(C#N)c2cc(Oc3ccc(NC(=O)[C@@H]4CCCN4)cc3)ccc21		inhibition of PFKFB3 leads to inhibition of glycolysis;PFKFB3 inhibitor	PFKFB3																																																															CHEMBL3422676											91668554					member	10.1021/acs.jmedchem.5b00352																																																																																																																																																															25849762																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.05872																																0.38234																																8																																5742	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-162-833|MOABOX:6764|PFKFB3|inhibition of PFKFB3 leads to inhibition of glycolysis;PFKFB3 inhibitor	Cc1onc(C)c1Cn2cc(C#N)c3cc(Oc4ccc(NC(=O)[C@@H]5CCCN5)cc4)ccc23	1704741-11-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468123	455.5084	AZ PFKFB3 67	AZ PFKFB3 67 | AZ PFKFB3 67			MOABOX:6764	PFKFB3	inhibition of PFKFB3 leads to inhibition of glycolysis;PFKFB3 inhibitor
SJ001035165-1	SJ001035165	1	MOABOX:6769	KQEPIRKXSUIUTH-UHFFFAOYSA-N	O=C1CSC(c2ccccc2Cl)c2cc(Cl)ccc2N1	75450-34-9	Na+/Ca2+ Exchanger (NCX) Inhibitors;SERCA Inhibitors	ATP2A1	SLC8A2	SLC8A1																														6543	6546																														CHEMBL1495071											2688					virtual	10.1021/cn300009e.																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0	0																														0.0	0.0	0.0																														7	7	7																														HY-15754	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Cancer; Neurological Disease|MOABOX:6769|ATP2A1|Na+/Ca2+ Exchanger (NCX) Inhibitors;SERCA Inhibitors	Clc1ccc2NC(=O)CSC(c3ccccc3Cl)c2c1	75450-34-9	29993	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468972	324.22494	CGP37157	CGP37157 | CGP37157	Pathway: Membrane Transporter/Ion Channel	Research Area: Cancer; Neurological Disease	MOABOX:6769	ATP2A1	Na+/Ca2+ Exchanger (NCX) Inhibitors;SERCA Inhibitors
SJ001035166-1	SJ001035166	1	MOABOX:6771	PROGRNRRJJYCNX-UHFFFAOYSA-N	COc1ccc(C(CC(=O)N2CCCC2)c2c(OC)cc(OC)c3c(-c4ccccc4)cc(=O)oc23)cc1		HuR-ARE interaction disruptor	ELAVL1																																																															CHEMBL1499653											16746438					virtual	10.1021/cb500851u																																																																																																																																																															28587461																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.01801																																0.14543																																7																																HY-124828	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis | Research Area: Cancer|MOABOX:6771|ELAVL1|HuR-ARE interaction disruptor	COc1ccc(cc1)C(CC(=O)N2CCCC2)c3c(OC)cc(OC)c4C(=CC(=O)Oc34)c5ccccc5	958843-91-9	90487	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468973	513.58094	CMLD-2	CMLD-2 | CMLD-2	Pathway: Apoptosis	Research Area: Cancer	MOABOX:6771	ELAVL1	HuR-ARE interaction disruptor
SJ001033311-2	SJ001033311	2	MOABOX:6773	UPZWINBEAHDTLA-UHFFFAOYSA-N	Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(F)cc1	1034442-21-1	MGLUR5 NAM	GRM5																																																															CHEMBL3301626											11438771	25000479	25000480	131634700		virtual	10.1124/jpet.114.222463.																																																																																																																																																															25565255	26706173	28838696																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.91608																																0.48951																																8																																CS-3388	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-063-482|MOABOX:6773|GRM5|MGLUR5 NAM	Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1c3ccc(F)cc3	802906-73-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468596	325.76732	BASIMGLURANT; RG7090; CTEP DERIVATIVE	BASIMGLURANT; RG7090; CTEP DERIVATIVE | BASIMGLURANT; RG7090; CTEP DERIVATIVE			MOABOX:6773	GRM5	MGLUR5 NAM
SJ001035102-1	SJ001035102	1	MOABOX:6774	WAFJKVGCIWVHQC-UHFFFAOYSA-N	O=C(CCCCCc1ccc(-c2ccccc2)cc1)OCc1ccc2c(c1)OCO2	1643657-35-5	Monoacylglycerol Lipase inhibitor	MGLL																																																																										78209996					member	10.1002/anie.201407807																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.69335																																0.09905																																7																																16964	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-561-380|MOABOX:6774|MGLL|Monoacylglycerol Lipase inhibitor	O=C(CCCCCc1ccc(cc1)c2ccccc2)OCc3ccc4OCOc4c3	1643657-35-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468692	402.48224	MONOACYLGLYCEROL LIPASE INHIBITOR 21 | MAGL INHIBITOR 21 | MGL INHIBITOR 21	"""MONOACYLGLYCEROL LIPASE INHIBITOR 21 | MAGL INHIBITOR 21 | MGL INHIBITOR 21"" | ""MONOACYLGLYCEROL LIPASE INHIBITOR 21 | MAGL INHIBITOR 21 | MGL INHIBITOR 21"""			MOABOX:6774	MGLL	Monoacylglycerol Lipase inhibitor
SJ001035275-1	SJ001035275	1	MOABOX:6775	RCSLEKLNDJJJLF-UHFFFAOYSA-N	CCOc1ccccc1NC(=O)c1ccccc1NS(=O)(=O)C1CC1		MrgX1 PAM	MRGPRX1																																																																										71598556					member	10.1002/cmdc.201402277																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-110285	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Neurological Disease|MOABOX:6775|MRGPRX1|MrgX1 PAM	CCOc1ccccc1NC(=O)c2ccccc2NS(=O)(=O)C3CC3	1646499-97-9	79229	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469469	360.4274	ML382	ML382 | ML382	Pathway: Others	Research Area: Neurological Disease	MOABOX:6775	MRGPRX1	MrgX1 PAM
SJ000870757-4	SJ000870757	4	MOABOX:6778	ZGBAJMQHJDFTQJ-DEOSSOPVSA-N	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1	859212-16-1	Dual BCR-ABL/LYN inhibitor	ABL1	LYN																															4067																															CHEMBL206834											11387605	68696060				member	10.1038/leu.2009.228																																																																																																																																																															16105974	16546254	17376680	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		1.15696	0.72408																															0.14462	0.09051																															8	8																															HY-50868	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:6778|ABL1|Dual BCR-ABL/LYN inhibitor	CN(C)[C@H]1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cncnc5)c3)C1	859212-16-1	19802	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469309	576.61535	BAFETINIB	"BAFETINIB | ""BAFETINIB | CNS-9 | INNO-406 | NS-187"" | BAFETINIB | ""BAFETINIB | CNS-9 | INNO-406 | NS-187"""	Pathway: Autophagy; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:6778	ABL1	Dual BCR-ABL/LYN inhibitor
SJ001034841-1	SJ001034841	1	MOABOX:6779	XJFPWEGWVPIYIH-NSHDSACASA-N	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N[C@H]1CCN(c2ccc3nncn3n2)C1		CDK8 inhibitor	CDK8																																																																										91668231					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.33336																																0.16667																																8																																Z3953647092	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-475-320|MOABOX:6779|CDK8|CDK8 inhibitor	FC(F)(F)c1cc(NC(=O)NC2CCN(C2)c3ccc4nncn4n3)ccc1Cl	2637057-78-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468083	425.79551	Z3953647092	Z3953647092 | Z3953647092			MOABOX:6779	CDK8	CDK8 inhibitor
SJ001035055-1	SJ001035055	1	MOABOX:6801	AJIAMIPUWJQSPR-UHFFFAOYSA-N	Cn1cnnc1C1CCN(c2ncccc2-c2ccc(F)nc2)CC1		QPCT inhibitor	QPCT																																																																										91618245					member	10.1038/nchembio.1790																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																EN300-1700016	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-148-416|MOABOX:6801|QPCT|QPCT inhibitor	Cn1cnnc1C2CCN(CC2)c3ncccc3c4ccc(F)nc4	2117405-13-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468560	338.38206	EN300-1700016	EN300-1700016 | EN300-1700016			MOABOX:6801	QPCT	QPCT inhibitor
SJ000574296-22	SJ000574296	22	MOABOX:6809	HFNKQEVNSGCOJV-OAHLLOKOSA-N	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1	1092939-15-5	JAK tyrosine kinase inhibitor	JAK1	JAK2																															3717																															CHEMBL1789941	CHEMBL1795071										25126797	25126798	25127111	25127112	66597531	virtual	10.1007/s00011-019-01293-1	10.1007/s10637-019-00794-4	10.1021/acs.jmedchem.7b01598	10.1021/acs.jmedchem.8b00076	10.1021/jm300628c	10.1021/jm501262q	10.1124/jpet.119.256263	10.1182/blood-2009-04-214957																																																																																																																																																								20130243	21106455	22037378	22286129	22399854	22591402	22698084	22830345	23061660	23317159	23540648	23668484	24417533	24461299	25369270	26258521	26288683	26927423	27137359	27555284	28953386	29191878	29298069	29545103	29856615	29945795	30833158	30981578																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										2.30064	2.72136																															0.28758	0.34017																															8	8																															AS-18619	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-020-006-045|MOABOX:6809|JAK1|JAK tyrosine kinase inhibitor	N#CC[C@H](C1CCCC1)n2cc(cn2)c3ncnc4[nH]ccc34	941678-49-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468362	306.36502	RUXOLITINIB	"RUXOLITINIB | ""INCB-18424 | INCB-018424 | NCB018424 | INC-424 | INCB-424"" | ""RUXOLITINIB | INCB-18424 | INCB-018424 | NCB018424 | INC-424 | INCB-424 |"" | RUXOLITINIB (INCB018424) | S-RUXOLITINIB (INCB018424) | RUXOLITINIB | ""INCB-18424 | INCB-018424 | NCB018424 | INC-424 | INCB-424"" | ""RUXOLITINIB | INCB-18424 | INCB-018424 | NCB018424 | INC-424 | INCB-424 |"" | RUXOLITINIB (INCB018424) | S-RUXOLITINIB (INCB018424)"			MOABOX:6809	JAK1	JAK tyrosine kinase inhibitor
SJ001034873-1	SJ001034873	1	MOABOX:6813	FLCRMGKKLKMMAE-UHFFFAOYSA-N	Cc1ccc(N2C(=O)C(O)=C(C(=O)c3ccc(Cl)cc3)C2c2cccc(F)c2)cc1Br		PLAUR gene inhibitor	PLAUR																																																																															member	10.1021/cb500832q																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																STK768663	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-715-214|MOABOX:6813|PLAUR|PLAUR gene inhibitor	Cc1ccc(cc1Br)N2C(C(=C(O)C2=O)C(=O)c3ccc(Cl)cc3)c4cccc(F)c4	442666-56-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468156	500.74414	STK768663	STK768663 | STK768663			MOABOX:6813	PLAUR	PLAUR gene inhibitor
SJ001033545-2	SJ001033545	2	MOABOX:6814	AGPIHNZOZNKRGT-CYBMUJFWSA-N	O=C(c1cc(S(=O)(=O)Nc2ccccc2F)c(F)cc1Cl)N1CCN2CCC[C@@H]2C1	1235560-28-7	T-type calcium channel inhibitor	CACNA1I	CACNA1H	CACNA1G																														8912	8913																														CHEMBL3589557	CHEMBL3590674										46851313	122180940				member	10.1021/acsmedchemlett.5b00023																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	2.49592	0																														0.0	0.35656	0.0																														7	7	7																														HY-19721	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:6814|CACNA1I|T-type calcium channel inhibitor	Fc1ccccc1NS(=O)(=O)c2cc(C(=O)N3CCN4CCC[C@@H]4C3)c(Cl)cc2F	1235560-28-7	20264	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469103	455.90591	ABT-639	ABT-639 | ABT-639	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:6814	CACNA1I	T-type calcium channel inhibitor
SJ000982905-2	SJ000982905	2	MOABOX:6817	PGPHHJBZEGSUNE-JYRVWZFOSA-N	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2		CLK1 protein kinase inhibitor	CLK1	DYRK1A	DYRK2																														1859	8445																														CHEMBL1802358											135398522					member	10.1016/j.ejmech.2013.01.035	10.1021/cb500697f/	10.1021/jm200274d	10.1021/jm301034u	10.1111/jnc.13018	10.2174/15701808113100890024	10.3390/md15100316																																																																																																																																																									21615147	22998443	23454515	23642479	26048785	27128181	27721154	27766861	28206758	29039762																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												2.92e-002	1.8056	0.39928																														0.00365	0.2257	0.04991																														8	8	8																														29225	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-857-319|MOABOX:6817|CLK1|CLK1 protein kinase inhibitor	O=C1NC(=N/C/1=C\c2ccc3OCOc3c2)Nc4ccccc4	1112978-84-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468656	307.30342	LEUCETTINE L41	LEUCETTINE L41 | LEUCETTINE L41			MOABOX:6817	CLK1	CLK1 protein kinase inhibitor
SJ000982877-2	SJ000982877	2	MOABOX:6819	JQSJAVBMIMDUFO-UHFFFAOYSA-N	Clc1cc(Cl)cc(CNc2ncncc2-c2ccc3c(c2)OCO3)c1	1440251-53-5	CLK4 inhibitor	CLK4																																																															CHEMBL1885748											46926514	127021037				member																																																																																																																																																																23642479																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.17104																																0.14638																																8																																5700	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-045-998-181|MOABOX:6819|CLK4|CLK4 inhibitor	Clc1cc(Cl)cc(CNc2ncncc2c3ccc4OCOc4c3)c1	1440251-53-5	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468579	374.22072	ML315 HCL	ML315 HCL | ML315 HCL			MOABOX:6819	CLK4	CLK4 inhibitor
SJ000855244-4	SJ000855244	4	MOABOX:6820	ROCFOIBAEVAOLQ-UHFFFAOYSA-N	Cc1ccc(CNc2ncnc3ccc(-c4ccc(CO)o4)cc23)o1	1285702-20-6	CLK and Dryk1A inhibitor	CLK1	CLK4	DYRK1A																														57396	1859																														CHEMBL1604618											44968231	56643210				virtual	10.1016/j.bmcl.2011.02.114																																																																																																																																																															21450467	23642479																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.16877	-0.40915	3.25504																														-0.02411	-0.05845	0.40688																														7	7	8																														HY-15951	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:6820|CLK1|CLK and Dryk1A inhibitor	Cc1oc(CNc2ncnc3ccc(cc23)c4oc(CO)cc4)cc1	1285702-20-6	26280	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468773	335.35658	ML167	ML167 | ML167	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:6820	CLK1	CLK and Dryk1A inhibitor
SJ001033286-2	SJ001033286	2	MOABOX:6823	YUUGYIUSCYNSQR-LBPRGKRZSA-N	C[C@H](Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ncc(C(F)(F)F)cc2F)CC1)C(F)(F)F	845614-11-1	glycine reuptake inhibitor	SLC6A9																																																															CHEMBL1171829											24946690	87572254				member																																																																																																																																																																20491477	30080045																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.84592																																0.10574																																8																																HY-10809	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:6823|SLC6A9|glycine reuptake inhibitor	C[C@H](Oc1ccc(cc1C(=O)N2CCN(CC2)c3ncc(cc3F)C(F)(F)F)S(=O)(=O)C)C(F)(F)F	845614-11-1	8403	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469576	543.45502	BITOPERTIN; RG1678; RO4917838	BITOPERTIN; RG1678; RO4917838 | BITOPERTIN; RG1678; RO4917838	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:6823	SLC6A9	glycine reuptake inhibitor
SJ001034977-1	SJ001034977	1	MOABOX:6824	KSAUCBGUWGWPDL-UHFFFAOYSA-N	CSc1nn2c(C)cc(C)nc2c1S(=O)(=O)c1ccccc1	1173103-84-8	5HT6 antagonist	HTR6																																																															CHEMBL1668500											44155874	142790920				member	10.1007/s11094-012-0779-z	10.1007/s11094-013-0861-1																																																																																																																																																														21277782	21333408	24850589	25282268	27326337																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	4.51224																																0.56403																																8																																C201-0627	CHEMDIV	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-019-973-796|MOABOX:6824|HTR6|5HT6 antagonist	CSc1nn2c(C)cc(C)nc2c1S(=O)(=O)c3ccccc3	1173103-84-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468419	333.4285	C201-0627	C201-0627 | C201-0627			MOABOX:6824	HTR6	5HT6 antagonist
SJ001032968-2	SJ001032968	2	MOABOX:6826	AZEXWHKOMMASPA-UHFFFAOYSA-N	Cn1cc(-c2ccncc2)c(-c2ccc(OCc3ccc4ccccc4n3)cc2)n1	1037309-45-7	Phosphodiesterase 10A Inhibitors	PDE10A																																																															CHEMBL562318											11581936	24857794	91885504	122412737		member	10.1016/j.bmc.2010.10.038	10.1016/j.bmc.2014.11.039	10.1016/j.bmcl.2012.07.076	10.1016/j.bmcl.2013.10.027	10.1016/j.bmcl.2014.03.054	10.1016/j.bmcl.2014.12.076	10.1016/j.bmcl.2015.10.100	10.1016/j.ejmech.2011.05.072	10.1016/j.ejmech.2014.07.020	10.1016/j.ejmech.2015.10.028	10.1021/jm1002793	10.1021/jm3002372	10.1021/jm3004976	10.1248/cpb.c14-00509																																																																																																																																																		19630403	20450197	21087867	21355834	21602043	21705115	22548439	22834877	22902656	23978358	24231362	24721831	24725435	25016376	25515954	25592707	25630223	26113188	26378882	26562545	26597534	26908025	27491708	30888810	31235264																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2.25392																																0.28174																																8																																HY-50098	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Neurological Disease|MOABOX:6826|PDE10A|Phosphodiesterase 10A Inhibitors	Cn1cc(c2ccncc2)c(n1)c3ccc(OCc4ccc5ccccc5n4)cc3	898562-94-2	12098	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469416	392.4525	PF-2545920	PF-2545920 | PF-2545920	Pathway: Metabolic Enzyme/Protease	Research Area: Neurological Disease	MOABOX:6826	PDE10A	Phosphodiesterase 10A Inhibitors
SJ001033343-2	SJ001033343	2	MOABOX:6828	YZZVIKDAOTXDEB-JTQLQIEISA-N	NCc1c[nH]c(=S)n1[C@H]1CCc2c(F)cc(F)cc2C1	170151-24-3	Dopamine-Î²-hydroxylase inhibitor	DBH																																																															CHEMBL1188395	CHEMBL536282										9796181	9840545	11954368	87525246		virtual	10.1016/j.ejphar.2015.01.034	10.1021/jm051051f	10.1038/sj.bjp.0701315																																																																																																																																																													9283721	16451083																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.66232																																0.20779																																8																																HY-13289A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease|MOABOX:6828|DBH|Dopamine-??-hydroxylase inhibitor	NCC1=CNC(=S)N1[C@H]2CCc3c(F)cc(F)cc3C2	170151-24-3	34680	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469904	295.35081	NEPICASTAT (HYDROCHLORIDE); SYN-117 HYDROCHLORIDE; RS-25560-197 HYDROCHLORIDE	NEPICASTAT (HYDROCHLORIDE); SYN-117 HYDROCHLORIDE; RS-25560-197 HYDROCHLORIDE | NEPICASTAT (HYDROCHLORIDE); SYN-117 HYDROCHLORIDE; RS-25560-197 HYDROCHLORIDE	Pathway: Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease	MOABOX:6828	DBH	Dopamine-??-hydroxylase inhibitor
SJ001035012-1	SJ001035012	1	MOABOX:6829	DMJWENQHWZZWDF-PKOBYXMFSA-N	CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21	112108-01-7	selective dopamine D1/D5 receptor antagonist	DRD1																																																															CHEMBL1535402	CHEMBL1822916	CHEMBL298406									107930	170317	16759171	71297098	90806300	member																																																																																																																																																																1531365	1973733	10591286	15689153	18642350	18782049	20061148	20064718	21413808																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1.94656																																0.24332																																8																																25331	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-677|MOABOX:6829|DRD1|selective dopamine D1/D5 receptor antagonist	CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4ccccc34	1227675-51-5	NA	GENERAL	BROMIDE	1	NO_SOLVATE	0	1468466	313.8212	SCH 39166 HBR	SCH 39166 HBR | SCH 39166 HBR			MOABOX:6829	DRD1	selective dopamine D1/D5 receptor antagonist
SJ000833837-5	SJ000833837	5	MOABOX:6833	BLVQHYHDYFTPDV-VCABWLAWSA-N	Nc1cc(F)ccc1NC(=O)/C=C/c1cnn(C/C=C/c2ccccc2)c1	1357389-11-7	HDAC3;HDAC3 active-site competitive inhibitor	HDAC3																																																															CHEMBL4078477											56650312	60163641				member																																																																																																																																																																24300735	26400942	28771357	29541372	31181405																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	2.69288																																0.33661																																8																																HY-13909	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:6833|HDAC3|HDAC3;HDAC3 active-site competitive inhibitor	Nc1cc(F)ccc1NC(=O)\C=C\c2cnn(C\C=C\c3ccccc3)c2	1357389-11-7	9664	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469777	362.40016	RGFP966	RGFP966 | RGFP966	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:6833	HDAC3	HDAC3;HDAC3 active-site competitive inhibitor
SJ000834164-3	SJ000834164	3	MOABOX:6835	NEEVCWPRIZJJRJ-UHFFFAOYSA-N	Oc1nc(S)nc(N=Cc2ccccc2)c1N=Cc1ccccc1	1533426-72-0	DNA Ligase 4 Inhibitor;DNA ligase 4 inhibitor	LIG4																																																																															member	10.1038/nbt.3198.																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																AG00ABP1	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-137-474|MOABOX:6835|LIG4|DNA Ligase 4 Inhibitor;DNA ligase 4 inhibitor	O=C1NC(=S)NC(=C1\N=C\c2ccccc2)\N=C\c3ccccc3	1533426-72-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468397	334.39496	SCR7	SCR7 | SCR7			MOABOX:6835	LIG4	DNA Ligase 4 Inhibitor;DNA ligase 4 inhibitor
SJ000784293-16	SJ000784293	16	MOABOX:6839	ZLHFILGSQDJULK-UHFFFAOYSA-N	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O	1028486-01-2	AURKA gene inhibitor	AURKA																																																															CHEMBL483158											24771867	71488634	89809304			member	10.1002/cmdc.201200479	10.1016/j.bmcl.2011.02.110	10.1021/cb100053q	10.1021/ml500409n																																																																																																																																																												19320489	22803810	23664099	23937569	25369539	26101564	27391133	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														3.5168																																0.4396																																8																																HY-10971	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:6839|AURKA|AURKA gene inhibitor	COc1cccc(F)c1C2=NCc3cnc(Nc4ccc(C(=O)O)c(OC)c4)nc3c5ccc(Cl)cc25	1028486-01-2	26708	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468826	518.9235	ALISERTIB	ALISERTIB | MLN-8237 | ALISERTIB (MLN8237) | MLN8237 | ALISERTIB | MLN-8237 | ALISERTIB (MLN8237) | MLN8237	Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:6839	AURKA	AURKA gene inhibitor
SJ000796048-4	SJ000796048	4	MOABOX:6844	JNGVJMBLXIUVRD-SFHVURJKSA-N	C[C@](O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	1202044-20-9	Selective Androgen Receptor Modulator	AR																																																															CHEMBL1738889											11326715					virtual	10.1002/jcb.25751																																																																																																																																																															16515480	22897611	27131065	30525603																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		3.32528																																0.41566																																8																																T2408	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-293-521|MOABOX:6844|AR|Selective Androgen Receptor Modulator	C[C@](O)(COc1ccc(cc1)C#N)C(=O)Nc2ccc(C#N)c(c2)C(F)(F)F	841205-47-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468588	389.32797	OSTARINE | MK-2866 | GTX-024 | S-22 | ENOBOSARM |	"""OSTARINE | MK-2866 | GTX-024 | S-22 | ENOBOSARM |"" | MK-2866 (GTX-024) | ""OSTARINE | MK-2866 | GTX-024 | S-22 | ENOBOSARM |"" | MK-2866 (GTX-024)"			MOABOX:6844	AR	Selective Androgen Receptor Modulator
SJ001033247-2	SJ001033247	2	MOABOX:6854	ZRJGMDIPCQOGNI-UHFFFAOYSA-N	COc1ccc(Cl)c(-c2ccc(NC(=O)c3ccnn3C)nc2N)c1	1079400-07-9	NaV 1.8 inhibitor	SCN10A																																																															CHEMBL3589904											57582353					member	10.1021/acsmedchemlett.5b00059																																																																																																																																																															26101568	30538065																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.98768																																0.37346																																8																																HY-105283	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Neurological Disease|MOABOX:6854|SCN10A|NaV 1.8 inhibitor	COc1ccc(Cl)c(c1)c2ccc(NC(=O)c3ccnn3C)nc2N	1079400-07-9	44827	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469474	357.79424	PF 04531083	PF 04531083 | PF 04531083	Pathway: Membrane Transporter/Ion Channel	Research Area: Neurological Disease	MOABOX:6854	SCN10A	NaV 1.8 inhibitor
SJ001011035-2	SJ001011035	2	MOABOX:6860	ZFOMCSNUEHMROO-UHFFFAOYSA-N	COc1ccc2nc3ccc(OC)cc3c(SCCCN)c2c1	184582-62-5	Serine/Threonine Kinase Haspin (Gsg2) Inhibitors;Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 2 (DYRK2) Inhibitors	DYRK3	DYRK2	HASPIN																														8445	83903																																									53390843	54613582	71699942	91885401		member	10.1016/j.bmcl.2010.04.150																																																																																																																																																															20836251	22335895																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.89776	1.3596	1.87152																														0.11222	0.16995	0.23394																														8	8	8																														HY-13455A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:6860|DYRK3|Serine/Threonine Kinase Haspin (Gsg2) Inhibitors;Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 2 (DYRK2) Inhibitors	COc1ccc2nc3ccc(OC)cc3c(SCCCN)c2c1	2309172-48-1	89293	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468962	328.4286	LDN-192960 (HYDROCHLORIDE)	LDN-192960 (HYDROCHLORIDE) | LDN-192960 (HYDROCHLORIDE)	Pathway: Cell Cycle/DNA Damage; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:6860	DYRK3	Serine/Threonine Kinase Haspin (Gsg2) Inhibitors;Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 2 (DYRK2) Inhibitors
SJ000780468-17	SJ000780468	17	MOABOX:6863	ZHJGWYRLJUCMRT-QGZVFWFLSA-N	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F	929095-18-1	PLK1 inhibitor	PLK1																																																															CHEMBL1908394											15983966					member																																																																																																																																																																22037378	22709006	28792760																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.66352																																0.20794																																8																																HY-50877	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:6863|PLK1|PLK1 inhibitor	C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(CN4CCN(C)CC4)cc23)c5ccccc5C(F)(F)F	929095-18-1	3145	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469369	543.60373	GSK461364	GSK461364 | GSK-461364A | GSK-461364 | GSK461364A | GSK461364 | GSK-461364A | GSK-461364 | GSK461364A	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:6863	PLK1	PLK1 inhibitor
SJ000780471-15	SJ000780471	15	MOABOX:6864	SXNJFOWDRLKDSF-STROYTFGSA-N	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C	755038-65-4	pan PLK inhibitor	PLK3	PLK1	PLK2																														5347	10769																														CHEMBL1233528	CHEMBL2105742															member	10.1016/j.canlet.2018.12.012	10.1158/1078-0432.CCR-08-2445																																																																																																																																																														19383823	19474163	23103095	27299736	28280261																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	-0.46864	3.36112	-0.1376																														-0.05858	0.42014	-0.0172																														8	8	8																														HY-12137	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:6864|PLK3|pan PLK inhibitor	CC[C@H]1N(C(C)C)c2nc(Nc3ccc(cc3OC)C(=O)N[C@@H]4CC[C@H](CC4)N5CCN(CC6CC6)CC5)ncc2N(C)C1=O	755038-65-4	12094	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469900	618.8126	VOLASERTIB	"VOLASERTIB | ""BI-6727 | BI6727"" | VOLASERTIB (BI 6727) | VOLASERTIB | ""BI-6727 | BI6727"" | VOLASERTIB (BI 6727)"	Pathway: Apoptosis; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:6864	PLK3	pan PLK inhibitor
SJ000801093-4	SJ000801093	4	MOABOX:6875	COUMZXFUZDBRCZ-UHFFFAOYSA-N	COc1ccc(Cn2c3ncnc4c(ncn4Cc4ccc(OC)cc4)c-3nc2=O)cc1	1070773-09-9	DDX3X gene inhibitor	DDX3X																																																															CHEMBL1672984											46184988	144714854				member	10.15252/emmm.201404368;																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																T6970	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-560-370|MOABOX:6875|DDX3X|DDX3X gene inhibitor	COc1ccc(CN2C(=O)N=C3C2=NC=Nc4c3ncn4Cc5ccc(OC)cc5)cc1	1070773-09-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468154	428.4433	RK-33 | RK33	"""RK-33 | RK33"" | ""RK-33 | RK33"""			MOABOX:6875	DDX3X	DDX3X gene inhibitor
SJ001035396-1	SJ001035396	1	MOABOX:6882	QUZLMKNNIUSREV-UHFFFAOYSA-N	O=C(c1ccc(F)cc1)N1CCc2nc(COc3ccccc3)oc2C1	1363281-27-9	GRM5 positive allosteric modulator	GRM5																																																																										56846694					member	10.1016/j.bmcl.2015.06.096	10.1021/acsmedchemlett.5b00181																																																																																																																																																														26157544	26183084	26475522																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.93272																																0.11659																																8																																HY-19559	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:6882|GRM5|GRM5 positive allosteric modulator	Fc1ccc(cc1)C(=O)N2CCc3nc(COc4ccccc4)oc3C2	1363281-27-9	33265	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469897	352.35898	JNJ-46778212 | VU 0409551	"""JNJ-46778212 | VU 0409551"" | ""JNJ-46778212 | VU 0409551"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:6882	GRM5	GRM5 positive allosteric modulator
SJ000851858-6	SJ000851858	6	MOABOX:6883	PNYRDVBFYVDJJI-UHFFFAOYSA-N	Cc1cn(CCN2CCN(c3ccccc3-c3cc(C#N)cc(C(=O)NCCCN4CCCC4)c3)CC2)c2ccccc12	1793053-37-8	SMYD2 / KMT3C;SMYD2 gene inhibitor	SMYD2																																																															CHEMBL3414623											91623361					member	10.1074/jbc.M114.626861																																																																																																																																																															25406853	26101576	27075367	28002961																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.19496																																0.27437																																8																																HY-19313	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:6883|SMYD2|SMYD2 / KMT3C;SMYD2 gene inhibitor	Cc1cn(CCN2CCN(CC2)c3ccccc3c4cc(cc(c4)C(=O)NCCCN5CCCC5)C#N)c6ccccc16	1793053-37-8	20228	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469188	574.75828	LLY-507	LLY-507 | LLY-507	Pathway: Epigenetics	Research Area: Cancer	MOABOX:6883	SMYD2	SMYD2 / KMT3C;SMYD2 gene inhibitor
SJ000556737-8	SJ000556737	8	MOABOX:6888	FBOUYBDGKBSUES-VXKWHMMOSA-N	O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1	1172613-99-8	NVP-CEH592 is a competitive cholinergic receptor antagonist	CHRM3	CHRNA7																															1139																															CHEMBL1200803	CHEMBL1734	CHEMBL2361425									154058	154059	216457	11706835	24811835	member	10.1016/j.bmcl.2011.03.096																																																																																																																																																															17202659	19835561	20235539	21524581	28609709																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.32088	0																															0.16511	0.0																															8	7																															AG00393T	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-850-268|MOABOX:6888|CHRM3|NVP-CEH592 is a competitive cholinergic receptor antagonist	O=C(O[C@H]1CN2CCC1CC2)N3CCc4ccccc4[C@@H]3c5ccccc5	242478-38-2	NA	GENERAL	SUCCINATE	1	NO_SOLVATE	0	1468356	362.46474	SOLIFENACIN HYDROCHLORIDE	"SOLIFENACIN HYDROCHLORIDE | ""SOLIFENICIN HYDROCHLORIDE | YM-53705 |"" | SOLIFENACIN SUCCINATE | SOLIFENACIN HYDROCHLORIDE | ""SOLIFENICIN HYDROCHLORIDE | YM-53705 |"" | SOLIFENACIN SUCCINATE"			MOABOX:6888	CHRM3	NVP-CEH592 is a competitive cholinergic receptor antagonist
SJ000287062-6	SJ000287062	6	MOABOX:6896	OYHLRJGDELITAF-INIZCTEOSA-N	O=C(N[C@@H](Cc1ccccc1)C(=O)CCl)OCc1ccccc1	26049-94-5	ATG4B gene Inhibitor	ATG4B																																																															CHEMBL303579											99625					member	10.1089/adt.2013.561																																																																																																																																																															25979376	27517808																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.72536																																0.09067																																8																																15225	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-939-363|MOABOX:6896|ATG4B|ATG4B gene Inhibitor	ClCC(=O)[C@H](Cc1ccccc1)NC(=O)OCc2ccccc2	26049-94-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468298	331.79342	1-BENZYLOXYCARBONYLAMINOPHENETHYL  CHLOROMETHYL KETONE	"1-BENZYLOXYCARBONYLAMINOPHENETHYL  CHLOROMETHYL KETONE | Z-L-PHE CHLOROMETHYL KETONE | ""Z-L-PHE CHLOROMETHYL KETONE | ZPCK |"" | 1-BENZYLOXYCARBONYLAMINOPHENETHYL  CHLOROMETHYL KETONE | Z-L-PHE CHLOROMETHYL KETONE | ""Z-L-PHE CHLOROMETHYL KETONE | ZPCK |"""			MOABOX:6896	ATG4B	ATG4B gene Inhibitor
SJ000865899-6	SJ000865899	6	MOABOX:6897	DUYJMQONPNNFPI-UHFFFAOYSA-N	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C	1421373-65-0	EGFR family tyrosine kinase receptor inhibitor	EGFR																																																															CHEMBL3353410	CHEMBL3545063										71496458	78357807	91971325	92044416	118796892	virtual	10.1016/j.bmc.2018.11.009	10.1016/j.bmcl.2017.12.009	"10.1016/j.ccell.2015.05.012,"	10.1016/j.ejmech.2018.11.069	10.1021/jm500973a	10.1038/s41467-019-09734-5	10.1039/c7md00571g	10.1158/1078-0432.CCR-14-2789.																																																																																																																																																								25271963	26275028	26396685	26639762	26756222	26968253	27131639	27433829	27564586	27827863	27996267	28033579	28225269	28282122	28426996	28435529	28482151	28528303	28603991	28716641	28853575	29191878	29466773	29486953	29523467	29576272	29655612	29730192	29853340	30442506	30471829	30530173	31223440																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.16984																																0.39623																																8																																HY-15772	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: JAK/STAT Signaling; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:6897|EGFR|EGFR family tyrosine kinase receptor inhibitor	COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc2nccc(n2)c3cn(C)c4ccccc34	1421373-65-0	25959	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469322	499.60732	Osimertinib	Osimertinib | AZD-9291 | Osimertinib | AZD-9291	Pathway: JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:6897	EGFR	EGFR family tyrosine kinase receptor inhibitor
SJ001010722-2	SJ001010722	2	MOABOX:6900	GDJANRNMFHNVOW-DCPHZVHLSA-N	C[C@H](NC(=O)[C@H]1NCC[C@@H]1O)c1ccc(-c2noc(CCC3CCCC3)n2)cc1	1218816-71-7	SPHK1 inhibitor	SPHK1																																																															CHEMBL1209617											46911228					member	10.1016/j.bmcl.2010.06.019																																																																																																																																																															20598880	28231433																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.07808																																0.25976																																8																																HY-101805	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Cancer; Inflammation/Immunology|MOABOX:6900|SPHK1|SPHK1 inhibitor	C[C@H](NC(=O)[C@H]1NCC[C@@H]1O)c2ccc(cc2)c3noc(CCC4CCCC4)n3	1218816-71-7	25240	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469093	398.4986	SK1-IN-1	SK1-IN-1 | SK1-IN-1	Pathway: Immunology/Inflammation	Research Area: Cancer; Inflammation/Immunology	MOABOX:6900	SPHK1	SPHK1 inhibitor
SJ001010651-2	SJ001010651	2	MOABOX:6901	NPUXORBZRBIOMQ-RUZDIDTESA-N	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1	1415562-82-1	SPHK1 inhibitor	SPHK1																																																															CHEMBL3134157											66577038	71576669	121230770			member	10.1021/acs.jmedchem.7b00070																																																																																																																																																															22397330	24396570	25516793	25643074	26780304	27255176	28231433	28406646	28408190	28822281	31155566																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											3.42168																																0.42771																																8																																HY-15425A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; GPCR/G Protein; Immunology/Inflammation | Research Area: Cancer; Inflammation/Immunology; Cardiovascular Disease|MOABOX:6901|SPHK1|SPHK1 inhibitor	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc3ccc(CN4CCC[C@@H]4CO)cc3)c1	1415562-83-2	7151	GENERAL	CITRATE	1	NO_SOLVATE	0	1469817	465.60434	PF-543 (CITRATE)	PF-543 (CITRATE) | PF-543 (CITRATE)	Pathway: Apoptosis; Autophagy; GPCR/G Protein; Immunology/Inflammation	Research Area: Cancer; Inflammation/Immunology; Cardiovascular Disease	MOABOX:6901	SPHK1	SPHK1 inhibitor
SJ001033354-2	SJ001033354	2	MOABOX:6911	GERJIEKMNDGSCS-DQEYMECFSA-N	O=C(O)c1ccc(CN2C[C@@H]3C[C@H]2CN3Cc2ccc(Oc3ccc(-c4ncco4)cc3)cc2)cc1	943764-99-6	inhibition of leukotriene A4 hydrolase	LTA4H																																																																										68488178					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.39072																																0.29884																																8																																HY-17625	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Inflammation/Immunology|MOABOX:6911|LTA4H|inhibition of leukotriene A4 hydrolase	OC(=O)c1ccc(CN2C[C@@H]3C[C@H]2CN3Cc4ccc(Oc5ccc(cc5)c6occn6)cc4)cc1	943764-99-6	22550	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469386	481.54238	ACEBILUSTAT; CTX-4430	ACEBILUSTAT; CTX-4430 | ACEBILUSTAT; CTX-4430	Pathway: Others	Research Area: Inflammation/Immunology	MOABOX:6911	LTA4H	inhibition of leukotriene A4 hydrolase
SJ000855432-6	SJ000855432	6	MOABOX:6916	SJVQHLPISAIATJ-ZDUSSCGKSA-N	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1	1201438-56-3	lipid kinase inhibitor	PIK3CD																																																															CHEMBL3039502											50905713	137528190				member	10.1016/j.chembiol.2013.09.017																																																																																																																																																															24211136	27774127	30237123	30655957	31033293																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	3.23568																																0.40446																																8																																HY-17044	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:6916|PIK3CD|lipid kinase inhibitor	C[C@H](Nc1ncnc2[nH]cnc12)C3=Cc4cccc(Cl)c4C(=O)N3c5ccccc5	1201438-56-3	16252	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468918	416.86298	IPI-145 (INK1197)	IPI-145 (INK1197) | IPI-145 (INK1197)	Pathway: PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:6916	PIK3CD	lipid kinase inhibitor
SJ000862697-3	SJ000862697	3	MOABOX:6924	HJGMCDHQPXTGAV-IYARVYRRSA-N	O=C(COc1ccc(Cl)cc1)N[C@H]1CC[C@H](NC(=O)COc2ccc(Cl)cc2)CC1	1597403-47-8	"Inhibits UPR, reactives translation;EIF2B4 modulator"	EIF2B4																																																																															member	10.1126/science.aaa6986																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-12495	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage | Research Area: Neurological Disease|MOABOX:6924|EIF2B4|Inhibits UPR, reactives translation;EIF2B4 modulator"	Clc1ccc(OCC(=O)N[C@@H]2CC[C@H](CC2)NC(=O)COc3ccc(Cl)cc3)cc1	1597403-47-8	24479	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469463	451.34296	ISRIB TRANS-ISOMER	ISRIB TRANS-ISOMER | ISRIB TRANS-ISOMER	Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage	Research Area: Neurological Disease	MOABOX:6924	EIF2B4	"Inhibits UPR, reactives translation;EIF2B4 modulator"
SJ001033363-2	SJ001033363	2	MOABOX:6936	KSGCNXAZROJSNW-UHFFFAOYSA-N	CCS(=O)(=O)c1ccc2oc(-c3ccc4ccccc4c3)nc2c1	945531-77-1	UTRN (Utrophin gene) Expression Enhancers	AHR																																																															CHEMBL1773683											25109292					virtual	10.1002/anie.201912392																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-17614	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Others|MOABOX:6936|AHR|UTRN (Utrophin gene) Expression Enhancers	CCS(=O)(=O)c1ccc2oc(nc2c1)c3ccc4ccccc4c3	945531-77-1	21101	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469849	337.3923	EZUTROMID; SMT C1100; BMN 195; VOX-C1100	EZUTROMID; SMT C1100; BMN 195; VOX-C1100 | EZUTROMID; SMT C1100; BMN 195; VOX-C1100	Pathway: Others	Research Area: Others	MOABOX:6936	AHR	UTRN (Utrophin gene) Expression Enhancers
SJ000855313-11	SJ000855313	11	MOABOX:6937	LIOLIMKSCNQPLV-UHFFFAOYSA-N	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F	1029712-80-8	Kinase inhibitors	MET																																																															CHEMBL3188267	CHEMBL3989937										25145656	44512901	44513225	44513226	68811036	virtual																																																																																																																																																																24320965	26717201	28411455	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		3.67464																																0.45933																																8																																HY-13404	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:6937|MET|Kinase inhibitors	CNC(=O)c1ccc(cc1F)c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2	1029712-80-8	10211	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469184	412.41908	Capmatinib	Capmatinib | INCB28060 | Capmatinib | INCB28060	Pathway: Apoptosis; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:6937	MET	Kinase inhibitors
SJ001035163-1	SJ001035163	1	MOABOX:6940	ZPVUIOVIUFJGHO-UHFFFAOYSA-N	Cc1ccc(CNC(=O)Nc2cccc(F)c2)cc1NC(=O)c1cnc2ccccn12		DDR2 inhibitor	DDR2																																																															CHEMBL3608786											86764579	117798934				member	10.1021/acsmedchemlett.5b00143																																																																																																																																																															26191369	27739691																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.9468																																0.36835																																8																																HY-W018931	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:6940|DDR2|DDR2 inhibitor	Cc1ccc(CNC(=O)Nc2cccc(F)c2)cc1NC(=O)c3cnc4ccccn34	1644069-80-6	40418	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468970	417.4356	DDR INHIBITOR	DDR INHIBITOR | DDR INHIBITOR	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:6940	DDR2	DDR2 inhibitor
SJ001034927-1	SJ001034927	1	MOABOX:6941	ZDERDCQPANYYQW-UHFFFAOYSA-N	CCn1c(-c2nc3ccc(C(=O)N4CCCC(N)C4)cc3n2C)cc2ccccc21		PAD4 (Protein-arginine deiminase type-4) substrate competitive reversible inhibitor	PADI4																																																																										86340158	86340171				member	10.1038/nchembio.1735																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																AA01E2K2	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-183-390|MOABOX:6941|PADI4|PAD4 (Protein-arginine deiminase type-4) substrate competitive reversible inhibitor	CCn1c(cc2ccccc12)c3nc4ccc(cc4n3C)C(=O)N5CCCC(N)C5	1652591-82-6	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468261	401.50408	AA01E2K2	AA01E2K2 | AA01E2K2			MOABOX:6941	PADI4	PAD4 (Protein-arginine deiminase type-4) substrate competitive reversible inhibitor
SJ000865779-6	SJ000865779	6	MOABOX:6942	BDYDINKSILYBOL-WMZHIEFXSA-N	COc1cc(C(=O)N2CC[C@@H](O)[C@@H](N)C2)cc2nc(-c3cc4ccccc4n3CC3CC3)n(C)c12	1652591-81-5	PAD4 (Protein-arginine deiminase type-4) substrate competitive reversible inhibitor	PADI4																																																																										86340151	86340175				member																																																																																																																																																																25622091																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.80959																																0.40137																																7																																HY-100514	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer; Inflammation/Immunology; Cardiovascular Disease|MOABOX:6942|PADI4|PAD4 (Protein-arginine deiminase type-4) substrate competitive reversible inhibitor	COc1cc(cc2nc(c3cc4ccccc4n3CC5CC5)n(C)c12)C(=O)N6CC[C@@H](O)[C@@H](N)C6	1652591-81-5	33062	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469715	473.56674	GSK-484	GSK-484 | GSK-484	Pathway: Epigenetics	Research Area: Cancer; Inflammation/Immunology; Cardiovascular Disease	MOABOX:6942	PADI4	PAD4 (Protein-arginine deiminase type-4) substrate competitive reversible inhibitor
SJ001035391-1	SJ001035391	1	MOABOX:6952	LCYAYKSMOVLVRL-UHFFFAOYSA-N	CCCC[S+]([O-])c1sc2nc(-c3cccs3)cc(-c3ccccc3)c2c1N	459147-39-8	Prostaglandin-degrading enzyme 15-PGDH inhibitor;inhibitor of the prostaglandin-degrading enzyme 15-PGDH	HPGD																																																															CHEMBL4061483											3337839					member	10.1021/acs.jmedchem.7b00271	10.1126/science.aaa2340																																																																																																																																																														28398755																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.85928																																0.35741																																8																																HY-16968	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Others|MOABOX:6952|HPGD|Prostaglandin-degrading enzyme 15-PGDH inhibitor;inhibitor of the prostaglandin-degrading enzyme 15-PGDH	CCCCS(=O)c1sc2nc(cc(c3ccccc3)c2c1N)c4cccs4	459147-39-8	17820	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469880	412.5913	SW033291	SW033291 | SW033291	Pathway: Metabolic Enzyme/Protease	Research Area: Others	MOABOX:6952	HPGD	Prostaglandin-degrading enzyme 15-PGDH inhibitor;inhibitor of the prostaglandin-degrading enzyme 15-PGDH
SJ001010865-2	SJ001010865	2	MOABOX:6953	FHWSAZXFPUMKFL-UHFFFAOYSA-N	Cc1ccc(Oc2nc3cc(-c4ccc5c(ccn5C)c4)c(Cl)cc3[nH]2)cc1C(=O)O	1219739-36-2	AMPK allosteric activator	PRKAA1	PRKAA2	PRKAB1	PRKAB2																													5563	5564	5565																													CHEMBL3393127											45256693					member	10.1021/jm401994c	10.1038/ncomms4017																																																																																																																																																														25122135	27727125	29035567																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.8664	0.24888	1.03832	-0.18361																													0.1083	0.03111	0.12979	-0.02623																													8	8	8	7																													HY-112769	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics; PI3K/Akt/mTOR | Research Area: Metabolic Disease|MOABOX:6953|PRKAA1|AMPK allosteric activator	Cc1ccc(Oc2nc3cc(Cl)c(cc3[nH]2)c4ccc5c(ccn5C)c4)cc1C(=O)O	1219739-36-2	35810	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468996	431.87102	EX229	EX229 | EX229	Pathway: Epigenetics; PI3K/Akt/mTOR	Research Area: Metabolic Disease	MOABOX:6953	PRKAA1	AMPK allosteric activator
SJ001033325-2	SJ001033325	2	MOABOX:6960	BBTFKAOFCSOZMB-UHFFFAOYSA-N	CNc1nc(-c2cccc(NC(=O)c3ccc(C(=O)OC)cc3)c2)c2cc(OC)c(OC)cc2n1	947620-48-6	PDE4 inhibitor for topical application	PDE4A	PDE4B	PDE4C	PDE4D																													5142	5143	5144																													CHEMBL3989967											24864553					member	10.1111/1346-8138.12534	10.1124/jpet.113.205542																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.83265	0	0	1.09067																													0.11895	0.0	0.0	0.15581																													7	7	7	7																													HY-12740	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:6960|PDE4A|PDE4 inhibitor for topical application	CNc1nc(c2cccc(NC(=O)c3ccc(cc3)C(=O)OC)c2)c4cc(OC)c(OC)cc4n1	947620-48-6	25759	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469101	472.49256	LOTAMILAST; RVT-501; E6005	LOTAMILAST; RVT-501; E6005 | LOTAMILAST; RVT-501; E6005	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:6960	PDE4A	PDE4 inhibitor for topical application
SJ001035058-1	SJ001035058	1	MOABOX:6963	MVWWLCCKVBTYTD-UHFFFAOYSA-N	Nc1c(O)ccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O	1547162-41-3	CRBN neomorph;E3 ligase inhibitor	CRBN																																																																										72736581					member	10.1038/nature13527																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-7.7e-003																																-0.0011																																7																																EN300-6477659	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-831-692|MOABOX:6963|CRBN|CRBN neomorph;E3 ligase inhibitor	Nc1c(O)ccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12	1547162-41-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468563	289.24354	EN300-6477659	EN300-6477659 | EN300-6477659			MOABOX:6963	CRBN	CRBN neomorph;E3 ligase inhibitor
SJ001010665-3	SJ001010665	3	MOABOX:6970	KXMZDGSRSGHMMK-VWLOTQADSA-N	Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2	1037624-75-1	Axl tyrosine kinase receptor inhibitor	AXL																																																															CHEMBL3809489											46215462	46830331	91826491	91971968		member																																																																																																																																																																26555154	27379978	28082036	29466002	30731400																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.19936																																0.14992																																8																																HY-15150	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:6970|AXL|Axl tyrosine kinase receptor inhibitor	Nc1nc(Nc2ccc3CC[C@@H](CCc3c2)N4CCCC4)nn1c5cc6CCCc7ccccc7c6nn5	1037624-75-1	28535	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469847	506.64456	BEMCENTINIB	BEMCENTINIB | BEMCENTINIB	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:6970	AXL	Axl tyrosine kinase receptor inhibitor
SJ000312287-23	SJ000312287	23	MOABOX:6971	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N	Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c2c(=O)[nH]1	1006872-74-7	de novo synthesis inhibitor;Antimetabolites;DHFR inhibitor	DHFR	GART	TYMS																														2618	7298																														CHEMBL225072	CHEMBL3989962										135410874	135410875	135565166	135565228	135565678	virtual	10.1021/cr0301144																																																																																																																																																															16078850	18680275	19371039	20527892	25602637	26317331																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																-0.19152	0.56768	-0.44088																														-0.02394	0.07096	-0.05511																														8	8	8																														AG00131R	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-016-638-470|MOABOX:6971|DHFR|de novo synthesis inhibitor;Antimetabolites;DHFR inhibitor	NC1=Nc2[nH]cc(CCc3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)c2C(=O)N1	137281-23-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468200	427.41064	PEMETREXED	PEMETREXED | LY-231514 | DISODIUM | PEMETREXED DISODIUM SALT HEPTAHYDRATE | PEMETREXED | LY-231514 | DISODIUM | PEMETREXED DISODIUM SALT HEPTAHYDRATE			MOABOX:6971	DHFR	de novo synthesis inhibitor;Antimetabolites;DHFR inhibitor
SJ000983391-2	SJ000983391	2	MOABOX:6974	DZACSLYTXLZAAF-UHFFFAOYSA-N	Cc1c(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)ccc2[nH]c(C#N)cc12	1628317-18-9	Menin inhibitor	MEN1																																																															CHEMBL3780895											90455046					member																																																																																																																																																																26744767	27513308	29738674																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.82504																																0.10313																																8																																HY-19809	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:6974|MEN1|Menin inhibitor	Cc1c(CN2CCC(CC2)Nc3ncnc4sc(CC(F)(F)F)cc34)ccc5[nH]c(cc15)C#N	1628317-18-9	23516	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468839	484.53983	MI-463	MI-463 | MI-463	Pathway: Epigenetics	Research Area: Cancer	MOABOX:6974	MEN1	Menin inhibitor
SJ000866046-5	SJ000866046	5	MOABOX:6975	DETOMBLLEOZTMZ-UHFFFAOYSA-N	Cc1c(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)ccc2c1cc(C#N)n2Cc1cn[nH]c1	1857417-13-0	Menin inhibitor	MEN1																																																															CHEMBL3780822											91667931					member																																																																																																																																																																26744767	27513308	29738674																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.69088																																0.08636																																8																																HY-16925	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:6975|MEN1|Menin inhibitor	Cc1c(CN2CCC(CC2)Nc3ncnc4sc(CC(F)(F)F)cc34)ccc5c1cc(C#N)n5Cc6cn[nH]c6	1857417-13-0	23512	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469038	564.62779	MI-503	MI-503 | MI-503	Pathway: Epigenetics	Research Area: Cancer	MOABOX:6975	MEN1	Menin inhibitor
SJ001035193-1	SJ001035193	1	MOABOX:6979	GIYKJPISDNWSJD-UHFFFAOYSA-N	O=C(O)c1ccc(-c2nc(C(=O)c3c(Cl)cccc3C3CC3)n3cccnc23)cc1O		RORC inverse agonist;RORC gene inhibitor	RORC																																																															CHEMBL3596279											117964975					member	10.1016/j.bmcl.2015.05.055																																																																																																																																																															26048793																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.60552																																0.45069																																8																																HY-19775	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:6979|RORC|RORC inverse agonist;RORC gene inhibitor	OC(=O)c1ccc(cc1O)c2nc(C(=O)c3c(Cl)cccc3C4CC4)n5cccnc25	1677668-27-7	56893	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469047	433.84384	GNE-6468	GNE-6468 | GNE-6468	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:6979	RORC	RORC inverse agonist;RORC gene inhibitor
SJ001034829-1	SJ001034829	1	MOABOX:6985	GAGGCNZJYKWGJL-UHFFFAOYSA-N	O=C(Nc1ccc(Cl)cc1Cl)c1cn[nH]n1	1080008-87-2	ALOX15 gene inhibitor	ALOX15																																																															CHEMBL3604174											16663122	69174719				virtual	10.1016/j.bmc.2016.01.042																																																																																																																																																															26037322	26899595																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.47896																																0.30987																																8																																EN300-267480	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-027-565-854|MOABOX:6985|ALOX15|ALOX15 gene inhibitor	Clc1ccc(NC(=O)c2c[nH]nn2)c(Cl)c1	936323-17-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468070	257.07614	EN300-267480	EN300-267480 | EN300-267480			MOABOX:6985	ALOX15	ALOX15 gene inhibitor
SJ000556691-2	SJ000556691	2	MOABOX:6987	GNOZQRKYZJSIPZ-UHFFFAOYSA-N	CN(C(=O)c1cc2ccccc2cc1C(=O)C(c1cccc2ccccc12)P(=O)(O)O)C1CCN(C(=O)c2ccccc2)CC1	429676-93-7	"Dual mast cell chymase, Cathepsin G inhibitor"	CMA1	CTSG																															1511																															CHEMBL164694											9830518					member																																																																																																																																																																14761180																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.5964	-0.17064																															0.32455	-0.02133																															8	8																															AA00C5NI	AABLOCKS	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-183-275|MOABOX:6987|CMA1|Dual mast cell chymase, Cathepsin G inhibitor"	CN(C1CCN(CC1)C(=O)c2ccccc2)C(=O)c3cc4ccccc4cc3C(=O)C(c5cccc6ccccc56)P(=O)(O)O	429676-93-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468267	620.63078	CATHEPSIN G INHIBITOR I	CATHEPSIN G INHIBITOR I | CATHEPSIN G INHIBITOR I			MOABOX:6987	CMA1	"Dual mast cell chymase, Cathepsin G inhibitor"
SJ001033269-2	SJ001033269	2	MOABOX:6989	RJCWBNBKOKFWNY-IDPLTSGASA-N	CC1(C)CC[C@]2(NC(=O)C(C)(F)F)CC[C@]3(C)[C@H](C(=O)C=C4[C@@]3(C)CC[C@H]3C(C)(C)C(=O)C(C#N)=C[C@]43C)[C@@H]2C1	1474034-05-3	"Erythroid Derived 2, Like 2 (Nrf2) Activators"	KEAP1																																																																										71811910					member	10.1371/journal.pone.0122942																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-12212	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Immunology/Inflammation; NF-?B | Research Area: Cancer; Inflammation/Immunology|MOABOX:6989|KEAP1|Erythroid Derived 2, Like 2 (Nrf2) Activators"	CC(F)(F)C(=O)N[C@]12CCC(C)(C)C[C@H]1[C@H]3C(=O)C=C4[C@@](C)(CC[C@H]5C(C)(C)C(=O)C(=C[C@]45C)C#N)[C@]3(C)CC2	1474034-05-3	13614	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469517	554.71087	OMAVELOXOLONE; RTA 408	OMAVELOXOLONE; RTA 408 | OMAVELOXOLONE; RTA 408	Pathway: Apoptosis; Immunology/Inflammation; NF-?B	Research Area: Cancer; Inflammation/Immunology	MOABOX:6989	KEAP1	"Erythroid Derived 2, Like 2 (Nrf2) Activators"
SJ000866009-4	SJ000866009	4	MOABOX:6990	NEXGBSJERNQRSV-UHFFFAOYSA-N	CNC(=O)c1ccccc1Oc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Br	1884220-36-3	ULK1 gene inhibitor	ULK1																																																																										92044402					member	10.1016/j.molcel.2015.05.031																																																																																																																																																															26118643																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.50218																																0.07174																																7																																HY-16966	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy | Research Area: Cancer|MOABOX:6990|ULK1|ULK1 gene inhibitor	CNC(=O)c1ccccc1Oc2nc(Nc3cc(OC)c(OC)c(OC)c3)ncc2Br	1884220-36-3	18381	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469399	489.31924	SBI-0206965	SBI-0206965 | SBI-0206965	Pathway: Apoptosis; Autophagy	Research Area: Cancer	MOABOX:6990	ULK1	ULK1 gene inhibitor
SJ001035078-1	SJ001035078	1	MOABOX:6992	YSIHYROEMJSOAS-UHFFFAOYSA-N	CC(C)C(NC(=O)Cn1c(-c2ccccc2)ncc(N)c1=O)C(=O)c1nnc(C(C)(C)C)o1	208848-19-5	Elastase inhibitor	ELANE																																																															CHEMBL25892											216294	9848373				virtual																																																																																																																																																																11150162	11312926	18053726	26358162																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0.6036																																0.07545																																8																																5651	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-624-544|MOABOX:6992|ELANE|Elastase inhibitor	CC(C)C(NC(=O)CN1C(=O)C(=CN=C1c2ccccc2)N)C(=O)c3oc(nn3)C(C)(C)C	208848-19-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468611	452.50622	ONO 6818	ONO 6818 | ONO 6818			MOABOX:6992	ELANE	Elastase inhibitor
SJ001033474-2	SJ001033474	2	MOABOX:6993	QNQZWEGMKJBHEM-UHFFFAOYSA-N	Cc1c(-c2ccnn2C)cc(C(=O)NCc2ccc(S(C)(=O)=O)cn2)c(=O)n1-c1cccc(C(F)(F)F)c1	1240425-05-1	Elastase inhibitor	ELANE																																																															CHEMBL3617964											46861622	46861623	87467823			virtual	10.1124/jpet.110.174433	10.1124/jpet.111.182139	10.1126/science.aam7355																																																																																																																																																													21825000	26358162	30385225																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.6772																																0.45965																																8																																HY-15651	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:6993|ELANE|Elastase inhibitor	CC1=C(C=C(C(=O)NCc2ccc(cn2)S(=O)(=O)C)C(=O)N1c3cccc(c3)C(F)(F)F)c4ccnn4C	848141-11-7	9910	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469109	545.53349	ALVELESTAT; AZD9668	ALVELESTAT; AZD9668 | ALVELESTAT; AZD9668	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:6993	ELANE	Elastase inhibitor
SJ001034833-1	SJ001034833	1	MOABOX:7004	BVILYIQBHXIHEN-UHFFFAOYSA-N	Cc1oc(-c2ccccc2)nc1COc1ccc(CCC(=O)O)cc1		Free Fatty Acid Receptor 1 (FFAR1;GPR40) Agonists	FFAR1																																																															CHEMBL3600993											86803224					member	10.1016/j.bmcl.2015.06.018																																																																																																																																																															26096679																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.39896																																0.42487																																8																																EN300-374328	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-030-032-974|MOABOX:7004|FFAR1|Free Fatty Acid Receptor 1 (FFAR1;GPR40) Agonists	Cc1oc(nc1COc2ccc(CCC(=O)O)cc2)c3ccccc3	1798751-25-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468074	337.36916	EN300-374328	EN300-374328 | EN300-374328			MOABOX:7004	FFAR1	Free Fatty Acid Receptor 1 (FFAR1;GPR40) Agonists
SJ001035205-1	SJ001035205	1	MOABOX:7008	FYQFEJFTCLKXTQ-UHFFFAOYSA-N	Cc1cc(C)c(S(=O)(=O)N(CCc2cccc(Br)c2)Cc2ccc(-c3cccc(S(C)(=O)=O)c3)cc2)c(C)c1	1613028-81-1	NR1D1 gene inhibitor	NR1H2																																																																										76073169					virtual	10.1016/j.ccell.2015.05.007																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.44657																																0.34951																																7																																HY-16972	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:7008|NR1H2|NR1D1 gene inhibitor	Cc1cc(C)c(c(C)c1)S(=O)(=O)N(CCc2cccc(Br)c2)Cc3ccc(cc3)c4cccc(c4)S(=O)(=O)C	1613028-81-1	17480	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469096	626.62408	SR9243	SR9243 | SR9243	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:7008	NR1H2	NR1D1 gene inhibitor
SJ000828562-2	SJ000828562	2	MOABOX:7015	LLVPDBRSUHNJQQ-UHFFFAOYSA-N	COC(=O)c1cccc(NC(=O)NC2CCN(c3ccnc(Nc4ccc(F)cc4)n3)C2)c1		BPTF gene inhibitor	BPTF																																																															CHEMBL586426											44525934					member	10.1021/acschembio.5b00483																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.49581																																-0.07083																																7																																CS-0045417	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-683-280|MOABOX:7015|BPTF|BPTF gene inhibitor	COC(=O)c1cccc(NC(=O)NC2CCN(C2)c3ccnc(Nc4ccc(F)cc4)n3)c1	1802251-00-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468167	450.46552	ST/1024586	ST/1024586 | ST/1024586			MOABOX:7015	BPTF	BPTF gene inhibitor
SJ000884177-5	SJ000884177	5	MOABOX:7019	JGWRKYUXBBNENE-UHFFFAOYSA-N	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1	1029044-16-3	CSF1R inhibitor	CSF1R																																																															CHEMBL3813873	CHEMBL3989973										25151352	73053710	145183755			member	10.1038/s41401-018-0056-0																																																																																																																																																															29107425	29499108																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.16048																																0.14506																																8																																HY-16749	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:7019|CSF1R|CSF1R inhibitor	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1	1029044-16-3	68287	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469175	417.81481	PEXIDARTINIB	PEXIDARTINIB | PLX-3397 | PEXIDARTINIB | PLX-3397	Pathway: Apoptosis; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:7019	CSF1R	CSF1R inhibitor
SJ001035224-1	SJ001035224	1	MOABOX:7020	SILHYVDKGHXGBL-UHFFFAOYSA-N	Cc1c(F)cccc1CCCCOc1ccc(C#Cc2ccc(F)c3c(CCCC(=O)O)c(C)n(CCCC(=O)O)c23)cc1	1232861-58-3	Dual CysLT1 and CysLT2 antagonist	CYSLTR1	CYSLTR2																															57105																															CHEMBL3597634											46830962					virtual	10.1021/acs.jmedchem.5b00741																																																																																																																																																															26200813																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.9692	1.56384																															0.24615	0.19548																															8	8																															HY-16780	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Inflammation/Immunology|MOABOX:7020|CYSLTR1|Dual CysLT1 and CysLT2 antagonist	Cc1c(F)cccc1CCCCOc2ccc(cc2)C#Cc3ccc(F)c4c(CCCC(=O)O)c(C)n(CCCC(=O)O)c34	1232861-58-3	44804	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469177	601.67949	GEMILUKAST | ONO-6950	"""GEMILUKAST | ONO-6950"" | ""GEMILUKAST | ONO-6950"""	Pathway: GPCR/G Protein	Research Area: Inflammation/Immunology	MOABOX:7020	CYSLTR1	Dual CysLT1 and CysLT2 antagonist
SJ001033427-2	SJ001033427	2	MOABOX:7025	RGYQPQARIQKJKH-UHFFFAOYSA-N	CN(C)c1cccc(-c2c3c(=O)n(-c4ccccc4Cl)[nH]c3cc(=O)n2C)c1	1218942-37-0	"NOX1, NOX4 inhibitor"	NOX1	NOX4																															50507																																										58496428					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.03064	2.06752																															0.12883	0.25844																															8	8																															HY-12298	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease|MOABOX:7025|NOX1|NOX1, NOX4 inhibitor"	CN(C)c1cccc(c1)C2=C3C(=CC(=O)N2C)NN(C3=O)c4ccccc4Cl	1218942-37-0	15647	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469514	394.85416	SETANAXIB; GKT137831; GKT831	SETANAXIB; GKT137831; GKT831 | SETANAXIB; GKT137831; GKT831	Pathway: Apoptosis; Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease	MOABOX:7025	NOX1	"NOX1, NOX4 inhibitor"
SJ001034973-1	SJ001034973	1	MOABOX:7036	INQUULPXCZAKMS-XKZIYDEJSA-N	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(NC(=O)CCN5CCCCC5)cc43)c2c1	181222-54-8	MAPK1 gene modulator	MAPK1																																																																										11224574					member	10.1016/j.ccell.2015.07.001																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																CS-5355	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-624-571|MOABOX:7036|MAPK1|MAPK1 gene modulator	COc1ccc2[nH]cc(\C=C\3/C(=O)Nc4ccc(NC(=O)CCN5CCCCC5)cc34)c2c1	181223-80-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468411	444.52552	DEL-22379	DEL-22379 | DEL-22379			MOABOX:7036	MAPK1	MAPK1 gene modulator
SJ000573295-6	SJ000573295	6	MOABOX:7039	LDTAHRLHGHFHKP-UHFFFAOYSA-N	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC	862812-98-4	TBK1 gene inhibitor;IKBKE (IKK-epsilon;IKK-i) Inhibitors	IKBKE	TBK1																															29110																															CHEMBL373751											11626927					member	"10.
The tool originated from literature/patent"																																																																																																																																																															16997559	17502144	24462666																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.0484	1.83464																															0.13105	0.22933																															8	8																															HY-14682	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: NF-?B | Research Area: Inflammation/Immunology|MOABOX:7039|IKBKE|TBK1 gene inhibitor;IKBKE (IKK-epsilon;IKK-i) Inhibitors	COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC	862812-98-4	60682	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469706	469.53336	U24235/171/40	U24235/171/40 | IKK-3 INHIBITOR IX | CAY10576 | U24235/171/40 | IKK-3 INHIBITOR IX | CAY10576	Pathway: NF-?B	Research Area: Inflammation/Immunology	MOABOX:7039	IKBKE	TBK1 gene inhibitor;IKBKE (IKK-epsilon;IKK-i) Inhibitors
SJ000782340-4	SJ000782340	4	MOABOX:7046	GGXICVAJURFBLW-CEYXHVGTSA-N	CC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1	130209-82-4	Prostaglandin F agonists	PTGFR																																																															CHEMBL1051											5311221	9831939	9832593	9897261	9897283	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.33464																																0.29183																																8																																HY-B0577	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Others|MOABOX:7046|PTGFR|Prostaglandin F agonists	CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc2ccccc2	130209-82-4	52043	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469490	432.5928	"LATANOPROST | AR-202 | L-PPDS | NOVA-21027 | PHXA34 AS 15 R,S-ISOMER | PHXA41 | XA41 |"	"""LATANOPROST | AR-202 | L-PPDS | NOVA-21027 | PHXA34 AS 15 R,S-ISOMER | PHXA41 | XA41 |"" | LATANOPROST | ""LATANOPROST | AR-202 | L-PPDS | NOVA-21027 | PHXA34 AS 15 R,S-ISOMER | PHXA41 | XA41 |"" | LATANOPROST"	Pathway: GPCR/G Protein	Research Area: Others	MOABOX:7046	PTGFR	Prostaglandin F agonists
SJ000181351-3	SJ000181351	3	MOABOX:7047	JZSPHTPWUXNQGB-UHFFFAOYSA-N	COc1ccc(OC)c(S(=O)(=O)Nc2cnc3ccccc3c2)c1	496014-13-2	Alkaline phosphatase inhibitor	ALPL																																																															CHEMBL567850											2931238					member	10.1021/jm900383s																																																																																																																																																															19821572	29174347																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.73392																																0.21674																																8																																AP-263/41417798	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-644-541|MOABOX:7047|ALPL|Alkaline phosphatase inhibitor	COc1ccc(OC)c(c1)S(=O)(=O)Nc2cnc3ccccc3c2	496014-13-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468526	344.38494	TNAP INHIBITOR | MLS-0038949 |	"""TNAP INHIBITOR | MLS-0038949 |"" | ""TNAP INHIBITOR | MLS-0038949 |"""			MOABOX:7047	ALPL	Alkaline phosphatase inhibitor
SJ000782328-3	SJ000782328	3	MOABOX:7050	NFLWUMRGJYTJIN-PNIOQBSNSA-N	N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O	113-81-5	Vasopressin (AVP) V2 Receptor Agonists	AVPR2																																																															CHEMBL1200556	CHEMBL1429										5311065	9812234	9833407	46783812	74538699	member	10.1021/acs.jmedchem.9b00132	10.1021/jm500365s	10.1038/sj.bjp.0703221	10.1210/mend.16.4.0796																																																																																																																																																												15084136	24874785																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.0172																																0.25215																																8																																HS-2010	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(=O)N)NC1=O)C(=O)N4CCC[C@H]4C(=O)N[C@H](CCCNC(=N)N)C(=O)NCC(=O)N	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466749	1069.21696	DESMOPRESSIN ACETATE | DDAVP | FE-992026 | KW-8008 | OX-19 |	"""DESMOPRESSIN ACETATE | DDAVP | FE-992026 | KW-8008 | OX-19 |"" | ""DESMOPRESSIN ACETATE | DDAVP | FE-992026 | KW-8008 | OX-19 |"""			MOABOX:7050	AVPR2	Vasopressin (AVP) V2 Receptor Agonists
SJ000312390-4	SJ000312390	4	MOABOX:7051	BLCLNMBMMGCOAS-URPVMXJPSA-N	CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O	1233494-97-7	gonadotropin releasing hormone agonist	GNRHR	LHCGR	GNRH1																														3973	2796																														CHEMBL1200501	CHEMBL1201247										5311128	11981235	11982741	16052011	86614451	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0																														0.0	0.0	0.0																														7	8	7																														HS-2015	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@@H]5CCC(=O)N5)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N6CCC[C@H]6C(=O)NNC(=O)N	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466750	1269.41046	GOSERELIN ACETATE| ZOLADEX	"GOSERELIN ACETATE| ZOLADEX | ""GOSERELIN ACETATE| ZOLADEX | N-(21-((1H-INDOL-3-YL)METHYL)-1,1-DIAMINO-12-(TERT-BUTOXYMETHYL)-6-(2-(2-CARBAMOYLHYDRAZINECARBONYL)PYRROLIDINE-1-CARBONYL)-15-(4-HYDROXYBENZYL)-18-(HYDROXYMETHYL)-25-(1H-IMIDAZOL-4-YL)-9-ISOBUTYL-8,11,14,17,20,23-HEXAOXO-2,7,"" | GOSERELIN ACETATE| ZOLADEX | ""GOSERELIN ACETATE| ZOLADEX | N-(21-((1H-INDOL-3-YL)METHYL)-1,1-DIAMINO-12-(TERT-BUTOXYMETHYL)-6-(2-(2-CARBAMOYLHYDRAZINECARBONYL)PYRROLIDINE-1-CARBONYL)-15-(4-HYDROXYBENZYL)-18-(HYDROXYMETHYL)-25-(1H-IMIDAZOL-4-YL)-9-ISOBUTYL-8,11,14,17,20,23-HEXAOXO-2,7,"""			MOABOX:7051	GNRHR	gonadotropin releasing hormone agonist
SJ001010804-2	SJ001010804	2	MOABOX:7057	HUEKBQXFNHWTQQ-UHFFFAOYSA-N	CNc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]cc(Cl)c12	1700693-08-8	LRRK2 inhibitor	LRRK2																																																																										112499966					member																																																																																																																																																																26005538																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.57864																																0.32233																																8																																HY-16936	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy | Research Area: Neurological Disease|MOABOX:7057|LRRK2|LRRK2 inhibitor	CNc1[nH]c(Nc2ccc(cc2OC)C(=O)N3CCOCC3)nc4ncc(Cl)c14	1700693-08-8	18634	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469662	416.86144	JH-II-127	JH-II-127 | JH-II-127	Pathway: Autophagy	Research Area: Neurological Disease	MOABOX:7057	LRRK2	LRRK2 inhibitor
SJ000285935-12	SJ000285935	12	MOABOX:7066	XEEQGYMUWCZPDN-DOMZBBRYSA-N	O[C@@H](c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)[C@H]1CCCCN1	147368-41-0	Antimalarial;Pannexin 1 (PANX1) Inhibitors	GJA8	PANX1	GJD2																														24145	57369																														CHEMBL1606	CHEMBL172										40692	65329	114972	21140863	21146010	member	10.1073/pnas.0402044101																																																																																																																																																															20939816																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.1498	0	0																														0.0214	0.0	0.0																														7	7	7																														AG00I991	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-005-933-138|MOABOX:7066|GJA8|Antimalarial;Pannexin 1 (PANX1) Inhibitors	OC(C1CCCCN1)c2cc(nc3c(cccc23)C(F)(F)F)C(F)(F)F	51773-92-3	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468625	378.31216	MEFLOQUINE	MEFLOQUINE | MEFLOQUINE HYDROCHLORIDE | LARIAM | NSC-157387 | MEFLOQUINE | MEFLOQUINE HYDROCHLORIDE | LARIAM | NSC-157387			MOABOX:7066	GJA8	Antimalarial;Pannexin 1 (PANX1) Inhibitors
SJ001035329-1	SJ001035329	1	MOABOX:7067	UIEBLUZPSFAFOC-UHFFFAOYSA-N	CCOC(=O)C1Cc2ccccc2CN1C(=O)c1ccc(SC)s1	1254944-66-5	REV-ERB anatagonist	NR1D1																																																																										53393127					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.65712																																-0.08214																																8																																HY-14415	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Metabolic Disease|MOABOX:7067|NR1D1|REV-ERB anatagonist	CCOC(=O)C1Cc2ccccc2CN1C(=O)c3ccc(SC)s3	1254944-66-5	67962	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469599	361.47836	SR8278	SR8278 | SR8278	Pathway: Others	Research Area: Metabolic Disease	MOABOX:7067	NR1D1	REV-ERB anatagonist
SJ001035162-1	SJ001035162	1	MOABOX:7071	OTEIUEJPHNOGBG-ACDBMABISA-N	O=C1Cc2cc(C(=O)N[C@@H]3C[C@@H]4CC[C@H](C3)N4S(=O)(=O)CC3CCN(CCCC(F)(F)F)CC3)c(Cl)cc2N1	1808011-22-4	non competitive SMYD3 inhibitor	SMYD3																																																															CHEMBL3798741																member																																																																																																																																																																26985287																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.97384																																0.49673																																8																																HY-19324	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:7071|SMYD3|non competitive SMYD3 inhibitor	FC(F)(F)CCCN1CCC(CS(=O)(=O)N2[C@@H]3CC[C@H]2C[C@H](C3)NC(=O)c4cc5CC(=O)Nc5cc4Cl)CC1	1808011-22-4	30689	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468969	591.08577	EPZ031686	EPZ031686 | EPZ031686	Pathway: Epigenetics	Research Area: Cancer	MOABOX:7071	SMYD3	non competitive SMYD3 inhibitor
SJ001035222-1	SJ001035222	1	MOABOX:7072	RLKRLNQEXBPQGQ-OZOXKJRCSA-N	N#Cc1ccc(O[C@@H]2c3ccccc3C[C@H]2N2CCC[C@@H](N)C2)c(Cl)c1	1333207-63-8	TRPC6 ion channel inhibitor	TRPC6																																																																										53378752	78357800	118987086			member	10.1016/j.bmcl.2018.03.056																																																																																																																																																															29752182																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.17992																																0.27249																																8																																HY-15699A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:7072|TRPC6|TRPC6 ion channel inhibitor	N[C@@H]1CCCN(C1)[C@@H]2Cc3ccccc3[C@H]2Oc4ccc(cc4Cl)C#N	1333207-63-8	10486	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469172	367.87188	SAR7334 HYDROCHLORIDE	SAR7334 HYDROCHLORIDE | SAR7334 HYDROCHLORIDE	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:7072	TRPC6	TRPC6 ion channel inhibitor
SJ000286341-5	SJ000286341	5	MOABOX:7073	MIJYXULNPSFWEK-GTOFXWBISA-N	CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1	508-02-1	Insulin Secretagogues;Secretory Phospholipase A2 (sPLA2) Inhibitors;LDL Antioxidants;G-Protein Coupled Bile Acid Receptor 1 Agonists;Protein Tyrosine Phosphatase PTP-1B Inhibitors	PLA2G2A	PTPN1	PTPN2	AKR1B10	GPBAR1																												5770	5771	57016	151306																												CHEMBL168	CHEMBL1783815										10494	11491492	46851370	46851371	46865534	member	10.1007/s11418-017-1094-5	10.1007/s11418-018-1193-y	10.1016/j.bbrc.2007.06.130	10.1021/np200118q																																																																																																																																																												21561086	26083682	26100442	26115570	26253631	26711144	28389151																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															1.24648	0.24752	-0.1631	2.67992	0.4388																												0.15581	0.03536	-0.0233	0.33499	0.05485																												8	7	7	8	8																												HY-N0156	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Autophagy; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:7073|PLA2G2A|Insulin Secretagogues;Secretory Phospholipase A2 (sPLA2) Inhibitors;LDL Antioxidants;G-Protein Coupled Bile Acid Receptor 1 Agonists;Protein Tyrosine Phosphatase PTP-1B Inhibitors	CC1(C)CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2C1)C(=O)O	508-02-1	17668	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469391	456.70032	OLEANOIC ACID	OLEANOIC ACID | OLEANOLIC ACID; ASTRANTIAGENIN C; CARYOPHYLLIN; GIGANTEUMGENIN C; GLEDIGENIN 1; VIRGAUREAGENIN B | OLEANOIC ACID | OLEANOLIC ACID; ASTRANTIAGENIN C; CARYOPHYLLIN; GIGANTEUMGENIN C; GLEDIGENIN 1; VIRGAUREAGENIN B	Pathway: Anti-infection; Autophagy; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:7073	PLA2G2A	Insulin Secretagogues;Secretory Phospholipase A2 (sPLA2) Inhibitors;LDL Antioxidants;G-Protein Coupled Bile Acid Receptor 1 Agonists;Protein Tyrosine Phosphatase PTP-1B Inhibitors
SJ001035164-1	SJ001035164	1	MOABOX:7080	GRXCLNMCJWKTAT-UHFFFAOYSA-N	COc1cccc(CC(=O)N2Cc3ccc(S(=O)(=O)Nc4cnn(C5CCC5)n4)cc3C2)c1		MOGAT 3 inhibitor	MOGAT3																																																															CHEMBL3613709											122189255					member	10.1021/acs.jmedchem.5b01008																																																																																																																																																															26258602																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.77264																																0.22158																																8																																HY-108339	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:7080|MOGAT3|MOGAT 3 inhibitor	COc1cccc(CC(=O)N2Cc3ccc(cc3C2)S(=O)(=O)Nc4cnn(n4)C5CCC5)c1	1808094-07-6	61711	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468971	467.5407	PF-06471553	PF-06471553 | PF-06471553	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:7080	MOGAT3	MOGAT 3 inhibitor
SJ001034926-1	SJ001034926	1	MOABOX:7110	BKPCQXGBKRAJDW-UHFFFAOYSA-N	O=C(Cc1ccc(Cl)cc1Cl)NCc1ccc(O)c(O)c1		ERCC1-XPF inhibitor	ERCC1	ERCC4																															2072																															CHEMBL3617002											122189958					virtual																																																																																																																																																																26318993																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.77784	0.7777																															0.22223	0.1111																															8	7																															Z1451206212	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-468-058|MOABOX:7110|ERCC1|ERCC1-XPF inhibitor	Oc1ccc(CNC(=O)Cc2ccc(Cl)cc2Cl)cc1O	1808986-37-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468256	326.17462	Z1451206212	Z1451206212 | Z1451206212			MOABOX:7110	ERCC1	ERCC1-XPF inhibitor
SJ000285191-13	SJ000285191	13	MOABOX:7122	VSNHCAURESNICA-UHFFFAOYSA-N	NC(=O)NO	127-07-1	Nitric oxide donor;Ribonucleoside-Diphosphate Reductase Inhibitors;Antimetabolites	RRM1																																																															CHEMBL467											3657	427262	427667	427821	6331027	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.16758																																-0.02394																																7																																HY-B0313	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:7122|RRM1|Nitric oxide donor;Ribonucleoside-Diphosphate Reductase Inhibitors;Antimetabolites	NC(=O)NO	127-07-1	11938	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469276	76.05466	HYDROXYUREA	HYDROXYUREA | DROXIA | HYDROXYUREA | DROXIA	Pathway: Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:7122	RRM1	Nitric oxide donor;Ribonucleoside-Diphosphate Reductase Inhibitors;Antimetabolites
SJ000833839-6	SJ000833839	6	MOABOX:7134	ONDYALNGTUAJDX-UHFFFAOYSA-N	COc1cccc2c1c(O)c(C(=O)N(C)c1ccc(C(F)(F)F)cc1)c(=O)n2C	254964-60-8	S100A9 Inhibitors;Histone Deacetylase 4 (HDAC4) Inhibitors	S100A9	HDAC4																															9759																															CHEMBL2107784											54682876	144309315				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-10528	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:7134|S100A9|S100A9 Inhibitors;Histone Deacetylase 4 (HDAC4) Inhibitors	COc1cccc2N(C)C(=O)C(=C(O)c12)C(=O)N(C)c3ccc(cc3)C(F)(F)F	254964-60-8	11506	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469222	406.35519	TASQUINIMOD	TASQUINIMOD | TASQUINIMOD	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:7134	S100A9	S100A9 Inhibitors;Histone Deacetylase 4 (HDAC4) Inhibitors
SJ001033296-2	SJ001033296	2	MOABOX:7135	ONBSHRSJOPSEGS-INIZCTEOSA-N	CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)C(F)(F)C2	1672665-49-4	HIF2a / Hif-2 alpha inhibitor (gene: EPAS1);HIF2A inhibitor (HIF-2 alpha inhibitor)	EPAS1																																																																										91754484					member																																																																																																																																																																30289716																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.76568																																0.47071																																8																																HY-12867	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:7135|EPAS1|HIF2a / Hif-2 alpha inhibitor (gene: EPAS1);HIF2A inhibitor (HIF-2 alpha inhibitor)	CS(=O)(=O)c1ccc(Oc2cc(F)cc(c2)C#N)c3CC(F)(F)[C@@H](O)c13	1672665-49-4	18477	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469190	383.34169	PT-2385	PT-2385 | PT-2385	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:7135	EPAS1	HIF2a / Hif-2 alpha inhibitor (gene: EPAS1);HIF2A inhibitor (HIF-2 alpha inhibitor)
SJ001035074-1	SJ001035074	1	MOABOX:7136	SQOCEMCKYDVLMM-IYBDPMFKSA-N	Cc1cc(C)nc(N2C[C@H]3CN(C(=O)c4c(F)cccc4-n4nccn4)C[C@H]3C2)n1	1452539-75-1	Orexin 2 receptor antagonist	HCRTR2																																																															CHEMBL3586436											86278359					virtual																																																																																																																																																																26087021																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.958																																0.24475																																8																																CS-0114023	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-156-021|MOABOX:7136|HCRTR2|Orexin 2 receptor antagonist	Cc1cc(C)nc(n1)N2CC3CN(CC3C2)C(=O)c4c(F)cccc4n5nccn5	1293284-49-7	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468598	407.44408	SELTOREXANT HCL	SELTOREXANT HCL | SELTOREXANT HCL			MOABOX:7136	HCRTR2	Orexin 2 receptor antagonist
SJ000855534-4	SJ000855534	4	MOABOX:7143	WHXMKTBCFHIYNQ-SECBINFHSA-N	C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1	131741-08-7	Troponin C slow skeletal muscle stabilizer;Calcium sensitizer;K(ATP) Channel Activators;Nitric Oxide (NO) Production Inhibitors	KCNJ8	KCNJ11	PDE3A	TNNC1																													3767	5139	7134																													CHEMBL2051955											3033825	9952373	11635803	76959325	87295905	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	3.6e-002	0																													0.0	0.0	0.0045	0.0																													7	7	8	7																													AG007KSJ	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-848-382|MOABOX:7143|KCNJ8|Troponin C slow skeletal muscle stabilizer;Calcium sensitizer;K(ATP) Channel Activators;Nitric Oxide (NO) Production Inhibitors	C[C@@H]1CC(=O)NN=C1c2ccc(NN=C(C#N)C#N)cc2	141505-33-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468247	280.28468	LEVOSIMENDAN	LEVOSIMENDAN | LEVOSIMENDAN			MOABOX:7143	KCNJ8	Troponin C slow skeletal muscle stabilizer;Calcium sensitizer;K(ATP) Channel Activators;Nitric Oxide (NO) Production Inhibitors
SJ001033470-2	SJ001033470	2	MOABOX:7144	JBPUGFODGPKTDW-UHFFFAOYSA-N	COc1cc(NC(=O)Nc2cccc(CNC(=O)OC3CCOC3)c2)ccc1-c1cnco1		Inosine monophosphate dehydrogenase inhibitor	IMPDH1	IMPDH2																															3615																																										11964344	91454986				virtual																																																																																																																																																																21507206																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.20393	1.16886																															0.17199	0.16698																															7	7																															T3444	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-170-006|MOABOX:7144|IMPDH1|Inosine monophosphate dehydrogenase inhibitor	COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@H]3CCOC3)c2)ccc1c4ocnc4	198821-22-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468152	452.45986	MERIMEPODIB; VX-497; MMPD	MERIMEPODIB; VX-497; MMPD | MERIMEPODIB; VX-497; MMPD			MOABOX:7144	IMPDH1	Inosine monophosphate dehydrogenase inhibitor
SJ001034928-1	SJ001034928	1	MOABOX:7148	PBLNJFVQMUMOJY-JXZOILRNSA-N	CC(=O)N[C@H]1/C(=N/OC(=O)Nc2ccccc2)O[C@H](CO)[C@@H](O)[C@@H]1O	132489-69-1	Hexosaminidase A inhibitor	HEXA																																																															CHEMBL404482											9576811					virtual																																																																																																																																																																2029909	15795231	21095575																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.94061																																0.27723																																7																																AA0010NN	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-782|MOABOX:7148|HEXA|Hexosaminidase A inhibitor	CC(=O)NC1C(O)C(O)C(CO)O/C/1=N\OC(=O)Nc2ccccc2	132489-69-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468262	353.32726	AA0010NN	AA0010NN | AA0010NN			MOABOX:7148	HEXA	Hexosaminidase A inhibitor
SJ000984351-3	SJ000984351	3	MOABOX:7149	VOASEWXFCTZRDF-UHFFFAOYSA-N	COc1c(C)cnc(Cn2cc(C#CCC(C)(C)O)c3c(Cl)nc(N)nc32)c1C	911397-80-3	Hsp90 inhibitor	HSP90AA1	HSP90AB1																															3326																															CHEMBL1230584											11517212					member																																																																																																																																																																22938030																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.85336	0.83335																															0.23167	0.11905																															8	7																															4701	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-035-765-802|MOABOX:7149|HSP90AA1|Hsp90 inhibitor	COc1c(C)cnc(Cn2cc(C#CCC(C)(C)O)c3c(Cl)nc(N)nc23)c1C	911397-80-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468509	413.90056	EC144	EC144 | EC144			MOABOX:7149	HSP90AA1	Hsp90 inhibitor
SJ001033572-2	SJ001033572	2	MOABOX:7153	QNTASHOAVRSLMD-FCARAQADSA-N	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=C/C(=N\O)CC[C@]4(C)[C@H]3CC[C@@]21C	22033-87-0	neuroprotective;Mitochondrial VDAC channel blocker	VDAC1																																																																										21763506					member	10.1124/jpet.107.123000	10.3390/ph3020345																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0																																0.0																																7																																HY-14796	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Neurological Disease|MOABOX:7153|VDAC1|neuroprotective;Mitochondrial VDAC channel blocker	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=NO)CC[C@]4(C)[C@H]3CC[C@]12C	22033-87-0	11213	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469822	399.6523	OLESOXIME; TRO 19622; NSC 21311	OLESOXIME; TRO 19622; NSC 21311 | OLESOXIME; TRO 19622; NSC 21311	Pathway: Metabolic Enzyme/Protease	Research Area: Neurological Disease	MOABOX:7153	VDAC1	neuroprotective;Mitochondrial VDAC channel blocker
SJ001035230-1	SJ001035230	1	MOABOX:7154	KKVYOWPPMNSLCP-UHFFFAOYSA-N	S=C(SSC(=S)N1CCOCC1)N1CCOCC1	729-46-4	PDK1 gene inhibitor	PDK1																																																															CHEMBL121556											12892					member																																																																																																																																																																28230989	30470491	30597326																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.62208																																0.20276																																8																																HY-19564	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:7154|PDK1|PDK1 gene inhibitor	S=C(SSC(=S)N1CCOCC1)N2CCOCC2	729-46-4	87475	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469223	324.50624	JX06	JX06 | JX06	Pathway: Apoptosis; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:7154	PDK1	PDK1 gene inhibitor
SJ001035206-1	SJ001035206	1	MOABOX:7163	LPUCBGGXXIUBAZ-UHFFFAOYSA-N	O=C(NC1CCN(CC(F)(F)F)CC1)c1ccc(-c2cccc(F)c2)nc1	1033836-12-2	Hematopoietic Prostaglandin D Synthase Inhibitor	HPGDS																																																															CHEMBL1233897											24991044					member																																																																																																																																																																25978964																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.75248																																0.21906																																8																																HY-10439	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Inflammation/Immunology|MOABOX:7163|HPGDS|Hematopoietic Prostaglandin D Synthase Inhibitor	Fc1cccc(c1)c2ccc(cn2)C(=O)NC3CCN(CC(F)(F)F)CC3	1033836-12-2	10473	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469099	381.36727	HPGDS INHIBITOR 1	HPGDS INHIBITOR 1 | HPGDS INHIBITOR 1	Pathway: Immunology/Inflammation	Research Area: Inflammation/Immunology	MOABOX:7163	HPGDS	Hematopoietic Prostaglandin D Synthase Inhibitor
SJ001035392-1	SJ001035392	1	MOABOX:7164	GRVNJOGSEQKVQW-AVGNSLFASA-N	Cn1cncc1C[C@H](NC(=O)[C@@H]1CCC(=O)N1)C(=O)N1CCC[C@H]1C(N)=O	34367-54-9	Thyrotropin releasing hormone agonists	TRHR																																																																										5311410					member	10.1002/cmdc.201000481																																																																																																																																																															21302359																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.15936																																0.39492																																8																																HY-107380A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Endocrinology|MOABOX:7164|TRHR|Thyrotropin releasing hormone agonists	Cn1cncc1C[C@H](NC(=O)[C@@H]2CCC(=O)N2)C(=O)N3CCC[C@H]3C(=O)N	NA	58698	GENERAL	"2,2,2-TRIFLUOROACETATE"	1	NO_SOLVATE	0	1469889	376.41026	PGLU-3-METHYL-HIS-PRO-NH2 TFA | A-42872 TFA	"""PGLU-3-METHYL-HIS-PRO-NH2 TFA | A-42872 TFA"" | ""PGLU-3-METHYL-HIS-PRO-NH2 TFA | A-42872 TFA"""	Pathway: Others	Research Area: Endocrinology	MOABOX:7164	TRHR	Thyrotropin releasing hormone agonists
SJ001033524-2	SJ001033524	2	MOABOX:7165	XNSAINXGIQZQOO-SRVKXCTJSA-N	NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1	11096-37-0	Thyrotropin releasing hormone agonists	TRHR																																																															CHEMBL1472											638678	656645	5282469	11699159	13372120	virtual																																																																																																																																																																17035026																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.386																																0.04825																																8																																HS-2023	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H]3CCC(=O)N3	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466746	362.38368	PROTIRELIN (ACETATE); TRF ACETATE; TRH ACETATE; TSH-RF ACETATE	PROTIRELIN (ACETATE); TRF ACETATE; TRH ACETATE; TSH-RF ACETATE | PROTIRELIN (ACETATE); TRF ACETATE; TRH ACETATE; TSH-RF ACETATE			MOABOX:7165	TRHR	Thyrotropin releasing hormone agonists
SJ001033312-2	SJ001033312	2	MOABOX:7166	SNFYYXUGUBUECJ-UHFFFAOYSA-N	CCC(CC)C(c1ccc(Nc2nc3ccccc3s2)cc1)n1cncn1	201410-53-9	An inhibitor of CYP26	CYP26A1																																																															CHEMBL459505											9799888	91177107	91355411	143659698	143659709	member	10.1016/j.bmc.2006.02.041	10.1016/j.bmc.2007.06.048	10.1021/acs.jmedchem.5b01780	10.1021/jm0501681	10.2174/1389557023406223																																																																																																																																																											12370067	16530416	17979744	18722776	21521770	22989911	23688132	26918322																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														2.59744																																0.32468																																8																																HY-14531	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:7166|CYP26A1|An inhibitor of CYP26	CCC(CC)C(c1ccc(Nc2nc3ccccc3s2)cc1)n4cncn4	201410-53-9	8432	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469106	377.50582	TALAROZOLE; R115866	TALAROZOLE; R115866 | TALAROZOLE; R115866	Pathway: Autophagy; Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:7166	CYP26A1	An inhibitor of CYP26
SJ000855167-3	SJ000855167	3	MOABOX:7168	FSZPIAXLCCQFCM-FCQUAONHSA-N	CN(C)Cc1cccc(N/C(=C2\C(=O)Nc3cc(C(N)=O)ccc32)c2ccccc2)c1	1094614-84-2	MEK5/ERK5 Inhibitor	MAP2K5																																																																															virtual	10.1016/j.ejmech.2013.10.052																																																																																																																																																															18834865	24239623																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.98952																																0.24869																																8																																T6324	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-009-679-458|MOABOX:7168|MAP2K5|MEK5/ERK5 Inhibitor	CNC(=O)c1ccc2c(C(=Nc3cccc(CN(C)C)c3)c4ccccc4)c(O)[nH]c2c1	1094614-84-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468159	426.51024	BIX 02188	BIX 02188 | BIX 02188			MOABOX:7168	MAP2K5	MEK5/ERK5 Inhibitor
SJ000784289-13	SJ000784289	13	MOABOX:7169	SUDAHWBOROXANE-SECBINFHSA-N	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F	391209-97-5	MEK Inhibitor	MAP2K3	MAP2K5	MAP2K6																														5607	5608																														CHEMBL507361											9826528					member																																																																																																																																																																18056456	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.5026	0.5744	0.5026																														0.0718	0.0718	0.0718																														7	8	7																														ES-0007	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC[C@@H](O)CONC(=O)c1ccc(F)c(F)c1Nc2ccc(I)cc2F	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466678	482.19304	PD-0325901	PD-0325901 | Mirdametinib  | PD0325901 | PD-0325901 | Mirdametinib  | PD0325901			MOABOX:7169	MAP2K3	MEK Inhibitor
SJ001035276-1	SJ001035276	1	MOABOX:7173	GHVMTHKJUAOZJP-CGTJXYLNSA-N	CNC(=O)[C@@H](NC(=O)[C@H](CCCc1ccccc1)[C@H](C)N(O)C=O)C(C)(C)C	260264-93-5	ADAM10 gene inhibitor	ADAM10																																																															CHEMBL1229516											9952396					virtual	10.1016/j.ejmech.2016.01.053																																																																																																																																																															24662289	26871660																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.56888																																0.07111																																8																																HY-19956	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:7173|ADAM10|ADAM10 gene inhibitor	CNC(=O)[C@@H](NC(=O)[C@H](CCCc1ccccc1)[C@H](C)N(O)C=O)C(C)(C)C	260264-93-5	63034	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469471	391.50442	GI254023X | GI4023 | SRI028594	"""GI254023X | GI4023 | SRI028594"" | ""GI254023X | GI4023 | SRI028594"""	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:7173	ADAM10	ADAM10 gene inhibitor
SJ001035209-1	SJ001035209	1	MOABOX:7174	JVRRRKAXHMGUHZ-XDJHFCHBSA-N	COc1cc(C(=O)N(CCC2CCCN2C)C/C(C)=C/c2ccccc2F)cc(OC)c1OC	1378524-41-4	ACKR3 agonist	ACKR3																																																															CHEMBL2013230											59052285	90488970	91885428			member																																																																																																																																																																22424612																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.7764																																0.22205																																8																																HY-110318	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation | Research Area: Cancer|MOABOX:7174|ACKR3|ACKR3 agonist	COc1cc(cc(OC)c1OC)C(=O)N(CCC2CCCN2C)C\C(=C\c3ccccc3F)\C	1785665-61-3	61648	GENERAL	FUMARATE	1	NO_SOLVATE	0	1469108	470.5762	VUF11207 FUMARATE	VUF11207 FUMARATE | VUF11207 FUMARATE	Pathway: GPCR/G Protein; Immunology/Inflammation	Research Area: Cancer	MOABOX:7174	ACKR3	ACKR3 agonist
SJ000160468-2	SJ000160468	2	MOABOX:7175	BYXZFAIHAQVBAH-XYOKQWHBSA-N	O=C(O)CNC(=O)/C(=C\c1cccc(Br)c1)NC(=O)c1ccco1		ADAM12 gene inhibitor	ADAM12																																																															CHEMBL366034											2270052					member																																																																																																																																																																15546732	19601832																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.27312																																-0.03414																																8																																6146494	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-973-302|MOABOX:7175|ADAM12|ADAM12 gene inhibitor	OC(=O)CNC(=O)\C(=C/c1cccc(Br)c1)\NC(=O)c2occc2	303999-83-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468437	393.18882					MOABOX:7175	ADAM12	ADAM12 gene inhibitor
SJ001033570-2	SJ001033570	2	MOABOX:7176	YVPGZQLRPAGKLA-UHFFFAOYSA-N	Cc1cc(C(N)=O)ccc1-n1c(CCC(=O)O)ccc1-c1ccc(-n2ccnc2)cc1	1208315-24-5	Alcohol Dehydrogenase class-3 (GSNOR;ADH5) Inhibitors	ADH5																																																															CHEMBL1738699											44623946					member	10.1016/j.bmcl.2011.04.086																																																																																																																																																															21570838	21855338	22342142	30340896																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.86864																																0.35858																																8																																HY-14984	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:7176|ADH5|Alcohol Dehydrogenase class-3 (GSNOR;ADH5) Inhibitors	Cc1cc(ccc1n2c(CCC(=O)O)ccc2c3ccc(cc3)n4ccnc4)C(=O)N	1208315-24-5	11455	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469181	414.45648	N6022	N6022 | N6022	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:7176	ADH5	Alcohol Dehydrogenase class-3 (GSNOR;ADH5) Inhibitors
SJ000862241-4	SJ000862241	4	MOABOX:7178	GGQCIOOSELPMBB-UHFFFAOYSA-N	COc1ccccc1-c1cc(Nc2cccc(CS(N)(=O)=O)c2)ncn1	1073485-20-7	CDK9 inhibitor	CDK9																																																															CHEMBL3263773											25104564					member																																																																																																																																																																24742150	26741853	27171036	28174091	30234987	31238183																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.76472																																0.22059																																8																																HY-15878	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:7178|CDK9|CDK9 inhibitor	COc1ccccc1c2cc(Nc3cccc(CS(=O)(=O)N)c3)ncn2	1073485-20-7	13456	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468796	370.42552	LDC000067	LDC000067 | LDC000067	Pathway: Apoptosis; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:7178	CDK9	CDK9 inhibitor
SJ001033225-2	SJ001033225	2	MOABOX:7183	YWGYNGCRVZLMCS-UHFFFAOYSA-N	O=C(Nc1cnccc1Cl)N1CCN(Cc2ccc3c(c2)OC(F)(F)O3)CC1	1346528-50-4	FAAH inhibitor	FAAH																																																																										54576693	54576694	67465468	141310119		member																																																																																																																																																																26713105																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.31352																																0.28919																																8																																HY-19636	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:7183|FAAH|FAAH inhibitor	FC1(F)Oc2ccc(CN3CCN(CC3)C(=O)Nc4cnccc4Cl)cc2O1	1346528-50-4	19587	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469105	410.80239	JNJ-42165279	JNJ-42165279 | JNJ-42165279	Pathway: Autophagy; Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:7183	FAAH	FAAH inhibitor
SJ000286068-8	SJ000286068	8	MOABOX:7185	PSIFNNKUMBGKDQ-UHFFFAOYSA-N	CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1	114798-26-4	AGTR1 gene inhibitor	AGTR1																																																															CHEMBL191	CHEMBL367465										3961	9810469	9832578	9891565	9917654	virtual	10.1002/cmdc.201100498	10.1016/S0006-291X(05)80288-8	10.1016/S0006-291X(05)80804-6	10.1016/j.ejmech.2012.07.040	10.1016/j.ejmech.2015.09.010	10.1021/jm00019a004	10.1021/jm060338p	10.1038/sj.bjp.0707323	10.1248/bpb.b16-00987	10.2174/1568016043477378																																																																																																																																																						1895308	7530721	7562905	8340920	8360871	8410980	8576904	14761190	15509155	15974591	16610806	17572702	17628868	17931598	20235539	20801892	21071232	21470174	22309912	22727371	22889560	23376252	24007859	26397395	26810314	26824643	27480029	29195045																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										1.43984																																0.17998																																8																																HY-17512	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cardiovascular Disease; Endocrinology; Cancer|MOABOX:7185|AGTR1|AGTR1 gene inhibitor	CCCCc1nc(Cl)c(CO)n1Cc2ccc(cc2)c3ccccc3c4nn[nH]n4	114798-26-4	27304	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469414	422.91062	LOSARTAN	"LOSARTAN | ""LOSARTAN POTASSIUM | COZAAR"" | SJ000565176 | LOSARTAN | ""LOSARTAN POTASSIUM | COZAAR"" | SJ000565176"	Pathway: GPCR/G Protein	Research Area: Cardiovascular Disease; Endocrinology; Cancer	MOABOX:7185	AGTR1	AGTR1 gene inhibitor
SJ001035018-1	SJ001035018	1	MOABOX:7202	NTHMDFGHOCNNOE-ZJUUUORDSA-N	CSC[C@H]1CN(Cc2c[nH]c3c(N)ncnc23)C[C@@H]1O		Methylthioadenosine Phosphorylase (MTAP) Inhibitors	MTAP																																																															CHEMBL405346											656970	73890969	76072297	76072298	76072299	member																																																																																																																																																																18251493	22854195	26260335																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.8464																																0.2308																																8																																CS-6393	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-416-807|MOABOX:7202|MTAP|Methylthioadenosine Phosphorylase (MTAP) Inhibitors	CSC[C@H]1CN(Cc2c[nH]c3c(N)ncnc23)C[C@@H]1O	653592-04-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468486	293.38786	MT-DADME-IMMA	MT-DADME-IMMA | MT-DADME-IMMA			MOABOX:7202	MTAP	Methylthioadenosine Phosphorylase (MTAP) Inhibitors
SJ000841719-4	SJ000841719	4	MOABOX:7206	YBPIBGNBHHGLEB-UHFFFAOYSA-N	Nc1ccc(C(=O)Nc2cccc(-c3nc(N4CCOCC4)c4oc5ncccc5c4n3)c2)cn1	371942-69-7	PIKFYVE gene inhibitor;Apoptosis-independent	PIKFYVE																																																															CHEMBL2178735											9956222	56965897	91895221			member	10.1038/sj.embor.7401155	10.1371/journal.pone.0060152																																																																																																																																																														18188180																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.41056																																0.17632																																8																																HY-13228	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Autophagy; PI3K/Akt/mTOR | Research Area: Cancer; Infection|MOABOX:7206|PIKFYVE|PIKFYVE gene inhibitor;Apoptosis-independent	Nc1ccc(cn1)C(=O)Nc2cccc(c2)c3nc(N4CCOCC4)c5oc6ncccc6c5n3	371942-69-7	5494	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468925	467.47934	PIKFYVE INHIBITOR | YM201636 | PTDINS3P 5-KINASE INHIBITOR |	"""PIKFYVE INHIBITOR | YM201636 | PTDINS3P 5-KINASE INHIBITOR |"" | YM201636 | ""PIKFYVE INHIBITOR | YM201636 | PTDINS3P 5-KINASE INHIBITOR |"" | YM201636"	Pathway: Anti-infection; Autophagy; PI3K/Akt/mTOR	Research Area: Cancer; Infection	MOABOX:7206	PIKFYVE	PIKFYVE gene inhibitor;Apoptosis-independent
SJ001035182-1	SJ001035182	1	MOABOX:7207	MDGIEDNDSFMSLP-UHFFFAOYSA-N	Nc1nc(NCc2ccccc2)nc(-c2ccccc2CO)n1	1309198-71-7	positive allosteric modulator of GPR68	GPR68																																																																										56707820					member	10.1038/nature15699																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-110279	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Neurological Disease|MOABOX:7207|GPR68|positive allosteric modulator of GPR68	Nc1nc(NCc2ccccc2)nc(n1)c3ccccc3CO	1309198-71-7	39811	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469020	307.34978	OGERIN	OGERIN | OGERIN	Pathway: Others	Research Area: Neurological Disease	MOABOX:7207	GPR68	positive allosteric modulator of GPR68
SJ000862703-4	SJ000862703	4	MOABOX:7208	IBGLGMOPHJQDJB-IHRRRGAJSA-N	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1	899805-25-5	JNK inhibitor	MAPK8	MAPK9	MAPK10																														5601	5602																														CHEMBL1950289																member																																																																																																																																																																22244937	29191878	31268308																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			-0.1806	1.43199	1.25678																														-0.0258	0.20457	0.17954																														7	7	7																														HY-15495	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: MAPK/ERK Pathway | Research Area: Inflammation/Immunology|MOABOX:7208|MAPK8|JNK inhibitor	O[C@@H]1CC[C@H](CC1)Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]5CCOC5)c3n2	899805-25-5	16766	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469400	448.44153	TANZISERTIB	"TANZISERTIB | ""CC-930 | TANZISERTIB | JNK-930 | JNKI-1 |"" | TANZISERTIB | ""CC-930 | TANZISERTIB | JNK-930 | JNKI-1 |"""	Pathway: MAPK/ERK Pathway	Research Area: Inflammation/Immunology	MOABOX:7208	MAPK8	JNK inhibitor
SJ000287595-4	SJ000287595	4	MOABOX:7209	AGSPXMVUFBBBMO-UHFFFAOYSA-N	N#CCCN	1119-28-4	LOX inhibitor	LOX	LOXL2																															4017																															CHEMBL1618272											1647	9856120	12244473	88094664	88138814	member	10.1021/acsmedchemlett.7b00014																																																																																																																																																															28435530	28471663																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.4496	2.24608																															0.0562	0.28076																															8	8																															AG001MZZ	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-781-446|MOABOX:7209|LOX|LOX inhibitor	NCCC#N	151-18-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468534	70.09314	3-AMINOPROPIONITRILE FUMARATE	3-AMINOPROPIONITRILE FUMARATE | 3-AMINOPROPIONITRILE FUMARATE			MOABOX:7209	LOX	LOX inhibitor
SJ000866972-4	SJ000866972	4	MOABOX:7211	RDALZZCKQFLGJP-UHFFFAOYSA-N	Cc1cc2c(C(N)=O)cccc2n1-c1nc2c(c(NCc3ccccc3)n1)COCC2	1542705-92-9	p97 AAA ATPase inhibitor	VCP																																																															CHEMBL3747513											73051434					member	10.1002/cmdc.201600036	10.1021/acs.jmedchem.5b01346																																																																																																																																																														26565666	30606672																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.928																																0.366																																8																																HY-12861	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:7211|VCP|p97 AAA ATPase inhibitor	Cc1cc2c(cccc2n1c3nc4CCOCc4c(NCc5ccccc5)n3)C(=O)N	1542705-92-9	19554	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468814	413.47172	CB-5083	CB-5083 | CB-5083	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:7211	VCP	p97 AAA ATPase inhibitor
SJ001032981-2	SJ001032981	2	MOABOX:7212	LVASCWIMLIKXLA-CABCVRRESA-N	O=C(C[C@H]1NCCC[C@@H]1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O	1217623-74-9	glutamyl-prolyl-tRNA synthetase inhibitor	EPRS1																																																															CHEMBL1162015	CHEMBL1199540										456390	11591339	46905589	57505105	71711563	member	10.1038/nchembio.790																																																																																																																																																															22327401																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.6349																																0.0907																																7																																AA00399U	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-008-266-629|MOABOX:7212|EPRS1|glutamyl-prolyl-tRNA synthetase inhibitor	O[C@H]1CCCN[C@@H]1CC(=O)CN2C=Nc3cc(Br)c(Cl)cc3C2=O	55837-20-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468636	414.68148	HALOFUGINONE HYDROBROMIDE	HALOFUGINONE HYDROBROMIDE | HALOFUGINONE HYDROBROMIDE			MOABOX:7212	EPRS1	glutamyl-prolyl-tRNA synthetase inhibitor
SJ001034914-1	SJ001034914	1	MOABOX:7214	YBSDQTBCNYWBMX-ONEGZZNKSA-N	Fc1ccc2c(/C=C/c3cccnc3)c[nH]c2c1	163239-22-3	"Tryptophan 2,3 dioxygenase inhibitor"	TDO2																																																															CHEMBL355606											10014426	129716517				member	10.1021/acs.jmedchem.5b00461	10.1073/pnas.1113873109																																																																																																																																																														21726069	22308364	22626654	26207924	30103191																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	1.9996																																0.24995																																8																																4392	TOCRIS	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-277-173|MOABOX:7214|TDO2|Tryptophan 2,3 dioxygenase inhibitor"	Fc1ccc2c(\C=C\c3cccnc3)c[nH]c2c1	163239-22-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468224	238.25964	680C91	680C91 | 680C91			MOABOX:7214	TDO2	"Tryptophan 2,3 dioxygenase inhibitor"
SJ001034924-1	SJ001034924	1	MOABOX:7215	JDBSZVDIUIRSDG-DAFODLJHSA-N	Fc1ccc2c(/C=C/c3nnn[nH]3)c[nH]c2c1	1316695-35-8	"Tryptophan 2,3 dioxygenase inhibitor;Immunosuppressant"	TDO2																																																															CHEMBL1812545											135743630					member	10.1021/acs.jmedchem.5b00461	10.1073/pnas.1113873109																																																																																																																																																														22308364	26207924	30321802																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.51248																																0.31406																																8																																AG000ZJU	ANGENE	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-423-271|MOABOX:7215|TDO2|Tryptophan 2,3 dioxygenase inhibitor;Immunosuppressant"	Fc1ccc2c(\C=C\c3nn[nH]n3)c[nH]c2c1	1316695-35-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468252	229.21312	AG000ZJU	AG000ZJU | AG000ZJU			MOABOX:7215	TDO2	"Tryptophan 2,3 dioxygenase inhibitor;Immunosuppressant"
SJ000286145-9	SJ000286145	9	MOABOX:7216	KNAHARQHSZJURB-UHFFFAOYSA-N	CCCc1cc(O)nc(S)n1	500-50-5	"Thyroid peroxidase inhibitor;Type 1 deiodinase inhibitor;""Thyroid peroxidase inhibitor;Type 1 deiodinase inhibitor"""	TPO	DIO1																															1733																															CHEMBL1518											657298	21444403	70976637	87371031	87843787	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	-1.687e-002																															0.0	-0.00241																															7	7																															PS-3436	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCCc1cc(O)nc(S)n1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466740	170.2321	PROPYLTHIOURACIL	PROPYLTHIOURACIL | PROPYLTHIOURACIL			MOABOX:7216	TPO	"Thyroid peroxidase inhibitor;Type 1 deiodinase inhibitor;""Thyroid peroxidase inhibitor;Type 1 deiodinase inhibitor"""
SJ000285746-14	SJ000285746	14	MOABOX:7218	UVTNFZQICZKOEM-UHFFFAOYSA-N	CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C	1216989-88-6	Antiarrhythmic agent;Sodium Channel Blocker	CHRM1	CHRM2	CHRM3	KCND2	KCND3	SCN5A																											1129	1131	3751	3752	6331																											CHEMBL1201020	CHEMBL517										3114	30928	3041677	21756474	22930351	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0	0	-0.27972																											0.0	0.0	0.0	0.0	0.0	-0.03996																											7	7	7	7	7	7																											WXCD00181312	WUXI_APPTECH	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-846-985|MOABOX:7218|CHRM1|Antiarrhythmic agent;Sodium Channel Blocker	CC(C)N(CCC(C(=O)N)(c1ccccc1)c2ccccn2)C(C)C	1216989-88-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468608	339.47446	DISOPYRAMIDE PHOSPHATE	"DISOPYRAMIDE PHOSPHATE | DISOPYRAMIDE | ""DISOPYRAMIDE | SC-13597 |"" | DISOPYRAMIDE PHOSPHATE | DISOPYRAMIDE | ""DISOPYRAMIDE | SC-13597 |"""			MOABOX:7218	CHRM1	Antiarrhythmic agent;Sodium Channel Blocker
SJ000870743-2	SJ000870743	2	MOABOX:7220	ABGOSOMRWSYAOB-UHFFFAOYSA-N	Clc1cc2c(NC3CCCC3)nnc(-c3ccncc3)c2cc1Cl		SUV420H1/H2 inhibitor;kmt5b and kmt5c inhibitor	KMT5B	KMT5C																															84787																																										117072548					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.16328	0																															0.39541	0.0																															8	7																															T4343	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-561-489|MOABOX:7220|KMT5B|SUV420H1/H2 inhibitor;kmt5b and kmt5c inhibitor	Clc1cc2c(NC3CCCC3)nnc(c4ccncc4)c2cc1Cl	1982372-88-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468140	359.25244	A-196	A-196 | A-196			MOABOX:7220	KMT5B	SUV420H1/H2 inhibitor;kmt5b and kmt5c inhibitor
SJ000866047-3	SJ000866047	3	MOABOX:7221	UEMQPCYDWCSVCU-UHFFFAOYSA-N	COc1cc(C#N)ccc1S(=O)(=O)Nc1ccc2c(c1)cc(C)c(=O)n2C		BRPFs;Bromodomain inhibitor	BRPF1	BRD1	BRPF3																														23774	27154																														CHEMBL3752151											91827373					member																																																																																																																																																																26572217	28714688	29902720																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.08352	1.33024	8.944e-002																														0.26044	0.16628	0.01118																														8	8	8																														HY-19537	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer; Inflammation/Immunology|MOABOX:7221|BRPF1|BRPFs;Bromodomain inhibitor	COc1cc(ccc1S(=O)(=O)Nc2ccc3N(C)C(=O)C(=Cc3c2)C)C#N	1883548-89-7	31184	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469914	383.42098	NI-57	NI-57 | NI-57	Pathway: Epigenetics	Research Area: Cancer; Inflammation/Immunology	MOABOX:7221	BRPF1	BRPFs;Bromodomain inhibitor
SJ001034936-1	SJ001034936	1	MOABOX:7223	WFOVEDJTASPCIR-UHFFFAOYSA-N	Cn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncc1		beta adrenergic receptor kinase 1 and 2	GRK2	GRK3	GRK1																														157	6011																														CHEMBL1738877											11677079	137797638				member	10.1124/mol.111.071522																																																																																																																																																															21596927	28323425	28699740																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.31288	1.8024	-0.44954																														0.16411	0.2253	-0.06422																														8	8	7																														26808	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-338-070|MOABOX:7223|GRK2|beta adrenergic receptor kinase 1 and 2	Cn1c(CNc2cccc(c2)C(=O)NCc3ccccc3C(F)(F)F)nnc1c4ccncc4	865608-11-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468292	466.45835	CMPD101	CMPD101 | CMPD101			MOABOX:7223	GRK2	beta adrenergic receptor kinase 1 and 2
SJ000852525-5	SJ000852525	5	MOABOX:7227	MYKOWOGZBMOVBJ-UHFFFAOYSA-N	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21	1173022-21-3	calcium/calmodulin-dependent protein kinase inhibitor	CAMKK2	CAMKK1																															84254																															CHEMBL1182777	CHEMBL265470										3467590	16760660	143981767			member																																																																																																																																																																17850214	29783765																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.84544	0.37376																															0.10568	0.04672																															8	8																															HY-19805	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Epigenetics; Neuronal Signaling; PI3K/Akt/mTOR | Research Area: Metabolic Disease|MOABOX:7227|CAMKK2|calcium/calmodulin-dependent protein kinase inhibitor	OC(=O)c1ccc2c3nc4ccccc4n3C(=O)c5cccc1c25	52029-86-4	23622	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469546	314.2943	STO-609	STO-609 | STO-609	Pathway: Autophagy; Epigenetics; Neuronal Signaling; PI3K/Akt/mTOR	Research Area: Metabolic Disease	MOABOX:7227	CAMKK2	calcium/calmodulin-dependent protein kinase inhibitor
SJ001035388-1	SJ001035388	1	MOABOX:7235	GHBUPSVATJKTRR-UHFFFAOYSA-N	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1	1333146-24-9		ILK																																																															CHEMBL1830587											51051074					member	10.1021/jm2007744																																																																																																																																																															21823616																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.58056																																0.19757																																8																																HY-18676B	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cytoskeleton | Research Area: Cancer|MOABOX:7235|ILK|	CNC(=O)CCc1cc(c2ccc(cc2)c3ccc(cc3)C(F)(F)F)n(n1)c4ccc(cc4)N5CCNCC5	1333146-24-9	64084	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469876	533.58731	ILK-IN-2 | OSU-T315 ANALOG	"""ILK-IN-2 | OSU-T315 ANALOG"" | ""ILK-IN-2 | OSU-T315 ANALOG"""	Pathway: Cytoskeleton	Research Area: Cancer	MOABOX:7235	ILK	
SJ001035337-1	SJ001035337	1	MOABOX:7239	QIHBWVVVRYYYRO-ZDUSSCGKSA-N	C[C@H](NC(=O)CCc1nc2ccccc2c(=O)[nH]1)c1ccccc1	1445251-22-8	PARP3 inhibitor	PARP3																																																															CHEMBL3092537											135566764					member																																																																																																																																																																24188023																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.95104																																0.11888																																8																																HY-100225	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:7239|PARP3|PARP3 inhibitor	C[C@H](NC(=O)CCC1=NC(=O)c2ccccc2N1)c3ccccc3	1445251-22-8	32802	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469643	321.37306	ME0328	ME0328 | ME0328	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:7239	PARP3	PARP3 inhibitor
SJ001010614-2	SJ001010614	2	MOABOX:7240	XCFRUAOZMVFDPQ-AWEZNQCLSA-N	Cc1cc(O)c(-c2ccc([C@@H](C)CN(C)C)cc2)c2c1[nH]c(=O)c1sccc12	1338545-07-5	TOPK inihibitor	PBK																																																															CHEMBL3672369											67448186	89675898	131709236			member	10.1016/j.ejmech.2018.11.007																																																																																																																																																															30453248																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.69248																																0.33656																																8																																HY-12467	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:7240|PBK|TOPK inihibitor	C[C@@H](CN(C)C)c1ccc(cc1)c2c(O)cc(C)c3NC(=O)c4sccc4c23	1338545-07-5	29577	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469196	392.51386	OTS964 (HYDROCHLORIDE)	OTS964 (HYDROCHLORIDE) | OTS964 (HYDROCHLORIDE)	Pathway: Apoptosis; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:7240	PBK	TOPK inihibitor
SJ000841748-2	SJ000841748	2	MOABOX:7244	OJHMDRZMENMQFP-UHFFFAOYSA-N	Nc1c(C(=O)c2ccccc2)sc2[nH]c(=O)c(C(=O)O)cc12	439946-22-2	Ubiquitin C-terminal Hydrolase L1 (UCH-L1) Inhibitors;Inhibitor of Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4)	UCHL1																																																															CHEMBL1190585	CHEMBL541136										950368	45265922				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.45759																																0.06537																																7																																HY-12989	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer; Neurological Disease|MOABOX:7244|UCHL1|Ubiquitin C-terminal Hydrolase L1 (UCH-L1) Inhibitors;Inhibitor of Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4)	Nc1c2C=C(C(=O)O)C(=O)Nc2sc1C(=O)c3ccccc3	439946-22-2	79627	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469697	314.3159	UCH-L1 INHIBITOR II | LDN-91946 |	"""UCH-L1 INHIBITOR II | LDN-91946 |"" | ""UCH-L1 INHIBITOR II | LDN-91946 |"""	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer; Neurological Disease	MOABOX:7244	UCHL1	Ubiquitin C-terminal Hydrolase L1 (UCH-L1) Inhibitors;Inhibitor of Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4)
SJ000855525-3	SJ000855525	3	MOABOX:7245	IDLAOWFFKWRNHB-UHFFFAOYSA-N	O=C1CC(=O)c2c(Cl)c(Cl)c(Cl)c(Cl)c21	30675-13-9		UCHL3																																																															CHEMBL1241028											2729042					virtual	10.1016/j.bmc.2007.07.016																																																																																																																																																															17761421	17948018																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.90432																																0.23804																																8																																HY-18638	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Neurological Disease|MOABOX:7245|UCHL3|	Clc1c(Cl)c(Cl)c2C(=O)CC(=O)c2c1Cl	30675-13-9	61376	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469313	283.92298	TCID	TCID | TCID	Pathway: Cell Cycle/DNA Damage	Research Area: Neurological Disease	MOABOX:7245	UCHL3	
SJ001010928-2	SJ001010928	2	MOABOX:7249	ICCFXXDUYSPKOL-UHFFFAOYSA-N	O=[N+]([O-])c1ccc(Sc2cccc[n+]2[O-])c2nonc12	113104-25-9	EGFR dimerization inducer	EGFR																																																															CHEMBL505670											313619					virtual	10.1038/srep03977																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-101084	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:7249|EGFR|EGFR dimerization inducer	[O-][N+](=O)c1ccc(Sc2cccc[n+]2[O-])c3nonc13	113104-25-9	39191	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469353	290.25474	NSC 228155	NSC 228155 | NSC 228155	Pathway: Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:7249	EGFR	EGFR dimerization inducer
SJ000834140-5	SJ000834140	5	MOABOX:7251	ULFUJLFTRWWLPO-UHFFFAOYSA-N	CCOC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2)cc1	1099644-42-4	TGFBR2 degrador	TGFBR2																																																															CHEMBL2180273											44135961					member	10.1021/jm301144g																																																																																																																																																															23130626																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.5756																																-0.07195																																8																																HY-12704	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: TGF-beta/Smad | Research Area: Cardiovascular Disease|MOABOX:7251|TGFBR2|TGFBR2 degrador	CCOC(=O)C1=C(C)NC2=C(C1c3ccc(cc3)c4ccccc4)C(=O)CC(C)(C)C2	1099644-42-4	39980	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468965	415.52406	ITD-1	ITD-1 | ITD-1	Pathway: TGF-beta/Smad	Research Area: Cardiovascular Disease	MOABOX:7251	TGFBR2	TGFBR2 degrador
SJ001035372-1	SJ001035372	1	MOABOX:7254	JYSLFQTWNRYWJT-UHFFFAOYSA-N	CC(C)NCCCn1c(Sc2cc(Cl)cc(Cl)c2)nc2c(N)ncnc21	1454619-14-7	inhibitor of Grp94	HSP90B1																																																															CHEMBL3426781											71660551					member																																																																																																																																																																25141341	25901531																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.9548																																0.11935																																8																																HY-18680	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:7254|HSP90B1|inhibitor of Grp94	CC(C)NCCCn1c(Sc2cc(Cl)cc(Cl)c2)nc3c(N)ncnc13	1454619-14-7	58687	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469826	411.3519	PU-WS13	PU-WS13 | PU-WS13	Pathway: Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:7254	HSP90B1	inhibitor of Grp94
SJ000785945-3	SJ000785945	3	MOABOX:7260	RQCXKDWOCUJWQZ-UHFFFAOYSA-N	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12	214697-26-4	Adenylate kinase inhibitor	AK1	AK2	AK4	AK5	AK3	AK7	AK8	AK9	AK6																								204	205	26289	50808	122481	158067	221264	102157402																								CHEMBL1394464	CHEMBL66089										1973	16218884	16759178	16760265	71297123	member																																																																																																																																																																11082453	11123986	11140740	11160636	11514141	15050645	15078144	15214773	15638777	15863000	16918456	17197188	21291368	27410258																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								0.31059	0.31059	0.31059	0.31059	0.31059	0.31059	0.31059	0.31059	0.23303																								0.04437	0.04437	0.04437	0.04437	0.04437	0.04437	0.04437	0.04437	0.03329																								7	7	7	7	7	7	7	7	7																								HY-103161	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Inflammation/Immunology|MOABOX:7260|AK1|Adenylate kinase inhibitor	Nc1ncnc2nc(cc(c3cccc(Br)c3)c12)c4ccc(nc4)N5CCOCC5	1188890-28-9	32434	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469431	463.32986	ABT-702 DIHYDROCHLORIDE |	ABT-702 DIHYDROCHLORIDE | | ABT-702 DIHYDROCHLORIDE |	Pathway: Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Inflammation/Immunology	MOABOX:7260	AK1	Adenylate kinase inhibitor
SJ001015386-2	SJ001015386	2	MOABOX:7262	VVWGPQZBDQVQRC-RMKNXTFCSA-N	O=C(/C=C/c1cncc(F)c1)c1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		EIF4G gene inhibitor	EIF4G1																																																																										121241171					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-19560	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:7262|EIF4G1|EIF4G gene inhibitor	Fc1cncc(\C=C\C(=O)C2=C(c3ccccc3)c4cc(Cl)ccc4NC2=O)c1	1821280-29-8	21057	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469470	404.82086	SBI-0640756 | SBI-756	"""SBI-0640756 | SBI-756"" | ""SBI-0640756 | SBI-756"""	Pathway: Autophagy; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:7262	EIF4G1	EIF4G gene inhibitor
SJ001035326-1	SJ001035326	1	MOABOX:7263	GSRTWXVBHGOUBU-UHFFFAOYSA-N	O=c1[nH]c(=S)[nH]c2nc(-c3ccccc3)c(-c3ccccc3)nc12	14892-97-8	inhibitor of dna ligase IV	LIG4																																																																										10688007					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-107845	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:7263|LIG4|inhibitor of dna ligase IV	O=C1NC(=S)Nc2nc(c3ccccc3)c(nc12)c4ccccc4	14892-97-8	15473	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469590	332.37908	SCR7 PYRAZINE	SCR7 PYRAZINE | SCR7 PYRAZINE	Pathway: Apoptosis; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:7263	LIG4	inhibitor of dna ligase IV
SJ001035399-1	SJ001035399	1	MOABOX:7266	PWDYHMBTPGXCSN-VCBMUGGBSA-N	C/C(=N\NC(=N)N)c1cc(NC(=O)CCCCCCCCC(=O)Nc2cc(/C(C)=N/NC(=N)N)cc(/C(C)=N/NC(=N)N)c2)cc(/C(C)=N/NC(=N)N)c1	164301-51-3	"""inhibits TNF-alpha - proposed NO inhibitor and/or p38 MAPK pathway; proposed to act via vagus nerve"""	DHPS																																																															CHEMBL2107779											5745214	9554199	9575813	11600433	72941929	member																																																																																																																																																																15296643																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-1.302e-002																																-0.00186																																7																																HY-15509A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Immunology/Inflammation; MAPK/ERK Pathway | Research Area: Inflammation/Immunology|MOABOX:7266|DHPS|\inhibits TNF-alpha - proposed NO inhibitor and/or p38 MAPK pathway; proposed to act via vagus nerve\	C\C(=N/NC(=N)N)\c1cc(NC(=O)CCCCCCCCC(=O)Nc2cc(cc(c2)\C(=N\NC(=N)N)\C)\C(=N\NC(=N)N)\C)cc(c1)\C(=N\NC(=N)N)\C	164301-51-3	85012	GENERAL	CHLORIDE	4	NO_SOLVATE	0	1469909	744.89608	SEMAPIMOD TETRAHYDROCHLORIDE | CNI-1493 | CPSI-2364 TETRAHYDROCHLORIDE	"""SEMAPIMOD TETRAHYDROCHLORIDE | CNI-1493 | CPSI-2364 TETRAHYDROCHLORIDE"" | ""SEMAPIMOD TETRAHYDROCHLORIDE | CNI-1493 | CPSI-2364 TETRAHYDROCHLORIDE"""	Pathway: Apoptosis; Immunology/Inflammation; MAPK/ERK Pathway	Research Area: Inflammation/Immunology	MOABOX:7266	DHPS	\inhibits TNF-alpha - proposed NO inhibitor and/or p38 MAPK pathway; proposed to act via vagus nerve\
SJ001035007-1	SJ001035007	1	MOABOX:7267	JHOPCCOYRKEHQU-UHFFFAOYSA-N	COc1cc(OC)c2ccccc2c1C=C1C(=O)NC(=S)NC1=O		C-Rel proto-oncogene protein inhibitor	REL																																																																										90082813					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																22298	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-571-694|MOABOX:7267|REL|C-Rel proto-oncogene protein inhibitor	COc1cc(OC)c2ccccc2c1C=C3C(=O)NC(=S)NC3=O	1584121-99-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468461	342.36906	IT-901	IT-901 | IT-901			MOABOX:7267	REL	C-Rel proto-oncogene protein inhibitor
SJ001035004-1	SJ001035004	1	MOABOX:7272	DFNOJNBNTVQPCA-UHFFFAOYSA-N	Nc1c(C(=O)Nc2c(F)cc(F)cc2Br)sc2nc3c(cc12)CCC3	497061-48-0	ATOX1 inhibitor	ATOX1																																																																										1025330					member	10.1038/NCHEM.2381																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																19283	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-719-812|MOABOX:7272|ATOX1|ATOX1 inhibitor	Nc1c(sc2nc3CCCc3cc12)C(=O)Nc4c(F)cc(F)cc4Br	497061-48-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468456	424.26249	DC_AC50	DC_AC50 | DC_AC50			MOABOX:7272	ATOX1	ATOX1 inhibitor
SJ000841247-3	SJ000841247	3	MOABOX:7273	CVSVTCORWBXHQV-UHFFFAOYSA-N	CN(CC(=O)O)C(=N)N	1093737-19-9	ADP to ATP Phosphate donor;Creatine Kinase substrate	CKB	CKBE	CKM	CKMT1B	CKMT2	CKMT1A																											1156	1158	1159	1160	548596																											CHEMBL283800											586	80116	134732	7058172	9794442	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0	0	0																											0.0	0.0	0.0	0.0	0.0	0.0																											7	7	7	7	7	7																											STR05570	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CN(CC(=O)O)C(=N)N	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466787	131.13316	"CREATINE, ANHYDROUS | AL-02 | ALS-02 | CMT-02 | DMD-02 | HD-02 | PD-02 |"	"""CREATINE, ANHYDROUS | AL-02 | ALS-02 | CMT-02 | DMD-02 | HD-02 | PD-02 |"" | ""CREATINE, ANHYDROUS | AL-02 | ALS-02 | CMT-02 | DMD-02 | HD-02 | PD-02 |"""			MOABOX:7273	CKB	ADP to ATP Phosphate donor;Creatine Kinase substrate
SJ001034920-1	SJ001034920	1	MOABOX:7279	KIAPWMKFHIKQOZ-UHFFFAOYSA-N	COC(=O)c1ccccc1NC(=O)c1ccc(F)cc1	461681-88-9	Golgi ARF 1 (ADP-Ribosylation Factor) GTPase activator	ARF1																																																															CHEMBL250428											310557					virtual	10.1073/pnas.0631766100																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																STK514439	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-133-329|MOABOX:7279|ARF1|Golgi ARF 1 (ADP-Ribosylation Factor) GTPase activator	COC(=O)c1ccccc1NC(=O)c2ccc(F)cc2	461681-88-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468240	273.25908	STK514439	STK514439 | STK514439			MOABOX:7279	ARF1	Golgi ARF 1 (ADP-Ribosylation Factor) GTPase activator
SJ000288241-5	SJ000288241	5	MOABOX:7280	XCCTYIAWTASOJW-XVFCMESISA-N	O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1	27821-45-0	P2Y6 purinoceptor antagonist	P2RY6																																																															CHEMBL130266											6031	21155597	21155601	22797839	23616595	virtual	10.1016/S0960-894X(00)00612-0	10.1016/j.bcp.2004.01.011	10.1016/j.bmc.2008.05.013	10.1016/j.bmc.2012.07.042	10.1016/j.bmcl.2009.04.027	10.1021/jm020046y	10.1021/jm050911p	10.1021/jm060485n	10.1021/jm060848j	10.1021/jm060903o	10.1021/jm100287t	10.1021/jm1016297	10.1021/jm901432g	10.1021/jm901450d	10.2174/187152712803581047																																																																																																																																																	11206448	11754592	12213051	16366591	16942026	17125260	17302398	18514530	19902968	20095577	20446735	21417463	22901672																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									3.07536																																0.38442																																8																																HY-W010832	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; GPCR/G Protein; Metabolic Enzyme/Protease | Research Area: Metabolic Disease; Inflammation/Immunology|MOABOX:7280|P2RY6|P2Y6 purinoceptor antagonist	O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(=O)(O)OP(=O)(O)O)N2C=CC(=O)NC2=O	27821-45-0	28471	GENERAL	SODIUM(I)	2	NO_SOLVATE	0	1468987	404.16118	URIDINE 5'-DIPHOSPHATE SODIUM	URIDINE 5'-DIPHOSPHATE SODIUM | URIDINE-5'-DIPHOSPHATE | URIDINE 5'-DIPHOSPHATE SODIUM | URIDINE-5'-DIPHOSPHATE	Pathway: Cell Cycle/DNA Damage; GPCR/G Protein; Metabolic Enzyme/Protease	Research Area: Metabolic Disease; Inflammation/Immunology	MOABOX:7280	P2RY6	P2Y6 purinoceptor antagonist
SJ000855495-4	SJ000855495	4	MOABOX:7283	CJLMANFTWLNAKC-UHFFFAOYSA-N	COc1cc(-c2cc(-c3cccc(O)c3)cnc2N)cc(OC)c1OC	1431985-92-0	ACVRL1 gene inhibitor	ACVRL1																																																															CHEMBL1230714											46173038					virtual																																																																																																																																																																23646137																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.86952																																0.10869																																8																																HY-12278	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: TGF-beta/Smad | Research Area: Others|MOABOX:7283|ACVRL1|ACVRL1 gene inhibitor	COc1cc(cc(OC)c1OC)c2cc(cnc2N)c3cccc(O)c3	1431985-92-0	13316	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469395	352.3838	K02288	K02288 | K02288	Pathway: TGF-beta/Smad	Research Area: Others	MOABOX:7283	ACVRL1	ACVRL1 gene inhibitor
SJ000855343-3	SJ000855343	3	MOABOX:7285	GKWPCEFFIHSJOE-UHFFFAOYSA-N	CCN(C(=O)c1c(O)c2c(Cl)cccc2n(C)c1=O)c1ccccc1	248281-84-7	Immunomodulator	AHR																																																															CHEMBL66092											54677946	54717327	54721379	67081938	69149679	member	10.1016/j.jns.2011.02.019	10.1016/j.tiv.2018.06.010																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0																																0.0																																7																																HY-13010	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; NF-?B | Research Area: Inflammation/Immunology|MOABOX:7285|AHR|Immunomodulator	CCN(C(=O)C1=C(O)c2c(Cl)cccc2N(C)C1=O)c3ccccc3	248281-84-7	6537	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468846	356.80288	LAQUINIMOD	LAQUINIMOD | LAQUINIMOD	Pathway: Apoptosis; NF-?B	Research Area: Inflammation/Immunology	MOABOX:7285	AHR	Immunomodulator
SJ000796078-2	SJ000796078	2	MOABOX:7286	FZHHRERIIVOATI-UHFFFAOYSA-N	OC(CNc1ccccc1)Cn1c2ccc(Br)cc2c2cc(Br)ccc21	301353-96-8	Neuroprotective;Neuroprotectant;Nicotinamide Phosphoribosyltransferase (NAmPRTase;Nampt) Activators	NAMPT																																																															CHEMBL2442630											2836187	91933876				member	10.1021/jm401919s																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-15976	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Neurological Disease|MOABOX:7286|NAMPT|Neuroprotective;Neuroprotectant;Nicotinamide Phosphoribosyltransferase (NAmPRTase;Nampt) Activators	OC(CNc1ccccc1)Cn2c3ccc(Br)cc3c4cc(Br)ccc24	301353-96-8	21400	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469277	474.18842	P7C3	P7C3 | P7C3	Pathway: Others	Research Area: Neurological Disease	MOABOX:7286	NAMPT	Neuroprotective;Neuroprotectant;Nicotinamide Phosphoribosyltransferase (NAmPRTase;Nampt) Activators
SJ001035278-1	SJ001035278	1	MOABOX:7287	LFMPVTVPXHNXOT-HNNXBMFYSA-N	CCC[C@H](C)Oc1nc(N)c2[nH]c(=O)n(CCCCCN3CCCCC3)c2n1	1207629-49-9	TLR7 antagonist	TLR7																																																																										44623937	53342522	117641407			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-118250	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Immunology/Inflammation | Research Area: Inflammation/Immunology|MOABOX:7287|TLR7|TLR7 antagonist	CCC[C@H](C)Oc1nc(N)c2NC(=O)N(CCCCCN3CCCCC3)c2n1	1207629-49-9	66705	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469473	390.52296	GSK2245035	GSK2245035 | GSK2245035	Pathway: Apoptosis; Immunology/Inflammation	Research Area: Inflammation/Immunology	MOABOX:7287	TLR7	TLR7 antagonist
SJ000287674-5	SJ000287674	5	MOABOX:7293	KRWMERLEINMZFT-UHFFFAOYSA-N	Nc1nc(OCc2ccccc2)c2[nH]cnc2n1	1000874-21-4	O6-Alkylguanine-DNA Alkyltransferase (MGMT) Inhibitors	MGMT																																																															CHEMBL130333	CHEMBL407874										4578	9932671	10125375	10286198	69120729	member	10.1016/j.bmc.2011.01.038	10.1016/j.bmcl.2012.08.008	10.1016/j.ejmech.2005.11.007	10.1021/jm010006e	10.2174/1389557033487980																																																																																																																																																											1447749	7830279	9857094	11063604	11181929	11708909	12769698	15239666	15993610	16458393	17880193	17996846	18973327	21320783	22932317	25612194	27347909																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.77344																																0.47168																																8																																KS-5281	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Nc1nc(OCc2ccccc2)c3nc[nH]c3n1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466700	241.24864	O6-BENZYLGUANINE	O6-BENZYLGUANINE | O6-BENZYLGUANINE			MOABOX:7293	MGMT	O6-Alkylguanine-DNA Alkyltransferase (MGMT) Inhibitors
SJ000285195-16	SJ000285195	16	MOABOX:7293	KRWMERLEINMZFT-UHFFFAOYSA-N	Nc1nc(OCc2ccccc2)c2[nH]cnc2n1	1000874-21-4	O6-Alkylguanine-DNA Alkyltransferase (MGMT) Inhibitors	MGMT																																																															CHEMBL130333	CHEMBL407874										4578	9932671	10125375	10286198	69120729	member	10.1016/j.bmc.2011.01.038	10.1016/j.bmcl.2012.08.008	10.1016/j.ejmech.2005.11.007	10.1021/jm010006e	10.2174/1389557033487980																																																																																																																																																											1447749	7830279	9857094	11063604	11181929	11708909	12769698	15239666	15993610	16458393	17880193	17996846	18973327	21320783	22932317	25612194	27347909																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.77344																																0.47168																																8																																AS-13109	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Sc1ncnc2nc[nH]c12	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466848	152.17706	MERCAPTOPURINE	"MERCAPTOPURINE | 6-MERCAPTOPURINE | ""6-MERCAPTOPURINE MONOHYDRATE | DR-6MP | NCS-755 | MERCAPTOPURINE |"" | ""MERCAPTOPURINE | DR-6MP | NCS-755 | 6-MERCAPTOPURINE |"" | MERCAPTOPURINE (6-MP) | MERCAPTOPURINE | 6-MERCAPTOPURINE | ""6-MERCAPTOPURINE MONOHYDRATE | DR-6MP | NCS-755 | MERCAPTOPURINE |"" | ""MERCAPTOPURINE | DR-6MP | NCS-755 | 6-MERCAPTOPURINE |"" | MERCAPTOPURINE (6-MP)"			MOABOX:7293	MGMT	O6-Alkylguanine-DNA Alkyltransferase (MGMT) Inhibitors
SJ000234189-2	SJ000234189	2	MOABOX:7295	QBVIRPJBDIZKBC-UHFFFAOYSA-N	CCOC(=O)c1sc(NC(=O)c2ccco2)c(SC#N)c1C	681159-27-3	PHGDH inhibitor	PHGDH																																																															CHEMBL4070806											4674993					virtual	10.1073/pnas.1521548113																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.27657																																-0.03951																																7																																HY-100012	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:7295|PHGDH|PHGDH inhibitor	CCOC(=O)c1sc(NC(=O)c2occc2)c(SC#N)c1C	681159-27-3	20828	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469270	336.38608			Pathway: Others	Research Area: Cancer	MOABOX:7295	PHGDH	PHGDH inhibitor
SJ000884179-3	SJ000884179	3	MOABOX:7297	DYLUUSLLRIQKOE-UHFFFAOYSA-N	CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1	1446502-11-9	IDH2 R140Q mutant inhibitor	IDH2																																																															CHEMBL3989908	CHEMBL3989931										89683805	90480031				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.96896																																0.37112																																8																																HY-18690	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:7297|IDH2|IDH2 R140Q mutant inhibitor	CC(C)(O)CNc1nc(Nc2ccnc(c2)C(F)(F)F)nc(n1)c3cccc(n3)C(F)(F)F	1446502-11-9	18195	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468803	473.375	ENASIDENIB	ENASIDENIB | AG-221 | ENASIDENIB | AG-221	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:7297	IDH2	IDH2 R140Q mutant inhibitor
SJ000826809-2	SJ000826809	2	MOABOX:7301	BPBPYQWMFCTCNG-UHFFFAOYSA-N	CCC(C)SSc1ncc[nH]1	141400-58-0	Thioredoxin 1 competitive irrreversible inhibitor	TXN	TXNRD1	TXNRD2																														7296	10587																														CHEMBL406050											219104					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.39335	-0.1603	0																														0.19905	-0.0229	0.0																														7	7	7																														HY-13734	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:7301|TXN|Thioredoxin 1 competitive irrreversible inhibitor	CCC(C)SSc1ncc[nH]1	141400-58-0	15244	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469793	188.31358	PX 12	PX 12 | PX 12	Pathway: Others	Research Area: Cancer	MOABOX:7301	TXN	Thioredoxin 1 competitive irrreversible inhibitor
SJ000870804-2	SJ000870804	2	MOABOX:7303	UMRRDXVUROEIKJ-JCXBGQGISA-N	CCN(CC)CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(C(C)(C)C)cc1)C(=O)N[C@@H](CO)C(=O)OC		CDX4 gene inhibitor;CBX and CDY Kme inhibitor	CBX4	CBX7	CDYL2																														23492	124359																														CHEMBL3939958											101043861					member																																																																																																																																																																27571219																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.94432	1.1488	-1.784e-002																														0.24304	0.1436	-0.00223																														8	8	8																														HY-100832	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:7303|CBX4|CDX4 gene inhibitor;CBX and CDY Kme inhibitor	CCN(CC)CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)c2ccc(cc2)C(C)(C)C)C(=O)N[C@@H](CO)C(=O)OC	1872382-47-2	22848	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469210	795.01954	UNC3866	UNC3866 | UNC3866	Pathway: Epigenetics	Research Area: Cancer	MOABOX:7303	CBX4	CDX4 gene inhibitor;CBX and CDY Kme inhibitor
SJ001034988-1	SJ001034988	1	MOABOX:7305	JCTUPGHJPIIZOK-UHFFFAOYSA-N	O=C(Nc1ccccc1)Nc1ccc(OC(F)(F)F)cc1		P2Y1 antagonist	P2RY1																																																																										2067709					member																																																																																																																																																																24164581																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.80448																																0.40064																																7																																5637090	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-117-166|MOABOX:7305|P2RY1|P2Y1 antagonist	FC(F)(F)Oc1ccc(NC(=O)Nc2ccccc2)cc1	380186-64-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468432	296.24455	5637090	5637090 | 5637090			MOABOX:7305	P2RY1	P2Y1 antagonist
SJ000285700-12	SJ000285700	12	MOABOX:7308	MLYYVTUWGNIJIB-BXKDBHETSA-N	Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1	115850-11-8	paraoxonase 1 inhibitor;antibiotic	PON1																																																															CHEMBL1435											33255	6479528	23620088	52937190	56843020	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					5.691e-002																																0.00813																																7																																HY-B1078	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Infection|MOABOX:7308|PON1|paraoxonase 1 inhibitor;antibiotic	Cc1nnc(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)Cn4cnnn4)C3=O)C(=O)O)s1	27164-46-1	17764	GENERAL	SODIUM(I)	1	NO_SOLVATE	0	1468836	454.50716	CEFAZOLIN SODIUM	"CEFAZOLIN SODIUM | CEFAZOLIN SODIUM SALT | ""CEFAZOLIN SODIUM SALT | SK AND F-41558 |"" | CEFAZOLIN SODIUM | CEFAZOLIN SODIUM SALT | ""CEFAZOLIN SODIUM SALT | SK AND F-41558 |"""	Pathway: Anti-infection	Research Area: Infection	MOABOX:7308	PON1	paraoxonase 1 inhibitor;antibiotic
SJ001010966-3	SJ001010966	3	MOABOX:7309	HYHMLYSLQUKXKP-UHFFFAOYSA-N	CC(C)(CCCCCC(O)CCCCCC(C)(C)C(=O)O)C(=O)O	738606-46-7	ATP citrate lyase inhibitor	ACLY																																																															CHEMBL3545313											10472693	69694768	91664366			virtual	10.1038/ncomms13457																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-12357	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics; Metabolic Enzyme/Protease; PI3K/Akt/mTOR | Research Area: Metabolic Disease|MOABOX:7309|ACLY|ATP citrate lyase inhibitor	CC(C)(CCCCCC(O)CCCCCC(C)(C)C(=O)O)C(=O)O	738606-46-7	25200	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469005	344.48614	BEMPEDOIC ACID	BEMPEDOIC ACID | BEMPEDOIC ACID	Pathway: Epigenetics; Metabolic Enzyme/Protease; PI3K/Akt/mTOR	Research Area: Metabolic Disease	MOABOX:7309	ACLY	ATP citrate lyase inhibitor
SJ000285927-6	SJ000285927	6	MOABOX:7310	XRCFXMGQEVUZFC-UHFFFAOYSA-N	COc1ccc(C2C(=O)c3ccccc3C2=O)cc1	117-37-3	gamma carboxylation inhibitor	GGCX																																																															CHEMBL712											2197	117868175	142185527			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-B0924	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cardiovascular Disease|MOABOX:7310|GGCX|gamma carboxylation inhibitor	COc1ccc(cc1)C2C(=O)c3ccccc3C2=O	117-37-3	21779	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469627	252.26468	ANISINDIONE	"ANISINDIONE | ""ANISINDIONE | MIRADON"" | ANISINDIONE | ""ANISINDIONE | MIRADON"""	Pathway: Others	Research Area: Cardiovascular Disease	MOABOX:7310	GGCX	gamma carboxylation inhibitor
SJ000518945-7	SJ000518945	7	MOABOX:7311	BMKDZUISNHGIBY-ZETCQYMHSA-N	C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1	149003-01-0	Topoisomerase II inhibitor	TOP2B																																																															CHEMBL1200778	CHEMBL1738										71384	6918223	16737299	16737300	16737301	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																BD123889	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-167-534|MOABOX:7311|TOP2B|Topoisomerase II inhibitor	C[C@@H](CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2	24584-09-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468352	268.26914	DEXRAZOXANE	"DEXRAZOXANE | DEXRAZOXANE HYDROCHLORIDE | DEXRAZOXANE HCL (ICRF-187, ADR-529) | DEXRAZOXANE | DEXRAZOXANE HYDROCHLORIDE | DEXRAZOXANE HCL (ICRF-187, ADR-529)"			MOABOX:7311	TOP2B	Topoisomerase II inhibitor
SJ001035108-1	SJ001035108	1	MOABOX:7319	ZVSFNBNLNLXEFQ-RQZHXJHFSA-N	CN(C)CCOc1ccc(/C(=C(/CCCO)c2ccccc2)c2ccc(O)cc2)cc1	877387-37-6	Estrogen-Related Receptor gamma (ERRgamma) Inverse Agonists	ESRRG																																																															CHEMBL201013	CHEMBL3932162										6852176	134138492				member	10.1016/j.bmcl.2005.11.030	10.1021/acs.jmedchem.8b01296																																																																																																																																																														16307879	26771593	27236015	27805390	30657313																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	2.28184																																0.28523																																8																																CS-0113537	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-737-033|MOABOX:7319|ESRRG|Estrogen-Related Receptor gamma (ERRgamma) Inverse Agonists	CN(C)CCOc1ccc(cc1)\C(=C(\CCCO)/c2ccccc2)\c3ccc(O)cc3	877387-37-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468705	417.53994	(E/Z)-GSK5182	(E/Z)-GSK5182 | (E/Z)-GSK5182			MOABOX:7319	ESRRG	Estrogen-Related Receptor gamma (ERRgamma) Inverse Agonists
SJ000855502-3	SJ000855502	3	MOABOX:7325	SHHUPGSHGSNPDB-UHFFFAOYSA-N	O=C(COc1ccc(C(=O)c2ccccc2)cc1)NC1CCN(Cc2ccccc2)CC1	924416-43-3	Adiponectin Receptor 1 (ADIPOR1) and Adiponectin Receptor 2 (ADIPOR2) Agonist.	ADIPOR1	ADIPOR2																															79602																															CHEMBL3393145											16307093	78243714				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.82656	-5.516e-002																															0.11808	-0.00788																															7	7																															HY-15848	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Metabolic Disease|MOABOX:7325|ADIPOR1|Adiponectin Receptor 1 (ADIPOR1) and Adiponectin Receptor 2 (ADIPOR2) Agonist.	O=C(COc1ccc(cc1)C(=O)c2ccccc2)NC3CCN(Cc4ccccc4)CC3	924416-43-3	16727	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469324	428.52282	ADIPORON	ADIPORON | ADIPORON	Pathway: GPCR/G Protein	Research Area: Metabolic Disease	MOABOX:7325	ADIPOR1	Adiponectin Receptor 1 (ADIPOR1) and Adiponectin Receptor 2 (ADIPOR2) Agonist.
SJ000851905-3	SJ000851905	3	MOABOX:7326	PTQXTEKSNBVPQJ-UHFFFAOYSA-N	CC(C)c1cc(C(C)C)c(CC(=O)NS(=O)(=O)Oc2c(C(C)C)cccc2C(C)C)c(C(C)C)c1	166518-60-1	ACAT Inhibitor	SOAT1	SOAT2																															8435																															CHEMBL101309											166558	9919302	9962655	67393679	87551997	member																																																																																																																																																																19167888																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.9304	0.4298																															0.1163	0.0614																															8	7																															HY-13215	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:7326|SOAT1|ACAT Inhibitor	CC(C)c1cc(C(C)C)c(CC(=O)NS(=O)(=O)Oc2c(cccc2C(C)C)C(C)C)c(c1)C(C)C	166518-60-1	21055	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469727	501.72102	AVASIMIBE	AVASIMIBE | CI-1011 | AVASIMIBE | CI-1011	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:7326	SOAT1	ACAT Inhibitor
SJ000784280-6	SJ000784280	6	MOABOX:7333	GOVYBPLHWIEHEJ-UHFFFAOYSA-N	CN1CCc2c(c3ccccc3n2Cc2ccc(C(=O)NO)cc2)C1	1239262-52-2	HDAC 6/8;Histone deacetylase-6 inhibitor	HDAC6																																																															CHEMBL2018302	CHEMBL3770936										49850262	50898504	57336514	129010448		member	10.1016/j.bmcl.2014.10.022	10.1016/j.ejmech.2016.12.032	10.1021/acs.jmedchem.5b01493	10.1021/acs.jmedchem.8b01090	10.1021/acsmedchemlett.6b00124	10.1021/jm301098e	10.1021/jm301355j	10.1021/jm400564j																																																																																																																																																								22165909	23009203	23276137	23368884	23627282	23651307	23672185	23905680	23964961	25240614	25454270	25637120	26086931	26653328	26681404	27060764	27541357	27650925	28038324	28337317	28453994	28953386	29102179	29150330	29549837	29589441	29738953	29940115	29945795	30385227	30448419	30525585	30645113	30964290	30996781	31235266																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		5.72464																																0.71558																																8																																HY-13271	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:7333|HDAC6|HDAC 6/8;Histone deacetylase-6 inhibitor	CN1CCc2c(C1)c3ccccc3n2Cc4ccc(cc4)C(=O)NO	1310693-92-5	34432	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469784	335.39964	TUBASTATIN A	TUBASTATIN A | TUBASTATIN A HCL SALT | TUBASTATIN A HCL | TUBASTATIN A | TUBASTATIN A HCL SALT | TUBASTATIN A HCL	Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:7333	HDAC6	HDAC 6/8;Histone deacetylase-6 inhibitor
SJ000285432-10	SJ000285432	10	MOABOX:7336	GMZVRMREEHBGGF-UHFFFAOYSA-N	NC(=O)CN1CCCC1=O	7491-74-9	Nootropic;AMPA Receptor Postiive Allosteric Modulators	GRIA1	GRIA2	GRIA3	GRIA4																													2891	2892	2893																													CHEMBL36715											4843	11536078	21738045	21738283	67150289	virtual	10.1016/j.drugalcdep.2015.02.026																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0	0	0																													0.0	0.0	0.0	0.0																													7	7	7	7																													HY-B0585	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:7336|GRIA1|Nootropic;AMPA Receptor Postiive Allosteric Modulators	NC(=O)CN1CCCC1=O	7491-74-9	16657	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469634	142.1558	PIRACETAM	PIRACETAM | PIRACETAM	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:7336	GRIA1	Nootropic;AMPA Receptor Postiive Allosteric Modulators
SJ001034877-1	SJ001034877	1	MOABOX:7338	FSEZESVJDPKRDS-UWJYYQICSA-N	CN1CC(=O)N2[C@@H](Cc3cc4c(cc3[C@H]2c2c[nH]c3ccc(Cl)cc23)OCO4)C1=O		PIP5K1alpha inhibitor	PIP5K1A																																																																										49853637					member	10.1073/pnas.1405801111																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																CS-6374	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-417-169|MOABOX:7338|PIP5K1A|PIP5K1alpha inhibitor	CN1CC(=O)N2[C@@H](Cc3cc4OCOc4cc3[C@H]2c5c[nH]c6ccc(Cl)cc56)C1=O	1395347-24-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468175	423.84902	ISA-2011B	ISA-2011B | ISA-2011B			MOABOX:7338	PIP5K1A	PIP5K1alpha inhibitor
SJ001033212-2	SJ001033212	2	MOABOX:7341	STWTUEAWRAIWJG-UHFFFAOYSA-N	CC1(C)CC(Oc2ccc(-c3ccc(-c4cn[nH]c4)cc3O)nn2)CC(C)(C)N1	1562338-42-4	splicing modulator	SMN2	RNU1-4	SNRPC	RNU1-3	RNU1-2	RNU1-1																											6060	6631	26869	26870	26871																																						135565041	135565042	137361980			virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0	0	0																											0.0	0.0	0.0	0.0	0.0	0.0																											7	8	7	7	7	7																											HY-19620	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Membrane Transporter/Ion Channel | Research Area: Cancer|MOABOX:7341|SMN2|splicing modulator	CC1(C)CC(CC(C)(C)N1)Oc2ccc(nn2)c3ccc(cc3O)c4cn[nH]c4	1562338-42-4	20152	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468808	393.48208	BRANAPLAM; LMI070; NVS-SM1	BRANAPLAM; LMI070; NVS-SM1 | BRANAPLAM; LMI070; NVS-SM1	Pathway: Cell Cycle/DNA Damage; Membrane Transporter/Ion Channel	Research Area: Cancer	MOABOX:7341	SMN2	splicing modulator
SJ001035149-1	SJ001035149	1	MOABOX:7343	LFEFEOLVKXXVGD-UHFFFAOYSA-N	Cc1ccc2[nH]c(-n3nc(C)c(Cc4ccccc4)c3O)nc2c1	1453097-13-6	Alpha-Ketoglutarate-Dependent Dioxygenase AlkB Homolog 3 (ALKBH3 PCA-1 DEPC-1) Inhibitors;DNA Repair Inhibitors	ALKBH3																																																																															member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.77968																																0.47246																																8																																HY-100199	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:7343|ALKBH3|Alpha-Ketoglutarate-Dependent Dioxygenase AlkB Homolog 3 (ALKBH3 PCA-1 DEPC-1) Inhibitors;DNA Repair Inhibitors	Cc1ccc2nc([nH]c2c1)n3nc(C)c(Cc4ccccc4)c3O	1453097-13-6	20842	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468927	318.37242	HUHS015	HUHS015 | HUHS015	Pathway: Others	Research Area: Cancer	MOABOX:7343	ALKBH3	Alpha-Ketoglutarate-Dependent Dioxygenase AlkB Homolog 3 (ALKBH3 PCA-1 DEPC-1) Inhibitors;DNA Repair Inhibitors
SJ001035000-1	SJ001035000	1	MOABOX:7345	IYIGLWQQAMROOF-HHHXNRCGSA-N	COc1ccccc1[C@@H](NS(=O)(=O)c1ccc2[nH]c(=O)ccc2c1)C(=O)N(Cc1ccco1)Cc1cccs1		OGT (O-linked N-acetylglucosamine (GlcNAc) transferase) inhibitor	OGT																																																																										118634407					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.63595																																0.09085																																7																																21894	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-727-654|MOABOX:7345|OGT|OGT (O-linked N-acetylglucosamine (GlcNAc) transferase) inhibitor	COc1ccccc1[C@@H](NS(=O)(=O)c2ccc3NC(=O)C=Cc3c2)C(=O)N(Cc4occc4)Cc5cccs5	1681056-61-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468451	563.6446	OSMI-1	OSMI-1 | OSMI-1			MOABOX:7345	OGT	OGT (O-linked N-acetylglucosamine (GlcNAc) transferase) inhibitor
SJ000851876-10	SJ000851876	10	MOABOX:7349	GRZXWCHAXNAUHY-NSISKUIASA-N	CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1	1001264-89-6	AKT inhibitor	AKT1	AKT2	AKT3																														208	10000																														CHEMBL2177390											24788740	62705068	62707512	66553170	66570841	member	10.1021/jm301024w																																																																																																																																																															22934575	24508830	28506751																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.30488	0.7472	0.7796																														0.16311	0.0934	0.09745																														8	8	8																														HY-15186	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:7349|AKT1|AKT inhibitor	CC(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@H](O)C[C@@H](C)c23)c4ccc(Cl)cc4	1001264-89-6	67584	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469442	457.99618	IPATASERTIB	IPATASERTIB | GDC-0068 | IPATASERTIB | GDC-0068	Pathway: PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:7349	AKT1	AKT inhibitor
SJ000870748-3	SJ000870748	3	MOABOX:7354	BJFSUDWKXGMUKA-UHFFFAOYSA-N	COc1cc(-c2cn(C)c(=O)c3cnccc23)c(OC)cc1CN(C)C		BRD7/9 inhibitor;BRD9 gene inhibitor	BRD7	BRD9																															65980																															CHEMBL3823101											117072549					member	10.1021/acs.jmedchem.5b01865																																																																																																																																																															26914985	27120693	30824168																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			-0.17496	2.74752																															-0.02187	0.34344																															8	8																															T6786	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-624-536|MOABOX:7354|BRD7|BRD7/9 inhibitor;BRD9 gene inhibitor	COc1cc(C2=CN(C)C(=O)c3cnccc23)c(OC)cc1CN(C)C	1883429-22-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468590	353.41492	BI-9564	BI-9564 | BI-9564			MOABOX:7354	BRD7	BRD7/9 inhibitor;BRD9 gene inhibitor
SJ000855285-3	SJ000855285	3	MOABOX:7359	VTGBZWHPJFMTKS-UHFFFAOYSA-N	CCc1ccc(OCc2ccccc2C(=O)Nc2ccc3nc(C)cc(N)c3c2)cc1	244218-51-7	OPRL1 gene inhibitor;OPRM1 gene inhibitor	OPRL1	OPRM1																															4988																															CHEMBL140979	CHEMBL531742										5311339	5311340	22397076	71297147		member	10.1038/sj.bjp.0704478																																																																																																																																																															10785553	11101358	12369963	12431062	14593080	15571866	18991730	21330016																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														3.49672	0.664																															0.43709	0.083																															8	8																															HY-13274	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:7359|OPRL1|OPRL1 gene inhibitor;OPRM1 gene inhibitor	CCc1ccc(OCc2ccccc2C(=O)Nc3ccc4nc(C)cc(N)c4c3)cc1	244218-51-7	15617	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469505	411.4956	JTC-801	JTC-801 | JTC-801	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:7359	OPRL1	OPRL1 gene inhibitor;OPRM1 gene inhibitor
SJ001035107-1	SJ001035107	1	MOABOX:7363	CJQGLLUJIVNREL-UHFFFAOYSA-N	CCCCCCCCCCCCCC(=S)NCCCCC(NC(=O)OCc1ccccc1)C(=O)Nc1ccccc1		SIRT2 gene inhibitor	SIRT2																																																																										131801626					virtual																																																																																																																																																																28415012	29921476	29957526																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.16029																																0.45147																																7																																19398	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-426-175|MOABOX:7363|SIRT2|SIRT2 gene inhibitor	CCCCCCCCCCCCCC(=S)NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)Nc2ccccc2	1429749-41-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468699	581.85204	THIOMYRISTOYL | TM	"""THIOMYRISTOYL | TM"" | ""THIOMYRISTOYL | TM"""			MOABOX:7363	SIRT2	SIRT2 gene inhibitor
SJ001033158-2	SJ001033158	2	MOABOX:7365	QQHMKNYGKVVGCZ-UHFFFAOYSA-N	N=C1CCCN1Cc1[nH]c(=O)[nH]c(=O)c1Cl	183204-72-0	Thymidine Phosphorylase Inhibitors	TYMP																																																															CHEMBL235668	CHEMBL65375										6323266	9903778	21699310	141520154	142509028	member	10.1002/med.20159	10.1016/S0960-894X(02)00828-4	10.1016/j.bcp.2007.05.008	10.1016/j.bmc.2004.04.046	10.1016/j.ejmech.2007.07.015	10.1016/j.ejmech.2011.01.035	10.1111/cbdd.12171	10.2174/138955705774933301																																																																																																																																																								12467627	12519058	14552762	15658853	17870212	17963370	20053558	23688695	24177367	27783978																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												1.6332																																0.20415																																8																																HY-A0063	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:7365|TYMP|Thymidine Phosphorylase Inhibitors	ClC1=C(CN2CCCC2=N)NC(=O)NC1=O	183204-72-0	10231	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468853	242.66224	TIPIRACIL (HYDROCHLORIDE)	TIPIRACIL (HYDROCHLORIDE) | TIPIRACIL (HYDROCHLORIDE)	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:7365	TYMP	Thymidine Phosphorylase Inhibitors
SJ000855164-3	SJ000855164	3	MOABOX:7367	MJQMRGWYPNIERM-HNNXBMFYSA-N	C[C@@]1(c2cc(-c3cncnc3)c(F)cc2F)CCSC(N)=N1	1194044-20-6	BACE1 gene inhibitor	BACE1																																																															CHEMBL2333941											44251605	131868722				member																																																																																																																																																																22090477	23509904	24704031	25695670	26985314	27559936	27816517	28749667	29613789	30181028	30207465																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											1.11656																																0.13957																																8																																HY-10472	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Neuronal Signaling | Research Area: Neurological Disease|MOABOX:7367|BACE1|BACE1 gene inhibitor	C[C@]1(CCSC(=N1)N)c2cc(c(F)cc2F)c3cncnc3	1194044-20-6	19870	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468757	320.36027	LY2811376	LY2811376 | LY2811376	Pathway: Neuronal Signaling	Research Area: Neurological Disease	MOABOX:7367	BACE1	BACE1 gene inhibitor
SJ001035006-1	SJ001035006	1	MOABOX:7370	NZRBRJQYGLEINZ-UHFFFAOYSA-N	N#Cc1c(-c2cc(OCc3ccccc3)cc(OCc3ccccc3)c2)cc(-c2cc(Cl)ccc2O)[nH]c1=O	1453835-43-2	Survivin Dimerization Inhibitors	BIRC5																																																															CHEMBL2424939											56935694					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																19088	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-561-547|MOABOX:7370|BIRC5|Survivin Dimerization Inhibitors	Oc1ccc(Cl)cc1C2=CC(=C(C#N)C(=O)N2)c3cc(OCc4ccccc4)cc(OCc5ccccc5)c3	1453835-43-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468458	534.98902	LLP-3	LLP-3 | LLP-3			MOABOX:7370	BIRC5	Survivin Dimerization Inhibitors
SJ000869579-2	SJ000869579	2	MOABOX:7374	ZDOTZEDNGNPOEW-UHFFFAOYSA-N	O=c1c(O)c(-c2ccc(O)cc2)oc2c(O)c(O)cc(O)c12	527-95-7	ODC1 gene inhibitor	ODC1																																																															CHEMBL611029											5280544					member	10.1158/0008-5472.CAN-15-0442																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-N0240	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:7374|ODC1|ODC1 gene inhibitor	OC1=C(Oc2c(O)c(O)cc(O)c2C1=O)c3ccc(O)cc3	527-95-7	67519	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469500	302.2357	HERBACETIN(P)	HERBACETIN(P) | HERBACETIN(P)	Pathway: Others	Research Area: Cancer	MOABOX:7374	ODC1	ODC1 gene inhibitor
SJ000876089-4	SJ000876089	4	MOABOX:7376	BFTKDWYIRJGJCA-CYBMUJFWSA-N	C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)c2N1		dual CBP/EP300 inhibitor	CREBBP	EP300																															2033																															CHEMBL3814752											121271792					member	10.1021/acs.jmedchem.6b01022	10.1038/s41401-019-0237-5																																																																																																																																																														27190605	27682507	29155580																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.60136	0.38536																															0.32517	0.04817																															8	8																															T6811	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-560-377|MOABOX:7376|CREBBP|dual CBP/EP300 inhibitor	C[C@@H]1CC(=O)Nc2cccc(c2N1)c3ccc4c(c3)c(nn4C)c5cnn(C)c5	1884712-47-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468144	386.44968	CPI-637	CPI-637 | CPI 637 | CPI-637 | CPI 637			MOABOX:7376	CREBBP	dual CBP/EP300 inhibitor
SJ000855359-2	SJ000855359	2	MOABOX:7383	DFOVLSMXPWPCFH-UHFFFAOYSA-N	CCCC(=O)Nc1cccc(NC(=O)c2ccccc2Br)c1	423735-93-7	PAR-1 antagonist	F2R																																																															CHEMBL1411333											1048267					member	10.1016/j.bmc.2018.04.016																																																																																																																																																															22408714	29685684	31320211																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.21216																																0.40152																																8																																HY-13965	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cardiovascular Disease|MOABOX:7383|F2R|PAR-1 antagonist	CCCC(=O)Nc1cccc(NC(=O)c2ccccc2Br)c1	423735-93-7	55543	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469255	361.23308	ML161	ML161 | ML161	Pathway: GPCR/G Protein	Research Area: Cardiovascular Disease	MOABOX:7383	F2R	PAR-1 antagonist
SJ000884161-2	SJ000884161	2	MOABOX:7385	ZBGXUVOIWDMMJE-QHNZEKIYSA-N	CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@H]1C(=O)O[C@H](C)[C@H]1[C@H]2/C=C/c1ccc(-c2cccc(F)c2)cn1	312617-89-3	PAR-1 antagonist	F2R																																																															CHEMBL2107386	CHEMBL493982										10077129	10077130	16750334	24879127	44251633	member	10.1021/acs.jmedchem.7b00951	10.1021/ml400235c																																																																																																																																																														18447380	19519491	19601827	20888225	22607152	24900604	24900795	28745507	29685684																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3.35248																																0.41906																																8																																T7013	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-062-225|MOABOX:7385|F2R|PAR-1 antagonist	CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@@H]([C@@H](C)OC3=O)[C@H]2\C=C\c4ccc(cn4)c5cccc(F)c5	618385-01-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468135	492.58172	VORAPAXAR SULFATE	VORAPAXAR SULFATE | VORAPAXAR SULFATE			MOABOX:7385	F2R	PAR-1 antagonist
SJ001033178-2	SJ001033178	2	MOABOX:7393	YOZBGTLTNGAVFU-UHFFFAOYSA-N	Cc1nc(C(=O)NCC(=O)O)c(O)c2ccc(Oc3ccccc3)cc12	808118-40-3	hypoxia-inducible factor prolyl hydroxylase inhibitor	EGLN1	EGLN2	EGLN3																														112398	112399																														CHEMBL2338329											11256664	72948801	72948802	72948836	72948837	member	10.1042/BSR20170275																																																																																																																																																															26713111	28002958	29259755	30737136	31244107																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	2.10992	0.99743	0.89166																														0.26374	0.14249	0.12738																														8	7	7																														HY-13426	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:7393|EGLN1|hypoxia-inducible factor prolyl hydroxylase inhibitor	Cc1nc(C(=O)NCC(=O)O)c(O)c2ccc(Oc3ccccc3)cc12	808118-40-3	27325	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468752	352.34074	ROXADUSTAT | FG-4592	"""ROXADUSTAT | FG-4592"" | ""ROXADUSTAT | FG-4592"""	Pathway: Apoptosis; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:7393	EGLN1	hypoxia-inducible factor prolyl hydroxylase inhibitor
SJ000796067-2	SJ000796067	2	MOABOX:7396	GKWHICIUSVVNGX-MRXNPFEDSA-N	CN(C)[C@@H]1CCc2[nH]c3ccc(NC(=O)c4ccc(F)cc4)cc3c2C1	1217756-94-9	5-hydroxytryptamine receptor 1F receptor agonist	HTR1F																																																																										5311097	9809957	56972176	71297135		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.85064																																0.23133																																8																																HY-13788	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:7396|HTR1F|5-hydroxytryptamine receptor 1F receptor agonist	CN(C)[C@@H]1CCc2[nH]c3ccc(NC(=O)c4ccc(F)cc4)cc3c2C1	186544-26-3	29293	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468815	351.41728	LY 344864 HYDROCHLORIDE	LY 344864 HYDROCHLORIDE | LY 344864 HYDROCHLORIDE	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:7396	HTR1F	5-hydroxytryptamine receptor 1F receptor agonist
SJ001035052-1	SJ001035052	1	MOABOX:7399	RXGUTQNKCXHALN-BJMVGYQFSA-N	O=C(/C=C/c1ccc(O)cc1)NCCc1ccc(O)cc1	111129-11-4	uncompetitive inhibitor	GAA																																																															CHEMBL64286											5372945					member																																																																																																																																																																26974386	30004411																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.6764																																0.08455																																8																																TB0865-0025	CHEMNORM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-741-837|MOABOX:7399|GAA|uncompetitive inhibitor	Oc1ccc(CCNC(=O)\C=C\c2ccc(O)cc2)cc1	36417-86-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468555	283.32178	PAPRAZINE	PAPRAZINE | PAPRAZINE			MOABOX:7399	GAA	uncompetitive inhibitor
SJ000564439-4	SJ000564439	4	MOABOX:7405	PRRZDZJYSJLDBS-UHFFFAOYSA-N	O=C(O)C(=O)CBr	1113-59-3	HK2 inhibitor	HK2																																																															CHEMBL177837											70684	44118703	140074173			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					9.8e-003																																0.0014																																7																																HY-19992	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:7405|HK2|HK2 inhibitor	OC(=O)C(=O)CBr	1113-59-3	42988	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469820	166.95812	3-BROMOPYRUVATE	3-BROMOPYRUVATE | BROMOPYRUVIC ACID | 3-BROMOPYRUVATE | BROMOPYRUVIC ACID	Pathway: Apoptosis; Autophagy; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:7405	HK2	HK2 inhibitor
SJ000855506-3	SJ000855506	3	MOABOX:7407	UFSKUSARDNFIRC-UHFFFAOYSA-N	Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(C(=O)O)c1	1160221-26-0	"Specific stabilization of CFTR MSD1, specifically TMD1."	CFTR																																																															CHEMBL2103870											16678941	45480518	51347960	130476661	145283512	member																																																																																																																																																																21976485																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.57784																																0.44723																																8																																CS-0479	CHEMSCENE	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-009-198-874|MOABOX:7407|CFTR|Specific stabilization of CFTR MSD1, specifically TMD1."	Cc1ccc(NC(=O)C2(CC2)c3ccc4OC(F)(F)Oc4c3)nc1c5cccc(c5)C(=O)O	936727-05-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468177	452.40693	VX-809 (LUMACAFTOR)	VX-809 (LUMACAFTOR) | VX-809 (LUMACAFTOR)			MOABOX:7407	CFTR	"Specific stabilization of CFTR MSD1, specifically TMD1."
SJ000796036-11	SJ000796036	11	MOABOX:7411	OWBFCJROIKNMGD-BQYQJAHWSA-N	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1	1225497-78-8	Antagonist of Raf-Ras interaction	BRAF	RAF1	ZHX2																														5894	22882																														CHEMBL1241855											6918736	91799371				member	10.1016/j.cell.2016.03.045																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.25634	-0.23989	0																														-0.03662	-0.03427	0.0																														7	7	7																														T5818	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-016-633-202|MOABOX:7411|BRAF|Antagonist of Raf-Ras interaction	COc1cc(OC)c(\C=C\S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1	592542-60-4	NA	GENERAL	SODIUM(I)	1	NO_SOLVATE	0	1468158	451.4901	RIGOSERTIB	"RIGOSERTIB | ""ON-01910 | ONC-01910 | SYB C-1101 | SYB L-1101"" | RIGOSERTIB (ON-01910) | RIGOSERTIB | ""ON-01910 | ONC-01910 | SYB C-1101 | SYB L-1101"" | RIGOSERTIB (ON-01910)"			MOABOX:7411	BRAF	Antagonist of Raf-Ras interaction
SJ001032999-2	SJ001032999	2	MOABOX:7412	XRPSUWYWZUQALB-UHFFFAOYSA-N	CCOc1ccc2c(-c3cccc(F)c3)nn(CC(=O)N(C)c3ccc4nc(C)oc4c3)c(=O)c2c1		CFTR corrector	CFTR																																																																										86298861					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.41712																																0.42714																																8																																HY-125381	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Membrane Transporter/Ion Channel | Research Area: Inflammation/Immunology; Cancer|MOABOX:7412|CFTR|CFTR corrector	CCOc1ccc2C(=NN(CC(=O)N(C)c3ccc4nc(C)oc4c3)C(=O)c2c1)c5cccc(F)c5	1628416-28-3	40754	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469827	486.49432	FDL169	FDL169 | FDL169	Pathway: Autophagy; Membrane Transporter/Ion Channel	Research Area: Inflammation/Immunology; Cancer	MOABOX:7412	CFTR	CFTR corrector
SJ000855443-3	SJ000855443	3	MOABOX:7413	MJUVRTYWUMPBTR-MRXNPFEDSA-N	CC(C)(CO)c1cc2cc(NC(=O)C3(c4ccc5c(c4)OC(F)(F)O5)CC3)c(F)cc2n1C[C@@H](O)CO	1152311-62-0	CFTR corrector	CFTR																																																															CHEMBL3544914											46199646	53497466	53497467	72722243	121393248	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.588																																0.4485																																8																																HY-15448	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Membrane Transporter/Ion Channel | Research Area: Cancer|MOABOX:7413|CFTR|CFTR corrector	CC(C)(CO)c1cc2cc(NC(=O)C3(CC3)c4ccc5OC(F)(F)Oc5c4)c(F)cc2n1C[C@@H](O)CO	1152311-62-0	9361	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469666	520.49759	VX-661	VX-661 | VX-661	Pathway: Autophagy; Membrane Transporter/Ion Channel	Research Area: Cancer	MOABOX:7413	CFTR	CFTR corrector
SJ001034840-1	SJ001034840	1	MOABOX:7416	GKDHWOUMCGRQHR-UHFFFAOYSA-N	CSc1ccc(C(=O)C=Cc2cccc3c2OCO3)cc1		MAO-B Inhibitor	MAOB																																																																										72027194					virtual	10.1016/j.ejmech.2016.02.038																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																PB449811686	UKRORGSYNTH	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-389-632|MOABOX:7416|MAOB|MAO-B Inhibitor	CSc1ccc(cc1)C(=O)C=Cc2cccc3OCOc23	1181475-24-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468082	298.35626	PB449811686	PB449811686 | PB449811686			MOABOX:7416	MAOB	MAO-B Inhibitor
SJ001035034-1	SJ001035034	1	MOABOX:7418	GXACZGNQWBODIY-UHFFFAOYSA-N	O=C(CSc1nnc(Cc2cccnc2)c(=O)[nH]1)c1cccs1		PLK1 non-ATP competivive inhibior	PLK1																																																																										135878269					virtual	10.1002/cmdc.201600051																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																AO-476/43421010	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-009-014-906|MOABOX:7418|PLK1|PLK1 non-ATP competivive inhibior	O=C(CSC1=NN=C(Cc2cccnc2)C(=O)N1)c3cccs3	1201911-69-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468522	344.41138	AO-476/43421010	AO-476/43421010 | AO-476/43421010			MOABOX:7418	PLK1	PLK1 non-ATP competivive inhibior
SJ001035343-1	SJ001035343	1	MOABOX:7423	ZDNGJXBUEQNFBQ-GCJKJVERSA-N	COc1cc([C@@H](CC(=O)O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)cc2nnn(C)c12		Inhibitor of KEAP1-Nrf2 PPI	KEAP1																																																															CHEMBL3819587											118170767					member																																																																																																																																																																27031670	30973731																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.97832																																0.24729																																8																																HY-101140	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: NF-?B | Research Area: Metabolic Disease; Inflammation/Immunology|MOABOX:7423|KEAP1|Inhibitor of KEAP1-Nrf2 PPI	COc1cc(cc2nnn(C)c12)[C@@H](CC(=O)O)c3ccc(C)c(CN4C[C@@H](C)Oc5ccccc5S4(=O)=O)c3	1799974-70-1	38843	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469655	550.626	KI696	KI696 | KI696	Pathway: NF-?B	Research Area: Metabolic Disease; Inflammation/Immunology	MOABOX:7423	KEAP1	Inhibitor of KEAP1-Nrf2 PPI
SJ001035333-1	SJ001035333	1	MOABOX:7426	BLLLAUHTNAVSQR-VXKWHMMOSA-N	N=C(N)NCCCCC(=O)Nc1ccc(C[C@H](NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccccc2)C(=O)O)cc1		alpha-v Beta1 integrin inhibitor	ITGAV	ITGA6																															3655																															CHEMBL3892042											117978172	134159262				member																																																																																																																																																																27774126																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	1.33336																															0.0	0.16667																															7	8																															HY-100445A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cytoskeleton | Research Area: Cancer; Cardiovascular Disease|MOABOX:7426|ITGAV|alpha-v Beta1 integrin inhibitor	NC(=N)NCCCCC(=O)Nc1ccc(C[C@H](NC(=O)[C@@H]2CCCN2S(=O)(=O)c3ccccc3)C(=O)O)cc1	NA	63536	GENERAL	"2,2,2-TRIFLUOROACETATE"	1	NO_SOLVATE	0	1469609	558.64976	HY-100445A	HY-100445A | HY-100445A	Pathway: Cytoskeleton	Research Area: Cancer; Cardiovascular Disease	MOABOX:7426	ITGAV	alpha-v Beta1 integrin inhibitor
SJ000494601-3	SJ000494601	3	MOABOX:7429	ZROSUBKIGBSZCG-UHFFFAOYSA-N	CCCc1cc(-c2nc(-c3ccc(C)cc3)cs2)ccn1	125256-00-0	Inhibition of SREBP blocks fat synthesis	SREBF1																																																															CHEMBL1455549	CHEMBL1621019										1889993	2850562	20426347	144801156		member	10.1016/j.chembiol.2009.07.007																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.3514																																0.0502																																7																																HY-14452	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:7429|SREBF1|Inhibition of SREBP blocks fat synthesis	CCCc1cc(ccn1)c2nc(cs2)c3ccc(C)cc3	125256-00-0	21573	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469696	294.41392	FATOSTATIN	FATOSTATIN | 125B11 | FATOSTATIN A  | FATOSTATIN | 125B11 | FATOSTATIN A 	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:7429	SREBF1	Inhibition of SREBP blocks fat synthesis
SJ000782378-18	SJ000782378	18	MOABOX:7432	BLMPQMFVWMYDKT-NZTKNTHTSA-N	CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1	868540-17-4	Proteasome inhibitor	PSMB1	PSMB2	PSMB5	PSMB8	PSMB9	PSMB10																											5690	5693	5696	5698	5699																											CHEMBL451887											11556711	56967341	87055943	102593935	142305291	member	10.1016/j.bmc.2019.07.044	10.1016/j.ejmech.2018.10.056	10.1021/acsmedchemlett.6b00496	10.1073/pnas.1806109115																																																																																																																																																												19348473	24767818	27765408	28027531	28435528	30165344	30639896	31283222	31383629																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																													5.44e-002	-5.024e-002	0.51512	0.15744	6.728e-002	7.832e-002																											0.0068	-0.00628	0.06439	0.01968	0.00841	0.00979																											8	8	8	8	8	8																											HY-10455	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:7432|PSMB1|Proteasome inhibitor	CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4	868540-17-4	39385	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469043	719.90988	CARFILZOMIB	"CARFILZOMIB | ""PR-171 | ONO-7057"" | ""CARFILZOMIB | PR-171 | ONO-7057 |"" | CARFILZOMIB (PR-171) | CARFILZOMIB | ""PR-171 | ONO-7057"" | ""CARFILZOMIB | PR-171 | ONO-7057 |"" | CARFILZOMIB (PR-171)"	Pathway: Apoptosis; Autophagy; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:7432	PSMB1	Proteasome inhibitor
SJ000574280-7	SJ000574280	7	MOABOX:7434	VEPKQEUBKLEPRA-UHFFFAOYSA-N	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl	209410-46-8	P38 alpha MAP kinase inhibitor	MAPK14																																																															CHEMBL119385											3038525					member	10.1016/j.bmcl.2008.02.033	10.1021/jm9012906	10.1124/jpet.119.259663																																																																																																																																																													12171518	12540232	14667219	15032672	15711537	16178742	16178743	16178744	16283677	16378500	16454763	16750367	16787217	16945533	17010605	17482683	17541990	17659871	17896971	18183025	18325768	18991731	19689372	19751974	19950901	22037378	23442188	23937569	24900264	29133046																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								4.406																																0.55075																																8																																HY-10328	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; MAPK/ERK Pathway | Research Area: Inflammation/Immunology|MOABOX:7434|MAPK14|P38 alpha MAP kinase inhibitor	Fc1ccc(SC2=NN3C=NC(=O)C(=C3C=C2)c4c(Cl)cccc4Cl)c(F)c1	209410-46-8	4974	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468780	436.26207	VX-745	VX-745 | VX-745	Pathway: Autophagy; MAPK/ERK Pathway	Research Area: Inflammation/Immunology	MOABOX:7434	MAPK14	P38 alpha MAP kinase inhibitor
SJ000855289-4	SJ000855289	4	MOABOX:7435	KCAJXIDMCNPGHZ-UHFFFAOYSA-N	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1	1073667-47-6	P38a inhibitor	MAPK14																																																															CHEMBL1088751											22049997					member	10.1124/jpet.109.158329	10.1124/jpet.119.259663																																																																																																																																																														19950901	20395140	21291394	21620699	21641211	22174080	28834431	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														3.92632																																0.49079																																8																																T1974	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-021-804-991|MOABOX:7435|MAPK14|P38a inhibitor	CNC(=O)c1ccc(C)c(c1)N2C(=CC(=C(Br)C2=O)OCc3ccc(F)cc3F)C	586379-66-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468127	477.29867	PH-797804	PH-797804 | PH-797804			MOABOX:7435	MAPK14	P38a inhibitor
SJ000556686-7	SJ000556686	7	MOABOX:7436	FYSRKRZDBHOFAY-UHFFFAOYSA-N	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F	479543-46-9	P38a kinase inhibitor	MAPK14																																																															CHEMBL1090090											10341154					member	10.1124/jpet.119.259663																																																																																																																																																															19950901	29191878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.332																																0.2915																																8																																13108	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-021-805-020|MOABOX:7436|MAPK14|P38a kinase inhibitor	NC(=O)N(c1ccc(C(=O)N)c(n1)c2ccc(F)cc2F)c3c(F)cccc3F	745833-23-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468334	404.31779	VX-702	VX-702 | VX-702			MOABOX:7436	MAPK14	P38a kinase inhibitor
SJ000287667-9	SJ000287667	9	MOABOX:7438	QHKYPYXTTXKZST-UHFFFAOYSA-N	Oc1ccc(-c2nc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)cc1	152121-30-7	p38 alpha/beta inhibitor	MAPK14	MAPK11																															5600																															CHEMBL278041											5169	135451580	136239895	136661871		member	10.1002/cmdc.201100188	10.1016/S0960-894X(01)00498-X	10.1016/S0968-0896(96)00212-X	10.1021/ja907795q	10.1021/jm0301787	10.1053/joca.2002.0851	10.1124/jpet.105.098020	10.1124/jpet.108.146241	10.1124/jpet.119.259663	10.1128/AAC.00680-07	10.2174/156802606775270323																																																																																																																																																					9043657	10998351	11549467	12464556	15711537	16178739	16283677	16454763	16509574	16787380	17923491	18077363	18183025	19591487	19601892	22014755	24878193	24930833	28195723	28280261	30258545	30384048	30973727	31013427																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														2.68416	0.71224																															0.33552	0.08903																															8	8																															HY-10295	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; MAPK/ERK Pathway | Research Area: Cancer; Neurological Disease|MOABOX:7438|MAPK14|p38 alpha/beta inhibitor	Oc1ccc(cc1)c2nc(c3ccc(F)cc3)c([nH]2)c4ccncc4	152121-30-7	39354	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468774	331.34306	SB 202190	"SB 202190 | ""SB 202190 | SB202190"" | SB202190 | SB202190 (FHPI) | SB 202190 | ""SB 202190 | SB202190"" | SB202190 | SB202190 (FHPI)"	Pathway: Apoptosis; Autophagy; MAPK/ERK Pathway	Research Area: Cancer; Neurological Disease	MOABOX:7438	MAPK14	p38 alpha/beta inhibitor
SJ000840364-2	SJ000840364	2	MOABOX:7439	CKLGZXFOLMHCMC-UHFFFAOYSA-N	COc1ccc(CN2C(=O)C(=O)c3cc(OC(F)(F)F)ccc32)cc1	1160247-92-6	M5 positive allosteric modulator	CHRM5																																																															CHEMBL466253											42633508					member																																																																																																																																																																19438238																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.39416																																0.04927																																8																																HY-12157	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Others|MOABOX:7439|CHRM5|M5 positive allosteric modulator	COc1ccc(CN2C(=O)C(=O)c3cc(OC(F)(F)F)ccc23)cc1	1160247-92-6	59322	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468906	351.27669	VU 0238429	VU 0238429 | VU 0238429	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Others	MOABOX:7439	CHRM5	M5 positive allosteric modulator
SJ001034906-1	SJ001034906	1	MOABOX:7440	CTEGQKDJTBWFHW-UHFFFAOYSA-N	COc1nc2sc(C(=O)NC3CC3)c(N)c2c(C)c1Cl	886047-13-8	M4 positive allosteric modulator	CHRM4																																																															CHEMBL3770346											11536903					member	10.1016/j.bmcl.2012.10.073																																																																																																																																																															23177787																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.49456																																0.31182																																8																																7027	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-331-145|MOABOX:7440|CHRM4|M4 positive allosteric modulator	COc1nc2sc(C(=O)NC3CC3)c(N)c2c(C)c1Cl	886047-13-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468215	311.78716	LY 2033298	LY 2033298 | LY 2033298			MOABOX:7440	CHRM4	M4 positive allosteric modulator
SJ001010763-2	SJ001010763	2	MOABOX:7442	XLOGLWKOHPIJLV-UHFFFAOYSA-N	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		RIPK2 inhibitor	RIPK2																																																															CHEMBL3823499											67469084					member	10.1021/acs.jmedchem.6b00211	10.1021/acsmedchemlett.8b00344																																																																																																																																																														27109867	30344914																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.44952																																0.30619																																8																																19739	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-560-411|MOABOX:7442|RIPK2|RIPK2 inhibitor	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1	1346547-00-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468473	398.45386	GSK583	GSK583 | GSK583			MOABOX:7442	RIPK2	RIPK2 inhibitor
SJ001035277-1	SJ001035277	1	MOABOX:7447	AXXNRMISICMFNS-UHFFFAOYSA-N	CC(=O)N1CCN(c2ccc(NC(=O)Cc3cnc(-c4ccnc(F)c4)c(C)c3)nc2)CC1	1243245-18-2	Porcupine inhibitors	PORCN																																																																										46927297					member																																																																																																																																																																27437076																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.2248																																-0.0281																																8																																HY-100408	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Stem Cell/Wnt | Research Area: Cancer|MOABOX:7447|PORCN|Porcupine inhibitors	CC(=O)N1CCN(CC1)c2ccc(NC(=O)Cc3cnc(c(C)c3)c4ccnc(F)c4)nc2	1243245-18-2	21096	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469472	448.4927	GNF-6231	GNF-6231 | GNF-6231	Pathway: Stem Cell/Wnt	Research Area: Cancer	MOABOX:7447	PORCN	Porcupine inhibitors
SJ000565178-4	SJ000565178	4	MOABOX:7450	SPPTWHFVYKCNNK-FQEVSTJZSA-N	O=C(O)c1ccc(NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)c2ccccc2)cc1	37106-97-1	Pancreatic trypsin inhibitor	HPN																																																															CHEMBL1200368											6957673	67747211	70440085			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-B1493	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Endocrinology|MOABOX:7450|HPN|Pancreatic trypsin inhibitor	OC(=O)c1ccc(NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)c3ccccc3)cc1	37106-97-1	44232	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469046	404.4153	BENTIROMIDE	BENTIROMIDE | BENTIROMIDE	Pathway: Others	Research Area: Endocrinology	MOABOX:7450	HPN	Pancreatic trypsin inhibitor
SJ001035145-1	SJ001035145	1	MOABOX:7462	ABXIUYMKZDZUDC-UHFFFAOYSA-N	Cc1cncc(-c2nc(NCCc3c[nH]c4ccccc34)c3ncn(C(C)C)c3n2)c1	1227634-69-6	Aryl hydrocarbon receptor antagonist	AHR																																																																										46216378					member	10.1124/jpet.110.178392																																																																																																																																																															21493753																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.02856																																0.25357																																8																																HY-102023	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Others|MOABOX:7462|AHR|Aryl hydrocarbon receptor antagonist	CC(C)n1cnc2c(NCCc3c[nH]c4ccccc34)nc(nc12)c5cncc(C)c5	1227634-69-6	65683	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468889	411.5022	GNF351	GNF351 | GNF351	Pathway: Immunology/Inflammation	Research Area: Others	MOABOX:7462	AHR	Aryl hydrocarbon receptor antagonist
SJ001035246-1	SJ001035246	1	MOABOX:7465	FDTXHWQFIXYHCL-QGZVFWFLSA-N	O=C(c1ccc(-n2nnc3cccnc32)cc1)N(c1ncccc1Cl)[C@@H]1CCCNC1		pcsk9 translation inhbitor	RPL17	PCSK9																															255738																															CHEMBL4109308											86271238					member	10.1021/acs.jmedchem.8b00650	10.1101/083097																																																																																																																																																														29878763	30482620																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	3.18104																															0.0	0.39763																															7	8																															HY-120088A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cardiovascular Disease|MOABOX:7465|RPL17|pcsk9 translation inhbitor	Clc1cccnc1N([C@@H]2CCCNC2)C(=O)c3ccc(cc3)n4nnc5cccnc45	1632250-50-0	55358	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469289	433.8935	PF-06446846 HYDROCHLORIDE	PF-06446846 HYDROCHLORIDE | PF-06446846 HYDROCHLORIDE	Pathway: Metabolic Enzyme/Protease	Research Area: Cardiovascular Disease	MOABOX:7465	RPL17	pcsk9 translation inhbitor
SJ000288123-7	SJ000288123	7	MOABOX:7468	LOGJQOUIVKBFGH-YBEGLDIGSA-N	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2	1240328-42-0	Src inhibitor	SRC																																																															CHEMBL605003											5312137					virtual	10.1128/MCB.20.23.9018-9027.2000																																																																																																																																																															11074000	17627544	18077363	18473810	21651487	22818848																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.60584																																0.07573																																8																																ES-0024	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466679	371.45334	SU 6656	SU 6656 | SU 6656			MOABOX:7468	SRC	Src inhibitor
SJ000851913-8	SJ000851913	8	MOABOX:7469	HUNGUWOZPQBXGX-UHFFFAOYSA-N	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1	1038395-65-1	c-src allosteric inihitor;allosteric Src inhibitor;Src Kinase Inhibitors;Antimitotic Drugs;Inhibitors of Signal Transduction Pathways;Tubulin polymerization inhibitors	SRC	TUBG2																															27175																															CHEMBL571546											23635314	24989633	25100013	67199979	141223545	virtual																																																																																																																																																																21459579	21852023	22050754																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			-2.808e-002	0																															-0.00351	0.0																															8	7																															HY-10340A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Cytoskeleton; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:7469|SRC|c-src allosteric inihitor;allosteric Src inhibitor;Src Kinase Inhibitors;Antimitotic Drugs;Inhibitors of Signal Transduction Pathways;Tubulin polymerization inhibitors	O=C(Cc1ccc(cn1)c2ccc(OCCN3CCOCC3)cc2)NCc4ccccc4	1038395-65-1	4795	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469200	431.52676	KX2-391	KX2-391 | KX2-391	Pathway: Cell Cycle/DNA Damage; Cytoskeleton; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:7469	SRC	c-src allosteric inihitor;allosteric Src inhibitor;Src Kinase Inhibitors;Antimitotic Drugs;Inhibitors of Signal Transduction Pathways;Tubulin polymerization inhibitors
SJ001034883-1	SJ001034883	1	MOABOX:7471	CVBJUEIAUOTXLV-UHFFFAOYSA-N	CS(=O)(=O)c1ccc(Cl)cc1Cn1cc(Cl)cc(C(N)=O)c1=N	1192347-42-4	Orally Active Î±1D Adrenoceptor	ADRA1D																																																															CHEMBL3799553											44247584	66970086				member																																																																																																																																																																26954848	28800452																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.70864																																0.33858																																8																																2579	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-562-351|MOABOX:7471|ADRA1D|Orally Active ??1D Adrenoceptor	CS(=O)(=O)c1ccc(Cl)cc1CN2C=C(Cl)C=C(C(=O)N)C2=N	1192347-42-4	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468183	374.24232	TAK 259	TAK 259 | TAK 259			MOABOX:7471	ADRA1D	Orally Active ??1D Adrenoceptor
SJ001035217-1	SJ001035217	1	MOABOX:7473	VKVAJBRQGBRHIK-UHFFFAOYSA-N	CCON=C1c2ccccc2-c2nc(C#N)c(C#N)nc21		Selective USP8 Inhibitor	USP8																																																																										73230796					member	10.1002/cmdc.200900409																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-50737A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:7473|USP8|Selective USP8 Inhibitor	CCO\N=C\1/c2ccccc2c3nc(C#N)c(nc13)C#N	924296-19-5	11867	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469159	275.26486	DUB-IN-2	DUB-IN-2 | DUB-IN-2	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:7473	USP8	Selective USP8 Inhibitor
SJ001034866-1	SJ001034866	1	MOABOX:7478	NVOBVSWSDYFEMR-UHFFFAOYSA-N	C=C(C)C(=O)Nc1cc(C(=O)O)cc(C(=O)O)c1	73912-52-4	GPR171 agonist	GPR171																																																																										773544					member	10.1126/scisignal.aac8035																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																STK894855	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-015-719|MOABOX:7478|GPR171|GPR171 agonist	CC(=C)C(=O)Nc1cc(cc(c1)C(=O)O)C(=O)O	73912-52-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468121	249.21944	STK894855	STK894855 | STK894855			MOABOX:7478	GPR171	GPR171 agonist
SJ001035081-1	SJ001035081	1	MOABOX:7479	MMYRYMMKMUTPBB-UHFFFAOYSA-N	CCCCCCC(=O)c1cc(-c2ccc(CC(=O)O)cc2)c2nccn2c1		Serine Palmitoyl Transferase inhibitor	SPTLC1																																																																										131954583					member	10.1021/acs.jmedchem.5b01851																																																																																																																																																															27213958																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					4.34264																																0.54283																																8																																6055	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-162-879|MOABOX:7479|SPTLC1|Serine Palmitoyl Transferase inhibitor	CCCCCCC(=O)c1cc(c2ccc(CC(=O)O)cc2)c3nccn3c1	1933533-18-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468615	364.43756	SPT IMIDAZOPYRIDINE 1	SPT IMIDAZOPYRIDINE 1 | SPT IMIDAZOPYRIDINE 1			MOABOX:7479	SPTLC1	Serine Palmitoyl Transferase inhibitor
SJ001035373-1	SJ001035373	1	MOABOX:7487	YTRNLFYTHYWDAU-KDOFPFPSSA-N	O=C(O)C[C@@]1(O)C[C@@H](CCCCCCc2ccc(Cl)cc2Cl)OC1=O		ATP citrate lyase inhibitor	ACLY																																																															CHEMBL121446											10340264					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-16450	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:7487|ACLY|ATP citrate lyase inhibitor	OC(=O)C[C@@]1(O)C[C@@H](CCCCCCc2ccc(Cl)cc2Cl)OC1=O	154566-12-8	58492	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469828	389.27028	SB 204990	SB 204990 | SB 204990	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:7487	ACLY	ATP citrate lyase inhibitor
SJ001033642-3	SJ001033642	3	MOABOX:7496	HTJWLEGCECXGSQ-UHFFFAOYSA-N	O=C(Nc1ccc(O)c(C(=O)O)c1)c1cccc(NC(=O)c2ccco2)c1	887686-02-4	SIRT6 inhibitor	SIRT6																																																															CHEMBL1588664											6496840					member	10.1021/jm500487d																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-7.252e-002																																-0.01036																																7																																HY-107454	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer; Infection; Metabolic Disease; Inflammation/Immunology|MOABOX:7496|SIRT6|SIRT6 inhibitor	OC(=O)c1cc(NC(=O)c2cccc(NC(=O)c3occc3)c2)ccc1O	887686-02-4	28222	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469066	366.32426	OSS_128167	OSS_128167 | OSS_128167	Pathway: Anti-infection; Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer; Infection; Metabolic Disease; Inflammation/Immunology	MOABOX:7496	SIRT6	SIRT6 inhibitor
SJ001035070-1	SJ001035070	1	MOABOX:7499	DIXMMXNNKLCLOM-UHFFFAOYSA-N	O=C1N=C(N2CCCCN2)SC1=Cc1ccc(F)cc1OC(=O)N1CCCC1		KCC2 agonist	SLC12A5																																																																										68637267					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																T5444	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-035-943-060|MOABOX:7499|SLC12A5|KCC2 agonist	Fc1ccc(\C=C\2/SC(=NC2=O)N3CCCCN3)c(OC(=O)N4CCCC4)c1	1181083-81-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468591	404.45844	CLP-290	CLP-290 | CLP-290			MOABOX:7499	SLC12A5	KCC2 agonist
SJ000855327-2	SJ000855327	2	MOABOX:7502	QOHNRGHTJPFMSL-UHFFFAOYSA-N	S=C=Nc1cccc(NC(=S)NCCCCNC(=S)Nc2cccc(N=C=S)c2)c1	711019-86-2	antagonists of P2Y6 nucleotide receptors	P2RY6																																																															CHEMBL1321988											16078986					member	10.1016/j.bcp.2004.01.011	10.1111/j.1476-5381.2009.00172.x	10.2174/092986706775476052																																																																																																																																																													15081875	16475938	19422377																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.52056																																0.31507																																8																																HY-13104	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; GPCR/G Protein | Research Area: Cardiovascular Disease|MOABOX:7502|P2RY6|antagonists of P2Y6 nucleotide receptors	S=C=Nc1cccc(NC(=S)NCCCCNC(=S)Nc2cccc(c2)N=C=S)c1	711019-86-2	5903	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469073	472.673	MRS 2578	MRS 2578 | MRS 2578	Pathway: Apoptosis; GPCR/G Protein	Research Area: Cardiovascular Disease	MOABOX:7502	P2RY6	antagonists of P2Y6 nucleotide receptors
SJ001035143-1	SJ001035143	1	MOABOX:7505	BPWATVWOHQZVRP-NSHDSACASA-N	N=C(CCl)NCCC[C@H](NC(=O)c1ccccc1)C(N)=O	1373232-26-8	Protein Arginine Deiminase (PAD) Inhibitor	PADI4	PADI1																															29943																															CHEMBL1910972	CHEMBL1962361										24970878	57402549	74889978			member																																																																																																																																																																21882827																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.80502	0.78582																															0.25786	0.11226																															7	7																															HY-100574A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Epigenetics | Research Area: Cancer; Inflammation/Immunology|MOABOX:7505|PADI4|Protein Arginine Deiminase (PAD) Inhibitor	NC(=O)[C@H](CCCNC(=N)CCl)NC(=O)c1ccccc1	1373232-26-8	41507	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468882	310.77926	CL-AMIDINE HYDROCHLORIDE	CL-AMIDINE HYDROCHLORIDE | CL-AMIDINE HYDROCHLORIDE	Pathway: Apoptosis; Epigenetics	Research Area: Cancer; Inflammation/Immunology	MOABOX:7505	PADI4	Protein Arginine Deiminase (PAD) Inhibitor
SJ001035099-1	SJ001035099	1	MOABOX:7508	FNGXWOIGFSRSSD-ZROIWOOFSA-N	O=C(O)CCN1C(=O)/C(=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)SC1=S			KRAS	AXIN1																															8312																															CHEMBL2349217											1641056					member	10.1038/nchembio.2103																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0																															0.0	0.0																															7	7																															5561469	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-301-394|MOABOX:7508|KRAS|	OC(=O)CCN1C(=S)S\C(=C/c2oc(cc2)c3ccc(cc3)[N+](=O)[O-])\C1=O	851304-36-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468686	404.41698	5561469	5561469 | 5561469			MOABOX:7508	KRAS	
SJ001035129-1	SJ001035129	1	MOABOX:7510	KAKPGJJRYRYSTP-UHFFFAOYSA-N	COc1cc(OC)cc(N2CCN(C(=O)Nc3nc4cc(F)ccc4nc3OC)CC2)c1	888478-45-3	phosphorylated-p68 RNA helicase inhibitor	DDX5																																																															CHEMBL1278118											11619093					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-123611	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:7510|DDX5|phosphorylated-p68 RNA helicase inhibitor	COc1cc(OC)cc(c1)N2CCN(CC2)C(=O)Nc3nc4cc(F)ccc4nc3OC	888478-45-3	85983	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468783	441.45546	SUPINOXIN | RX-5902	"""SUPINOXIN | RX-5902"" | ""SUPINOXIN | RX-5902"""	Pathway: Apoptosis; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:7510	DDX5	phosphorylated-p68 RNA helicase inhibitor
SJ001035067-1	SJ001035067	1	MOABOX:7514	DLNAKYFPFYUBDR-HDICACEKSA-N	Nc1ccc(C(=O)N2C[C@H]3C[C@H](CN(Cc4ccccc4)C3)C2)cc1		Potassium Channels Blocker	KCNC3	KCNE1	KCNH1	KCNS3	KCNAB2	KCNE2	KCNE3	KCNE4	KCNC2	KCNA2	KCNC1	KCNQ5																					3753	3756	3790	8514	9992	10008	23704	3747	3737	3746	56479																					CHEMBL2107656											10449626	69761767				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0	0	0	0	0	0	0	0	0																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0																					7	7	7	7	7	7	7	7	7	7	7	7																					RAM3282	RAMIDUS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-033-164|MOABOX:7514|KCNC3|Potassium Channels Blocker	Nc1ccc(cc1)C(=O)N2CC3CC(CN(Cc4ccccc4)C3)C2	83991-25-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468575	335.4427	RAM3282	RAM3282 | RAM3282			MOABOX:7514	KCNC3	Potassium Channels Blocker
SJ001034955-1	SJ001034955	1	MOABOX:7517	TVNSCKMVODVWRS-UHFFFAOYSA-N	CC(C)(O)Cn1nc(-c2ccccc2)c2c(Cl)c(-c3ccccc3)nnc21	1404506-35-9	CLRN stabilizer	CLRN1																																																																										66576257					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																2624	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-562-355|MOABOX:7517|CLRN1|CLRN stabilizer	CC(C)(O)Cn1nc(c2ccccc2)c3c(Cl)c(nnc13)c4ccccc4	1404506-35-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468367	378.85476	BF844	BF844 | BF844			MOABOX:7517	CLRN1	CLRN stabilizer
SJ001011093-2	SJ001011093	2	MOABOX:7522	YUYJEQHNWKQNBT-UHFFFAOYSA-N	Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCOCC3)cc2)cc1F	1627709-94-7	Ribosomal Protein S6 Kinase alpha Inhibitors	RPS6KA1	RPS6KA2	RPS6KA3																														6196	6197																														CHEMBL3604794											118704762					virtual																																																																																																																																																																26270416	30170943																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.61088	0.4024	2.434																														0.07636	0.0503	0.30425																														8	8	8																														HY-19713	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: MAPK/ERK Pathway | Research Area: Cancer|MOABOX:7522|RPS6KA1|Ribosomal Protein S6 Kinase alpha Inhibitors	Oc1c(F)cc(cc1F)c2cnccc2c3ccc(cc3)N4CCOCC4	1627709-94-7	19492	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469499	368.37663	LJI308	LJI308 | LJI308	Pathway: MAPK/ERK Pathway	Research Area: Cancer	MOABOX:7522	RPS6KA1	Ribosomal Protein S6 Kinase alpha Inhibitors
SJ001010929-2	SJ001010929	2	MOABOX:7528	GFGMISOSPOPSHN-NOCYUORASA-N	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1	315694-89-4	DAPK1/3 inhibitor	DAPK1																																																															CHEMBL565286											2360773					member	10.1021/jm901191q																																																																																																																																																															19877644																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.84608																																0.23076																																8																																HY-15513	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis | Research Area: Cancer|MOABOX:7528|DAPK1|DAPK1/3 inhibitor	O=C1OC(=N/C/1=C/c2cccnc2)\C=C\c3ccccc3	315694-89-4	7732	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469659	276.28938	TC-DAPK 6	TC-DAPK 6 | TC-DAPK 6	Pathway: Apoptosis	Research Area: Cancer	MOABOX:7528	DAPK1	DAPK1/3 inhibitor
SJ000870627-2	SJ000870627	2	MOABOX:7529	FQWDVNSBYDXPIO-CQSZACIVSA-N	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCNC[C@H]1C)n(C)c(=O)n2C		BRPF1 inhibitor;BRPF1 inhibitors	BRPF1																																																															CHEMBL3828191											121232405					member	10.1021/acsmedchemlett.6b00092																																																																																																																																																															27326325																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.62488																																0.20311																																8																																HY-100220	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:7529|BRPF1|BRPF1 inhibitor;BRPF1 inhibitors	COc1ccccc1C(=O)Nc2cc3N(C)C(=O)N(C)c3cc2N4CCNC[C@H]4C	1910124-24-1	21776	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469701	409.48148	GSK6853	GSK6853 | GSK853 | GSK6853 | GSK853	Pathway: Epigenetics	Research Area: Cancer	MOABOX:7529	BRPF1	BRPF1 inhibitor;BRPF1 inhibitors
SJ001010693-2	SJ001010693	2	MOABOX:7530	IZLPVLBNRGPOHA-AWEZNQCLSA-N	CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3C)c3c(n2)C(C)(C)S(=O)(=O)C3)cc1	1429639-50-8	mTOR inhibitors	MTOR																																																																										71547699					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-100222	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:7530|MTOR|mTOR inhibitors	CCNC(=O)Nc1ccc(cc1)c2nc(N3CCOC[C@@H]3C)c4CS(=O)(=O)C(C)(C)c4n2	1429639-50-8	22926	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469079	459.56176	CZ415	CZ415 | CZ415	Pathway: PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:7530	MTOR	mTOR inhibitors
SJ000870727-2	SJ000870727	2	MOABOX:7531	RPBMXJHQYJLPDN-UHFFFAOYSA-N	CC(=O)c1cc(-c2cc(C(=O)NC3CC3)ccc2C)c2ncccn12		BRD9/BRD7 inhibitor	BRD7	BRD9																															65980																															CHEMBL4065619											123773279					member																																																																																																																																																																27935314																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.24504	2.33112																															-0.03063	0.29139																															8	8																															20030	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-430-536|MOABOX:7531|BRD7|BRD9/BRD7 inhibitor	CC(=O)c1cc(c2cc(ccc2C)C(=O)NC3CC3)c4ncccn14	2079895-62-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468460	333.38376	TP-472	TP-472 | TP-472			MOABOX:7531	BRD7	BRD9/BRD7 inhibitor
SJ001035254-1	SJ001035254	1	MOABOX:7532	PEOQAZBGLOADFJ-UHFFFAOYSA-N	Cn1cc(C(=O)Nc2ccc3c(c2)OCCO3)c2ccccc2c1=O		TAF1 inhibitor	TAF1																																																																										24152379	129896724				member	10.1038/nchembio.2080																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-111445	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:7532|TAF1|TAF1 inhibitor	CN1C=C(C(=O)Nc2ccc3OCCOc3c2)c4ccccc4C1=O	440662-09-9	29204	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469325	336.34134	CEMMEC1	CEMMEC1 | CEMMEC1	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:7532	TAF1	TAF1 inhibitor
SJ001034888-1	SJ001034888	1	MOABOX:7535	QIEDALLWQOZBSN-UHFFFAOYSA-N	COC(=O)c1cccc(NS(=O)(=O)c2ccc(OC)cc2)c1		beta-catenin binder and promoter of its proteasome-mediated degradation	CTNNB1																																																																										6467481					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																STK411195	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-107-691|MOABOX:7535|CTNNB1|beta-catenin binder and promoter of its proteasome-mediated degradation	COC(=O)c1cccc(NS(=O)(=O)c2ccc(OC)cc2)c1	902713-03-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468188	321.3483	STK411195	STK411195 | STK411195			MOABOX:7535	CTNNB1	beta-catenin binder and promoter of its proteasome-mediated degradation
SJ001033318-2	SJ001033318	2	MOABOX:7536	MPYLDWFDPHRTEG-PAAYLBSLSA-N	C[C@]12CC[C@H]3[C@@H](CC(=O)[C@H]4C/C(=N/OCCN)CC[C@@]43C)[C@@H]1CCC2=O	203737-93-3	"Na+/K+-ATPase Inhibitors;SERCA2a Activator;""Na+/K+-ATPase Inhibitors;SERCA2a Activator"""	ATP2A2	ATP1B1	ATP1A1	ATP1A1	ATP1A2	ATP1A3	ATP1A4	ATP1B1	ATP1B2	ATP1B3	FXYD2	ATP1B4																					403966	403992	476	477	478	480	481	482	483	486	23439																																9841834	78357801	145710367			member	10.1111/bph.12278																																																																																																																																																															12388640	12904068	16181136	18637667	20494582																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	0	0	0	0	0	0	0	0	0	0	1.1879	1.1879																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1697	0.1697																					7	7	7	7	7	7	7	7	7	7	7	7																					HY-15718A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Cardiovascular Disease|MOABOX:7536|ATP2A2|Na+/K+-ATPase Inhibitors;SERCA2a Activator;\Na+/K+-ATPase Inhibitors;SERCA2a Activator\	C[C@]12CC\C(=N/OCCN)\C[C@@H]1C(=O)C[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CCC4=O	374559-48-5	11395	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469301	360.49038	ISTAROXIME (HYDROCHLORIDE); PST2744 (HYDROCHLORIDE)	ISTAROXIME (HYDROCHLORIDE); PST2744 (HYDROCHLORIDE) | ISTAROXIME (HYDROCHLORIDE); PST2744 (HYDROCHLORIDE)	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Cardiovascular Disease	MOABOX:7536	ATP2A2	Na+/K+-ATPase Inhibitors;SERCA2a Activator;\Na+/K+-ATPase Inhibitors;SERCA2a Activator\
SJ000773184-2	SJ000773184	2	MOABOX:7538	ZCMFEWUYBFMLIN-UHFFFAOYSA-N	O=C(O)c1cc2cc(O)c(O)cc2c(C(=O)c2ccc(O)c(O)c2)n1	374620-70-9	IGFBP1-6 Inhibitor	IGFBP4																																																															CHEMBL292700											135543997	136239891				member																																																																																																																																																																11445558	11689087																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.52936																																0.19117																																8																																19122	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-052-198|MOABOX:7538|IGFBP4|IGFBP1-6 Inhibitor	OC(=O)c1cc2cc(O)c(O)cc2c(n1)C(=O)c3ccc(O)c(O)c3	374620-70-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468654	341.27174	NBI-31772	NBI-31772 | NBI-31772			MOABOX:7538	IGFBP4	IGFBP1-6 Inhibitor
SJ001010599-2	SJ001010599	2	MOABOX:7541	TXEBNKKOLVBTFK-UHFFFAOYSA-N	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1	1538604-68-0	FGFR4 inhibior	FGFR4																																																															CHEMBL4068896											72710839					member																																																																																																																																																																28433531	28523108	29541363																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.53192																																0.31649																																8																																HY-12823	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:7541|FGFR4|FGFR4 inhibior	COc1cc(OC)c(Cl)c(c1Cl)c2ccc3nc(Nc4c(C)cccc4NC(=O)C=C)ncc3c2	1538604-68-0	59229	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469081	509.38388	BLU9931	BLU9931 | BLU9931	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:7541	FGFR4	FGFR4 inhibior
SJ001035160-1	SJ001035160	1	MOABOX:7545	MWDVCHRYCKXEBY-LBPRGKRZSA-N	C[C@H](NC(=O)CNC(=O)c1cccc(Cl)c1)c1ccccc1	1802326-66-4	potent and selective agonist of hGPR139 with an EC50 = 16 nM;GPR139 inhibitor	GPR139																																																															CHEMBL3633720											2548547					member	10.1021/acsmedchemlett.5b00247	10.1124/mol.115.100412																																																																																																																																																														26396690																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.82808																																0.35351																																8																																HY-19838	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:7545|GPR139|potent and selective agonist of hGPR139 with an EC50 = 16 nM;GPR139 inhibitor	C[C@H](NC(=O)CNC(=O)c1cccc(Cl)c1)c2ccccc2	1802326-66-4	19904	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468958	316.78208	JNJ-63533054	JNJ-63533054 | JNJ-63533054	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:7545	GPR139	potent and selective agonist of hGPR139 with an EC50 = 16 nM;GPR139 inhibitor
SJ001035170-1	SJ001035170	1	MOABOX:7547	RXRVCJFGSOVYLG-LLVKDONJSA-N	C[C@@H]1CN(c2cccnc2F)C(=O)c2cc(COc3ccc(Cl)cn3)nn21		selective mGlu3 NAM	GRM3																																																															CHEMBL3617655											122190433					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-108710	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:7547|GRM3|selective mGlu3 NAM	C[C@@H]1CN(C(=O)c2cc(COc3ccc(Cl)cn3)nn12)c4cccnc4F	1809085-30-0	39946	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468981	387.7954	VU0650786	VU0650786 | VU0650786	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:7547	GRM3	selective mGlu3 NAM
SJ001035216-1	SJ001035216	1	MOABOX:7557	VMVOHHPQIAPYHG-NRFANRHFSA-N	O=C(CF)CNC(=O)[C@H](Cc1ccccc1)NC(=O)c1cccc2ccccc12		ATG4B inhibitor	ATG4B																																																																										127020966					member																																																																																																																																																																27563406																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.3872																																0.0484																																8																																HY-100522	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy | Research Area: Cancer|MOABOX:7557|ATG4B|ATG4B inhibitor	FCC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)c2cccc3ccccc23	1955550-51-2	24715	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469158	392.42284	FMK 9A	FMK 9A | FMK 9A	Pathway: Autophagy	Research Area: Cancer	MOABOX:7557	ATG4B	ATG4B inhibitor
SJ001035113-1	SJ001035113	1	MOABOX:7560	APSOPISMEDAYTH-LBPRGKRZSA-N	CNC(=O)Nc1cc(Oc2cncc(OC)c2)c([C@H]2CCCOC2)cn1		GCK inhibitors	GCK																																																																										71603520					virtual	10.1021/acsmedchemlett.6b00145																																																																																																																																																															27437074																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.9456																																0.4932																																8																																ST110899	TIMTEC	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-151-597|MOABOX:7560|GCK|GCK inhibitors	CNC(=O)Nc1cc(Oc2cncc(OC)c2)c(cn1)C3CCCOC3	1442677-60-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468720	358.39168	ST110899	ST110899 | ST110899			MOABOX:7560	GCK	GCK inhibitors
SJ000840405-2	SJ000840405	2	MOABOX:7562	YBMGNDPBARCLFT-UHFFFAOYSA-N	COc1ccc(C2C(C#N)=C(N)OC3=C2C(=O)CC(c2cccc4ccccc24)C3)cc1	1118460-77-7	SLC1A3 - EAAT1/GLAST inhibitor	SLC1A3																																																															CHEMBL474133											25223366					member	10.1016/j.bmc.2012.09.049	10.1021/jm1009154	10.1021/jm300345z	10.1021/jm8013458																																																																																																																																																												19161278	20857912	22594609																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.97344																																0.24668																																8																																HY-10914	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Neurological Disease|MOABOX:7562|SLC1A3|SLC1A3 - EAAT1/GLAST inhibitor	COc1ccc(cc1)C2C(=C(N)OC3=C2C(=O)CC(C3)c4cccc5ccccc45)C#N	1118460-77-7	27650	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468855	422.47518	UCPH 101	UCPH 101 | UCPH 101	Pathway: Others	Research Area: Neurological Disease	MOABOX:7562	SLC1A3	SLC1A3 - EAAT1/GLAST inhibitor
SJ001033367-2	SJ001033367	2	MOABOX:7564	GHTGYZMBQPXTCQ-UHFFFAOYSA-N	CC1(C)Cc2c(sc(NC(=O)c3ccn[nH]3)c2C(N)=O)C(C)(C)O1		CFTR modulator	CFTR																																																															CHEMBL4075348											117857370					virtual																																																																																																																																																																29148763																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.606																																0.45075																																8																																HY-111099	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Membrane Transporter/Ion Channel | Research Area: Others|MOABOX:7564|CFTR|CFTR modulator	CC1(C)Cc2c(C(=O)N)c(NC(=O)c3cc[nH]n3)sc2C(C)(C)O1	1654725-02-6	29253	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469376	348.42	GLPG1837; ABBV-974	GLPG1837; ABBV-974 | GLPG1837; ABBV-974	Pathway: Autophagy; Membrane Transporter/Ion Channel	Research Area: Others	MOABOX:7564	CFTR	CFTR modulator
SJ001010668-3	SJ001010668	3	MOABOX:7581	IOMMMLWIABWRKL-WUTDNEBXSA-N	Cc1cc(C(=O)Nc2nc3cccc(Cl)c3n2[C@@H]2CCCCN(C(=O)/C=C/CN(C)C)C2)ccn1	1508250-71-2	Tec Protein Tyrosine Kinase inhibitor;ITK inhibitor;EGFR inhibitor	EGFR																																																															CHEMBL3787344	CHEMBL3984979										72703790	91809207	131634510	134157201		member																																																																																																																																																																26968253	27433829																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.41352																																0.30169																																8																																HY-12872	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: JAK/STAT Signaling; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:7581|EGFR|Tec Protein Tyrosine Kinase inhibitor;ITK inhibitor;EGFR inhibitor	CN(C)C\C=C\C(=O)N1CCCC[C@H](C1)n2c(NC(=O)c3ccnc(C)c3)nc4cccc(Cl)c24	1508250-71-2	18665	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469082	495.01634	NAZARTINIB	NAZARTINIB | NAZARTINIB	Pathway: JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:7581	EGFR	Tec Protein Tyrosine Kinase inhibitor;ITK inhibitor;EGFR inhibitor
SJ000907289-2	SJ000907289	2	MOABOX:7587	DHXKRMSKXLDZGY-UHFFFAOYSA-N	CC(C)c1c(-c2ccccc2)[nH]c2c(C#N)cnn2c1=O		KDM5A pan Inhibitor	KDM5A																																																																															member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.0996																																0.4428																																7																																T3552	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-624-154|MOABOX:7587|KDM5A|KDM5A pan Inhibitor	CC(C)C1=C(Nc2c(cnn2C1=O)C#N)c3ccccc3	1628208-23-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468586	278.30856	CPI 455	CPI 455 | CPI 455			MOABOX:7587	KDM5A	KDM5A pan Inhibitor
SJ001033382-2	SJ001033382	2	MOABOX:7589	YBAWYTYNMZWMMJ-UHFFFAOYSA-N	Fc1ccc2c(CCNCc3cccc(OCC(F)(F)C(F)F)c3)c[nH]c2c1	467458-02-2	5-hydroxytryptamine receptor 6 inhibitor	HTR6																																																															CHEMBL3286580											21071390	21071391	145379953			member	10.1517/13543784.2015.1052402																																																																																																																																																															20569520	20932009	21093272	24850589	24878269	27326337	28212021	29291439																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														3.73568																																0.46696																																8																																HY-14338A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:7589|HTR6|5-hydroxytryptamine receptor 6 inhibitor	FC(F)C(F)(F)COc1cccc(CNCCc2c[nH]c3cc(F)ccc23)c1	467458-02-2	9149	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469140	398.36968	IDALOPIRDINE HYDROCHLORIDE; LU AE58054 (HYDROCHLORIDE)	IDALOPIRDINE HYDROCHLORIDE; LU AE58054 (HYDROCHLORIDE) | IDALOPIRDINE HYDROCHLORIDE; LU AE58054 (HYDROCHLORIDE)	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:7589	HTR6	5-hydroxytryptamine receptor 6 inhibitor
SJ001035223-1	SJ001035223	1	MOABOX:7595	JWCUSQCZMQIBMR-UHFFFAOYSA-N	Cc1cccc(NC(=O)c2ccc(C(F)(F)F)cc2C(=O)O)n1	1531634-31-7	sortilin inhibitor (SORT1)	SORT1																																																															CHEMBL3098745											72706115					member	10.1016/j.bmcl.2013.11.046																																																																																																																																																															24355129	28462834																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.63776																																0.07972																																8																																HY-12802	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:7595|SORT1|sortilin inhibitor (SORT1)	Cc1cccc(NC(=O)c2ccc(cc2C(=O)O)C(F)(F)F)n1	1531634-31-7	63798	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469176	324.25465	AF38469	AF38469 | AF38469	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:7595	SORT1	sortilin inhibitor (SORT1)
SJ000983394-4	SJ000983394	4	MOABOX:7598	XUMALORDVCFWKV-IBGZPJMESA-N	C[C@H](NC(=O)c1c(N)nn2cccnc12)c1cc2cccc(C#Cc3cnn(C)c3)c2c(=O)n1-c1ccccc1		PIK3CG inhibitors	PIK3CG																																																															CHEMBL3984425											91933882	91933883				member	10.1021/acsmedchemlett.6b00238																																																																																																																																																															27660692																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.17536																																0.27192																																8																																HY-100716	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:7598|PIK3CG|PIK3CG inhibitors	C[C@H](NC(=O)c1c(N)nn2cccnc12)C3=Cc4cccc(C#Cc5cnn(C)c5)c4C(=O)N3c6ccccc6	1693758-51-8	29506	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469721	528.56396	IPI-549	IPI-549 | IPI-549	Pathway: PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:7598	PIK3CG	PIK3CG inhibitors
SJ001035141-1	SJ001035141	1	MOABOX:7605	IPNJQCVHNPGYOX-UHFFFAOYSA-N	COC(=O)CN(c1ccc(CN(c2ccc(OCc3ccc(C)cc3)c(C(=O)OC)c2)S(=O)(=O)Cc2ccccc2)cc1)S(C)(=O)=O		PTPN1 (PTP1B) inhibitor;PTPN1 inhibitors	PTPN1																																																															CHEMBL3822604											127050086					virtual																																																																																																																																																																27123900																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.78392																																0.22299																																8																																HY-100462	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:7605|PTPN1|PTPN1 (PTP1B) inhibitor;PTPN1 inhibitors	COC(=O)CN(c1ccc(CN(c2ccc(OCc3ccc(C)cc3)c(c2)C(=O)OC)S(=O)(=O)Cc4ccccc4)cc1)S(=O)(=O)C	1919853-46-5	24918	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468879	680.78764	PTP1B-IN-2	PTP1B-IN-2 | PTP1B-IN-2	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:7605	PTPN1	PTPN1 (PTP1B) inhibitor;PTPN1 inhibitors
SJ001034908-1	SJ001034908	1	MOABOX:7612	BVRXQXNVDLUWMV-UHFFFAOYSA-N	CC(=O)NCCSc1nc2cscc2c(=O)n1-c1ccc(OCC(F)(F)F)cc1	1356354-09-0	Delta 5 desaturase inhibitor;delta 5 destaurase inhibitors	FADS1																																																																										86685411					member	10.1021/acsmedchemlett.6b00241																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.67648																																0.20956																																8																																6106	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-628-961|MOABOX:7612|FADS1|Delta 5 desaturase inhibitor;delta 5 destaurase inhibitors	CC(=O)NCCSC1=Nc2cscc2C(=O)N1c3ccc(OCC(F)(F)F)cc3	1356354-09-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468217	443.46315	T 3364366	T 3364366 | T 3364366			MOABOX:7612	FADS1	Delta 5 desaturase inhibitor;delta 5 destaurase inhibitors
SJ000285513-13	SJ000285513	13	MOABOX:7618	QEVHRUUCFGRFIF-MDEJGZGSSA-N	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC	1263-94-1	Norepinephrine Uptake Inhibitor;Vesicular Monoamine Transporter 2 (VMAT2) Inhibitors	SLC18A1	SLC18A2																															6571																															CHEMBL1203461	CHEMBL356010	CHEMBL424331	CHEMBL772								5770	121434	162111	192044	193444	member	10.1021/acs.jmedchem.8b00542																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0.6556																															0.0	0.08195																															7	8																															KS-5106	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c6cc(OC)c(OC)c(OC)c6	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466803	608.6787	RESERPINE | ISORESERPINE	"""RESERPINE | ISORESERPINE"" | RESERPINE | SERPASIL | ""RESERPINE | ISORESERPINE"" | RESERPINE | SERPASIL"			MOABOX:7618	SLC18A1	Norepinephrine Uptake Inhibitor;Vesicular Monoamine Transporter 2 (VMAT2) Inhibitors
SJ001032997-2	SJ001032997	2	MOABOX:7619	YGIDGBAHDZEYMT-MQFIMZJJSA-N	OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4cccc(F)c4)nn3)[C@H]2O)[C@H](O)[C@@H](n2cc(-c3cccc(F)c3)nn2)[C@H]1O	1450824-22-2	Galectin 3 Inhibitors;Galectin-3 inhibitor	LGALS3																																																																										73774610					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-3.84e-002																																-0.0048																																8																																T5121	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-417-276|MOABOX:7619|LGALS3|Galectin 3 Inhibitors;Galectin-3 inhibitor	OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@@H]([C@H]2O)n3cc(nn3)c4cccc(F)c4)[C@H](O)[C@H]([C@H]1O)n5cc(nn5)c6cccc(F)c6	1450824-22-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468153	648.63501	TD139	TD139 | TD139			MOABOX:7619	LGALS3	Galectin 3 Inhibitors;Galectin-3 inhibitor
SJ001035225-1	SJ001035225	1	MOABOX:7622	ZJHZBDRZEZEDGB-UHFFFAOYSA-N	N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)cc3)o2)cc1	55368-40-6	Protein Arginine N-Methyltransferase 1 (PRMT1) Inhibitors;Antimalarial;reverse mis-splicing in Myotonic dystrophy type 1 (DM1)	PRMT1																																																															CHEMBL1964991	CHEMBL24057	CHEMBL3769989									126437	5458660	9799856	19977173	24198848	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-6.314e-002																																-0.00902																																7																																HY-110137	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Epigenetics; Metabolic Enzyme/Protease | Research Area: Cancer; Infection; Inflammation/Immunology|MOABOX:7622|PRMT1|Protein Arginine N-Methyltransferase 1 (PRMT1) Inhibitors;Antimalarial;reverse mis-splicing in Myotonic dystrophy type 1 (DM1)	NC(=N)c1ccc(cc1)c2oc(cc2)c3ccc(cc3)C(=N)N	55368-40-6	79927	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469178	304.34584	FURAMIDINE DIHYDROCHLORIDE | DB75 DIHYDROCHLORIDE | NSC 305831 DIHYDROCHLORIDE	"""FURAMIDINE DIHYDROCHLORIDE | DB75 DIHYDROCHLORIDE | NSC 305831 DIHYDROCHLORIDE"" | ""FURAMIDINE DIHYDROCHLORIDE | DB75 DIHYDROCHLORIDE | NSC 305831 DIHYDROCHLORIDE"""	Pathway: Anti-infection; Epigenetics; Metabolic Enzyme/Protease	Research Area: Cancer; Infection; Inflammation/Immunology	MOABOX:7622	PRMT1	Protein Arginine N-Methyltransferase 1 (PRMT1) Inhibitors;Antimalarial;reverse mis-splicing in Myotonic dystrophy type 1 (DM1)
SJ001034964-1	SJ001034964	1	MOABOX:7629	PXRCDPVYRPKGGI-MRXNPFEDSA-N	C[C@H](Cc1cccc(-c2cc(Cc3ccccc3)ccc2C(N)=O)c1)C(=O)O		sPLA2 inhibitors	PLA2G2A	PLA2G5	PLA2G10																														5322	8399																																									129909859					member																																																																																																																																																																27774123																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.06664	-0.3738	-0.60718																														0.13333	-0.0534	-0.08674																														8	7	7																														2661	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-830-629|MOABOX:7629|PLA2G2A|sPLA2 inhibitors	C[C@H](Cc1cccc(c1)c2cc(Cc3ccccc3)ccc2C(=O)N)C(=O)O	1845753-81-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468381	373.44432	AZD2716	AZD2716 | AZD2716			MOABOX:7629	PLA2G2A	sPLA2 inhibitors
SJ001035322-1	SJ001035322	1	MOABOX:7633	YRDHKIFCGOZTGD-UHFFFAOYSA-N	CN1C(=O)c2sccc2N(C)c2nc(Nc3ccc(S(N)(=O)=O)cc3)ncc21		MST1/2 inhibitor	STK3	STK4																															6789																																										121499143					virtual	10.1126/scitranslmed.aaf2304																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.7796	1.33888																															0.09745	0.16736																															8	8																															HY-100526	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Stem Cell/Wnt | Research Area: Cancer|MOABOX:7633|STK3|MST1/2 inhibitor	CN1C(=O)c2sccc2N(C)c3nc(Nc4ccc(cc4)S(=O)(=O)N)ncc13	2061980-01-4	40126	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469566	416.47734	XMU-MP-1	XMU-MP-1 | XMU-MP-1	Pathway: Stem Cell/Wnt	Research Area: Cancer	MOABOX:7633	STK3	MST1/2 inhibitor
SJ001035244-1	SJ001035244	1	MOABOX:7635	IRGYSXZCDAWOOC-UHFFFAOYSA-N	Cc1ccc(S(=O)(=O)Nc2ccccc2N2CCCCC2)s1	1062271-24-2	Mucolipin agonist	MCOLN1																																																																										18191179					member	10.1038/ncomms5681																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.64626																																0.23518																																7																																HY-110238	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Metabolic Disease|MOABOX:7635|MCOLN1|Mucolipin agonist	Cc1ccc(s1)S(=O)(=O)Nc2ccccc2N3CCCCC3	1062271-24-2	79788	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469286	336.4722	MK6-83	MK6-83 | MK6-83	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Metabolic Disease	MOABOX:7635	MCOLN1	Mucolipin agonist
SJ000286912-13	SJ000286912	13	MOABOX:7637	DRLFMBDRBRZALE-UHFFFAOYSA-N	COc1ccc2[nH]cc(CCNC(C)=O)c2c1	51023-76-8	Antioxidants;Apoptosis Inducers;Free Radical Scavengers;NOS2 Expression Inhibitors;TH Expression Enhancers	MTNR1A	MTNR1B																															4544																															CHEMBL45											896	473254	9931479	9933426	9952543	virtual	10.1021/acs.jmedchem.6b01173	10.1021/acs.jnatprod.7b00853																																																																																																																																																														7932550	8258829	8411005	8879554	9207940	9207941	9435890	9618428	9733487	9748358	9804685	10381796	10737738	10919077	10968275	11063602	11354661	11520198	11960497	12061881	12213062	12213063	12538005	12538010	12604667	12643943	12646022	12672242	12943203	14643330	14757166	14980664	15013015	15135299	15203165	15293992	15358287	15380218	15713384	15816047	15916895	15943478	16290939	16431121	16759094	16955531	17149869	17223160	17346859	17459711	17481904	17581657	17907131	18052314	18372181	18384758	18657980	18673165	18778943	18983139	19193160	19329323	19473848	19728346	20227878	20235539	20444610	20674373	21084390	21377769	21392858	21419469	21420861	21473625	21476953	21568291	21688779	21726069	21764185	21775151	21777010	21887801	22680635	22709004	22927210	23023262	23131177	23228808	23265885	23332368	23403082	23466604	23582449	23815579	24228714	24930835	25232966	25542766	26023814	26334942	26367450	26478787	26785296	26820449	26988801	27876250	28106992	28131094	28471663	28947942	29595267	29631962	30126274	30810314	31204226																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.17112	1.47952																															0.27139	0.18494																															8	8																															KS-1454	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1ccc2[nH]cc(CCNC(=O)C)c2c1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466826	232.27834	MELATONIN	MELATONIN | MELATONIN			MOABOX:7637	MTNR1A	Antioxidants;Apoptosis Inducers;Free Radical Scavengers;NOS2 Expression Inhibitors;TH Expression Enhancers
SJ001035249-1	SJ001035249	1	MOABOX:7638	WGABOZPQOOZAOI-UHFFFAOYSA-N	COc1cc(C(=O)N(CCCc2ccccc2)Cc2ccc(CC(=O)O)cc2)cc(OC)c1C		LPA1 antagonist	LPAR1																																																															CHEMBL3941037											66775043					member																																																																																																																																																																27774128	29259748																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.47328																																0.43416																																8																																HY-100882	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cardiovascular Disease|MOABOX:7638|LPAR1|LPA1 antagonist	COc1cc(cc(OC)c1C)C(=O)N(CCCc2ccccc2)Cc3ccc(CC(=O)O)cc3	638132-34-0	22841	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469299	461.54944	ONO-7300243	ONO-7300243 | ONO-7300243	Pathway: GPCR/G Protein	Research Area: Cardiovascular Disease	MOABOX:7638	LPAR1	LPA1 antagonist
SJ001010880-2	SJ001010880	2	MOABOX:7642	NJQVSLWJBLPTMD-LBPRGKRZSA-N	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		inhibitor of RIPK1	RIPK1																																																																										122703613					member	10.1021/acs.jmedchem.9b00318	10.1038/cdd.2017.58																																																																																																																																																														31013427																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.35888																																0.41986																																8																																CS-0029820	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-684-134|MOABOX:7642|RIPK1|inhibitor of RIPK1	CC(C)(C)C(=O)N1N=CC[C@H]1c2ccccc2	2049868-46-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468483	230.30552	GSK963	GSK963 | GSK963			MOABOX:7642	RIPK1	inhibitor of RIPK1
SJ000796043-3	SJ000796043	3	MOABOX:7646	AQMPIDSGLFVVPL-UHFFFAOYSA-N	COC(=O)CN1CN(c2ccccc2)C2(CCN(Cc3cccc4ccccc34)CC2)C1=O	250685-44-0	OPRL1 (Nociceptin Receptor) agonist	OPRL1																																																															CHEMBL2088036											9803475					member	10.1021/jm201629q	10.1038/sj.bjp.0703661	10.2174/1389557013406657																																																																																																																																																													11053209	12369963	22541041																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.43184																																0.30398																																8																																1780	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-204|MOABOX:7646|OPRL1|OPRL1 (Nociceptin Receptor) agonist	COC(=O)CN1CN(c2ccccc2)C3(CCN(Cc4cccc5ccccc45)CC3)C1=O	250685-44-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468370	443.53746	NNC 63-0532	NNC 63-0532 | NNC 63-0532			MOABOX:7646	OPRL1	OPRL1 (Nociceptin Receptor) agonist
SJ001035261-1	SJ001035261	1	MOABOX:7654	SUFXXEIVBZJOAP-RUZDIDTESA-N	O=C1N[C@](c2ccc(N3CCOCC3)cc2)(c2ccsc2)CC(O)=C1Sc1ccccc1Cl		LDHA inhibitors	LDHA																																																															CHEMBL4065858											121225870					member	10.1021/acs.jmedchem.7b00941																																																																																																																																																															27774125	29120638																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.6976																																0.2122																																8																																HY-100742A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:7654|LDHA|LDHA inhibitors	OC1=C(Sc2ccccc2Cl)C(=O)N[C@](C1)(c3ccc(cc3)N4CCOCC4)c5ccsc5	2003234-63-5	26999	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469389	499.04472	(R)-GNE-140	(R)-GNE-140 | (R)-GNE-140	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:7654	LDHA	LDHA inhibitors
SJ000851857-5	SJ000851857	5	MOABOX:7660	RRZVGDGTWNQAPW-UHFFFAOYSA-N	Cn1cc(CCn2cnc(-c3cnn(C)c3)c2-c2ccc(C#N)cc2)cn1	1665195-94-7	"BAZ2A, BAZ2B dual inhibitor;Dual BAZ2A/BAZ2B inhibitor"	BAZ2A	BAZ2B																															29994																																										91654625					member																																																																																																																																																																25719566	26572217																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.83624	-5.096e-002																															0.35453	-0.00637																															8	8																															HY-19336	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:7660|BAZ2A|BAZ2A, BAZ2B dual inhibitor;Dual BAZ2A/BAZ2B inhibitor"	Cn1cc(CCn2cnc(c3cnn(C)c3)c2c4ccc(cc4)C#N)cn1	1665195-94-7	90853	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469805	357.41176	BAZ2-ICR	BAZ2-ICR | BAZ2-ICR	Pathway: Epigenetics	Research Area: Cancer	MOABOX:7660	BAZ2A	"BAZ2A, BAZ2B dual inhibitor;Dual BAZ2A/BAZ2B inhibitor"
SJ000836335-5	SJ000836335	5	MOABOX:7666	HESLKTSGTIBHJU-UHFFFAOYSA-N	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1	869288-64-2	FAK inhbitor;Inhibitor of fibronectin-directed migration;Co-Inducer of apoptosis in pancreatic cancer	PTK2																																																															CHEMBL514554											11612883	118905968				member	10.1038/s41388-018-0320-2	10.1074/jbc.M606695200	10.1111/bcpt.12553	10.1177/1010428317699120																																																																																																																																																												17395594	19716803																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.81768																																0.35221																																8																																HY-10461	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:7666|PTK2|FAK inhbitor;Inhibitor of fibronectin-directed migration;Co-Inducer of apoptosis in pancreatic cancer	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4NC(=O)CCc4c3)ncc2C(F)(F)F)c1	869288-64-2	13762	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468761	491.48611	PF-573228	PF-573228 | PF 573228 | PF-573228 | PF 573228	Pathway: Apoptosis; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:7666	PTK2	FAK inhbitor;Inhibitor of fibronectin-directed migration;Co-Inducer of apoptosis in pancreatic cancer
SJ000982641-4	SJ000982641	4	MOABOX:7667	IGUBBWJDMLCRIK-UHFFFAOYSA-N	CNC(=O)c1ccccc1Nc1cc(Nc2ccc(N3CCOCC3)cc2OC)ncc1C(F)(F)F	1061353-68-1	FAK inhibitor	PTK2																																																															CHEMBL2430358	CHEMBL3040440										25073775	56654067	131865374	144318392		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.80088																																0.22511																																8																																HY-13917	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:7667|PTK2|FAK inhibitor	CNC(=O)c1ccccc1Nc2cc(Nc3ccc(cc3OC)N4CCOCC4)ncc2C(F)(F)F	1061353-68-1	9746	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468904	501.50085	VS-4718 | VS 4718 | VS4718 | PND1186 | PND-1186 | PND 1186	"""VS-4718 | VS 4718 | VS4718 | PND1186 | PND-1186 | PND 1186"" | ""VS-4718 | VS 4718 | VS4718 | PND1186 | PND-1186 | PND 1186"""	Pathway: Apoptosis; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:7667	PTK2	FAK inhibitor
SJ001034901-1	SJ001034901	1	MOABOX:7671	WPFLVPJXKWCRQK-UHFFFAOYSA-N	CCS(=O)(=O)c1cc(Nc2ncc(F)c(N(Cc3ccccc3C#N)c3cc(CO)ccc3C)n2)ccc1N1CCN(C)CC1		PAK1 inhibitors	PAK1																																																															CHEMBL3923175											129909860					virtual																																																																																																																																																																27994749																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.2232																																0.1529																																8																																6177	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-830-630|MOABOX:7671|PAK1|PAK1 inhibitors	CCS(=O)(=O)c1cc(Nc2ncc(F)c(n2)N(Cc3ccccc3C#N)c4cc(CO)ccc4C)ccc1N5CCN(C)CC5	2016806-57-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468207	629.74744	AZ 13705339	AZ 13705339 | AZ 13705339			MOABOX:7671	PAK1	PAK1 inhibitors
SJ000286505-7	SJ000286505	7	MOABOX:7675	BHQCQFFYRZLCQQ-OELDTZBJSA-N	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O	10321-98-9	Cholesterol-7-alpha-hydroxylase product and feedback inhibitor	GPBAR1	NR1H4	CYP7A1																														9971	1581																														CHEMBL205596	CHEMBL3114538	CHEMBL3187726									221493	239671	9871915	11629138	20848902	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	-0.24556	1.14667																														0.0	-0.03508	0.16381																														7	7	7																														AS-69849	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466801	408.5714	CHOLIC ACID	CHOLIC ACID | SODIUM CHOLATE | CHOLIC ACID | SODIUM CHOLATE			MOABOX:7675	GPBAR1	Cholesterol-7-alpha-hydroxylase product and feedback inhibitor
SJ001035044-1	SJ001035044	1	MOABOX:7678	PNEWYJAVBOHPBV-UHFFFAOYSA-N	COc1ccc(Cl)cc1NC(=O)N1CCN(c2ncccc2C(F)(F)F)CC1		Retinol-Binding Protein 4 Inhibitors	RBP4																																																															CHEMBL3288136											2741694					member																																																																																																																																																																24835984																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.82256																																0.10282																																8																																SEW06096	MAYBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-840-965|MOABOX:7678|RBP4|Retinol-Binding Protein 4 Inhibitors	COc1ccc(Cl)cc1NC(=O)N2CCN(CC2)c3ncccc3C(F)(F)F	260553-24-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468544	414.80933	SEW06096	SEW06096 | SEW06096			MOABOX:7678	RBP4	Retinol-Binding Protein 4 Inhibitors
SJ000870749-3	SJ000870749	3	MOABOX:7682	HBOJWAYLSJLULG-UHFFFAOYSA-N	CNCCN1CCC(OCc2ccccc2)CC1		PRMT4/6 inhibitor;PRMT4 and PRMT6 inhibitor	CARM1	PRMT6																															55170																															CHEMBL3961701											53868701	121513883	124203907	129626588		member																																																																																																																																																																27584694	31117515																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.6948	1.14608																															0.21185	0.14326																															8	8																															HY-100360	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:7682|CARM1|PRMT4/6 inhibitor;PRMT4 and PRMT6 inhibitor	CNCCN1CCC(CC1)OCc2ccccc2	1502816-23-0	21823	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469702	248.36386	MS049	MS049 | MS049	Pathway: Epigenetics	Research Area: Cancer	MOABOX:7682	CARM1	PRMT4/6 inhibitor;PRMT4 and PRMT6 inhibitor
SJ000036451-2	SJ000036451	2	MOABOX:7689	LJJFWRJTXCWPQO-UHFFFAOYSA-N	CC1=NN(c2cccc(C(=O)O)c2)C(=O)C1=Cc1ccc(-c2cccc(C(F)(F)F)c2)o1		Lbc-RhoA Interaction Inhibitor	AKAP13																																																																										5167636					member	10.1016/j.chembiol.2016.07.015																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																STK107245	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-947-429|MOABOX:7689|AKAP13|Lbc-RhoA Interaction Inhibitor	CC1=NN(C(=O)/C/1=C\c2oc(cc2)c3cccc(c3)C(F)(F)F)c4cccc(c4)C(=O)O	1668604-67-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468605	440.37141					MOABOX:7689	AKAP13	Lbc-RhoA Interaction Inhibitor
SJ001035127-1	SJ001035127	1	MOABOX:7694	PDKDOPJQPKXNCT-UHFFFAOYSA-N	Cc1cc(C)c(CN2CCc3c(Cl)cc(-c4c(C)noc4C)c(Cl)c3C2=O)c(=O)[nH]1	1616287-82-1	EZH2 inhibitor	EZH2																																																															CHEMBL3911017											86723730	124201861				virtual																																																																																																																																																																27512831	29211475																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				4.51712																																0.56464																																8																																HY-103682	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:7694|EZH2|EZH2 inhibitor	CC1=CC(=C(CN2CCc3c(Cl)cc(c(Cl)c3C2=O)c4c(C)onc4C)C(=O)N1)C	1616287-82-1	27239	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468769	446.32644	PF-06726304	PF-06726304 | PF-06726304	Pathway: Epigenetics	Research Area: Cancer	MOABOX:7694	EZH2	EZH2 inhibitor
SJ000841694-2	SJ000841694	2	MOABOX:7697	CMYCCJYVZIMDFU-UHFFFAOYSA-N	C=CCN(C)CCCCCCOc1ccc(C(=O)c2ccc(Br)cc2)c(F)c1	161582-11-2	lanosterol synthetase inhibitor	LSS																																																															CHEMBL304858	CHEMBL324162										1949	9959583	18434331	44631915	69043964	member	10.1016/j.bmcl.2008.12.040	10.1016/j.ejmech.2013.03.002	10.1021/jm021120f	10.1021/jm0211218	10.1021/jm300256z																																																																																																																																																											12747780	12852766	17760433	17981368	19119009	21824085	22533316	23583910	26745812	29771525																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												3.63496																																0.45437																																8																																HY-18630A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:7697|LSS|lanosterol synthetase inhibitor	CN(CCCCCCOc1ccc(C(=O)c2ccc(Br)cc2)c(F)c1)CC=C	189197-69-1	14274	GENERAL	FUMARATE	1	NO_SOLVATE	0	1469381	448.36838	RO 48-8071	RO 48-8071 | RO 48-8071	Pathway: Others	Research Area: Cancer	MOABOX:7697	LSS	lanosterol synthetase inhibitor
SJ001033494-2	SJ001033494	2	MOABOX:7698	YNUAEEJQYHYLMS-UHFFFAOYSA-N	O=C1c2cc(-c3ccc(OC(F)(F)F)cc3)ccc2OCCN1Cc1ncccn1	1443211-72-0	Nav1.5 channel inhibitor	SCN5A																																																															CHEMBL3707392											71183216	90479986	91827432	118292148	118292149	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.58696																																0.07337																																8																																HY-16738A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Others|MOABOX:7698|SCN5A|Nav1.5 channel inhibitor	FC(F)(F)Oc1ccc(cc1)c2ccc3OCCN(Cc4ncccn4)C(=O)c3c2	1448754-43-5	21641	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469804	415.36525	ELECLAZINE (HYDROCHLORIDE); GS 6615 HYDROCHLORIDE	ELECLAZINE (HYDROCHLORIDE); GS 6615 HYDROCHLORIDE | ELECLAZINE (HYDROCHLORIDE); GS 6615 HYDROCHLORIDE	Pathway: Membrane Transporter/Ion Channel	Research Area: Others	MOABOX:7698	SCN5A	Nav1.5 channel inhibitor
SJ001034887-1	SJ001034887	1	MOABOX:7704	SPTWXRJNCFIDRQ-UHFFFAOYSA-N	CCc1ccc(C=CC(=O)Nc2ccc(C(C)=O)cc2)o1		HECT E3 ligase inhibitor	NEDD4	WWP1	SMURF2																														11059	64750																																									72168298					member	10.1073/pnas.1412152111																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0	0																														0.0	0.0	0.0																														7	7	7																														STK866074	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-638-734|MOABOX:7704|NEDD4|HECT E3 ligase inhibitor	CCc1oc(\C=C\C(=O)Nc2ccc(cc2)C(=O)C)cc1	890605-54-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468187	283.32178	STK866074	STK866074 | STK866074			MOABOX:7704	NEDD4	HECT E3 ligase inhibitor
SJ001033516-2	SJ001033516	2	MOABOX:7713	AEXFXNFMSAAELR-RXVVDRJESA-N	Cn1c(=O)oc2ccc(-c3ccc(C[C@@H](C#N)NC(=O)[C@@H]4CNCCCO4)cc3)cc21		DPP1 inhibitor	CTSC																																																															CHEMBL3900409											118253852					member																																																																																																																																																																27690432																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.82672																																0.35334																																8																																HY-101056	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:7713|CTSC|DPP1 inhibitor	CN1C(=O)Oc2ccc(cc12)c3ccc(C[C@H](NC(=O)[C@@H]4CNCCCO4)C#N)cc3	1802148-05-5	28780	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469677	420.46106	BRENSOCATIB; AZD7986; INS 1007	BRENSOCATIB; AZD7986; INS 1007 | BRENSOCATIB; AZD7986; INS 1007	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:7713	CTSC	DPP1 inhibitor
SJ000855489-6	SJ000855489	6	MOABOX:7715	SDGJBAUIGHSMRI-UHFFFAOYSA-N	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1	1214265-58-3	inhibitor of NUAK1 and NUAK2	NUAK1	NUAK2																															81788																																										72200024					member	10.1042/BJ20131152																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0																															0.0	0.0																															7	7																															HY-15802	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:7715|NUAK1|inhibitor of NUAK1 and NUAK2	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(cc3OC)N4CCN(C)CC4)ncc2Cl)c1	1214265-58-3	12734	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469462	496.98916	WZ4003	WZ4003 | WZ4003	Pathway: Epigenetics; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:7715	NUAK1	inhibitor of NUAK1 and NUAK2
SJ000883655-10	SJ000883655	10	MOABOX:17032	ZFBHXVOCZBPADE-SSEXGKCCSA-N	Cc1c(-c2c(-c3ccc(F)o3)sc3ncnc(O[C@H](Cc4ccccc4OCc4ccnn4CC(F)(F)F)C(=O)O)c23)ccc(OCCN2CCN(C)CC2)c1Cl			MCL1																																																																										122197581					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.00976																																0.37622																																8																																HY-100741	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis | Research Area: Cancer|MOABOX:17032|MCL1|	CN1CCN(CCOc2ccc(c(C)c2Cl)c3c(sc4ncnc(O[C@H](Cc5ccccc5OCc6ccnn6CC(F)(F)F)C(=O)O)c34)c7oc(F)cc7)CC1	1799633-27-4	63264	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469228	829.25929	S63845	S63845 | S63845	Pathway: Apoptosis	Research Area: Cancer	MOABOX:17032	MCL1	
SJ001034962-1	SJ001034962	1	MOABOX:17056	KYOIGHSNTIJBPW-UHFFFAOYSA-N	CCC(C)CNCC(=O)N1CCc2sccc2C1c1cccc(C)n1			HHAT																																																																										71726792	126480616				member	10.1021/acschembio.6b00896																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																2673	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-562-366|MOABOX:17056|HHAT|	CCC(C)CNCC(=O)N1CCc2sccc2C1c3cccc(C)n3	2320262-09-5	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468379	357.51288	RUSKI-201 DIHCL	RUSKI-201 DIHCL | RUSKI-201 DIHCL			MOABOX:17056	HHAT	
SJ000169432-3	SJ000169432	3	MOABOX:17062	VEWFTYOFWIXCIO-UHFFFAOYSA-N	COc1ccc(S(=O)(=O)ON=C2C=C(C)C(=O)C(C)=C2)cc1	321695-57-2	Histone Acetyltransferase KAT3B (p300) Inhibitors;Histone Acetyltransferase KAT2A Inhibitors;Histone N-Acetyltransferase (HAT) Inhibitors	EP300	KAT2A	KAT2B																														2648	8850																														CHEMBL3775671											2221149					member	10.1158/1535-7163.MCT-12-0930																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-3.157e-002	-0.32011	-0.32361																														-0.00451	-0.04573	-0.04623																														7	7	7																														HY-100671	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics; JAK/STAT Signaling; Stem Cell/Wnt | Research Area: Cancer; Inflammation/Immunology|MOABOX:17062|EP300|Histone Acetyltransferase KAT3B (p300) Inhibitors;Histone Acetyltransferase KAT2A Inhibitors;Histone N-Acetyltransferase (HAT) Inhibitors	COc1ccc(cc1)S(=O)(=O)ON=C2C=C(C)C(=O)C(=C2)C	321695-57-2	57583	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468998	321.3483			Pathway: Epigenetics; JAK/STAT Signaling; Stem Cell/Wnt	Research Area: Cancer; Inflammation/Immunology	MOABOX:17062	EP300	Histone Acetyltransferase KAT3B (p300) Inhibitors;Histone Acetyltransferase KAT2A Inhibitors;Histone N-Acetyltransferase (HAT) Inhibitors
SJ001035307-1	SJ001035307	1	MOABOX:17520	WXLPERVDMILVIF-UHFFFAOYSA-N	COc1ccc(C(NC(=O)c2cnc(-c3cccnn3)nc2O)c2ccc(OC)cc2)cc1	1187990-87-9		EGLN1																																																																										44230662	69080641				member																																																																																																																																																																28002958																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.50108																																0.21444																																7																																HY-101023	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:17520|EGLN1|	COc1ccc(cc1)C(NC(=O)c2cnc(nc2O)c3cccnn3)c4ccc(OC)cc4	1187990-87-9	29060	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469538	443.45464	MK-8617	MK-8617 | MK-8617	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:17520	EGLN1	
SJ000285940-7	SJ000285940	7	MOABOX:17523	JBDGDEWWOUBZPM-XYPYZODXSA-N	Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1	107814-37-9	Pulmonary surfactant;lysosomal exocytosis	GBA																																																															CHEMBL1514634	CHEMBL153479															member	10.1016/j.ceca.2015.10.002	10.1038/mt.2014.224																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			9.338e-002																																0.01334																																7																																BD14893	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-986-647|MOABOX:17523|GBA|Pulmonary surfactant;lysosomal exocytosis	Nc1c(Br)cc(Br)cc1CN[C@@H]2CC[C@@H](O)CC2	23828-92-4	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468661	378.10282	AMBROXOL HYDROCHLORIDE	AMBROXOL HYDROCHLORIDE | AMBROXOL | AMBROXOL HCL | AMBROXOL HYDROCHLORIDE | AMBROXOL | AMBROXOL HCL			MOABOX:17523	GBA	Pulmonary surfactant;lysosomal exocytosis
SJ001035248-1	SJ001035248	1	MOABOX:17527	GBHKWXUSQTVIBN-UHFFFAOYSA-N	CC1(C)Oc2cc(N3CCN(C(=O)OCc4ccccc4)CC3)c([N+](=O)[O-])cc2-c2c1cnn2-c1ccc(C(=O)O)cc1			LIN28A																																																																										134694995					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-100692	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:17527|LIN28A|	CC1(C)Oc2cc(N3CCN(CC3)C(=O)OCc4ccccc4)c(cc2c5c1cnn5c6ccc(cc6)C(=O)O)[N+](=O)[O-]	2024548-03-4	68312	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469295	583.59126	LIN28-LET-7A ANTAGONIST 1	LIN28-LET-7A ANTAGONIST 1 | LIN28-LET-7A ANTAGONIST 1	Pathway: Epigenetics	Research Area: Cancer	MOABOX:17527	LIN28A	
SJ000870751-2	SJ000870751	2	MOABOX:17528	CACMCLIHCDTJHL-IDTAVKCVSA-N	CCNC(=O)NCCSC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		Dual PRMT5 and PRMT7 inhibitor	PRMT5	PRMT7																															54496																															CHEMBL3577854											122178085					member	10.1021/ml500467h																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.78988	1.155e-002																															0.11284	0.00165																															7	7																															HY-124131	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer; Inflammation/Immunology|MOABOX:17528|PRMT5|Dual PRMT5 and PRMT7 inhibitor	CCNC(=O)NCCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(N)ncnc23	1674364-87-4	80863	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469036	397.45262	DS-437	DS-437 | DS-437	Pathway: Epigenetics	Research Area: Cancer; Inflammation/Immunology	MOABOX:17528	PRMT5	Dual PRMT5 and PRMT7 inhibitor
SJ000865782-12	SJ000865782	12	MOABOX:17534	WRUWGLUCNBMGPS-UHFFFAOYSA-N	CCn1cc(-c2cccc(C(F)(F)F)c2)c2sc(C(=N)NC3CCS(=O)(=O)CC3)cc2c1=O	1714146-59-4	BRD9 inhibitor	BRD9																																																															CHEMBL3769507											91668541					member	10.1021/acs.jmedchem.5b00256																																																																																																																																																															25856009	26572217	27120693	30824168																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		3.28848																																0.41106																																8																																HY-18975	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:17534|BRD9|BRD9 inhibitor	CCN1C=C(c2cccc(c2)C(F)(F)F)c3sc(cc3C1=O)C(=N)NC4CCS(=O)(=O)CC4	1714146-59-4	33739	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469728	497.55359	I-BRD9	I-BRD9 | I-BRD9	Pathway: Epigenetics	Research Area: Cancer	MOABOX:17534	BRD9	BRD9 inhibitor
SJ001035247-1	SJ001035247	1	MOABOX:17536	NKOJNOBJGYTLLZ-KRWDZBQOSA-N	CC(=O)N1CCc2c(c(Nc3ccc(-c4cnn(C)c4)cc3F)nn2[C@H]2CCOC2)C1		N-Ac Lysine competitive CREBBP/EP300 inhibitor	CREBBP	EP300																															2033																															CHEMBL3897393											121372887					member	10.1021/acs.jmedchem.6b01022																																																																																																																																																															27682507	28892380	29155580																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.25488	0.77931																															0.28186	0.11133																															8	7																															HY-100726	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:17536|CREBBP|N-Ac Lysine competitive CREBBP/EP300 inhibitor	CC(=O)N1CCc2c(C1)c(Nc3ccc(cc3F)c4cnn(C)c4)nn2[C@H]5CCOC5	1936428-93-1	26317	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469293	424.4713	GNE-272	GNE-272 | GNE-272	Pathway: Epigenetics	Research Area: Cancer	MOABOX:17536	CREBBP	N-Ac Lysine competitive CREBBP/EP300 inhibitor
SJ001034937-1	SJ001034937	1	MOABOX:17540	MSFPLTWUFWOKBX-IFXJQAMLSA-N	Cc1nnc2c3ccccc3c(N[C@@H](C)[C@H](c3ccccc3)N(C)C)nn12		"KAT2B, KAT2A inhibitor"	KAT2B																																																																										131698638	134691749				member	10.1002/anie.201610816																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																21288	CAYMAN	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-417-623|MOABOX:17540|KAT2B|KAT2B, KAT2A inhibitor"	CN(C)[C@H](CNc1nn2c(C)nnc2c3ccccc13)c4ccccc4	2320308-53-8	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468297	346.42888	L-MOSES HCL | L-45	"""L-MOSES HCL | L-45"" | ""L-MOSES HCL | L-45"""			MOABOX:17540	KAT2B	"KAT2B, KAT2A inhibitor"
SJ001035051-1	SJ001035051	1	MOABOX:17544	HIUOABSWQSUEGK-UHFFFAOYSA-N	Cc1nc(-c2ccccn2)nc(NCCc2ccccc2)c1Cl		MetAPN inhibitor;Plasmodium falciparum Methionine Aminopeptidase-1b (PfMetAP1b) Inhibitors	METAP1																																																															CHEMBL472879											2740174					member	10.1016/j.bmc.2013.02.023	10.1021/jm400227z	10.1073/pnas.0604101103																																																																																																																																																													20166950	23507151	23634668																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.34888																																0.29361																																8																																SEW02975	MAYBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-840-843|MOABOX:17544|METAP1|MetAPN inhibitor;Plasmodium falciparum Methionine Aminopeptidase-1b (PfMetAP1b) Inhibitors	Cc1nc(nc(NCCc2ccccc2)c1Cl)c3ccccn3	256370-30-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468554	324.80738	SEW02975	SEW02975 | SEW02975			MOABOX:17544	METAP1	MetAPN inhibitor;Plasmodium falciparum Methionine Aminopeptidase-1b (PfMetAP1b) Inhibitors
SJ001035360-1	SJ001035360	1	MOABOX:17547	KOBHCUDVWOTEKO-VKHMYHEASA-N	N=C(NO)NCC[C@H](N)C(=O)O	189302-40-7		ARG1																																																															CHEMBL1234777											446124	16760508	26248652	91886101	91886147	virtual																																																																																																																																																																12023942	20153713																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.68376																																0.21047																																8																																HY-112885A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease | Research Area: Cancer; Metabolic Disease; Inflammation/Immunology|MOABOX:17547|ARG1|	N[C@@H](CCNC(=N)NO)C(=O)O	1140844-63-8	82014	GENERAL	ACETATE	1	NO_SOLVATE	0	1469735	176.17378	NOR-NOHA ACETATE	NOR-NOHA ACETATE | NOR-NOHA ACETATE	Pathway: Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease	Research Area: Cancer; Metabolic Disease; Inflammation/Immunology	MOABOX:17547	ARG1	
SJ000555703-6	SJ000555703	6	MOABOX:17548	XFDJYSQDBULQSI-UHFFFAOYSA-N	CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O	113-07-5		KCNK3	KCNK9																															51305																															CHEMBL1200876	CHEMBL1754	CHEMBL3989519									3156	64647	64648	192102	23624036	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															8	8																															AA00IC12	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-005-940-749|MOABOX:17548|KCNK3|	CCN1CC(CCN2CCOCC2)C(C1=O)(c3ccccc3)c4ccccc4	7081-53-0	NA	GENERAL	CHLORIDE	1	H2O	1	1468283	378.5072	DOXAPRAM HYDROCHLORIDE	DOXAPRAM HYDROCHLORIDE | DOXAPRAM HCL | DOXAPRAM HYDROCHLORIDE | DOXAPRAM HCL			MOABOX:17548	KCNK3	
SJ000285438-10	SJ000285438	10	MOABOX:17549	GDLBFKVLRPITMI-UHFFFAOYSA-N	CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1	1098065-76-9	potassium channel activator;K(ATP) Channel Activators	CA1	KCNJ11																															3767																															CHEMBL181											3019	23126766	46853701	66625981	67135387	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0.3927																															0.0	0.0561																															7	7																															KS-1444	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466718	230.67138	DIAZOXIDE	DIAZOXIDE | DIAZOXIDE			MOABOX:17549	CA1	potassium channel activator;K(ATP) Channel Activators
SJ000870726-2	SJ000870726	2	MOABOX:17551	OFWWWKWUCDUISA-UHFFFAOYSA-N	Cc1cc2c(cc1N1C(=O)c3cccc4c(CCCO)ccc(c34)C1=O)n(C)c(=O)n2C		Bromodomain inhibitor	TAF1	BRD1	TAF1L																														23774	138474																														CHEMBL4086276											122705990					member	10.1021/acs.jmedchem.7b00306																																																																																																																																																															27935314	28402630																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.57328	0.8792	-9.704e-002																														0.19666	0.1099	-0.01213																														8	8	8																														CS-0028452	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-561-639|MOABOX:17551|TAF1|Bromodomain inhibitor	CN1C(=O)N(C)c2cc(N3C(=O)c4cccc5c(CCCO)ccc(C3=O)c45)c(C)cc12	2080306-23-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468407	429.46782	BAY-299	BAY-299 | BAY-299			MOABOX:17551	TAF1	Bromodomain inhibitor
SJ000036452-3	SJ000036452	3	MOABOX:17553	SFVRJPWNVAZKMP-UHFFFAOYSA-N	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1ccc(-c2cccc(C(F)(F)F)c2)o1			AKAP13																																																																										1304739					member	10.1016/j.chembiol.2016.07.015																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																7390017	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-248-805|MOABOX:17553|AKAP13|	CC1=NN(C(=O)/C/1=C\c2oc(cc2)c3cccc(c3)C(F)(F)F)c4ccc(cc4)C(=O)O	1668604-47-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468438	440.37141					MOABOX:17553	AKAP13	
SJ000983208-2	SJ000983208	2	MOABOX:17555	VZAFGXCWAWRULT-UONOGXRCSA-N	CN1C[C@H](Nc2cnn(C)c(=O)c2Br)C[C@H](c2ccccc2)C1		"KAT2A, KAT2B inhibitor"	KAT2A	KAT2B																															8850																															CHEMBL4069412											126961735					member																																																																																																																																																																28002667																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.86904	1.16104																															0.23363	0.14513																															8	8																															23421	CAYMAN	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-683-162|MOABOX:17555|KAT2A|KAT2A, KAT2B inhibitor"	CN1C[C@@H](C[C@@H](C1)c2ccccc2)NC3=C(Br)C(=O)N(C)N=C3	2079896-25-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468294	377.27884	GSK-4027	GSK-4027 | GSK-4027			MOABOX:17555	KAT2A	"KAT2A, KAT2B inhibitor"
SJ000870783-3	SJ000870783	3	MOABOX:17562	FNPPHVLYVGMZMZ-XBXARRHUSA-N	COc1nccnc1NS(=O)(=O)c1ccc(NC(=O)/C=C/c2ccc([N+](=O)[O-])s2)cc1	1360614-48-7	Reduces sulfur mustard intoxication;Covalent Necroptosis Inhibitors	GSDMD	MLKL																															197259																															CHEMBL3220918											1566236	101561822				member	10.1016/j.cbi.2018.10.030	10.1016/j.cell.2011.11.031	10.1126/sciimmunol.aat2738																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		0	0																															0.0	0.0																															7	7																															HY-100573	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: MAPK/ERK Pathway | Research Area: Cancer|MOABOX:17562|GSDMD|Reduces sulfur mustard intoxication;Covalent Necroptosis Inhibitors	COc1nccnc1NS(=O)(=O)c2ccc(NC(=O)\C=C\c3ccc(s3)[N+](=O)[O-])cc2	1360614-48-7	21797	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469004	461.4716	NECROSULFONAMIDE	NECROSULFONAMIDE | NECROSULFONAMIDE	Pathway: MAPK/ERK Pathway	Research Area: Cancer	MOABOX:17562	GSDMD	Reduces sulfur mustard intoxication;Covalent Necroptosis Inhibitors
SJ000986010-3	SJ000986010	3	MOABOX:17567	SETFNECMODOHTO-UHFFFAOYSA-N	NS(=O)(=O)c1ccc(S(=O)(=O)Nc2cccc3c(Cl)c[nH]c23)cc1	165668-41-7	DCAF15 molecular glue	CA2	RBM39	DCAF15																														9584	90379																														CHEMBL77517											216468	68673212				member	10.1016/j.bmcl.2003.11.014	10.1042/BJ20041037	10.1126/science.aal3755																																																																																																																																																													14698154	15012984	15081039	15084132	15388166	15453828	15454239	15501039	15664816	15771455	15837325	15905091	15908204	16033263	16119190	16134940	16165351	16302824	16459077	16539401	16809036	16873019	16942027	17059166	17064072	17194028	17228881	17251018	17276072	17343373	17482815	17826101	17880011	18242998	18336307	18336316	18481843	18513964	19124253	19193158	19317447	19338333	19438226	19450983	19520577	19601749	19846301	20158185	20202722	20349499	20478708	20554082	20819061	20819063	20819064	21208801	21251841	21757360	21820216	22285172	22380772	22424239	22883029	22910138	23181552	23199478	23391336	23511020	23777827	23867389	23965175	23977960	24095761	24291567	24314394	24316122	24513184	24792813	24852120	24871996	25016228	25129169	25533402	25773015	25882523	25913118	25913199	26174556	26525863	26691758	26804228	26832216	26850377	26920803	27485387	28025002	28501430	28511911	30826507	30832211																																																																																																																																																																																																																																																																																																																																																																																																																																																																		4.93656	-0.4192	0																														0.61707	-0.0524	0.0																														8	8	7																														HY-13650	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:17567|CA2|DCAF15 molecular glue	NS(=O)(=O)c1ccc(cc1)S(=O)(=O)Nc2cccc3c(Cl)c[nH]c23	165668-41-7	51486	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469334	385.84578	INDISULAM	INDISULAM | INDISULAM	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:17567	CA2	DCAF15 molecular glue
SJ001035284-1	SJ001035284	1	MOABOX:17568	QGAMAWMLTUNPAB-UHFFFAOYSA-N	Cn1ncc2c1-c1c(Oc3ccc(OCc4ccc5ccccc5n4)cc3)sc(C(N)=O)c1CC2	364762-86-7	"Small Molecule, Unknown Target: New targets for disease modifying osteoarthritis  drugs(DMOD)"	RUNX1																																																																										9826550					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-15642	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Inflammation/Immunology|MOABOX:17568|RUNX1|Small Molecule, Unknown Target: New targets for disease modifying osteoarthritis drugs(DMOD)"	Cn1ncc2CCc3c(sc(Oc4ccc(OCc5ccc6ccccc6n5)cc4)c3c12)C(=O)N	364762-86-7	24794	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469488	482.55358	TD-198946	TD-198946 | TD-198946	Pathway: Others	Research Area: Inflammation/Immunology	MOABOX:17568	RUNX1	"Small Molecule, Unknown Target: New targets for disease modifying osteoarthritis drugs(DMOD)"
SJ001010858-2	SJ001010858	2	MOABOX:17570	GMPQGWXPDRNCBL-UHFFFAOYSA-N	COc1cc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C			FYN	SRC	YES1																														6714	7525																														CHEMBL3824089											121231408					member	10.1021/acs.jmedchem.6b00065																																																																																																																																																															27115835																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.15784	1.09992	1.20832																														-0.01973	0.13749	0.15104																														8	8	8																														T8499	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-417-982|MOABOX:17570|FYN|	COc1cc(ccc1NC(=O)OC(C)(C)C)c2nn(CCN3CCC(CC3)N(C)C)c4ncnc(N)c24	1914078-41-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468582	510.63172	ECF506	ECF506 | ECF506			MOABOX:17570	FYN	
SJ001035144-1	SJ001035144	1	MOABOX:17571	WKKAVTNXNVPCCN-HSZRJFAPSA-N	O=C(c1cnn2cc(Br)ccc12)N1CCN(C(=O)c2ccc(Br)cc2)[C@@H](c2ccc(Cl)cc2)C1			EIF4A3																																																															CHEMBL4070071											131953885					member	10.1021/acs.jmedchem.6b01904	10.1021/acschembio.7b00041	10.1021/acsmedchemlett.7b00283																																																																																																																																																													28358513	29057054																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.05504																																0.38188																																8																																HY-101785	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:17571|EIF4A3|	Clc1ccc(cc1)[C@H]2CN(CCN2C(=O)c3ccc(Br)cc3)C(=O)c4cnn5cc(Br)ccc45	2095677-20-4	42052	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468883	602.70496	EIF4A3-IN-2	EIF4A3-IN-2 | EIF4A3-IN-2	Pathway: Autophagy; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:17571	EIF4A3	
SJ001035146-1	SJ001035146	1	MOABOX:17572	BDGKKHWJYBQRIE-HHHXNRCGSA-N	Cc1c(C(=O)N2CCN(C(=O)c3ccc(Br)cc3)[C@@H](c3ccc(Cl)cc3)C2)cnn1-c1cccc(C#N)c1			EIF4A3																																																															CHEMBL4073833											137640621					member	10.1021/acs.jmedchem.6b01904																																																																																																																																																															28358513																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.18968																																0.39871																																8																																HY-101513	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:17572|EIF4A3|	Cc1c(cnn1c2cccc(c2)C#N)C(=O)N3CCN([C@H](C3)c4ccc(Cl)cc4)C(=O)c5ccc(Br)cc5	2095486-67-0	79258	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468891	588.88222	EIF4A3-IN-1	EIF4A3-IN-1 | EIF4A3-IN-1	Pathway: Autophagy; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:17572	EIF4A3	
SJ000186603-2	SJ000186603	2	MOABOX:17573	GYZZRJRJYVMXNS-UHFFFAOYSA-N	COc1ccccc1C(=O)Nc1ccc(C(=O)Nc2ccccc2C(=O)O)cc1		PAX inhibitor	PAX2																																																															CHEMBL1705891											2193203					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																7543962	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-559-462|MOABOX:17573|PAX2|PAX inhibitor	COc1ccccc1C(=O)Nc2ccc(cc2)C(=O)Nc3ccccc3C(=O)O	693241-54-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468431	390.38872					MOABOX:17573	PAX2	PAX inhibitor
SJ001035158-1	SJ001035158	1	MOABOX:17575	PNFMVADNCOGWME-UHFFFAOYSA-N	CCN(CCN(C)C)C(=O)CNCc1cc(C(N)=O)ccn1			KDM5A	KDM5C	KDM5D	KDM5B																													8242	8284	10765																													CHEMBL4078388											91810435	139290992	139600262			member	10.1016/j.chembiol.2017.02.006																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-8.4e-003	0	0	0																													-0.0012	0.0	0.0	0.0																													7	7	7	7																													HY-102047B	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:17575|KDM5A|	CCN(CCN(C)C)C(=O)CNCc1cc(ccn1)C(=O)N	NA	46779	GENERAL	CITRATE	1	NO_SOLVATE	0	1468949	307.3913	KDOAM-25 CITRATE	KDOAM-25 CITRATE | KDOAM-25 CITRATE	Pathway: Epigenetics	Research Area: Cancer	MOABOX:17575	KDM5A	
SJ000783706-3	SJ000783706	3	MOABOX:17576	SCULJPGYOQQXTK-OLRINKBESA-N	CC(=O)O[C@@H]1[C@H](c2ccc(=O)oc2)[C@@]2(C)CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@]23O[C@H]13	36121-84-3	"Cinobufagin, SMUT;Na+/K+-ATPase Inhibitors;Chloride Channel Activators"	ATAD5																																																															CHEMBL250785											11969542	88441793	90013528	135289848		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.52366																																0.50338																																7																																T3432	TARGETMOL	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-940-630|MOABOX:17576|ATAD5|Cinobufagin, SMUT;Na+/K+-ATPase Inhibitors;Chloride Channel Activators"	CC(=O)O[C@H]1[C@H]2O[C@]23[C@@H]4CC[C@@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1C6=COC(=O)C=C6	470-37-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468141	442.54456	CINOBUFAGIN	CINOBUFAGIN | CINOBUFAGIN			MOABOX:17576	ATAD5	"Cinobufagin, SMUT;Na+/K+-ATPase Inhibitors;Chloride Channel Activators"
SJ000561050-5	SJ000561050	5	MOABOX:17578	ACNHBCIZLNNLRS-UBGQALKQSA-N	CC(C)(O)[C@H]1O[C@H]2CC[C@@]3(C)[C@@](O)(CC[C@H]4Cc5c([nH]c6ccccc56)[C@@]43C)C2=CC1=O	57186-25-1		KCNMA1	KCNMB1																															3779																															CHEMBL410063											105008	69619339	138506320			member	10.1016/0028-3908(96)00137-2	10.1074/jbc.M111.312264																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.19882	1.19882																															0.17126	0.17126																															7	7																															HY-N6778	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:17578|KCNMA1|	CC(C)(O)[C@H]1O[C@H]2CC[C@@]3(C)[C@@](O)(CC[C@H]4Cc5c([nH]c6ccccc56)[C@]34C)C2=CC1=O	57186-25-1	67747	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469432	435.55522	PAXILLINE	PAXILLINE | PAXILLINE	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:17578	KCNMA1	
SJ001033596-2	SJ001033596	2	MOABOX:17583	YFHRCLAKZBDRHN-MRXNPFEDSA-N	CC(C)(NC(=O)O[C@@H]1CN2CCC1CC2)c1csc(-c2ccc(F)cc2)n1	1401090-53-6		UGCG																																																																										60199241	60199242	78425810	91618117	91618134	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-16743	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Metabolic Disease|MOABOX:17583|UGCG|	CC(C)(NC(=O)O[C@@H]1CN2CCC1CC2)c3csc(n3)c4ccc(F)cc4	1401090-53-6	37187	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469477	389.48686	IBIGLUSTAT; VENGLUSTAT; SAR402671; GZ402671	IBIGLUSTAT; VENGLUSTAT; SAR402671; GZ402671 | IBIGLUSTAT; VENGLUSTAT; SAR402671; GZ402671	Pathway: Others	Research Area: Metabolic Disease	MOABOX:17583	UGCG	
SJ001034665-1	SJ001034665	1	MOABOX:17590	PSCXFXNEYIHJST-QPJJXVBHSA-N	O=C(O)C/C=C/c1ccccc1	1914-58-5	Peptidyl-Glycine alpha-Amidating Monooxygenase (PAM) Inhibitors	PAM																																																															CHEMBL2269608											5370625	87100419	87370017	88315101		virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.3852																																0.42315																																8																																AS-47645	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC(=O)C\C=C\c1ccccc1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466779	162.1852	AS-47645	AS-47645 | AS-47645			MOABOX:17590	PAM	Peptidyl-Glycine alpha-Amidating Monooxygenase (PAM) Inhibitors
SJ001034972-1	SJ001034972	1	MOABOX:17600	ZLDUVUWIYLENNC-UHFFFAOYSA-N	CNc1nccc(CN(C2CCC(N)CC2)S(=O)(=O)c2ccc(S(=O)(=O)N(Cc3ccc(Cl)cc3)C3CCCC3)cc2)n1		Inhibitor of Prenyl Binding Protein (PDE6d)	PDE6D																																																																										135222708	138454775	138911315			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																CS-0100504	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-836-600|MOABOX:17600|PDE6D|Inhibitor of Prenyl Binding Protein (PDE6d)	CNc1nccc(CN([C@@H]2CC[C@@H](N)CC2)S(=O)(=O)c3ccc(cc3)S(=O)(=O)N(Cc4ccc(Cl)cc4)C5CCCC5)n1	2448341-55-5	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468409	647.25146	DELTASONAMIDE 2 HCL	DELTASONAMIDE 2 HCL | DELTASONAMIDE 2 HCL			MOABOX:17600	PDE6D	Inhibitor of Prenyl Binding Protein (PDE6d)
SJ000879505-3	SJ000879505	3	MOABOX:17601	HZASIAXCPXTISQ-NVXWUHKLSA-N	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC	1262849-73-9	Checkpoint Kinase 2 (Chk2) Inhibitors	CHEK2																																																															CHEMBL1236782											135564841	136218645	137025388			member	10.1021/jm101150b	10.1158/0008-5472.CAN-10-1252																																																																																																																																																														21186793	30832206																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.48056																																0.43507																																8																																HY-14715B	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:17601|CHEK2|Checkpoint Kinase 2 (Chk2) Inhibitors	COc1cc2nc(nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC)c4cc(F)ccc4O	1431697-96-9	7991	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468948	442.48328	CCT241533	CCT241533 | CCT241533	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:17601	CHEK2	Checkpoint Kinase 2 (Chk2) Inhibitors
SJ001035140-1	SJ001035140	1	MOABOX:17602	WJIGGYYSZBWCGC-MRXNPFEDSA-N	NCC[C@@H](O)c1cccc(OCC2CCCCC2)c1	1141777-14-1	Retinoid Isomerohydrolase (RPE65) Inhibitors	RPE65																																																															CHEMBL2107821	CHEMBL2107829										25221720	60162270	67316154	143785909		member	10.1172/JCI80950																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-19720	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Metabolic Disease|MOABOX:17602|RPE65|Retinoid Isomerohydrolase (RPE65) Inhibitors	NCC[C@@H](O)c1cccc(OCC2CCCCC2)c1	1141777-14-1	23289	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468874	263.3752	EMIXUSTAT | ACU-4429	"""EMIXUSTAT | ACU-4429"" | ""EMIXUSTAT | ACU-4429"""	Pathway: Others	Research Area: Metabolic Disease	MOABOX:17602	RPE65	Retinoid Isomerohydrolase (RPE65) Inhibitors
SJ001035319-1	SJ001035319	1	MOABOX:17604	KWJDHELCGJFUHW-SFTDATJTSA-N	COC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(NS(=O)(=O)O)cc1)c1csc(-c2cccs2)n1	1008510-37-9	Protein Tyrosine Phosphatase beta (PTPRB) Inhibitors	PTPN1	PTPRB																															5787																															CHEMBL3931971											46700782					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.75838	3.55208																															-0.10834	0.44401																															7	8																															HY-109041	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:17604|PTPN1|Protein Tyrosine Phosphatase beta (PTPRB) Inhibitors	COC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc2ccc(NS(=O)(=O)O)cc2)c3csc(n3)c4cccs4	1008510-37-9	87486	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469561	586.70284	RAZUPROTAFIB | AKB-9778	"""RAZUPROTAFIB | AKB-9778"" | ""RAZUPROTAFIB | AKB-9778"""	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:17604	PTPN1	Protein Tyrosine Phosphatase beta (PTPRB) Inhibitors
SJ000546523-7	SJ000546523	7	MOABOX:17605	OLTZHXYLLRJLST-UHFFFAOYSA-N	Cc1ccc(C(=O)Cn2c3c(sc2=N)CCCC3)cc1	206983-57-5		ATAD5																																																															CHEMBL198759	CHEMBL556353										4817	9929138	44390074	90862458	129835535	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.58739																																0.22677																																7																																HY-15484	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Immunology/Inflammation | Research Area: Cancer|MOABOX:17605|ATAD5|	Cc1ccc(cc1)C(=O)CN2C(=N)SC3=C2CCCC3	63208-82-2	24195	GENERAL	BROMIDE	1	NO_SOLVATE	0	1468850	286.39192	PIFITHRIN-ALPHA HYDROBROMIDE	PIFITHRIN-ALPHA HYDROBROMIDE | PIFITHRIN-ALPHA HYDROBROMIDE | | PIFITHRIN-ALPHA (PFTALPHA) | PIFITHRIN-ALPHA HYDROBROMIDE | PIFITHRIN-ALPHA HYDROBROMIDE | | PIFITHRIN-ALPHA (PFTALPHA)	Pathway: Apoptosis; Immunology/Inflammation	Research Area: Cancer	MOABOX:17605	ATAD5	
SJ000985989-3	SJ000985989	3	MOABOX:17638	DYIRSNMPIZZNBK-UHFFFAOYSA-N	CS(=O)(=O)c1ccc(-c2cnc(NCc3ccco3)n3cnnc23)cc1		PRC2/EED	EED																																																															CHEMBL4065484											123132228					member																																																																																																																																																																28092155																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.60664																																0.32583																																8																																HY-101117	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:17638|EED|PRC2/EED	CS(=O)(=O)c1ccc(cc1)c2cnc(NCc3occc3)n4cnnc24	2083627-02-3	24238	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469700	369.3977	EED226	EED226 | EED226	Pathway: Epigenetics	Research Area: Cancer	MOABOX:17638	EED	PRC2/EED
SJ001034828-1	SJ001034828	1	MOABOX:17640	JJFJQFJFFVLMCX-UHFFFAOYSA-N	O=C1CC(N2CCN(c3ccc(O)cc3)CC2)C(=O)N1c1ccccc1		malic enzyme inhibitor	ME1																																																															CHEMBL372408											2936632	3399257				member	10.1016/j.bmcl.2005.10.065																																																																																																																																																															16288866	23016852																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.14296																																0.14287																																8																																PHAR013159	PHARMEKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-706-729|MOABOX:17640|ME1|malic enzyme inhibitor	Oc1ccc(cc1)N2CCN(CC2)C3CC(=O)N(C3=O)c4ccccc4	522649-59-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468069	351.39904	PHAR013159	PHAR013159 | PHAR013159			MOABOX:17640	ME1	malic enzyme inhibitor
SJ001033091-2	SJ001033091	2	MOABOX:17644	FWCVZAQENIZVMY-UHFFFAOYSA-N	CC(C)n1nccc1-c1ncccc1COc1cccc(O)c1C=O	1446321-46-5	Hemoglobin Subunit beta (Sickle Cell Anemia Variant) Polimerization Inhibitors	HBB																																																															CHEMBL4101807											71602803	89654750	91663329	145401287		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-18681	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cardiovascular Disease|MOABOX:17644|HBB|Hemoglobin Subunit beta (Sickle Cell Anemia Variant) Polimerization Inhibitors	CC(C)n1nccc1c2ncccc2COc3cccc(O)c3C=O	1446321-46-5	44805	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469480	337.37246	VOXELOTOR | GBT 440	"""VOXELOTOR | GBT 440"" | ""VOXELOTOR | GBT 440"""	Pathway: Others	Research Area: Cardiovascular Disease	MOABOX:17644	HBB	Hemoglobin Subunit beta (Sickle Cell Anemia Variant) Polimerization Inhibitors
SJ000285592-20	SJ000285592	20	MOABOX:17645	NKANXQFJJICGDU-QPLCGJKRSA-N	CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	10540-29-1	Selective Estrogen Receptor Modulator (SERM)	ESR1	ESR2	EBP																														2100	10682																														CHEMBL786	CHEMBL83										2733525	2733526	9831054	9832575	9874333	member	10.1002/cmdc.201000146	10.1016/0022-4731(88)90014-3	10.1016/S0006-2952(99)00308-1	10.1016/S0039-128X(01)00194-5	10.1016/S0300-483X(01)00437-1	10.1016/S0960-0760(00)00126-6	10.1016/S0960-0760(03)00385-6	10.1016/S0960-0760(97)00118-0	10.1016/S0960-894X(97)00130-3	10.1016/S0968-0896(01)00038-4	10.1016/j.bmc.2004.09.048	10.1016/j.bmc.2008.09.035	10.1016/j.bmc.2010.06.016	10.1016/j.chemosphere.2018.12.185	10.1016/j.ejmech.2016.02.026	10.1016/j.ejpb.2013.04.024	10.1016/j.steroids.2006.06.007	10.1016/j.steroids.2006.08.001	10.1021/ac020088u	10.1021/acs.jmedchem.6b01917	10.1021/acs.jmedchem.9b00171	10.1021/acschembio.6b00918	10.1021/jm00037a002	10.1021/jm0209230	10.1021/jm0210562	10.1021/jm030086h	10.1021/jm040858p	10.1021/jm950624t	10.1021/jm950938g	10.1021/jm970167b	10.1021/jm990078u	10.1039/b303985d	10.1080/14756360701503232	10.1124/jpet.106.104349	10.1124/mol.110.065250	10.1124/mol.54.1.105	10.1124/mol.61.3.562	10.1210/en.2006-0113	10.1248/bpb.b13-00129	10.1248/cpb.52.79	10.1248/cpb.60.270	10.2174/157340606776056142																																																																																																																						2909731	8784443	9089332	9216828	10328300	10447957	11003145	11297454	11965371	12133002	12431063	12620065	12659775	12672249	12825935	15210143	15658851	15752472	16033255	16965798	18035834	18835176	19131248	20598555	20615952	20621492	22293490	22582136	23199475	23786452	25369367	26407012	26896706	27176944	27647375	28426931	28882502	30731397																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																0.99688	4.33432	2.44248																														0.12461	0.54179	0.30531																														8	8	8																														HY-13757A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Others | Research Area: Cancer|MOABOX:17645|ESR1|Selective Estrogen Receptor Modulator (SERM)	CC\C(=C(/c1ccccc1)\c2ccc(OCCN(C)C)cc2)\c3ccccc3	10540-29-1	23623	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468919	371.51456	TAMOXIFEN	TAMOXIFEN | ICI-46474 | TAMOXIFEN CITRATE | TAMOXIFEN | ICI-46474 | TAMOXIFEN CITRATE	Pathway: Apoptosis; Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Others	Research Area: Cancer	MOABOX:17645	ESR1	Selective Estrogen Receptor Modulator (SERM)
SJ001035093-1	SJ001035093	1	MOABOX:17649	KLHOCHQJHXNKAS-UHFFFAOYSA-N	Cc1ccc(NC(=O)c2ccc3c(c2)OCCO3)cc1NC(=O)c1ccc2nc(OCCN3CCCC3)ccc2c1			PIR																																																															CHEMBL4087666											117996749					member																																																																																																																																																																28004573	30613326																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.01408																																0.12676																																8																																2699	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-729-672|MOABOX:17649|PIR|	Cc1ccc(NC(=O)c2ccc3OCCOc3c2)cc1NC(=O)c4ccc5nc(OCCN6CCCC6)ccc5c4	1693731-40-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468672	552.62028	CCT251236	CCT251236 | CCT251236			MOABOX:17649	PIR	
SJ001035155-1	SJ001035155	1	MOABOX:17654	JGDCRWYOMWSTFC-AZGSIFHYSA-N	C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2[C@H](O)C(=O)[C@]2(C)[C@@H](c3ccc(=O)oc3)CC[C@]12O	464-74-4	"Arenobufagin, SMUT"	PSMB1	PSMB2	PSMB5	ATP1B4																													5690	5693	23439																													CHEMBL4086974											12305198					member	10.1371/journal.pone.0159034																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0	0	0																													0.0	0.0	0.0	0.0																													7	7	7	7																													HY-N0876	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:17654|PSMB1|Arenobufagin, SMUT"	C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]3[C@@H]2[C@H](O)C(=O)[C@]4(C)[C@H](CC[C@]34O)C5=COC(=O)C=C5	464-74-4	64444	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468940	416.50728	ARENOBUFAGIN	ARENOBUFAGIN | ARENOBUFAGIN	Pathway: Others	Research Area: Cancer	MOABOX:17654	PSMB1	"Arenobufagin, SMUT"
SJ001035291-1	SJ001035291	1	MOABOX:17660	SCKXBVLYWLLALY-UHFFFAOYSA-N	C=CC(=O)N1CCC(=Cc2ccc(F)c([N+](=O)[O-])c2)C(=O)C(=Cc2ccc(F)c([N+](=O)[O-])c2)C1		"Inhibitor of proteasome deubiquitinase, selectivity for ubiquitin-specific protease-14"	USP14																																																																										78097461					member	10.1038/srep26979	10.1182/blood-2013-05-500033																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0																																0.0																																7																																HY-12471	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:17660|USP14|Inhibitor of proteasome deubiquitinase, selectivity for ubiquitin-specific protease-14"	[O-][N+](=O)c1cc(\C=C\2/CCN(C\C(=C/c3ccc(F)c(c3)[N+](=O)[O-])\C2=O)C(=O)C=C)ccc1F	1431280-51-1	25849	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469515	469.39439	VLX1570	VLX1570 | VLX1570	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:17660	USP14	"Inhibitor of proteasome deubiquitinase, selectivity for ubiquitin-specific protease-14"
SJ000211056-2	SJ000211056	2	MOABOX:17663	OXKNHBBDOIMFFQ-UHFFFAOYSA-N	O=C(CN1CCN(C(=O)c2ccco2)CC1)Nc1cc(C(F)(F)F)ccc1Cl	899713-86-1	acyl protein thioesterase 1 inhibitor	LYPLAL1																																																															CHEMBL600764											3238952					member	10.1021/acschembio.6b00720																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-100736	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:17663|LYPLAL1|acyl protein thioesterase 1 inhibitor	FC(F)(F)c1ccc(Cl)c(NC(=O)CN2CCN(CC2)C(=O)c3occc3)c1	899713-86-1	22423	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469077	415.79409			Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:17663	LYPLAL1	acyl protein thioesterase 1 inhibitor
SJ001010737-2	SJ001010737	2	MOABOX:17664	KNOUWGGQMADIBV-UHFFFAOYSA-N	CN1C(=O)C(NC(=O)c2cc(Cc3ccccc3)on2)COc2ccccc21		RIP1 kinase inhibitor	RIPK1																																																																										118557318					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																CS-5709	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-665-899|MOABOX:17664|RIPK1|RIP1 kinase inhibitor	CN1C(=O)[C@H](COc2ccccc12)NC(=O)c3cc(Cc4ccccc4)on3	1622849-58-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468493	377.39326	GSK481	GSK481 | GSK481			MOABOX:17664	RIPK1	RIP1 kinase inhibitor
SJ000870756-6	SJ000870756	6	MOABOX:17668	FMTVWAGUJRUAKE-UHFFFAOYSA-N	CC(C)Oc1ccc(-c2c[nH]cc2CN(C)CCN)cc1	1831110-54-3	Type I PRMT inhibitor	PRMT1	PRMT6	PRMT8																														55170	56341																														CHEMBL3901808											92136227	121513886	124203908	129626591		member																																																																																																																																																																27584694																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.53336	0.53336	0.53336																														0.06667	0.06667	0.06667																														8	8	8																														HY-19615	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:17668|PRMT1|Type I PRMT inhibitor	CC(C)Oc1ccc(cc1)c2c[nH]cc2CN(C)CCN	1831110-54-3	19944	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469137	287.3999	MS-023	MS-023 | MS 023 | MS-023 | MS 023	Pathway: Epigenetics	Research Area: Cancer	MOABOX:17668	PRMT1	Type I PRMT inhibitor
SJ001035028-1	SJ001035028	1	MOABOX:17674	LMFWCWAOQYNELV-UHFFFAOYSA-N	O=C(N=C1SSC2=NCCN21)c1cccs1			GPR6																																																																															member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																SC-02139	SYNCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-028-745-351|MOABOX:17674|GPR6|	O=C(\N=C\1/SSC2=NCCN12)c3cccs3	357605-28-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468515	269.36638	SC-02139	SC-02139 | SC-02139			MOABOX:17674	GPR6	
SJ000520507-11	SJ000520507	11	MOABOX:18284	IVTVGDXNLFLDRM-HNNXBMFYSA-N	Cc1nc(=O)c2cc(CN(C)c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)s3)ccc2[nH]1	112887-68-0	dual thymidylate synthase and dihydrofolate reductase inhibitors	DHFR	FOLR1	GART	SLC19A1	TYMS																												2348	2618	6573	7298																												CHEMBL225071											135400182	136232962	136351574	136364055	136385935	member	10.1016/j.bmc.2009.11.029	10.1016/j.bmc.2011.03.067	10.1016/j.bmc.2012.05.068	10.1016/j.bmc.2013.02.008	10.1016/j.ejmech.2013.04.017	10.1021/jm0100382	10.1021/jm200739e	10.1021/jm201688n	10.1021/jm401139z	10.1021/jm8011323	10.1021/jm9015729																																																																																																																																																					8230138	8917644	11052789	11384244	12570380	15615522	15700958	15837298	16279780	16451071	17300160	19371039	20056546	20085328	20092323	20153089	20626411	21550809	21879757	22243528	22739090	23490159	23665106	24111942	24256410	25234128	25602637	27458733	28258797																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									-2.296e-002	0.48144	0	3.12128	-0.3216																												-0.00287	0.06018	0.0	0.39016	-0.0402																												8	8	7	8	8																												HY-10821	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:18284|DHFR|dual thymidylate synthase and dihydrofolate reductase inhibitors	CN(Cc1ccc2N=C(C)NC(=O)c2c1)c3ccc(s3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	112887-68-0	98871	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469330	458.48758	RALTITREXED	"RALTITREXED | ""RALTITREXED | D-1694 | ICI-D-1694 | NSC-639186 | ZD-1694 | ZN-D1694 |"" | RALTITREXED | ""RALTITREXED | D-1694 | ICI-D-1694 | NSC-639186 | ZD-1694 | ZN-D1694 |"""	Pathway: Apoptosis; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:18284	DHFR	dual thymidylate synthase and dihydrofolate reductase inhibitors
SJ000833835-7	SJ000833835	7	MOABOX:17689	QGZYDVAGYRLSKP-UHFFFAOYSA-N	O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2)nc1)NO	1316214-52-4	HDAC6	HDAC6																																																															CHEMBL2364628											53340666	91669243	91669248	91801250	144828644	member	10.1016/j.bcp.2018.07.018	10.1021/acschembio.6b01014																																																																																																																																																														22262760	23627282	24730063	24766560	26443078	28038324	29304284	29500130	29549837	29940115	30448419	30594434	30996781																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									3.35144																																0.41893																																8																																HY-16026	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:17689|HDAC6|HDAC6	ONC(=O)CCCCCCNC(=O)c1cnc(nc1)N(c2ccccc2)c3ccccc3	1316214-52-4	47064	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469736	433.50288	ROCILINOSTAT	ROCILINOSTAT | ROCILINOSTAT (ACY-1215) | ACY-1215 | ROCILINOSTAT | ROCILINOSTAT (ACY-1215) | ACY-1215	Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:17689	HDAC6	HDAC6
SJ001011139-2	SJ001011139	2	MOABOX:17693	DDKHTWASHUKHLD-UHFFFAOYSA-N	Nc1n[nH]c2nc(-c3ccc(NS(=O)(=O)c4cc(Cl)ccc4F)cc3)cnc12	1279829-87-6	Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Inhibitors	SGK1	SGK2																															10110																															CHEMBL3092468											71506845	89464254				member	10.1021/ml5003376																																																																																																																																																															24900601	25589934																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.9016	-0.51728																															0.4877	-0.06466																															8	8																															HY-18607	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Inflammation/Immunology|MOABOX:17693|SGK1|Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Inhibitors	Nc1n[nH]c2nc(cnc12)c3ccc(NS(=O)(=O)c4cc(Cl)ccc4F)cc3	1279829-87-6	59108	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469509	418.83258	SGK1-IN-1	SGK1-IN-1 | SGK1-IN-1	Pathway: Metabolic Enzyme/Protease	Research Area: Inflammation/Immunology	MOABOX:17693	SGK1	Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Inhibitors
SJ000884154-2	SJ000884154	2	MOABOX:17696	RVGLGHVJXCETIO-UHFFFAOYSA-N	N#Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1	53882-12-5		ARRB2	GPR35																															2859																															CHEMBL1201175	CHEMBL1201266	CHEMBL3989725									44563	44564	11192129	70467892		member	10.1124/mol.113.089482																																																																																																																																																															27976894																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.21998	0.3804																															0.31714	0.04755																															7	8																															HY-14270	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling | Research Area: Inflammation/Immunology; Endocrinology|MOABOX:17696|ARRB2|	OC(=O)C(=O)Nc1cc(cc(NC(=O)C(=O)O)c1Cl)C#N	53882-12-5	24621	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469615	311.63484	U-42585E | LODOXAMIDE TROMETHAMINE	"""U-42585E | LODOXAMIDE TROMETHAMINE"" | ""U-42585E | LODOXAMIDE TROMETHAMINE"""	Pathway: GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Research Area: Inflammation/Immunology; Endocrinology	MOABOX:17696	ARRB2	
SJ000773137-6	SJ000773137	6	MOABOX:17697	ARAIBEBZBOPLMB-UFGQHTETSA-N	CC(=O)N[C@@H]1[C@@H](N=C(N)N)C=C(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO	139110-80-8	inhibitor of neuraminidase and Sialidase	NEU1	NEU2	NEU3																														4759	10825																														CHEMBL222813	CHEMBL57705										60855	636424	44300291	44473359	44511868	member	10.1128/AAC.00344-08																																																																																																																																																															7932570	9526555	9526556	10098672	10632058	11000002	11217798	11257030	11257037	11266166	11278042	11557461	11728184	12435681	16641465	16801417	16940075	16979342	17018003	17112602	17137644	17868928	17919541	18310920	18453004	18611414	18625765	18694948	18955520	19199994	19414262	19428593	20222851	20695427	20873795	21489803	21720632	21752202	22001088	22795831	22963668	22965667	23009169	23139022	23330908	23695381	23800724	24649802	26077494	27167096	27487569	29107426	29198893	29397718	29425031	29843102	29903413	30365885	31022584																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											0.39172	0.43072	0.43096																														0.05596	0.05384	0.05387																														7	8	8																														HY-13210	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Infection|MOABOX:17697|NEU1|inhibitor of neuraminidase and Sialidase	CC(=O)N[C@@H]1[C@@H](NC(=N)N)C=C(O[C@H]1[C@H](O)[C@H](O)CO)C(=O)O	139110-80-8	16843	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469821	332.3098	ZANAMIVIR	"ZANAMIVIR | ""ZANAMIVIR | 4-GUANIDINO-NEU5AC2EN | RELENZA2"" | ZANAMIVIR | ""ZANAMIVIR | 4-GUANIDINO-NEU5AC2EN | RELENZA2"""	Pathway: Anti-infection	Research Area: Infection	MOABOX:17697	NEU1	inhibitor of neuraminidase and Sialidase
SJ001035180-1	SJ001035180	1	MOABOX:17698	GVGVYDCVFBGALZ-UHFFFAOYSA-N	Cc1ccc2cccc(NC(=O)c3ccc(OC(C)C)cc3)c2n1	892711-75-0	activator of ATP2A2 (SERCA2)	ATP2A2																																																															CHEMBL1474314											16016585	145025364				member	10.1074/jbc.M115.705012	10.1177/1087057112456878																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			-3.71e-003																																-0.00053																																7																																HY-101455	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Metabolic Disease|MOABOX:17698|ATP2A2|activator of ATP2A2 (SERCA2)	CC(C)Oc1ccc(cc1)C(=O)Nc2cccc3ccc(C)nc23	892711-75-0	27365	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469009	320.385	CDN1163	CDN1163 | CDN1163	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Metabolic Disease	MOABOX:17698	ATP2A2	activator of ATP2A2 (SERCA2)
SJ001035293-1	SJ001035293	1	MOABOX:17699	VMMKGVRPILDZML-UHFFFAOYSA-N	COc1ccc2c(c1)C(c1ccc(F)cc1)=C(CN1CCCC1)CO2	1370544-73-2		NCK1	NCK2																															8440																																										56949412	129909862				member	10.1038/nri.2017.5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0																															0.0	0.0																															7	7																															HY-107390	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Immunology/Inflammation | Research Area: Inflammation/Immunology|MOABOX:17699|NCK1|	COc1ccc2OCC(=C(c3ccc(F)cc3)c2c1)CN4CCCC4	1370544-73-2	27186	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469519	339.40328	AX-024	AX-024 | AX-024	Pathway: Apoptosis; Immunology/Inflammation	Research Area: Inflammation/Immunology	MOABOX:17699	NCK1	
SJ000870785-2	SJ000870785	2	MOABOX:17702	IFWUBRBMMNTBRZ-UHFFFAOYSA-N	Cc1cc(Cn2c(=O)n(Cc3cnc(C)s3)c(=O)c3cc(S(=O)(=O)NC4(C)CC4)ccc32)n(C)n1		PARG inhibitor	PARG																																																																										121398766					member	10.1021/acs.jmedchem.8b01407																																																																																																																																																															30403352																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.38664																																0.17333																																8																																CS-0028457	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-162-859|MOABOX:17702|PARG|PARG inhibitor	Cc1cc(CN2C(=O)N(Cc3cnc(C)s3)C(=O)c4cc(ccc24)S(=O)(=O)NC5(C)CC5)n(C)n1	1945950-21-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468593	514.62034	PDD-00017273	"PDD-00017273 | ""PDD00017273 | PDD 00017273 | PDD-00017273"" | PDD-00017273 | ""PDD00017273 | PDD 00017273 | PDD-00017273"""			MOABOX:17702	PARG	PARG inhibitor
SJ000826780-6	SJ000826780	6	MOABOX:17704	TXGKRVFSSHPBAJ-JKSUJKDBSA-N	NC(=O)c1cnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1	1370261-96-3		SYK																																																															CHEMBL2177736											44462758	56948284	56948400	56948527		virtual	10.1021/jm301367c	10.1021/jm301720p																																																																																																																																																														23151054	23350847	24726806	25633741	26320624																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	3.13976																																0.39247																																8																																HY-15323	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:17704|SYK|	N[C@H]1CCCC[C@H]1Nc2ncc(C(=O)N)c(Nc3cccc(c3)n4nccn4)n2	1370261-97-4	9263	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468954	393.44562	PRT062607	"PRT062607 | P505-15, BIIB057 HCL | PRT062607 | P505-15, BIIB057 HCL"	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:17704	SYK	
SJ001010678-2	SJ001010678	2	MOABOX:17705	KKISLZKMBSCLSS-UHFFFAOYSA-N	CN1CCc2cc(Nc3ncc(C4CC4)c(NCCCNC(=O)C4CCC4)n3)ccc2C1	1190379-70-4		ULK1																																																																										59225335	121230974	124201611			member																																																																																																																																																																25833948																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.74336																																0.21792																																8																																HY-100006A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy | Research Area: Cancer|MOABOX:17705|ULK1|	CN1CCc2cc(Nc3ncc(C4CC4)c(NCCCNC(=O)C5CCC5)n3)ccc2C1	2080306-21-2	20632	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469833	434.57706	MRT68921 (DIHYDROCHLORIDE)	MRT68921 (DIHYDROCHLORIDE) | MRT68921 (DIHYDROCHLORIDE)	Pathway: Autophagy	Research Area: Cancer	MOABOX:17705	ULK1	
SJ001035210-1	SJ001035210	1	MOABOX:17706	GGHCWJWUOSNCSK-UHFFFAOYSA-N	NCc1ccnc(Cl)c1	144900-57-2	LOXL2 inhibitor	LOXL2																																																															CHEMBL4068784											2794167	66570668	121553449			member	10.1021/acs.jmedchem.7b00345	10.1021/acsmedchemlett.7b00014																																																																																																																																																														28435530	28471663																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.27624																																0.28453																																8																																HY-101771A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Neuronal Signaling | Research Area: Inflammation/Immunology; Cardiovascular Disease|MOABOX:17706|LOXL2|LOXL2 inhibitor	NCc1ccnc(Cl)c1	916210-98-5	27170	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469112	142.58618	(2-CHLOROPYRIDIN-4-YL)METHANAMINE HYDROCHLORIDE	(2-CHLOROPYRIDIN-4-YL)METHANAMINE HYDROCHLORIDE | (2-CHLOROPYRIDIN-4-YL)METHANAMINE HYDROCHLORIDE	Pathway: Neuronal Signaling	Research Area: Inflammation/Immunology; Cardiovascular Disease	MOABOX:17706	LOXL2	LOXL2 inhibitor
SJ000849537-8	SJ000849537	8	MOABOX:17707	VPHJABWIKCBGMC-UHFFFAOYSA-N	CCCCN1CCC(N(Cc2ccccc2)C(=O)Nc2ccc(Cl)c(Cl)c2)CC1			UBE2M	DCUN1D1	NEDD8																														54165	4738																														CHEMBL4074213											126711307	139035788				member																																																																																																																																																																29547693	30803229																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	-3.328e-002	2.7																														0.0	-0.00416	0.3375																														7	8	8																														CS-0042279	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-795-898|MOABOX:17707|UBE2M|	CCCCN1CCC(CC1)N(Cc2ccccc2)C(=O)Nc3ccc(Cl)c(Cl)c3	2089293-61-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468402	434.40186	SJ000849537	SJ000849537 | SJ000849537			MOABOX:17707	UBE2M	
SJ000288159-6	SJ000288159	6	MOABOX:17709	WPVVMKYQOMJPIN-UHFFFAOYSA-N	NC1CCN(c2cccc(Cl)n2)CC1	77145-51-8	Selective HTR3 agonist	HTR3A	HTR3B	HTR3C	HTR3D	HTR3E																												9177	170572	200909	285242																												CHEMBL1256322	CHEMBL90472										131746	131747	45114190	50986999	129848853	member	10.1016/0014-2999(93)90282-M																																																																																																																																																															12217367																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.56544	0.56544	0.56544	0.56544	0.56544																												0.07068	0.07068	0.07068	0.07068	0.07068																												8	8	8	8	8																												HY-102064	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:17709|HTR3A|Selective HTR3 agonist	NC1CCN(CC1)c2cccc(Cl)n2	77145-61-0	81866	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468910	211.69126	SR 57227A	SR 57227A | SR 57227 HCL | SR 57227 HYDROCHLORIDE | SR 57227A | SR 57227 HCL | SR 57227 HYDROCHLORIDE	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:17709	HTR3A	Selective HTR3 agonist
SJ001035296-1	SJ001035296	1	MOABOX:17711	CEUMAXLRGBKFQP-UHFFFAOYSA-N	Cc1cc(Nc2cc(Cl)nc(Oc3ccc([N+](=O)[O-])cc3)n2)n[nH]1			PIK3C3																																																																										129626605					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-101920	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; PI3K/Akt/mTOR | Research Area: Cancer; Neurological Disease|MOABOX:17711|PIK3C3|	Cc1cc(Nc2cc(Cl)nc(Oc3ccc(cc3)[N+](=O)[O-])n2)n[nH]1	1644443-47-9	26169	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469524	346.72854	AUTOPHINIB	AUTOPHINIB | AUTOPHINIB	Pathway: Autophagy; PI3K/Akt/mTOR	Research Area: Cancer; Neurological Disease	MOABOX:17711	PIK3C3	
SJ000870640-4	SJ000870640	4	MOABOX:17713	QTCSXAUJBQZZSN-UHFFFAOYSA-N	CC(C)(CNC(=O)c1cccc(-c2noc(C(F)(F)F)n2)c1)c1coc(-c2ccccc2)n1	1314891-22-9		HDAC9	HDAC4	HDAC5	HDAC7																													9759	10014	51564																																								67324851					member	10.1038/nature21409																																																																																																																																																															23524983																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.28888	-2.176e-002	-2.744e-002	1.06968																													0.28611	-0.00272	-0.00343	0.13371																													8	8	8	8																													HY-18361	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:17713|HDAC9|	CC(C)(CNC(=O)c1cccc(c1)c2noc(n2)C(F)(F)F)c3coc(n3)c4ccccc4	1314891-22-9	25009	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469071	456.41717	TMP195	TMP195 | GSK195 | TMP195 | GSK195	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:17713	HDAC9	
SJ000983386-3	SJ000983386	3	MOABOX:17716	DVNVYWLKGWAELS-UHFFFAOYSA-N	CC(C)CN(CC(=O)N1CCN(CC(OCc2ccc3ccccc3c2)c2ccc(Cl)cc2Cl)CC1)CC(C)C		Agonist of ULK1	ULK1																																																																										131801112	131801113	131954512			member																																																																																																																																																																28553505																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.66863																																0.52409																																7																																HY-101923B	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy | Research Area: Cancer|MOABOX:17716|ULK1|Agonist of ULK1	CC(C)CN(CC(C)C)CC(=O)N1CCN(CC(OCc2ccc3ccccc3c2)c4ccc(Cl)cc4Cl)CC1	2310109-38-5	26841	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469333	584.61942	LYN-1604	LYN-1604 | LYN-1604	Pathway: Apoptosis; Autophagy	Research Area: Cancer	MOABOX:17716	ULK1	Agonist of ULK1
SJ001035370-1	SJ001035370	1	MOABOX:17726	NTDFYGSSDDMNHI-UHFFFAOYSA-N	CC[S+]([O-])c1nc(-c2cccc(OCc3ccccc3)c2)cc(C(F)(F)F)n1	1371569-69-5	covalent positive allosteric modulator of GLP1R	GLP1R																																																																										49868481					member	10.1038/nature22378	10.1074/jbc.M115.696039																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.60448																																0.32556																																8																																HY-103546	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Metabolic Disease|MOABOX:17726|GLP1R|covalent positive allosteric modulator of GLP1R	CCS(=O)c1nc(cc(n1)C(F)(F)F)c2cccc(OCc3ccccc3)c2	1371569-69-5	47485	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469823	406.42139	BETP	BETP | BETP	Pathway: GPCR/G Protein	Research Area: Metabolic Disease	MOABOX:17726	GLP1R	covalent positive allosteric modulator of GLP1R
SJ001034979-1	SJ001034979	1	MOABOX:17727	NWAOQEFDCMNPGW-WYMLVPIESA-N	O/N=C1\c2ccccc2-c2ncccc21	65939-03-9	PERK Kinase inhibitor	EIF2AK3																																																																															member	10.1177/1087057114525853																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																6232-1463	CHEMDIV	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-004-954-292|MOABOX:17727|EIF2AK3|PERK Kinase inhibitor	O\N=C/1\c2ccccc2c3ncccc13	65939-03-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468421	196.20472	6232-1463	6232-1463 | 6232-1463			MOABOX:17727	EIF2AK3	PERK Kinase inhibitor
SJ000803717-7	SJ000803717	7	MOABOX:17735	VFBGXTUGODTSPK-BAQGIRSFSA-N	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1	608512-97-6	PKR Inhibitor	EIF2AK2																																																															CHEMBL235641											6490494					member	10.1016/S0006-291X(03)01318-4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-13977A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Neurological Disease|MOABOX:17735|EIF2AK2|PKR Inhibitor	O=C1Nc2ccc3ncsc3c2/C/1=C/c4cnc[nH]4	608512-97-6	85233	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469207	268.29382	IMIDAZOLO-OXINDOLE PKR INHIBITOR C16	"IMIDAZOLO-OXINDOLE PKR INHIBITOR C16 | ""PKR INHIBITOR | EIF2AK2 INHIBITOR 1 | C16 |"" | PKR INHIBITOR | IMIDAZOLO-OXINDOLE PKR INHIBITOR C16 | ""PKR INHIBITOR | EIF2AK2 INHIBITOR 1 | C16 |"" | PKR INHIBITOR"	Pathway: Others	Research Area: Neurological Disease	MOABOX:17735	EIF2AK2	PKR Inhibitor
SJ001035304-1	SJ001035304	1	MOABOX:17738	BSISGUIVBKDTQO-QIKYYPRYSA-N	COc1cc(Cl)c(C(=O)N[C@@H](CN[C@H]2CC[C@@H](N)CC2)Cc2ccc(C#N)cc2)cc1-c1ccc(CN[C@H](C)c2ccc(C)cc2)o1		ATAD2A inhibitor	ATAD2																																																																															member																																																																																																																																																																31398032																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.94128																																0.49266																																8																																HY-119254	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Metabolic Disease|MOABOX:17738|ATAD2|ATAD2A inhibitor	COc1cc(Cl)c(cc1c2oc(CN[C@H](C)c3ccc(C)cc3)cc2)C(=O)N[C@@H](CN[C@@H]4CC[C@H](N)CC4)Cc5ccc(cc5)C#N	2099142-76-2	45074	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469534	654.24066	BAY-850	BAY-850 | BAY-850	Pathway: Others	Research Area: Metabolic Disease	MOABOX:17738	ATAD2	ATAD2A inhibitor
SJ000855238-5	SJ000855238	5	MOABOX:17739	KDGFLJKFZUIJMX-UHFFFAOYSA-N	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O	1256580-46-7	ALK Tyrosine Kinase Receptor Inhibitors;Echinoderm Microtubule-Associated Protein-like 4-ALK Tyrosine Kinase Receptor (EML4- ALK) Inhibitors	ALK	EML4																															27436																															CHEMBL1738797	CHEMBL3707320										49806720	53239799	118796890	126688874	129851378	member	10.1016/j.ccr.2011.04.004	10.1016/j.ejmech.2019.111571	10.1021/acs.jmedchem.5b01136																																																																																																																																																													21575866	22225917	26476749	26568289	27131066	27769623																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																3.89272	0.3392																															0.48659	0.0424																															8	8																															HY-13011	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:17739|ALK|ALK Tyrosine Kinase Receptor Inhibitors;Echinoderm Microtubule-Associated Protein-like 4-ALK Tyrosine Kinase Receptor (EML4- ALK) Inhibitors	CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N5CCC(CC5)N6CCOCC6	1256580-46-7	27052	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469917	482.61656	CH5424802	CH5424802 | ALECTINIB (CH5424802) | CH5424802 | ALECTINIB (CH5424802)	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:17739	ALK	ALK Tyrosine Kinase Receptor Inhibitors;Echinoderm Microtubule-Associated Protein-like 4-ALK Tyrosine Kinase Receptor (EML4- ALK) Inhibitors
SJ000851856-6	SJ000851856	6	MOABOX:17743	BKCDJTRMYWSXMC-UHFFFAOYSA-N	COc1cc2c(cc1OCCCN1CCCC1)N=C(N)C21CCC1	1527503-11-2	EHMT1/2 inhibitor	EHMT2	EHMT1																															79813																															CHEMBL3109630											76285486					member																																																																																																																																																																24900801	25406944	27720557	29890830	29953809	30753076	31350126																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															3.54192	-0.21856																															0.44274	-0.02732																															8	8																															HY-12583	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:17743|EHMT2|EHMT1/2 inhibitor	COc1cc2c(cc1OCCCN3CCCC3)N=C(N)C24CCC4	1527503-11-2	19515	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469681	329.43658	A-366	A-366 | A-366	Pathway: Epigenetics	Research Area: Cancer	MOABOX:17743	EHMT2	EHMT1/2 inhibitor
SJ000843882-4	SJ000843882	4	MOABOX:17744	RNAMYOYQYRYFQY-UHFFFAOYSA-N	COc1cc2c(NC3CCN(C(C)C)CC3)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1	1481677-78-4	EHMT1/2	EHMT2	EHMT1																															79813																															CHEMBL2441082											53315878					member	10.1021/jm401480r																																																																																																																																																															24102134	27720557	29953809	30753076																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		2.4404	0.76872																															0.30505	0.09609																															8	8																															HY-13980	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:17744|EHMT2|EHMT1/2	COc1cc2c(NC3CCN(CC3)C(C)C)nc(nc2cc1OCCCN4CCCC4)N5CCC(F)(F)CC5	1481677-78-4	28151	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468835	546.69547	UNC0642	UNC0642 | UNC0642	Pathway: Epigenetics	Research Area: Cancer	MOABOX:17744	EHMT2	EHMT1/2
SJ001033487-2	SJ001033487	2	MOABOX:17746	CDJNNOJINJAXPV-UHFFFAOYSA-N	Cc1cc(-c2nc(-c3ccc(OC(F)(F)F)cc3)no2)nn1Cc1ccnc(N2CCN(C3CC3)CC2)c1	1227158-85-1	HIF-1 inhibitor;HIF target gene expression suppressor	HIF1A																																																																										67377767	67378269	67378302	86691205		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-15836	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:17746|HIF1A|HIF-1 inhibitor;HIF target gene expression suppressor	Cc1cc(nn1Cc2ccnc(c2)N3CCN(CC3)C4CC4)c5onc(n5)c6ccc(OC(F)(F)F)cc6	1227158-85-1	13773	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469234	525.52555	BAY 87-2243	BAY 87-2243 | BAY 87-2243	Pathway: Apoptosis; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:17746	HIF1A	HIF-1 inhibitor;HIF target gene expression suppressor
SJ000784246-8	SJ000784246	8	MOABOX:17752	VAZAPHZUAVEOMC-UHFFFAOYSA-N	CC(=O)Nc1ccc(C(=O)Nc2ccccc2N)cc1	112522-64-2	HDAC 1/2/3	HDAC1	HDAC2	HDAC3																														3066	8841																														CHEMBL235191											2746	9915009	52919976	56596977	75422411	member	10.1016/j.bmcl.2007.12.031	10.1016/j.ejps.2018.08.030	10.1021/acschemneuro.8b00116	10.1021/jm701079h	10.2174/138161208783885353																																																																																																																																																											17941625	18182289	18336297	18537607	18568166	20139990	20153566	20616024	21436030	22827519	28885834																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											1.364	1.02528	0.8688																														0.1705	0.12816	0.1086																														8	8	8																														HY-50934	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:17752|HDAC1|HDAC 1/2/3	CC(=O)Nc1ccc(cc1)C(=O)Nc2ccccc2N	112522-64-2	13613	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469280	269.2985	TACEDINALINE	"TACEDINALINE | ""CI-994 |GOE-5549 | PD-123654 | ACETYLDINALINE"" | TACEDINALINE  | CI994 (TACEDINALINE) | TACEDINALINE | ""CI-994 |GOE-5549 | PD-123654 | ACETYLDINALINE"" | TACEDINALINE  | CI994 (TACEDINALINE)"	Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:17752	HDAC1	HDAC 1/2/3
SJ000870760-2	SJ000870760	2	MOABOX:17753	PFHDWRIVDDIFRP-UHFFFAOYSA-N	CCC(CC)n1ccc2c(C(=O)NCc3c(C)cc(C)[nH]c3=O)cc(C#N)cc21	1418308-27-6	PRC2/EZH2	EZH2																																																															CHEMBL3414574											72199293					virtual																																																																																																																																																																24300735	25406853																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.25648																																0.40706																																8																																HY-15573	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Epigenetics | Research Area: Cancer|MOABOX:17753|EZH2|PRC2/EZH2	CCC(CC)n1ccc2c(cc(cc12)C#N)C(=O)NCC3=C(C)C=C(C)NC3=O	1418308-27-6	9984	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469795	390.47814	EI1	EI1 | EI1	Pathway: Apoptosis; Epigenetics	Research Area: Cancer	MOABOX:17753	EZH2	PRC2/EZH2
SJ000862656-3	SJ000862656	3	MOABOX:17759	FBKMWOJEPMPVTQ-UHFFFAOYSA-N	NS(=O)(=O)NCCNc1nonc1/C(=N\O)Nc1ccc(F)c(Br)c1	1204669-37-3	"Epacadostat is an investigational cancer drug.[1] Epacadostat is an inhibitor of indoleamine 2,3-dioxygenase-1) (IDO1).[1][2];Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immunooncolog"	IDO1																																																															CHEMBL3545369											135564890					member	10.1002/cmdc.201700666	10.1016/j.bcp.2019.07.011	10.1016/j.bmc.2016.10.003	10.1016/j.ejmech.2018.11.010	10.1016/j.ejmech.2019.06.037	10.1016/j.ejmech.2019.111750	10.1021/acsmedchemlett.6b00391	10.1021/acsmedchemlett.7b00488	10.1038/s41401-019-0246-4																																																																																																																																																							25970480	26207924	27690429	27769672	28523098	29456801	29670692	30321802	30469041	30889860																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												1.96208																																0.24526																																8																																CS-1496	CHEMSCENE	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-137-699|MOABOX:17759|IDO1|Epacadostat is an investigational cancer drug.[1] Epacadostat is an inhibitor of indoleamine 2,3-dioxygenase-1) (IDO1).[1][2];Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immunooncolog"	NS(=O)(=O)NCCNc1nonc1\C(=N/O)\Nc2ccc(F)c(Br)c2	1204669-58-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468496	438.23282	EPACADOSTAT | INCB24360 | INCB024360 |	"""EPACADOSTAT | INCB24360 | INCB024360 |"" | ""EPACADOSTAT | INCB24360 | INCB024360 |"""			MOABOX:17759	IDO1	"Epacadostat is an investigational cancer drug.[1] Epacadostat is an inhibitor of indoleamine 2,3-dioxygenase-1) (IDO1).[1][2];Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immunooncolog"
SJ000865900-4	SJ000865900	4	MOABOX:17761	WEXCGGWTIDNVNT-UHFFFAOYSA-N	COc1cc2nc(N3CCCC3)nc(NCCCCCN3CCCC3)c2cc1OC	1620401-82-2		KMT5A																																																															CHEMBL3318285											78357767	92044361				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.52805																																0.36115																																7																																HY-12335	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:17761|KMT5A|	COc1cc2nc(nc(NCCCCCN3CCCC3)c2cc1OC)N4CCCC4	1620401-82-2	14938	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469584	413.5563	UNC0379	UNC0379 | UNC0379	Pathway: Epigenetics	Research Area: Cancer	MOABOX:17761	KMT5A	
SJ000833872-6	SJ000833872	6	MOABOX:17765	DPJNKUOXBZSZAI-UHFFFAOYSA-N	CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C(C)C)CC3)nc2)cc2c1cnn2C(C)C	1431612-23-5	EZH2 inhibitor	EZH1	EZH2																															2146																															CHEMBL3414619											72551585					member	10.1021/cb400133j																																																																																																																																																															25406853	27468126																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0.422	2.15848																															0.05275	0.26981																															8	8																															HY-15646	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Epigenetics | Research Area: Cancer|MOABOX:17765|EZH1|EZH2 inhibitor	CCCC1=C(CNC(=O)c2cc(cc3c2cnn3C(C)C)c4ccc(nc4)N5CCN(CC5)C(C)C)C(=O)NC(=C1)C	1431612-23-5	41923	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468980	569.74022	UNC1999	UNC1999 | UNC1999	Pathway: Autophagy; Epigenetics	Research Area: Cancer	MOABOX:17765	EZH1	EZH2 inhibitor
SJ000874165-3	SJ000874165	3	MOABOX:17773	REVJNSVNICWODC-KIDMSAQOSA-N	CN(C)[C@H]1CN(C2CCc3cccc(F)c32)C[C@@H]1c1ccc(N2CCN(S(C)(=O)=O)CC2)cc1			EED																																																															CHEMBL4104741											123132213					member																																																																																																																																																																28254486	28926243																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.36048																																0.42006																																8																																CS-0021615	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-417-636|MOABOX:17773|EED|	CN(C)[C@H]1CN(C[C@@H]1c2ccc(cc2)N3CCN(CC3)S(=O)(=O)C)C4CCc5cccc(F)c45	2089148-72-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468491	486.6451	A-395	A-395 | A-395			MOABOX:17773	EED	
SJ001005353-2	SJ001005353	2	MOABOX:17776	CGWBJJZOKGZCSJ-UHFFFAOYSA-N	CCCOc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2CCN2CCOCC2)cc1		N-Ac Lysine competitive CREBBP/EP300 inhibitor	CREBBP	EP300																															2033																															CHEMBL3963965											119081416	119081417				virtual	10.1016/j.chembiol.2015.10.013	10.1021/acs.jmedchem.6b01022																																																																																																																																																														27682507	28375629																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.09472	-8.33e-002																															0.26184	-0.0119																															8	7																															HY-19999A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Neurological Disease|MOABOX:17776|CREBBP|N-Ac Lysine competitive CREBBP/EP300 inhibitor	CCCOc1ccc(CCc2nc3cc(ccc3n2CCN4CCOCC4)c5c(C)onc5C)cc1	2070014-93-4	20331	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469298	488.62114	PF-CBP1	PF-CBP1 | PF-CBP1	Pathway: Epigenetics	Research Area: Neurological Disease	MOABOX:17776	CREBBP	N-Ac Lysine competitive CREBBP/EP300 inhibitor
SJ001035353-1	SJ001035353	1	MOABOX:17781	MXUSGDMIHGLCNC-HNNXBMFYSA-N	N#Cc1cc(F)cc(Oc2ccc(S(=O)(=O)C(F)F)c3c2CC(F)(F)[C@H]3O)c1		HIF2A/EPAS1 inhibitor	EPAS1																																																																										91663289					member	10.1038/nature19795																																																																																																																																																															30289716																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.71184																																0.46398																																8																																HY-108697	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:17781|EPAS1|HIF2A/EPAS1 inhibitor	O[C@H]1c2c(CC1(F)F)c(Oc3cc(F)cc(c3)C#N)ccc2S(=O)(=O)C(F)F	1672662-14-4	43959	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469680	419.32262	PT2399	PT2399 | PT2399	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:17781	EPAS1	HIF2A/EPAS1 inhibitor
SJ001035306-1	SJ001035306	1	MOABOX:17782	RNEOHKZPZKEZCQ-UHFFFAOYSA-N	O=C(NCCc1nccs1)c1cnc2c(SSc3cccc4cc(C(=O)NCCc5nccs5)cnc34)cccc2c1		Proteasome inhibitor	PSMD14																																																															CHEMBL4073553											126599606					member	10.1038/nchembio.2326																																																																																																																																																															28191850																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.98432																																0.37304																																8																																HY-110404	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:17782|PSMD14|Proteasome inhibitor	O=C(NCCc1nccs1)c2cnc3c(SSc4cccc5cc(cnc45)C(=O)NCCc6nccs6)cccc3c2	2084868-04-0	30950	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469537	628.81056	CAPZIMIN	CAPZIMIN | CAPZIMIN	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:17782	PSMD14	Proteasome inhibitor
SJ000870502-2	SJ000870502	2	MOABOX:17788	IQVDLEXWAPYWDT-LJQANCHMSA-N	Cc1ccc(-c2ncc(OC[C@@H]3CCNC3)cc2-c2ccc(C#N)cc2)cc1			KDM1A																																																															CHEMBL3134377											72793898	135397147				member																																																																																																																																																																28927796	30409536	30472603																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.48232																																0.43529																																8																																CS-0077433	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-683-384|MOABOX:17788|KDM1A|	Cc1ccc(cc1)c2ncc(OC[C@@H]3CCNC3)cc2c4ccc(cc4)C#N	2436760-79-9	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468408	369.45892	CPI18	CPI18 | CPI18			MOABOX:17788	KDM1A	
SJ000982885-4	SJ000982885	4	MOABOX:17793	ALHBJBCQLJZYON-ZQDZILKHSA-N	N[C@H]1CC[C@H](N[C@@H]2C[C@H]2c2ccccc2)CC1	1431303-72-8	KDM1A (LSD1) inhibitor	KDM1A																																																															CHEMBL3781751																member	10.1021/acs.jmedchem.6b01018																																																																																																																																																															26057211	26702542	28186755	28186757	30448189	30472603																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																3.44912																																0.43114																																8																																HY-12782T	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:17793|KDM1A|KDM1A (LSD1) inhibitor	N[C@@H]1CC[C@H](CC1)N[C@@H]2C[C@H]2c3ccccc3	1431303-72-8	30732	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1469856	230.34858	ORY-1001 	ORY-1001  | RG-6016 | ORY-1001  | RG-6016	Pathway: Epigenetics	Research Area: Cancer	MOABOX:17793	KDM1A	KDM1A (LSD1) inhibitor
SJ000851860-5	SJ000851860	5	MOABOX:17795	BASFYRLYJAZPPL-UONOGXRCSA-N	c1ccc([C@@H]2C[C@H]2NC2CCNCC2)cc1	1431367-51-9	KDM1A/B	KDM1A																																																																										71522234	71543363	91663353			virtual																																																																																																																																																																31096156																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.82088																																0.47761																																8																																T2315	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-035-944-335|MOABOX:17795|KDM1A|KDM1A/B	C1CC(CCN1)N[C@@H]2C[C@H]2c3ccccc3	1431368-48-7	NA	GENERAL	CHLORIDE	2	NO_SOLVATE	0	1468132	216.322	GSK-LSD1	GSK-LSD1 | GSK-LSD1			MOABOX:17795	KDM1A	KDM1A/B
SJ001035189-1	SJ001035189	1	MOABOX:18256	LYLASWLQCMKZAT-UHFFFAOYSA-N	CN(C)CCc1nnc2cc(-c3ccccc3)c3cc(Cl)ccc3n12	72882-78-1		MAT2A																																																															CHEMBL337420											12612431					member	10.1038/nchembio.2384																																																																																																																																																															28553945																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.19968																																0.39996																																8																																HY-107778	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:18256|MAT2A|	CN(C)CCc1nnc2cc(c3ccccc3)c4cc(Cl)ccc4n12	72882-78-1	29182	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469039	350.84466	PF-9366	PF-9366 | PF-9366	Pathway: Others	Research Area: Cancer	MOABOX:18256	MAT2A	
SJ000512462-7	SJ000512462	7	MOABOX:18257	PBBRWFOVCUAONR-UHFFFAOYSA-N	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21	172889-27-9	Src Kinase Inhibitors	FYN	HCK	SRC																														3055	6714																														CHEMBL406845											4878	17751074				member	10.1016/S0014-5793(03)00069-3	10.1021/ci4002553	10.1111/j.1747-0285.2005.00316.x	10.1161/01.RES.85.1.12																																																																																																																																																												8557675	10608920	16492148	16509573	16722646	16722656	17627544	17929792	18045061	18077363	18342402	18473810	18782057	19601892	20570525	22119472	22943437	23143416	23352142	23410168	23602444	27474918																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																1.2992	0.208	0.96736																														0.1624	0.026	0.12092																														8	8	8																														HY-13805	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:18257|FYN|Src Kinase Inhibitors	CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13	172889-27-9	9736	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469123	301.77404	PP 2	"PP 2 | ""PP2 | AG-1879 |"" | PP2 | PP 2 | ""PP2 | AG-1879 |"" | PP2"	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:18257	FYN	Src Kinase Inhibitors
SJ001035318-1	SJ001035318	1	MOABOX:18260	UCYSSYGGXOFJKK-UHFFFAOYSA-N	CCc1c(-c2ccc(C(=O)NC)nc2)cnc(N)c1-c1ccc(O)cc1			USP7																																																															CHEMBL4092976											122531750					member	10.1038/nature24006																																																																																																																																																															29045385																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.69944																																0.46243																																8																																HY-107986	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:18260|USP7|	CCc1c(cnc(N)c1c2ccc(O)cc2)c3ccc(nc3)C(=O)NC	2009273-71-4	29633	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469560	348.3984	GNE-6776	GNE-6776 | GNE-6776	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:18260	USP7	
SJ000855456-3	SJ000855456	3	MOABOX:18262	RMAMGGNACJHXHO-UHFFFAOYSA-N	CC(=O)c1cc([N+](=O)[O-])c(Sc2ccc(F)cc2F)s1	1247819-59-5		USP7																																																															CHEMBL2159498											46931953					member	10.1016/j.chembiol.2017.09.004																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.43523																																0.34789																																7																																HY-13865	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:18262|USP7|	CC(=O)c1cc(c(Sc2ccc(F)cc2F)s1)[N+](=O)[O-]	1247819-59-5	10635	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468893	315.31569	P22077	P22077 | P22077	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:18262	USP7	
SJ001035192-1	SJ001035192	1	MOABOX:18264	BLSNYSFLZAWBIV-SFHVURJKSA-N	O=C(C[C@@H](C(F)F)n1ccc(F)n1)N1CCC(O)(Cn2cnc3c(cnn3-c3ccc(F)cc3)c2=O)CC1			USP7																																																																										121457027					member	10.1038/nature24451																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-107985	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:18264|USP7|	OC1(CN2C=Nc3c(cnn3c4ccc(F)cc4)C2=O)CCN(CC1)C(=O)C[C@@H](C(F)F)n5ccc(F)n5	1959551-26-8	47058	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469045	533.47813	FT671	FT671 | FT671	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:18264	USP7	
SJ001035379-1	SJ001035379	1	MOABOX:18267	GFNJQQBUZURQMA-UHFFFAOYSA-N	C=CS(=O)(=O)Nc1ccccc1-c1ccc(C(=O)N2CCC(O)(Cn3cnc4c(cnn4C)c3=O)CC2)cc1			USP7																																																																										121435663					member	10.1038/nature24451																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-111350	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:18267|USP7|	Cn1ncc2C(=O)N(CC3(O)CCN(CC3)C(=O)c4ccc(cc4)c5ccccc5NS(=O)(=O)C=C)C=Nc12	1959537-86-0	38653	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469850	548.61342	FT827	FT827 | FT827	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:18267	USP7	
SJ001035352-1	SJ001035352	1	MOABOX:18269	GUDJFFQZIISQJB-UHFFFAOYSA-N	CS(=O)(=O)c1ccc(NC(=O)c2cc(C#N)c(Sc3c(Cl)cncc3Cl)s2)cc1	1247825-37-1		USP7																																																															CHEMBL2159508											51031028					member	10.1021/ml200276j																																																																																																																																																															23684893	24900381																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.99664																																0.37458																																8																																HY-13487	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:18269|USP7|	CS(=O)(=O)c1ccc(NC(=O)c2cc(C#N)c(Sc3c(Cl)cncc3Cl)s2)cc1	1247825-37-1	11234	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469674	484.39924	USP7/USP47 INHIBITOR	USP7/USP47 INHIBITOR | USP7/USP47 INHIBITOR	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:18269	USP7	
SJ000784279-4	SJ000784279	4	MOABOX:18277	HPTXLHAHLXOAKV-INIZCTEOSA-N	O=C(O)[C@H](Cc1c[nH]c2ccccc12)N1C(=O)c2ccccc2C1=O	32675-71-1	DNMT direct inhibitor	DNMT1																																																															CHEMBL1564869											702558	130331671	143645333			member																																																																																																																																																																22854677																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.80962																																0.11566																																7																																ES-0018	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC(=O)[C@H](Cc1c[nH]c2ccccc12)N3C(=O)c4ccccc4C3=O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466652	334.32546	RG108	"RG108 | ""DNA METHYLTRANSFERASE INHIBITOR | NSC-401077"" | RG108 | ""DNA METHYLTRANSFERASE INHIBITOR | NSC-401077"""			MOABOX:18277	DNMT1	DNMT direct inhibitor
SJ001035153-1	SJ001035153	1	MOABOX:18278	SPYIETQLOVDJCF-UHFFFAOYSA-N	COc1ccc(N2C(=O)C(=Cc3ccc([N+](=O)[O-])s3)SC2=S)cc1		Inhibitor of protein disulfide isomerases (PDI)	P4HB																																																																										2901297					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-100430	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:18278|P4HB|Inhibitor of protein disulfide isomerases (PDI)	COc1ccc(cc1)N2C(=S)S\C(=C\c3ccc(s3)[N+](=O)[O-])\C2=O	346640-08-2	21466	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468936	378.4459	CCF642	CCF642 | CCF642	Pathway: Others	Research Area: Cancer	MOABOX:18278	P4HB	Inhibitor of protein disulfide isomerases (PDI)
SJ001035282-1	SJ001035282	1	MOABOX:18280	XAEJIFARBQJLML-UHFFFAOYSA-N	N#Cc1ccc(-c2csc(NN=C3CCCC3)n2)cc1	1622921-15-6	Inhibitor of NAT10	NAT10																																																															CHEMBL399572											44442376	86280479				member	10.1126/science.1252651																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.36708																																-0.05244																																7																																HY-16706A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:18280|NAT10|Inhibitor of NAT10	N#Cc1ccc(cc1)c2csc(NN=C3CCCC3)n2	1622921-15-6	13854	GENERAL	BROMIDE	1	NO_SOLVATE	0	1469486	282.36346	REMODELIN HYDROBROMIDE	REMODELIN HYDROBROMIDE | REMODELIN HYDROBROMIDE	Pathway: Epigenetics	Research Area: Cancer	MOABOX:18280	NAT10	Inhibitor of NAT10
SJ000544331-16	SJ000544331	16	MOABOX:18287	JNAHVYVRKWKWKQ-CYBMUJFWSA-N	C[C@]1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1	912444-00-9		PARP1	PARP2																															10038																															CHEMBL506871											11960529	16654997	45480520	92045027	140655321	member	10.1016/j.bmc.2013.12.031	10.1016/j.bmc.2014.12.071	10.1016/j.bmcl.2013.02.032	10.1016/j.bmcl.2013.12.048	10.1016/j.chembiol.2012.08.014	10.1016/j.ejmech.2018.01.018	10.1021/jm100012m	10.1021/jm5002502	10.1021/jm801171j	10.1021/jm900697r																																																																																																																																																						19143569	19888760	20364863	20420408	21436403	21585709	23102222	23481647	23850199	24388690	24398383	24922587	25614115	25761096	26088338	26222319	26422786	26652717	27304949	27353531	27561983	28001384	28340412	29335205	31042381	31108884																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												2.15232	0.84976																															0.26904	0.10622																															8	8																															HY-10129	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:18287|PARP1|	C[C@@]1(CCCN1)c2nc3cccc(C(=O)N)c3[nH]2	912444-00-9	62228	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469922	244.29234	VELIPARIB	"VELIPARIB | ""ABT-888 | NSC-737664 | A-861695"" | VELIPARIB (ABT-888) | VELIPARIB | ""ABT-888 | NSC-737664 | A-861695"" | VELIPARIB (ABT-888)"	Pathway: Autophagy; Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:18287	PARP1	
SJ000833838-3	SJ000833838	3	MOABOX:18290	HORXBWNTEDOVKN-UHFFFAOYSA-N	O=C(NCC1(c2nc(-c3ccccc3)cs2)CCOCC1)c1cccc(-c2noc(C(F)(F)F)n2)c1	1314890-29-3		HDAC9	HDAC4	HDAC5	HDAC7																													9759	10014	51564																													CHEMBL3110004											53344908					member	10.1021/acschemneuro.8b00600	10.1038/nchembio.1223																																																																																																																																																														23524983	24261862	27060764	27886544	28581289	28987602	29150335	29456804	29589441	30366254	30973727																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											1.90872	8.136e-002	0.17016	0.43344																													0.23859	0.01017	0.02127	0.05418																													8	8	8	8																													HY-18360	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:18290|HDAC9|	FC(F)(F)c1onc(n1)c2cccc(c2)C(=O)NCC3(CCOCC3)c4nc(cs4)c5ccccc5	1314890-29-3	12717	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468813	514.51945	TMP269	TMP269 | TMP269	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:18290	HDAC9	
SJ000986087-2	SJ000986087	2	MOABOX:18299	VIBHJPDPEVVDTB-UHFFFAOYSA-N	Cc1onc(C(=O)N2CCN(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)CC2)c1[N+](=O)[O-]	1360705-96-9		GPX4																																																															CHEMBL1951048											49766530					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-100003	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:18299|GPX4|	Cc1onc(C(=O)N2CCN(CC2)C(c3ccc(Cl)cc3)c4ccc(Cl)cc4)c1[N+](=O)[O-]	1360705-96-9	57813	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468766	475.3246	ML-210	ML-210 | ML-210	Pathway: Apoptosis; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:18299	GPX4	
SJ001033003-2	SJ001033003	2	MOABOX:18300	PZCKLTWSXFDLLP-OGWOLHLISA-N	NS(=O)(=O)OC[C@H]1C[C@@H](Nc2ncncc2C(=O)c2ccn(Cc3cccc(Br)c3)n2)C[C@@H]1O		inhibitor of the SUMO-activating enzyme	SAE1																																																																										86566743					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.16669																																0.16667																																7																																HY-108702	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:18300|SAE1|inhibitor of the SUMO-activating enzyme	NS(=O)(=O)OC[C@H]1C[C@H](C[C@@H]1O)Nc2ncncc2C(=O)c3ccn(Cc4cccc(Br)c4)n3	1644342-14-2	66065	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469027	551.41352	ML-792	ML-792 | ML-792	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:18300	SAE1	inhibitor of the SUMO-activating enzyme
SJ001035285-1	SJ001035285	1	MOABOX:18301	ZAIULUYKQLVQFH-UHFFFAOYSA-N	Nc1ccccc1NC(=O)CCCCCC(=O)Nc1ccccc1	537034-15-4	HDACs	HDAC1	HDAC3																															8841																															CHEMBL277805											9543539	118917414				virtual																																																																																																																																																																28771357																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.1416	1.14896																															0.1427	0.14362																															8	8																															HY-100384	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Neurological Disease|MOABOX:18301|HDAC1|HDACs	Nc1ccccc1NC(=O)CCCCCC(=O)Nc2ccccc2	537034-15-4	21041	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469489	325.40482	NKL 22	NKL 22 | NKL 22	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Neurological Disease	MOABOX:18301	HDAC1	HDACs
SJ001034912-1	SJ001034912	1	MOABOX:18302	XKBSPAZCFAIBJL-OAHLLOKOSA-N	CN(C)[C@@H]1CCN(c2cc(-c3ccccc3)nc3ccnn23)C1		MRGPRX2 agonist	MRGPRX2																																																																										95882507					member	10.1038/nchembio.2334																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																6351	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-697-003|MOABOX:18302|MRGPRX2|MRGPRX2 agonist	CN(C)[C@@H]1CCN(C1)c2cc(nc3ccnn23)c4ccccc4	2089389-15-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468222	307.39284	(R)-ZINC 3573	(R)-ZINC 3573 | (R)-ZINC 3573			MOABOX:18302	MRGPRX2	MRGPRX2 agonist
SJ000870625-4	SJ000870625	4	MOABOX:18305	TWKYXZSXXXKKJU-FQEVSTJZSA-N	O=C(NC[C@H](O)CN1CCc2ccccc2C1)c1ccnc(NC2CCC2)c1	1616391-87-7	PRMT5 inhibitor	PRMT5																																																																										117072552	124201849				virtual	10.1021/acsmedchemlett.5b00380																																																																																																																																																															26985292																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.8728																																0.1091																																8																																HY-100235	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:18305|PRMT5|PRMT5 inhibitor	O[C@@H](CNC(=O)c1ccnc(NC2CCC2)c1)CN3CCc4ccccc4C3	1616391-87-7	39417	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469675	380.48332	GSK-3203591	GSK-3203591 | EPZ015866 | GSK591 | GSK-3203591 | EPZ015866 | GSK591	Pathway: Epigenetics	Research Area: Cancer	MOABOX:18305	PRMT5	PRMT5 inhibitor
SJ000833836-5	SJ000833836	5	MOABOX:18306	AJRGHIGYPXNABY-UHFFFAOYSA-N	COc1ccc(Cn2ccc3ccc(C(=O)NO)cc32)cc1	950762-95-5	HDAC8 inhibitor	HDAC8																																																															CHEMBL2170177											24753719					virtual	10.1016/j.bmcl.2012.08.104	10.1016/j.ejmech.2016.12.032	10.1021/acs.jmedchem.5b01478	10.1021/acs.jmedchem.7b01447	10.1021/acs.jmedchem.8b00050	10.1021/acs.jmedchem.8b01087	10.1021/acsmedchemlett.7b00126	10.1021/jm300837y																																																																																																																																																								18568166	20472442	20701588	21436030	22907916	23010266	23116147	23672185	24730063	25240614	26681404	26937828	27774131	28771357	28835796	29190092	30004697	30347148	30964290																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			4.25976																																0.53247																																8																																HY-15224	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:18306|HDAC8|HDAC8 inhibitor	COc1ccc(Cn2ccc3ccc(cc23)C(=O)NO)cc1	950762-95-5	22985	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469281	296.32054	PCI 34051	PCI 34051 | PCI-34051 | PCI 34051 | PCI-34051	Pathway: Apoptosis; Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:18306	HDAC8	HDAC8 inhibitor
SJ000851864-6	SJ000851864	6	MOABOX:18309	GNMUEVRJHCWKTO-HXUWFJFHSA-N	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		N-Ac Lysine competitive BET family inhibitor BRD4	BRD4																																																																										118704772					virtual	10.1016/S2352-3026(15)00247-1																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																CS-1598	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-035-395-872|MOABOX:18309|BRD4|N-Ac Lysine competitive BET family inhibitor BRD4	Cc1sc2c(C(=N[C@@H](CC(=O)Nc3ccc(O)cc3)c4nnc(C)n24)c5ccc(Cl)cc5)c1C	202590-98-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468678	491.99248	OTX015	OTX015 | OTX-015 | OTX015 | OTX-015			MOABOX:18309	BRD4	N-Ac Lysine competitive BET family inhibitor BRD4
SJ000574791-10	SJ000574791	10	MOABOX:18310	AAAQFGUYHFJNHI-SFHVURJKSA-N	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21	1260907-17-2	BRD2/3/4/T BET familiy inhibitor	BRD4																																																															CHEMBL1232461											46943432	52932937	132006956	133082230	144547638	virtual	10.1016/j.bmcl.2017.09.025	10.1016/j.bmcl.2018.04.016	10.1016/j.bmcl.2019.03.014	10.1016/j.ejmech.2017.05.049	10.1021/acs.jmedchem.7b00193	10.1021/acsmedchemlett.7b00389	10.1021/jm300915b																																																																																																																																																									21568322	22136469	22316554	22924434	23517011	24015967	24107192	24497428	24900758	25559428	25851940	26080064	26367539	26572217	26731490	26815195	27528113	28209615	28463487	28586718	28939121	29259751	29525435	29566488	29657099	29758518	29764756	30268702	30606676	30926312																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								2.12456																																0.26557																																8																																HY-13032	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:18310|BRD4|BRD2/3/4/T BET familiy inhibitor	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c3cc(OC)ccc3n4c(C)nnc14	1260907-17-2	42990	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469008	423.89538	MLAF-024	MLAF-024 | GSK525762A | GSK 525762A | I-BET-762 | IBET762 | MLAF-024 | GSK525762A | GSK 525762A | I-BET-762 | IBET762	Pathway: Epigenetics	Research Area: Cancer	MOABOX:18310	BRD4	BRD2/3/4/T BET familiy inhibitor
SJ000826826-8	SJ000826826	8	MOABOX:18311	TXZPMHLMPKIUGK-UHFFFAOYSA-N	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2	1403764-72-6	BRD2/3/4/T BET familiy inhibitor	BRD4																																																															CHEMBL2179387											71271629	144547564				member	10.1021/jm301588r	10.1111/cbdd.13109																																																																																																																																																														23095041	23517011	23576556	24090311	24497428	26572217	26731490	27266999	28068087	29541371	29730189	29764756	29776834	29941841																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								1.83296																																0.22912																																8																																HY-16586	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Epigenetics | Research Area: Cancer|MOABOX:18311|BRD4|BRD2/3/4/T BET familiy inhibitor	COc1ccccc1S(=O)(=O)Nc2ccc3NC(=O)N(C)Cc3c2	1403764-72-6	8691	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469773	347.38888	PFI-1	PFI-1 | PFI-1	Pathway: Apoptosis; Autophagy; Epigenetics	Research Area: Cancer	MOABOX:18311	BRD4	BRD2/3/4/T BET familiy inhibitor
SJ000851862-4	SJ000851862	4	MOABOX:18314	YHHFKWKMXWRVTJ-OQKWZONESA-N	Clc1ccc(N/N=C(\c2ccccc2)c2ccccn2)nc1	199596-05-9	JMJD2 Histone Demethylase Inhibitor	KDM4C	KDM4E	KDM4B																														390245	23030																														CHEMBL1982368											6519698					virtual																																																																																																																																																																26682034																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	-0.61472	-0.45768																														0.0	-0.07684	-0.05721																														7	8	8																														HY-13953	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Epigenetics | Research Area: Cancer|MOABOX:18314|KDM4C|JMJD2 Histone Demethylase Inhibitor	Clc1ccc(N\N=C(/c2ccccc2)\c3ccccn3)nc1	199596-05-9	68465	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469339	308.76492	JIB-04	JIB-04 | JIB-04	Pathway: Apoptosis; Epigenetics	Research Area: Cancer	MOABOX:18314	KDM4C	JMJD2 Histone Demethylase Inhibitor
SJ000128365-5	SJ000128365	5	MOABOX:18316	PBZYAPZLINAHET-UHFFFAOYSA-N	CC(C)C(=O)NC(c1ccco1)c1ccc2cccnc2c1O		KDM4C inhibitor	KDM4C																																																															CHEMBL1601133											2876959					virtual	10.1073/pnas.1404303111																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																5928956	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-085-270|MOABOX:18316|KDM4C|KDM4C inhibitor	CC(C)C(=O)NC(c1occc1)c2ccc3cccnc3c2O	332173-89-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468684	310.34712	SD70	SD70 | SD70			MOABOX:18316	KDM4C	KDM4C inhibitor
SJ000851867-4	SJ000851867	4	MOABOX:18318	QDBVSOZTVKXUES-UHFFFAOYSA-N	CN(C)CCCNC(=O)c1ccc(-c2cc(O)c3ncccc3c2)cc1	1222800-79-4	KDM4E	KDM4E																																																															CHEMBL1398529	CHEMBL1592706										44143208	44143209	86346661	91826498		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-6.489e-002																																-0.00927																																7																																HY-12725	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Epigenetics | Research Area: Cancer|MOABOX:18318|KDM4E|KDM4E	CN(C)CCCNC(=O)c1ccc(cc1)c2cc(O)c3ncccc3c2	1222800-79-4	25158	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469797	349.42622	ML324	ML324 | ML324	Pathway: Anti-infection; Epigenetics	Research Area: Cancer	MOABOX:18318	KDM4E	KDM4E
SJ001033653-2	SJ001033653	2	MOABOX:18319	KRXWJZIHQRIGSJ-UHFFFAOYSA-N	CC(C)c1c(-c2cnn(C(C)(C)C)c2)[nH]c2c(C#N)cnn2c1=O		KDM5A inhibitor	KDM5A																																																															CHEMBL3785583																virtual	10.1016/j.bmcl.2016.06.078																																																																																																																																																															26710088																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.97632																																0.37204																																8																																2809	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-153-892|MOABOX:18319|KDM5A|KDM5A inhibitor	CC(C)C1=C(Nc2c(cnn2C1=O)C#N)c3cnn(c3)C(C)(C)C	1628210-26-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468604	324.3803	KDM5-IN-1	KDM5-IN-1 | KDM5-IN-1			MOABOX:18319	KDM5A	KDM5A inhibitor
SJ001033198-2	SJ001033198	2	MOABOX:18320	YAUMOGALQJYOJQ-UHFFFAOYSA-N	COc1cccc(C(=O)COc2ccc(CC3SC(=O)NC3=O)cc2)c1	1133819-87-0		MPC2																																																																										25230266	53353834	143780070	144721220		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.3454																																0.1922																																7																																HY-108022	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:18320|MPC2|	COc1cccc(c1)C(=O)COc2ccc(CC3SC(=O)NC3=O)cc2	1133819-87-0	41842	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469899	371.40698	MSDC-0602	MSDC-0602 | MSDC-0602	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:18320	MPC2	
SJ001010791-3	SJ001010791	3	MOABOX:18322	IRNJSRAGRIZIHD-QGZVFWFLSA-N	CCc1ccc(C(=O)COc2ccc(C[C@H]3SC(=O)NC3=O)cc2)nc1		Inhibitor of mitochondrial pyruvate carrier	MPC1																																																																										40466907	144721180				virtual	10.1186/s13024-018-0260-x																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																CS-6405	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-009-018-762|MOABOX:18322|MPC1|Inhibitor of mitochondrial pyruvate carrier	CCc1ccc(nc1)C(=O)COc2ccc(CC3SC(=O)NC3=O)cc2	146062-49-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468475	370.42222	MSDC 0160	MSDC 0160 | MSDC 0160			MOABOX:18322	MPC1	Inhibitor of mitochondrial pyruvate carrier
SJ000869459-2	SJ000869459	2	MOABOX:18327	VRYZCEONIWEUAV-UHFFFAOYSA-N	Cc1cc(C)cc(C(=O)NOCCCCCC(=O)NO)c1	1418033-25-6	HDAC 4/5	HDAC4	HDAC5																															10014																															CHEMBL2312168											71520717					virtual																																																																																																																																																																23252603	24300735	24730063																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			1.01752	1.15584																															0.12719	0.14448																															8	8																															HY-18998	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:18327|HDAC4|HDAC 4/5	Cc1cc(C)cc(c1)C(=O)NOCCCCCC(=O)NO	1418033-25-6	18800	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469814	294.34618	LMK-235	LMK-235 | LMK-235	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:18327	HDAC4	HDAC 4/5
SJ001035311-1	SJ001035311	1	MOABOX:18330	YTIYJNWWLQSAAU-UHFFFAOYSA-N	CN(C(=O)c1ccn2ncc(-c3ccc(C(N)=O)cc3)c2c1)c1ccc(C#N)cn1	1610610-48-4		PI4KA	PI4KB																															5298																																										76281701					virtual	10.1038/nature22337																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0.70252																															0.0	0.10036																															7	7																															HY-103583	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; PI3K/Akt/mTOR | Research Area: Infection|MOABOX:18330|PI4KA|	CN(C(=O)c1ccn2ncc(c3ccc(cc3)C(=O)N)c2c1)c4ccc(cn4)C#N	1610610-48-4	45286	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469549	396.40144	KDU731	KDU731 | KDU731	Pathway: Anti-infection; PI3K/Akt/mTOR	Research Area: Infection	MOABOX:18330	PI4KA	
SJ001035073-1	SJ001035073	1	MOABOX:18331	RPHDOVLXDYWDGF-UHFFFAOYSA-N	Cc1ccc2[nH]c(CNCCCOc3ccccc3)cc(=O)c2c1			DRD4																																																															CHEMBL3480577											72901200					member	10.1126/science.aan5468																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																CS-0094882	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-027-876-982|MOABOX:18331|DRD4|	Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1	1434515-70-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468597	322.40088	UCSF924	UCSF924 | UCSF924			MOABOX:18331	DRD4	
SJ001035048-1	SJ001035048	1	MOABOX:18333	OIDZPEDDRCNOLM-UHFFFAOYSA-N	CSC(Nc1cccc(C(F)(F)F)c1)=C(C#N)S(=O)(=O)c1ccc(Cl)cc1		Inhibitors of the Diadenosine Tetraphosphate Phosphorylase Rv2613c (Ap4A)	NUDT2																																																																										3601308					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																KM00887	MAYBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-905-323|MOABOX:18333|NUDT2|Inhibitors of the Diadenosine Tetraphosphate Phosphorylase Rv2613c (Ap4A)	CS\C(=C(\C#N)/S(=O)(=O)c1ccc(Cl)cc1)\Nc2cccc(c2)C(F)(F)F	882282-38-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468551	432.86759	KM00887	KM00887 | KM00887			MOABOX:18333	NUDT2	Inhibitors of the Diadenosine Tetraphosphate Phosphorylase Rv2613c (Ap4A)
SJ001034874-1	SJ001034874	1	MOABOX:18334	YVBSNHLFRIVWFQ-UHFFFAOYSA-N	O=C(C1CC1)N1CCN(Cn2sc3ccccc3c2=O)CC1	877963-94-5		PDIA3	P4HB																															5034																																										9117962					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															CS-0018902	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-004-150-750|MOABOX:18334|PDIA3|	O=C(C1CC1)N2CCN(CN3Sc4ccccc4C3=O)CC2	877963-94-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468165	317.40596	LOC14	LOC14 | LOC14			MOABOX:18334	PDIA3	
SJ000063181-7	SJ000063181	7	MOABOX:18340	PBZNVOPQXYXTPC-UHFFFAOYSA-N	CC(C)Cc1cc(C(=O)Nc2ccc(F)c(Cl)c2)no1		activators of BMP4	BMP4																																																															CHEMBL4073693											17253337	145701508				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.76692																																0.10956																																7																																Z2735278957	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-844-261|MOABOX:18340|BMP4|activators of BMP4	CC(C)Cc1onc(c1)C(=O)Nc2ccc(F)c(Cl)c2	945189-68-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468084	296.72456					MOABOX:18340	BMP4	activators of BMP4
SJ001035309-1	SJ001035309	1	MOABOX:18352	KNYVRFXIVWUGBZ-UHFFFAOYSA-N	O=C(NCc1ncccc1F)c1coc(CCNCCc2nc3ccccc3[nH]2)n1		Ferroportin inhibitor	SLC40A1																																																																										129052159	140928408				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-112220	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Metabolic Disease|MOABOX:18352|SLC40A1|Ferroportin inhibitor	Fc1cccnc1CNC(=O)c2coc(CCNCCc3nc4ccccc4[nH]3)n2	2095668-10-1	84176	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469540	408.42884	VIT-2763	VIT-2763 | VIT-2763	Pathway: Others	Research Area: Metabolic Disease	MOABOX:18352	SLC40A1	Ferroportin inhibitor
SJ001033418-2	SJ001033418	2	MOABOX:18356	BGGMLMAPVODXAU-UHFFFAOYSA-N	O=C(COCC(=O)Nc1ccc(Cl)cc1C(=O)O)Nc1cccc(-c2ccoc2)c1	1190221-43-2		SERPINE1																																																																										44250349	66877607	66878441	138469363	138469365	member	10.1073/pnas.1321942111																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-101761	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:18356|SERPINE1|	OC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)Nc2cccc(c2)c3cocc3	1190221-43-2	25033	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469180	428.82248	TM5441	TM5441 | TM5441	Pathway: Apoptosis; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:18356	SERPINE1	
SJ000982837-5	SJ000982837	5	MOABOX:18357	VRVJKILQRBSEAG-LFPIHBKWSA-N	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CREBBP/ EP300 KAT inhibitor	CREBBP	EP300																															2033																																										118958122					member	10.1038/nature24028																																																																																																																																																															29348807	31256587																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	2.93104																															0.0	0.36638																															7	8																															CS-8185	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-417-887|MOABOX:18357|CREBBP|CREBBP/ EP300 KAT inhibitor	CNC(=O)Nc1ccc2c(CC[C@@]23OC(=O)N(CC(=O)N(Cc4ccc(F)cc4)[C@@H](C)C(F)(F)F)C3=O)c1	1889279-16-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468173	536.47547	A-485	"A-485 | ""A-485 | A485 | A 485"" | A-485 | ""A-485 | A485 | A 485"""			MOABOX:18357	CREBBP	CREBBP/ EP300 KAT inhibitor
SJ001005259-2	SJ001005259	2	MOABOX:18360	WWOOWAHTEXIWBO-QFRSUPTLSA-N	Nc1ncnc2c1ccn2[C@@H]1O[C@H]([C@H](O)c2ccccc2)[C@@H](O)[C@H]1O			PRMT5																																																																										122669401					virtual	10.1021/acsmedchemlett.8b00014																																																																																																																																																															29870258	30034588	30366617	30930442	30956011																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	2.17904																																0.27238																																8																																HY-107777	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:18360|PRMT5|	Nc1ncnc2c1ccn2[C@@H]3O[C@H]([C@H](O)c4ccccc4)[C@@H](O)[C@H]3O	2040291-27-6	45277	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469212	342.34922	LLY-283	LLY-283 | LLY-283	Pathway: Epigenetics	Research Area: Cancer	MOABOX:18360	PRMT5	
SJ000851907-4	SJ000851907	4	MOABOX:18363	FWFGIHPGRQZWIW-SQNIBIBYSA-N	CC(C)C[C@@H](C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1)[C@H](O)C(=O)NO	238750-77-1		ANPEP	NPEPPS	LTA4H																														9520	4048																														CHEMBL2103847											15547703	44155051				member	10.1016/j.ejmech.2017.07.048	10.1158/0008-5472.CAN-07-6627																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0.8888	0	0.7777																														0.1111	0.0	0.1111																														8	7	7																														HY-14807	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:18363|ANPEP|	CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)c2ccccc2	238750-77-1	28364	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469121	406.4727	CHR-2797 | TOSEDOSTAT	"""CHR-2797 | TOSEDOSTAT"" | TOSEDOSTAT (CHR2797) | ""CHR-2797 | TOSEDOSTAT"" | TOSEDOSTAT (CHR2797)"	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:18363	ANPEP	
SJ000287087-8	SJ000287087	8	MOABOX:18364	QAWIHIJWNYOLBE-OKKQSCSOSA-N	N[C@H](C(=O)O)[C@@H]1CC(Cl)=NO1	42228-92-2	gamma-Glutamyltransferase Inhibitors;Anti-viral	GGT1																																																															CHEMBL1231101											294641	40467943	132015413			member																																																																																																																																																																9829740																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-W016586	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Cancer; Infection|MOABOX:18364|GGT1|gamma-Glutamyltransferase Inhibitors;Anti-viral	N[C@@H]([C@@H]1CC(=NO1)Cl)C(=O)O	42228-92-2	84265	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468795	178.57368	ACIVICIN	"ACIVICIN | ACIVICIN|(2R)-2-AMINO-2-[(5S)-3-CHLORO-4,5-DIHYDRO-1,2-OXAZOL-5-YL]ACETIC ACID | ""ACIVICIN | ACIA | AT-125 | NSC-163501 | U-42126 |"" | ACIVICIN | ACIVICIN|(2R)-2-AMINO-2-[(5S)-3-CHLORO-4,5-DIHYDRO-1,2-OXAZOL-5-YL]ACETIC ACID | ""ACIVICIN | ACIA | AT-125 | NSC-163501 | U-42126 |"""	Pathway: Anti-infection	Research Area: Cancer; Infection	MOABOX:18364	GGT1	gamma-Glutamyltransferase Inhibitors;Anti-viral
SJ001033383-2	SJ001033383	2	MOABOX:18366	RSQGZEAXODVTOL-UHFFFAOYSA-N	C#Cc1cnc2nc(O)n(C(CC)CC)c2n1	1005491-05-3		TNNI2	TNNT3																															7140																															CHEMBL3039529											23729157	71499511				member	10.1038/nm.2618																																																																																																																																																															22344294																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-15964	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Neurological Disease|MOABOX:18366|TNNI2|	CCC(CC)N1C(=O)Nc2ncc(nc12)C#C	1005491-05-3	11576	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469831	230.26576	TIRASEMTIV; CK-2017357	TIRASEMTIV; CK-2017357 | TIRASEMTIV; CK-2017357	Pathway: Others	Research Area: Neurological Disease	MOABOX:18366	TNNI2	
SJ001035259-1	SJ001035259	1	MOABOX:18367	HFLMLZKGLUEWBU-UHFFFAOYSA-N	CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12	1303469-70-6		KHK																																																															CHEMBL2017214											53348216	92044374				member	10.1016/j.bmcl.2012.06.008	10.1021/ml200070g																																																																																																																																																														22795331	24900346	28853885																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.92688																																0.36586																																8																																HY-12841A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Others|MOABOX:18367|KHK|	CSc1ccccc1Nc2nc(nc3c(NCC4CC4)ncnc23)N5CCNCC5	1303470-48-5	59941	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469379	422.54974	KHK-IN-1 HYDROCHLORIDE	KHK-IN-1 HYDROCHLORIDE | KHK-IN-1 HYDROCHLORIDE	Pathway: Others	Research Area: Others	MOABOX:18367	KHK	
SJ000870754-3	SJ000870754	3	MOABOX:18379	JIFCFQDXHMUPGP-UHFFFAOYSA-N	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1	910232-84-7		BTK																																																															CHEMBL1230541											24857323					virtual	10.1021/jm300035p	10.1038/nchembio.481																																																																																																																																																														21113169	22394077	22594639	23958373	25701252	25843639	25872980	28315597	30817167	30888232	31234030																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											4.21464																																0.52683																																8																																HY-11999	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Protein Tyrosine Kinase/RTK | Research Area: Inflammation/Immunology|MOABOX:18379|BTK|	CN1C=C(N=C(Nc2ccc(cc2)C(=O)N3CCOCC3)C1=O)c4cccc(NC(=O)c5ccc(cc5)C(C)(C)C)c4C	910232-84-7	4106	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468764	579.68868	CGI-1746	"CGI-1746 | ""CGI1746 | CGI-1746 | CGI 1746"" | CGI-1746 | ""CGI1746 | CGI-1746 | CGI 1746"""	Pathway: Autophagy; Protein Tyrosine Kinase/RTK	Research Area: Inflammation/Immunology	MOABOX:18379	BTK	
SJ001034905-1	SJ001034905	1	MOABOX:18380	XHNKFGYYGPLYPT-ZDUSSCGKSA-N	COCc1ccc(-c2cc3c(N[C@@H](C)c4ccn(C)n4)c(C(N)=O)cnc3cc2F)cn1		ATN kinase inhibitor	ATM																																																																										130470684					member																																																																																																																																																																27259031	29683659	30128072																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.30216																																0.41277																																8																																6330	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-628-978|MOABOX:18380|ATM|ATN kinase inhibitor	COCc1ccc(cn1)c2cc3c(N[C@@H](C)c4ccn(C)n4)c(cnc3cc2F)C(=O)N	1941214-06-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468213	434.46612	AZ 5704	AZ 5704 | AZ 5704			MOABOX:18380	ATM	ATN kinase inhibitor
SJ001035300-1	SJ001035300	1	MOABOX:18387	QWDMZDSZMVJFFJ-UHFFFAOYSA-N	CCOc1cc2ncc(-c3cc(N)nc(F)c3)n2cc1S(=O)(=O)C(C)(C)C			RIPK2																																																																										131801159					virtual	10.1021/acsmedchemlett.7b00258																																																																																																																																																															29057049																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.05648																																0.25706																																8																																HY-107978	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis | Research Area: Inflammation/Immunology|MOABOX:18387|RIPK2|	CCOc1cc2ncc(c3cc(N)nc(F)c3)n2cc1S(=O)(=O)C(C)(C)C	2141969-56-2	65588	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469530	392.44774	RIPK-IN-4	RIPK-IN-4 | RIPK-IN-4	Pathway: Apoptosis	Research Area: Inflammation/Immunology	MOABOX:18387	RIPK2	
SJ000862689-5	SJ000862689	5	MOABOX:18390	OTTJIRVZJJGFTK-SFHVURJKSA-N	CCN(C(=O)CO)[C@H]1CN(/C(=N\C#N)Nc2cccc(OC(F)F)c2)N=C1c1ccc(Cl)c(Cl)c1		SMYD2 inhibitor	SMYD2																																																															CHEMBL3818617											117072551					member																																																																																																																																																																27075367																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.4816																																0.4352																																8																																HY-19546	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:18390|SMYD2|SMYD2 inhibitor	CCN([C@H]1CN(N=C1c2ccc(Cl)c(Cl)c2)\C(=N\c3cccc(OC(F)F)c3)\NC#N)C(=O)CO	1906919-67-2	40594	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468915	525.33541	BAY 598	BAY 598 | BAY 598	Pathway: Epigenetics	Research Area: Cancer	MOABOX:18390	SMYD2	SMYD2 inhibitor
SJ000782352-3	SJ000782352	3	MOABOX:18391	MBWXNTAXLNYFJB-NKFFZRIASA-N	CC1=C(C/C=C(\C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=O)c2ccccc2C1=O	10485-69-5	Cytochrome P450 CYP4F2 Inhibitors;Vitamin K analogs	BGLAP	GGCX	CYP4F2																														2677	8529																														CHEMBL1550											5284607	20839546	21155401	54591936	54708631	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0																														0.0	0.0	0.0																														7	7	7																														AS-13734	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(=C\CC1=C(C)C(=O)c2ccccc2C1=O)\C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466791	450.69574	PHYTONADIONE  | VITAMIN K1  | PHYTOMENADIONE | PHYLLOQUINONE | RO-01-6722-120 |	"""PHYTONADIONE  | VITAMIN K1  | PHYTOMENADIONE | PHYLLOQUINONE | RO-01-6722-120 |"" | ""PHYTONADIONE  | VITAMIN K1  | PHYTOMENADIONE | PHYLLOQUINONE | RO-01-6722-120 |"""			MOABOX:18391	BGLAP	Cytochrome P450 CYP4F2 Inhibitors;Vitamin K analogs
SJ001034993-1	SJ001034993	1	MOABOX:18392	HQAGTEJQOVMWJI-UHFFFAOYSA-N	CN(C(=O)COc1ccccc1)c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1			MLYCD																																																															CHEMBL203290											4610393					member	10.1016/j.bmcl.2005.10.020	10.1016/j.bmcl.2006.09.023	10.1021/jm050109n																																																																																																																																																													16257202	16509570																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.1876																																0.27345																																8																																5138876	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-321-508|MOABOX:18392|MLYCD|	CN(C(=O)COc1ccccc1)c2ccc(cc2)C(O)(C(F)(F)F)C(F)(F)F	294196-85-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468440	407.30702	5138876	5138876 | 5138876			MOABOX:18392	MLYCD	
SJ001035371-1	SJ001035371	1	MOABOX:18402	NALAUGMPMIVAOW-UHFFFAOYSA-N	O=C(O)CNC(=O)c1c(O)cc(CCc2ccccc2)n2ncnc12	1262131-60-1		P4HA2																																																																															member	10.1021/acsmedchemlett.7b00404																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-109057	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Metabolic Disease|MOABOX:18402|P4HA2|	OC(=O)CNC(=O)c1c(O)cc(CCc2ccccc2)n3ncnc13	1262132-81-9	63028	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469824	340.33334	ENARODUSTAT | JTZ-951	"""ENARODUSTAT | JTZ-951"" | ""ENARODUSTAT | JTZ-951"""	Pathway: Metabolic Enzyme/Protease	Research Area: Metabolic Disease	MOABOX:18402	P4HA2	
SJ001005261-2	SJ001005261	2	MOABOX:18435	CKFRXCBNKKOFGO-IGEOTXOUSA-N	C[C@H]1CC(=O)Nc2cc(C(=O)NCCC3CC3)ccc2N1C(=O)N1CC2CC2C1			SMYD3																																																																										137499231					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					4.06128																																0.50766																																8																																6561	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-792-730|MOABOX:18435|SMYD3|	C[C@H]1CC(=O)Nc2cc(ccc2N1C(=O)N3CC4CC4C3)C(=O)NCCC5CC5	2247890-13-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468618	396.48272	BAY6035	BAY6035 | BAY6035			MOABOX:18435	SMYD3	
SJ001035299-1	SJ001035299	1	MOABOX:18440	WLQXBRYTQYYCMW-REWPJTCUSA-N	Cc1ncc(F)cc1NC(=O)C[C@H](C(=O)N[C@@H]1C(=O)N2CC3(CC3)CN2C(=O)c2ccccc21)C1CC1		SPPL2A Inhibitor	SPPL2A																																																															CHEMBL4069936											134691740					member	10.1021/acs.jmedchem.7b01371	10.1021/acsmedchemlett.9b00044																																																																																																																																																														29359565	31223443																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.78784																																0.22348																																8																																HY-111360	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Neuronal Signaling; Stem Cell/Wnt | Research Area: Inflammation/Immunology|MOABOX:18440|SPPL2A|SPPL2A Inhibitor	Cc1ncc(F)cc1NC(=O)C[C@@H](C2CC2)C(=O)N[C@@H]3C(=O)N4CC5(CC5)CN4C(=O)c6ccccc36	2195361-33-0	89414	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469528	505.54072	SPL-707	SPL-707 | SPL-707	Pathway: Neuronal Signaling; Stem Cell/Wnt	Research Area: Inflammation/Immunology	MOABOX:18440	SPPL2A	SPPL2A Inhibitor
SJ001011008-2	SJ001011008	2	MOABOX:18443	NCKLQXXBRWCYMA-FQEVSTJZSA-N	CC[C@@]1(c2ccccc2)C2=C(CC(C)(C)CC2=O)Nc2n[nH]cc21			GSK3A																																																																										136980453					member																																																																																																																																																																30925338																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.01904																																0.25238																																8																																2931	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-356-273|MOABOX:18443|GSK3A|	CC[C@@]1(C2=CNNC2=NC3=C1C(=O)CC(C)(C)C3)c4ccccc4	2056261-41-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468384	321.41612	BRD0705	BRD0705 | BRD0705			MOABOX:18443	GSK3A	
SJ000862669-4	SJ000862669	4	MOABOX:18450	KJDAGXLMHXUAGV-DGWLBADLSA-N	NS(=O)(=O)OC[C@H]1C[C@@H](Nc2ccnc3cc(-c4cccc(SC(F)(F)F)c4)nn23)[C@H](O)[C@@H]1O	1450833-55-2	Ubiquitin-Activating Enzyme E1 Inhibitors	UBA1																																																																										71715374					member	10.1038/nm.4474																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-100487	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease; NF-?B | Research Area: Cancer|MOABOX:18450|UBA1|Ubiquitin-Activating Enzyme E1 Inhibitors	NS(=O)(=O)OC[C@H]1C[C@@H](Nc2ccnc3cc(nn23)c4cccc(SC(F)(F)F)c4)[C@H](O)[C@@H]1O	1450833-55-2	32149	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468830	519.51781	MLN7243	MLN7243 | TAK-243 | MLN7243 | TAK-243	Pathway: Apoptosis; Metabolic Enzyme/Protease; NF-?B	Research Area: Cancer	MOABOX:18450	UBA1	Ubiquitin-Activating Enzyme E1 Inhibitors
SJ000862669-3	SJ000862669	3	MOABOX:18450	KJDAGXLMHXUAGV-DGWLBADLSA-N	NS(=O)(=O)OC[C@H]1C[C@@H](Nc2ccnc3cc(-c4cccc(SC(F)(F)F)c4)nn23)[C@H](O)[C@@H]1O	1450833-55-2	Ubiquitin-Activating Enzyme E1 Inhibitors	UBA1																																																																										71715374					member	10.1038/nm.4474																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																CS-0019384	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-683-153|MOABOX:18450|UBA1|Ubiquitin-Activating Enzyme E1 Inhibitors	NS(=O)(=O)OC[C@H]1C[C@@H](Nc2ccnc3cc(nn23)c4cccc(SC(F)(F)F)c4)[C@H](O)[C@@H]1O	1450833-55-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468174	519.51781	MLN7243	MLN7243 | TAK-243 | MLN7243 | TAK-243			MOABOX:18450	UBA1	Ubiquitin-Activating Enzyme E1 Inhibitors
SJ001035186-1	SJ001035186	1	MOABOX:18452	RGXYYAZGELLKDA-UHFFFAOYSA-N	O=[N+]([O-])c1ccc(SCCCCCCO)c2nonc12	787634-60-0	Glutathione-S-Transferase P1 (GSTP1) Inhibitors	GSTM2	GSTP1																															2950																															CHEMBL1234570											9817686	87933413				member	10.1016/j.ejmech.2014.10.033																																																																																																																																																															15888444	25462236																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.44296	-0.50056																															0.43037	-0.06257																															8	8																															HY-135318	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:18452|GSTM2|Glutathione-S-Transferase P1 (GSTP1) Inhibitors	OCCCCCCSc1ccc(c2nonc12)[N+](=O)[O-]	787634-60-0	61478	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469029	297.3302	NBDHEX	NBDHEX | NBDHEX	Pathway: Apoptosis; Autophagy; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:18452	GSTM2	Glutathione-S-Transferase P1 (GSTP1) Inhibitors
SJ001033149-2	SJ001033149	2	MOABOX:18456	FGQFOYHRJSUHMR-UHFFFAOYSA-N	O=C(O)CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12	1151516-14-1		SLC22A11	SLC22A12																															116085																															CHEMBL2105720											53465279	54772239	67340387	71472681	137083676	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	2.60295																															0.0	0.37185																															7	7																															HY-15258A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Metabolic Disease|MOABOX:18456|SLC22A11|	OC(=O)CSc1nnc(Br)n1c2ccc(C3CC3)c4ccccc24	1151516-14-1	18688	GENERAL	SODIUM(I)	1	NO_SOLVATE	0	1469851	404.28096	LESINURAD (SODIUM) | RDEA-594 SODIUM	"""LESINURAD (SODIUM) | RDEA-594 SODIUM"" | ""LESINURAD (SODIUM) | RDEA-594 SODIUM"""	Pathway: Membrane Transporter/Ion Channel	Research Area: Metabolic Disease	MOABOX:18456	SLC22A11	
SJ001035303-1	SJ001035303	1	MOABOX:18471	NYBZCKAQIIPSDS-UHFFFAOYSA-N	COc1ccc(-c2c(C)nn3c(C(F)(F)F)cc(C)nc23)c(F)c1F			GRM7	GRM8																															2918																																										131954513					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-107982	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:18471|GRM7|	COc1ccc(c(F)c1F)c2c(C)nn3c(cc(C)nc23)C(F)(F)F	2137047-43-7	27998	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469533	357.278	VU6005649	VU6005649 | VU6005649	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:18471	GRM7	
SJ001033480-2	SJ001033480	2	MOABOX:18497	LSYANGLAZUZYFX-UHFFFAOYSA-N	N#Cc1ccc(Cn2ccc(NC(=O)Cc3ccc(C4(C(F)(F)F)CC4)cc3)n2)nc1			CACNA1I	CACNA1H	CACNA1G																														8912	8913																																									118560618					member	10.1021/acs.jmedchem.7b01236																																																																																																																																																															29116786																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.8256	-0.10136	0.39944																														0.1032	-0.01267	0.04993																														8	8	8																														HY-112723	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:18497|CACNA1I|	FC(F)(F)C1(CC1)c2ccc(CC(=O)Nc3ccn(Cc4ccc(cn4)C#N)n3)cc2	1838651-58-3	38936	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469042	425.40643	ACT-709478	ACT-709478 | ACT-709478	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:18497	CACNA1I	
SJ001035313-1	SJ001035313	1	MOABOX:18507	FAOMZVDZARKPFJ-UHFFFAOYSA-N	O=C(NCCCCCCCCNC(=O)C(Cl)Cl)C(Cl)Cl	1477-57-2		ALDH1A2																																																															CHEMBL3276621											15134					member	10.1016/j.cbi.2019.04.004	10.1021/acschembio.7b00685																																																																																																																																																														30221940																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.91528																																0.23941																																8																																HY-W011094	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Endocrinology|MOABOX:18507|ALDH1A2|	ClC(Cl)C(=O)NCCCCCCCCNC(=O)C(Cl)Cl	1477-57-2	68464	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469551	366.1114	WIN 18446	WIN 18446 | WIN 18446	Pathway: Metabolic Enzyme/Protease	Research Area: Endocrinology	MOABOX:18507	ALDH1A2	
SJ001010589-2	SJ001010589	2	MOABOX:18508	MPZXLTZVPUSTFY-UHFFFAOYSA-N	CCCCOc1ccc(CCC=C2SC(=O)N(CCN)C2=O)cc1	1309444-75-4		SPHK2																																																																										78142827	78142828				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-15779A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Immunology/Inflammation | Research Area: Cancer|MOABOX:18508|SPHK2|	CCCCOc1ccc(CC\C=C\2/SC(=O)N(CCN)C2=O)cc1	1449240-68-9	36708	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469033	348.45976	K145 (HYDROCHLORIDE)	K145 (HYDROCHLORIDE) | K145 (HYDROCHLORIDE)	Pathway: Apoptosis; Immunology/Inflammation	Research Area: Cancer	MOABOX:18508	SPHK2	
SJ001035221-1	SJ001035221	1	MOABOX:18509	FLSMVCMSUNISFK-UHFFFAOYSA-N	COc1nccnc1NS(=O)(=O)c1cccc(Cl)c1Cl			CCR4																																																																										10308720					virtual	10.1021/acsmedchemlett.7b00315																																																																																																																																																															28947948																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																8																																HY-U00064	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation | Research Area: Inflammation/Immunology; Endocrinology|MOABOX:18509|CCR4|	COc1nccnc1NS(=O)(=O)c2cccc(Cl)c2Cl	566203-88-1	27550	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469171	334.17846	AZD2098	AZD2098 | AZD2098	Pathway: GPCR/G Protein; Immunology/Inflammation	Research Area: Inflammation/Immunology; Endocrinology	MOABOX:18509	CCR4	
SJ000287867-8	SJ000287867	8	MOABOX:18510	PQCXVIPXISBFPN-UHFFFAOYSA-N	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1	264218-23-7		GSK3A	GSK3B																															2932																															CHEMBL322970											4210951					virtual	10.1002/med.20142	10.1016/S0960-894X(00)00721-6	10.1016/S1074-5521(00)00025-9	10.1016/j.bmc.2006.09.021	10.1016/j.ejmech.2008.08.012	10.1021/acsmedchemlett.8b00507	10.1021/jm021095d	10.1021/jm050504d	10.1021/np100633k	10.2174/1389557043403459																																																																																																																																																						11033082	11266159	11966463	12111750	12852764	15032729	15078145	15173837	15544551	15559249	16335919	16892358	17010615	18324764	18855890	18929433	20138512	20138514	20858169	21126094	22168279	23016545	23931441	26600430	29561817	30996781																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												1.53816	2.58256																															0.19227	0.32282																															8	8																															HY-15438	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; PI3K/Akt/mTOR; Stem Cell/Wnt | Research Area: Metabolic Disease|MOABOX:18510|GSK3A|	Oc1ccc(NC2=C(C(=O)NC2=O)c3ccccc3[N+](=O)[O-])cc1Cl	264218-23-7	7108	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469132	359.7207	SB 415286	SB 415286 | SB415286 | SB 415286 | SB415286	Pathway: Apoptosis; PI3K/Akt/mTOR; Stem Cell/Wnt	Research Area: Metabolic Disease	MOABOX:18510	GSK3A	
SJ001035196-1	SJ001035196	1	MOABOX:18526	BXDZOYLPNAIDOC-UHFFFAOYSA-N	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCN(CC(=O)NCCOCCOCCOCCNc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)s2)o1			CDK9																																																																										131801483					member	10.1038/nchembio.2538																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-123937	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; PROTAC | Research Area: Cancer|MOABOX:18526|CDK9|	CC(C)(C)c1oc(CSc2cnc(NC(=O)C3CCN(CC(=O)NCCOCCOCCOCCNc4cccc5C(=O)N(C6CCC(=O)NC6=O)C(=O)c45)CC3)s2)nc1	2139287-33-3	45875	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469050	869.01848	THAL-SNS-032	THAL-SNS-032 | THAL-SNS-032	Pathway: Cell Cycle/DNA Damage; PROTAC	Research Area: Cancer	MOABOX:18526	CDK9	
SJ001034913-1	SJ001034913	1	MOABOX:18528	XEVJUIZOZCFECP-UHFFFAOYSA-N	CCN1CCN(c2ccc(C(C)(C)NC(=O)c3cc4[nH]c5ccccc5c(=O)c4cc3F)cn2)CC1	566161-24-8		IMPDH2																																																															CHEMBL229008											9913339					member																																																																																																																																																																17585753	21507206																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.91672																																0.36459																																8																																5492	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-101-320|MOABOX:18528|IMPDH2|	CCN1CCN(CC1)c2ccc(cn2)C(C)(C)NC(=O)c3cc4Nc5ccccc5C(=O)c4cc3F	566161-24-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468223	487.5685	BMS 566419	BMS 566419 | BMS 566419			MOABOX:18528	IMPDH2	
SJ001008023-2	SJ001008023	2	MOABOX:18534	ZRPZPNYZFSJUPA-UHFFFAOYSA-N	C=CC(=O)N1CCN(c2ncnc3c(F)c(-c4c(O)cccc4F)c(Cl)cc23)CC1			KRAS																																																																										137003167	137247534	137699228	145168740	145329408	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.4266																																0.2038																																7																																HY-U00416	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cancer|MOABOX:18534|KRAS|	Oc1cccc(F)c1c2c(Cl)cc3c(ncnc3c2F)N4CCN(CC4)C(=O)C=C	1698024-73-5	28599	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469211	430.83509	ARS-1620	ARS-1620 | ARS-1620	Pathway: GPCR/G Protein	Research Area: Cancer	MOABOX:18534	KRAS	
SJ001034989-1	SJ001034989	1	MOABOX:18536	FIQOSSLORKDEGE-UHFFFAOYSA-N	O=C(Nc1ccccc1N1CCCCC1)c1ccc(F)cc1			PTGER2																																																															CHEMBL1327732											890517					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																7428390	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-250-417|MOABOX:18536|PTGER2|	Fc1ccc(cc1)C(=O)Nc2ccccc2N3CCCCC3	530131-99-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468433	298.35466	7428390	7428390 | 7428390			MOABOX:18536	PTGER2	
SJ000986083-3	SJ000986083	3	MOABOX:18551	FYNMINFUAIDIFL-UHFFFAOYSA-N	Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cnc(OC2CCOCC2)c(N2CCOCC2)c1			BRAF	RAF1																															5894																															CHEMBL3962812											90408826					member	10.1158/0008-5472.CAN-17-2033																																																																																																																																																															28557458																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.95216	2.51952																															0.24402	0.31494																															8	8																															HY-100510	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: MAPK/ERK Pathway | Research Area: Cancer|MOABOX:18551|BRAF|	Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1c3cnc(OC4CCOCC4)c(c3)N5CCOCC5	1628838-42-5	22808	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469204	542.54947	RAF709	RAF709 | RAF709	Pathway: MAPK/ERK Pathway	Research Area: Cancer	MOABOX:18551	BRAF	
SJ001035187-1	SJ001035187	1	MOABOX:18552	PHGTYMRDHDEHLI-HIFRSBDPSA-N	O=C(N[C@H]1CCCC[C@H]1C(=O)O)c1cnn2c(O)cc(-c3ccccc3)nc12			CGAS																																																															CHEMBL4096573																member																																																																																																																																																																28934246																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.19641																																0.45663																																7																																HY-114182	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Inflammation/Immunology|MOABOX:18552|CGAS|	OC(=O)[C@@H]1CCCC[C@@H]1NC(=O)c2cnn3c(O)cc(nc23)c4ccccc4	2378173-15-8	89317	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469035	380.3972	PF-06928215	PF-06928215 | PF-06928215	Pathway: Immunology/Inflammation	Research Area: Inflammation/Immunology	MOABOX:18552	CGAS	
SJ000806132-6	SJ000806132	6	MOABOX:18553	GYHCTFXIZSNGJT-UHFFFAOYSA-N	Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc32)c(C)c1	150683-30-0	antagonist of AVPR2	AVPR2																																																															CHEMBL344159											216237	66733246	71471846	87483433	91290305	member	10.1021/jm000108p																																																																																																																																																															10482466	11087564																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.8116																																0.22645																																8																																HY-17000	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; GPCR/G Protein | Research Area: Cardiovascular Disease; Endocrinology; Cancer|MOABOX:18553|AVPR2|antagonist of AVPR2	Cc1ccccc1C(=O)Nc2ccc(C(=O)N3CCCC(O)c4cc(Cl)ccc34)c(C)c2	150683-30-0	5105	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469869	448.9413	TOLVAPTAN	"TOLVAPTAN | ""TOLVAPTAN | OPC-41061 |"" | TOLVAPTAN | ""TOLVAPTAN | OPC-41061 |"""	Pathway: Autophagy; GPCR/G Protein	Research Area: Cardiovascular Disease; Endocrinology; Cancer	MOABOX:18553	AVPR2	antagonist of AVPR2
SJ001034992-1	SJ001034992	1	MOABOX:18556	ALMRJTRVZAXYSA-UHFFFAOYSA-N	Cc1ccc(-c2ccnc(-c3ccnc4[nH]ccc34)n2)c(C)n1			BRAF																																																																										56885986					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																21358097	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-020-191-260|MOABOX:18556|BRAF|	Cc1ccc(c(C)n1)c2ccnc(n2)c3ccnc4[nH]ccc34	1360366-93-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468436	301.3452	21358097	21358097 | 21358097			MOABOX:18556	BRAF	
SJ001035298-1	SJ001035298	1	MOABOX:18557	HRJWSEPIRZRGCL-UHFFFAOYSA-N	O=C(O)c1ccc(OCCCc2ccc(OCCCCOC3CCCCC3)cc2)c(C(=O)NC2CCCC(C(=O)O)C2)c1	712313-35-4	GPR17 antagonist	GPR17	CYSLTR2																															57105																															CHEMBL3342944											10438479					member	10.1016/j.chembiol.2018.03.012	10.1021/acs.jmedchem.5b00741	10.1111/j.1476-5381.2010.00730.x																																																																																																																																																													25408836	26200813	26985325																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			0	3.59072																															0.0	0.44884																															7	8																															HY-112248	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Inflammation/Immunology; Neurological Disease; Cardiovascular Disease|MOABOX:18557|GPR17|GPR17 antagonist	OC(=O)C1CCCC(C1)NC(=O)c2cc(ccc2OCCCc3ccc(OCCCCOC4CCCCC4)cc3)C(=O)O	712313-35-4	91667	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469527	595.723	HAMI 3379	HAMI 3379 | HAMI 3379	Pathway: GPCR/G Protein	Research Area: Inflammation/Immunology; Neurological Disease; Cardiovascular Disease	MOABOX:18557	GPR17	GPR17 antagonist
SJ000982871-5	SJ000982871	5	MOABOX:18929	RSMYFSPOTCDHHJ-GOSISDBHSA-N	COc1nnc2ccc(N3CCC(c4ccc(OCCN5CCN(C)C(=O)[C@H]5C)cc4)CC3)nn12		inhibitor of BRD4	BRD4																																																															CHEMBL4078100											118693658	118693659				member																																																																																																																																																																27528113	28195723	29655612																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			4.34696																																0.54337																																8																																20864	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-561-768|MOABOX:18929|BRD4|inhibitor of BRD4	COc1nnc2ccc(nn12)N3CCC(CC3)c4ccc(OCCN5CCN(C)C(=O)[C@H]5C)cc4	1869912-39-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468459	479.57462	AZD5153	AZD5153 | AZD5153			MOABOX:18929	BRD4	inhibitor of BRD4
SJ001035104-1	SJ001035104	1	MOABOX:18944	OSVNGDATIGOCLA-UHFFFAOYSA-N	COc1ncccc1-c1cnc(OC)c(C(O)c2ccc3ccccc3c2)c1OC			ALOX5																																																																															virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.10359																																0.44337																																7																																26310	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-605-420|MOABOX:18944|ALOX5|	COc1ncccc1c2cnc(OC)c(C(O)c3ccc4ccccc4c3)c2OC	2247911-68-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468695	402.44248	LIPOXYGENIN	LIPOXYGENIN | LIPOXYGENIN			MOABOX:18944	ALOX5	
SJ000141526-4	SJ000141526	4	MOABOX:18953	SLUINPGXGFUMLL-UHFFFAOYSA-N	O=C(O)c1ccccc1C(=O)Nc1ccc(-c2ccccc2)cc1	4727-31-5	Chondrogenesis activator	FLNA																																																															CHEMBL3185782											2826191					member	10.1126/science.1215157																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-16268	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Stem Cell/Wnt; TGF-beta/Smad | Research Area: Inflammation/Immunology|MOABOX:18953|FLNA|Chondrogenesis activator	OC(=O)c1ccccc1C(=O)Nc2ccc(cc2)c3ccccc3	4727-31-5	13149	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469691	317.338	KARTOGENIN | AKT | AKT-093 | KGN | PRO1 |	"""KARTOGENIN | AKT | AKT-093 | KGN | PRO1 |"" | ""KARTOGENIN | AKT | AKT-093 | KGN | PRO1 |"""	Pathway: Stem Cell/Wnt; TGF-beta/Smad	Research Area: Inflammation/Immunology	MOABOX:18953	FLNA	Chondrogenesis activator
SJ001010703-2	SJ001010703	2	MOABOX:18994	ZTQLCNOQWGSELY-UHFFFAOYSA-N	Cn1c(=O)c2c(nc(S(C)(=O)=O)n2C)n(CC#Cc2cccc(O)c2)c1=O			MLKL																																																																										134691750					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																CS-0021627	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-509-648|MOABOX:18994|MLKL|	CN1C(=O)N(CC#Cc2cccc(O)c2)c3nc(n(C)c3C1=O)S(=O)(=O)C	2093393-05-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468406	388.39774	TC13172	TC13172 | TC13172			MOABOX:18994	MLKL	
SJ000855540-4	SJ000855540	4	MOABOX:18995	SDHTXBWLVGWJFT-UMXDBTPVSA-N	C=C1C(=O)[C@]23C(O)[C@H]1CC[C@H]2[C@@]12CO[C@]3(O)[C@@H](O)[C@@H]1C(C)(C)CC[C@@H]2O	28957-04-2		NLRP3																																																																										124220043					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.91445																																0.41635																																7																																HY-N0004	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; PI3K/Akt/mTOR | Research Area: Cancer; Infection; Inflammation/Immunology|MOABOX:18995|NLRP3|	CC1(C)CC[C@H](O)[C@]23CO[C@](O)([C@@H](O)[C@H]12)[C@@]45[C@H](O)[C@@H](CC[C@@H]34)C(=C)C5=O	28957-04-2	38669	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469613	364.43272	ORIDONIN	ORIDONIN | ORIDONIN	Pathway: Anti-infection; PI3K/Akt/mTOR	Research Area: Cancer; Infection; Inflammation/Immunology	MOABOX:18995	NLRP3	
SJ001035198-1	SJ001035198	1	MOABOX:19000	XZIZUQSOFMLIIR-CQSZACIVSA-N	c1ccc2c(c1)CCC[C@H]2Nc1nc2ccccc2[nH]1	875755-24-1		KCNN2																																																															CHEMBL510780											11587013	51371165	71311765			member	10.1016/j.hrthm.2014.12.028.																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-110105	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Neurological Disease|MOABOX:19000|KCNN2|	C1C[C@@H](Nc2nc3ccccc3[nH]2)c4ccccc4C1	875755-24-1	65847	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469052	263.33698	NS8593 HYDROCHLORIDE	NS8593 HYDROCHLORIDE | NS8593 HYDROCHLORIDE	Pathway: Membrane Transporter/Ion Channel	Research Area: Neurological Disease	MOABOX:19000	KCNN2	
SJ000982675-4	SJ000982675	4	MOABOX:19010	XSMABFRQESMONQ-SFHVURJKSA-N	CN(c1ccccc1)c1ccc2c(c1)CCC[C@H]2CNc1cnccc1C(=O)O			KDM4A	KDM4B	KDM4C	KDM4D																													23030	23081	55693																																								118598059					member																																																																																																																																																																28835804																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.11864	-2.936e-002	3.2108	-0.11864																													-0.01483	-0.00367	0.40135	-0.01483																													8	8	8	8																													CS-7916	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-417-862|MOABOX:19010|KDM4A|	CN(c1ccccc1)c2ccc3[C@H](CNc4cnccc4C(=O)O)CCCc3c2	1851373-36-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468680	387.4742	QC6352	QC6352 | QC6352			MOABOX:19010	KDM4A	
SJ000870496-2	SJ000870496	2	MOABOX:19012	PHHZKBMVRPULAW-UHFFFAOYSA-N	Cc1cc(-c2ccccc2)cc(C(=O)NNS(=O)(=O)c2ccccc2)c1F			KAT6A																																																																										133053564					member																																																																																																																																																																31256587																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.2692																																0.40865																																8																																27402	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-417-802|MOABOX:19012|KAT6A|	Cc1cc(cc(C(=O)NNS(=O)(=O)c2ccccc2)c1F)c3ccccc3	2055397-18-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468646	384.42398	CPI8	CPI8 | CPI8			MOABOX:19012	KAT6A	
SJ001005263-2	SJ001005263	2	MOABOX:19013	NZYTZRHHBAJPKN-UHFFFAOYSA-N	COc1cc(OC)cc(-c2noc(N3CCN(C)C4(CCN(c5ccnc(C)c5)CC4)C3)n2)c1		PRDM9 inhibitor	PRDM9																																																																										137331596					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																CS-0079607	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-866-859|MOABOX:19013|PRDM9|PRDM9 inhibitor	COc1cc(OC)cc(c1)c2noc(n2)N3CCN(C)C4(CCN(CC4)c5ccnc(C)c5)C3	2387510-80-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468708	464.55998	MRK-740	MRK-740 | MRK-740			MOABOX:19013	PRDM9	PRDM9 inhibitor
SJ001033189-2	SJ001033189	2	MOABOX:19015	UMOGNCVNHXWFIX-VIFPVBQESA-N	C[C@H](O)CNC(=O)c1ncc(S(=O)(=O)c2ccc(OC(F)(F)F)cc2)cc1N			CFTR																																																																										124106089					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.45467																																0.48489																																3																																HY-119936	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Membrane Transporter/Ion Channel | Research Area: Inflammation/Immunology|MOABOX:19015|CFTR|	C[C@H](O)CNC(=O)c1ncc(cc1N)S(=O)(=O)c2ccc(OC(F)(F)F)cc2	2055015-61-5	46223	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469552	419.37555	GLPG2451	GLPG2451 | GLPG2451	Pathway: Autophagy; Membrane Transporter/Ion Channel	Research Area: Inflammation/Immunology	MOABOX:19015	CFTR	
SJ001035181-1	SJ001035181	1	MOABOX:19019	DZGZFXRKNSZUSK-MKGJDZFWSA-N	CO[C@H]1CN(C)C(=O)c2cc(NC(=O)NC(C)C)ccc2OC[C@H](C)N(Cc2ccc(-c3ccccn3)cc2)C[C@@H]1C		BAF but not PBAF inhibitor is of high interest!	ARID1A																																																															CHEMBL2130605											54633693					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-114268	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Infection|MOABOX:19019|ARID1A|BAF but not PBAF inhibitor is of high interest!	CO[C@H]1CN(C)C(=O)c2cc(NC(=O)NC(C)C)ccc2OC[C@H](C)N(Cc3ccc(cc3)c4ccccn4)C[C@@H]1C	1357647-78-9	62290	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469013	573.72562	BRD-K98645985	BRD-K98645985 | BRD-K98645985	Pathway: Anti-infection	Research Area: Infection	MOABOX:19019	ARID1A	BAF but not PBAF inhibitor is of high interest!
SJ001035117-1	SJ001035117	1	MOABOX:19022	MEWRLQUBVOVSGN-UHFFFAOYSA-N	COc1ccc(-c2nn3c(-c4ccccn4)nnc3s2)cc1OC		dCTP Pyrophosphatase 1 (DCTPP1) Inhibitors	DCTPP1																																																															CHEMBL1519124											662931					member	10.1021/acs.jmedchem.6b01786																																																																																																																																																															28145708																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.49232																																0.43654																																8																																AO-365/43401691	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-858-634|MOABOX:19022|DCTPP1|dCTP Pyrophosphatase 1 (DCTPP1) Inhibitors	COc1ccc(cc1OC)c2nn3c(nnc3s2)c4ccccn4	578755-52-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468724	339.37172	AO-365/43401691	AO-365/43401691 | AO-365/43401691			MOABOX:19022	DCTPP1	dCTP Pyrophosphatase 1 (DCTPP1) Inhibitors
SJ001035072-1	SJ001035072	1	MOABOX:19025	ZDBWLRLGUBSLPG-FDHYQTMZSA-N	COc1ccc(CC[C@@H](OC(=O)[C@@H]2CCCCN2C(=O)[C@H](c2cc(OC)c(OC)c(OC)c2)C2CCCCC2)c2cccc(OCCN3CCOCC3)c2)cc1OC		FKBP5 antagonist	FKBP5																																																															CHEMBL3623630											86277887					member	10.1021/acs.jmedchem.5b00785	10.1021/acs.jmedchem.5b01355																																																																																																																																																														26419422	26954324																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				4.32584																																0.54073																																8																																CS-0022959	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-417-803|MOABOX:19025|FKBP5|FKBP5 antagonist	COc1ccc(CC[C@@H](OC(=O)[C@@H]2CCCCN2C(=O)[C@@H](C3CCCCC3)c4cc(OC)c(OC)c(OC)c4)c5cccc(OCCN6CCOCC6)c5)cc1OC	1643125-33-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468594	802.99188	SAFIT2	SAFIT2 | SAFIT2			MOABOX:19025	FKBP5	FKBP5 antagonist
SJ001035023-1	SJ001035023	1	MOABOX:19035	WVIPVRJNDZWQGP-UHFFFAOYSA-N	Cc1cc2[nH]c(=O)cc(C)c2cc1NC(=O)c1cc(S(=O)(=O)N(C)C)ccc1N1CCOCC1		bET inhibitor BD1 selective	BRD4																																																																										118695109					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					4.24552																																0.53069																																8																																Z2519038778	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-690-486|MOABOX:19035|BRD4|bET inhibitor BD1 selective	CN(C)S(=O)(=O)c1ccc(N2CCOCC2)c(c1)C(=O)Nc3cc4c(C)cc(O)nc4cc3C	1870849-34-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468502	484.56792	Z2519038778	Z2519038778 | Z2519038778			MOABOX:19035	BRD4	bET inhibitor BD1 selective
SJ001035011-1	SJ001035011	1	MOABOX:19036	QGNDVASWIHEXCL-AWEZNQCLSA-N	C[C@H]1CCCN1Cc1nc2cc(NC(=O)c3ccc4c(cnn4C)c3)ccc2[nH]1			MLLT1	MLLT3																															4300																																										134820948					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															28113	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-788-365|MOABOX:19036|MLLT1|	C[C@H]1CCCN1Cc2nc3cc(NC(=O)c4ccc5c(cnn5C)c4)ccc3[nH]2	2255338-25-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468465	388.46556	SGC-IMLLT	SGC-IMLLT | SGC-IMLLT			MOABOX:19036	MLLT1	
SJ001005262-2	SJ001005262	2	MOABOX:19037	WOAOENGFAAUUGT-UHFFFAOYSA-N	Cc1cc(CN)cc(C)c1-c1ncn(C)c1-c1ccnc2cc(F)ccc12		NSD3 inhibitor	NSD3																																																																										138115329					member	10.1038/s41589-019-0310-x																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																CS-0113692	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-792-731|MOABOX:19037|NSD3|NSD3 inhibitor	Cc1cc(CN)cc(C)c1c2ncn(C)c2c3ccnc4cc(F)ccc34	2387510-87-2	NA	GENERAL	CHLORIDE	3	NO_SOLVATE	0	1468413	360.42734	BI-9321	BI-9321 | BI-9321			MOABOX:19037	NSD3	NSD3 inhibitor
SJ001034871-1	SJ001034871	1	MOABOX:19039	QLXULUNLCRKWRD-UHFFFAOYSA-N	O=C(NNS(=O)(=O)c1ccccc1F)c1cc(F)cc(-c2ccccn2)c1			KAT6A	KAT6B																															23522																																										133080719					member	10.1038/s41586-018-0387-5																																																																																																																																																															31256587																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					4.078	0																															0.50975	0.0																															8	7																															T4679	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-203-045|MOABOX:19039|KAT6A|	Fc1cc(cc(c1)c2ccccn2)C(=O)NNS(=O)(=O)c3ccccc3F	2055397-28-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468151	389.37593	WM1119	WM1119 | WM1119			MOABOX:19039	KAT6A	
SJ000984305-5	SJ000984305	5	MOABOX:19040	OEDSFMUSNZDJFD-UHFFFAOYSA-N	CCNC(=O)c1cc2c(-c3cc(C(C)(C)O)ccc3Oc3c(C)cc(F)cc3C)cn(C)c(=O)c2[nH]1		BET inhibitor BD2 selective	BRD2	BRD3	BRD4																														8019	23476																																									132010322					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0																														0.0	0.0	0.0																														7	7	7																														30470	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-417-981|MOABOX:19040|BRD2|BET inhibitor BD2 selective	CCNC(=O)c1cc2C(=CN(C)C(=O)c2[nH]1)c3cc(ccc3Oc4c(C)cc(F)cc4C)C(C)(C)O	2138861-99-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468693	491.5539	ABBV-744	ABBV-744 | ABBV-744			MOABOX:19040	BRD2	BET inhibitor BD2 selective
SJ001034825-1	SJ001034825	1	MOABOX:19042	OSFZBGUNRGOXKG-UHFFFAOYSA-N	Cc1cc(=O)[nH]c2ccc(NC(=O)c3cccnc3N3CCOCC3)cc12		BET inhibitor BD1 selective	BRD4																																																																										118694876					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.02464																																0.37808																																8																																EN300-310883	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-616-233|MOABOX:19042|BRD4|BET inhibitor BD1 selective	CC1=CC(=O)Nc2ccc(NC(=O)c3cccnc3N4CCOCC4)cc12	1870849-58-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468066	364.3978	EN300-310883	EN300-310883 | EN300-310883			MOABOX:19042	BRD4	BET inhibitor BD1 selective
SJ001035334-1	SJ001035334	1	MOABOX:19053	XWAONOGAGZNUSF-UHFFFAOYSA-N	Fc1ccc(-n2cc(CCCCN3CCC4(CC3)OCc3ccccc34)c3ccccc32)cc1	147817-50-3		TMEM97																																																															CHEMBL61479											9829525	9829526	9891778	22596105	22596106	member	10.1021/acschemneuro.7b00200																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-14221A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; GPCR/G Protein; Neuronal Signaling | Research Area: Cancer|MOABOX:19053|TMEM97|	Fc1ccc(cc1)n2cc(CCCCN3CCC4(CC3)OCc5ccccc45)c6ccccc26	224177-60-0	11196	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469612	454.57834	SIRAMESINE HYDROCHLORIDE | LU 28-179 HYDROCHLORIDE	"""SIRAMESINE HYDROCHLORIDE | LU 28-179 HYDROCHLORIDE"" | ""SIRAMESINE HYDROCHLORIDE | LU 28-179 HYDROCHLORIDE"""	Pathway: Apoptosis; GPCR/G Protein; Neuronal Signaling	Research Area: Cancer	MOABOX:19053	TMEM97	
SJ001035213-1	SJ001035213	1	MOABOX:19054	YDTCRGKEOJGNHD-SFHVURJKSA-N	COc1cc(OC)c(-c2cn3ccc(N4CC[C@H](NCc5ccncc5)C4)cc3n2)cc1Cl			SUV39H2																																																																										135281262	140914439				member	10.18632/oncotarget.25806																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.34352																																0.41794																																8																																HY-122181B	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:19054|SUV39H2|	COc1cc(OC)c(cc1Cl)c2cn3ccc(cc3n2)N4CC[C@@H](C4)NCc5ccncc5	NA	65479	GENERAL	CHLORIDE	1.6	NO_SOLVATE	0	1469152	463.95924	OTS186935 HYDROCHLORIDE	OTS186935 HYDROCHLORIDE | OTS186935 HYDROCHLORIDE	Pathway: Epigenetics	Research Area: Cancer	MOABOX:19054	SUV39H2	
SJ000285640-14	SJ000285640	14	MOABOX:19054	YDTCRGKEOJGNHD-SFHVURJKSA-N	COc1cc(OC)c(-c2cn3ccc(N4CC[C@H](NCc5ccncc5)C4)cc3n2)cc1Cl			SUV39H2																																																																										135281262	140914439				member	10.18632/oncotarget.25806																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.34352																																0.41794																																8																																HY-B0105	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; GPCR/G Protein; Metabolic Enzyme/Protease | Research Area: Infection; Cancer|MOABOX:19054|SUV39H2|	CC(=O)N1CCN(CC1)c2ccc(OC[C@@H]3CO[C@](Cn4ccnc4)(O3)c5ccc(Cl)cc5Cl)cc2	65277-42-1	14239	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469149	531.43092	KETOCONAZOLE	"KETOCONAZOLE | ""KETOCONAZOLE | CORT-001 | R-41400 |"" | KETOCONAZOLE | ""KETOCONAZOLE | CORT-001 | R-41400 |"""	Pathway: Anti-infection; GPCR/G Protein; Metabolic Enzyme/Protease	Research Area: Infection; Cancer	MOABOX:19054	SUV39H2	
SJ001010609-2	SJ001010609	2	MOABOX:19056	FWRFPHJSGLYXTD-UHFFFAOYSA-N	N#Cc1ccc(-c2cnc3ccc(-c4ccc(C(=O)N5CCOCC5)cc4)cn23)cc1	1464151-33-4		MKNK2	MKNK1																															8569																																										71766360					member																																																																																																																																																																29683667	30824167																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.338	1.37176																															0.16725	0.17147																															8	8																															HY-112424	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: MAPK/ERK Pathway | Research Area: Cancer|MOABOX:19056|MKNK2|	O=C(N1CCOCC1)c2ccc(cc2)c3ccc4ncc(c5ccc(cc5)C#N)n4c3	1464151-33-4	31500	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469356	408.4519	ETC-206	ETC-206 | ETC-206	Pathway: MAPK/ERK Pathway	Research Area: Cancer	MOABOX:19056	MKNK2	
SJ001033110-2	SJ001033110	2	MOABOX:19063	HEAUOKZIVMZVQL-VWLOTQADSA-N	COc1cccc(-c2c(C)n(Cc3c(F)cccc3C(F)(F)F)c(=O)n(C[C@H](NCCCC(=O)O)c3ccccc3)c2=O)c1F	832720-36-2	Antagonist of GNRHR	GNRHR																																																															CHEMBL1208155											11250647	78318346				member	10.1016/j.ejmech.2017.12.095	10.1021/jm8006454																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.21965																																0.45995																																7																																HY-14369	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Endocrinology; Cancer|MOABOX:19063|GNRHR|Antagonist of GNRHR	COc1cccc(C2=C(C)N(Cc3c(F)cccc3C(F)(F)F)C(=O)N(C[C@H](NCCCC(=O)O)c4ccccc4)C2=O)c1F	832720-36-2	28896	GENERAL	SODIUM(I)	1	NO_SOLVATE	0	1469483	631.58972	ELAGOLIX SODIUM | NBI-56418 SODIUM	"""ELAGOLIX SODIUM | NBI-56418 SODIUM"" | ""ELAGOLIX SODIUM | NBI-56418 SODIUM"""	Pathway: GPCR/G Protein	Research Area: Endocrinology; Cancer	MOABOX:19063	GNRHR	Antagonist of GNRHR
SJ000786032-4	SJ000786032	4	MOABOX:19071	UXGJAOIJSROTTN-UHFFFAOYSA-N	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1	516480-79-8		CHEK2																																																															CHEMBL179583											9969021	91886188				member	10.1016/j.bmcl.2005.12.096	10.1016/j.bmcl.2007.09.098	10.1021/jm0495935	10.1124/mol.107.035832	10.2174/092986707780362844	10.2174/092986709788803015																																																																																																																																																										15771432	16442290	17456020	17937984	18077363	19689287	21861812	23058106	23190032	24144850																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												2.18492																																0.54623																																4																																HY-13946	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:19071|CHEK2|	NC(=O)c1ccc2[nH]c(nc2c1)c3ccc(Oc4ccc(Cl)cc4)cc3	516480-79-8	41783	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468789	363.79706	BML-277 | CHK2 INHIBITOR II |	"""BML-277 | CHK2 INHIBITOR II |"" | ""BML-277 | CHK2 INHIBITOR II |"""	Pathway: Apoptosis; Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:19071	CHEK2	
SJ001033145-2	SJ001033145	2	MOABOX:19074	NSTRIRCPWQHTIA-DTRKZRJBSA-N	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O	37025-55-1		OXTR																																																															CHEMBL3301668											16681432	88753096	129319308			member	10.1016/j.neuropharm.2018.10.036	10.1021/acs.jmedchem.8b01691	10.1021/jm500365s																																																																																																																																																													24874785	30896946																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.1528																																0.3941																																8																																HY-17573	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Endocrinology; Neurological Disease|MOABOX:19074|OXTR|	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@H](NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N	37025-55-1	23196	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468860	988.16086	CARBETOCIN	CARBETOCIN | CARBETOCIN	Pathway: GPCR/G Protein	Research Area: Endocrinology; Neurological Disease	MOABOX:19074	OXTR	
SJ000285293-11	SJ000285293	11	MOABOX:19079	NZCRJKRKKOLAOJ-XRCRFVBUSA-N	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C	80621-81-4	"Inhibitor of transcription by by binding to the Î²-subunit of bacterial RNA polymerase, also activator of NR1I2"	NR1I2	rpoB																															948488																															CHEMBL1617											6436173	16734760	25227470	46783403	60143067	member	10.1124/jpet.107.121913	10.1124/jpet.110.170225																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			2.892	0																															0.3615	0.0																															8	7																															HY-13234	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Infection|MOABOX:19079|NR1I2|Inhibitor of transcription by by binding to the ??-subunit of bacterial RNA polymerase, also activator of NR1I2"	CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)\C(=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@@H]1C)\C)c5c(nc6cc(C)ccn56)c4c3C2=O	80621-81-4	23273	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469806	785.87854	RIFAXIMIN	"RIFAXIMIN | ""RIFAXIMIN | L-105 | ALPHA-0817185 |"" | RIFAXIMIN | ""RIFAXIMIN | L-105 | ALPHA-0817185 |"""	Pathway: Anti-infection	Research Area: Infection	MOABOX:19079	NR1I2	"Inhibitor of transcription by by binding to the ??-subunit of bacterial RNA polymerase, also activator of NR1I2"
SJ000985988-3	SJ000985988	3	MOABOX:19080	WIJZXSAJMHAVGX-DHLKQENFSA-N	N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1	1448347-49-6	Inhibitor of mutant IDH1	IDH1																																																															CHEMBL3989958											71657455	142599692				member	10.1021/acsmedchemlett.7b00421																																																																																																																																																															29079473	29670690																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.49128																																0.31141																																8																																HY-18767	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer; Metabolic Disease|MOABOX:19080|IDH1|Inhibitor of mutant IDH1	Fc1cncc(c1)N([C@H](C(=O)NC2CC(F)(F)C2)c3ccccc3Cl)C(=O)[C@@H]4CCC(=O)N4c5cc(ccn5)C#N	1448347-49-6	20567	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468799	582.96089	IVOSIDENIB | AG-120 | RG-120	"""IVOSIDENIB | AG-120 | RG-120"" | ""IVOSIDENIB | AG-120 | RG-120"""	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer; Metabolic Disease	MOABOX:19080	IDH1	Inhibitor of mutant IDH1
SJ001035380-1	SJ001035380	1	MOABOX:19082	LWXLECMNBTVASW-UHFFFAOYSA-N	CC(=O)N1CCc2c(c(N3CCCc4cc(-c5cnn(C)c5)c(C(F)F)cc43)nn2C2CCOCC2)C1			CREBBP	EP300																															2033																															CHEMBL4076748											121373418	145091866				member	10.1158/0008-5472.CAN-17-0314																																																																																																																																																															28892380																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.59968	1.77504																															0.19996	0.22188																															8	8																															HY-108435	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:19082|CREBBP|	CC(=O)N1CCc2c(C1)c(nn2C3CCOCC3)N4CCCc5cc(c(cc45)C(F)F)c6cnn(C)c6	1936421-41-8	43431	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469852	510.57879	GNE-049	GNE-049 | GNE-049	Pathway: Epigenetics	Research Area: Cancer	MOABOX:19082	CREBBP	
SJ001035040-1	SJ001035040	1	MOABOX:19083	NFEQFEDSWINARK-KBPBESRZSA-N	CC(C)CN[C@H]1CS(=O)(=O)C[C@@H]1S(=O)(=O)c1ccc(Cl)cc1			PGK1																																																																										20898025					member	10.1038/s41586-018-0622-0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																7020532092	OTAVA	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-007-709-024|MOABOX:19083|PGK1|	CC(C)CN[C@H]1CS(=O)(=O)C[C@@H]1S(=O)(=O)c2ccc(Cl)cc2	1177921-72-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468537	365.8959	7020532092	7020532092 | 7020532092			MOABOX:19083	PGK1	
SJ001034938-1	SJ001034938	1	MOABOX:19084	GRRDUDJQILRRES-OAHLLOKOSA-N	NCc1ccc(Oc2ccc(S(=O)(=O)C[C@H]3CS3)cc2)cc1			MMP9																																																																										118335773					virtual																																																																																																																																																																30212201																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.87912																																0.35989																																8																																AA01EPHF	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-561-558|MOABOX:19084|MMP9|	NCc1ccc(Oc2ccc(cc2)S(=O)(=O)CC3CS3)cc1	1807453-83-3	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468313	335.44108	AA01EPHF	AA01EPHF | AA01EPHF			MOABOX:19084	MMP9	
SJ001010681-3	SJ001010681	3	MOABOX:19096	IDXKJSSOUXWLDB-UHFFFAOYSA-N	CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(C(C)(C)C(F)(F)F)on2)c(F)c1			RET																																																															CHEMBL3355009											78427026					member	10.1021/acsmedchemlett.8b00035	10.1124/jpet.118.252973																																																																																																																																																														25589919	30034590																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				2.76656																																0.34582																																8																																T5491	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-416-747|MOABOX:19096|RET|	CCOC1=CC(=O)NC=C1c2ccc(CC(=O)Nc3cc(on3)C(C)(C)C(F)(F)F)c(F)c2	1627856-64-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468589	467.41345	GSK3179106	GSK3179106 | GSK3179106			MOABOX:19096	RET	
SJ000572403-3	SJ000572403	3	MOABOX:19101	JKJLETUKWLALKV-UHFFFAOYSA-N	CCn1c(C)c(C)n2c3c(=O)n(C)c(=O)n(C)c3nc12	19970-45-7	"""Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B; p27Kip1) Inhibitors"""	CDKN1B																																																																										3162678					member	10.1038/srep15686																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																HY-114712	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:19101|CDKN1B|\Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B; p27Kip1) Inhibitors\	CCn1c(C)c(C)n2c3C(=O)N(C)C(=O)N(C)c3nc12	19970-45-7	41910	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469507	275.30638	"8-ETHYL-1,3,6,7-TETRAMETHYL-1H-IMIDAZO[2,1-F]PURINE-2,4(3H,8H)-DIONE | STK854403"	"""8-ETHYL-1,3,6,7-TETRAMETHYL-1H-IMIDAZO[2,1-F]PURINE-2,4(3H,8H)-DIONE | STK854403"" | ""8-ETHYL-1,3,6,7-TETRAMETHYL-1H-IMIDAZO[2,1-F]PURINE-2,4(3H,8H)-DIONE | STK854403"""	Pathway: Others	Research Area: Cancer	MOABOX:19101	CDKN1B	\Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B; p27Kip1) Inhibitors\
SJ001035382-1	SJ001035382	1	MOABOX:19104	XNARHFDDQALZPZ-UHFFFAOYSA-N	CC(C)(C)c1cc(C(c2cc3c(cc2O)OCO3)N2CCOCC2)cc(C(C)(C)C)c1O		TET1 inhibitor	TET1																																																																										339892					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-120395	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; JAK/STAT Signaling; Stem Cell/Wnt | Research Area: Cancer; Inflammation/Immunology|MOABOX:19104|TET1|TET1 inhibitor	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)C(N2CCOCC2)c3cc4OCOc4cc3O	299420-83-0	64892	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469854	441.5598	UC-514321	UC-514321 | UC-514321	Pathway: Apoptosis; JAK/STAT Signaling; Stem Cell/Wnt	Research Area: Cancer; Inflammation/Immunology	MOABOX:19104	TET1	TET1 inhibitor
SJ001033396-2	SJ001033396	2	MOABOX:19106	HDHDTKMUACZDAA-PHNIDTBTSA-N	CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](C)NC1=O	920014-72-8		MC4R																																																															CHEMBL3301624											11993702	138911306				member	10.1021/acs.jmedchem.7b00353																																																																																																																																																															28972753	29605997																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.11736																																0.38967																																8																																HY-19870	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Metabolic Disease; Endocrinology|MOABOX:19106|MC4R|	C[C@H]1NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc4ccccc4)NC(=O)[C@H](Cc5cnc[nH]5)NC1=O)C(=O)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C	920014-72-8	24256	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469536	1117.30942	SETMELANOTIDE; RM-493; BIM-22493; IRC-022493	SETMELANOTIDE; RM-493; BIM-22493; IRC-022493 | SETMELANOTIDE; RM-493; BIM-22493; IRC-022493	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Metabolic Disease; Endocrinology	MOABOX:19106	MC4R	
SJ001033205-3	SJ001033205	3	MOABOX:19107	YIDDLAAKOYYGJG-UHFFFAOYSA-N	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1	1448428-04-3	MAP3K5 inhibitor	MAP3K5																																																															CHEMBL3916717											71245288	71654746	121439179	121439232	121439233	member																																																																																																																																																																28291695	28337323	29277458																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			3.81288																																0.47661																																8																																HY-18938	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; MAPK/ERK Pathway | Research Area: Cancer|MOABOX:19107|MAP3K5|MAP3K5 inhibitor	CC(C)n1cnnc1c2cccc(NC(=O)c3cc(c(C)cc3F)n4cnc(c4)C5CC5)n2	1448428-04-3	37527	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469017	445.49206	SELONSERTIB; GS-4997	SELONSERTIB; GS-4997 | SELONSERTIB; GS-4997	Pathway: Apoptosis; MAPK/ERK Pathway	Research Area: Cancer	MOABOX:19107	MAP3K5	MAP3K5 inhibitor
SJ001035016-1	SJ001035016	1	MOABOX:19120	DHSASSJDMAHICE-UHFFFAOYSA-N	O=c1occ2c3cc(O)ccc3oc3ccc(O)c1c32		TLR2/4 pathway antagonist	TLR2	TLR4																															7099																																															member	10.1016/j.ejphar.2018.08.040																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0	0																															0.0	0.0																															7	7																															CS-0064377	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-482-490|MOABOX:19120|TLR2|TLR2/4 pathway antagonist	Oc1ccc2Oc3ccc(O)c4C(=O)OC=C(c2c1)c34	1259330-61-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468482	268.22102	SPARSTOLONIN B	SPARSTOLONIN B | SPARSTOLONIN B			MOABOX:19120	TLR2	TLR2/4 pathway antagonist
SJ001035169-1	SJ001035169	1	MOABOX:19121	UBQFTTUFRSSOHE-UHFFFAOYSA-N	CCCCCCOC(=O)c1cc(O)c(=O)c2c(O)c(O)c(OC)cc2c1	1416324-85-0	TLR1/2 complex inhibitor	TLR1	TLR2																															7097																															CHEMBL3935646											71503400	137347162				member	10.1002/anie.201204910																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.16669	1.16669																															0.16667	0.16667																															7	7																															HY-108471	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Cancer|MOABOX:19121|TLR1|TLR1/2 complex inhibitor	CCCCCCOC(=O)C1=Cc2cc(OC)c(O)c(O)c2C(=O)C(=C1)O	1416324-85-0	29575	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468978	362.37378	CU-CPT22	CU-CPT22 | CU-CPT22	Pathway: Immunology/Inflammation	Research Area: Cancer	MOABOX:19121	TLR1	TLR1/2 complex inhibitor
SJ000880532-5	SJ000880532	5	MOABOX:19122	IIXWYSCJSQVBQM-LLVKDONJSA-N	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21	1454846-35-5	inhibitor of ALK	ALK	ROS1																															6098																															CHEMBL3286830											71731823	124203822				member	10.1016/S1470-2045(17)30680-0	10.1016/S1470-2045(18)30649-1																																																																																																																																																														24819116	26568289																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				1.09888	2.77536																															0.13736	0.34692																															8	8																															HY-12215	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:19122|ALK|inhibitor of ALK	C[C@H]1Oc2cc(cnc2N)c3c(CN(C)C(=O)c4ccc(F)cc14)nn(C)c3C#N	1454846-35-5	27585	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469867	406.41296	LORLATINIB	LORLATINIB | LORLATINIB	Pathway: Apoptosis; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:19122	ALK	inhibitor of ALK
SJ000870799-12	SJ000870799	12	MOABOX:19126	HWGQMRYQVZSGDQ-HZPDHXFCSA-N	Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1	1207456-01-6	Inhibitor of PARP1 and PARP2	PARP1	PARP2																															10038																															CHEMBL3137318	CHEMBL3137320										135565082	135565654	136666741	137184068		member	10.1056/NEJMoa1802905	10.1126/scitranslmed.aaf9246	10.1158/1078-0432.CCR-13-1391																																																																																																																																																													25614115	25761096	26422786	26652717	27353531	28692916	31042381																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															2.0864	0.15648																															0.2608	0.01956																															8	8																															HY-16106	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Epigenetics | Research Area: Cancer|MOABOX:19126|PARP1|Inhibitor of PARP1 and PARP2	Cn1ncnc1[C@@H]2[C@H](Nc3cc(F)cc4C(=O)NN=C2c34)c5ccc(F)cc5	1207456-01-6	8329	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469063	380.35087	TALAZOPARIB	TALAZOPARIB | BMN673 | TALAZOPARIB | BMN673	Pathway: Cell Cycle/DNA Damage; Epigenetics	Research Area: Cancer	MOABOX:19126	PARP1	Inhibitor of PARP1 and PARP2
SJ000870057-10	SJ000870057	10	MOABOX:19127	NYNZQNWKBKUAII-KBXCAEBGSA-N	O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12)N1CC[C@H](O)C1	1223403-58-4	Inhibitor of TRK	NTRK1	NTRK2	NTRK3																														4915	4916																														CHEMBL3889654	CHEMBL3989939										46188928	67330085	121333493	121333501	121333504	member	10.1007/s11523-018-0590-1	10.1056/NEJMoa1714448																																																																																																																																																														27779399																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.2644	0.3624	0.86416																														0.15805	0.0453	0.10802																														8	8	8																														HY-12866	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Neuronal Signaling; Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:19127|NTRK1|Inhibitor of TRK	O[C@H]1CCN(C1)C(=O)Nc2cnn3ccc(nc23)N4CCC[C@@H]4c5cc(F)ccc5F	1223403-58-4	44020	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469214	428.43519	Larotrectinib	"Larotrectinib | ""LOXO-101 | ARRY-470"" | Larotrectinib | ""LOXO-101 | ARRY-470"""	Pathway: Apoptosis; Neuronal Signaling; Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:19127	NTRK1	Inhibitor of TRK
SJ001034839-1	SJ001034839	1	MOABOX:19128	PIAWQVCBQLTEIY-UHFFFAOYSA-N	CN1N=C(SCc2ccc(Cl)cc2Cl)Sc2c1cnn(C)c2=O	245728-44-3		GPR65																																																																										2801217					member	10.1016/j.ejphar.2012.03.007																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				0																																0.0																																7																																14900668	OTAVA	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-892-881|MOABOX:19128|GPR65|	CN1N=CC2=C(SC(=NN2C)SCc3ccc(Cl)cc3Cl)C1=O	245728-44-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468081	387.30728	14900668	14900668 | 14900668			MOABOX:19128	GPR65	
SJ001035197-1	SJ001035197	1	MOABOX:19132	XJRUWGFZGQNPPD-UHFFFAOYSA-N	C=CCCn1cc(-c2cc(C(=O)N3CCOCC3)cc3c2ncn3C)c2cc[nH]c2c1=O		TAF1 inhibitor	TAF1																																																																										121335283					member																																																																																																																																																																30289257																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.59096																																0.07387																																8																																HY-112803	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Cancer|MOABOX:19132|TAF1|TAF1 inhibitor	Cn1cnc2c(cc(cc12)C(=O)N3CCOCC3)C4=CN(CCC=C)C(=O)c5[nH]ccc45	1926986-36-8	84407	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469051	431.487	GNE-371	GNE-371 | GNE-371	Pathway: Cell Cycle/DNA Damage	Research Area: Cancer	MOABOX:19132	TAF1	TAF1 inhibitor
SJ001011050-2	SJ001011050	2	MOABOX:19137	SJVGFKBLUYAEOK-SFHVURJKSA-N	N#Cc1cc(N2CCC(C(=O)N3N=CC[C@H]3c3cc(F)cc(F)c3)CC2)ncn1			RIPK1																																																																										134521814					virtual	10.1021/acs.jmedchem.9b00318																																																																																																																																																															30613318	31013427																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				3.068																																0.3835																																8																																T7397	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-782-689|MOABOX:19137|RIPK1|	Fc1cc(F)cc(c1)[C@@H]2CC=NN2C(=O)C3CCN(CC3)c4cc(ncn4)C#N	2226735-55-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468147	396.39333	GSK547	GSK547 | GSK547			MOABOX:19137	RIPK1	
SJ001035039-1	SJ001035039	1	MOABOX:19291	JBDVEYSPMQRWAN-UHFFFAOYSA-N	N#Cc1c(-c2ccccc2)nc(SCc2cccc(C(=O)O)c2)[nH]c1=O		ACMSD inhibitor	ACMSD																																																															CHEMBL4067706											135781005					member	10.1021/acs.jmedchem.7b01254	10.1038/s41586-018-0645-6																																																																																																																																																														29345930																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					4.09248																																0.51156																																8																																7020310145	OTAVA	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-758-593|MOABOX:19291|ACMSD|ACMSD inhibitor	OC(=O)c1cccc(CSC2=NC(=C(C#N)C(=O)N2)c3ccccc3)c1	900706-55-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468536	363.38982	7020310145	7020310145 | 7020310145			MOABOX:19291	ACMSD	ACMSD inhibitor
SJ001035119-1	SJ001035119	1	MOABOX:19297	DALBJAQPFUGPCJ-UHFFFAOYSA-N	N#Cc1c(-c2ccccc2)nc(SCc2ccc(C(=O)O)cc2)[nH]c1=O		ACMSD inhibitor	ACMSD																																																																										135734203					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.50241																																0.21463																																7																																7020310148	OTAVA	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-608-193|MOABOX:19297|ACMSD|ACMSD inhibitor	OC(=O)c1ccc(CSC2=NC(=C(C#N)C(=O)N2)c3ccccc3)cc1	881251-56-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468728	363.38982	7020310148	7020310148 | 7020310148			MOABOX:19297	ACMSD	ACMSD inhibitor
SJ001035032-1	SJ001035032	1	MOABOX:6	UUKJKGJWLSRNNK-UHFFFAOYSA-N	O=c1oc(-c2ccco2)nc2ccccc12	20492-07-3	Elastase inhibitor	CELA1																																																															CHEMBL24450											296003					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.51268																																0.07324																																7																																AH-357/03468042	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-251-914|MOABOX:6|CELA1|Elastase inhibitor	O=C1OC(=Nc2ccccc12)c3occc3	20492-07-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468519	213.18888	AH-357/03468042	AH-357/03468042 | AH-357/03468042			MOABOX:6	CELA1	Elastase inhibitor
SJ000287352-7	SJ000287352	7	MOABOX:80	WIGIZIANZCJQQY-RUCARUNLSA-N	CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O	93479-97-1	K(ATP) Channel Blockers	ABCC8	ABCC9	KCNJ8	KCNJ11																													10060	3764	3767																													CHEMBL1481																member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0																													0.0	0.0	0.0	0.0																													7	7	7	7																													HY-B0104	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Metabolic Disease|MOABOX:80|ABCC8|K(ATP) Channel Blockers	CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@@H]3CC[C@@H](C)CC3)C1=O	93479-97-1	11790	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468787	490.61556	GLIMEPIRIDE	"GLIMEPIRIDE | ""GLIMEPIRIDE | AMARYL"" | GLIMEPIRIDE | ""GLIMEPIRIDE | AMARYL"""	Pathway: Others	Research Area: Metabolic Disease	MOABOX:80	ABCC8	K(ATP) Channel Blockers
SJ001035060-1	SJ001035060	1	MOABOX:146	NCTLNAWWXKBSSW-IYARVYRRSA-N	CC(C)(C)OC(=O)NC[C@H]1CC[C@H](CNS(=O)(=O)c2ccc3ccccc3c2)CC1	192323-14-1	Acetyl-CoA Carboxylase 2 (ACC2) Inhibitors	ACACB																																																															CHEMBL1818184																member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.63252																																0.09036																																7																																Z3953647673	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-475-319|MOABOX:146|ACACB|Acetyl-CoA Carboxylase 2 (ACC2) Inhibitors	CC(C)(C)OC(=O)NC[C@@H]1CC[C@@H](CNS(=O)(=O)c2ccc3ccccc3c2)CC1	192323-14-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468566	432.57618	Z3953647673	Z3953647673 | Z3953647673			MOABOX:146	ACACB	Acetyl-CoA Carboxylase 2 (ACC2) Inhibitors
SJ001035002-1	SJ001035002	1	MOABOX:556	XUSDVLHKNBOGJY-FYYLOGMGSA-N	CCCCCCCCCCCCCC(=O)N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1	35922-06-6	Apoptosis Inducers;Ceramidase Inhibitors	ASAH1																																																															CHEMBL408217											10070893					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.27491																																0.18213																																7																																10006305	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-138-822|MOABOX:556|ASAH1|Apoptosis Inducers;Ceramidase Inhibitors	CCCCCCCCCCCCCC(=O)N[C@H](CO)[C@H](O)c1ccc(cc1)[N+](=O)[O-]	35922-06-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468454	422.55822	"D-NMAPPD | CAY10466 | (1R,2R)-B13"	"""D-NMAPPD | CAY10466 | (1R,2R)-B13"" | ""D-NMAPPD | CAY10466 | (1R,2R)-B13"""			MOABOX:556	ASAH1	Apoptosis Inducers;Ceramidase Inhibitors
SJ001035049-1	SJ001035049	1	MOABOX:762	UAJYCSUKECWQFQ-UHFFFAOYSA-N	CC(C)(C)c1ccc(C(=O)Nc2cccc(S(N)(=O)=O)c2)cc1		Carbonic anhydrase inhibitor	CA1	CA3	CA4	CA5A	CA8	CA11	CA5B	CA10																									761	762	763	767	770	11238	56934																									CHEMBL203112											2812911					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.39872	0	0	0	0	0	0	0																									-0.05696	0.0	0.0	0.0	0.0	0.0	0.0	0.0																									7	7	7	7	7	7	7	7																									HTS06214	MAYBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-901-440|MOABOX:762|CA1|Carbonic anhydrase inhibitor	CC(C)(C)c1ccc(cc1)C(=O)Nc2cccc(c2)S(=O)(=O)N	698974-39-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468552	332.4173	HTS06214	HTS06214 | HTS06214			MOABOX:762	CA1	Carbonic anhydrase inhibitor
SJ000287428-4	SJ000287428	4	MOABOX:782	QCDFBFJGMNKBDO-UHFFFAOYSA-N	Oc1c(I)cc(Cl)c2cccnc12	130-26-7	Chelating Agents;Carbonic Anhydrase Inhibitors;Antiamyloidogenic Agents	CA12																																																															CHEMBL497											2788	3334943	6338237	9820731	9999175	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-4.179e-002																																-0.00597																																7																																HY-14603	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Autophagy | Research Area: Infection; Cancer|MOABOX:782|CA12|Chelating Agents;Carbonic Anhydrase Inhibitors;Antiamyloidogenic Agents	Oc1c(I)cc(Cl)c2cccnc12	130-26-7	32709	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469443	305.49957	CLIOQUINOL	CLIOQUINOL | CLIOQUINOL	Pathway: Anti-infection; Autophagy	Research Area: Infection; Cancer	MOABOX:782	CA12	Chelating Agents;Carbonic Anhydrase Inhibitors;Antiamyloidogenic Agents
SJ000550824-2	SJ000550824	2	MOABOX:1156	HTTLBYITFHMYFK-UHFFFAOYSA-N	O=c1oc(-c2ccccc2)nc2ccccc12	1022-46-4	Elastase inhibitor	CELA1																																																															CHEMBL24449											13926	91192157	143077396			virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-1.953e-002																																-0.00279																																7																																JS-3012	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	O=C1OC(=Nc2ccccc12)c3ccccc3	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466765	223.22676					MOABOX:1156	CELA1	Elastase inhibitor
SJ000286488-7	SJ000286488	7	MOABOX:1562	FTVWIRXFELQLPI-ZDUSSCGKSA-N	O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(O)cc(O)c21	13308-00-4	Apoptosis Inducers;Cytochrome P450 CYP3A4 Inhibitors;Antioxidants;Cell Adhesion Inhibitors	CYP3A4																																																															CHEMBL9352											439246	21158481	45157617	66592513	66687732	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-3.381e-002																																-0.00483																																7																																FS-4072	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Oc1ccc(cc1)[C@@H]2CC(=O)c3c(O)cc(O)cc3O2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466818	272.25278	NARINGENIN	NARINGENIN | NARINGENINE | NARINGENIN | NARINGENINE			MOABOX:1562	CYP3A4	Apoptosis Inducers;Cytochrome P450 CYP3A4 Inhibitors;Antioxidants;Cell Adhesion Inhibitors
SJ000312378-11	SJ000312378	11	MOABOX:2090	JTEGQNOMFQHVDC-NKWVEPMBSA-N	Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1	1117764-41-6	Reverse Transcriptase Inhibitors	POLB	POLG	POLD1	POLD2	POLE	POLE2	POLH	POLD3	POLQ	TENT4A	POLI	POLG2	POLL	POLM	POLK	POLE3	POLE4	POLD4	POLN														5428	5424	5425	5426	5427	5429	10714	10721	11044	11201	11232	27343	27434	51426	54107	56655	57804	353497														CHEMBL141	CHEMBL537885										60825	460615	467505	513436	9907230	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.19474	0	0	0	0	-0.34986	0	0	0	0	0	0	0	0	0	0	0	0	0														0.02782	0.0	0.0	0.0	0.0	-0.04998	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0														7	7	7	7	7	7	7	7	7	7	7	7	7	7	7	7	7	7	7														KS-1073	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466705	229.25624	LAMIVUDINE	"LAMIVUDINE | ""LAMIVUDINE | EPIVIR"" | ""LAMIVUDINE| 3TC| EPIVIR| HEPITEC| HEPTOVIR| ZEFFIX| EPZICOM | 4-AMINO-1-(2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)PYRIMIDIN-2(1H)-ONE | """"LAMIVUDINE | EPIVIR"""" | 4-AMINO-1-((2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)PYRIMIDIN-2(1H)-ONE"" | LAMIVUDINE | LAMIVUDINE | ""LAMIVUDINE | EPIVIR"" | ""LAMIVUDINE| 3TC| EPIVIR| HEPITEC| HEPTOVIR| ZEFFIX| EPZICOM | 4-AMINO-1-(2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)PYRIMIDIN-2(1H)-ONE | """"LAMIVUDINE | EPIVIR"""" | 4-AMINO-1-((2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)PYRIMIDIN-2(1H)-ONE"""			MOABOX:2090	POLB	Reverse Transcriptase Inhibitors
SJ000126019-8	SJ000126019	8	MOABOX:2224	WHUUTDBJXJRKMK-GSVOUGTGSA-N	N[C@H](CCC(=O)O)C(=O)O	11070-68-1		GRIA4	GRIK3	GRIK5																														2899	2901																														CHEMBL76232											23327	12248504	53249694	87104146	87139887	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.198e-002	0	0																														0.00314	0.0	0.0																														7	7	7																														AS-12791	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	N[C@H](CCC(=O)O)C(=O)O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466814	147.12926	L-GLUTAMIC ACID HYDROCHLORIDE	L-GLUTAMIC ACID HYDROCHLORIDE | D-(-)-GLUTAMIC ACID | L-GLUTAMIC ACID | L-GLUTAMIC ACID HYDROCHLORIDE | D-(-)-GLUTAMIC ACID | L-GLUTAMIC ACID			MOABOX:2224	GRIA4	
SJ000286569-6	SJ000286569	6	MOABOX:2420	OBKXEAXTFZPCHS-UHFFFAOYSA-N	O=C(O)CCCc1ccccc1	1262970-43-3	Apoptosis Inducers;Histone Deacetylase (HDAC) Inhibitors	HDAC3																																																															CHEMBL1469											4775	265124	420326	22040259	22040292	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.15736																																0.02248																																7																																PS-4322	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC(=O)CCCc1ccccc1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466742	164.20108	SODIUM GAMMA-PHENYLBUTYRATE	SODIUM GAMMA-PHENYLBUTYRATE | SODIUM PHENYLBUTYRATE | SODIUM GAMMA-PHENYLBUTYRATE | SODIUM PHENYLBUTYRATE			MOABOX:2420	HDAC3	Apoptosis Inducers;Histone Deacetylase (HDAC) Inhibitors
SJ001011733-3	SJ001011733	3	MOABOX:2984	LFQDNHWZDQTITF-UHFFFAOYSA-N	OB1OCc2cc(F)ccc21	174671-46-6	Leucyl-tRNA Synthetase Inhibitors	LARS2																																																															CHEMBL443052											11499245	66738565	139203388			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-10980	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Infection|MOABOX:2984|LARS2|Leucyl-tRNA Synthetase Inhibitors	OB1OCc2cc(F)ccc12	174671-46-6	7710	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469672	151.93074	TAVABOROLE	TAVABOROLE | TAVABOROLE	Pathway: Anti-infection	Research Area: Infection	MOABOX:2984	LARS2	Leucyl-tRNA Synthetase Inhibitors
SJ000784324-4	SJ000784324	4	MOABOX:3390	OJPLJFIFUQPSJR-INIZCTEOSA-N	CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@@H]1C(=O)Nc2ccccc2-c2ccccc21	847925-91-1	gamma-Secretase Inhibitors;Drugs Acting on Notch Receptors	PSEN1																																																																										49867930					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.58207																																0.22601																																7																																HY-11102	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Neuronal Signaling; Stem Cell/Wnt | Research Area: Neurological Disease; Cancer|MOABOX:3390|PSEN1|gamma-Secretase Inhibitors;Drugs Acting on Notch Receptors	CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@@H]1C(=O)Nc2ccccc2c3ccccc13	847925-91-1	13657	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469574	469.40452	RO-4929097	"RO-4929097 | ""R-4733 | RG-4733 | RO-4929097"" | RO-4929097 | ""R-4733 | RG-4733 | RO-4929097"""	Pathway: Neuronal Signaling; Stem Cell/Wnt	Research Area: Neurological Disease; Cancer	MOABOX:3390	PSEN1	gamma-Secretase Inhibitors;Drugs Acting on Notch Receptors
SJ000285433-11	SJ000285433	11	MOABOX:3560	RRGUKTPIGVIEKM-UHFFFAOYSA-N	O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1	1073608-02-2	Phosphodiesterase III Inhibitors	PDE2A																																																															CHEMBL799											2754	11479708	11954572	44205215	46835835	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.46466																																-0.06638																																7																																KS-5154	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	O=C1CCc2cc(OCCCCc3nnnn3C4CCCCC4)ccc2N1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466663	369.46068	CILOSTAZOL	CILOSTAZOL | CILOSTAZOL			MOABOX:3560	PDE2A	Phosphodiesterase III Inhibitors
SJ000287562-10	SJ000287562	10	MOABOX:3768	ATEBXHFBFRCZMA-VXTBVIBXSA-N	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O	72559-06-9	DNA-Directed RNA Polymerase Inhibitors	POLRMT																																																															CHEMBL444633																member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-17025	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Infection|MOABOX:3768|POLRMT|DNA-Directed RNA Polymerase Inhibitors	CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C)c(O)c4C(=O)C(=C5NC6(CCN(CC(C)C)CC6)N=C5c4c3C2=O)NC(=O)\C(=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@@H]1C)\C	72559-06-9	8846	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469453	847.00468	RIFABUTIN	RIFABUTIN | SJ000556734 | RIFABUTIN | RIFABUTIN | SJ000556734	Pathway: Anti-infection	Research Area: Infection	MOABOX:3768	POLRMT	DNA-Directed RNA Polymerase Inhibitors
SJ000556738-8	SJ000556738	8	MOABOX:3770	WDZCUPBHRAEYDL-GZAUEHORSA-N	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C	61379-65-5	DNA-Directed RNA Polymerase Inhibitors	POLRMT																																																															CHEMBL1660											135403821	135480777	135483787	135483788	135483789	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-B0269	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Infection|MOABOX:3770|POLRMT|DNA-Directed RNA Polymerase Inhibitors	CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)\C(=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@@H]1C)\C)c(\C=N\N5CCN(CC5)C6CCCC6)c(O)c4c3C2=O	61379-65-5	16323	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469335	877.03066	RIFAPENTINE	RIFAPENTINE | RIFAPENTINE	Pathway: Anti-infection	Research Area: Infection	MOABOX:3770	POLRMT	DNA-Directed RNA Polymerase Inhibitors
SJ001034645-1	SJ001034645	1	MOABOX:4110	CFMZSMGAMPBRBE-UHFFFAOYSA-N	O=C1c2ccccc2C(=O)N1O	3229-40-1	Ribonucleoside-Diphosphate Reductase Inhibitors	RRM1	GABRA1	RRM2																														2554	6241																														CHEMBL276057											10665	17875577	18003815	19746698	19794649	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0																														0.0	0.0	0.0																														7	7	7																														FS-3185	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	ON1C(=O)c2ccccc2C1=O	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466648	163.1302	FS-3185	FS-3185 | FS-3185			MOABOX:4110	RRM1	Ribonucleoside-Diphosphate Reductase Inhibitors
SJ000829234-2	SJ000829234	2	MOABOX:4372	HCBULGQMULJTCM-ZSOIEALJSA-N	O=C1/C(=C/c2ccc(O)c(O)c2)Oc2ccccc21	24418-86-8	Sphingosine Kinase Inhibitors	SPHK2																																																															CHEMBL1478023											5793932					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.56448																																0.08064																																7																																HY-12895	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Immunology/Inflammation; PI3K/Akt/mTOR | Research Area: Cancer|MOABOX:4372|SPHK2|Sphingosine Kinase Inhibitors	Oc1ccc(\C=C\2/Oc3ccccc3C2=O)cc1O	24418-86-8	66071	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469498	254.2375			Pathway: Apoptosis; Immunology/Inflammation; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:4372	SPHK2	Sphingosine Kinase Inhibitors
SJ000288258-4	SJ000288258	4	MOABOX:4424	OQQVFCKUDYMWGV-UHFFFAOYSA-N	OCc1ccc(-c2nn(Cc3ccccc3)c3ccccc23)o1	154453-18-6	"Apoptosis Inhibitors;Hypoxia Inducible Factor 1-alpha (HIF-1alpha) Inhibitors;Guanylate Cyclase Activators;Angiogenesis Inhibitors;""Apoptosis Inhibitors;Hypoxia Inducible Factor 1-alpha (HIF-1alpha) Inhibitors;Guanylate Cyclase Activators;Angiogenesis Inhibitors"""	GUCY1B2	GUCY1A2	GUCY1A1	GUCY1B1	STAT2																												2977	2982	2983	6773																												CHEMBL333985											5712	9873444	86291009			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-7.322e-002	-7.322e-002	-7.322e-002	-7.322e-002	0																												-0.01046	-0.01046	-0.01046	-0.01046	0.0																												7	7	7	7	7																												CS-3363	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-960-223|MOABOX:4424|GUCY1B2|Apoptosis Inhibitors;Hypoxia Inducible Factor 1-alpha (HIF-1alpha) Inhibitors;Guanylate Cyclase Activators;Angiogenesis Inhibitors;\Apoptosis Inhibitors;Hypoxia Inducible Factor 1-alpha (HIF-1alpha) Inhibitors;Guanylate Cyclase Activators;Angiogenesis Inhibitors\	OCc1oc(cc1)c2nn(Cc3ccccc3)c4ccccc24	170632-47-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468164	304.34254	YC-1	YC-1 | YC-1			MOABOX:4424	GUCY1B2	Apoptosis Inhibitors;Hypoxia Inducible Factor 1-alpha (HIF-1alpha) Inhibitors;Guanylate Cyclase Activators;Angiogenesis Inhibitors;\Apoptosis Inhibitors;Hypoxia Inducible Factor 1-alpha (HIF-1alpha) Inhibitors;Guanylate Cyclase Activators;Angiogenesis Inhibitors\
SJ001033547-2	SJ001033547	2	MOABOX:4542	ANDGGVOPIJEHOF-UHFFFAOYSA-N	O=C(c1ccc2nccnc2c1)N1CCCCC1	154235-83-3	AMPA Receptor Modulators	GRIA1	GRIA2	GRIA3	GRIA4																													2891	2892	2893																													CHEMBL136800											148184					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-3.08e-003	-3.08e-003	-4.627e-002	-3.983e-002																													-0.00044	-0.00044	-0.00661	-0.00569																													7	7	7	7																													HY-10933	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:4542|GRIA1|AMPA Receptor Modulators	O=C(N1CCCCC1)c2ccc3nccnc3c2	154235-83-3	34628	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469007	241.2884	CX516; BDP 12	CX516; BDP 12 | CX516; BDP 12	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:4542	GRIA1	AMPA Receptor Modulators
SJ000286240-4	SJ000286240	4	MOABOX:4694	AEQDJSLRWYMAQI-UHFFFAOYSA-N	COc1cc2c(cc1OC)C1Cc3ccc(OC)c(OC)c3CN1CC2	10097-84-4	5-HT Release Inhibitors	DRD1	DRD2	DRD3	DRD4	DRD5																												1813	1814	1815	1816																												CHEMBL1412574	CHEMBL187892	CHEMBL585481									5417	645223	6602555	18694977	44512344	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0	0																												0.0	0.0	0.0	0.0	0.0																												7	7	7	7	7																												AA00039Q	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-487-312|MOABOX:4694|DRD1|5-HT Release Inhibitors	COc1cc2CCN3Cc4c(CC3c2cc1OC)ccc(OC)c4OC	2934-97-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468286	355.4275	TETRAHYDROPALMATINE	TETRAHYDROPALMATINE | ROTUNDINE | TETRAHYDROPALMATINE | ROTUNDINE			MOABOX:4694	DRD1	5-HT Release Inhibitors
SJ000287762-4	SJ000287762	4	MOABOX:4726	SDJLVPMBBFRBLL-UHFFFAOYSA-N	CCN(CCCl)Cc1ccccc1Br	40616-75-9	Adrenergic Neuron Blockers	SLC22A3	SLC22A2																															6582																															CHEMBL1255650	CHEMBL1334976										3172	11957497	53313246			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.34755	-3.871e-002																															0.04965	-0.00553																															7	7																															HY-103210	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Neurological Disease|MOABOX:4726|SLC22A3|Adrenergic Neuron Blockers	CCN(CCCl)Cc1ccccc1Br	40616-75-9	43242	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468779	276.6005	DSP-4 HYDROCHLORIDE	DSP-4 HYDROCHLORIDE | DSP-4 HYDROCHLORIDE	Pathway: Others	Research Area: Neurological Disease	MOABOX:4726	SLC22A3	Adrenergic Neuron Blockers
SJ000986579-2	SJ000986579	2	MOABOX:4818	OLIKCJUMYWSDIV-UHFFFAOYSA-N	Cc1oc2ccccc2c1Cc1cc(I)c(OCC(=O)O)c(I)c1	147030-48-6	Antithyroid Drugs	CHRM2	THRA																															7067																															CHEMBL157885											9872203					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0.94297																															0.0	0.13471																															7	7																															RAM2463	RAMIDUS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-039-033-056|MOABOX:4818|CHRM2|Antithyroid Drugs	Cc1oc2ccccc2c1Cc3cc(I)c(OCC(=O)O)c(I)c3	147030-48-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468532	548.1103	2463	2463 | 2463			MOABOX:4818	CHRM2	Antithyroid Drugs
SJ000287278-2	SJ000287278	2	MOABOX:4910	JYTUSYBCFIZPBE-AMTLMPIISA-N	O=C(O)[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO	110638-68-1	Chelating Agents;Matrix Metalloproteinase Inhibitors;Antioxidants	LGALS1																																																															CHEMBL2106421	CHEMBL3039602										7314	3038222	9845211	11753282	20055401	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-N7059	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Infection|MOABOX:4910|LGALS1|Chelating Agents;Matrix Metalloproteinase Inhibitors;Antioxidants	OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)C(=O)O	96-82-2	58007	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469427	358.29588	LACTOBIONIC ACID	LACTOBIONIC ACID | LACTOBIONIC ACID	Pathway: Anti-infection	Research Area: Infection	MOABOX:4910	LGALS1	Chelating Agents;Matrix Metalloproteinase Inhibitors;Antioxidants
SJ001035281-1	SJ001035281	1	MOABOX:4912	CTNQAPPDQTYTHM-UHFFFAOYSA-N	O=C(Nc1cccc(C(F)(F)F)c1)Nc1ccccc1C(=O)O	1566-81-0	Chloride Channel Blockers	GRIK1																																																															CHEMBL156519											9883705					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.40551																																-0.05793																																7																																HY-100244	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Neurological Disease|MOABOX:4912|GRIK1|Chloride Channel Blockers	OC(=O)c1ccccc1NC(=O)Nc2cccc(c2)C(F)(F)F	1566-81-0	61507	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469482	324.25465	NS1652	NS1652 | NS1652	Pathway: Membrane Transporter/Ion Channel	Research Area: Neurological Disease	MOABOX:4912	GRIK1	Chloride Channel Blockers
SJ000111301-5	SJ000111301	5	MOABOX:4990	XBBDACCLCFWBSI-ZETCQYMHSA-N	COC(=O)[C@@H](N)Cc1ccc(O)c(O)c1	1421-65-4	Dopamine Precursors	DRD1	DRD3	DRD2	DRD4	DRD5																												1814	1813	1815	1816																												CHEMBL1255756	CHEMBL1328898										23497	10131132	51371161	67069288	67363713	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.14252	0	-0.1645	0	0																												-0.02036	0.0	-0.0235	0.0	0.0																												7	7	7	7	7																												AG001HT2	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-850|MOABOX:4990|DRD1|Dopamine Precursors	COC(=O)[C@@H](N)Cc1ccc(O)c(O)c1	1421-65-4	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468251	211.21452	"L-3,4-DIHYDROXYPHENYLALANINE METHYL ESTER HYDROCHLORIDE"	"L-3,4-DIHYDROXYPHENYLALANINE METHYL ESTER HYDROCHLORIDE | L-3,4-DIHYDROXYPHENYLALANINE METHYL ESTER HYDROCHLORIDE"			MOABOX:4990	DRD1	Dopamine Precursors
SJ001035302-1	SJ001035302	1	MOABOX:5020	FACMWMBWGSPRKO-UHFFFAOYSA-N	CN1CCN(C2=Nc3ccccc3Sc3nccn32)CC1	81382-51-6	Drugs Acting on Dopaminergic Transmission	ADRA2B	ADRA2C	DRD1																														152	1812																														CHEMBL2105337											54742	6435401	20057132	87068798		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.91812	0	0																														-0.13116	0.0	0.0																														7	7	7																														HY-100143	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:5020|ADRA2B|Drugs Acting on Dopaminergic Transmission	CN1CCN(CC1)C2=Nc3ccccc3Sc4nccn24	81382-51-6	45487	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469532	299.39398	PENTIAPINE | CGS 10746	"""PENTIAPINE | CGS 10746"" | ""PENTIAPINE | CGS 10746"""	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:5020	ADRA2B	Drugs Acting on Dopaminergic Transmission
SJ000286127-9	SJ000286127	9	MOABOX:5072	CWRVKFFCRWGWCS-UHFFFAOYSA-N	C1CCc2nnnn2CC1	20192-24-9	GABA(A) Receptor Antagonists	GABRA1																																																															CHEMBL116943	CHEMBL350551										5917	192853	21115239	67081218	67938725	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.31297																																-0.04471																																7																																T1413	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-783-580|MOABOX:5072|GABRA1|GABA(A) Receptor Antagonists	C1CCc2nnnn2CC1	54-95-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468133	138.1704	PENTETRAZOLE	PENTETRAZOLE | PENTYLENETETRAZOLE | PENTETRAZOLE | PENTYLENETETRAZOLE			MOABOX:5072	GABRA1	GABA(A) Receptor Antagonists
SJ000287770-8	SJ000287770	8	MOABOX:5074	BOCUKUHCLICSIY-UHFFFAOYSA-N	NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O	2259-96-3	AMPA Receptor Modulators	GRIA2																																																															CHEMBL61593											2910	173791	11422638	69521084	70145989	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.44744																																0.06392																																7																																16335	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-666-800|MOABOX:5074|GRIA2|AMPA Receptor Modulators	NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C3CC4CC3C=C4)cc1Cl	2259-96-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468655	389.87754	CYCLOTHIAZIDE	CYCLOTHIAZIDE | CYCLOTHIAZIDE			MOABOX:5074	GRIA2	AMPA Receptor Modulators
SJ000288080-5	SJ000288080	5	MOABOX:5170	YLFMCMWKHSDUCT-UHFFFAOYSA-N	O=c1[nH]c2cc(C(F)(F)F)ccc2n1-c1cc(C(F)(F)F)ccc1O	153587-01-0	"Large Conductance K(Ca) 1.1 (BK, maxi K+) Channel Activators"	KCNMA1																																																															CHEMBL384903											4552	9826958	11228436	11491225		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-1.799e-002																																-0.00257																																7																																HY-12496	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Cardiovascular Disease|MOABOX:5170|KCNMA1|Large Conductance K(Ca) 1.1 (BK, maxi K+) Channel Activators"	Oc1ccc(cc1N2C(=O)Nc3cc(ccc23)C(F)(F)F)C(F)(F)F	153587-01-0	21010	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469307	362.22664	NS-1619	NS-1619 | NS-1619	Pathway: Membrane Transporter/Ion Channel	Research Area: Cardiovascular Disease	MOABOX:5170	KCNMA1	"Large Conductance K(Ca) 1.1 (BK, maxi K+) Channel Activators"
SJ001034902-1	SJ001034902	1	MOABOX:5208	XFFITGBWVLQNCD-UHFFFAOYSA-N	CC(C)c1cccc(C(C)C)c1NC(=O)Nc1ccc(Sc2ccc([N+](=O)[O-])cc2)cc1	228544-65-8	"Lipid Lowering Agents;ACAT Inhibitors;""Lipid Lowering Agents;ACAT Inhibitors"""	ACAT1	ACAT2	SOAT1																														39	6646																																									9933427					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-9.191e-002	0	0																														-0.01313	0.0	0.0																														7	7	7																														2988	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-624|MOABOX:5208|ACAT1|Lipid Lowering Agents;ACAT Inhibitors;\Lipid Lowering Agents;ACAT Inhibitors\	CC(C)c1cccc(C(C)C)c1NC(=O)Nc2ccc(Sc3ccc(cc3)[N+](=O)[O-])cc2	228544-65-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468208	449.56518	VULM 1457	VULM 1457 | VULM 1457			MOABOX:5208	ACAT1	Lipid Lowering Agents;ACAT Inhibitors;\Lipid Lowering Agents;ACAT Inhibitors\
SJ001032944-2	SJ001032944	2	MOABOX:5274	QPCVHQBVMYCJOM-UHFFFAOYSA-N	CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1	54556-98-8	Muscarinic Antagonists	CHRM1	CHRM2	CHRM3																														1129	1131																														CHEMBL1078261	CHEMBL2359059										4942	441412	46856316	68524389	69913936	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.90797	-1.771e-002	0.57127																														0.12971	-0.00253	0.08161																														7	7	7																														T5023	TARGETMOL	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-850-000|MOABOX:5274|CHRM1|Muscarinic Antagonists	CCCOC(C(=O)OC1CCN(C)CC1)(c2ccccc2)c3ccccc3	54556-98-8	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468161	367.48126	PROPIVERINE HYDROCHLORIDE	PROPIVERINE HYDROCHLORIDE | PROPIVERINE HYDROCHLORIDE			MOABOX:5274	CHRM1	Muscarinic Antagonists
SJ000285220-16	SJ000285220	16	MOABOX:5304	KTEXNACQROZXEV-SLXBATTESA-N	C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21	20554-84-1	NF-kappaB (NFKB) Activation Inhibitors	IKBKB																																																															CHEMBL540445											6473881	24884532	90119774	117655233		virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-N0141	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; NF-?B | Research Area: Cancer|MOABOX:5304|IKBKB|NF-kappaB (NFKB) Activation Inhibitors	C\C\1=C/CC[C@@]2(C)O[C@@H]2[C@H]3OC(=O)C(=C)[C@@H]3CC1	20554-84-1	10589	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468977	248.3175	PARTHENOLIDE	"PARTHENOLIDE | ""PARTHENOLIDE | NSC-157035 |"" | (-)-PARTHENOLIDE | PARTHENOLIDE | ""PARTHENOLIDE | NSC-157035 |"" | (-)-PARTHENOLIDE"	Pathway: Apoptosis; Autophagy; NF-?B	Research Area: Cancer	MOABOX:5304	IKBKB	NF-kappaB (NFKB) Activation Inhibitors
SJ000286909-6	SJ000286909	6	MOABOX:5334	HCZHHEIFKROPDY-UHFFFAOYSA-N	O=C(O)c1cc(O)c2ccccc2n1	13593-94-7	NMDA Antagonists;AMPA Receptor Modulators;a7 nicotinic acetylcholine receptor Inhibitor	CHRNA7																																																															CHEMBL299155											3845	18530299	66699512	69121825	70467608	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.17374																																0.02482																																7																																GS-3763	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC(=O)c1cc(O)c2ccccc2n1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466825	189.16748	KYNURENIC ACID	KYNURENIC ACID | KYNURENIC ACID			MOABOX:5334	CHRNA7	NMDA Antagonists;AMPA Receptor Modulators;a7 nicotinic acetylcholine receptor Inhibitor
SJ000287641-6	SJ000287641	6	MOABOX:5344	HCKUBNLZMKAEIN-GSVOUGTGSA-N	N[C@@H]1CCN(O)C1=O	123931-04-4	NMDA Glycine B Receptor Partial Agonists	GRIN1																																																															CHEMBL335231											6603720	121490176	121490177	121491121	121493149	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.14945																																0.02135																																7																																281	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-941-595|MOABOX:5344|GRIN1|NMDA Glycine B Receptor Partial Agonists	N[C@@H]1CCN(O)C1=O	123931-04-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468116	116.11852	(±)-HA-966	(±)-HA-966 | (R)-(+)-HA-966 | (S)-(-)-HA-966 | (±)-HA-966 | (R)-(+)-HA-966 | (S)-(-)-HA-966			MOABOX:5344	GRIN1	NMDA Glycine B Receptor Partial Agonists
SJ000782334-2	SJ000782334	2	MOABOX:5352	VPPJLAIAVCUEMN-GFCCVEGCSA-N	COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1	175481-26-2	NMDA Glycine-Site Antagonists;Sodium Channel  Blockers	GRIN1																																																															CHEMBL58323											219078	23628278	23658552	91801195		virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.22834																																-0.03262																																7																																KS-1227	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COC[C@@H](NC(=O)C)C(=O)NCc1ccccc1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466654	250.29362	LACOSAMIDE | ADD-234037 | SPM-927 | SPM-929 |	"""LACOSAMIDE | ADD-234037 | SPM-927 | SPM-929 |"" | ""LACOSAMIDE | ADD-234037 | SPM-927 | SPM-929 |"""			MOABOX:5352	GRIN1	NMDA Glycine-Site Antagonists;Sodium Channel  Blockers
SJ001034923-1	SJ001034923	1	MOABOX:5408	CXUCKELNYMZTRT-UHFFFAOYSA-N	CCn1c(=O)[nH]c2ccccc21	10045-45-1	SK2 Potassium Channel Activators	KCNN2																																																															CHEMBL452887											82320	91266819	91613121	140333126	143756849	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.26789																																-0.03827																																7																																AG000217	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-874-485|MOABOX:5408|KCNN2|SK2 Potassium Channel Activators	CCN1C(=O)Nc2ccccc12	10045-45-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468250	162.1885	AG000217	AG000217 | AG000217			MOABOX:5408	KCNN2	SK2 Potassium Channel Activators
SJ001035115-1	SJ001035115	1	MOABOX:5466	IBQJWZNNSYUOII-UHFFFAOYSA-N	N#Cc1c(NC(=S)NC(=O)c2ccccc2)sc2c1CCCC2	121746-08-5	Serotonin Antagonists	HTR1A																																																															CHEMBL1409180											796265					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																AJ-292/40175630	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-018-919|MOABOX:5466|HTR1A|Serotonin Antagonists	O=C(NC(=S)Nc1sc2CCCCc2c1C#N)c3ccccc3	121746-08-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468722	341.4505	AJ-292/40175630	AJ-292/40175630 | AJ-292/40175630			MOABOX:5466	HTR1A	Serotonin Antagonists
SJ000796017-2	SJ000796017	2	MOABOX:5663	IKNOZZKXIDSTRN-PXLJZGITSA-N	Cc1cc(=O)oc2cc(NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC3CCCCC3)NC(=O)OCC3c4ccccc4-c4ccccc43)ccc12	475115-35-6	GALR2 agonist	GALR2																																																															CHEMBL592414											5311268	16219413				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.23744																																-0.03392																																7																																29925	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-047-605-920|MOABOX:5663|GALR2|GALR2 agonist	CC1=CC(=O)Oc2cc(NC(=O)C(CCCCN)NC(=O)C(CC3CCCCC3)NC(=O)OCC4c5ccccc5c6ccccc46)ccc12	1217448-19-5	NA	GENERAL	"2,2,2-TRIFLUOROACETATE"	1	NO_SOLVATE	0	1468651	678.81644	GALNON	GALNON | GALNON			MOABOX:5663	GALR2	GALR2 agonist
SJ001034668-1	SJ001034668	1	MOABOX:5779	ILJDAFPFCCVDKU-UHFFFAOYSA-N	NCC1OCCc2ccccc21	19158-90-8	MC4R antagonist	MC4R																																																																										209070	44658136				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																PS-13411	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	NCC1OCCc2ccccc12	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466804	163.21632	PS-13411	PS-13411 | PS-13411			MOABOX:5779	MC4R	MC4R antagonist
SJ001035139-1	SJ001035139	1	MOABOX:5824	GYBXWOPENJVQKE-UFYCRDLUSA-N	CSCC[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O	67247-12-5	FPR1 antagonist	FPR1																																																															CHEMBL1770296											14655143	131748826	137628636			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.24905																																0.46415																																7																																HY-103473A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Inflammation/Immunology|MOABOX:5824|FPR1|FPR1 antagonist	CSCC[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O	NA	37558	GENERAL	"2,2,2-TRIFLUOROACETATE"	1	NO_SOLVATE	0	1468873	509.65866	BOC-MLF TFA | BOC-MET-LEU-PHE-OH TFA	"""BOC-MLF TFA | BOC-MET-LEU-PHE-OH TFA"" | ""BOC-MLF TFA | BOC-MET-LEU-PHE-OH TFA"""	Pathway: Others	Research Area: Inflammation/Immunology	MOABOX:5824	FPR1	FPR1 antagonist
SJ000786022-3	SJ000786022	3	MOABOX:5830	IGODGTDUQSMDQU-UHFFFAOYSA-N	NC(C(=O)O)(c1ccc(P(=O)(O)O)cc1)C1CC1	183364-82-1	GRM4 antagonist;GRM6 antagonist;GRM7 antagonist;GRM8 antagonist	GRM4	GRM6	GRM7	GRM8																													2916	2917	2918																													CHEMBL164642											2878					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-6.671e-002	1.26308	-0.23765	1.442																													-0.00953	0.18044	-0.03395	0.206																													7	7	7	7																													972	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-544|MOABOX:5830|GRM4|GRM4 antagonist;GRM6 antagonist;GRM7 antagonist;GRM8 antagonist	NC(C1CC1)(C(=O)O)c2ccc(cc2)P(=O)(O)O	183364-82-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468126	271.20632	CPPG	CPPG | (±)-ALPHA-CYCLOPROPYL-4-PHOSPHONOPHENYLGLYCINE | CPPG | (±)-ALPHA-CYCLOPROPYL-4-PHOSPHONOPHENYLGLYCINE			MOABOX:5830	GRM4	GRM4 antagonist;GRM6 antagonist;GRM7 antagonist;GRM8 antagonist
SJ000029097-2	SJ000029097	2	MOABOX:5977	ACLUEOBQFRYTQS-UHFFFAOYSA-N	CC(C)(C)C1CCc2c(sc(NC(=O)c3ccco3)c2C(=O)O)C1	407587-33-1	Calcium activated chloride channel 1 inhibitor	ANO1																																																															CHEMBL4104747											2898877					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					2.09251																																0.29893																																7																																HY-100611	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel | Research Area: Cancer; Inflammation/Immunology|MOABOX:5977|ANO1|Calcium activated chloride channel 1 inhibitor	CC(C)(C)C1CCc2c(C1)sc(NC(=O)c3occc3)c2C(=O)O	407587-33-1	26884	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468758	347.42864			Pathway: Membrane Transporter/Ion Channel	Research Area: Cancer; Inflammation/Immunology	MOABOX:5977	ANO1	Calcium activated chloride channel 1 inhibitor
SJ001034957-1	SJ001034957	1	MOABOX:5993	ZXMXAOYWSLZLQM-NZNGGYBSSA-N	CCC(C)[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccno1)C(=O)N1CCC2(CCc3ccccc32)CC1	1252806-86-2	Proteinase activated receptor 2 (PAR2) partial agonist	F2RL1																																																																										49843509					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.72515																																0.24645																																7																																1622	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-665-727|MOABOX:5993|F2RL1|Proteinase activated receptor 2 (PAR2) partial agonist	CCC(C)[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)c2oncc2)C(=O)N3CCC4(CC3)CCc5ccccc45	1252806-86-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468371	548.71616	GB 83	GB 83 | GB 83			MOABOX:5993	F2RL1	Proteinase activated receptor 2 (PAR2) partial agonist
SJ001035015-1	SJ001035015	1	MOABOX:6038	IIBBJCNVTRCTDV-QYQHSDTDSA-N	CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\Nc1cccc(-c2cccc(-c3nnn[nH]3)c2)c1O		Signal Transduction Modulators;Thrombopoietin Receptor (TpoR) Agonists	MPL																																																															CHEMBL3545303																member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																CS-5711	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-416-736|MOABOX:6038|MPL|Signal Transduction Modulators;Thrombopoietin Receptor (TpoR) Agonists	CC1=NN(C(=O)/C/1=N/Nc2cccc(c2O)c3cccc(c3)c4nnn[nH]4)c5ccc(C)c(C)c5	1033040-23-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468474	466.49458	TPO AGONIST 1	TPO AGONIST 1 | TPO AGONIST 1			MOABOX:6038	MPL	Signal Transduction Modulators;Thrombopoietin Receptor (TpoR) Agonists
SJ001010987-2	SJ001010987	2	MOABOX:6257	AOUZPXZGMZUQQS-YPAWHYETSA-N	CC(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](Cc1ccccc1)C(N)=O	1809784-29-9	GADD45Beta/ MKK7 complex disruptor	MAP2K7																																																																										86295191	139600260				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-100538A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; MAPK/ERK Pathway | Research Area: Cancer|MOABOX:6257|MAP2K7|GADD45Beta/ MKK7 complex disruptor	CC(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](Cc2ccccc2)C(=O)N	NA	57029	GENERAL	"2,2,2-TRIFLUOROACETATE"	1	NO_SOLVATE	0	1468887	525.6	DTP3 (TFA)	DTP3 (TFA) | DTP3 (TFA)	Pathway: Cell Cycle/DNA Damage; MAPK/ERK Pathway	Research Area: Cancer	MOABOX:6257	MAP2K7	GADD45Beta/ MKK7 complex disruptor
SJ000565162-3	SJ000565162	3	MOABOX:6573	UKTAZPQNNNJVKR-YXSUXZIUSA-N	O=C(O[C@@H]1C[C@@H]2C[C@@H]3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12	115956-13-3	"Carbonyl reductase inhibitor;5HT3 antagonist;HTR3A antagonist;""Carbonyl reductase inhibitor;5HT3 antagonist;HTR3A antagonist"""	HTR3A	CBR1																															873																																															member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-B0750	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Others|MOABOX:6573|HTR3A|Carbonyl reductase inhibitor;5HT3 antagonist;HTR3A antagonist;\Carbonyl reductase inhibitor;5HT3 antagonist;HTR3A antagonist\	O=C(O[C@@H]1C[C@@H]2CC3C[C@H](C1)[N@]2CC3=O)c4c[nH]c5ccccc45	115956-12-2	25495	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469338	324.3737	DOLASETRON MESYLATE	DOLASETRON MESYLATE | DOLASETRON MESYLATE	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Others	MOABOX:6573	HTR3A	Carbonyl reductase inhibitor;5HT3 antagonist;HTR3A antagonist;\Carbonyl reductase inhibitor;5HT3 antagonist;HTR3A antagonist\
SJ001034969-1	SJ001034969	1	MOABOX:6803	TVZCRIROJQEVOT-CABCVRRESA-N	CC1(C)Oc2ccc(C#N)cc2[C@@H](N2CCCC2=O)[C@@H]1O	94470-67-4	"Potassium channel stimulator;K(ATP) channel activator;""Potassium channel stimulator;K(ATP) channel activator"""	KCNJ11	KCNJ8																															3764																															CHEMBL100											93504	68114124	68727051	76968376		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	-0.7091																															0.0	-0.1013																															7	7																															CS-6950	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-883-719|MOABOX:6803|KCNJ11|Potassium channel stimulator;K(ATP) channel activator;\Potassium channel stimulator;K(ATP) channel activator\	CC1(C)Oc2ccc(cc2[C@H]([C@@H]1O)N3CCCC3=O)C#N	94535-50-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468395	286.32572	LEVCROMAKALIM	LEVCROMAKALIM | LEVCROMAKALIM			MOABOX:6803	KCNJ11	Potassium channel stimulator;K(ATP) channel activator;\Potassium channel stimulator;K(ATP) channel activator\
SJ001035083-1	SJ001035083	1	MOABOX:7141	VZMLEMYJUIIHNF-QURGRASLSA-N	CCC(=O)Oc1ccc(/C(CC)=C(\CC)c2ccc(OC(=O)CC)cc2)cc1	130-80-3	Estrogen Receptor Agonist	ESR1																																																															CHEMBL1525298											657220	70562071				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.75929																																0.10847																																7																																STK366319	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-837-192|MOABOX:7141|ESR1|Estrogen Receptor Agonist	CCC(=O)Oc1ccc(cc1)\C(=C(/CC)\c2ccc(OC(=O)CC)cc2)\CC	130-80-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468619	380.47672	STK366319	STK366319 | STK366319			MOABOX:7141	ESR1	Estrogen Receptor Agonist
SJ000288334-2	SJ000288334	2	MOABOX:7179	OQAFDLPAPSSOHY-UHFFFAOYSA-N	CS(=O)(=O)N(Cc1ccco1)CC(O)Cn1c2ccccc2c2ccccc21	309928-48-1	"CRY1, CRY2 stabilizer"	CRY1	CRY2																															1408																															CHEMBL1498001											2888648					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.6363	0																															0.0909	0.0																															7	7																															PHAR012828	PHARMEKS	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-687-454|MOABOX:7179|CRY1|CRY1, CRY2 stabilizer"	CS(=O)(=O)N(CC(O)Cn1c2ccccc2c3ccccc13)Cc4occc4	309928-48-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468105	398.47538					MOABOX:7179	CRY1	"CRY1, CRY2 stabilizer"
SJ000951734-2	SJ000951734	2	MOABOX:7198	NOFOAYPPHIUXJR-APNQCZIXSA-N	C[C@]12CC[C@@H](O)[C@@](C)(CO)[C@@H]1CC[C@H]1C[C@@H]3C[C@@]12CC[C@]3(O)CO	38966-21-1	Inhibitor of DNA polymerase alpha;DNA polymerase alpha inhibitor	POLA1																																																															CHEMBL29711											457964	499877	66718958	67110357	67685126	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.12733																																0.01819																																7																																HY-N6733	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Apoptosis; Cell Cycle/DNA Damage | Research Area: Infection; Inflammation/Immunology|MOABOX:7198|POLA1|Inhibitor of DNA polymerase alpha;DNA polymerase alpha inhibitor	C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H]1CC[C@H]3C[C@@H]4C[C@]23CC[C@]4(O)CO	38966-21-1	91082	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469709	338.48156	(+)-APHIDICOLIN	(+)-APHIDICOLIN | (+)-APHIDICOLIN	Pathway: Anti-infection; Apoptosis; Cell Cycle/DNA Damage	Research Area: Infection; Inflammation/Immunology	MOABOX:7198	POLA1	Inhibitor of DNA polymerase alpha;DNA polymerase alpha inhibitor
SJ001033344-2	SJ001033344	2	MOABOX:7306	PKKNCEXEVUFFFI-UHFFFAOYSA-N	CC(C)c1cccc(C(C)C)c1NC(=O)NCC1(c2ccc(N(C)C)cc2)CCCC1	133825-81-7	SOAT-2 inhibitor	SOAT1	SOAT2																															8435																															CHEMBL46423	CHEMBL542103										131678	131679				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	-0.45017																															0.0	-0.06431																															7	7																															HY-100399A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:7306|SOAT1|SOAT-2 inhibitor	CC(C)c1cccc(C(C)C)c1NC(=O)NCC2(CCCC2)c3ccc(cc3)N(C)C	133825-81-7	40808	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469594	421.61806	NEVANIMIBE HYDROCHLORIDE; PD-132301 HYDROCHLORIDE; ATR101 HYDROCHLORIDE	NEVANIMIBE HYDROCHLORIDE; PD-132301 HYDROCHLORIDE; ATR101 HYDROCHLORIDE | NEVANIMIBE HYDROCHLORIDE; PD-132301 HYDROCHLORIDE; ATR101 HYDROCHLORIDE	Pathway: Apoptosis; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:7306	SOAT1	SOAT-2 inhibitor
SJ000855297-2	SJ000855297	2	MOABOX:7486	HINJNZFCMLSBCI-MJGOQNOKSA-N	CN(C)C(=O)[C@@H](O)[C@@H](Cc1ccccc1)NC(=O)c1cc2cc(Cl)ccc2[nH]1		PYGL Inhibitor	PYGL																																																															CHEMBL317026											10668660					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					3.20712																																0.45816																																7																																17709	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-293-515|MOABOX:7486|PYGL|PYGL Inhibitor	CN(C)C(=O)[C@H](O)[C@H](Cc1ccccc1)NC(=O)c2cc3cc(Cl)ccc3[nH]2	186392-40-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468309	399.87068	CP-91149	CP-91149 | CP-91149			MOABOX:7486	PYGL	PYGL Inhibitor
SJ000870759-2	SJ000870759	2	MOABOX:7513	NVNSXBXKNMWKEJ-UHFFFAOYSA-N	O=C1C(=Cc2ccc(-c3ccccc3[N+](=O)[O-])o2)C(=O)N(c2ccccc2)C(=S)N1c1ccccc1	313649-08-0	Omi/HtrA2 Inhibitor	HTRA2																																																															CHEMBL2430327											1102771					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																5568252	CHEMBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-932-835|MOABOX:7513|HTRA2|Omi/HtrA2 Inhibitor	[O-][N+](=O)c1ccccc1c2oc(C=C3C(=O)N(C(=S)N(C3=O)c4ccccc4)c5ccccc5)cc2	313649-08-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468443	495.50598	UCF 101	UCF 101 | UCF 101			MOABOX:7513	HTRA2	Omi/HtrA2 Inhibitor
SJ000821843-6	SJ000821843	6	MOABOX:17715	OOUGLTULBSNHNF-UHFFFAOYSA-N	O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1	775304-57-9	Putative translational readthrough (TRT) molecule;Nonsense Mutation Suppressors;modulator of translational readthrough	CFTR																																																															CHEMBL256997											11219835	91884623				member	10.1002/14651858.CD012040.pub2.																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				-0.23086																																-0.03298																																7																																AG005T7O	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-170-046|MOABOX:17715|CFTR|Putative translational readthrough (TRT) molecule;Nonsense Mutation Suppressors;modulator of translational readthrough	OC(=O)c1cccc(c1)c2noc(n2)c3ccccc3F	775304-57-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468392	284.24196	ATALUREN	ATALUREN | PTC124 | ATALUREN (PTC124) | ATALUREN | PTC124 | ATALUREN (PTC124)			MOABOX:17715	CFTR	Putative translational readthrough (TRT) molecule;Nonsense Mutation Suppressors;modulator of translational readthrough
SJ000784275-3	SJ000784275	3	MOABOX:18374	JGRPKOGHYBAVMW-UHFFFAOYSA-N	O=C(O)c1ccc(O)c2ncccc12	5852-78-8	broad-spectrum inhibitor of 2OG oxygenases	KDM2A																																																															CHEMBL1230640											459617	122163420	122236270			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.10066																																-0.01438																																7																																HY-12304	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics | Research Area: Cancer|MOABOX:18374|KDM2A|broad-spectrum inhibitor of 2OG oxygenases	OC(=O)c1ccc(O)c2ncccc12	5852-78-8	86570	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469302	189.16748	IOX1	"IOX1 | ""SID 85736331 | 5-CARBOXY-8-HYDROXYQUINOLINE"" | IOX1 | ""SID 85736331 | 5-CARBOXY-8-HYDROXYQUINOLINE"""	Pathway: Epigenetics	Research Area: Cancer	MOABOX:18374	KDM2A	broad-spectrum inhibitor of 2OG oxygenases
SJ001033185-2	SJ001033185	2	MOABOX:42	MUFJHYRCIHHATF-UHFFFAOYSA-N	O=C(O)CC1CC(c2ccccc2)=NO1	6501-72-0	Cytokine Modulators	TLR4																																																															CHEMBL1320667											10798271					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-15507	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Immunology/Inflammation | Research Area: Metabolic Disease; Inflammation/Immunology|MOABOX:42|TLR4|Cytokine Modulators	OC(=O)CC1CC(=NO1)c2ccccc2	6501-72-0	11461	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469478	205.20994	VGX-1027; GIT 27	VGX-1027; GIT 27 | VGX-1027; GIT 27	Pathway: Apoptosis; Immunology/Inflammation	Research Area: Metabolic Disease; Inflammation/Immunology	MOABOX:42	TLR4	Cytokine Modulators
SJ001035056-1	SJ001035056	1	MOABOX:72	JOWMTYWOBJALGB-KYZUINATSA-N	C[C@H]1CC[C@H](C(=O)CCC(=O)O)CC1	195137-72-5	"""K(ATP) Channel Blockers;Insulin Secretagogues"";K(ATP) Channel Blockers;Insulin Secretagogues"	KCNJ8	KCNJ11	ABCC8	ABCC9																													3767	6833	10060																													CHEMBL149959																member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0																													0.0	0.0	0.0	0.0																													7	7	7	7																													EN300-257275	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-026-972-200|MOABOX:72|KCNJ8|\K(ATP) Channel Blockers;Insulin Secretagogues\;K(ATP) Channel Blockers;Insulin Secretagogues	CC1CCC(CC1)C(=O)CCC(=O)O	220203-23-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468561	198.25882	EN300-257275	EN300-257275 | EN300-257275			MOABOX:72	KCNJ8	\K(ATP) Channel Blockers;Insulin Secretagogues\;K(ATP) Channel Blockers;Insulin Secretagogues
SJ000855198-5	SJ000855198	5	MOABOX:212	LBHIOVVIQHSOQN-UHFFFAOYSA-N	O=C(NCCO[N+](=O)[O-])c1cccnc1	65141-45-9	"""Nitrate;Natriuretic peptide receptor A agonist;Vasodilator;K(ATP) Channel Activators"";Nitrate;Natriuretic peptide receptor A agonist;Vasodilator;K(ATP) Channel Activators"	NPR1																																																															CHEMBL284906											47528	3017561	19762097	67362425	67364223	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HS-0049	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	[O-][N+](=O)OCCNC(=O)c1cccnc1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466722	211.17476	NICORANDIL	NICORANDIL | NICORANDIL			MOABOX:212	NPR1	"""Nitrate;Natriuretic peptide receptor A agonist;Vasodilator;K(ATP) Channel Activators"";Nitrate;Natriuretic peptide receptor A agonist;Vasodilator;K(ATP) Channel Activators"
SJ000287268-4	SJ000287268	4	MOABOX:314	DCSUBABJRXZOMT-IRLDBZIGSA-N	COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1CCN(CCCOc2ccc(F)cc2)C[C@@H]1OC	104860-66-4	alpha-Adrenoceptor Antagonists	ADRA1B																																																															CHEMBL1546244	CHEMBL560739										6917697	6917698	11764377	21967310	67721143	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																AG00500Y	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-451|MOABOX:314|ADRA1B|alpha-Adrenoceptor Antagonists	CO[C@H]1CN(CCCOc2ccc(F)cc2)CC[C@H]1NC(=O)c3cc(Cl)c(N)cc3OC	81098-60-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468622	465.94546	CISAPRIDE	CISAPRIDE | CISAPRIDE MONOHYDRATE | CISAPRIDE | CISAPRIDE MONOHYDRATE			MOABOX:314	ADRA1B	alpha-Adrenoceptor Antagonists
SJ001034660-1	SJ001034660	1	MOABOX:330	KQFRTJUIRPBBAB-UHFFFAOYSA-N	Clc1cccc(N2CCNCC2)n1	87394-54-5	alpha-Adrenoceptor Antagonists	ADRA1B																																																															CHEMBL45773											3024498	3024499				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																6B-103	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Clc1cccc(n1)N2CCNCC2	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466771	197.66468	6B-103	6B-103 | 6B-103			MOABOX:330	ADRA1B	alpha-Adrenoceptor Antagonists
SJ000831427-4	SJ000831427	4	MOABOX:336	SVJMLYUFVDMUHP-UHFFFAOYSA-N	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1	102993-22-6	"""Adrenergic receptor modulator;Calcium Channel Blockers"";Adrenergic receptor modulator;Calcium Channel Blockers"	ADRA1B	CACNA1I	CACNA1H	CACNA1G																													8911	8912	8913																													CHEMBL1275655	CHEMBL1965632										1236	357904	44275635			virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					9.282e-002	8.176e-002	7.756e-002	8.176e-002																													0.01326	0.01168	0.01108	0.01168																													7	7	7	7																													1123	TOCRIS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-958-916|MOABOX:336|ADRA1B|\Adrenergic receptor modulator;Calcium Channel Blockers\;Adrenergic receptor modulator;Calcium Channel Blockers	COC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OCCCN3CCC(CC3)(c4ccccc4)c5ccccc5)C	102993-22-6	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468234	609.71136	NIGULDIPINE	NIGULDIPINE | NIGULDIPINE			MOABOX:336	ADRA1B	\Adrenergic receptor modulator;Calcium Channel Blockers\;Adrenergic receptor modulator;Calcium Channel Blockers
SJ001034844-1	SJ001034844	1	MOABOX:364	XVHTYXUNNDYUPK-MRXNPFEDSA-N	COc1ccccc1[C@@H]1CCN(Cc2ccc3c(c2)OCCO3)C1	352312-63-1	alpha2-Adrenoceptor Antagonists	ADRA2A																																																																										9945160					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																Z1241450951	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-859-192|MOABOX:364|ADRA2A|alpha2-Adrenoceptor Antagonists	COc1ccccc1C2CCN(Cc3ccc4OCCOc4c3)C2	352312-63-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468087	325.40152	Z1241450951	Z1241450951 | Z1241450951			MOABOX:364	ADRA2A	alpha2-Adrenoceptor Antagonists
SJ001035118-1	SJ001035118	1	MOABOX:426	MTFDMQASMMCFHB-UHFFFAOYSA-N	O=C(O)CNS(=O)(=O)c1ccc2ccccc2c1	92740-48-2	Aldose Reductase Inhibitors	AKR1A1																																																															CHEMBL288077											702481					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																AG-690/11669240	SPECS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-566-948|MOABOX:426|AKR1A1|Aldose Reductase Inhibitors	OC(=O)CNS(=O)(=O)c1ccc2ccccc2c1	92740-48-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468725	265.28504	AG-690/11669240	AG-690/11669240 | AG-690/11669240			MOABOX:426	AKR1A1	Aldose Reductase Inhibitors
SJ000287708-7	SJ000287708	7	MOABOX:558	WWUZIQQURGPMPG-KRWOKUGFSA-N	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO	10140-30-4	Ceramidase Inhibitors	ASAH1																																																															CHEMBL67166											5280335	12359048	17998971	66583563	68464114	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																CS-0020759	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-850-275|MOABOX:558|ASAH1|Ceramidase Inhibitors	CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO	123-78-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468447	299.49188	SPHINGOSINE	SPHINGOSINE | SPHINGOSINE			MOABOX:558	ASAH1	Ceramidase Inhibitors
SJ000541094-8	SJ000541094	8	MOABOX:840	ZKFQEACEUNWPMT-UHFFFAOYSA-N	CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1	123524-52-7	Calcium Channel Blockers	CACNA1S																																																															CHEMBL1275868											65948	11274703	14405120	16118999	16750173	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-B0023	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Cardiovascular Disease|MOABOX:840|CACNA1S|Calcium Channel Blockers	CC(C)OC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC3CN(C3)C(c4ccccc4)c5ccccc5)N	123524-52-7	7190	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469269	582.64626	AZELNIDIPINE	"AZELNIDIPINE | ""RS-9054 | CS-905"" | AZELNIDIPINE | ""RS-9054 | CS-905"""	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Cardiovascular Disease	MOABOX:840	CACNA1S	Calcium Channel Blockers
SJ000312336-8	SJ000312336	8	MOABOX:1266	HXGBXQDTNZMWGS-UHFFFAOYSA-N	NC(=O)C(c1ccccc1)(c1ccccc1)C1CCN(CCc2ccc3c(c2)CCO3)C1	133099-04-4	Muscarinic M5 receptor antagonist	CHRM5																																																																										72054	21883196	22340519	22340520	51371305	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-A0012	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Neuronal Signaling | Research Area: Neurological Disease; Cancer|MOABOX:1266|CHRM5|Muscarinic M5 receptor antagonist	NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c4ccccc4)c5ccccc5	133099-07-7	11	GENERAL	BROMIDE	1	NO_SOLVATE	0	1469315	426.55	DARIFENACIN HYDROBROMIDE	"DARIFENACIN HYDROBROMIDE | ""DARIFENACIN HYDROBROMIDE | 2-(1-(2-(2,3-DIHYDROBENZOFURAN-5-YL)ETHYL)PYRROLIDIN-3-YL)-2,2-DIPHENYLACETAMIDE"" | DARIFENACIN HBR | DARIFENACIN HYDROBROMIDE | ""DARIFENACIN HYDROBROMIDE | 2-(1-(2-(2,3-DIHYDROBENZOFURAN-5-YL)ETHYL)PYRROLIDIN-3-YL)-2,2-DIPHENYLACETAMIDE"" | DARIFENACIN HBR"	Pathway: GPCR/G Protein; Neuronal Signaling	Research Area: Neurological Disease; Cancer	MOABOX:1266	CHRM5	Muscarinic M5 receptor antagonist
SJ000833130-2	SJ000833130	2	MOABOX:1270	CJAWPFJGFFNXQI-UHFFFAOYSA-N	Clc1cncc(N2CCNCC2)n1	61655-58-1	5-HT2C Agonists	CHRNA1	CHRNA2	CHRNA3	CHRNA5	CHRNB1	CHRNB3	CHRNB4	CHRND	CHRNE	CHRNG	CHRNA6	CHRNA9	CHRNA10																				1135	1136	1138	1140	1142	1143	1144	1145	1146	8973	55584	57053																				CHEMBL269521	CHEMBL3250751										107992	198421	86600710	88925775		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0	0	0	0	0	0	0	0	0	0																				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0																				7	7	7	7	7	7	7	7	7	7	7	7	7																				BD140208	BLDPHARM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-009-681-474|MOABOX:1270|CHRNA1|5-HT2C Agonists	Clc1cncc(n1)N2CCNCC2	64022-27-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468727	198.65274	MK 212 HCL	MK 212 HCL | MK 212 HCL			MOABOX:1270	CHRNA1	5-HT2C Agonists
SJ000285582-11	SJ000285582	11	MOABOX:1274	PVNIIMVLHYAWGP-UHFFFAOYSA-N	O=C(O)c1cccnc1	101113-41-1	Nicotinic receptor agonist	CHRNA1	CHRNA2	CHRNA3	CHRNA5	CHRNB1	CHRNB3	CHRNB4	CHRND	CHRNE	CHRNG	CHRNA6	CHRNA9	CHRNA10																				1135	1136	1138	1140	1142	1143	1144	1145	1146	8973	55584	57053																				CHEMBL1988337	CHEMBL573										938	71558	168970	409437	3950314	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0	0	0	0	0	0	0	0	0	0																				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0																				7	7	7	7	7	7	7	7	7	7	7	7	7																				PS-4255	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	OC(=O)c1cccnc1	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466741	123.1094	NIACIN	NIACIN | NICOTINIC ACID | NIACIN | NICOTINIC ACID			MOABOX:1274	CHRNA1	Nicotinic receptor agonist
SJ001035064-1	SJ001035064	1	MOABOX:1278	PXXYOLIWFSWZNP-UHFFFAOYSA-P	COc1cc2c3cc1Oc1cc(ccc1O)CC1c4c(cc(OC)c(O)c4Oc4ccc(cc4)CC3[N+](C)(C)CC2)CC[N+]1(C)C	1398-92-1	"""Relaxant;nicotinic acetylcholine receptor antagonist"";Relaxant;nicotinic acetylcholine receptor antagonist"	CHRNA2																																																																										411885	10372191	12359187	75062533	129667904	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																PHAR008788	PHARMEKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-703-191|MOABOX:1278|CHRNA2|\Relaxant;nicotinic acetylcholine receptor antagonist\;Relaxant;nicotinic acetylcholine receptor antagonist	COc1cc2CC[N+](C)(C)[C@@H]3Cc4ccc(O)c(Oc5cc6[C@H](Cc7ccc(Oc(c1O)c23)cc7)[N+](C)(C)CCc6cc5OC)c4	1398-92-1	NA	GENERAL	CHLORIDE	2	H2O	5	1468571	624.76576	PHAR008788	PHAR008788 | PHAR008788			MOABOX:1278	CHRNA2	\Relaxant;nicotinic acetylcholine receptor antagonist\;Relaxant;nicotinic acetylcholine receptor antagonist
SJ001035314-1	SJ001035314	1	MOABOX:1376	SRPNQDXRVRCTNK-UHFFFAOYSA-N	CC(C)(C)C(=O)NCCCC(=O)O	69542-93-4	CRF Receptor Antagonists	CRHR1	CRHR2																															1395																															CHEMBL1870796											68888	143686096	143686106			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-108295	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling | Research Area: Neurological Disease|MOABOX:1376|CRHR1|CRF Receptor Antagonists	CC(C)(C)C(=O)NCCCC(=O)O	69542-93-4	58954	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469553	187.23618	PIVAGABINE | CXB-722	"""PIVAGABINE | CXB-722"" | ""PIVAGABINE | CXB-722"""	Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling	Research Area: Neurological Disease	MOABOX:1376	CRHR1	CRF Receptor Antagonists
SJ000849540-2	SJ000849540	2	MOABOX:1480	GPLUUMAKBFSDIE-KRWDZBQOSA-N	NC(=O)c1ccc(CNC(=O)NC[C@H]2CN(Cc3ccc(Cl)c(Cl)c3)CCO2)cc1	408303-43-5	Chemokine CCR3 Antagonists	CXCR3																																																																										10218764	10218765	69069597	69507384	69528995	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-107051	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein; Immunology/Inflammation | Research Area: Inflammation/Immunology; Endocrinology|MOABOX:1480|CXCR3|Chemokine CCR3 Antagonists	NC(=O)c1ccc(CNC(=O)NC[C@H]2CN(Cc3ccc(Cl)c(Cl)c3)CCO2)cc1	408303-43-5	41029	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469690	451.34626	GW766994	GW766994 | GW766994	Pathway: GPCR/G Protein; Immunology/Inflammation	Research Area: Inflammation/Immunology; Endocrinology	MOABOX:1480	CXCR3	Chemokine CCR3 Antagonists
SJ000287596-5	SJ000287596	5	MOABOX:1560	JCXKHYLLVKZPKE-UHFFFAOYSA-N	Nn1nnc2ccccc21	1614-12-6	Cytochrome P450 Inhibitors	CYP2W1																																																															CHEMBL101168											1367	88680435	132222912			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-103389	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:1560|CYP2W1|Cytochrome P450 Inhibitors	Nn1nnc2ccccc12	1614-12-6	41043	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469885	134.13864	1-AMINOBENZOTRIAZOLE	1-AMINOBENZOTRIAZOLE | 1-AMINOBENZOTRIAZOLE	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:1560	CYP2W1	Cytochrome P450 Inhibitors
SJ001035046-1	SJ001035046	1	MOABOX:1612	USWLOKMMUTWFMD-UHFFFAOYSA-N	c1cc(-c2sc(-c3ccncc3)c(-c3ccncc3)c2-c2ccncc2)ccn1	143222-43-9	Hedgehog Signaling Inhibitors	GLI1																																																															CHEMBL472994											253078	71344761				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					-0.2562																																-0.0366																																7																																CS-0507	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-824-810|MOABOX:1612|GLI1|Hedgehog Signaling Inhibitors	c1cc(ccn1)c2sc(c3ccncc3)c(c4ccncc4)c2c5ccncc5	64048-12-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468547	392.47564	GANT 58	GANT 58 | GANT 58			MOABOX:1612	GLI1	Hedgehog Signaling Inhibitors
SJ000286018-10	SJ000286018	10	MOABOX:1624	AGBQKNBQESQNJD-SSDOTTSWSA-N	O=C(O)CCCC[C@@H]1CCSS1	1077-27-6	Pyruvate Dehydrogenase Activators	DLAT	PDHA1	PDHA2	PDHB																													5160	5161	5162																													CHEMBL134342											6112	3081262	9817230	9840368	16095367	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0																													0.0	0.0	0.0	0.0																													7	7	7	7																													AA000PZH	AABLOCKS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-520-478|MOABOX:1624|DLAT|Pyruvate Dehydrogenase Activators	OC(=O)CCCC[C@@H]1CCSS1	1200-22-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468274	206.32556	THIOCTIC ACID	THIOCTIC ACID | (±)-ALPHA-LIPOIC ACID | DL-ALPHA-LIPOIC ACID | THIOCTIC ACID | (±)-ALPHA-LIPOIC ACID | DL-ALPHA-LIPOIC ACID			MOABOX:1624	DLAT	Pyruvate Dehydrogenase Activators
SJ001035094-1	SJ001035094	1	MOABOX:1736	YONLFQNRGZXBBF-UHFFFAOYSA-N	O=C(OC(C(=O)O)C(OC(=O)c1ccccc1)C(=O)O)c1ccccc1	100632-52-8	Dopamine D3 Antagonists	DRD3																																																																										86498	299819	299822	419609	2723865	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																AG003BCP	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-001-788-465|MOABOX:1736|DRD3|Dopamine D3 Antagonists	OC(=O)C(OC(=O)c1ccccc1)C(OC(=O)c2ccccc2)C(=O)O	17026-42-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468675	358.29896	AG003BCP	AG003BCP | AG003BCP			MOABOX:1736	DRD3	Dopamine D3 Antagonists
SJ001035041-1	SJ001035041	1	MOABOX:1914	ALGFQPMFHIDLFQ-UHFFFAOYSA-N	Cc1ccc2oc(-c3cc(Br)ccc3O)cc(=O)c2c1	468060-99-3		GABRA1	GABRA2	GABRA3	GABRA4	GABRA5	GABRA6																											2555	2556	2557	2558	2559																											CHEMBL335086											1188139					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0	0	0																											0.0	0.0	0.0	0.0	0.0	0.0																											7	7	7	7	7	7																											7715560102	OTAVA	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-695-869|MOABOX:1914|GABRA1|	Cc1ccc2OC(=CC(=O)c2c1)c3cc(Br)ccc3O	468060-99-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468538	331.16074	7715560102	7715560102 | 7715560102			MOABOX:1914	GABRA1	
SJ001034886-1	SJ001034886	1	MOABOX:2096	IADDKCXMFDEECY-UHFFFAOYSA-N	CCOc1ccc(N=C2C(=O)N(c3ccccc3)c3ccccc32)cc1	1098979-63-5	Galanin receptor type 3 antagonist	GALR3																																																																															member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.26096																																0.03728																																7																																11L-351S	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-854-345|MOABOX:2096|GALR3|Galanin receptor type 3 antagonist	CCOc1ccc(cc1)\N=C\2/C(=O)N(c3ccccc3)c4ccccc24	1098979-63-5	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468186	342.39052	11L-351S	11L-351S | 11L-351S			MOABOX:2096	GALR3	Galanin receptor type 3 antagonist
SJ001034934-1	SJ001034934	1	MOABOX:2098	GUOCQDADKJJVBQ-UHFFFAOYSA-N	O=C1C(=Nc2cc(Cl)cc(Cl)c2)c2ccccc2N1c1ccccc1	303984-51-2		GALR3																																																																															virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																11L-324S	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-854-328|MOABOX:2098|GALR3|	Clc1cc(Cl)cc(c1)\N=C\2/C(=O)N(c3ccccc3)c4ccccc24	303984-51-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468287	367.22808	11L-324S	11L-324S | 11L-324S			MOABOX:2098	GALR3	
SJ000860022-2	SJ000860022	2	MOABOX:2332	WXXSNCNJFUAIDG-UHFFFAOYSA-N	COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N	625115-55-1	Guanylate Cyclase Activators	GUCY1A2																																																															CHEMBL2107834											11304743	53232381	86304290	91755065	91824783	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-14779	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: GPCR/G Protein | Research Area: Cardiovascular Disease|MOABOX:2332|GUCY1A2|Guanylate Cyclase Activators	COC(=O)N(C)c1c(N)nc(nc1N)c2nn(Cc3ccccc3F)c4ncccc24	625115-55-1	6023	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469125	422.41566	RIOCIGUAT | BAY 63-2521 | BAY 632521 |	"""RIOCIGUAT | BAY 63-2521 | BAY 632521 |"" | ""RIOCIGUAT | BAY 63-2521 | BAY 632521 |"""	Pathway: GPCR/G Protein	Research Area: Cardiovascular Disease	MOABOX:2332	GUCY1A2	Guanylate Cyclase Activators
SJ001034641-1	SJ001034641	1	MOABOX:2334	LUGXKWLXOYRDIS-UHFFFAOYSA-N	Nc1nc(-c2ccccn2)nc(N)c1Cc1ccc(Cl)cc1Cl	338965-09-6	"""Hepcidin (LEAP-1) Antagonists;Antianemic;Ferroportin antagonist"";Hepcidin (LEAP-1) Antagonists;Antianemic;Ferroportin antagonist"	SLC40A1																																																															CHEMBL1299757											3379829					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																6K-011	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	Nc1nc(nc(N)c1Cc2ccc(Cl)cc2Cl)c3ccccn3	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466639	346.21392	6K-011	6K-011 | 6K-011			MOABOX:2334	SLC40A1	"""Hepcidin (LEAP-1) Antagonists;Antianemic;Ferroportin antagonist"";Hepcidin (LEAP-1) Antagonists;Antianemic;Ferroportin antagonist"
SJ000785892-3	SJ000785892	3	MOABOX:2338	QDKLRKZQSOQWJQ-SMDXAGPFSA-N	C=C(C)[C@@H](CC=C(C)C)C[C@@]12C[C@@H](CC=C(C)C)C(C)(C)[C@@](CC=C(C)C)(C(=O)C(C(=O)c3ccc(O)c(O)c3)=C1O)C2=O	147782-04-5	"""Apoptosis Inducers;Histone N-Acetyltransferase (HAT) Inhibitors;Antioxidants"";Apoptosis Inducers;Histone N-Acetyltransferase (HAT) Inhibitors;Antioxidants"	HAT1																																																															CHEMBL502489																member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																10566	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-822-457|MOABOX:2338|HAT1|\Apoptosis Inducers;Histone N-Acetyltransferase (HAT) Inhibitors;Antioxidants\;Apoptosis Inducers;Histone N-Acetyltransferase (HAT) Inhibitors;Antioxidants	CC(=CC[C@@H](C[C@@]12C[C@@H](CC=C(C)C)C(C)(C)[C@@](CC=C(C)C)(C(=C(C(=O)c3ccc(O)c(O)c3)C1=O)O)C2=O)C(=C)C)C	78824-30-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468453	602.8	GARCINOL	GARCINOL | GARCINOL			MOABOX:2338	HAT1	\Apoptosis Inducers;Histone N-Acetyltransferase (HAT) Inhibitors;Antioxidants\;Apoptosis Inducers;Histone N-Acetyltransferase (HAT) Inhibitors;Antioxidants
SJ000025189-3	SJ000025189	3	MOABOX:2342	DUBPJEDOCJXVKG-UHFFFAOYSA-N	CCOC(=O)c1cc2ccccc2nc1C	15785-08-7	Histone N-Acetyltransferase (HAT) Inhibitors	HAT1																																																															CHEMBL214673											647634	45047891				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-W008804	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: | Research Area: |MOABOX:2342|HAT1|Histone N-Acetyltransferase (HAT) Inhibitors	CCOC(=O)c1cc2ccccc2nc1C	15785-08-7	66225	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469542	215.24782	MC-1626	MC-1626 | 2-METHYL-QUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER | MC-1626 | 2-METHYL-QUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER	Pathway:	Research Area:	MOABOX:2342	HAT1	Histone N-Acetyltransferase (HAT) Inhibitors
SJ001034968-1	SJ001034968	1	MOABOX:2394	DWIYBCKFYUQVLU-UHFFFAOYSA-N	N#Cc1ccc(-c2ccc(OCCCCCCC(=O)NO)cc2)cc1	191228-04-3	TNF-alpha Production Inhibitors	HDAC9	HDAC5	HDAC7	HDAC8	HDAC11	HDAC10																											10014	51564	55869	79885	83933																											CHEMBL115812											9949740	142276379				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0	0	0																											0.0	0.0	0.0	0.0	0.0	0.0																											7	7	7	7	7	7																											AG002F4R	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-042-682-549|MOABOX:2394|HDAC9|TNF-alpha Production Inhibitors	ONC(=O)CCCCCCOc1ccc(cc1)c2ccc(cc2)C#N	191228-04-3	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468394	338.40028	AG002F4R	AG002F4R | AG002F4R			MOABOX:2394	HDAC9	TNF-alpha Production Inhibitors
SJ000463021-2	SJ000463021	2	MOABOX:2504	DQTMJIUNXVVYJR-IDUWFGFVSA-N	COc1cc(OC)c(OC)cc1/C=C1\Oc2cc(O)ccc2C1=O	256531-54-1	17beta-Hydroxysteroid Dehydrogenase (17beta-HSD)  Inhibitors	HSD17B1	HSD17B4																															3295																																										667730					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															STK923971	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-254-038|MOABOX:2504|HSD17B1|17beta-Hydroxysteroid Dehydrogenase (17beta-HSD) Inhibitors	COc1cc(OC)c(\C=C\2/Oc3cc(O)ccc3C2=O)cc1OC	256531-54-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468539	328.31604					MOABOX:2504	HSD17B1	17beta-Hydroxysteroid Dehydrogenase (17beta-HSD) Inhibitors
SJ001034960-1	SJ001034960	1	MOABOX:2524	MQUYTXDAVCOCMX-UHFFFAOYSA-N	NS(=O)(=O)c1nn2cc(-c3ccccc3)nc2s1	63735-71-7	"""Apoptosis Inhibitors;Stress-Activated Protein (SAP/Jun) Kinase Inhibitors;Heat Shock Protein 70 (hsp70) Inducers"";Apoptosis Inhibitors;Stress-Activated Protein (SAP/Jun) Kinase Inhibitors;Heat Shock Protein 70 (hsp70) Inducers"	HSPA1A																																																															CHEMBL19231											698112	143559988				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																1291	AXON_MEDCHEM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-022-863-704|MOABOX:2524|HSPA1A|\Apoptosis Inhibitors;Stress-Activated Protein (SAP/Jun) Kinase Inhibitors;Heat Shock Protein 70 (hsp70) Inducers\;Apoptosis Inhibitors;Stress-Activated Protein (SAP/Jun) Kinase Inhibitors;Heat Shock Protein 70 (hsp70) Inducers	NS(=O)(=O)c1nn2cc(nc2s1)c3ccccc3	63735-71-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468376	280.32612	AEG 3482	AEG 3482 | AEG 3482			MOABOX:2524	HSPA1A	\Apoptosis Inhibitors;Stress-Activated Protein (SAP/Jun) Kinase Inhibitors;Heat Shock Protein 70 (hsp70) Inducers\;Apoptosis Inhibitors;Stress-Activated Protein (SAP/Jun) Kinase Inhibitors;Heat Shock Protein 70 (hsp70) Inducers
SJ000287668-9	SJ000287668	9	MOABOX:2530	ODZBBRURCPAEIQ-PIXDULNESA-N	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1/C=C/Br	69304-47-8	"""Heat Shock Protein 27 (hsp27) Inhibitors;Reverse Transcriptase Inhibitors"";Heat Shock Protein 27 (hsp27) Inhibitors;Reverse Transcriptase Inhibitors"	HSPB1																																																															CHEMBL31634											446727	5272751	5273433	6479519	6479522	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-13578	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Infection; Cancer|MOABOX:2530|HSPB1|\Heat Shock Protein 27 (hsp27) Inhibitors;Reverse Transcriptase Inhibitors\;Heat Shock Protein 27 (hsp27) Inhibitors;Reverse Transcriptase Inhibitors	OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(\C=C\Br)C(=O)NC2=O	69304-47-8	23884	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469636	333.13532	BRIVUDINE	BRIVUDINE | (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE | BRIVUDINE | (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE	Pathway: Anti-infection	Research Area: Infection; Cancer	MOABOX:2530	HSPB1	\Heat Shock Protein 27 (hsp27) Inhibitors;Reverse Transcriptase Inhibitors\;Heat Shock Protein 27 (hsp27) Inhibitors;Reverse Transcriptase Inhibitors
SJ000287589-5	SJ000287589	5	MOABOX:2576	NNAIYOXJNVGUOM-UHFFFAOYSA-N	CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1	75529-73-6	"""5-HT2A Antagonists;Dopamine D2 Antagonists"";5-HT2A Antagonists;Dopamine D2 Antagonists"	HTR1E	HTR1F																															3355																															CHEMBL1079935	CHEMBL1257106	CHEMBL2092874									73333	73334	50986842	51371113	70682892	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															SYN5499	AK_SCIENTIFIC	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-983-867|MOABOX:2576|HTR1E|\5-HT2A Antagonists;Dopamine D2 Antagonists\;5-HT2A Antagonists;Dopamine D2 Antagonists	CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c3ccc(F)cc3)CC1	86725-37-3	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468260	401.49267	AMPEROZIDE HYDROCHLORIDE	AMPEROZIDE HYDROCHLORIDE | AMPEROZIDE HCL | AMPEROZIDE HYDROCHLORIDE | AMPEROZIDE HCL			MOABOX:2576	HTR1E	\5-HT2A Antagonists;Dopamine D2 Antagonists\;5-HT2A Antagonists;Dopamine D2 Antagonists
SJ000855172-4	SJ000855172	4	MOABOX:3106	VPBYZLCHOKSGRX-UHFFFAOYSA-N	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl	286370-15-8	"""Angiogenesis Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-2 (FLK-1/KDR) Inhibitors"";Angiogenesis Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-2 (FLK-1/KDR) Inhibitors"	MAPK4	MAPK6	MAPK7	MAPK12	MAPK15																												5597	5598	6300	225689																												CHEMBL406381											9549295	11339964				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0	0																												0.0	0.0	0.0	0.0	0.0																												7	7	7	7	7																												HY-12060	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:3106|MAPK4|\Angiogenesis Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-2 (FLK-1/KDR) Inhibitors\;Angiogenesis Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-2 (FLK-1/KDR) Inhibitors	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl	286370-15-8	13485	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469586	416.85814	KRN 633	KRN 633 | KRN 633	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:3106	MAPK4	\Angiogenesis Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-2 (FLK-1/KDR) Inhibitors\;Angiogenesis Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-2 (FLK-1/KDR) Inhibitors
SJ001034981-1	SJ001034981	1	MOABOX:3162	KMWOUFLMUAYYDF-CAOOACKPSA-N	O=C(CNC(=O)c1cccs1)N/N=C/c1ccc(C(=O)O)cc1		Methionyl-tRNA Synthetase Inhibitors	MARS1																																																															CHEMBL214826											9661196					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																1286-0243	CHEMDIV	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-007-550-101|MOABOX:3162|MARS1|Methionyl-tRNA Synthetase Inhibitors	OC(=O)c1ccc(\C=N\NC(=O)CNC(=O)c2cccs2)cc1	1322262-99-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468423	331.34642	1286-0243	1286-0243 | 1286-0243			MOABOX:3162	MARS1	Methionyl-tRNA Synthetase Inhibitors
SJ000784301-8	SJ000784301	8	MOABOX:3662	SZFPYBIJACMNJV-UHFFFAOYSA-O	CCCCCCCCCCCCCCCCCCOP(=O)(O)OC1CC[N+](C)(C)CC1	157716-52-4	"""Apoptosis Inducers;Protein Kinase B (PKB/Akt) Inhibitors"";Apoptosis Inducers;Protein Kinase B (PKB/Akt) Inhibitors"	AKT1																																																																										148178	69769151				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					1.197e-002																																0.00171																																7																																HY-50909	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; PI3K/Akt/mTOR | Research Area: Cancer | DISSOLVED IN H2O|MOABOX:3662|AKT1|\Apoptosis Inducers;Protein Kinase B (PKB/Akt) Inhibitors\;Apoptosis Inducers;Protein Kinase B (PKB/Akt) Inhibitors	CCCCCCCCCCCCCCCCCCOP(=O)(O)OC1CC[N+](C)(C)CC1	157716-52-4	8415	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469746	462.66638	PERIFOSINE	"PERIFOSINE | ""NSC-639966 | D-21266 | KRK-0401 | NKA17"" | ""PERIFOSINE | KRX-0401 | NKA17 |"" | PERIFOSINE | ""NSC-639966 | D-21266 | KRK-0401 | NKA17"" | ""PERIFOSINE | KRX-0401 | NKA17 |"""	Pathway: Apoptosis; Autophagy; PI3K/Akt/mTOR	Research Area: Cancer	MOABOX:3662	AKT1	
SJ000286942-2	SJ000286942	2	MOABOX:3894	DSCFFEYYQKSRSV-KLJZZCKASA-N	CO[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O	10284-63-6	gamma-Secretase Inhibitors	PSENEN																																																															CHEMBL493737																member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-N0655	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Infection; Inflammation/Immunology; Cardiovascular Disease|MOABOX:3894|PSENEN|gamma-Secretase Inhibitors	CO[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O	10284-63-6	61943	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469841	194.18246	QUEBRACHITOL	QUEBRACHITOL | QUEBRACHITOL	Pathway: Anti-infection	Research Area: Infection; Inflammation/Immunology; Cardiovascular Disease	MOABOX:3894	PSENEN	gamma-Secretase Inhibitors
SJ000855284-2	SJ000855284	2	MOABOX:3910	QSHGISMANBKLQL-OWJWWREXSA-N	C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@@H]1C(=O)N(C)c2ccccc2-c2ccccc21	209984-56-5	"""Antiamyloidogenic Agents;gamma-Secretase Inhibitors;Notch Signaling Inhibitors"";Antiamyloidogenic Agents;gamma-Secretase Inhibitors;Notch Signaling Inhibitors"	APH1A	PSENEN	APH1B																														55851	83464																																									11454028	57375694				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0																														0.0	0.0	0.0																														7	7	7																														HY-13526	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Neuronal Signaling; Stem Cell/Wnt | Research Area: Cancer|MOABOX:3910|APH1A|\Antiamyloidogenic Agents;gamma-Secretase Inhibitors;Notch Signaling Inhibitors\;Antiamyloidogenic Agents;gamma-Secretase Inhibitors;Notch Signaling Inhibitors	C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@@H]2C(=O)N(C)c3ccccc3c4ccccc24	209984-56-5	31704	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469259	463.47593	YO-01027	YO-01027 | YO-01027	Pathway: Neuronal Signaling; Stem Cell/Wnt	Research Area: Cancer	MOABOX:3910	APH1A	\Antiamyloidogenic Agents;gamma-Secretase Inhibitors;Notch Signaling Inhibitors\;Antiamyloidogenic Agents;gamma-Secretase Inhibitors;Notch Signaling Inhibitors
SJ000855410-4	SJ000855410	4	MOABOX:4182	SOYCMDCMZDHQFP-UHFFFAOYSA-N	Nc1c(CC(=O)O)cccc1C(=O)c1ccccc1	51579-82-9	Non-Steroidal Antiinflammatory Drugs	SC5D																																																															CHEMBL25146											2136	67919504	68003772	126963341	140324015	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					6.58e-002																																0.0094																																7																																HY-17479A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Inflammation/Immunology|MOABOX:4182|SC5D|Non-Steroidal Antiinflammatory Drugs	Nc1c(CC(=O)O)cccc1C(=O)c2ccccc2	61618-27-7	28487	GENERAL	SODIUM(I)	1	H2O	1	1469544	255.26862	AMFENAC SODIUM MONOHYDRATE	AMFENAC SODIUM MONOHYDRATE | AMFENAC SODIUM MONOHYDRATE	Pathway: Immunology/Inflammation	Research Area: Inflammation/Immunology	MOABOX:4182	SC5D	Non-Steroidal Antiinflammatory Drugs
SJ000286979-3	SJ000286979	3	MOABOX:4362	MBRLOUHOWLUMFF-UHFFFAOYSA-N	COc1ccc2ccc(=O)oc2c1CC=C(C)C	1440642-68-1	ACAT Inhibitors	SOAT1																																																															CHEMBL52229											10228	87436876	118878636	143778654	143778668	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																DS-0881	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	COc1ccc2C=CC(=O)Oc2c1CC=C(C)C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466830	244.28574	OSTHOL	OSTHOL | OSTHOLE | OSTHOL | OSTHOLE			MOABOX:4362	SOAT1	ACAT Inhibitors
SJ000861337-5	SJ000861337	5	MOABOX:4376	VPHPQNGOVQYUMG-UHFFFAOYSA-N	COc1cccc(N(C)C(=S)Oc2ccc3c(c2)CCCC3)n1	88678-31-3	Fungal Squalene Monooxygenase Inhibitors	SQLE																																																															CHEMBL1591365											3936					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-B0348	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection | Research Area: Infection|MOABOX:4376|SQLE|Fungal Squalene Monooxygenase Inhibitors	COc1cccc(n1)N(C)C(=S)Oc2ccc3CCCCc3c2	88678-31-3	13494	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469131	328.4286	LIRANAFTATE	LIRANAFTATE | LIRANAFTATE	Pathway: Anti-infection	Research Area: Infection	MOABOX:4376	SQLE	Fungal Squalene Monooxygenase Inhibitors
SJ000285424-18	SJ000285424	18	MOABOX:4388	VOXZDWNPVJITMN-SFFUCWETSA-N	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@H]2O	50-28-2	"""Estrogen Receptor (ER) Agonists;Steroid 5alpha-Reductase Inhibitors"";Estrogen Receptor (ER) Agonists;Steroid 5alpha-Reductase Inhibitors"	SRD5A1	SRD5A2																															6716																															CHEMBL1627817	CHEMBL286452	CHEMBL3349337									68570	16213098	53317240	66706146	68839938	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-B0141	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease; Others | Research Area: Endocrinology; Cancer|MOABOX:4388|SRD5A1|\Estrogen Receptor (ER) Agonists;Steroid 5alpha-Reductase Inhibitors\;Estrogen Receptor (ER) Agonists;Steroid 5alpha-Reductase Inhibitors	C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	50-28-2	25250	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469678	272.38196	ESTRADIOL	ESTRADIOL | 17-ALPHA-ESTRADIOL | 17-BETA-ESTRADIOL | 17B-ESTRADIOL | ESTRADIOL | 17-ALPHA-ESTRADIOL | 17-BETA-ESTRADIOL | 17B-ESTRADIOL	Pathway: Metabolic Enzyme/Protease; Others	Research Area: Endocrinology; Cancer	MOABOX:4388	SRD5A1	\Estrogen Receptor (ER) Agonists;Steroid 5alpha-Reductase Inhibitors\;Estrogen Receptor (ER) Agonists;Steroid 5alpha-Reductase Inhibitors
SJ000832106-2	SJ000832106	2	MOABOX:4614	BXBNADAPIHHXJQ-UHFFFAOYSA-N	O=C(c1ccc2c(c1)OCO2)N1CCCCC1	34023-62-6	AMPA Receptor Postiive Allosteric Modulators	GRIA1	GRIA2	GRIA3	GRIA4																													2891	2892	2893																													CHEMBL103469											1370					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0																													0.0	0.0	0.0	0.0																													7	7	7	7																													STK296800	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-999-395|MOABOX:4614|GRIA1|AMPA Receptor Postiive Allosteric Modulators	O=C(N1CCCCC1)c2ccc3OCOc3c2	34023-62-6	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468179	233.2631	"1-(1,3-BENZODIOXOL-5-YLCARBONYLPIPERIDINE"	"1-(1,3-BENZODIOXOL-5-YLCARBONYLPIPERIDINE | 1-(1,3-BENZODIOXOL-5-YLCARBONYLPIPERIDINE"			MOABOX:4614	GRIA1	AMPA Receptor Postiive Allosteric Modulators
SJ000836350-5	SJ000836350	5	MOABOX:4628	QXRSDHAAWVKZLJ-PVYNADRNSA-N	C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1	152044-54-7	"""Apoptosis Inducers;Antimitotic Drugs;Microtubule-Stabilizing Agents"";Apoptosis Inducers;Antimitotic Drugs;Microtubule-Stabilizing Agents"	TUBB																																																															CHEMBL1983958	CHEMBL94657										448013	9811698	9833067	9918618	9919482	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-17029	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton | Research Area: Cancer; Infection|MOABOX:4628|TUBB|\Apoptosis Inducers;Antimitotic Drugs;Microtubule-Stabilizing Agents\;Apoptosis Inducers;Antimitotic Drugs;Microtubule-Stabilizing Agents	C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(=C\c3csc(C)n3)\C	152044-54-7	30475	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469266	507.68254	EPOTHILONE B	"EPOTHILONE B | EPOTHILONE B (EPO906, PATUPILONE) | EPOTHILONE B | EPOTHILONE B (EPO906, PATUPILONE)"	Pathway: Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton	Research Area: Cancer; Infection	MOABOX:4628	TUBB	\Apoptosis Inducers;Antimitotic Drugs;Microtubule-Stabilizing Agents\;Apoptosis Inducers;Antimitotic Drugs;Microtubule-Stabilizing Agents
SJ001034875-1	SJ001034875	1	MOABOX:4720	RSOZZQTUMVBTMR-XGUNBQNXSA-N	C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](OC(=O)CCN(C)C)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C	113462-26-3	Adenylate Cyclase Activators	ADCY1	ADCY2	ADCY3	ADCY5	ADCY6	ADCY7	ADCY8	ADCY4																									108	109	111	112	113	114	196883																																				444028	444029	24737635	57515963	132281295	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0	0	0	0	0																									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0																									7	7	7	7	7	7	7	7																									CS-0025284	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-006-069-046|MOABOX:4720|ADCY1|Adenylate Cyclase Activators	CN(C)CCC(=O)O[C@@H]1[C@H](OC(=O)C)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]3(C)[C@@H](O)CCC(C)(C)[C@H]13)C=C	138605-00-2	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468166	509.63222	NKH477	NKH477 | NKH477			MOABOX:4720	ADCY1	Adenylate Cyclase Activators
SJ001034997-1	SJ001034997	1	MOABOX:4724	RTRIXVOSRYRSBP-VXKWHMMOSA-N	c1ccc([C@@H]2CCC[C@@H]2NC2=NCCCCCCCCCCC2)cc1	40297-09-4	"""Adenylate Cyclase Inhibitors;Calcium Channel Blockers"";Adenylate Cyclase Inhibitors;Calcium Channel Blockers"	ADCY1	ADCY2	ADCY3	ADCY5	ADCY6	ADCY7	ADCY9	CACNA1C																									108	109	111	112	113	115	775																									CHEMBL119336											6917816	6917817	141248655			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0	0	0	0	0																									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0																									7	7	7	7	7	7	7	7																									14559	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-958-658|MOABOX:4724|ADCY1|\Adenylate Cyclase Inhibitors;Calcium Channel Blockers\;Adenylate Cyclase Inhibitors;Calcium Channel Blockers	C1CCCCC\N=C(/CCCCC1)\N[C@H]2CCC[C@H]2c3ccccc3	40297-09-4	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468448	340.54534	MDL 12330A HCL | RMI 12330A	"""MDL 12330A HCL | RMI 12330A"" | ""MDL 12330A HCL | RMI 12330A"""			MOABOX:4724	ADCY1	\Adenylate Cyclase Inhibitors;Calcium Channel Blockers\;Adenylate Cyclase Inhibitors;Calcium Channel Blockers
SJ000285970-7	SJ000285970	7	MOABOX:4728	WXFIGDLSSYIKKV-UHFFFAOYSA-N	CC(N)C(O)c1cccc(O)c1	20890-83-9	Adrenoceptor Agonists	ADRA1A																																																															CHEMBL1480611	CHEMBL29829										4087	36457	164761	5702237	74069939	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																KS-1368	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-035-395-286|MOABOX:4728|ADRA1A|Adrenoceptor Agonists	CC(N)C(O)c1cccc(O)c1	33402-03-8	NA	GENERAL	TARTRATE	1	NO_SOLVATE	0	1468358	167.20502	METARAMINOL BITARTRATE	METARAMINOL BITARTRATE | METARAMINOL BITARTRATE | | METARAMINOL BITARTRATE | METARAMINOL BITARTRATE |			MOABOX:4728	ADRA1A	Adrenoceptor Agonists
SJ000286181-8	SJ000286181	8	MOABOX:4756	PQLXHQMOHUQAKB-UHFFFAOYSA-O	CCCCCCCCCCCCCCCCOP(=O)(O)OCC[N+](C)(C)C	58066-85-6	"Angiogenesis Inhibitors, proliferation inhibitor"	PCYT1A																																																															CHEMBL513021	CHEMBL540150										3600	11812308				virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-13685	MCE	"MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; PI3K/Akt/mTOR | Research Area: Infection; Cancer | DISSOLVED IN EtOH|MOABOX:4756|PCYT1A|Angiogenesis Inhibitors, proliferation inhibitor"	CCCCCCCCCCCCCCCCOP(=O)(O)OCC[N+](C)(C)C	58066-85-6	12122	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469249	408.57594	MILTEFOSINE	MILTEFOSINE | MILTEFOSINE	Pathway: Anti-infection; PI3K/Akt/mTOR	Research Area: Infection; Cancer	MOABOX:4756	PCYT1A	
SJ001033497-2	SJ001033497	2	MOABOX:4758	DOUMFZQKYFQNTF-WUTVXBCWSA-N	O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O	20283-92-5	"""Angiogenesis Inhibitors;Antioxidants;4-aminobutyrate transaminase inhibitor"";Angiogenesis Inhibitors;Antioxidants;4-aminobutyrate transaminase inhibitor"	ABAT																																																															CHEMBL324842											5281792					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-N0529	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Metabolic Enzyme/Protease; Neuronal Signaling | Research Area: Cancer|MOABOX:4758|ABAT|\Angiogenesis Inhibitors;Antioxidants;4-aminobutyrate transaminase inhibitor\;Angiogenesis Inhibitors;Antioxidants;4-aminobutyrate transaminase inhibitor	OC(=O)[C@@H](Cc1ccc(O)c(O)c1)OC(=O)\C=C\c2ccc(O)c(O)c2	20283-92-5	79089	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469600	360.31484	ROSMARINIC ACID; LABIATENIC ACID	ROSMARINIC ACID; LABIATENIC ACID | ROSMARINIC ACID; LABIATENIC ACID	Pathway: Apoptosis; Metabolic Enzyme/Protease; Neuronal Signaling	Research Area: Cancer	MOABOX:4758	ABAT	\Angiogenesis Inhibitors;Antioxidants;4-aminobutyrate transaminase inhibitor\;Angiogenesis Inhibitors;Antioxidants;4-aminobutyrate transaminase inhibitor
SJ001034822-1	SJ001034822	1	MOABOX:4760	ZPANWZBSGMDWON-UHFFFAOYSA-N	Oc1ccc2ccccc2c1Cc1c(O)ccc2ccccc12	1096-84-0	Antiamyloidogenic Agents	APP																																																															CHEMBL447347											14187	18662867	67882163	69303961	69325604	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																EN300-17534	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-000-525-637|MOABOX:4760|APP|Antiamyloidogenic Agents	Oc1ccc2ccccc2c1Cc3c(O)ccc4ccccc34	1096-84-0	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468063	300.35054	EN300-17534	EN300-17534 | EN300-17534			MOABOX:4760	APP	Antiamyloidogenic Agents
SJ000574311-5	SJ000574311	5	MOABOX:4776	BDSYKGHYMJNPAB-LICBFIPMSA-N	CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	66852-54-8	Antiinflammatory Drugs	NR3C1																																																															CHEMBL1200908											6918178	87228809	87646751	87925019	88463813	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-B0878	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Others|MOABOX:4776|NR3C1|Antiinflammatory Drugs	CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl	66852-54-8	16382	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468911	484.96045	HALOBETASOL PROPIONATE	HALOBETASOL PROPIONATE | HALOBETASOL PROPIONATE	Pathway: Others	Research Area: Others	MOABOX:4776	NR3C1	Antiinflammatory Drugs
SJ000285185-24	SJ000285185	24	MOABOX:4820	WHTVZRBIWZFKQO-UHFFFAOYSA-N	CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12	117399-83-4	"""Thiamine uptake inhibitor;Apoptosis Inducers"";Thiamine uptake inhibitor;Apoptosis Inducers"	SLC19A3																																																															CHEMBL1326	CHEMBL1669	CHEMBL2095223	CHEMBL58510	CHEMBL76							2719	64927	71670	83818	83820	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																KH-0005	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466736	319.87214	CHLOROQUINE DIPHOSPHATE	CHLOROQUINE DIPHOSPHATE | CHLOROQUINE | CHLOROQUINE DIPHOSPHATE | CHLOROQUINE			MOABOX:4820	SLC19A3	"""Thiamine uptake inhibitor;Apoptosis Inducers"";Thiamine uptake inhibitor;Apoptosis Inducers"
SJ001034849-1	SJ001034849	1	MOABOX:4836	YEYAKZXEBSVURO-UHFFFAOYSA-N	CCN(CC)CCNC(=O)c1ccc(N)c(Cl)c1	891-60-1	"""Apoptosis Inducers;NF-kappaB (NFKB) Activation Inhibitors;5-HT3 antagonist"";Apoptosis Inducers;NF-kappaB (NFKB) Activation Inhibitors;5-HT3 antagonist"	HTR3A	HTR3B	HTR3C	HTR3E																													9177	170572	285242																													CHEMBL1618378											70177	22737404	69609243			virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0																													0.0	0.0	0.0	0.0																													7	7	7	7																													EN300-1425545	ENAMINE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-004-952-397|MOABOX:4836|HTR3A|\Apoptosis Inducers;NF-kappaB (NFKB) Activation Inhibitors;5-HT3 antagonist\;Apoptosis Inducers;NF-kappaB (NFKB) Activation Inhibitors;5-HT3 antagonist	CCN(CC)CCNC(=O)c1ccc(N)c(Cl)c1	891-60-1	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468094	269.7704	EN300-1425545	EN300-1425545 | EN300-1425545			MOABOX:4836	HTR3A	\Apoptosis Inducers;NF-kappaB (NFKB) Activation Inhibitors;5-HT3 antagonist\;Apoptosis Inducers;NF-kappaB (NFKB) Activation Inhibitors;5-HT3 antagonist
SJ000829764-9	SJ000829764	9	MOABOX:4886	JGPMMRGNQUBGND-UHFFFAOYSA-N	COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O	58186-27-9	"""Calcium Channel Modulators;Antioxidants"";Calcium Channel Modulators;Antioxidants"	CACNA1A	CACNA1B	CACNA1C	CACNA1D	CACNA1E	CACNA1F	CACNA1S	CACNB2	CACNB4	CACNG1	CACNA1I	CACNA1H	CACNA1G	CACNA2D2	CACNG3	CACNG2	CACNG5	CACNA2D3	CACNG8	CACNA2D4													774	775	776	777	778	779	783	785	786	8911	8912	8913	9254	10368	10369	27091	55799	59283	93589													CHEMBL252556											3686	21738284	56947658	66601259	66963067	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0													0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0													7	7	7	7	7	7	7	7	7	7	7	7	7	7	7	7	7	7	7	7													HY-N0303	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis | Research Area: Neurological Disease|MOABOX:4886|CACNA1A|\Calcium Channel Modulators;Antioxidants\;Calcium Channel Modulators;Antioxidants	COC1=C(OC)C(=O)C(=C(C)C1=O)CCCCCCCCCCO	58186-27-9	16989	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469456	338.4385	IDEBENONE	IDEBENONE | IDEBENONE	Pathway: Apoptosis	Research Area: Neurological Disease	MOABOX:4886	CACNA1A	\Calcium Channel Modulators;Antioxidants\;Calcium Channel Modulators;Antioxidants
SJ000287965-5	SJ000287965	5	MOABOX:4914	RNOJGTHBMJBOSP-UHFFFAOYSA-N	CC1(C2CCCC2)Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O	53108-00-2	Chloride Channel Blockers	CLCN3																																																															CHEMBL79956											3667					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																CS-3904	CHEMSCENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-941-766|MOABOX:4914|CLCN3|Chloride Channel Blockers	C[C@]1(Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O)C3CCCC3	54197-31-8	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468595	357.22842	(+)-(R)-IAA-94	(+)-(R)-IAA-94 | IAA-94 | (+)-(R)-IAA-94 | IAA-94			MOABOX:4914	CLCN3	Chloride Channel Blockers
SJ000840417-2	SJ000840417	2	MOABOX:4948	QPGYAMIHXLCFTJ-UHFFFAOYSA-N	COc1nc(-c2ccc3c(c2)OCO3)n(-c2ccc(NC(=O)CSc3ccccc3)cc2)n1	853625-60-2	Cytohesin Inhibitors	CYTH2	CYTH1																															9267																															CHEMBL1731533											1029232					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-100559	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis | Research Area: Endocrinology; Metabolic Disease; Cancer|MOABOX:4948|CYTH2|Cytohesin Inhibitors	COc1nc(c2ccc3OCOc3c2)n(n1)c4ccc(NC(=O)CSc5ccccc5)cc4	853625-60-2	27662	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469206	460.505	SECINH3	SECINH3 | SECINH3	Pathway: Apoptosis	Research Area: Endocrinology; Metabolic Disease; Cancer	MOABOX:4948	CYTH2	Cytohesin Inhibitors
SJ001033469-2	SJ001033469	2	MOABOX:5114	SDMBRCRVFFHJKR-UHFFFAOYSA-N	CC(C)(CCCCOCCCCC(C)(C)C(=O)O)C(=O)O	183293-82-5	"""HDL-Cholesterol Increasing Agents;PPAR Agonists"";HDL-Cholesterol Increasing Agents;PPAR Agonists"	PPARA	PPARG																															5468																															CHEMBL2110686											157692	140456129				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-109567	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Metabolic Disease; Inflammation/Immunology|MOABOX:5114|PPARA|\HDL-Cholesterol Increasing Agents;PPAR Agonists\;HDL-Cholesterol Increasing Agents;PPAR Agonists	CC(C)(CCCCOCCCCC(C)(C)C(=O)O)C(=O)O	183293-82-5	42796	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469684	302.4064	GEMCABENE; PD-72953	GEMCABENE; PD-72953 | GEMCABENE; PD-72953	Pathway: Others	Research Area: Metabolic Disease; Inflammation/Immunology	MOABOX:5114	PPARA	\HDL-Cholesterol Increasing Agents;PPAR Agonists\;HDL-Cholesterol Increasing Agents;PPAR Agonists
SJ000840366-2	SJ000840366	2	MOABOX:5134	HIXSPVQXXDULHS-UHFFFAOYSA-N	COc1cc2c(cc1OC)-c1cc3nc4ccccc4nc3n1C(C)(C)C2	163769-88-8	IL-5 Receptor Antagonists	IL5RA																																																															CHEMBL1356775											1103147					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-19969	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Immunology/Inflammation | Research Area: Inflammation/Immunology|MOABOX:5134|IL5RA|IL-5 Receptor Antagonists	COc1cc2CC(C)(C)n3c(cc4nc5ccccc5nc34)c2cc1OC	163769-88-8	34541	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469421	359.42104	YM 90709	YM 90709 | YM 90709	Pathway: Immunology/Inflammation	Research Area: Inflammation/Immunology	MOABOX:5134	IL5RA	IL-5 Receptor Antagonists
SJ001035068-1	SJ001035068	1	MOABOX:5164	UNIHFYPVOQQXMQ-UHFFFAOYSA-N	C=CCN(c1ccc(C)cc1)c1nc(=O)c2cccnc2s1	190843-45-9	Kainate Antagonists	GRIA1	GRIA2	GRIA3	GRIA4																													2891	2892	2893																													CHEMBL3403181											4140923					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0																													0.0	0.0	0.0	0.0																													7	7	7	7																													BTB08216	MAYBRIDGE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-009-013-824|MOABOX:5164|GRIA1|Kainate Antagonists	Cc1ccc(cc1)N(CC=C)C2=NC(=O)c3cccnc3S2	190843-45-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468576	309.3855	BTB08216	BTB08216 | BTB08216			MOABOX:5164	GRIA1	Kainate Antagonists
SJ001034826-1	SJ001034826	1	MOABOX:5166	KVDWOQGDMAEJLM-UHFFFAOYSA-N	Cc1c(-c2ccccc2F)[nH]c(N)c1C#N	186033-14-7	"Large Conductance K(Ca) 1.1 (BK, maxi K+) Channel Activators"	KCNMA1																																																															CHEMBL42661											10176749					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																EN300-254366	ENAMINE	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-005-943-258|MOABOX:5166|KCNMA1|Large Conductance K(Ca) 1.1 (BK, maxi K+) Channel Activators"	Cc1c(C#N)c(N)[nH]c1c2ccccc2F	186033-14-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468067	215.2263	EN300-254366	EN300-254366 | EN300-254366			MOABOX:5166	KCNMA1	"Large Conductance K(Ca) 1.1 (BK, maxi K+) Channel Activators"
SJ001035038-1	SJ001035038	1	MOABOX:5298	JMPOIZCOJJMTHI-UHFFFAOYSA-N	O=C(CCn1cnc2c(=O)[nH]cnc21)Nc1ccc(C(=O)O)cc1	138117-50-7	Neurotrophic Agents	ADA	PNP																															4860																															CHEMBL2104345											135409548	135745767	136403357	136428687	136428731	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															21748	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-046-426-202|MOABOX:5298|ADA|Neurotrophic Agents	OC(=O)c1ccc(NC(=O)CCn2cnc3C(=O)N=CNc23)cc1	192564-13-9	NA	GENERAL	POTASSIUM(I)	1	NO_SOLVATE	0	1468535	327.29482	LETEPRINIM POTASSIUM SALT | AIT 082	"""LETEPRINIM POTASSIUM SALT | AIT 082"" | ""LETEPRINIM POTASSIUM SALT | AIT 082"""			MOABOX:5298	ADA	Neurotrophic Agents
SJ000288059-4	SJ000288059	4	MOABOX:5312	XZYRDNUZENBYFI-UHFFFAOYSA-N	Nc1c[n+](N2CCOCC2)no1	16142-27-1	Nitric Oxide Donors	GUCY1A2	GUCY1A1	GUCY1B1																														2982	2983																														CHEMBL1594149	CHEMBL2361429										65388	197942	52947026	143412608		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0																														0.0	0.0	0.0																														7	7	7																														82220	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-824-638|MOABOX:5312|GUCY1A2|Nitric Oxide Donors	Nc1on[n+](c1)N2CCOCC2	16142-27-1	NA	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1468315	171.17714	3-MORPHOLINOSYDNONIMINE HYDROCHLORIDE	3-MORPHOLINOSYDNONIMINE HYDROCHLORIDE | 3-MORPHOLINOSYDNONIMINE HYDROCHLORIDE			MOABOX:5312	GUCY1A2	Nitric Oxide Donors
SJ001034996-1	SJ001034996	1	MOABOX:5316	MZAGXDHQGXUDDX-JSRXJHBZSA-N	CC/C(=C\C(=N\O)C(N)=O)C(C)[N+](=O)[O-]	163180-49-2	"""Nitric Oxide Donors;Soluble Guanylyl Cyclase (sGC) Activators"";Nitric Oxide Donors;Soluble Guanylyl Cyclase (sGC) Activators"	GUCY1A2	GUCY1A1	GUCY1B1																														2982	2983																														CHEMBL125865											6413529					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0																														0.0	0.0	0.0																														7	7	7																														82290	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-183-544|MOABOX:5316|GUCY1A2|\Nitric Oxide Donors;Soluble Guanylyl Cyclase (sGC) Activators\;Nitric Oxide Donors;Soluble Guanylyl Cyclase (sGC) Activators	CC\C(=C/C(=N/O)/C(=O)N)\C(C)[N+](=O)[O-]	138472-01-2	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468446	215.20652	FK-409 | NOR-3	"""FK-409 | NOR-3"" | ""FK-409 | NOR-3"""			MOABOX:5316	GUCY1A2	\Nitric Oxide Donors;Soluble Guanylyl Cyclase (sGC) Activators\;Nitric Oxide Donors;Soluble Guanylyl Cyclase (sGC) Activators
SJ001035101-1	SJ001035101	1	MOABOX:5348	WZBNEZWCNKUOSM-VOTSOKGWSA-N	O=C(/C=C/c1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12)Nc1ccccc1	153436-22-7	NMDA Glycine-Site Antagonists	GRIN1																																																															CHEMBL44793											6450546	20843183	89921964			virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					6.93e-002																																0.0099																																7																																32845	CAYMAN	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-023-276-404|MOABOX:5348|GRIN1|NMDA Glycine-Site Antagonists	OC(=O)c1[nH]c2cc(Cl)cc(Cl)c2c1\C=C\C(=O)Nc3ccccc3	153436-38-5	NA	GENERAL	SODIUM(I)	1	NO_SOLVATE	0	1468691	375.20548	GAVESTINEL SODIUM SALT | GV150526A	"""GAVESTINEL SODIUM SALT | GV150526A"" | ""GAVESTINEL SODIUM SALT | GV150526A"""			MOABOX:5348	GRIN1	NMDA Glycine-Site Antagonists
SJ000288265-6	SJ000288265	6	MOABOX:5398	PWLXJBSAUKKGCM-UHFFFAOYSA-N	S=C(S)OC1CC2CC1C1CCCC21	83373-60-8	"""Phospholipase C Inhibitors;Antioxidants"";Phospholipase C Inhibitors;Antioxidants"	PLCG1	SGMS1																															259230																															CHEMBL1161894											2941	45479729				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	4.48e-003																															0.0	0.00064																															7	7																															HY-70072	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:5398|PLCG1|\Phospholipase C Inhibitors;Antioxidants\;Phospholipase C Inhibitors;Antioxidants	SC(=S)OC1CC2CC1C3CCCC23	83373-60-8	2398	GENERAL	POTASSIUM(I)	1	NO_SOLVATE	0	1469703	228.37414	D-609 POTASSIUM	D-609 POTASSIUM | D609 | D-609 POTASSIUM | D609	Pathway: Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:5398	PLCG1	\Phospholipase C Inhibitors;Antioxidants\;Phospholipase C Inhibitors;Antioxidants
SJ001034961-1	SJ001034961	1	MOABOX:5410	ULYONBAOIMCNEH-UHFFFAOYSA-N	COc1ccc(Cl)cc1C1(F)C(=O)Nc2cc(C(F)(F)F)ccc21	183720-28-7	"Large Conductance K(Ca) 1.1 (BK, maxi K+) Channel Activators"	KCNMA1																																																															CHEMBL7662											9885204	142810665	142810668			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																1112	AXON_MEDCHEM	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-035-765-895|MOABOX:5410|KCNMA1|Large Conductance K(Ca) 1.1 (BK, maxi K+) Channel Activators"	COc1ccc(Cl)cc1[C@]2(F)C(=O)Nc3cc(ccc23)C(F)(F)F	1837523-35-9	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468378	359.70271	BMS 204352 | FLINDOKALNER | BMS 204352	"""BMS 204352 | FLINDOKALNER | BMS 204352"" | ""BMS 204352 | FLINDOKALNER | BMS 204352"""			MOABOX:5410	KCNMA1	"Large Conductance K(Ca) 1.1 (BK, maxi K+) Channel Activators"
SJ000287502-4	SJ000287502	4	MOABOX:5430	GSNOZLZNQMLSKJ-UHFFFAOYSA-N	CCN(CC)c1cc(C)nc2ncnn12	15421-84-8	Platelet activating factor receptor antagonist	PDGFRA																																																															CHEMBL132767											5531	66871592	69783804	131988636		member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-B1016	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cardiovascular Disease; Cancer|MOABOX:5430|PDGFRA|Platelet activating factor receptor antagonist	CCN(CC)c1cc(C)nc2ncnn12	15421-84-8	22656	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469719	205.2596	TRAPIDIL	TRAPIDIL | TRAPIDIL	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cardiovascular Disease; Cancer	MOABOX:5430	PDGFRA	Platelet activating factor receptor antagonist
SJ000287221-3	SJ000287221	3	MOABOX:5480	XEAQIWGXBXCYFX-BQYQJAHWSA-N	COC1=CC(=O)OC(/C=C/c2ccccc2)C1	1635-33-2	"""Sodium Channel  Blockers;Calcium Channel Modulators;advanced lipoxidation endproduct inhibitors"";Sodium Channel  Blockers;Calcium Channel Modulators;advanced lipoxidation endproduct inhibitors"	CACNA1C	CACNA1D	CACNA1F	CACNA1S																													776	778	779																													CHEMBL1482039											5369129	6444199	90477129			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0																													0.0	0.0	0.0	0.0																													7	7	7	7																													AG00BXRB	ANGENE	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-003-937-647|MOABOX:5480|CACNA1C|\Sodium Channel Blockers;Calcium Channel Modulators;advanced lipoxidation endproduct inhibitors\;Sodium Channel Blockers;Calcium Channel Modulators;advanced lipoxidation endproduct inhibitors	COC1=CC(=O)O[C@H](C1)\C=C\c2ccccc2	3155-48-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468214	230.25916	KAWAIN	KAWAIN | KAWAIN			MOABOX:5480	CACNA1C	\Sodium Channel Blockers;Calcium Channel Modulators;advanced lipoxidation endproduct inhibitors\;Sodium Channel Blockers;Calcium Channel Modulators;advanced lipoxidation endproduct inhibitors
SJ000773196-4	SJ000773196	4	MOABOX:5544	LZAXPYOBKSJSEX-GOSISDBHSA-N	Cc1ccc2c(c1)C(=O)[C@]1(O)CCN(c3ccccc3)C1=N2	856925-71-8	"""MYH9 gene inhibitor;MYH10 gene inhibitor"";MYH9 gene inhibitor;MYH10 gene inhibitor"	MYH9	MYH10																															4628																															CHEMBL1231358											5287792					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-13441	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cytoskeleton | Research Area: Cardiovascular Disease; Cancer|MOABOX:5544|MYH9|\MYH9 gene inhibitor;MYH10 gene inhibitor\;MYH9 gene inhibitor;MYH10 gene inhibitor	Cc1ccc2N=C3N(CC[C@@]3(O)C(=O)c2c1)c4ccccc4	856925-71-8	64063	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469034	292.33184	(-)-BLEBBISTATIN | (-)-S-BLEBBISTATIN |	"""(-)-BLEBBISTATIN | (-)-S-BLEBBISTATIN |"" | (-)-BLEBBISTATIN | ""(-)-BLEBBISTATIN | (-)-S-BLEBBISTATIN |"" | (-)-BLEBBISTATIN"	Pathway: Cytoskeleton	Research Area: Cardiovascular Disease; Cancer	MOABOX:5544	MYH9	\MYH9 gene inhibitor;MYH10 gene inhibitor\;MYH9 gene inhibitor;MYH10 gene inhibitor
SJ001011175-2	SJ001011175	2	MOABOX:5851	KWJRSHZSULRJHE-UHFFFAOYSA-N	Cc1ccc(OCCSc2ncccn2)c(Br)c1	723249-01-2	"""AMP-Activated Protein Kinase (AMPK) Activators;PRKA gene stimulator"";AMP-Activated Protein Kinase (AMPK) Activators;PRKA gene stimulator"	PRKAA1	PRKAA2	PRKAB1	PRKAB2																													5563	5564	5565																																								1825716	91654626				member	10.1016/j.bmcl.2019.07.035																																																																																																																																																															31358465																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0.7777	0	0.7777	0																													0.1111	0.0	0.1111	0.0																													7	7	7	7																													HY-16708A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Epigenetics; PI3K/Akt/mTOR | Research Area: Metabolic Disease|MOABOX:5851|PRKAA1|\AMP-Activated Protein Kinase (AMPK) Activators;PRKA gene stimulator\;AMP-Activated Protein Kinase (AMPK) Activators;PRKA gene stimulator	Cc1ccc(OCCSc2ncccn2)c(Br)c1	1883548-91-1	14644	GENERAL	CHLORIDE	1	NO_SOLVATE	0	1469683	325.22412	ZLN024 (HYDROCHLORIDE)	ZLN024 (HYDROCHLORIDE) | ZLN024 (HYDROCHLORIDE)	Pathway: Epigenetics; PI3K/Akt/mTOR	Research Area: Metabolic Disease	MOABOX:5851	PRKAA1	\AMP-Activated Protein Kinase (AMPK) Activators;PRKA gene stimulator\;AMP-Activated Protein Kinase (AMPK) Activators;PRKA gene stimulator
SJ000053334-2	SJ000053334	2	MOABOX:5852	UXRKUKRXVWJFER-UHFFFAOYSA-N	Cc1[nH]c2ccccc2c1CCNC(=O)c1ccccc1F	442633-00-3	ARP2/3 Complex inhibitor	ACTR3	ACTR2																															10097																																										589075					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-16926	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cytoskeleton | Research Area: Cancer; Infection|MOABOX:5852|ACTR3|ARP2/3 Complex inhibitor	Cc1[nH]c2ccccc2c1CCNC(=O)c3ccccc3F	442633-00-3	43192	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469871	296.33878			Pathway: Cytoskeleton	Research Area: Cancer; Infection	MOABOX:5852	ACTR3	ARP2/3 Complex inhibitor
SJ001035231-1	SJ001035231	1	MOABOX:5853	MVWNPZYLNLATCH-UHFFFAOYSA-N	COc1ccc(N2C(=O)CSC2c2cccc(Br)c2)c(OC)c1	388592-44-7	Arp2/3 Complex inhibitor	ACTR3	ACTR2																															10097																															CHEMBL3261538											3574452					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-16927	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cytoskeleton | Research Area: Cancer|MOABOX:5853|ACTR3|Arp2/3 Complex inhibitor	COc1ccc(N2C(SCC2=O)c3cccc(Br)c3)c(OC)c1	388592-44-7	34260	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469224	394.28284	CK-869	CK-869 | CK-869	Pathway: Cytoskeleton	Research Area: Cancer	MOABOX:5853	ACTR3	Arp2/3 Complex inhibitor
SJ000852523-3	SJ000852523	3	MOABOX:6068	OFEZSBMBBKLLBJ-BAJZRUMYSA-N	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)C[C@H]1O	73-03-0	PAPOLA gene inhibitor	POLA1	POLB	POLG	PAPOLA	POLA2																												5423	5428	10914	23649																												CHEMBL305686											6303	23624181	53234646	53234647	53234723	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0	0																												0.0	0.0	0.0	0.0	0.0																												7	7	7	7	7																												HY-N0262	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Anti-infection; Autophagy; Metabolic Enzyme/Protease | Research Area: Cancer; Infection; Inflammation/Immunology|MOABOX:6068|POLA1|PAPOLA gene inhibitor	Nc1ncnc2c1ncn2[C@@H]3O[C@H](CO)C[C@H]3O	73-03-0	98025	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469340	251.24192	CORDYCEPIN	CORDYCEPIN | CORDYCEPIN	Pathway: Anti-infection; Autophagy; Metabolic Enzyme/Protease	Research Area: Cancer; Infection; Inflammation/Immunology	MOABOX:6068	POLA1	PAPOLA gene inhibitor
SJ000855457-3	SJ000855457	3	MOABOX:6383	SNMCWIDCSPHZRD-UHFFFAOYSA-N	COc1c(C)c(C(=O)c2ccc(N)c(C(=O)O)c2)n2ccccc12	848318-25-2	Allosteric inhibitor binding extracellular domain	FGFR3	FGFR2	FGFR4																														2263	2264																																									11347895	141606974				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0.23471	0																														0.0	0.03353	0.0																														7	7	7																														HY-15599	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Protein Tyrosine Kinase/RTK | Research Area: Cancer|MOABOX:6383|FGFR3|Allosteric inhibitor binding extracellular domain	COc1c(C)c(C(=O)c2ccc(N)c(c2)C(=O)O)n3ccccc13	848318-25-2	14185	GENERAL	SODIUM(I)	1	NO_SOLVATE	0	1469272	324.33064	SSR128129E	SSR128129E | SSR128129E	Pathway: Protein Tyrosine Kinase/RTK	Research Area: Cancer	MOABOX:6383	FGFR3	Allosteric inhibitor binding extracellular domain
SJ000796039-4	SJ000796039	4	MOABOX:6623	NZJKEVWTYMOYOR-UHFFFAOYSA-N	COc1cc(-n2c(S)nc3ccccc3c2=O)c(Cl)cc1Cl	338967-87-6	Inhibits mitochondrial division by inhibiting Dynamin	DNM1	DNM2																															1785																															CHEMBL1449747											3825829	71466728				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-15886	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Apoptosis; Autophagy; Cytoskeleton | Research Area: Cancer|MOABOX:6623|DNM1|Inhibits mitochondrial division by inhibiting Dynamin	COc1cc(N2C(=Nc3ccccc3C2=O)S)c(Cl)cc1Cl	338967-87-6	23337	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469782	353.2231	MDIVI-1 | MITOCHONDRIAL DIVISION INHIBITOR | MITOCHONDRIAL DIVISION DNM1/DRP1 ATPASE INHIBITOR | MFISI-1 |	"""MDIVI-1 | MITOCHONDRIAL DIVISION INHIBITOR | MITOCHONDRIAL DIVISION DNM1/DRP1 ATPASE INHIBITOR | MFISI-1 |"" | MDIVI-1 | ""MDIVI-1 | MITOCHONDRIAL DIVISION INHIBITOR | MITOCHONDRIAL DIVISION DNM1/DRP1 ATPASE INHIBITOR | MFISI-1 |"" | MDIVI-1"	Pathway: Apoptosis; Autophagy; Cytoskeleton	Research Area: Cancer	MOABOX:6623	DNM1	Inhibits mitochondrial division by inhibiting Dynamin
SJ000986039-3	SJ000986039	3	MOABOX:6640	QRLPSNLBUMVXBL-UHFFFAOYSA-N	CCOC(=O)c1c(NC(=O)CC2Nc3cc(C)c(C)cc3NC2=O)sc(C)c1C	307519-88-6	SMG7 Inhibitor	SMG7																																																															CHEMBL1585886											2886617					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-111374	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Cancer|MOABOX:6640|SMG7|SMG7 Inhibitor	CCOC(=O)c1c(C)c(C)sc1NC(=O)CC2Nc3cc(C)c(C)cc3NC2=O	307519-88-6	29954	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469216	415.5059	NMDI-14 | NMDI14	"""NMDI-14 | NMDI14"" | ""NMDI-14 | NMDI14"""	Pathway: Others	Research Area: Cancer	MOABOX:6640	SMG7	SMG7 Inhibitor
SJ001035301-1	SJ001035301	1	MOABOX:6748	FAZZYPIBZBGQSH-UHFFFAOYSA-N	CCc1cccc2c1N(C)Cc1cc3c(cc1-2)OCO3	854847-61-3	"""AXIN auto-inhibition inhibitor;Wnt pathway activator"";AXIN auto-inhibition inhibitor;Wnt pathway activator"	AXIN1	AXIN2																															8313																															CHEMBL223713											44422459					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															HY-122816	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Stem Cell/Wnt | Research Area: Cancer; Neurological Disease|MOABOX:6748|AXIN1|\AXIN auto-inhibition inhibitor;Wnt pathway activator\;AXIN auto-inhibition inhibitor;Wnt pathway activator	CCc1cccc2c3cc4OCOc4cc3CN(C)c12	854847-61-3	61983	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469531	267.32238	HLY78	HLY78 | HLY78	Pathway: Stem Cell/Wnt	Research Area: Cancer; Neurological Disease	MOABOX:6748	AXIN1	\AXIN auto-inhibition inhibitor;Wnt pathway activator\;AXIN auto-inhibition inhibitor;Wnt pathway activator
SJ000831450-9	SJ000831450	9	MOABOX:6913	RTRQQBHATOEIAF-UUOKFMHZSA-N	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1N	2627-69-2	"""AMP activated protein kinase stimulator;AMPK Activator"";AMP activated protein kinase stimulator;AMPK Activator"	PRKAG1	PRKAG2	PRKAG3																														51422	53632																														CHEMBL1551724											17513	9823500	16077667	16077669	16077672	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0																														0.0	0.0	0.0																														7	7	7																														HY-13417	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Epigenetics; PI3K/Akt/mTOR; Stem Cell/Wnt | Research Area: Cancer|MOABOX:6913|PRKAG1|\AMP activated protein kinase stimulator;AMPK Activator\;AMP activated protein kinase stimulator;AMPK Activator	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1N	2627-69-2	38929	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469794	258.23126	AICAR	AICAR | ACADESINE | AICAR | ACADESINE	Pathway: Autophagy; Epigenetics; PI3K/Akt/mTOR; Stem Cell/Wnt	Research Area: Cancer	MOABOX:6913	PRKAG1	\AMP activated protein kinase stimulator;AMPK Activator\;AMP activated protein kinase stimulator;AMPK Activator
SJ001034959-1	SJ001034959	1	MOABOX:6958	RZRWBKKAFHXNEQ-UHFFFAOYSA-N	CS(=O)(=O)c1ccccc1S(=O)(=O)NO		"activation for sGC, oxidation of sulfides for others"	ATP2A2	CTSB	GAPDH	GUCY1A1	PLN																												1508	2597	2982	5350																																							52939580					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0	0																												0.0	0.0	0.0	0.0	0.0																												7	7	7	7	7																												2653	AXON_MEDCHEM	"MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-044-562-362|MOABOX:6958|ATP2A2|activation for sGC, oxidation of sulfides for others"	CS(=O)(=O)c1ccccc1S(=O)(=O)NO	950834-06-7	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468374	251.28006	CXL-1020 | 2-MSPA	"""CXL-1020 | 2-MSPA"" | ""CXL-1020 | 2-MSPA"""			MOABOX:6958	ATP2A2	"activation for sGC, oxidation of sulfides for others"
SJ001035241-1	SJ001035241	1	MOABOX:7087	ZACWYYKZMLGOTG-UHFFFAOYSA-N	CCN1CCC(c2cc(C)c3nc(-c4cc5c(C)nc(C)cn5n4)cc(=O)n3c2)CC1		splicing modulator	RNU1-4	SNRPC	RNU1-3	RNU1-2	RNU1-1																												6631	26869	26870	26871																																							89741632					virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0	0	0	0																												0.0	0.0	0.0	0.0	0.0																												7	7	7	7	7																												HY-112633	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage | Research Area: Others | DISSOLVED IN EtOH|MOABOX:7087|RNU1-4|splicing modulator	CCN1CCC(CC1)C2=CN3C(=O)C=C(N=C3C(=C2)C)c4cc5c(C)nc(C)cn5n4	1449597-34-5	38859	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469250	416.51872	SMN-C3	SMN-C3 | SMN-C3	Pathway: Cell Cycle/DNA Damage	Research Area: Others	MOABOX:7087	RNU1-4	
SJ000560617-10	SJ000560617	10	MOABOX:7129	HYFHYPWGAURHIV-JFIAXGOJSA-N	COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4	26833-87-4	"""Translation inhibitor;treatment of orphan leukemia;Elongation inhibitor;Treatment of orphan leukemia"";Translation inhibitor;treatment of orphan leukemia;Elongation inhibitor;Treatment of orphan leukemia"	EIF4E																																																															CHEMBL46286											285033	9810039	9851264	45375962	91824178	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-14944	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: JAK/STAT Signaling; Stem Cell/Wnt | Research Area: Cancer|MOABOX:7129|EIF4E|\Translation inhibitor;treatment of orphan leukemia;Elongation inhibitor;Treatment of orphan leukemia\;Translation inhibitor;treatment of orphan leukemia;Elongation inhibitor;Treatment of orphan leukemia	COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@H]1[C@H]2c3cc4OCOc4cc3CCN5CCC[C@]25C=C1OC	26833-87-4	61847	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469122	545.62126	HOMOHARRINGTONINE	"HOMOHARRINGTONINE | ""HOMOHARRINGTONINE | OMACETAXINE"" | HOMOHARRINGTONINE | ""HOMOHARRINGTONINE | OMACETAXINE"""	Pathway: JAK/STAT Signaling; Stem Cell/Wnt	Research Area: Cancer	MOABOX:7129	EIF4E	\Translation inhibitor;treatment of orphan leukemia;Elongation inhibitor;Treatment of orphan leukemia\;Translation inhibitor;treatment of orphan leukemia;Elongation inhibitor;Treatment of orphan leukemia
SJ001035354-1	SJ001035354	1	MOABOX:7328	WBYNZQXAAWPAGR-UHFFFAOYSA-N	CC(C)Oc1cc(Cl)ccc1CNc1cc(-c2ccccc2)nc2ncnn12		GPR3 inverse agonist	GPR3																																																																										125286314					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-12664	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Others | Research Area: Others|MOABOX:7328|GPR3|GPR3 inverse agonist	CC(C)Oc1cc(Cl)ccc1CNc2cc(nc3ncnn23)c4ccccc4	1637300-25-4	33324	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469685	393.8694	AF64394	AF64394 | AF64394	Pathway: Others	Research Area: Others	MOABOX:7328	GPR3	GPR3 inverse agonist
SJ001034865-1	SJ001034865	1	MOABOX:7368	ZUQIFHLBPBLRRM-QPJJXVBHSA-N	NS(=O)(=O)c1ccc(NC(=S)N2CCN(C/C=C/c3ccccc3)CC2)cc1		CTNNBIP1 gene inhibitor	CTNNB1	TCF4																															6925																																										1213452					member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0	0																															0.0	0.0																															7	7																															STK143540	VITASM	MOA LIBRARY PURCHASED 2021 FROM MOLPORT | Molport ID: MolPort-002-252-980|MOABOX:7368|CTNNB1|CTNNBIP1 gene inhibitor	NS(=O)(=O)c1ccc(NC(=S)N2CCN(C\C=C\c3ccccc3)CC2)cc1	664969-54-4	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468120	416.56016	STK143540	STK143540 | STK143540			MOABOX:7368	CTNNB1	CTNNBIP1 gene inhibitor
SJ000286663-9	SJ000286663	9	MOABOX:7495	FPIPGXGPPPQFEQ-OVSJKPMPSA-N	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1	11103-57-4	1 Epidermal  transglutaminase inhibitor	TGM1																																																															CHEMBL3137697	CHEMBL986										445354	9822120	10269411	11319502	11626097	virtual																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																BS-17906	KEY_ORGANICS	MOA LIBRARY PURCHASED 2021	C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C	NA	NA	GENERAL	NO_SALT	0	NO_SOLVATE	0	1466781	286.4516	RETINOL	RETINOL | ALL-TRANS-RETINOL | 13-CIS-RETINOL | RETINOL | ALL-TRANS-RETINOL | 13-CIS-RETINOL			MOABOX:7495	TGM1	1 Epidermal  transglutaminase inhibitor
SJ000546519-5	SJ000546519	5	MOABOX:7542	LDGIHZJOIQSHPB-UHFFFAOYSA-N	O=C(O)c1ccc2cc(-c3ccc(O)c(C45CC6CC(CC(C6)C4)C5)c3)ccc2c1	125316-60-1	POLA1 inhibitor	POLA1																																																															CHEMBL1180											135411	143380628				member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-100532	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Autophagy; Metabolic Enzyme/Protease | Research Area: Cancer|MOABOX:7542|POLA1|POLA1 inhibitor	OC(=O)c1ccc2cc(ccc2c1)c3ccc(O)c(c3)C45CC6CC(CC(C6)C4)C5	125316-60-1	28961	GENERAL	NO_SALT	0	NO_SOLVATE	0	1468937	398.49354	CD 437	"CD 437 | ""CD437 | AHPN"" | ""CD-437 | AHPN | AGN-192837 |"" | CD 437 | ""CD437 | AHPN"" | ""CD-437 | AHPN | AGN-192837 |"""	Pathway: Autophagy; Metabolic Enzyme/Protease	Research Area: Cancer	MOABOX:7542	POLA1	POLA1 inhibitor
SJ001001492-3	SJ001001492	3	MOABOX:17034	PEKZLFZZBGBOPJ-UHFFFAOYSA-N	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3C)c2cc1OC	2002381-25-9		KSR1																																																																										121499159	122177134	122624385			member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-100627	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: MAPK/ERK Pathway | Research Area: Cancer|MOABOX:17034|KSR1|	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3C)c2cc1OC	2002381-25-9	22025	GENERAL	NO_SALT	0	NO_SOLVATE	0	1469203	387.43114	APS-2-79	APS-2-79 | APS-2-79	Pathway: MAPK/ERK Pathway	Research Area: Cancer	MOABOX:17034	KSR1	
SJ001035152-1	SJ001035152	1	MOABOX:19068	SGEIEGAXKLMUIZ-XUVDNFPMSA-N	[O-][n+]1cccc(/C(Cl)=N/OC[C@H](O)CN2CCCCC2)c1	289893-25-0	HSP70 co-inducer or chaperone	HSPA1A																																																															CHEMBL2107726											9568077	9867325	11489015	24763557	134715630	member																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					0																																0.0																																7																																HY-106443A	MCE	MOA LIBRARY PURCHASED IN 2021 | Pathway: Cell Cycle/DNA Damage; Metabolic Enzyme/Protease | Research Area: Metabolic Disease; Inflammation/Immunology; Neurological Disease|MOABOX:19068|HSPA1A|HSP70 co-inducer or chaperone	O[C@@H](CO\N=C(/Cl)\c1ccc[n+]([O-])c1)CN2CCCCC2	289893-26-1	56942	GENERAL	MALEATE	1	NO_SOLVATE	0	1468932	313.7799	ARIMOCLOMOL MALEATE | BRX-220	"""ARIMOCLOMOL MALEATE | BRX-220"" | ""ARIMOCLOMOL MALEATE | BRX-220"""	Pathway: Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Research Area: Metabolic Disease; Inflammation/Immunology; Neurological Disease	MOABOX:19068	HSPA1A	HSP70 co-inducer or chaperone
